Citrus Sinensis ID: 013636

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------44
Protein Sequence
MNMKKLLGLLLPMWAFFFSLFLSTLVAKPDTDISFVFGSLKEPISQFSAEMEAESPGIAEVRVVNHQDLNKKILIALVVSSTLLGVLLLFLLCFWIYRWKRLKNTNGNSKQTIDGGKGLSLSPILERFNSLRLAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPTDLGGSLRVT
Secondary Structure (PSIPRED)
cccHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccEEcHHHHHHHHcccccccEEccccccEEEEEEEccccEEEEEEccccccccHHHHHHHHHHHHcccccccccEEEEEEcccEEEEEEEEcccccHHHHcccccccccccHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccccHHHEEEccccccccHHHcccccccccccEEEEccccccHHHcccccccccEEEcccccccccccccccHEEEHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccEcHHHHHHHHccEEEEEEEEccccccEEEEEcccccEEEEEEEcccccccHHHHHHHHHHHHHHHHHHHHHHHEEEcccccEEEEEEEcccccHHHHHccccccccccHHHHHHHHHHHHHHHHHHHHccHcccccccccHHHEEEcccccEEEccccccccccHHHHHcccccccccccHHHHcccccccHHHHHHHHHHHHHHHccccccccccccccHHHHHHHHHHHHHcccHHHHccHcccccccHHHHHHHHHHHHHHccccHcccccHHHHHHHHHccccccccccEEEc
Coil and Loop (DISEMBL)
MNMKKLLGLLLPMWAFFFSLFLSTlvakpdtdisfvfgslkepisqfsaemeaespgiaEVRVVNHQDLNKKILIALVVSSTLLGVLLLFLLCFWIYRWKRlkntngnskqtidggkglslsPILERFNSlrlagkkdtVSVIEYELLEAAtnnfqesnvigeggrghvYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNgslekqlhgpthgsnlTWHLRMKIAVDVARGLEYLhehcnhpvvhrdlkssnilldssfnaklsdfglsvtagtqsrnvkisgtlgyvapeyllegkltdksdvYAFGVVLLELLmgrrpvekmsptqcQSMVTwampqltdrsklpnivdpvirdtmdLKHLYQVAAVAVLCiqpepsyrplITDVLHSliplvptdlggslrvt
Flexible Loop (DISEMBL)
MNMKKLLGLLLPMWAFFFSLFLSTLVAKPDTDISFVFGSLKEPISQFSAEMEAESPGIAEVRVVNHQDLNKKILIALVVSSTLLGVLLLFLLCFWIYRWKRLkntngnskqtidggkglslsPILERFNSLRLAGKKDTVSVIEYELLEaatnnfqesnvigeggrGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSvtagtqsrnvkisgTLGYVAPEYLLEgkltdksdVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWampqltdrskLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLiplvptdlggslrvt
Low Complexity Region (SEG)
MNMKKLLGLLLPMWAFFFSLFLSTLVAKPDTDISFVFGSLKEPISQFSAEMEAESPGIAEVRVVNHQDLNKKILIAlvvsstllgvlllfllCFWIYRWKRLKNTNGNSKQTIDGGKGLSLSPILERFNSLRLAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPTDLGGSLRVT
Disordered region (IsUnstruct)
*****LLGLLLPMWAFFFSLFLSTLVAKPDTDISFVFGSLKEPI************GIAEVRVVNHQDLNKKILIALVVSSTLLGVLLLFLLCFWIYRWKRLKNTN******I*GGKGLSLSPILERFNSLRLAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKM*PTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPTDL*******
Disordered Region (DISOPRED)
***KKLLGLLLPMWAFFFSLFLSTLV************************************************IALVVSSTLLGVLLLFLLCFW**********************************************VIEYELLEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVE*****QCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVP**********
Disordered Region (DISEMBL)
MNMKKLLGLLLPMWAFFFSLFLSTLVAKPDTDISFVFGSLKEPISQFSAEMEAESPGIAEVRVVNHQDLNKKILIALVVSSTLLGVLLLFLLCFWIYRWKRLKNTNGNSKQTIDGGKGLSLSPILERFNSLRLAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPTDLGGSLRVT
Disordered Region (DISPRO)
MNMKKLLGLLLPMWAFFFSLFLSTLVAKPDTDISFVFGSLKEPISQFSAEMEAESPGIAEVRVVNHQDLNKKILIALVVSSTLLGVLLLFLLCFWIYRWKRL************************************TVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPTDLGGSLRVT
Transmembrane Helix (TMHMM)
iiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
ooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MNMKKLLGLLLPMWAFFFSLFLSTLVAKPDTDISFVFGSLKEPISQFSAEMEAESPGIAEVRVVNHQDLNKKILIALVVSSTLLGVLLLFLLCFWIYRWKRLKNTNGNSKQTIDGGKGLSLSPILERFNSLRLAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPTDLGGSLRVT
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	439	2.2.26 [Sep-21-2011]
Q0V7T5	427	Probable receptor-like pr	yes	no	0.961	0.988	0.577	1e-142
Q8RWW0	744	Receptor-like serine/thre	no	no	0.842	0.497	0.363	5e-68
Q9FE20	456	Serine/threonine-protein	no	no	0.637	0.614	0.463	4e-67
Q6R2J8	703	Protein STRUBBELIG-RECEPT	no	no	0.660	0.412	0.444	2e-65
Q9SFT7	414	Serine/threonine-protein	no	no	0.651	0.690	0.443	8e-65
Q9LQQ8	423	Probable serine/threonine	no	no	0.660	0.685	0.421	2e-64
Q1PEM5	513	Proline-rich receptor-lik	no	no	0.662	0.567	0.429	2e-63
Q8GXZ3	410	Serine/threonine-protein	no	no	0.649	0.695	0.435	2e-63
Q9FX99	663	Probable receptor-like pr	no	no	0.794	0.526	0.397	4e-63
Q9LK03	717	Proline-rich receptor-lik	no	no	0.660	0.404	0.417	9e-63

>sp|Q0V7T5|Y1864_ARATH Probable receptor-like protein kinase At1g80640 OS=Arabidopsis thaliana GN=At1g80640 PE=2 SV=1

 Score =  505 bits (1300), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 251/435 (57%), Positives = 328/435 (75%), Gaps = 13/435 (2%)

Query: 6   LLGLLLPMWAFFFSLFLSTLVAKPDTDISFVFGSLKE-PISQFSAEMEAESPGIAEVRVV 64
           LL  LLP+W      F ST     ++ + +V G+  E PISQ S  M A+SPG   V+VV
Sbjct: 3   LLRHLLPIWVLLGFFFFSTATKSQESSVVYVSGASPEIPISQASPRMGAQSPGPPIVKVV 62

Query: 65  NHQDLNKKILIALVVSSTLLGVLLLFLLCFWIYRWKRLKNTNGNSKQTIDGGKGLSLSPI 124
             QDLNKKILIAL+VSS+LL V ++FL+   ++R++ +KN+    K+  D  K ++  P 
Sbjct: 63  LRQDLNKKILIALIVSSSLLCVTVMFLVYLLLWRYRNMKNSFTGIKRKSDSVKSVTTKPT 122

Query: 125 LERFNSLRLAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKR 184
           + + +S+R    K T+ V EY+LLE+ATN F +SNV+  GGRG +Y+A  +EK    VK+
Sbjct: 123 VHKIDSVR----KGTIPVYEYQLLESATNKFSDSNVLSRGGRGCLYRACLDEKSSVTVKK 178

Query: 185 IDDAGH-DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGP 243
           +D  G  D E++F  EV+WL KIRHQNI+SLLG+C++ +T  +VYE+MQNGSLE QLHGP
Sbjct: 179 LDGGGETDIEKQFETEVDWLAKIRHQNIVSLLGFCVYRQTSCIVYELMQNGSLESQLHGP 238

Query: 244 THGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSV 303
           + GS LTW LRMKIAVD+ARGLEYLHEHC+ PVVHRDLKSS+ILLDS FNAK+SDFG + 
Sbjct: 239 SQGSGLTWQLRMKIAVDIARGLEYLHEHCHPPVVHRDLKSSSILLDSDFNAKISDFGFAT 298

Query: 304 TAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQ 363
              TQ++N      L + A E LL+GK+TDK+DVY+FGV+LLELL+G++ VEK S ++ +
Sbjct: 299 VLTTQNKN------LIHKASEDLLDGKVTDKNDVYSFGVILLELLLGKKSVEKPS-SEPE 351

Query: 364 SMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS 423
           S+VTWA+P+L+DR+ LPNI+DP I+ TMDLKHLYQVAAVAVLC+QPEPSYRPLITDVLHS
Sbjct: 352 SIVTWAVPKLSDRANLPNILDPAIKGTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 411

Query: 424 LIPLVPTDLGGSLRV 438
           LIPL+P +LGGSLR+
Sbjct: 412 LIPLLPVELGGSLRI 426

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q8RWW0|ALE2_ARATH Receptor-like serine/threonine-protein kinase ALE2 OS=Arabidopsis thaliana GN=ALE2 PE=1 SV=1

 Score =  258 bits (660), Expect = 5e-68,   Method: Compositional matrix adjust.
 Identities = 148/407 (36%), Positives = 222/407 (54%), Gaps = 37/407 (9%)

Query: 43  PISQFSAEMEAESPGIAEVRVVNHQDLNKKI-----LIALVVSSTLLGVLLLFLLCFWIY 97
           P S  + ++  ++PG   + +      NK        IA++  S  + +L+L      I 
Sbjct: 222 PSSSPNGDVTGDAPGGLPIPINATTFANKSQGIGFRTIAIIALSGFVLILVLVGAISIIV 281

Query: 98  RWKRLKNTNGNSKQTIDGGKGLSLSPILER------------------FNSLRLAGKKDT 139
           +WK++    G S   +    G +L+P + +                       +A    +
Sbjct: 282 KWKKI----GKSSNAV----GPALAPSINKRPGAGSMFSSSARSSGSDSLMSSMATCALS 333

Query: 140 VSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNE 199
           V       LE AT+ F    V+GEGG G VY+    +    AVK +     + +REF  E
Sbjct: 334 VKTFTLSELEKATDRFSAKRVLGEGGFGRVYQGSMEDGTEVAVKLLTRDNQNRDREFIAE 393

Query: 200 VNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAV 259
           V  L+++ H+N++ L+G CI   TR L+YE++ NGS+E  LH  T    L W  R+KIA+
Sbjct: 394 VEMLSRLHHRNLVKLIGICIEGRTRCLIYELVHNGSVESHLHEGT----LDWDARLKIAL 449

Query: 260 DVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGT 317
             ARGL YLHE  N  V+HRD K+SN+LL+  F  K+SDFGL+   T G+Q  + ++ GT
Sbjct: 450 GAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGT 509

Query: 318 LGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRS 377
            GYVAPEY + G L  KSDVY++GVVLLELL GRRPV+   P+  +++VTWA P L +R 
Sbjct: 510 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRRPVDMSQPSGEENLVTWARPLLANRE 569

Query: 378 KLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
            L  +VDP +  T +   + +VAA+A +C+  E S+RP + +V+ +L
Sbjct: 570 GLEQLVDPALAGTYNFDDMAKVAAIASMCVHQEVSHRPFMGEVVQAL 616

Required during the differentiation of the protoderm into shoots epidermis and cuticle.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FE20|PBS1_ARATH Serine/threonine-protein kinase PBS1 OS=Arabidopsis thaliana GN=PBS1 PE=1 SV=1

 Score =  255 bits (652), Expect = 4e-67,   Method: Compositional matrix adjust.
 Identities = 132/285 (46%), Positives = 176/285 (61%), Gaps = 5/285 (1%)

Query: 145 YELLEAATNNFQESNVIGEGGRGHVYKARFNEK-LLAAVKRIDDAGHDAEREFNNEVNWL 203
           +  L AAT NF     +GEGG G VYK R +    + AVK++D  G    REF  EV  L
Sbjct: 76  FRELAAATMNFHPDTFLGEGGFGRVYKGRLDSTGQVVAVKQLDRNGLQGNREFLVEVLML 135

Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHG-PTHGSNLTWHLRMKIAVDVA 262
           + + H N+++L+GYC   + R LVYE M  GSLE  LH  P     L W++RMKIA   A
Sbjct: 136 SLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNMRMKIAAGAA 195

Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN---VKISGTLG 319
           +GLE+LH+  N PV++RD KSSNILLD  F+ KLSDFGL+    T  ++    ++ GT G
Sbjct: 196 KGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGPTGDKSHVSTRVMGTYG 255

Query: 320 YVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKL 379
           Y APEY + G+LT KSDVY+FGVV LEL+ GR+ ++   P   Q++V WA P   DR K 
Sbjct: 256 YCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSEMPHGEQNLVAWARPLFNDRRKF 315

Query: 380 PNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
             + DP ++     + LYQ  AVA +CIQ + + RPLI DV+ +L
Sbjct: 316 IKLADPRLKGRFPTRALYQALAVASMCIQEQAATRPLIADVVTAL 360

Protein kinase required for plant defense mechanism mediated by the disease resistance (R) protein RPS5. In case of infection by Pseudomonas syringae, RPS5 specifically recognizes the avrPphB type III effector avirulence protein and triggers a defense reaction. AvrPphB may trigger RPS5-mediated defense mechanism via the cleavage of PBS1. Both kinase activity and cleavage by avrPphB are independently required to trigger the RPS5-mediated resistance.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q6R2J8|SRF8_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 8 OS=Arabidopsis thaliana GN=SRF8 PE=2 SV=1

 Score =  250 bits (638), Expect = 2e-65,   Method: Compositional matrix adjust.
 Identities = 131/295 (44%), Positives = 178/295 (60%), Gaps = 5/295 (1%)

Query: 139 TVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFN- 197
           T S      L+ ATN+F + N+IGEG  G VY+A F    + A+K+ID+A    + E N 
Sbjct: 379 TASQYTVSSLQVATNSFSQENIIGEGSLGRVYRAEFPNGKIMAIKKIDNAALSLQEEDNF 438

Query: 198 -NEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGS-NLTWHLRM 255
              V+ ++++RH NI+ L GYC     R LVYE + NG+L+  LH     S NLTW+ R+
Sbjct: 439 LEAVSNMSRLRHPNIVPLAGYCTEHGQRLLVYEYVGNGNLDDTLHTNDDRSMNLTWNARV 498

Query: 256 KIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV--K 313
           K+A+  A+ LEYLHE C   +VHR+ KS+NILLD   N  LSD GL+       R V  +
Sbjct: 499 KVALGTAKALEYLHEVCLPSIVHRNFKSANILLDEELNPHLSDSGLAALTPNTERQVSTQ 558

Query: 314 ISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQL 373
           + G+ GY APE+ L G  T KSDVY FGVV+LELL GR+P++       QS+V WA PQL
Sbjct: 559 VVGSFGYSAPEFALSGIYTVKSDVYTFGVVMLELLTGRKPLDSSRTRAEQSLVRWATPQL 618

Query: 374 TDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLV 428
            D   L  +VDP +      K L + A +  LCIQPEP +RP +++V+  L+ LV
Sbjct: 619 HDIDALSKMVDPSLNGMYPAKSLSRFADIIALCIQPEPEFRPPMSEVVQQLVRLV 673

Arabidopsis thaliana (taxid: 3702)

>sp|Q9SFT7|Y3707_ARATH Serine/threonine-protein kinase At3g07070 OS=Arabidopsis thaliana GN=At3g07070 PE=2 SV=1

 Score =  248 bits (632), Expect = 8e-65,   Method: Compositional matrix adjust.
 Identities = 129/291 (44%), Positives = 179/291 (61%), Gaps = 5/291 (1%)

Query: 139 TVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFNEK-LLAAVKRIDDAGHDAEREFN 197
                 +  L  AT NF++  +IGEGG G VYK +  +  ++ AVK++D  G    +EF 
Sbjct: 63  AAQTFSFRELATATKNFRQECLIGEGGFGRVYKGKLEKTGMIVAVKQLDRNGLQGNKEFI 122

Query: 198 NEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGS-NLTWHLRMK 256
            EV  L+ + H+++++L+GYC   + R LVYE M  GSLE  L   T     L W  R++
Sbjct: 123 VEVLMLSLLHHKHLVNLIGYCADGDQRLLVYEYMSRGSLEDHLLDLTPDQIPLDWDTRIR 182

Query: 257 IAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS---VTAGTQSRNVK 313
           IA+  A GLEYLH+  N PV++RDLK++NILLD  FNAKLSDFGL+        Q  + +
Sbjct: 183 IALGAAMGLEYLHDKANPPVIYRDLKAANILLDGEFNAKLSDFGLAKLGPVGDKQHVSSR 242

Query: 314 ISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQL 373
           + GT GY APEY   G+LT KSDVY+FGVVLLEL+ GRR ++   P   Q++VTWA P  
Sbjct: 243 VMGTYGYCAPEYQRTGQLTTKSDVYSFGVVLLELITGRRVIDTTRPKDEQNLVTWAQPVF 302

Query: 374 TDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
            + S+ P + DP +      K L Q  AVA +C+Q E + RPL++DV+ +L
Sbjct: 303 KEPSRFPELADPSLEGVFPEKALNQAVAVAAMCLQEEATVRPLMSDVVTAL 353

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LQQ8|RLCK7_ARATH Probable serine/threonine-protein kinase RLCKVII OS=Arabidopsis thaliana GN=At1g07870 PE=2 SV=1

 Score =  246 bits (628), Expect = 2e-64,   Method: Compositional matrix adjust.
 Identities = 126/299 (42%), Positives = 184/299 (61%), Gaps = 9/299 (3%)

Query: 132 RLAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFNEKL--LAAVKRIDDAG 189
           ++ GKK       ++ L  AT NF+    +GEGG G V+K    EKL  + A+K++D  G
Sbjct: 82  QVTGKK--AQTFTFQELAEATGNFRSDCFLGEGGFGKVFKGTI-EKLDQVVAIKQLDRNG 138

Query: 190 HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHG-PTHGSN 248
               REF  EV  L+   H N++ L+G+C   + R LVYE M  GSLE  LH  P+    
Sbjct: 139 VQGIREFVVEVLTLSLADHPNLVKLIGFCAEGDQRLLVYEYMPQGSLEDHLHVLPSGKKP 198

Query: 249 LTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ 308
           L W+ RMKIA   ARGLEYLH+    PV++RDLK SNILL   +  KLSDFGL+    + 
Sbjct: 199 LDWNTRMKIAAGAARGLEYLHDRMTPPVIYRDLKCSNILLGEDYQPKLSDFGLAKVGPSG 258

Query: 309 SR---NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSM 365
            +   + ++ GT GY AP+Y + G+LT KSD+Y+FGVVLLEL+ GR+ ++     + Q++
Sbjct: 259 DKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDNTKTRKDQNL 318

Query: 366 VTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
           V WA P   DR   P +VDP+++    ++ LYQ  A++ +C+Q +P+ RP+++DV+ +L
Sbjct: 319 VGWARPLFKDRRNFPKMVDPLLQGQYPVRGLYQALAISAMCVQEQPTMRPVVSDVVLAL 377

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q1PEM5|PERK3_ARATH Proline-rich receptor-like protein kinase PERK3 OS=Arabidopsis thaliana GN=PERK3 PE=2 SV=2

 Score =  243 bits (620), Expect = 2e-63,   Method: Compositional matrix adjust.
 Identities = 128/298 (42%), Positives = 182/298 (61%), Gaps = 7/298 (2%)

Query: 141 SVIEYELLEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEV 200
           S   Y  L  ATN F E+N++GEGG G VYK   N     AVK++       E+EF  EV
Sbjct: 169 STFTYGELARATNKFSEANLLGEGGFGFVYKGILNNGNEVAVKQLKVGSAQGEKEFQAEV 228

Query: 201 NWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVD 260
           N +++I H+N++SL+GYCI    R LVYE + N +LE  LHG      + W LR+KIAV 
Sbjct: 229 NIISQIHHRNLVSLVGYCIAGAQRLLVYEFVPNNTLEFHLHGKGR-PTMEWSLRLKIAVS 287

Query: 261 VARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV--KISGTL 318
            ++GL YLHE+CN  ++HRD+K++NIL+D  F AK++DFGL+  A   + +V  ++ GT 
Sbjct: 288 SSKGLSYLHENCNPKIIHRDIKAANILIDFKFEAKVADFGLAKIALDTNTHVSTRVMGTF 347

Query: 319 GYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP---QLTD 375
           GY+APEY   GKLT+KSDVY+FGVVLLEL+ GRRPV+  +     S+V WA P   Q  +
Sbjct: 348 GYLAPEYAASGKLTEKSDVYSFGVVLLELITGRRPVDANNVYADDSLVDWARPLLVQALE 407

Query: 376 RSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIP-LVPTDL 432
            S    + D  + +  D + + ++ A A  C++     RP +  V+  L   + P+DL
Sbjct: 408 ESNFEGLADIKLNNEYDREEMARMVACAAACVRYTARRRPRMDQVVRVLEGNISPSDL 465

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1

 Score =  243 bits (620), Expect = 2e-63,   Method: Compositional matrix adjust.
 Identities = 131/301 (43%), Positives = 185/301 (61%), Gaps = 16/301 (5%)

Query: 140 VSVIEYEL--LEAATNNFQESNVIGEGGRGHVYKARFNEKLLA-------AVKRIDDAGH 190
             VI + L  LE  T +F+   ++GEGG G VYK   ++ L         AVK ++  G 
Sbjct: 52  AQVIPFTLFELETITKSFRPDYILGEGGFGTVYKGYIDDNLRVGLKSLPVAVKVLNKEGL 111

Query: 191 DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLT 250
              RE+  EVN+L ++RH N++ L+GYC   + R LVYE M  GSLE  L   T    L+
Sbjct: 112 QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMLRGSLENHLFRKTTAP-LS 170

Query: 251 WHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR 310
           W  RM IA+  A+GL +LH +   PV++RD K+SNILLDS + AKLSDFGL+  AG Q  
Sbjct: 171 WSRRMMIALGAAKGLAFLH-NAERPVIYRDFKTSNILLDSDYTAKLSDFGLA-KAGPQGD 228

Query: 311 NVKIS----GTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMV 366
              +S    GT GY APEY++ G LT +SDVY+FGVVLLE+L GR+ V+K  P++ Q++V
Sbjct: 229 ETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVDKTRPSKEQNLV 288

Query: 367 TWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIP 426
            WA P+L D+ KL  I+DP + +   ++   +  ++A  C+   P  RPL++DV+ +L P
Sbjct: 289 DWARPKLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEP 348

Query: 427 L 427
           L
Sbjct: 349 L 349

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FX99|Y1497_ARATH Probable receptor-like protein kinase At1g49730 OS=Arabidopsis thaliana GN=At1g49730 PE=1 SV=1

 Score =  242 bits (617), Expect = 4e-63,   Method: Compositional matrix adjust.
 Identities = 148/372 (39%), Positives = 215/372 (57%), Gaps = 23/372 (6%)

Query: 62  RVVNHQDLNKKILIALVVSSTLLGVLLLFLLCFWIYRWKRLKNTNGNSKQTIDGGKGLSL 121
           R  N   L     I +VV++  L +L++ ++        R KN   +  +++D     S+
Sbjct: 243 RSTNPYHLTMVPTIGIVVTAVALTMLVVLVILI------RRKNRELDESESLDRKSTKSV 296

Query: 122 SPILERFNSLRLAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFNEKLLAA 181
              L  F  +             Y+ +  ATN+F    VIG+GG G VYKA FN+ L+AA
Sbjct: 297 PSSLPVFK-IHEDDSSSAFRKFSYKEMTNATNDFN--TVIGQGGFGTVYKAEFNDGLIAA 353

Query: 182 VKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLH 241
           VK+++     AE++F  E+  L K+ H+N+++L G+CI+ + RFLVY+ M+NGSL+  LH
Sbjct: 354 VKKMNKVSEQAEQDFCREIGLLAKLHHRNLVALKGFCINKKERFLVYDYMKNGSLKDHLH 413

Query: 242 GPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGL 301
                   +W  RMKIA+DVA  LEYLH +C+ P+ HRD+KSSNILLD +F AKLSDFGL
Sbjct: 414 A-IGKPPPSWGTRMKIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLSDFGL 472

Query: 302 SVTAGTQS-----RNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEK 356
           + ++   S      N  I GT GYV PEY++  +LT+KSDVY++GVVLLEL+ GRR V+ 
Sbjct: 473 AHSSRDGSVCFEPVNTDIRGTPGYVDPEYVVTQELTEKSDVYSYGVVLLELITGRRAVD- 531

Query: 357 MSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDL---KHLYQVAAVAVLCIQPEPSY 413
               + +++V  +   L  +SK   +VDP I+D+++    K L  V  V  LC + E   
Sbjct: 532 ----EGRNLVEMSQRFLLAKSKHLELVDPRIKDSINDAGGKQLDAVVTVVRLCTEKEGRS 587

Query: 414 RPLITDVLHSLI 425
           RP I  VL  L 
Sbjct: 588 RPSIKQVLRLLC 599

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3

 Score =  241 bits (614), Expect = 9e-63,   Method: Compositional matrix adjust.
 Identities = 124/297 (41%), Positives = 183/297 (61%), Gaps = 7/297 (2%)

Query: 142 VIEYELLEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVN 201
              YE L  ATN F E+N++G+GG G+V+K         AVK++ +     EREF  EV 
Sbjct: 341 TFNYEELSRATNGFSEANLLGQGGFGYVFKGMLRNGKEVAVKQLKEGSSQGEREFQAEVG 400

Query: 202 WLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDV 261
            ++++ H+++++L+GYCI    R LVYE + N +LE  LHG      + W  R+KIAV  
Sbjct: 401 IISRVHHRHLVALVGYCIADAQRLLVYEFVPNNTLEFHLHGKGR-PTMEWSSRLKIAVGS 459

Query: 262 ARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV--KISGTLG 319
           A+GL YLHE+CN  ++HRD+K+SNIL+D  F AK++DFGL+  A   + +V  ++ GT G
Sbjct: 460 AKGLSYLHENCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTRVMGTFG 519

Query: 320 YVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKL 379
           Y+APEY   GKLT+KSDV++FGVVLLEL+ GRRP++  +     S+V WA P L   S+L
Sbjct: 520 YLAPEYASSGKLTEKSDVFSFGVVLLELITGRRPIDVNNVHADNSLVDWARPLLNQVSEL 579

Query: 380 PN---IVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIP-LVPTDL 432
            N   +VD  + +  D + + ++ A A  C++     RP +  V   L   + P+DL
Sbjct: 580 GNFEVVVDKKLNNEYDKEEMARMVACAAACVRSTAPRRPRMDQVARVLEGNISPSDL 636

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	439
297743614	456	unnamed protein product [Vitis vinifera]	0.972	0.936	0.740	0.0
147856780	453	hypothetical protein VITISV_019748 [Viti	0.965	0.935	0.736	0.0
359482424	446	PREDICTED: probable receptor-like protei	0.949	0.934	0.726	0.0
449436172	441	PREDICTED: probable receptor-like protei	0.968	0.963	0.747	0.0
255572785	397	Serine/threonine-protein kinase PBS1, pu	0.883	0.977	0.762	1e-177
224057565	377	predicted protein [Populus trichocarpa]	0.833	0.970	0.752	1e-168
359475853	455	PREDICTED: probable receptor-like protei	0.977	0.942	0.651	1e-160
356557227	428	PREDICTED: probable receptor-like protei	0.949	0.974	0.642	1e-156
356547462	424	PREDICTED: probable receptor-like protei	0.949	0.983	0.624	1e-151
356552492	440	PREDICTED: probable receptor-like protei	0.904	0.902	0.640	1e-147

>gi|297743614|emb|CBI36481.3| unnamed protein product [Vitis vinifera]

 Score =  674 bits (1739), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 320/432 (74%), Positives = 374/432 (86%), Gaps = 5/432 (1%)

Query: 13  MWAFFFSLFLSTLVAKPDTDISFVFGSL----KEPISQFSAEMEAESPGIAEVRVVNHQD 68
           +W F  +LF   + A+PD  +S ++  L      PISQ SA++EA SPG+ EVRVV+HQD
Sbjct: 12  IWVFTTTLFSLPVHARPDPLVSTIYNPLLPSHYPPISQISAQLEAVSPGMPEVRVVHHQD 71

Query: 69  LNKKILIALVVSSTLLGVLLLFLLCFWIYRWKRLKNTNGNSKQTIDGGKGLSLSPILERF 128
           +NK+ILIALVV+STLLG +LLFL CFWI R + L+N+   S+Q +D  KGLSL PIL +F
Sbjct: 72  VNKRILIALVVASTLLGGILLFLSCFWIQRQRNLRNSGRKSQQNLDAAKGLSLGPILGKF 131

Query: 129 NSLRLAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDA 188
           NSLR  GKKD+V+VIEY LL AATNNF ESNV+GEGG G VYKARFNE  LAAVKR+D  
Sbjct: 132 NSLRANGKKDSVTVIEYHLLVAATNNFSESNVLGEGGSGRVYKARFNENFLAAVKRLDRG 191

Query: 189 GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSN 248
           G D EREF NEV+WL+KI+HQNI+SLLG CIH ETRFLVYEMMQNGSLE QLHGP+HGS 
Sbjct: 192 GQDGEREFENEVDWLSKIQHQNIVSLLGCCIHGETRFLVYEMMQNGSLEAQLHGPSHGST 251

Query: 249 LTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ 308
           LTWHLRMKIAVDVARGLE+LHEHCN PV+HRDLKSSNILLDS FNAKLSDFGL++T+GTQ
Sbjct: 252 LTWHLRMKIAVDVARGLEHLHEHCNPPVIHRDLKSSNILLDSDFNAKLSDFGLAITSGTQ 311

Query: 309 SR-NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVT 367
           ++ N+K+SGT+GYVAPEYLL+GKLTDKSDVYAFGV+LLELLMGR+PVEKM+  +CQS+VT
Sbjct: 312 NKNNLKLSGTVGYVAPEYLLDGKLTDKSDVYAFGVILLELLMGRKPVEKMASAECQSIVT 371

Query: 368 WAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPL 427
           WAMPQLTDRSKLPNIVDP++RDTMD+KHLYQV+AVAVLC+QPEPSYRPLITDVLHSLIPL
Sbjct: 372 WAMPQLTDRSKLPNIVDPIVRDTMDMKHLYQVSAVAVLCVQPEPSYRPLITDVLHSLIPL 431

Query: 428 VPTDLGGSLRVT 439
           +P +LGGSLR+T
Sbjct: 432 LPVELGGSLRIT 443

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147856780|emb|CAN79180.1| hypothetical protein VITISV_019748 [Vitis vinifera]

 Score =  664 bits (1714), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 318/432 (73%), Positives = 371/432 (85%), Gaps = 8/432 (1%)

Query: 13  MWAFFFSLFLSTLVAKPDTDISFVFGSL----KEPISQFSAEMEAESPGIAEVRVVNHQD 68
           +W F  +LF   + A+PD  +S ++  L      PISQ SA++EA SPG+ EVRVV+HQD
Sbjct: 12  IWVFTTTLFSLPVHARPDPLVSTIYNPLLPSHYPPISQISAQLEAVSPGMPEVRVVHHQD 71

Query: 69  LNKKILIALVVSSTLLGVLLLFLLCFWIYRWKRLKNTNGNSKQTIDGGKGLSLSPILERF 128
           +NK+ILIALVV+STLLG +LLFL CFWI R + L+N+   S+Q +D  KGLSL PIL +F
Sbjct: 72  VNKRILIALVVASTLLGGILLFLSCFWIQRQRNLRNSGRKSQQNLDAAKGLSLGPILGKF 131

Query: 129 NSLRLAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDA 188
           NSLR  GKKD+V+VIEY LL AATNNF ESNV+GEGG G VYKARFNE  LAAVKR++  
Sbjct: 132 NSLRANGKKDSVTVIEYHLLVAATNNFSESNVLGEGGSGRVYKARFNENFLAAVKRLERG 191

Query: 189 GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSN 248
           G D EREF NEV+WL+KI+HQNI+SLLG CIH ETRFLVYEMMQNGSLE QLHGP+HGS 
Sbjct: 192 GQDGEREFENEVDWLSKIQHQNIVSLLGCCIHGETRFLVYEMMQNGSLEAQLHGPSHGST 251

Query: 249 LTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ 308
           LTWHLRMKIAVDVARGLEYLHEHCN PV+HRDLKSSNILLDS FNAKLSDFGL++T+GTQ
Sbjct: 252 LTWHLRMKIAVDVARGLEYLHEHCNPPVIHRDLKSSNILLDSDFNAKLSDFGLAITSGTQ 311

Query: 309 SR-NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVT 367
           ++ N+K+SGT+GYVAPEYLL+GKLTDKSDVYAFGV+LLELLMGR+PVEKM+  +CQS+  
Sbjct: 312 NKNNLKLSGTVGYVAPEYLLDGKLTDKSDVYAFGVILLELLMGRKPVEKMASAECQSI-- 369

Query: 368 WAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPL 427
            AMPQLTDRSKLPNIVDP++RDTMD+KHLYQVAAVAVLC+QPEPSYRPLITDVLHSLIPL
Sbjct: 370 -AMPQLTDRSKLPNIVDPIVRDTMDMKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPL 428

Query: 428 VPTDLGGSLRVT 439
           +P +LGGSLR+T
Sbjct: 429 LPVELGGSLRIT 440

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359482424|ref|XP_002272617.2| PREDICTED: probable receptor-like protein kinase At1g80640-like [Vitis vinifera]

 Score =  652 bits (1682), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 314/432 (72%), Positives = 364/432 (84%), Gaps = 15/432 (3%)

Query: 13  MWAFFFSLFLSTLVAKPDTDISFVFGSL----KEPISQFSAEMEAESPGIAEVRVVNHQD 68
           +W F  +LF   + A+PD  +S ++  L      PISQ SA++EA SPG+ EVRVV+HQD
Sbjct: 12  IWVFTTTLFSLPVHARPDPLVSTIYNPLLPSHYPPISQISAQLEAVSPGMPEVRVVHHQD 71

Query: 69  LNKKILIALVVSSTLLGVLLLFLLCFWIYRWKRLKNTNGNSKQTIDGGKGLSLSPILERF 128
           +NK+ILIALVV+STLLG +LLFL CFWI R + L+N+   S+Q +D  KGLSL PIL +F
Sbjct: 72  VNKRILIALVVASTLLGGILLFLSCFWIQRQRNLRNSGRKSQQNLDAAKGLSLGPILGKF 131

Query: 129 NSLRLAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDA 188
           NSLR  GKKD+V+VIEY LL AATNNF ESNV+GEGG G VYKARFNE  LAAVKR+D  
Sbjct: 132 NSLRANGKKDSVTVIEYHLLVAATNNFSESNVLGEGGSGRVYKARFNENFLAAVKRLDRG 191

Query: 189 GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSN 248
           G D EREF           HQNI+SLLG CIH ETRFLVYEMMQNGSLE QLHGP+HGS 
Sbjct: 192 GQDGEREF----------EHQNIVSLLGCCIHGETRFLVYEMMQNGSLEAQLHGPSHGST 241

Query: 249 LTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ 308
           LTWHLRMKIAVDVARGLE+LHEHCN PV+HRDLKSSNILLDS FNAKLSDFGL++T+GTQ
Sbjct: 242 LTWHLRMKIAVDVARGLEHLHEHCNPPVIHRDLKSSNILLDSDFNAKLSDFGLAITSGTQ 301

Query: 309 SRN-VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVT 367
           ++N +K+SGT+GYVAPEYLL+GKLTDKSDVYAFGV+LLELLMGR+PVEKM+  +CQS+VT
Sbjct: 302 NKNNLKLSGTVGYVAPEYLLDGKLTDKSDVYAFGVILLELLMGRKPVEKMASAECQSIVT 361

Query: 368 WAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPL 427
           WAMPQLTDRSKLPNIVDP++RDTMD+KHLYQVAAVAVLC+QPEPSYRPLITDVLHSLIPL
Sbjct: 362 WAMPQLTDRSKLPNIVDPIVRDTMDMKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPL 421

Query: 428 VPTDLGGSLRVT 439
           +P +LGGSLR+T
Sbjct: 422 LPVELGGSLRIT 433

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449436172|ref|XP_004135868.1| PREDICTED: probable receptor-like protein kinase At1g80640-like [Cucumis sativus] gi|449533246|ref|XP_004173587.1| PREDICTED: probable receptor-like protein kinase At1g80640-like [Cucumis sativus]

 Score =  649 bits (1675), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 322/431 (74%), Positives = 373/431 (86%), Gaps = 6/431 (1%)

Query: 13  MWAFFFSLFLSTLVAKPD----TDISFVFGSLKEPISQFSAEMEAESPGIAEVRVVNHQD 68
           MW F+ SLF S + A+PD    +  S VF S  +PIS   A+MEA+SPG++EV+VV+HQD
Sbjct: 1   MWVFY-SLF-SIIDARPDLPGFSISSTVFASHSQPISLIVAKMEAQSPGVSEVKVVHHQD 58

Query: 69  LNKKILIALVVSSTLLGVLLLFLLCFWIYRWKRLKNTNGNSKQTIDGGKGLSLSPILERF 128
           LNK+ILIAL++SSTLLG +LLFLLCFWIYR K   N +G  ++ ++  KG +L+PI+ RF
Sbjct: 59  LNKRILIALIISSTLLGAILLFLLCFWIYRRKTSNNDDGKCQKNLEASKGTALNPIISRF 118

Query: 129 NSLRLAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDA 188
           NSLRLA  K +VS I+Y+LLEAAT+NF +SNV+GEGG GHVYKA FN+KLLAAVKRID+ 
Sbjct: 119 NSLRLANFKGSVSTIDYKLLEAATDNFSKSNVLGEGGSGHVYKACFNDKLLAAVKRIDNG 178

Query: 189 GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSN 248
           G DAEREF NEVNWL+KIRHQN+I LLG+CIH ETRFLVYEMMQNGSLE QLHGP+HGS 
Sbjct: 179 GLDAEREFENEVNWLSKIRHQNVIKLLGHCIHGETRFLVYEMMQNGSLESQLHGPSHGSA 238

Query: 249 LTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ 308
           LTWH+RMKIAVDVARGLEYLHEH N PVVHRDLKSSNILLDS FNAKLSDFGL+V  G Q
Sbjct: 239 LTWHIRMKIAVDVARGLEYLHEHRNPPVVHRDLKSSNILLDSDFNAKLSDFGLTVNLGAQ 298

Query: 309 SRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTW 368
           ++N+K+SGTLGYVAPEYLL+GKLTDKSDVYAFGVVLLELL G+ PVEKM PTQ QS+V+W
Sbjct: 299 NKNIKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLTGKMPVEKMGPTQSQSLVSW 358

Query: 369 AMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLV 428
           A+PQL+DRSKLP IVDPVIRDTMDLKHLYQVAAVAVLC+Q EPSYRPL+TDVLHSLIPLV
Sbjct: 359 AIPQLSDRSKLPKIVDPVIRDTMDLKHLYQVAAVAVLCVQSEPSYRPLVTDVLHSLIPLV 418

Query: 429 PTDLGGSLRVT 439
           P +LGGSLR+T
Sbjct: 419 PVELGGSLRMT 429

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255572785|ref|XP_002527325.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] gi|223533325|gb|EEF35077.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis]

 Score =  628 bits (1619), Expect = e-177,   Method: Compositional matrix adjust.
 Identities = 299/392 (76%), Positives = 354/392 (90%), Gaps = 4/392 (1%)

Query: 51  MEAESPGIAE---VRVVNHQDLNKKILIALVVSSTLLGVLLLFLLCFWIYRWKRLKNTNG 107
           MEA+SPGI     V VV+HQDLNK+ILIAL+++S+LLG +LLFL CFWIYR K  K ++ 
Sbjct: 1   MEAQSPGITMAPVVTVVHHQDLNKRILIALIIASSLLGGILLFLSCFWIYRMKSSKKSST 60

Query: 108 NSKQTIDGGKGLSLSPILERFNSLRLAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRG 167
            +KQ +D G G +LSPIL++FNSLR+ GKK +++V+EY+LLEAATNNF+E+N++GEGG G
Sbjct: 61  KNKQNLDAGNGHTLSPILDKFNSLRMVGKKGSIAVMEYQLLEAATNNFRENNLLGEGGHG 120

Query: 168 HVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLV 227
            +YKARF++KLLAAVK+++  G D EREF NE+ WLTKI+HQNIISLLGYC H + +FLV
Sbjct: 121 SIYKARFSDKLLAAVKKLE-GGQDVEREFQNELKWLTKIQHQNIISLLGYCNHDKAKFLV 179

Query: 228 YEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNIL 287
           YEMMQNGSL++QLHGPTHGS LTWHLRMKIAV+VARGLEYLHEHCN P+VHRDLKSSNIL
Sbjct: 180 YEMMQNGSLDRQLHGPTHGSKLTWHLRMKIAVNVARGLEYLHEHCNPPLVHRDLKSSNIL 239

Query: 288 LDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLEL 347
           LDS+FNAKLSDFGL+VT+G +++N+K+SGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLEL
Sbjct: 240 LDSNFNAKLSDFGLAVTSGVENKNIKLSGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLEL 299

Query: 348 LMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCI 407
           LMGR+PVEKMS  QCQS+VTWAMPQLTDRSKLPNIVDPV++DTMDLKHLYQVAAVAVLC+
Sbjct: 300 LMGRKPVEKMSQDQCQSIVTWAMPQLTDRSKLPNIVDPVVKDTMDLKHLYQVAAVAVLCV 359

Query: 408 QPEPSYRPLITDVLHSLIPLVPTDLGGSLRVT 439
           Q EPSYRPLITDVLHSLIPL+P +LGGSLR+T
Sbjct: 360 QQEPSYRPLITDVLHSLIPLLPLELGGSLRIT 391

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224057565|ref|XP_002299270.1| predicted protein [Populus trichocarpa] gi|222846528|gb|EEE84075.1| predicted protein [Populus trichocarpa]

 Score =  597 bits (1539), Expect = e-168,   Method: Compositional matrix adjust.
 Identities = 289/384 (75%), Positives = 327/384 (85%), Gaps = 18/384 (4%)

Query: 56  PGIAEVRVVNHQDLNKKILIALVVSSTLLGVLLLFLLCFWIYRWKRLKNTNGNSKQTIDG 115
           P +  V  V+HQDLNKKILIALVV+STLLG ++LF  CFWIYR K+ +     SK     
Sbjct: 2   PLVPVVEEVHHQDLNKKILIALVVASTLLGGIVLFFSCFWIYRLKKSRKCRAKSK----- 56

Query: 116 GKGLSLSPILERFNSLRLAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFN 175
           G G+  +             +K +V+V+EY+LL+AATNNF+E NV+G+GG G VYKARF+
Sbjct: 57  GDGIFFT-------------RKGSVAVMEYQLLQAATNNFREDNVLGQGGHGCVYKARFS 103

Query: 176 EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGS 235
           EKLLAAVKR +    D  REF NE+NWLTKI+HQNIISLLGYC+H ETRFLVYEMMQNGS
Sbjct: 104 EKLLAAVKRFEGEAQDIGREFENELNWLTKIQHQNIISLLGYCLHGETRFLVYEMMQNGS 163

Query: 236 LEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAK 295
           LE QLHGPTHGS LTWHLRMKIAVDVARGLEYLHEHCN PVVHRDLKSSNILLDSSFNAK
Sbjct: 164 LESQLHGPTHGSALTWHLRMKIAVDVARGLEYLHEHCNPPVVHRDLKSSNILLDSSFNAK 223

Query: 296 LSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVE 355
           LSDFGL+VT+G QS+N+++SGTLGYVAPEYLL+GKLTDKSDVYAFGVVLLELL+GR+PVE
Sbjct: 224 LSDFGLAVTSGIQSKNIELSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLIGRKPVE 283

Query: 356 KMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRP 415
           +MSP QCQS+V+WAMPQ TDRSKLPNIVDPVI+DTMDLKHLYQVAAVAVLC+Q EPSYRP
Sbjct: 284 QMSPDQCQSIVSWAMPQFTDRSKLPNIVDPVIKDTMDLKHLYQVAAVAVLCVQQEPSYRP 343

Query: 416 LITDVLHSLIPLVPTDLGGSLRVT 439
           LITDVLHSLIPLVP +LGGSLRVT
Sbjct: 344 LITDVLHSLIPLVPLELGGSLRVT 367

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359475853|ref|XP_002285386.2| PREDICTED: probable receptor-like protein kinase At1g80640-like [Vitis vinifera] gi|296082091|emb|CBI21096.3| unnamed protein product [Vitis vinifera]

 Score =  572 bits (1475), Expect = e-160,   Method: Compositional matrix adjust.
 Identities = 286/439 (65%), Positives = 348/439 (79%), Gaps = 10/439 (2%)

Query: 6   LLGLLLPMWAFFFSLFLSTLVAKPDTDISFVFGSLKEP----ISQFSAEMEAESPGIAEV 61
           +L LL  +W+F FS+    + A  D  +S +   L  P     S  S+ M A SP I E 
Sbjct: 7   ILPLLQSIWSFHFSI----VEAISDPPLSSISAPLSSPPIGATSPISSSMAAFSPAIQEG 62

Query: 62  RVVNHQDLNKKILIALVVSSTLLGVLLLFLLCFWIYRWKRLKNTNGNSKQTIDGGKGLSL 121
              N +D +KK  IAL V+S  LGV +L LL  WI++    K+   N+ Q+ D  K L+L
Sbjct: 63  SEENQKDSHKKTFIALTVASAALGVTILILLSLWIHKKCSQKSHKSNA-QSSDAEKALTL 121

Query: 122 SPILERFNSLRLAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFNEKLLAA 181
            P+L +FN++++ G+K +VS I+Y++LE ATNNFQESN++GEGG G VYKAR ++    A
Sbjct: 122 GPLLAKFNTMKVIGRKGSVSCIDYKVLETATNNFQESNILGEGGFGCVYKARLDDNSHVA 181

Query: 182 VKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLH 241
           VK+ID  G DAEREF NEV+ LTKI+H NIISLLGY  H E++FLVYE+MQNGSLE +LH
Sbjct: 182 VKKIDGRGQDAEREFENEVDLLTKIQHPNIISLLGYSSHEESKFLVYELMQNGSLETELH 241

Query: 242 GPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGL 301
           GP+HGS+LTWH+RMKIA+D ARGLEYLHEHCN PV+HRDLKSSNILLDS+FNAKLSDFGL
Sbjct: 242 GPSHGSSLTWHIRMKIALDAARGLEYLHEHCNPPVIHRDLKSSNILLDSNFNAKLSDFGL 301

Query: 302 SVTAGTQSR-NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPT 360
           +V  G Q++ N+K+SGTLGY+APEYLL+GKLTDKSDVYAFGVVLLELL+GR+PVEK++P 
Sbjct: 302 AVIDGPQNKNNLKLSGTLGYLAPEYLLDGKLTDKSDVYAFGVVLLELLLGRKPVEKLAPA 361

Query: 361 QCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDV 420
           QCQS+VTWAMPQLTDRSKLP IVDPV+RDTMDLKHLYQVAAVAVLC+QPEPSYRPLITDV
Sbjct: 362 QCQSIVTWAMPQLTDRSKLPGIVDPVVRDTMDLKHLYQVAAVAVLCVQPEPSYRPLITDV 421

Query: 421 LHSLIPLVPTDLGGSLRVT 439
           LHSLIPLVP +LGG L+VT
Sbjct: 422 LHSLIPLVPVELGGMLKVT 440

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356557227|ref|XP_003546919.1| PREDICTED: probable receptor-like protein kinase At1g80640-like [Glycine max]

 Score =  556 bits (1433), Expect = e-156,   Method: Compositional matrix adjust.
 Identities = 279/434 (64%), Positives = 337/434 (77%), Gaps = 17/434 (3%)

Query: 6   LLGLLLPMWAFFFSLFLSTLVAKPDTDISFVFGSLKEPISQFSAEMEAESPGIAEVRVVN 65
           LL L LP+W    S    TL+A     +S                 +AESPGI EVR V+
Sbjct: 3   LLVLFLPIWVLSISFSSPTLLAASSISLS--------------QNAQAESPGIQEVRTVH 48

Query: 66  HQDLNKKILIALVVSSTLLGVLLLFLLCFWIYRWKRLKNTNGNSKQTIDGGKGLSLSPIL 125
           HQ+LNK+ILIALV  STLLG + LFLL  W  R K L+ +   S++TI+  KG ++S + 
Sbjct: 49  HQNLNKRILIALVACSTLLGGVFLFLLYVWFRRHKNLRCSKSISQETIETAKGETISSVN 108

Query: 126 ERFNSLRLAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRI 185
            + N  R+A K+ +V++ +Y+LLEAATN+F  SN++GE G   VY+ARF+E   AAVK+ 
Sbjct: 109 AKLNYSRMADKRSSVAIFDYQLLEAATNSFSTSNIMGESGSRIVYRARFDEHFQAAVKK- 167

Query: 186 DDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTH 245
             A  DA+REF NEV+WL+KIRHQNII L+GYCIH E+RFLVYE+M+NGSLE QLHGP  
Sbjct: 168 --AESDADREFENEVSWLSKIRHQNIIKLMGYCIHGESRFLVYELMENGSLETQLHGPNW 225

Query: 246 GSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA 305
           GS+LTWHLR++IAVDVAR LEYLHEH N PVVHRDLK SN+LLDS+FNAKLSDFG +V +
Sbjct: 226 GSSLTWHLRLRIAVDVARALEYLHEHNNPPVVHRDLKCSNVLLDSNFNAKLSDFGFAVVS 285

Query: 306 GTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSM 365
           G Q +N+K+SGTLGYVAPEY+  GKLTDKSDVYAFGVVLLELL G++P+E M+  Q QS+
Sbjct: 286 GMQHKNIKMSGTLGYVAPEYISHGKLTDKSDVYAFGVVLLELLTGKKPMENMTSNQYQSL 345

Query: 366 VTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLI 425
           V+WAMPQLTDRSKLP+I+DPVIRDTMDLKHLYQVAAVAVLC+Q EPSYRPLITDVLHSLI
Sbjct: 346 VSWAMPQLTDRSKLPSILDPVIRDTMDLKHLYQVAAVAVLCVQSEPSYRPLITDVLHSLI 405

Query: 426 PLVPTDLGGSLRVT 439
           PLVP +LGGSLRVT
Sbjct: 406 PLVPVELGGSLRVT 419

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356547462|ref|XP_003542131.1| PREDICTED: probable receptor-like protein kinase At1g80640-like [Glycine max]

 Score =  542 bits (1397), Expect = e-151,   Method: Compositional matrix adjust.
 Identities = 271/434 (62%), Positives = 334/434 (76%), Gaps = 17/434 (3%)

Query: 6   LLGLLLPMWAFFFSLFLSTLVAKPDTDISFVFGSLKEPISQFSAEMEAESPGIAEVRVVN 65
           LL L LP+W    S+  S+ +    + IS             S   +AESPGI EVR V+
Sbjct: 3   LLVLFLPVWVL--SISFSSPILHAASSISL------------SQNAQAESPGIQEVRTVH 48

Query: 66  HQDLNKKILIALVVSSTLLGVLLLFLLCFWIYRWKRLKNTNGNSKQTIDGGKGLSLSPIL 125
           HQ+LNK+ILIALV  S LL  + LFLL  W  R K L+ +   S++TI+  KG ++S + 
Sbjct: 49  HQNLNKRILIALVACSALLVGVFLFLLYVWFGRHKNLRCSKSKSQETIEAAKGETISSVN 108

Query: 126 ERFNSLRLAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRI 185
            + N  ++A KK +V++ +Y+LLEAATN+F  SN++GE G   VY+A F+E   AAVK+ 
Sbjct: 109 AKLNYSKMADKKSSVAIFDYQLLEAATNSFNTSNIMGESGSRIVYRAHFDEHFQAAVKKA 168

Query: 186 DDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTH 245
           D    DA+REF NEV+WL+KI+HQNII ++GYCIH E+RFLVYE+M+NGSLE QLHGP  
Sbjct: 169 DS---DADREFENEVSWLSKIQHQNIIKIMGYCIHGESRFLVYELMENGSLETQLHGPNR 225

Query: 246 GSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA 305
           GS+LTW LR++IAVDVAR LEYLHEH N PVVHRDLKSSN+ LDS+FNAKLSDFG ++  
Sbjct: 226 GSSLTWPLRLRIAVDVARALEYLHEHNNPPVVHRDLKSSNVFLDSNFNAKLSDFGFAMVL 285

Query: 306 GTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSM 365
           G Q +N+K+SGTLGY+APEY+  GKLTDKSDVYAFGVVLLELL G++P+E M+  Q QS+
Sbjct: 286 GMQHKNMKMSGTLGYLAPEYISHGKLTDKSDVYAFGVVLLELLTGKKPMENMTSNQYQSL 345

Query: 366 VTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLI 425
           V+WAMPQLTDRSKLP+I+DPVIRDTMDLKHLYQVAAVAVLC+Q EPSYRPLITDVLHSLI
Sbjct: 346 VSWAMPQLTDRSKLPSILDPVIRDTMDLKHLYQVAAVAVLCVQSEPSYRPLITDVLHSLI 405

Query: 426 PLVPTDLGGSLRVT 439
           PLVP +LGGSLRVT
Sbjct: 406 PLVPVELGGSLRVT 419

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356552492|ref|XP_003544601.1| PREDICTED: probable receptor-like protein kinase At1g80640-like [Glycine max]

 Score =  527 bits (1358), Expect = e-147,   Method: Compositional matrix adjust.
 Identities = 255/398 (64%), Positives = 317/398 (79%), Gaps = 1/398 (0%)

Query: 43  PISQFSAEMEAESPGIAEVRVVNHQDLNKKILIALVVSSTLLGVLLLFLLCFWIYRWKRL 102
           P S F   M A SPGI       H D +KK++IA+ V+ST LG ++L +LC WIY  K  
Sbjct: 37  PFSPFPTSMSASSPGIVMGAEQQHMDSHKKMVIAVAVASTSLGAVILCVLCIWIYYTKYP 96

Query: 103 KNTNGNSKQTIDGGKGLSLSPILERFNSLRLAGKKDTVSVIEYELLEAATNNFQESNVIG 162
             + G + Q  D  KGL+ SP L +F+S++L GKK  V +I+Y+ +E  T NF+E N++G
Sbjct: 97  SKSKGKNVQRSDAEKGLASSPFLSKFSSIKLVGKKGCVPIIDYKQIEKTTGNFEEINILG 156

Query: 163 EGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE 222
           EGG G VYKA  ++ L  AVK++      AE+EF NEV+ L+KI+H N+ISLLG   + +
Sbjct: 157 EGGFGCVYKAHLDDNLDVAVKKLHCENQYAEQEFENEVDLLSKIQHPNVISLLGCSSNDD 216

Query: 223 TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLK 282
           TR +VYE+M NGSLE QLHGP+HGS LTWHLRMKIA+D ARGL+YLHEHC  PV+HRDLK
Sbjct: 217 TRIIVYELMHNGSLETQLHGPSHGSALTWHLRMKIALDTARGLKYLHEHCYPPVIHRDLK 276

Query: 283 SSNILLDSSFNAKLSDFGLSVTAGTQSR-NVKISGTLGYVAPEYLLEGKLTDKSDVYAFG 341
           SSN+LLD+ FNAKLSDFGL++T G+Q++ N+K+SGTLGYVAPEYLL+GKLTDKSDVYAFG
Sbjct: 277 SSNVLLDTKFNAKLSDFGLAITNGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFG 336

Query: 342 VVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAA 401
           VVLLELL+G++PVEK++P QCQS+VTWAMP LTDRSKLPNIVDPVI++TMD KHLYQVAA
Sbjct: 337 VVLLELLLGKKPVEKLAPAQCQSIVTWAMPLLTDRSKLPNIVDPVIKNTMDPKHLYQVAA 396

Query: 402 VAVLCIQPEPSYRPLITDVLHSLIPLVPTDLGGSLRVT 439
           VAVLC+QPEPSYRPLI DVLHSLIPLVP +LGG+L+V+
Sbjct: 397 VAVLCVQPEPSYRPLIADVLHSLIPLVPVELGGTLKVS 434

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	439
TAIR|locus:2198998	427	AT1G80640 [Arabidopsis thalian	0.961	0.988	0.556	3.5e-123
TAIR|locus:2183835	433	AT5G11020 [Arabidopsis thalian	0.890	0.903	0.545	2.9e-112
TAIR|locus:2099009	400	AT3G58690 [Arabidopsis thalian	0.658	0.722	0.483	2.6e-70
TAIR|locus:2085720	386	AT3G20530 [Arabidopsis thalian	0.692	0.787	0.456	3.6e-66
TAIR|locus:2010965	458	AT1G54820 [Arabidopsis thalian	0.658	0.631	0.456	2.9e-64
TAIR|locus:2036818	389	AT1G61860 [Arabidopsis thalian	0.656	0.740	0.460	4.7e-64
TAIR|locus:2120683	703	SRF8 "STRUBBELIG-receptor fami	0.660	0.412	0.440	6.1e-64
TAIR|locus:2038992	744	ALE2 "Abnormal Leaf Shape 2" [	0.740	0.436	0.419	1.6e-63
TAIR|locus:2179857	456	PBS1 "avrPphB susceptible 1" [	0.630	0.607	0.468	1.1e-62
TAIR|locus:2087263	363	AT3G24790 [Arabidopsis thalian	0.644	0.779	0.458	1.8e-62

TAIR|locus:2198998 AT1G80640 [Arabidopsis thaliana (taxid:3702)]

 Score = 1211 (431.4 bits), Expect = 3.5e-123, P = 3.5e-123
 Identities = 242/435 (55%), Positives = 314/435 (72%)

Query:     6 LLGLLLPMWAFFFSLFLSTLVAKPDTDISFVFGSLKE-PISQFSAEMEAESPGIAEVRVV 64
             LL  LLP+W      F ST     ++ + +V G+  E PISQ S  M A+SPG   V+VV
Sbjct:     3 LLRHLLPIWVLLGFFFFSTATKSQESSVVYVSGASPEIPISQASPRMGAQSPGPPIVKVV 62

Query:    65 NHQDLNKKILIAXXXXXXXXXXXXXXXXCFWIYRWKRLKNTNGNSKQTIDGGKGLSLSPI 124
               QDLNKKILIA                   ++R++ +KN+    K+  D  K ++  P 
Sbjct:    63 LRQDLNKKILIALIVSSSLLCVTVMFLVYLLLWRYRNMKNSFTGIKRKSDSVKSVTTKPT 122

Query:   125 LERFNSLRLAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKR 184
             + + +S+R    K T+ V EY+LLE+ATN F +SNV+  GGRG +Y+A  +EK    VK+
Sbjct:   123 VHKIDSVR----KGTIPVYEYQLLESATNKFSDSNVLSRGGRGCLYRACLDEKSSVTVKK 178

Query:   185 IDDAGH-DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGP 243
             +D  G  D E++F  EV+WL KIRHQNI+SLLG+C++ +T  +VYE+MQNGSLE QLHGP
Sbjct:   179 LDGGGETDIEKQFETEVDWLAKIRHQNIVSLLGFCVYRQTSCIVYELMQNGSLESQLHGP 238

Query:   244 THGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSV 303
             + GS LTW LRMKIAVD+ARGLEYLHEHC+ PVVHRDLKSS+ILLDS FNAK+SDFG + 
Sbjct:   239 SQGSGLTWQLRMKIAVDIARGLEYLHEHCHPPVVHRDLKSSSILLDSDFNAKISDFGFAT 298

Query:   304 TAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQ 363
                TQ++N      L + A E LL+GK+TDK+DVY+FGV+LLELL+G++ VEK S ++ +
Sbjct:   299 VLTTQNKN------LIHKASEDLLDGKVTDKNDVYSFGVILLELLLGKKSVEKPS-SEPE 351

Query:   364 SMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS 423
             S+VTWA+P+L+DR+ LPNI+DP I+ TMDLKHLYQVAAVAVLC+QPEPSYRPLITDVLHS
Sbjct:   352 SIVTWAVPKLSDRANLPNILDPAIKGTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 411

Query:   424 LIPLVPTDLGGSLRV 438
             LIPL+P +LGGSLR+
Sbjct:   412 LIPLLPVELGGSLRI 426

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2183835 AT5G11020 [Arabidopsis thaliana (taxid:3702)]

 Score = 1108 (395.1 bits), Expect = 2.9e-112, P = 2.9e-112
 Identities = 218/400 (54%), Positives = 290/400 (72%)

Query:    41 KEPISQFSAEMEAESPGIAE-VRVVNHQDLNK-KILIAXXXXXXXXXXXXXXXXCFWIYR 98
             + P  Q SA   A SP   +  + ++ Q+ N  +++I+                 +W   
Sbjct:    30 ESPSPQPSAFTPALSPDYQQREKELHKQESNNMRLVISLAATFSLVGIILLCSLLYWFCH 89

Query:    99 WKRLKNTNGNSKQTIDGGKGLSLSPILERFNSL-RLAGKKDTVSVIEYELLEAATNNFQE 157
              +R      N K +  G  G++      R  +L +   K+ TVS+I+Y +LE  T+ F+E
Sbjct:    90 RRR------NLKSSGCGCSGITFLNRFSRSKTLDKRTTKQGTVSLIDYNILEEGTSGFKE 143

Query:   158 SNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGY 217
             SN++G+GG G VY A     + AAVK++D A  DA +EF +EV  L+K++H NIISLLGY
Sbjct:   144 SNILGQGGFGCVYSATLENNISAAVKKLDCANEDAAKEFKSEVEILSKLQHPNIISLLGY 203

Query:   218 CIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVV 277
               +   RF+VYE+M N SLE  LHG + GS +TW +RMKIA+DV RGLEYLHEHC+  ++
Sbjct:   204 STNDTARFIVYELMPNVSLESHLHGSSQGSAITWPMRMKIALDVTRGLEYLHEHCHPAII 263

Query:   278 HRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDV 337
             HRDLKSSNILLDS+FNAK+SDFGL+V  G +++N K+SGT+GYVAPEYLL G+LT+KSDV
Sbjct:   264 HRDLKSSNILLDSNFNAKISDFGLAVVDGPKNKNHKLSGTVGYVAPEYLLNGQLTEKSDV 323

Query:   338 YAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLY 397
             YAFGVVLLELL+G++PVEK++P +CQS++TWAMP LTDR+KLP+++DP I+DTMDLKHLY
Sbjct:   324 YAFGVVLLELLLGKKPVEKLAPGECQSIITWAMPYLTDRTKLPSVIDPAIKDTMDLKHLY 383

Query:   398 QVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPTDLGGSLR 437
             QVAAVA+LC+QPEPSYRPLITDVLHSLIPLVP +LGG+L+
Sbjct:   384 QVAAVAILCVQPEPSYRPLITDVLHSLIPLVPMELGGTLK 423

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2099009 AT3G58690 [Arabidopsis thaliana (taxid:3702)]

 Score = 712 (255.7 bits), Expect = 2.6e-70, P = 2.6e-70
 Identities = 143/296 (48%), Positives = 194/296 (65%)

Query:   140 VSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNE 199
             + +  ++ L +AT  F +SNV+G GG G VY+   N+    A+K +D AG   E EF  E
Sbjct:    72 LQIFTFKQLHSATGGFSKSNVVGNGGFGLVYRGVLNDGRKVAIKLMDHAGKQGEEEFKME 131

Query:   200 VNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTH-GS---NLTWHLRM 255
             V  L+++R   +++LLGYC     + LVYE M NG L++ L+ P   GS    L W  RM
Sbjct:   132 VELLSRLRSPYLLALLGYCSDNSHKLLVYEFMANGGLQEHLYLPNRSGSVPPRLDWETRM 191

Query:   256 KIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR---NV 312
             +IAV+ A+GLEYLHE  + PV+HRD KSSNILLD +FNAK+SDFGL+     ++    + 
Sbjct:   192 RIAVEAAKGLEYLHEQVSPPVIHRDFKSSNILLDRNFNAKVSDFGLAKVGSDKAGGHVST 251

Query:   313 KISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQ 372
             ++ GT GYVAPEY L G LT KSDVY++GVVLLELL GR PV+    T    +V+WA+PQ
Sbjct:   252 RVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPVDMKRATGEGVLVSWALPQ 311

Query:   373 LTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLV 428
             L DR K+ +I+DP +      K + QVAA+A +C+Q E  YRPL+ DV+ SL+PLV
Sbjct:   312 LADRDKVVDIMDPTLEGQYSTKEVVQVAAIAAMCVQAEADYRPLMADVVQSLVPLV 367

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2085720 AT3G20530 [Arabidopsis thaliana (taxid:3702)]

 Score = 673 (242.0 bits), Expect = 3.6e-66, P = 3.6e-66
 Identities = 143/313 (45%), Positives = 193/313 (61%)

Query:   127 RFNSLRLA--GKKD-TVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAV 182
             R+ S  +A  GK + +  +  +  L  AT NF   N +GEGG G VYK +    + + AV
Sbjct:    51 RYISEEIAKLGKGNISAHIFTFRELCVATKNFNPDNQLGEGGFGRVYKGQIETPEQVVAV 110

Query:   183 KRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHG 242
             K++D  G+   REF  EV  L+ + HQN+++L+GYC   + R LVYE MQNGSLE  L  
Sbjct:   111 KQLDRNGYQGNREFLVEVMMLSLLHHQNLVNLVGYCADGDQRILVYEYMQNGSLEDHLLE 170

Query:   243 PTHGSN--LTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFG 300
                     L W  RMK+A   ARGLEYLHE  + PV++RD K+SNILLD  FN KLSDFG
Sbjct:   171 LARNKKKPLDWDTRMKVAAGAARGLEYLHETADPPVIYRDFKASNILLDEEFNPKLSDFG 230

Query:   301 LSV---TAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKM 357
             L+    T G    + ++ GT GY APEY L G+LT KSDVY+FGVV LE++ GRR ++  
Sbjct:   231 LAKVGPTGGETHVSTRVMGTYGYCAPEYALTGQLTVKSDVYSFGVVFLEMITGRRVIDTT 290

Query:   358 SPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLI 417
              PT+ Q++VTWA P   DR K   + DP++     +K LYQ  AVA +C+Q E + RP++
Sbjct:   291 KPTEEQNLVTWASPLFKDRRKFTLMADPLLEGKYPIKGLYQALAVAAMCLQEEAATRPMM 350

Query:   418 TDVLHSLIPLVPT 430
             +DV+ +L  L  T
Sbjct:   351 SDVVTALEYLAVT 363

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2010965 AT1G54820 [Arabidopsis thaliana (taxid:3702)]

 Score = 655 (235.6 bits), Expect = 2.9e-64, P = 2.9e-64
 Identities = 141/309 (45%), Positives = 197/309 (63%)

Query:   136 KKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRI----DDAGHD 191
             + + V V  Y+ LE ATNNF E   IG G    VYK   ++  +AA+K++    D+A + 
Sbjct:   128 RAEGVEVYTYKELEIATNNFSEEKKIGNGD---VYKGVLSDGTVAAIKKLHMFNDNASNQ 184

Query:   192 A--EREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGS-- 247
                ER F  EV+ L++++   ++ LLGYC     R L+YE M NG++E  LH     +  
Sbjct:   185 KHEERSFRLEVDLLSRLQCPYLVELLGYCADQNHRILIYEFMPNGTVEHHLHDHNFKNLK 244

Query:   248 ----NLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSV 303
                  L W  R++IA+D AR LE+LHE+    V+HR+ K +NILLD +  AK+SDFGL+ 
Sbjct:   245 DRPQPLDWGARLRIALDCARALEFLHENTISTVIHRNFKCTNILLDQNNRAKVSDFGLAK 304

Query:   304 TAGTQSRNVKIS----GTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSP 359
             T G+   N +IS    GT GY+APEY   GKLT KSDVY++G+VLL+LL GR P++   P
Sbjct:   305 T-GSDKLNGEISTRVIGTTGYLAPEYASTGKLTTKSDVYSYGIVLLQLLTGRTPIDSRRP 363

Query:   360 TQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITD 419
                  +V+WA+P+LT+R K+  +VDP ++     K L QVAA+A +C+QPE SYRPL+TD
Sbjct:   364 RGQDVLVSWALPRLTNREKISEMVDPTMKGQYSQKDLIQVAAIAAVCVQPEASYRPLMTD 423

Query:   420 VLHSLIPLV 428
             V+HSLIPLV
Sbjct:   424 VVHSLIPLV 432

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2036818 AT1G61860 [Arabidopsis thaliana (taxid:3702)]

 Score = 653 (234.9 bits), Expect = 4.7e-64, P = 4.7e-64
 Identities = 135/293 (46%), Positives = 188/293 (64%)

Query:   137 KDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAERE 195
             K+   + +++ L AAT+NF    +IGEGG G VYK        + AVKR+D  G    RE
Sbjct:    67 KNCGRIFKFKELIAATDNFSMDCMIGEGGFGRVYKGFLTSLNQVVAVKRLDRNGLQGTRE 126

Query:   196 FNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGS-NLTWHLR 254
             F  EV  L+  +H N+++L+GYC+  E R LVYE M NGSLE  L     GS +L W  R
Sbjct:   127 FFAEVMVLSLAQHPNLVNLIGYCVEDEQRVLVYEFMPNGSLEDHLFDLPEGSPSLDWFTR 186

Query:   255 MKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN--- 311
             M+I    A+GLEYLH++ + PV++RD K+SNILL S FN+KLSDFGL+    T+ ++   
Sbjct:   187 MRIVHGAAKGLEYLHDYADPPVIYRDFKASNILLQSDFNSKLSDFGLARLGPTEGKDHVS 246

Query:   312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
              ++ GT GY APEY + G+LT KSDVY+FGVVLLE++ GRR ++   PT+ Q++++WA P
Sbjct:   247 TRVMGTYGYCAPEYAMTGQLTAKSDVYSFGVVLLEIISGRRAIDGDRPTEEQNLISWAEP 306

Query:   372 QLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
              L DR     IVDP +     +K L+Q  A+A +C+Q E   RPL+ DV+ +L
Sbjct:   307 LLKDRRMFAQIVDPNLDGNYPVKGLHQALAIAAMCLQEEAETRPLMGDVVTAL 359

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2120683 SRF8 "STRUBBELIG-receptor family 8" [Arabidopsis thaliana (taxid:3702)]

 Score = 627 (225.8 bits), Expect = 6.1e-64, Sum P(2) = 6.1e-64
 Identities = 130/295 (44%), Positives = 181/295 (61%)

Query:   139 TVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFN- 197
             T S      L+ ATN+F + N+IGEG  G VY+A F    + A+K+ID+A    + E N 
Sbjct:   379 TASQYTVSSLQVATNSFSQENIIGEGSLGRVYRAEFPNGKIMAIKKIDNAALSLQEEDNF 438

Query:   198 -NEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLH-GPTHGSNLTWHLRM 255
                V+ ++++RH NI+ L GYC     R LVYE + NG+L+  LH       NLTW+ R+
Sbjct:   439 LEAVSNMSRLRHPNIVPLAGYCTEHGQRLLVYEYVGNGNLDDTLHTNDDRSMNLTWNARV 498

Query:   256 KIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS-VTAGTQSR-NVK 313
             K+A+  A+ LEYLHE C   +VHR+ KS+NILLD   N  LSD GL+ +T  T+ + + +
Sbjct:   499 KVALGTAKALEYLHEVCLPSIVHRNFKSANILLDEELNPHLSDSGLAALTPNTERQVSTQ 558

Query:   314 ISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQL 373
             + G+ GY APE+ L G  T KSDVY FGVV+LELL GR+P++       QS+V WA PQL
Sbjct:   559 VVGSFGYSAPEFALSGIYTVKSDVYTFGVVMLELLTGRKPLDSSRTRAEQSLVRWATPQL 618

Query:   374 TDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLV 428
              D   L  +VDP +      K L + A +  LCIQPEP +RP +++V+  L+ LV
Sbjct:   619 HDIDALSKMVDPSLNGMYPAKSLSRFADIIALCIQPEPEFRPPMSEVVQQLVRLV 673

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009624 "response to nematode" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0048653 "anther development" evidence=RCA

TAIR|locus:2038992 ALE2 "Abnormal Leaf Shape 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 648 (233.2 bits), Expect = 1.6e-63, P = 1.6e-63
 Identities = 143/341 (41%), Positives = 205/341 (60%)

Query:    96 IYRWKRL-KNTN--GNS-KQTIDG--GKGLSLSPILERFNSLRLAGKKDT--VSVIEYEL 147
             I +WK++ K++N  G +   +I+   G G   S       S  L     T  +SV  + L
Sbjct:   280 IVKWKKIGKSSNAVGPALAPSINKRPGAGSMFSSSARSSGSDSLMSSMATCALSVKTFTL 339

Query:   148 --LEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTK 205
               LE AT+ F    V+GEGG G VY+    +    AVK +     + +REF  EV  L++
Sbjct:   340 SELEKATDRFSAKRVLGEGGFGRVYQGSMEDGTEVAVKLLTRDNQNRDREFIAEVEMLSR 399

Query:   206 IRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
             + H+N++ L+G CI   TR L+YE++ NGS+E  LH  T    L W  R+KIA+  ARGL
Sbjct:   400 LHHRNLVKLIGICIEGRTRCLIYELVHNGSVESHLHEGT----LDWDARLKIALGAARGL 455

Query:   266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAP 323
              YLHE  N  V+HRD K+SN+LL+  F  K+SDFGL+   T G+Q  + ++ GT GYVAP
Sbjct:   456 AYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHISTRVMGTFGYVAP 515

Query:   324 EYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
             EY + G L  KSDVY++GVVLLELL GRRPV+   P+  +++VTWA P L +R  L  +V
Sbjct:   516 EYAMTGHLLVKSDVYSYGVVLLELLTGRRPVDMSQPSGEENLVTWARPLLANREGLEQLV 575

Query:   384 DPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
             DP +  T +   + +VAA+A +C+  E S+RP + +V+ +L
Sbjct:   576 DPALAGTYNFDDMAKVAAIASMCVHQEVSHRPFMGEVVQAL 616

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010068 "protoderm histogenesis" evidence=IMP

GO:0042335 "cuticle development" evidence=IMP

GO:0048367 "shoot system development" evidence=IGI

GO:0048645 "organ formation" evidence=IMP

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009664 "plant-type cell wall organization" evidence=RCA

GO:0009965 "leaf morphogenesis" evidence=RCA

GO:0042545 "cell wall modification" evidence=RCA

TAIR|locus:2179857 PBS1 "avrPphB susceptible 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 640 (230.4 bits), Expect = 1.1e-62, P = 1.1e-62
 Identities = 132/282 (46%), Positives = 175/282 (62%)

Query:   148 LEAATNNFQESNVIGEGGRGHVYKARFNEK-LLAAVKRIDDAGHDAEREFNNEVNWLTKI 206
             L AAT NF     +GEGG G VYK R +    + AVK++D  G    REF  EV  L+ +
Sbjct:    79 LAAATMNFHPDTFLGEGGFGRVYKGRLDSTGQVVAVKQLDRNGLQGNREFLVEVLMLSLL 138

Query:   207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHG-PTHGSNLTWHLRMKIAVDVARGL 265
              H N+++L+GYC   + R LVYE M  GSLE  LH  P     L W++RMKIA   A+GL
Sbjct:   139 HHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNMRMKIAAGAAKGL 198

Query:   266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN---VKISGTLGYVA 322
             E+LH+  N PV++RD KSSNILLD  F+ KLSDFGL+    T  ++    ++ GT GY A
Sbjct:   199 EFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCA 258

Query:   323 PEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNI 382
             PEY + G+LT KSDVY+FGVV LEL+ GR+ ++   P   Q++V WA P   DR K   +
Sbjct:   259 PEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSEMPHGEQNLVAWARPLFNDRRKFIKL 318

Query:   383 VDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
              DP ++     + LYQ  AVA +CIQ + + RPLI DV+ +L
Sbjct:   319 ADPRLKGRFPTRALYQALAVASMCIQEQAATRPLIADVVTAL 360

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0009816 "defense response to bacterium, incompatible interaction" evidence=IMP

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0006952 "defense response" evidence=TAS

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0004672 "protein kinase activity" evidence=IDA

GO:0042742 "defense response to bacterium" evidence=IMP

TAIR|locus:2087263 AT3G24790 [Arabidopsis thaliana (taxid:3702)]

 Score = 638 (229.6 bits), Expect = 1.8e-62, P = 1.8e-62
 Identities = 132/288 (45%), Positives = 185/288 (64%)

Query:   142 VIEYELLEAATNNFQESNVIGEGGRGHVYKARF-NEKLLAAVKRIDDAGHDAEREFNNEV 200
             +  +  L  AT NF++  +IGEGG G VYK +  N   + AVK++D  G   +REF  EV
Sbjct:    34 IFTFRELATATKNFRQECLIGEGGFGRVYKGKLENPAQVVAVKQLDRNGLQGQREFLVEV 93

Query:   201 NWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSN-LTWHLRMKIAV 259
               L+ + H+N+++L+GYC   + R LVYE M  GSLE  L     G   L W+ R+KIA+
Sbjct:    94 LMLSLLHHRNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLLDLEPGQKPLDWNTRIKIAL 153

Query:   260 DVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSV---TAGTQSRNVKISG 316
               A+G+EYLH+  + PV++RDLKSSNILLD  + AKLSDFGL+       T   + ++ G
Sbjct:   154 GAAKGIEYLHDEADPPVIYRDLKSSNILLDPEYVAKLSDFGLAKLGPVGDTLHVSSRVMG 213

Query:   317 TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDR 376
             T GY APEY   G LT+KSDVY+FGVVLLEL+ GRR ++ M P+  Q++VTWA+P   D 
Sbjct:   214 TYGYCAPEYQRTGYLTNKSDVYSFGVVLLELISGRRVIDTMRPSHEQNLVTWALPIFRDP 273

Query:   377 SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
             ++   + DP++R     K L Q  AVA +C+  EP+ RPL++DV+ +L
Sbjct:   274 TRYWQLADPLLRGDYPEKSLNQAIAVAAMCLHEEPTVRPLMSDVITAL 321

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q0V7T5	Y1864_ARATH	2, ., 7, ., 1, 1, ., 1	0.5770	0.9612	0.9882	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	439
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	9e-52
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	5e-51
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-49
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	6e-48
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-47
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-47
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-41
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	5e-39
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	4e-37
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	9e-32
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-31
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-31
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	4e-30
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-29
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	4e-29
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	8e-29
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	3e-28
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	6e-28
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	7e-28
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-27
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	9e-27
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	9e-27
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-26
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-26
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	7e-26
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-25
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-25
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-25
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-25
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-25
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-25
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-25
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	6e-25
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	6e-25
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	6e-25
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-23
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-23
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-23
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-23
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-23
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-23
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-23
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-23
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	5e-23
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	6e-23
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	6e-23
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	7e-23
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	9e-23
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-22
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-22
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-22
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-22
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-22
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	5e-22
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	9e-22
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	9e-22
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	9e-22
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-21
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-21
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-21
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-21
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	3e-21
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	3e-21
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	5e-21
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	5e-21
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	6e-21
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	8e-21
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	8e-21
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-20
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-20
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-20
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-20
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	4e-20
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	6e-20
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	9e-20
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-19
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-19
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-19
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-19
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-19
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-19
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	4e-19
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	4e-19
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	4e-19
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	4e-19
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	4e-19
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	4e-19
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	5e-19
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	5e-19
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	5e-19
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	5e-19
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	6e-19
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	6e-19
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	8e-19
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	9e-19
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	9e-19
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-18
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-18
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-18
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-18
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-18
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-18
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-18
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-18
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-18
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-18
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-18
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	4e-18
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	5e-18
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	5e-18
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	7e-18
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	7e-18
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	8e-18
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	8e-18
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-17
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-17
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-17
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-17
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-17
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-17
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-17
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-17
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-17
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	3e-17
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	4e-17
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	5e-17
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	5e-17
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	5e-17
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	6e-17
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	7e-17
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	7e-17
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	9e-17
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	9e-17
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-16
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-16
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-16
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-16
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-16
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-16
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-16
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-16
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-16
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-16
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-16
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-16
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-16
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	4e-16
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	4e-16
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	4e-16
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	4e-16
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	4e-16
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	6e-16
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	6e-16
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	7e-16
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	9e-16
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	9e-16
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-15
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-15
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-15
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-15
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-15
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-15
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-15
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-15
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-15
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-15
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	4e-15
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	5e-15
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	5e-15
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	5e-15
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	6e-15
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	6e-15
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	6e-15
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-14
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-14
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-14
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-14
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-14
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-14
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-14
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	4e-14
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	4e-14
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	4e-14
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	5e-14
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-13
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-13
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-13
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-13
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-13
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-13
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	4e-13
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	4e-13
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	5e-13
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	5e-13
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	6e-13
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	6e-13
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	7e-13
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	8e-13
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	8e-13
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	9e-13
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	9e-13
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-12
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-12
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-12
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-12
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-12
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-12
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-12
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-12
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-12
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	4e-12
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	4e-12
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	6e-12
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	8e-12
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	8e-12
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	9e-12
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-11
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-11
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-11
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-11
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-11
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-11
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-11
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	3e-11
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	4e-11
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	5e-11
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	6e-11
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	7e-11
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	9e-11
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-10
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	1e-10
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-10
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-10
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-10
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-10
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-10
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-10
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-10
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-10
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	2e-10
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-10
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	3e-10
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	3e-10
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	4e-10
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	4e-10
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	4e-10
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	4e-10
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	5e-10
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	5e-10
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	6e-10
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	6e-10
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	6e-10
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	8e-10
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-09
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-09
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	1e-09
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-09
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-09
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-09
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	2e-09
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	2e-09
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-09
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-09
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-09
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	4e-09
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	4e-09
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	6e-09
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	7e-09
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	7e-09
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-08
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-08
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-08
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-08
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-08
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-08
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-08
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-08
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-08
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	3e-08
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	4e-08
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	6e-08
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	7e-08
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	7e-08
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	7e-08
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	8e-08
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-07
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-07
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-07
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	3e-07
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	3e-07
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	3e-07
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	9e-07
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	9e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-06
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	1e-06
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-06
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-06
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-06
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	6e-06
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	6e-06
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	9e-06
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	3e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	4e-05
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	9e-05
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-04
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	3e-04
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	3e-04
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	0.002

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  174 bits (444), Expect = 9e-52
 Identities = 85/277 (30%), Positives = 127/277 (45%), Gaps = 36/277 (12%)

Query: 160 VIGEGGRGHVYKAR-----FNEKLLAAVKRI-DDAGHDAEREFNNEVNWLTKIRHQNIIS 213
            +GEG  G VYK          +   AVK + + A  +   EF  E + + K+ H NI+ 
Sbjct: 6   KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65

Query: 214 LLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
           LLG C   E  ++V E M  G L   L    HG  LT    +++A+ +A+G+EYL     
Sbjct: 66  LLGVCTQGEPLYIVTEYMPGGDLLDFLR--KHGEKLTLKDLLQMALQIAKGMEYLES--- 120

Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLG---YVAPEYLLEGK 330
              VHRDL + N L+  +   K+SDFGLS          K  G      ++APE L +GK
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGK 180

Query: 331 LTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRSKL--PNIVDPVI 387
            T KSDV++FGV+L E+  +G +P   MS  +        +  L D  +L  P      +
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE-------VLELLEDGYRLPRPENCPDEL 233

Query: 388 RDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
            + M            + C   +P  RP  ++++  L
Sbjct: 234 YELM------------LQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  171 bits (435), Expect = 5e-51
 Identities = 73/192 (38%), Positives = 103/192 (53%), Gaps = 10/192 (5%)

Query: 161 IGEGGRGHVYKAR-FNEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNIISLLGYC 218
           +GEGG G VY AR        A+K I  +       E   E+  L K+ H NI+ L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 219 IHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVH 278
                 +LV E  + GSL+  L    +   L+    ++I + +  GLEYLH    + ++H
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLK--ENEGKLSEDEILRILLQILEGLEYLHS---NGIIH 115

Query: 279 RDLKSSNILLDS-SFNAKLSDFGLSVTAGTQSRNVK-ISGTLGYVAPEYLL-EGKLTDKS 335
           RDLK  NILLDS +   KL+DFGLS    +    +K I GT  Y+APE LL +G  ++KS
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKS 175

Query: 336 DVYAFGVVLLEL 347
           D+++ GV+L EL
Sbjct: 176 DIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  168 bits (428), Expect = 2e-49
 Identities = 80/285 (28%), Positives = 125/285 (43%), Gaps = 43/285 (15%)

Query: 159 NVIGEGGRGHVYKARF----NEKLLAAVKRI-DDAGHDAEREFNNEVNWLTKIRHQNIIS 213
             +GEG  G VYK +      +    AVK + +DA  +  ++F  E   + K+ H N++ 
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 214 LLGYCIHAETRFLVYEMMQNGSL------EKQLHGPTHGSNLTWHLRMKIAVDVARGLEY 267
           LLG C   E  +LV E M+ G L       + +      S L+    +  A+ +A+G+EY
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 268 LHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYV-----A 322
           L        VHRDL + N L+      K+SDFGLS        +     T G +     A
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRD--VYDDDYYRKKTGGKLPIRWMA 175

Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRSKL-- 379
           PE L +G  T KSDV++FGV+L E+  +G  P   +S  +        +  L    +L  
Sbjct: 176 PESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV-------LEYLRKGYRLPK 228

Query: 380 PNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
           P      + + M            + C Q +P  RP  ++++  L
Sbjct: 229 PEYCPDELYELM------------LSCWQLDPEDRPTFSELVERL 261

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  164 bits (418), Expect = 6e-48
 Identities = 86/276 (31%), Positives = 128/276 (46%), Gaps = 35/276 (12%)

Query: 160 VIGEGGRGHVYKAR-----FNEKLLAAVKRI-DDAGHDAEREFNNEVNWLTKIRHQNIIS 213
            +GEG  G VYK +       +K+  AVK + +DA      EF  E   + K+ H N++ 
Sbjct: 6   KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65

Query: 214 LLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
           LLG C   E  ++V E M+ G L   L    +   L+    +  A+ +ARG+EYL     
Sbjct: 66  LLGVCTEEEPLYIVMEYMEGGDLLSYLR--KNRPKLSLSDLLSFALQIARGMEYLES--- 120

Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGY--VAPEYLLEGKL 331
              +HRDL + N L+  +   K+SDFGLS          K  G L    +APE L EGK 
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKF 180

Query: 332 TDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRSKL--PNIVDPVIR 388
           T KSDV++FGV+L E+  +G +P   MS  +        +  L +  +L  P    P + 
Sbjct: 181 TSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE-------VLEYLKNGYRLPQPPNCPPELY 233

Query: 389 DTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
           D M            + C   +P  RP  ++++  L
Sbjct: 234 DLM------------LQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  163 bits (415), Expect = 1e-47
 Identities = 68/201 (33%), Positives = 94/201 (46%), Gaps = 8/201 (3%)

Query: 155 FQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAERE-FNNEVNWLTKIRHQNII 212
           ++    +GEG  G VY AR  +   L A+K I       +RE    E+  L K++H NI+
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 213 SLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
            L       +  +LV E  + G L   L     G  L+          +   LEYLH   
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLLK--KRGR-LSEDEARFYLRQILSALEYLHSKG 117

Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLT 332
              +VHRDLK  NILLD   + KL+DFGL+       +     GT  Y+APE LL     
Sbjct: 118 ---IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYG 174

Query: 333 DKSDVYAFGVVLLELLMGRRP 353
              D+++ GV+L ELL G+ P
Sbjct: 175 KAVDIWSLGVILYELLTGKPP 195

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  163 bits (414), Expect = 2e-47
 Identities = 82/274 (29%), Positives = 120/274 (43%), Gaps = 30/274 (10%)

Query: 160 VIGEGGRGHVYKAR-----FNEKLLAAVKRI-DDAGHDAEREFNNEVNWLTKIRHQNIIS 213
            +GEG  G VYK         +++  AVK + +DA      EF  E   + K+ H NI+ 
Sbjct: 6   KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65

Query: 214 LLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
           LLG C   E   +V E M  G L   L        L+    +  A+ +ARG+EYL     
Sbjct: 66  LLGVCTEEEPLMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQIARGMEYLES--- 121

Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGY--VAPEYLLEGKL 331
              +HRDL + N L+  +   K+SDFGLS             G L    +APE L EGK 
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKF 181

Query: 332 TDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDT 390
           T KSDV++FGV+L E+  +G  P   MS  +        +  L    +LP          
Sbjct: 182 TSKSDVWSFGVLLWEIFTLGEEPYPGMSNAE-------VLEYLKKGYRLP------KPPN 228

Query: 391 MDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
              +    +  + + C   +P  RP  ++++  L
Sbjct: 229 CPPE----LYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  147 bits (374), Expect = 2e-41
 Identities = 70/204 (34%), Positives = 103/204 (50%), Gaps = 11/204 (5%)

Query: 155 FQESNVIGEGGRGHVYKARF-NEKLLAAVKRI--DDAGHDAEREFNNEVNWLTKIRHQNI 211
           ++    +G G  G VYKA+      + AVK +         ++    E+  L ++ H NI
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 212 ISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
           + L+      +  +LV E  + G L   L     G  L+     KIA+ + RGLEYLH +
Sbjct: 61  VRLIDAFEDKDHLYLVMEYCEGGDLFDYLS--RGG-PLSEDEAKKIALQILRGLEYLHSN 117

Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK-ISGTLGYVAPEYLLEGK 330
               ++HRDLK  NILLD +   K++DFGL+      S ++    GT  Y+APE LL G 
Sbjct: 118 ---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGN 174

Query: 331 L-TDKSDVYAFGVVLLELLMGRRP 353
               K DV++ GV+L ELL G+ P
Sbjct: 175 GYGPKVDVWSLGVILYELLTGKPP 198

Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  140 bits (356), Expect = 5e-39
 Identities = 68/211 (32%), Positives = 109/211 (51%), Gaps = 14/211 (6%)

Query: 155 FQESNVIGEGGRGHVYKARF-NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIIS 213
           F+    IG+GG G VYKAR        A+K I     + + +  NE+  L K +H NI+ 
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 214 LLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAV---DVARGLEYLHE 270
             G  +  +  ++V E    GSL+  L         +      IA    ++ +GLEYLH 
Sbjct: 62  YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQ-----IAYVCKELLKGLEYLH- 115

Query: 271 HCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT-AGTQSRNVKISGTLGYVAPEYLLEG 329
             ++ ++HRD+K++NILL S    KL DFGLS   + T++RN  + GT  ++APE +   
Sbjct: 116 --SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN-TMVGTPYWMAPEVINGK 172

Query: 330 KLTDKSDVYAFGVVLLELLMGRRPVEKMSPT 360
               K+D+++ G+  +EL  G+ P  ++ P 
Sbjct: 173 PYDYKADIWSLGITAIELAEGKPPYSELPPM 203

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  135 bits (343), Expect = 4e-37
 Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 14/208 (6%)

Query: 154 NFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAE--REFNNEVNWLTKIRHQN 210
            +    ++G G  G VY A   +   L AVK ++ +G   E       E+  L+ ++H N
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60

Query: 211 IISLLGYCIHAETRFL-VY-EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYL 268
           I+   G     E   L ++ E +  GSL   L        L   +  K    +  GL YL
Sbjct: 61  IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKK---FGKLPEPVIRKYTRQILEGLAYL 117

Query: 269 HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSV---TAGTQSRNVKISGTLGYVAPEY 325
           H +    +VHRD+K +NIL+DS    KL+DFG +       T      + GT  ++APE 
Sbjct: 118 HSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV 174

Query: 326 LLEGKLTDKSDVYAFGVVLLELLMGRRP 353
           +   +    +D+++ G  ++E+  G+ P
Sbjct: 175 IRGEEYGRAADIWSLGCTVIEMATGKPP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  124 bits (311), Expect = 9e-32
 Identities = 74/287 (25%), Positives = 115/287 (40%), Gaps = 25/287 (8%)

Query: 154 NFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRHQ- 209
           +++    +GEG  G VY AR  +    A+K +             F  E+  L  + H  
Sbjct: 1   SYRILRKLGEGSFGEVYLARDRKL--VALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 210 NIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLH 269
           NI+ L  +     + +LV E +  GSLE  L        L+    + I   +   LEYLH
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 270 EHCNHPVVHRDLKSSNILLDS-SFNAKLSDFGLS-------VTAGTQSRNVKISGTLGYV 321
                 ++HRD+K  NILLD      KL DFGL+        T+   +      GT GY+
Sbjct: 119 SKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175

Query: 322 APEYLL---EGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSK 378
           APE LL       +  SD+++ G+ L ELL G  P E    +   S  T  +        
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQ-TLKIILELPTPS 234

Query: 379 LPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLI 425
           L + + P   + +        + +    +  +P  R   +  L   +
Sbjct: 235 LASPLSPSNPELISK----AASDLLKKLLAKDPKNRLSSSSDLSHDL 277

Length = 384

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  121 bits (305), Expect = 2e-31
 Identities = 74/225 (32%), Positives = 113/225 (50%), Gaps = 43/225 (19%)

Query: 160 VIGEGGRGHVYKARF------NEKLLAAVKRIDD-AGHDAEREFNNEVNWLTKIRHQNII 212
            +GEG  G V+          N+K L AVK + + A +DA ++F  E   LT  +H+NI+
Sbjct: 12  ELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIV 71

Query: 213 SLLGYCIHAETRFLVYEMMQNGSLEKQL--HGP----------THGSNLTWHLRMKIAVD 260
              G C   +   +V+E M++G L K L  HGP            G  LT    ++IAV 
Sbjct: 72  KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGE-LTLSQLLQIAVQ 130

Query: 261 VARGLEYL-HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV------K 313
           +A G+ YL  +H     VHRDL + N L+      K+ DFG+       SR+V      +
Sbjct: 131 IASGMVYLASQH----FVHRDLATRNCLVGYDLVVKIGDFGM-------SRDVYTTDYYR 179

Query: 314 ISGT----LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRP 353
           + G     + ++ PE ++  K T +SDV++FGVVL E+   G++P
Sbjct: 180 VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  120 bits (302), Expect = 3e-31
 Identities = 75/267 (28%), Positives = 126/267 (47%), Gaps = 29/267 (10%)

Query: 154 NFQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHDAE--REFNNEVNWLTKIRHQ 209
           N+Q  ++IG G  G VYK   N +     A+K+I       E  +    E++ L  ++H 
Sbjct: 1   NYQLGDLIGRGAFGVVYKG-LNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHP 59

Query: 210 NIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLH 269
           NI+  +G    +++ +++ E  +NGSL + +     G      L       V +GL YLH
Sbjct: 60  NIVKYIGSIETSDSLYIILEYAENGSLRQIIK--KFG-PFPESLVAVYVYQVLQGLAYLH 116

Query: 270 EHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK-ISGTLGYVAPEYLLE 328
           E     V+HRD+K++NIL       KL+DFG++      S++   + GT  ++APE +  
Sbjct: 117 EQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEM 173

Query: 329 GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIR 388
              +  SD+++ G  ++ELL G  P   ++P        + + Q  D   LP  + P ++
Sbjct: 174 SGASTASDIWSLGCTVIELLTGNPPYYDLNPMA----ALFRIVQ-DDHPPLPEGISPELK 228

Query: 389 DTMDLKHLYQVAAVAVLCIQPEPSYRP 415
           D      L Q       C Q +P+ RP
Sbjct: 229 D-----FLMQ-------CFQKDPNLRP 243

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  117 bits (294), Expect = 4e-30
 Identities = 83/280 (29%), Positives = 130/280 (46%), Gaps = 37/280 (13%)

Query: 156 QESNVIGEGGRGHVYKA-RFNEKLLAAVK--RIDDAGHDAEREFNNEVNWLTKIRHQNII 212
           Q  N IG G  G VY A   +   L AVK  RI D      +E  +E+  L  ++H N++
Sbjct: 3   QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLV 62

Query: 213 SLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
              G  +H E  ++  E    G+LE+ L    HG  L  H+     + +  GL YLH H 
Sbjct: 63  KYYGVEVHREKVYIFMEYCSGGTLEELLE---HGRILDEHVIRVYTLQLLEGLAYLHSH- 118

Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV-----KISGTLGYVAPEYLL 327
              +VHRD+K +NI LD +   KL DFG +V     +  +      ++GT  Y+APE + 
Sbjct: 119 --GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176

Query: 328 EGKLTDK---SDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAM---PQLTDRSKLPN 381
            GK       +D+++ G V+LE+  G+RP  ++   + Q M        P + D  +L  
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD-NEFQIMFHVGAGHKPPIPDSLQL-- 233

Query: 382 IVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
              P  +D +D             C++ +P  RP  +++L
Sbjct: 234 --SPEGKDFLD------------RCLESDPKKRPTASELL 259

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  115 bits (291), Expect = 1e-29
 Identities = 73/279 (26%), Positives = 115/279 (41%), Gaps = 37/279 (13%)

Query: 158 SNVIGEGGRGHVYKARF-----NEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNI 211
              +GEG  G V   R+     N     AVK ++         +F  E+  L  + H+NI
Sbjct: 9   IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68

Query: 212 ISLLGYC--IHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLH 269
           +   G C      +  L+ E + +GSL   L    H   +     +  +  + +G++YL 
Sbjct: 69  VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLG 126

Query: 270 EHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLG-----YVAPE 324
              +   +HRDL + NIL++S    K+SDFGL+     + ++       G     + APE
Sbjct: 127 ---SQRYIHRDLAARNILVESEDLVKISDFGLA-KVLPEDKDYYYVKEPGESPIFWYAPE 182

Query: 325 YLLEGKLTDKSDVYAFGVVLLELLMGRRP--------VEKMSPTQCQSMVTWAMPQLTDR 376
            L   K +  SDV++FGV L EL     P        +  +   Q Q +VT  +  L + 
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEG 242

Query: 377 SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRP 415
            +LP        +  DL           LC + EP  RP
Sbjct: 243 ERLPR-PPSCPDEVYDL---------MKLCWEAEPQDRP 271

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  114 bits (287), Expect = 4e-29
 Identities = 76/277 (27%), Positives = 113/277 (40%), Gaps = 39/277 (14%)

Query: 159 NVIGEGGRGHVYKARFNE-KLLAAVKRID-DAGHDAEREF-NNEVNWLTKIRHQNIISLL 215
             IG+G  G VY  R      L  +K ID     + ERE   NEV  L K+ H NII   
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65

Query: 216 GYCIHAETRFLVYEMMQNGSLEKQLH-GPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNH 274
                     +V E    G L +++      G        +   V +   L+YLH     
Sbjct: 66  ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR--- 122

Query: 275 PVVHRDLKSSNILLDSSFNAKLSDFGLS-VTAGTQSRNVKISGTLGYVAPEYLLEGK-LT 332
            ++HRD+K  NI L S+   KL DFG+S V + T      + GT  Y++PE L + K   
Sbjct: 123 KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPE-LCQNKPYN 181

Query: 333 DKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDR------SKLPNIVDPV 386
            KSD+++ G VL EL   + P E  +           + +L  +        +P+     
Sbjct: 182 YKSDIWSLGCVLYELCTLKHPFEGEN-----------LLELALKILKGQYPPIPSQYSSE 230

Query: 387 IRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS 423
           +R+ +               +Q +P  RP I  +L S
Sbjct: 231 LRNLVS------------SLLQKDPEERPSIAQILQS 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  113 bits (284), Expect = 8e-29
 Identities = 67/218 (30%), Positives = 106/218 (48%), Gaps = 24/218 (11%)

Query: 161 IGEGGRGHVYKARFNEKLLAAVK--RIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYC 218
           IG+G  G VYK         AVK  R        +R+F  E   L +  H NI+ L+G C
Sbjct: 3   IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDL-KRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 219 IHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVH 278
           +  +  ++V E++  GSL   L      + LT    +++++D A G+EYL        +H
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIH 116

Query: 279 RDLKSSNILLDSSFNAKLSDFGLS---------VTAGTQSRNVKISGTLGYVAPEYLLEG 329
           RDL + N L+  +   K+SDFG+S         V+ G +   +K      + APE L  G
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIK------WTAPEALNYG 170

Query: 330 KLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
           + T +SDV+++G++L E   +G  P   MS  Q +  +
Sbjct: 171 RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI 208

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  112 bits (281), Expect = 3e-28
 Identities = 71/203 (34%), Positives = 108/203 (53%), Gaps = 17/203 (8%)

Query: 161 IGEGGRGHVYKARF-NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCI 219
           IG+G  G V    +  +K+  AVK + D    A+  F  E + +T +RH N++ LLG  +
Sbjct: 14  IGKGEFGDVMLGDYRGQKV--AVKCLKDDSTAAQ-AFLAEASVMTTLRHPNLVQLLGVVL 70

Query: 220 HAETRFLVYEMMQNGSLEKQLHGPTHG-SNLTWHLRMKIAVDVARGLEYLHEHCNHPVVH 278
                ++V E M  GSL   L   + G + +T   ++  A+DV  G+EYL E      VH
Sbjct: 71  QGNPLYIVTEYMAKGSLVDYLR--SRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVH 125

Query: 279 RDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSD 336
           RDL + N+L+     AK+SDFGL+   + G  S  + +  T    APE L E K + KSD
Sbjct: 126 RDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----APEALREKKFSTKSD 181

Query: 337 VYAFGVVLLELL-MGRRPVEKMS 358
           V++FG++L E+   GR P  ++ 
Sbjct: 182 VWSFGILLWEIYSFGRVPYPRIP 204

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  111 bits (280), Expect = 6e-28
 Identities = 74/304 (24%), Positives = 130/304 (42%), Gaps = 53/304 (17%)

Query: 138 DTVSVIEYELLEAA--TNNFQESNVIGEGGRGHVYKAR---FNEKLLAAVKRIDDAGHDA 192
           + +     +++        ++    IGEG  G VYKA      +++  A+K++     + 
Sbjct: 2   EELKAALKDIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEV--AIKKMRLRKQNK 59

Query: 193 EREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWH 252
           E   N E+  +   +H NI+      +  +  ++V E M  GSL   +         T +
Sbjct: 60  ELIIN-EILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDII---------TQN 109

Query: 253 -LRMK------IAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSV-- 303
            +RM       +  +V +GLEYLH   +  V+HRD+KS NILL    + KL+DFG +   
Sbjct: 110 FVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQL 166

Query: 304 TAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQ 363
           T     RN  + GT  ++APE +       K D+++ G++ +E+  G  P  +  P +  
Sbjct: 167 TKEKSKRN-SVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR-- 223

Query: 364 SMVTWAMPQLTD----RSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITD 419
                A+  +T       K P    P  +D ++             C+  +P  RP   +
Sbjct: 224 -----ALFLITTKGIPPLKNPEKWSPEFKDFLN------------KCLVKDPEKRPSAEE 266

Query: 420 VLHS 423
           +L  
Sbjct: 267 LLQH 270

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  110 bits (278), Expect = 7e-28
 Identities = 82/278 (29%), Positives = 132/278 (47%), Gaps = 37/278 (13%)

Query: 159 NVIGEGGRGHVYKARFN----EKLLAAVKRIDDAGHDAER-EFNNEVNWLTKIRHQNIIS 213
            VIG G  G V + R      +++  A+K +     D +R +F  E + + +  H NII 
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69

Query: 214 LLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
           L G    +    ++ E M+NGSL+K L    +    T    + +   +A G++YL E   
Sbjct: 70  LEGVVTKSRPVMIITEYMENGSLDKFLR--ENDGKFTVGQLVGMLRGIASGMKYLSEMN- 126

Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLS-----VTAGTQSRNVKISGTLGYVAPEYLLE 328
              VHRDL + NIL++S+   K+SDFGLS       A   ++  KI   + + APE +  
Sbjct: 127 --YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIP--IRWTAPEAIAY 182

Query: 329 GKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVD-PV 386
            K T  SDV++FG+V+ E++  G RP   MS           +  + D  +LP  +D P 
Sbjct: 183 RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD-------VIKAVEDGYRLPPPMDCPS 235

Query: 387 IRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
                    LYQ   + + C Q + + RP  + ++ +L
Sbjct: 236 A--------LYQ---LMLDCWQKDRNERPTFSQIVSTL 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score =  110 bits (276), Expect = 2e-27
 Identities = 82/295 (27%), Positives = 126/295 (42%), Gaps = 40/295 (13%)

Query: 149 EAATNNFQESNVIGEGGRGHVYKARF------NEKLLAAVKRI-DDAGHDAEREFNNEVN 201
           E   ++      +G G  G VY+  +        +L  AVK + +      E +F  E  
Sbjct: 2   EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61

Query: 202 WLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLH----GPTHGSNLTWHLRMKI 257
            ++K  HQNI+ L+G       RF++ E+M  G L+  L      P   S+LT    +  
Sbjct: 62  IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121

Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDS---SFNAKLSDFGLS---VTAGTQSRN 311
           A DVA+G +YL E  NH  +HRD+ + N LL        AK++DFG++     A    + 
Sbjct: 122 ARDVAKGCKYLEE--NH-FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKG 178

Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAM 370
            +    + ++ PE  L+G  T K+DV++FGV+L E+  +G  P    +  +    VT   
Sbjct: 179 GRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT--- 235

Query: 371 PQLTDRSKLP-NIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
                R   P     PV R   D             C Q  P  RP    +L  +
Sbjct: 236 --GGGRLDPPKGCPGPVYRIMTD-------------CWQHTPEDRPNFATILERI 275

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  107 bits (270), Expect = 9e-27
 Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 10/208 (4%)

Query: 155 FQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISL 214
           F     +G G  G V++  +  ++  A+K +       +++F  EV  L ++RH+++ISL
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67

Query: 215 LGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNH 274
              C   E  +++ E+M+ GSL   L  P  G  L     + +A  VA G+ YL E    
Sbjct: 68  FAVCSVGEPVYIITELMEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEE---Q 123

Query: 275 PVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ---SRNVKISGTLGYVAPEYLLEGKL 331
             +HRDL + NIL+      K++DFGL+         S + KI     + APE    G  
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIP--YKWTAPEAASHGTF 181

Query: 332 TDKSDVYAFGVVLLELLM-GRRPVEKMS 358
           + KSDV++FG++L E+   G+ P   M+
Sbjct: 182 STKSDVWSFGILLYEMFTYGQVPYPGMN 209

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  113 bits (283), Expect = 9e-27
 Identities = 84/280 (30%), Positives = 138/280 (49%), Gaps = 19/280 (6%)

Query: 148 LEAATNNFQESNVIGEGGRGHVYKAR-FNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKI 206
           +    ++ +E NVI  G +G  YK +     +   VK I+D       E  +    + K+
Sbjct: 685 INDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD----MGKL 740

Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
           +H NI+ L+G C   +  +L++E ++  +L + L       NL+W  R KIA+ +A+ L 
Sbjct: 741 QHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL------RNLSWERRRKIAIGIAKALR 794

Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYL 326
           +LH  C+  VV  +L    I++D      L    LS+  G    + K   +  YVAPE  
Sbjct: 795 FLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR---LSL-PGLLCTDTKCFISSAYVAPETR 850

Query: 327 LEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPV 386
               +T+KSD+Y FG++L+ELL G+ P +        S+V WA    +D   L   +DP 
Sbjct: 851 ETKDITEKSDIYGFGLILIELLTGKSPADAEFGVH-GSIVEWARYCYSD-CHLDMWIDPS 908

Query: 387 IRDTMDL--KHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
           IR  + +    + +V  +A+ C   +P+ RP   DVL +L
Sbjct: 909 IRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948

Length = 968

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  107 bits (269), Expect = 1e-26
 Identities = 73/261 (27%), Positives = 118/261 (45%), Gaps = 31/261 (11%)

Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           +G G  G V++  +N     AVK +   G    ++F  E   + K+RH  +I L   C  
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLK-PGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTL 72

Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
            E  ++V E+M+ GSL + L G   G  L     + +A  VA G+ YL    N+  +HRD
Sbjct: 73  EEPIYIVTELMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQ-NY--IHRD 128

Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT---LGYVAPEYLLEGKLTDKSDV 337
           L + N+L+  +   K++DFGL+          +  G    + + APE  L  + + KSDV
Sbjct: 129 LAARNVLVGENNICKVADFGLARVIKEDIYEAR-EGAKFPIKWTAPEAALYNRFSIKSDV 187

Query: 338 YAFGVVLLELLM-GRRPVEKMSPTQCQSMVT--WAMPQLTDRSKLPNIVDPVIRDTMDLK 394
           ++FG++L E++  GR P   M+  +    V   + MP        P      + D M   
Sbjct: 188 WSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPC-------PPGCPKELYDIM--- 237

Query: 395 HLYQVAAVAVLCIQPEPSYRP 415
                    + C + +P  RP
Sbjct: 238 ---------LDCWKEDPDDRP 249

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  107 bits (269), Expect = 1e-26
 Identities = 68/223 (30%), Positives = 105/223 (47%), Gaps = 22/223 (9%)

Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           +G G  G V+   +N     AVK +       E  F  E   + K+RH  ++ L   C  
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE-AFLQEAQIMKKLRHDKLVQLYAVCSE 72

Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
            E  ++V E M  GSL   L     G  L     + +A  +A G+ YL E  N+  +HRD
Sbjct: 73  EEPIYIVTEYMSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYL-ESRNY--IHRD 128

Query: 281 LKSSNILLDSSFNAKLSDFGLS-------VTAGTQSR-NVKISGTLGYVAPEYLLEGKLT 332
           L + NIL+  +   K++DFGL+        TA   ++  +K      + APE    G+ T
Sbjct: 129 LAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIK------WTAPEAANYGRFT 182

Query: 333 DKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVT--WAMPQ 372
            KSDV++FG++L E++  GR P   M+  +    V   + MP+
Sbjct: 183 IKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPR 225

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  105 bits (263), Expect = 7e-26
 Identities = 58/221 (26%), Positives = 95/221 (42%), Gaps = 30/221 (13%)

Query: 154 NFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNN---EVNWLTKIRHQ 209
           +F+   VIG+G  G V   +  + K + A+K ++      +    N   E   L ++ H 
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 210 NIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMK----------IAV 259
            +++L       E  +LV +++              G +L +HL  K             
Sbjct: 61  FLVNLWYSFQDEENMYLVVDLLL-------------GGDLRYHLSQKVKFSEEQVKFWIC 107

Query: 260 DVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLG 319
           ++   LEYLH      ++HRD+K  NILLD   +  ++DF ++      +     SGT G
Sbjct: 108 EIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPG 164

Query: 320 YVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPT 360
           Y+APE L     +   D ++ GV   E L G+RP    S T
Sbjct: 165 YMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT 205

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  104 bits (262), Expect = 1e-25
 Identities = 74/273 (27%), Positives = 115/273 (42%), Gaps = 38/273 (13%)

Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           +G G  G V+  ++  K+  A+K I + G  +E +F  E   + K+ H N++ L G C  
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIRE-GAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70

Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
               F+V E M NG L   L          W L M    DV   +EYL  +     +HRD
Sbjct: 71  QRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDM--CSDVCEAMEYLESNG---FIHRD 125

Query: 281 LKSSNILLDSSFNAKLSDFGLS-------VTAGTQSR-NVKISGTLGYVAPEYLLEGKLT 332
           L + N L+      K+SDFGL+        T+   ++  VK +       PE     + +
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWA------PPEVFDYSRFS 179

Query: 333 DKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTM 391
            KSDV++FGV++ E+   G+ P E+ S ++    V  +      R KL            
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESV--SAGYRLYRPKLAP---------- 227

Query: 392 DLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
               +Y +      C   +P  RP    +L  L
Sbjct: 228 --TEVYTIMY---SCWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  104 bits (262), Expect = 1e-25
 Identities = 64/199 (32%), Positives = 90/199 (45%), Gaps = 13/199 (6%)

Query: 161 IGEGGRGHVYKARFNE-KLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRHQNIISLLG 216
           +G+G  G V   R  +   L A+K +                E N L++I H  I+ L  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59

Query: 217 YCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHP 275
           Y    E + +LV E    G L   L     G       R   A ++   LEYLH   +  
Sbjct: 60  YAFQTEEKLYLVLEYAPGGELFSHLS--KEGRFSEERARF-YAAEIVLALEYLH---SLG 113

Query: 276 VVHRDLKSSNILLDSSFNAKLSDFGLSVTAG-TQSRNVKISGTLGYVAPEYLLEGKLTDK 334
           +++RDLK  NILLD+  + KL+DFGL+       SR     GT  Y+APE LL       
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKA 173

Query: 335 SDVYAFGVVLLELLMGRRP 353
            D ++ GV+L E+L G+ P
Sbjct: 174 VDWWSLGVLLYEMLTGKPP 192

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  104 bits (261), Expect = 2e-25
 Identities = 67/201 (33%), Positives = 96/201 (47%), Gaps = 13/201 (6%)

Query: 159 NVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAER-EFNNEVNWLTKIRHQNIISLLG 216
             +G G  G V K        + AVK I    ++A + +   E++ L K     I+   G
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66

Query: 217 YCIHAETRFLVYEMMQNGSLE---KQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
              +     +  E M  GSL+   K++ G      L      KIAV V +GL YLHE   
Sbjct: 67  AFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLHE--K 119

Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTD 333
           H ++HRD+K SNIL++S    KL DFG+S      S      GT  Y+APE +     + 
Sbjct: 120 HKIIHRDVKPSNILVNSRGQIKLCDFGVS-GQLVNSLAKTFVGTSSYMAPERIQGNDYSV 178

Query: 334 KSDVYAFGVVLLELLMGRRPV 354
           KSD+++ G+ L+EL  GR P 
Sbjct: 179 KSDIWSLGLSLIELATGRFPY 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score =  104 bits (261), Expect = 2e-25
 Identities = 82/286 (28%), Positives = 132/286 (46%), Gaps = 45/286 (15%)

Query: 161 IGEGGRGHVYKARF------NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISL 214
           +GEG  G V+ A         +K+L AVK + +A   A ++F  E   LT ++HQ+I+  
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 215 LGYCIHAETRFLVYEMMQNGSLEKQL--HGPTHG----------SNLTWHLRMKIAVDVA 262
            G C       +V+E M++G L + L  HGP               LT    + IA  +A
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG----TL 318
            G+ YL    +   VHRDL + N L+      K+ DFG+S    + +   ++ G     +
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS-TDYYRVGGRTMLPI 188

Query: 319 GYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRS 377
            ++ PE +L  K T +SD+++FGVVL E+   G++P  ++S T+    +T    +L    
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGR-ELERPR 247

Query: 378 KLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS 423
             P  V  +++                 C Q EP  R +I D+ HS
Sbjct: 248 TCPPEVYAIMQG----------------CWQREPQQRMVIKDI-HS 276

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  104 bits (261), Expect = 2e-25
 Identities = 67/213 (31%), Positives = 108/213 (50%), Gaps = 32/213 (15%)

Query: 161 IGEGGRGHVYKARF---NEKLLA---AVKRIDD-AGHDAEREFNNEVNWLTKIRHQNIIS 213
           +GEG  G VYK      NE+L A   A+K + + A    ++EF  E   ++ ++H NI+ 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 214 LLGYCIHAETRFLVYEMMQNGSLEKQL--HGPTHGSNLT----------WHLRM-KIAVD 260
           LLG C   +   +++E + +G L + L  + P                        IA+ 
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 261 VARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAG----TQSRNVKI 314
           +A G+EYL    +H  VHRDL + N L+      K+SDFGLS  + +      QS+++  
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL- 188

Query: 315 SGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLEL 347
              + ++ PE +L GK T +SD+++FGVVL E+
Sbjct: 189 --PVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score =  104 bits (260), Expect = 3e-25
 Identities = 83/299 (27%), Positives = 139/299 (46%), Gaps = 48/299 (16%)

Query: 161 IGEGGRGHVYKAR------FNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISL 214
           +GEG  G V+ A         +K+L AVK + D    A ++F  E   LT ++H++I+  
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 215 LGYCIHAETRFLVYEMMQNGSLEKQL--HGP-----------THGSNLTWHLRMKIAVDV 261
            G C   +   +V+E M++G L K L  HGP                L     + IA  +
Sbjct: 73  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132

Query: 262 ARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG----T 317
           A G+ YL    +   VHRDL + N L+ ++   K+ DFG+S    + +   ++ G     
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYS-TDYYRVGGHTMLP 188

Query: 318 LGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDR 376
           + ++ PE ++  K T +SDV++FGV+L E+   G++P  ++S T+    +T    ++ +R
Sbjct: 189 IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQG--RVLER 246

Query: 377 SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITD---VLHSLIPLVPTDL 432
              P +    + D M            + C Q EP  R  I +   +LH+L    P  L
Sbjct: 247 ---PRVCPKEVYDIM------------LGCWQREPQQRLNIKEIYKILHALGKATPIYL 290

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  103 bits (259), Expect = 4e-25
 Identities = 73/286 (25%), Positives = 120/286 (41%), Gaps = 40/286 (13%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAER-EFNNEVNWLTKIRHQN 210
           ++ +   V+G+G  G VYK R      + A+K+I   G +  R +   E+  L       
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60

Query: 211 IISLLGYCIHAETRFLVYEMMQNGSLEKQL--HGPTHGSNLTWHLRMKIAVDVARGLEYL 268
           ++   G         +V E M  GSL   L   G      L       IA  + +GL+YL
Sbjct: 61  VVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVL-----AYIARQILKGLDYL 115

Query: 269 HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS-VTAGTQSRNVKISGTLGYVAPEYLL 327
           H      ++HRD+K SN+L++S    K++DFG+S V   T  +     GT+ Y++PE + 
Sbjct: 116 HT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQ 173

Query: 328 EGKLTDKSDVYAFGVVLLELLMGRRP---VEKMSPTQCQSMVTWA-MPQLTDRSKL---P 380
               +  +D+++ G+ LLE  +G+ P     + S         +  M  + D        
Sbjct: 174 GESYSYAADIWSLGLTLLECALGKFPFLPPGQPSF--------FELMQAICDGPPPSLPA 225

Query: 381 NIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVL-HSLI 425
               P  RD +              C+Q +P  RP   ++L H  I
Sbjct: 226 EEFSPEFRDFIS------------ACLQKDPKKRPSAAELLQHPFI 259

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score =  103 bits (258), Expect = 6e-25
 Identities = 70/228 (30%), Positives = 120/228 (52%), Gaps = 25/228 (10%)

Query: 161 IGEGGRGHVYKAR-FN-----EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISL 214
           +GEG  G V+ A  +N     +K+L AVK + DA  +A ++F+ E   LT ++H++I+  
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 215 LGYCIHAETRFLVYEMMQNGSLEKQL--HGP--------THGSNLTWHLRMKIAVDVARG 264
            G C+  +   +V+E M++G L K L  HGP           + LT    + IA  +A G
Sbjct: 73  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132

Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG----TLGY 320
           + YL    +   VHRDL + N L+  +   K+ DFG+S    + +   ++ G     + +
Sbjct: 133 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYS-TDYYRVGGHTMLPIRW 188

Query: 321 VAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVT 367
           + PE ++  K T +SDV++ GVVL E+   G++P  ++S  +    +T
Sbjct: 189 MPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 236

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  102 bits (256), Expect = 6e-25
 Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 8/206 (3%)

Query: 154 NFQESNVIGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDA--EREFNNEVNWLTKIRHQN 210
           +F+  N IG+G  G V+K  R  +K + A+K+ID +  +     E  +E   L K+    
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 211 IISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHE 270
           II      +      +V E  +NG L K L     G  L      +  + +  GL +LH 
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDLHKLLKM-QRGRPLPEDQVWRFFIQILLGLAHLH- 118

Query: 271 HCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK-ISGTLGYVAPEYLLEG 329
             +  ++HRD+KS N+ LD+  N K+ D G++      +     I GT  Y++PE   + 
Sbjct: 119 --SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDK 176

Query: 330 KLTDKSDVYAFGVVLLELLMGRRPVE 355
              +KSDV+A GVVL E   G+ P +
Sbjct: 177 PYNEKSDVWALGVVLYECCTGKHPFD 202

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score =  103 bits (258), Expect = 6e-25
 Identities = 77/230 (33%), Positives = 120/230 (52%), Gaps = 32/230 (13%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNE---KLLAAVKRIDD-AGHDAEREFNNEVNWLTKI-R 207
           N+ +  +VIGEG  G V KAR  +   ++ AA+KR+ + A  D  R+F  E+  L K+  
Sbjct: 7   NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66

Query: 208 HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLH-------------GPTHGSNLTWHLR 254
           H NII+LLG C H    +L  E   +G+L   L                +  S L+    
Sbjct: 67  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126

Query: 255 MKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKI 314
           +  A DVARG++YL +      +HRDL + NIL+  ++ AK++DFGLS     + + V +
Sbjct: 127 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLS-----RGQEVYV 178

Query: 315 SGTLG-----YVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMS 358
             T+G     ++A E L     T  SDV+++GV+L E++ +G  P   M+
Sbjct: 179 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 228

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 98.9 bits (246), Expect = 1e-23
 Identities = 74/202 (36%), Positives = 111/202 (54%), Gaps = 15/202 (7%)

Query: 160 VIGEGGRGHVYKARFNEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNIISLLGYC 218
           +IGEG  G V +  +  + +A VK I  D    A   F  E   +TK+ H+N++ LLG  
Sbjct: 13  IIGEGEFGAVLQGEYTGQKVA-VKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVI 68

Query: 219 IHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRM-KIAVDVARGLEYLHEHCNHPVV 277
           +H    ++V E+M  G+L   L   T G  L   +++ + ++DVA G+EYL    +  +V
Sbjct: 69  LH-NGLYIVMELMSKGNLVNFLR--TRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLV 122

Query: 278 HRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDV 337
           HRDL + NIL+     AK+SDFGL+        N K+   + + APE L   K + KSDV
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLP--VKWTAPEALKHKKFSSKSDV 180

Query: 338 YAFGVVLLELL-MGRRPVEKMS 358
           +++GV+L E+   GR P  KMS
Sbjct: 181 WSYGVLLWEVFSYGRAPYPKMS 202

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 99.0 bits (247), Expect = 1e-23
 Identities = 69/218 (31%), Positives = 109/218 (50%), Gaps = 21/218 (9%)

Query: 161 IGEGGRGHV----YKARFNEKLLAAVKRI-DDAGHDAEREFNNEVNWLTKIRHQNIISLL 215
           +G G  G V    Y  +  +++  AVK +  +     ++EF  E + + ++ H  I+ L+
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 216 GYCIHAETRFLVYEMMQNGSLEKQL--HGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
           G C   E   LV E+   G L K L        S+L      ++A  VA G+ YL E  +
Sbjct: 63  GVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLK-----ELAHQVAMGMAYL-ESKH 115

Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGT--LGYVAPEYLLEG 329
              VHRDL + N+LL +   AK+SDFG+S  + AG+       +G   L + APE +  G
Sbjct: 116 --FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYG 173

Query: 330 KLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
           K + KSDV+++GV L E    G +P  +M   +  +M+
Sbjct: 174 KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAML 211

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 99.4 bits (248), Expect = 1e-23
 Identities = 62/209 (29%), Positives = 104/209 (49%), Gaps = 14/209 (6%)

Query: 161 IGEGGRGHVYKARF-NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCI 219
           +G+G  G VYKA+     L AA K I     +   +F  E++ L++ +H NI+ L     
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 220 HAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHR 279
           +    +++ E    G+L+  +     G  LT      +   +   L +LH   +H V+HR
Sbjct: 73  YENKLWILIEFCDGGALDSIMLELERG--LTEPQIRYVCRQMLEALNFLH---SHKVIHR 127

Query: 280 DLKSSNILLDSSFNAKLSDFGLSV--TAGTQSRNVKISGTLGYVAPEYLLEGKLTD---- 333
           DLK+ NILL    + KL+DFG+S    +  Q R+  I GT  ++APE +      D    
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEVVACETFKDNPYD 186

Query: 334 -KSDVYAFGVVLLELLMGRRPVEKMSPTQ 361
            K+D+++ G+ L+EL     P  +++P +
Sbjct: 187 YKADIWSLGITLIELAQMEPPHHELNPMR 215

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 99.5 bits (248), Expect = 1e-23
 Identities = 68/244 (27%), Positives = 112/244 (45%), Gaps = 41/244 (16%)

Query: 149 EAATNNFQESNVIGEGGRGHVYKAR------FNEKLLAAVKRI-DDAGHDAEREFNNEVN 201
           E   NN +    IG+G  G V++AR      +    + AVK + ++A  D + +F  E  
Sbjct: 1   EYPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 60

Query: 202 WLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLE--------KQLHGPTHGSN----- 248
            + +  H NI+ LLG C   +   L++E M  G L         +     +H ++     
Sbjct: 61  LMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKC 120

Query: 249 ------LTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS 302
                 L+   ++ IA  VA G+ YL E      VHRDL + N L+  +   K++DFGLS
Sbjct: 121 GLNPLPLSCTEQLCIAKQVAAGMAYLSE--RK-FVHRDLATRNCLVGENMVVKIADFGLS 177

Query: 303 -------VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPV 354
                      +++  + I     ++ PE +   + T +SDV+A+GVVL E+   G +P 
Sbjct: 178 RNIYSADYYKASENDAIPIR----WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPY 233

Query: 355 EKMS 358
             M+
Sbjct: 234 YGMA 237

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 99.3 bits (248), Expect = 1e-23
 Identities = 80/228 (35%), Positives = 106/228 (46%), Gaps = 25/228 (10%)

Query: 151 ATNNFQESNVIGEGGRGHVYKARFNEK-LLAAVKRIDDAGHDAEREFNNEVNWLTKI-RH 208
            T  F+   VIGEG  G VYKAR  +   L A+K I D   D E E   E N L K   H
Sbjct: 4   PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIK-IMDIIEDEEEEIKEEYNILRKYSNH 62

Query: 209 QNIISLLG------YCIHAETRFLVYEMMQNGS---LEKQLHGPTHGSNLTWHLRMKIAV 259
            NI +  G         + +  +LV E+   GS   L K L     G  L       I  
Sbjct: 63  PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLR--KKGKRLKEEWIAYILR 120

Query: 260 DVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGT 317
           +  RGL YLHE+    V+HRD+K  NILL  +   KL DFG+S  + +    RN  I GT
Sbjct: 121 ETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-GT 176

Query: 318 LGYVAPE-----YLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPT 360
             ++APE        +     +SDV++ G+  +EL  G+ P+  M P 
Sbjct: 177 PYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM 224

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 98.9 bits (247), Expect = 2e-23
 Identities = 68/236 (28%), Positives = 106/236 (44%), Gaps = 27/236 (11%)

Query: 144 EYELLEAATNNFQESNVIGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFN---NE 199
           +YE+LE           IG+G  G V K  R ++  +   K ID  G+  E+E     +E
Sbjct: 1   DYEVLE----------TIGKGSFGTVRKVRRKSDGKILVWKEID-YGNMTEKEKQQLVSE 49

Query: 200 VNWLTKIRHQNIISLLGYCIH-----AETRFLVYEMMQNGSLEKQL-HGPTHGSNLTWHL 253
           VN L +++H NI+    Y         +T ++V E  + G L + +         +    
Sbjct: 50  VNILRELKHPNIV---RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEF 106

Query: 254 RMKIAVDVARGLEYLH--EHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
             +I   +   L   H      + V+HRDLK +NI LD++ N KL DFGL+   G  S  
Sbjct: 107 IWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF 166

Query: 312 VK-ISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMV 366
            K   GT  Y++PE L      +KSD+++ G ++ EL     P    +  Q  S +
Sbjct: 167 AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKI 222

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 98.6 bits (246), Expect = 3e-23
 Identities = 58/206 (28%), Positives = 103/206 (50%), Gaps = 16/206 (7%)

Query: 160 VIGEGGRGHVYKARF-----NEKLLAAVKRI-DDAGHDAEREFNNEVNWLTKIRHQNIIS 213
           V+G G  G VYK  +       K+  A+K + ++    A +E  +E   +  + H +++ 
Sbjct: 14  VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73

Query: 214 LLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
           LLG C+ +    L+ ++M  G L   +    H  N+     +   V +A+G+ YL E   
Sbjct: 74  LLGICL-SSQVQLITQLMPLGCLLDYVR--NHKDNIGSQYLLNWCVQIAKGMSYLEEK-- 128

Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAPEYLLEGK 330
             +VHRDL + N+L+ +  + K++DFGL+       +     G    + ++A E +L   
Sbjct: 129 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRI 187

Query: 331 LTDKSDVYAFGVVLLELL-MGRRPVE 355
            T KSDV+++GV + EL+  G +P E
Sbjct: 188 YTHKSDVWSYGVTVWELMTFGAKPYE 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 98.3 bits (246), Expect = 3e-23
 Identities = 68/204 (33%), Positives = 98/204 (48%), Gaps = 27/204 (13%)

Query: 161 IGEGGRGHVYKAR---FNEKLLAAVKRIDDAGHDAEREFNN-----EVNWLTKIRHQNII 212
           +GEG  G VYKAR     E +  A+K+I     D E E        E++ L +++H NI+
Sbjct: 7   LGEGTYGVVYKARDKKTGEIV--ALKKIR---LDNEEEGIPSTALREISLLKELKHPNIV 61

Query: 213 SLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
            LL         +LV+E      L+K L        L+ +L   I   + RGL Y H H 
Sbjct: 62  KLLDVIHTERKLYLVFEYCDM-DLKKYLD--KRPGPLSPNLIKSIMYQLLRGLAYCHSHR 118

Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR----NVKISGTLGYVAPEYLLE 328
              ++HRDLK  NIL++     KL+DFGL+   G   R     V    TL Y APE LL 
Sbjct: 119 ---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV---TLWYRAPEILLG 172

Query: 329 GKLTDKS-DVYAFGVVLLELLMGR 351
            K    + D+++ G +  E++ G+
Sbjct: 173 SKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 97.9 bits (244), Expect = 5e-23
 Identities = 64/228 (28%), Positives = 104/228 (45%), Gaps = 27/228 (11%)

Query: 154 NFQESNVIGEGGRGHVYKARF------NEKLLAAVK---RIDDAGHDAEREFNNEVNWLT 204
           N QE   +G G  G V+ A+         + L  VK   +  D   + + EF  E++   
Sbjct: 6   NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD--ENLQSEFRRELDMFR 63

Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQL------HGPTHGSNLTWHLRMKIA 258
           K+ H+N++ LLG C  AE  +++ E    G L++ L              L+   ++ + 
Sbjct: 64  KLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALC 123

Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS----RNVKI 314
             +A G+++L    N   VHRDL + N L+ S    K+S   LS           RN  I
Sbjct: 124 TQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI 180

Query: 315 SGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQ 361
              L ++APE + E   + KSDV++FGV++ E+   G  P   +S  +
Sbjct: 181 P--LRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE 226

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 97.8 bits (244), Expect = 6e-23
 Identities = 64/197 (32%), Positives = 91/197 (46%), Gaps = 13/197 (6%)

Query: 161 IGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNN--EVNWLTKIRHQNIISLLGY 217
           IGEG  G VYKAR      + A+K+I               E+  L ++ H NII LL  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66

Query: 218 CIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVV 277
             H    +LV+E M    L K +     G  L   L       + +GL + H H    ++
Sbjct: 67  FRHKGDLYLVFEFMDT-DLYKLIKDRQRG--LPESLIKSYLYQLLQGLAFCHSH---GIL 120

Query: 278 HRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV--KISGTLGYVAPEYLLEGKLTDKS 335
           HRDLK  N+L+++    KL+DFGL+ + G+  R     +  T  Y APE LL  K     
Sbjct: 121 HRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV-TRWYRAPELLLGDKGYSTP 179

Query: 336 -DVYAFGVVLLELLMGR 351
            D+++ G +  ELL  R
Sbjct: 180 VDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 97.6 bits (244), Expect = 6e-23
 Identities = 65/244 (26%), Positives = 95/244 (38%), Gaps = 56/244 (22%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDA---GHDAEREFNNEVNWLTKI-R 207
           ++F+   +IGEG    V  A+  E     A+K +D          +    E   LT++  
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 208 HQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR--- 263
           H  II L  Y    E   + V E   NG L + +    +GS         +     R   
Sbjct: 61  HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIR--KYGS---------LDEKCTRFYA 108

Query: 264 -----GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS--- 315
                 LEYLH   +  ++HRDLK  NILLD   + K++DFG   TA     N       
Sbjct: 109 AEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFG---TAKVLDPNSSPESNK 162

Query: 316 ---------------------GTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPV 354
                                GT  YV+PE L E      SD++A G ++ ++L G+ P 
Sbjct: 163 GDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPF 222

Query: 355 EKMS 358
              +
Sbjct: 223 RGSN 226

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 97.5 bits (243), Expect = 7e-23
 Identities = 75/276 (27%), Positives = 120/276 (43%), Gaps = 31/276 (11%)

Query: 153 NNFQESNVIGEGGRGHVYKARF-NEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQN 210
               E + +GEG  G V K R  N  ++ A+K I  D   D +++   E+      +   
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 211 IISLLGYCI--HAETRFLVYEMMQNGSLE---KQLHGPTHGSNLTWHLRMKIAVDVARGL 265
           I+   G  +   + +  +  E  + GSL+   K++     G  +   +  KIA  V +GL
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVK--KRGGRIGEKVLGKIAESVLKGL 118

Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEY 325
            YLH      ++HRD+K SNILL      KL DFG+S      S     +GT  Y+APE 
Sbjct: 119 SYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN-SLAGTFTGTSFYMAPER 174

Query: 326 LLEGKLTDKSDVYAFGVVLLELLMGRRPVE-----KMSPTQCQSM-VTWAMPQLTDRSKL 379
           +     +  SDV++ G+ LLE+   R P        + P +  S  V    P+L D    
Sbjct: 175 IQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGN 234

Query: 380 PNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRP 415
                  I+ + + K   +       C++ +P+ RP
Sbjct: 235 G------IKWSEEFKDFIKQ------CLEKDPTRRP 258

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 97.4 bits (243), Expect = 9e-23
 Identities = 67/233 (28%), Positives = 107/233 (45%), Gaps = 36/233 (15%)

Query: 150 AATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAER-EFNNEVNWLTKIRH 208
              +  Q+ +      +        +  +L AVK +     D  R +F  EV  L+++  
Sbjct: 24  CEADGLQDFSE-----KAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSD 78

Query: 209 QNIISLLGYCIHAETRFLVYEMMQNGSLEKQLH-------GPTHGSN-LTWHLRMKIAVD 260
            NI  LLG C       ++ E M+NG L + L        G    S  L++   + +A  
Sbjct: 79  PNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQ 138

Query: 261 VARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV------KI 314
           +A G+ YL    N   VHRDL + N L+  ++  K++DFG+       SRN+      ++
Sbjct: 139 IASGMRYLESL-N--FVHRDLATRNCLVGKNYTIKIADFGM-------SRNLYSSDYYRV 188

Query: 315 SGT----LGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM--GRRPVEKMSPTQ 361
            G     + ++A E +L GK T KSDV+AFGV L E+L     +P E ++  Q
Sbjct: 189 QGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ 241

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 96.6 bits (240), Expect = 1e-22
 Identities = 79/270 (29%), Positives = 125/270 (46%), Gaps = 41/270 (15%)

Query: 149 EAATNNFQESNVIGEGGRGHVYKARFN----EKLLAAVKRIDDAGHDAER-EFNNEVNWL 203
           E   ++  +  VIG G  G V++        +++  A+K +     + +R +F +E + +
Sbjct: 1   EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIM 60

Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
            +  H NII L G     +   ++ E M+NG+L+K L    H    + +  + +   +A 
Sbjct: 61  GQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLR--DHDGEFSSYQLVGMLRGIAA 118

Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--------VTAGTQSRNVKIS 315
           G++YL    +   VHRDL + NIL++S+   K+SDFGLS         T  T    + I 
Sbjct: 119 GMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIR 175

Query: 316 GTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMS---------------- 358
            T    APE +   K T  SDV++FG+V+ E++  G RP   MS                
Sbjct: 176 WT----APEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPA 231

Query: 359 PTQCQSMVTWAMPQ--LTDRSKLPNIVDPV 386
           P  C S V   M Q    DR++ P  VD V
Sbjct: 232 PMDCPSAVYQLMLQCWQQDRARRPRFVDIV 261

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 96.2 bits (240), Expect = 1e-22
 Identities = 71/236 (30%), Positives = 112/236 (47%), Gaps = 21/236 (8%)

Query: 155 FQESNVIGEGGRGHVYKAR-FNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIIS 213
           ++    IG G  G VYKAR      L A+K I     D       E++ L + RH NI++
Sbjct: 5   YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA 64

Query: 214 LLGYCIHAETRFLVYEMMQNGSLE---KQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHE 270
             G  +  +  ++V E    GSL+   +   GP     L+      +  +  +GL YLHE
Sbjct: 65  YFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGP-----LSELQIAYVCRETLKGLAYLHE 119

Query: 271 HCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLE 328
                 +HRD+K +NILL    + KL+DFG+S  +TA    R   I GT  ++APE    
Sbjct: 120 --TG-KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMAPEVAAV 175

Query: 329 ---GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVT---WAMPQLTDRSK 378
              G    K D++A G+  +EL   + P+  + P +   +++   +  P+L D+ K
Sbjct: 176 ERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEK 231

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 95.2 bits (237), Expect = 3e-22
 Identities = 71/270 (26%), Positives = 126/270 (46%), Gaps = 33/270 (12%)

Query: 161 IGEGGRGHVYKARFNEK-LLAAVKR--IDDAGHDAE---REFNNEVNWLTKIRHQNIISL 214
           +G G  G VY+    +     AVK   + D G   +   ++   E+  L+K++H NI+  
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 215 LGYCIHAETRFLVYEMMQNGSLEKQL--HGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
           LG     +  ++  E++  GSL K L  +G      +  + R  +      GLEYLH   
Sbjct: 68  LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL-----GLEYLH--- 119

Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLL-EGKL 331
           +   VHRD+K +NIL+D++   KL+DFG++      S      G+  ++APE +  +G  
Sbjct: 120 DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGY 179

Query: 332 TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTM 391
              +D+++ G  +LE+  G+ P  ++           A+ ++    +LP I D +  +  
Sbjct: 180 GLAADIWSLGCTVLEMATGKPPWSQLEGVA-------AVFKIGRSKELPPIPDHLSDEAK 232

Query: 392 DLKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
           D           + C+Q +PS RP   ++L
Sbjct: 233 DF---------ILKCLQRDPSLRPTAAELL 253

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 95.0 bits (236), Expect = 3e-22
 Identities = 61/203 (30%), Positives = 96/203 (47%), Gaps = 13/203 (6%)

Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           IG G  G V+   + EK   A+K I + G  +E +F  E   + K+ H  ++ L G C  
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIRE-GAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70

Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
                LV+E M++G L   L         +    + + +DV  G+ YL       V+HRD
Sbjct: 71  RSPICLVFEFMEHGCLSDYLR--AQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRD 125

Query: 281 LKSSNILLDSSFNAKLSDFGLSVTA----GTQSRNVKISGTLGYVAPEYLLEGKLTDKSD 336
           L + N L+  +   K+SDFG++        T S   K    + + +PE     K + KSD
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFP--VKWSSPEVFSFSKYSSKSD 183

Query: 337 VYAFGVVLLELLM-GRRPVEKMS 358
           V++FGV++ E+   G+ P E  S
Sbjct: 184 VWSFGVLMWEVFSEGKTPYENRS 206

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 94.9 bits (236), Expect = 3e-22
 Identities = 64/204 (31%), Positives = 100/204 (49%), Gaps = 9/204 (4%)

Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           +G G  G V   ++  +   A+K I + G  +E EF  E   + K+ H+ ++ L G C  
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70

Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
               ++V E M NG L   L         +  L M    DV  G+ YL    +   +HRD
Sbjct: 71  QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEM--CKDVCEGMAYLE---SKQFIHRD 125

Query: 281 LKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVY 338
           L + N L+D     K+SDFGLS  V     + +V     + +  PE LL  K + KSDV+
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVW 185

Query: 339 AFGVVLLELL-MGRRPVEKMSPTQ 361
           AFGV++ E+  +G+ P E+ + ++
Sbjct: 186 AFGVLMWEVYSLGKMPYERFNNSE 209

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 94.6 bits (236), Expect = 5e-22
 Identities = 57/207 (27%), Positives = 96/207 (46%), Gaps = 21/207 (10%)

Query: 161 IGEGGRGHVYKARFN--EKLLA--AVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLG 216
           I +G  G V+ A+      + A   +K+ D    +   +   E + L++ +   ++ L  
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 217 YCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPV 276
                +  +LV E +  G L   L    +  +L   +      ++   LEYLH   ++ +
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLLE---NVGSLDEDVARIYIAEIVLALEYLH---SNGI 114

Query: 277 VHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR----------NVKISGTLGYVAPEYL 326
           +HRDLK  NIL+DS+ + KL+DFGLS   G   R          + +I GT  Y+APE +
Sbjct: 115 IHRDLKPDNILIDSNGHLKLTDFGLS-KVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173

Query: 327 LEGKLTDKSDVYAFGVVLLELLMGRRP 353
           L    +   D ++ G +L E L+G  P
Sbjct: 174 LGQGHSKTVDWWSLGCILYEFLVGIPP 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 93.8 bits (233), Expect = 9e-22
 Identities = 73/240 (30%), Positives = 116/240 (48%), Gaps = 26/240 (10%)

Query: 155 FQESNVIGEGGRGHVYKARFNEKLLAAVKRI--DDAGHDA-EREF---NNEVNWLTKIRH 208
           + +  V+G+G  G VY    N+  L AVK++  D +   A E+E+     EV+ L  ++H
Sbjct: 2   WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61

Query: 209 QNIISLLGYCIHAETRFLVYEMMQNGSLEKQLH--GPTHGSNLTWHLRMKIAVDVARGLE 266
            NI+  LG C+   T  +  E +  GS+   L+  GP     L   +  K    +  G+ 
Sbjct: 62  VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGP-----LPEPVFCKYTKQILDGVA 116

Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSV------TAGTQSRNVK-ISGTLG 319
           YLH +C   VVHRD+K +N++L  +   KL DFG +         GT S  +K + GT  
Sbjct: 117 YLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPY 173

Query: 320 YVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMV---TWAMPQLTDR 376
           ++APE + E     KSD+++ G  + E+  G+ P+  M        +      MP+L D 
Sbjct: 174 WMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDS 233

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 93.7 bits (233), Expect = 9e-22
 Identities = 76/274 (27%), Positives = 116/274 (42%), Gaps = 25/274 (9%)

Query: 154 NFQESNVIGEGGRGHVYKA-RFNEKLLAAVKRID-DAGHDAEREFN-NEVNWLTKIRHQN 210
           +F+    +G+G  G VYK  R ++    A+K +D  +    ERE   NE+  L  + H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 211 IISLLGYCIHAETRFLVYEMMQNGSLEKQL-HGPTHGSNLTWHLRMKIAVDVARGLEYLH 269
           IIS     +      +V E    G L K +         +      +I + + RGL+ LH
Sbjct: 61  IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120

Query: 270 EHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEG 329
           E     ++HRDLKS+NILL ++   K+ D G+S          +I GT  Y+APE     
Sbjct: 121 EQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI-GTPHYMAPEVWKGR 176

Query: 330 KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRD 389
             + KSD+++ G +L E+     P E  S    +  V         R K P I     +D
Sbjct: 177 PYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQ--------RGKYPPIPPIYSQD 228

Query: 390 TMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS 423
             +              +Q +P  RP    +L S
Sbjct: 229 LQNFIR---------SMLQVKPKLRPNCDKILAS 253

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 94.0 bits (234), Expect = 9e-22
 Identities = 82/289 (28%), Positives = 121/289 (41%), Gaps = 53/289 (18%)

Query: 145 YELLEAATNNFQESNVIGEGGRGHVYKARF---NEKLLAAVKRIDDAGHDAE-REFNNEV 200
           YEL+E          VIG G    VY A     NEK+  A+KRID         E   EV
Sbjct: 3   YELIE----------VIGVGATAVVYAAICLPNNEKV--AIKRIDLEKCQTSVDELRKEV 50

Query: 201 NWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAV- 259
             +++  H N++      +  +  +LV   +  GSL   L                IA  
Sbjct: 51  QAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSL---LDIMKSSYPRGGLDEAIIATV 107

Query: 260 --DVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSV---TAGTQSRNVK- 313
             +V +GLEYLH +     +HRD+K+ NILL    + K++DFG+S      G ++R V+ 
Sbjct: 108 LKEVLKGLEYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRK 164

Query: 314 -ISGTLGYVAPEYLLEGK-LTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
              GT  ++APE + +      K+D+++FG+  +EL  G  P  K  P     M    + 
Sbjct: 165 TFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP-----MKVLMLT 219

Query: 372 QLTDRSKLPNIVDP-----VIRDTMDLKHLYQVAAVAVLCIQPEPSYRP 415
              D   L    D        R  +             LC+Q +PS RP
Sbjct: 220 LQNDPPSLETGADYKKYSKSFRKMIS------------LCLQKDPSKRP 256

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 93.5 bits (233), Expect = 2e-21
 Identities = 64/218 (29%), Positives = 103/218 (47%), Gaps = 30/218 (13%)

Query: 155 FQESNVIGEGGRGHVYKARFNEK-LLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNII 212
           F     IG+G  G VYKA       + A+K ID +   D   +   E+ +L++ R   I 
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 213 SLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRM------KIAV---DVAR 263
              G  +     +++ E    GS            +L   L+        IA    +V  
Sbjct: 63  KYYGSFLKGSKLWIIMEYCGGGSC----------LDL---LKPGKLDETYIAFILREVLL 109

Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYV 321
           GLEYLHE      +HRD+K++NILL    + KL+DFG+S  +T+ T S+     GT  ++
Sbjct: 110 GLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTS-TMSKRNTFVGTPFWM 165

Query: 322 APEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSP 359
           APE + +    +K+D+++ G+  +EL  G  P+  + P
Sbjct: 166 APEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP 203

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 92.7 bits (231), Expect = 2e-21
 Identities = 77/285 (27%), Positives = 123/285 (43%), Gaps = 57/285 (20%)

Query: 160 VIGEGGRGHVYKARFNE-KLLAAVK--RIDDAGHDAEREFNNEVNWLTKIRHQNIISLLG 216
            +GEG  G VYKA   E   + A+K   +++   +  +E    ++ L +     I+   G
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKE----ISILKQCDSPYIVKYYG 65

Query: 217 YCIHAETR-FLVYEMMQNGSL-------EKQLHGPTHGSNLTWHLRMKIAV---DVARGL 265
                 T  ++V E    GS+        K L               +IA       +GL
Sbjct: 66  -SYFKNTDLWIVMEYCGAGSVSDIMKITNKTLT------------EEEIAAILYQTLKGL 112

Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAP 323
           EYLH   ++  +HRD+K+ NILL+    AKL+DFG+S  +T     RN  I GT  ++AP
Sbjct: 113 EYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI-GTPFWMAP 168

Query: 324 EYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMV-TWAMPQLTDRSKL-PN 381
           E + E    +K+D+++ G+  +E+  G+ P   + P +   M+     P L+D  K  P 
Sbjct: 169 EVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPE 228

Query: 382 IVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVL-HSLI 425
             D V +                 C+  +P  RP    +L H  I
Sbjct: 229 FNDFVKK-----------------CLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 93.0 bits (231), Expect = 2e-21
 Identities = 69/269 (25%), Positives = 121/269 (44%), Gaps = 28/269 (10%)

Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           +G G  G V+  ++  ++  A+K I++ G  +E +F  E   + K+ H  ++ L G C  
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAINE-GAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70

Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
            +  ++V E M+NG L   L        L+  + + +  DV  G+EYL     +  +HRD
Sbjct: 71  QKPLYIVTEFMENGCLLNYLR--QRQGKLSKDMLLSMCQDVCEGMEYLER---NSFIHRD 125

Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT---LGYVAPEYLLEGKLTDKSDV 337
           L + N L+ S+   K+SDFG++            SG    + +  PE     K + KSDV
Sbjct: 126 LAARNCLVSSTGVVKVSDFGMTRYV-LDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDV 184

Query: 338 YAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHL 396
           ++FGV++ E+   G+ P EK S  +   M++        R   P +    + + M     
Sbjct: 185 WSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRG-----FRLYRPKLASMTVYEVM----- 234

Query: 397 YQVAAVAVLCIQPEPSYRPLITDVLHSLI 425
                    C   +P  RP   ++L ++ 
Sbjct: 235 -------YSCWHEKPEGRPTFAELLRAIT 256

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 92.6 bits (230), Expect = 3e-21
 Identities = 66/215 (30%), Positives = 112/215 (52%), Gaps = 24/215 (11%)

Query: 153 NNFQESNVIGEGGRGHVY---KARFNEKLLAAVKRI--DDAGHDAEREFN---NEVNWLT 204
            N++   ++G+G  G VY         +L  AVK++  D    + ++E N    E+  L 
Sbjct: 2   TNWRRGKLLGQGAFGRVYLCYDVDTGREL--AVKQVPFDPDSPETKKEVNALECEIQLLK 59

Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
            ++H+ I+   G     ET  +  E M  GS++ QL    +G+ LT  +  K    +  G
Sbjct: 60  NLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLK--AYGA-LTETVTRKYTRQILEG 116

Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS------VTAGTQSRNVKISGTL 318
           +EYLH   ++ +VHRD+K +NIL DS+ N KL DFG S       ++GT  ++V  +GT 
Sbjct: 117 VEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSV--TGTP 171

Query: 319 GYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
            +++PE +       K+DV++ G  ++E+L  + P
Sbjct: 172 YWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 92.4 bits (229), Expect = 3e-21
 Identities = 66/219 (30%), Positives = 103/219 (47%), Gaps = 25/219 (11%)

Query: 161 IGEGGRGHVYKARFN-EKLLAAVKRIDDA-GHDAEREFNNEVNWLTKIRHQNIISLLGYC 218
           IG G  G V+  R   +    AVK   +    D + +F  E   L +  H NI+ L+G C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 219 IHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLH-EHCNHPVV 277
              +  ++V E++Q G     L   T G  L     +++  + A G+EYL  +HC    +
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFLR--TEGPRLKVKELIQMVENAAAGMEYLESKHC----I 116

Query: 278 HRDLKSSNILLDSSFNAKLSDFGLS---------VTAGTQSRNVKISGTLGYVAPEYLLE 328
           HRDL + N L+      K+SDFG+S          T G +   VK      + APE L  
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVK------WTAPEALNY 170

Query: 329 GKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
           G+ + +SDV++FG++L E   +G  P   +S  Q +  +
Sbjct: 171 GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAI 209

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 92.6 bits (230), Expect = 3e-21
 Identities = 69/241 (28%), Positives = 101/241 (41%), Gaps = 26/241 (10%)

Query: 161 IGEGGRGHVYKARFNE--KLLAAV----KRIDDAGHDAEREFNNEVNWLTKIRHQNIISL 214
           +G+GG G V   +     K+ A      KR+       E+   NE   L K+  + I+SL
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRK--GEQMALNEKKILEKVSSRFIVSL 58

Query: 215 LGYCIHAETRF-LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKI-AVDVARGLEYLHEHC 272
             Y    +    LV  +M  G L  + H    G       R    A  +  GLE+LH   
Sbjct: 59  -AYAFETKDDLCLVMTLMNGGDL--KYHIYNVGEPGFPEARAIFYAAQIICGLEHLH--- 112

Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLT 332
              +V+RDLK  N+LLD   N ++SD GL+V      +    +GT GY+APE L      
Sbjct: 113 QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYD 172

Query: 333 DKSDVYAFGVVLLELLMGRRPV----EKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIR 388
              D +A G  L E++ GR P     EK+   + +         L    + P+   P  +
Sbjct: 173 FSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRT------LEMAVEYPDKFSPEAK 226

Query: 389 D 389
           D
Sbjct: 227 D 227

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 91.8 bits (228), Expect = 5e-21
 Identities = 63/213 (29%), Positives = 102/213 (47%), Gaps = 22/213 (10%)

Query: 160 VIGEGGRGHVYKARFNEK----LLAAVK--RIDDAGHDAEREFNNEVNWLTKIRHQNIIS 213
           ++GEG  G V + + ++     L  AVK  ++D   +    EF +E   +    H N++ 
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 214 LLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGS---NLTWHLRMKIAVDVARG 264
           L+G C  A +        ++   M++G L   L     G     L     +K  VD+A G
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125

Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGT-LGYV 321
           +EYL    N   +HRDL + N +L       ++DFGLS  + +G   R  +I+   + ++
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182

Query: 322 APEYLLEGKLTDKSDVYAFGVVLLELL-MGRRP 353
           A E L +   T KSDV+AFGV + E+   G+ P
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 91.8 bits (228), Expect = 5e-21
 Identities = 70/223 (31%), Positives = 109/223 (48%), Gaps = 38/223 (17%)

Query: 159 NVIGEGGRGHVYKARFNEKLL-------AAVKRIDDAGHDAER-EFNNEVNWLTKIRHQN 210
           N +G G  G VY+    + L         AVK +     D E+ EF  E + ++   H N
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 211 IISLLGYCIHAETRFLVYEMMQNGSLEKQLHGP----THGSNLTWHLRMKIAVDVARGLE 266
           I+ LLG C+  E ++++ E+M+ G L   L            LT    + I +DVA+G  
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 267 YLHE-HCNHPVVHRDLKSSNILL-----DSSFNAKLSDFGLS---------VTAGTQSRN 311
           YL + H     +HRDL + N L+     D+    K+ DFGL+            G     
Sbjct: 121 YLEQMH----FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176

Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRP 353
           V+      ++APE LL+GK T +SDV++FGV++ E+L +G++P
Sbjct: 177 VR------WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 92.3 bits (229), Expect = 6e-21
 Identities = 67/203 (33%), Positives = 104/203 (51%), Gaps = 29/203 (14%)

Query: 170 YKARFNEKLLAAVKRI-DDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVY 228
           +  R    LL AVK +  DA  +A  +F  EV  L++++  NII LLG C+  +   ++ 
Sbjct: 39  FNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMIT 98

Query: 229 EMMQNGSLEKQLH---------------GPTH-GSNLTWHLRMKIAVDVARGLEYLHEHC 272
           E M+NG L + L                 P H    +++   + +A+ +A G++YL    
Sbjct: 99  EYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---S 155

Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISG----TLGYVAPEYL 326
           +   VHRDL + N L+  +   K++DFG+S  + AG   R   I G     + ++A E +
Sbjct: 156 SLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYR---IQGRAVLPIRWMAWECI 212

Query: 327 LEGKLTDKSDVYAFGVVLLELLM 349
           L GK T  SDV+AFGV L E+LM
Sbjct: 213 LMGKFTTASDVWAFGVTLWEILM 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 91.2 bits (226), Expect = 8e-21
 Identities = 80/262 (30%), Positives = 126/262 (48%), Gaps = 30/262 (11%)

Query: 160 VIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAERE-FNNEVNWLTKIRHQNIISLLGYC 218
            IG+G  G V    +    +A VK I    +DA  + F  E + +T++RH N++ LLG  
Sbjct: 13  TIGKGEFGDVMLGDYRGNKVA-VKCIK---NDATAQAFLAEASVMTQLRHSNLVQLLGVI 68

Query: 219 IHAE-TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVV 277
           +  +   ++V E M  GSL   L      S L     +K ++DV   +EYL     +  V
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLE---ANNFV 124

Query: 278 HRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDV 337
           HRDL + N+L+     AK+SDFGL+  A +     K+   + + APE L E K + KSDV
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP--VKWTAPEALREKKFSTKSDV 182

Query: 338 YAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRSKL--PNIVDPVIRDTMDLK 394
           ++FG++L E+   GR P  ++            +P++    K+  P+   PV+ D M  K
Sbjct: 183 WSFGILLWEIYSFGRVPYPRIPLKD-------VVPRVEKGYKMDAPDGCPPVVYDVM--K 233

Query: 395 HLYQVAAVAVLCIQPEPSYRPL 416
             + + A         PS+  L
Sbjct: 234 QCWHLDAAT------RPSFLQL 249

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 91.1 bits (226), Expect = 8e-21
 Identities = 68/215 (31%), Positives = 109/215 (50%), Gaps = 25/215 (11%)

Query: 160 VIGEGGRGHVYKARFN----EKLLAAVKRIDDAGHDAE--REFNNEVNWLTKIRHQNIIS 213
           VIG G  G V + R       ++  A+K +  +G+  +  R+F +E + + +  H NII 
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLK-SGYTEKQRRDFLSEASIMGQFDHPNIIH 69

Query: 214 LLGYCIHAETRFLVYEMMQNGSLE---KQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHE 270
           L G    +    ++ E M+NG+L+   +Q  G      L   LR      +A G++YL E
Sbjct: 70  LEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR-----GIAAGMKYLSE 124

Query: 271 HCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLG------YVAPE 324
                 VHRDL + NIL++S+   K+SDFGLS      + +   + +LG      + APE
Sbjct: 125 M---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPE 181

Query: 325 YLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMS 358
            +   K T  SDV+++G+V+ E++  G RP   MS
Sbjct: 182 AIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS 216

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 91.2 bits (226), Expect = 1e-20
 Identities = 74/224 (33%), Positives = 114/224 (50%), Gaps = 32/224 (14%)

Query: 159 NVIGEGGRGHVYKARFNE---KLLAAVKRIDD-AGHDAEREFNNEVNWLTKI-RHQNIIS 213
           +VIGEG  G V +A   +   K+ AA+K + + A  +  R+F  E+  L K+  H NII+
Sbjct: 8   DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67

Query: 214 LLGYCIHAETRFLVYEMMQNGSLEKQLH-----------GPTHG--SNLTWHLRMKIAVD 260
           LLG C +    ++  E    G+L   L               HG  S LT    ++ A D
Sbjct: 68  LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127

Query: 261 VARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLG- 319
           VA G++YL E      +HRDL + N+L+  +  +K++DFGLS     +   V +  T+G 
Sbjct: 128 VATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLS-----RGEEVYVKKTMGR 179

Query: 320 ----YVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMS 358
               ++A E L     T KSDV++FGV+L E++ +G  P   M+
Sbjct: 180 LPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT 223

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 90.9 bits (225), Expect = 1e-20
 Identities = 72/221 (32%), Positives = 106/221 (47%), Gaps = 19/221 (8%)

Query: 155 FQESNVIGEGGRGHVYKAR-FNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKI-RHQNII 212
           F+   ++G G  G VYK R      LAA+K +D  G D E E   E+N L K   H+NI 
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIA 66

Query: 213 SLLGYCIHA------ETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
           +  G  I        +  +LV E    GS+   +   T G+ L       I  ++ RGL 
Sbjct: 67  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN-TKGNTLKEEWIAYICREILRGLS 125

Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAG-TQSRNVKISGTLGYVAPEY 325
           +LH+H    V+HRD+K  N+LL  +   KL DFG+S     T  R     GT  ++APE 
Sbjct: 126 HLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEV 182

Query: 326 LLEGKLTD-----KSDVYAFGVVLLELLMGRRPVEKMSPTQ 361
           +   +  D     KSD+++ G+  +E+  G  P+  M P +
Sbjct: 183 IACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR 223

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 91.3 bits (227), Expect = 2e-20
 Identities = 71/211 (33%), Positives = 106/211 (50%), Gaps = 25/211 (11%)

Query: 154 NFQESNVIGEGGRGHVYKAR-FNEKLLAAVKRIDDAGHDAERE-----FNNEVNWLTKIR 207
            F++ N IGEG  G VY+AR      + A+K++     D ER+        E+  L  +R
Sbjct: 8   EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVR---MDNERDGIPISSLREITLLLNLR 64

Query: 208 HQNIISLLGYCI--HAETRFLVYEMMQN--GSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           H NI+ L    +  H ++ FLV E  +    SL   +  P   S +       + + + R
Sbjct: 65  HPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVK-----CLMLQLLR 119

Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT--QSRNVKISGTLGYV 321
           GL+YLHE+    ++HRDLK SN+LL      K++DFGL+ T G   +    K+  TL Y 
Sbjct: 120 GLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYR 175

Query: 322 APEYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           APE LL       + D++A G +L ELL  +
Sbjct: 176 APELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 90.7 bits (226), Expect = 2e-20
 Identities = 67/210 (31%), Positives = 104/210 (49%), Gaps = 36/210 (17%)

Query: 161 IGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFN----NEVNWLTKIRHQNIISLL 215
           IGEG  G VYKAR  +   L A+K+I     + +  F      E+  L K+RH NI+ L 
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIR--MENEKEGFPITAIREIKLLQKLRHPNIVRL- 63

Query: 216 GYCI-HAETR---FLVYEMMQ---NGSLEKQLHGPTHGSNLTWHLR--MKIAVDVARGLE 266
              I  ++ +   ++V+E M     G L+      T        ++  MK    +  GL+
Sbjct: 64  -KEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTES-----QIKCYMK---QLLEGLQ 114

Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS-VTAGTQSR---NVKISGTLGYVA 322
           YLH   ++ ++HRD+K SNIL+++    KL+DFGL+       S    N  I  TL Y  
Sbjct: 115 YLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI--TLWYRP 169

Query: 323 PEYLL-EGKLTDKSDVYAFGVVLLELLMGR 351
           PE LL   +   + D+++ G +L EL +G+
Sbjct: 170 PELLLGATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 89.6 bits (222), Expect = 4e-20
 Identities = 65/205 (31%), Positives = 106/205 (51%), Gaps = 32/205 (15%)

Query: 179 LAAVKRI-DDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLE 237
           L AVK +  D    A  +F  E+  ++++++ NII LLG C+  +   ++ E M+NG L 
Sbjct: 46  LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN 105

Query: 238 KQLHGP------THGSNL---TWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILL 288
           + L         TH +N+   +    + +AV +A G++YL    +   VHRDL + N L+
Sbjct: 106 QFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLV 162

Query: 289 DSSFNAKLSDFGLSVTAGTQSRNV------KISG----TLGYVAPEYLLEGKLTDKSDVY 338
            + +  K++DFG+       SRN+      +I G     + ++A E +L GK T  SDV+
Sbjct: 163 GNHYTIKIADFGM-------SRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVW 215

Query: 339 AFGVVLLEL--LMGRRPVEKMSPTQ 361
           AFGV L E+  L   +P   +S  Q
Sbjct: 216 AFGVTLWEMFTLCKEQPYSLLSDEQ 240

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 89.1 bits (221), Expect = 6e-20
 Identities = 83/300 (27%), Positives = 130/300 (43%), Gaps = 50/300 (16%)

Query: 155 FQESNVI-----GEGGRGHVYKARF-----NEKLLAAVKRIDDAGHDAEREFNNEVNWLT 204
           F+E ++      G+G  G V   R+     N   + AVK++  +  +  R+F  E+  L 
Sbjct: 1   FEERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILK 60

Query: 205 KIRHQNIISLLGYCIHAETR--FLVYEMMQNGSL----EKQLHGPTHGSNLTWHLRMKIA 258
            ++H NI+   G C  A  R   LV E +  GSL    +K      H   L +      A
Sbjct: 61  SLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLY------A 114

Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISG 316
             + +G+EYL        VHRDL + NIL++S    K+ DFGL+  +    +   V+  G
Sbjct: 115 SQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPG 171

Query: 317 T--LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL----MGRRP----VEKMSP-TQCQSM 365
              + + APE L E K +  SDV++FGVVL EL         P    +  M    Q Q +
Sbjct: 172 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMI 231

Query: 366 VTWAMPQLTDRSKLPNIVD-PVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
           V   +  L +  +LP     P            ++ A+   C   +PS RP  +++   +
Sbjct: 232 VYHLIELLKNNGRLPAPPGCPA-----------EIYAIMKECWNNDPSQRPSFSELALQV 280

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 88.1 bits (218), Expect = 9e-20
 Identities = 74/249 (29%), Positives = 117/249 (46%), Gaps = 22/249 (8%)

Query: 161 IGEGGRGHVYKARFNEKLLA---AVKRIDDAGHDA--EREFNNEVNWLTKIRHQNIISLL 215
           +G G  G V K  +  K      AVK + +  +D   + E   E N + ++ +  I+ ++
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 216 GYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHP 275
           G C  AE+  LV E+ + G L K L    H   +T     ++   V+ G++YL E     
Sbjct: 63  GIC-EAESWMLVMELAELGPLNKFLQKNKH---VTEKNITELVHQVSMGMKYLEET---N 115

Query: 276 VVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT----LGYVAPEYLLEGKL 331
            VHRDL + N+LL +   AK+SDFGLS   G      K        + + APE +   K 
Sbjct: 116 FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKF 175

Query: 332 TDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDT 390
           + KSDV++FGV++ E    G++P + M   +   M+     +  +R + P    P + D 
Sbjct: 176 SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMI-----ESGERMECPQRCPPEMYDL 230

Query: 391 MDLKHLYQV 399
           M L   Y V
Sbjct: 231 MKLCWTYGV 239

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 88.1 bits (218), Expect = 1e-19
 Identities = 73/221 (33%), Positives = 105/221 (47%), Gaps = 19/221 (8%)

Query: 155 FQESNVIGEGGRGHVYKAR-FNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKI-RHQNII 212
           F+   V+G G  G VYK R      LAA+K + D   D E E   E+N L K   H+NI 
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTEDEEEEIKLEINMLKKYSHHRNIA 76

Query: 213 SLLGYCI------HAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
           +  G  I      H +  +LV E    GS+   L   T G+ L       I  ++ RGL 
Sbjct: 77  TYYGAFIKKSPPGHDDQLWLVMEFCGAGSV-TDLVKNTKGNALKEDWIAYICREILRGLA 135

Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAG-TQSRNVKISGTLGYVAPEY 325
           +LH H    V+HRD+K  N+LL  +   KL DFG+S     T  R     GT  ++APE 
Sbjct: 136 HLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEV 192

Query: 326 LLEGKLTD-----KSDVYAFGVVLLELLMGRRPVEKMSPTQ 361
           +   +  D     +SD+++ G+  +E+  G  P+  M P +
Sbjct: 193 IACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR 233

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 88.0 bits (218), Expect = 1e-19
 Identities = 75/287 (26%), Positives = 130/287 (45%), Gaps = 34/287 (11%)

Query: 143 IEYELLEAATNNFQESNVIGEGGRGHVYKAR-FNEKLLAAVKRIDDAGHDAEREFNNEVN 201
            EYE      +   E  V+G+G  G VY AR  + ++  A+K I +      +  + E+ 
Sbjct: 3   YEYEY-----DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIA 57

Query: 202 WLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLH---GPTHGSNLTWHLRMKIA 258
             + ++H+NI+  LG         +  E +  GSL   L    GP   +  T     K  
Sbjct: 58  LHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK-- 115

Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDS-SFNAKLSDFGLSVT-AGTQSRNVKISG 316
             +  GL+YLH+   + +VHRD+K  N+L+++ S   K+SDFG S   AG        +G
Sbjct: 116 -QILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTG 171

Query: 317 TLGYVAPEYLLEGK--LTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLT 374
           TL Y+APE + +G       +D+++ G  ++E+  G+ P  ++   Q  +M    M +  
Sbjct: 172 TLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA-AMFKVGMFK-- 228

Query: 375 DRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
                   + P I +++  +         + C +P+P  R    D+L
Sbjct: 229 --------IHPEIPESLSAE----AKNFILRCFEPDPDKRASAHDLL 263

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 87.4 bits (216), Expect = 2e-19
 Identities = 63/200 (31%), Positives = 100/200 (50%), Gaps = 9/200 (4%)

Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           +G+G  G V+   +N     A+K +   G  +   F  E   + K+RH+ ++ L    + 
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 71

Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
            E  ++V E M  GSL   L G   G  L     + +A  +A G+ Y+ E  N+  VHRD
Sbjct: 72  EEPIYIVTEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYV-ERMNY--VHRD 127

Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
           L+++NIL+  +   K++DFGL+          +      + + APE  L G+ T KSDV+
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187

Query: 339 AFGVVLLELLM-GRRPVEKM 357
           +FG++L EL   GR P   M
Sbjct: 188 SFGILLTELTTKGRVPYPGM 207

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 87.0 bits (215), Expect = 2e-19
 Identities = 62/216 (28%), Positives = 107/216 (49%), Gaps = 19/216 (8%)

Query: 160 VIGEGGRGHVYKARFNEKLLAAVKRI-DDAGHDAEREFNNEVNWLTKIRHQNIISLLGYC 218
           ++G+G  G V+K    +K   AVK   +D   + + +F +E   L +  H NI+ L+G C
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 219 IHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLH-EHCNHPVV 277
              +  ++V E++  G     L        L     +K A+D A G+ YL  ++C    +
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFLR--KKKDELKTKQLVKFALDAAAGMAYLESKNC----I 115

Query: 278 HRDLKSSNILLDSSFNAKLSDFGLS------VTAGTQSRNVKISGTLGYVAPEYLLEGKL 331
           HRDL + N L+  +   K+SDFG+S      + + +  + + I  T    APE L  G+ 
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWT----APEALNYGRY 171

Query: 332 TDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
           + +SDV+++G++L E   +G  P   M+  Q +  V
Sbjct: 172 SSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQV 207

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 87.1 bits (216), Expect = 2e-19
 Identities = 58/206 (28%), Positives = 87/206 (42%), Gaps = 21/206 (10%)

Query: 161 IGEGGRGHVYKARF----NEKLLAAVKRI-DDAGHDAEREFNNEVNWLTKIRHQNIISLL 215
           +G+G  G V +  +     + +  AVK +  D   D   +F  E   +  + H+N+I L 
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62

Query: 216 GYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLH-EHCNH 274
           G  +      +V E+   GSL  +L     G           AV +A G+ YL  +    
Sbjct: 63  G-VVLTHPLMMVTELAPLGSLLDRLRKDALGH-FLISTLCDYAVQIANGMRYLESKRF-- 118

Query: 275 PVVHRDLKSSNILLDSSFNAKLSDFGLSVTAG------TQSRNVKISGTLGYVAPEYLLE 328
             +HRDL + NILL S    K+ DFGL               ++K+     + APE L  
Sbjct: 119 --IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVP--FAWCAPESLRT 174

Query: 329 GKLTDKSDVYAFGVVLLELL-MGRRP 353
              +  SDV+ FGV L E+   G  P
Sbjct: 175 RTFSHASDVWMFGVTLWEMFTYGEEP 200

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 86.8 bits (215), Expect = 3e-19
 Identities = 73/209 (34%), Positives = 104/209 (49%), Gaps = 32/209 (15%)

Query: 159 NVIGEGGRGHVYKARF----NEKLLAAVK---RIDDAGHDAEREFNNEVNWLTKIRHQNI 211
            VIG+G  G VY         +K+  AVK   RI D     +  F  E   +    H N+
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQ--FLKEGIIMKDFSHPNV 58

Query: 212 ISLLGYCIHAE-TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHE 270
           +SLLG C+ +E +  +V   M++G L   +   TH  N T    +   + VA+G+EYL  
Sbjct: 59  LSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETH--NPTVKDLIGFGLQVAKGMEYL-- 114

Query: 271 HCNHPVVHRDLKSSNILLDSSFNAKLSDFGL----------SVTAGTQSR-NVKISGTLG 319
             +   VHRDL + N +LD SF  K++DFGL          SV   T ++  VK      
Sbjct: 115 -ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVK------ 167

Query: 320 YVAPEYLLEGKLTDKSDVYAFGVVLLELL 348
           ++A E L   K T KSDV++FGV+L EL+
Sbjct: 168 WMALESLQTQKFTTKSDVWSFGVLLWELM 196

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 86.9 bits (215), Expect = 4e-19
 Identities = 74/238 (31%), Positives = 113/238 (47%), Gaps = 35/238 (14%)

Query: 154 NFQESNVIGEGGRGHVYKA-RFNEKLLA-----AVKRIDDAGHDAE-REFNNEVNWLTKI 206
           N      +GEG  G V KA  F  K  A     AVK + +    +E R+  +E N L ++
Sbjct: 1   NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60

Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLH-----GPTH-GSN------------ 248
            H ++I L G C       L+ E  + GSL   L      GP++ GS+            
Sbjct: 61  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120

Query: 249 ---LTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA 305
              LT    +  A  ++RG++YL E     +VHRDL + N+L+      K+SDFGLS   
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177

Query: 306 GTQSRNVKISG---TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSP 359
             +   VK S     + ++A E L +   T +SDV++FGV+L E++ +G  P   ++P
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 86.6 bits (214), Expect = 4e-19
 Identities = 75/274 (27%), Positives = 121/274 (44%), Gaps = 39/274 (14%)

Query: 166 RGHVYKARFNEKLLAAVKRIDDAGHDAE-REFNNEVNWLTKIRHQNIISLLGYCIHAETR 224
           +GH+Y    +   L A+K + D  +  +  EF  E + + ++ H NI+ LLG     +  
Sbjct: 23  KGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV 82

Query: 225 FLVYEMMQNGSLEKQL--HGP------------THGSNLTWHLRMKIAVDVARGLEYLHE 270
            +++E +  G L + L    P            T  S+L     + IA+ +A G+EYL  
Sbjct: 83  CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYL-- 140

Query: 271 HCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTL---GYVAPEYLL 327
             +H  VH+DL + NIL+    + K+SD GLS    +         +L    ++ PE ++
Sbjct: 141 -SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIM 199

Query: 328 EGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPV 386
            GK +  SD+++FGVVL E+   G +P    S  +   MV         R  LP   D  
Sbjct: 200 YGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV-------RKRQLLPCSEDCP 252

Query: 387 IRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDV 420
            R          + ++   C Q  PS RP   D+
Sbjct: 253 PR----------MYSLMTECWQEGPSRRPRFKDI 276

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 86.6 bits (215), Expect = 4e-19
 Identities = 70/291 (24%), Positives = 122/291 (41%), Gaps = 52/291 (17%)

Query: 161 IGEGGRGHVYKA------RFNEKLLAAVKRIDDAGHDAER-EFNNEVNWLTKIRHQNIIS 213
           +G+G  G VY+       +   +   A+K +++     ER EF NE + + +    +++ 
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 214 LLGYCIHAETRFLVYEMMQNGSLEKQL--HGPTH-----GSNLTWHLRMKIAVDVARGLE 266
           LLG     +   +V E+M  G L+  L    P           T    +++A ++A G+ 
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133

Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTL---GYVAP 323
           YL        VHRDL + N ++      K+ DFG++          K    L    ++AP
Sbjct: 134 YLAA--KK-FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190

Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNI 382
           E L +G  T KSDV++FGVVL E+  +  +P + +S  +                     
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE--------------------- 229

Query: 383 VDPVIRDTMDLKHL-------YQVAAVAVLCIQPEPSYRPLITDVLHSLIP 426
              V++  +D  HL        ++  +  +C Q  P  RP   +++ SL  
Sbjct: 230 ---VLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 86.8 bits (215), Expect = 4e-19
 Identities = 68/205 (33%), Positives = 105/205 (51%), Gaps = 13/205 (6%)

Query: 154 NFQESNVIGEGGRGHVYKARFNE--KLLAAVK-RIDDAGHDAEREFNNEVNWLTKIRHQN 210
           NFQ+   IGEG  G VYKAR     +++A  K R+D            E++ L ++ H N
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60

Query: 211 IISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLH 269
           I+ LL   IH E + +LV+E + +  L+K +   +  S +   L       + +GL + H
Sbjct: 61  IVKLLD-VIHTENKLYLVFEFL-HQDLKKFMDA-SPLSGIPLPLIKSYLFQLLQGLAFCH 117

Query: 270 EHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPEYLLE 328
              +H V+HRDLK  N+L+++    KL+DFGL+   G   R       TL Y APE LL 
Sbjct: 118 ---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 174

Query: 329 GKL-TDKSDVYAFGVVLLELLMGRR 352
            K  +   D+++ G +  E ++ RR
Sbjct: 175 CKYYSTAVDIWSLGCIFAE-MVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 86.1 bits (213), Expect = 4e-19
 Identities = 62/207 (29%), Positives = 97/207 (46%), Gaps = 10/207 (4%)

Query: 154 NFQESNVIGEGGRGHVYKA-RFNEKLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQN 210
            +++  V+G G  G V+   R  ++ L  +K+I       D      NE   L  + H N
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60

Query: 211 IISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHE 270
           II      +  +   +V E    G+L + +    + S L     +   V +   L ++H 
Sbjct: 61  IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCN-SLLDEDTILHFFVQILLALHHVH- 118

Query: 271 HCNHPVVHRDLKSSNILLDSSFNA-KLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEG 329
                ++HRDLK+ NILLD      K+ DFG+S    ++S+   + GT  Y++PE L EG
Sbjct: 119 --TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPE-LCEG 175

Query: 330 K-LTDKSDVYAFGVVLLELLMGRRPVE 355
           K    KSD++A G VL EL   +R  E
Sbjct: 176 KPYNQKSDIWALGCVLYELASLKRAFE 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 86.5 bits (214), Expect = 4e-19
 Identities = 70/212 (33%), Positives = 109/212 (51%), Gaps = 21/212 (9%)

Query: 160 VIGEGGRGHVYKARFN----EKLLAAVKRIDDAGHDAE--REFNNEVNWLTKIRHQNIIS 213
           VIG G  G V   R       ++  A+K +  AG+  +  R+F +E + + +  H NII 
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLK-AGYTEKQRRDFLSEASIMGQFDHPNIIH 69

Query: 214 LLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
           L G    ++   +V E M+NGSL+  L    H    T    + +   +A G++YL    +
Sbjct: 70  LEGVVTKSKPVMIVTEYMENGSLDAFLR--KHDGQFTVIQLVGMLRGIASGMKYL---SD 124

Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLSVT------AGTQSRNVKISGTLGYVAPEYLL 327
              VHRDL + NIL++S+   K+SDFGLS        A   +R  KI   + + APE + 
Sbjct: 125 MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP--IRWTAPEAIA 182

Query: 328 EGKLTDKSDVYAFGVVLLELL-MGRRPVEKMS 358
             K T  SDV+++G+V+ E++  G RP  +MS
Sbjct: 183 YRKFTSASDVWSYGIVMWEVMSYGERPYWEMS 214

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 86.9 bits (215), Expect = 5e-19
 Identities = 58/193 (30%), Positives = 104/193 (53%), Gaps = 29/193 (15%)

Query: 175 NEKLLAAVKRI-DDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQN 233
           N+ +L AVK + +DA  +A  +F  E+  +++++  NII LL  CI ++   ++ E M+N
Sbjct: 44  NQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMEN 103

Query: 234 GSLEK-----QLHGPTHGSN---LTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSN 285
           G L +     +       ++   +++   + +A  +A G++YL    +   VHRDL + N
Sbjct: 104 GDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRN 160

Query: 286 ILLDSSFNAKLSDFGLSVTAGTQSRNV------KISG----TLGYVAPEYLLEGKLTDKS 335
            L+  ++  K++DFG+       SRN+      +I G     + +++ E +L GK T  S
Sbjct: 161 CLVGKNYTIKIADFGM-------SRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTAS 213

Query: 336 DVYAFGVVLLELL 348
           DV+AFGV L E+L
Sbjct: 214 DVWAFGVTLWEIL 226

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 86.3 bits (214), Expect = 5e-19
 Identities = 71/272 (26%), Positives = 125/272 (45%), Gaps = 40/272 (14%)

Query: 155 FQESNVIGEGGRGHVYKARFNE-KLLAAVKRID-DAGHDAEREFNNEVNWLTKIRH---Q 209
           +Q   +IG G  G VY+ +      + A+K I+ D   D   +   EV  L+++R     
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62

Query: 210 NIISLLGYCIHAETRFLVYEMMQNGSLEKQLH-GPTHGSNLTWHLRMKIAVDVARGLEYL 268
           NI    G  +     +++ E  + GS+   +  GP     ++  +R     +V   L+Y+
Sbjct: 63  NITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIR-----EVLVALKYI 117

Query: 269 HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT-AGTQSRNVKISGTLGYVAPEYLL 327
           H+     V+HRD+K++NIL+ ++ N KL DFG++       S+     GT  ++APE + 
Sbjct: 118 HKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVIT 174

Query: 328 EGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVD-- 384
           EGK  D K+D+++ G+ + E+  G  P   +   +       AM  L  +SK P + D  
Sbjct: 175 EGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR-------AM-MLIPKSKPPRLEDNG 226

Query: 385 --PVIRDTMDLKHLYQVAAVAVLCIQPEPSYR 414
              ++R+ +              C+  EP  R
Sbjct: 227 YSKLLREFV------------AACLDEEPKER 246

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 86.1 bits (213), Expect = 5e-19
 Identities = 58/194 (29%), Positives = 100/194 (51%), Gaps = 12/194 (6%)

Query: 159 NVIGEGGRGHVYKA---RFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLL 215
           + +G G  G VY+    +++  L  AVK + +   + E EF  E   + +I+H N++ LL
Sbjct: 12  HKLGGGQYGEVYEGVWKKYS--LTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLL 68

Query: 216 GYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHP 275
           G C      +++ E M  G+L   L    +   +   + + +A  ++  +EYL +     
Sbjct: 69  GVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISSAMEYLEK---KN 124

Query: 276 VVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTD 333
            +HRDL + N L+  +   K++DFGLS  +T  T + +      + + APE L   K + 
Sbjct: 125 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 184

Query: 334 KSDVYAFGVVLLEL 347
           KSDV+AFGV+L E+
Sbjct: 185 KSDVWAFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 86.6 bits (215), Expect = 5e-19
 Identities = 63/211 (29%), Positives = 94/211 (44%), Gaps = 24/211 (11%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNEK-LLAAVKRIDDAGHDAE---REFNNEVNWLTKIRH 208
           N ++   V+GEG  G V K R      + A+K+  ++  D E   +    EV  L ++RH
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKES-EDDEDVKKTALREVKVLRQLRH 59

Query: 209 QNIISLLGYCIHAETRFLVYEMMQNG---SLEKQLHG--PTHGSNLTWHLRMKIAVDVAR 263
           +NI++L          +LV+E ++      LE    G  P    +  W L         +
Sbjct: 60  ENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQL--------LQ 111

Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGL--SVTAGTQSRNVKISGTLGYV 321
            + Y H H    ++HRD+K  NIL+  S   KL DFG   ++ A   S       T  Y 
Sbjct: 112 AIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYR 168

Query: 322 APEYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           APE L+      K  DV+A G ++ ELL G 
Sbjct: 169 APELLVGDTNYGKPVDVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 85.7 bits (212), Expect = 6e-19
 Identities = 61/203 (30%), Positives = 104/203 (51%), Gaps = 13/203 (6%)

Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           +G G  G V+   +N     A+K +       E  F  E N + +++H  ++ L    + 
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPE-AFLAEANLMKQLQHPRLVRLYA-VVT 71

Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
            E  +++ E M+NGSL   L  P  G  LT +  + +A  +A G+ ++ E  N+  +HRD
Sbjct: 72  QEPIYIITEYMENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFI-ERKNY--IHRD 127

Query: 281 LKSSNILLDSSFNAKLSDFGLS----VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSD 336
           L+++NIL+  +   K++DFGL+        T     K    + + APE +  G  T KSD
Sbjct: 128 LRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFP--IKWTAPEAINYGTFTIKSD 185

Query: 337 VYAFGVVLLELLM-GRRPVEKMS 358
           V++FG++L E++  GR P   M+
Sbjct: 186 VWSFGILLTEIVTYGRIPYPGMT 208

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 86.1 bits (213), Expect = 6e-19
 Identities = 67/285 (23%), Positives = 123/285 (43%), Gaps = 40/285 (14%)

Query: 154 NFQESNVIGEGGRGHVYKAR-FNEKLLAAVKRI----DDAGHDAE--REFNNEVNWLTKI 206
            + +   +G G     Y+AR      L AVK++    + +    E       E+  + ++
Sbjct: 1   EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60

Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLH--GPTHGSNLTWHLRMKIAVDVARG 264
            H +II +LG         L  E M  GS+   L   G    + +  +        + RG
Sbjct: 61  NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTE-----QLLRG 115

Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSS-FNAKLSDFGLSVTAGTQSRNV-----KISGTL 318
           L YLHE+    ++HRD+K +N+L+DS+    +++DFG +     +         ++ GT+
Sbjct: 116 LSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTI 172

Query: 319 GYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP--VEKMSPTQCQSMVTWAMPQLTDR 376
            ++APE L   +     DV++ G V++E+   + P   EK S       + + +   T  
Sbjct: 173 AFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN---HLALIFKIASATTA 229

Query: 377 SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
             +P  + P +RD            V + C++ +P  RP   ++L
Sbjct: 230 PSIPEHLSPGLRD------------VTLRCLELQPEDRPPSRELL 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 85.5 bits (211), Expect = 8e-19
 Identities = 75/224 (33%), Positives = 117/224 (52%), Gaps = 32/224 (14%)

Query: 159 NVIGEGGRGHVYKARFNE---KLLAAVKRIDD-AGHDAEREFNNEVNWLTKI-RHQNIIS 213
           +VIGEG  G V KAR  +   ++ AA+KR+ + A  D  R+F  E+  L K+  H NII+
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 214 LLGYCIHAETRFLVYEMMQNGSLEKQLH-----------GPTHGSNLTWHLR--MKIAVD 260
           LLG C H    +L  E   +G+L   L               + +  T   +  +  A D
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 261 VARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLG- 319
           VARG++YL +      +HRDL + NIL+  ++ AK++DFGLS     + + V +  T+G 
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLS-----RGQEVYVKKTMGR 172

Query: 320 ----YVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMS 358
               ++A E L     T  SDV+++GV+L E++ +G  P   M+
Sbjct: 173 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 216

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 85.6 bits (212), Expect = 9e-19
 Identities = 75/282 (26%), Positives = 123/282 (43%), Gaps = 42/282 (14%)

Query: 160 VIGEGGRGHVYKA-RFNEKLLAAVKRID----DAGHDAERE------FNNEVNWLTKIRH 208
           +IG+G  G VY A       + AVK+++     AG    R+        +E+  L  + H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 209 QNIISLLGYCIHAETRFLVYEMMQNGSLEKQL--HGPTHGSNLTWHLRMKIAVDVARGLE 266
            NI+  LG+    E   +  E +  GS+   L  +G      L      +    V  GL 
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQ-LVRFFTEQ----VLEGLA 122

Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGL---SVTAGTQSRNVKISGTLGYVAP 323
           YLH   +  ++HRDLK+ N+L+D+    K+SDFG+   S       +N+ + G++ ++AP
Sbjct: 123 YLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAP 179

Query: 324 EYL-LEGK-LTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPN 381
           E +    +  + K D+++ G V+LE+  GRRP               AM +L ++   P 
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA-------AMFKLGNKRSAPP 232

Query: 382 IVDPVIRDTMDLKHLYQVAAVAVL--CIQPEPSYRPLITDVL 421
           I         D+       A+  L  C    P  RP   ++L
Sbjct: 233 IPP-------DVSMNLSPVALDFLNACFTINPDNRPTARELL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 85.5 bits (212), Expect = 9e-19
 Identities = 71/293 (24%), Positives = 132/293 (45%), Gaps = 32/293 (10%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNEK-LLAAVKRIDDAGHDAE--REFNNEVNWLTKIRHQ 209
             ++   ++GEG  G V K +  E   + A+K+  ++  D    +    E+  L ++RH+
Sbjct: 1   EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60

Query: 210 NIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLH 269
           N+++L+      +  +LV+E + +  L+     P +G  L      K    + RG+E+ H
Sbjct: 61  NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYP-NG--LDESRVRKYLFQILRGIEFCH 117

Query: 270 EHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT-AGTQSRNVKISGTLGYVAPEYLL- 327
              +H ++HRD+K  NIL+  S   KL DFG + T A           T  Y APE L+ 
Sbjct: 118 ---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVG 174

Query: 328 EGKLTDKSDVYAFGVVLLELLMGRRPVEKMSP-----------TQCQSMVTWAMPQLTDR 376
           + K     D++A G ++ E+L G    E + P            +C   +     ++  +
Sbjct: 175 DTKYGRAVDIWAVGCLVTEMLTG----EPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQK 230

Query: 377 SKLPNIVD-PVIRDTMDLKHLY-----QVAAVAVLCIQPEPSYRPLITDVLHS 423
           + L   +  P +++   L+  +      V  +A  C++ +P  RP  + +LH 
Sbjct: 231 NPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 85.6 bits (212), Expect = 1e-18
 Identities = 65/245 (26%), Positives = 111/245 (45%), Gaps = 32/245 (13%)

Query: 161 IGEGGRGHVYKAR-FNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCI 219
           IGEG  G V  A   +     AVK++D           NEV  +   +H NI+ +    +
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86

Query: 220 HAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMK------IAVDVARGLEYLHEHCN 273
             +  ++V E ++ G+L          +++  H RM       + + V + L +LH    
Sbjct: 87  VGDELWVVMEFLEGGAL----------TDIVTHTRMNEEQIATVCLAVLKALSFLH---A 133

Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGL-SVTAGTQSRNVKISGTLGYVAPEYLLEGKLT 332
             V+HRD+KS +ILL S    KLSDFG  +  +    R   + GT  ++APE +      
Sbjct: 134 QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYG 193

Query: 333 DKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTD----RSKLPNIVDPVIR 388
            + D+++ G++++E++ G  P     P Q       AM ++ D    + K  + V P +R
Sbjct: 194 TEVDIWSLGIMVIEMVDGEPPYFNEPPLQ-------AMKRIRDNLPPKLKNLHKVSPRLR 246

Query: 389 DTMDL 393
             +D 
Sbjct: 247 SFLDR 251

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 85.1 bits (210), Expect = 1e-18
 Identities = 66/213 (30%), Positives = 101/213 (47%), Gaps = 9/213 (4%)

Query: 149 EAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRH 208
           E    + Q    +G G  G V+   +N     AVK +   G  +   F  E   + K+RH
Sbjct: 2   EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLK-PGTMSPESFLEEAQIMKKLRH 60

Query: 209 QNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYL 268
             ++ L    +  E  ++V E M  GSL   L     G  L     + +A  VA G+ Y+
Sbjct: 61  DKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKD-GEGRALKLPNLVDMAAQVAAGMAYI 118

Query: 269 HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYL 326
            E  N+  +HRDL+S+NIL+      K++DFGL+          +      + + APE  
Sbjct: 119 -ERMNY--IHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 175

Query: 327 LEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMS 358
           L G+ T KSDV++FG++L EL+  GR P   M+
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN 208

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 85.5 bits (212), Expect = 1e-18
 Identities = 70/219 (31%), Positives = 104/219 (47%), Gaps = 26/219 (11%)

Query: 149 EAATNNFQESNVIGEGGRGHVYKARFNEK-LLAAVKRIDDAGHDAEREFNNEVNWLTKIR 207
            A  N+ +    IG G  G VYK RF +   + AVK++   G+   +E N  +  L  + 
Sbjct: 11  PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN---KEENKRI--LMDLD 65

Query: 208 -----HQ--NIISLLGYCIHAETRFLVYEMMQN--GSLEKQLHGPTHGSNLTWHLRMKIA 258
                H    I+   GY I     F+  E+M      L K++ GP     +   +  K+ 
Sbjct: 66  VVLKSHDCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGP-----IPEDILGKMT 120

Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTL 318
           V + + L YL E   H V+HRD+K SNILLD+S N KL DFG+S          + +G  
Sbjct: 121 VAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCA 178

Query: 319 GYVAPEYLLEGKLTDK----SDVYAFGVVLLELLMGRRP 353
            Y+APE +       K    +DV++ G+ L+EL  G+ P
Sbjct: 179 AYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 85.5 bits (211), Expect = 1e-18
 Identities = 65/212 (30%), Positives = 112/212 (52%), Gaps = 17/212 (8%)

Query: 160 VIGEGGRGHVYKARF-----NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKIRHQNIIS 213
           V+G G  G VYK  +       K+  A+K +++  G  A  EF +E   +  + H +++ 
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 214 LLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
           LLG C+ + T  LV ++M +G L   +H   H  N+   L +   V +A+G+ YL E   
Sbjct: 74  LLGVCL-SPTIQLVTQLMPHGCLLDYVH--EHKDNIGSQLLLNWCVQIAKGMMYLEER-- 128

Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAPEYLLEGK 330
             +VHRDL + N+L+ S  + K++DFGL+       +     G    + ++A E +   K
Sbjct: 129 -RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRK 187

Query: 331 LTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQ 361
            T +SDV+++GV + EL+  G +P + + PT+
Sbjct: 188 FTHQSDVWSYGVTIWELMTFGGKPYDGI-PTR 218

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 85.0 bits (210), Expect = 2e-18
 Identities = 83/292 (28%), Positives = 125/292 (42%), Gaps = 43/292 (14%)

Query: 160 VIGEGGRGHVYKARFNEK-----LLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNIIS 213
           V+GEG  G V    ++        + AVK +  + G      +  E+N L  + H+NI+ 
Sbjct: 11  VLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVK 70

Query: 214 LLGYCIHA--ETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
             G C     +   L+ E +  GSL   L  P H  NL     +  A  +  G+ YLH  
Sbjct: 71  YKGCCSEQGGKGLQLIMEYVPLGSLRDYL--PKHKLNLAQ--LLLFAQQICEGMAYLH-- 124

Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGT--LGYVAPEYLL 327
            +   +HRDL + N+LLD+    K+ DFGL+  V  G +   V+  G   + + A E L 
Sbjct: 125 -SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK 183

Query: 328 EGKLTDKSDVYAFGVVLLELLMGRRP--------VEKMSPTQCQSMVTWAMPQLTDRSKL 379
           E K +  SDV++FGV L ELL              E + P Q Q  V   +  L    +L
Sbjct: 184 ENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRL 243

Query: 380 PNIVD-PVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPT 430
           P   + P      ++  L +       C + E  +RP       SLIP++  
Sbjct: 244 PCPKNCP-----QEVYILMKN------CWETEAKFRP----TFRSLIPILKE 280

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 84.6 bits (210), Expect = 2e-18
 Identities = 68/225 (30%), Positives = 98/225 (43%), Gaps = 47/225 (20%)

Query: 155 FQESNVIGEGGRGHVYKAR-FNEKLLAAVKRI----DDAGHDAE--REFNNEVNWLTKIR 207
           ++E   IGEG  G VYKAR  N     A+K++     + G      RE    +  L ++ 
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLRE----IALLKQLE 56

Query: 208 ---HQNIISLLGYC-IHAETR----FLVYEMMQNGSLEKQLHG-----PTHG------SN 248
              H NI+ LL  C      R     LV+E +     ++ L       P  G       +
Sbjct: 57  SFEHPNIVRLLDVCHGPRTDRELKLTLVFEHV-----DQDLATYLSKCPKPGLPPETIKD 111

Query: 249 LTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ 308
           L   L         RG+++LH H    +VHRDLK  NIL+ S    K++DFGL+     +
Sbjct: 112 LMRQL--------LRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFE 160

Query: 309 SRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
                +  TL Y APE LL+       D+++ G +  EL   RRP
Sbjct: 161 MALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFR-RRP 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 84.4 bits (209), Expect = 2e-18
 Identities = 72/282 (25%), Positives = 123/282 (43%), Gaps = 35/282 (12%)

Query: 152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRID-----DAGHDAEREFNNEVNWLTK 205
             NF+    IG+G    VYKA    +  + A+K++      DA   A ++   E++ L +
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDA--KARQDCLKEIDLLKQ 58

Query: 206 IRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQL-HGPTHGSNLTWHLRMKIAVDVARG 264
           + H N+I  L   I      +V E+   G L + + H       +      K  V +   
Sbjct: 59  LDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSA 118

Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGL-----SVTAGTQSRNVKISGTLG 319
           LE++H      ++HRD+K +N+ + ++   KL D GL     S T    S    + GT  
Sbjct: 119 LEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS----LVGTPY 171

Query: 320 YVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKL 379
           Y++PE + E     KSD+++ G +L E+          SP     M  +++ +  ++   
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEM------AALQSPFYGDKMNLYSLCKKIEKCDY 225

Query: 380 PNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
           P +  P    + +L+ L         CI P+P  RP I+ VL
Sbjct: 226 PPL--PADHYSEELRDLVSR------CINPDPEKRPDISYVL 259

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 84.2 bits (208), Expect = 3e-18
 Identities = 72/240 (30%), Positives = 114/240 (47%), Gaps = 25/240 (10%)

Query: 161 IGEGGRGHVYKARF-----NEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNIISL 214
           +GEG  G V   R+     N     AVK +  ++G +   +   E+  L  + H+NI+  
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 215 LGYCIHAETRF--LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
            G C         L+ E + +GSL++ L  P + + +    ++K AV + +G++YL    
Sbjct: 72  KGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINLKQQLKYAVQICKGMDYLG--- 126

Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLG----YVAPEYLLE 328
           +   VHRDL + N+L++S    K+ DFGL+    T      +   L     + APE L++
Sbjct: 127 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ 186

Query: 329 GKLTDKSDVYAFGVVLLELLM----GRRPVE---KM-SPTQCQSMVTWAMPQLTDRSKLP 380
            K    SDV++FGV L ELL        P+    KM  PT  Q  VT  +  L +  +LP
Sbjct: 187 SKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLP 246

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 84.9 bits (210), Expect = 3e-18
 Identities = 67/210 (31%), Positives = 98/210 (46%), Gaps = 16/210 (7%)

Query: 155 FQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNN---EVNWLTKIRHQN 210
           F +   IG G  G VY AR      + A+K++  +G  +  ++ +   EV +L ++RH N
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76

Query: 211 IISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHE 270
            I   G  +   T +LV E    GS    L    H   L       I     +GL YLH 
Sbjct: 77  TIEYKGCYLREHTAWLVMEYCL-GSASDILE--VHKKPLQEVEIAAICHGALQGLAYLHS 133

Query: 271 HCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLL--- 327
           H     +HRD+K+ NILL      KL+DFG   +A   S      GT  ++APE +L   
Sbjct: 134 HER---IHRDIKAGNILLTEPGTVKLADFG---SASLVSPANSFVGTPYWMAPEVILAMD 187

Query: 328 EGKLTDKSDVYAFGVVLLELLMGRRPVEKM 357
           EG+   K DV++ G+  +EL   + P+  M
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNM 217

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 84.2 bits (208), Expect = 3e-18
 Identities = 78/284 (27%), Positives = 122/284 (42%), Gaps = 41/284 (14%)

Query: 154 NFQESNVIGEGGRGHVYKA-RFNEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNI 211
           + Q   ++G G  G VYKA     + + AVK I  D   + +++  +E+  L K     I
Sbjct: 2   DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYI 61

Query: 212 ISLLGYCIHAETRF-LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHE 270
           I   G     E R  +  E M  GSL+     P H       +  +IAV V +GL YL  
Sbjct: 62  IGFYG-AFFVENRISICTEFMDGGSLDVYRKIPEH-------VLGRIAVAVVKGLTYL-- 111

Query: 271 HCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGK 330
             +  ++HRD+K SN+L+++    KL DFG+S T    S      GT  Y+APE +   +
Sbjct: 112 -WSLKILHRDVKPSNMLVNTRGQVKLCDFGVS-TQLVNSIAKTYVGTNAYMAPERISGEQ 169

Query: 331 LTDKSDVYAFGVVLLELLMGRRPVEKMSPTQC--------QSMVTWAMPQLTDRSKLPNI 382
               SDV++ G+  +EL +GR P  ++   Q         Q +V    P L         
Sbjct: 170 YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKF 229

Query: 383 VDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVL-HSLI 425
           V  + +                 C++ +P  RP   +++ H  I
Sbjct: 230 VHFITQ-----------------CMRKQPKERPAPENLMDHPFI 256

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 84.5 bits (210), Expect = 3e-18
 Identities = 69/215 (32%), Positives = 100/215 (46%), Gaps = 43/215 (20%)

Query: 161 IGEGGRGHVYKARFNE-KLLAAVKRI--------DDAGH-DAEREFNNEVNWLTKIRHQN 210
           +GEG    VYKAR  E   + A+K+I         D  +  A RE    +  L +++H N
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALRE----IKLLQELKHPN 63

Query: 211 IISLLGYCIHAETRFLVYEMMQNGSLEKQLH------GPTHGSNLTWHLRMKIAVDVARG 264
           II LL    H     LV+E M+   LEK +        P    +              RG
Sbjct: 64  IIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMT--------LRG 114

Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN-----VKISGTLG 319
           LEYLH   ++ ++HRDLK +N+L+ S    KL+DFGL+ + G+ +R      V    T  
Sbjct: 115 LEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV----TRW 167

Query: 320 YVAPEYLLEGKL-TDKSDVYAFGVVLLELLMGRRP 353
           Y APE L   +      D+++ G +  ELL+ R P
Sbjct: 168 YRAPELLFGARHYGVGVDMWSVGCIFAELLL-RVP 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 84.1 bits (208), Expect = 4e-18
 Identities = 66/262 (25%), Positives = 111/262 (42%), Gaps = 41/262 (15%)

Query: 98  RWKRLKNTNGNSKQTIDGGKGLSLSPILERFNSLRLAGKKDTVSVIEYELLEAATNNFQE 157
           RWK +++ NGN    ID        P    ++                   E   NN   
Sbjct: 4   RWKVIESINGNEYVYID--------PTQLPYD----------------LKWEFPRNNLSF 39

Query: 158 SNVIGEGGRGHVYKA------RFNEKLLAAVKRIDDAGHDAERE-FNNEVNWLTKI-RHQ 209
              +G G  G V +A      + +  +  AVK +    H +ERE   +E+  ++ +  H+
Sbjct: 40  GKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHE 99

Query: 210 NIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYL- 268
           NI++LLG C       ++ E    G L   L            L +  +  VA+G+ +L 
Sbjct: 100 NIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDL-LSFSYQVAKGMAFLA 158

Query: 269 HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT---LGYVAPEY 325
            ++C    +HRDL + N+LL      K+ DFGL+      S  V        + ++APE 
Sbjct: 159 SKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPES 214

Query: 326 LLEGKLTDKSDVYAFGVVLLEL 347
           +     T +SDV+++G++L E+
Sbjct: 215 IFNCVYTFESDVWSYGILLWEI 236

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 84.3 bits (209), Expect = 5e-18
 Identities = 80/298 (26%), Positives = 124/298 (41%), Gaps = 52/298 (17%)

Query: 164 GGRGHVYKARFNEKLLAAVKRI--DDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHA 221
               H+ K +    L+A VK+I  D    +  +    E+    +++H NI+  +   I  
Sbjct: 13  LMIVHLAKHKPTNTLVA-VKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD 71

Query: 222 ETRFLVYEMMQNGSLEKQL--HGPTHGSNLTWHLRMKIAVDVARGLEYLH-EHCNHPVVH 278
              ++V  +M  GS E  L  H P     L     +K   DV   L+Y+H +      +H
Sbjct: 72  SELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILK---DVLNALDYIHSKGF----IH 124

Query: 279 RDLKSSNILLDSSFNAKLSDFGLS---VTAGTQSRNVKISGT-----LGYVAPEYL---L 327
           R +K+S+ILL       LS    S   +  G + R V          L +++PE L   L
Sbjct: 125 RSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNL 184

Query: 328 EGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVT----WAMPQLTDRSKLP--- 380
           +G   +KSD+Y+ G+   EL  G  P + M  TQ   M+       +P L D+S  P   
Sbjct: 185 QG-YNEKSDIYSVGITACELANGHVPFKDMPATQ---MLLEKVRGTVPCLLDKSTYPLYE 240

Query: 381 --------NIVDPVIRDTMDLKHLYQ------VAAVAVLCIQPEPSYRPLITDVL-HS 423
                   +   P  RD++D  H Y             LC+Q +P  RP  + +L HS
Sbjct: 241 DSMSQSRSSNEHPNNRDSVD--HPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS 296

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 83.2 bits (205), Expect = 5e-18
 Identities = 71/239 (29%), Positives = 115/239 (48%), Gaps = 20/239 (8%)

Query: 154 NFQESNVIGEGGRGHVYKAR-FNEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNI 211
           +F+    IG G  G VYKAR  N   LAA+K I  + G D       E+  +   +H NI
Sbjct: 10  DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFA-VVQQEIIMMKDCKHSNI 68

Query: 212 ISLLGYCIHAETRFLVYEMMQNGSLEKQLH--GPTHGSNLTWHLRMKIAVDVARGLEYLH 269
           ++  G  +  +  ++  E    GSL+   H  GP   S + +  R     +  +GL YLH
Sbjct: 69  VAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSR-----ETLQGLYYLH 123

Query: 270 EHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT-AGTQSRNVKISGTLGYVAPEYLL- 327
              +   +HRD+K +NILL  + + KL+DFG+S     T ++     GT  ++APE    
Sbjct: 124 ---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAV 180

Query: 328 --EGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVT---WAMPQLTDRSKLPN 381
             +G      D++A G+  +EL   + P+  + P +   ++T   +  P+L D+ K  N
Sbjct: 181 ERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSN 239

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 83.3 bits (206), Expect = 7e-18
 Identities = 63/199 (31%), Positives = 100/199 (50%), Gaps = 16/199 (8%)

Query: 161 IGEGGRGHVYKA-RFNEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNIISLLGYC 218
           +G G  G V K        + A K +   A     ++   E+  + + R   I+S  G  
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 219 IHAETRFLVYEMMQNGSLEK--QLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPV 276
           ++     +  E M  GSL++  +  GP     +   +  KIAV V  GL YL+    H +
Sbjct: 73  LNENNICMCMEFMDCGSLDRIYKKGGP-----IPVEILGKIAVAVVEGLTYLYN--VHRI 125

Query: 277 VHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS--GTLGYVAPEYLLEGKLTDK 334
           +HRD+K SNIL++S    KL DFG+S   G    ++  +  GT  Y++PE +  GK T K
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGVS---GELINSIADTFVGTSTYMSPERIQGGKYTVK 182

Query: 335 SDVYAFGVVLLELLMGRRP 353
           SDV++ G+ ++EL +G+ P
Sbjct: 183 SDVWSLGISIIELALGKFP 201

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 83.2 bits (205), Expect = 7e-18
 Identities = 71/276 (25%), Positives = 126/276 (45%), Gaps = 30/276 (10%)

Query: 155 FQESNVIGEGGRGHVYKARFNE-KLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNII 212
           F +   IG+G  G V+K   N  + + A+K ID +   D   +   E+  L++     + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 213 SLLGYCIHAETRFLVYEMMQNGSLEKQLH-GPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
              G  +     +++ E +  GS    L  GP   + +   LR     ++ +GL+YLH  
Sbjct: 66  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR-----EILKGLDYLH-- 118

Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLS-VTAGTQSRNVKISGTLGYVAPEYLLEGK 330
            +   +HRD+K++N+LL      KL+DFG++     TQ +     GT  ++APE + +  
Sbjct: 119 -SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA 177

Query: 331 LTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDT 390
              K+D+++ G+  +EL  G  P  ++ P +    V + +P+    +   N   P     
Sbjct: 178 YDSKADIWSLGITAIELAKGEPPHSELHPMK----VLFLIPKNNPPTLEGNYSKP----- 228

Query: 391 MDLKHLYQVAAVAVLCIQPEPSYRPLITDVL-HSLI 425
             LK   +       C+  EPS+RP   ++L H  I
Sbjct: 229 --LKEFVEA------CLNKEPSFRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 82.8 bits (204), Expect = 8e-18
 Identities = 64/215 (29%), Positives = 109/215 (50%), Gaps = 24/215 (11%)

Query: 154 NFQESNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHDAEREFNN---EVNWLTKIR 207
           N++   ++G+G  G V   Y      +L A   + D    +  +E +    E+  L  ++
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62

Query: 208 HQNIISLLGYCI--HAETRFLVY-EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
           H+ I+   G C+   AE    ++ E M  GS++ QL    +G+ LT  +  K    +  G
Sbjct: 63  HERIVQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQLKA--YGA-LTESVTRKYTRQILEG 118

Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS------VTAGTQSRNVKISGTL 318
           + YLH   ++ +VHRD+K +NIL DS+ N KL DFG S        +GT  R+V  +GT 
Sbjct: 119 MSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSV--TGTP 173

Query: 319 GYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
            +++PE +       K+DV++ G  ++E+L  + P
Sbjct: 174 YWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 82.4 bits (203), Expect = 8e-18
 Identities = 59/218 (27%), Positives = 105/218 (48%), Gaps = 10/218 (4%)

Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           +G G  G V+   +N     AVK +   G  + + F  E N +  ++H  ++ L      
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72

Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
            E  +++ E M  GSL   L     G  +     +  +  +A G+ Y+ E  N+  +HRD
Sbjct: 73  EEPIYIITEYMAKGSLLDFLKS-DEGGKVLLPKLIDFSAQIAEGMAYI-ERKNY--IHRD 128

Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
           L+++N+L+  S   K++DFGL+          +      + + APE +  G  T KSDV+
Sbjct: 129 LRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 188

Query: 339 AFGVVLLELLM-GRRPVEKMSPTQCQSMVT--WAMPQL 373
           +FG++L E++  G+ P   MS +   S +   + MP++
Sbjct: 189 SFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRM 226

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 82.8 bits (205), Expect = 1e-17
 Identities = 66/213 (30%), Positives = 100/213 (46%), Gaps = 29/213 (13%)

Query: 161 IGEGGRGHVYKARF------NEKLLAAVKRIDDAGHDAE-REFNNEVNWLTKI-RHQNII 212
           +GEG  G V KA        NE    AVK + D   + +  +  +E+  +  I +H+NII
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79

Query: 213 SLLGYCIHAETRFLVYEMMQNGSLEKQL--HGP-----------THGSNLTWHLRMKIAV 259
           +LLG C      ++V E   +G+L   L    P                LT    +  A 
Sbjct: 80  NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139

Query: 260 DVARGLEYL-HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GT 317
            VARG+E+L  + C    +HRDL + N+L+      K++DFGL+          K + G 
Sbjct: 140 QVARGMEFLASKKC----IHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGR 195

Query: 318 LGY--VAPEYLLEGKLTDKSDVYAFGVVLLELL 348
           L    +APE L +   T +SDV++FGV+L E+ 
Sbjct: 196 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF 228

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 83.4 bits (207), Expect = 1e-17
 Identities = 74/217 (34%), Positives = 106/217 (48%), Gaps = 47/217 (21%)

Query: 161 IGEGGRGHVYKA---RFNEKLLAAVKRIDDA---GHDAEREFNNEVNWLTKIR-HQNIIS 213
           +G+G  G V+KA   R  E +  A+K+I DA     DA+R F  E+ +L ++  H NI+ 
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVV--ALKKIFDAFRNATDAQRTFR-EIMFLQELGDHPNIVK 71

Query: 214 LLGYCIHAETR---FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDV--------- 261
           LL   I AE     +LV+E M     E  LH           +R  I  DV         
Sbjct: 72  LLN-VIKAENDKDIYLVFEYM-----ETDLHAV---------IRANILEDVHKRYIMYQL 116

Query: 262 ARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYV 321
            + L+Y+H   +  V+HRDLK SNILL+S    KL+DFGL+ +      N +      YV
Sbjct: 117 LKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYV 173

Query: 322 A------PEYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           A      PE LL      K  D+++ G +L E+L+G+
Sbjct: 174 ATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 82.2 bits (203), Expect = 1e-17
 Identities = 61/223 (27%), Positives = 111/223 (49%), Gaps = 25/223 (11%)

Query: 160 VIGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAERE---------FNNEVNWLTKIRHQ 209
           +IG G  G VY     +   L AVK+++     A  +            E+  L +++H+
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 210 NIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLH 269
           NI+  LG  + A+   +  E +  GS+   L+   +G+     L       + +GL YLH
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALLN--NYGA-FEETLVRNFVRQILKGLNYLH 123

Query: 270 EHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS-------VTAGTQSRNVKISGTLGYVA 322
              N  ++HRD+K +NIL+D+    K+SDFG+S       ++  T      + G++ ++A
Sbjct: 124 ---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMA 180

Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSM 365
           PE + +   T K+D+++ G +++E+L G+ P      TQ Q++
Sbjct: 181 PEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC--TQLQAI 221

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 82.0 bits (202), Expect = 2e-17
 Identities = 67/276 (24%), Positives = 125/276 (45%), Gaps = 30/276 (10%)

Query: 155 FQESNVIGEGGRGHVYKARFNE-KLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNII 212
           F +   IG+G  G V+K   N  + + A+K ID +   D   +   E+  L++     + 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 213 SLLGYCIHAETRFLVYEMMQNGS-LEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
              G  +     +++ E +  GS L+    GP     +   L+     ++ +GL+YLH  
Sbjct: 66  KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK-----EILKGLDYLH-- 118

Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLS-VTAGTQSRNVKISGTLGYVAPEYLLEGK 330
            +   +HRD+K++N+LL    + KL+DFG++     TQ +     GT  ++APE + +  
Sbjct: 119 -SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSA 177

Query: 331 LTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDT 390
              K+D+++ G+  +EL  G  P   M P +    V + +P    ++  P +     +  
Sbjct: 178 YDSKADIWSLGITAIELAKGEPPNSDMHPMR----VLFLIP----KNNPPTLTGEFSKPF 229

Query: 391 MDLKHLYQVAAVAVLCIQPEPSYRPLITDVL-HSLI 425
            +             C+  +PS+RP   ++L H  I
Sbjct: 230 KEFID---------ACLNKDPSFRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 82.9 bits (205), Expect = 2e-17
 Identities = 69/222 (31%), Positives = 101/222 (45%), Gaps = 35/222 (15%)

Query: 150 AATNNFQE---SNVIGEGGRGHVYKARFNEK-LLAAVKRI----DDAGHDAEREFNNEVN 201
           +A  +  E    N IG G  G VYK        L A+K I    +D      R+   E+ 
Sbjct: 68  SAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDT---VRRQICREIE 124

Query: 202 WLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDV 261
            L  + H N++       H     ++ E M  GSLE      TH        +     DV
Sbjct: 125 ILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEG-----TH----IADEQF--LADV 173

Query: 262 AR----GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS-VTAGTQSRNVKISG 316
           AR    G+ YLH      +VHRD+K SN+L++S+ N K++DFG+S + A T        G
Sbjct: 174 ARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVG 230

Query: 317 TLGYVAPEYL---LEGKLTD--KSDVYAFGVVLLELLMGRRP 353
           T+ Y++PE +   L     D    D+++ GV +LE  +GR P
Sbjct: 231 TIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272

Length = 353

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 81.6 bits (202), Expect = 2e-17
 Identities = 64/235 (27%), Positives = 105/235 (44%), Gaps = 21/235 (8%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRI-DDAGHDAEREFNNEVNWLTKIRH-Q 209
            + ++   IG G  G V K        + AVKRI        ++    +++ + +     
Sbjct: 4   EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCP 63

Query: 210 NIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHG---SNLTWHLRMKIAVDVARGLE 266
            I+   G        ++  E+M + SL+K  +   +    S +   +  KIAV   + L 
Sbjct: 64  YIVKFYGALFREGDCWICMELM-DISLDK-FYKYVYEVLKSVIPEEILGKIAVATVKALN 121

Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS---VTAGTQSRNVKISGTLGYVAP 323
           YL E     ++HRD+K SNILLD + N KL DFG+S   V +  ++R+    G   Y+AP
Sbjct: 122 YLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDA---GCRPYMAP 176

Query: 324 EYLLEGKLTD---KSDVYAFGVVLLELLMGRRPVEKMSPT--QCQSMVTWAMPQL 373
           E +          +SDV++ G+ L E+  G+ P  K +    Q   +V    P L
Sbjct: 177 ERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPIL 231

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 81.3 bits (201), Expect = 2e-17
 Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 16/203 (7%)

Query: 160 VIGEGGRGHVYKARF----NEKLLAAVK--RIDDAGHDAEREFNNEVNWLTKIRHQNIIS 213
            IGEG  G VY+  +    NEK+  AVK  +   +    E+ F  E   + +  H +I+ 
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREK-FLQEAYIMRQFDHPHIVK 71

Query: 214 LLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
           L+G        ++V E+   G L   L    +  +L     +  +  ++  L YL    +
Sbjct: 72  LIGVITENPV-WIVMELAPLGELRSYLQ--VNKYSLDLASLILYSYQLSTALAYLE---S 125

Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTL--GYVAPEYLLEGKL 331
              VHRD+ + N+L+ S    KL DFGLS     +S      G L   ++APE +   + 
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRF 185

Query: 332 TDKSDVYAFGVVLLELLM-GRRP 353
           T  SDV+ FGV + E+LM G +P
Sbjct: 186 TSASDVWMFGVCMWEILMLGVKP 208

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 81.6 bits (201), Expect = 2e-17
 Identities = 62/212 (29%), Positives = 105/212 (49%), Gaps = 20/212 (9%)

Query: 161 IGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCI 219
           +G+G  G VYKA+  E  +LAA K ID    +   ++  E++ L    H NI+ LL    
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 220 HAETRFLVYEMMQNGSLEK---QLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPV 276
           +    +++ E    G+++    +L  P     +    +  +       L YLHE+    +
Sbjct: 73  YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTL-----EALNYLHEN---KI 124

Query: 277 VHRDLKSSNILLDSSFNAKLSDFGLSV--TAGTQSRNVKISGTLGYVAPEYLLEGKLTD- 333
           +HRDLK+ NIL     + KL+DFG+S   T   Q R+  I GT  ++APE ++     D 
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDR 183

Query: 334 ----KSDVYAFGVVLLELLMGRRPVEKMSPTQ 361
               K+DV++ G+ L+E+     P  +++P +
Sbjct: 184 PYDYKADVWSLGITLIEMAQIEPPHHELNPMR 215

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 81.1 bits (201), Expect = 3e-17
 Identities = 65/238 (27%), Positives = 100/238 (42%), Gaps = 16/238 (6%)

Query: 161 IGEGGRGHVYKARFN-EKLLAAVKRIDDA---GHDAEREFNNEVNWLTKIRHQNIISLLG 216
           +G GG G V   +   +    A+K +          +    +E   L +  H  I+ L  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 217 YCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPV 276
                +  +++ E    G L   L     G    +  R  IA  V    EYLH   N  +
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILR--DRGLFDEYTARFYIAC-VVLAFEYLH---NRGI 114

Query: 277 VHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKS- 335
           ++RDLK  N+LLDS+   KL DFG +    +  +     GT  YVAPE +L  K  D S 
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIIL-NKGYDFSV 173

Query: 336 DVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTW-AMPQLTDRSKLPNIVDPVIRDTMD 392
           D ++ G++L ELL GR P           M  +  + +   + + PN +D   +D + 
Sbjct: 174 DYWSLGILLYELLTGRPP---FGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIK 228

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 81.2 bits (201), Expect = 3e-17
 Identities = 70/213 (32%), Positives = 106/213 (49%), Gaps = 29/213 (13%)

Query: 155 FQESNVIGEGGRGHVYKARFNEK-LLAAVKRI----DDAG--HDAEREFNNEVNWLTKIR 207
           +Q+   IGEG  G VYKAR      + A+K+I    +D G    A RE    ++ L ++ 
Sbjct: 1   YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIRE----ISLLKELN 56

Query: 208 HQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
           H NI+ LL   +H+E + +LV+E + +  L+K +        L   L       + +G+ 
Sbjct: 57  HPNIVRLLD-VVHSENKLYLVFEFL-DLDLKKYMDSSPLTG-LDPPLIKSYLYQLLQGIA 113

Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN-----VKISGTLGYV 321
           Y H   +H V+HRDLK  N+L+D     KL+DFGL+   G   R      V    TL Y 
Sbjct: 114 YCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV----TLWYR 166

Query: 322 APEYLLEGKLTDKS-DVYAFGVVLLELLMGRRP 353
           APE LL  +      D+++ G +  E++  RRP
Sbjct: 167 APEILLGSRQYSTPVDIWSIGCIFAEMVN-RRP 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 80.8 bits (199), Expect = 4e-17
 Identities = 73/236 (30%), Positives = 114/236 (48%), Gaps = 20/236 (8%)

Query: 141 SVIEYELLEAATNNFQESNVIGEGGRGHVYK-ARFNEKLLAAVKRIDDAGHDAEREFNNE 199
           S++  E L   T+ ++    IG+G  G VYK     +  LAAVK +D    D + E   E
Sbjct: 10  SMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI-SDVDEEIEAE 68

Query: 200 VNWLTKI-RHQNIISLLGYCIHAE-----TRFLVYEMMQNGSLEKQLHGPTH-GSNLTWH 252
            N L  +  H N++   G    A+       +LV E+   GS+ + + G    G  L   
Sbjct: 69  YNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEA 128

Query: 253 LRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSR 310
           +   I      GL++LH   N+ ++HRD+K +NILL +    KL DFG+S  +T+    R
Sbjct: 129 MISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR 185

Query: 311 NVKISGTLGYVAPEYLLEGKLTDKS-----DVYAFGVVLLELLMGRRPVEKMSPTQ 361
           N  + GT  ++APE +   +  D S     DV++ G+  +EL  G  P+  M P +
Sbjct: 186 NTSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK 240

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 80.5 bits (198), Expect = 5e-17
 Identities = 62/215 (28%), Positives = 106/215 (49%), Gaps = 24/215 (11%)

Query: 154 NFQESNVIGEGGRGHVY---KARFNEKLLAAVKRIDDAGHDAEREFNN---EVNWLTKIR 207
           N++   ++G G  G VY    A    +L       D    +  +E N    E+  L  +R
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 208 HQNIISLLGYCI--HAETRFLVY-EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
           H  I+   G C+    E +  ++ E M  GS++ QL    +G+ LT ++  +    + +G
Sbjct: 63  HDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKA--YGA-LTENVTRRYTRQILQG 118

Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS------VTAGTQSRNVKISGTL 318
           + YLH +    +VHRD+K +NIL DS+ N KL DFG S        +GT  ++V  +GT 
Sbjct: 119 VSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSV--TGTP 173

Query: 319 GYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
            +++PE +       K+DV++    ++E+L  + P
Sbjct: 174 YWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 80.5 bits (198), Expect = 5e-17
 Identities = 68/276 (24%), Positives = 122/276 (44%), Gaps = 30/276 (10%)

Query: 155 FQESNVIGEGGRGHVYKARFNE-KLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNII 212
           F +   IG+G  G VYK   N  K + A+K ID +   D   +   E+  L++     I 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 213 SLLGYCIHAETRFLVYEMMQNGS-LEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
              G  +     +++ E +  GS L+    GP   + +   LR     ++ +GL+YLH  
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILR-----EILKGLDYLHSE 120

Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLS-VTAGTQSRNVKISGTLGYVAPEYLLEGK 330
                +HRD+K++N+LL    + KL+DFG++     TQ +     GT  ++APE + +  
Sbjct: 121 RK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA 177

Query: 331 LTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDT 390
              K+D+++ G+  +EL  G  P   + P +   ++    P                  T
Sbjct: 178 YDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPP-----------------T 220

Query: 391 MDLKHLYQVAAVAVLCIQPEPSYRPLITDVL-HSLI 425
           ++ ++          C+  +P +RP   ++L H  I
Sbjct: 221 LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 80.1 bits (197), Expect = 5e-17
 Identities = 61/200 (30%), Positives = 98/200 (49%), Gaps = 9/200 (4%)

Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           +G+G  G V+   +N     A+K +   G      F  E   + K+RH  ++ L    + 
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLK-PGTMMPEAFLQEAQIMKKLRHDKLVPLYA-VVS 71

Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
            E  ++V E M  GSL   L     G  L     + +A  +A G+ Y+ E  N+  +HRD
Sbjct: 72  EEPIYIVTEFMGKGSLLDFLK-EGDGKYLKLPQLVDMAAQIADGMAYI-ERMNY--IHRD 127

Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
           L+++NIL+  +   K++DFGL+          +      + + APE  L G+ T KSDV+
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187

Query: 339 AFGVVLLELLM-GRRPVEKM 357
           +FG++L EL+  GR P   M
Sbjct: 188 SFGILLTELVTKGRVPYPGM 207

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 80.0 bits (197), Expect = 6e-17
 Identities = 61/204 (29%), Positives = 100/204 (49%), Gaps = 13/204 (6%)

Query: 169 VYKARFNEKLLAAVKRIDDAGHDAER-EFNNEVNWLTKIRHQNIISLLGYCIHAETRFLV 227
           VYK R  +++  A+K + +    + R E   E   + ++ +  I+ ++G C  AE   LV
Sbjct: 15  VYKMR-KKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVC-EAEALMLV 72

Query: 228 YEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNIL 287
            EM   G L K L G      +T    +++   V+ G++YL        VHRDL + N+L
Sbjct: 73  MEMASGGPLNKFLSGKK--DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVL 127

Query: 288 LDSSFNAKLSDFGLSVTAGTQSRNVKISGT----LGYVAPEYLLEGKLTDKSDVYAFGVV 343
           L +   AK+SDFGLS   G      K        L + APE +   K + +SDV+++G+ 
Sbjct: 128 LVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGIT 187

Query: 344 LLELL-MGRRPVEKMSPTQCQSMV 366
           + E    G++P +KM   +  S +
Sbjct: 188 MWEAFSYGQKPYKKMKGPEVMSFI 211

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 80.9 bits (199), Expect = 7e-17
 Identities = 66/211 (31%), Positives = 100/211 (47%), Gaps = 16/211 (7%)

Query: 155 FQESNVIGEGGRGHVYKAR-FNEKLLAAVKRIDDAGHDAEREFNN---EVNWLTKIRHQN 210
           F +   IG G  G VY AR      + A+K++  +G  +  ++ +   EV +L K+RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 211 IISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHE 270
            I   G  +   T +LV E    GS    L    H   L       +     +GL YLH 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCL-GSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYLH- 132

Query: 271 HCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLL--- 327
             +H ++HRD+K+ NILL      KL DFG   +A   +      GT  ++APE +L   
Sbjct: 133 --SHNMIHRDVKAGNILLSEPGLVKLGDFG---SASIMAPANXFVGTPYWMAPEVILAMD 187

Query: 328 EGKLTDKSDVYAFGVVLLELLMGRRPVEKMS 358
           EG+   K DV++ G+  +EL   + P+  M+
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNMN 218

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 80.5 bits (198), Expect = 7e-17
 Identities = 69/243 (28%), Positives = 111/243 (45%), Gaps = 28/243 (11%)

Query: 161 IGEGGRGHVYKARFNEKLLA---AVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGY 217
           IGEG  G V  A   EK      AVK++D           NEV  +    H+N++ +   
Sbjct: 30  IGEGSTGIVCIA--TEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNS 87

Query: 218 CIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMK------IAVDVARGLEYLHEH 271
            +  +  ++V E ++ G+L          +++  H RM       + + V R L YLH  
Sbjct: 88  YLVGDELWVVMEFLEGGAL----------TDIVTHTRMNEEQIATVCLSVLRALSYLH-- 135

Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK-ISGTLGYVAPEYLLEGK 330
            N  V+HRD+KS +ILL S    KLSDFG       +    K + GT  ++APE +    
Sbjct: 136 -NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLP 194

Query: 331 LTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDT 390
              + D+++ G++++E++ G  P     P Q    +   +P    R K  + V  V+R  
Sbjct: 195 YGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPP---RVKDSHKVSSVLRGF 251

Query: 391 MDL 393
           +DL
Sbjct: 252 LDL 254

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 80.2 bits (198), Expect = 9e-17
 Identities = 42/110 (38%), Positives = 65/110 (59%), Gaps = 3/110 (2%)

Query: 256 KIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS 315
           KI++ V RGL YL E   H ++HRD+K SNIL++S    KL DFG+S        N  + 
Sbjct: 103 KISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV- 159

Query: 316 GTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSM 365
           GT  Y++PE L     T +SD+++ G+ L+E+ +GR P+      + ++M
Sbjct: 160 GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAM 209

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 79.8 bits (197), Expect = 9e-17
 Identities = 81/286 (28%), Positives = 129/286 (45%), Gaps = 25/286 (8%)

Query: 154 NFQESNVIGEGGRGHVYKARFNEK-LLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNI 211
           NF++   +GEG    VYK R      + A+K I  DA          E++ + +++H+NI
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60

Query: 212 ISLLGYCIHAETRF-LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHE 270
           + L    IH E +  LV+E M    L+K +        L  +        + +G+ + HE
Sbjct: 61  VRLHD-VIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118

Query: 271 HCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAG----TQSRNVKISGTLGYVAPEYL 326
           +    V+HRDLK  N+L++     KL+DFGL+   G    T S  V    TL Y AP+ L
Sbjct: 119 N---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV---TLWYRAPDVL 172

Query: 327 LEGKLTDKS-DVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVD- 384
           L  +    S D+++ G ++ E++ G RP+   +  + Q +  + +      S  P I   
Sbjct: 173 LGSRTYSTSIDIWSVGCIMAEMITG-RPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQL 231

Query: 385 PVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPT 430
           P  + T      Y    +  L     P   PL  D+LH L+ L P 
Sbjct: 232 PEYKPTFP---RYPPQDLQQL----FPHADPLGIDLLHRLLQLNPE 270

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 79.6 bits (196), Expect = 1e-16
 Identities = 60/220 (27%), Positives = 108/220 (49%), Gaps = 16/220 (7%)

Query: 152 TNNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDD-AGHDAEREFNNEVNWLTK 205
               ++  ++G G  G V+K  +     + K+  A+K I D +G    +E  + +  +  
Sbjct: 6   ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGS 65

Query: 206 IRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
           + H  I+ LLG C  A  + LV ++   GSL   +    H  +L     +   V +A+G+
Sbjct: 66  LDHAYIVRLLGICPGASLQ-LVTQLSPLGSLLDHVR--QHRDSLDPQRLLNWCVQIAKGM 122

Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV---KISGTLGYVA 322
            YL EH    +VHR+L + NILL S    +++DFG++       +     +    + ++A
Sbjct: 123 YYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMA 179

Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQ 361
            E +L G+ T +SDV+++GV + E++  G  P   M P +
Sbjct: 180 LESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE 219

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 79.3 bits (195), Expect = 1e-16
 Identities = 69/229 (30%), Positives = 108/229 (47%), Gaps = 20/229 (8%)

Query: 161 IGEGGRGHVYKAR-FNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCI 219
           +G G  G VYKAR  +   LAAVK I     D       E+  + + +H NI++  G  +
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76

Query: 220 HAETRFLVYEMMQNGSLEKQLH--GPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVV 277
             E  ++  E    GSL+   H  GP     + +  R     +  +GL YLH       +
Sbjct: 77  SREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCR-----ETLQGLAYLHSKGK---M 128

Query: 278 HRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLL---EGKLT 332
           HRD+K +NILL  + + KL+DFG++  +TA    R   I GT  ++APE       G   
Sbjct: 129 HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAPEVAAVEKNGGYN 187

Query: 333 DKSDVYAFGVVLLELLMGRRPVEKMSPTQC---QSMVTWAMPQLTDRSK 378
              D++A G+  +EL   + P+  + P +     S   +  P+L D++K
Sbjct: 188 QLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTK 236

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 79.7 bits (196), Expect = 1e-16
 Identities = 59/222 (26%), Positives = 113/222 (50%), Gaps = 16/222 (7%)

Query: 155 FQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKIRH 208
           F++  V+G G  G VYK  +       K+  A+K + +A    A +E  +E   +  + +
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 209 QNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYL 268
            ++  LLG C+ +  + L+ ++M  G L   +    H  N+     +   V +A+G+ YL
Sbjct: 69  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMNYL 125

Query: 269 HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAPEY 325
            E     +VHRDL + N+L+ +  + K++DFGL+   G   +     G    + ++A E 
Sbjct: 126 EER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALES 182

Query: 326 LLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
           +L    T +SDV+++GV + EL+  G +P + +  ++  S++
Sbjct: 183 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 224

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 79.3 bits (195), Expect = 2e-16
 Identities = 72/246 (29%), Positives = 114/246 (46%), Gaps = 36/246 (14%)

Query: 161 IGEGGRGHVYKARFNEK---LLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGY 217
           IGEG  G V  AR  EK      AVK +D           NEV  +   +HQN++ +   
Sbjct: 29  IGEGSTGIVCIAR--EKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKS 86

Query: 218 CIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRM---KIAV---DVARGLEYLHEH 271
            +  E  +++ E +Q G+L          +++    R+   +IA     V + L YLH  
Sbjct: 87  YLVGEELWVLMEFLQGGAL----------TDIVSQTRLNEEQIATVCESVLQALCYLH-- 134

Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ-SRNVKISGTLGYVAPEYLLEGK 330
            +  V+HRD+KS +ILL      KLSDFG          +   + GT  ++APE +    
Sbjct: 135 -SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTP 193

Query: 331 LTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDR--SKLPNI--VDPV 386
              + D+++ G++++E++ G  P    SP Q       AM +L D    KL N   + PV
Sbjct: 194 YGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ-------AMKRLRDSPPPKLKNAHKISPV 246

Query: 387 IRDTMD 392
           +RD ++
Sbjct: 247 LRDFLE 252

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 79.6 bits (197), Expect = 2e-16
 Identities = 65/216 (30%), Positives = 107/216 (49%), Gaps = 32/216 (14%)

Query: 154 NFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHD--AEREFNNEVNWLTKIRHQN 210
            +Q  + IGEG  G V  A      +  A+K+I    H    +R    E+  L + +H+N
Sbjct: 6   RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR-EIKILRRFKHEN 64

Query: 211 IISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTW-HLRMKIAVDVAR 263
           II +L   I   +       ++V E+M     E  L+      +L+  H++  +   + R
Sbjct: 65  IIGILD-IIRPPSFESFNDVYIVQELM-----ETDLYKLIKTQHLSNDHIQYFL-YQILR 117

Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLG---- 319
           GL+Y+H   N  V+HRDLK SN+LL+++ + K+ DFGL+  A  +  +   +G L     
Sbjct: 118 GLKYIHS-AN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDH---TGFLTEYVA 171

Query: 320 ---YVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
              Y APE +L  K   K+ D+++ G +L E+L  R
Sbjct: 172 TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 78.8 bits (194), Expect = 2e-16
 Identities = 75/254 (29%), Positives = 115/254 (45%), Gaps = 34/254 (13%)

Query: 160 VIGEGGRGHVYKARFNE--KLLAAV----KRIDDAGHDAEREFNNEVNWLTKIRHQN--I 211
           +IG GG G VY  R  +  K+ A      KRI       E    NE   L+ +   +   
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ--GETLALNERIMLSLVSTGDCPF 58

Query: 212 ISLLGYCIHAETRF-LVYEMMQNGSLEKQL--HGPTHGSNLTWHLRMKIAVDVARGLEYL 268
           I  + Y  H   +   + ++M  G L   L  HG    + + ++     A ++  GLE++
Sbjct: 59  IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFY-----AAEIILGLEHM 113

Query: 269 HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLE 328
           H   N  VV+RDLK +NILLD   + ++SD GL+     +  +  + GT GY+APE L +
Sbjct: 114 H---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEVLQK 169

Query: 329 GKLTDKS-DVYAFGVVLLELLMGRRPVEKM---SPTQCQSMVTWAMPQLTDRSKLPNIVD 384
           G   D S D ++ G +L +LL G  P  +       +   M       LT   +LP+   
Sbjct: 170 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT------LTMAVELPDSFS 223

Query: 385 PVIRDTMDLKHLYQ 398
           P +R    L+ L Q
Sbjct: 224 PELRSL--LEGLLQ 235

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 78.3 bits (193), Expect = 2e-16
 Identities = 58/236 (24%), Positives = 102/236 (43%), Gaps = 34/236 (14%)

Query: 198 NEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKI 257
           NE+  L+ ++H NII+   + +   T  +  E    G+L  ++          +   M +
Sbjct: 48  NEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKI---VRQKGQLFEEEMVL 104

Query: 258 AV--DVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK-I 314
                +   + Y+H+     ++HRD+K+ NI L  +   KL DFG+S   G++    + +
Sbjct: 105 WYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETV 161

Query: 315 SGTLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQ-CQSMVT--WAM 370
            GT  Y++PE L +G K   KSD++A G VL ELL  +R  +  +P      +V   +  
Sbjct: 162 VGTPYYMSPE-LCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTP 220

Query: 371 PQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIP 426
                      +V     + + L H           +Q +P  RP   +VL   + 
Sbjct: 221 -----------VVSVYSSELISLVH---------SLLQQDPEKRPTADEVLDQPLL 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 78.9 bits (194), Expect = 2e-16
 Identities = 60/207 (28%), Positives = 102/207 (49%), Gaps = 14/207 (6%)

Query: 161 IGEGGRGHVYKARFNEK-LLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCI 219
           +G+G  G VYKA+  E   LAA K I+    +   ++  E+  L    H  I+ LLG   
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 220 HAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHR 279
                +++ E    G+++  +     G  LT      I   +   L+YLH   +  ++HR
Sbjct: 80  WDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVICRQMLEALQYLH---SMKIIHR 134

Query: 280 DLKSSNILLDSSFNAKLSDFGLSV--TAGTQSRNVKISGTLGYVAPEYLLEGKLTD---- 333
           DLK+ N+LL    + KL+DFG+S       Q R+  I GT  ++APE ++   + D    
Sbjct: 135 DLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-GTPYWMAPEVVMCETMKDTPYD 193

Query: 334 -KSDVYAFGVVLLELLMGRRPVEKMSP 359
            K+D+++ G+ L+E+     P  +++P
Sbjct: 194 YKADIWSLGITLIEMAQIEPPHHELNP 220

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 78.5 bits (193), Expect = 2e-16
 Identities = 75/297 (25%), Positives = 131/297 (44%), Gaps = 44/297 (14%)

Query: 149 EAATNNFQESNVIGEGGRGHVYKA------RFNEKLLAAVKRIDDAGHDAER-EFNNEVN 201
           E A      S  +G+G  G VY+       +   +   A+K +++A    ER EF NE +
Sbjct: 2   EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 61

Query: 202 WLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHG--PTHGSNLTWHL-----R 254
            + +    +++ LLG     +   ++ E+M  G L+  L    P   +N           
Sbjct: 62  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKM 121

Query: 255 MKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKI 314
           +++A ++A G+ YL+ +     VHRDL + N ++   F  K+ DFG+  T      +   
Sbjct: 122 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGM--TRDIYETDYYR 176

Query: 315 SGTLG-----YVAPEYLLEGKLTDKSDVYAFGVVLLEL-LMGRRPVEKMSPTQCQSMVTW 368
            G  G     +++PE L +G  T  SDV++FGVVL E+  +  +P + MS  Q    V  
Sbjct: 177 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME 236

Query: 369 AMPQLTDR-SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
               L D+    P+++  ++R                +C Q  P  RP   +++ S+
Sbjct: 237 G--GLLDKPDNCPDMLFELMR----------------MCWQYNPKMRPSFLEIISSI 275

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 78.1 bits (192), Expect = 2e-16
 Identities = 59/201 (29%), Positives = 100/201 (49%), Gaps = 9/201 (4%)

Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           +G G  G V+ A +N+    AVK +       E  F  E N +  ++H  ++ L    + 
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKL-HAVVT 71

Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
            E  +++ E M  GSL   L     GS       +  +  +A G+ ++ E  N+  +HRD
Sbjct: 72  KEPIYIITEFMAKGSLLDFLKS-DEGSKQPLPKLIDFSAQIAEGMAFI-EQRNY--IHRD 127

Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
           L+++NIL+ +S   K++DFGL+          +      + + APE +  G  T KSDV+
Sbjct: 128 LRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 187

Query: 339 AFGVVLLELL-MGRRPVEKMS 358
           +FG++L+E++  GR P   MS
Sbjct: 188 SFGILLMEIVTYGRIPYPGMS 208

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 79.0 bits (195), Expect = 3e-16
 Identities = 37/101 (36%), Positives = 56/101 (55%), Gaps = 8/101 (7%)

Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS---VTAGTQSRNVKI 314
           A ++  GL++LHE     +++RDLK  N+LLDS  + K++DFG+    +  G  +     
Sbjct: 102 AAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST--F 156

Query: 315 SGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVE 355
            GT  Y+APE L         D +A GV+L E+L G+ P E
Sbjct: 157 CGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 78.5 bits (194), Expect = 3e-16
 Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 24/210 (11%)

Query: 154 NFQESNVIGEGGRGHVYKARFNE-------KLLAAVKRIDDAGHDAEREFNNEVNWLTKI 206
            ++    IGEG  G V+KA+  E       K +A  +      + A RE    +  L   
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALRE----IKALQAC 56

Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNG--SLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
           +H  ++ LL    H     LV E M +    + +    P   + +  ++RM     + +G
Sbjct: 57  QHPYVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRM-----LLKG 111

Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS--GTLGYVA 322
           + Y+H +    ++HRDLK +N+L+ +    K++DFGL+     +   +      T  Y A
Sbjct: 112 VAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRA 168

Query: 323 PEYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           PE L   +  D   D++A G +  ELL G 
Sbjct: 169 PELLYGARKYDPGVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 78.5 bits (193), Expect = 3e-16
 Identities = 70/270 (25%), Positives = 117/270 (43%), Gaps = 34/270 (12%)

Query: 161 IGEGGRGHVYKARFNEK-LLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCI 219
           IGEG  G V  A       L AVK++D           NEV  +   +H+N++ +    +
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 220 HAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMK------IAVDVARGLEYLHEHCN 273
             +  ++V E ++ G+L          +++  H RM       + + V + L  LH    
Sbjct: 88  VGDELWVVMEFLEGGAL----------TDIVTHTRMNEEQIAAVCLAVLKALSVLHAQ-- 135

Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ-SRNVKISGTLGYVAPEYLLEGKLT 332
             V+HRD+KS +ILL      KLSDFG       +  R   + GT  ++APE +      
Sbjct: 136 -GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYG 194

Query: 333 DKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAM-PQLTDRSKLPNIV-------- 383
            + D+++ G++++E++ G  P     P +   M+   + P+L +  K+   +        
Sbjct: 195 PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLL 254

Query: 384 --DPVIRDTMD--LKHLYQVAAVAVLCIQP 409
             DP  R T    LKH +   A    CI P
Sbjct: 255 VRDPAQRATAAELLKHPFLAKAGPPSCIVP 284

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 78.4 bits (193), Expect = 4e-16
 Identities = 71/269 (26%), Positives = 123/269 (45%), Gaps = 22/269 (8%)

Query: 161 IGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCI 219
           IG+G  G VY A         A+K+++      +    NE+  + + +H NI++ L   +
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86

Query: 220 HAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAV---DVARGLEYLHEHCNHPV 276
             +  ++V E +  GSL       T     T     +IA    +  + LE+LH   N  V
Sbjct: 87  VGDELWVVMEYLAGGSL-------TDVVTETCMDEGQIAAVCRECLQALEFLHS--NQ-V 136

Query: 277 VHRDLKSSNILLDSSFNAKLSDFGLSVT-AGTQSRNVKISGTLGYVAPEYLLEGKLTDKS 335
           +HRD+KS NILL    + KL+DFG        QS+   + GT  ++APE +       K 
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196

Query: 336 DVYAFGVVLLELLMGRRPVEKMSPTQCQSMV-TWAMPQLTDRSKLPNIVDPVIRDTMDLK 394
           D+++ G++ +E++ G  P    +P +   ++ T   P+L +  KL  I    +   +++ 
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMD 256

Query: 395 HLYQVAAVAVL------CIQPEPSYRPLI 417
              + +A  +L        +P  S  PLI
Sbjct: 257 VEKRGSAKELLQHPFLKIAKPLSSLTPLI 285

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 78.6 bits (193), Expect = 4e-16
 Identities = 68/213 (31%), Positives = 102/213 (47%), Gaps = 20/213 (9%)

Query: 155 FQESNVIGEGGRGHVY---KARFNEKLLAAVKRIDDAGHDAEREFNN---EVNWLTKIRH 208
           F +   IG G  G VY     R NE  + A+K++  +G  +  ++ +   EV +L +I+H
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNE--VVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKH 84

Query: 209 QNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYL 268
            N I   G  +   T +LV E    GS    L    H   L       I     +GL YL
Sbjct: 85  PNSIEYKGCYLREHTAWLVMEYCL-GSASDLLE--VHKKPLQEVEIAAITHGALQGLAYL 141

Query: 269 HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLL- 327
           H   +H ++HRD+K+ NILL      KL+DFG   +A   S      GT  ++APE +L 
Sbjct: 142 H---SHNMIHRDIKAGNILLTEPGQVKLADFG---SASIASPANSFVGTPYWMAPEVILA 195

Query: 328 --EGKLTDKSDVYAFGVVLLELLMGRRPVEKMS 358
             EG+   K DV++ G+  +EL   + P+  M+
Sbjct: 196 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 228

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 77.8 bits (192), Expect = 4e-16
 Identities = 60/229 (26%), Positives = 106/229 (46%), Gaps = 35/229 (15%)

Query: 155 FQESNVIGEGGRGHVYKARFNEKLL-----AAVKRIDDAGHDAEREFN---NEVNWLTKI 206
              S+++ EG  G ++     ++         VK + D  H +E +      E   L  +
Sbjct: 8   VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD--HASEIQVTLLLQESCLLYGL 65

Query: 207 RHQNIISLLGYCIH-AETRFLVYEMMQNGSLEKQLHGPTHGSN-----LTWHLRMKIAVD 260
            HQNI+ +L  CI   E  F++Y  M  G+L+  L     G       L+    + +A+ 
Sbjct: 66  SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQ 125

Query: 261 VARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS---------VTAGTQSRN 311
           +A G+ YLH      V+H+D+ + N ++D     K++D  LS              ++R 
Sbjct: 126 IACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRP 182

Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSP 359
           VK      ++A E L+  + +  SDV++FGV+L EL+ +G+ P  ++ P
Sbjct: 183 VK------WMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP 225

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 77.7 bits (191), Expect = 4e-16
 Identities = 65/261 (24%), Positives = 108/261 (41%), Gaps = 41/261 (15%)

Query: 176 EKLLAAVKRIDDAGHDAERE-FNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNG 234
            +L  A+  +     D +R  F  E   L +  H NI+ L G      T  +V E M NG
Sbjct: 32  RELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNG 91

Query: 235 SLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA 294
           +L+  L    H   L     M +   +A G++YL E      VH+ L +  +L++S    
Sbjct: 92  ALDSFLR--KHEGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVC 146

Query: 295 KLSDFGLSVTAGTQSRNVKISGTLG------YVAPEYLLEGKLTDKSDVYAFGVVLLELL 348
           K+S F        + ++  I  T+       + APE +     +  SDV++FG+V+ E++
Sbjct: 147 KISGFR----RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVM 202

Query: 349 -MGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLP---NIVDPVIRDTMDLKHLYQVAAVAV 404
             G RP   MS           +  + D  +LP   N  + + +  +D            
Sbjct: 203 SYGERPYWDMSGQD-------VIKAVEDGFRLPAPRNCPNLLHQLMLD------------ 243

Query: 405 LCIQPEPSYRPLITDVLHSLI 425
            C Q E   RP  + + HS++
Sbjct: 244 -CWQKERGERPRFSQI-HSIL 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 78.5 bits (193), Expect = 4e-16
 Identities = 66/207 (31%), Positives = 99/207 (47%), Gaps = 20/207 (9%)

Query: 161 IGEGGRGHVY---KARFNEKLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRHQNIISL 214
           IG G  G VY    +  NE  + AVK++  +G   ++  ++   EV +L +++H N I  
Sbjct: 29  IGHGSFGAVYFATNSHTNE--VVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86

Query: 215 LGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNH 274
            G  +   T +LV E    GS    L    H   L       I     +GL YLH H   
Sbjct: 87  KGCYLKEHTAWLVMEYCL-GSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHN-- 141

Query: 275 PVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLL---EGKL 331
            ++HRD+K+ NILL      KL+DFG   +A   S      GT  ++APE +L   EG+ 
Sbjct: 142 -MIHRDIKAGNILLTEPGQVKLADFG---SASKSSPANSFVGTPYWMAPEVILAMDEGQY 197

Query: 332 TDKSDVYAFGVVLLELLMGRRPVEKMS 358
             K DV++ G+  +EL   + P+  M+
Sbjct: 198 DGKVDVWSLGITCIELAERKPPLFNMN 224

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 77.8 bits (191), Expect = 6e-16
 Identities = 64/240 (26%), Positives = 117/240 (48%), Gaps = 24/240 (10%)

Query: 161 IGEGGRGHVYKAR---FNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGY 217
           IG+G  G V+ A      +++  A+K+I+      +    NE+  + ++++ NI++ L  
Sbjct: 27  IGQGASGTVFTAIDVATGQEV--AIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDS 84

Query: 218 CIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAV---DVARGLEYLHEHCNH 274
            +  +  F+V E +  GSL       T     T     +IA    +  + LE+LH +   
Sbjct: 85  FLVGDELFVVMEYLAGGSL-------TDVVTETCMDEAQIAAVCRECLQALEFLHAN--- 134

Query: 275 PVVHRDLKSSNILLDSSFNAKLSDFGLSVT-AGTQSRNVKISGTLGYVAPEYLLEGKLTD 333
            V+HRD+KS N+LL    + KL+DFG        QS+   + GT  ++APE +       
Sbjct: 135 QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194

Query: 334 KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMV-TWAMPQLTDRSKLPNIVDPVIRDTMD 392
           K D+++ G++ +E++ G  P    +P +   ++ T   P+L +  KL     P+ RD ++
Sbjct: 195 KVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKL----SPIFRDFLN 250

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 77.1 bits (190), Expect = 6e-16
 Identities = 37/106 (34%), Positives = 58/106 (54%), Gaps = 6/106 (5%)

Query: 256 KIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS 315
           +   +V  G+E LH+     ++HRD+K  N+L+D + + KL+DFGLS   G +++  K  
Sbjct: 101 QYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLS-RNGLENK--KFV 154

Query: 316 GTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQ 361
           GT  Y+APE +L       SD ++ G V+ E L G  P    +P  
Sbjct: 155 GTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 77.8 bits (191), Expect = 7e-16
 Identities = 67/242 (27%), Positives = 109/242 (45%), Gaps = 35/242 (14%)

Query: 144 EYELLEAATNNFQESNV-----IGEGGRGHVY--------KARFNEKLLAAVKRI-DDAG 189
           EYEL E     F    +     +GEG  G V         K +  E +  AVK + DDA 
Sbjct: 1   EYELPEDPRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT 60

Query: 190 HDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHG------ 242
                +  +E+  +  I +H+NII+LLG C      +++ E    G+L + L        
Sbjct: 61  EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 120

Query: 243 -------PTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAK 295
                        +T+   +     VARG+EYL    +   +HRDL + N+L+  +   K
Sbjct: 121 EYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMK 177

Query: 296 LSDFGLSVTAGTQSRNVKISG---TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGR 351
           ++DFGL+          K +     + ++APE L +   T +SDV++FGV++ E+  +G 
Sbjct: 178 IADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG 237

Query: 352 RP 353
            P
Sbjct: 238 SP 239

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 77.1 bits (190), Expect = 9e-16
 Identities = 60/275 (21%), Positives = 120/275 (43%), Gaps = 35/275 (12%)

Query: 160 VIGEGGRGHVYKARFNEKLLAAVKRI--DDAGHDAE-REFNNEVNWLTKIRHQNIISLLG 216
           +I E  +  +YK  FN K +  ++       GH        NE+  L +I   NI+ + G
Sbjct: 27  LIKENDQNSIYKGIFNNKEVI-IRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYG 85

Query: 217 YCIHAETRF----LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
           + I          L+ E    G L + L       +L++  ++ +A+D  +GL  L+++ 
Sbjct: 86  FIIDIVDDLPRLSLILEYCTRGYLREVLD---KEKDLSFKTKLDMAIDCCKGLYNLYKYT 142

Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGL-SVTAGTQSRNVKISGTLGYVAPEYLLE--G 329
           N P  +++L S + L+  ++  K+   GL  + +    +NV     + Y + + L +   
Sbjct: 143 NKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVN---FMVYFSYKMLNDIFS 197

Query: 330 KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRD 389
           + T K D+Y+ GVVL E+  G+ P E ++  +   ++      +   + L          
Sbjct: 198 EYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLI------INKNNSLK--------- 242

Query: 390 TMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
            + L    ++  +   C   +   RP I ++L++L
Sbjct: 243 -LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNL 276

Length = 283

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 77.6 bits (192), Expect = 9e-16
 Identities = 72/215 (33%), Positives = 103/215 (47%), Gaps = 35/215 (16%)

Query: 159 NVIGEGGRGHVYKA---RFNEKLLAAVKRI----DDAGHDAEREFNNEVNWLTKIRHQNI 211
             IG G  G V  A   R   K+  A+K+I    DD   DA+R    E+  L  +RH+NI
Sbjct: 6   KPIGSGAYGVVCSAVDKRTGRKV--AIKKISNVFDDL-IDAKRILR-EIKLLRHLRHENI 61

Query: 212 ISLLGYCIHAETR-----FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
           I LL              ++V E+M+   L K +  P   ++   H++      + RGL+
Sbjct: 62  IGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDD--HIQY-FLYQILRGLK 117

Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTL-GYV---- 321
           YLH   N  V+HRDLK SNIL++S+ + K+ DFGL+             G L  YV    
Sbjct: 118 YLHS-AN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE---KGFLTEYVVTRW 171

Query: 322 --APEYLLEGKLTDKS-DVYAFGVVLLELLMGRRP 353
             APE LL      K+ D+++ G +  ELL  R+P
Sbjct: 172 YRAPELLLSSSRYTKAIDIWSVGCIFAELL-TRKP 205

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 77.4 bits (190), Expect = 1e-15
 Identities = 63/208 (30%), Positives = 99/208 (47%), Gaps = 8/208 (3%)

Query: 149 EAATNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAER-EFNNEVNWLTKI 206
           E   ++F+  + +G G  G V K +     L+ A K I      A R +   E+  L + 
Sbjct: 1   ELKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60

Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
               I+   G         +  E M  GSL++ L        +   +  K+++ V RGL 
Sbjct: 61  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KEAKRIPEEILGKVSIAVLRGLA 117

Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYL 326
           YL E   H ++HRD+K SNIL++S    KL DFG+S        N    GT  Y++PE L
Sbjct: 118 YLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERL 174

Query: 327 LEGKLTDKSDVYAFGVVLLELLMGRRPV 354
                + +SD+++ G+ L+EL +GR P+
Sbjct: 175 QGTHYSVQSDIWSMGLSLVELAIGRYPI 202

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 77.4 bits (191), Expect = 1e-15
 Identities = 64/219 (29%), Positives = 96/219 (43%), Gaps = 39/219 (17%)

Query: 155 FQESNVIGEGGRGHVYKARFNE--KLLA--AVKRIDDAGHD------AEREFNNEVNWLT 204
           F+   V+G G  G V  A + +  +L A  A+K+ D    D       E+      N   
Sbjct: 1   FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETAN--- 57

Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKI------- 257
             RH  +++L   C   E    V  +M+  +          G +L  H+   +       
Sbjct: 58  SERHPFLVNLFA-CFQTEDH--VCFVMEYAA----------GGDLMMHIHTDVFSEPRAV 104

Query: 258 --AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA-GTQSRNVKI 314
             A  V  GL+YLHE+    +V+RDLK  N+LLD+    K++DFGL     G   R    
Sbjct: 105 FYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTF 161

Query: 315 SGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
            GT  ++APE L E   T   D +  GV++ E+L+G  P
Sbjct: 162 CGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 76.2 bits (187), Expect = 1e-15
 Identities = 64/205 (31%), Positives = 98/205 (47%), Gaps = 15/205 (7%)

Query: 160 VIGEGGRGHVYKAR-FNEKLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRHQN--IIS 213
           +IG GG G VY  R  +   + A+K +D         E    NE   L+ +   +   I 
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 214 LLGYCIHAETRF-LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
            + Y  H   +   + ++M  G L    H   HG      +R   A ++  GLE++H   
Sbjct: 61  CMTYAFHTPDKLCFILDLMNGGDL--HYHLSQHGVFSEKEMRF-YATEIILGLEHMH--- 114

Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLT 332
           N  VV+RDLK +NILLD   + ++SD GL+     +  +  + GT GY+APE L +G   
Sbjct: 115 NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEVLQKGTAY 173

Query: 333 DKS-DVYAFGVVLLELLMGRRPVEK 356
           D S D ++ G +L +LL G  P  +
Sbjct: 174 DSSADWFSLGCMLFKLLRGHSPFRQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 76.4 bits (188), Expect = 2e-15
 Identities = 72/208 (34%), Positives = 109/208 (52%), Gaps = 28/208 (13%)

Query: 161 IGEGGRGHVYKAR---FNEKLLAAVKRI----DDAG--HDAEREFNNEVNWLTKIRHQNI 211
           IGEG  G VYKAR    NE +  A+K+I    +D G    A RE    ++ L +++H NI
Sbjct: 10  IGEGTYGVVYKARDRVTNETI--ALKKIRLEQEDEGVPSTAIRE----ISLLKEMQHGNI 63

Query: 212 ISLLGYCIHAETR-FLVYEMMQNGSLEKQL-HGPTHGSNLTWHLRMKIAVDVARGLEYLH 269
           + L    +H+E R +LV+E + +  L+K +   P    N    L       + RG+ Y H
Sbjct: 64  VRLQD-VVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNP--RLIKTYLYQILRGIAYCH 119

Query: 270 EHCNHPVVHRDLKSSNILLDSSFNA-KLSDFGLSVTAGTQSRNVKIS-GTLGYVAPEYLL 327
              +H V+HRDLK  N+L+D   NA KL+DFGL+   G   R       TL Y APE LL
Sbjct: 120 ---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILL 176

Query: 328 EGK-LTDKSDVYAFGVVLLELLMGRRPV 354
             +  +   D+++ G +  E++  ++P+
Sbjct: 177 GSRHYSTPVDIWSVGCIFAEMV-NQKPL 203

Length = 294

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 75.6 bits (186), Expect = 2e-15
 Identities = 73/297 (24%), Positives = 125/297 (42%), Gaps = 43/297 (14%)

Query: 144 EYELLEAATNNFQESNVIGEGGRGHVYKARF--NEKLLAAVKRID-------DAGHDAER 194
           EY +LE           +G G  G VYK R   N + L A+K I+           + ++
Sbjct: 1   EYAVLEH----------LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDK 50

Query: 195 EFNNEVNWLTKI----RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHG-PTHGSNL 249
              + V+ +T I    RH NI+      +  +  ++V ++++   L +  +         
Sbjct: 51  SIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRF 110

Query: 250 TWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS 309
           T      I V +   L YLH+     +VHRDL  +NI+L       ++DFGL+     +S
Sbjct: 111 TEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES 168

Query: 310 RNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWA 369
           +   + GT+ Y  PE +      +K+DV+AFG +L ++    +P     P    +M++ A
Sbjct: 169 KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT-LQP-----PFYSTNMLSLA 222

Query: 370 MPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIP 426
                       IV+ V     +  +   V  V   C+ P+   RP I  V  ++I 
Sbjct: 223 T----------KIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQV-SAMIS 268

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 75.9 bits (187), Expect = 2e-15
 Identities = 51/140 (36%), Positives = 72/140 (51%), Gaps = 18/140 (12%)

Query: 256 KIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS-----VTAGTQSR 310
           KIAV + + LEYLH   +  V+HRD+K SN+L++ +   KL DFG+S       A T   
Sbjct: 107 KIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTID- 163

Query: 311 NVKISGTLGYVAPEYL---LEGKLTD-KSDVYAFGVVLLELLMGRRPVE--KMSPTQCQS 364
               +G   Y+APE +   L  K  D KSDV++ G+ ++EL  GR P +  K    Q + 
Sbjct: 164 ----AGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQ 219

Query: 365 MVTWAMPQLTDRSKLPNIVD 384
           +V    PQL      P   D
Sbjct: 220 VVEEPSPQLPAEKFSPEFQD 239

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 75.5 bits (185), Expect = 2e-15
 Identities = 62/214 (28%), Positives = 104/214 (48%), Gaps = 22/214 (10%)

Query: 154 NFQESNVIGEGGRGHVY---KARFNEKLLAAVKRIDDAGHDAEREFNN---EVNWLTKIR 207
           N++   ++G+G  G VY    A    +L     + D    +  +E N    E+  L  + 
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 208 HQNIISLLGYCIHAETRFL--VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
           H+ I+   G       R L    E M  GS++ QL   ++G+ LT ++  K    +  G+
Sbjct: 63  HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLK--SYGA-LTENVTRKYTRQILEGV 119

Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS------VTAGTQSRNVKISGTLG 319
            YLH +    +VHRD+K +NIL DS  N KL DFG S        +GT  ++V  +GT  
Sbjct: 120 SYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSV--TGTPY 174

Query: 320 YVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
           +++PE +       K+D+++ G  ++E+L  + P
Sbjct: 175 WMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 75.6 bits (187), Expect = 3e-15
 Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 39/216 (18%)

Query: 155 FQESNVIGEGGRGHVYKARFNEKL-LAAVKRIDDAGHDAEREFNN--------EVNWLTK 205
           ++    +G+G  G VY AR  E   L A+K++       +++F +        EV  L K
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMNLREVKSLRK 53

Query: 206 I-RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
           +  H NI+ L       +  + V+E M  G+L  QL     G   +  +   I   + +G
Sbjct: 54  LNEHPNIVKLKEVFRENDELYFVFEYM-EGNL-YQLMKDRKGKPFSESVIRSIIYQILQG 111

Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK--------ISG 316
           L ++H    H   HRDLK  N+L+      K++DFGL       +R ++        +S 
Sbjct: 112 LAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGL-------AREIRSRPPYTDYVS- 160

Query: 317 TLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           T  Y APE LL         D++A G ++ EL   R
Sbjct: 161 TRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 75.4 bits (185), Expect = 3e-15
 Identities = 61/224 (27%), Positives = 105/224 (46%), Gaps = 18/224 (8%)

Query: 152 TNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR-HQN 210
           ++ ++    IG+G  G V+K    +    A  +I D  HD + E   E N L  +  H N
Sbjct: 17  SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPN 76

Query: 211 IISLLGYCIHAETR-----FLVYEMMQNGSLEKQLHG-PTHGSNLTWHLRMKIAVDVARG 264
           ++   G     + +     +LV E+   GS+   + G    G  +   +   I  +   G
Sbjct: 77  VVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMG 136

Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVA 322
           L++LH    +  +HRD+K +NILL +    KL DFG+S  +T+    RN  + GT  ++A
Sbjct: 137 LQHLH---VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMA 192

Query: 323 PEYL-----LEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQ 361
           PE +     L+     + DV++ G+  +EL  G  P+  + P +
Sbjct: 193 PEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR 236

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 76.2 bits (187), Expect = 3e-15
 Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 29/214 (13%)

Query: 161 IGEGGRGHVY--------KARFNEKLLAAVKRIDDAGHDAE-REFNNEVNWLTKI-RHQN 210
           +GEG  G V         K + N+ +  AVK + D   D +  +  +E+  +  I +H+N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 211 IISLLGYCIHAETRFLVYEMMQNGSLEKQLHG-------------PTHGSNLTWHLRMKI 257
           II+LLG C      +++ E    G+L + L                     LT+   +  
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG- 316
           A  VARG+EYL    +   +HRDL + N+L+      K++DFGL+          K +  
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196

Query: 317 --TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELL 348
              + ++APE L +   T +SDV++FGV+L E+ 
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF 230

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 74.9 bits (185), Expect = 4e-15
 Identities = 71/264 (26%), Positives = 115/264 (43%), Gaps = 46/264 (17%)

Query: 153 NNFQESNVIGEG--GRGHVYKARFNEKLLAAVKRIDDAG---HDAEREFNNEVNWLTKIR 207
           ++F+    +G G  GR  + + + + K  A +K +  A            NE   L  IR
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYA-LKILSKAKIVKLKQVEHVLNEKRILQSIR 59

Query: 208 HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRM-KIAVDVAR--- 263
           H  +++L G        +LV E +  G L             +   +  +    VAR   
Sbjct: 60  HPFLVNLYGSFQDDSNLYLVMEYVPGGEL------------FSHLRKSGRFPEPVARFYA 107

Query: 264 -----GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISG 316
                 LEYLH   +  +V+RDLK  N+LLDS    K++DFG +  V   T +    + G
Sbjct: 108 AQVVLALEYLH-SLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYT----LCG 160

Query: 317 TLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTD 375
           T  Y+APE +L  K   K+ D +A G+++ E+L G  P    +P Q    +      L  
Sbjct: 161 TPEYLAPEIIL-SKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKI------LEG 213

Query: 376 RSKLPNIVDPVIRDTMDLKHLYQV 399
           + + P+   P  +D   +++L QV
Sbjct: 214 KVRFPSFFSPDAKDL--IRNLLQV 235

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 75.0 bits (184), Expect = 5e-15
 Identities = 65/206 (31%), Positives = 95/206 (46%), Gaps = 18/206 (8%)

Query: 161 IGEGGRGHVYKAR--FNEKLLAAVKRIDDAGHDAEREFNN--EVNWLTKIR---HQNIIS 213
           IGEG  G V+KAR   N     A+KR+     +     +   EV  L  +    H N++ 
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 214 LLGYCIHA----ETRF-LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYL 268
           L   C  +    ET+  LV+E +           P  G  +       +   + RGL++L
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--VPTETIKDMMFQLLRGLDFL 126

Query: 269 HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLE 328
           H   +H VVHRDLK  NIL+ SS   KL+DFGL+     Q     +  TL Y APE LL+
Sbjct: 127 H---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ 183

Query: 329 GKLTDKSDVYAFGVVLLELLMGRRPV 354
                  D+++ G +  E+   R+P+
Sbjct: 184 SSYATPVDLWSVGCIFAEMFR-RKPL 208

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 74.9 bits (184), Expect = 5e-15
 Identities = 70/275 (25%), Positives = 117/275 (42%), Gaps = 49/275 (17%)

Query: 161 IGEGGRGHVYKARFNEK-LLAAVKRI----DDAGHDAEREFNN---EVNWLTKIRHQNII 212
           +G+G  G VYK       +  A+K I    D++      +FN    E++ L K     I+
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDES------KFNQIIMELDILHKAVSPYIV 62

Query: 213 SLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
              G        ++  E M  GSL+K   G      +   +  +I   V +GL++L E  
Sbjct: 63  DFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE-- 120

Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGK 330
            H ++HRD+K +N+L++ +   KL DFG+S  + A     N+   G   Y+APE +  G 
Sbjct: 121 EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI---GCQSYMAPERIKSGG 177

Query: 331 LTD------KSDVYAFGVVLLELLMGRRPVEKMSPT----QCQSMVTWAMPQLTDRSKLP 380
                    +SDV++ G+ +LE+ +GR P    +      Q  ++V    P       LP
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPP------TLP 231

Query: 381 NIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRP 415
           +      +D +              C+   P+ RP
Sbjct: 232 SGYSDDAQDFVA------------KCLNKIPNRRP 254

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 75.0 bits (184), Expect = 5e-15
 Identities = 63/220 (28%), Positives = 106/220 (48%), Gaps = 30/220 (13%)

Query: 161 IGEGGRGHVYKA--------RFNEKLLAAVKRIDDAGHDAE-REFNNEVNWLTKI-RHQN 210
           +GEG  G V +A        R ++ +  AVK + D   D +  +  +E+  +  I +H+N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 211 IISLLGYCIHAETRFLVYEMMQNGSLEKQLH-----GP--------THGSNLTWHLRMKI 257
           II+LLG C      +++ E    G+L + L      GP             L++   +  
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG- 316
           A  VARG+EYL    +   +HRDL + N+L+      K++DFGL+          K S  
Sbjct: 140 AYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196

Query: 317 --TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRP 353
              + ++APE L +   T +SDV++FG+++ E+  +G  P
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSP 236

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 75.0 bits (184), Expect = 6e-15
 Identities = 70/246 (28%), Positives = 114/246 (46%), Gaps = 39/246 (15%)

Query: 142 VIEYELLEAATNNFQESNVI-----GEGGRGHVY--------KARFNEKLLAAVKRI-DD 187
           V EYEL E          ++     GEG  G V         K + N     AVK +  D
Sbjct: 2   VSEYELPEDPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD 61

Query: 188 AGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQL------ 240
           A      +  +E+  +  I +H+NII+LLG C      +++ E    G+L + L      
Sbjct: 62  ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 121

Query: 241 -----HGPTHG--SNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFN 293
                + PT      L++   +  A  VARG+EYL    +   +HRDL + N+L+     
Sbjct: 122 GMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNV 178

Query: 294 AKLSDFGLS-----VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELL 348
            K++DFGL+     +    ++ N ++   + ++APE L +   T +SDV++FGV+L E+ 
Sbjct: 179 MKIADFGLARDIHHIDYYKKTTNGRLP--VKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 236

Query: 349 -MGRRP 353
            +G  P
Sbjct: 237 TLGGSP 242

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 74.5 bits (183), Expect = 6e-15
 Identities = 52/155 (33%), Positives = 79/155 (50%), Gaps = 9/155 (5%)

Query: 203 LTKIRHQNIISLLGYCIHAETRF-LVYEMMQNGSLEKQLHG-PTHGSNLTWHLRMKIAVD 260
           L K+  + I+SL  Y    +T   LV  +M  G L   ++                    
Sbjct: 47  LAKVHSRFIVSL-AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQ 105

Query: 261 VARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT-AGTQSRNVKISGTLG 319
           +  GLE+LH+     +++RDLK  N+LLD+  N ++SD GL+V     QS+    +GT G
Sbjct: 106 IISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPG 162

Query: 320 YVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRP 353
           ++APE LL+G+  D S D +A GV L E++  R P
Sbjct: 163 FMAPE-LLQGEEYDFSVDYFALGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 74.4 bits (183), Expect = 6e-15
 Identities = 63/210 (30%), Positives = 101/210 (48%), Gaps = 24/210 (11%)

Query: 154 NFQESNVIGEGGRGHVYKAR-------FNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKI 206
           + +    +G G  G V+  R       +  K++A  + I       E+  +NE   L ++
Sbjct: 2   DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIR---LKQEQHVHNEKRVLKEV 58

Query: 207 RHQNIISLLGYCIHAETRFL--VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
            H  II L  +    + RFL  + E +  G L   L      SN T       A ++   
Sbjct: 59  SHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLF---YASEIVCA 113

Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
           LEYLH   +  +V+RDLK  NILLD   + KL+DFG +     + R   + GT  Y+APE
Sbjct: 114 LEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFA--KKLRDRTWTLCGTPEYLAPE 168

Query: 325 YLLEGKLTDKS-DVYAFGVVLLELLMGRRP 353
            +++ K  +K+ D +A G+++ E+L+G  P
Sbjct: 169 -VIQSKGHNKAVDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 73.5 bits (180), Expect = 1e-14
 Identities = 58/204 (28%), Positives = 98/204 (48%), Gaps = 20/204 (9%)

Query: 161 IGEGGRGHVYKARFNEK---LLAAVK--RIDDAGHDAEREFNNEVNWLTKIRHQNIISLL 215
           +GEG  G V + + N+    L  AVK  +I         +F +E   + +  H N++ L+
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 216 GYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSN---LTWHLRMKIAVDVARGLE 266
           G C+            ++   M++G L   L     G     L   + +K   D+A G+E
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGT-LGYVAP 323
           YL    +   +HRDL + N +L+ + N  ++DFGLS  +  G   R  +I+   + ++A 
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183

Query: 324 EYLLEGKLTDKSDVYAFGVVLLEL 347
           E L +   T KSDV++FGV + E+
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEI 207

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 73.1 bits (179), Expect = 1e-14
 Identities = 60/212 (28%), Positives = 97/212 (45%), Gaps = 19/212 (8%)

Query: 154 NFQESNVIGEGGRGHVYKARFN-EKLLAAVKRID-DAGHDAEREFN-NEVNWLTKIRHQN 210
            ++    IGEG  G +Y A+   +     +K ID       E+E +  EV  L K++H N
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60

Query: 211 IISLLGYCIHAETRFLVYEMMQNGSLEKQL---HGPTHGSN--LTWHLRMKIAVDVARGL 265
           I++           F+V E    G L K++    G     +  L+W       V ++ GL
Sbjct: 61  IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWF------VQISLGL 114

Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSS-FNAKLSDFGLSVTAGTQSRNVKI-SGTLGYVAP 323
           +++H+     ++HRD+KS NI L  +   AKL DFG++              GT  Y++P
Sbjct: 115 KHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSP 171

Query: 324 EYLLEGKLTDKSDVYAFGVVLLELLMGRRPVE 355
           E        +K+D+++ G VL EL   + P E
Sbjct: 172 EICQNRPYNNKTDIWSLGCVLYELCTLKHPFE 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 74.0 bits (181), Expect = 1e-14
 Identities = 71/274 (25%), Positives = 127/274 (46%), Gaps = 21/274 (7%)

Query: 161 IGEGGRGHVYKAR-FNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCI 219
           IG+G  G VY A         A+++++      +    NE+  + + ++ NI++ L   +
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87

Query: 220 HAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAV---DVARGLEYLHEHCNHPV 276
             +  ++V E +  GSL       T     T     +IA    +  + LE+LH   ++ V
Sbjct: 88  VGDELWVVMEYLAGGSL-------TDVVTETCMDEGQIAAVCRECLQALEFLH---SNQV 137

Query: 277 VHRDLKSSNILLDSSFNAKLSDFGLSVT-AGTQSRNVKISGTLGYVAPEYLLEGKLTDKS 335
           +HRD+KS NILL    + KL+DFG        QS+   + GT  ++APE +       K 
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 197

Query: 336 DVYAFGVVLLELLMGRRPVEKMSPTQCQSMV-TWAMPQLTDRSKLPNIVDPVIRDTMDLK 394
           D+++ G++ +E++ G  P    +P +   ++ T   P+L +  KL  I    +   +D+ 
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMD 257

Query: 395 HLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLV 428
              + +A  +L  Q     +P     L SL PL+
Sbjct: 258 VEKRGSAKELLQHQFLKIAKP-----LSSLTPLI 286

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 73.3 bits (180), Expect = 2e-14
 Identities = 71/224 (31%), Positives = 106/224 (47%), Gaps = 39/224 (17%)

Query: 155 FQESNVIGEGGRGHVYKARFNEK-LLAAVKRIDDAGHDAERE-FN----NEVNWLTKIRH 208
           F     IGEG  G VYKAR  +   L A+K++     D E+E F      E+  L ++ H
Sbjct: 9   FDIIGQIGEGTYGQVYKARDKDTGELVALKKVR---LDNEKEGFPITAIREIKILRQLNH 65

Query: 209 QNIISL----------LGYCIHAETRFLVYEMMQN---GSLEKQLHGPTHGSNLTWHLRM 255
           +NI++L          L +       +LV+E M +   G LE  L   +     ++   M
Sbjct: 66  RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSF---M 122

Query: 256 KIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR----N 311
           K  ++   GL Y H       +HRD+K SNILL++    KL+DFGL+    ++      N
Sbjct: 123 KQLLE---GLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTN 176

Query: 312 VKISGTLGYVAPEYLL-EGKLTDKSDVYAFGVVLLELLMGRRPV 354
             I  TL Y  PE LL E +     DV++ G +L EL   ++P+
Sbjct: 177 KVI--TLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 72.7 bits (178), Expect = 2e-14
 Identities = 72/280 (25%), Positives = 128/280 (45%), Gaps = 43/280 (15%)

Query: 160 VIGEGGRGHVYKARF-----NEKLLAAVKRI-DDAGHDAEREFNNEVNWLTKIRHQNIIS 213
           V+G G  G VYK  +     N K+  A+K + ++    A +E  +E   +  +    +  
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 214 LLGYCIHAETRFLVYEMMQNGSLEKQL--HGPTHGSN--LTWHLRMKIAVDVARGLEYLH 269
           LLG C+ +  + LV ++M  G L   +  +    GS   L W       V +A+G+ YL 
Sbjct: 74  LLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIAKGMSYLE 126

Query: 270 EHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAPEYL 326
           E     +VHRDL + N+L+ S  + K++DFGL+             G    + ++A E +
Sbjct: 127 EV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI 183

Query: 327 LEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDR-SKLPNIVD 384
           L  + T +SDV+++GV + EL+  G +P + +   +        +P L ++  +LP    
Sbjct: 184 LHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE--------IPDLLEKGERLPQ--P 233

Query: 385 PVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
           P+   T+D      V  + V C   +   RP   +++   
Sbjct: 234 PIC--TID------VYMIMVKCWMIDSECRPRFRELVDEF 265

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 72.7 bits (178), Expect = 3e-14
 Identities = 74/286 (25%), Positives = 126/286 (44%), Gaps = 46/286 (16%)

Query: 161 IGEGGRGHVYKA------RFNEKLLAAVKRIDDAGHDAER-EFNNEVNWLTKIRHQNIIS 213
           +G+G  G VY+       +   +   AVK ++++    ER EF NE + +      +++ 
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 214 LLGYCIHAETRFLVYEMMQNGSLEKQLHG--PTHGSN---LTWHLR--MKIAVDVARGLE 266
           LLG     +   +V E+M +G L+  L    P   +N       L+  +++A ++A G+ 
Sbjct: 74  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133

Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLG-----YV 321
           YL+       VHRDL + N ++   F  K+ DFG+  T      +    G  G     ++
Sbjct: 134 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGM--TRDIYETDYYRKGGKGLLPVRWM 188

Query: 322 APEYLLEGKLTDKSDVYAFGVVLLEL-LMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKL- 379
           APE L +G  T  SD+++FGVVL E+  +  +P + +S  Q    V        D   L 
Sbjct: 189 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV-------MDGGYLD 241

Query: 380 -PNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
            P+     + D M             +C Q  P  RP   ++++ L
Sbjct: 242 QPDNCPERVTDLMR------------MCWQFNPKMRPTFLEIVNLL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 73.1 bits (179), Expect = 3e-14
 Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 8/208 (3%)

Query: 149 EAATNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAER-EFNNEVNWLTKI 206
           E   ++F++ + +G G  G V+K       L+ A K I      A R +   E+  L + 
Sbjct: 1   ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60

Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
               I+   G         +  E M  GSL++ L        +   +  K+++ V +GL 
Sbjct: 61  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLT 117

Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYL 326
           YL E   H ++HRD+K SNIL++S    KL DFG+S        N    GT  Y++PE L
Sbjct: 118 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERL 174

Query: 327 LEGKLTDKSDVYAFGVVLLELLMGRRPV 354
                + +SD+++ G+ L+E+ +GR P+
Sbjct: 175 QGTHYSVQSDIWSMGLSLVEMAIGRYPI 202

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 72.4 bits (177), Expect = 4e-14
 Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 16/210 (7%)

Query: 155 FQESNVIGEGGRGHVY--KARFNEKLLAAVK----RIDDAGHDAEREFNNEVNWLTKIRH 208
           F++  V+G+GG G V   + R   K+ A  K    RI       E    NE   L K+  
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK--RKGESMALNEKQILEKVNS 59

Query: 209 QNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKI--AVDVARGLE 266
           + ++SL       +   LV  +M  G L+  ++   H     +     +  A ++  GLE
Sbjct: 60  RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY---HMGEAGFEEGRAVFYAAEICCGLE 116

Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYL 326
            LH+     +V+RDLK  NILLD   + ++SD GL+V            GT+GY+APE +
Sbjct: 117 DLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV 173

Query: 327 LEGKLTDKSDVYAFGVVLLELLMGRRPVEK 356
              + T   D +A G +L E++ G+ P ++
Sbjct: 174 KNERYTFSPDWWALGCLLYEMIAGQSPFQQ 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 72.0 bits (176), Expect = 4e-14
 Identities = 70/277 (25%), Positives = 120/277 (43%), Gaps = 31/277 (11%)

Query: 154 NFQESNVIGEGGRGHVYKARFN-EKLLAAVKRI---DDAGHDAEREFNNEVNWLTKIRHQ 209
           NF+    IG G    VY+A    + +  A+K++   D     A  +   E++ L ++ H 
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 210 NIISLLGYCIHAETRFLVYEMMQNGSLEKQL-HGPTHGSNLTWHLRMKIAVDVARGLEYL 268
           N+I      I      +V E+   G L + + H       +      K  V +   LE++
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122

Query: 269 HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGL-----SVTAGTQSRNVKISGTLGYVAP 323
           H   +  V+HRD+K +N+ + ++   KL D GL     S T    S    + GT  Y++P
Sbjct: 123 H---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS----LVGTPYYMSP 175

Query: 324 EYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
           E + E     KSD+++ G +L E+          SP     M  +++ +  ++   P + 
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEM------AALQSPFYGDKMNLYSLCKKIEQCDYPPL- 228

Query: 384 DPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDV 420
            P    + +L+ L        +CI P+P  RP IT V
Sbjct: 229 -PSDHYSEELRQLVN------MCINPDPEKRPDITYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 72.1 bits (177), Expect = 4e-14
 Identities = 60/200 (30%), Positives = 97/200 (48%), Gaps = 13/200 (6%)

Query: 161 IGEGGRGHVYKARFNEKL-LAAVKRI--DDAGHDAEREFNNEVNWLTKIRHQNIISLLGY 217
           IGEG  G V+KA+  E   + A+KR+  DD           E+  L +++H+NI+ L   
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD- 66

Query: 218 CIHAETRF-LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPV 276
            +H++ +  LV+E      L+K     +   ++   +       + +GL + H H    V
Sbjct: 67  VLHSDKKLTLVFEYCDQ-DLKKYFD--SCNGDIDPEIVKSFMFQLLKGLAFCHSH---NV 120

Query: 277 VHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPEYLLEGKLTDKS 335
           +HRDLK  N+L++ +   KL+DFGL+   G   R       TL Y  P+ L   KL   S
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 180

Query: 336 -DVYAFGVVLLELLMGRRPV 354
            D+++ G +  EL    RP+
Sbjct: 181 IDMWSAGCIFAELANAGRPL 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 71.9 bits (177), Expect = 5e-14
 Identities = 61/215 (28%), Positives = 114/215 (53%), Gaps = 33/215 (15%)

Query: 154 NFQESNVIGEGGRGHVYKARFNEKL---LAAVKRIDDAGHDAERE-FN----NEVNWLTK 205
            +++ N I EG  G VY+AR  +K    + A+K++     + E+E F      E+N L K
Sbjct: 6   EYEKLNRIEEGTYGVVYRAR--DKKTGEIVALKKLK---MEKEKEGFPITSLREINILLK 60

Query: 206 IRHQNIISL----LGYCIHAETRFLVYEMMQNG--SLEKQLHGPTHGSNLTWHLRMK-IA 258
           ++H NI+++    +G  +     ++V E +++   SL + +  P   S +      K + 
Sbjct: 61  LQHPNIVTVKEVVVGSNLD--KIYMVMEYVEHDLKSLMETMKQPFLQSEV------KCLM 112

Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN-VKISGT 317
           + +  G+ +LH++    ++HRDLK+SN+LL++    K+ DFGL+   G+  +   ++  T
Sbjct: 113 LQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVT 169

Query: 318 LGYVAPEYLL-EGKLTDKSDVYAFGVVLLELLMGR 351
           L Y APE LL   + +   D+++ G +  ELL  +
Sbjct: 170 LWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 70.9 bits (174), Expect = 1e-13
 Identities = 62/203 (30%), Positives = 89/203 (43%), Gaps = 27/203 (13%)

Query: 161 IGEGGRGHVYKARFNEK-LLAAVKRIDDAGHD------AEREFNNEVNWLTKIRHQNIIS 213
           IGEG  G V+K R  E   + A+K+  ++  D      A RE    +  L +++H N+++
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALRE----IRMLKQLKHPNLVN 64

Query: 214 LLGYCIHAETRFLVYEMMQN---GSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHE 270
           L+          LV+E   +     LEK   G      +  HL  KI     + + + H+
Sbjct: 65  LIEVFRRKRKLHLVFEYCDHTVLNELEKNPRG------VPEHLIKKIIWQTLQAVNFCHK 118

Query: 271 HCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS-VTAGTQSRNVKISGTLGYVAPEYLLEG 329
           H     +HRD+K  NIL+      KL DFG + +  G          T  Y APE LL G
Sbjct: 119 H---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPE-LLVG 174

Query: 330 KLTDKS--DVYAFGVVLLELLMG 350
                   DV+A G V  ELL G
Sbjct: 175 DTQYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 70.3 bits (172), Expect = 1e-13
 Identities = 48/172 (27%), Positives = 83/172 (48%), Gaps = 16/172 (9%)

Query: 195 EFNNEVNWLTKIRHQNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGS- 247
           EF  E   + +  H N+I L+G  + +  +       ++   M++G L   L     G  
Sbjct: 47  EFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEE 106

Query: 248 --NLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--V 303
              L     ++  +D+A G+EYL    +   +HRDL + N +L+ +    ++DFGLS  +
Sbjct: 107 PFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKI 163

Query: 304 TAGTQSRNVKISG-TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRP 353
            +G   R    S   + ++A E L +   T  SDV+AFGV + E++  G+ P
Sbjct: 164 YSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 70.8 bits (174), Expect = 1e-13
 Identities = 66/230 (28%), Positives = 106/230 (46%), Gaps = 35/230 (15%)

Query: 151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFN----NEVNWLTK 205
              +++    +GEG  G VYKAR  +   + A+K+I    H+ +  F      E+  L K
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKI--LMHNEKDGFPITALREIKILKK 63

Query: 206 IRHQNIISLLGYCI-----HAETRFLVYEMM--QNGSLEKQLHGPTHGSNLTWHLRMK-I 257
           ++H N++ L+   +         R  VY +    +  L   L  P+    LT   ++K  
Sbjct: 64  LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPS--VKLT-ESQIKCY 120

Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT 317
            + +  G+ YLH   NH ++HRD+K++NIL+D+    K++DFGL+        N K  G 
Sbjct: 121 MLQLLEGINYLH--ENH-ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGG 177

Query: 318 LG------------YVAPEYLL-EGKLTDKSDVYAFGVVLLELLMGRRPV 354
            G            Y  PE LL E + T   D++  G V  E+   RRP+
Sbjct: 178 GGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFT-RRPI 226

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 69.7 bits (170), Expect = 2e-13
 Identities = 70/279 (25%), Positives = 119/279 (42%), Gaps = 31/279 (11%)

Query: 154 NFQESNVIGEGGRGHVYKAR--FNEKLLA--AVKRIDDAGHDAEREFNNEVNWLTKIRHQ 209
           NFQ    IG G    VY+A    + K +A   V+  +     A ++   E++ L ++ H 
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 210 NIISLLGYCIHAETRFLVYEMMQNGSLEKQL-HGPTHGSNLTWHLRMKIAVDVARGLEYL 268
           N+I  L   I      +V E+   G L + + +       +      K  V +   +E++
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122

Query: 269 HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGL-----SVTAGTQSRNVKISGTLGYVAP 323
           H   +  V+HRD+K +N+ + ++   KL D GL     S T    S    + GT  Y++P
Sbjct: 123 H---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS----LVGTPYYMSP 175

Query: 324 EYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
           E + E     KSD+++ G +L E+          SP     M  +++ Q  ++   P + 
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEM------AALQSPFYGDKMNLFSLCQKIEQCDYPPL- 228

Query: 384 DPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLH 422
            P    +  L+ L        +CI P+P  RP I  V  
Sbjct: 229 -PTEHYSEKLRELVS------MCIYPDPDQRPDIGYVHQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 63/230 (27%), Positives = 100/230 (43%), Gaps = 43/230 (18%)

Query: 144 EYELLEAATNNFQESNVIGEGGRGHVYKA---RFNEKLLAAVKRIDDAGHD---AEREFN 197
            Y+ +E           IG G  G V  A   R  +K+  A+K+I  A      A+R   
Sbjct: 6   RYKPIE----------NIGSGAYGVVCSAIDTRSGKKV--AIKKIPHAFDVPTLAKRTLR 53

Query: 198 NEVNWLTKIRHQNIISLLGYCI------HAETRFLVYEMMQNGSLEKQLHGPTHGSN-LT 250
            E+  L   +H NII++    I        +  ++V ++M++      LH   H    LT
Sbjct: 54  -ELKILRHFKHDNIIAIRD--ILRPPGADFKDVYVVMDLMES-----DLHHIIHSDQPLT 105

Query: 251 WHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR 310
                     + RGL+Y+H      V+HRDLK SN+L++     ++ DFG++    +   
Sbjct: 106 EEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162

Query: 311 NVKI-----SGTLGYVAPEYLLE-GKLTDKSDVYAFGVVLLELLMGRRPV 354
             K        T  Y APE LL   + T   D+++ G +  E+L GRR +
Sbjct: 163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 70.1 bits (172), Expect = 3e-13
 Identities = 68/210 (32%), Positives = 109/210 (51%), Gaps = 30/210 (14%)

Query: 161 IGEGGRGHVYKAR---FNEKLLAAVKRIDDAGH---DAEREFNNEVNWLTKIRHQNIISL 214
           IG G  G V  A+    NEK+  A+K+I +A     DA+R    E+  L  + H+N+I++
Sbjct: 13  IGRGAYGIVCSAKNSETNEKV--AIKKIANAFDNRIDAKRTLR-EIKLLRHLDHENVIAI 69

Query: 215 LGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSN-LTW-HLRMKIAVDVARGLE 266
               +    R      ++VYE+M     +  LH     S  L+  H +  +   + RGL+
Sbjct: 70  KD-IMPPPHREAFNDVYIVYELM-----DTDLHQIIRSSQTLSDDHCQYFL-YQLLRGLK 122

Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS-VTAGTQSRNVKISGTLGYVAPEY 325
           Y+H   +  V+HRDLK SN+LL+++ + K+ DFGL+  T+       +   T  Y APE 
Sbjct: 123 YIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPEL 179

Query: 326 LLE-GKLTDKSDVYAFGVVLLELLMGRRPV 354
           LL   + T   DV++ G +  E L+GR+P+
Sbjct: 180 LLNCSEYTTAIDVWSVGCIFAE-LLGRKPL 208

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 69.4 bits (169), Expect = 4e-13
 Identities = 62/238 (26%), Positives = 113/238 (47%), Gaps = 20/238 (8%)

Query: 161 IGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCI 219
           IG+G  G VY A         A+K+++      +    NE+  + + ++ NI++ L   +
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86

Query: 220 HAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAV---DVARGLEYLHEHCNHPV 276
             +  ++V E +  GSL       T     T     +IA    +  + L++LH   ++ V
Sbjct: 87  VGDELWVVMEYLAGGSL-------TDVVTETCMDEGQIAAVCRECLQALDFLH---SNQV 136

Query: 277 VHRDLKSSNILLDSSFNAKLSDFGLSVT-AGTQSRNVKISGTLGYVAPEYLLEGKLTDKS 335
           +HRD+KS NILL    + KL+DFG        QS+   + GT  ++APE +       K 
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196

Query: 336 DVYAFGVVLLELLMGRRPVEKMSPTQCQSMV-TWAMPQLTDRSKLPNIVDPVIRDTMD 392
           D+++ G++ +E++ G  P    +P +   ++ T   P+L +    P  +  V RD ++
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQN----PERLSAVFRDFLN 250

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 69.3 bits (169), Expect = 4e-13
 Identities = 61/209 (29%), Positives = 93/209 (44%), Gaps = 14/209 (6%)

Query: 155 FQESNVIGEGGRGHVY--KARFNEKLLAAVK----RIDDAGHDAEREFNNEVNWLTKIRH 208
           F+   V+G+GG G V   + R   K+ A  K    RI       E    NE   L K+  
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK--RKGEAMALNEKRILEKVNS 59

Query: 209 QNIISLLGYCIHAETRF-LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEY 267
           + ++SL  Y    +    LV  +M  G L+  ++             +  A ++  GLE 
Sbjct: 60  RFVVSL-AYAYETKDALCLVLTIMNGGDLKFHIYN-MGNPGFDEQRAIFYAAELCCGLED 117

Query: 268 LHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLL 327
           L       +V+RDLK  NILLD   + ++SD GL+V            GT+GY+APE + 
Sbjct: 118 LQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVIN 174

Query: 328 EGKLTDKSDVYAFGVVLLELLMGRRPVEK 356
             K T   D +  G ++ E++ G+ P  K
Sbjct: 175 NEKYTFSPDWWGLGCLIYEMIQGQSPFRK 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 69.0 bits (169), Expect = 5e-13
 Identities = 69/256 (26%), Positives = 111/256 (43%), Gaps = 35/256 (13%)

Query: 154 NFQESNVIGEGGRGHVYKAR----------FNEKLL---AAVKRIDDAGHD-AEREFNNE 199
           NF+   V+G G  G V+  R          +  K+L     V++   A H   ER+    
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQV--- 57

Query: 200 VNWLTKIRHQNIISLLGYCIHAETRF-LVYEMMQNGSLEKQLHGPTHGSNLTWH-LRMKI 257
              L  +R    +  L Y    +T+  L+ + +  G L   L+      + T   +R+ I
Sbjct: 58  ---LEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLY---QREHFTESEVRVYI 111

Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKIS 315
           A ++   L++LH+     +++RD+K  NILLDS  +  L+DFGLS    A  + R     
Sbjct: 112 A-EIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFC 167

Query: 316 GTLGYVAPEYLLEGKL--TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQL 373
           GT+ Y+APE +  G        D ++ GV+  ELL G  P         QS ++  +  L
Sbjct: 168 GTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRI--L 225

Query: 374 TDRSKLPNIVDPVIRD 389
             +   P  +    RD
Sbjct: 226 KSKPPFPKTMSAEARD 241

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 68.6 bits (168), Expect = 5e-13
 Identities = 63/205 (30%), Positives = 103/205 (50%), Gaps = 22/205 (10%)

Query: 161 IGEGGRGHVYKARFNEKL--LAAVKRI----DDAG--HDAEREFNNEVNWLTKIRHQNII 212
           IGEG  G VYK R N+K   + A+K+I    ++ G    A RE    ++ L +++H NI+
Sbjct: 8   IGEGTYGVVYKGR-NKKTGQIVAMKKIRLESEEEGVPSTAIRE----ISLLKELQHPNIV 62

Query: 213 SLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
            L    +  E+R +L++E +    L+K L     G  +   L       + +G+ + H  
Sbjct: 63  CLQD-VLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120

Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR-NVKISGTLGYVAPEYLLEG- 329
               V+HRDLK  N+L+D+    KL+DFGL+   G   R       TL Y APE LL   
Sbjct: 121 ---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSP 177

Query: 330 KLTDKSDVYAFGVVLLELLMGRRPV 354
           + +   D+++ G +  E+   ++P+
Sbjct: 178 RYSTPVDIWSIGTIFAEMAT-KKPL 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 68.7 bits (168), Expect = 6e-13
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 22/213 (10%)

Query: 155 FQESNVIGEGGRGHVY--KARFNEKLLAAV----KRIDDAGHDAEREFNNEVNWLTKIRH 208
           F+   V+G+GG G V   + R   K+ A      KRI       E    NE   L K+  
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK--RKGEAMALNEKQILEKVNS 59

Query: 209 QNIISLLGYCIHAETR---FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKI--AVDVAR 263
           + ++SL  Y    ET+    LV  +M  G L+  ++   +  N  +     +  A ++  
Sbjct: 60  RFVVSL-AYAY--ETKDALCLVLTLMNGGDLKFHIY---NMGNPGFDEERAVFYAAEITC 113

Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           GLE LH      +V+RDLK  NILLD   + ++SD GL+V            GT+GY+AP
Sbjct: 114 GLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAP 170

Query: 324 EYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEK 356
           E +   + T   D +  G ++ E++ G+ P  +
Sbjct: 171 EVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQ 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 68.5 bits (167), Expect = 6e-13
 Identities = 60/205 (29%), Positives = 92/205 (44%), Gaps = 12/205 (5%)

Query: 155 FQESNVIGEGGRGHVY--KARFNEKLLAAV----KRIDDAGHDAEREFNNEVNWLTKIRH 208
           F++  V+G+GG G V   + R   K+ A      KRI       E    NE   L K+  
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKK--RKGESMALNEKQILEKVNS 59

Query: 209 QNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYL 268
           Q +++L       +   LV  +M  G L+  ++             +  A ++  GLE L
Sbjct: 60  QFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYN-MGNPGFEEERALFYAAEILCGLEDL 118

Query: 269 HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLE 328
           H       V+RDLK  NILLD   + ++SD GL+V            GT+GY+APE L  
Sbjct: 119 HRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNN 175

Query: 329 GKLTDKSDVYAFGVVLLELLMGRRP 353
            + T   D +  G ++ E++ G+ P
Sbjct: 176 QRYTLSPDYWGLGCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 69.9 bits (171), Expect = 7e-13
 Identities = 40/88 (45%), Positives = 54/88 (61%), Gaps = 4/88 (4%)

Query: 269 HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS-VTAGTQSRNV--KISGTLGYVAPEY 325
           H H  H ++HRD+KS+NILL S+   KL DFG S + A T S +V     GT  YVAPE 
Sbjct: 158 HVHSKH-MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEI 216

Query: 326 LLEGKLTDKSDVYAFGVVLLELLMGRRP 353
                 + K+D+++ GV+L ELL  +RP
Sbjct: 217 WRRKPYSKKADMFSLGVLLYELLTLKRP 244

Length = 496

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 68.9 bits (168), Expect = 8e-13
 Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 30/211 (14%)

Query: 160 VIGEGGRGHVYKARF--NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRH-------QN 210
           VIG G    V   R   N+++ A      +  HD E     +++W+   +H         
Sbjct: 2   VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDE-----DIDWVQTEKHVFEQASSNP 56

Query: 211 IISLLGYCIHAETR-FLVYEMMQNGSL----EKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
            +  L  C    +R FLV E +  G L    ++Q   P        H R   A ++   L
Sbjct: 57  FLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEE------HARF-YAAEICIAL 109

Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA-GTQSRNVKISGTLGYVAPE 324
            +LHE     +++RDLK  N+LLD+  + KL+D+G+     G         GT  Y+APE
Sbjct: 110 NFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPE 166

Query: 325 YLLEGKLTDKSDVYAFGVVLLELLMGRRPVE 355
            L   +     D +A GV++ E++ GR P +
Sbjct: 167 ILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 68.5 bits (167), Expect = 8e-13
 Identities = 41/120 (34%), Positives = 66/120 (55%), Gaps = 14/120 (11%)

Query: 245 HGSNLTWHLRMKIAVDVAR----------GLEYLHEHCNHPVVHRDLKSSNILLDSSFNA 294
           +G +L +H++     D+ R          GL++LH   +  +V+RDLK  NILLD+  + 
Sbjct: 79  NGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHI 135

Query: 295 KLSDFGLSVTAGT-QSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
           K++DFG+        ++     GT  Y+APE LL  K     D ++FGV+L E+L+G+ P
Sbjct: 136 KIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 68.1 bits (166), Expect = 9e-13
 Identities = 63/205 (30%), Positives = 90/205 (43%), Gaps = 17/205 (8%)

Query: 161 IGEGGRGHVYKAR-FNEKLLAAVK--RIDDAGHDAEREFNNEVNWLTKIR---HQNIISL 214
           IG G  G VYKAR  +     A+K  R+             EV  L ++    H NI+ L
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 215 LGYCIHAETR-----FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLH 269
           +  C  + T       LV+E +           P  G  L       +     RGL++LH
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG--LPAETIKDLMRQFLRGLDFLH 125

Query: 270 EHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEG 329
            +C   +VHRDLK  NIL+ S    KL+DFGL+     Q     +  TL Y APE LL+ 
Sbjct: 126 ANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQS 182

Query: 330 KLTDKSDVYAFGVVLLELLMGRRPV 354
                 D+++ G +  E+   R+P+
Sbjct: 183 TYATPVDMWSVGCIFAEMFR-RKPL 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 68.0 bits (166), Expect = 9e-13
 Identities = 60/218 (27%), Positives = 94/218 (43%), Gaps = 20/218 (9%)

Query: 161 IGEGGRGHVYKARFNEKLLAA---VKRID-DAGHDAEREFNNEVNWLTKIRHQNIISLLG 216
           IG G  G V     N     A   VK +   A    + +F  E      ++H N++  LG
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 217 YCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRM--KIAVDVARGLEYLHEHCNH 274
            C       LV E    G L+  L        +T       ++A ++A GL +LH+   +
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---N 119

Query: 275 PVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV---KISGTLGYVAPEYLLE--G 329
             +H DL   N LL +    K+ D+GLS     +   V   ++   L ++APE + E  G
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179

Query: 330 KL-----TDKSDVYAFGVVLLELL-MGRRPVEKMSPTQ 361
            L     T +S+V++ GV + EL  +G +P   +S  Q
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ 217

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 67/227 (29%), Positives = 105/227 (46%), Gaps = 40/227 (17%)

Query: 151 ATNNFQESNVIGEGGRGHVYKARF------NEKLLAAVKRIDDAGHDAERE-FNNEVNWL 203
           +T  F E   +GE   G VYK          +    A+K + D      RE F +E    
Sbjct: 5   STVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMR 62

Query: 204 TKIRHQNIISLLG-------------YCIHAET-RFLVYEMMQN--GSLEKQLHGPTHGS 247
           ++++H NI+ LLG             YC H++   FLV     +  GS +      T  S
Sbjct: 63  SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDD---KTVKS 119

Query: 248 NLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGL--SVTA 305
            L     + I   +A G+E+L    +H VVH+DL + N+L+    N K+SD GL   V A
Sbjct: 120 TLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYA 176

Query: 306 GTQSRNVKISGT----LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL 348
                  K+ G     + +++PE ++ GK +  SD++++GVVL E+ 
Sbjct: 177 ADY---YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVF 220

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 68.2 bits (167), Expect = 1e-12
 Identities = 62/216 (28%), Positives = 94/216 (43%), Gaps = 22/216 (10%)

Query: 153 NNFQESNVIGEGGRGHVYKAR-FNEKLLAAVKRIDDA---GHDAEREFNNEVNWLTKIRH 208
            +FQ    +G+GG G V+ A+  +   + A+KR+  +     +  R    E + LT  + 
Sbjct: 1   KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60

Query: 209 QNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLR-----MKIAVDVAR 263
           + ++ LL      E  +L  E +  G     L+    G     H R     M  AVD   
Sbjct: 61  EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLN--NLGVLSEDHARFYMAEMFEAVDALH 118

Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
            L Y         +HRDLK  N L+D+S + KL+DFGLS   G  +    + G+  Y+AP
Sbjct: 119 ELGY---------IHRDLKPENFLIDASGHIKLTDFGLS--KGIVTYANSVVGSPDYMAP 167

Query: 324 EYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSP 359
           E L         D ++ G +L E L G  P    +P
Sbjct: 168 EVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP 203

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 67.9 bits (166), Expect = 1e-12
 Identities = 50/157 (31%), Positives = 74/157 (47%), Gaps = 27/157 (17%)

Query: 246 GSNLTWHLRM--KIAVDVAR--------GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAK 295
           G  L  HLR   +   DVA+          EYLH   +  +++RDLK  N+LLD+  + K
Sbjct: 102 GGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHS-KD--IIYRDLKPENLLLDNKGHVK 158

Query: 296 LSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRR 352
           ++DFG +  V      R   + GT  Y+APE +++ K   K+ D +  GV+L E + G  
Sbjct: 159 VTDFGFAKKVP----DRTFTLCGTPEYLAPE-VIQSKGHGKAVDWWTMGVLLYEFIAGYP 213

Query: 353 PVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRD 389
           P    +P +    +      L  R K PN  D   RD
Sbjct: 214 PFFDDTPFRIYEKI------LAGRLKFPNWFDGRARD 244

Length = 329

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 68.1 bits (166), Expect = 2e-12
 Identities = 68/258 (26%), Positives = 110/258 (42%), Gaps = 36/258 (13%)

Query: 154 NFQESNVIGEGGRGHVYKAR----------FNEKLL---AAVKRIDDAGHDAEREFNNEV 200
           NF+   V+G G  G V+  R          +  K+L   A V++     H        E 
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHT-----RTER 55

Query: 201 NWLTKIRHQNIISLLGYCIHAETRF-LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAV 259
           N L  +R    +  L Y    E +  L+ + +  G +   L+   + S     +R     
Sbjct: 56  NVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDE--VRFYSG- 112

Query: 260 DVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGT 317
           ++   LE+LH+     +V+RD+K  NILLDS  +  L+DFGLS    +  + R     GT
Sbjct: 113 EIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGT 169

Query: 318 LGYVAPEYLL----EGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQL 373
           + Y+APE +      GK     D ++ G+++ ELL G  P         QS V+  +  L
Sbjct: 170 IEYMAPEIIRGKGGHGKAV---DWWSLGILIFELLTGASPFTLEGERNTQSEVSRRI--L 224

Query: 374 TDRSKLPNIVDPVIRDTM 391
                 P+ + P  +D +
Sbjct: 225 KCDPPFPSFIGPEAQDLL 242

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 57/199 (28%), Positives = 93/199 (46%), Gaps = 12/199 (6%)

Query: 161 IGEGGRGHVYKARF-NEKLLAAVKRIDDA---GHDAEREFNNEVNWLTKIRHQNIISLLG 216
           +G+GG G V   +  N   + A K++D         E+    E   L K+    I++L  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59

Query: 217 YCIHAETRF-LVYEMMQNGSLEKQL-HGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNH 274
           Y   ++T   LV  +M  G L+  + +    G  +   +    +  +  G+ +LH     
Sbjct: 60  YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHY--SAQITCGILHLHSM--- 114

Query: 275 PVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDK 334
            +V+RD+K  N+LLD   N +LSD GL+V         + +GT GY+APE L E   +  
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYP 174

Query: 335 SDVYAFGVVLLELLMGRRP 353
            D +A G  + E++ GR P
Sbjct: 175 VDWFAMGCSIYEMVAGRTP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 44/120 (36%), Positives = 65/120 (54%), Gaps = 15/120 (12%)

Query: 246 GSNLTWHLRM--KIAVDVAR--------GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAK 295
           G  L WHL+   + + D A+         LE+LH++    +V+RDLK  NILLD++ +  
Sbjct: 80  GGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIA 136

Query: 296 LSDFGLSVTAGTQSRNVK-ISGTLGYVAPEYLLEGK-LTDKSDVYAFGVVLLELLMGRRP 353
           L DFGLS    T ++      GT  Y+APE LL+ K  T   D ++ GV++ E+  G  P
Sbjct: 137 LCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 67.5 bits (165), Expect = 2e-12
 Identities = 40/117 (34%), Positives = 66/117 (56%), Gaps = 7/117 (5%)

Query: 260 DVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA-GTQSRNVKISGTL 318
           ++A  L++LH   +  +++RDLK  NILLD   + KL+DFGLS  +   + +     GT+
Sbjct: 106 ELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTV 162

Query: 319 GYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWA---MPQ 372
            Y+APE +     T  +D ++FGV++ E+L G  P +     +  +M+  A   MPQ
Sbjct: 163 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQ 219

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 69.1 bits (169), Expect = 2e-12
 Identities = 56/192 (29%), Positives = 85/192 (44%), Gaps = 24/192 (12%)

Query: 186 DDAGHDAER--EFNNEVNWLTKIRHQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQL-- 240
            DA  +  +   F  E     ++ H NI++LL          F V+E +   +L + L  
Sbjct: 13  TDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAA 72

Query: 241 HGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILL---DSSFNAKLS 297
            G       T  L ++    V   L   H   N  +VHRDLK  NI++       +AK+ 
Sbjct: 73  DGALPAGE-TGRLMLQ----VLDALACAH---NQGIVHRDLKPQNIMVSQTGVRPHAKVL 124

Query: 298 DFGLS--------VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM 349
           DFG+             T +R  ++ GT  Y APE L    +T  SD+YA+G++ LE L 
Sbjct: 125 DFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLT 184

Query: 350 GRRPVEKMSPTQ 361
           G+R V+  S  +
Sbjct: 185 GQRVVQGASVAE 196

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 66.8 bits (163), Expect = 3e-12
 Identities = 65/219 (29%), Positives = 105/219 (47%), Gaps = 43/219 (19%)

Query: 152 TNNFQESNVIGEGGRGHVYKARFNEKLLA---AVKRIDD---AGHDAEREFNNEVNWLTK 205
           TN + +   +G G  G V  AR  ++L     A+K+I         A+R +  E+  L  
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSAR--DQLTGQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKH 65

Query: 206 IRHQNIISLLGYCIH-AETRFLVYEMM--------QNGSLEKQLHGPTHGSNLTWHLRMK 256
           +RH+NIISL    I   E  + V E++         +  LEKQ                 
Sbjct: 66  LRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQF-------------IQY 112

Query: 257 IAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG 316
               + RGL+Y+H   +  VVHRDLK SNIL++ + + K+ DFGL+     + ++ +++G
Sbjct: 113 FLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLA-----RIQDPQMTG 164

Query: 317 ---TLGYVAPEYLLE-GKLTDKSDVYAFGVVLLELLMGR 351
              T  Y APE +L   K   + D+++ G +  E+L G+
Sbjct: 165 YVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 66.1 bits (161), Expect = 4e-12
 Identities = 75/284 (26%), Positives = 117/284 (41%), Gaps = 38/284 (13%)

Query: 161 IGEGGRGHVYKARFNEKLLAA---VKRI-DDAGHDAEREFNNEVNWLTKIRHQNIISLLG 216
           IG G  G V     +  +  A   VK +   A  D +  F  EV    ++ H N++  LG
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 217 YCIHAETRFLVYEMMQNGSLEKQL---HGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
            CI +    LV E    G L+  L    G          +  ++A +VA GL +LH+   
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQK-DVLQRMACEVASGLLWLHQ--A 119

Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV---KISGTLGYVAPEY----- 325
              +H DL   N  L +  + K+ D+GL++    +   +     +  L ++APE      
Sbjct: 120 D-FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178

Query: 326 --LLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNI 382
             LL    T KS++++ GV + EL     +P   +S  Q    V     Q     KLP  
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVV--REQDI---KLP-- 231

Query: 383 VDPVIRDTMDLKHLYQVAAVAVLC-IQPEPSYRPLITDVLHSLI 425
                +  +DLK+  +   V   C + PE   RP   +V H L+
Sbjct: 232 -----KPQLDLKYSDRWYEVMQFCWLDPET--RPTAEEV-HELL 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 66.4 bits (162), Expect = 4e-12
 Identities = 38/101 (37%), Positives = 56/101 (55%), Gaps = 8/101 (7%)

Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGL---SVTAGTQSRNVKI 314
           A +V   L +LH H    V++RDLK  NILLD+  + KL+DFG+    +  G  +     
Sbjct: 102 AAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTT--F 156

Query: 315 SGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVE 355
            GT  Y+APE L E +     D +A GV++ E++ G+ P E
Sbjct: 157 CGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFE 197

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 66.1 bits (161), Expect = 6e-12
 Identities = 40/120 (33%), Positives = 66/120 (55%), Gaps = 14/120 (11%)

Query: 245 HGSNLTWHLRMKIAVDVAR----------GLEYLHEHCNHPVVHRDLKSSNILLDSSFNA 294
           +G +L +H++ K   D+ R          GL++LH   +  +++RDLK  N++LD   + 
Sbjct: 79  NGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHI 135

Query: 295 KLSDFGL-SVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
           K++DFG+        +R     GT  Y+APE L   K T   D ++FGV+L E+L+G+ P
Sbjct: 136 KIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 65.9 bits (160), Expect = 8e-12
 Identities = 63/215 (29%), Positives = 98/215 (45%), Gaps = 38/215 (17%)

Query: 160 VIGEGGRGHVYKARFNEKLLAAVKRIDD--AGHDAEREFNNE---VNWLTKIRH-----Q 209
           VIG G    V        LL  +K+ +   A    ++E  N+   ++W+   +H      
Sbjct: 2   VIGRGSYAKV--------LLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS 53

Query: 210 NIISLLGY--CIHAETR-FLVYEMMQNGSL----EKQLHGPTHGSNLTWHLRMKIAVDVA 262
           N   L+G   C   E+R F V E +  G L    ++Q   P        H R   A +++
Sbjct: 54  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE------HARFYSA-EIS 106

Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK--ISGTLGY 320
             L YLHE     +++RDLK  N+LLDS  + KL+D+G+    G +  +      GT  Y
Sbjct: 107 LALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGM-CKEGLRPGDTTSTFCGTPNY 162

Query: 321 VAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVE 355
           +APE L         D +A GV++ E++ GR P +
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 65.6 bits (160), Expect = 8e-12
 Identities = 39/120 (32%), Positives = 64/120 (53%), Gaps = 14/120 (11%)

Query: 245 HGSNLTWHLRMKIAVDVAR----------GLEYLHEHCNHPVVHRDLKSSNILLDSSFNA 294
           +G +L +H++     D AR          GL++LH      +++RDLK  N+LLD   + 
Sbjct: 79  NGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHI 135

Query: 295 KLSDFGLSVTAGT-QSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
           K++DFG+       + +     GT  Y+APE L   K  +  D ++FGV+L E+L+G+ P
Sbjct: 136 KIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 64.6 bits (157), Expect = 9e-12
 Identities = 56/208 (26%), Positives = 87/208 (41%), Gaps = 19/208 (9%)

Query: 160 VIGEGGRGH---VYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLG 216
           V+GEG  G    V     ++K      R+  +    E     E   L K++H NI++   
Sbjct: 7   VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDS-RKEAVLLAKMKHPNIVAFKE 65

Query: 217 YCIHAETRFLVYEMMQNGSLE---KQLHGP--THGSNLTWHLRMKIAVDVARGLEYLHEH 271
                   ++V E    G L    K   G      + L W ++M + V      +++HE 
Sbjct: 66  SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGV------QHIHEK 119

Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLS-VTAGTQSRNVKISGTLGYVAPEYLLEGK 330
               V+HRD+KS NI L  +   KL DFG + +     +      GT  YV PE      
Sbjct: 120 ---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMP 176

Query: 331 LTDKSDVYAFGVVLLELLMGRRPVEKMS 358
             +KSD+++ G +L EL   + P +  S
Sbjct: 177 YNNKSDIWSLGCILYELCTLKHPFQANS 204

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 65.6 bits (160), Expect = 1e-11
 Identities = 35/101 (34%), Positives = 59/101 (58%), Gaps = 8/101 (7%)

Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGL---SVTAGTQSRNVKI 314
           A ++A GL +LH   +  +++RDLK  N++LD+  + K++DFG+   ++  G  +R    
Sbjct: 107 AAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT--F 161

Query: 315 SGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVE 355
            GT  Y+APE +         D +AFGV+L E+L G+ P +
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 65.3 bits (159), Expect = 1e-11
 Identities = 66/218 (30%), Positives = 93/218 (42%), Gaps = 44/218 (20%)

Query: 160 VIGEGGRGHVYKARFNEK-LLAAVK--RIDDAGHDAEREFN-NEVNWLTKIRHQNIISLL 215
           V+G+G  G V  AR  E   L AVK  + D    D + E    E   L+  R+   ++ L
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61

Query: 216 GYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG---------- 264
             C     R F V E +             +G +L +H++     D AR           
Sbjct: 62  YCCFQTPDRLFFVMEFV-------------NGGDLMFHIQKSRRFDEARARFYAAEITSA 108

Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGL-------SVTAGTQSRNVKISGT 317
           L +LH+     +++RDLK  N+LLD   + KL+DFG+         T  T        GT
Sbjct: 109 LMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST------FCGT 159

Query: 318 LGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVE 355
             Y+APE L E       D +A GV+L E+L G  P E
Sbjct: 160 PDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFE 197

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 64.6 bits (157), Expect = 1e-11
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 11/204 (5%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNN--EVNWLTKIRHQ 209
           N F+   V+GEG  G V K R  E K + A+K+  D+  + E +     E+  L  ++ +
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60

Query: 210 NIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLH 269
           NI+ L          +LV+E ++   LE     P            K+   + + ++ +H
Sbjct: 61  NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGV------PPEKVRSYIYQLIKAIH 114

Query: 270 EHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLL 327
               + +VHRD+K  N+L+  +   KL DFG +  ++ G+ +   +   T  Y +PE LL
Sbjct: 115 WCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLL 174

Query: 328 EGKLTDKSDVYAFGVVLLELLMGR 351
                   D+++ G +L EL  G+
Sbjct: 175 GAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 66.7 bits (162), Expect = 1e-11
 Identities = 67/243 (27%), Positives = 105/243 (43%), Gaps = 31/243 (12%)

Query: 144 EYELLEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNN---E 199
           +Y+  E+  N ++    IG G  G V+  +    +     K I   G   ERE +    E
Sbjct: 4   KYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIE 62

Query: 200 VNWLTKIRHQNIISLLGYCIHAETR--FLVYEMMQNGSLEKQLHGPTHG-SNLTWHLRMK 256
           VN + +++H+NI+  +   ++   +  +++ E    G L + +         +  H  + 
Sbjct: 63  VNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVD 122

Query: 257 IAVDVARGLEYLHEHCNHP----VVHRDLKSSNILLDSSFN-----------------AK 295
           I   +   L Y H   + P    V+HRDLK  NI L +                    AK
Sbjct: 123 ITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAK 182

Query: 296 LSDFGLSVTAGTQSRNVKISGTLGYVAPEYLL-EGK-LTDKSDVYAFGVVLLELLMGRRP 353
           + DFGLS   G +S      GT  Y +PE LL E K   DKSD++A G ++ EL  G+ P
Sbjct: 183 IGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242

Query: 354 VEK 356
             K
Sbjct: 243 FHK 245

Length = 1021

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 66/207 (31%), Positives = 95/207 (45%), Gaps = 32/207 (15%)

Query: 160 VIGEGGRGHVYKAR--FNEKLLAAVKRI-----DDAGHDAEREFNNEVNWLTKIRHQNII 212
            +GEG    VYK R     +L+A +K I     + A   A RE     + L  ++H NI+
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVA-LKEIRLEHEEGAPFTAIRE----ASLLKDLKHANIV 66

Query: 213 SLLGYCIHAETRF-LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
             L   IH +    LV+E +    L++ +     G  L+ H        + RGL Y H+ 
Sbjct: 67  -TLHDIIHTKKTLTLVFEYLDT-DLKQYMD--DCGGGLSMHNVRLFLFQLLRGLAYCHQR 122

Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGL----SVTAGTQSRNVKISGTLGYVAPEYLL 327
               V+HRDLK  N+L+      KL+DFGL    SV + T S  V    TL Y  P+ LL
Sbjct: 123 ---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV---TLWYRPPDVLL 176

Query: 328 EGKLTDKS---DVYAFGVVLLELLMGR 351
               T+ S   D++  G +  E+  GR
Sbjct: 177 GS--TEYSTSLDMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 64.7 bits (157), Expect = 2e-11
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 30/211 (14%)

Query: 155 FQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNN---------EVNWLTK 205
           +Q+   IG G +G V  A         V  I+ A     R F N         E+  L  
Sbjct: 23  YQQLKPIGSGAQGIVCAA------FDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKC 76

Query: 206 IRHQNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAV 259
           + H+NIISLL      ++       +LV E+M + +L + +H       +++ L   +  
Sbjct: 77  VNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIHMELDHERMSYLLYQMLC- 134

Query: 260 DVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLG 319
               G+++LH   +  ++HRDLK SNI++ S    K+ DFGL+ TA T         T  
Sbjct: 135 ----GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRY 187

Query: 320 YVAPEYLLEGKLTDKSDVYAFGVVLLELLMG 350
           Y APE +L     +  D+++ G ++ EL+ G
Sbjct: 188 YRAPEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 64.2 bits (156), Expect = 2e-11
 Identities = 58/215 (26%), Positives = 93/215 (43%), Gaps = 23/215 (10%)

Query: 154 NFQESNVIGEGGRGHVYKAR----------FNEKLLAAVKRIDDAGHDAEREFNNEVNWL 203
           NF+   V+G G  G V+  R          +  K+L     +  A          +V  L
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQV--L 58

Query: 204 TKIRHQNIISLLGYCIHAETRF-LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
             IR    +  L Y    +T+  L+ + +  G L   L   +             + ++ 
Sbjct: 59  EHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHL---SQRERFKEQEVQIYSGEIV 115

Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGY 320
             LE+LH+     +++RD+K  NILLDS+ +  L+DFGLS         R     GT+ Y
Sbjct: 116 LALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEY 172

Query: 321 VAPEYLLEGKLT-DKS-DVYAFGVVLLELLMGRRP 353
           +AP+ +  G    DK+ D ++ GV++ ELL G  P
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 63.6 bits (155), Expect = 3e-11
 Identities = 42/119 (35%), Positives = 60/119 (50%), Gaps = 27/119 (22%)

Query: 259 VDVAR--------GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS-------- 302
           VD+AR         LEYLH   N+ +VHRDLK  N+L+ S  + KL+DFGLS        
Sbjct: 100 VDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156

Query: 303 --VTAGTQSRNVK------ISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
             +  G   ++ +      + GT  Y+APE +L        D +A G++L E L+G  P
Sbjct: 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 63.5 bits (155), Expect = 4e-11
 Identities = 55/232 (23%), Positives = 92/232 (39%), Gaps = 61/232 (26%)

Query: 155 FQESNVIGEGGRGHVYKAR---FNEKLLAAVKRIDDAGHD-------AEREFNNEVNWLT 204
           ++    IG G  G VYKA+     +    A+K+              A RE    +  L 
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACRE----IALLR 57

Query: 205 KIRHQNIISLLGYCIHAETR--FLVYEMMQNGSLE----------KQLHGPTHGSNLTWH 252
           +++H+N++SL+   +    +  +L+++  ++   +            +      S L W 
Sbjct: 58  ELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKS-LLWQ 116

Query: 253 LRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA----KLSDFGLSVTAGTQ 308
           +          G+ YLH   N  V+HRDLK +NIL+          K+ D GL       
Sbjct: 117 I--------LNGVHYLHS--NW-VLHRDLKPANILVMGEGPERGVVKIGDLGL------- 158

Query: 309 SRNV-----------KISGTLGYVAPEYLLEGK-LTDKSDVYAFGVVLLELL 348
           +R              +  T+ Y APE LL  +  T   D++A G +  ELL
Sbjct: 159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 62.7 bits (152), Expect = 5e-11
 Identities = 69/206 (33%), Positives = 101/206 (49%), Gaps = 32/206 (15%)

Query: 161 IGEGGRGHVYKARFNEKL---LAAVKRI-----DDAGHDAEREFNNEVNWLTKIRHQNII 212
           +GEG    V+K R   KL   L A+K I     + A   A RE    V+ L  ++H NI+
Sbjct: 13  LGEGTYATVFKGR--SKLTENLVALKEIRLEHEEGAPCTAIRE----VSLLKNLKHANIV 66

Query: 213 SLLGYCIHAETRF-LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAV-DVARGLEYLHE 270
           +L    IH E    LV+E + +  L++ L    +  NL     +KI +  + RGL Y H+
Sbjct: 67  TLHD-IIHTERCLTLVFEYLDS-DLKQYL---DNCGNLMSMHNVKIFMFQLLRGLSYCHK 121

Query: 271 HCNHPVVHRDLKSSNILLDSSFNAKLSDFGL----SVTAGTQSRNVKISGTLGYVAPEYL 326
                ++HRDLK  N+L++     KL+DFGL    SV   T S  V    TL Y  P+ L
Sbjct: 122 R---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV---TLWYRPPDVL 175

Query: 327 L-EGKLTDKSDVYAFGVVLLELLMGR 351
           L   + +   D++  G +L E+  GR
Sbjct: 176 LGSTEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 63.5 bits (154), Expect = 6e-11
 Identities = 70/268 (26%), Positives = 118/268 (44%), Gaps = 25/268 (9%)

Query: 96  IYRWKRLKNTNGNSKQTIDGGKGLSLSPILERFNSLRLAGKKDTVSVIEYELLEAATNNF 155
           IY  K  K   G S +     K L      ER ++      +D   +I+ ++  +   ++
Sbjct: 12  IYEEKNHKANKGGSGKFEMNDKKLDE---EERSHNNNAGEDEDEEKMIDNDINRSPNKSY 68

Query: 156 QESNVIGEGGRGHVYKA---RFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNII 212
           +  N+IG G  G VY+A     +EK+  A+K++     D + + N E+  +  + H NII
Sbjct: 69  KLGNIIGNGSFGVVYEAICIDTSEKV--AIKKVL---QDPQYK-NRELLIMKNLNHINII 122

Query: 213 SLLGY----CIHAETR--FL--VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
            L  Y    C     +  FL  V E +     +   H   +   L   L    +  + R 
Sbjct: 123 FLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRA 182

Query: 265 LEYLHEHCNHPVVHRDLKSSNILLD-SSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           L Y+H      + HRDLK  N+L+D ++   KL DFG +       R+V    +  Y AP
Sbjct: 183 LAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAP 239

Query: 324 EYLL-EGKLTDKSDVYAFGVVLLELLMG 350
           E +L     T   D+++ G ++ E+++G
Sbjct: 240 ELMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 62.9 bits (153), Expect = 7e-11
 Identities = 59/227 (25%), Positives = 99/227 (43%), Gaps = 38/227 (16%)

Query: 156 QESNVIGEGGRGHVYKAR-FNEKLLAAVKR--IDDAGHDAEREFNN------------EV 200
           Q+   +GEG  G V KA       + A+K+  I +  +D  ++               E+
Sbjct: 12  QKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLREL 71

Query: 201 NWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVD 260
             + +I+H+NI+ L+   +  +   LV ++M    L+K +        LT      I + 
Sbjct: 72  KIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIR---LTESQVKCILLQ 127

Query: 261 VARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAG------------TQ 308
           +  GL  LH       +HRDL  +NI ++S    K++DFGL+   G            T 
Sbjct: 128 ILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184

Query: 309 SRNVKISG---TLGYVAPEYLL-EGKLTDKSDVYAFGVVLLELLMGR 351
            R  +++    TL Y APE L+   K     D+++ G +  ELL G+
Sbjct: 185 QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 62.7 bits (152), Expect = 9e-11
 Identities = 50/172 (29%), Positives = 78/172 (45%), Gaps = 31/172 (18%)

Query: 261 VARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--- 317
           VARG+E+L    +   +HRDL + NILL  +   K+ DFGL+         V+       
Sbjct: 183 VARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239

Query: 318 LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQ--CQSMVTWAMPQLT 374
           L ++APE + +   T +SDV++FGV+L E+  +G  P   +   +  CQ        +L 
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQ--------RLK 291

Query: 375 D--RSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
           D  R + P    P I   M            + C Q +P  RP  + ++  L
Sbjct: 292 DGTRMRAPENATPEIYRIM------------LACWQGDPKERPTFSALVEIL 331

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 62.5 bits (152), Expect = 1e-10
 Identities = 61/212 (28%), Positives = 100/212 (47%), Gaps = 36/212 (16%)

Query: 160 VIGEGGRGHVYKARFNE-KLLAAVKRIDDA-GHDAEREFNNEVNWLTKIRH-----QNII 212
           VIG G    V      + + + A+K I     +D E     +++W+   +H      N  
Sbjct: 2   VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDE-----DIDWVQTEKHVFETASNHP 56

Query: 213 SLLGY--CIHAETR-FLVYEMMQNGSL----EKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
            L+G   C   E+R F V E +  G L    ++Q   P        H R   + +++  L
Sbjct: 57  FLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEE------HARF-YSAEISLAL 109

Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGL---SVTAGTQSRNVKISGTLGYVA 322
            +LHE     +++RDLK  N+LLD+  + KL+D+G+    +  G  +      GT  Y+A
Sbjct: 110 NFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST--FCGTPNYIA 164

Query: 323 PEYLLEGKLTDKS-DVYAFGVVLLELLMGRRP 353
           PE +L G+    S D +A GV++ E++ GR P
Sbjct: 165 PE-ILRGEDYGFSVDWWALGVLMFEMMAGRSP 195

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 61.3 bits (149), Expect = 1e-10
 Identities = 48/207 (23%), Positives = 95/207 (45%), Gaps = 30/207 (14%)

Query: 161 IGEGGRGHVYKARFNEK-----------LLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQ 209
           +G+G   ++YK     +           +   +K +     D+   F    + ++++ H+
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSL-AFFETASLMSQLSHK 61

Query: 210 NIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLH 269
           +++ L G C+  E   +V E ++ G L+  LH   +  +L W  ++ +A  +A  L YL 
Sbjct: 62  HLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLE 118

Query: 270 EHCNHPVVHRDLKSSNILL-------DSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
           +     +VH ++   NIL+             KLSD G+ +T  ++   V+      ++A
Sbjct: 119 D---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERI---PWIA 172

Query: 323 PEYL--LEGKLTDKSDVYAFGVVLLEL 347
           PE +   +  LT  +D ++FG  LLE+
Sbjct: 173 PECIRNGQASLTIAADKWSFGTTLLEI 199

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 62.3 bits (152), Expect = 1e-10
 Identities = 55/222 (24%), Positives = 101/222 (45%), Gaps = 50/222 (22%)

Query: 155 FQESNVIGEGGRGHVYKA---RFNEKLLAAVKRID---DAGHDAEREFNNEVNWLTKIRH 208
           +Q  + +G G  G V  A   +   K+  A+K++     +   A+R +  E+  L  + H
Sbjct: 17  YQNLSPVGSGAYGQVCSAFDTKTGRKV--AIKKLSRPFQSAIHAKRTYR-ELRLLKHMDH 73

Query: 209 QNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMK------ 256
           +N+I LL     A +       +LV  +M              G++L   ++ +      
Sbjct: 74  ENVIGLLDVFTPASSLEDFQDVYLVTHLM--------------GADLNNIVKCQKLSDDH 119

Query: 257 ---IAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK 313
              +   + RGL+Y+H   +  ++HRDLK SNI ++     K+ DFGL+     +  + +
Sbjct: 120 IQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLA-----RHTDDE 171

Query: 314 ISG---TLGYVAPEYLLE-GKLTDKSDVYAFGVVLLELLMGR 351
           ++G   T  Y APE +L         D+++ G ++ ELL G+
Sbjct: 172 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 61.9 bits (150), Expect = 1e-10
 Identities = 34/101 (33%), Positives = 57/101 (56%), Gaps = 8/101 (7%)

Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGL---SVTAGTQSRNVKI 314
           A +++ GL +LH      +++RDLK  N++LDS  + K++DFG+    +  G  +R    
Sbjct: 107 AAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT--F 161

Query: 315 SGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVE 355
            GT  Y+APE +         D +A+GV+L E+L G+ P +
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 61.8 bits (150), Expect = 1e-10
 Identities = 42/120 (35%), Positives = 61/120 (50%), Gaps = 14/120 (11%)

Query: 245 HGSNLTWHLRMK--IAVDVAR--------GLEYLHEHCNHPVVHRDLKSSNILLDSSFNA 294
           +G  L +HL  +   + D AR         L YLH  C+  VV+RDLK  N++LD   + 
Sbjct: 78  NGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHS-CD--VVYRDLKLENLMLDKDGHI 134

Query: 295 KLSDFGLSVTAGTQSRNVK-ISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
           K++DFGL     +    +K   GT  Y+APE L +       D +  GVV+ E++ GR P
Sbjct: 135 KITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 61.9 bits (150), Expect = 1e-10
 Identities = 36/101 (35%), Positives = 59/101 (58%), Gaps = 8/101 (7%)

Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGL---SVTAGTQSRNVKI 314
           A ++A GL +LH   +  +++RDLK  N++LDS  + K++DFG+   ++  G  ++    
Sbjct: 107 AAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT--F 161

Query: 315 SGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVE 355
            GT  Y+APE +         D +AFGV+L E+L G+ P E
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 61.9 bits (150), Expect = 1e-10
 Identities = 34/95 (35%), Positives = 52/95 (54%), Gaps = 4/95 (4%)

Query: 260 DVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK-ISGTL 318
           ++   LEYLH   +  VV+RD+K  N++LD   + K++DFGL     +    +K   GT 
Sbjct: 103 EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP 159

Query: 319 GYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
            Y+APE L +       D +  GVV+ E++ GR P
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 61.6 bits (150), Expect = 2e-10
 Identities = 54/198 (27%), Positives = 95/198 (47%), Gaps = 36/198 (18%)

Query: 153 NNFQESNVIGEGGRGHVYKARF-NEKLLAAVKRIDDAGHDAERE-FN----NEVNWLTKI 206
           + +++   IG+G  G V+KAR    K + A+K++     + E+E F      E+  L  +
Sbjct: 12  SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVL---MENEKEGFPITALREIKILQLL 68

Query: 207 RHQNIISLLGYCIHAE---------TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLR--M 255
           +H+N+++L+  C   +         + +LV+E       E  L G     N+ + L    
Sbjct: 69  KHENVVNLIEIC-RTKATPYNRYKGSFYLVFEF-----CEHDLAGLLSNKNVKFTLSEIK 122

Query: 256 KIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS---VTAGTQSRNV 312
           K+   +  GL Y+H    + ++HRD+K++NIL+      KL+DFGL+     +     N 
Sbjct: 123 KVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPN- 178

Query: 313 KISG---TLGYVAPEYLL 327
           + +    TL Y  PE LL
Sbjct: 179 RYTNRVVTLWYRPPELLL 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 61.1 bits (148), Expect = 2e-10
 Identities = 67/207 (32%), Positives = 96/207 (46%), Gaps = 34/207 (16%)

Query: 161 IGEGGRGHVYK--ARFNEKLLA----AVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISL 214
           +GEG    VYK  +R N +L+A    ++K  +     A RE     + L  ++H NI+ L
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIRE----ASLLKGLKHANIV-L 67

Query: 215 LGYCIHA-ETRFLVYEMMQN--GSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
           L   IH  ET   V+E M         Q  G  H  N+           + RGL Y+H  
Sbjct: 68  LHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNV-----RLFMFQLLRGLAYIH-- 120

Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGL----SVTAGTQSRNVKISGTLGYVAPEYLL 327
               ++HRDLK  N+L+      KL+DFGL    S+ + T S  V    TL Y  P+ LL
Sbjct: 121 -GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV---TLWYRPPDVLL 176

Query: 328 EGKLTDKS---DVYAFGVVLLELLMGR 351
               TD S   D++  G + +E+L G+
Sbjct: 177 GA--TDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 60/200 (30%), Positives = 92/200 (46%), Gaps = 20/200 (10%)

Query: 161 IGEGGRGHVYKAR--FNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYC 218
           +GEG    V+K R    E L+A  +   +    A      EV+ L  ++H NI++L    
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73

Query: 219 IHAETRFLVYEMMQNGSLEKQL--HGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPV 276
              ++  LV+E      L+K L  +    G+ ++ H        + RGL Y H      V
Sbjct: 74  HTDKSLTLVFEY-----LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---KV 125

Query: 277 VHRDLKSSNILLDSSFNAKLSDFGL----SVTAGTQSRNVKISGTLGYVAPEYLL-EGKL 331
           +HRDLK  N+L++     KL+DFGL    SV   T S  V    TL Y  P+ LL   + 
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV---TLWYRPPDVLLGSSEY 182

Query: 332 TDKSDVYAFGVVLLELLMGR 351
           + + D++  G +  E+  GR
Sbjct: 183 STQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 60.7 bits (147), Expect = 2e-10
 Identities = 52/208 (25%), Positives = 95/208 (45%), Gaps = 29/208 (13%)

Query: 161 IGEGGRGHVYKARFN------------EKLLAAVKRIDDAGH-DAEREFNNEVNWLTKIR 207
           +G G R  +Y    N            EK +  + ++ D  H D    F    + + ++ 
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 208 HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEY 267
           H++I+ L G C+      +V E ++ G L+  +H  +      W  + K+A  +A  L Y
Sbjct: 63  HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASALSY 120

Query: 268 LHEHCNHPVVHRDLKSSNILL-----DSSFNA--KLSDFGLSVTAGTQSRNVKISGTLGY 320
           L +     +VH ++ + NILL     D       KLSD G+ +T  ++   V+    + +
Sbjct: 121 LED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVE---RIPW 174

Query: 321 VAPEYLLEGK-LTDKSDVYAFGVVLLEL 347
           +APE + + K L+  +D ++FG  L E+
Sbjct: 175 IAPECVEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 60.9 bits (147), Expect = 3e-10
 Identities = 67/224 (29%), Positives = 107/224 (47%), Gaps = 28/224 (12%)

Query: 153 NNFQESNVIGEGGRGHVYK--ARFNEKLLA-AVKRIDDAGHDAEREFN--NEVNWLTKIR 207
           +++++   +GEG    VYK  ++ N KL+A  V R+ +   +    F    E + L  ++
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQE---EEGTPFTAIREASLLKGLK 61

Query: 208 HQNIISLLGYCIHA-ETRFLVYEMMQNGSLE--KQLHGPTHGSNLTWHLRMKIAVDVARG 264
           H NI+ LL   IH  ET  LV+E +     +   +  G  H  N+   L       + RG
Sbjct: 62  HANIV-LLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFL-----FQLLRG 115

Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGL----SVTAGTQSRNVKISGTLGY 320
           L Y+H+     ++HRDLK  N+L+  +   KL+DFGL    SV + T S  V    TL Y
Sbjct: 116 LSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV---TLWY 169

Query: 321 VAPEYLL-EGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQ 363
             P+ LL   + +   D++  G + +E++ G      M   Q Q
Sbjct: 170 RPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQ 213

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 61.3 bits (148), Expect = 3e-10
 Identities = 56/206 (27%), Positives = 101/206 (49%), Gaps = 24/206 (11%)

Query: 155 FQESNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRH 208
           +Q    IG G +G V   Y A  +  +  A+K++     +   A+R +  E+  +  + H
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 75

Query: 209 QNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
           +NIISLL      ++       +LV E+M + +L + +        +++ L   +     
Sbjct: 76  KNIISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQMLC---- 130

Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
            G+++LH   +  ++HRDLK SNI++ S    K+ DFGL+ TAGT         T  Y A
Sbjct: 131 -GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 186

Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELL 348
           PE +L     +  D+++ G ++ E++
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 61.0 bits (148), Expect = 3e-10
 Identities = 63/214 (29%), Positives = 101/214 (47%), Gaps = 37/214 (17%)

Query: 160 VIGEGGRGHVYKAR----------FNEKLL---AAVKRIDDAGH-DAEREFNNEVNWLTK 205
           V+G+GG G V++ R          F  K+L     V+   D  H  AER      N L  
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAER------NILEA 56

Query: 206 IRHQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLH--GPTHGSNLTWHLRMKIAVDVA 262
           ++H  I+ L+ Y      + +L+ E +  G L   L   G        ++L      +++
Sbjct: 57  VKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS-----EIS 110

Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGL---SVTAGTQSRNVKISGTLG 319
             LE+LH+     +++RDLK  NILLD+  + KL+DFGL   S+  GT +      GT+ 
Sbjct: 111 LALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT--FCGTIE 165

Query: 320 YVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
           Y+APE L+        D ++ G ++ ++L G  P
Sbjct: 166 YMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 60.4 bits (146), Expect = 4e-10
 Identities = 70/207 (33%), Positives = 99/207 (47%), Gaps = 34/207 (16%)

Query: 161 IGEGGRGHVYKARFNEKL---LAAVKRI-----DDAGHDAEREFNNEVNWLTKIRHQNII 212
           +GEG    VYK R   KL   L A+K I     + A   A RE    V+ L  ++H NI+
Sbjct: 14  LGEGTYATVYKGR--SKLTDNLVALKEIRLEHEEGAPCTAIRE----VSLLKDLKHANIV 67

Query: 213 SLLGYCIHAE-TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
           +L    IH E +  LV+E + +  L++ L     G+++  H        + RGL Y H  
Sbjct: 68  TLHD-IIHTEKSLTLVFEYL-DKDLKQYLD--DCGNSINMHNVKLFLFQLLRGLNYCHRR 123

Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGL----SVTAGTQSRNVKISGTLGYVAPEYLL 327
               V+HRDLK  N+L++     KL+DFGL    S+   T S  V    TL Y  P+ LL
Sbjct: 124 ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV---TLWYRPPDILL 177

Query: 328 EGKLTDKS---DVYAFGVVLLELLMGR 351
               TD S   D++  G +  E+  GR
Sbjct: 178 GS--TDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 60.5 bits (146), Expect = 4e-10
 Identities = 34/95 (35%), Positives = 53/95 (55%), Gaps = 4/95 (4%)

Query: 260 DVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK-ISGTL 318
           ++   L+YLH   +  +V+RDLK  N++LD   + K++DFGL     T +  +K   GT 
Sbjct: 103 EIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTP 159

Query: 319 GYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
            Y+APE L +       D +  GVV+ E++ GR P
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 60.6 bits (147), Expect = 4e-10
 Identities = 64/213 (30%), Positives = 90/213 (42%), Gaps = 38/213 (17%)

Query: 160 VIGEGGRGHVYKARFNE-------KLL--AAVKRIDDAGH-DAEREFNNEVNWLTK-IRH 208
           VIG+G  G V  A+          K+L   A+ +  +  H  AER      N L K ++H
Sbjct: 2   VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAER------NVLLKNVKH 55

Query: 209 QNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKI-AVDVARGLEY 267
             ++ L      A+  + V + +  G L   L             R +  A ++A  L Y
Sbjct: 56  PFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFP----EPRARFYAAEIASALGY 111

Query: 268 LHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGL-------SVTAGTQSRNVKISGTLGY 320
           LH      +++RDLK  NILLDS  +  L+DFGL       S T  T        GT  Y
Sbjct: 112 LHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST------FCGTPEY 162

Query: 321 VAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
           +APE L +       D +  G VL E+L G  P
Sbjct: 163 LAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 59.8 bits (145), Expect = 4e-10
 Identities = 54/193 (27%), Positives = 90/193 (46%), Gaps = 10/193 (5%)

Query: 161 IGEG--GRGHVYKARFNEKLLAAVKRIDDAG-HDAER-EFNNEVNWLTKIRHQNIISLLG 216
           IGEG  G+  + K++ + K    +K I+ +     ER E   EV  L+ ++H NI+    
Sbjct: 8   IGEGSFGKAILVKSKEDGKQYV-IKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66

Query: 217 YCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPV 276
                   ++V +  + G L K+++    G        +   V +   L+++H+     +
Sbjct: 67  SFEENGNLYIVMDYCEGGDLYKKINA-QRGVLFPEDQILDWFVQICLALKHVHDR---KI 122

Query: 277 VHRDLKSSNILLDSSFNAKLSDFGLS-VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKS 335
           +HRD+KS NI L      KL DFG++ V   T        GT  Y++PE        +KS
Sbjct: 123 LHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKS 182

Query: 336 DVYAFGVVLLELL 348
           D++A G VL E+ 
Sbjct: 183 DIWALGCVLYEMC 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 60.7 bits (147), Expect = 5e-10
 Identities = 27/88 (30%), Positives = 46/88 (52%), Gaps = 3/88 (3%)

Query: 261 VARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGY 320
           +  GL YLH      ++HRD+K+ NI ++      + D G +         + ++GT+  
Sbjct: 166 ILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVET 222

Query: 321 VAPEYLLEGKLTDKSDVYAFGVVLLELL 348
            APE L   K   K+D+++ G+VL E+L
Sbjct: 223 NAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 60.4 bits (146), Expect = 5e-10
 Identities = 48/170 (28%), Positives = 80/170 (47%), Gaps = 27/170 (15%)

Query: 261 VARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--- 317
           VA+G+E+L    +   +HRDL + NILL  +   K+ DFGL+         V+       
Sbjct: 188 VAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244

Query: 318 LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVE--KMSPTQCQSMVTWAMPQLT 374
           L ++APE + +   T +SDV++FGV+L E+  +G  P    K+    C+ +      +  
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL------KEG 298

Query: 375 DRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
            R + P+   P +  TM            + C   EPS RP  ++++  L
Sbjct: 299 TRMRAPDYTTPEMYQTM------------LDCWHGEPSQRPTFSELVEHL 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 59.9 bits (145), Expect = 6e-10
 Identities = 42/120 (35%), Positives = 57/120 (47%), Gaps = 14/120 (11%)

Query: 245 HGSNLTWHLRMKIAVDVAR----------GLEYLHEHCNHPVVHRDLKSSNILLDSSFNA 294
           +G  L  HL+ +   D++R           LE LH+     V++RDLK  NILLD   + 
Sbjct: 76  NGGELFHHLQREGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHI 132

Query: 295 KLSDFGL-SVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
            L DFGL  +      +     GT  Y+APE LL    T   D +  GV+L E+L G  P
Sbjct: 133 ALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 60.0 bits (145), Expect = 6e-10
 Identities = 35/95 (36%), Positives = 51/95 (53%), Gaps = 3/95 (3%)

Query: 260 DVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK-ISGTL 318
           ++   L+YLH   N  VV+RDLK  N++LD   + K++DFGL          +K   GT 
Sbjct: 103 EIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTP 160

Query: 319 GYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
            Y+APE L +       D +  GVV+ E++ GR P
Sbjct: 161 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 59.5 bits (144), Expect = 6e-10
 Identities = 46/160 (28%), Positives = 72/160 (45%), Gaps = 26/160 (16%)

Query: 206 IRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLR-------MKIA 258
           ++H NI+  LG C+ A    LV+E  + G L+  L      S   WH R        ++A
Sbjct: 52  LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYL------SQEQWHRRNSQLLLLQRMA 105

Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ---SRNVKIS 315
            ++A G+ ++H+   H  +H DL   N  L S    K+ D+G+  +   +          
Sbjct: 106 CEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKC 162

Query: 316 GTLGYVAPEYL--LEGKL-----TDKSDVYAFGVVLLELL 348
             L ++APE +    G L     T  S+V+A GV L EL 
Sbjct: 163 VPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 60.0 bits (146), Expect = 8e-10
 Identities = 58/257 (22%), Positives = 94/257 (36%), Gaps = 84/257 (32%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRI--------DDAGHD-AEREF----NN 198
           ++F+   VIG G  G V+  R  +   + A+K +        +   H  AER+     ++
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60

Query: 199 EVNWLTKIRHQNIISLLGYCIHAETRFL--VYEMMQNGSLEKQLHGPTHGSNLTWHLRMK 256
              W+ K+          Y    +   L  V E M  G L            +   +R  
Sbjct: 61  P--WIVKL----------YYSFQDEEHLYLVMEYMPGGDL------------MNLLIRKD 96

Query: 257 I-AVDVAR--------GLEYLHE-HCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS---- 302
           +   + AR         L+ +H+       +HRD+K  NIL+D+  + KL+DFGL     
Sbjct: 97  VFPEETARFYIAELVLALDSVHKLGF----IHRDIKPDNILIDADGHIKLADFGLCKKMN 152

Query: 303 -------------VTAGTQSRNVKIS-------------GTLGYVAPEYLLEGKLTDKSD 336
                              +  V+               GT  Y+APE L       + D
Sbjct: 153 KAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECD 212

Query: 337 VYAFGVVLLELLMGRRP 353
            ++ GV+L E+L G  P
Sbjct: 213 WWSLGVILYEMLYGFPP 229

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 59.3 bits (144), Expect = 1e-09
 Identities = 69/232 (29%), Positives = 103/232 (44%), Gaps = 50/232 (21%)

Query: 154 NFQESNVIGEGGRGHVYKARFNEKLLA---AVKRIDDAGHDAEREFNNEVNWLTK--IR- 207
            ++    +G+G  G V  AR  E       A+K+I +        F+ ++  L K  +R 
Sbjct: 1   RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNV-------FSKKI--LAKRALRE 51

Query: 208 ---------HQNIISLLGYCIHAETRF----LVYEMMQNGSLEKQLHGPTH-GSNLT-WH 252
                    H+NI  L    I     F    L  E+M     E  LH     G  LT  H
Sbjct: 52  LKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELM-----EADLHQIIRSGQPLTDAH 106

Query: 253 LRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV 312
            +  I   +  GL+Y+H   +  V+HRDLK  N+L+++    K+ DFGL+   G      
Sbjct: 107 FQSFI-YQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLA--RGFSENPG 160

Query: 313 KISG-------TLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRPVEK 356
           + +G       T  Y APE +L  +   K+ DV++ G +L ELL GR+PV K
Sbjct: 161 ENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPVFK 211

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 60.0 bits (145), Expect = 1e-09
 Identities = 52/177 (29%), Positives = 82/177 (46%), Gaps = 19/177 (10%)

Query: 198 NEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMK- 256
           +E++ L    H  I+         +   L+ E    G L KQ+        L  HL  + 
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIK-----QRLKEHLPFQE 168

Query: 257 -----IAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT-AGTQSR 310
                +   +   L+ +H      ++HRDLKS+NI L  +   KL DFG S   + + S 
Sbjct: 169 YEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225

Query: 311 NVKIS--GTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSM 365
           +V  S  GT  Y+APE     + + K+D+++ GV+L ELL   RP +   P+Q + M
Sbjct: 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFK--GPSQREIM 280

Length = 478

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 58.3 bits (141), Expect = 1e-09
 Identities = 57/273 (20%), Positives = 119/273 (43%), Gaps = 45/273 (16%)

Query: 161 IGEGGRGHVYKARFNE--------KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNII 212
           +G+G    ++K    E        K    +K +D +  +    F    + ++++ H++++
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 213 SLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
              G C+  +   +V E ++ GSL+  L    +  N++W L  ++A  +A  L +L +  
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKL--EVAKQLAWALHFLED-- 118

Query: 273 NHPVVHRDLKSSNILL-----DSSFNA---KLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
              + H ++ + N+LL       + N    KLSD G+S+T     + + +   + +V PE
Sbjct: 119 -KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT--VLPKEI-LLERIPWVPPE 174

Query: 325 YLLEGK-LTDKSDVYAFGVVLLELLMG-RRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNI 382
            +   + L+  +D ++FG  L E+  G  +P+  +   +        +    DR +LP  
Sbjct: 175 CIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK-------KLQFYEDRHQLP-- 225

Query: 383 VDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRP 415
                          ++A +   C+  EP +RP
Sbjct: 226 ----------APKWTELANLINQCMDYEPDFRP 248

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 58.6 bits (142), Expect = 2e-09
 Identities = 63/210 (30%), Positives = 93/210 (44%), Gaps = 29/210 (13%)

Query: 160 VIGEGGRGHVYKA---RFNEKLLAAVKRIDDA-GH--DAEREFNNEVNWLTKIRHQNIIS 213
           VIG+G  G V  A      EK+  A+K+I+D   H  DA R    E+  L  +RH +I+ 
Sbjct: 7   VIGKGSYGVVCSAIDTHTGEKV--AIKKINDVFEHVSDATRILR-EIKLLRLLRHPDIVE 63

Query: 214 LLGYCIHAETR-----FLVYEMMQNGSLEKQLHGPTHGSN-LTWHLRMKIAVDVARGLEY 267
           +    +    R     ++V+E+M     E  LH     ++ LT          + R L+Y
Sbjct: 64  IKHIMLPPSRREFKDIYVVFELM-----ESDLHQVIKANDDLTPEHHQFFLYQLLRALKY 118

Query: 268 LHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA----GTQSRNVKISGTLGYVAP 323
           +H      V HRDLK  NIL ++    K+ DFGL+  A     T         T  Y AP
Sbjct: 119 IH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 175

Query: 324 EYL--LEGKLTDKSDVYAFGVVLLELLMGR 351
           E       K T   D+++ G +  E+L G+
Sbjct: 176 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 57/199 (28%), Positives = 102/199 (51%), Gaps = 19/199 (9%)

Query: 180 AAVKRIDDAGHD---AEREFNNEVNWLTKIRHQNIISLL-----GYCIHAETRFLVYEMM 231
            A+K++ +   +    +R F  E+  L   +H N++S L      +    E  ++V E+M
Sbjct: 28  VALKKMPNVFQNLVSCKRVFR-ELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELM 86

Query: 232 QNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS 291
           Q+  L K +  P   S  + H+++     + RGL+YLH   +  ++HRD+K  N+L++S+
Sbjct: 87  QS-DLHKIIVSPQPLS--SDHVKV-FLYQILRGLKYLH---SAGILHRDIKPGNLLVNSN 139

Query: 292 FNAKLSDFGLS-VTAGTQSRNVKIS-GTLGYVAPEYLLEGK-LTDKSDVYAFGVVLLELL 348
              K+ DFGL+ V    +S+++     T  Y APE L+  +  T   D+++ G +  ELL
Sbjct: 140 CVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELL 199

Query: 349 MGRRPVEKMSPTQCQSMVT 367
             R   +  SP Q   ++T
Sbjct: 200 GRRILFQAQSPIQQLDLIT 218

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 66/203 (32%), Positives = 90/203 (44%), Gaps = 18/203 (8%)

Query: 160 VIGEGGRGHVYKARF-NEKLLAAVKRIDDAG---HDAEREFNNEVNWLTK-IRHQNIISL 214
           VIG+G  G V  AR   E+   AVK +          E+   +E N L K ++H  ++ L
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61

Query: 215 LGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNH 274
                 A+  + V + +  G L   L        L    R   A ++A  L YLH   + 
Sbjct: 62  HFSFQTADKLYFVLDYINGGELFYHLQ--RERCFLEPRARF-YAAEIASALGYLH---SL 115

Query: 275 PVVHRDLKSSNILLDSSFNAKLSDFGLSVT----AGTQSRNVKISGTLGYVAPEYLLEGK 330
            +V+RDLK  NILLDS  +  L+DFGL        GT S      GT  Y+APE L +  
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTS---TFCGTPEYLAPEVLHKQP 172

Query: 331 LTDKSDVYAFGVVLLELLMGRRP 353
                D +  G VL E+L G  P
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 57.2 bits (138), Expect = 2e-09
 Identities = 45/171 (26%), Positives = 71/171 (41%), Gaps = 17/171 (9%)

Query: 210 NIISLLGYCIHAETRFLVYEMMQNGSL----EKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
           N++ L  Y +  ++ FLV +  + G L     K L+ P       W   M +A      L
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIP-EECVKRWAAEMVVA------L 98

Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEY 325
           + LH      +V RDL  +NILLD   + +L+ F              +     Y APE 
Sbjct: 99  DALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM--YCAPEV 153

Query: 326 LLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDR 376
               + T+  D ++ G +L ELL G+  VE   P+   +  T  +P+    
Sbjct: 154 GGISEETEACDWWSLGAILFELLTGKTLVE-CHPSGINTHTTLNIPEWVSE 203

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 58.0 bits (140), Expect = 2e-09
 Identities = 51/196 (26%), Positives = 93/196 (47%), Gaps = 23/196 (11%)

Query: 176 EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGS 235
            +L   +K +D +  D    F    + ++++ H ++  + G C+      +V E +++G 
Sbjct: 43  RELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGP 102

Query: 236 LEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILL------- 288
           L+  L        + W  ++ +A  +A  L YL    +  +VH ++ + NILL       
Sbjct: 103 LDVCLRKEKGRVPVAW--KITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAE 157

Query: 289 DSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEG-KLTDKSDVYAFGVVLLEL 347
            +S   KLSD G+S TA ++   V+    + ++APE +  G  L+  +D ++FG  LLE+
Sbjct: 158 GTSPFIKLSDPGVSFTALSREERVE---RIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214

Query: 348 -------LMGRRPVEK 356
                  L  R P EK
Sbjct: 215 CFDGEVPLKERTPSEK 230

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 38/97 (39%), Positives = 51/97 (52%), Gaps = 4/97 (4%)

Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS-RNVKISG 316
           A ++A  L YLH   +  +V+RDLK  NILLDS  +  L+DFGL      QS       G
Sbjct: 102 AAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCG 158

Query: 317 TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
           T  Y+APE + +    +  D +  G VL E+L G  P
Sbjct: 159 TPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 65/210 (30%), Positives = 93/210 (44%), Gaps = 32/210 (15%)

Query: 160 VIGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNN---EVNWLTK-IRHQNIISL 214
           VIG+G  G V  A R ++    AVK +       ++E N+   E N L K ++H  ++ L
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61

Query: 215 LGYCIHAETRFLVYEMMQNGSL------EKQLHGPTHGSNLTWHLRMKI-AVDVARGLEY 267
                 AE  + V + +  G L      E+    P          R +  A +VA  + Y
Sbjct: 62  HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEP----------RARFYAAEVASAIGY 111

Query: 268 LHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA----GTQSRNVKISGTLGYVAP 323
           LH   +  +++RDLK  NILLDS  +  L+DFGL         T S      GT  Y+AP
Sbjct: 112 LH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTS---TFCGTPEYLAP 165

Query: 324 EYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
           E L +       D +  G VL E+L G  P
Sbjct: 166 EVLRKEPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 58.7 bits (142), Expect = 3e-09
 Identities = 47/146 (32%), Positives = 69/146 (47%), Gaps = 10/146 (6%)

Query: 161 IGEGGRGHVYKAR--FNEKLLA--AVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLG 216
           I  G  G VY  R   N KL A   VK+ D    +   +   E + L   +   I+ L  
Sbjct: 12  ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71

Query: 217 YCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPV 276
               A   +LV E +  G ++  LH   +G      + +K   +VA  L+YLH H    +
Sbjct: 72  SLQSANNVYLVMEYLIGGDVKSLLH--IYGY-FDEEMAVKYISEVALALDYLHRH---GI 125

Query: 277 VHRDLKSSNILLDSSFNAKLSDFGLS 302
           +HRDLK  N+L+ +  + KL+DFGLS
Sbjct: 126 IHRDLKPDNMLISNEGHIKLTDFGLS 151

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 57.7 bits (139), Expect = 4e-09
 Identities = 62/241 (25%), Positives = 102/241 (42%), Gaps = 14/241 (5%)

Query: 125 LERFNSLRLAGKKDTVSVIEYELL-EAATNNFQESNVIGEGGRGHVYKARFNEKLL--AA 181
           ++   +L+L  KKD+ S  E +   +    +F     +G G  G V  A +  +     A
Sbjct: 1   IQFLKNLQLHKKKDSDSTKEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVA 60

Query: 182 VKRIDDAGHDAEREFN---NEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEK 238
           +KR + +    +++ +   +E   L  I H   ++L G        +LV E +  G    
Sbjct: 61  IKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFT 120

Query: 239 QLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSD 298
            L       N    +    A  +    EYL    +  +V+RDLK  N+LLD     K++D
Sbjct: 121 FLRRNKRFPN---DVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTD 174

Query: 299 FGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMS 358
           FG +    T  R   + GT  Y+APE LL       +D +  G+ + E+L+G  P     
Sbjct: 175 FGFAKVVDT--RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE 232

Query: 359 P 359
           P
Sbjct: 233 P 233

Length = 340

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 57.7 bits (139), Expect = 4e-09
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)

Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
           +Q  + +G G  G V  A F+ K  L  AVK++         A+R +  E+  L  ++H+
Sbjct: 19  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 76

Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           N+I LL     A +       +LV  +M        L+       LT      +   + R
Sbjct: 77  NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 131

Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           GL+Y+H   +  ++HRDLK SN+ ++     K+ DFGL+    T         T  Y AP
Sbjct: 132 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 186

Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           E +L     +++ D+++ G ++ ELL GR
Sbjct: 187 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 56.7 bits (137), Expect = 6e-09
 Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 32/219 (14%)

Query: 153 NNFQESNVIGEGGRGHVYKAR-FNEKLLAAVKR----IDDAG--HDAEREFNNEVNWLTK 205
           + +++   IGEG  G VYKAR  N   L A+K+    +D+ G    A RE    ++ L  
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALRE----ISLLQM 56

Query: 206 IRHQNIISLLGYCIHAETR------FLVYEMMQNGSLEK--QLHGPTHGSNLTWHLRMKI 257
           +     I  L    H E +      +LV+E + +  L+K    +G   G  L        
Sbjct: 57  LSESIYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSF 115

Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA-KLSDFGL----SVTAGTQSRNV 312
              + +G+ + H+H    V+HRDLK  N+L+D      K++D GL    S+   + +  +
Sbjct: 116 MYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEI 172

Query: 313 KISGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMG 350
               TL Y APE LL         D+++ G +  E+   
Sbjct: 173 V---TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 57.1 bits (138), Expect = 7e-09
 Identities = 64/224 (28%), Positives = 96/224 (42%), Gaps = 45/224 (20%)

Query: 154 NFQESNVIGEGGRGHVYKAR-------FNEKLLAA---VKRIDDAGHDAEREFNNEVN-- 201
           +F    VIG G  G V   R       +  KLL+    +KR D A    ER+     N  
Sbjct: 44  DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSE 103

Query: 202 WLTKIRHQNIISLLGYCIHAETRFL--VYEMMQNGSLEKQLHGPTHGSNL----TWHLRM 255
           W+ ++          +    + ++L  V E M  G L   +      SN      W  R 
Sbjct: 104 WIVQL----------HYAFQDDKYLYMVMEYMPGGDLVNLM------SNYDIPEKW-ARF 146

Query: 256 KIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFG--LSVTAGTQSRNVK 313
             A +V   L+ +H   +   +HRD+K  N+LLD S + KL+DFG  + + A    R   
Sbjct: 147 YTA-EVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDT 202

Query: 314 ISGTLGYVAPEYLL----EGKLTDKSDVYAFGVVLLELLMGRRP 353
             GT  Y++PE L     +G    + D ++ GV L E+L+G  P
Sbjct: 203 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 57.2 bits (138), Expect = 7e-09
 Identities = 59/218 (27%), Positives = 94/218 (43%), Gaps = 32/218 (14%)

Query: 164 GGRGHVY---KARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           G  G V+   K    ++    VK +   G    RE    ++ L  I H+ II+L    IH
Sbjct: 103 GSEGEVFVCTKHGDEQRKKVIVKAVT-GGKTPGRE----IDILKTISHRAIINL----IH 153

Query: 221 A-ETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL----EYLHEHCNHP 275
           A   +  V  +M     +   +    G      L ++ A+ + R L     YLH      
Sbjct: 154 AYRWKSTVCMVMPKYKCDLFTYVDRSGP-----LPLEQAITIQRRLLEALAYLHGR---G 205

Query: 276 VVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKI---SGTLGYVAPEYLLEGKLT 332
           ++HRD+K+ NI LD   NA L DFG +          +    SGTL   +PE L      
Sbjct: 206 IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYC 265

Query: 333 DKSDVYAFGVVLLELLMGRRPV----EKMSPTQCQSMV 366
            K+D+++ G+VL E+ +    +     K S +Q +S++
Sbjct: 266 AKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSII 303

Length = 392

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 57.5 bits (139), Expect = 1e-08
 Identities = 61/234 (26%), Positives = 94/234 (40%), Gaps = 54/234 (23%)

Query: 161 IGEGGRGHVYKA---RFNEKLLAAVKRIDDAGHDAER---EFNNEVNWLTKIRHQNIISL 214
           IG+GG G VY A     + ++  A+K+I +   +       F  E      + H  I+ +
Sbjct: 10  IGKGGMGEVYLAYDPVCSRRV--ALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67

Query: 215 LGYCIHAETRFLVYEMM----------------QNGSLEKQLHGPTHGSNLTWHLRMKIA 258
              C   +    VY  M                Q  SL K+L   T          + I 
Sbjct: 68  YSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF-----LSIF 119

Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS--------- 309
             +   +EY+H   +  V+HRDLK  NILL       + D+G ++    +          
Sbjct: 120 HKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVD 176

Query: 310 -RNV---------KISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
            RN+         KI GT  Y+APE LL    ++ +D+YA GV+L ++L    P
Sbjct: 177 ERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230

Length = 932

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 56.6 bits (136), Expect = 1e-08
 Identities = 55/208 (26%), Positives = 101/208 (48%), Gaps = 22/208 (10%)

Query: 155 FQESNVIGEGGRGHVYKARFNEKLL--AAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
           +Q    IG G +G V  A ++  L    A+K++     +   A+R +  E+  +  + H+
Sbjct: 26  YQNLKPIGSGAQGIVCAA-YDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHK 83

Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           NII LL      ++       ++V E+M + +L + +        +++ L   +      
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSYLLYQMLC----- 137

Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           G+++LH   +  ++HRDLK SNI++ S    K+ DFGL+ TAGT         T  Y AP
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194

Query: 324 EYLLEGKLTDKSDVYAFGVVLLELLMGR 351
           E +L     +  D+++ G ++ E++ G 
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 55.7 bits (135), Expect = 1e-08
 Identities = 57/210 (27%), Positives = 85/210 (40%), Gaps = 45/210 (21%)

Query: 161 IGEGGRGHVYKARF--NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR-------HQNI 211
           IGEG    V KA+     K  A  K +       E     +VN L +I+       H NI
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAI-KCMKKHFKSLE-----QVNNLREIQALRRLSPHPNI 60

Query: 212 ISLLGYCIHAETRFL----------VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDV 261
           + L+      +T  L          +YE+++     K+        +  + L        
Sbjct: 61  LRLIEVLFDRKTGRLALVFELMDMNLYELIKG---RKRPLPEKRVKSYMYQL-------- 109

Query: 262 ARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSV--TAGTQSRNVKISGTLG 319
            + L+++H +    + HRD+K  NIL+      KL+DFG S             IS T  
Sbjct: 110 LKSLDHMHRN---GIFHRDIKPENILIKDD-ILKLADFG-SCRGIYSKPPYTEYIS-TRW 163

Query: 320 YVAPEYLL-EGKLTDKSDVYAFGVVLLELL 348
           Y APE LL +G    K D++A G V  E+L
Sbjct: 164 YRAPECLLTDGYYGPKMDIWAVGCVFFEIL 193

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 56.3 bits (136), Expect = 1e-08
 Identities = 59/216 (27%), Positives = 100/216 (46%), Gaps = 38/216 (17%)

Query: 155 FQESNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHDAEREFNN---------EVNW 202
           +Q    IG G +G V   Y     + +  A+K++        R F N         E+  
Sbjct: 18  YQNLKPIGSGAQGIVCAAYDTVTGQNV--AIKKL-------SRPFQNVTHAKRAYRELVL 68

Query: 203 LTKIRHQNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMK 256
           +  + H+NII LL      ++       +LV E+M + +L + +       +L  H RM 
Sbjct: 69  MKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQ-----MDLD-HERMS 121

Query: 257 IAV-DVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS 315
             +  +  G+++LH   +  ++HRDLK SNI++ S    K+ DFGL+ TAGT        
Sbjct: 122 YLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV 178

Query: 316 GTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGR 351
            T  Y APE +L     +  D+++ G ++ E++ G 
Sbjct: 179 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 56.6 bits (136), Expect = 1e-08
 Identities = 50/174 (28%), Positives = 79/174 (45%), Gaps = 28/174 (16%)

Query: 261 VARGLEYL-HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT-- 317
           VARG+E+L  ++C    VHRDL + N+LL      K+ DFGL+      S  V    T  
Sbjct: 246 VARGMEFLASKNC----VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFL 301

Query: 318 -LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTD 375
            + ++APE + +   T  SDV+++G++L E+  +G  P                 P +  
Sbjct: 302 PVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTP----------------YPGMIV 345

Query: 376 RSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPL---ITDVLHSLIP 426
            S   N +    R         +V  + V C   EP  RP    ++D++ SL+P
Sbjct: 346 DSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 61/225 (27%), Positives = 100/225 (44%), Gaps = 44/225 (19%)

Query: 154 NFQESNVIGEGGRGHV--YKARFNEKLLAA--------VKRIDDAGHDAEREF--NNEVN 201
           +F+   VIG G  G V   K +  +K+ A         +KR + A    ER+   N +  
Sbjct: 2   DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61

Query: 202 WLTKIRH-----QNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMK 256
           W+T + +      N+  ++ Y +  +   L+         E +L  P   +   +   M 
Sbjct: 62  WITTLHYAFQDENNLYLVMDYYVGGDLLTLL------SKFEDRL--PEDMARF-YLAEMV 112

Query: 257 IAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA---GTQSRNVK 313
           IA+D    L Y         VHRD+K  NIL+D + + +L+DFG  +     GT   +V 
Sbjct: 113 IAIDSVHQLHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA 163

Query: 314 ISGTLGYVAPEYLL-----EGKLTDKSDVYAFGVVLLELLMGRRP 353
           + GT  Y++PE L      +GK   + D ++ GV + E+L G  P
Sbjct: 164 V-GTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 55.6 bits (134), Expect = 2e-08
 Identities = 36/98 (36%), Positives = 55/98 (56%), Gaps = 9/98 (9%)

Query: 261 VARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--- 317
           VARG+E+L    +   +HRDL + NILL  +   K+ DFGL+         V+  G    
Sbjct: 182 VARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR-KGDARL 237

Query: 318 -LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRP 353
            L ++APE + +   T +SDV++FGV+L E+  +G  P
Sbjct: 238 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 275

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 54.9 bits (132), Expect = 2e-08
 Identities = 52/196 (26%), Positives = 94/196 (47%), Gaps = 14/196 (7%)

Query: 161 IGEGGRGHVY-----KARFNEKLLAAVKRID--DAGHDAEREFNNEVNWLTKIRHQNIIS 213
           +G+G  G VY     KA   E+L   +K I   +   +   + N E   L+K+ H  I+ 
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERL-KVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66

Query: 214 LLGYCIHAETRFLVYEMMQNGSLEKQLHGPTH-GSNLTWHLRMKIAVDVARGLEYLHEHC 272
                +  +   ++ E  +   L+ +L    H G  L+ +   +  + +  G+ Y+H+  
Sbjct: 67  FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR- 125

Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLS-VTAGTQSRNVKISGTLGYVAPEYLLEGKL 331
              ++HRDLK+ NI L ++   K+ DFG+S +  G+       +GT  Y++PE L     
Sbjct: 126 --RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGY 182

Query: 332 TDKSDVYAFGVVLLEL 347
             KSD+++ G +L E+
Sbjct: 183 DSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 72/271 (26%), Positives = 113/271 (41%), Gaps = 58/271 (21%)

Query: 153 NNFQESNVIGEGGRGHV--YKARFNEKLLAA--------VKRIDDAGHDAEREF--NNEV 200
           ++F+   VIG G  G V   K +  E++ A         +KR + A    ER    N + 
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60

Query: 201 NWLTKIRHQNIISLLGYCIHAETR-FLVYEMMQNGSL-------EKQLHGPTHGSNLTWH 252
            W+T          L Y    E   +LV +    G L       E +L  P   +   + 
Sbjct: 61  QWITT---------LHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRL--PEDMARF-YI 108

Query: 253 LRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA---GTQS 309
             M +A+     L Y         VHRD+K  N+LLD + + +L+DFG  +     GT  
Sbjct: 109 AEMVLAIHSIHQLHY---------VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ 159

Query: 310 RNVKISGTLGYVAPEYL--LE---GKLTDKSDVYAFGVVLLELLMGRRP--VEKMSPTQC 362
            +V + GT  Y++PE L  +E   GK   + D ++ GV + E+L G  P   E +  T  
Sbjct: 160 SSVAV-GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG 218

Query: 363 QSMVTWAMPQLTDRSKLPNIVDPVIRDTMDL 393
           + M         +R + P+ +  V  +  DL
Sbjct: 219 KIM------NHEERFQFPSHITDVSEEAKDL 243

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 54.9 bits (132), Expect = 3e-08
 Identities = 34/103 (33%), Positives = 56/103 (54%), Gaps = 11/103 (10%)

Query: 261 VARGLEYL-HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT-- 317
           VA+G+ +L  ++C    +HRDL + NILL      K+ DFGL+      S N  + G   
Sbjct: 223 VAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIRNDS-NYVVKGNAR 277

Query: 318 --LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKM 357
             + ++APE +     T +SDV+++G++L E+  +G  P   M
Sbjct: 278 LPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGM 320

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 54.7 bits (132), Expect = 4e-08
 Identities = 33/132 (25%), Positives = 53/132 (40%), Gaps = 40/132 (30%)

Query: 277 VHRDLKSSNILLDSSFNAKLSDFGL-------------------------SVTAGTQSRN 311
           +HRD+K  N+LLD+  + KLSDFGL                            +   S  
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182

Query: 312 VKIS--------------GTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKM 357
            K                GT  Y+APE  L+     + D ++ GV++ E+L+G  P    
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSD 242

Query: 358 SPTQ-CQSMVTW 368
           +P +  + ++ W
Sbjct: 243 NPQETYRKIINW 254

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 53.9 bits (129), Expect = 6e-08
 Identities = 58/213 (27%), Positives = 98/213 (46%), Gaps = 32/213 (15%)

Query: 155 FQESNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRH 208
           +Q    +G G  G V   Y  R  +K+  AVK++         A R +  E+  L  ++H
Sbjct: 17  YQNLTPVGSGAYGSVCSAYDTRLRQKV--AVKKLSRPFQSLIHARRTYR-ELRLLKHMKH 73

Query: 209 QNIISLLGYCIHAET------RFLVYEMMQ---NGSLEKQLHGPTHGSNLTWHLRMKIAV 259
           +N+I LL     A +       +LV  +M    N  ++ Q     H   L + L      
Sbjct: 74  ENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQL------ 127

Query: 260 DVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLG 319
              RGL+Y+H   +  ++HRDLK SN+ ++     ++ DFGL+  A  +        T  
Sbjct: 128 --LRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGY--VATRW 180

Query: 320 YVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           Y APE +L     +++ D+++ G ++ ELL G+
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 53.4 bits (129), Expect = 7e-08
 Identities = 39/127 (30%), Positives = 55/127 (43%), Gaps = 35/127 (27%)

Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA------------ 305
           A +V   LEYLH      +V+RDLK  NILL  S +  LSDF LS  +            
Sbjct: 109 AAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALR 165

Query: 306 -GTQSRNVKIS-----------------GTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLE 346
            G++  +V                    GT  Y+APE ++ G     + D +  G++L E
Sbjct: 166 KGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPE-VISGDGHGSAVDWWTLGILLYE 224

Query: 347 LLMGRRP 353
           +L G  P
Sbjct: 225 MLYGTTP 231

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 54.0 bits (130), Expect = 7e-08
 Identities = 41/157 (26%), Positives = 61/157 (38%), Gaps = 48/157 (30%)

Query: 254 RMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGL------------ 301
           R  IA ++   +E +H       +HRD+K  NIL+D   + KL+DFGL            
Sbjct: 104 RFYIA-ELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159

Query: 302 --------------SVTAGTQS---------RNVK---------ISGTLGYVAPEYLLEG 329
                         S                R  +         + GT  Y+APE LL  
Sbjct: 160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT 219

Query: 330 KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMV 366
             T   D ++ GV+L E+L+G+ P    +P + Q  V
Sbjct: 220 GYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKV 256

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 53.6 bits (129), Expect = 7e-08
 Identities = 38/107 (35%), Positives = 57/107 (53%), Gaps = 18/107 (16%)

Query: 255 MKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFG--LSVTA-GTQSRN 311
           M +A+D    L Y         VHRD+K  N+LLD + + +L+DFG  L + A GT   N
Sbjct: 111 MVLAIDSVHQLGY---------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSN 161

Query: 312 VKISGTLGYVAPEYLL-----EGKLTDKSDVYAFGVVLLELLMGRRP 353
           V + GT  Y++PE L      +G+   + D ++ GV + E+L G  P
Sbjct: 162 VAV-GTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 53.8 bits (129), Expect = 8e-08
 Identities = 27/99 (27%), Positives = 48/99 (48%), Gaps = 5/99 (5%)

Query: 255 MKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSV--TAGTQSRNV 312
           + I   V R ++YLH    + ++HRD+K+ NI ++   +  L DFG +        ++  
Sbjct: 185 LAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY 241

Query: 313 KISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGR 351
             +GT+   APE L         D+++ G+VL E+    
Sbjct: 242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 52/199 (26%), Positives = 89/199 (44%), Gaps = 21/199 (10%)

Query: 160 VIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAERE---FNNEVNWLTKIRHQNIISLLG 216
           V+G+G  G V   R        V +  +  + + RE      E   L++++H NI++   
Sbjct: 7   VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVA--- 63

Query: 217 YCIHAET-------RFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLH 269
              + E+        ++V    + G L  +L     G  L  +  ++  V +A  L+YLH
Sbjct: 64  ---YRESWEGEDGLLYIVMGFCEGGDLYHKLK-EQKGKLLPENQVVEWFVQIAMALQYLH 119

Query: 270 EHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK-ISGTLGYVAPEYLLE 328
           E   H ++HRDLK+ N+ L  +   K+ D G++     Q      + GT  Y++PE    
Sbjct: 120 E--KH-ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSN 176

Query: 329 GKLTDKSDVYAFGVVLLEL 347
                KSDV+A G  + E+
Sbjct: 177 KPYNYKSDVWALGCCVYEM 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 60/256 (23%), Positives = 102/256 (39%), Gaps = 60/256 (23%)

Query: 155 FQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGH-DAEREFNNEVN--WLTKIRH--Q 209
           F E  ++ +   GHVY  +   K  A +   +  GH  AER+   E +  W+ K+ +  Q
Sbjct: 14  FGEVRLVQKKDTGHVYAMKILRK--ADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQ 71

Query: 210 NIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLH 269
           + ++L          +L+ E +  G +   L        LT         +    ++ +H
Sbjct: 72  DKLNL----------YLIMEFLPGGDMMTLL---MKKDTLTEEETQFYIAETVLAIDSIH 118

Query: 270 EHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSV-------------------------- 303
           +      +HRD+K  N+LLDS  + KLSDFGL                            
Sbjct: 119 QL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQN 175

Query: 304 -----TAGTQSRNVK-----ISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
                 A T  RN +       GT  Y+APE  ++       D ++ GV++ E+L+G  P
Sbjct: 176 MNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235

Query: 354 VEKMSPTQC-QSMVTW 368
               +P +  + ++ W
Sbjct: 236 FCSETPQETYKKVMNW 251

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 53.2 bits (127), Expect = 2e-07
 Identities = 49/184 (26%), Positives = 85/184 (46%), Gaps = 25/184 (13%)

Query: 176 EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISL--------LGYCIHAETRFLV 227
           E+L+A  KR+  AG  A  +  NE+  L ++ H+NI+ +          Y I  +  F +
Sbjct: 193 ERLIA--KRVK-AGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDL 249

Query: 228 YEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNIL 287
           Y  M + + + +         L    R  I   +   +EY+H   +  ++HRD+K  NI 
Sbjct: 250 YSFMYDEAFDWK------DRPLLKQTR-AIMKQLLCAVEYIH---DKKLIHRDIKLENIF 299

Query: 288 LDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA---PEYLLEGKLTDKSDVYAFGVVL 344
           L+      L DFG +     + R     G +G VA   PE L      + +D+++ G++L
Sbjct: 300 LNCDGKIVLGDFG-TAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLIL 358

Query: 345 LELL 348
           L++L
Sbjct: 359 LDML 362

Length = 501

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 52.2 bits (125), Expect = 2e-07
 Identities = 33/104 (31%), Positives = 58/104 (55%), Gaps = 21/104 (20%)

Query: 261 VARGLEYL-HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS---------VTAGTQSR 310
           VA+G+++L  ++C    +HRD+ + N+LL     AK+ DFGL+         V  G    
Sbjct: 221 VAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL 276

Query: 311 NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRP 353
            VK      ++APE + +   T +SDV+++G++L E+  +G+ P
Sbjct: 277 PVK------WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 51.4 bits (124), Expect = 3e-07
 Identities = 37/103 (35%), Positives = 51/103 (49%), Gaps = 9/103 (8%)

Query: 256 KIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLD-SSFNAKLSDFGLSVTAGTQSRNVKI 314
           KI   +   L  LH    H ++H D+K  N+L D +     L D+GL    GT S     
Sbjct: 113 KIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS---CY 166

Query: 315 SGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRPVEK 356
            GTL Y +PE +  G   D S D +A GV+  ELL G+ P ++
Sbjct: 167 DGTLDYFSPEKIK-GHNYDVSFDWWAVGVLTYELLTGKHPFKE 208

Length = 267

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 51.7 bits (124), Expect = 3e-07
 Identities = 53/221 (23%), Positives = 92/221 (41%), Gaps = 35/221 (15%)

Query: 155 FQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNII- 212
           + +   +G G  G V+ A  ++     AVK+I      + +    E+  + ++ H NI+ 
Sbjct: 7   YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66

Query: 213 -------------SLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAV 259
                          +G      + ++V E M+   L   L     G     H R+    
Sbjct: 67  VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLE---QGPLSEEHARL-FMY 121

Query: 260 DVARGLEYLHEHCNHPVVHRDLKSSNILLDS-SFNAKLSDFGLSVT-------AGTQSRN 311
            + RGL+Y+H   +  V+HRDLK +N+ +++     K+ DFGL+          G  S  
Sbjct: 122 QLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEG 178

Query: 312 VKISGTLGYVAPEYLLE-GKLTDKSDVYAFGVVLLELLMGR 351
           +    T  Y +P  LL     T   D++A G +  E+L G+
Sbjct: 179 LV---TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 51.6 bits (123), Expect = 3e-07
 Identities = 66/237 (27%), Positives = 102/237 (43%), Gaps = 39/237 (16%)

Query: 137 KDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKAR-------FNEKLLAA---VKRID 186
           KDT++ I    L     +++   VIG G  G V   R       +  KLL+    +KR D
Sbjct: 29  KDTINKIRD--LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSD 86

Query: 187 DAGHDAEREFNNEVN--WLTKIRHQNIISLLGYCIHAETRFL--VYEMMQNGSLEKQLHG 242
            A    ER+     N  W+ ++          +    + R+L  V E M  G L   +  
Sbjct: 87  SAFFWEERDIMAFANSPWVVQL----------FYAFQDDRYLYMVMEYMPGGDLVNLM-- 134

Query: 243 PTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS 302
             +     W  R   A +V   L+ +H   +   +HRD+K  N+LLD S + KL+DFG  
Sbjct: 135 SNYDVPEKW-ARFYTA-EVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTC 189

Query: 303 VTAGTQS--RNVKISGTLGYVAPEYLL----EGKLTDKSDVYAFGVVLLELLMGRRP 353
           +    +   R     GT  Y++PE L     +G    + D ++ GV L E+L+G  P
Sbjct: 190 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 50.4 bits (120), Expect = 9e-07
 Identities = 60/235 (25%), Positives = 97/235 (41%), Gaps = 43/235 (18%)

Query: 142 VIEYELLEAATNNFQESNVIGEGGRGHVYKAR-------FNEKLLAA---VKRIDDAGHD 191
           V +   L+    ++    VIG G  G V   R       +  KLL+    +KR D A   
Sbjct: 32  VRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFW 91

Query: 192 AEREFNNEVN--WLTKIRHQNIISLLGYCIHAETRFL--VYEMMQNGSLEKQLHG---PT 244
            ER+     N  W+ ++          +C   + ++L  V E M  G L   +     P 
Sbjct: 92  EERDIMAFANSPWVVQL----------FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE 141

Query: 245 HGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFG--LS 302
             +            +V   L+ +H   +  ++HRD+K  N+LLD   + KL+DFG  + 
Sbjct: 142 KWAKF-------YTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMK 191

Query: 303 VTAGTQSRNVKISGTLGYVAPEYLL----EGKLTDKSDVYAFGVVLLELLMGRRP 353
           +      R     GT  Y++PE L     +G    + D ++ GV L E+L+G  P
Sbjct: 192 MDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 50.2 bits (120), Expect = 9e-07
 Identities = 30/90 (33%), Positives = 46/90 (51%), Gaps = 14/90 (15%)

Query: 277 VHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-----GTLGYVAPEYLLEGKL 331
           VHRD+K  N+L+D + + KL+DFG   +A   + N  ++     GT  Y+APE L     
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFG---SAARLTANKMVNSKLPVGTPDYIAPEVLTTMNG 180

Query: 332 TDKS------DVYAFGVVLLELLMGRRPVE 355
             K       D ++ GV+  E++ GR P  
Sbjct: 181 DGKGTYGVECDWWSLGVIAYEMIYGRSPFH 210

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 32/92 (34%), Positives = 50/92 (54%), Gaps = 8/92 (8%)

Query: 261 VARGLEYL-HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT-- 317
           VA G+E+L  ++C    VHRDL + N+L+      K+ DFGL+      S  +    T  
Sbjct: 248 VANGMEFLASKNC----VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL 303

Query: 318 -LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL 348
            L ++APE +     T  SDV++FG++L E+ 
Sbjct: 304 PLKWMAPESIFNNLYTTLSDVWSFGILLWEIF 335

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 49.7 bits (118), Expect = 1e-06
 Identities = 51/207 (24%), Positives = 95/207 (45%), Gaps = 24/207 (11%)

Query: 161 IGEGGRGHVYKARF---NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLG- 216
           +G G  GHVYKA+     ++   A+K+I+  G         E+  L +++H N+I+L   
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKV 66

Query: 217 YCIHAETR-FLVYEMMQNG-----SLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHE 270
           +  H++ + +L+++  ++         +          L   +   +   +  G+ YLH 
Sbjct: 67  FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126

Query: 271 HCNHPVVHRDLKSSNILL----DSSFNAKLSDFGLSVTAGTQSRNVK----ISGTLGYVA 322
           +    V+HRDLK +NIL+          K++D G +    +  + +     +  T  Y A
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183

Query: 323 PEYLLEGKLTDKS-DVYAFGVVLLELL 348
           PE LL  +   K+ D++A G +  ELL
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELL 210

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 49.3 bits (117), Expect = 2e-06
 Identities = 53/207 (25%), Positives = 94/207 (45%), Gaps = 24/207 (11%)

Query: 161 IGEGGRGHVYKARFNE---KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLG- 216
           +G G  GHVYKA+  +       A+K+I+  G         E+  L +++H N+ISL   
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKV 66

Query: 217 YCIHAETR-FLVYEMMQNG-----SLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHE 270
           +  HA+ + +L+++  ++         +          L   +   +   +  G+ YLH 
Sbjct: 67  FLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 126

Query: 271 HCNHPVVHRDLKSSNILL----DSSFNAKLSDFGLSVTAGTQSRNVK----ISGTLGYVA 322
           +    V+HRDLK +NIL+          K++D G +    +  + +     +  T  Y A
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183

Query: 323 PEYLLEGKLTDKS-DVYAFGVVLLELL 348
           PE LL  +   K+ D++A G +  ELL
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELL 210

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 41/172 (23%), Positives = 80/172 (46%), Gaps = 28/172 (16%)

Query: 192 AEREFNNEVNWLTKIRHQNIISLLGYCIHAET--RFLVYEMMQNGSLEKQLHGPTHGSNL 249
           A+R +  E+  L  ++H+N+I LL       +  RF  + ++           P  G++L
Sbjct: 58  AKRAYR-ELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVM----------PFMGTDL 106

Query: 250 TWHLRMK---------IAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFG 300
              ++ +         +   + +GL+Y+H      ++HRDLK  N+ ++     K+ DFG
Sbjct: 107 GKLMKHEKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG 163

Query: 301 LSVTAGTQSRNVKISGTLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGR 351
           L+    ++     +  T  Y APE +L     T   D+++ G ++ E+L G+
Sbjct: 164 LARQTDSEMTGYVV--TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 48.7 bits (116), Expect = 3e-06
 Identities = 54/204 (26%), Positives = 96/204 (47%), Gaps = 27/204 (13%)

Query: 161 IGEGGRGHVYKA---RFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQNIISL 214
           +G G  G V  A   R  EK+  A+K++         A+R +  E+  L  ++H+N+I L
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKV--AIKKLSRPFQSEIFAKRAYR-ELTLLKHMQHENVIGL 79

Query: 215 LGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYL 268
           L     A +       +LV   MQ   L+K +  P     + +     +   +  GL+Y+
Sbjct: 80  LDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHPLSEDKVQY-----LVYQMLCGLKYI 133

Query: 269 HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLE 328
           H      ++HRDLK  N+ ++     K+ DFGL+  A  +     +  T  Y APE +L 
Sbjct: 134 HSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV--TRWYRAPEVILN 188

Query: 329 GKLTDKS-DVYAFGVVLLELLMGR 351
               +++ D+++ G ++ E+L G+
Sbjct: 189 WMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 47.7 bits (113), Expect = 6e-06
 Identities = 33/129 (25%), Positives = 54/129 (41%), Gaps = 37/129 (28%)

Query: 277 VHRDLKSSNILLDSSFNAKLSDFGLSV-------------------------------TA 305
           +HRD+K  N+LLD+  + KLSDFGL                                  A
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182

Query: 306 GTQSRNVK-----ISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPT 360
            T  +N +       GT  Y+APE  ++       D ++ GV++ E+L+G  P    +P 
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQ 242

Query: 361 QC-QSMVTW 368
           +  + ++ W
Sbjct: 243 ETYRKVMNW 251

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 47.7 bits (113), Expect = 6e-06
 Identities = 36/141 (25%), Positives = 54/141 (38%), Gaps = 49/141 (34%)

Query: 277 VHRDLKSSNILLDSSFNAKLSDFG------------------------------------ 300
           +HRD+K  NIL+D   + KL+DFG                                    
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182

Query: 301 ---------LSVTAGTQSRNV---KISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELL 348
                    L   A  Q +      + GT  Y+APE LL    T   D ++ GV+L E+L
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242

Query: 349 MGRRPVEKMSPTQCQ-SMVTW 368
           +G+ P    +P + Q  ++ W
Sbjct: 243 VGQPPFLAQTPLETQMKVINW 263

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 47.6 bits (113), Expect = 9e-06
 Identities = 31/93 (33%), Positives = 50/93 (53%), Gaps = 10/93 (10%)

Query: 261 VARGL----EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA-GTQSRNVK-- 313
           VAR L    +Y+H      ++HRD+K+ N+L++   +  L DFG +  A G+ S      
Sbjct: 265 VARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG 321

Query: 314 ISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLE 346
           I+GT+   APE L     T   D+++ G+V+ E
Sbjct: 322 IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 45.3 bits (107), Expect = 3e-05
 Identities = 64/220 (29%), Positives = 91/220 (41%), Gaps = 28/220 (12%)

Query: 163 EGGRG-----HVYKARFNEKLLAAVKRIDDAGHDAEREFN---NEVNWLTKIRHQNIISL 214
           E GRG      VY AR          RI D  +  E       NEV      RH NI++ 
Sbjct: 5   EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTS 64

Query: 215 LGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNH 274
                     +++   M  GS    L        ++  L   I     RGL YLH++   
Sbjct: 65  WTVFTTGSWLWVISPFMAYGS-ANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN--- 120

Query: 275 PVVHRDLKSSNILLDSSFNAKLSDFGLS-----VTAGTQSRNVK-----ISGTLGYVAPE 324
             +HR++K+S+IL+       LS  GLS     V  G +++ V       +  L +++PE
Sbjct: 121 GYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPE 178

Query: 325 YLLEGKLTD---KSDVYAFGVVLLELLMGRRPVEKMSPTQ 361
            LL   L     KSD+Y+ G+   EL  GR P + M  TQ
Sbjct: 179 -LLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ 217

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 43.5 bits (103), Expect = 4e-05
 Identities = 28/144 (19%), Positives = 52/144 (36%), Gaps = 15/144 (10%)

Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIIS--LLGYC 218
           +  G    VY     ++    +K        A+RE   EV  L  +  + +    +L   
Sbjct: 6   LKGGLTNRVYLLGTKDEDYV-LKINPSREKGADRE--REVAILQLLARKGLPVPKVLASG 62

Query: 219 IHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVH 278
                 +L+ E ++  +L++               +  IA  +A  L  LH+     + H
Sbjct: 63  ESDGWSYLLMEWIEGETLDEVSEEE----------KEDIAEQLAELLAKLHQLPLLVLCH 112

Query: 279 RDLKSSNILLDSSFNAKLSDFGLS 302
            DL   NIL+D      + D+  +
Sbjct: 113 GDLHPGNILVDDGKILGIIDWEYA 136

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 44.2 bits (104), Expect = 9e-05
 Identities = 21/54 (38%), Positives = 32/54 (59%), Gaps = 1/54 (1%)

Query: 316 GTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQ-SMVTW 368
           GT  Y+APE LL    T   D ++ GV+L E+L+G+ P    +PT+ Q  ++ W
Sbjct: 210 GTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINW 263

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 43.3 bits (102), Expect = 1e-04
 Identities = 32/125 (25%), Positives = 47/125 (37%), Gaps = 48/125 (38%)

Query: 277 VHRDLKSSNILLDSSFNAKLSDFGLS--------------------VTAGTQSRNV---- 312
           +HRD+K  NIL+D   + KLSDFGLS                          +RN     
Sbjct: 123 IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVD 182

Query: 313 ----------KIS--------------GTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELL 348
                     +I+              GT  Y+APE  L+     + D ++ G ++ E L
Sbjct: 183 SINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECL 242

Query: 349 MGRRP 353
           +G  P
Sbjct: 243 IGWPP 247

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 42.2 bits (99), Expect = 3e-04
 Identities = 44/138 (31%), Positives = 68/138 (49%), Gaps = 20/138 (14%)

Query: 257 IAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS-----VTAGTQSRN 311
           I   V + L+Y+H H  +  VHR +K+S+IL+  S + K+   GL      +  G + R 
Sbjct: 106 ILQGVLKALDYIH-HMGY--VHRSVKASHILI--SVDGKVYLSGLRSNLSMINHGQRLRV 160

Query: 312 V----KIS-GTLGYVAPEYL---LEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQ 363
           V    K S   L +++PE L   L+G    KSD+Y+ G+   EL  G  P + M  TQ  
Sbjct: 161 VHDFPKYSVKVLPWLSPEVLQQNLQG-YDAKSDIYSVGITACELANGHVPFKDMPATQML 219

Query: 364 -SMVTWAMPQLTDRSKLP 380
              +   +P L D + +P
Sbjct: 220 LEKLNGTVPCLLDTTTIP 237

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 41.9 bits (98), Expect = 3e-04
 Identities = 25/98 (25%), Positives = 47/98 (47%), Gaps = 11/98 (11%)

Query: 257 IAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS- 315
           I  D+   LEY+HEH    + H D+K  NI++D +    + D+G++       ++++ S 
Sbjct: 131 IMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSK 187

Query: 316 -------GTLGYVAPEYLLEGKLTDKSDVYAFGVVLLE 346
                  GTL Y   +      +T + D+ + G  +L+
Sbjct: 188 EQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225

Length = 294

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 39.4 bits (92), Expect = 0.002
 Identities = 39/147 (26%), Positives = 60/147 (40%), Gaps = 32/147 (21%)

Query: 98  RWKRLKNTNGNSKQTIDGGKGLSLSPILERFNSLRLAGKKDTVSVIEYELLEAATNNFQE 157
           RWK ++   GN+   ID        P    +N                E  E   +N Q 
Sbjct: 7   RWKIIEAAEGNNYTFID--------PTQLPYN----------------EKWEFPRDNLQF 42

Query: 158 SNVIGEGGRGHVYKA------RFNEKLLAAVKRIDDAGHDAERE-FNNEVNWLTKI-RHQ 209
              +G G  G V +A      + +  L  AVK +  + H  ERE   +E+  L+ + +H+
Sbjct: 43  GKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHK 102

Query: 210 NIISLLGYCIHAETRFLVYEMMQNGSL 236
           NI++LLG C H     ++ E    G L
Sbjct: 103 NIVNLLGACTHGGPVLVITEYCCYGDL 129

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	439
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.97
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.96
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.96
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.96
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.96
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.95
PLN00181	793	protein SPA1-RELATED; Provisional	99.95
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.94
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.93
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.92
PRK09188	365	serine/threonine protein kinase; Provisional	99.92
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.91
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.87
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.87
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.87
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.86
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.85
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.85
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.85
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.84
PRK12274	218	serine/threonine protein kinase; Provisional	99.84
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.83
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.83
PRK10345	210	hypothetical protein; Provisional	99.81
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.8
PRK14879	211	serine/threonine protein kinase; Provisional	99.78
smart00090	237	RIO RIO-like kinase.	99.77
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.77
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.77
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.75
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.75
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.75
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.71
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.7
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.65
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.63
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.61
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.56
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.51
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.38
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.37
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.33
KOG1243	690	consensus Protein kinase [General function predict	99.28
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.25
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.23
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.21
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.16
KOG3087	229	consensus Serine/threonine protein kinase [General	99.15
COG4248	637	Uncharacterized protein with protein kinase and he	99.12
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.06
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.94
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.88
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.88
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.76
PRK09902	216	hypothetical protein; Provisional	98.74
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.66
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.65
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.54
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.48
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.41
PF01636	239	APH: Phosphotransferase enzyme family This family	98.33
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.33
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.33
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.27
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.23
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.13
PLN02876	822	acyl-CoA dehydrogenase	98.1
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.0
PRK10593	297	hypothetical protein; Provisional	97.99
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.91
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.88
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.85
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.84
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.81
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.65
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.61
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.57
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.49
PRK05231	319	homoserine kinase; Provisional	97.45
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.39
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.19
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.16
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.96
PLN02236	344	choline kinase	96.9
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.79
KOG2268	465	consensus Serine/threonine protein kinase [Signal	96.6
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.42
PLN02756	418	S-methyl-5-thioribose kinase	96.23
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.08
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.99
COG2334	331	Putative homoserine kinase type II (protein kinase	95.95
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	95.9
KOG2270	520	consensus Serine/threonine protein kinase involved	95.87
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	95.76
PRK11768	325	serine/threonine protein kinase; Provisional	95.57
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.5
PRK06148	1013	hypothetical protein; Provisional	95.24
PTZ00384	383	choline kinase; Provisional	94.95
PRK12396	409	5-methylribose kinase; Reviewed	94.38
PF01102	122	Glycophorin_A: Glycophorin A; InterPro: IPR001195	94.01
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	94.0
PF02439	38	Adeno_E3_CR2: Adenovirus E3 region protein CR2; In	93.85
KOG1093	725	consensus Predicted protein kinase (contains TBC a	93.74

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7e-60  Score=461.28  Aligned_cols=289  Identities=49%  Similarity=0.842  Sum_probs=257.3

Q ss_pred             ccccccHHHHHHHhcCCCccceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEE
Q 013636          139 TVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYC  218 (439)
Q Consensus       139 ~~~~~~~~~l~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  218 (439)
                      ....|.+++++.+|++|...+.||+|+||.||+|.+.++..+|||++.....+..++|.+|+.++.+++|||+|+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            46779999999999999999999999999999999999999999988775543155699999999999999999999999


Q ss_pred             EeCC-eeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEE
Q 013636          219 IHAE-TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLS  297 (439)
Q Consensus       219 ~~~~-~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~  297 (439)
                      .+.+ ..+||||||++|+|.++|++.... .++|.+|++||.++|+||+|||+.+.++|+||||||+|||||+++++||+
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence            9999 599999999999999999975544 89999999999999999999999988899999999999999999999999


Q ss_pred             ecccccccCC-CCcceee-ccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhccccc
Q 013636          298 DFGLSVTAGT-QSRNVKI-SGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTD  375 (439)
Q Consensus       298 DfGls~~~~~-~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~  375 (439)
                      |||+|+.... ....... .||.+|+|||+...+..+.|+|||||||+|+|++||+.|.+...+....+++.|+.+.+.+
T Consensus       220 DFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~  299 (361)
T KOG1187|consen  220 DFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE  299 (361)
T ss_pred             CccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence            9999976654 3333333 7999999999999999999999999999999999999998876555556689998777665


Q ss_pred             CCCCCccCCchhc-CccCH-HHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCC
Q 013636          376 RSKLPNIVDPVIR-DTMDL-KHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVP  429 (439)
Q Consensus       376 ~~~~~~~~d~~l~-~~~~~-~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~  429 (439)
                      . .+.+++|+.+. ..... +++.+++.++.+|++.+|++||+|.||++.|+++..
T Consensus       300 ~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  300 G-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             c-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence            5 89999999987 55554 689999999999999999999999999999966654

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-51  Score=398.55  Aligned_cols=254  Identities=36%  Similarity=0.599  Sum_probs=212.9

Q ss_pred             CccceecccCcEEEEEEEECCccEEEEEEecCCCchH--HHHHHHHHHHHHhcCCCceeeeeeEEEeCC-eeEEEEEecc
Q 013636          156 QESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDA--EREFNNEVNWLTKIRHQNIISLLGYCIHAE-TRFLVYEMMQ  232 (439)
Q Consensus       156 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lV~e~~~  232 (439)
                      ...+.||+|+||+||+|.+++...+|||++.......  .++|.+|+.+|.+++|||||+++|+|.+.. ..++||||++
T Consensus        44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~  123 (362)
T KOG0192|consen   44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP  123 (362)
T ss_pred             hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence            3355699999999999999998889999998654332  568999999999999999999999999887 7999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC-eEecCCCCCCEEEcCCC-cEEEEecccccccCCC-C
Q 013636          233 NGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHP-VVHRDLKSSNILLDSSF-NAKLSDFGLSVTAGTQ-S  309 (439)
Q Consensus       233 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~-ivH~Dlk~~NiLl~~~~-~~kl~DfGls~~~~~~-~  309 (439)
                      +|+|.+++++. ....+++..+++++.|||+||.|||+.   + ||||||||+|||++.++ ++||+|||+++..... .
T Consensus       124 ~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~  199 (362)
T KOG0192|consen  124 GGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKT  199 (362)
T ss_pred             CCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeeccccc
Confidence            99999999864 456799999999999999999999998   6 99999999999999998 9999999999776543 2


Q ss_pred             cceeeccccCccchhhhc--CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchh
Q 013636          310 RNVKISGTLGYVAPEYLL--EGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVI  387 (439)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  387 (439)
                      ......||++|||||++.  ...|+.|+||||||++||||+||+.||....+.+....+..    -..+..++..     
T Consensus       200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~----~~~Rp~~p~~-----  270 (362)
T KOG0192|consen  200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVV----GGLRPPIPKE-----  270 (362)
T ss_pred             cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh----cCCCCCCCcc-----
Confidence            222356999999999999  56999999999999999999999999999887443333221    1112222222     


Q ss_pred             cCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCC
Q 013636          388 RDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVP  429 (439)
Q Consensus       388 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~  429 (439)
                             +...+..++..||+.||+.||++.+++..|+.+..
T Consensus       271 -------~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~  305 (362)
T KOG0192|consen  271 -------CPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS  305 (362)
T ss_pred             -------CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence                   34467778889999999999999999999986654

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-51  Score=394.42  Aligned_cols=256  Identities=30%  Similarity=0.481  Sum_probs=218.7

Q ss_pred             CCccceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEeccCC
Q 013636          155 FQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNG  234 (439)
Q Consensus       155 ~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  234 (439)
                      +...+.||+|-||+||.|++++...+|+|.++... ...++|.+|+.+|++|+|+|||+++|+|...+..+||||||++|
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G  286 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG  286 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence            34467899999999999999999999999998753 45568999999999999999999999999989999999999999


Q ss_pred             ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCcceee
Q 013636          235 SLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKI  314 (439)
Q Consensus       235 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~~~~~  314 (439)
                      +|.++|.. ..+..+...+.+.++.|||+||+||+++   ++|||||.++||||+++..+||+|||||+...++....+.
T Consensus       287 sLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~  362 (468)
T KOG0197|consen  287 SLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASE  362 (468)
T ss_pred             cHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceeecC
Confidence            99999986 4567799999999999999999999998   9999999999999999999999999999955443332222


Q ss_pred             c--cccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCcc
Q 013636          315 S--GTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTM  391 (439)
Q Consensus       315 ~--gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  391 (439)
                      .  -...|.|||.+..+.++.|||||||||+||||+| |+.||++++..++...++..       .+++          .
T Consensus       363 ~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~G-------yRlp----------~  425 (468)
T KOG0197|consen  363 GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERG-------YRLP----------R  425 (468)
T ss_pred             CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhcc-------CcCC----------C
Confidence            1  2568999999999999999999999999999999 99999999887766665432       1111          1


Q ss_pred             CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCCCC
Q 013636          392 DLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPTDL  432 (439)
Q Consensus       392 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~~~  432 (439)
                      +..++..+.+++..||..+|++|||+..+...|+.+...+.
T Consensus       426 P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~~  466 (468)
T KOG0197|consen  426 PEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTSTE  466 (468)
T ss_pred             CCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhccc
Confidence            11234567779999999999999999999999988876543

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-49  Score=369.27  Aligned_cols=250  Identities=28%  Similarity=0.413  Sum_probs=206.5

Q ss_pred             CCccceecccCcEEEEEEEECC-ccEEEEEEecCC-CchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC-eeEEEEEec
Q 013636          155 FQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDA-GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE-TRFLVYEMM  231 (439)
Q Consensus       155 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lV~e~~  231 (439)
                      ++..+.||+|..|+|||++++. +..+|+|.+... .....+++.+|++++++.+|||||.++|.|+... ...++||||
T Consensus        81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM  160 (364)
T KOG0581|consen   81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM  160 (364)
T ss_pred             hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence            3446889999999999999875 678899999533 3455678999999999999999999999999999 599999999


Q ss_pred             cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCcc
Q 013636          232 QNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN  311 (439)
Q Consensus       232 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~~  311 (439)
                      ++|||++++..   .+.+++....+++.++++||.|||+.  ++|+||||||+|+|++.+|++||||||.|....+. ..
T Consensus       161 DgGSLd~~~k~---~g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-~a  234 (364)
T KOG0581|consen  161 DGGSLDDILKR---VGRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-IA  234 (364)
T ss_pred             CCCCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-hc
Confidence            99999999964   35699999999999999999999963  39999999999999999999999999999876554 44


Q ss_pred             eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC--hhhhhhhHhhhhcccccCCCCCccCCchhcC
Q 013636          312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMS--PTQCQSMVTWAMPQLTDRSKLPNIVDPVIRD  389 (439)
Q Consensus       312 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  389 (439)
                      .++.||..|||||.+.+..|+.++||||||+.++|+.+|+.||....  ......+..+...  ...+.+++-       
T Consensus       235 ~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~--~ppP~lP~~-------  305 (364)
T KOG0581|consen  235 NTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD--EPPPRLPEG-------  305 (364)
T ss_pred             ccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc--CCCCCCCcc-------
Confidence            56779999999999999999999999999999999999999998642  1222333332211  011222221       


Q ss_pred             ccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          390 TMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       390 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                          ....++..++..||++||.+||+++|+++|
T Consensus       306 ----~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  306 ----EFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             ----cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                123356779999999999999999999976

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=7.8e-50  Score=405.44  Aligned_cols=259  Identities=30%  Similarity=0.499  Sum_probs=219.0

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEE------CCccEEEEEEecCCCch-HHHHHHHHHHHHHhcCCCceeeeeeEEEeC
Q 013636          149 EAATNNFQESNVIGEGGRGHVYKARF------NEKLLAAVKRIDDAGHD-AEREFNNEVNWLTKIRHQNIISLLGYCIHA  221 (439)
Q Consensus       149 ~~~~~~~~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  221 (439)
                      +....+.+..+.||+|+||+||+|+.      ++...||||.+++.... ...+|++|++++..++|||||+|+|.|..+
T Consensus       482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~  561 (774)
T KOG1026|consen  482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG  561 (774)
T ss_pred             EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence            34445666678899999999999975      34678999999987766 678899999999999999999999999999


Q ss_pred             CeeEEEEEeccCCChhhhhcCCC-------CCC----CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC
Q 013636          222 ETRFLVYEMMQNGSLEKQLHGPT-------HGS----NLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDS  290 (439)
Q Consensus       222 ~~~~lV~e~~~~gsL~~~l~~~~-------~~~----~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~  290 (439)
                      +..++|+|||..|||.+||....       .+.    +|+..+.+.||.|||.||+||.++   .+|||||..+|+||.+
T Consensus       562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge  638 (774)
T KOG1026|consen  562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGE  638 (774)
T ss_pred             CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceecc
Confidence            99999999999999999996311       122    389999999999999999999998   9999999999999999


Q ss_pred             CCcEEEEecccccccCCCCcceee---ccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhH
Q 013636          291 SFNAKLSDFGLSVTAGTQSRNVKI---SGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMV  366 (439)
Q Consensus       291 ~~~~kl~DfGls~~~~~~~~~~~~---~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~  366 (439)
                      +..|||+|||+++.....+.+...   .-..+|||||.+..+++|++||||||||+|||+++ |+.||.+.+.+++...+
T Consensus       639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i  718 (774)
T KOG1026|consen  639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECI  718 (774)
T ss_pred             ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHH
Confidence            999999999999887654443211   13579999999999999999999999999999999 99999999888776666


Q ss_pred             hhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhcccc
Q 013636          367 TWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPL  427 (439)
Q Consensus       367 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l  427 (439)
                      ....- +.                .+..++.++.+++..||+.+|++||+++||-..|+..
T Consensus       719 ~~g~l-L~----------------~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~  762 (774)
T KOG1026|consen  719 RAGQL-LS----------------CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAW  762 (774)
T ss_pred             HcCCc-cc----------------CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence            42111 11                1224456788899999999999999999999888654

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.7e-48  Score=378.99  Aligned_cols=247  Identities=26%  Similarity=0.473  Sum_probs=215.2

Q ss_pred             cCCCccceecccCcEEEEEEEE-CCccEEEEEEecCC---CchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARF-NEKLLAAVKRIDDA---GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      ..|...+.||+|||+.||.++. ..+..+|+|.+.+.   .....+...+|+++.+.|+|||||++++++++.+..|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            4688899999999999999998 78999999999763   2344567889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~  308 (439)
                      |+|++|+|..++.   ..+.+++..+..+..||+.||.|||+.   +|+|||||..|++++++.++||+|||||.....+
T Consensus        98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~  171 (592)
T KOG0575|consen   98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD  171 (592)
T ss_pred             EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCc
Confidence            9999999999995   456799999999999999999999998   9999999999999999999999999999887654


Q ss_pred             -CcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchh
Q 013636          309 -SRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVI  387 (439)
Q Consensus       309 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  387 (439)
                       ....+.||||.|.|||++....++..+||||+||+||-|+.|++||+..+-.+..+.+...      +..+|..+    
T Consensus       172 ~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~------~Y~~P~~l----  241 (592)
T KOG0575|consen  172 GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN------EYSMPSHL----  241 (592)
T ss_pred             ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc------Cccccccc----
Confidence             6667899999999999999999999999999999999999999999987666555444321      22222222    


Q ss_pred             cCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          388 RDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       388 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                              .....+++.++|+.||.+|||+++|+.+
T Consensus       242 --------s~~A~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  242 --------SAEAKDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             --------CHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                    2345569999999999999999999964

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-48  Score=362.50  Aligned_cols=207  Identities=27%  Similarity=0.453  Sum_probs=187.5

Q ss_pred             cCCCccceecccCcEEEEEEEECC-ccEEEEEEecCC--CchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDA--GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYE  229 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  229 (439)
                      .+|...+.||+|+||+||+|+.+. +..||||.+...  .....+....|+.+|+.++|||||++++++..++..+||||
T Consensus        10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME   89 (429)
T KOG0595|consen   10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME   89 (429)
T ss_pred             ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence            467777889999999999998864 689999999876  44555678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC------CcEEEEeccccc
Q 013636          230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS------FNAKLSDFGLSV  303 (439)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~------~~~kl~DfGls~  303 (439)
                      ||.+|+|.+|++..   +.+++.....+..|+|.||++||++   +|+||||||+||||+.+      -.+||+|||+|+
T Consensus        90 yC~gGDLs~yi~~~---~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR  163 (429)
T KOG0595|consen   90 YCNGGDLSDYIRRR---GRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR  163 (429)
T ss_pred             eCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence            99999999999753   3699999999999999999999998   99999999999999765      468999999999


Q ss_pred             ccCCCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhh
Q 013636          304 TAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSM  365 (439)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~  365 (439)
                      .........+.+|++-|||||++..++|+.|+|+||.|++||++++|+.||+..++.+....
T Consensus       164 ~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~  225 (429)
T KOG0595|consen  164 FLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLY  225 (429)
T ss_pred             hCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH
Confidence            99887777788999999999999999999999999999999999999999998887765543

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-48  Score=378.62  Aligned_cols=268  Identities=26%  Similarity=0.398  Sum_probs=218.6

Q ss_pred             HHHHHhcCCCccceecccCcEEEEEEEECCccEEEEEEecCCCchH-HHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeE
Q 013636          147 LLEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDA-EREFNNEVNWLTKIRHQNIISLLGYCIHAETRF  225 (439)
Q Consensus       147 ~l~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  225 (439)
                      ..|.+.+...+.++||+|-||+|.....++...||||+++...... .++|.+|+++|.+++||||+.++|+|..++..+
T Consensus       532 l~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePic  611 (807)
T KOG1094|consen  532 LVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLC  611 (807)
T ss_pred             hhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchH
Confidence            3456667788899999999999999999999999999998765544 478999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccccccc
Q 013636          226 LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA  305 (439)
Q Consensus       226 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~  305 (439)
                      +|+|||++|+|.+||..... ..+.-....+|+.|||.||+||.+.   .+|||||.++|||+|.++++||+|||+++..
T Consensus       612 mI~EYmEnGDLnqFl~ahea-pt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~l  687 (807)
T KOG1094|consen  612 MITEYMENGDLNQFLSAHEL-PTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNL  687 (807)
T ss_pred             HHHHHHhcCcHHHHHHhccC-cccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCccccccc
Confidence            99999999999999975322 2245566778999999999999998   9999999999999999999999999999876


Q ss_pred             CCCCcce---eeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh--CCCCCCCCChhhhhhhHhhhhcccccCCCCC
Q 013636          306 GTQSRNV---KISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM--GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLP  380 (439)
Q Consensus       306 ~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt--G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  380 (439)
                      .......   +..-..+|||||.+..+++|+++|||+||+++||+++  ...||...+.+++......   .+...+.- 
T Consensus       688 ysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~---~~~~~~~~-  763 (807)
T KOG1094|consen  688 YSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGE---FFRDQGRQ-  763 (807)
T ss_pred             ccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhh---hcCCCCcc-
Confidence            6554432   2234689999999999999999999999999999776  8899988776543322221   11111111 


Q ss_pred             ccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccC
Q 013636          381 NIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLV  428 (439)
Q Consensus       381 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~  428 (439)
                            ..-..+.-+...+.++++.||..|-++||+++++...|++..
T Consensus       764 ------~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~  805 (807)
T KOG1094|consen  764 ------VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA  805 (807)
T ss_pred             ------eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence                  111122234567778999999999999999999999988754

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-48  Score=385.92  Aligned_cols=255  Identities=27%  Similarity=0.453  Sum_probs=218.6

Q ss_pred             CCCccceecccCcEEEEEEEEC----CccEEEEEEecCCCch-HHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEE
Q 013636          154 NFQESNVIGEGGRGHVYKARFN----EKLLAAVKRIDDAGHD-AEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      ...+.++||.|.||+|++|+++    ....||||.++....+ .+++|+.|+.||.++.||||++|.|+.......++|+
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT  709 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT  709 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence            4456789999999999999875    3578999999875543 4468999999999999999999999999999999999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~  308 (439)
                      |||+||+|+.||+.  +.+++++.++.-+..+||.||.||.+.   ++|||||.++|||++.+..+|++|||+++...++
T Consensus       710 EyMENGsLDsFLR~--~DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd  784 (996)
T KOG0196|consen  710 EYMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  784 (996)
T ss_pred             hhhhCCcHHHHHhh--cCCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccC
Confidence            99999999999985  345699999999999999999999998   9999999999999999999999999999987655


Q ss_pred             Ccc-ee-ec--cccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCccC
Q 013636          309 SRN-VK-IS--GTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV  383 (439)
Q Consensus       309 ~~~-~~-~~--gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  383 (439)
                      ... .. ..  -..+|.|||.+..+++|.+|||||||++|||.++ |..||.+++..++.+-++.       .-++|.- 
T Consensus       785 ~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~-------gyRLPpP-  856 (996)
T KOG0196|consen  785 PEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQ-------GYRLPPP-  856 (996)
T ss_pred             CCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHh-------ccCCCCC-
Confidence            422 11 11  2479999999999999999999999999999887 9999999988776655542       2223222 


Q ss_pred             CchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCC
Q 013636          384 DPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPT  430 (439)
Q Consensus       384 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~  430 (439)
                               .+++..+.++++.|||+|-.+||++.|++..|+++.+.
T Consensus       857 ---------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn  894 (996)
T KOG0196|consen  857 ---------MDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN  894 (996)
T ss_pred             ---------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence                     24567788999999999999999999999999888764

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.9e-47  Score=356.87  Aligned_cols=254  Identities=25%  Similarity=0.393  Sum_probs=205.7

Q ss_pred             HHhcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCc-------hHHHHHHHHHHHHHhcCCCceeeeeeEEEeC
Q 013636          150 AATNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGH-------DAEREFNNEVNWLTKIRHQNIISLLGYCIHA  221 (439)
Q Consensus       150 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  221 (439)
                      ...+.|.+.+.||+|+||.|-+|..+ .+..+|||.++....       .......+|+++|++++|||||++++++...
T Consensus       169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~  248 (475)
T KOG0615|consen  169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP  248 (475)
T ss_pred             hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence            35577888999999999999999764 588999999975321       1223457999999999999999999999999


Q ss_pred             CeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC---CcEEEEe
Q 013636          222 ETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS---FNAKLSD  298 (439)
Q Consensus       222 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~---~~~kl~D  298 (439)
                      +..|+||||++||+|.+.+-+   .+.+.+..-..++.|++.|+.|||++   ||+||||||+|||+..+   ..+||+|
T Consensus       249 ds~YmVlE~v~GGeLfd~vv~---nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItD  322 (475)
T KOG0615|consen  249 DSSYMVLEYVEGGELFDKVVA---NKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITD  322 (475)
T ss_pred             CceEEEEEEecCccHHHHHHh---ccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecc
Confidence            999999999999999999964   34577777888999999999999999   99999999999999766   7899999


Q ss_pred             cccccccCCCCcceeeccccCccchhhhcCCC---CCCchhhHHHHHHHHHHHhCCCCCCCCChhh-hhhhHhhhhcccc
Q 013636          299 FGLSVTAGTQSRNVKISGTLGYVAPEYLLEGK---LTDKSDVYAFGVVLLELLMGRRPVEKMSPTQ-CQSMVTWAMPQLT  374 (439)
Q Consensus       299 fGls~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwS~Gvll~elltG~~P~~~~~~~~-~~~~~~~~~~~~~  374 (439)
                      ||+|+..+..+...+.|||+.|.|||++.+..   +..+.|+||+||+||-+++|.+||.....+. +...+..      
T Consensus       323 FGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~------  396 (475)
T KOG0615|consen  323 FGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILK------  396 (475)
T ss_pred             cchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhc------
Confidence            99999988777778899999999999998754   3348899999999999999999997653322 2222211      


Q ss_pred             cCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          375 DRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       375 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                        ++.  .+-|....    +-..+..+++.+||..||++|||+.|+|++
T Consensus       397 --G~y--~f~p~~w~----~Iseea~dlI~~mL~VdP~~R~s~~eaL~h  437 (475)
T KOG0615|consen  397 --GRY--AFGPLQWD----RISEEALDLINWMLVVDPENRPSADEALNH  437 (475)
T ss_pred             --Ccc--cccChhhh----hhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence              111  11111111    223467789999999999999999999865

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.6e-48  Score=344.45  Aligned_cols=257  Identities=24%  Similarity=0.360  Sum_probs=206.3

Q ss_pred             cCCCccceecccCcEEEEEEEE-CCccEEEEEEecC--CCchHHHHHHHHHHHHHhcCCCceeeeee-EEEeCCe-eEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARF-NEKLLAAVKRIDD--AGHDAEREFNNEVNWLTKIRHQNIISLLG-YCIHAET-RFLV  227 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~~lV  227 (439)
                      .+|++.++||+|.||+|||+.. .++..+|.|.++-  .......+...|+.+|++|+|||||++++ .+.++.. .+||
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            3566778899999999999965 6788889998863  33344567899999999999999999998 4444444 8999


Q ss_pred             EEeccCCChhhhhcC-CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-CeEecCCCCCCEEEcCCCcEEEEeccccccc
Q 013636          228 YEMMQNGSLEKQLHG-PTHGSNLTWHLRMKIAVDVARGLEYLHEHCNH-PVVHRDLKSSNILLDSSFNAKLSDFGLSVTA  305 (439)
Q Consensus       228 ~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~-~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~  305 (439)
                      ||||..|+|...+.. +.+...+++..+++++.|+++||.++|+.-.. -|+||||||.||+|+.+|.+||+|||+++..
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            999999999999865 34456799999999999999999999994221 3999999999999999999999999999987


Q ss_pred             CCCCcc-eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCC
Q 013636          306 GTQSRN-VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVD  384 (439)
Q Consensus       306 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  384 (439)
                      .+.... ....|||.||+||.+.+..|+.||||||+||++|||+.-++||.+.+--+....+.        ....+.+.|
T Consensus       179 ~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~--------qgd~~~~p~  250 (375)
T KOG0591|consen  179 SSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIE--------QGDYPPLPD  250 (375)
T ss_pred             cchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHH--------cCCCCCCcH
Confidence            664433 45679999999999999999999999999999999999999999875433332222        122222221


Q ss_pred             chhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhcc
Q 013636          385 PVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLI  425 (439)
Q Consensus       385 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  425 (439)
                              ......+.+++..|+..||+.||+.-.+++.++
T Consensus       251 --------~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~  283 (375)
T KOG0591|consen  251 --------EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ  283 (375)
T ss_pred             --------HHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence                    234456778999999999999999666555554

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-46  Score=391.18  Aligned_cols=263  Identities=29%  Similarity=0.450  Sum_probs=217.0

Q ss_pred             HHhcCCCccceecccCcEEEEEEEECC------ccEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC
Q 013636          150 AATNNFQESNVIGEGGRGHVYKARFNE------KLLAAVKRIDDAG-HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE  222 (439)
Q Consensus       150 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  222 (439)
                      ...++.+..+.||+|.||.||.|...+      ...||+|.++... .+...+|.+|..+|+.++|||||+++|.|.+..
T Consensus       689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~  768 (1025)
T KOG1095|consen  689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG  768 (1025)
T ss_pred             CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence            334566678899999999999998754      3458999998654 455678999999999999999999999999999


Q ss_pred             eeEEEEEeccCCChhhhhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEe
Q 013636          223 TRFLVYEMMQNGSLEKQLHGPT----HGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSD  298 (439)
Q Consensus       223 ~~~lV~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~D  298 (439)
                      ..++++|||++|+|..||+..+    ....++..+.+.++.|||+|+.||+++   ++|||||.++|+||++...+||+|
T Consensus       769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaD  845 (1025)
T KOG1095|consen  769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIAD  845 (1025)
T ss_pred             CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcc
Confidence            9999999999999999998641    245799999999999999999999998   999999999999999999999999


Q ss_pred             cccccccCCCCcceee---ccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccc
Q 013636          299 FGLSVTAGTQSRNVKI---SGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLT  374 (439)
Q Consensus       299 fGls~~~~~~~~~~~~---~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~  374 (439)
                      ||+|+.......+..-   .-..+|||||.+..+.+|.|+|||||||+|||++| |..||...+..++...+..      
T Consensus       846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~------  919 (1025)
T KOG1095|consen  846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLE------  919 (1025)
T ss_pred             cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHh------
Confidence            9999865444333221   12468999999999999999999999999999999 9999998887665443321      


Q ss_pred             cCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCCCC
Q 013636          375 DRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPTDL  432 (439)
Q Consensus       375 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~~~  432 (439)
                       .+++    +      ....+...+.+++.+||+.+|++||++..+++.+..+....+
T Consensus       920 -ggRL----~------~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~  966 (1025)
T KOG1095|consen  920 -GGRL----D------PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL  966 (1025)
T ss_pred             -CCcc----C------CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence             1111    1      112334567789999999999999999999999887765543

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=8e-46  Score=334.57  Aligned_cols=265  Identities=22%  Similarity=0.339  Sum_probs=209.3

Q ss_pred             cCCCccceecccCcEEEEEEEECC-ccEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGH--DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYE  229 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  229 (439)
                      +.|+...++|+|+||.|||.+.++ |+.||||++.....  .-.+-.++|+++|++++|||+|.++.+|......+||+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            356677899999999999999876 78999999976543  233457899999999999999999999999999999999


Q ss_pred             eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccC-CC
Q 013636          230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAG-TQ  308 (439)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~-~~  308 (439)
                      ||+. ++.+-|....  ..++.+.+.+++.|+++|+.|+|++   +++||||||+||||+.++.+||||||+|+... ..
T Consensus        82 ~~dh-TvL~eLe~~p--~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg  155 (396)
T KOG0593|consen   82 YCDH-TVLHELERYP--NGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG  155 (396)
T ss_pred             ecch-HHHHHHHhcc--CCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence            9998 4444454322  3488999999999999999999998   99999999999999999999999999999876 45


Q ss_pred             CcceeeccccCccchhhhcC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhc--------ccccCCC-
Q 013636          309 SRNVKISGTLGYVAPEYLLE-GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP--------QLTDRSK-  378 (439)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~--------~~~~~~~-  378 (439)
                      ........|.+|+|||.+.+ .+|....|||+.||++.||++|.+-|++.+.-+....+.....        .+..++- 
T Consensus       156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F  235 (396)
T KOG0593|consen  156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF  235 (396)
T ss_pred             chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence            55566778999999999987 7899999999999999999999999998876554433332211        1222222 


Q ss_pred             ----CCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          379 ----LPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       379 ----~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                          +|+.-++.--+..-..-..-+++++..|++.||.+|++-+|++++
T Consensus       236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H  284 (396)
T KOG0593|consen  236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH  284 (396)
T ss_pred             eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence                222222211111111223467899999999999999999999865

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-45  Score=340.12  Aligned_cols=241  Identities=26%  Similarity=0.381  Sum_probs=202.5

Q ss_pred             hcCCCccceecccCcEEEEEEEECC-ccEEEEEEecCCCc---hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGH---DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLV  227 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  227 (439)
                      .++|++.++||+|+||+||.++.++ +..+|+|.+++...   ...+...+|..+|.+++||.||+++-.+++.+.+|+|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            4678899999999999999998765 77889999876432   3456788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccC-
Q 013636          228 YEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAG-  306 (439)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~-  306 (439)
                      +||+.||.|..+|.   +.+.+++..+.-++..|+.||.|||+.   +|+||||||+|||+|++|+++|+|||+++... 
T Consensus       104 ld~~~GGeLf~hL~---~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~  177 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQ---REGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK  177 (357)
T ss_pred             EeccCCccHHHHHH---hcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence            99999999999995   345689999999999999999999998   99999999999999999999999999998543 


Q ss_pred             CCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCch
Q 013636          307 TQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPV  386 (439)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  386 (439)
                      ......+++||+.|||||++.+..|+..+|.||+|+++|||++|.+||...+.......+....     ....+..+++ 
T Consensus       178 ~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k-----~~~~p~~ls~-  251 (357)
T KOG0598|consen  178 DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK-----LPLPPGYLSE-  251 (357)
T ss_pred             CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc-----CCCCCccCCH-
Confidence            3344456799999999999999999999999999999999999999999877554333332110     1222222333 


Q ss_pred             hcCccCHHHHHHHHHHHHHhcCCCCCCCC
Q 013636          387 IRDTMDLKHLYQVAAVAVLCIQPEPSYRP  415 (439)
Q Consensus       387 l~~~~~~~~~~~l~~l~~~cl~~dP~~RP  415 (439)
                                 ...+++...++.||++|.
T Consensus       252 -----------~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  252 -----------EARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             -----------HHHHHHHHHhccCHHHhc
Confidence                       445588889999999995

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-45  Score=350.13  Aligned_cols=266  Identities=24%  Similarity=0.316  Sum_probs=219.9

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCchHHHH-HHHHHHHHHhcC-CCceeeeeeEEEeCC-eeEEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAERE-FNNEVNWLTKIR-HQNIISLLGYCIHAE-TRFLV  227 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~-~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~lV  227 (439)
                      -++|...+.||.|+||+||+|+.. .+..||||+++..-...++- =++|+..|++++ ||||+++.+++.+.+ .+++|
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV   88 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV   88 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence            467888899999999999999765 47789999998765544432 368999999998 999999999998888 99999


Q ss_pred             EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCC
Q 013636          228 YEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT  307 (439)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~  307 (439)
                      ||||+. +|++++.+.  +..+++..+..|+.||++||+|+|.+   |+.|||+||+|||+..+..+||+|||+|+....
T Consensus        89 fE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S  162 (538)
T KOG0661|consen   89 FEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRS  162 (538)
T ss_pred             HHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccccc
Confidence            999977 999999853  67899999999999999999999998   999999999999999999999999999999888


Q ss_pred             CCcceeeccccCccchhhhc-CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccC----------
Q 013636          308 QSRNVKISGTLGYVAPEYLL-EGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDR----------  376 (439)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~----------  376 (439)
                      .........|.+|+|||++. .+-|+.+.|+|++|||++|+.+-++-|.+.++.+....+..+.+.....          
T Consensus       163 kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~  242 (538)
T KOG0661|consen  163 KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLAS  242 (538)
T ss_pred             CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHH
Confidence            87777888999999999976 5789999999999999999999999999988765544444333222111          


Q ss_pred             ---CCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhc
Q 013636          377 ---SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL  424 (439)
Q Consensus       377 ---~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  424 (439)
                         -.++......+...+.. ...+.++++.+|++.||++|||+.|.+++=
T Consensus       243 ~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~p  292 (538)
T KOG0661|consen  243 AMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQHP  292 (538)
T ss_pred             HhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence               12222222223332332 566788999999999999999999999874

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-45  Score=360.87  Aligned_cols=267  Identities=28%  Similarity=0.455  Sum_probs=217.6

Q ss_pred             ccHHHHHHHhcCCCccceecccCcEEEEEEEECCc----cE-EEEEEecC---CCchHHHHHHHHHHHHHhcCCCceeee
Q 013636          143 IEYELLEAATNNFQESNVIGEGGRGHVYKARFNEK----LL-AAVKRIDD---AGHDAEREFNNEVNWLTKIRHQNIISL  214 (439)
Q Consensus       143 ~~~~~l~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~----~~-vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l  214 (439)
                      +....++...++....++||+|+||.||+|++..+    .. ||+|..+.   .......+|.+|+++|++++|||||++
T Consensus       147 I~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~  226 (474)
T KOG0194|consen  147 IPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRF  226 (474)
T ss_pred             ccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence            34445556667777789999999999999987542    23 89999885   345667889999999999999999999


Q ss_pred             eeEEEeCCeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcE
Q 013636          215 LGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA  294 (439)
Q Consensus       215 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~  294 (439)
                      +|++......++|||+|+||+|.++|...  +..++..++++++.+.|+||+|||+.   +++||||.++|||++.++.+
T Consensus       227 yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~--~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~v  301 (474)
T KOG0194|consen  227 YGVAVLEEPLMLVMELCNGGSLDDYLKKN--KKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVV  301 (474)
T ss_pred             EEEEcCCCccEEEEEecCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeE
Confidence            99999999999999999999999999753  34699999999999999999999998   99999999999999999999


Q ss_pred             EEEecccccccCCCCcce-eeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcc
Q 013636          295 KLSDFGLSVTAGTQSRNV-KISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQ  372 (439)
Q Consensus       295 kl~DfGls~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~  372 (439)
                      ||+|||+++......... ...-..+|+|||.+..+.|+.++|||||||++||+++ |..||.+....++...+...   
T Consensus       302 KISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~---  378 (474)
T KOG0194|consen  302 KISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKN---  378 (474)
T ss_pred             EeCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhc---
Confidence            999999997654211111 1124679999999999999999999999999999999 89999999877655444210   


Q ss_pred             cccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCC
Q 013636          373 LTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPT  430 (439)
Q Consensus       373 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~  430 (439)
                       ..+...+.            .....+..++.+||..+|++||+|.++.+.|+.+...
T Consensus       379 -~~r~~~~~------------~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~  423 (474)
T KOG0194|consen  379 -GYRMPIPS------------KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKK  423 (474)
T ss_pred             -CccCCCCC------------CCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhc
Confidence             00111111            2244566678899999999999999999999777654

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-45  Score=342.90  Aligned_cols=252  Identities=25%  Similarity=0.475  Sum_probs=200.3

Q ss_pred             cCCCccceecccCcEEEEEEEECC-ccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC--eeEEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE--TRFLVYE  229 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lV~e  229 (439)
                      .++...+.||+|+||+||++...+ +...|||.....+....+.+.+|+.+|++++|||||+.+|.....+  .+++.||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            345667899999999999998865 7888999987654334667899999999999999999999855555  5899999


Q ss_pred             eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC-CCcEEEEecccccccCC-
Q 013636          230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDS-SFNAKLSDFGLSVTAGT-  307 (439)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~-~~~~kl~DfGls~~~~~-  307 (439)
                      |+++|+|.+++.+..  ..+++..+.+++.|+++||+|||++   +++||||||+|||++. ++.+||+|||++..... 
T Consensus        97 y~~~GsL~~~~~~~g--~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~  171 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYG--GKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK  171 (313)
T ss_pred             ccCCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence            999999999997532  2799999999999999999999998   9999999999999999 79999999999976653 


Q ss_pred             ---CCcceeeccccCccchhhhcCCCC-CCchhhHHHHHHHHHHHhCCCCCCCC-ChhhhhhhHhhhhcccccCCCCCcc
Q 013636          308 ---QSRNVKISGTLGYVAPEYLLEGKL-TDKSDVYAFGVVLLELLMGRRPVEKM-SPTQCQSMVTWAMPQLTDRSKLPNI  382 (439)
Q Consensus       308 ---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvll~elltG~~P~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  382 (439)
                         ........||+.|||||++.++.. ..++||||+||++.||+||+.||... ........+  ...  ...+.+++.
T Consensus       172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~i--g~~--~~~P~ip~~  247 (313)
T KOG0198|consen  172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLI--GRE--DSLPEIPDS  247 (313)
T ss_pred             cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHH--hcc--CCCCCCCcc
Confidence               122234679999999999996433 35999999999999999999999863 222111111  000  011222332


Q ss_pred             CCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhcc
Q 013636          383 VDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLI  425 (439)
Q Consensus       383 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  425 (439)
                      +.            ....+++..|++.||+.|||+.+++++--
T Consensus       248 ls------------~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf  278 (313)
T KOG0198|consen  248 LS------------DEAKDFLRKCFKRDPEKRPTAEELLEHPF  278 (313)
T ss_pred             cC------------HHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence            22            24556889999999999999999998763

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.1e-44  Score=344.20  Aligned_cols=265  Identities=28%  Similarity=0.367  Sum_probs=208.8

Q ss_pred             hcCCCccceecccCcEEEEEEEE-CCccEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCceeeeeeEEEeC--CeeEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARF-NEKLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLLGYCIHA--ETRFL  226 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  226 (439)
                      .+.|+..++||+|.||.||+|+. ..+..||+|++.-..  .....-..+|+.+|++|+||||++|.+.....  ...||
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            35677778999999999999986 568899999987543  33345567999999999999999999998876  68999


Q ss_pred             EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccC
Q 013636          227 VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAG  306 (439)
Q Consensus       227 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~  306 (439)
                      |+|||++ ||.-++..  .+-.+++.++..++.|++.||+|+|++   +|+|||||.+|||||++|.+||+|||||+.+.
T Consensus       196 VFeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~  269 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYT  269 (560)
T ss_pred             EEecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeecc
Confidence            9999998 89888863  345799999999999999999999998   99999999999999999999999999999765


Q ss_pred             CCCc--ceeeccccCccchhhhcCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccC----CCC
Q 013636          307 TQSR--NVKISGTLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDR----SKL  379 (439)
Q Consensus       307 ~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~----~~~  379 (439)
                      ....  ....+-|++|+|||.+.+. .|+.+.|+||.||||.||++|++.|.+.++-+....+-.......+.    ..+
T Consensus       270 ~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kL  349 (560)
T KOG0600|consen  270 PSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKL  349 (560)
T ss_pred             CCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccC
Confidence            5442  3445579999999999874 79999999999999999999999999887655443333222211111    111


Q ss_pred             C--ccC------CchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          380 P--NIV------DPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       380 ~--~~~------d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      +  ..+      ...+++. ........++++..+|..||++|.|+.+++++
T Consensus       350 P~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s  400 (560)
T KOG0600|consen  350 PHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQS  400 (560)
T ss_pred             CcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence            1  111      1112111 11123457789999999999999999999965

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=8.8e-44  Score=348.72  Aligned_cols=260  Identities=26%  Similarity=0.422  Sum_probs=203.9

Q ss_pred             HhcCCCccceecccCcEEEEEEEE------CCccEEEEEEecCCCc-hHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCC
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARF------NEKLLAAVKRIDDAGH-DAEREFNNEVNWLTKI-RHQNIISLLGYCIHAE  222 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  222 (439)
                      ..++|++.+.||+|+||.||+|..      ..+..+|+|.+..... .....+.+|+.++..+ +||||++++++|...+
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            456888999999999999999974      2346789999875432 3345789999999999 8999999999887644


Q ss_pred             -eeEEEEEeccCCChhhhhcCCCC--------------------------------------------------------
Q 013636          223 -TRFLVYEMMQNGSLEKQLHGPTH--------------------------------------------------------  245 (439)
Q Consensus       223 -~~~lV~e~~~~gsL~~~l~~~~~--------------------------------------------------------  245 (439)
                       ..+++|||+++|+|.+++.....                                                        
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence             57899999999999999864211                                                        


Q ss_pred             ---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCcc---eeeccccC
Q 013636          246 ---GSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN---VKISGTLG  319 (439)
Q Consensus       246 ---~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~~---~~~~gt~~  319 (439)
                         ...+++..+.+++.|+++||+|||+.   +++||||||+|||+++++.+||+|||+++........   ....+++.
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence               13488889999999999999999998   9999999999999999999999999999764322211   12235678


Q ss_pred             ccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhh-hhhHhhhhcccccCCCCCccCCchhcCccCHHHHH
Q 013636          320 YVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQC-QSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLY  397 (439)
Q Consensus       320 y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  397 (439)
                      |+|||.+.+..++.++|||||||++|||++ |..||......+. ......     ......+.            ....
T Consensus       242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-----~~~~~~~~------------~~~~  304 (338)
T cd05102         242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD-----GTRMRAPE------------NATP  304 (338)
T ss_pred             ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhc-----CCCCCCCC------------CCCH
Confidence            999999999999999999999999999997 9999987543221 111100     00011111            1123


Q ss_pred             HHHHHHHHhcCCCCCCCCCHHHHHHhccccCCC
Q 013636          398 QVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPT  430 (439)
Q Consensus       398 ~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~  430 (439)
                      .+.+++.+||+.||++|||+.|+++.|+.+..+
T Consensus       305 ~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~  337 (338)
T cd05102         305 EIYRIMLACWQGDPKERPTFSALVEILGDLLQE  337 (338)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            567899999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-44  Score=350.73  Aligned_cols=249  Identities=25%  Similarity=0.439  Sum_probs=211.9

Q ss_pred             hcCCCccceecccCcEEEEEEEE-CCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEe
Q 013636          152 TNNFQESNVIGEGGRGHVYKARF-NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      ...|..-.+||+|+.|.||.|+. ..+..||+|++.......++-+.+|+.+|+..+|+|||.++..+...++.|+||||
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy  351 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY  351 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence            35677778899999999999975 45788999999887777777789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCC-
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS-  309 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~-  309 (439)
                      |++|+|.+.+...    .+++.++..|+.++++||+|||.+   +|+|||||.+|||++.+|.+||+|||++..+.... 
T Consensus       352 m~ggsLTDvVt~~----~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~  424 (550)
T KOG0578|consen  352 MEGGSLTDVVTKT----RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS  424 (550)
T ss_pred             cCCCchhhhhhcc----cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence            9999999998643    399999999999999999999998   99999999999999999999999999997765443 


Q ss_pred             cceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhh-hcccccCCCCCccCCchhc
Q 013636          310 RNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWA-MPQLTDRSKLPNIVDPVIR  388 (439)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~d~~l~  388 (439)
                      ...+..||+.|||||++....|+.|.||||||++++||+-|.+||-..+|-....++.-. .+.    -..++.+.    
T Consensus       425 KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~----lk~~~klS----  496 (550)
T KOG0578|consen  425 KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPK----LKNPEKLS----  496 (550)
T ss_pred             ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCC----cCCccccC----
Confidence            556778999999999999999999999999999999999999999876665444444311 111    11122222    


Q ss_pred             CccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          389 DTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       389 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                              ..+.++..+||+.||++||+++|+|+|
T Consensus       497 --------~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  497 --------PELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             --------HHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence                    345568888999999999999999975

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-44  Score=353.48  Aligned_cols=264  Identities=30%  Similarity=0.488  Sum_probs=213.2

Q ss_pred             HHHHHHhcCCCccceecccCcEEEEEEEECCccEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCe
Q 013636          146 ELLEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAET  223 (439)
Q Consensus       146 ~~l~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  223 (439)
                      ++++...+.+.+...||+|+||+||+|++.+.  ||||.++...  .+..+.|.+|+..+++.+|.||+-+.|||.+...
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd--VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~  462 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD--VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL  462 (678)
T ss_pred             cccccCHHHhhccceeccccccceeecccccc--eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence            56677777788899999999999999999875  6888886543  3455789999999999999999999999988777


Q ss_pred             eEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccccc
Q 013636          224 RFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSV  303 (439)
Q Consensus       224 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~  303 (439)
                       .+|+.+|++-+|+.++|-.  ...++..+.++||.|+|+||.|||.+   +|+|||||+.||++.++++|||+|||++.
T Consensus       463 -AIiTqwCeGsSLY~hlHv~--etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLat  536 (678)
T KOG0193|consen  463 -AIITQWCEGSSLYTHLHVQ--ETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLAT  536 (678)
T ss_pred             -eeeehhccCchhhhhccch--hhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEeccccee
Confidence             9999999999999999953  35688999999999999999999998   99999999999999999999999999985


Q ss_pred             ccCC---CCcceeeccccCccchhhhcC---CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCC
Q 013636          304 TAGT---QSRNVKISGTLGYVAPEYLLE---GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRS  377 (439)
Q Consensus       304 ~~~~---~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  377 (439)
                      ....   ........|...|||||++..   .+|+..+||||||+++|||++|..||...+.++...++..       ..
T Consensus       537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGr-------G~  609 (678)
T KOG0193|consen  537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGR-------GY  609 (678)
T ss_pred             eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecc-------cc
Confidence            4321   111122347788999999974   4789999999999999999999999995554443333221       10


Q ss_pred             CCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCC
Q 013636          378 KLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPT  430 (439)
Q Consensus       378 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~  430 (439)
                      ..++....      ...+...|.+++..||..++++||.+.+++..|+.+.+.
T Consensus       610 l~pd~s~~------~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~  656 (678)
T KOG0193|consen  610 LMPDLSKI------RSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS  656 (678)
T ss_pred             cCccchhh------hccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence            01111111      113455778899999999999999999999999888874

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-43  Score=343.78  Aligned_cols=249  Identities=28%  Similarity=0.416  Sum_probs=209.5

Q ss_pred             HhcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCC----Cc-hHHHHHHHHHHHHHhcC-CCceeeeeeEEEeCCe
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDA----GH-DAEREFNNEVNWLTKIR-HQNIISLLGYCIHAET  223 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~  223 (439)
                      ..++|...+.||+|+||+|+.|... .+..+|+|.++..    .. ...+.+.+|+.++++++ ||||++++.++...+.
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            3468888999999999999999764 5689999976653    11 23456778999999999 9999999999999999


Q ss_pred             eEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC-CcEEEEecccc
Q 013636          224 RFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS-FNAKLSDFGLS  302 (439)
Q Consensus       224 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~-~~~kl~DfGls  302 (439)
                      .++||||+.+|+|.+++..   .+.+.+....+++.|++.|++|||+.   +|+||||||+|+|++.+ +++||+|||++
T Consensus        95 ~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s  168 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLS  168 (370)
T ss_pred             EEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence            9999999999999999974   45688899999999999999999998   99999999999999999 99999999999


Q ss_pred             ccc-CCCCcceeeccccCccchhhhcCCC-CC-CchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCC
Q 013636          303 VTA-GTQSRNVKISGTLGYVAPEYLLEGK-LT-DKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKL  379 (439)
Q Consensus       303 ~~~-~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  379 (439)
                      ... .......+.+||+.|+|||++.+.. |+ .++||||+||+||-|++|+.||+..+.......+      ......+
T Consensus       169 ~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki------~~~~~~~  242 (370)
T KOG0583|consen  169 AISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKI------RKGEFKI  242 (370)
T ss_pred             cccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHH------hcCCccC
Confidence            887 4555556788999999999999977 75 7899999999999999999999986544332222      2233455


Q ss_pred             CccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 013636          380 PNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLH  422 (439)
Q Consensus       380 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  422 (439)
                      +..++           ...+..++.+|++.||.+|+|+.++++
T Consensus       243 p~~~~-----------S~~~~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  243 PSYLL-----------SPEARSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             CCCcC-----------CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence            55552           124566899999999999999999993

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=3.4e-42  Score=381.50  Aligned_cols=263  Identities=31%  Similarity=0.540  Sum_probs=212.6

Q ss_pred             hcCCCccceecccCcEEEEEEEE-CCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEe
Q 013636          152 TNNFQESNVIGEGGRGHVYKARF-NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      ...+...++||+|+||.||+|+. .++..+|+|++.......    .+|++.+++++||||++++++|.+.+..++||||
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey  764 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY  764 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc----HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence            34577788999999999999987 468899999987543222    3468889999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR  310 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~  310 (439)
                      +++|+|.++++.      ++|..+.+++.|+|+|++|||+.+.++++||||||+||+++.++..++. ||......... 
T Consensus       765 ~~~g~L~~~l~~------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~~-  836 (968)
T PLN00113        765 IEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDT-  836 (968)
T ss_pred             CCCCcHHHHHhc------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccCC-
Confidence            999999999952      8899999999999999999997766799999999999999999988875 66654332211 


Q ss_pred             ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCc
Q 013636          311 NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDT  390 (439)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  390 (439)
                        ...+|+.|+|||++.+..++.++|||||||++|||+||+.||+.... .....+.|+..... ......++|+.+...
T Consensus       837 --~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  912 (968)
T PLN00113        837 --KCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYS-DCHLDMWIDPSIRGD  912 (968)
T ss_pred             --CccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcC-ccchhheeCccccCC
Confidence              22478999999999999999999999999999999999999964322 22344455433221 223445566666432


Q ss_pred             --cCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCC
Q 013636          391 --MDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPT  430 (439)
Q Consensus       391 --~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~  430 (439)
                        ...++..++.+++.+||+.||++||||.|+++.|+.+...
T Consensus       913 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  954 (968)
T PLN00113        913 VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS  954 (968)
T ss_pred             CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence              3456777899999999999999999999999999988764

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-44  Score=350.04  Aligned_cols=256  Identities=29%  Similarity=0.511  Sum_probs=209.9

Q ss_pred             HHHHHhcCCCccceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEE
Q 013636          147 LLEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFL  226 (439)
Q Consensus       147 ~l~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  226 (439)
                      .++...+.....+-||.|+.|.||+|++.+.+ ||||+++...       ..+++-|++|+||||+.+.|+|.....+||
T Consensus       118 ~WeiPFe~IsELeWlGSGaQGAVF~Grl~net-VAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCI  189 (904)
T KOG4721|consen  118 LWEIPFEEISELEWLGSGAQGAVFLGRLHNET-VAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCI  189 (904)
T ss_pred             hccCCHHHhhhhhhhccCcccceeeeeccCce-ehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEE
Confidence            34444444455677999999999999998654 6888876432       347888999999999999999999999999


Q ss_pred             EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccC
Q 013636          227 VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAG  306 (439)
Q Consensus       227 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~  306 (439)
                      |||||..|-|...|+   .+..++......+..+||.||.|||.+   .|||||||+-||||..+..+||+|||-++...
T Consensus       190 iMEfCa~GqL~~VLk---a~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~  263 (904)
T KOG4721|consen  190 IMEFCAQGQLYEVLK---AGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELS  263 (904)
T ss_pred             eeeccccccHHHHHh---ccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhh
Confidence            999999999999995   456789999999999999999999998   99999999999999999999999999998877


Q ss_pred             CCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCch
Q 013636          307 TQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPV  386 (439)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  386 (439)
                      .......++||..|||||++.+.+.+.|+|||||||+||||+||..||.+.+...    +-|...    ...        
T Consensus       264 ~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA----IIwGVG----sNs--------  327 (904)
T KOG4721|consen  264 DKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA----IIWGVG----SNS--------  327 (904)
T ss_pred             hhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe----eEEecc----CCc--------
Confidence            6666677889999999999999999999999999999999999999998765332    222211    111        


Q ss_pred             hcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCCCC
Q 013636          387 IRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPTDL  432 (439)
Q Consensus       387 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~~~  432 (439)
                      +.-.+...+..-+.-++.+||+..|..||++.+++.||+-.-++.+
T Consensus       328 L~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pell  373 (904)
T KOG4721|consen  328 LHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPELL  373 (904)
T ss_pred             ccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHh
Confidence            1111122333445558889999999999999999999976555433

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-43  Score=330.67  Aligned_cols=260  Identities=27%  Similarity=0.421  Sum_probs=208.5

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCchH-HHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDA-EREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYE  229 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  229 (439)
                      .+.|+..+.||.|..++||+|+.. .+..||||+++-...+. .+.+.+|+..|+.++||||++++..|..++.+|+||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            367888899999999999999864 46889999998554433 4789999999999999999999999999999999999


Q ss_pred             eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCC
Q 013636          230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS  309 (439)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~  309 (439)
                      ||.+||+.+.+...- ...+++..+..|..++++||.|||.+   |.+|||||+.||||+.+|.+||+|||.+..+....
T Consensus       105 fMa~GS~ldIik~~~-~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G  180 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYY-PDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG  180 (516)
T ss_pred             hhcCCcHHHHHHHHc-cccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence            999999999997522 23499999999999999999999998   99999999999999999999999999885543322


Q ss_pred             cc-----eeeccccCccchhhhcC--CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCcc
Q 013636          310 RN-----VKISGTLGYVAPEYLLE--GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNI  382 (439)
Q Consensus       310 ~~-----~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  382 (439)
                      ..     ..+.||+.|||||++..  .-|+.|+||||||++..||.+|..||..+.|..+.-+-      +...  .+..
T Consensus       181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~t------Lqn~--pp~~  252 (516)
T KOG0582|consen  181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLT------LQND--PPTL  252 (516)
T ss_pred             ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHH------hcCC--CCCc
Confidence            11     23469999999999543  46899999999999999999999999998876532211      1111  1111


Q ss_pred             CCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          383 VDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       383 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      ....+...........+.+++..||+.||++|||+.+++.+
T Consensus       253 ~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  253 LTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             ccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence            11112222222334478889999999999999999999854

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-43  Score=333.29  Aligned_cols=264  Identities=28%  Similarity=0.411  Sum_probs=197.1

Q ss_pred             CCCccceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhc--CCCceeeeeeEEEeCC----eeEEE
Q 013636          154 NFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKI--RHQNIISLLGYCIHAE----TRFLV  227 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~~----~~~lV  227 (439)
                      ..+..+++|+|+||.||||++.+ +.||||++..   +....|.+|-++.+..  +|+||++++++-...+    +++||
T Consensus       211 pl~l~eli~~Grfg~V~KaqL~~-~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV  286 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQLDN-RLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV  286 (534)
T ss_pred             chhhHHHhhcCccceeehhhccC-ceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence            33446789999999999999987 6789999975   4556788888887764  8999999999987766    88999


Q ss_pred             EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc------CCCCeEecCCCCCCEEEcCCCcEEEEeccc
Q 013636          228 YEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH------CNHPVVHRDLKSSNILLDSSFNAKLSDFGL  301 (439)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~------~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGl  301 (439)
                      ++|.++|+|.+||...    .++|....+|+..+++||+|||+.      .+++|+|||||++||||.+|+++.|+|||+
T Consensus       287 t~fh~kGsL~dyL~~n----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL  362 (534)
T KOG3653|consen  287 TEFHPKGSLCDYLKAN----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL  362 (534)
T ss_pred             eeeccCCcHHHHHHhc----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence            9999999999999754    489999999999999999999963      467899999999999999999999999999


Q ss_pred             ccccCCCCc---ceeeccccCccchhhhcCCC-CC-----CchhhHHHHHHHHHHHhCCCCCCCCC--------hhhhhh
Q 013636          302 SVTAGTQSR---NVKISGTLGYVAPEYLLEGK-LT-----DKSDVYAFGVVLLELLMGRRPVEKMS--------PTQCQS  364 (439)
Q Consensus       302 s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~-~~-----~~~DvwS~Gvll~elltG~~P~~~~~--------~~~~~~  364 (439)
                      |..+.....   .....||.+|||||++.+.- +.     .+.||||+|.+||||++...-++...        +.++.+
T Consensus       363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~  442 (534)
T KOG3653|consen  363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN  442 (534)
T ss_pred             eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence            977654322   22356999999999998642 22     37899999999999999654432111        001100


Q ss_pred             --hHhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCC
Q 013636          365 --MVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVP  429 (439)
Q Consensus       365 --~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~  429 (439)
                        .++...........-|.+.|.-.+.    ..+..+.+.+..||+.||+.|.|+.=|-+++.++..
T Consensus       443 hPt~e~mq~~VV~kK~RP~~p~~W~~h----~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~  505 (534)
T KOG3653|consen  443 HPTLEEMQELVVRKKQRPKIPDAWRKH----AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM  505 (534)
T ss_pred             CCCHHHHHHHHHhhccCCCChhhhhcC----ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence              0000000111112222222222222    446778899999999999999999887777655543

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.3e-42  Score=332.01  Aligned_cols=246  Identities=23%  Similarity=0.383  Sum_probs=199.0

Q ss_pred             cceecccCcEEEEEEEECCccEEEEEEecCCCchH---HHHHHHHHHHHHhcCCCceeeeeeEEEe----CCeeEEEEEe
Q 013636          158 SNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDA---EREFNNEVNWLTKIRHQNIISLLGYCIH----AETRFLVYEM  230 (439)
Q Consensus       158 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~e~  230 (439)
                      ...||+|++|.||+|++ ++..+|+|.+.......   .+.|.+|+.+|++++||||+++++++.+    ....++||||
T Consensus        25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            36799999999999998 46788999987643322   4678899999999999999999999877    3467899999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR  310 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~  310 (439)
                      +++|+|.+++..   ...+++....+++.|++.|++|||+.  .+++||||||+||++++++.+||+|||++....... 
T Consensus       104 ~~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-  177 (283)
T PHA02988        104 CTRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-  177 (283)
T ss_pred             CCCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence            999999999964   34689999999999999999999974  267899999999999999999999999987654322 


Q ss_pred             ceeeccccCccchhhhcC--CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhc
Q 013636          311 NVKISGTLGYVAPEYLLE--GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIR  388 (439)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  388 (439)
                       ....|+..|+|||.+.+  ..++.++|||||||++|||++|+.||...+..+....+...    ..+...+        
T Consensus       178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~----~~~~~~~--------  244 (283)
T PHA02988        178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINK----NNSLKLP--------  244 (283)
T ss_pred             -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc----CCCCCCC--------
Confidence             23347899999999976  68999999999999999999999999887655433322100    0011111        


Q ss_pred             CccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhcccc
Q 013636          389 DTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPL  427 (439)
Q Consensus       389 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l  427 (439)
                          ......+.+++.+||+.||++|||++|+++.|+++
T Consensus       245 ----~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~  279 (283)
T PHA02988        245 ----LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY  279 (283)
T ss_pred             ----CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence                01234577899999999999999999999998765

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=4.5e-42  Score=331.54  Aligned_cols=260  Identities=27%  Similarity=0.421  Sum_probs=202.2

Q ss_pred             cCCCccceecccCcEEEEEEEECC-----------------ccEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCceeee
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNE-----------------KLLAAVKRIDDAG-HDAEREFNNEVNWLTKIRHQNIISL  214 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l  214 (439)
                      ++|++.+.||+|+||.||++.+++                 +..+|+|.+.... .....+|.+|+.++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            578888999999999999997643                 3368999887643 3344679999999999999999999


Q ss_pred             eeEEEeCCeeEEEEEeccCCChhhhhcCCC----------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 013636          215 LGYCIHAETRFLVYEMMQNGSLEKQLHGPT----------------HGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVH  278 (439)
Q Consensus       215 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH  278 (439)
                      ++++...+..++||||+++|+|.+++....                ....+++..+.+++.|++.||+|||+.   +++|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence            999999999999999999999999985421                113578899999999999999999998   9999


Q ss_pred             cCCCCCCEEEcCCCcEEEEecccccccCCCCcc---eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh--CCCC
Q 013636          279 RDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN---VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM--GRRP  353 (439)
Q Consensus       279 ~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt--G~~P  353 (439)
                      |||||+|||+++++.+||+|||++.........   ....++..|+|||++..+.++.++||||||+++|||++  +..|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            999999999999999999999999765332221   12235778999999999999999999999999999987  6678


Q ss_pred             CCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhcc
Q 013636          354 VEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLI  425 (439)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  425 (439)
                      |...+..+.......   .............       .......+.+++.+||+.||++|||+.+|.+.|+
T Consensus       242 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~-------~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         242 YGELTDEQVIENAGE---FFRDQGRQVYLFR-------PPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCcCCHHHHHHHHHH---HhhhccccccccC-------CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            876654432221111   1110000000000       0112346788999999999999999999998875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.4e-42  Score=330.49  Aligned_cols=252  Identities=25%  Similarity=0.352  Sum_probs=201.2

Q ss_pred             CCCccceecccCcEEEEEEEE-CCccEEEEEEecCCC---chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEE
Q 013636          154 NFQESNVIGEGGRGHVYKARF-NEKLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYE  229 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  229 (439)
                      .|+..+.||+|+||+||++.. .++..+|+|.+....   ......+.+|+.++++++|+|++++.+++...+..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            366788999999999999987 467899999886432   2233467899999999999999999999999999999999


Q ss_pred             eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCC
Q 013636          230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS  309 (439)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~  309 (439)
                      |+++|+|.+++... ....+++..+..++.|++.||+|||+.   +++||||||+|||+++++.+||+|||++.......
T Consensus        81 ~~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05631          81 IMNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE  156 (285)
T ss_pred             ecCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence            99999999887542 223589999999999999999999998   99999999999999999999999999997754433


Q ss_pred             cceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcC
Q 013636          310 RNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRD  389 (439)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  389 (439)
                      ......||..|+|||.+.+..++.++|||||||++|||++|+.||...........+.....  ......+        .
T Consensus       157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~--------~  226 (285)
T cd05631         157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVK--EDQEEYS--------E  226 (285)
T ss_pred             eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhh--cccccCC--------c
Confidence            33344689999999999999999999999999999999999999987543221111111000  0001111        1


Q ss_pred             ccCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHh
Q 013636          390 TMDLKHLYQVAAVAVLCIQPEPSYRPL-----ITDVLHS  423 (439)
Q Consensus       390 ~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~  423 (439)
                          .....+.+++..||+.||++||+     +.+++++
T Consensus       227 ----~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         227 ----KFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             ----cCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence                11235667999999999999997     8888865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.2e-42  Score=309.07  Aligned_cols=264  Identities=26%  Similarity=0.342  Sum_probs=208.8

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGH--DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYE  229 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  229 (439)
                      ++|...+.||+|.||.||+|+.. .++.||||+++....  .-.....+|++.|+.++|+||+.+++++.+.+...||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            35666788999999999999864 588999999975432  223567899999999999999999999999999999999


Q ss_pred             eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCC
Q 013636          230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS  309 (439)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~  309 (439)
                      ||+. +|+..++.  ....++..++..++.++.+|++|||+.   .|+||||||.|+|++++|.+||+|||+++.++...
T Consensus        82 fm~t-dLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~  155 (318)
T KOG0659|consen   82 FMPT-DLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN  155 (318)
T ss_pred             eccc-cHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence            9987 99999974  345799999999999999999999998   99999999999999999999999999999887654


Q ss_pred             cce-eeccccCccchhhhcC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhccc-----ccCCCCCcc
Q 013636          310 RNV-KISGTLGYVAPEYLLE-GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQL-----TDRSKLPNI  382 (439)
Q Consensus       310 ~~~-~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~  382 (439)
                      ... ...-|.+|+|||.+.+ ..|+...|+||.||++.||+.|.+-|.+.+.-+....+-.+....     .+-..+++.
T Consensus       156 ~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY  235 (318)
T KOG0659|consen  156 RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY  235 (318)
T ss_pred             cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence            432 2357899999999887 579999999999999999999988888876654444443322211     111111111


Q ss_pred             C------CchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          383 V------DPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       383 ~------d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      .      .+.... .-........+++..++..||.+|+|+.|++++
T Consensus       236 ~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  236 VKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             HHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            1      111111 112234456899999999999999999999965

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-43  Score=336.81  Aligned_cols=250  Identities=25%  Similarity=0.348  Sum_probs=206.2

Q ss_pred             HhcCCCccceecccCcEEEEEEEECC-ccEEEEEEecCCC---chHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeeE
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAG---HDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRF  225 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  225 (439)
                      ..++|..++.||+|+|++|++|+... +..+|||.+.+.-   ....+.+..|-+.|.+| .||.|++|+..+.+...+|
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY  150 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY  150 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence            34678889999999999999998754 7889999987532   12234567888999999 8999999999999999999


Q ss_pred             EEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccccccc
Q 013636          226 LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA  305 (439)
Q Consensus       226 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~  305 (439)
                      +|+||+++|+|.+++++.   +.+++.....++.+|+.||+|||+.   |||||||||+|||+|+|+++||+|||-|+.+
T Consensus       151 FvLe~A~nGdll~~i~K~---Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l  224 (604)
T KOG0592|consen  151 FVLEYAPNGDLLDLIKKY---GSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKIL  224 (604)
T ss_pred             EEEEecCCCcHHHHHHHh---CcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccC
Confidence            999999999999999753   5689999999999999999999998   9999999999999999999999999999765


Q ss_pred             CCCCc------------c--eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhc
Q 013636          306 GTQSR------------N--VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP  371 (439)
Q Consensus       306 ~~~~~------------~--~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~  371 (439)
                      .....            .  ..++||..|.+||++.++..+..+|+|+|||+||+|+.|++||...++--....+.    
T Consensus       225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~----  300 (604)
T KOG0592|consen  225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQ----  300 (604)
T ss_pred             ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHH----
Confidence            33211            1  34789999999999999999999999999999999999999999877532211111    


Q ss_pred             ccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhc
Q 013636          372 QLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL  424 (439)
Q Consensus       372 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  424 (439)
                        .-.-.+++-+.+            ...+|+...|..||++|+|..++-+|-
T Consensus       301 --~l~y~fp~~fp~------------~a~dLv~KLLv~dp~~Rlt~~qIk~Hp  339 (604)
T KOG0592|consen  301 --ALDYEFPEGFPE------------DARDLIKKLLVRDPSDRLTSQQIKAHP  339 (604)
T ss_pred             --HhcccCCCCCCH------------HHHHHHHHHHccCccccccHHHHhhCc
Confidence              112233333333            445688899999999999999988663

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-42  Score=324.73  Aligned_cols=277  Identities=26%  Similarity=0.358  Sum_probs=210.3

Q ss_pred             CccccccHHHHHHHhcCCCccceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHh--cCCCceeeee
Q 013636          138 DTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTK--IRHQNIISLL  215 (439)
Q Consensus       138 ~~~~~~~~~~l~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~  215 (439)
                      ++.+..+.-..+....+.+..+.||+|+||+||+|+++++ .||||++...   +++.+.+|.++.+.  |+|+||+.++
T Consensus       196 GSGSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~wrGe-~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFI  271 (513)
T KOG2052|consen  196 GSGSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWRGE-DVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFI  271 (513)
T ss_pred             CCCCCchhHhHHhhhheeEEEEEecCccccceeeccccCC-ceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhh
Confidence            4445566666778888999999999999999999999865 5799999753   44566777777765  5999999999


Q ss_pred             eEEEeCC----eeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-----cCCCCeEecCCCCCCE
Q 013636          216 GYCIHAE----TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHE-----HCNHPVVHRDLKSSNI  286 (439)
Q Consensus       216 ~~~~~~~----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~-----~~~~~ivH~Dlk~~Ni  286 (439)
                      +.-..++    .++||++|.++|||+|||.+    ..++....++++..+|.||+|||.     +.++.|.|||||+.||
T Consensus       272 aaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNI  347 (513)
T KOG2052|consen  272 AADNKDNGSWTQLWLVTDYHEHGSLYDYLNR----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNI  347 (513)
T ss_pred             hccccCCCceEEEEEeeecccCCcHHHHHhh----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccE
Confidence            9876543    67999999999999999975    359999999999999999999994     5678899999999999


Q ss_pred             EEcCCCcEEEEecccccccCCCCcc-----eeeccccCccchhhhcCCC------CCCchhhHHHHHHHHHHHhC-----
Q 013636          287 LLDSSFNAKLSDFGLSVTAGTQSRN-----VKISGTLGYVAPEYLLEGK------LTDKSDVYAFGVVLLELLMG-----  350 (439)
Q Consensus       287 Ll~~~~~~kl~DfGls~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~------~~~~~DvwS~Gvll~elltG-----  350 (439)
                      |+.+++.+.|+|+|||.........     ...+||.+|||||++...-      .-..+||||||.++||+.-.     
T Consensus       348 LVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~gg  427 (513)
T KOG2052|consen  348 LVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGG  427 (513)
T ss_pred             EEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCC
Confidence            9999999999999999776554322     2346999999999987532      12379999999999998752     


Q ss_pred             -----CCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhcc
Q 013636          351 -----RRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLI  425 (439)
Q Consensus       351 -----~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  425 (439)
                           +.||.+..+.+-. ..+  |....-..++...++.   ...+.+.+..+.+++..||..||.-|-|+--+-..|.
T Consensus       428 i~eey~~Pyyd~Vp~DPs-~ee--MrkVVCv~~~RP~ipn---rW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~  501 (513)
T KOG2052|consen  428 IVEEYQLPYYDVVPSDPS-FEE--MRKVVCVQKLRPNIPN---RWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLA  501 (513)
T ss_pred             EehhhcCCcccCCCCCCC-HHH--HhcceeecccCCCCCc---ccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHH
Confidence                 5677665432210 000  0000001111111111   1223467889999999999999999999988888777


Q ss_pred             ccC
Q 013636          426 PLV  428 (439)
Q Consensus       426 ~l~  428 (439)
                      ++.
T Consensus       502 ~l~  504 (513)
T KOG2052|consen  502 KLS  504 (513)
T ss_pred             HHh
Confidence            665

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=5.9e-42  Score=324.40  Aligned_cols=253  Identities=25%  Similarity=0.370  Sum_probs=204.5

Q ss_pred             cCCCccceecccCcEEEEEEEEC----CccEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN----EKLLAAVKRIDDAGH-DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLV  227 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  227 (439)
                      ++|++.+.||+|+||.||+|.+.    .+..+|+|.++.... ...+.|.+|+..+++++||||+++++++..++..++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            56888899999999999999764    356889999876533 3345789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCC
Q 013636          228 YEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT  307 (439)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~  307 (439)
                      |||+++|+|.+++...  ...+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+|++|||.+.....
T Consensus        85 ~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~  159 (266)
T cd05064          85 TEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS  159 (266)
T ss_pred             EEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence            9999999999999742  34689999999999999999999998   999999999999999999999999998765432


Q ss_pred             CCcce--eeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCccCC
Q 013636          308 QSRNV--KISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVD  384 (439)
Q Consensus       308 ~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  384 (439)
                      .....  ...++..|+|||.+.+..++.++|||||||++||+++ |..||...+..+....+.       +....+    
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~-------~~~~~~----  228 (266)
T cd05064         160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVE-------DGFRLP----  228 (266)
T ss_pred             cchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH-------CCCCCC----
Confidence            21111  1224678999999999999999999999999999875 999998776544222221       111100    


Q ss_pred             chhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhcccc
Q 013636          385 PVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPL  427 (439)
Q Consensus       385 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l  427 (439)
                        ..    ......+.+++.+||+.+|++||++.++++.|..+
T Consensus       229 --~~----~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         229 --AP----RNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             --CC----CCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence              00    11234577899999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-42  Score=311.48  Aligned_cols=236  Identities=25%  Similarity=0.383  Sum_probs=201.8

Q ss_pred             cCCCccceecccCcEEEEEEEECC-ccEEEEEEecCCCchH---HHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDA---EREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      ++|+..+.||.|+||.|..++.+. +..+|+|.++...-..   .+...+|..+|+.+.||.++++++.+.+.+..++||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            567778999999999999998864 7788999998654333   345778999999999999999999999999999999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~  308 (439)
                      ||++||.|..+|++   .+.+++.....+|.||+.|++|||+.   +|++|||||+|||+|.+|.+||+|||+|+.....
T Consensus       124 eyv~GGElFS~Lrk---~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r  197 (355)
T KOG0616|consen  124 EYVPGGELFSYLRK---SGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR  197 (355)
T ss_pred             eccCCccHHHHHHh---cCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence            99999999999974   34689999999999999999999998   9999999999999999999999999999887543


Q ss_pred             CcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhc
Q 013636          309 SRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIR  388 (439)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  388 (439)
                        ..+.||||.|+|||.++...+..++|.|||||++|||+.|.+||...++......+      +..+-.+|..+++.++
T Consensus       198 --T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI------~~~~v~fP~~fs~~~k  269 (355)
T KOG0616|consen  198 --TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKI------LEGKVKFPSYFSSDAK  269 (355)
T ss_pred             --EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHH------HhCcccCCcccCHHHH
Confidence              56789999999999999999999999999999999999999999988875443333      2334456666666554


Q ss_pred             CccCHHHHHHHHHHHHHhcCCCCCCC
Q 013636          389 DTMDLKHLYQVAAVAVLCIQPEPSYR  414 (439)
Q Consensus       389 ~~~~~~~~~~l~~l~~~cl~~dP~~R  414 (439)
                      +            ++...++.|-.+|
T Consensus       270 d------------Ll~~LL~vD~t~R  283 (355)
T KOG0616|consen  270 D------------LLKKLLQVDLTKR  283 (355)
T ss_pred             H------------HHHHHHhhhhHhh
Confidence            4            6666777777776

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1e-41  Score=333.26  Aligned_cols=265  Identities=24%  Similarity=0.380  Sum_probs=205.9

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG-HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYE  229 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  229 (439)
                      .++|++.+.||+|+||.||+++.. .+..+|+|.+.... ......+.+|++++++++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            368888999999999999999886 46778888887543 2334679999999999999999999999999999999999


Q ss_pred             eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCC
Q 013636          230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS  309 (439)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~  309 (439)
                      |+++|+|.+++..   ...+++..+..++.|++.||.|||+.  .+++||||||+|||+++++.+||+|||++.......
T Consensus        84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  158 (331)
T cd06649          84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  158 (331)
T ss_pred             cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence            9999999999964   23588999999999999999999985  269999999999999999999999999987653322


Q ss_pred             cceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCcc-------
Q 013636          310 RNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNI-------  382 (439)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------  382 (439)
                       .....||+.|+|||.+.+..++.++|||||||++|||++|+.||...+..+....+....  ..........       
T Consensus       159 -~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~  235 (331)
T cd06649         159 -ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPV--VDGEEGEPHSISPRPRP  235 (331)
T ss_pred             -cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccc--cccccCCccccCccccc
Confidence             223458999999999999999999999999999999999999997665443322211100  0000000000       


Q ss_pred             ---------CCc------------hh----cCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhc
Q 013636          383 ---------VDP------------VI----RDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL  424 (439)
Q Consensus       383 ---------~d~------------~l----~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  424 (439)
                               .+.            ..    ...........+.+++.+||+.||++|||++|++++-
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~  302 (331)
T cd06649         236 PGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT  302 (331)
T ss_pred             ccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence                     000            00    0000011234678899999999999999999999874

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.3e-42  Score=345.18  Aligned_cols=259  Identities=24%  Similarity=0.369  Sum_probs=204.1

Q ss_pred             HHhcCCCccceecccCcEEEEEEEE------CCccEEEEEEecCCC-chHHHHHHHHHHHHHhc-CCCceeeeeeEEEeC
Q 013636          150 AATNNFQESNVIGEGGRGHVYKARF------NEKLLAAVKRIDDAG-HDAEREFNNEVNWLTKI-RHQNIISLLGYCIHA  221 (439)
Q Consensus       150 ~~~~~~~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  221 (439)
                      ...++|+..+.||+|+||.||+|+.      +.+..+|+|.++... ....+.+.+|+.++..+ +||||++++++|...
T Consensus        32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~  111 (375)
T cd05104          32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVG  111 (375)
T ss_pred             cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence            3345788899999999999999964      235678999987543 33445788999999999 899999999999999


Q ss_pred             CeeEEEEEeccCCChhhhhcCCCC--------------------------------------------------------
Q 013636          222 ETRFLVYEMMQNGSLEKQLHGPTH--------------------------------------------------------  245 (439)
Q Consensus       222 ~~~~lV~e~~~~gsL~~~l~~~~~--------------------------------------------------------  245 (439)
                      +..++||||+++|+|.++++....                                                        
T Consensus       112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (375)
T cd05104         112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS  191 (375)
T ss_pred             CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence            999999999999999999864210                                                        


Q ss_pred             ----------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCC
Q 013636          246 ----------------GSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS  309 (439)
Q Consensus       246 ----------------~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~  309 (439)
                                      ...+++..+.+++.|+++||+|||+.   +++||||||+|||+++++.+||+|||++.......
T Consensus       192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~  268 (375)
T cd05104         192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDS  268 (375)
T ss_pred             ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence                            12478999999999999999999997   99999999999999999999999999997654332


Q ss_pred             cce---eeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCc
Q 013636          310 RNV---KISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDP  385 (439)
Q Consensus       310 ~~~---~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  385 (439)
                      ...   ...++..|+|||.+.+..++.++|||||||++|||++ |..||........  .........  ....+..   
T Consensus       269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~--~~~~~~~~~--~~~~~~~---  341 (375)
T cd05104         269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK--FYKMIKEGY--RMLSPEC---  341 (375)
T ss_pred             cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH--HHHHHHhCc--cCCCCCC---
Confidence            211   1224567999999999999999999999999999998 8999976543221  111111000  0001111   


Q ss_pred             hhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhcccc
Q 013636          386 VIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPL  427 (439)
Q Consensus       386 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l  427 (439)
                               ...++.+++.+||+.||++|||+.|+++.|++.
T Consensus       342 ---------~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         342 ---------APSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             ---------CCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence                     123577899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-42  Score=330.37  Aligned_cols=246  Identities=24%  Similarity=0.321  Sum_probs=203.4

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC---chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      ++|++.+.||+|+||.||++... ++..+|+|.+....   ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            46888899999999999999886 57889999986432   123456889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~  308 (439)
                      ||+++|+|.+++..   ...+++.....++.|++.||+|||+.   +++||||||+|||+++++.+||+|||++......
T Consensus        81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  154 (291)
T cd05612          81 EYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR  154 (291)
T ss_pred             eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence            99999999999964   34689999999999999999999998   9999999999999999999999999999765432


Q ss_pred             CcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhc
Q 013636          309 SRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIR  388 (439)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  388 (439)
                        .....||+.|+|||.+.+..++.++|||||||++|||++|+.||...+..+....+..      ....++..+     
T Consensus       155 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~------~~~~~~~~~-----  221 (291)
T cd05612         155 --TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILA------GKLEFPRHL-----  221 (291)
T ss_pred             --cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh------CCcCCCccC-----
Confidence              2234689999999999999999999999999999999999999987665443222211      111222222     


Q ss_pred             CccCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHhc
Q 013636          389 DTMDLKHLYQVAAVAVLCIQPEPSYRPL-----ITDVLHSL  424 (439)
Q Consensus       389 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~L  424 (439)
                             ...+.+++.+||+.||.+||+     +.|++++-
T Consensus       222 -------~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~  255 (291)
T cd05612         222 -------DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHR  255 (291)
T ss_pred             -------CHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCc
Confidence                   224667999999999999995     89988763

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=3.1e-42  Score=325.17  Aligned_cols=247  Identities=36%  Similarity=0.604  Sum_probs=195.0

Q ss_pred             ccceecccCcEEEEEEEEC-----CccEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEe
Q 013636          157 ESNVIGEGGRGHVYKARFN-----EKLLAAVKRIDDAGH-DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       157 ~~~~LG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      ..+.||.|.||.||+|.+.     .+..|+||.++.... ...+.|.+|++.+++++||||++++|+|...+..++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            3578999999999999887     367889999966433 3467899999999999999999999999988889999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR  310 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~  310 (439)
                      +++|+|.++|+.. ....+++..+..|+.|+++||+|||+.   +++|+||+++||++++++.+||+|||++........
T Consensus        83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred             ccccccccccccc-ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence            9999999999864 245699999999999999999999998   999999999999999999999999999977632222


Q ss_pred             c---eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCch
Q 013636          311 N---VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPV  386 (439)
Q Consensus       311 ~---~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  386 (439)
                      .   ........|+|||.+.+..++.++||||||+++|||++ |+.||...+..+....+....     ....+.     
T Consensus       159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~-----~~~~~~-----  228 (259)
T PF07714_consen  159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQ-----RLPIPD-----  228 (259)
T ss_dssp             EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTE-----ETTSBT-----
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-----cceecc-----
Confidence            1   11236678999999999999999999999999999999 789998776554332322110     000111     


Q ss_pred             hcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhc
Q 013636          387 IRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL  424 (439)
Q Consensus       387 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  424 (439)
                             .....+.+++.+||+.||++|||+.++++.|
T Consensus       229 -------~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  229 -------NCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             -------TSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             -------chhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                   1134567799999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=4.8e-42  Score=335.23  Aligned_cols=245  Identities=22%  Similarity=0.366  Sum_probs=203.0

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC---chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      ++|++.+.||+|+||.||+++.. ++..+|+|.+....   ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            56888899999999999999886 47789999886432   223456889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~  308 (439)
                      ||+++|+|.+++..   ...+++..+..++.|++.||+|||+.   +++||||||+|||+++++.+||+|||++......
T Consensus        98 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  171 (329)
T PTZ00263         98 EFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR  171 (329)
T ss_pred             cCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence            99999999999964   34588899999999999999999998   9999999999999999999999999999766433


Q ss_pred             CcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhc
Q 013636          309 SRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIR  388 (439)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  388 (439)
                      .  ....||+.|+|||.+.+..++.++|||||||++|||++|+.||...++......+.      .....++..++    
T Consensus       172 ~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~------~~~~~~p~~~~----  239 (329)
T PTZ00263        172 T--FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKIL------AGRLKFPNWFD----  239 (329)
T ss_pred             c--ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHh------cCCcCCCCCCC----
Confidence            2  24569999999999999999999999999999999999999998766543222221      11222233332    


Q ss_pred             CccCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHh
Q 013636          389 DTMDLKHLYQVAAVAVLCIQPEPSYRPL-----ITDVLHS  423 (439)
Q Consensus       389 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~  423 (439)
                              ..+.+++..||+.||++||+     +.+++.+
T Consensus       240 --------~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        240 --------GRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             --------HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence                    24567999999999999997     6888865

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-42  Score=335.53  Aligned_cols=253  Identities=25%  Similarity=0.331  Sum_probs=206.2

Q ss_pred             cCCCccceecccCcEEEEEEEECC-ccEEEEEEecCCC---chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      ++|++.+.||+|+||.||+|+..+ +..+|+|.+....   ....+.+.+|+.++..++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            368889999999999999999864 7889999987432   233456889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~  308 (439)
                      ||+++|+|.+++..   ...+++..+..++.|++.||+|||+.   +++||||||+|||+++++.+||+|||++..... 
T Consensus        81 e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-  153 (333)
T cd05600          81 EYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-  153 (333)
T ss_pred             eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence            99999999999963   34588999999999999999999998   999999999999999999999999999976543 


Q ss_pred             CcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhc
Q 013636          309 SRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIR  388 (439)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  388 (439)
                       ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...++.+....+.......    ..+...++.  
T Consensus       154 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~----~~~~~~~~~--  226 (333)
T cd05600         154 -YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETL----QRPVYDDPR--  226 (333)
T ss_pred             -ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccc----cCCCCCccc--
Confidence             2234468999999999999999999999999999999999999998876654332222111111    111111111  


Q ss_pred             CccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          389 DTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       389 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                          ......+.+++.+||+.+|++||++.+++++
T Consensus       227 ----~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         227 ----FNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             ----cccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence                1123456779999999999999999999976

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=8.9e-43  Score=337.17  Aligned_cols=246  Identities=31%  Similarity=0.439  Sum_probs=205.8

Q ss_pred             cCCCccceecccCcEEEEEEEECC-ccEEEEEEecCCCch--HHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHD--AEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYE  229 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  229 (439)
                      ++|.+.+.||+|+||.||||+-+. ...||+|.+.+....  +.+.+.+|++++++++||||+.++++|+...+.++|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            467778899999999999998765 678899998765543  34678999999999999999999999999999999999


Q ss_pred             eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCC
Q 013636          230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS  309 (439)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~  309 (439)
                      |+.+ +|..+|.   ....++++.+..++.++..||.|||+.   +|.|||+||+|||++.++++|+||||+++......
T Consensus        82 ~a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t  154 (808)
T KOG0597|consen   82 YAVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT  154 (808)
T ss_pred             hhhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence            9987 9999995   445799999999999999999999998   99999999999999999999999999998876644


Q ss_pred             cc-eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhc
Q 013636          310 RN-VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIR  388 (439)
Q Consensus       310 ~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  388 (439)
                      .. ....|||-|||||.+.++.|+..+|.||+||++||+.+|++||...+-.+....+      ..+....+.       
T Consensus       155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I------~~d~v~~p~-------  221 (808)
T KOG0597|consen  155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSI------LKDPVKPPS-------  221 (808)
T ss_pred             eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHH------hcCCCCCcc-------
Confidence            43 4467999999999999999999999999999999999999999754332222221      112211111       


Q ss_pred             CccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          389 DTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       389 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                           .....+..++...|+.||..|.|..+++.|
T Consensus       222 -----~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  222 -----TASSSFVNFLQGLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             -----cccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence                 122345668888999999999999999865

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=7.4e-42  Score=333.07  Aligned_cols=241  Identities=22%  Similarity=0.310  Sum_probs=197.5

Q ss_pred             ceecccCcEEEEEEEEC-CccEEEEEEecCCC---chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEeccCC
Q 013636          159 NVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNG  234 (439)
Q Consensus       159 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  234 (439)
                      +.||+|+||.||+++.. ++..+|+|.+....   ......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999875 57889999987532   233456788999999999999999999999999999999999999


Q ss_pred             ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC-Cccee
Q 013636          235 SLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ-SRNVK  313 (439)
Q Consensus       235 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~-~~~~~  313 (439)
                      +|.+++..   ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++...... .....
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  154 (323)
T cd05571          81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT  154 (323)
T ss_pred             cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccc
Confidence            99999864   34689999999999999999999998   9999999999999999999999999998753222 22234


Q ss_pred             eccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCccCH
Q 013636          314 ISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDL  393 (439)
Q Consensus       314 ~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  393 (439)
                      ..||+.|+|||.+.+..++.++|||||||++|||++|+.||...+.......+.      .....++..+          
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~------~~~~~~p~~~----------  218 (323)
T cd05571         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL------MEEIRFPRTL----------  218 (323)
T ss_pred             eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHH------cCCCCCCCCC----------
Confidence            569999999999999999999999999999999999999998765443222221      1111222211          


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHh
Q 013636          394 KHLYQVAAVAVLCIQPEPSYRP-----LITDVLHS  423 (439)
Q Consensus       394 ~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  423 (439)
                        ...+.+++.+||+.||++||     ++.+++++
T Consensus       219 --~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         219 --SPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             --CHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence              23466799999999999999     89999865

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-43  Score=333.19  Aligned_cols=248  Identities=27%  Similarity=0.467  Sum_probs=207.7

Q ss_pred             cCCCccceecccCcEEEEEEEECC-ccEEEEEEecCC-CchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEe
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDA-GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      ..|+..+.||+|+||.||+|.+.. +..||+|.+.-. .....+++.+|+.++.+++++||.+++|.+..+..++++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            456667889999999999998764 778899999743 344557899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR  310 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~  310 (439)
                      |.+|++.+.|..   +..+++..+.-+..++..|+.|||++   +.+|||||+.|||+..+|.+|++|||.+........
T Consensus        93 ~~gGsv~~lL~~---~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~  166 (467)
T KOG0201|consen   93 CGGGSVLDLLKS---GNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK  166 (467)
T ss_pred             hcCcchhhhhcc---CCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhh
Confidence            999999999953   44457888888999999999999998   999999999999999999999999999976654333


Q ss_pred             -ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcC
Q 013636          311 -NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRD  389 (439)
Q Consensus       311 -~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  389 (439)
                       ..++.||+.|||||++....|+.|+||||||++.+||.+|.+|+....|..+..++             ++...|.+.+
T Consensus       167 rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI-------------pk~~PP~L~~  233 (467)
T KOG0201|consen  167 RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI-------------PKSAPPRLDG  233 (467)
T ss_pred             ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec-------------cCCCCCcccc
Confidence             35678999999999999889999999999999999999999999988774333222             2222233333


Q ss_pred             ccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          390 TMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       390 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      .+    ...+.+++..||+.||+.||++.+++.+
T Consensus       234 ~~----S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  234 DF----SPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             cc----CHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence            22    2346678999999999999999999965

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.6e-41  Score=317.83  Aligned_cols=250  Identities=26%  Similarity=0.467  Sum_probs=203.7

Q ss_pred             cCCCccceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEecc
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQ  232 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  232 (439)
                      ++|+..+.||+|+||.||+++++++..+++|.+.... ....++.+|+.++++++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            4577788999999999999999888889999886443 335678999999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCcc-
Q 013636          233 NGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN-  311 (439)
Q Consensus       233 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~~-  311 (439)
                      +|+|.++++..  ...+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||.+......... 
T Consensus        83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05114          83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS  157 (256)
T ss_pred             CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence            99999999742  23589999999999999999999998   9999999999999999999999999998765332221 


Q ss_pred             -eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcC
Q 013636          312 -VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRD  389 (439)
Q Consensus       312 -~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  389 (439)
                       ....++..|+|||.+.+..++.++||||||+++|||++ |+.||...+..+....+..       ...   ...+..  
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~-------~~~---~~~~~~--  225 (256)
T cd05114         158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR-------GFR---LYRPKL--  225 (256)
T ss_pred             cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-------CCC---CCCCCC--
Confidence             11224568999999998899999999999999999999 9999987654433222211       000   001111  


Q ss_pred             ccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhcc
Q 013636          390 TMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLI  425 (439)
Q Consensus       390 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  425 (439)
                           ....+.+++.+||+.+|++||++.++++.|.
T Consensus       226 -----~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         226 -----ASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             -----CCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                 1235788999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=9.8e-42  Score=338.60  Aligned_cols=260  Identities=26%  Similarity=0.434  Sum_probs=204.6

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEEC------CccEEEEEEecCCCc-hHHHHHHHHHHHHHhc-CCCceeeeeeEEEe
Q 013636          149 EAATNNFQESNVIGEGGRGHVYKARFN------EKLLAAVKRIDDAGH-DAEREFNNEVNWLTKI-RHQNIISLLGYCIH  220 (439)
Q Consensus       149 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  220 (439)
                      ....++|++.+.||+|+||.||+++..      +...+|+|.+..... .....+.+|+.+++.+ +|+||++++++|..
T Consensus        34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~  113 (374)
T cd05106          34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH  113 (374)
T ss_pred             cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence            344567888999999999999998742      235799999975433 3345688999999999 89999999999999


Q ss_pred             CCeeEEEEEeccCCChhhhhcCCC--------------------------------------------------------
Q 013636          221 AETRFLVYEMMQNGSLEKQLHGPT--------------------------------------------------------  244 (439)
Q Consensus       221 ~~~~~lV~e~~~~gsL~~~l~~~~--------------------------------------------------------  244 (439)
                      .+..++||||+++|+|.++++...                                                        
T Consensus       114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (374)
T cd05106         114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ  193 (374)
T ss_pred             CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence            999999999999999999885321                                                        


Q ss_pred             -----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCcce-
Q 013636          245 -----------HGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV-  312 (439)
Q Consensus       245 -----------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~~~-  312 (439)
                                 ....+++..+.+++.|++.||+|||+.   +++||||||+|||+++++++||+|||++.......... 
T Consensus       194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~  270 (374)
T cd05106         194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV  270 (374)
T ss_pred             cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence                       112478899999999999999999998   99999999999999999999999999997654322211 


Q ss_pred             --eeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhh-hhhHhhhhcccccCCCCCccCCchhc
Q 013636          313 --KISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQC-QSMVTWAMPQLTDRSKLPNIVDPVIR  388 (439)
Q Consensus       313 --~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~d~~l~  388 (439)
                        ...++..|+|||++.+..++.++|||||||++|||++ |+.||........ ......     ......+...     
T Consensus       271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~-----~~~~~~~~~~-----  340 (374)
T cd05106         271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKR-----GYQMSRPDFA-----  340 (374)
T ss_pred             ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHc-----ccCccCCCCC-----
Confidence              1224567999999999999999999999999999997 9999976543221 111110     0011111111     


Q ss_pred             CccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccC
Q 013636          389 DTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLV  428 (439)
Q Consensus       389 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~  428 (439)
                             ...+.+++.+||+.||++|||+.++++.|+++.
T Consensus       341 -------~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         341 -------PPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             -------CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence                   235677999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2.2e-41  Score=323.77  Aligned_cols=265  Identities=22%  Similarity=0.295  Sum_probs=202.4

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYE  229 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  229 (439)
                      ++|++.+.||+|+||+||+++.+ ++..+|+|++....  ....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            46888999999999999999986 46788999886532  2234568899999999999999999999999999999999


Q ss_pred             eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCC
Q 013636          230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS  309 (439)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~  309 (439)
                      |++++++..+..   ....+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  154 (287)
T cd07848          81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS  154 (287)
T ss_pred             cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence            999987765543   234689999999999999999999998   99999999999999999999999999997654322


Q ss_pred             c--ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhccc--------ccCCCC
Q 013636          310 R--NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQL--------TDRSKL  379 (439)
Q Consensus       310 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~--------~~~~~~  379 (439)
                      .  .....||+.|+|||.+.+..++.++|||||||++|||++|+.||...+.......+.......        ......
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07848         155 NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF  234 (287)
T ss_pred             cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence            1  123458999999999999899999999999999999999999998765433221111111000        000000


Q ss_pred             CccCCchhcCcc------CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          380 PNIVDPVIRDTM------DLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       380 ~~~~d~~l~~~~------~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      .....+......      .......+.+++.+||+.||++|||++|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            000000000000      00123458899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.1e-41  Score=321.05  Aligned_cols=257  Identities=28%  Similarity=0.478  Sum_probs=211.8

Q ss_pred             HHhcCCCccceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEE
Q 013636          150 AATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYE  229 (439)
Q Consensus       150 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  229 (439)
                      ....+|+..+.||+|+||.||+|...++..+++|.+.........++.+|+.+++.++|+|++++++++...+..++|||
T Consensus         3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   82 (261)
T cd05148           3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE   82 (261)
T ss_pred             CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence            34567888899999999999999998899999999987665556789999999999999999999999999999999999


Q ss_pred             eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCC
Q 013636          230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS  309 (439)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~  309 (439)
                      |+++|+|.+++... .+..+++..+.+++.|++.|++|||+.   +++|+||+|+||++++++.+||+|||.+.......
T Consensus        83 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~  158 (261)
T cd05148          83 LMEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV  158 (261)
T ss_pred             ecccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence            99999999999753 345689999999999999999999997   99999999999999999999999999997654322


Q ss_pred             cc-eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchh
Q 013636          310 RN-VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVI  387 (439)
Q Consensus       310 ~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  387 (439)
                      .. ....++..|+|||.+.+..++.++||||||+++|+|++ |+.||...+..+......   ...  ....+       
T Consensus       159 ~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~---~~~--~~~~~-------  226 (261)
T cd05148         159 YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT---AGY--RMPCP-------  226 (261)
T ss_pred             ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH---hCC--cCCCC-------
Confidence            11 12235678999999998899999999999999999998 899998766443222221   100  00010       


Q ss_pred             cCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhcccc
Q 013636          388 RDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPL  427 (439)
Q Consensus       388 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l  427 (439)
                           ......+.+++.+||+.||++|||+.++++.|+.+
T Consensus       227 -----~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         227 -----AKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             -----CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence                 11234577899999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=3.6e-41  Score=317.69  Aligned_cols=254  Identities=23%  Similarity=0.415  Sum_probs=207.9

Q ss_pred             hcCCCccceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEec
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMM  231 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  231 (439)
                      .++|++.++||+|+||.||+|...++..+++|.+.... ...+.+.+|+.++++++|+|++++++++...+..+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            35788899999999999999998888889999886533 34567899999999999999999999999999999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCcc
Q 013636          232 QNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN  311 (439)
Q Consensus       232 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~~  311 (439)
                      ++|+|.++++.. .+..+++..+..++.|++.||+|||+.   +++||||||+||++++++.++|+|||++.........
T Consensus        84 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05072          84 AKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT  159 (261)
T ss_pred             CCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence            999999999753 345688999999999999999999997   9999999999999999999999999999765432211


Q ss_pred             --eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhc
Q 013636          312 --VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIR  388 (439)
Q Consensus       312 --~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  388 (439)
                        ....++..|+|||.+..+.++.++||||||+++|||++ |+.||...........+..       ....+.      .
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~-------~~~~~~------~  226 (261)
T cd05072         160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQR-------GYRMPR------M  226 (261)
T ss_pred             ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHc-------CCCCCC------C
Confidence              12235678999999998899999999999999999998 9999987655433222211       001100      0


Q ss_pred             CccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhcccc
Q 013636          389 DTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPL  427 (439)
Q Consensus       389 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l  427 (439)
                      .    .....+.+++.+|++.+|++||+++++.+.|+.+
T Consensus       227 ~----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         227 E----NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             C----CCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence            1    1123567899999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.7e-41  Score=323.68  Aligned_cols=265  Identities=23%  Similarity=0.326  Sum_probs=200.8

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEe
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGH-DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      ++|+..+.||+|+||.||+|... ++..+|+|.+..... .....+.+|+.++++++||||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            46888899999999999999875 578899998864332 2334678999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR  310 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~  310 (439)
                      +++ +|.+++..  .+..+++..+..++.|++.||+|||+.   +++||||||+|||+++++.+||+|||++........
T Consensus        85 ~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~  158 (288)
T cd07871          85 LDS-DLKQYLDN--CGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK  158 (288)
T ss_pred             CCc-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence            975 99998863  234578999999999999999999998   999999999999999999999999999875433221


Q ss_pred             -ceeeccccCccchhhhcC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhc--------ccccCCCCC
Q 013636          311 -NVKISGTLGYVAPEYLLE-GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP--------QLTDRSKLP  380 (439)
Q Consensus       311 -~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~--------~~~~~~~~~  380 (439)
                       .....+++.|+|||.+.+ ..++.++||||+||++|||++|+.||...+..+..........        .........
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd07871         159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR  238 (288)
T ss_pred             cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence             123457899999999875 5689999999999999999999999987665443222211111        000000111


Q ss_pred             ccCCchhcCc----cCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          381 NIVDPVIRDT----MDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       381 ~~~d~~l~~~----~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      ....+..+..    ..........+++..||+.||.+|||++|++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            1111100000    000112356789999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=3.1e-41  Score=327.59  Aligned_cols=256  Identities=25%  Similarity=0.478  Sum_probs=204.8

Q ss_pred             cCCCccceecccCcEEEEEEEECC-c----cEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNE-K----LLAAVKRIDDAG-HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFL  226 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~-~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  226 (439)
                      .+|+..+.||+|+||.||+|++.. +    ..+|+|.++... ....+++.+|+.+++.++||||++++|+|... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            468888999999999999998642 2    248999987543 34456789999999999999999999999764 5789


Q ss_pred             EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccC
Q 013636          227 VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAG  306 (439)
Q Consensus       227 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~  306 (439)
                      ++||+++|+|.+++...  ...+++..+++++.|+++||+|||+.   +++||||||+|||+++++.+||+|||++....
T Consensus        86 v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          86 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             eeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccccc
Confidence            99999999999999743  34588999999999999999999998   99999999999999999999999999998765


Q ss_pred             CCCccee---eccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCcc
Q 013636          307 TQSRNVK---ISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNI  382 (439)
Q Consensus       307 ~~~~~~~---~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  382 (439)
                      .......   ..++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.......       ....+. 
T Consensus       161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~-------~~~~~~-  232 (316)
T cd05108         161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK-------GERLPQ-  232 (316)
T ss_pred             CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhC-------CCCCCC-
Confidence            4332221   224568999999999999999999999999999998 9999987655443222211       111110 


Q ss_pred             CCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCCC
Q 013636          383 VDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPTD  431 (439)
Q Consensus       383 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~~  431 (439)
                        +   .    .....+.+++..||+.||++||++.+++..+..+....
T Consensus       233 --~---~----~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~  272 (316)
T cd05108         233 --P---P----ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  272 (316)
T ss_pred             --C---C----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence              0   0    11235678999999999999999999999998776543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=3.6e-41  Score=321.52  Aligned_cols=254  Identities=30%  Similarity=0.494  Sum_probs=206.0

Q ss_pred             cCCCccceecccCcEEEEEEEECCc------cEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNEK------LLAAVKRIDDAGH-DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRF  225 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~~------~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  225 (439)
                      ++|++.+.||+|+||.||+|.....      ..+++|.+..... ....+|.+|+..+++++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            4677789999999999999986432      5789998875433 33457899999999999999999999999989999


Q ss_pred             EEEEeccCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC
Q 013636          226 LVYEMMQNGSLEKQLHGPTH-------------GSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSF  292 (439)
Q Consensus       226 lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~  292 (439)
                      ++|||+++|+|.+++.....             ...+++..+..++.|++.||+|||+.   +++||||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence            99999999999999964221             14588999999999999999999998   999999999999999999


Q ss_pred             cEEEEecccccccCCCCc---ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhh
Q 013636          293 NAKLSDFGLSVTAGTQSR---NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTW  368 (439)
Q Consensus       293 ~~kl~DfGls~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~  368 (439)
                      .+||+|||++........   .....+++.|+|||.+.++.++.++|||||||++|||++ |..||.+.++.+....+..
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~  241 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRS  241 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            999999999976533221   122346788999999999999999999999999999998 9999987766543332211


Q ss_pred             hhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccc
Q 013636          369 AMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIP  426 (439)
Q Consensus       369 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  426 (439)
                              ......         ......++.+++.+||+.||.+||++.|++++|..
T Consensus       242 --------~~~~~~---------~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         242 --------RQLLPC---------PEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             --------CCcCCC---------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence                    011110         11234567889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.4e-41  Score=333.20  Aligned_cols=245  Identities=23%  Similarity=0.329  Sum_probs=201.8

Q ss_pred             cCCCccceecccCcEEEEEEEECC--ccEEEEEEecCCC---chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNE--KLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLV  227 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  227 (439)
                      ++|++.+.||+|+||.||+|+..+  ...+|+|.+....   ......+.+|+.+++.++||||+++++++...+..++|
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv  109 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV  109 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence            568888999999999999998654  3578999886422   23345688999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCC
Q 013636          228 YEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT  307 (439)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~  307 (439)
                      |||+++|+|.+++..   ...+++..+..++.|++.||+|||+.   +++||||||+|||++.++++||+|||++.....
T Consensus       110 ~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~  183 (340)
T PTZ00426        110 LEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT  183 (340)
T ss_pred             EeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence            999999999999964   24589999999999999999999998   999999999999999999999999999976543


Q ss_pred             CCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchh
Q 013636          308 QSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVI  387 (439)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  387 (439)
                      .  .....||+.|+|||++.+..++.++|||||||++|||++|+.||...++......+.      .....++..++   
T Consensus       184 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~------~~~~~~p~~~~---  252 (340)
T PTZ00426        184 R--TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKIL------EGIIYFPKFLD---  252 (340)
T ss_pred             C--cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHh------cCCCCCCCCCC---
Confidence            2  234569999999999999899999999999999999999999998766543222221      11111222222   


Q ss_pred             cCccCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHh
Q 013636          388 RDTMDLKHLYQVAAVAVLCIQPEPSYRP-----LITDVLHS  423 (439)
Q Consensus       388 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  423 (439)
                               ..+.+++.+|++.||++|+     ++++++++
T Consensus       253 ---------~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        253 ---------NNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             ---------HHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence                     2356799999999999995     89999876

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2e-42  Score=303.32  Aligned_cols=250  Identities=27%  Similarity=0.425  Sum_probs=211.2

Q ss_pred             hcCCCccceecccCcEEEEEEEECC-ccEEEEEEecCCC---chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLV  227 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  227 (439)
                      -++|++.+.||+|.||.||.|+.+. +..+|+|.+.+..   .+...++.+|+++-+.|+||||+++++++.+....||+
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            3678889999999999999998864 6788999986532   23446789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCC
Q 013636          228 YEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT  307 (439)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~  307 (439)
                      +||.++|++...|.+ .....+++.....+..|+|.|+.|+|..   .++||||||+|+|++.++.+||+|||.+.... 
T Consensus       101 lEya~~gel~k~L~~-~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-  175 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQE-GRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP-  175 (281)
T ss_pred             EEecCCchHHHHHHh-cccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence            999999999999975 2345688888899999999999999997   99999999999999999999999999997765 


Q ss_pred             CCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchh
Q 013636          308 QSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVI  387 (439)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  387 (439)
                      .....+.+||..|.+||...+..++...|+|++|++.||++.|.+||+..+..+....+...      +-.++.      
T Consensus       176 ~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~------~~~~p~------  243 (281)
T KOG0580|consen  176 SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV------DLKFPS------  243 (281)
T ss_pred             CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc------cccCCc------
Confidence            45556789999999999999999999999999999999999999999987655433333211      111111      


Q ss_pred             cCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhc
Q 013636          388 RDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL  424 (439)
Q Consensus       388 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  424 (439)
                        .+    .....++++.|+..+|.+|.+..|++.+-
T Consensus       244 --~i----s~~a~dlI~~ll~~~p~~r~~l~~v~~hp  274 (281)
T KOG0580|consen  244 --TI----SGGAADLISRLLVKNPIERLALTEVMDHP  274 (281)
T ss_pred             --cc----ChhHHHHHHHHhccCccccccHHHHhhhH
Confidence              11    12456799999999999999999998763

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=3.6e-41  Score=322.81  Aligned_cols=264  Identities=25%  Similarity=0.324  Sum_probs=197.0

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CccEEEEEEecCCCc--hHHHHHHHHHHHHHhc---CCCceeeeeeEEEe-----
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN--EKLLAAVKRIDDAGH--DAEREFNNEVNWLTKI---RHQNIISLLGYCIH-----  220 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----  220 (439)
                      ++|++.+.||+|+||.||+|+..  ++..+|+|.+.....  .....+.+|+.+++.+   +||||++++++|..     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36888899999999999999873  467889998864322  2234566777777665   69999999999863     


Q ss_pred             CCeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecc
Q 013636          221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFG  300 (439)
Q Consensus       221 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfG  300 (439)
                      ....++||||++ ++|.+++.... ...+++..+..++.|++.||+|||+.   +++||||||+|||+++++.+||+|||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG  155 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEcccc
Confidence            346899999996 59999986532 34589999999999999999999998   99999999999999999999999999


Q ss_pred             cccccCCCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhh-hhHhhhhcccccCCCC
Q 013636          301 LSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQ-SMVTWAMPQLTDRSKL  379 (439)
Q Consensus       301 ls~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~-~~~~~~~~~~~~~~~~  379 (439)
                      ++.............||+.|+|||.+.+..++.++|||||||++|||++|+.||...+..+.. ...... ... .....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~-~~~-~~~~~  233 (290)
T cd07862         156 LARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI-GLP-GEEDW  233 (290)
T ss_pred             ceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHh-CCC-Chhhc
Confidence            997665443334456899999999999999999999999999999999999999876553322 222111 000 00000


Q ss_pred             Cc-------cCCchhcC---ccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          380 PN-------IVDPVIRD---TMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       380 ~~-------~~d~~l~~---~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      +.       .+.+.-..   .........+.+++.+||+.||++|||+.|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h  287 (290)
T cd07862         234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  287 (290)
T ss_pred             hhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence            00       00000000   0000122356689999999999999999999964

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.1e-42  Score=337.39  Aligned_cols=247  Identities=24%  Similarity=0.351  Sum_probs=209.7

Q ss_pred             CCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC---chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEE
Q 013636          154 NFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYE  229 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  229 (439)
                      -|+.++-||.|+.|.|-.|+.. .|+.+|||.+....   ......+.+|+-+|+.+.|||++++++++++...+|+|.|
T Consensus        13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE   92 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE   92 (786)
T ss_pred             ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence            4556788999999999999875 58999999997652   2223458899999999999999999999999999999999


Q ss_pred             eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCC
Q 013636          230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS  309 (439)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~  309 (439)
                      |+++|.|++++-.   .+.+++....+++.||+.|+.|+|..   +|+||||||+|+|||.++++||+|||+|..-..+.
T Consensus        93 yv~gGELFdylv~---kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk  166 (786)
T KOG0588|consen   93 YVPGGELFDYLVR---KGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK  166 (786)
T ss_pred             ecCCchhHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCCc
Confidence            9999999999953   45689999999999999999999998   99999999999999999999999999998766666


Q ss_pred             cceeeccccCccchhhhcCCCCC-CchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhc
Q 013636          310 RNVKISGTLGYVAPEYLLEGKLT-DKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIR  388 (439)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  388 (439)
                      .-.+.||.+.|.|||++.+.+|. .++||||.|||||.|++|+.||++.+-......+..      ..-.+|..+.+   
T Consensus       167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~------G~f~MPs~Is~---  237 (786)
T KOG0588|consen  167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQR------GVFEMPSNISS---  237 (786)
T ss_pred             cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHc------CcccCCCcCCH---
Confidence            66678899999999999999884 699999999999999999999997765443333321      12233333333   


Q ss_pred             CccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhc
Q 013636          389 DTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL  424 (439)
Q Consensus       389 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  424 (439)
                               +..+++.+|+..||++|.|+.||++|-
T Consensus       238 ---------eaQdLLr~ml~VDp~~RiT~~eI~kHP  264 (786)
T KOG0588|consen  238 ---------EAQDLLRRMLDVDPSTRITTEEILKHP  264 (786)
T ss_pred             ---------HHHHHHHHHhccCccccccHHHHhhCc
Confidence                     455689999999999999999999874

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2e-41  Score=330.00  Aligned_cols=241  Identities=23%  Similarity=0.317  Sum_probs=196.6

Q ss_pred             ceecccCcEEEEEEEEC-CccEEEEEEecCCC---chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEeccCC
Q 013636          159 NVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNG  234 (439)
Q Consensus       159 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  234 (439)
                      +.||+|+||.||+++.. ++..+|+|.+....   ......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999875 57889999986532   233456788999999999999999999999999999999999999


Q ss_pred             ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCC-ccee
Q 013636          235 SLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS-RNVK  313 (439)
Q Consensus       235 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~-~~~~  313 (439)
                      +|..++..   ...+++..+..++.|++.||+|||+.   +++||||||+|||+++++.+||+|||++....... ....
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~  154 (323)
T cd05595          81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT  154 (323)
T ss_pred             cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCcccc
Confidence            99998853   34689999999999999999999998   99999999999999999999999999987532222 2233


Q ss_pred             eccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCccCH
Q 013636          314 ISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDL  393 (439)
Q Consensus       314 ~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  393 (439)
                      ..||+.|+|||.+.+..++.++|||||||++|||++|+.||...+.......+.      .....++..+          
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~------~~~~~~p~~~----------  218 (323)
T cd05595         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL------MEEIRFPRTL----------  218 (323)
T ss_pred             ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHh------cCCCCCCCCC----------
Confidence            568999999999999999999999999999999999999998765543222221      1111222222          


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHh
Q 013636          394 KHLYQVAAVAVLCIQPEPSYRP-----LITDVLHS  423 (439)
Q Consensus       394 ~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  423 (439)
                        ...+.+++.+||+.||++||     ++.+++++
T Consensus       219 --~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         219 --SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             --CHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence              23456799999999999998     88888865

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=7e-41  Score=327.54  Aligned_cols=266  Identities=24%  Similarity=0.368  Sum_probs=202.9

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG-HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYE  229 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  229 (439)
                      .++|++.+.||+|+||.||++... ++..+|+|.+.... ......+.+|++++++++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            468889999999999999999886 46778888876542 2344678999999999999999999999999999999999


Q ss_pred             eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCC
Q 013636          230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS  309 (439)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~  309 (439)
                      |+++|+|.+++..   ...+++.....++.|++.||.|||+.  ++++||||||+|||+++++.+||+|||++.......
T Consensus        84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~  158 (333)
T cd06650          84 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  158 (333)
T ss_pred             cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence            9999999999964   23588999999999999999999974  279999999999999999999999999987553322


Q ss_pred             cceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhc-ccccCC------CCCc-
Q 013636          310 RNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP-QLTDRS------KLPN-  381 (439)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~-~~~~~~------~~~~-  381 (439)
                       .....||..|+|||.+.+..++.++|||||||++|||++|+.||................. ......      .... 
T Consensus       159 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (333)
T cd06650         159 -ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRP  237 (333)
T ss_pred             -cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccch
Confidence             1234589999999999998999999999999999999999999986554332211110000 000000      0000 


Q ss_pred             --cCCchhcCc-----------------c-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          382 --IVDPVIRDT-----------------M-DLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       382 --~~d~~l~~~-----------------~-~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                        ...+.-+..                 . ......++.+++.+||+.||++|||+.|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h  299 (333)
T cd06650         238 LSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH  299 (333)
T ss_pred             hhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence              000000000                 0 00112457789999999999999999999865

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=3.4e-41  Score=329.10  Aligned_cols=241  Identities=23%  Similarity=0.316  Sum_probs=197.5

Q ss_pred             ceecccCcEEEEEEEEC-CccEEEEEEecCCC---chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEeccCC
Q 013636          159 NVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNG  234 (439)
Q Consensus       159 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  234 (439)
                      +.||+|+||.||+++.. ++..+|+|.+....   ......+.+|+.+++.++||||+++.+++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999875 57889999987532   234456889999999999999999999999999999999999999


Q ss_pred             ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC-Cccee
Q 013636          235 SLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ-SRNVK  313 (439)
Q Consensus       235 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~-~~~~~  313 (439)
                      +|.+++..   ...+++..+..++.|++.||+|||+.   +++||||||+|||+++++.+||+|||++...... .....
T Consensus        81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~  154 (328)
T cd05593          81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT  154 (328)
T ss_pred             CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCccccccc
Confidence            99998864   34689999999999999999999998   9999999999999999999999999998754322 22233


Q ss_pred             eccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCccCH
Q 013636          314 ISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDL  393 (439)
Q Consensus       314 ~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  393 (439)
                      ..||+.|+|||.+.+..++.++|||||||++|||++|+.||...+.......+.      .....++..+          
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~------~~~~~~p~~~----------  218 (328)
T cd05593         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL------MEDIKFPRTL----------  218 (328)
T ss_pred             ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhc------cCCccCCCCC----------
Confidence            568999999999999999999999999999999999999998765443222221      1111222211          


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHh
Q 013636          394 KHLYQVAAVAVLCIQPEPSYRP-----LITDVLHS  423 (439)
Q Consensus       394 ~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  423 (439)
                        ...+.+++.+||+.||++||     ++.+++++
T Consensus       219 --~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         219 --SADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             --CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence              23466789999999999997     89999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.7e-42  Score=321.70  Aligned_cols=262  Identities=24%  Similarity=0.316  Sum_probs=203.3

Q ss_pred             CCCccceecccCcEEEEEEEECC-ccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCe-----eEEE
Q 013636          154 NFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAET-----RFLV  227 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----~~lV  227 (439)
                      .|...+++|.|+||.||+|...+ +..+|||+.-....    .-.+|+.+|++++|||||+++-++....+     ..+|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            45667899999999999998865 58899998754322    23468999999999999999988875432     3589


Q ss_pred             EEeccCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC-CcEEEEeccccccc
Q 013636          228 YEMMQNGSLEKQLHGP-THGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS-FNAKLSDFGLSVTA  305 (439)
Q Consensus       228 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~-~~~kl~DfGls~~~  305 (439)
                      ||||+. +|.+.++.. ..+..++...+.-+..|+.+||+|||+.   +|+||||||+|+|+|.+ |.+||||||.|+..
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            999998 999988742 2245677778888999999999999997   99999999999999966 99999999999998


Q ss_pred             CCCCcceeeccccCccchhhhcCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhccccc---------
Q 013636          306 GTQSRNVKISGTLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTD---------  375 (439)
Q Consensus       306 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~---------  375 (439)
                      .....+.....|..|+|||.+.+. .|+.+.||||.||++.||+-|++-|.+.+..+....+....+...+         
T Consensus       177 ~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~  256 (364)
T KOG0658|consen  177 VKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPN  256 (364)
T ss_pred             ccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcc
Confidence            887777777789999999999874 7999999999999999999999999987654433222222111111         


Q ss_pred             --CCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          376 --RSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       376 --~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                        +...+++...............+.++++.++++.+|.+|.++.|++.+
T Consensus       257 y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h  306 (364)
T KOG0658|consen  257 YTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH  306 (364)
T ss_pred             cccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence              112222222222121223345678889999999999999999999854

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-41  Score=326.86  Aligned_cols=239  Identities=26%  Similarity=0.352  Sum_probs=194.2

Q ss_pred             ecccCcEEEEEEEECC-ccEEEEEEecCC---CchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEeccCCCh
Q 013636          161 IGEGGRGHVYKARFNE-KLLAAVKRIDDA---GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSL  236 (439)
Q Consensus       161 LG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  236 (439)
                      ||+|+||.||+++..+ +..+|+|.+...   .......+.+|+.++++++||||+++++++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            6999999999998864 678999988643   223445688999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC-Ccceeec
Q 013636          237 EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ-SRNVKIS  315 (439)
Q Consensus       237 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~-~~~~~~~  315 (439)
                      .+++..   ...+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++...... .......
T Consensus        81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  154 (312)
T cd05585          81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC  154 (312)
T ss_pred             HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCcccccc
Confidence            999964   34589999999999999999999998   9999999999999999999999999999754322 2223456


Q ss_pred             cccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCccCHHH
Q 013636          316 GTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKH  395 (439)
Q Consensus       316 gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  395 (439)
                      ||+.|+|||.+.+..++.++|||||||++|||++|+.||...+..+.....      ......++..++           
T Consensus       155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~------~~~~~~~~~~~~-----------  217 (312)
T cd05585         155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKI------LQEPLRFPDGFD-----------  217 (312)
T ss_pred             CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHH------HcCCCCCCCcCC-----------
Confidence            899999999999999999999999999999999999999876543322111      111122222222           


Q ss_pred             HHHHHHHHHHhcCCCCCCCCC---HHHHHHh
Q 013636          396 LYQVAAVAVLCIQPEPSYRPL---ITDVLHS  423 (439)
Q Consensus       396 ~~~l~~l~~~cl~~dP~~RPt---~~evl~~  423 (439)
                       ..+.+++.+||+.||++||+   +.|++.+
T Consensus       218 -~~~~~li~~~L~~dp~~R~~~~~~~e~l~h  247 (312)
T cd05585         218 -RDAKDLLIGLLSRDPTRRLGYNGAQEIKNH  247 (312)
T ss_pred             -HHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence             34567899999999999975   5677654

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=5e-41  Score=335.47  Aligned_cols=261  Identities=25%  Similarity=0.397  Sum_probs=206.5

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEECC------ccEEEEEEecCCCc-hHHHHHHHHHHHHHhcC-CCceeeeeeEEEe
Q 013636          149 EAATNNFQESNVIGEGGRGHVYKARFNE------KLLAAVKRIDDAGH-DAEREFNNEVNWLTKIR-HQNIISLLGYCIH  220 (439)
Q Consensus       149 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~  220 (439)
                      +...++|++.++||+|+||.||+|+...      ...+|+|.+..... .....+.+|++++++++ ||||++++++|..
T Consensus        33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~  112 (400)
T cd05105          33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK  112 (400)
T ss_pred             eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence            3446788889999999999999998632      34689999975433 33457899999999996 9999999999999


Q ss_pred             CCeeEEEEEeccCCChhhhhcCCC--------------------------------------------------------
Q 013636          221 AETRFLVYEMMQNGSLEKQLHGPT--------------------------------------------------------  244 (439)
Q Consensus       221 ~~~~~lV~e~~~~gsL~~~l~~~~--------------------------------------------------------  244 (439)
                      .+..++||||+++|+|.++++...                                                        
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (400)
T cd05105         113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML  192 (400)
T ss_pred             CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence            999999999999999999886421                                                        


Q ss_pred             -------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEE
Q 013636          245 -------------------------------------HGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNIL  287 (439)
Q Consensus       245 -------------------------------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiL  287 (439)
                                                           ....+++..+.+++.|+++||+|||+.   +++||||||+|||
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nil  269 (400)
T cd05105         193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVL  269 (400)
T ss_pred             hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEE
Confidence                                                 012478889999999999999999997   9999999999999


Q ss_pred             EcCCCcEEEEecccccccCCCCcc---eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhh
Q 013636          288 LDSSFNAKLSDFGLSVTAGTQSRN---VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQ  363 (439)
Q Consensus       288 l~~~~~~kl~DfGls~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~  363 (439)
                      +++++.+||+|||++.........   ....++..|+|||.+.+..++.++|||||||++|||++ |..||.........
T Consensus       270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~  349 (400)
T cd05105         270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF  349 (400)
T ss_pred             EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH
Confidence            999999999999999765332221   12236678999999999999999999999999999997 99999765432211


Q ss_pred             -hhHhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCC
Q 013636          364 -SMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVP  429 (439)
Q Consensus       364 -~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~  429 (439)
                       ..+.       .....+      .    .......+.+++.+||+.||++|||+.+|.+.|+++.+
T Consensus       350 ~~~~~-------~~~~~~------~----~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         350 YNKIK-------SGYRMA------K----PDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             HHHHh-------cCCCCC------C----CccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence             1110       000000      0    01123467789999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=9.8e-41  Score=314.22  Aligned_cols=250  Identities=28%  Similarity=0.434  Sum_probs=203.6

Q ss_pred             cCCCccceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEecc
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQ  232 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  232 (439)
                      ++|+..+.||+|+||.||+|+..++..+|+|.+.... ....+|.+|+.++++++||||+++++++...+..+++|||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            3567788999999999999998888789999887543 334678999999999999999999999998889999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCcce
Q 013636          233 NGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV  312 (439)
Q Consensus       233 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~~~  312 (439)
                      +|+|.+++...  ...+++..++.++.|++.||+|||+.   +++|+||||+||++++++.+||+|||.+..........
T Consensus        83 ~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05113          83 NGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS  157 (256)
T ss_pred             CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence            99999999642  23689999999999999999999998   99999999999999999999999999987654322211


Q ss_pred             --eeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcC
Q 013636          313 --KISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRD  389 (439)
Q Consensus       313 --~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  389 (439)
                        ...++..|+|||.+.+..++.++||||||+++|||++ |..||...+.......+...     .....+.        
T Consensus       158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~--------  224 (256)
T cd05113         158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQG-----LRLYRPH--------  224 (256)
T ss_pred             cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcC-----CCCCCCC--------
Confidence              1234578999999998899999999999999999998 99999876654322222110     0000001        


Q ss_pred             ccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhcc
Q 013636          390 TMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLI  425 (439)
Q Consensus       390 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  425 (439)
                          .....+.+++.+||+.+|++||++.++++.|+
T Consensus       225 ----~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         225 ----LASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             ----CCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence                01346778999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.2e-41  Score=315.76  Aligned_cols=255  Identities=27%  Similarity=0.449  Sum_probs=208.3

Q ss_pred             HhcCCCccceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEe
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      ..++|++.+.||+|+||.||+|..+++..+|+|.+.... ...+++.+|+.++++++|||++++++++...+..+++|||
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL   82 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence            346788899999999999999998888889999987543 3456789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR  310 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~  310 (439)
                      +++++|.+++.... +..+++..+..++.|++.|+.|||+.   +++||||||+||++++++.+||+|||++........
T Consensus        83 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05068          83 MKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY  158 (261)
T ss_pred             ccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence            99999999997532 45689999999999999999999998   999999999999999999999999999976643221


Q ss_pred             ce--eeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchh
Q 013636          311 NV--KISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVI  387 (439)
Q Consensus       311 ~~--~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  387 (439)
                      ..  ....+..|+|||.+.+..++.++||||||+++|||++ |+.||...........+.       .....+  .    
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-------~~~~~~--~----  225 (261)
T cd05068         159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD-------QGYRMP--C----  225 (261)
T ss_pred             cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-------cCCCCC--C----
Confidence            11  1112357999999999999999999999999999999 999998765443222221       010110  0    


Q ss_pred             cCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhcccc
Q 013636          388 RDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPL  427 (439)
Q Consensus       388 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l  427 (439)
                          .......+.+++.+|++.+|++||++.++++.|+.+
T Consensus       226 ----~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         226 ----PPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             ----CCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence                001234577899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=9.5e-41  Score=341.68  Aligned_cols=250  Identities=22%  Similarity=0.287  Sum_probs=202.4

Q ss_pred             CCCccceecccCcEEEEEEEECC--ccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEec
Q 013636          154 NFQESNVIGEGGRGHVYKARFNE--KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMM  231 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  231 (439)
                      .|...+.||+|+||.||+|....  +..+++|.+..........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            47888999999999999997643  4677888775554445567888999999999999999999999999999999999


Q ss_pred             cCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc
Q 013636          232 QNGSLEKQLHGP-THGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR  310 (439)
Q Consensus       232 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~  310 (439)
                      ++|+|.++++.. .....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++........
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            999999988642 2334688999999999999999999998   999999999999999999999999999976543221


Q ss_pred             ---ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchh
Q 013636          311 ---NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVI  387 (439)
Q Consensus       311 ---~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  387 (439)
                         .....||+.|+|||.+.+..++.++|||||||++|||++|+.||...+..+....+..     ......+..     
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~-----~~~~~~~~~-----  294 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLY-----GKYDPFPCP-----  294 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----CCCCCCCcc-----
Confidence               2334699999999999999999999999999999999999999987655432222211     001111111     


Q ss_pred             cCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          388 RDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       388 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                             ....+.+++..||+.||++||++.+++++
T Consensus       295 -------~s~~~~~li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        295 -------VSSGMKALLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             -------CCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence                   12356779999999999999999998754

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-40  Score=313.91  Aligned_cols=254  Identities=28%  Similarity=0.437  Sum_probs=206.0

Q ss_pred             cCCCccceecccCcEEEEEEEECC----ccEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNE----KLLAAVKRIDDAG-HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLV  227 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  227 (439)
                      ++|+..+.||+|+||.||+|.+..    ...+++|.+.... .....+|.+|+.++++++||||+++++++...+..+++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            568889999999999999998743    4578999887543 33446789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCC
Q 013636          228 YEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT  307 (439)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~  307 (439)
                      |||+++|+|.+++...  ...+++..+.+++.|++.|++|||+.   +++|+||||+||++++++.++|+|||++.....
T Consensus        84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  158 (266)
T cd05033          84 TEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLED  158 (266)
T ss_pred             EEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence            9999999999999742  34689999999999999999999997   999999999999999999999999999987642


Q ss_pred             CCcc-e--eeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCccC
Q 013636          308 QSRN-V--KISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV  383 (439)
Q Consensus       308 ~~~~-~--~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  383 (439)
                      .... .  ...++..|+|||.+.+..++.++||||||+++|||++ |..||...........+..       ....+.  
T Consensus       159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~-------~~~~~~--  229 (266)
T cd05033         159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVED-------GYRLPP--  229 (266)
T ss_pred             cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHc-------CCCCCC--
Confidence            2111 1  1224578999999999999999999999999999998 9999977654432222210       000000  


Q ss_pred             CchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccC
Q 013636          384 DPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLV  428 (439)
Q Consensus       384 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~  428 (439)
                              .......+.+++.+||+.+|++||++.+++++|++++
T Consensus       230 --------~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~  266 (266)
T cd05033         230 --------PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI  266 (266)
T ss_pred             --------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence                    0012345778999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-42  Score=335.89  Aligned_cols=263  Identities=25%  Similarity=0.404  Sum_probs=223.1

Q ss_pred             HHHHHHhcCCCccceecccCcEEEEEEEECC-ccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCee
Q 013636          146 ELLEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETR  224 (439)
Q Consensus       146 ~~l~~~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  224 (439)
                      +.++-...+....++||-|-||.||.|.|+. ...||||.++... ...++|+.|..+|+.++|||+|+|+|+|......
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF  338 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF  338 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence            4555555667778999999999999999976 5688999998653 4567899999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccc
Q 013636          225 FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT  304 (439)
Q Consensus       225 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~  304 (439)
                      |||+|||..|+|.+||+... ...++....+.++.||+.||+||...   ++|||||.++|+|+.++..+|++|||+++.
T Consensus       339 YIiTEfM~yGNLLdYLRecn-r~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRl  414 (1157)
T KOG4278|consen  339 YIITEFMCYGNLLDYLRECN-RSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRL  414 (1157)
T ss_pred             EEEEecccCccHHHHHHHhc-hhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhh
Confidence            99999999999999998643 45678888899999999999999987   999999999999999999999999999998


Q ss_pred             cCCCCccee--eccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCc
Q 013636          305 AGTQSRNVK--ISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPN  381 (439)
Q Consensus       305 ~~~~~~~~~--~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  381 (439)
                      +..+.....  ..-...|.|||.+....++.|+|||+|||+|||+.| |..||.+.+-.++..+++...           
T Consensus       415 MtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgy-----------  483 (1157)
T KOG4278|consen  415 MTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGY-----------  483 (1157)
T ss_pred             hcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccc-----------
Confidence            765443321  113568999999999999999999999999999999 999999988777666654221           


Q ss_pred             cCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCC
Q 013636          382 IVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPT  430 (439)
Q Consensus       382 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~  430 (439)
                            +-.....+...+.+++.+||+.+|.+||++.|+-+.++.+..+
T Consensus       484 ------RM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~  526 (1157)
T KOG4278|consen  484 ------RMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS  526 (1157)
T ss_pred             ------cccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence                  1111234456788899999999999999999999998877754

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=9.1e-41  Score=317.96  Aligned_cols=256  Identities=26%  Similarity=0.418  Sum_probs=203.9

Q ss_pred             HhcCCCccceecccCcEEEEEEEEC------CccEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCe
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARFN------EKLLAAVKRIDDAG-HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAET  223 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  223 (439)
                      .+++|+..+.||+|+||.||+|...      .+..+|+|.+.... .....++.+|+.+++.++||||+++++++...+.
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4678999999999999999999764      24678999886433 2344578999999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhhhcCCCC-------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEE
Q 013636          224 RFLVYEMMQNGSLEKQLHGPTH-------GSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKL  296 (439)
Q Consensus       224 ~~lV~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl  296 (439)
                      .++||||+++|+|.+++.....       ...+++..+..++.|++.||+|||+.   +++||||||+||++++++.++|
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence            9999999999999999864221       23468889999999999999999997   9999999999999999999999


Q ss_pred             EecccccccCCCCcc---eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcc
Q 013636          297 SDFGLSVTAGTQSRN---VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQ  372 (439)
Q Consensus       297 ~DfGls~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~  372 (439)
                      +|||++.........   ....++..|+|||.+.++.++.++|||||||++|||++ |..||...+.......+..    
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~----  236 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME----  236 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc----
Confidence            999998754332211   11235678999999999999999999999999999999 7899987665432222210    


Q ss_pred             cccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccc
Q 013636          373 LTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIP  426 (439)
Q Consensus       373 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  426 (439)
                          .......     .    .....+.+++.+||+.||++|||+.|+++.|++
T Consensus       237 ----~~~~~~~-----~----~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         237 ----GGLLDKP-----D----NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             ----CCcCCCC-----C----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence                0110000     0    112357789999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8e-41  Score=319.97  Aligned_cols=252  Identities=24%  Similarity=0.349  Sum_probs=202.2

Q ss_pred             CCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCc---hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEE
Q 013636          154 NFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGH---DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYE  229 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  229 (439)
                      +|+..+.||+|+||+||++... ++..+|+|.+.....   .....+.+|+.++++++||||+++++++..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4777899999999999999875 578899999864321   223457889999999999999999999999999999999


Q ss_pred             eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCC
Q 013636          230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS  309 (439)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~  309 (439)
                      |+++|+|.+++... ....+++..+..++.|++.||+|||+.   +++||||||+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence            99999999888642 234689999999999999999999998   99999999999999999999999999997654433


Q ss_pred             cceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcC
Q 013636          310 RNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRD  389 (439)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  389 (439)
                      ......|+..|+|||.+.+..++.++||||+||++|||++|+.||...........+.....  ......+         
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~---------  225 (285)
T cd05605         157 TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVK--EDQEEYS---------  225 (285)
T ss_pred             ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhh--hcccccC---------
Confidence            33344689999999999999999999999999999999999999987544322111111100  0011111         


Q ss_pred             ccCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHh
Q 013636          390 TMDLKHLYQVAAVAVLCIQPEPSYRP-----LITDVLHS  423 (439)
Q Consensus       390 ~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  423 (439)
                         ......+.+++..||+.||++||     ++.+++++
T Consensus       226 ---~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         226 ---EKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             ---cccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence               11233567799999999999999     88899876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.2e-40  Score=317.23  Aligned_cols=253  Identities=29%  Similarity=0.486  Sum_probs=205.0

Q ss_pred             cCCCccceecccCcEEEEEEEECC------ccEEEEEEecCCCch-HHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNE------KLLAAVKRIDDAGHD-AEREFNNEVNWLTKIRHQNIISLLGYCIHAETRF  225 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  225 (439)
                      ++|.+.+.||+|+||.||+|+..+      +..+|+|.+...... ....+.+|++++++++|+|++++++++...+..+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            457778899999999999998643      478899998765544 4568999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcE
Q 013636          226 LVYEMMQNGSLEKQLHGPT-----------HGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA  294 (439)
Q Consensus       226 lV~e~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~  294 (439)
                      +||||+++|+|.+++....           ....+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence            9999999999999997422           224588999999999999999999998   99999999999999999999


Q ss_pred             EEEecccccccCCCCc---ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhh
Q 013636          295 KLSDFGLSVTAGTQSR---NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAM  370 (439)
Q Consensus       295 kl~DfGls~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~  370 (439)
                      ||+|||++........   .....++..|+|||.+.++.++.++||||||+++|||++ |..||...+..+....+.   
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~---  238 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT---  238 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH---
Confidence            9999999975432221   112235678999999999999999999999999999998 999997765543222221   


Q ss_pred             cccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhcc
Q 013636          371 PQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLI  425 (439)
Q Consensus       371 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  425 (439)
                           ....... .        ......+.+++.+||+.||++||++.|+++.|.
T Consensus       239 -----~~~~~~~-~--------~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         239 -----QGRLLQR-P--------RTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             -----cCCcCCC-C--------CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence                 1111000 0        012345778999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=5.6e-41  Score=324.49  Aligned_cols=249  Identities=24%  Similarity=0.363  Sum_probs=203.8

Q ss_pred             HhcCCCccceecccCcEEEEEEEECC-ccEEEEEEecCCCc---hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEE
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGH---DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFL  226 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  226 (439)
                      ..++|+....||+|+||.||.++-++ |..+|+|++++...   ...+....|-++|...++|+||+|+..+.+.+.+||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            45789999999999999999998765 78899999987543   334567899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccC
Q 013636          227 VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAG  306 (439)
Q Consensus       227 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~  306 (439)
                      ||||.+||++..+|.   ..+.|++.....++.+++.|+.-+|+.   |++||||||+|+|||.+|++||+||||+.-..
T Consensus       219 iMEylPGGD~mTLL~---~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~  292 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLM---RKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD  292 (550)
T ss_pred             EEEecCCccHHHHHH---hcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhh
Confidence            999999999999995   456799999999999999999999998   99999999999999999999999999983210


Q ss_pred             C-----------------------CCc-------------------------ceeeccccCccchhhhcCCCCCCchhhH
Q 013636          307 T-----------------------QSR-------------------------NVKISGTLGYVAPEYLLEGKLTDKSDVY  338 (439)
Q Consensus       307 ~-----------------------~~~-------------------------~~~~~gt~~y~aPE~~~~~~~~~~~Dvw  338 (439)
                      .                       +..                         .....|||.|+|||++.+..|+..+|.|
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW  372 (550)
T KOG0605|consen  293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW  372 (550)
T ss_pred             hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence            0                       000                         0123499999999999999999999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCChhhh-hhhHhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCC-
Q 013636          339 AFGVVLLELLMGRRPVEKMSPTQC-QSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPL-  416 (439)
Q Consensus       339 S~Gvll~elltG~~P~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-  416 (439)
                      |+|||+|||+.|.+||...++.+. ..++.|.. .+......    +          ...+..++|.+|+. ||++|.- 
T Consensus       373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~-~l~fP~~~----~----------~s~eA~DLI~rll~-d~~~RLG~  436 (550)
T KOG0605|consen  373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRE-TLKFPEEV----D----------LSDEAKDLITRLLC-DPENRLGS  436 (550)
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhh-hccCCCcC----c----------ccHHHHHHHHHHhc-CHHHhcCc
Confidence            999999999999999999888664 55555532 22111111    0          11455678899998 9999975 


Q ss_pred             --HHHHH
Q 013636          417 --ITDVL  421 (439)
Q Consensus       417 --~~evl  421 (439)
                        +.||-
T Consensus       437 ~G~~EIK  443 (550)
T KOG0605|consen  437 KGAEEIK  443 (550)
T ss_pred             ccHHHHh
Confidence              55554

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.7e-40  Score=318.10  Aligned_cols=257  Identities=30%  Similarity=0.499  Sum_probs=207.9

Q ss_pred             cCCCccceecccCcEEEEEEEE------CCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARF------NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFL  226 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  226 (439)
                      ++|.+.+.||+|+||+||++..      .++..+++|.+..........+.+|+.++++++|||++++++++...+..++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            5678889999999999999975      2345689999887665666789999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhcCCC----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEE
Q 013636          227 VYEMMQNGSLEKQLHGPT----------HGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKL  296 (439)
Q Consensus       227 V~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl  296 (439)
                      ||||+++++|.+++....          ....+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEe
Confidence            999999999999986421          123589999999999999999999998   9999999999999999999999


Q ss_pred             EecccccccCCCCcc---eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcc
Q 013636          297 SDFGLSVTAGTQSRN---VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQ  372 (439)
Q Consensus       297 ~DfGls~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~  372 (439)
                      +|||++.........   ....++..|+|||.+.+..++.++||||||+++|||++ |..||...........+.     
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~-----  236 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT-----  236 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-----
Confidence            999999765332211   12235678999999999999999999999999999998 999998766543222211     


Q ss_pred             cccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCC
Q 013636          373 LTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVP  429 (439)
Q Consensus       373 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~  429 (439)
                         ......     ....    ....+.+++.+||+.||++|||+.+++..|+.+..
T Consensus       237 ---~~~~~~-----~~~~----~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~  281 (288)
T cd05093         237 ---QGRVLQ-----RPRT----CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK  281 (288)
T ss_pred             ---cCCcCC-----CCCC----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence               011000     0011    12357889999999999999999999999987764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.9e-40  Score=320.06  Aligned_cols=266  Identities=24%  Similarity=0.336  Sum_probs=198.3

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGH-DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYE  229 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  229 (439)
                      .++|++.+.||+|+||.||+|+.. ++..+|+|.+..... .....+.+|+.+++.++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            367888999999999999999986 577899999864432 223467889999999999999999999999999999999


Q ss_pred             eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCC
Q 013636          230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS  309 (439)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~  309 (439)
                      |++ ++|.+++..  ....+++..+..++.|++.||+|||+.   +++||||||+|||+++++.+||+|||++.......
T Consensus        84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  157 (303)
T cd07869          84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS  157 (303)
T ss_pred             CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence            996 588888763  234588999999999999999999998   99999999999999999999999999986543222


Q ss_pred             -cceeeccccCccchhhhcC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhh-hhhhHhhhhccccc-----CCCCCc
Q 013636          310 -RNVKISGTLGYVAPEYLLE-GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQ-CQSMVTWAMPQLTD-----RSKLPN  381 (439)
Q Consensus       310 -~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~-~~~~~~~~~~~~~~-----~~~~~~  381 (439)
                       ......+|+.|+|||.+.+ ..++.++||||+||++|||++|+.||....... ..............     ....+.
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (303)
T cd07869         158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH  237 (303)
T ss_pred             ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence             1223457899999999875 457889999999999999999999998654321 11111110000000     000000


Q ss_pred             c--------CCchhcCccC-HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          382 I--------VDPVIRDTMD-LKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       382 ~--------~d~~l~~~~~-~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      .        ....+....+ ......+.+++..||+.||++|||+.|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h  288 (303)
T cd07869         238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH  288 (303)
T ss_pred             cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence            0        0000000000 0012356789999999999999999999964

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2.5e-40  Score=315.95  Aligned_cols=253  Identities=28%  Similarity=0.447  Sum_probs=202.1

Q ss_pred             cCCCccceecccCcEEEEEEEE-----CCccEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDAGH-DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFL  226 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  226 (439)
                      +.|++.+.||+|+||.||+|..     ..+..+++|.+..... ....++.+|+.++++++|||++++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4567789999999999999985     2457889999875433 334678999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhcCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC
Q 013636          227 VYEMMQNGSLEKQLHGPT--------------HGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSF  292 (439)
Q Consensus       227 V~e~~~~gsL~~~l~~~~--------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~  292 (439)
                      +|||+++|+|.+++....              ....+++.....++.|++.||+|||+.   +++||||||+||++++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence            999999999999985321              123588999999999999999999998   999999999999999999


Q ss_pred             cEEEEecccccccCCCCc---ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhh
Q 013636          293 NAKLSDFGLSVTAGTQSR---NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTW  368 (439)
Q Consensus       293 ~~kl~DfGls~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~  368 (439)
                      .+||+|||++........   .....++..|+|||.+.+..++.++||||||+++|||++ |..||...++......+..
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~  241 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK  241 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            999999999976533221   122335678999999998899999999999999999998 9999977654433222221


Q ss_pred             hhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhcc
Q 013636          369 AMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLI  425 (439)
Q Consensus       369 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  425 (439)
                      .     .....++.            ....+.+++.+||+.||++||++.+++++|.
T Consensus       242 ~-----~~~~~~~~------------~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  281 (283)
T cd05090         242 R-----QLLPCSED------------CPPRMYSLMTECWQEGPSRRPRFKDIHTRLR  281 (283)
T ss_pred             C-----CcCCCCCC------------CCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence            0     00011111            1235677999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=8.7e-41  Score=325.54  Aligned_cols=241  Identities=24%  Similarity=0.375  Sum_probs=195.3

Q ss_pred             ceecccCcEEEEEEEE----CCccEEEEEEecCCC----chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEe
Q 013636          159 NVIGEGGRGHVYKARF----NEKLLAAVKRIDDAG----HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       159 ~~LG~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      +.||+|+||.||+++.    ..+..+|+|.+....    ......+.+|+.+++.++||||+++++++..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            5799999999999976    356789999986421    12334578899999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC-C
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ-S  309 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~-~  309 (439)
                      +++|+|.+++..   ...+.+..+..++.|++.||+|||+.   +++||||||+|||+++++.+||+|||++...... .
T Consensus        82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (323)
T cd05584          82 LSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT  155 (323)
T ss_pred             CCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence            999999999864   34578888999999999999999998   9999999999999999999999999998653222 2


Q ss_pred             cceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcC
Q 013636          310 RNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRD  389 (439)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  389 (439)
                      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...+.......+.      .....++..+      
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~------~~~~~~~~~~------  223 (323)
T cd05584         156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKIL------KGKLNLPPYL------  223 (323)
T ss_pred             cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHH------cCCCCCCCCC------
Confidence            2233568999999999999889999999999999999999999998765433221111      1111222222      


Q ss_pred             ccCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHh
Q 013636          390 TMDLKHLYQVAAVAVLCIQPEPSYRP-----LITDVLHS  423 (439)
Q Consensus       390 ~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  423 (439)
                            ...+.+++.+||+.||++||     ++.+++++
T Consensus       224 ------~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         224 ------TPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             ------CHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence                  23466799999999999999     88888865

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=5.3e-41  Score=327.33  Aligned_cols=241  Identities=22%  Similarity=0.308  Sum_probs=196.7

Q ss_pred             ceecccCcEEEEEEEEC-CccEEEEEEecCCC---chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEeccCC
Q 013636          159 NVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNG  234 (439)
Q Consensus       159 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  234 (439)
                      +.||+|+||.||+++.. .+..+|+|.+....   ......+.+|+.+++.++||||+++.+++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999875 57889999986532   233456788999999999999999999999999999999999999


Q ss_pred             ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC-Ccce
Q 013636          235 SLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHE-HCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ-SRNV  312 (439)
Q Consensus       235 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~-~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~-~~~~  312 (439)
                      +|..++..   ...+++..+..++.|++.||+|||+ .   +++||||||+|||+++++.+||+|||++...... ....
T Consensus        81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~  154 (325)
T cd05594          81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK  154 (325)
T ss_pred             cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccc
Confidence            99998853   3468999999999999999999997 5   8999999999999999999999999998653322 2223


Q ss_pred             eeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCccC
Q 013636          313 KISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMD  392 (439)
Q Consensus       313 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  392 (439)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+..      ....++..+         
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~------~~~~~p~~~---------  219 (325)
T cd05594         155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM------EEIRFPRTL---------  219 (325)
T ss_pred             cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhc------CCCCCCCCC---------
Confidence            34699999999999999999999999999999999999999987665433322211      111222222         


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHh
Q 013636          393 LKHLYQVAAVAVLCIQPEPSYRP-----LITDVLHS  423 (439)
Q Consensus       393 ~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  423 (439)
                         ...+.+++.+||+.||++|+     ++.+++++
T Consensus       220 ---~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         220 ---SPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             ---CHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence               22456789999999999996     89999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-42  Score=333.15  Aligned_cols=258  Identities=27%  Similarity=0.444  Sum_probs=211.6

Q ss_pred             HHhcCCCccceecccCcEEEEEEEECC-----ccEEEEEEecCC-CchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCe
Q 013636          150 AATNNFQESNVIGEGGRGHVYKARFNE-----KLLAAVKRIDDA-GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAET  223 (439)
Q Consensus       150 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  223 (439)
                      ...+.....++||+|-||.||+|.+.+     ...||||..+.. ..+..+.|.+|..+|++++||||++++|.|.+ ..
T Consensus       386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P  464 (974)
T KOG4257|consen  386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QP  464 (974)
T ss_pred             eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cc
Confidence            334455667889999999999997632     467899999864 34556779999999999999999999999975 68


Q ss_pred             eEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccccc
Q 013636          224 RFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSV  303 (439)
Q Consensus       224 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~  303 (439)
                      .|+|||.++-|.|..||..  +...++......++.||+.+|+|||+.   .+|||||.++|||+.....+||+|||+++
T Consensus       465 ~WivmEL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR  539 (974)
T KOG4257|consen  465 MWIVMELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSR  539 (974)
T ss_pred             eeEEEecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhh
Confidence            8999999999999999984  445688999999999999999999998   99999999999999999999999999999


Q ss_pred             ccCCCCcceeecc--ccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCC
Q 013636          304 TAGTQSRNVKISG--TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLP  380 (439)
Q Consensus       304 ~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  380 (439)
                      ...++.......|  ...|||||.+...++|.+||||-|||++||++. |..||.+....++.-.       +....++|
T Consensus       540 ~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~-------iEnGeRlP  612 (974)
T KOG4257|consen  540 YLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGH-------IENGERLP  612 (974)
T ss_pred             hccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEE-------ecCCCCCC
Confidence            8877665533333  467999999999999999999999999999887 9999988755443222       22222221


Q ss_pred             ccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCC
Q 013636          381 NIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPT  430 (439)
Q Consensus       381 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~  430 (439)
                                +++.++..+..++.+||..+|.+||+++++...|..++.+
T Consensus       613 ----------~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qe  652 (974)
T KOG4257|consen  613 ----------CPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQE  652 (974)
T ss_pred             ----------CCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHH
Confidence                      1222344566799999999999999999999998777653

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-41  Score=330.97  Aligned_cols=250  Identities=23%  Similarity=0.298  Sum_probs=203.9

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC---chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      ++|++.+.||+|+||+||+|+.. ++..+|+|.+....   ......+.+|+.++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            46888999999999999999886 57889999986432   234457889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~  308 (439)
                      ||+++|+|.+++...   ..+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++......
T Consensus        81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence            999999999999743   4689999999999999999999997   9999999999999999999999999999765433


Q ss_pred             C------------------------------cceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC
Q 013636          309 S------------------------------RNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMS  358 (439)
Q Consensus       309 ~------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~  358 (439)
                      .                              ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~  234 (350)
T cd05573         155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT  234 (350)
T ss_pred             CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence            2                              1123458999999999999999999999999999999999999998776


Q ss_pred             hhhhhhhHhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHh
Q 013636          359 PTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPL-ITDVLHS  423 (439)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-~~evl~~  423 (439)
                      .......+...    ......+....          ....+.+++..|++ ||++||+ +.+++++
T Consensus       235 ~~~~~~~i~~~----~~~~~~p~~~~----------~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         235 LQETYNKIINW----KESLRFPPDPP----------VSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             HHHHHHHHhcc----CCcccCCCCCC----------CCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            54322222110    01111111110          12356678889998 9999999 9999976

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2.2e-40  Score=312.94  Aligned_cols=253  Identities=26%  Similarity=0.437  Sum_probs=205.7

Q ss_pred             cCCCccceecccCcEEEEEEEECC-ccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEec
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMM  231 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  231 (439)
                      .+|+..+.||+|+||.||+|...+ +..+++|.+.... ....++.+|++++++++|+|++++++++...+..+++|||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            357778899999999999998754 7788999887543 34567899999999999999999999999999999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCcc
Q 013636          232 QNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN  311 (439)
Q Consensus       232 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~~  311 (439)
                      ++++|.+++... ....+++..++.++.|+++||+|||+.   +++||||||+||++++++.+||+|||++.........
T Consensus        85 ~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~  160 (263)
T cd05052          85 TYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT  160 (263)
T ss_pred             CCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence            999999998652 234689999999999999999999997   9999999999999999999999999999765433221


Q ss_pred             e--eeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhc
Q 013636          312 V--KISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIR  388 (439)
Q Consensus       312 ~--~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  388 (439)
                      .  ...++..|+|||.+.+..++.++||||||+++|||++ |..||...+..+........   .  ....+        
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~---~--~~~~~--------  227 (263)
T cd05052         161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKG---Y--RMERP--------  227 (263)
T ss_pred             ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC---C--CCCCC--------
Confidence            1  1224568999999999999999999999999999998 99999876554332222110   0  01111        


Q ss_pred             CccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhcccc
Q 013636          389 DTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPL  427 (439)
Q Consensus       389 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l  427 (439)
                      .    .....+.+++.+||+.||++||++.++++.|+.+
T Consensus       228 ~----~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         228 E----GCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             C----CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            1    1134677899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.7e-40  Score=328.76  Aligned_cols=204  Identities=24%  Similarity=0.380  Sum_probs=176.4

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC---chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      ++|+..+.||+|+||+||+++.. .+..+|+|.+....   ......+.+|+.++.+++|+||+++++.+.+.+..++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            46888999999999999999875 47889999986532   223356788999999999999999999999999999999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~  308 (439)
                      ||+++|+|.+++..   ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++++||+|||++......
T Consensus        81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~  154 (363)
T cd05628          81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA  154 (363)
T ss_pred             cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence            99999999999964   34689999999999999999999998   9999999999999999999999999998653221


Q ss_pred             C------------------------------------cceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCC
Q 013636          309 S------------------------------------RNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRR  352 (439)
Q Consensus       309 ~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~  352 (439)
                      .                                    ......||+.|+|||.+.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~  234 (363)
T cd05628         155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (363)
T ss_pred             ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence            0                                    0123469999999999999999999999999999999999999


Q ss_pred             CCCCCChhhh
Q 013636          353 PVEKMSPTQC  362 (439)
Q Consensus       353 P~~~~~~~~~  362 (439)
                      ||...++.+.
T Consensus       235 Pf~~~~~~~~  244 (363)
T cd05628         235 PFCSETPQET  244 (363)
T ss_pred             CCCCCCHHHH
Confidence            9987765543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.9e-40  Score=319.27  Aligned_cols=257  Identities=29%  Similarity=0.441  Sum_probs=203.0

Q ss_pred             cCCCccceecccCcEEEEEEEECCc---cEEEEEEecCC-CchHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeeEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNEK---LLAAVKRIDDA-GHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLV  227 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV  227 (439)
                      ++|++.+.||+|+||.||+|...+.   ..+++|.++.. .....+.+.+|+.++.++ +|||++++++++...+..+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            4688889999999999999987542   34688877643 233446789999999999 799999999999999999999


Q ss_pred             EEeccCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcE
Q 013636          228 YEMMQNGSLEKQLHGPT-------------HGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA  294 (439)
Q Consensus       228 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~  294 (439)
                      +||+++|+|.++++...             ....+++..+..++.|++.|++|||+.   +++||||||+|||+++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence            99999999999996422             123588999999999999999999997   99999999999999999999


Q ss_pred             EEEecccccccCCCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhccc
Q 013636          295 KLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQL  373 (439)
Q Consensus       295 kl~DfGls~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~  373 (439)
                      ||+|||++..............+..|+|||.+....++.++|||||||++|||++ |..||..............   ..
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~---~~  235 (297)
T cd05089         159 KIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ---GY  235 (297)
T ss_pred             EECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc---CC
Confidence            9999999864322111111223557999999998899999999999999999997 9999987765442222110   00


Q ss_pred             ccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCC
Q 013636          374 TDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVP  429 (439)
Q Consensus       374 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~  429 (439)
                        ....+..            ....+.+++.+||+.+|++|||+.++++.|..++.
T Consensus       236 --~~~~~~~------------~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~  277 (297)
T cd05089         236 --RMEKPRN------------CDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE  277 (297)
T ss_pred             --CCCCCCC------------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence              0011111            12356789999999999999999999999877664

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2.8e-41  Score=330.84  Aligned_cols=261  Identities=25%  Similarity=0.395  Sum_probs=203.3

Q ss_pred             HhcCCCccceecccCcEEEEEEEECC------ccEEEEEEecCCCc-hHHHHHHHHHHHHHhc-CCCceeeeeeEEEeC-
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARFNE------KLLAAVKRIDDAGH-DAEREFNNEVNWLTKI-RHQNIISLLGYCIHA-  221 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-  221 (439)
                      ..++|++.+.||+|+||.||+|...+      +..+|+|++..... ...+.+.+|+.++.++ +|+||++++++|... 
T Consensus         5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~   84 (337)
T cd05054           5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG   84 (337)
T ss_pred             CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence            44678889999999999999996422      46799999875432 3345678899999999 899999999988654 


Q ss_pred             CeeEEEEEeccCCChhhhhcCCCC--------------------------------------------------------
Q 013636          222 ETRFLVYEMMQNGSLEKQLHGPTH--------------------------------------------------------  245 (439)
Q Consensus       222 ~~~~lV~e~~~~gsL~~~l~~~~~--------------------------------------------------------  245 (439)
                      ...++++||+++|+|.+++.....                                                        
T Consensus        85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (337)
T cd05054          85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE  164 (337)
T ss_pred             CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence            567899999999999999854211                                                        


Q ss_pred             --CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCcc---eeeccccCc
Q 013636          246 --GSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN---VKISGTLGY  320 (439)
Q Consensus       246 --~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~~---~~~~gt~~y  320 (439)
                        ...+++..+.+++.|++.||+|||+.   +|+||||||+||++++++.+||+|||++.........   ....++..|
T Consensus       165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y  241 (337)
T cd05054         165 LYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW  241 (337)
T ss_pred             HhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence              12689999999999999999999998   9999999999999999999999999999765332211   123356789


Q ss_pred             cchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCccCHHHHHHH
Q 013636          321 VAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQV  399 (439)
Q Consensus       321 ~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l  399 (439)
                      +|||.+.+..++.++|||||||++|||++ |..||......+..  .. .   +......  ..        .......+
T Consensus       242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~--~~-~---~~~~~~~--~~--------~~~~~~~~  305 (337)
T cd05054         242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEF--CR-R---LKEGTRM--RA--------PEYATPEI  305 (337)
T ss_pred             cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHH--HH-H---HhccCCC--CC--------CccCCHHH
Confidence            99999999999999999999999999998 99999764432211  00 0   0000000  00        01113457


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHHHhccccCCC
Q 013636          400 AAVAVLCIQPEPSYRPLITDVLHSLIPLVPT  430 (439)
Q Consensus       400 ~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~  430 (439)
                      .+++.+||+.+|++||++.|++++|..++++
T Consensus       306 ~~l~~~cl~~~p~~RPs~~ell~~l~~~~~~  336 (337)
T cd05054         306 YSIMLDCWHNNPEDRPTFSELVEILGDLLQE  336 (337)
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            7899999999999999999999999887653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=3e-40  Score=316.80  Aligned_cols=257  Identities=28%  Similarity=0.473  Sum_probs=207.9

Q ss_pred             cCCCccceecccCcEEEEEEEEC------CccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN------EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFL  226 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  226 (439)
                      .+|...+.||+|+||.||+++..      +...+++|.+........+.+.+|+.++++++|+|++++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            35777889999999999999753      345688898877665556789999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCc
Q 013636          227 VYEMMQNGSLEKQLHGPT-------------HGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFN  293 (439)
Q Consensus       227 V~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~  293 (439)
                      ||||+++++|.+++....             ....+++..++.++.|++.|++|||+.   +++||||||+||++++++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence            999999999999996422             123589999999999999999999998   9999999999999999999


Q ss_pred             EEEEecccccccCCCCc---ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhh
Q 013636          294 AKLSDFGLSVTAGTQSR---NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWA  369 (439)
Q Consensus       294 ~kl~DfGls~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~  369 (439)
                      ++|+|||++........   .....++..|+|||.+.+..++.++||||||+++|||++ |+.||...+.........  
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~--  239 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT--  239 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh--
Confidence            99999999975543221   112335788999999999999999999999999999999 999997766543222111  


Q ss_pred             hcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCC
Q 013636          370 MPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVP  429 (439)
Q Consensus       370 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~  429 (439)
                            ........     .    .....+.+++.+||+.||++|||+.+|++.|+.+..
T Consensus       240 ------~~~~~~~~-----~----~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         240 ------QGRVLERP-----R----VCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             ------CCCCCCCC-----c----cCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence                  11111100     0    123457789999999999999999999999987743

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.5e-40  Score=323.88  Aligned_cols=262  Identities=23%  Similarity=0.319  Sum_probs=195.0

Q ss_pred             CCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC-----eeE
Q 013636          154 NFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE-----TRF  225 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  225 (439)
                      +|++.+.||+|+||.||+|+.. ++..+|+|.+....  ......+.+|+.++++++||||+++++++...+     ..+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4778899999999999999875 57889999987432  233456889999999999999999999886433     479


Q ss_pred             EEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccccccc
Q 013636          226 LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA  305 (439)
Q Consensus       226 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~  305 (439)
                      +||||+. ++|.+++..   ...+++..+..++.|+++||+|||+.   +++||||||+|||+++++.+||+|||++...
T Consensus        81 lv~e~~~-~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~  153 (338)
T cd07859          81 VVFELME-SDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVA  153 (338)
T ss_pred             EEEecCC-CCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence            9999995 689988853   34589999999999999999999998   9999999999999999999999999999754


Q ss_pred             CCCCc----ceeeccccCccchhhhcC--CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcc-------
Q 013636          306 GTQSR----NVKISGTLGYVAPEYLLE--GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQ-------  372 (439)
Q Consensus       306 ~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~-------  372 (439)
                      .....    .....||+.|+|||.+.+  ..++.++|||||||++|||++|+.||...+.......+......       
T Consensus       154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  233 (338)
T cd07859         154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS  233 (338)
T ss_pred             ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            32211    123458999999999876  67899999999999999999999999765532211111100000       


Q ss_pred             -cccC------CCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          373 -LTDR------SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       373 -~~~~------~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                       +...      ..+............ ......+.+++.+||+.||++|||+.|++++
T Consensus       234 ~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         234 RVRNEKARRYLSSMRKKQPVPFSQKF-PNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             HhhhhhHHHHHHhhcccCCCchHHhc-CCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence             0000      000000000000000 0012356789999999999999999999975

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2e-40  Score=335.74  Aligned_cols=266  Identities=23%  Similarity=0.317  Sum_probs=197.5

Q ss_pred             HHhcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeC-------
Q 013636          150 AATNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHA-------  221 (439)
Q Consensus       150 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------  221 (439)
                      ...++|+..+.||+|+||.||+|... .+..+|+|++....    ....+|+.+++.++||||+++++++...       
T Consensus        63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~  138 (440)
T PTZ00036         63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK  138 (440)
T ss_pred             CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence            34568999999999999999999875 57789999885432    2345799999999999999999876432       


Q ss_pred             -CeeEEEEEeccCCChhhhhcC-CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC-cEEEEe
Q 013636          222 -ETRFLVYEMMQNGSLEKQLHG-PTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSF-NAKLSD  298 (439)
Q Consensus       222 -~~~~lV~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~-~~kl~D  298 (439)
                       ...++||||+++ +|.+++.. ......+++..+..++.|++.||+|||+.   +|+||||||+|||++.++ .+||+|
T Consensus       139 ~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~D  214 (440)
T PTZ00036        139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCD  214 (440)
T ss_pred             ceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeec
Confidence             135789999985 77766642 12345689999999999999999999998   999999999999999664 799999


Q ss_pred             cccccccCCCCcceeeccccCccchhhhcCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccc---
Q 013636          299 FGLSVTAGTQSRNVKISGTLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLT---  374 (439)
Q Consensus       299 fGls~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~---  374 (439)
                      ||+++............||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.+..+....+........   
T Consensus       215 FGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~  294 (440)
T PTZ00036        215 FGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQ  294 (440)
T ss_pred             cccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            9999876544444455689999999998764 689999999999999999999999987654332111111100000   


Q ss_pred             --------cCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          375 --------DRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       375 --------~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                              ....++......+...+......++.+++.+||+.||++|||+.|++++
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        295 LKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             HHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence                    0001111111111111111223467889999999999999999999965

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=3.5e-40  Score=314.48  Aligned_cols=255  Identities=26%  Similarity=0.431  Sum_probs=201.3

Q ss_pred             cCCCccceecccCcEEEEEEEECC-cc----EEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNE-KL----LAAVKRIDDAGH-DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFL  226 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  226 (439)
                      ++|+..+.||+|+||+||+|.+.. +.    .+++|....... ....++..|+..+++++||||+++++++. ....++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence            467778999999999999998743 22    467788764432 23357888999999999999999999875 456789


Q ss_pred             EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccC
Q 013636          227 VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAG  306 (439)
Q Consensus       227 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~  306 (439)
                      ++||+++|+|.++++.  ....+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||+++...
T Consensus        86 i~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          86 VTQLSPLGSLLDHVRQ--HRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             EEEeCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            9999999999999974  234689999999999999999999998   99999999999999999999999999997653


Q ss_pred             CCCcc---eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCcc
Q 013636          307 TQSRN---VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNI  382 (439)
Q Consensus       307 ~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  382 (439)
                      .....   ....++..|+|||.+.++.++.++||||||+++||+++ |+.||.+..+......+..       ....+  
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~-------~~~~~--  231 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEK-------GERLA--  231 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-------CCcCC--
Confidence            32211   22346678999999999999999999999999999998 9999987765543333221       11110  


Q ss_pred             CCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCC
Q 013636          383 VDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPT  430 (439)
Q Consensus       383 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~  430 (439)
                       .+..       ....+.+++..||+.||++|||+.|+++.|..+.+.
T Consensus       232 -~~~~-------~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~  271 (279)
T cd05111         232 -QPQI-------CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD  271 (279)
T ss_pred             -CCCC-------CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence             1111       123456788999999999999999999999876643

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=8.2e-41  Score=305.80  Aligned_cols=265  Identities=24%  Similarity=0.312  Sum_probs=204.6

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCchH--HHHHHHHHHHHHhcCCCceeeeeeEEEeC--CeeEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDA--EREFNNEVNWLTKIRHQNIISLLGYCIHA--ETRFLV  227 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV  227 (439)
                      ++|+..+.|++|+||.||+|++. .+..||+|+++......  --.-.+|+.+|.+++|||||.+..+....  +..|+|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            46777889999999999999985 47889999997543111  12357899999999999999998877644  578999


Q ss_pred             EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCC
Q 013636          228 YEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT  307 (439)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~  307 (439)
                      ||||++ +|..+++.  -..++...+...+..|+++|++|||+.   .|+|||||++|+|+++.|.+||+|||+|+.++.
T Consensus       156 Me~~Eh-DLksl~d~--m~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs  229 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMET--MKQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGS  229 (419)
T ss_pred             HHHHHh-hHHHHHHh--ccCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcC
Confidence            999998 99999984  335788999999999999999999998   999999999999999999999999999999877


Q ss_pred             CCcc-eeeccccCccchhhhcCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccC-----CC--
Q 013636          308 QSRN-VKISGTLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDR-----SK--  378 (439)
Q Consensus       308 ~~~~-~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~-----~~--  378 (439)
                      .... ....-|.+|+|||.+.+. .|++..|+||+|||+.||+++++-|.+.++-+..+.+-.......+.     ..  
T Consensus       230 p~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp  309 (419)
T KOG0663|consen  230 PLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP  309 (419)
T ss_pred             CcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence            6433 445679999999999874 69999999999999999999999998877644433333222211111     00  


Q ss_pred             ------CCccCCchhcCccCHH-HHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          379 ------LPNIVDPVIRDTMDLK-HLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       379 ------~~~~~d~~l~~~~~~~-~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                            .++..-..++..+... -..+-+++.-..+..||.+|-|+.|.|++
T Consensus       310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence                  1111111112111111 12456678888999999999999999965

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.5e-41  Score=330.96  Aligned_cols=249  Identities=22%  Similarity=0.358  Sum_probs=198.9

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC---chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      ++|+..+.||+|+||+||+++.. .+..+|+|.+....   ......+.+|+.++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            46888999999999999999886 47889999986432   233456788999999999999999999999999999999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~  308 (439)
                      ||+++|+|.+++..   ...+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++......
T Consensus        81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  154 (364)
T cd05599          81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS  154 (364)
T ss_pred             CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence            99999999999964   34589999999999999999999998   9999999999999999999999999998643211


Q ss_pred             Cc---------------------------------------ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh
Q 013636          309 SR---------------------------------------NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM  349 (439)
Q Consensus       309 ~~---------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt  349 (439)
                      ..                                       .....||+.|+|||++....++.++|||||||++|||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~  234 (364)
T cd05599         155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV  234 (364)
T ss_pred             ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence            10                                       012358999999999999999999999999999999999


Q ss_pred             CCCCCCCCChhhhhhhH-hhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHh
Q 013636          350 GRRPVEKMSPTQCQSMV-TWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPL---ITDVLHS  423 (439)
Q Consensus       350 G~~P~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt---~~evl~~  423 (439)
                      |+.||...++.+....+ .|.     .....+...      ..    ...+.+++.+|+. +|.+|++   +.|++++
T Consensus       235 G~~Pf~~~~~~~~~~~i~~~~-----~~~~~~~~~------~~----s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h  296 (364)
T cd05599         235 GYPPFCSDNPQETYRKIINWK-----ETLQFPDEV------PL----SPEAKDLIKRLCC-EAERRLGNNGVNEIKSH  296 (364)
T ss_pred             CCCCCCCCCHHHHHHHHHcCC-----CccCCCCCC------CC----CHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence            99999877654432221 111     000111100      01    2245567888886 9999998   9988865

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=2.2e-40  Score=317.53  Aligned_cols=256  Identities=29%  Similarity=0.446  Sum_probs=204.9

Q ss_pred             CCCccceecccCcEEEEEEEECC------ccEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEE
Q 013636          154 NFQESNVIGEGGRGHVYKARFNE------KLLAAVKRIDDAGH-DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFL  226 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  226 (439)
                      +|++.+.||+|+||.||+|....      ...+++|.+..... ....++.+|+.+++.++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            46778999999999999997632      35678888765432 334678999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhcCCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCC
Q 013636          227 VYEMMQNGSLEKQLHGPT---------------------HGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSN  285 (439)
Q Consensus       227 V~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~N  285 (439)
                      ++||+++|+|.+++....                     ....+++..++.++.|++.||+|||+.   +++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence            999999999999986421                     123588999999999999999999997   99999999999


Q ss_pred             EEEcCCCcEEEEecccccccCCCCc---ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhh
Q 013636          286 ILLDSSFNAKLSDFGLSVTAGTQSR---NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQ  361 (439)
Q Consensus       286 iLl~~~~~~kl~DfGls~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~  361 (439)
                      |++++++.+||+|||++........   .....++..|+|||.+.+..++.++||||||+++|||++ |..||....+..
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~  237 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER  237 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            9999999999999999875432221   112235678999999999899999999999999999998 999998776554


Q ss_pred             hhhhHhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCC
Q 013636          362 CQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVP  429 (439)
Q Consensus       362 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~  429 (439)
                      ........   .  ....+        .    .....+.+++..||+.+|++||++.++++.|+++..
T Consensus       238 ~~~~~~~~---~--~~~~~--------~----~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         238 LFNLLKTG---Y--RMERP--------E----NCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             HHHHHhCC---C--CCCCC--------C----CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence            33322110   0  00001        1    112457789999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-40  Score=330.38  Aligned_cols=242  Identities=26%  Similarity=0.408  Sum_probs=205.5

Q ss_pred             HhcCCCccceecccCcEEEEEEEECC-ccEEEEEEecCCC---chHHHHHHHHHHHHHhcC-CCceeeeeeEEEeCCeeE
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAG---HDAEREFNNEVNWLTKIR-HQNIISLLGYCIHAETRF  225 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  225 (439)
                      .-++|...++||+|+||+|+++..+. +..+|||.+++..   .++.+....|.+++...+ ||.+++++.++...+..+
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~  445 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF  445 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence            34789999999999999999998865 6688999998643   455567788888888874 999999999999999999


Q ss_pred             EEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccccccc
Q 013636          226 LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA  305 (439)
Q Consensus       226 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~  305 (439)
                      .||||+.||++..+.+    .+.+++..+..++..++.||+|||++   +|++||||.+|||||.+|++||+|||+++..
T Consensus       446 fvmey~~Ggdm~~~~~----~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~  518 (694)
T KOG0694|consen  446 FVMEYVAGGDLMHHIH----TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEG  518 (694)
T ss_pred             EEEEecCCCcEEEEEe----cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccccccccc
Confidence            9999999999554443    35699999999999999999999998   9999999999999999999999999999764


Q ss_pred             -CCCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCC
Q 013636          306 -GTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVD  384 (439)
Q Consensus       306 -~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  384 (439)
                       .......+++||+.|+|||++.+..|+..+|.|||||+||||+.|..||.+.++++....+.      .++...|.++ 
T Consensus       519 m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~------~d~~~yP~~l-  591 (694)
T KOG0694|consen  519 MGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV------NDEVRYPRFL-  591 (694)
T ss_pred             CCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh------cCCCCCCCcc-
Confidence             35566678999999999999999999999999999999999999999999988877654442      2233333322 


Q ss_pred             chhcCccCHHHHHHHHHHHHHhcCCCCCCCCCH
Q 013636          385 PVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLI  417 (439)
Q Consensus       385 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~  417 (439)
                                 ..+...++.+++..||++|.-+
T Consensus       592 -----------s~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  592 -----------SKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             -----------cHHHHHHHHHHhccCcccccCC
Confidence                       3356678999999999999865

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.2e-40  Score=309.77  Aligned_cols=248  Identities=27%  Similarity=0.435  Sum_probs=201.5

Q ss_pred             CCCccceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEeccC
Q 013636          154 NFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQN  233 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  233 (439)
                      +|+..+.||+|+||.||+++++++..+++|.+.... ....++.+|++++++++|||++++++++...+..++||||+++
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN   83 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence            467788999999999999998887789999886433 2345788999999999999999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCcce-
Q 013636          234 GSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV-  312 (439)
Q Consensus       234 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~~~-  312 (439)
                      ++|.+++...  ...+++..+..++.|++.|++|||+.   +++||||||+||++++++.+||+|||+++......... 
T Consensus        84 ~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~  158 (256)
T cd05059          84 GCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS  158 (256)
T ss_pred             CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence            9999999742  23689999999999999999999998   99999999999999999999999999987654322111 


Q ss_pred             -eeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCc
Q 013636          313 -KISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDT  390 (439)
Q Consensus       313 -~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  390 (439)
                       ...++..|+|||.+.+..++.++||||||+++||+++ |+.||...++.+....+...   .  ....+.         
T Consensus       159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~---~--~~~~~~---------  224 (256)
T cd05059         159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAG---Y--RLYRPK---------  224 (256)
T ss_pred             CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcC---C--cCCCCC---------
Confidence             1123457999999999999999999999999999999 89999876544322222110   0  000010         


Q ss_pred             cCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhc
Q 013636          391 MDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL  424 (439)
Q Consensus       391 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  424 (439)
                         .....+.+++.+||+.+|++|||+.|+++.|
T Consensus       225 ---~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         225 ---LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             ---CCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence               1234677899999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.8e-40  Score=322.95  Aligned_cols=241  Identities=26%  Similarity=0.352  Sum_probs=194.7

Q ss_pred             ceecccCcEEEEEEEECC-ccEEEEEEecCCC---chHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeeEEEEEeccC
Q 013636          159 NVIGEGGRGHVYKARFNE-KLLAAVKRIDDAG---HDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMMQN  233 (439)
Q Consensus       159 ~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~  233 (439)
                      +.||+|+||+||+|+... +..+|+|.+....   ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            369999999999998864 7789999886431   23345677888888876 699999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC-Ccce
Q 013636          234 GSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ-SRNV  312 (439)
Q Consensus       234 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~-~~~~  312 (439)
                      |+|.+++..   ...+++..+..++.|++.||+|||+.   +++||||||+|||+++++.+||+|||++...... ....
T Consensus        81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~  154 (320)
T cd05590          81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTS  154 (320)
T ss_pred             chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccc
Confidence            999998864   24589999999999999999999998   9999999999999999999999999998653222 2223


Q ss_pred             eeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCccC
Q 013636          313 KISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMD  392 (439)
Q Consensus       313 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  392 (439)
                      ...||+.|+|||.+.+..++.++|||||||++|||++|+.||...+.......+.      ......+..+         
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~------~~~~~~~~~~---------  219 (320)
T cd05590         155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL------NDEVVYPTWL---------  219 (320)
T ss_pred             ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHh------cCCCCCCCCC---------
Confidence            4568999999999999999999999999999999999999998776544322221      1111122222         


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCH------HHHHHh
Q 013636          393 LKHLYQVAAVAVLCIQPEPSYRPLI------TDVLHS  423 (439)
Q Consensus       393 ~~~~~~l~~l~~~cl~~dP~~RPt~------~evl~~  423 (439)
                         ...+.+++.+||+.||++||++      ++++++
T Consensus       220 ---~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h  253 (320)
T cd05590         220 ---SQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH  253 (320)
T ss_pred             ---CHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence               2346679999999999999998      666654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-41  Score=299.37  Aligned_cols=263  Identities=25%  Similarity=0.371  Sum_probs=209.7

Q ss_pred             HhcCCCccceecccCcEEEEEEEE-CCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC-----ee
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARF-NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE-----TR  224 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~  224 (439)
                      ..++|++.+.||+|||+.||.++. .++..+|+|++...+.++.+..++|++..++++|||++++++++..+.     ..
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            357899999999999999999984 567889999998887778888999999999999999999999876543     48


Q ss_pred             EEEEEeccCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccccc
Q 013636          225 FLVYEMMQNGSLEKQLHGP-THGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSV  303 (439)
Q Consensus       225 ~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~  303 (439)
                      |++++|...|||.+.+... ..+..+++.+.+.|+.++++||++||+. .++++||||||.|||+.+++.++|.|||.+.
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~  177 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSAT  177 (302)
T ss_pred             EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcc
Confidence            9999999999999998763 3455799999999999999999999997 3469999999999999999999999999986


Q ss_pred             ccCCCCcc----------eeeccccCccchhhhc---CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhh
Q 013636          304 TAGTQSRN----------VKISGTLGYVAPEYLL---EGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAM  370 (439)
Q Consensus       304 ~~~~~~~~----------~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~  370 (439)
                      ...-.-..          .....|..|+|||.+.   +...++++|||||||+||+|+.|..||+..-... . .+..+ 
T Consensus       178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G-g-SlaLA-  254 (302)
T KOG2345|consen  178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG-G-SLALA-  254 (302)
T ss_pred             ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC-C-eEEEe-
Confidence            54322111          1123688999999886   4567889999999999999999999998643211 1 11111 


Q ss_pred             cccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccC
Q 013636          371 PQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLV  428 (439)
Q Consensus       371 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~  428 (439)
                                 +..+.+.-.-+......+.+++.+|++.||.+||++.+++..++.+.
T Consensus       255 -----------v~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  255 -----------VQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             -----------eeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence                       00111111111124567888999999999999999999999988764

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=4.2e-40  Score=313.51  Aligned_cols=256  Identities=29%  Similarity=0.445  Sum_probs=203.7

Q ss_pred             HhcCCCccceecccCcEEEEEEEECC------ccEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCe
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARFNE------KLLAAVKRIDDAG-HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAET  223 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  223 (439)
                      .+++|++.+.||+|+||.||+|.+.+      +..+++|...... ......|.+|+.++++++|+||+++++++.+.+.
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            34678889999999999999998854      5678888886443 3344579999999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhhhcCCCC----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC---cEEE
Q 013636          224 RFLVYEMMQNGSLEKQLHGPTH----GSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSF---NAKL  296 (439)
Q Consensus       224 ~~lV~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~---~~kl  296 (439)
                      .++||||+++|+|.++++....    ...+++..+++++.|++.|++|||+.   +++||||||+||+++.++   .+||
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEe
Confidence            9999999999999999975321    23589999999999999999999998   999999999999998754   5999


Q ss_pred             EecccccccCCCCcce---eeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcc
Q 013636          297 SDFGLSVTAGTQSRNV---KISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQ  372 (439)
Q Consensus       297 ~DfGls~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~  372 (439)
                      +|||++..........   ....+..|+|||.+.+..++.++|||||||++|||++ |+.||...+.......+...   
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~---  237 (277)
T cd05036         161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG---  237 (277)
T ss_pred             ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC---
Confidence            9999997653222111   1123467999999999999999999999999999997 99999876654432222110   


Q ss_pred             cccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccc
Q 013636          373 LTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIP  426 (439)
Q Consensus       373 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  426 (439)
                        .....+        .    .....+.+++.+|++.+|++||++.+|+++|++
T Consensus       238 --~~~~~~--------~----~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~  277 (277)
T cd05036         238 --GRLDPP--------K----GCPGPVYRIMTDCWQHTPEDRPNFATILERIQY  277 (277)
T ss_pred             --CcCCCC--------C----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence              001110        1    112467789999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.6e-40  Score=322.37  Aligned_cols=244  Identities=26%  Similarity=0.380  Sum_probs=195.6

Q ss_pred             CCccceecccCcEEEEEEEEC-CccEEEEEEecCCC---chHHHHHHHHHHHH---HhcCCCceeeeeeEEEeCCeeEEE
Q 013636          155 FQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG---HDAEREFNNEVNWL---TKIRHQNIISLLGYCIHAETRFLV  227 (439)
Q Consensus       155 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lV  227 (439)
                      |++.+.||+|+||.||++... ++..+|+|.++...   ....+.+.+|.+++   +.++||||+++++++...+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            566789999999999999875 47889999986432   22334566666655   566899999999999999999999


Q ss_pred             EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCC
Q 013636          228 YEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT  307 (439)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~  307 (439)
                      |||+++|+|..+++.    ..+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||++.....
T Consensus        81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05589          81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG  153 (324)
T ss_pred             EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence            999999999988853    3589999999999999999999998   999999999999999999999999999865322


Q ss_pred             -CCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCch
Q 013636          308 -QSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPV  386 (439)
Q Consensus       308 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  386 (439)
                       ........||+.|+|||.+.+..++.++|||||||++|||++|+.||...+..+....+..      .....+..+   
T Consensus       154 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~------~~~~~p~~~---  224 (324)
T cd05589         154 FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN------DEVRYPRFL---  224 (324)
T ss_pred             CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh------CCCCCCCCC---
Confidence             2222345689999999999999999999999999999999999999987765443322211      111111111   


Q ss_pred             hcCccCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHh
Q 013636          387 IRDTMDLKHLYQVAAVAVLCIQPEPSYRP-----LITDVLHS  423 (439)
Q Consensus       387 l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  423 (439)
                               ...+.+++.+||+.||++||     ++.+++++
T Consensus       225 ---------~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~  257 (324)
T cd05589         225 ---------SREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ  257 (324)
T ss_pred             ---------CHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence                     23456799999999999999     57777765

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=3.1e-40  Score=321.75  Aligned_cols=246  Identities=22%  Similarity=0.300  Sum_probs=197.7

Q ss_pred             CCCccceecccCcEEEEEEEECC-ccEEEEEEecCC---CchHHHHHHHHHHHHHhcCCC-ceeeeeeEEEeCCeeEEEE
Q 013636          154 NFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDA---GHDAEREFNNEVNWLTKIRHQ-NIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lV~  228 (439)
                      +|++.+.||+|+||.||+|+..+ +..+|+|.+...   .....+.+..|..++..++|+ +++++.+++...+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            47778999999999999998765 578999998643   223445678899999999765 5888899999999999999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCC-
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT-  307 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~-  307 (439)
                      ||+++|+|.+++..   ...+++..+..++.|++.||+|||+.   +++||||||+|||+++++.+||+|||++..... 
T Consensus        81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05587          81 EYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG  154 (324)
T ss_pred             cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence            99999999999864   34588999999999999999999998   999999999999999999999999999864322 


Q ss_pred             CCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchh
Q 013636          308 QSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVI  387 (439)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  387 (439)
                      ........||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+....+.      ......+..+    
T Consensus       155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~------~~~~~~~~~~----  224 (324)
T cd05587         155 GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM------EHNVSYPKSL----  224 (324)
T ss_pred             CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH------cCCCCCCCCC----
Confidence            222234569999999999999999999999999999999999999998766543322221      1111222222    


Q ss_pred             cCccCHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHh
Q 013636          388 RDTMDLKHLYQVAAVAVLCIQPEPSYRPLI-----TDVLHS  423 (439)
Q Consensus       388 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~-----~evl~~  423 (439)
                              ...+.+++.+||+.||++||+.     .+++++
T Consensus       225 --------~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  257 (324)
T cd05587         225 --------SKEAVSICKGLLTKHPAKRLGCGPTGERDIREH  257 (324)
T ss_pred             --------CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence                    2346679999999999999976     676654

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=5.9e-40  Score=310.08  Aligned_cols=240  Identities=23%  Similarity=0.432  Sum_probs=191.7

Q ss_pred             ceecccCcEEEEEEEECC-------------ccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeE
Q 013636          159 NVIGEGGRGHVYKARFNE-------------KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRF  225 (439)
Q Consensus       159 ~~LG~G~fg~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  225 (439)
                      +.||+|+||.||+|+...             ...+++|.+..........|.+|+.+++.++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            358999999999997542             2357888877655555567889999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCc-------EEEEe
Q 013636          226 LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFN-------AKLSD  298 (439)
Q Consensus       226 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~-------~kl~D  298 (439)
                      +||||+++|+|..+++.  ....+++..+.+++.|+++||+|||+.   +++||||||+|||++.++.       ++++|
T Consensus        81 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          81 MVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             EEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            99999999999998864  234689999999999999999999998   9999999999999987664       89999


Q ss_pred             cccccccCCCCcceeeccccCccchhhhc-CCCCCCchhhHHHHHHHHHHH-hCCCCCCCCChhhhhhhHhhhhcccccC
Q 013636          299 FGLSVTAGTQSRNVKISGTLGYVAPEYLL-EGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDR  376 (439)
Q Consensus       299 fGls~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwS~Gvll~ell-tG~~P~~~~~~~~~~~~~~~~~~~~~~~  376 (439)
                      ||++.......   ...++..|+|||.+. +..++.++|||||||++|||+ +|..|+......+......         
T Consensus       156 ~g~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~---------  223 (262)
T cd05077         156 PGIPITVLSRQ---ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYE---------  223 (262)
T ss_pred             CCCCccccCcc---cccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHh---------
Confidence            99986653322   234788999999887 467899999999999999998 5888887654332221111         


Q ss_pred             CCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhcc
Q 013636          377 SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLI  425 (439)
Q Consensus       377 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  425 (439)
                      ... ....         .....+.+++.+||+.||++||++.++++.++
T Consensus       224 ~~~-~~~~---------~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         224 GQC-MLVT---------PSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             cCc-cCCC---------CChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            000 0011         11245778999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=4.2e-40  Score=311.36  Aligned_cols=259  Identities=24%  Similarity=0.348  Sum_probs=206.1

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCC---CchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDA---GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      ++|++.+.||+|+||.||+|+.. ++..+|+|.+...   .......+.+|+.+++.++|||++++++++...+..++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            47888999999999999999875 5788899987532   2333456889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCC
Q 013636          229 EMMQNGSLEKQLHGPT-HGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT  307 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~  307 (439)
                      ||+++|+|.+++.... ....+++..+..++.|+++||+|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            9999999998885322 234588999999999999999999998   999999999999999999999999999876543


Q ss_pred             CCcc-eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCch
Q 013636          308 QSRN-VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPV  386 (439)
Q Consensus       308 ~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  386 (439)
                      .... ....+++.|+|||.+.+..++.++|+||||+++|||++|+.||....... ....... .    ....+...   
T Consensus       159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-~~~~~~~-~----~~~~~~~~---  229 (267)
T cd08228         159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-FSLCQKI-E----QCDYPPLP---  229 (267)
T ss_pred             hhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH-HHHHHHH-h----cCCCCCCC---
Confidence            3221 22357889999999998889999999999999999999999996543211 1111111 0    00111110   


Q ss_pred             hcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccC
Q 013636          387 IRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLV  428 (439)
Q Consensus       387 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~  428 (439)
                           .......+.+++.+||+.+|++||++.++++.++++.
T Consensus       230 -----~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         230 -----TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             -----hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence                 1122346778999999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2e-40  Score=319.99  Aligned_cols=259  Identities=32%  Similarity=0.479  Sum_probs=203.9

Q ss_pred             cCCCccceecccCcEEEEEEEECC-c--cEEEEEEecCCC-chHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeeEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNE-K--LLAAVKRIDDAG-HDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLV  227 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~-~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV  227 (439)
                      ++|++.+.||+|+||.||+|.+.. +  ..+++|.+.... .....++.+|++++.++ +|||++++++++...+..++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            567888999999999999998753 3  345777776432 34456788999999999 899999999999999999999


Q ss_pred             EEeccCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcE
Q 013636          228 YEMMQNGSLEKQLHGPT-------------HGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA  294 (439)
Q Consensus       228 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~  294 (439)
                      +||+++|+|.++++...             ....+++..++.++.|++.|++|||+.   +++||||||+|||+++++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcE
Confidence            99999999999996432             123588999999999999999999998   99999999999999999999


Q ss_pred             EEEecccccccCCCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhccc
Q 013636          295 KLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQL  373 (439)
Q Consensus       295 kl~DfGls~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~  373 (439)
                      ||+|||++.............++..|+|||.+.+..++.++|||||||++|||+| |..||...+..+......      
T Consensus       164 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~------  237 (303)
T cd05088         164 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP------  237 (303)
T ss_pred             EeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHh------
Confidence            9999999864322111112224568999999988889999999999999999998 999997665443222111      


Q ss_pred             ccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCCC
Q 013636          374 TDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPTD  431 (439)
Q Consensus       374 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~~  431 (439)
                       .......      ..    .....+.+++.+||+.+|++||++.+++++|..++..+
T Consensus       238 -~~~~~~~------~~----~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~  284 (303)
T cd05088         238 -QGYRLEK------PL----NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  284 (303)
T ss_pred             -cCCcCCC------CC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence             0000000      00    11235678999999999999999999999998776544

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=4.6e-40  Score=311.17  Aligned_cols=253  Identities=26%  Similarity=0.403  Sum_probs=201.8

Q ss_pred             cCCCccceecccCcEEEEEEEE-CCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEec
Q 013636          153 NNFQESNVIGEGGRGHVYKARF-NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMM  231 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  231 (439)
                      ++|++.+.||+|+||.||+|+. .++..+|+|.+..........+.+|+.++++++|||++++++++...+..++|+||+
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~   88 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC   88 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence            5788899999999999999987 457788999987655455567889999999999999999999999999999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc-
Q 013636          232 QNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR-  310 (439)
Q Consensus       232 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~-  310 (439)
                      ++++|.++++.   ...+++..+..++.|++.|++|||+.   +++||||+|+||++++++.+||+|||++........ 
T Consensus        89 ~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~  162 (267)
T cd06646          89 GGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK  162 (267)
T ss_pred             CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecccccc
Confidence            99999999863   24589999999999999999999998   999999999999999999999999999976543221 


Q ss_pred             ceeeccccCccchhhhc---CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchh
Q 013636          311 NVKISGTLGYVAPEYLL---EGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVI  387 (439)
Q Consensus       311 ~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  387 (439)
                      .....|+..|+|||.+.   ...++.++|||||||++|||++|+.||....+.......       .. ..   ...+..
T Consensus       163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~-------~~-~~---~~~~~~  231 (267)
T cd06646         163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM-------SK-SN---FQPPKL  231 (267)
T ss_pred             cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee-------ec-CC---CCCCCC
Confidence            22345888999999884   345788999999999999999999999655432211000       00 00   000111


Q ss_pred             cCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhc
Q 013636          388 RDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL  424 (439)
Q Consensus       388 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  424 (439)
                      ...  ......+.+++.+||+.+|++|||+++++++|
T Consensus       232 ~~~--~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         232 KDK--TKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             ccc--cccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            100  01134677899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.9e-40  Score=329.09  Aligned_cols=249  Identities=23%  Similarity=0.338  Sum_probs=195.7

Q ss_pred             CCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC---chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEE
Q 013636          154 NFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYE  229 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  229 (439)
                      .|+..+.||+|+||+||+|+.. .+..+|+|.+....   ......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5778899999999999999875 46789999986532   2334568899999999999999999999999999999999


Q ss_pred             eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCC
Q 013636          230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS  309 (439)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~  309 (439)
                      |+++|+|.+++..   ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++++||+|||++.......
T Consensus        82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~  155 (381)
T cd05626          82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH  155 (381)
T ss_pred             cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence            9999999999964   23588899999999999999999998   99999999999999999999999999975321000


Q ss_pred             ------------------------------------------------cceeeccccCccchhhhcCCCCCCchhhHHHH
Q 013636          310 ------------------------------------------------RNVKISGTLGYVAPEYLLEGKLTDKSDVYAFG  341 (439)
Q Consensus       310 ------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G  341 (439)
                                                                      ......||+.|+|||.+.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (381)
T cd05626         156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG  235 (381)
T ss_pred             ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence                                                            00124589999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCCChhhhhh-hHhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHH--hcCCCCCCCCCHH
Q 013636          342 VVLLELLMGRRPVEKMSPTQCQS-MVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVL--CIQPEPSYRPLIT  418 (439)
Q Consensus       342 vll~elltG~~P~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~--cl~~dP~~RPt~~  418 (439)
                      |++|||++|+.||...++.+... ...|.     .....+..      ...    ..++.+++.+  |+..+|..||++.
T Consensus       236 ~il~elltG~~Pf~~~~~~~~~~~i~~~~-----~~~~~~~~------~~~----s~~~~dli~~ll~~~~~~~~R~~~~  300 (381)
T cd05626         236 VILFEMLVGQPPFLAPTPTETQLKVINWE-----NTLHIPPQ------VKL----SPEAVDLITKLCCSAEERLGRNGAD  300 (381)
T ss_pred             hHHHHHHhCCCCCcCCCHHHHHHHHHccc-----cccCCCCC------CCC----CHHHHHHHHHHccCcccccCCCCHH
Confidence            99999999999998766543221 21111     01111110      001    1234456655  5667777799999


Q ss_pred             HHHHh
Q 013636          419 DVLHS  423 (439)
Q Consensus       419 evl~~  423 (439)
                      |++++
T Consensus       301 ~~l~h  305 (381)
T cd05626         301 DIKAH  305 (381)
T ss_pred             HHhcC
Confidence            99976

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.8e-41  Score=325.98  Aligned_cols=250  Identities=23%  Similarity=0.355  Sum_probs=211.0

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCe-eEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAET-RFLVY  228 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lV~  228 (439)
                      ++|...+.+|+|+||.++..+.+ ++..+++|.+.-..  ...++...+|+.++++++|||||.+.+.+..++. .+|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            46777899999999999988765 45678888876433  3334567899999999999999999999999888 99999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~  308 (439)
                      +||+||++.+.+...+ +..++++.+.+++.|++.|+.|||+.   .|+|||||+.||+++.+..+||+|||+|+..+..
T Consensus        84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            9999999999998643 67899999999999999999999987   9999999999999999999999999999998877


Q ss_pred             C-cceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchh
Q 013636          309 S-RNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVI  387 (439)
Q Consensus       309 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  387 (439)
                      . ......||+.|+.||.+.+.+|..|+||||+||++|||++-+++|...+.......+...            .+    
T Consensus       160 ~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~------------~~----  223 (426)
T KOG0589|consen  160 DSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRG------------LY----  223 (426)
T ss_pred             hhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhc------------cC----
Confidence            6 556778999999999999999999999999999999999999999877654432222110            01    


Q ss_pred             cCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          388 RDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       388 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                       ...+......+..++..|++.+|+.||++.+++.+
T Consensus       224 -~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  224 -SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             -CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence             11222334566778999999999999999999976

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=3e-40  Score=309.77  Aligned_cols=245  Identities=28%  Similarity=0.443  Sum_probs=197.8

Q ss_pred             ceecccCcEEEEEEEEC-CccEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEeccCCCh
Q 013636          159 NVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG-HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSL  236 (439)
Q Consensus       159 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  236 (439)
                      +.||+|+||.||+|+.. ++..+|+|...... .+....+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            36999999999999875 57888999876433 34456799999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCcce---e
Q 013636          237 EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV---K  313 (439)
Q Consensus       237 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~~~---~  313 (439)
                      .+++..  .+..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++..........   .
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  155 (252)
T cd05084          81 LTFLRT--EGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM  155 (252)
T ss_pred             HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence            999964  234689999999999999999999998   99999999999999999999999999987543221111   1


Q ss_pred             eccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCccC
Q 013636          314 ISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMD  392 (439)
Q Consensus       314 ~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  392 (439)
                      ...+..|+|||.+.++.++.++||||||+++|||++ |..||...++......+...     .....+.           
T Consensus       156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~-----~~~~~~~-----------  219 (252)
T cd05084         156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG-----VRLPCPE-----------  219 (252)
T ss_pred             CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcC-----CCCCCcc-----------
Confidence            112456999999999999999999999999999998 99999776554332222210     0001111           


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhcc
Q 013636          393 LKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLI  425 (439)
Q Consensus       393 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  425 (439)
                       .....+.+++.+|++.+|++|||+.++++.|+
T Consensus       220 -~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         220 -LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             -cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence             11346778999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3.9e-40  Score=319.93  Aligned_cols=240  Identities=25%  Similarity=0.386  Sum_probs=193.1

Q ss_pred             ceecccCcEEEEEEEECC-ccEEEEEEecCCC---chHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeeEEEEEeccC
Q 013636          159 NVIGEGGRGHVYKARFNE-KLLAAVKRIDDAG---HDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMMQN  233 (439)
Q Consensus       159 ~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~  233 (439)
                      +.||+|+||+||+|+..+ +..+|+|.++...   ......+..|..++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            469999999999999865 6789999987532   22334566778888764 899999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCC-CCcce
Q 013636          234 GSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT-QSRNV  312 (439)
Q Consensus       234 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~-~~~~~  312 (439)
                      |+|.+++..   ...+++..+..++.|++.||+|||+.   +++||||||+|||+++++.+||+|||++..... .....
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (316)
T cd05619          81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTC  154 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCcee
Confidence            999999864   24588999999999999999999998   999999999999999999999999999865322 22223


Q ss_pred             eeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCccC
Q 013636          313 KISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMD  392 (439)
Q Consensus       313 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  392 (439)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+...      ....+..+         
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~------~~~~~~~~---------  219 (316)
T cd05619         155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD------NPCYPRWL---------  219 (316)
T ss_pred             eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------CCCCCccC---------
Confidence            456899999999999999999999999999999999999999876654433222211      11112111         


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCHH-HHHH
Q 013636          393 LKHLYQVAAVAVLCIQPEPSYRPLIT-DVLH  422 (439)
Q Consensus       393 ~~~~~~l~~l~~~cl~~dP~~RPt~~-evl~  422 (439)
                         ...+.+++.+||+.||++||++. ++.+
T Consensus       220 ---~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         220 ---TREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             ---CHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence               12456789999999999999997 6654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2.3e-40  Score=322.29  Aligned_cols=241  Identities=25%  Similarity=0.328  Sum_probs=195.6

Q ss_pred             ceecccCcEEEEEEEECC-ccEEEEEEecCCC---chHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeeEEEEEeccC
Q 013636          159 NVIGEGGRGHVYKARFNE-KLLAAVKRIDDAG---HDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMMQN  233 (439)
Q Consensus       159 ~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~  233 (439)
                      ++||+|+||.||+|+..+ +..+|+|.+....   ....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            369999999999998864 6789999986532   23345577888888876 799999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC-Ccce
Q 013636          234 GSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ-SRNV  312 (439)
Q Consensus       234 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~-~~~~  312 (439)
                      |+|..++..   ...+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||++...... ....
T Consensus        81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~  154 (321)
T cd05591          81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTT  154 (321)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCcccc
Confidence            999998863   34588999999999999999999998   9999999999999999999999999998754322 2223


Q ss_pred             eeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCccC
Q 013636          313 KISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMD  392 (439)
Q Consensus       313 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  392 (439)
                      ...||+.|+|||.+.+..++.++|||||||++|||++|+.||...++......+.      ......+..+         
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~------~~~~~~p~~~---------  219 (321)
T cd05591         155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESIL------HDDVLYPVWL---------  219 (321)
T ss_pred             ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHH------cCCCCCCCCC---------
Confidence            3568999999999999999999999999999999999999998776544322221      1111122221         


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCC-------CHHHHHHh
Q 013636          393 LKHLYQVAAVAVLCIQPEPSYRP-------LITDVLHS  423 (439)
Q Consensus       393 ~~~~~~l~~l~~~cl~~dP~~RP-------t~~evl~~  423 (439)
                         ...+.+++..||+.||++||       ++.+++++
T Consensus       220 ---~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         220 ---SKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             ---CHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence               13566789999999999999       88888865

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.3e-40  Score=319.28  Aligned_cols=260  Identities=26%  Similarity=0.413  Sum_probs=207.7

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEECC------ccEEEEEEecCCC-chHHHHHHHHHHHHHhc-CCCceeeeeeEEEe
Q 013636          149 EAATNNFQESNVIGEGGRGHVYKARFNE------KLLAAVKRIDDAG-HDAEREFNNEVNWLTKI-RHQNIISLLGYCIH  220 (439)
Q Consensus       149 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  220 (439)
                      +...++|+..+.||+|+||.||++...+      ...+++|.+.... .....++.+|+.++.++ +|+||+++++++..
T Consensus         8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   87 (293)
T cd05053           8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ   87 (293)
T ss_pred             ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence            3345678888999999999999998643      3678999887543 23345688999999999 89999999999999


Q ss_pred             CCeeEEEEEeccCCChhhhhcCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEE
Q 013636          221 AETRFLVYEMMQNGSLEKQLHGP-------------THGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNIL  287 (439)
Q Consensus       221 ~~~~~lV~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiL  287 (439)
                      .+..+++|||+++|+|.++++..             .....+++..+++++.|++.||+|||+.   +++||||||+||+
T Consensus        88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil  164 (293)
T cd05053          88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVL  164 (293)
T ss_pred             CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEE
Confidence            99999999999999999999642             2245689999999999999999999997   9999999999999


Q ss_pred             EcCCCcEEEEecccccccCCCCcc---eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhh
Q 013636          288 LDSSFNAKLSDFGLSVTAGTQSRN---VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQ  363 (439)
Q Consensus       288 l~~~~~~kl~DfGls~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~  363 (439)
                      +++++.+||+|||++.........   ....++..|+|||.+.+..++.++|||||||++|||++ |..||......+..
T Consensus       165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~  244 (293)
T cd05053         165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF  244 (293)
T ss_pred             EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHH
Confidence            999999999999999765432211   11224567999999999999999999999999999998 99999876554433


Q ss_pred             hhHhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccC
Q 013636          364 SMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLV  428 (439)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~  428 (439)
                      .....       .... .         ........+.+++.+||+.||++|||+.|+++.|+.++
T Consensus       245 ~~~~~-------~~~~-~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         245 KLLKE-------GYRM-E---------KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             HHHHc-------CCcC-C---------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            22210       0000 0         00111345778999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.1e-40  Score=316.45  Aligned_cols=269  Identities=27%  Similarity=0.378  Sum_probs=200.5

Q ss_pred             cCCCccceecccCcEEEEEEEEC-----CccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeC--CeeE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-----EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHA--ETRF  225 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  225 (439)
                      +.|++.+.||+|+||.||++...     ++..+++|.+........+.+.+|++++++++|||++++++++...  ...+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            46778899999999999999753     4678999998876666667899999999999999999999987543  4678


Q ss_pred             EEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccccccc
Q 013636          226 LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA  305 (439)
Q Consensus       226 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~  305 (439)
                      +|+||+++|+|.+++...  ...+++..+..++.|++.||+|||+.   +++||||||+||++++++++||+|||++...
T Consensus        84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccc
Confidence            999999999999999642  34589999999999999999999998   9999999999999999999999999999765


Q ss_pred             CCCCccee----eccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCc
Q 013636          306 GTQSRNVK----ISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPN  381 (439)
Q Consensus       306 ~~~~~~~~----~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  381 (439)
                      ........    ..++..|+|||.+.+..++.++||||||+++|||++|..|+.................... ...+.+
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  237 (284)
T cd05081         159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMI-VYHLIE  237 (284)
T ss_pred             cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccc-hHHHHH
Confidence            43322111    1133469999999999999999999999999999998877643321110000000000000 000000


Q ss_pred             cCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhcccc
Q 013636          382 IVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPL  427 (439)
Q Consensus       382 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l  427 (439)
                      .................+.+++.+||+.+|++|||+.|+++.|+.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         238 LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            0000000000111234688899999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2.4e-40  Score=323.56  Aligned_cols=250  Identities=24%  Similarity=0.323  Sum_probs=196.4

Q ss_pred             CCCccceecccCcEEEEEEEEC----CccEEEEEEecCCC----chHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCee
Q 013636          154 NFQESNVIGEGGRGHVYKARFN----EKLLAAVKRIDDAG----HDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETR  224 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  224 (439)
                      +|++.+.||+|+||.||+++..    .+..+|+|.+....    ....+.+.+|+.++..+ +|+||+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4778899999999999999763    57889999886421    22335678899999999 599999999999999999


Q ss_pred             EEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccc
Q 013636          225 FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT  304 (439)
Q Consensus       225 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~  304 (439)
                      ++||||+++|+|.+++..   ...+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++..
T Consensus        81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            999999999999999864   34589999999999999999999998   999999999999999999999999999976


Q ss_pred             cCCCC--cceeeccccCccchhhhcCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCc
Q 013636          305 AGTQS--RNVKISGTLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPN  381 (439)
Q Consensus       305 ~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  381 (439)
                      .....  ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||...........+...  .......++.
T Consensus       155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~  232 (332)
T cd05614         155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRR--ILKCDPPFPS  232 (332)
T ss_pred             ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHH--HhcCCCCCCC
Confidence            43322  22335699999999999865 4788999999999999999999999754322111111110  0111112222


Q ss_pred             cCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHh
Q 013636          382 IVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRP-----LITDVLHS  423 (439)
Q Consensus       382 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  423 (439)
                      .+            ...+.+++.+||+.||++||     ++++++++
T Consensus       233 ~~------------~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         233 FI------------GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             CC------------CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence            22            22456789999999999999     77888865

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=7.3e-41  Score=325.33  Aligned_cols=237  Identities=25%  Similarity=0.363  Sum_probs=193.0

Q ss_pred             ceecccCcEEEEEEEE----CCccEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEecc
Q 013636          159 NVIGEGGRGHVYKARF----NEKLLAAVKRIDDAGH--DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQ  232 (439)
Q Consensus       159 ~~LG~G~fg~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  232 (439)
                      +.||+|+||.||+++.    ..+..+|+|.+.....  .....+.+|++++++++||||+++++++...+..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999875    3578899999875322  233457789999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC-Ccc
Q 013636          233 NGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ-SRN  311 (439)
Q Consensus       233 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~-~~~  311 (439)
                      +|+|.+++..   ...+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||++...... ...
T Consensus        82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~  155 (318)
T cd05582          82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA  155 (318)
T ss_pred             CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCce
Confidence            9999999864   34589999999999999999999998   9999999999999999999999999999765433 222


Q ss_pred             eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCcc
Q 013636          312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTM  391 (439)
Q Consensus       312 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  391 (439)
                      ....||+.|+|||.+.+..++.++|||||||++|||++|+.||...+..+....+.      .....++..++       
T Consensus       156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~------~~~~~~p~~~~-------  222 (318)
T cd05582         156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMIL------KAKLGMPQFLS-------  222 (318)
T ss_pred             ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHH------cCCCCCCCCCC-------
Confidence            34568999999999998889999999999999999999999998766543322221      11112222222       


Q ss_pred             CHHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 013636          392 DLKHLYQVAAVAVLCIQPEPSYRPLITD  419 (439)
Q Consensus       392 ~~~~~~~l~~l~~~cl~~dP~~RPt~~e  419 (439)
                           ..+.+++.+||+.||++||++.+
T Consensus       223 -----~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         223 -----PEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             -----HHHHHHHHHHhhcCHhHcCCCCC
Confidence                 24567899999999999999433

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.7e-41  Score=315.48  Aligned_cols=249  Identities=22%  Similarity=0.338  Sum_probs=210.8

Q ss_pred             hcCCCccceecccCcEEEEEEEE-CCccEEEEEEecCCCc---hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARF-NEKLLAAVKRIDDAGH---DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLV  227 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  227 (439)
                      ..+|++.+.||+|.||+|-+|.. ..+..||||.+++..-   ++.-.+.+|+++|+.|+||||+.++.+|++.+...+|
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            35677788999999999999987 6789999999876433   3445688999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCC
Q 013636          228 YEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT  307 (439)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~  307 (439)
                      |||..+|.|++|+.   +.+.+++.....++.||..|+.|+|.+   +++|||||.+|||+|.|+++||+|||++..+..
T Consensus       132 MEYaS~GeLYDYiS---er~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~  205 (668)
T KOG0611|consen  132 MEYASGGELYDYIS---ERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYAD  205 (668)
T ss_pred             EEecCCccHHHHHH---HhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhcc
Confidence            99999999999995   455799999999999999999999997   999999999999999999999999999998877


Q ss_pred             CCcceeeccccCccchhhhcCCCC-CCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCch
Q 013636          308 QSRNVKISGTLGYVAPEYLLEGKL-TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPV  386 (439)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  386 (439)
                      .....++||++-|.+||.+.+.+| .+..|-||+||+||-|+.|..||++.+-..   ++..    +. ++.   ...|.
T Consensus       206 ~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~---lvrQ----Is-~Ga---YrEP~  274 (668)
T KOG0611|consen  206 KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR---LVRQ----IS-RGA---YREPE  274 (668)
T ss_pred             ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH---HHHH----hh-ccc---ccCCC
Confidence            777778999999999999999888 478999999999999999999999876432   2221    11 111   11111


Q ss_pred             hcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhcc
Q 013636          387 IRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLI  425 (439)
Q Consensus       387 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  425 (439)
                      -        .....-++.+||..||++|.|+.|+..+..
T Consensus       275 ~--------PSdA~gLIRwmLmVNP~RRATieDiAsHWW  305 (668)
T KOG0611|consen  275 T--------PSDASGLIRWMLMVNPERRATIEDIASHWW  305 (668)
T ss_pred             C--------CchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence            1        122344899999999999999999998864

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=3.6e-40  Score=320.18  Aligned_cols=240  Identities=25%  Similarity=0.379  Sum_probs=191.2

Q ss_pred             ceecccCcEEEEEEEECC-ccEEEEEEecCCC---chHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeeEEEEEeccC
Q 013636          159 NVIGEGGRGHVYKARFNE-KLLAAVKRIDDAG---HDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMMQN  233 (439)
Q Consensus       159 ~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~  233 (439)
                      +.||+|+||.||+|+..+ +..+|+|.++...   ....+.+..|..++... +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            369999999999998864 6789999886432   22334456677777654 899999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCC-CCcce
Q 013636          234 GSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT-QSRNV  312 (439)
Q Consensus       234 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~-~~~~~  312 (439)
                      |+|.+++..   ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++..... .....
T Consensus        81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~  154 (316)
T cd05592          81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAS  154 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccc
Confidence            999999864   23589999999999999999999998   999999999999999999999999999975432 22223


Q ss_pred             eeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCccC
Q 013636          313 KISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMD  392 (439)
Q Consensus       313 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  392 (439)
                      ...||+.|+|||.+.+..++.++|||||||++|||++|+.||...+..+....+..      ....++..+         
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~------~~~~~~~~~---------  219 (316)
T cd05592         155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN------DRPHFPRWI---------  219 (316)
T ss_pred             cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc------CCCCCCCCC---------
Confidence            45689999999999999999999999999999999999999987765443222211      111222222         


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCHH-HHHH
Q 013636          393 LKHLYQVAAVAVLCIQPEPSYRPLIT-DVLH  422 (439)
Q Consensus       393 ~~~~~~l~~l~~~cl~~dP~~RPt~~-evl~  422 (439)
                         ...+.+++.+||+.||++||++. ++++
T Consensus       220 ---~~~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         220 ---SKEAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             ---CHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence               22456788999999999999875 5554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.9e-40  Score=315.46  Aligned_cols=265  Identities=26%  Similarity=0.369  Sum_probs=200.6

Q ss_pred             CCccceecccCcEEEEEEEE-----CCccEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCceeeeeeEEEeC--CeeEE
Q 013636          155 FQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDAGH-DAEREFNNEVNWLTKIRHQNIISLLGYCIHA--ETRFL  226 (439)
Q Consensus       155 ~~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  226 (439)
                      |+..+.||+|+||+||++..     .++..+|+|.+..... .....|.+|++++++++|||++++++++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            37789999999999988653     3467899999875432 3456788999999999999999999988754  35789


Q ss_pred             EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccC
Q 013636          227 VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAG  306 (439)
Q Consensus       227 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~  306 (439)
                      +|||+++|+|.+++..    ..+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||++....
T Consensus        86 v~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  158 (283)
T cd05080          86 IMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  158 (283)
T ss_pred             EecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccC
Confidence            9999999999999864    2489999999999999999999998   99999999999999999999999999997654


Q ss_pred             CCCcc----eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCcc
Q 013636          307 TQSRN----VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNI  382 (439)
Q Consensus       307 ~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  382 (439)
                      .....    ....++..|+|||.+.+..++.++||||||+++|||++|+.|+....... ............ ...+.+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~-~~~~~~~  236 (283)
T cd05080         159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMT-VVRLIEL  236 (283)
T ss_pred             CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccc-hhhhhhh
Confidence            32221    11234567999999998899999999999999999999999986543211 111111100000 0001111


Q ss_pred             CCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccC
Q 013636          383 VDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLV  428 (439)
Q Consensus       383 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~  428 (439)
                      .+..............+.+++.+||+.+|++|||++++++.|+.+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            1111111111223457888999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=7.9e-40  Score=311.77  Aligned_cols=245  Identities=24%  Similarity=0.341  Sum_probs=192.4

Q ss_pred             ecccCcEEEEEEEEC-CccEEEEEEecCCC---chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEeccCCCh
Q 013636          161 IGEGGRGHVYKARFN-EKLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSL  236 (439)
Q Consensus       161 LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  236 (439)
                      ||+|+||.||+++.. ++..+|+|.+....   ......+..|++++++++||||+++.+++..++..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999875 47889999886422   12234566799999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCcceeecc
Q 013636          237 EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG  316 (439)
Q Consensus       237 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~~~~~~g  316 (439)
                      .+++... ....+++..+..++.|++.||+|||+.   +++||||||+||++++++.++|+|||++.............|
T Consensus        81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  156 (277)
T cd05607          81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAG  156 (277)
T ss_pred             HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCC
Confidence            9888642 234588999999999999999999998   999999999999999999999999999976654333334568


Q ss_pred             ccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCccCHHHH
Q 013636          317 TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHL  396 (439)
Q Consensus       317 t~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  396 (439)
                      +..|+|||++.+..++.++||||+||++|||++|+.||...........+.  ......  ... ...    .    ...
T Consensus       157 ~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~--~~~~~~--~~~-~~~----~----~~~  223 (277)
T cd05607         157 TNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELK--RRTLED--EVK-FEH----Q----NFT  223 (277)
T ss_pred             CCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHH--HHhhcc--ccc-ccc----c----cCC
Confidence            999999999999999999999999999999999999997643221111111  000100  000 000    0    112


Q ss_pred             HHHHHHHHHhcCCCCCCCCCHHHHHH
Q 013636          397 YQVAAVAVLCIQPEPSYRPLITDVLH  422 (439)
Q Consensus       397 ~~l~~l~~~cl~~dP~~RPt~~evl~  422 (439)
                      ..+.+++..||+.||++||++.|+++
T Consensus       224 ~~~~~li~~~L~~~P~~R~~~~~~~~  249 (277)
T cd05607         224 EESKDICRLFLAKKPEDRLGSREKND  249 (277)
T ss_pred             HHHHHHHHHHhccCHhhCCCCccchh
Confidence            35678999999999999999976653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=3.5e-40  Score=325.20  Aligned_cols=246  Identities=26%  Similarity=0.406  Sum_probs=192.2

Q ss_pred             CCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEec
Q 013636          154 NFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGH-DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMM  231 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  231 (439)
                      +|+..+.||+|+||+||+++.. ++..+|+|.+..... ...+.+.+|+++++.++|+||+++++++...+..++||||+
T Consensus        75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  154 (353)
T PLN00034         75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM  154 (353)
T ss_pred             HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence            4455688999999999999875 578899999865432 33467899999999999999999999999999999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc-
Q 013636          232 QNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR-  310 (439)
Q Consensus       232 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~-  310 (439)
                      ++|+|.+..       ..++..+..++.|++.||+|||+.   +++||||||+|||+++++.+||+|||++........ 
T Consensus       155 ~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~  224 (353)
T PLN00034        155 DGGSLEGTH-------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP  224 (353)
T ss_pred             CCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccccc
Confidence            999986532       356778889999999999999998   999999999999999999999999999976543221 


Q ss_pred             ceeeccccCccchhhhcC-----CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCc
Q 013636          311 NVKISGTLGYVAPEYLLE-----GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDP  385 (439)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  385 (439)
                      .....||..|+|||.+..     ...+.++|||||||++|||++|+.||......+.........  .......+.    
T Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~----  298 (353)
T PLN00034        225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC--MSQPPEAPA----  298 (353)
T ss_pred             ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh--ccCCCCCCC----
Confidence            123458999999998753     234568999999999999999999997443322222211110  000111111    


Q ss_pred             hhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          386 VIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       386 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                              .....+.+++..||+.||++|||+.|++++
T Consensus       299 --------~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        299 --------TASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             --------ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                    122357789999999999999999999987

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=6.2e-40  Score=312.87  Aligned_cols=253  Identities=30%  Similarity=0.493  Sum_probs=204.0

Q ss_pred             cCCCccceecccCcEEEEEEEEC------CccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN------EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFL  226 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  226 (439)
                      .+|+..+.||+|+||.||++...      ++..+++|.+..........+.+|+++++.++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            46777899999999999999642      356788998887766667789999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhcCCCC------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcE
Q 013636          227 VYEMMQNGSLEKQLHGPTH------------GSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA  294 (439)
Q Consensus       227 V~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~  294 (439)
                      ++||+++|+|.++++....            ...+++..++.++.|++.|++|||+.   +++||||||+||++++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCE
Confidence            9999999999999874321            13588999999999999999999998   99999999999999999999


Q ss_pred             EEEecccccccCCCCcc---eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhh
Q 013636          295 KLSDFGLSVTAGTQSRN---VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAM  370 (439)
Q Consensus       295 kl~DfGls~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~  370 (439)
                      ||+|||++.........   ....+++.|+|||.+.+..++.++|||||||++|||++ |..||............... 
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-  240 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQG-  240 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcC-
Confidence            99999998654332211   11224678999999999999999999999999999998 99999766544322221110 


Q ss_pred             cccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhcc
Q 013636          371 PQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLI  425 (439)
Q Consensus       371 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  425 (439)
                          .....+.            .....+.+++.+||+.||++||++.+|++.|+
T Consensus       241 ----~~~~~~~------------~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         241 ----RELERPR------------TCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             ----ccCCCCC------------CCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence                0001111            11235678999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.4e-39  Score=314.87  Aligned_cols=266  Identities=25%  Similarity=0.387  Sum_probs=203.2

Q ss_pred             cCCCccceecccCcEEEEEEEECC-ccEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEe
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAG-HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      ++|++.+.||+|+||.||+++... +..+++|.+.... .....++.+|++++++++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            468889999999999999998764 6677888876442 23345688999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR  310 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~  310 (439)
                      +++++|.++++..   ..+++..+..++.|+++||.|||+.  .+++|+||||+||++++++.+||+|||++....... 
T Consensus        81 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  154 (308)
T cd06615          81 MDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  154 (308)
T ss_pred             cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCcccccccc-
Confidence            9999999999643   4588999999999999999999973  289999999999999999999999999986553322 


Q ss_pred             ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCC----------C
Q 013636          311 NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKL----------P  380 (439)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~----------~  380 (439)
                      .....++..|+|||.+.+..++.++||||||+++|||++|+.||...+.....................          +
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (308)
T cd06615         155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSP  234 (308)
T ss_pred             cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCcc
Confidence            223458899999999988889999999999999999999999997655433222221111000000000          0


Q ss_pred             ------ccCCchhc---Ccc-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhc
Q 013636          381 ------NIVDPVIR---DTM-DLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL  424 (439)
Q Consensus       381 ------~~~d~~l~---~~~-~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  424 (439)
                            +..+....   ... .......+.+++.+||+.||++|||+.+++++-
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~  288 (308)
T cd06615         235 RPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP  288 (308)
T ss_pred             chhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence                  00000000   000 001233578899999999999999999999874

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=6.6e-40  Score=309.64  Aligned_cols=254  Identities=27%  Similarity=0.420  Sum_probs=205.2

Q ss_pred             hcCCCccceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEec
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMM  231 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  231 (439)
                      .++|++.+.||+|+||.||+|+..+...+++|.+.... ...+++.+|+.++++++|||++++++.+. .+..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM   82 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence            35688899999999999999998887789999987533 23457899999999999999999999874 45679999999


Q ss_pred             cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCcc
Q 013636          232 QNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN  311 (439)
Q Consensus       232 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~~  311 (439)
                      ++|+|.+++... .+..+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||.+.........
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~  158 (262)
T cd05071          83 SKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  158 (262)
T ss_pred             CCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence            999999999742 234689999999999999999999998   9999999999999999999999999999765433221


Q ss_pred             --eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhc
Q 013636          312 --VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIR  388 (439)
Q Consensus       312 --~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  388 (439)
                        ....++..|+|||...+..++.++||||||+++|||++ |..||......+.......       ....+        
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~-------~~~~~--------  223 (262)
T cd05071         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-------GYRMP--------  223 (262)
T ss_pred             cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhc-------CCCCC--------
Confidence              12235678999999998999999999999999999999 8889987655432222111       00000        


Q ss_pred             CccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccC
Q 013636          389 DTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLV  428 (439)
Q Consensus       389 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~  428 (439)
                        ...+....+.+++.+|++.||++||++.++++.|+...
T Consensus       224 --~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~  261 (262)
T cd05071         224 --CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  261 (262)
T ss_pred             --CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence              01122446788999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=3.5e-40  Score=310.86  Aligned_cols=252  Identities=27%  Similarity=0.438  Sum_probs=203.6

Q ss_pred             hcCCCccceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEec
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMM  231 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  231 (439)
                      .++|++.+.||+|+||.||+|..+++..+++|.+..... ....+.+|+.++++++|+|++++++++. .+..+++|||+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM   82 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence            356788899999999999999988888899999876433 3457899999999999999999999875 45689999999


Q ss_pred             cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCcc
Q 013636          232 QNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN  311 (439)
Q Consensus       232 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~~  311 (439)
                      ++++|.++++.. ....+++..+..++.|++.||+|||+.   +++||||||+||++++++.++|+|||++.........
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05070          83 SKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence            999999999752 234589999999999999999999998   9999999999999999999999999999765432221


Q ss_pred             --eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhc
Q 013636          312 --VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIR  388 (439)
Q Consensus       312 --~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  388 (439)
                        ....++..|+|||.+.+..++.++||||||+++|||++ |..||...+..+......       .....+      . 
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-------~~~~~~------~-  224 (260)
T cd05070         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE-------RGYRMP------C-  224 (260)
T ss_pred             cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-------cCCCCC------C-
Confidence              11224567999999998899999999999999999999 899998765443222211       010100      0 


Q ss_pred             CccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccc
Q 013636          389 DTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIP  426 (439)
Q Consensus       389 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  426 (439)
                         .......+.+++.+|++.+|++|||+.++.+.|++
T Consensus       225 ---~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         225 ---PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             ---CCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence               11123457889999999999999999999988864

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=4e-40  Score=337.62  Aligned_cols=254  Identities=24%  Similarity=0.315  Sum_probs=203.0

Q ss_pred             HHhcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCC--CchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC----
Q 013636          150 AATNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDA--GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE----  222 (439)
Q Consensus       150 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  222 (439)
                      ...++|++.+.||+|+||+||+++.. ++..+|+|.+...  .......+.+|+..+..++|+|++++...+...+    
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~  108 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP  108 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence            34578999999999999999999864 5789999998643  2344457889999999999999999988765432    


Q ss_pred             ----eeEEEEEeccCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEE
Q 013636          223 ----TRFLVYEMMQNGSLEKQLHGP-THGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLS  297 (439)
Q Consensus       223 ----~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~  297 (439)
                          ..++||||+++|+|.++++.. .....+++..+..++.|++.||+|||+.   +++||||||+|||+++++.+||+
T Consensus       109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~  185 (496)
T PTZ00283        109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLG  185 (496)
T ss_pred             ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEE
Confidence                367999999999999998642 2345689999999999999999999998   99999999999999999999999


Q ss_pred             ecccccccCCC---CcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccc
Q 013636          298 DFGLSVTAGTQ---SRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLT  374 (439)
Q Consensus       298 DfGls~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~  374 (439)
                      |||+++.....   .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...+..+.......     .
T Consensus       186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~-----~  260 (496)
T PTZ00283        186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLA-----G  260 (496)
T ss_pred             ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-----C
Confidence            99999765332   112335699999999999999999999999999999999999999987654332211110     0


Q ss_pred             cCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          375 DRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       375 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      ....++.            .....+.+++..||+.||++||++.+++++
T Consensus       261 ~~~~~~~------------~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        261 RYDPLPP------------SISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             CCCCCCC------------CCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            0011111            112357779999999999999999999865

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=5.7e-40  Score=312.31  Aligned_cols=239  Identities=25%  Similarity=0.470  Sum_probs=190.5

Q ss_pred             eecccCcEEEEEEEEC-------------------------CccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeee
Q 013636          160 VIGEGGRGHVYKARFN-------------------------EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISL  214 (439)
Q Consensus       160 ~LG~G~fg~Vy~~~~~-------------------------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  214 (439)
                      .||+|+||.||+|.+.                         ....+++|.+..........|.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            5999999999999742                         124578888876554555678899999999999999999


Q ss_pred             eeEEEeCCeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC--
Q 013636          215 LGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSF--  292 (439)
Q Consensus       215 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~--  292 (439)
                      +++|...+..++||||+++|+|..++..  ....+++..+.+++.|+++||+|||+.   +++||||||+||+++.++  
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCcc
Confidence            9999999999999999999999999864  234688999999999999999999998   999999999999997643  


Q ss_pred             -----cEEEEecccccccCCCCcceeeccccCccchhhhcC-CCCCCchhhHHHHHHHHHHH-hCCCCCCCCChhhhhhh
Q 013636          293 -----NAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLE-GKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSM  365 (439)
Q Consensus       293 -----~~kl~DfGls~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvll~ell-tG~~P~~~~~~~~~~~~  365 (439)
                           .+|++|||++.......   ...++..|+|||.+.+ ..++.++||||||+++||++ +|+.||....+.+....
T Consensus       157 ~~~~~~~kl~d~g~~~~~~~~~---~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~  233 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTALSRE---ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF  233 (274)
T ss_pred             cCccceeeecCCcccccccccc---ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHH
Confidence                 38999999885443221   2236788999998875 56899999999999999985 69999987655432222


Q ss_pred             HhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhcc
Q 013636          366 VTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLI  425 (439)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  425 (439)
                      ..       .....+...            ...+.+++.+||+.+|++|||+.++++.|.
T Consensus       234 ~~-------~~~~~~~~~------------~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         234 YE-------KKHRLPEPS------------CKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             HH-------hccCCCCCC------------ChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            11       111111111            125678999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.3e-39  Score=305.67  Aligned_cols=249  Identities=27%  Similarity=0.372  Sum_probs=203.8

Q ss_pred             CCCccceecccCcEEEEEEEEC-CccEEEEEEecCC--CchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEe
Q 013636          154 NFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDA--GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      +|+..+.||+|+||.||++... ++..+++|.+...  .......+.+|+.++++++|||++++++++...+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4667789999999999999875 4778899987643  334556789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR  310 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~  310 (439)
                      +++++|.++++.. .+..+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++........
T Consensus        81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~  156 (256)
T cd08529          81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN  156 (256)
T ss_pred             CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence            9999999999753 245689999999999999999999997   999999999999999999999999999876544322


Q ss_pred             -ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcC
Q 013636          311 -NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRD  389 (439)
Q Consensus       311 -~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  389 (439)
                       .....|++.|+|||+..+..++.++|+||||+++|||++|+.||...++........   .  .....++.        
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~--~~~~~~~~--------  223 (256)
T cd08529         157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKII---R--GVFPPVSQ--------  223 (256)
T ss_pred             hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---c--CCCCCCcc--------
Confidence             123457889999999999999999999999999999999999998766433211111   0  00011111        


Q ss_pred             ccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          390 TMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       390 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                          .....+.+++.+||+.+|++||++.+++++
T Consensus       224 ----~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         224 ----MYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             ----ccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence                123467789999999999999999999975

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.2e-39  Score=308.46  Aligned_cols=255  Identities=28%  Similarity=0.477  Sum_probs=204.5

Q ss_pred             hcCCCccceecccCcEEEEEEEECC----ccEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFNE----KLLAAVKRIDDAG-HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFL  226 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  226 (439)
                      .++|+..+.||+|+||.||+|+...    ...+++|.+.... .....++.+|++++++++|||++++.+++...+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            3567788999999999999998753    2368899886543 3345678999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccC
Q 013636          227 VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAG  306 (439)
Q Consensus       227 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~  306 (439)
                      ||||+++++|.+++..  ....+++..+..++.|++.|++|||+.   +++||||||+||++++++.+||+|||++....
T Consensus        84 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  158 (268)
T cd05063          84 ITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLE  158 (268)
T ss_pred             EEEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecc
Confidence            9999999999999964  235689999999999999999999998   99999999999999999999999999987553


Q ss_pred             CCCcce----eeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCc
Q 013636          307 TQSRNV----KISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPN  381 (439)
Q Consensus       307 ~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  381 (439)
                      ......    ....+..|+|||.+.+..++.++|||||||++||+++ |+.||...+.......+.       .....+.
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~-------~~~~~~~  231 (268)
T cd05063         159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIN-------DGFRLPA  231 (268)
T ss_pred             cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHh-------cCCCCCC
Confidence            322111    1113457999999998899999999999999999997 999997665433222221       1111111


Q ss_pred             cCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccC
Q 013636          382 IVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLV  428 (439)
Q Consensus       382 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~  428 (439)
                      .          ......+.+++.+||+.+|++||++.++++.|++++
T Consensus       232 ~----------~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~  268 (268)
T cd05063         232 P----------MDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL  268 (268)
T ss_pred             C----------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence            0          012345778999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=7.1e-40  Score=313.77  Aligned_cols=262  Identities=25%  Similarity=0.413  Sum_probs=206.5

Q ss_pred             HHhcCCCccceecccCcEEEEEEEECC------ccEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC
Q 013636          150 AATNNFQESNVIGEGGRGHVYKARFNE------KLLAAVKRIDDAGH-DAEREFNNEVNWLTKIRHQNIISLLGYCIHAE  222 (439)
Q Consensus       150 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  222 (439)
                      ...++|++.+.||+|+||.||+|...+      +..+|+|.+..... .....+.+|+.++++++|||++++++++...+
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ   82 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            346789999999999999999997542      45789998864432 33346889999999999999999999999999


Q ss_pred             eeEEEEEeccCCChhhhhcCCCC-------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEE
Q 013636          223 TRFLVYEMMQNGSLEKQLHGPTH-------GSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAK  295 (439)
Q Consensus       223 ~~~lV~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~k  295 (439)
                      ..++||||+++|+|.+++.....       ....++..+.+++.|++.||.|||+.   +++||||||+||++++++.++
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEE
Confidence            99999999999999999964211       23467788899999999999999997   999999999999999999999


Q ss_pred             EEecccccccCCCCcc---eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhc
Q 013636          296 LSDFGLSVTAGTQSRN---VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMP  371 (439)
Q Consensus       296 l~DfGls~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~  371 (439)
                      |+|||+++........   ....++..|+|||.+.++.++.++|||||||++|||++ |..||...+..+....+.   .
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~---~  236 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM---D  236 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---c
Confidence            9999998754332211   11234678999999999999999999999999999998 888998765544322211   0


Q ss_pred             ccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCCC
Q 013636          372 QLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPTD  431 (439)
Q Consensus       372 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~~  431 (439)
                        ......+.            .....+.+++.+|++.||++|||+.++++.|......-
T Consensus       237 --~~~~~~~~------------~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~  282 (288)
T cd05061         237 --GGYLDQPD------------NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPS  282 (288)
T ss_pred             --CCCCCCCC------------CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCC
Confidence              00001111            11246778999999999999999999999988765443

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-39  Score=309.30  Aligned_cols=253  Identities=26%  Similarity=0.432  Sum_probs=200.5

Q ss_pred             CCccceecccCcEEEEEEEECC----ccEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCe-----
Q 013636          155 FQESNVIGEGGRGHVYKARFNE----KLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAET-----  223 (439)
Q Consensus       155 ~~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  223 (439)
                      |++.+.||+|+||.||+|....    +..+|+|.++...  ......+.+|+..++.++|||++++++++...+.     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            4567899999999999998743    3678999887532  2334678999999999999999999999876554     


Q ss_pred             -eEEEEEeccCCChhhhhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEec
Q 013636          224 -RFLVYEMMQNGSLEKQLHGPT---HGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDF  299 (439)
Q Consensus       224 -~~lV~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~Df  299 (439)
                       .++++||+++|+|..++....   ....+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence             799999999999999985422   224689999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCCcc---eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhccccc
Q 013636          300 GLSVTAGTQSRN---VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTD  375 (439)
Q Consensus       300 Gls~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~  375 (439)
                      |+++........   ....++..|+|||.+.+..++.++||||||+++|||++ |..||...+..+....+.   .  ..
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~---~--~~  232 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLR---H--GN  232 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---c--CC
Confidence            999765432211   11224678999999988899999999999999999999 999997765433221111   0  00


Q ss_pred             CCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhcccc
Q 013636          376 RSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPL  427 (439)
Q Consensus       376 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l  427 (439)
                      ....+.            ....++.+++.+||+.||++|||+.|+++.|+++
T Consensus       233 ~~~~~~------------~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         233 RLKQPE------------DCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             CCCCCc------------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            111111            1234678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=4.2e-40  Score=320.72  Aligned_cols=246  Identities=24%  Similarity=0.300  Sum_probs=197.3

Q ss_pred             CCCccceecccCcEEEEEEEECC-ccEEEEEEecCCC---chHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeeEEEE
Q 013636          154 NFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAG---HDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      +|++.+.||+|+||.||+|+..+ +..+|+|.+....   ....+.+..|..++..+ +|++++++.+++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            47778999999999999998764 6789999887432   22334567788888777 5899999999999999999999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~  308 (439)
                      ||+++|+|.+++..   ...+++..+..++.|++.||+|||+.   +++||||||+|||+++++.+||+|||++......
T Consensus        81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~  154 (323)
T cd05616          81 EYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD  154 (323)
T ss_pred             cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence            99999999999864   24588999999999999999999998   9999999999999999999999999999754322


Q ss_pred             -CcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchh
Q 013636          309 -SRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVI  387 (439)
Q Consensus       309 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  387 (439)
                       .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...+.......+..      .....+..+    
T Consensus       155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~------~~~~~p~~~----  224 (323)
T cd05616         155 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME------HNVAYPKSM----  224 (323)
T ss_pred             CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHh------CCCCCCCcC----
Confidence             222345689999999999999999999999999999999999999987765443222211      111111111    


Q ss_pred             cCccCHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHh
Q 013636          388 RDTMDLKHLYQVAAVAVLCIQPEPSYRPLI-----TDVLHS  423 (439)
Q Consensus       388 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~-----~evl~~  423 (439)
                              ...+.+++.+|++.||++|++.     .++.++
T Consensus       225 --------s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05616         225 --------SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  257 (323)
T ss_pred             --------CHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence                    2356779999999999999984     666654

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=2.9e-40  Score=322.66  Aligned_cols=247  Identities=22%  Similarity=0.344  Sum_probs=193.5

Q ss_pred             ceecccCcEEEEEEEEC-CccEEEEEEecCCC---chHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeeEEEEEeccC
Q 013636          159 NVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG---HDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMMQN  233 (439)
Q Consensus       159 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~  233 (439)
                      ++||+|+||.||+++.. ++..+|+|.++...   ....+.+.+|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999875 47789999987532   22335678899999998 799999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccC-CCCcce
Q 013636          234 GSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAG-TQSRNV  312 (439)
Q Consensus       234 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~-~~~~~~  312 (439)
                      |+|.+++..   ...+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||++.... ......
T Consensus        81 g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~  154 (329)
T cd05588          81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTS  154 (329)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCCccc
Confidence            999998853   24689999999999999999999998   99999999999999999999999999986432 222223


Q ss_pred             eeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhh--hhhhHhhhhccc-ccCCCCCccCCchhcC
Q 013636          313 KISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQ--CQSMVTWAMPQL-TDRSKLPNIVDPVIRD  389 (439)
Q Consensus       313 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~--~~~~~~~~~~~~-~~~~~~~~~~d~~l~~  389 (439)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||+......  ......+..... .....++..+      
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~------  228 (329)
T cd05588         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSL------  228 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCC------
Confidence            4568999999999999999999999999999999999999997432111  000111111101 1111222211      


Q ss_pred             ccCHHHHHHHHHHHHHhcCCCCCCCCC------HHHHHHh
Q 013636          390 TMDLKHLYQVAAVAVLCIQPEPSYRPL------ITDVLHS  423 (439)
Q Consensus       390 ~~~~~~~~~l~~l~~~cl~~dP~~RPt------~~evl~~  423 (439)
                            ...+.+++.+||+.||++||+      +.+++++
T Consensus       229 ------~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05588         229 ------SVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH  262 (329)
T ss_pred             ------CHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence                  234677999999999999997      6788754

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=4.9e-40  Score=311.87  Aligned_cols=250  Identities=32%  Similarity=0.489  Sum_probs=197.2

Q ss_pred             ceecccCcEEEEEEEECCc---cEEEEEEecCCC-chHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeeEEEEEeccC
Q 013636          159 NVIGEGGRGHVYKARFNEK---LLAAVKRIDDAG-HDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMMQN  233 (439)
Q Consensus       159 ~~LG~G~fg~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~  233 (439)
                      ++||+|+||.||+|+..+.   ..+++|.+.... ....+.+.+|+.++.++ +|||++++++++...+..+++|||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            3689999999999988543   346888877533 34456788999999999 899999999999999999999999999


Q ss_pred             CChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecc
Q 013636          234 GSLEKQLHGPT-------------HGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFG  300 (439)
Q Consensus       234 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfG  300 (439)
                      |+|.+++....             ....+++..+..++.|++.|++|||+.   +++||||||+||++++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence            99999986422             123588999999999999999999997   99999999999999999999999999


Q ss_pred             cccccCCCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCC
Q 013636          301 LSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKL  379 (439)
Q Consensus       301 ls~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  379 (439)
                      ++..............+..|+|||++....++.++||||||+++|||++ |..||...+.......+.       .....
T Consensus       158 l~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~-------~~~~~  230 (270)
T cd05047         158 LSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-------QGYRL  230 (270)
T ss_pred             CccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHh-------CCCCC
Confidence            9854322111111223567999999988899999999999999999997 999997765433222211       00000


Q ss_pred             CccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccC
Q 013636          380 PNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLV  428 (439)
Q Consensus       380 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~  428 (439)
                      .      ...    .....+.+++.+||+.||.+|||+.+++..|.+++
T Consensus       231 ~------~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         231 E------KPL----NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             C------CCC----cCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            0      000    11235778999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.4e-40  Score=306.76  Aligned_cols=271  Identities=26%  Similarity=0.352  Sum_probs=206.3

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCch--HHHHHHHHHHHHHhcCCCc-eeeeeeEEEeCC------
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHD--AEREFNNEVNWLTKIRHQN-IISLLGYCIHAE------  222 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~------  222 (439)
                      ..|+..++||+|+||+||+|+.. .+..||+|++.-...+  ......+|+.++++++|+| |+++.+++...+      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            34555677999999999999875 5779999998754332  2234578999999999999 999999999887      


Q ss_pred             eeEEEEEeccCCChhhhhcCCCCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccc
Q 013636          223 TRFLVYEMMQNGSLEKQLHGPTHG-SNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGL  301 (439)
Q Consensus       223 ~~~lV~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGl  301 (439)
                      ..++|+||++. +|.+++...... ..++...+..+..|+++||+|||++   +|+||||||+|+||+++|.+||+|||+
T Consensus        91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccch
Confidence            78899999976 999999763321 4577789999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCCc-ceeeccccCccchhhhcCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccC---
Q 013636          302 SVTAGTQSR-NVKISGTLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDR---  376 (439)
Q Consensus       302 s~~~~~~~~-~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~---  376 (439)
                      |+...-... .....+|..|+|||++.+. .|++..||||+|||++||++++.-|.+.++.+....+-.........   
T Consensus       167 Ara~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp  246 (323)
T KOG0594|consen  167 ARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWP  246 (323)
T ss_pred             HHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCC
Confidence            987653333 3445689999999999986 79999999999999999999999999887654433333222211111   


Q ss_pred             --CCCCccCC--chhcCccC-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh--cccc
Q 013636          377 --SKLPNIVD--PVIRDTMD-----LKHLYQVAAVAVLCIQPEPSYRPLITDVLHS--LIPL  427 (439)
Q Consensus       377 --~~~~~~~d--~~l~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~l  427 (439)
                        ..+++.--  +......+     ........+++.+|++.+|..|.|++..++|  +.++
T Consensus       247 ~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~  308 (323)
T KOG0594|consen  247 GVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL  308 (323)
T ss_pred             CccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence              00111000  00000000     0011357789999999999999999999987  5444

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=6.2e-40  Score=312.64  Aligned_cols=257  Identities=25%  Similarity=0.412  Sum_probs=206.9

Q ss_pred             hcCCCccceecccCcEEEEEEEECC-----ccEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCceeeeeeEEEe-CCee
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFNE-----KLLAAVKRIDDAG-HDAEREFNNEVNWLTKIRHQNIISLLGYCIH-AETR  224 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~  224 (439)
                      .++|++.+.||+|+||.||+|...+     +..+++|.+.... ......+.+|+.++++++|+|++++++++.. ....
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            4678889999999999999998866     6788999887543 3345678899999999999999999998876 4678


Q ss_pred             EEEEEeccCCChhhhhcCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEec
Q 013636          225 FLVYEMMQNGSLEKQLHGPTHG-----SNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDF  299 (439)
Q Consensus       225 ~lV~e~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~Df  299 (439)
                      ++++||+++|+|.+++......     ..+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCC
Confidence            9999999999999998653322     5699999999999999999999997   9999999999999999999999999


Q ss_pred             ccccccCCCCcc---eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhccccc
Q 013636          300 GLSVTAGTQSRN---VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTD  375 (439)
Q Consensus       300 Gls~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~  375 (439)
                      |+++........   ....++..|+|||.+.+..++.++||||||+++||+++ |+.||...++.+....+.       .
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-------~  234 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLK-------D  234 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHH-------c
Confidence            999765332211   11235678999999999899999999999999999999 999998766543222211       0


Q ss_pred             CCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccC
Q 013636          376 RSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLV  428 (439)
Q Consensus       376 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~  428 (439)
                      ......      ..    .....+.+++.+||+.||++|||+.++++.|+.+.
T Consensus       235 ~~~~~~------~~----~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~  277 (280)
T cd05043         235 GYRLAQ------PI----NCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH  277 (280)
T ss_pred             CCCCCC------CC----cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            111100      00    11245778999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=4.8e-40  Score=319.59  Aligned_cols=241  Identities=25%  Similarity=0.343  Sum_probs=195.6

Q ss_pred             ceecccCcEEEEEEEECC-ccEEEEEEecCCC---chHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeeEEEEEeccC
Q 013636          159 NVIGEGGRGHVYKARFNE-KLLAAVKRIDDAG---HDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMMQN  233 (439)
Q Consensus       159 ~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~  233 (439)
                      +.||+|+||+||+++... +..+|+|.+....   ......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            469999999999998864 6789999887432   23345677888899888 799999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCC-CCcce
Q 013636          234 GSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT-QSRNV  312 (439)
Q Consensus       234 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~-~~~~~  312 (439)
                      |+|..++..   ...+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||++..... .....
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (318)
T cd05570          81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTS  154 (318)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCccc
Confidence            999998864   34689999999999999999999998   999999999999999999999999999865322 22223


Q ss_pred             eeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCccC
Q 013636          313 KISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMD  392 (439)
Q Consensus       313 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  392 (439)
                      ...||+.|+|||.+.+..++.++|||||||++|||++|+.||...+.......+.      ......+..+         
T Consensus       155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~------~~~~~~~~~~---------  219 (318)
T cd05570         155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSIL------EDEVRYPRWL---------  219 (318)
T ss_pred             ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHH------cCCCCCCCcC---------
Confidence            3468999999999999999999999999999999999999998766543322221      1111111111         


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHh
Q 013636          393 LKHLYQVAAVAVLCIQPEPSYRPLI-----TDVLHS  423 (439)
Q Consensus       393 ~~~~~~l~~l~~~cl~~dP~~RPt~-----~evl~~  423 (439)
                         ...+.+++.+||+.||++||++     .+++++
T Consensus       220 ---~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         220 ---SKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             ---CHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence               2356779999999999999999     888865

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-40  Score=339.10  Aligned_cols=257  Identities=27%  Similarity=0.358  Sum_probs=208.0

Q ss_pred             hcCCCccceecccCcEEEEEEEECCc-cEEEEEEecCCCchHHHHHHHHHHHHHhcC-CCceeeeeeE-EEeC------C
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFNEK-LLAAVKRIDDAGHDAEREFNNEVNWLTKIR-HQNIISLLGY-CIHA------E  222 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~~~------~  222 (439)
                      ..++++.+.|.+|||+.||.|+...+ ..+|+|++-..+....+.+.+|+++|++|+ |+|||.+++. ....      -
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~  115 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW  115 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence            45677789999999999999999877 999999998777788889999999999996 9999999993 3221      2


Q ss_pred             eeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccc
Q 013636          223 TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS  302 (439)
Q Consensus       223 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls  302 (439)
                      +.+|.||||.+|+|-+++....+. .|++.++++|+.|+++|+++||.. .++|||||||-+||||+.+++.||||||.+
T Consensus       116 EvllLmEyC~gg~Lvd~mn~Rlq~-~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSa  193 (738)
T KOG1989|consen  116 EVLLLMEYCKGGSLVDFMNTRLQT-RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSA  193 (738)
T ss_pred             EEEeehhhccCCcHHHHHHHHHhc-cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccc
Confidence            568999999999999999854333 399999999999999999999986 668999999999999999999999999998


Q ss_pred             cccCCCC-cc---------eeeccccCccchhhhc---CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhh
Q 013636          303 VTAGTQS-RN---------VKISGTLGYVAPEYLL---EGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWA  369 (439)
Q Consensus       303 ~~~~~~~-~~---------~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~  369 (439)
                      ....... ..         ....-|+-|+|||++.   +...++|+|||+|||+||-|+....||+....-..       
T Consensus       194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laI-------  266 (738)
T KOG1989|consen  194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAI-------  266 (738)
T ss_pred             ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeE-------
Confidence            5432211 10         0112488999999985   56789999999999999999999999986532110       


Q ss_pred             hcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCC
Q 013636          370 MPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPT  430 (439)
Q Consensus       370 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~  430 (439)
                         +...-.+|.          .......+.+||..||+.||++||++.+|++.+-++...
T Consensus       267 ---lng~Y~~P~----------~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~  314 (738)
T KOG1989|consen  267 ---LNGNYSFPP----------FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK  314 (738)
T ss_pred             ---EeccccCCC----------CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence               111111111          124566788899999999999999999999999777654

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-39  Score=305.96  Aligned_cols=250  Identities=31%  Similarity=0.482  Sum_probs=206.1

Q ss_pred             cCCCccceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEecc
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQ  232 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  232 (439)
                      ++|+..+.||+|+||.||++... +..+++|.+..... ..+++.+|+.++++++|+|++++++++...+..++||||++
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   83 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA   83 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence            56788899999999999999876 56789999976544 56789999999999999999999999999899999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCcce
Q 013636          233 NGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV  312 (439)
Q Consensus       233 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~~~  312 (439)
                      +++|.+++.... ...+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.+||+|||.+........  
T Consensus        84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--  157 (256)
T cd05039          84 KGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--  157 (256)
T ss_pred             CCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence            999999997532 23689999999999999999999998   999999999999999999999999999976633222  


Q ss_pred             eeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCcc
Q 013636          313 KISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTM  391 (439)
Q Consensus       313 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  391 (439)
                      ....+..|+|||.+..+.++.++||||||+++||+++ |..||...+.......+..   ..  ....+.          
T Consensus       158 ~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~---~~--~~~~~~----------  222 (256)
T cd05039         158 SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK---GY--RMEAPE----------  222 (256)
T ss_pred             cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc---CC--CCCCcc----------
Confidence            2234668999999998899999999999999999997 9999987655443322211   00  001111          


Q ss_pred             CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhcccc
Q 013636          392 DLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPL  427 (439)
Q Consensus       392 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l  427 (439)
                        .....+.+++.+||+.+|++|||+.+++..|+.+
T Consensus       223 --~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         223 --GCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             --CCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence              1134677899999999999999999999999754

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=3.9e-40  Score=321.74  Aligned_cols=247  Identities=23%  Similarity=0.370  Sum_probs=192.1

Q ss_pred             ceecccCcEEEEEEEECC-ccEEEEEEecCC---CchHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeeEEEEEeccC
Q 013636          159 NVIGEGGRGHVYKARFNE-KLLAAVKRIDDA---GHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMMQN  233 (439)
Q Consensus       159 ~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~  233 (439)
                      +.||+|+||.||+++... +..+|+|.+...   .......+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            469999999999998764 678899998753   223345677888888777 899999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCC-CCcce
Q 013636          234 GSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT-QSRNV  312 (439)
Q Consensus       234 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~-~~~~~  312 (439)
                      |+|..++..   ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++..... .....
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~  154 (329)
T cd05618          81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS  154 (329)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccc
Confidence            999988853   34689999999999999999999998   999999999999999999999999999875322 22223


Q ss_pred             eeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhh--hhhhHhhhhcc-cccCCCCCccCCchhcC
Q 013636          313 KISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQ--CQSMVTWAMPQ-LTDRSKLPNIVDPVIRD  389 (439)
Q Consensus       313 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~--~~~~~~~~~~~-~~~~~~~~~~~d~~l~~  389 (439)
                      ...||+.|+|||.+.+..++.++|||||||++|||++|+.||.......  ......+.... ......++...      
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~------  228 (329)
T cd05618         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL------  228 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCC------
Confidence            4568999999999999999999999999999999999999996422111  00011111000 11111222211      


Q ss_pred             ccCHHHHHHHHHHHHHhcCCCCCCCCC------HHHHHHh
Q 013636          390 TMDLKHLYQVAAVAVLCIQPEPSYRPL------ITDVLHS  423 (439)
Q Consensus       390 ~~~~~~~~~l~~l~~~cl~~dP~~RPt------~~evl~~  423 (439)
                            ...+.+++.+||+.||++||+      +.+++++
T Consensus       229 ------~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         229 ------SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             ------CHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence                  234667999999999999998      4677655

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.5e-39  Score=308.50  Aligned_cols=252  Identities=25%  Similarity=0.394  Sum_probs=197.2

Q ss_pred             CccceecccCcEEEEEEEECCcc---EEEEEEecCC--CchHHHHHHHHHHHHHhcCCCceeeeeeEEEeC------Cee
Q 013636          156 QESNVIGEGGRGHVYKARFNEKL---LAAVKRIDDA--GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHA------ETR  224 (439)
Q Consensus       156 ~~~~~LG~G~fg~Vy~~~~~~~~---~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~  224 (439)
                      .+.+.||+|+||.||+|++.+..   .+|+|.++..  .....+.+.+|+.+++.++|+||+++++++...      ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            45688999999999999876532   5788887643  234456789999999999999999999987532      246


Q ss_pred             EEEEEeccCCChhhhhcCC---CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccc
Q 013636          225 FLVYEMMQNGSLEKQLHGP---THGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGL  301 (439)
Q Consensus       225 ~lV~e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGl  301 (439)
                      ++++||+++|+|.+++...   .....+++.....++.|++.||+|||+.   +++||||||+|||+++++.+||+|||+
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~  158 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGL  158 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCc
Confidence            8999999999999887421   1234589999999999999999999997   999999999999999999999999999


Q ss_pred             ccccCCCCcc---eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCC
Q 013636          302 SVTAGTQSRN---VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRS  377 (439)
Q Consensus       302 s~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~  377 (439)
                      +.........   ....+++.|+|||...+..++.++||||||+++|||++ |+.||......+....+.       ...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-------~~~  231 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLR-------QGN  231 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-------cCC
Confidence            9765432211   11235678999999999999999999999999999999 899997765443222221       111


Q ss_pred             CCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhcccc
Q 013636          378 KLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPL  427 (439)
Q Consensus       378 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l  427 (439)
                      ... . .    .    .....+.+++.+||+.||++|||+.++++.|+++
T Consensus       232 ~~~-~-~----~----~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         232 RLK-Q-P----P----DCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CCC-C-C----C----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            100 0 0    0    1123567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=4.8e-40  Score=319.30  Aligned_cols=240  Identities=24%  Similarity=0.348  Sum_probs=192.4

Q ss_pred             ceecccCcEEEEEEEEC-CccEEEEEEecCCC---chHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeeEEEEEeccC
Q 013636          159 NVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG---HDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMMQN  233 (439)
Q Consensus       159 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~  233 (439)
                      +.||+|+||.||+|+.. .+..+|+|.++...   ......+..|..++... +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999886 46789999986532   22344566788887754 899999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCC-CCcce
Q 013636          234 GSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT-QSRNV  312 (439)
Q Consensus       234 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~-~~~~~  312 (439)
                      |+|.+++..   ...+++..+..++.|+++||+|||+.   +++||||||+|||+++++.+||+|||++..... .....
T Consensus        81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (316)
T cd05620          81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAS  154 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCcee
Confidence            999999864   34588999999999999999999998   999999999999999999999999999864322 12223


Q ss_pred             eeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCccC
Q 013636          313 KISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMD  392 (439)
Q Consensus       313 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  392 (439)
                      ...||+.|+|||.+.+..++.++|||||||++|||++|+.||...+.......+..      .....+..++        
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~--------  220 (316)
T cd05620         155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV------DTPHYPRWIT--------  220 (316)
T ss_pred             ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh------CCCCCCCCCC--------
Confidence            45689999999999999999999999999999999999999987665433222211      1122222222        


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCHH-HHHH
Q 013636          393 LKHLYQVAAVAVLCIQPEPSYRPLIT-DVLH  422 (439)
Q Consensus       393 ~~~~~~l~~l~~~cl~~dP~~RPt~~-evl~  422 (439)
                          ..+.+++.+||+.||++||++. ++++
T Consensus       221 ----~~~~~li~~~l~~dP~~R~~~~~~~~~  247 (316)
T cd05620         221 ----KESKDILEKLFERDPTRRLGVVGNIRG  247 (316)
T ss_pred             ----HHHHHHHHHHccCCHHHcCCChHHHHc
Confidence                2456789999999999999985 6653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-39  Score=313.49  Aligned_cols=261  Identities=26%  Similarity=0.392  Sum_probs=201.6

Q ss_pred             cCCCccceecccCcEEEEEEEECC---------------ccEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCceeeeee
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNE---------------KLLAAVKRIDDAG-HDAEREFNNEVNWLTKIRHQNIISLLG  216 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~  216 (439)
                      ++|++.+.||+|+||.||++...+               ...+|+|...... ......|.+|++++++++|+|++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            578888999999999999987643               2357899887543 334457999999999999999999999


Q ss_pred             EEEeCCeeEEEEEeccCCChhhhhcCCC---------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEE
Q 013636          217 YCIHAETRFLVYEMMQNGSLEKQLHGPT---------HGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNIL  287 (439)
Q Consensus       217 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiL  287 (439)
                      ++...+..++||||+++++|.+++....         ....+++..++.++.|++.||+|||+.   +++||||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEE
Confidence            9999999999999999999999986421         112478899999999999999999998   9999999999999


Q ss_pred             EcCCCcEEEEecccccccCCCCcc---eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh--CCCCCCCCChhhh
Q 013636          288 LDSSFNAKLSDFGLSVTAGTQSRN---VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM--GRRPVEKMSPTQC  362 (439)
Q Consensus       288 l~~~~~~kl~DfGls~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt--G~~P~~~~~~~~~  362 (439)
                      +++++.+||+|||++.........   ....++..|+|||.+.++.++.++||||||+++|||++  |..||...+....
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~  241 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV  241 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence            999999999999999754332211   11234678999999999999999999999999999998  6778876554332


Q ss_pred             hhhHhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccc
Q 013636          363 QSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIP  426 (439)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  426 (439)
                      ........   ...........+   .    .....+.+++.+||+.||++||++.+|++.|.+
T Consensus       242 ~~~~~~~~---~~~~~~~~~~~~---~----~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         242 IENTGEFF---RNQGRQIYLSQT---P----LCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             HHHHHHhh---hhccccccCCCC---C----CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence            22111100   000000000000   0    112468889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=4.9e-40  Score=309.91  Aligned_cols=253  Identities=25%  Similarity=0.451  Sum_probs=205.6

Q ss_pred             HhcCCCccceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEe
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      ..++|++.++||+|+||.||+|...++..+|+|.+..... ...++.+|+.++++++|+|++++++++. .+..+++|||
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   81 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY   81 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence            3467888999999999999999998889999999875443 3467899999999999999999999864 5678999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR  310 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~  310 (439)
                      +++|+|.+++... .+..+++..+..++.|++.||+|||+.   +++||||||+||++++++.++|+|||++........
T Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05067          82 MENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY  157 (260)
T ss_pred             CCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence            9999999998653 245689999999999999999999997   999999999999999999999999999976542221


Q ss_pred             c--eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchh
Q 013636          311 N--VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVI  387 (439)
Q Consensus       311 ~--~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  387 (439)
                      .  ....++..|+|||.+....++.++||||||+++||+++ |+.||...+..+......       .....+      .
T Consensus       158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-------~~~~~~------~  224 (260)
T cd05067         158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE-------RGYRMP------R  224 (260)
T ss_pred             ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHH-------cCCCCC------C
Confidence            1  12235678999999998899999999999999999999 999998765443222211       000000      0


Q ss_pred             cCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccc
Q 013636          388 RDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIP  426 (439)
Q Consensus       388 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  426 (439)
                      ..    ....++.+++.+|++.+|++||+++++++.|+.
T Consensus       225 ~~----~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         225 PD----NCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CC----CCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            01    112457889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-40  Score=328.58  Aligned_cols=249  Identities=22%  Similarity=0.337  Sum_probs=196.8

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC---chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      ++|++.+.||+|+||+||+++.. ++..+|+|.+....   ......+.+|++++++++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            46888899999999999999875 57889999886432   223456889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~  308 (439)
                      ||+++|+|.+++..   ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++++||+|||+++.....
T Consensus        81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  154 (377)
T cd05629          81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ  154 (377)
T ss_pred             eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence            99999999999964   34588999999999999999999998   9999999999999999999999999998532110


Q ss_pred             Cc------------------------------------------------ceeeccccCccchhhhcCCCCCCchhhHHH
Q 013636          309 SR------------------------------------------------NVKISGTLGYVAPEYLLEGKLTDKSDVYAF  340 (439)
Q Consensus       309 ~~------------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~  340 (439)
                      ..                                                .....||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  234 (377)
T cd05629         155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL  234 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence            00                                                001358999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCCCChhhhhh-hHhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCC---CC
Q 013636          341 GVVLLELLMGRRPVEKMSPTQCQS-MVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYR---PL  416 (439)
Q Consensus       341 Gvll~elltG~~P~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~R---Pt  416 (439)
                      ||++|||++|+.||...++.+... ...|.     ....+++..      .    ....+.+++..|++ +|.+|   ++
T Consensus       235 Gvil~elltG~~Pf~~~~~~~~~~~i~~~~-----~~~~~p~~~------~----~s~~~~dli~~lL~-~~~~r~~r~~  298 (377)
T cd05629         235 GAIMFECLIGWPPFCSENSHETYRKIINWR-----ETLYFPDDI------H----LSVEAEDLIRRLIT-NAENRLGRGG  298 (377)
T ss_pred             chhhhhhhcCCCCCCCCCHHHHHHHHHccC-----CccCCCCCC------C----CCHHHHHHHHHHhc-CHhhcCCCCC
Confidence            999999999999998766543222 22211     111111100      0    12346678888997 66665   69


Q ss_pred             HHHHHHh
Q 013636          417 ITDVLHS  423 (439)
Q Consensus       417 ~~evl~~  423 (439)
                      +.|++++
T Consensus       299 ~~~~l~h  305 (377)
T cd05629         299 AHEIKSH  305 (377)
T ss_pred             HHHHhcC
Confidence            9999976

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.9e-40  Score=311.14  Aligned_cols=255  Identities=25%  Similarity=0.415  Sum_probs=205.9

Q ss_pred             hcCCCccceecccCcEEEEEEEECC------ccEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCee
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFNE------KLLAAVKRIDDAGH-DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETR  224 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  224 (439)
                      .++|++.+.||+|+||.||+|...+      +..+++|.+..... .....+.+|+.+++.++|||++++++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            4678888999999999999998743      36789999875432 3445788999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhcCCCC-------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEE
Q 013636          225 FLVYEMMQNGSLEKQLHGPTH-------GSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLS  297 (439)
Q Consensus       225 ~lV~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~  297 (439)
                      ++||||+++|+|.+++.....       ...+++..+..++.|++.||.|||+.   +++||||||+||++++++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEEC
Confidence            999999999999999864221       23478999999999999999999997   99999999999999999999999


Q ss_pred             ecccccccCCCCc---ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhccc
Q 013636          298 DFGLSVTAGTQSR---NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQL  373 (439)
Q Consensus       298 DfGls~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~  373 (439)
                      |||+++.......   .....++..|+|||.+.++.++.++|||||||++||+++ |..||...++.........     
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~-----  236 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID-----  236 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc-----
Confidence            9999875433221   122336788999999998899999999999999999998 9999987665543332220     


Q ss_pred             ccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccc
Q 013636          374 TDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIP  426 (439)
Q Consensus       374 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  426 (439)
                      ......+..            ....+.+++..||+.+|++|||+.++++.|++
T Consensus       237 ~~~~~~~~~------------~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         237 GGHLDLPEN------------CPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             CCCCCCCCC------------CCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence            001111111            13467789999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=9e-40  Score=311.90  Aligned_cols=245  Identities=24%  Similarity=0.318  Sum_probs=194.0

Q ss_pred             ecccCcEEEEEEEEC-CccEEEEEEecCCCc---hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEeccCCCh
Q 013636          161 IGEGGRGHVYKARFN-EKLLAAVKRIDDAGH---DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSL  236 (439)
Q Consensus       161 LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  236 (439)
                      ||+|+||+||++... ++..+|+|.+.....   ...+.+..|+.+++.++|+|++++.+++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999875 577899999864322   2234678899999999999999999999999999999999999999


Q ss_pred             hhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc-ceee
Q 013636          237 EKQLHGP-THGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR-NVKI  314 (439)
Q Consensus       237 ~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~-~~~~  314 (439)
                      .+++... .....+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||++........ ....
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~  157 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY  157 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccccc
Confidence            9887542 2345689999999999999999999998   999999999999999999999999999976543222 2234


Q ss_pred             ccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhh-hhHhhhhcccccCCCCCccCCchhcCccCH
Q 013636          315 SGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQ-SMVTWAMPQLTDRSKLPNIVDPVIRDTMDL  393 (439)
Q Consensus       315 ~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  393 (439)
                      .||+.|+|||.+.+..++.++||||||+++|||++|+.||......... .....   ........+            .
T Consensus       158 ~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~------------~  222 (280)
T cd05608         158 AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQR---ILNDSVTYP------------D  222 (280)
T ss_pred             CCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHh---hcccCCCCc------------c
Confidence            5899999999999999999999999999999999999999764322111 11110   001111111            1


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHh
Q 013636          394 KHLYQVAAVAVLCIQPEPSYRP-----LITDVLHS  423 (439)
Q Consensus       394 ~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  423 (439)
                      .....+.+++.+||+.||++||     ++++++++
T Consensus       223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence            1234567799999999999999     77888865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.2e-39  Score=307.88  Aligned_cols=259  Identities=24%  Similarity=0.359  Sum_probs=207.5

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCC---CchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDA---GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      ++|+..+.||+|+||.||+|... ++..+++|.++..   .......+.+|++++++++|+|++++++++...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57888999999999999999887 6788999987532   2233567899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCC
Q 013636          229 EMMQNGSLEKQLHGP-THGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT  307 (439)
Q Consensus       229 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~  307 (439)
                      ||+++|+|.+++... .....+++..+..++.+++.|+.|||+.   +++||||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            999999999998642 2345689999999999999999999998   999999999999999999999999999876543


Q ss_pred             CCc-ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCch
Q 013636          308 QSR-NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPV  386 (439)
Q Consensus       308 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  386 (439)
                      ... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||....... ......    ... ...+...   
T Consensus       159 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~----~~~-~~~~~~~---  229 (267)
T cd08224         159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLCKK----IEK-CDYPPLP---  229 (267)
T ss_pred             CCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccH-HHHHhh----hhc-CCCCCCC---
Confidence            221 223458889999999998899999999999999999999999996543211 111110    000 0000000   


Q ss_pred             hcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccC
Q 013636          387 IRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLV  428 (439)
Q Consensus       387 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~  428 (439)
                           .......+.+++.+||+.+|++|||+.++++.|+++.
T Consensus       230 -----~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         230 -----ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             -----hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence                 0122346778999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2.1e-39  Score=311.79  Aligned_cols=261  Identities=26%  Similarity=0.424  Sum_probs=202.3

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-----------------CccEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCceee
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-----------------EKLLAAVKRIDDAG-HDAEREFNNEVNWLTKIRHQNIIS  213 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~  213 (439)
                      .++|++.+.||+|+||.||++...                 +...+|+|.+.... .....++.+|+.+++.++|+|+++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            357888999999999999998543                 23468899887543 334567999999999999999999


Q ss_pred             eeeEEEeCCeeEEEEEeccCCChhhhhcCCC--------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCC
Q 013636          214 LLGYCIHAETRFLVYEMMQNGSLEKQLHGPT--------HGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSN  285 (439)
Q Consensus       214 l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~N  285 (439)
                      +++++...+..+++|||+++|+|.+++....        ....+++..+..++.|++.|++|||+.   +++||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~N  160 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhe
Confidence            9999999999999999999999999987522        123478889999999999999999998   99999999999


Q ss_pred             EEEcCCCcEEEEecccccccCCCCcc---eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh--CCCCCCCCChh
Q 013636          286 ILLDSSFNAKLSDFGLSVTAGTQSRN---VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM--GRRPVEKMSPT  360 (439)
Q Consensus       286 iLl~~~~~~kl~DfGls~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt--G~~P~~~~~~~  360 (439)
                      |++++++.++|+|||++.........   ....++..|+|||....+.++.++|||||||++|||++  |..||...+..
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE  240 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence            99999999999999999765332211   11224578999999988899999999999999999998  77888765543


Q ss_pred             hhhhhH-hhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccc
Q 013636          361 QCQSMV-TWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIP  426 (439)
Q Consensus       361 ~~~~~~-~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  426 (439)
                      +..... .+.... ......     +.     .......+.+++.+||+.||++||++.+|++.|++
T Consensus       241 ~~~~~~~~~~~~~-~~~~~~-----~~-----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         241 QVIENTGEFFRDQ-GRQVYL-----PK-----PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             HHHHHHHHHHhhc-cccccC-----CC-----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            322111 111000 000000     00     00122467789999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=9e-40  Score=312.00  Aligned_cols=253  Identities=26%  Similarity=0.389  Sum_probs=201.7

Q ss_pred             CCCccceecccCcEEEEEEEECC------ccEEEEEEecCCCch-HHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEE
Q 013636          154 NFQESNVIGEGGRGHVYKARFNE------KLLAAVKRIDDAGHD-AEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFL  226 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  226 (439)
                      +|++.+.||+|+||.||+|+..+      +..+|+|.+...... ..+.+.+|+.+++.++||||+++++++...+..++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            35567889999999999998643      478999999755433 34568899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhcCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCc
Q 013636          227 VYEMMQNGSLEKQLHGP-------------THGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFN  293 (439)
Q Consensus       227 V~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~  293 (439)
                      ++||+++++|.+++...             .....+++..+.+++.|++.||+|||+.   +++||||||+||++++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence            99999999999998521             1123588899999999999999999998   9999999999999999999


Q ss_pred             EEEEecccccccCCCCcc---eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhh
Q 013636          294 AKLSDFGLSVTAGTQSRN---VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWA  369 (439)
Q Consensus       294 ~kl~DfGls~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~  369 (439)
                      +||+|||+++........   ....+++.|+|||.+.++.++.++||||||+++|||++ |..||.+....+....+.. 
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~-  241 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRN-  241 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc-
Confidence            999999998765332211   12235678999999998899999999999999999998 8889987655443322211 


Q ss_pred             hcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccc
Q 013636          370 MPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIP  426 (439)
Q Consensus       370 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  426 (439)
                            . ....     ...    .....+.+++..||+.+|++||++++++..|+.
T Consensus       242 ------~-~~~~-----~~~----~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         242 ------R-QVLP-----CPD----DCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             ------C-CcCC-----CCC----CCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence                  0 0000     001    123457789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=4.1e-40  Score=326.58  Aligned_cols=252  Identities=22%  Similarity=0.293  Sum_probs=200.3

Q ss_pred             HhcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCC---CchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEE
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDA---GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFL  226 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  226 (439)
                      ..++|++.+.||+|+||.||+++.. ++..+|+|.+...   .......+.+|+.+++.++||||+++++++.+.+..++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            3568899999999999999999886 4778999998642   12233457889999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccC
Q 013636          227 VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAG  306 (439)
Q Consensus       227 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~  306 (439)
                      ||||+++|+|.+++...    .+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+||+|||++....
T Consensus       121 v~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~  193 (370)
T cd05596         121 VMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD  193 (370)
T ss_pred             EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence            99999999999998642    478888999999999999999998   99999999999999999999999999997654


Q ss_pred             CCCc--ceeeccccCccchhhhcCC----CCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCC
Q 013636          307 TQSR--NVKISGTLGYVAPEYLLEG----KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLP  380 (439)
Q Consensus       307 ~~~~--~~~~~gt~~y~aPE~~~~~----~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  380 (439)
                      ....  .....||+.|+|||.+.+.    .++.++|||||||++|||++|+.||...+.......+...    ......+
T Consensus       194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~----~~~~~~~  269 (370)
T cd05596         194 ANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDH----KNSLTFP  269 (370)
T ss_pred             CCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcC----CCcCCCC
Confidence            3221  1234589999999998753    4788999999999999999999999876643322211100    0001111


Q ss_pred             ccCCchhcCccCHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHh
Q 013636          381 NIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSY--RPLITDVLHS  423 (439)
Q Consensus       381 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~evl~~  423 (439)
                      ..          ......+.+++..||+.+|++  ||++.|++++
T Consensus       270 ~~----------~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         270 DD----------IEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             Cc----------CCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            10          011235667899999999988  9999999876

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2.8e-39  Score=302.69  Aligned_cols=245  Identities=28%  Similarity=0.440  Sum_probs=199.1

Q ss_pred             ceecccCcEEEEEEEECCccEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEeccCCChh
Q 013636          159 NVIGEGGRGHVYKARFNEKLLAAVKRIDDAGH-DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLE  237 (439)
Q Consensus       159 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~  237 (439)
                      ++||+|+||.||+|...++..+|+|.+..... .....+.+|+++++.++|||++++++++...+..++||||+++|+|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            36999999999999988888999999876543 33456889999999999999999999999999999999999999999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCcc--eeec
Q 013636          238 KQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN--VKIS  315 (439)
Q Consensus       238 ~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~~--~~~~  315 (439)
                      +++...  ...+++..+..++.|++.+|.|||+.   +++||||+|+||++++++.+||+|||++.........  ....
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (250)
T cd05085          81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ  155 (250)
T ss_pred             HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence            998642  34588999999999999999999997   9999999999999999999999999998654322111  1122


Q ss_pred             cccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCccCHH
Q 013636          316 GTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLK  394 (439)
Q Consensus       316 gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  394 (439)
                      ++..|+|||++.++.++.++||||||+++||+++ |..||...........+..   .  .....+        .    .
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~---~--~~~~~~--------~----~  218 (250)
T cd05085         156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEK---G--YRMSCP--------Q----K  218 (250)
T ss_pred             CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHc---C--CCCCCC--------C----C
Confidence            4567999999999999999999999999999998 9999987655432222210   0  000000        0    1


Q ss_pred             HHHHHHHHHHHhcCCCCCCCCCHHHHHHhcc
Q 013636          395 HLYQVAAVAVLCIQPEPSYRPLITDVLHSLI  425 (439)
Q Consensus       395 ~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  425 (439)
                      ....+.+++.+|++.+|++||++.|+++.|.
T Consensus       219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            2346788999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2e-39  Score=305.31  Aligned_cols=244  Identities=29%  Similarity=0.430  Sum_probs=196.1

Q ss_pred             eecccCcEEEEEEEEC---CccEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEeccCC
Q 013636          160 VIGEGGRGHVYKARFN---EKLLAAVKRIDDAGH--DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNG  234 (439)
Q Consensus       160 ~LG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  234 (439)
                      .||+|+||.||+|.++   ++..+|+|.++....  ...+++.+|+.+++.++||||+++++++. .+..++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            5899999999999753   467889998864432  34467899999999999999999999885 45779999999999


Q ss_pred             ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCcc---
Q 013636          235 SLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN---  311 (439)
Q Consensus       235 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~~---  311 (439)
                      +|.+++..   ...+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||++.........   
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  154 (257)
T cd05116          81 PLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA  154 (257)
T ss_pred             cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence            99999964   23589999999999999999999998   9999999999999999999999999999765443221   


Q ss_pred             -eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcC
Q 013636          312 -VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRD  389 (439)
Q Consensus       312 -~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  389 (439)
                       ....++..|+|||.+....++.++|+||||+++|||++ |+.||...+..+....+...     .....+..       
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~-----~~~~~~~~-------  222 (257)
T cd05116         155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESG-----ERMECPQR-------  222 (257)
T ss_pred             cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCC-----CCCCCCCC-------
Confidence             11123578999999988889999999999999999998 99999876654433332210     01111111       


Q ss_pred             ccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhcccc
Q 013636          390 TMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPL  427 (439)
Q Consensus       390 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l  427 (439)
                           ....+.+++.+||+.||++||++.+|.+.|+..
T Consensus       223 -----~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         223 -----CPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             -----CCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence                 123567899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.5e-39  Score=311.22  Aligned_cols=251  Identities=25%  Similarity=0.341  Sum_probs=199.9

Q ss_pred             CCccceecccCcEEEEEEEEC-CccEEEEEEecCCCc---hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEe
Q 013636          155 FQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGH---DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       155 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      |+..+.||+|+||+||++... ++..+|+|.+.....   .....+.+|+.++++++|+|++++.+++..++..+++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            566788999999999999885 577899998865322   2234578899999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR  310 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~  310 (439)
                      +++|+|.+++.... ...+++..+..++.|++.||.|||+.   +++||||||+||++++++.+||+|||++........
T Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05632          82 MNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES  157 (285)
T ss_pred             ccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence            99999998886422 34689999999999999999999998   999999999999999999999999999976543333


Q ss_pred             ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCc
Q 013636          311 NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDT  390 (439)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  390 (439)
                      .....|+..|+|||.+.+..++.++|+||||+++|||++|..||....+.............  .....+        . 
T Consensus       158 ~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~--~~~~~~--------~-  226 (285)
T cd05632         158 IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLE--TEEVYS--------A-  226 (285)
T ss_pred             ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhc--cccccC--------c-
Confidence            33446899999999999999999999999999999999999999876543222222111100  001111        1 


Q ss_pred             cCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHh
Q 013636          391 MDLKHLYQVAAVAVLCIQPEPSYRPL-----ITDVLHS  423 (439)
Q Consensus       391 ~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~  423 (439)
                         .....+.+++..|++.||++||+     +.+++++
T Consensus       227 ---~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         227 ---KFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             ---cCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence               11234577999999999999999     6777765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.8e-40  Score=325.71  Aligned_cols=259  Identities=20%  Similarity=0.257  Sum_probs=195.1

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEe
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      .++|++.+.||+|+||.||++... .+..+|+|...      ...+.+|++++++++||||+++++++......++|+|+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            367999999999999999999875 46788998643      23567899999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC--
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ--  308 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~--  308 (439)
                      +. ++|..++..   ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++......  
T Consensus       165 ~~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~  237 (391)
T PHA03212        165 YK-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA  237 (391)
T ss_pred             CC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence            95 689888854   24589999999999999999999998   9999999999999999999999999999653321  


Q ss_pred             CcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhh----hhhHhhhhccccc-CCCCCc--
Q 013636          309 SRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQC----QSMVTWAMPQLTD-RSKLPN--  381 (439)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~----~~~~~~~~~~~~~-~~~~~~--  381 (439)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.|+........    ...+......... ....+.  
T Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~  317 (391)
T PHA03212        238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA  317 (391)
T ss_pred             cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence            122345699999999999999999999999999999999999988753221000    0000000000000 000000  


Q ss_pred             ------c---------CCchhcCcc--CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          382 ------I---------VDPVIRDTM--DLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       382 ------~---------~d~~l~~~~--~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                            .         ..+..+...  .......+.+++.+||+.||++|||++|++++
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h  376 (391)
T PHA03212        318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF  376 (391)
T ss_pred             hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence                  0         000000000  01123467889999999999999999999964

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.7e-39  Score=307.63  Aligned_cols=257  Identities=25%  Similarity=0.404  Sum_probs=201.3

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEE
Q 013636          149 EAATNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLV  227 (439)
Q Consensus       149 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  227 (439)
                      +.+++++.....||+|+||.||+|+.. ++..+++|.+........+.+.+|+.++++++|+||+++++++...+..+++
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   83 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF   83 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence            345566766789999999999999865 4678999998876666677899999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC-CCcEEEEecccccccC
Q 013636          228 YEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDS-SFNAKLSDFGLSVTAG  306 (439)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~-~~~~kl~DfGls~~~~  306 (439)
                      +||+++++|.+++.........++..+..++.|++.|++|||+.   +++||||||+||+++. ++.++|+|||++....
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~  160 (268)
T cd06624          84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA  160 (268)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence            99999999999997432111227888899999999999999997   9999999999999986 6799999999986553


Q ss_pred             CCCc-ceeeccccCccchhhhcCCC--CCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccC
Q 013636          307 TQSR-NVKISGTLGYVAPEYLLEGK--LTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV  383 (439)
Q Consensus       307 ~~~~-~~~~~gt~~y~aPE~~~~~~--~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  383 (439)
                      .... .....++..|+|||.+.+..  ++.++||||||+++|+|++|+.||.........   .+..........++.. 
T Consensus       161 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~-  236 (268)
T cd06624         161 GINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA---MFKVGMFKIHPEIPES-  236 (268)
T ss_pred             cCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh---HhhhhhhccCCCCCcc-
Confidence            3221 22334789999999987644  788999999999999999999999754322111   1111111111111111 


Q ss_pred             CchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          384 DPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       384 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                                 ....+.+++.+||+.+|++|||+.|++++
T Consensus       237 -----------~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         237 -----------LSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             -----------cCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence                       12346678999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.6e-39  Score=309.64  Aligned_cols=256  Identities=24%  Similarity=0.418  Sum_probs=203.5

Q ss_pred             cCCCccceecccCcEEEEEEEEC-Ccc----EEEEEEecCCC-chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKL----LAAVKRIDDAG-HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFL  226 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  226 (439)
                      ++|+..+.||+|+||+||+|++. ++.    .+|+|.+.... ....+++.+|+.+++.++|||++++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l   85 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL   85 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence            56778899999999999999863 232    47899886543 3345678999999999999999999999875 45789


Q ss_pred             EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccC
Q 013636          227 VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAG  306 (439)
Q Consensus       227 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~  306 (439)
                      ++||+++|+|.++++..  ...+++..++.++.|++.||+|||+.   +++||||||+|||+++++.+||+|||+++...
T Consensus        86 ~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~  160 (279)
T cd05109          86 VTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLD  160 (279)
T ss_pred             EEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeecc
Confidence            99999999999999742  34689999999999999999999998   99999999999999999999999999997654


Q ss_pred             CCCcce---eeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCcc
Q 013636          307 TQSRNV---KISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNI  382 (439)
Q Consensus       307 ~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  382 (439)
                      ......   ...++..|+|||.+.+..++.++|||||||++|||++ |..||...........+..   .  .....+. 
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~---~--~~~~~~~-  234 (279)
T cd05109         161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK---G--ERLPQPP-  234 (279)
T ss_pred             cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC---C--CcCCCCc-
Confidence            322211   1124678999999999999999999999999999998 9999976654433222211   0  0000000 


Q ss_pred             CCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCCC
Q 013636          383 VDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPTD  431 (439)
Q Consensus       383 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~~  431 (439)
                                 .....+.+++..||+.||++||++.++++.|+.+....
T Consensus       235 -----------~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         235 -----------ICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             -----------cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence                       11235678999999999999999999999998876654

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=7e-40  Score=309.81  Aligned_cols=259  Identities=24%  Similarity=0.352  Sum_probs=205.6

Q ss_pred             cCCCccceecccCcEEEEEEEE-CCccEEEEEEecCCC---chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARF-NEKLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      ++|++.+.||+|+||.||++.. .++..+++|.+....   .....++.+|+.+++.++|||++++++++..++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4677788999999999999986 467889999876432   233457889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCC
Q 013636          229 EMMQNGSLEKQLHGP-THGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT  307 (439)
Q Consensus       229 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~  307 (439)
                      ||+++++|.+++... .....+++..+..++.|++.|++|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            999999999988642 2245689999999999999999999998   999999999999999999999999999876543


Q ss_pred             CCcc-eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCch
Q 013636          308 QSRN-VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPV  386 (439)
Q Consensus       308 ~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  386 (439)
                      .... ....++..|+|||.+.+..++.++|+||||+++|||++|..||....... ........     ....     +.
T Consensus       159 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~-----~~~~-----~~  227 (267)
T cd08229         159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLCKKIE-----QCDY-----PP  227 (267)
T ss_pred             CCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH-HHHhhhhh-----cCCC-----CC
Confidence            3221 23458889999999998899999999999999999999999997543221 11111100     0000     00


Q ss_pred             hcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccC
Q 013636          387 IRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLV  428 (439)
Q Consensus       387 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~  428 (439)
                      +.   .......+.+++.+||+.||++|||+.+|++.+.++.
T Consensus       228 ~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         228 LP---SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             CC---cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence            00   0112346778999999999999999999999887653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=2.6e-39  Score=304.80  Aligned_cols=244  Identities=27%  Similarity=0.438  Sum_probs=195.5

Q ss_pred             ecccCcEEEEEEEEC---CccEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEeccCCCh
Q 013636          161 IGEGGRGHVYKARFN---EKLLAAVKRIDDAGH-DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSL  236 (439)
Q Consensus       161 LG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  236 (439)
                      ||+|+||.||+|.+.   .+..+|+|.+..... ...+.+.+|+.++++++||||+++++++. .+..++||||+++|+|
T Consensus         3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L   81 (257)
T cd05115           3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPL   81 (257)
T ss_pred             cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCH
Confidence            899999999999764   345689998876533 33457899999999999999999999885 4578999999999999


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCcce----
Q 013636          237 EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV----  312 (439)
Q Consensus       237 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~~~----  312 (439)
                      .+++..  ....+++..+++++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++..........    
T Consensus        82 ~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05115          82 NKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS  156 (257)
T ss_pred             HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence            999964  234689999999999999999999998   99999999999999999999999999997554322211    


Q ss_pred             eeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCcc
Q 013636          313 KISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTM  391 (439)
Q Consensus       313 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  391 (439)
                      ...++..|+|||.+.+..++.++||||||+++||+++ |..||......+....+...     .....+           
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~-----------  220 (257)
T cd05115         157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQG-----KRLDCP-----------  220 (257)
T ss_pred             CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC-----CCCCCC-----------
Confidence            1123568999999998889999999999999999996 99999877654433322210     011111           


Q ss_pred             CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhcccc
Q 013636          392 DLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPL  427 (439)
Q Consensus       392 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l  427 (439)
                       ......+.+++..||+.||++||++.+|.+.|..+
T Consensus       221 -~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         221 -AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             -CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence             11234666799999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.8e-39  Score=313.33  Aligned_cols=257  Identities=24%  Similarity=0.391  Sum_probs=204.7

Q ss_pred             HHhcCCCccceecccCcEEEEEEEEC------CccEEEEEEecCCCc-hHHHHHHHHHHHHHhc-CCCceeeeeeEEEeC
Q 013636          150 AATNNFQESNVIGEGGRGHVYKARFN------EKLLAAVKRIDDAGH-DAEREFNNEVNWLTKI-RHQNIISLLGYCIHA  221 (439)
Q Consensus       150 ~~~~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  221 (439)
                      ...++|+..+.||+|+||.||++...      .+..+|+|.++.... ...+.+.+|+.+++++ +||||+++++++...
T Consensus        32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  111 (302)
T cd05055          32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG  111 (302)
T ss_pred             ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence            33467888999999999999999752      245789998875432 3345789999999999 799999999999999


Q ss_pred             CeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccc
Q 013636          222 ETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGL  301 (439)
Q Consensus       222 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGl  301 (439)
                      +..+++|||+++|+|.++++... ...+++.++..++.|++.||+|||+.   +++|+||||+||+++.++.++++|||+
T Consensus       112 ~~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~  187 (302)
T cd05055         112 GPILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGL  187 (302)
T ss_pred             CceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcc
Confidence            99999999999999999997522 23489999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCCcc---eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhh-hhHhhhhcccccC
Q 013636          302 SVTAGTQSRN---VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQ-SMVTWAMPQLTDR  376 (439)
Q Consensus       302 s~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~-~~~~~~~~~~~~~  376 (439)
                      +.........   ....++..|+|||.+.+..++.++|||||||++|||++ |..||......+.. ....   ...  .
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~---~~~--~  262 (302)
T cd05055         188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIK---EGY--R  262 (302)
T ss_pred             cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHH---cCC--c
Confidence            9765432211   11235678999999999999999999999999999998 99999765543211 1111   000  0


Q ss_pred             CCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhcccc
Q 013636          377 SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPL  427 (439)
Q Consensus       377 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l  427 (439)
                      ...+.            .....+.+++.+|++.+|++|||+.|+++.|+++
T Consensus       263 ~~~~~------------~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         263 MAQPE------------HAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             CCCCC------------CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            00001            1123577899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.1e-39  Score=312.18  Aligned_cols=251  Identities=24%  Similarity=0.348  Sum_probs=199.0

Q ss_pred             CCccceecccCcEEEEEEEEC-CccEEEEEEecCCCc---hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEe
Q 013636          155 FQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGH---DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       155 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      |+..+.||+|+||.||++... .+..+|+|.+.....   .....+.+|+.++++++|+|++++.+.+...+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            566789999999999999876 477899998864322   2234578899999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR  310 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~  310 (439)
                      +++|+|.+++... ....+++..+..++.|++.||.|||+.   +++||||||+||++++++.++|+|||++........
T Consensus        82 ~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05630          82 MNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT  157 (285)
T ss_pred             cCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence            9999999988642 224589999999999999999999997   999999999999999999999999999976543333


Q ss_pred             ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCc
Q 013636          311 NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDT  390 (439)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  390 (439)
                      .....|+..|+|||.+.+..++.++||||||+++|||++|+.||...................  ....+.        .
T Consensus       158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~--------~  227 (285)
T cd05630         158 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV--QEEYSE--------K  227 (285)
T ss_pred             ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh--hhhcCc--------c
Confidence            233468999999999999999999999999999999999999998653221111111000000  001111        1


Q ss_pred             cCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHh
Q 013636          391 MDLKHLYQVAAVAVLCIQPEPSYRPL-----ITDVLHS  423 (439)
Q Consensus       391 ~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~  423 (439)
                          ....+.+++..||+.||++|||     +.|++++
T Consensus       228 ----~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h  261 (285)
T cd05630         228 ----FSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH  261 (285)
T ss_pred             ----CCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence                1234667999999999999999     8899875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.1e-39  Score=325.79  Aligned_cols=261  Identities=25%  Similarity=0.410  Sum_probs=205.3

Q ss_pred             HHHHhcCCCccceecccCcEEEEEEEECC------ccEEEEEEecCCCch-HHHHHHHHHHHHHhcC-CCceeeeeeEEE
Q 013636          148 LEAATNNFQESNVIGEGGRGHVYKARFNE------KLLAAVKRIDDAGHD-AEREFNNEVNWLTKIR-HQNIISLLGYCI  219 (439)
Q Consensus       148 l~~~~~~~~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-h~niv~l~~~~~  219 (439)
                      ++...++|.+.+.||+|+||.||+|++.+      +..+|+|+++..... ....+.+|+.++.++. ||||++++++|.
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~  111 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT  111 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence            34445677788999999999999998643      457999999764333 3356889999999997 999999999999


Q ss_pred             eCCeeEEEEEeccCCChhhhhcCCCC------------------------------------------------------
Q 013636          220 HAETRFLVYEMMQNGSLEKQLHGPTH------------------------------------------------------  245 (439)
Q Consensus       220 ~~~~~~lV~e~~~~gsL~~~l~~~~~------------------------------------------------------  245 (439)
                      ..+..++|+||+++|+|.+++++...                                                      
T Consensus       112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (401)
T cd05107         112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP  191 (401)
T ss_pred             cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence            99999999999999999999975311                                                      


Q ss_pred             -----------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 013636          246 -----------------------------------------GSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSS  284 (439)
Q Consensus       246 -----------------------------------------~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~  284 (439)
                                                               ...+++..+.+++.|++.||+|||+.   +++||||||+
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~  268 (401)
T cd05107         192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAAR  268 (401)
T ss_pred             hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcc
Confidence                                                     12467888999999999999999987   9999999999


Q ss_pred             CEEEcCCCcEEEEecccccccCCCCc---ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChh
Q 013636          285 NILLDSSFNAKLSDFGLSVTAGTQSR---NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPT  360 (439)
Q Consensus       285 NiLl~~~~~~kl~DfGls~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~  360 (439)
                      |||+++++.+||+|||+++.......   .....++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus       269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~  348 (401)
T cd05107         269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN  348 (401)
T ss_pred             eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence            99999999999999999976432211   112346788999999999899999999999999999998 89999765432


Q ss_pred             hhh-hhHhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccC
Q 013636          361 QCQ-SMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLV  428 (439)
Q Consensus       361 ~~~-~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~  428 (439)
                      +.. ..+..     ..+...+.            .....+.+++..||+.+|++||+++|+++.|+.++
T Consensus       349 ~~~~~~~~~-----~~~~~~p~------------~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         349 EQFYNAIKR-----GYRMAKPA------------HASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             HHHHHHHHc-----CCCCCCCC------------CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            211 11110     00001111            11245778999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=2e-40  Score=323.84  Aligned_cols=251  Identities=21%  Similarity=0.265  Sum_probs=200.2

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC---chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      ++|++.+.||+|+||+||+++.. ++..+|+|.++...   ....+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            46888999999999999999875 57889999987532   233456889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~  308 (439)
                      ||+++|+|.+++...  ...+++..+..++.|++.||.|||+.   +++||||||+|||++.++++||+|||++......
T Consensus        81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            999999999999743  24689999999999999999999998   9999999999999999999999999999765443


Q ss_pred             Ccc--eeeccccCccchhhhc------CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCC
Q 013636          309 SRN--VKISGTLGYVAPEYLL------EGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLP  380 (439)
Q Consensus       309 ~~~--~~~~gt~~y~aPE~~~------~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  380 (439)
                      ...  ....||+.|+|||++.      ...++.++|||||||++|||++|+.||...+.......+...    ......+
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~----~~~~~~~  231 (330)
T cd05601         156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNF----QRFLKFP  231 (330)
T ss_pred             CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcC----CCccCCC
Confidence            222  2235899999999987      456788999999999999999999999876543322211100    0000111


Q ss_pred             ccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          381 NIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       381 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      ..  +        .....+.+++..|++ +|++|||+.+++.+
T Consensus       232 ~~--~--------~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         232 ED--P--------KVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             CC--C--------CCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence            10  0        112346678888998 99999999999865

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2.7e-39  Score=310.63  Aligned_cols=262  Identities=26%  Similarity=0.409  Sum_probs=203.9

Q ss_pred             hcCCCccceecccCcEEEEEEEECC-----------------ccEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCceee
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFNE-----------------KLLAAVKRIDDAG-HDAEREFNNEVNWLTKIRHQNIIS  213 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~  213 (439)
                      .++|++.+.||+|+||.||+++..+                 +..+|+|.+.... ......+.+|++++++++|||+++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            3578889999999999999997643                 2457899887543 234567899999999999999999


Q ss_pred             eeeEEEeCCeeEEEEEeccCCChhhhhcCCC--------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCC
Q 013636          214 LLGYCIHAETRFLVYEMMQNGSLEKQLHGPT--------HGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSN  285 (439)
Q Consensus       214 l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~N  285 (439)
                      +++++..++..++++||+++++|.+++....        ....+++..++.++.|++.||+|||+.   +++||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence            9999999999999999999999999996532        123689999999999999999999997   99999999999


Q ss_pred             EEEcCCCcEEEEecccccccCCCCc---ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh--CCCCCCCCChh
Q 013636          286 ILLDSSFNAKLSDFGLSVTAGTQSR---NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM--GRRPVEKMSPT  360 (439)
Q Consensus       286 iLl~~~~~~kl~DfGls~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt--G~~P~~~~~~~  360 (439)
                      |++++++.++|+|||++........   .....++..|+|||.+.+..++.++||||||+++|||++  |..||...+..
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ  240 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence            9999999999999999876433221   122335678999999998899999999999999999998  77888765543


Q ss_pred             hhhhhHhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccc
Q 013636          361 QCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIP  426 (439)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  426 (439)
                      +......   ......... ....      .......++.+++.+||+.||++|||+.++++.|++
T Consensus       241 ~~~~~~~---~~~~~~~~~-~~~~------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         241 QVIENAG---HFFRDDGRQ-IYLP------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             HHHHHHH---hcccccccc-ccCC------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence            3211111   000000000 0000      001122467889999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-39  Score=303.87  Aligned_cols=247  Identities=30%  Similarity=0.514  Sum_probs=203.6

Q ss_pred             ceecccCcEEEEEEEECC----ccEEEEEEecCCCchH-HHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEeccC
Q 013636          159 NVIGEGGRGHVYKARFNE----KLLAAVKRIDDAGHDA-EREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQN  233 (439)
Q Consensus       159 ~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  233 (439)
                      +.||+|+||.||++....    +..+++|.+....... .+.+.+|++.++.++|+|++++++++......++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            469999999999998864    7788999987654433 57899999999999999999999999999999999999999


Q ss_pred             CChhhhhcCCCC------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCC
Q 013636          234 GSLEKQLHGPTH------GSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT  307 (439)
Q Consensus       234 gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~  307 (439)
                      ++|.+++.....      ...+++..+..++.|+++|++|||+.   +++||||+|+||++++++.+||+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence            999999975311      36799999999999999999999997   999999999999999999999999999977654


Q ss_pred             CC---cceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCccC
Q 013636          308 QS---RNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV  383 (439)
Q Consensus       308 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  383 (439)
                      ..   ......++..|+|||.+....++.++||||+|+++|||++ |..||...+..+....+..     ......+.  
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~--  230 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK-----GYRLPKPE--  230 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-----CCCCCCCc--
Confidence            32   1223347889999999998899999999999999999999 6999988765443222211     00011111  


Q ss_pred             CchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhcc
Q 013636          384 DPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLI  425 (439)
Q Consensus       384 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  425 (439)
                                ....++.+++.+||+.+|++|||+.|++++|+
T Consensus       231 ----------~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         231 ----------YCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ----------cCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                      11346778999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=5.3e-40  Score=327.42  Aligned_cols=248  Identities=23%  Similarity=0.343  Sum_probs=193.7

Q ss_pred             CCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC---chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEE
Q 013636          154 NFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYE  229 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  229 (439)
                      .|+..+.||+|+||+||+|+.. .+..+|+|.+....   ......+.+|+.++++++||||+++++.+.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5778899999999999999875 46788999986532   2234568899999999999999999999999999999999


Q ss_pred             eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC-
Q 013636          230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ-  308 (439)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~-  308 (439)
                      |+++|+|.+++...   ..+++.....++.|++.||+|||+.   +|+||||||+|||++.++++||+|||++...... 
T Consensus        82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~  155 (382)
T cd05625          82 YIPGGDMMSLLIRM---GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (382)
T ss_pred             CCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence            99999999999642   3588899999999999999999998   9999999999999999999999999997432100 


Q ss_pred             -----------------------------------------------CcceeeccccCccchhhhcCCCCCCchhhHHHH
Q 013636          309 -----------------------------------------------SRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFG  341 (439)
Q Consensus       309 -----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G  341 (439)
                                                                     .......||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (382)
T cd05625         156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG  235 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence                                                           000123589999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCCChhhhhhhH-hhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCC---H
Q 013636          342 VVLLELLMGRRPVEKMSPTQCQSMV-TWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPL---I  417 (439)
Q Consensus       342 vll~elltG~~P~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt---~  417 (439)
                      |++|||++|+.||...++.+....+ .|.     .....+..      ...    .....+++.+|+ .+|++|++   +
T Consensus       236 vil~elltG~~Pf~~~~~~~~~~~i~~~~-----~~~~~p~~------~~~----s~~~~~li~~l~-~~p~~R~~~~~~  299 (382)
T cd05625         236 VILYEMLVGQPPFLAQTPLETQMKVINWQ-----TSLHIPPQ------AKL----SPEASDLIIKLC-RGPEDRLGKNGA  299 (382)
T ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHccC-----CCcCCCCc------ccC----CHHHHHHHHHHc-cCHhHcCCCCCH
Confidence            9999999999999877654332221 111     01111100      011    123444555555 49999987   8


Q ss_pred             HHHHHh
Q 013636          418 TDVLHS  423 (439)
Q Consensus       418 ~evl~~  423 (439)
                      .+++++
T Consensus       300 ~ei~~h  305 (382)
T cd05625         300 DEIKAH  305 (382)
T ss_pred             HHHhcC
Confidence            888764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.1e-39  Score=315.39  Aligned_cols=259  Identities=25%  Similarity=0.407  Sum_probs=206.6

Q ss_pred             hcCCCccceecccCcEEEEEEEECC--------ccEEEEEEecCCC-chHHHHHHHHHHHHHhc-CCCceeeeeeEEEeC
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFNE--------KLLAAVKRIDDAG-HDAEREFNNEVNWLTKI-RHQNIISLLGYCIHA  221 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  221 (439)
                      .++|.+.+.||+|+||.||+++..+        ...+|+|.+.... .....++.+|+.+++++ +||||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            4678889999999999999997532        3468999887542 33445788999999999 799999999999999


Q ss_pred             CeeEEEEEeccCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE
Q 013636          222 ETRFLVYEMMQNGSLEKQLHGPTH-------------GSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILL  288 (439)
Q Consensus       222 ~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl  288 (439)
                      +..++||||+++|+|.+++.....             ...+++..+++++.|++.||+|||+.   +++||||||+||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEE
Confidence            999999999999999999975321             23589999999999999999999997   99999999999999


Q ss_pred             cCCCcEEEEecccccccCCCCcc---eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhh
Q 013636          289 DSSFNAKLSDFGLSVTAGTQSRN---VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQS  364 (439)
Q Consensus       289 ~~~~~~kl~DfGls~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~  364 (439)
                      +.++.+||+|||++.........   ....++..|+|||.+.+..++.++|||||||++|||++ |..||...+..+...
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~  253 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK  253 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence            99999999999998755332111   11124568999999999999999999999999999998 899997765544332


Q ss_pred             hHhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCC
Q 013636          365 MVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPT  430 (439)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~  430 (439)
                      .+...     .....+.            .....+.+++.+||+.+|++|||+.++++.|+++.+.
T Consensus       254 ~~~~~-----~~~~~~~------------~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~  302 (307)
T cd05098         254 LLKEG-----HRMDKPS------------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL  302 (307)
T ss_pred             HHHcC-----CCCCCCC------------cCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence            22210     0001111            1134667799999999999999999999999987764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=2.5e-39  Score=304.37  Aligned_cols=249  Identities=29%  Similarity=0.430  Sum_probs=199.8

Q ss_pred             cCCCccceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEE-eCCeeEEEEEec
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCI-HAETRFLVYEMM  231 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lV~e~~  231 (439)
                      ++|++.+.||+|+||.||++... +..+++|......  ..+.+.+|+.++++++|+|++++++++. .++..++++||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            46778899999999999999876 5567888886532  3457899999999999999999999765 456789999999


Q ss_pred             cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCcc
Q 013636          232 QNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN  311 (439)
Q Consensus       232 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~~  311 (439)
                      ++|+|.+++... ....+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||++........ 
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~-  157 (256)
T cd05082          83 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-  157 (256)
T ss_pred             CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccCC-
Confidence            999999998742 234588999999999999999999998   999999999999999999999999999875433222 


Q ss_pred             eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCc
Q 013636          312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDT  390 (439)
Q Consensus       312 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  390 (439)
                       ...++..|+|||.+.+..++.++||||||+++|||++ |+.||...+..+....+..   .  .....+.         
T Consensus       158 -~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~---~--~~~~~~~---------  222 (256)
T cd05082         158 -TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK---G--YKMDAPD---------  222 (256)
T ss_pred             -CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc---C--CCCCCCC---------
Confidence             2234568999999999899999999999999999997 9999986654332222210   0  0111111         


Q ss_pred             cCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhcccc
Q 013636          391 MDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPL  427 (439)
Q Consensus       391 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l  427 (439)
                         .....+.+++.+||+.+|++|||+.++++.|+++
T Consensus       223 ---~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         223 ---GCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             ---CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence               1134567799999999999999999999998764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=3.3e-40  Score=328.16  Aligned_cols=248  Identities=23%  Similarity=0.337  Sum_probs=195.7

Q ss_pred             CCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC---chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEE
Q 013636          154 NFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYE  229 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  229 (439)
                      +|++.+.||+|+||.||+++.. .+..+|+|.+....   ......+.+|++++++++||||+++++.+.+.+..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            6888999999999999999875 47889999986432   1233567899999999999999999999999999999999


Q ss_pred             eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC-
Q 013636          230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ-  308 (439)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~-  308 (439)
                      |+++|+|.+++..   ...+++.....++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++...... 
T Consensus        82 ~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~  155 (376)
T cd05598          82 YIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (376)
T ss_pred             CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence            9999999999964   24588889999999999999999998   9999999999999999999999999997422100 


Q ss_pred             -------------------------------------------CcceeeccccCccchhhhcCCCCCCchhhHHHHHHHH
Q 013636          309 -------------------------------------------SRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLL  345 (439)
Q Consensus       309 -------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~  345 (439)
                                                                 .......||+.|+|||++.+..++.++|||||||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily  235 (376)
T cd05598         156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY  235 (376)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence                                                       0001235899999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCChhhhhhhH-hhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCC---CHHHHH
Q 013636          346 ELLMGRRPVEKMSPTQCQSMV-TWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRP---LITDVL  421 (439)
Q Consensus       346 elltG~~P~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP---t~~evl  421 (439)
                      ||++|+.||...++.+....+ .|.     .....+.      ....    ...+.+++.+|+ .+|++|+   ++.+++
T Consensus       236 ell~G~~Pf~~~~~~~~~~~i~~~~-----~~~~~~~------~~~~----s~~~~~li~~l~-~~p~~R~~~~t~~ell  299 (376)
T cd05598         236 EMLVGQPPFLADTPAETQLKVINWE-----TTLHIPS------QAKL----SREASDLILRLC-CGAEDRLGKNGADEIK  299 (376)
T ss_pred             ehhhCCCCCCCCCHHHHHHHHhccC-----ccccCCC------CCCC----CHHHHHHHHHHh-cCHhhcCCCCCHHHHh
Confidence            999999999887654432222 111     0001110      0111    123445666665 4999999   899999


Q ss_pred             Hh
Q 013636          422 HS  423 (439)
Q Consensus       422 ~~  423 (439)
                      ++
T Consensus       300 ~h  301 (376)
T cd05598         300 AH  301 (376)
T ss_pred             CC
Confidence            76

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=7.3e-40  Score=319.56  Aligned_cols=247  Identities=22%  Similarity=0.345  Sum_probs=192.9

Q ss_pred             ceecccCcEEEEEEEECC-ccEEEEEEecCCC---chHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeeEEEEEeccC
Q 013636          159 NVIGEGGRGHVYKARFNE-KLLAAVKRIDDAG---HDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMMQN  233 (439)
Q Consensus       159 ~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~  233 (439)
                      +.||+|+||+||+++... +..+|+|.+....   ....+.+.+|..++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            469999999999998754 6788999987532   22335678899999888 699999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccC-CCCcce
Q 013636          234 GSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAG-TQSRNV  312 (439)
Q Consensus       234 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~-~~~~~~  312 (439)
                      |+|..++..   ...+++..+..++.|++.||+|||+.   +++||||||+|||+++++.+||+|||++.... ......
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (327)
T cd05617          81 GDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTS  154 (327)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCcee
Confidence            999988853   24589999999999999999999998   99999999999999999999999999987532 222233


Q ss_pred             eeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhccc-ccCCCCCccCCchhcCcc
Q 013636          313 KISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQL-TDRSKLPNIVDPVIRDTM  391 (439)
Q Consensus       313 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~d~~l~~~~  391 (439)
                      ...||+.|+|||.+.+..++.++|||||||++|||++|+.||.............+..... .....++..++       
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~-------  227 (327)
T cd05617         155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLS-------  227 (327)
T ss_pred             cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCC-------
Confidence            4569999999999999999999999999999999999999996533211111111111111 11112222222       


Q ss_pred             CHHHHHHHHHHHHHhcCCCCCCCCCH------HHHHHh
Q 013636          392 DLKHLYQVAAVAVLCIQPEPSYRPLI------TDVLHS  423 (439)
Q Consensus       392 ~~~~~~~l~~l~~~cl~~dP~~RPt~------~evl~~  423 (439)
                           ..+.+++.+||+.||++||++      .+++++
T Consensus       228 -----~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  260 (327)
T cd05617         228 -----VKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH  260 (327)
T ss_pred             -----HHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence                 245678999999999999984      566654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-39  Score=304.88  Aligned_cols=254  Identities=26%  Similarity=0.433  Sum_probs=207.0

Q ss_pred             HhcCCCccceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEe
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      ..++|++.+.||+|+||.||+|..+++..+++|.+.... ....++.+|+.++++++|+|++++++++......++||||
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY   82 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence            346788899999999999999998888889999987543 3446789999999999999999999999988999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR  310 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~  310 (439)
                      +++++|.+++... .+..+++..+..++.|++.|++|||+.   +++|+||||+||++++++.+||+|||++........
T Consensus        83 ~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (261)
T cd05034          83 MSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY  158 (261)
T ss_pred             cCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence            9999999999752 235689999999999999999999998   999999999999999999999999999876543211


Q ss_pred             c--eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchh
Q 013636          311 N--VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVI  387 (439)
Q Consensus       311 ~--~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  387 (439)
                      .  ....++..|+|||.+.+..++.++|+||||+++||+++ |+.||...+.........   ...  ....+.      
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~---~~~--~~~~~~------  227 (261)
T cd05034         159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE---RGY--RMPRPP------  227 (261)
T ss_pred             hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---cCC--CCCCCC------
Confidence            1  11224568999999998899999999999999999998 999997665433221111   000  000000      


Q ss_pred             cCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccc
Q 013636          388 RDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIP  426 (439)
Q Consensus       388 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  426 (439)
                            .....+.+++.+|++.+|++||+++++.+.|+.
T Consensus       228 ------~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         228 ------NCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             ------CCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence                  113357789999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.3e-39  Score=308.51  Aligned_cols=252  Identities=27%  Similarity=0.462  Sum_probs=202.1

Q ss_pred             CCCccceecccCcEEEEEEEECC----ccEEEEEEecCC-CchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEE
Q 013636          154 NFQESNVIGEGGRGHVYKARFNE----KLLAAVKRIDDA-GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      .|++.+.||+|+||.||+|....    ...+++|.+... ......+|..|+.+++.++|||++++++++..++..++||
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   84 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT   84 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence            46778999999999999998753    246899998754 2334568999999999999999999999999999999999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~  308 (439)
                      ||+++|+|.+++...  ...+++..+..++.|++.|++|||+.   +++|+||||+||+++.++.+||+|||++......
T Consensus        85 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  159 (269)
T cd05065          85 EFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  159 (269)
T ss_pred             ecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccC
Confidence            999999999999742  34689999999999999999999998   9999999999999999999999999998755432


Q ss_pred             Cccee----ec--cccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCc
Q 013636          309 SRNVK----IS--GTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPN  381 (439)
Q Consensus       309 ~~~~~----~~--gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  381 (439)
                      .....    ..  .+..|+|||.+.+..++.++||||||+++||+++ |..||...+.......+.   .    ....+.
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~---~----~~~~~~  232 (269)
T cd05065         160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE---Q----DYRLPP  232 (269)
T ss_pred             ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHH---c----CCcCCC
Confidence            22111    11  1357999999999999999999999999999886 999998765543222221   0    111110


Q ss_pred             cCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhcccc
Q 013636          382 IVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPL  427 (439)
Q Consensus       382 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l  427 (439)
                      .          .+....+.+++..||+.+|++||++.+++..|+.+
T Consensus       233 ~----------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         233 P----------MDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             c----------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            0          11234567899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1e-39  Score=315.18  Aligned_cols=261  Identities=25%  Similarity=0.418  Sum_probs=208.0

Q ss_pred             HhcCCCccceecccCcEEEEEEEEC--------CccEEEEEEecCCC-chHHHHHHHHHHHHHhc-CCCceeeeeeEEEe
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARFN--------EKLLAAVKRIDDAG-HDAEREFNNEVNWLTKI-RHQNIISLLGYCIH  220 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  220 (439)
                      ..++|++.+.||+|+||.||+++..        ++..+++|...... ....+.+.+|+.+++.+ +||||+++++++..
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   92 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   92 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence            3467788899999999999999742        24578899886532 33456789999999999 89999999999999


Q ss_pred             CCeeEEEEEeccCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEE
Q 013636          221 AETRFLVYEMMQNGSLEKQLHGPT-------------HGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNIL  287 (439)
Q Consensus       221 ~~~~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiL  287 (439)
                      ....+++|||+++|+|.+++....             ....+++..+..++.|++.||+|||+.   +++||||||+||+
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nil  169 (304)
T cd05101          93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVL  169 (304)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEE
Confidence            999999999999999999997532             123588999999999999999999998   9999999999999


Q ss_pred             EcCCCcEEEEecccccccCCCCcc---eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhh
Q 013636          288 LDSSFNAKLSDFGLSVTAGTQSRN---VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQ  363 (439)
Q Consensus       288 l~~~~~~kl~DfGls~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~  363 (439)
                      +++++.+||+|||++.........   ....++..|+|||.+.+..++.++||||||+++|||++ |..||...+..+..
T Consensus       170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~  249 (304)
T cd05101         170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF  249 (304)
T ss_pred             EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH
Confidence            999999999999999765432221   11235678999999999899999999999999999998 88899776654433


Q ss_pred             hhHhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCCC
Q 013636          364 SMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPTD  431 (439)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~~  431 (439)
                      ..+..       .... ..         .......+.+++.+||+.+|++|||+.|+++.|+++....
T Consensus       250 ~~~~~-------~~~~-~~---------~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~  300 (304)
T cd05101         250 KLLKE-------GHRM-DK---------PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT  300 (304)
T ss_pred             HHHHc-------CCcC-CC---------CCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence            32211       1100 00         0112346777999999999999999999999998876543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.8e-39  Score=307.40  Aligned_cols=253  Identities=28%  Similarity=0.444  Sum_probs=203.4

Q ss_pred             cCCCccceecccCcEEEEEEEEC----CccEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN----EKLLAAVKRIDDAG-HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLV  227 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  227 (439)
                      ++|++.+.||+|+||.||+|...    ....+++|.++... ....+.+.+|+.++++++||||+++++++..++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            46778899999999999999863    23478899886543 23346789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCC
Q 013636          228 YEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT  307 (439)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~  307 (439)
                      |||+++|+|.+++...  ...+++..+..++.|++.|++|||+.   +++||||||+||++++++.++|+|||++.....
T Consensus        84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence            9999999999999742  34689999999999999999999998   999999999999999999999999999976543


Q ss_pred             CCcce----eeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCcc
Q 013636          308 QSRNV----KISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNI  382 (439)
Q Consensus       308 ~~~~~----~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  382 (439)
                      .....    ...++..|+|||.+.+..++.++|+||||+++||+++ |..||......+....+.       +....+. 
T Consensus       159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~-------~~~~~~~-  230 (267)
T cd05066         159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIE-------EGYRLPA-  230 (267)
T ss_pred             ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHh-------CCCcCCC-
Confidence            32211    1113467999999999899999999999999999887 999998765443222111       0111110 


Q ss_pred             CCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhcccc
Q 013636          383 VDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPL  427 (439)
Q Consensus       383 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l  427 (439)
                               .......+.+++.+|++.+|++||++.++++.|+++
T Consensus       231 ---------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         231 ---------PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             ---------CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                     001134567899999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=3.4e-39  Score=304.24  Aligned_cols=251  Identities=26%  Similarity=0.430  Sum_probs=202.5

Q ss_pred             cCCCccceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEecc
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQ  232 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  232 (439)
                      ++|++.+.||+|+||.||++...++..+++|.+.... ...+.+.+|+.++++++|+|++++++++. .+..+++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence            5677889999999999999998887788999876533 33467889999999999999999998875 456899999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCcc-
Q 013636          233 NGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN-  311 (439)
Q Consensus       233 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~~-  311 (439)
                      +|+|.++++.. ....+++..+..++.|++.||+|||+.   +++|+||||+||++++++.++|+|||++......... 
T Consensus        84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~  159 (260)
T cd05069          84 KGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA  159 (260)
T ss_pred             CCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence            99999999753 234589999999999999999999998   9999999999999999999999999999765432211 


Q ss_pred             -eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcC
Q 013636          312 -VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRD  389 (439)
Q Consensus       312 -~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  389 (439)
                       ....++..|+|||.+.+..++.++||||||+++|||++ |+.||....+.+......       .....+  .      
T Consensus       160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-------~~~~~~--~------  224 (260)
T cd05069         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE-------RGYRMP--C------  224 (260)
T ss_pred             cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------cCCCCC--C------
Confidence             12235678999999998999999999999999999999 999998765443222111       111100  0      


Q ss_pred             ccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccc
Q 013636          390 TMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIP  426 (439)
Q Consensus       390 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  426 (439)
                        .......+.+++.+||+.||++||+++++++.|+.
T Consensus       225 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         225 --PQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             --CcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence              01123467789999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=3.2e-39  Score=306.00  Aligned_cols=250  Identities=25%  Similarity=0.362  Sum_probs=191.6

Q ss_pred             eecccCcEEEEEEEECC---ccEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEeccCCC
Q 013636          160 VIGEGGRGHVYKARFNE---KLLAAVKRIDDAGH-DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGS  235 (439)
Q Consensus       160 ~LG~G~fg~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  235 (439)
                      .||+|+||.||+|...+   ...+++|.++.... .....+.+|+.++++++|||++++++++.+....++||||+++|+
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD   81 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence            58999999999998754   35688888865432 344578999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCcc--
Q 013636          236 LEKQLHGPT--HGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN--  311 (439)
Q Consensus       236 L~~~l~~~~--~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~~--  311 (439)
                      |.++++...  .....++..+..++.|++.|++|||+.   +++|+||||+||++++++++||+|||++.........  
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~  158 (269)
T cd05087          82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT  158 (269)
T ss_pred             HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence            999997532  223567788889999999999999998   9999999999999999999999999998654332211  


Q ss_pred             -eeeccccCccchhhhcCC-------CCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCcc
Q 013636          312 -VKISGTLGYVAPEYLLEG-------KLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNI  382 (439)
Q Consensus       312 -~~~~gt~~y~aPE~~~~~-------~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  382 (439)
                       ....++..|+|||++.+.       .++.++||||||+++|||++ |+.||....+.+......        .......
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~--------~~~~~~~  230 (269)
T cd05087         159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTV--------REQQLKL  230 (269)
T ss_pred             CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHh--------hcccCCC
Confidence             123467889999998642       35789999999999999996 999998765543222111        0011111


Q ss_pred             CCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhcc
Q 013636          383 VDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLI  425 (439)
Q Consensus       383 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  425 (439)
                      .++.+....    ...+.+++..|+ .+|++|||++||+..|+
T Consensus       231 ~~~~~~~~~----~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         231 PKPRLKLPL----SDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCccCCCC----ChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            222222111    224566888898 58999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2.7e-39  Score=311.09  Aligned_cols=249  Identities=22%  Similarity=0.375  Sum_probs=203.2

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEec
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMM  231 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  231 (439)
                      .+|+..+.||+|+||.||+|... ++..+++|.+..........+.+|+.+++.++|+|++++++.+......++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            57888899999999999999864 57889999887665555677899999999999999999999999999999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc-
Q 013636          232 QNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR-  310 (439)
Q Consensus       232 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~-  310 (439)
                      ++++|.+++..    ..+++.++..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++........ 
T Consensus       100 ~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~  172 (296)
T cd06654         100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  172 (296)
T ss_pred             CCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccccc
Confidence            99999999863    2478999999999999999999998   999999999999999999999999999876433221 


Q ss_pred             ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCc
Q 013636          311 NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDT  390 (439)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  390 (439)
                      .....+++.|+|||.+.+..++.++|||||||++|||++|+.||...++......  ...    ..  .+..-.+     
T Consensus       173 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~--~~~----~~--~~~~~~~-----  239 (296)
T cd06654         173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL--IAT----NG--TPELQNP-----  239 (296)
T ss_pred             cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHH--Hhc----CC--CCCCCCc-----
Confidence            1234588999999999998899999999999999999999999987654321111  100    00  0000000     


Q ss_pred             cCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          391 MDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       391 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                        ......+.+++.+||+.||++||++.+++++
T Consensus       240 --~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         240 --EKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             --cccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence              1112356779999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.2e-39  Score=304.25  Aligned_cols=249  Identities=27%  Similarity=0.421  Sum_probs=203.9

Q ss_pred             cCCCccceecccCcEEEEEEEECC-ccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEec
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMM  231 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  231 (439)
                      ++|+..+.||+|+||.||+|...+ +..+++|.+.....  ..++.+|++++++++|||++++++++......++++||+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~   80 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC   80 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence            578888999999999999999876 67889998865422  678999999999999999999999999999999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCC-c
Q 013636          232 QNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS-R  310 (439)
Q Consensus       232 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~-~  310 (439)
                      ++++|.+++..  .+..+++..+..++.|++.|+.|||+.   +++|+||+|+||++++++.++|+|||++....... .
T Consensus        81 ~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~  155 (256)
T cd06612          81 GAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK  155 (256)
T ss_pred             CCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCccc
Confidence            99999999863  235689999999999999999999998   99999999999999999999999999987654433 2


Q ss_pred             ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCc
Q 013636          311 NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDT  390 (439)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  390 (439)
                      .....++..|+|||.+.+..++.++||||||+++|||++|+.||...++........        .......-.      
T Consensus       156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~--------~~~~~~~~~------  221 (256)
T cd06612         156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIP--------NKPPPTLSD------  221 (256)
T ss_pred             cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhc--------cCCCCCCCc------
Confidence            223447889999999999999999999999999999999999998655432211110        000000000      


Q ss_pred             cCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          391 MDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       391 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                       .......+.+++.+||+.||++|||+.|++++
T Consensus       222 -~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         222 -PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             -hhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence             11122457789999999999999999999874

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=3.5e-39  Score=303.30  Aligned_cols=246  Identities=26%  Similarity=0.413  Sum_probs=199.9

Q ss_pred             ceecccCcEEEEEEEECC----ccEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEeccC
Q 013636          159 NVIGEGGRGHVYKARFNE----KLLAAVKRIDDAGH-DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQN  233 (439)
Q Consensus       159 ~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  233 (439)
                      +.||+|++|.||+|.+.+    ...+|+|.+..... ...+.+.+|+..+++++|||++++++.+.. ...++|+||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            368999999999998754    23689999987655 556789999999999999999999999988 889999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCcc--
Q 013636          234 GSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN--  311 (439)
Q Consensus       234 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~~--  311 (439)
                      |+|.+++..... ..+++.....++.|++.||+|||+.   +++|+||+|+||+++.++.+||+|||++.........  
T Consensus        80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            999999975332 5689999999999999999999998   9999999999999999999999999999766442211  


Q ss_pred             --eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhc
Q 013636          312 --VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIR  388 (439)
Q Consensus       312 --~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  388 (439)
                        ....++..|+|||.+.+..++.++||||||+++|||++ |+.||...+..+....+...    ......+        
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~----~~~~~~~--------  223 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKE----GERLERP--------  223 (257)
T ss_pred             cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc----CCcCCCC--------
Confidence              12346778999999999999999999999999999998 99999876654432222110    0000000        


Q ss_pred             CccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhcc
Q 013636          389 DTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLI  425 (439)
Q Consensus       389 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  425 (439)
                          ......+.+++.+|++.+|++||++.++++.|.
T Consensus       224 ----~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         224 ----EACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             ----ccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence                011346778999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-39  Score=304.49  Aligned_cols=250  Identities=26%  Similarity=0.377  Sum_probs=200.4

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCc-----hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGH-----DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFL  226 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  226 (439)
                      ++|+..+.||+|++|.||++... ++..+++|.+.....     .....+.+|++++++++||||+++++++...+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            57888999999999999999874 578899998764321     123468899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccC
Q 013636          227 VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAG  306 (439)
Q Consensus       227 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~  306 (439)
                      |+||+++++|.+++..   ...+++.....++.|++.|++|||+.   +++||||+|+||+++++++++|+|||++....
T Consensus        82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            9999999999999864   24588999999999999999999998   99999999999999999999999999986543


Q ss_pred             CCCcc----eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCcc
Q 013636          307 TQSRN----VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNI  382 (439)
Q Consensus       307 ~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  382 (439)
                      .....    ....++..|+|||.+.+..++.++||||+|+++|||++|+.||...+.........    .......++..
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~----~~~~~~~~~~~  231 (263)
T cd06625         156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA----TQPTNPQLPSH  231 (263)
T ss_pred             ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHh----ccCCCCCCCcc
Confidence            32111    12347789999999999899999999999999999999999997654332111110    00111111111


Q ss_pred             CCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhc
Q 013636          383 VDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL  424 (439)
Q Consensus       383 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  424 (439)
                                  ....+.+++.+||+.+|++|||+.+++++.
T Consensus       232 ------------~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~  261 (263)
T cd06625         232 ------------VSPDARNFLRRTFVENAKKRPSAEELLRHF  261 (263)
T ss_pred             ------------CCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence                        123466799999999999999999999763

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=3e-39  Score=308.32  Aligned_cols=250  Identities=26%  Similarity=0.418  Sum_probs=199.8

Q ss_pred             CCccceecccCcEEEEEEEECC-ccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEeccC
Q 013636          155 FQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQN  233 (439)
Q Consensus       155 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  233 (439)
                      |++.+.||+|+||.||++.... +..+++|.+........+.+.+|+++++.++|||++++++++...+..++|+||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            5567889999999999998865 667788888766555667789999999999999999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCC-cce
Q 013636          234 GSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS-RNV  312 (439)
Q Consensus       234 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~-~~~  312 (439)
                      |+|..++.+  ....+++..+..++.|+++||+|||+.   +++||||||+||+++.++.+||+|||++....... ...
T Consensus        87 ~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~  161 (282)
T cd06643          87 GAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD  161 (282)
T ss_pred             CcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccccccc
Confidence            999998864  234689999999999999999999998   99999999999999999999999999986543321 122


Q ss_pred             eeccccCccchhhhc-----CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchh
Q 013636          313 KISGTLGYVAPEYLL-----EGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVI  387 (439)
Q Consensus       313 ~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  387 (439)
                      ...++..|+|||.+.     +..++.++|||||||++|||++|+.||...++.+......  .      ...+....+  
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~--~------~~~~~~~~~--  231 (282)
T cd06643         162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIA--K------SEPPTLAQP--  231 (282)
T ss_pred             cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHh--h------cCCCCCCCc--
Confidence            345889999999984     3457789999999999999999999998765433211111  0      000000011  


Q ss_pred             cCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhc
Q 013636          388 RDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL  424 (439)
Q Consensus       388 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  424 (439)
                       .    .....+.+++.+||+.||++||++.+++++-
T Consensus       232 -~----~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  263 (282)
T cd06643         232 -S----RWSSEFKDFLKKCLEKNVDARWTTTQLLQHP  263 (282)
T ss_pred             -c----ccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence             0    1123567899999999999999999999764

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2.2e-39  Score=320.25  Aligned_cols=265  Identities=25%  Similarity=0.313  Sum_probs=199.1

Q ss_pred             HhcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCC--CchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC-----
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDA--GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE-----  222 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  222 (439)
                      ..++|+..+.||+|+||.||++... .+..+|+|.+...  .......+.+|+.+++.++||||+++++++...+     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            3478999999999999999999875 4788999998643  2234457889999999999999999999986543     


Q ss_pred             -eeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccc
Q 013636          223 -TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGL  301 (439)
Q Consensus       223 -~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGl  301 (439)
                       ..++||||+++ +|.+.++.     .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~  169 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  169 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCC
Confidence             46999999975 66666642     378889999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhH-h-------------
Q 013636          302 SVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMV-T-------------  367 (439)
Q Consensus       302 s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~-~-------------  367 (439)
                      +.............||+.|+|||.+.+..++.++|||||||++|||++|+.||...+........ .             
T Consensus       170 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (359)
T cd07876         170 ARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL  249 (359)
T ss_pred             ccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence            97654433333456899999999999999999999999999999999999999866532211000 0             


Q ss_pred             --hhhcccccCCCCC-----ccCCchhc---CccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhc
Q 013636          368 --WAMPQLTDRSKLP-----NIVDPVIR---DTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL  424 (439)
Q Consensus       368 --~~~~~~~~~~~~~-----~~~d~~l~---~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  424 (439)
                        ............+     +.......   ..........+.+++.+||+.||++|||+.|++++-
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp  316 (359)
T cd07876         250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP  316 (359)
T ss_pred             HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence              0000000011110     00000000   000111234577899999999999999999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.4e-39  Score=314.97  Aligned_cols=264  Identities=22%  Similarity=0.334  Sum_probs=199.3

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEe
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGH-DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      ++|+..+.||+|+||+||+|+.. .+..+|+|.++.... .....+.+|+.++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            56888899999999999999875 467889998864332 2334678899999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR  310 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~  310 (439)
                      +++ +|.+++...  +..+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||++........
T Consensus        86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  159 (309)
T cd07872          86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK  159 (309)
T ss_pred             CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence            985 888887642  34588999999999999999999998   999999999999999999999999999875433222


Q ss_pred             -ceeeccccCccchhhhcC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcc--------cccC----
Q 013636          311 -NVKISGTLGYVAPEYLLE-GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQ--------LTDR----  376 (439)
Q Consensus       311 -~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~--------~~~~----  376 (439)
                       .....+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||...+..+.........+.        ....    
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
T cd07872         160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK  239 (309)
T ss_pred             ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence             123357899999999865 46889999999999999999999999876654332222111110        0000    


Q ss_pred             -CCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          377 -SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       377 -~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                       ...+......... ........+.+++.+|++.||++|||+.|++++
T Consensus       240 ~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  286 (309)
T cd07872         240 NYNFPKYKPQPLIN-HAPRLDTEGIELLTKFLQYESKKRISAEEAMKH  286 (309)
T ss_pred             hhhcCccCCCchhh-hccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence             0000000000000 000112356789999999999999999999974

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=9.6e-40  Score=318.18  Aligned_cols=240  Identities=25%  Similarity=0.341  Sum_probs=190.5

Q ss_pred             ceecccCcEEEEEEEEC-CccEEEEEEecCCC---chHHHHHHHHHH-HHHhcCCCceeeeeeEEEeCCeeEEEEEeccC
Q 013636          159 NVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG---HDAEREFNNEVN-WLTKIRHQNIISLLGYCIHAETRFLVYEMMQN  233 (439)
Q Consensus       159 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  233 (439)
                      +.||+|+||+||+|+.. ++..+|+|.+....   .....++.+|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999885 57889999986432   122334555544 56789999999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCC-CCcce
Q 013636          234 GSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT-QSRNV  312 (439)
Q Consensus       234 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~-~~~~~  312 (439)
                      |+|.+++..   ...+++..+..++.|++.||+|||+.   +++||||||+|||+++++.+||+|||++..... .....
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (323)
T cd05575          81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTS  154 (323)
T ss_pred             CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccc
Confidence            999999864   34688999999999999999999998   999999999999999999999999999865322 22223


Q ss_pred             eeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCccC
Q 013636          313 KISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMD  392 (439)
Q Consensus       313 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  392 (439)
                      ...||+.|+|||.+.+..++.++|||||||++|||++|+.||...+..+....+.      .....++.        .. 
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~------~~~~~~~~--------~~-  219 (323)
T cd05575         155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNIL------NKPLRLKP--------NI-  219 (323)
T ss_pred             cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHH------cCCCCCCC--------CC-
Confidence            4568999999999999999999999999999999999999998765543222211      01111111        11 


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCHH----HHHH
Q 013636          393 LKHLYQVAAVAVLCIQPEPSYRPLIT----DVLH  422 (439)
Q Consensus       393 ~~~~~~l~~l~~~cl~~dP~~RPt~~----evl~  422 (439)
                         ...+.+++.+||+.||++||++.    ++++
T Consensus       220 ---~~~~~~li~~~l~~~p~~R~~~~~~~~~il~  250 (323)
T cd05575         220 ---SVSARHLLEGLLQKDRTKRLGAKDDFLEIKN  250 (323)
T ss_pred             ---CHHHHHHHHHHhhcCHHhCCCCCCCHHHHHc
Confidence               23566799999999999999984    6554

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-40  Score=313.85  Aligned_cols=256  Identities=26%  Similarity=0.328  Sum_probs=200.1

Q ss_pred             HhcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCc--------------hHHHHHHHHHHHHHhcCCCceeeee
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGH--------------DAEREFNNEVNWLTKIRHQNIISLL  215 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~l~  215 (439)
                      .-++|++.+.||+|.||.|-+|+.. ++..+|+|.+.+...              ...+...+|+.+|++++|||||+|+
T Consensus        95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li  174 (576)
T KOG0585|consen   95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI  174 (576)
T ss_pred             ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence            3478999999999999999999875 588999999865321              1224688999999999999999999


Q ss_pred             eEEEeC--CeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCc
Q 013636          216 GYCIHA--ETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFN  293 (439)
Q Consensus       216 ~~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~  293 (439)
                      .+..+.  +..|||+|||..|.+...=   .....++..+..+++.++..||+|||.+   +|+||||||+|+||+++|+
T Consensus       175 EvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~  248 (576)
T KOG0585|consen  175 EVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGT  248 (576)
T ss_pred             EeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCc
Confidence            998754  5789999999998875432   2223389999999999999999999999   9999999999999999999


Q ss_pred             EEEEecccccccCCC------CcceeeccccCccchhhhcCCC----CCCchhhHHHHHHHHHHHhCCCCCCCCChhhhh
Q 013636          294 AKLSDFGLSVTAGTQ------SRNVKISGTLGYVAPEYLLEGK----LTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQ  363 (439)
Q Consensus       294 ~kl~DfGls~~~~~~------~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~  363 (439)
                      +||+|||.+......      .......|||.|+|||.+.++.    .+.+.||||+||+||-|+.|+.||-+...-+..
T Consensus       249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~  328 (576)
T KOG0585|consen  249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELF  328 (576)
T ss_pred             EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHH
Confidence            999999999755221      1123456999999999998743    345889999999999999999999876543332


Q ss_pred             hhHhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccC
Q 013636          364 SMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLV  428 (439)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~  428 (439)
                      ..+..      +.-.+++          ..+....+.+++.++|++||+.|.+..+|..|..-..
T Consensus       329 ~KIvn------~pL~fP~----------~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~  377 (576)
T KOG0585|consen  329 DKIVN------DPLEFPE----------NPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR  377 (576)
T ss_pred             HHHhc------CcccCCC----------cccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence            22211      1111111          1123445667999999999999999999987765433

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=9.7e-40  Score=323.75  Aligned_cols=253  Identities=20%  Similarity=0.282  Sum_probs=198.3

Q ss_pred             HHhcCCCccceecccCcEEEEEEEECC-ccEEEEEEecCC---CchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeE
Q 013636          150 AATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDA---GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRF  225 (439)
Q Consensus       150 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  225 (439)
                      ...++|++.+.||+|+||.||+++... +..+|+|.+...   .......+.+|+.+++.++||||+++++++.+.+..+
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~  119 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY  119 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence            445789999999999999999999864 678899988642   1223456889999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccccccc
Q 013636          226 LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA  305 (439)
Q Consensus       226 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~  305 (439)
                      +||||+++|+|.+++...    .+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+||+|||++...
T Consensus       120 lv~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~  192 (370)
T cd05621         120 MVMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKM  192 (370)
T ss_pred             EEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceec
Confidence            999999999999998642    478899999999999999999998   9999999999999999999999999999765


Q ss_pred             CCCCc--ceeeccccCccchhhhcCC----CCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCC
Q 013636          306 GTQSR--NVKISGTLGYVAPEYLLEG----KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKL  379 (439)
Q Consensus       306 ~~~~~--~~~~~gt~~y~aPE~~~~~----~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  379 (439)
                      .....  .....||+.|+|||++.+.    .++.++||||+||++|||++|+.||...+.......+...    ......
T Consensus       193 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~----~~~~~~  268 (370)
T cd05621         193 DETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDH----KNSLNF  268 (370)
T ss_pred             ccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhC----CcccCC
Confidence            43222  1234699999999999764    3788999999999999999999999876543322211100    000111


Q ss_pred             CccCCchhcCccCHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHh
Q 013636          380 PNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSY--RPLITDVLHS  423 (439)
Q Consensus       380 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~evl~~  423 (439)
                      +..          ......+.+++..|++.++.+  ||++.|++++
T Consensus       269 p~~----------~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         269 PED----------VEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             CCc----------ccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            110          011234556778888765544  8999999987

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-40  Score=328.24  Aligned_cols=247  Identities=26%  Similarity=0.420  Sum_probs=209.1

Q ss_pred             CccceecccCcEEEEEEEECC----ccEEEEEEecCCCch-HHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEe
Q 013636          156 QESNVIGEGGRGHVYKARFNE----KLLAAVKRIDDAGHD-AEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       156 ~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      ...++||+|.||.|++|.|..    ...||||.++..... ...+|.+|+.+|.+|+|||+++|+|...+ ....+|+|.
T Consensus       113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL  191 (1039)
T KOG0199|consen  113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL  191 (1039)
T ss_pred             HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence            346789999999999998853    357899999876544 55789999999999999999999999987 788999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR  310 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~  310 (439)
                      ++.|||.+.|+. .....+-......++.|||.||+||.++   ++|||||.++|+|+-....+||+||||.+..+....
T Consensus       192 aplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned  267 (1039)
T KOG0199|consen  192 APLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENED  267 (1039)
T ss_pred             cccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence            999999999997 4556788889999999999999999998   999999999999999999999999999988776555


Q ss_pred             ceeec----cccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCc
Q 013636          311 NVKIS----GTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDP  385 (439)
Q Consensus       311 ~~~~~----gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  385 (439)
                      ...+.    -...|.|||.+....++.++|||+|||++|||+| |..||.+....+....++ .      ..++      
T Consensus       268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-~------~erL------  334 (1039)
T KOG0199|consen  268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-A------GERL------  334 (1039)
T ss_pred             ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-c------cccC------
Confidence            44332    3467999999999999999999999999999999 999999988766554443 1      1111      


Q ss_pred             hhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhc
Q 013636          386 VIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL  424 (439)
Q Consensus       386 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  424 (439)
                          .....+.+.+.+++..||..+|++|||+..+.+.+
T Consensus       335 ----pRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  335 ----PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             ----CCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence                12234577888999999999999999999997443

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.6e-39  Score=322.75  Aligned_cols=260  Identities=24%  Similarity=0.333  Sum_probs=198.5

Q ss_pred             CCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC-----eeE
Q 013636          154 NFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE-----TRF  225 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  225 (439)
                      +|+..+.||+|+||.||++... ++..+|+|.+....  ....+.+.+|+.+++.++||||+++++++...+     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4677899999999999999874 67889999986532  234467889999999999999999999998776     789


Q ss_pred             EEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccccccc
Q 013636          226 LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA  305 (439)
Q Consensus       226 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~  305 (439)
                      +|+||+. ++|.+.+..   ...+++..+..++.|++.||+|||+.   +++||||||+|||+++++.+||+|||++...
T Consensus        81 lv~e~~~-~~l~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~  153 (372)
T cd07853          81 VVTELMQ-SDLHKIIVS---PQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVE  153 (372)
T ss_pred             EEeeccc-cCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeec
Confidence            9999997 588887753   34689999999999999999999998   9999999999999999999999999999764


Q ss_pred             CCCCc--ceeeccccCccchhhhcCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhc-----------
Q 013636          306 GTQSR--NVKISGTLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP-----------  371 (439)
Q Consensus       306 ~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~-----------  371 (439)
                      .....  .....+|+.|+|||.+.+. .++.++||||+||++|||++|+.||...++......+.....           
T Consensus       154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~  233 (372)
T cd07853         154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC  233 (372)
T ss_pred             ccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence            33221  1223478899999998874 578999999999999999999999987765443222211100           


Q ss_pred             -----ccccC-CCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          372 -----QLTDR-SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       372 -----~~~~~-~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                           .+... ...+. .. .+. .........+.+++.+||+.||++|||+.|++++
T Consensus       234 ~~~~~~~~~~~~~~~~-~~-~~~-~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         234 EGARAHILRGPHKPPS-LP-VLY-TLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HHHHHHHHhCCCCCCc-hH-Hhc-ccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence                 00000 00000 00 000 0011113457789999999999999999999976

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.5e-39  Score=320.95  Aligned_cols=264  Identities=23%  Similarity=0.285  Sum_probs=199.5

Q ss_pred             HhcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC-----
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE-----  222 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  222 (439)
                      ..++|+..+.||+|+||.||++... .+..+|+|.+....  ......+.+|+.+++.++||||+++++++....     
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            4578999999999999999999875 47789999987532  233456788999999999999999999886433     


Q ss_pred             -eeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccc
Q 013636          223 -TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGL  301 (439)
Q Consensus       223 -~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGl  301 (439)
                       ..++||||+++ +|.+.+..     .+++..+..++.|+++||+|||+.   +++||||||+|||++.++.+||+|||+
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~  165 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcc
Confidence             46999999975 67766642     378899999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhH-h-------------
Q 013636          302 SVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMV-T-------------  367 (439)
Q Consensus       302 s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~-~-------------  367 (439)
                      ++............||..|+|||.+.+..++.++|||||||++|||++|+.||...+........ .             
T Consensus       166 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (355)
T cd07874         166 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  245 (355)
T ss_pred             cccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence            98765443333456899999999999999999999999999999999999999876532211100 0             


Q ss_pred             --hhhcccccCCCCC-----ccCCchhc---CccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          368 --WAMPQLTDRSKLP-----NIVDPVIR---DTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       368 --~~~~~~~~~~~~~-----~~~d~~l~---~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                        .............     ......+.   ..........+.+++.+||+.||++|||+.|++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence              0000000011111     10000000   00011123467889999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.7e-39  Score=308.10  Aligned_cols=253  Identities=30%  Similarity=0.503  Sum_probs=199.7

Q ss_pred             HHhcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCchHHHHHHHHHHHHHhc-CCCceeeeeeEEEeC------
Q 013636          150 AATNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHA------  221 (439)
Q Consensus       150 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------  221 (439)
                      .+++.|+..+.||+|+||.||+|... .+..+|+|.+.... .....+.+|+.+++++ +|+|++++++++...      
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            35677888899999999999999875 46788999886543 3445788999999998 799999999998753      


Q ss_pred             CeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccc
Q 013636          222 ETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGL  301 (439)
Q Consensus       222 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGl  301 (439)
                      ...+++|||+++|+|.+++... ....+++..+..++.|++.|++|||+.   +++|+||||+||++++++.+||+|||+
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~  157 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGV  157 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCC
Confidence            4578999999999999998752 234689999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCC-cceeeccccCccchhhhc-----CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhccccc
Q 013636          302 SVTAGTQS-RNVKISGTLGYVAPEYLL-----EGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTD  375 (439)
Q Consensus       302 s~~~~~~~-~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~  375 (439)
                      +....... ......|+..|+|||++.     +..++.++|||||||++|||++|+.||....+........        
T Consensus       158 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~--------  229 (272)
T cd06637         158 SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP--------  229 (272)
T ss_pred             ceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHh--------
Confidence            97653321 223355889999999986     3457889999999999999999999997655432221111        


Q ss_pred             CCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          376 RSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       376 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      ........+.        .....+.+++.+||+.||++|||+.+++++
T Consensus       230 ~~~~~~~~~~--------~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         230 RNPAPRLKSK--------KWSKKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             cCCCCCCCCC--------CcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence            0000111111        112357789999999999999999999864

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.2e-39  Score=320.19  Aligned_cols=261  Identities=26%  Similarity=0.420  Sum_probs=202.0

Q ss_pred             HhcCCCccceecccCcEEEEEEEE------CCccEEEEEEecCCC-chHHHHHHHHHHHHHhc-CCCceeeeeeEEEeC-
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARF------NEKLLAAVKRIDDAG-HDAEREFNNEVNWLTKI-RHQNIISLLGYCIHA-  221 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-  221 (439)
                      ..++|++.+.||+|+||.||+|..      ..+..+|+|.++... ......+.+|+.++.++ +||||++++++|... 
T Consensus         5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (343)
T cd05103           5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   84 (343)
T ss_pred             chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence            346788999999999999999974      346789999997543 23345688999999999 689999999988654 


Q ss_pred             CeeEEEEEeccCCChhhhhcCCCC--------------------------------------------------------
Q 013636          222 ETRFLVYEMMQNGSLEKQLHGPTH--------------------------------------------------------  245 (439)
Q Consensus       222 ~~~~lV~e~~~~gsL~~~l~~~~~--------------------------------------------------------  245 (439)
                      ...+++|||+++|+|.++++....                                                        
T Consensus        85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (343)
T cd05103          85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  164 (343)
T ss_pred             CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence            467899999999999999864210                                                        


Q ss_pred             --------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCcc---eee
Q 013636          246 --------GSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN---VKI  314 (439)
Q Consensus       246 --------~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~~---~~~  314 (439)
                              ...+++..+.+++.|+++||+|||+.   +++||||||+||++++++++||+|||++.........   ...
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  241 (343)
T cd05103         165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA  241 (343)
T ss_pred             hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence                    12378888999999999999999998   9999999999999999999999999998764322111   112


Q ss_pred             ccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCccCH
Q 013636          315 SGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDL  393 (439)
Q Consensus       315 ~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  393 (439)
                      .++..|+|||.+.+..++.++||||||+++|||++ |..||........  ..... .. ......+...+         
T Consensus       242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~~~~-~~-~~~~~~~~~~~---------  308 (343)
T cd05103         242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FCRRL-KE-GTRMRAPDYTT---------  308 (343)
T ss_pred             CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH--HHHHH-hc-cCCCCCCCCCC---------
Confidence            35677999999999999999999999999999997 9999976543211  11100 00 00111112111         


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCC
Q 013636          394 KHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPT  430 (439)
Q Consensus       394 ~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~  430 (439)
                         ..+.+++..||+.||++|||+.|++++|+.+...
T Consensus       309 ---~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~  342 (343)
T cd05103         309 ---PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  342 (343)
T ss_pred             ---HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence               2467799999999999999999999999887653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2.5e-39  Score=309.64  Aligned_cols=265  Identities=25%  Similarity=0.317  Sum_probs=195.5

Q ss_pred             CCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCc--hHHHHHHHHHHHHHhc---CCCceeeeeeEEEeC-----C
Q 013636          154 NFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGH--DAEREFNNEVNWLTKI---RHQNIISLLGYCIHA-----E  222 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~-----~  222 (439)
                      +|++.+.||+|+||+||+|+.. ++..+|+|.+.....  .....+.+|+.+++.+   +||||+++++++...     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4778899999999999999876 477899998864321  2223456677777665   799999999988642     3


Q ss_pred             eeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccc
Q 013636          223 TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS  302 (439)
Q Consensus       223 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls  302 (439)
                      ..+++|||+++ +|.+++.... ...+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||++
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~  155 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLA  155 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCcc
Confidence            57999999985 8988886522 34589999999999999999999998   9999999999999999999999999999


Q ss_pred             cccCCCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhh-hhHhhhhc----ccccCC
Q 013636          303 VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQ-SMVTWAMP----QLTDRS  377 (439)
Q Consensus       303 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~-~~~~~~~~----~~~~~~  377 (439)
                      .............||..|+|||.+.+..++.++||||+||++|||++|+.||......... ........    .+....
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07863         156 RIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV  235 (288)
T ss_pred             ccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence            7765433333445889999999999999999999999999999999999999776543322 11111000    000000


Q ss_pred             CCC-ccCCchhc---CccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          378 KLP-NIVDPVIR---DTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       378 ~~~-~~~d~~l~---~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      ..+ ..+.+...   ..........+.+++.+|++.||++|||+.|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            000 00000000   00001123456789999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.3e-39  Score=306.30  Aligned_cols=251  Identities=31%  Similarity=0.483  Sum_probs=201.2

Q ss_pred             CCccceecccCcEEEEEEEECC-ccEEEEEEecCCCchHHH--HHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEec
Q 013636          155 FQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAER--EFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMM  231 (439)
Q Consensus       155 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  231 (439)
                      |+..+.||+|+||+||+++... +..+|+|.+.........  ...+|+.++++++||||+++++++...+..++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            5667899999999999999876 457899999876543332  3456999999999999999999999999999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccccccc-CCCCc
Q 013636          232 QNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA-GTQSR  310 (439)
Q Consensus       232 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~-~~~~~  310 (439)
                      ++++|.+++.   ....+++..+..++.|+++||++||+.   +++|+||||+||++++++.++|+|||.+... .....
T Consensus        81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~  154 (260)
T PF00069_consen   81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNEN  154 (260)
T ss_dssp             TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSE
T ss_pred             cccccccccc---ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence            9999999997   334589999999999999999999998   9999999999999999999999999999753 22222


Q ss_pred             ceeeccccCccchhhhc-CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhc-ccccCCCCCccCCchhc
Q 013636          311 NVKISGTLGYVAPEYLL-EGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP-QLTDRSKLPNIVDPVIR  388 (439)
Q Consensus       311 ~~~~~gt~~y~aPE~~~-~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~d~~l~  388 (439)
                      .....++..|+|||.+. +...+.++||||+|+++|+|++|..||................. .......          
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----------  224 (260)
T PF00069_consen  155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQ----------  224 (260)
T ss_dssp             BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTT----------
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccccc----------
Confidence            33455889999999998 88899999999999999999999999987633222222221110 0000000          


Q ss_pred             CccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          389 DTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       389 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      .  .......+.+++..||+.||++||++.+++++
T Consensus       225 ~--~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  225 Q--SREKSEELRDLIKKMLSKDPEQRPSAEELLKH  257 (260)
T ss_dssp             S--HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred             c--cchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0  00012678889999999999999999999875

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=3.8e-39  Score=308.53  Aligned_cols=255  Identities=29%  Similarity=0.447  Sum_probs=204.3

Q ss_pred             hcCCCccceecccCcEEEEEEEEC------CccEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCee
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN------EKLLAAVKRIDDAG-HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETR  224 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  224 (439)
                      .++|+..+.||+|+||.||+++..      ++..+++|.+.... .....++.+|+.++++++|||++++++++...+..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            467888899999999999999864      46788999887543 23456799999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhcCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCC
Q 013636          225 FLVYEMMQNGSLEKQLHGPT-------------------HGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSN  285 (439)
Q Consensus       225 ~lV~e~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~N  285 (439)
                      ++++||+++|+|.+++....                   ....+++..++.++.|++.||+|||+.   +++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence            99999999999999996321                   123478899999999999999999997   99999999999


Q ss_pred             EEEcCCCcEEEEecccccccCCCCcc---eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhh
Q 013636          286 ILLDSSFNAKLSDFGLSVTAGTQSRN---VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQ  361 (439)
Q Consensus       286 iLl~~~~~~kl~DfGls~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~  361 (439)
                      |++++++.++|+|||++.........   .....+..|+|||.+.+..++.++|||||||++|||++ |..||...+..+
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~  240 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE  240 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            99999999999999998754322211   11224567999999999999999999999999999998 888997766544


Q ss_pred             hhhhHhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccc
Q 013636          362 CQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIP  426 (439)
Q Consensus       362 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  426 (439)
                      ....+..        ......     ..    ....++.+++.+||+.||++|||+.|+++.|++
T Consensus       241 ~~~~~~~--------~~~~~~-----~~----~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         241 VIYYVRD--------GNVLSC-----PD----NCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             HHHHHhc--------CCCCCC-----CC----CCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            3222211        111000     00    113467789999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.5e-39  Score=321.14  Aligned_cols=192  Identities=22%  Similarity=0.328  Sum_probs=165.4

Q ss_pred             HhcCCCccceecccCcEEEEEEEECC-ccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEE
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYE  229 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  229 (439)
                      ...+|++.+.||+|+||.||+|+... +..+|+|.....      ....|+.++++++||||+++++++...+..++|+|
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  137 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP  137 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence            34679999999999999999998865 567888875432      23568999999999999999999999999999999


Q ss_pred             eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCC
Q 013636          230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS  309 (439)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~  309 (439)
                      |+. |+|.+++..  ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++.......
T Consensus       138 ~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  211 (357)
T PHA03209        138 HYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP  211 (357)
T ss_pred             ccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccCc
Confidence            995 588888863  335689999999999999999999998   99999999999999999999999999997544333


Q ss_pred             cceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCC
Q 013636          310 RNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPV  354 (439)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~  354 (439)
                      ......||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus       212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            334456899999999999999999999999999999999855554

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.6e-39  Score=301.65  Aligned_cols=245  Identities=29%  Similarity=0.458  Sum_probs=196.8

Q ss_pred             ceecccCcEEEEEEEECC----ccEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEeccC
Q 013636          159 NVIGEGGRGHVYKARFNE----KLLAAVKRIDDAGH-DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQN  233 (439)
Q Consensus       159 ~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  233 (439)
                      +.||+|+||.||+|.+..    ...+++|.+..... ...+++.+|+.+++.++|+|++++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            469999999999997643    26789999875543 34567999999999999999999999876 4578999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCccee
Q 013636          234 GSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK  313 (439)
Q Consensus       234 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~~~~  313 (439)
                      |+|.+++...   ..+++..+..++.|++.|++|||+.   +++|+||||+||+++.++.+||+|||++...........
T Consensus        80 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~  153 (257)
T cd05060          80 GPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR  153 (257)
T ss_pred             CcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence            9999999642   3689999999999999999999998   999999999999999999999999999976543322111


Q ss_pred             ----eccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhc
Q 013636          314 ----ISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIR  388 (439)
Q Consensus       314 ----~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  388 (439)
                          ..++..|+|||.+.+..++.++||||||+++||+++ |+.||...+..+....+...     .....+        
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~--------  220 (257)
T cd05060         154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG-----ERLPRP--------  220 (257)
T ss_pred             cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-----CcCCCC--------
Confidence                113467999999999999999999999999999998 99999876654433222211     000111        


Q ss_pred             CccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhcccc
Q 013636          389 DTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPL  427 (439)
Q Consensus       389 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l  427 (439)
                      .    .....+.+++.+||+.+|++||++.++++.|+.+
T Consensus       221 ~----~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         221 E----ECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             C----CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence            1    1124677899999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=4e-39  Score=307.12  Aligned_cols=251  Identities=27%  Similarity=0.408  Sum_probs=197.2

Q ss_pred             cCCCccceecccCcEEEEEEEE-CCccEEEEEEecCC-CchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEe
Q 013636          153 NNFQESNVIGEGGRGHVYKARF-NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      ++|+..+.||+|+||.||+|.. .++..+|+|.+... .....+.+.+|++++++++|||++++++++...+..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            3577789999999999999986 45778999988643 233456789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR  310 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~  310 (439)
                      +++|+|..+.       .+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++........
T Consensus        81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~  150 (279)
T cd06619          81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIA  150 (279)
T ss_pred             CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccccc
Confidence            9999997553       367888999999999999999998   999999999999999999999999999976543322


Q ss_pred             ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhh-hHhhhhcccccCCCCCccCCchhcC
Q 013636          311 NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQS-MVTWAMPQLTDRSKLPNIVDPVIRD  389 (439)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~~  389 (439)
                       ....||..|+|||.+.+..++.++||||||+++|||++|+.||.......... ..... ...... ..+...    ..
T Consensus       151 -~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~----~~  223 (279)
T cd06619         151 -KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLL-QCIVDE-DPPVLP----VG  223 (279)
T ss_pred             -cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHH-HHHhcc-CCCCCC----CC
Confidence             23468999999999999999999999999999999999999997543221110 00000 000000 000000    00


Q ss_pred             ccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhc
Q 013636          390 TMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL  424 (439)
Q Consensus       390 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  424 (439)
                          .....+.+++.+|++.||++||++.|++++-
T Consensus       224 ----~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~  254 (279)
T cd06619         224 ----QFSEKFVHFITQCMRKQPKERPAPENLMDHP  254 (279)
T ss_pred             ----cCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence                1123567899999999999999999999763

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-40  Score=333.60  Aligned_cols=249  Identities=26%  Similarity=0.436  Sum_probs=209.5

Q ss_pred             cceecccCcEEEEEEEEC-----CccEEEEEEecCC-CchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEec
Q 013636          158 SNVIGEGGRGHVYKARFN-----EKLLAAVKRIDDA-GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMM  231 (439)
Q Consensus       158 ~~~LG~G~fg~Vy~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  231 (439)
                      .++||+|+||+||+|.+-     -+.+||+|.+... +.....++.+|+.+|.+++|||+++++|+|..+. ..||++||
T Consensus       701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m  779 (1177)
T KOG1025|consen  701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM  779 (1177)
T ss_pred             hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence            578999999999999762     1568899988654 3455678999999999999999999999998765 88999999


Q ss_pred             cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCcc
Q 013636          232 QNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN  311 (439)
Q Consensus       232 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~~  311 (439)
                      +.|+|.++++.  +...+-.+..+.|+.|||+||.|||++   .++||||.++|||+.+-.++||.|||+++....+...
T Consensus       780 P~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e  854 (1177)
T KOG1025|consen  780 PLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE  854 (1177)
T ss_pred             ccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence            99999999984  556788899999999999999999998   9999999999999999999999999999887665544


Q ss_pred             eeec---cccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchh
Q 013636          312 VKIS---GTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVI  387 (439)
Q Consensus       312 ~~~~---gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  387 (439)
                      ....   -.+.|||-|.+....|+.++|||||||++||++| |..||++...++..++++...       +++       
T Consensus       855 y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~ge-------RLs-------  920 (1177)
T KOG1025|consen  855 YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGE-------RLS-------  920 (1177)
T ss_pred             ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccc-------cCC-------
Confidence            3322   2467999999999999999999999999999999 999999998887766664211       111       


Q ss_pred             cCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCC
Q 013636          388 RDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVP  429 (439)
Q Consensus       388 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~  429 (439)
                         ..+.+...+..++..||..|+..||+++++..++.+...
T Consensus       921 ---qPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar  959 (1177)
T KOG1025|consen  921 ---QPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR  959 (1177)
T ss_pred             ---CCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence               112234567779999999999999999999988765543

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=5e-39  Score=303.10  Aligned_cols=253  Identities=25%  Similarity=0.431  Sum_probs=204.9

Q ss_pred             HhcCCCccceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEe
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      ..++|++.+.||+|+||.||++..+++..+++|.+.... .....+.+|+.++++++|+|++++.+++.. ...+++|||
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~   81 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF   81 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence            346788899999999999999998888889999887532 345678999999999999999999999887 778999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR  310 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~  310 (439)
                      +++|+|.+++... .+..+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.+||+|||.+........
T Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  157 (260)
T cd05073          82 MAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY  157 (260)
T ss_pred             CCCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence            9999999999753 245688999999999999999999997   999999999999999999999999999876543221


Q ss_pred             c--eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchh
Q 013636          311 N--VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVI  387 (439)
Q Consensus       311 ~--~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  387 (439)
                      .  ....++..|+|||.+..+.++.++|+||||+++|++++ |+.||...+.......+..       ....+      .
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~-------~~~~~------~  224 (260)
T cd05073         158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER-------GYRMP------R  224 (260)
T ss_pred             ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC-------CCCCC------C
Confidence            1  11234567999999998899999999999999999999 9999987654432222111       10100      0


Q ss_pred             cCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccc
Q 013636          388 RDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIP  426 (439)
Q Consensus       388 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  426 (439)
                      ..    .....+.+++.+|++.+|++||++.++++.|+.
T Consensus       225 ~~----~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         225 PE----NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             cc----cCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            01    123467789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=4.2e-39  Score=312.39  Aligned_cols=259  Identities=24%  Similarity=0.415  Sum_probs=205.3

Q ss_pred             HhcCCCccceecccCcEEEEEEEEC--------CccEEEEEEecCCC-chHHHHHHHHHHHHHhc-CCCceeeeeeEEEe
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARFN--------EKLLAAVKRIDDAG-HDAEREFNNEVNWLTKI-RHQNIISLLGYCIH  220 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  220 (439)
                      ..++|.+.+.||+|+||.||+++..        ....+|+|.+.... ......+.+|+.+++++ +||||+++++++..
T Consensus        10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (314)
T cd05099          10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ   89 (314)
T ss_pred             cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence            3467888899999999999999752        24568889887543 23446788999999999 69999999999999


Q ss_pred             CCeeEEEEEeccCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEE
Q 013636          221 AETRFLVYEMMQNGSLEKQLHGPT-------------HGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNIL  287 (439)
Q Consensus       221 ~~~~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiL  287 (439)
                      .+..++++||+++|+|.+++....             ....+++..+.+++.|++.||+|||+.   +++||||||+||+
T Consensus        90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nil  166 (314)
T cd05099          90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVL  166 (314)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEE
Confidence            899999999999999999996421             124589999999999999999999997   9999999999999


Q ss_pred             EcCCCcEEEEecccccccCCCCcc---eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhh
Q 013636          288 LDSSFNAKLSDFGLSVTAGTQSRN---VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQ  363 (439)
Q Consensus       288 l~~~~~~kl~DfGls~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~  363 (439)
                      +++++.+||+|||+++........   ....++..|+|||.+.++.++.++||||||+++|||++ |..||...+..+..
T Consensus       167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~  246 (314)
T cd05099         167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF  246 (314)
T ss_pred             EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            999999999999999765432111   11124467999999999999999999999999999999 89999876654433


Q ss_pred             hhHhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCC
Q 013636          364 SMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVP  429 (439)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~  429 (439)
                      .....       ... .+.     ..    .....+.+++.+||+.+|++|||+.++++.|+++..
T Consensus       247 ~~~~~-------~~~-~~~-----~~----~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~  295 (314)
T cd05099         247 KLLRE-------GHR-MDK-----PS----NCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA  295 (314)
T ss_pred             HHHHc-------CCC-CCC-----CC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence            32211       000 000     00    112356679999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=5.9e-39  Score=301.57  Aligned_cols=250  Identities=26%  Similarity=0.450  Sum_probs=202.4

Q ss_pred             cCCCccceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEecc
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQ  232 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  232 (439)
                      .+|+..+.||+|+||.||++.+.++..+++|.+.... ....+|.+|++++++++|||++++++++......++|+||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            3567788999999999999998877889999887543 234578999999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCcc-
Q 013636          233 NGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN-  311 (439)
Q Consensus       233 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~~-  311 (439)
                      +|+|.+++...  ...+++..+..++.|++.|++|||+.   +++|+||||+||+++.++.+||+|||++......... 
T Consensus        83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~  157 (256)
T cd05112          83 HGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS  157 (256)
T ss_pred             CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence            99999998642  24588999999999999999999998   9999999999999999999999999998755332211 


Q ss_pred             -eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcC
Q 013636          312 -VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRD  389 (439)
Q Consensus       312 -~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  389 (439)
                       ....++.+|+|||.+.++.++.++||||||+++|||++ |+.||.............       ...   ....+..  
T Consensus       158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-------~~~---~~~~~~~--  225 (256)
T cd05112         158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETIN-------AGF---RLYKPRL--  225 (256)
T ss_pred             cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHh-------CCC---CCCCCCC--
Confidence             11224578999999998999999999999999999998 999997655433222111       000   0011111  


Q ss_pred             ccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhcc
Q 013636          390 TMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLI  425 (439)
Q Consensus       390 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  425 (439)
                           ....+.+++.+||+.+|++|||+.++++.|.
T Consensus       226 -----~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         226 -----ASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             -----CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence                 1245778999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2.6e-39  Score=315.15  Aligned_cols=240  Identities=23%  Similarity=0.305  Sum_probs=192.9

Q ss_pred             CCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC---chHHHHHHHHHHHHHhcC-CCceeeeeeEEEeCCeeEEEE
Q 013636          154 NFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG---HDAEREFNNEVNWLTKIR-HQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~  228 (439)
                      +|+..+.||+|+||.||+++.. ++..+|+|.+....   ....+.+..|..++..+. |++++++.+++...+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            3667889999999999999875 57889999986431   233456778888998885 577888999999999999999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~  308 (439)
                      ||+++|+|.+++..   ...+++..+..++.|++.||+|||+.   +++||||||+|||+++++.+||+|||++......
T Consensus        81 Ey~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~  154 (323)
T cd05615          81 EYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD  154 (323)
T ss_pred             cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence            99999999999854   24589999999999999999999998   9999999999999999999999999998754322


Q ss_pred             C-cceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchh
Q 013636          309 S-RNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVI  387 (439)
Q Consensus       309 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  387 (439)
                      . ......||+.|+|||++.+..++.++|||||||++|||++|+.||...++......+.      ......+..+    
T Consensus       155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~------~~~~~~p~~~----  224 (323)
T cd05615         155 GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM------EHNVSYPKSL----  224 (323)
T ss_pred             CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH------hCCCCCCccC----
Confidence            2 2233458999999999999999999999999999999999999998776543322221      1111122111    


Q ss_pred             cCccCHHHHHHHHHHHHHhcCCCCCCCCCH
Q 013636          388 RDTMDLKHLYQVAAVAVLCIQPEPSYRPLI  417 (439)
Q Consensus       388 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~  417 (439)
                              ...+.+++.+||+.+|++|++.
T Consensus       225 --------~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         225 --------SKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             --------CHHHHHHHHHHcccCHhhCCCC
Confidence                    2345679999999999999974

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.2e-39  Score=302.82  Aligned_cols=238  Identities=26%  Similarity=0.487  Sum_probs=190.9

Q ss_pred             ceecccCcEEEEEEEECCcc-----------EEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEE
Q 013636          159 NVIGEGGRGHVYKARFNEKL-----------LAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLV  227 (439)
Q Consensus       159 ~~LG~G~fg~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  227 (439)
                      +.||+|+||.||+|...+..           .+++|.+...... ...|.+|+.++++++|||++++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            46999999999999886533           4677776544333 6788999999999999999999999988 788999


Q ss_pred             EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC-------cEEEEecc
Q 013636          228 YEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSF-------NAKLSDFG  300 (439)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~-------~~kl~DfG  300 (439)
                      +||+++|+|.+++....  ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++       .+||+|||
T Consensus        79 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          79 EEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             EEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCC
Confidence            99999999999997422  3689999999999999999999997   999999999999999888       79999999


Q ss_pred             cccccCCCCcceeeccccCccchhhhcCC--CCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCC
Q 013636          301 LSVTAGTQSRNVKISGTLGYVAPEYLLEG--KLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRS  377 (439)
Q Consensus       301 ls~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~  377 (439)
                      ++.......   ...++..|+|||.+...  .++.++||||||+++|||++ |..|+...++........       ...
T Consensus       154 ~a~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-------~~~  223 (259)
T cd05037         154 IPITVLSRE---ERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-------DQH  223 (259)
T ss_pred             ccccccccc---ccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-------cCC
Confidence            997654421   23367789999999876  78999999999999999999 688887654332211111       011


Q ss_pred             CCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhcc
Q 013636          378 KLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLI  425 (439)
Q Consensus       378 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  425 (439)
                      ..+   .+         ....+.+++.+||+.+|++|||+.++++.|.
T Consensus       224 ~~~---~~---------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         224 RLP---MP---------DCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             CCC---CC---------CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            110   00         0156778999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.7e-39  Score=316.24  Aligned_cols=236  Identities=26%  Similarity=0.341  Sum_probs=187.4

Q ss_pred             ceecccCcEEEEEEEEC-CccEEEEEEecCCC---chHHHHHHHHHH-HHHhcCCCceeeeeeEEEeCCeeEEEEEeccC
Q 013636          159 NVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG---HDAEREFNNEVN-WLTKIRHQNIISLLGYCIHAETRFLVYEMMQN  233 (439)
Q Consensus       159 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  233 (439)
                      ++||+|+||.||+|+.. ++..+|+|.+....   ......+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999885 47789999986432   122334555554 67889999999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCC-CCcce
Q 013636          234 GSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT-QSRNV  312 (439)
Q Consensus       234 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~-~~~~~  312 (439)
                      |+|..++..   ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++..... .....
T Consensus        81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (321)
T cd05603          81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTS  154 (321)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccc
Confidence            999988853   34588889999999999999999997   999999999999999999999999999875322 22223


Q ss_pred             eeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCccC
Q 013636          313 KISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMD  392 (439)
Q Consensus       313 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  392 (439)
                      ...||+.|+|||.+.+..++.++|||||||++|||++|+.||...+.......+.      .....++.           
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~------~~~~~~~~-----------  217 (321)
T cd05603         155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNIL------HKPLQLPG-----------  217 (321)
T ss_pred             cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHh------cCCCCCCC-----------
Confidence            4568999999999999999999999999999999999999998765433222211      01111111           


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCHH
Q 013636          393 LKHLYQVAAVAVLCIQPEPSYRPLIT  418 (439)
Q Consensus       393 ~~~~~~l~~l~~~cl~~dP~~RPt~~  418 (439)
                       .....+.+++.+||+.||++||+..
T Consensus       218 -~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         218 -GKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             -CCCHHHHHHHHHHccCCHhhcCCCC
Confidence             1123567899999999999999763

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=6e-39  Score=306.36  Aligned_cols=265  Identities=23%  Similarity=0.324  Sum_probs=201.5

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYE  229 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  229 (439)
                      ++|+..+.||+|+||.||+|+.. ++..+++|.+....  ....+.+.+|+.++++++|+|++++++++...+..++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46888899999999999999886 47889999886432  2233568899999999999999999999999999999999


Q ss_pred             eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCC
Q 013636          230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS  309 (439)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~  309 (439)
                      |+++++|..+...   ...+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07847          81 YCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPG  154 (286)
T ss_pred             ccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence            9999988887743   23589999999999999999999997   99999999999999999999999999997654433


Q ss_pred             -cceeeccccCccchhhhcC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhccc--------ccCCCC
Q 013636          310 -RNVKISGTLGYVAPEYLLE-GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQL--------TDRSKL  379 (439)
Q Consensus       310 -~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~--------~~~~~~  379 (439)
                       ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+..+............        ......
T Consensus       155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07847         155 DDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF  234 (286)
T ss_pred             ccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence             1223347889999999876 567899999999999999999999998765433222111110000        000000


Q ss_pred             CccCCchhcCccC-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          380 PNIVDPVIRDTMD-----LKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       380 ~~~~d~~l~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      .....+.......     ......+.+++.+||+.+|++||++.|++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence            0000000000000     0113467789999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-39  Score=302.47  Aligned_cols=261  Identities=25%  Similarity=0.346  Sum_probs=200.9

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCC--CchHHHHHHHHHHHHHhcCCCceeeeeeEEEe-----CCe
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDA--GHDAEREFNNEVNWLTKIRHQNIISLLGYCIH-----AET  223 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~  223 (439)
                      ...|...+.||+|++|.|.++... ++..||+|++.+.  +....++..+|+++|+.++|+||+.+.+.+..     -+.
T Consensus        21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D  100 (359)
T KOG0660|consen   21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND  100 (359)
T ss_pred             cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence            345555788999999999999875 4789999999743  34455678899999999999999999998865     346


Q ss_pred             eEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccccc
Q 013636          224 RFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSV  303 (439)
Q Consensus       224 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~  303 (439)
                      .|+|+|+|+ .+|.+.++.   ++.++......+..|+++||.|+|+.   +++||||||+|+|++.+..+||+|||+|+
T Consensus       101 vYiV~elMe-tDL~~iik~---~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR  173 (359)
T KOG0660|consen  101 VYLVFELME-TDLHQIIKS---QQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLAR  173 (359)
T ss_pred             eEEehhHHh-hHHHHHHHc---CccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEecccccee
Confidence            799999994 499999853   44599999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCC---CcceeeccccCccchhhhcC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhh---------
Q 013636          304 TAGTQ---SRNVKISGTLGYVAPEYLLE-GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAM---------  370 (439)
Q Consensus       304 ~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~---------  370 (439)
                      .....   ........|.+|+|||.+.+ ..||...||||.|||+.||++|++-|.+.+.-....++....         
T Consensus       174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~  253 (359)
T KOG0660|consen  174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ  253 (359)
T ss_pred             eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence            87542   22234567999999999875 689999999999999999999999998766433222222111         


Q ss_pred             --------cccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          371 --------PQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       371 --------~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                              +.+...+..+..--..+-..    ......++..+||..||.+|+|++|.+++
T Consensus       254 ~i~s~~ar~yi~slp~~p~~~f~~~fp~----a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  254 KIRSEKARPYIKSLPQIPKQPFSSIFPN----ANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             HhccHHHHHHHHhCCCCCCCCHHHHcCC----CCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence                    11111111111111111111    12346678999999999999999999976

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=5.4e-39  Score=306.67  Aligned_cols=265  Identities=23%  Similarity=0.340  Sum_probs=199.3

Q ss_pred             CCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEe
Q 013636          154 NFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      +|+..+.||+|+||.||+|+.. ++..+++|.+....  ....+.+.+|+.++++++|||++++++++..++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4677889999999999999875 57889999886432  22345788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR  310 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~  310 (439)
                      ++ ++|.+++.....+..+++..+..++.|++.||+|||+.   +++||||+|+||++++++.+||+|||++........
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  156 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR  156 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence            97 68998887544446799999999999999999999998   999999999999999999999999999875543221


Q ss_pred             c-eeeccccCccchhhhcCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhh-hhHhhhhccccc-----------C
Q 013636          311 N-VKISGTLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQ-SMVTWAMPQLTD-----------R  376 (439)
Q Consensus       311 ~-~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~-~~~~~~~~~~~~-----------~  376 (439)
                      . ....+++.|+|||.+.+. .++.++||||||+++|||++|+.||...++.... ............           .
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (285)
T cd07861         157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK  236 (285)
T ss_pred             cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHH
Confidence            1 223468899999988754 5788999999999999999999999865542211 111100000000           0


Q ss_pred             CCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          377 SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       377 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      ...+......+... ......++.+++.+||+.||++|||+.+++++
T Consensus       237 ~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         237 NTFPKWKKGSLRSA-VKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             hhccccCcchhHHh-cCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            00001111100000 00123456789999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=5.6e-39  Score=302.79  Aligned_cols=248  Identities=29%  Similarity=0.476  Sum_probs=193.2

Q ss_pred             ceecccCcEEEEEEEEC----CccEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCceeeeeeEEEe-CCeeEEEEEecc
Q 013636          159 NVIGEGGRGHVYKARFN----EKLLAAVKRIDDAG-HDAEREFNNEVNWLTKIRHQNIISLLGYCIH-AETRFLVYEMMQ  232 (439)
Q Consensus       159 ~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV~e~~~  232 (439)
                      +.||+|+||.||+|.+.    ....+|+|.+.... ....+.+.+|+.+++.++|||++++++++.. ++..++++||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999863    24578999886433 3345678899999999999999999998764 456799999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc--
Q 013636          233 NGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR--  310 (439)
Q Consensus       233 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~--  310 (439)
                      +|+|.+++.+.  ...+++..+..++.|++.|++|||+.   +++||||||+|||+++++.+||+|||++........  
T Consensus        81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~  155 (262)
T cd05058          81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS  155 (262)
T ss_pred             CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence            99999999743  23467888899999999999999997   999999999999999999999999999875432211  


Q ss_pred             ---ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCch
Q 013636          311 ---NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPV  386 (439)
Q Consensus       311 ---~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  386 (439)
                         .....++..|+|||.+.+..++.++||||||+++|||++ |..||...+.......+...     .....+.     
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~-----  225 (262)
T cd05058         156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQG-----RRLLQPE-----  225 (262)
T ss_pred             ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC-----CCCCCCC-----
Confidence               112235678999999998999999999999999999999 56677665543322111100     0000111     


Q ss_pred             hcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccC
Q 013636          387 IRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLV  428 (439)
Q Consensus       387 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~  428 (439)
                             .....+.+++..||+.+|++||++.|+++.|+.+.
T Consensus       226 -------~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         226 -------YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             -------cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence                   01235778999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=8.4e-39  Score=306.87  Aligned_cols=251  Identities=25%  Similarity=0.428  Sum_probs=201.6

Q ss_pred             cCCCccceecccCcEEEEEEEECC-ccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEec
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMM  231 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  231 (439)
                      ++|++.+.||+|+||.||+|+... +..+++|.+........+.+.+|+.+++.++|||++++++++..++..++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            568888999999999999998865 7788999987766566678999999999999999999999999999999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC-Cc
Q 013636          232 QNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ-SR  310 (439)
Q Consensus       232 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~-~~  310 (439)
                      ++++|..++...  ...+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||++...... ..
T Consensus        92 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~  166 (292)
T cd06644          92 PGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR  166 (292)
T ss_pred             CCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccccc
Confidence            999999887632  34589999999999999999999997   9999999999999999999999999998653322 11


Q ss_pred             ceeeccccCccchhhhc-----CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCc
Q 013636          311 NVKISGTLGYVAPEYLL-----EGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDP  385 (439)
Q Consensus       311 ~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  385 (439)
                      .....++..|+|||.+.     ...++.++|||||||++|||++|..||...++........        ....+....+
T Consensus       167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~--------~~~~~~~~~~  238 (292)
T cd06644         167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA--------KSEPPTLSQP  238 (292)
T ss_pred             cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHh--------cCCCccCCCC
Confidence            23345788999999985     3456789999999999999999999997665432211110        0000011110


Q ss_pred             hhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          386 VIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       386 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                         .    .....+.+++.+||+.||++||++.+++++
T Consensus       239 ---~----~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         239 ---S----KWSMEFRDFLKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             ---c----ccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence               0    112356779999999999999999999875

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=4.9e-39  Score=304.81  Aligned_cols=256  Identities=26%  Similarity=0.408  Sum_probs=204.2

Q ss_pred             cCCCccceecccCcEEEEEEEECC----ccEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNE----KLLAAVKRIDDAG-HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLV  227 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  227 (439)
                      ++|+..+.||+|+||.||+|...+    ...+++|...... ....+.+.+|+.++++++|||++++++++.+ +..++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            467788999999999999998643    3568888887554 3445679999999999999999999998875 567899


Q ss_pred             EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCC
Q 013636          228 YEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT  307 (439)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~  307 (439)
                      |||+++|+|.+++...  ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++.....
T Consensus        85 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  159 (270)
T cd05056          85 MELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED  159 (270)
T ss_pred             EEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeeccc
Confidence            9999999999999642  34589999999999999999999997   999999999999999999999999999876543


Q ss_pred             CCcce--eeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCccCC
Q 013636          308 QSRNV--KISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVD  384 (439)
Q Consensus       308 ~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  384 (439)
                      .....  ...++..|+|||.+....++.++||||||+++||+++ |..||...+..+....+...     .....+    
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~-----~~~~~~----  230 (270)
T cd05056         160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENG-----ERLPMP----  230 (270)
T ss_pred             ccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC-----CcCCCC----
Confidence            32111  1123467999999988889999999999999999986 99999876544322222110     000111    


Q ss_pred             chhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCCC
Q 013636          385 PVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPTD  431 (439)
Q Consensus       385 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~~  431 (439)
                          .    .....+.+++.+|+..+|++|||+.+++..|+.+..++
T Consensus       231 ----~----~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~  269 (270)
T cd05056         231 ----P----NCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE  269 (270)
T ss_pred             ----C----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence                1    11236777999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.2e-39  Score=306.97  Aligned_cols=240  Identities=23%  Similarity=0.432  Sum_probs=191.6

Q ss_pred             ceecccCcEEEEEEEECC--------ccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEe
Q 013636          159 NVIGEGGRGHVYKARFNE--------KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       159 ~~LG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      +.||+|+||.||+|....        ...+++|.+........+.+.+|+.+++.++|||++++++++..++..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            359999999999997643        234777887655545556789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCc--------EEEEecccc
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFN--------AKLSDFGLS  302 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~--------~kl~DfGls  302 (439)
                      +++|+|.++++..  +..+++..++.++.|++.||+|||+.   +++||||||+||+++.++.        ++++|||++
T Consensus        81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccccc
Confidence            9999999999743  33689999999999999999999998   9999999999999987765        699999998


Q ss_pred             cccCCCCcceeeccccCccchhhhcC-CCCCCchhhHHHHHHHHHHHhC-CCCCCCCChhhhhhhHhhhhcccccCCCCC
Q 013636          303 VTAGTQSRNVKISGTLGYVAPEYLLE-GKLTDKSDVYAFGVVLLELLMG-RRPVEKMSPTQCQSMVTWAMPQLTDRSKLP  380 (439)
Q Consensus       303 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvll~elltG-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  380 (439)
                      .......   ...++..|+|||++.+ ..++.++||||||+++|||++| ..|+...++........       ....++
T Consensus       156 ~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~-------~~~~~~  225 (258)
T cd05078         156 ITVLPKE---ILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYE-------DRHQLP  225 (258)
T ss_pred             cccCCch---hccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHH-------ccccCC
Confidence            6554322   2347889999999987 4578999999999999999998 46666554432221111       111111


Q ss_pred             ccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhcc
Q 013636          381 NIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLI  425 (439)
Q Consensus       381 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  425 (439)
                      ...            ..++.+++.+||+.||++|||++++++.|+
T Consensus       226 ~~~------------~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         226 APK------------WTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             CCC------------cHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            111            235678999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=4.1e-39  Score=318.96  Aligned_cols=264  Identities=23%  Similarity=0.296  Sum_probs=199.7

Q ss_pred             HhcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCceeeeeeEEEeC------
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLLGYCIHA------  221 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  221 (439)
                      ..++|+..+.||+|+||.||++... .+..+|+|.+....  ......+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            3478999999999999999999875 47789999986532  23345688999999999999999999987543      


Q ss_pred             CeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccc
Q 013636          222 ETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGL  301 (439)
Q Consensus       222 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGl  301 (439)
                      ...++||||+++ +|.+.+..     .+++..+..++.|+++||+|||+.   +++||||||+||+++.++.+||+|||+
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~  172 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  172 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCC
Confidence            356999999975 77777642     378899999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhh-----------
Q 013636          302 SVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAM-----------  370 (439)
Q Consensus       302 s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~-----------  370 (439)
                      +.............+|..|+|||.+.+..++.++|||||||++|||++|+.||...+..+....+....           
T Consensus       173 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (364)
T cd07875         173 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL  252 (364)
T ss_pred             ccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence            987654433334568999999999999999999999999999999999999998765432211110000           


Q ss_pred             -----cccccCCCCCc-----cCCchhc---CccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          371 -----PQLTDRSKLPN-----IVDPVIR---DTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       371 -----~~~~~~~~~~~-----~~d~~l~---~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                           ...........     .......   ..........+.+++.+|++.||++|||+.|++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                 00000111000     0000000   00001123467789999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=4.1e-39  Score=304.70  Aligned_cols=252  Identities=27%  Similarity=0.404  Sum_probs=200.0

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEec
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMM  231 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  231 (439)
                      ++|+..+.||+|+||.||+|+.. ++..+++|.++.........+.+|+.+++.++|||++++++++...+..++|+||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            46677788999999999999875 47788999887655445566889999999999999999999999999999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc-
Q 013636          232 QNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR-  310 (439)
Q Consensus       232 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~-  310 (439)
                      ++++|.+++..   ...+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.+||+|||++........ 
T Consensus        89 ~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~  162 (267)
T cd06645          89 GGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAK  162 (267)
T ss_pred             CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcccc
Confidence            99999999863   34689999999999999999999998   999999999999999999999999999865543221 


Q ss_pred             ceeeccccCccchhhhc---CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchh
Q 013636          311 NVKISGTLGYVAPEYLL---EGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVI  387 (439)
Q Consensus       311 ~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  387 (439)
                      .....|+..|+|||.+.   ...++.++|||||||++|||++|..||....+.........      .... +..    .
T Consensus       163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~------~~~~-~~~----~  231 (267)
T cd06645         163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTK------SNFQ-PPK----L  231 (267)
T ss_pred             cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhc------cCCC-CCc----c
Confidence            12345899999999975   45688999999999999999999999876543321111110      0000 000    0


Q ss_pred             cCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          388 RDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       388 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      ....  .....+.+++.+|++.+|++||++.+++++
T Consensus       232 ~~~~--~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         232 KDKM--KWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             cccC--CCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence            0000  112356789999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7e-39  Score=304.37  Aligned_cols=248  Identities=27%  Similarity=0.447  Sum_probs=202.9

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEe
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG-HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      ++|+..+.||.|+||.||+|+.. ++..+++|.+.... ......+.+|+.+++.++|+|++++++++......++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            36777889999999999999876 47788999886543 34446788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCC-
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS-  309 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~-  309 (439)
                      +++++|.++++..    .+++..+..++.|++.|+.|||+.   +++|+||+|+||++++++.++|+|||++....... 
T Consensus        81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  153 (274)
T cd06609          81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS  153 (274)
T ss_pred             eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence            9999999998642    689999999999999999999998   99999999999999999999999999997765432 


Q ss_pred             cceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcC
Q 013636          310 RNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRD  389 (439)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  389 (439)
                      ......++..|+|||.+.+..++.++||||||+++|||++|+.||...++......+..        ...+...+     
T Consensus       154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~--------~~~~~~~~-----  220 (274)
T cd06609         154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK--------NNPPSLEG-----  220 (274)
T ss_pred             ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhh--------cCCCCCcc-----
Confidence            22334578899999999998999999999999999999999999987654332211110        00111111     


Q ss_pred             ccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          390 TMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       390 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      .   .....+.+++.+||..+|++|||+++++++
T Consensus       221 ~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         221 N---KFSKPFKDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             c---ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            0   012356779999999999999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=7.1e-39  Score=300.99  Aligned_cols=250  Identities=25%  Similarity=0.341  Sum_probs=201.9

Q ss_pred             CCCccceecccCcEEEEEEEEC-CccEEEEEEecCC-CchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEec
Q 013636          154 NFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDA-GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMM  231 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  231 (439)
                      +|++.+.||+|+||.||+++.. ++..+++|.++.. .....+.+.+|+.+++.++|+|++++++++...+..+++|||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4677899999999999999875 4778899987543 2334567889999999999999999999999999999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc-
Q 013636          232 QNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR-  310 (439)
Q Consensus       232 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~-  310 (439)
                      ++|+|.+++... .+..+++.....++.|++.||.|||+.   +++|+||||+||++++++.++++|||++........ 
T Consensus        81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~  156 (255)
T cd08219          81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY  156 (255)
T ss_pred             CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence            999999988642 344588999999999999999999998   999999999999999999999999999976543222 


Q ss_pred             ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCc
Q 013636          311 NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDT  390 (439)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  390 (439)
                      .....|+..|+|||++.+..++.++|+||||+++|+|++|+.||...+.......+..     .....++.         
T Consensus       157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~---------  222 (255)
T cd08219         157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQ-----GSYKPLPS---------  222 (255)
T ss_pred             cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhc-----CCCCCCCc---------
Confidence            2234588899999999998999999999999999999999999987654332111110     00111111         


Q ss_pred             cCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhc
Q 013636          391 MDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL  424 (439)
Q Consensus       391 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  424 (439)
                         .....+.+++.+||+.||++|||+.+++...
T Consensus       223 ---~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~  253 (255)
T cd08219         223 ---HYSYELRSLIKQMFKRNPRSRPSATTILSRG  253 (255)
T ss_pred             ---ccCHHHHHHHHHHHhCCcccCCCHHHHhhcc
Confidence               1123466799999999999999999998653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-39  Score=307.20  Aligned_cols=252  Identities=26%  Similarity=0.435  Sum_probs=203.2

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEe
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      .++|++.+.||+|+||.||++... ++..+++|............|.+|++++++++|||++++++++...+..++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            456888899999999999999885 5788999998766555667899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCC-
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS-  309 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~-  309 (439)
                      +++++|.+++..  .+..+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++....... 
T Consensus        84 ~~~~~L~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (280)
T cd06611          84 CDGGALDSIMLE--LERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ  158 (280)
T ss_pred             cCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence            999999999864  234689999999999999999999998   99999999999999999999999999986543322 


Q ss_pred             cceeeccccCccchhhhc-----CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCC
Q 013636          310 RNVKISGTLGYVAPEYLL-----EGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVD  384 (439)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  384 (439)
                      ......++..|+|||.+.     ...++.++|+||||+++|||++|+.||...++........  .      ...+....
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~------~~~~~~~~  230 (280)
T cd06611         159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKIL--K------SEPPTLDQ  230 (280)
T ss_pred             ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHh--c------CCCCCcCC
Confidence            122345889999999985     3456789999999999999999999998765433221111  0      00000000


Q ss_pred             chhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          385 PVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       385 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      +       ......+.+++..||+.+|++||++.+++++
T Consensus       231 ~-------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         231 P-------SKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             c-------ccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            0       0112356679999999999999999999976

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.9e-39  Score=300.80  Aligned_cols=254  Identities=27%  Similarity=0.404  Sum_probs=205.7

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEe
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      .++|+..+.||+|+||.||++... ++..+++|.+........+.+.+|+.++++++|||++++++++...+..+++|||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            367888999999999999999875 4677899988765555667899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCC-
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS-  309 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~-  309 (439)
                      +++++|.+++...  ...+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.+||+|||++....... 
T Consensus        82 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  156 (262)
T cd06613          82 CGGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA  156 (262)
T ss_pred             CCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence            9999999998642  24689999999999999999999997   99999999999999999999999999987654322 


Q ss_pred             cceeeccccCccchhhhcCC---CCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCch
Q 013636          310 RNVKISGTLGYVAPEYLLEG---KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPV  386 (439)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  386 (439)
                      ......++..|+|||.+.+.   .++.++||||||+++|||++|+.||...++........  ....    ..     +.
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~--~~~~----~~-----~~  225 (262)
T cd06613         157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLIS--KSNF----PP-----PK  225 (262)
T ss_pred             ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hccC----CC-----cc
Confidence            22234578899999999876   88999999999999999999999998765443221111  0000    00     00


Q ss_pred             hcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          387 IRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       387 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      +.  ........+.+++.+||+.+|++|||+.+++.+
T Consensus       226 ~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         226 LK--DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             cc--chhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00  011234567889999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.6e-39  Score=305.04  Aligned_cols=254  Identities=26%  Similarity=0.474  Sum_probs=204.1

Q ss_pred             cCCCccceecccCcEEEEEEEECC-----ccEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNE-----KLLAAVKRIDDAGH-DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFL  226 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  226 (439)
                      .+|+..+.||+|+||.||+|...+     ...+++|....... ....++.+|+.++++++|||+++++++|.. +..++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            467778999999999999998643     23578888765543 345678999999999999999999999987 78899


Q ss_pred             EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccC
Q 013636          227 VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAG  306 (439)
Q Consensus       227 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~  306 (439)
                      |+||+++|+|.+++...  ...+++..+..++.|++.|++|||+.   +++||||||+||++++++.+||+|||++....
T Consensus        86 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          86 ITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             EEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccccccc
Confidence            99999999999999742  34589999999999999999999997   99999999999999999999999999997654


Q ss_pred             CCCccee---eccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCcc
Q 013636          307 TQSRNVK---ISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNI  382 (439)
Q Consensus       307 ~~~~~~~---~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  382 (439)
                      .......   ..++..|+|||.+....++.++|+||||+++||+++ |+.||......+....+...     .....+..
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~  235 (279)
T cd05057         161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKG-----ERLPQPPI  235 (279)
T ss_pred             CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC-----CCCCCCCC
Confidence            3322211   113567999999998899999999999999999998 99999877654433222210     00111111


Q ss_pred             CCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCC
Q 013636          383 VDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVP  429 (439)
Q Consensus       383 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~  429 (439)
                                  ....+.+++.+||..||++||++.++++.|..+..
T Consensus       236 ------------~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         236 ------------CTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             ------------CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                        12346778999999999999999999999987754

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.9e-39  Score=308.04  Aligned_cols=254  Identities=25%  Similarity=0.405  Sum_probs=201.1

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCC-CchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEe
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDA-GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      ++|++.+.||+|+||.||++... .+..+|+|.+... .......+.+|+.++++++|+|++++++++...+..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            35777899999999999999886 5788899988653 233346789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR  310 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~  310 (439)
                      +++++|..++........+++..+..++.|++.||.|||+.  .+++|+||||+||+++.++.+||+|||++........
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  158 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA  158 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc
Confidence            99999999987543345789999999999999999999963  2899999999999999999999999999876533222


Q ss_pred             ceeeccccCccchhhhcCC------CCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCC
Q 013636          311 NVKISGTLGYVAPEYLLEG------KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVD  384 (439)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~~------~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  384 (439)
                       ....++..|+|||.+.+.      .++.++|+|||||++|||++|+.||.................  .....++    
T Consensus       159 -~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~----  231 (286)
T cd06622         159 -KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD--GDPPTLP----  231 (286)
T ss_pred             -ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhh--cCCCCCC----
Confidence             223478899999998654      347899999999999999999999976543322221111000  0001111    


Q ss_pred             chhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          385 PVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       385 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                              ......+.+++.+||+.+|++||++.+++++
T Consensus       232 --------~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         232 --------SGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             --------cccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence                    1123456779999999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=5.7e-39  Score=306.78  Aligned_cols=260  Identities=27%  Similarity=0.414  Sum_probs=200.1

Q ss_pred             cCCCccceecccCcEEEEEEEE-----CCccEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCceeeeeeEEEeC--Cee
Q 013636          153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDAG-HDAEREFNNEVNWLTKIRHQNIISLLGYCIHA--ETR  224 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  224 (439)
                      ..|++.+.||+|+||.||.++.     ..+..+++|.+.... ......+.+|+.+++.++|||++++.+++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            3567789999999999999975     346789999987543 33346799999999999999999999998775  567


Q ss_pred             EEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccc
Q 013636          225 FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT  304 (439)
Q Consensus       225 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~  304 (439)
                      ++||||+++++|.+++...  ...+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||++..
T Consensus        84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKA  158 (284)
T ss_pred             EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccc
Confidence            9999999999999998642  23589999999999999999999998   999999999999999999999999999976


Q ss_pred             cCCCCcc----eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhh--------hhhhHhhhhcc
Q 013636          305 AGTQSRN----VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQ--------CQSMVTWAMPQ  372 (439)
Q Consensus       305 ~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~--------~~~~~~~~~~~  372 (439)
                      .......    ....++..|+|||.+.+..++.++||||||+++|||++++.|........        ...........
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05079         159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV  238 (284)
T ss_pred             cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence            5433221    12346678999999998899999999999999999999877653211000        00000000000


Q ss_pred             cccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhcccc
Q 013636          373 LTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPL  427 (439)
Q Consensus       373 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l  427 (439)
                      .......+          ........+.+++.+||+.||++|||++++++.|+.+
T Consensus       239 ~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         239 LEEGKRLP----------RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHcCccCC----------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            00000000          0011235688899999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=9.5e-39  Score=302.63  Aligned_cols=250  Identities=25%  Similarity=0.365  Sum_probs=188.4

Q ss_pred             eecccCcEEEEEEEECC---ccEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEeccCCC
Q 013636          160 VIGEGGRGHVYKARFNE---KLLAAVKRIDDAG-HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGS  235 (439)
Q Consensus       160 ~LG~G~fg~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  235 (439)
                      .||+|+||.||+|...+   ...+++|.+.... ......|.+|+..++.++|+||+++++++...+..++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            58999999999997643   3467888776433 2344678899999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc---
Q 013636          236 LEKQLHGPTH--GSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR---  310 (439)
Q Consensus       236 L~~~l~~~~~--~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~---  310 (439)
                      |.+++.....  ....++.....++.|++.|++|||+.   +++||||||+||++++++++||+|||++........   
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            9999975322  23456788899999999999999998   999999999999999999999999999865432211   


Q ss_pred             ceeeccccCccchhhhcC-------CCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCcc
Q 013636          311 NVKISGTLGYVAPEYLLE-------GKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNI  382 (439)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  382 (439)
                      .....++..|+|||++..       ..++.++|||||||++|||++ |..||....+.+.......        ......
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~--------~~~~~~  230 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVR--------EQDIKL  230 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhh--------ccCccC
Confidence            112235677999999753       356789999999999999999 8889977654332111110        000111


Q ss_pred             CCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhcc
Q 013636          383 VDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLI  425 (439)
Q Consensus       383 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  425 (439)
                      .++.+...    ....+.+++..|+ .||++|||+++|++.|.
T Consensus       231 ~~~~~~~~----~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         231 PKPQLDLK----YSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCCccccc----CCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            12222211    1234455777788 59999999999998873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.6e-39  Score=321.43  Aligned_cols=250  Identities=20%  Similarity=0.320  Sum_probs=196.1

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC---chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      ++|+..+.||+|+||.||+++.. .+..+|+|.+....   ......+.+|+.++..++|||++++++++.+.+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46788899999999999999876 47889999986432   233456888999999999999999999999999999999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~  308 (439)
                      ||+++|+|.+++..   ...+++..+..++.|++.||+|||+.   +++||||||+|||++.++++||+|||++......
T Consensus        81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~  154 (360)
T cd05627          81 EFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA  154 (360)
T ss_pred             eCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence            99999999999964   34589999999999999999999998   9999999999999999999999999998643211


Q ss_pred             C------------------------------------cceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCC
Q 013636          309 S------------------------------------RNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRR  352 (439)
Q Consensus       309 ~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~  352 (439)
                      .                                    ......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~  234 (360)
T cd05627         155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (360)
T ss_pred             cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence            0                                    0112458999999999999999999999999999999999999


Q ss_pred             CCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHh
Q 013636          353 PVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPL---ITDVLHS  423 (439)
Q Consensus       353 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt---~~evl~~  423 (439)
                      ||...++......+...    ......+..    .  ..    ...+.+++.+|+. ||.+|++   +.+++++
T Consensus       235 Pf~~~~~~~~~~~i~~~----~~~~~~p~~----~--~~----s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h  293 (360)
T cd05627         235 PFCSETPQETYRKVMNW----KETLVFPPE----V--PI----SEKAKDLILRFCT-DSENRIGSNGVEEIKSH  293 (360)
T ss_pred             CCCCCCHHHHHHHHHcC----CCceecCCC----C--CC----CHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence            99887665433222110    000011110    0  01    1234556666664 9999985   6777765

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.7e-39  Score=320.79  Aligned_cols=256  Identities=21%  Similarity=0.296  Sum_probs=199.9

Q ss_pred             HHHHhcCCCccceecccCcEEEEEEEECC-ccEEEEEEecCC---CchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCe
Q 013636          148 LEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDA---GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAET  223 (439)
Q Consensus       148 l~~~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  223 (439)
                      ++...++|++.+.||+|+||.||+++... +..+|+|.+...   .......+.+|+.+++.++||||+++++++...+.
T Consensus        38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (371)
T cd05622          38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY  117 (371)
T ss_pred             cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence            44456899999999999999999998864 678899988642   12234457889999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccccc
Q 013636          224 RFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSV  303 (439)
Q Consensus       224 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~  303 (439)
                      .++||||+++|+|.+++...    .++...+..++.|++.||+|||+.   +|+||||||+|||+++++++||+|||++.
T Consensus       118 ~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~  190 (371)
T cd05622         118 LYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCM  190 (371)
T ss_pred             EEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence            99999999999999998642    478888999999999999999998   99999999999999999999999999997


Q ss_pred             ccCCCCc--ceeeccccCccchhhhcCC----CCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCC
Q 013636          304 TAGTQSR--NVKISGTLGYVAPEYLLEG----KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRS  377 (439)
Q Consensus       304 ~~~~~~~--~~~~~gt~~y~aPE~~~~~----~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  377 (439)
                      .......  .....||+.|+|||++...    .++.++|||||||++|||++|+.||...+.......+...    ....
T Consensus       191 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~----~~~~  266 (371)
T cd05622         191 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNH----KNSL  266 (371)
T ss_pred             EcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC----CCcc
Confidence            6543221  1234699999999998754    3788999999999999999999999876653322222100    0001


Q ss_pred             CCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHhc
Q 013636          378 KLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSY--RPLITDVLHSL  424 (439)
Q Consensus       378 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~evl~~L  424 (439)
                      ..+.   .   .    .....+.+++..|++.++.+  ||++.|++++.
T Consensus       267 ~~~~---~---~----~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         267 TFPD---D---N----DISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             cCCC---c---C----CCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence            1111   0   0    11234566888899854443  78999999875

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-39  Score=313.42  Aligned_cols=253  Identities=21%  Similarity=0.271  Sum_probs=194.6

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCC---CchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDA---GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      ++|++.+.||+|+||.||+++.. ++..+|+|.+...   .....+.+.+|..++..++|+||+++++++...+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            46888999999999999999875 4788999998642   2223456889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~  308 (439)
                      ||+++|+|.+++..  ....+++..+..++.|++.||+|||+.   +++||||||+|||++.++++||+|||++......
T Consensus        81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (331)
T cd05597          81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD  155 (331)
T ss_pred             ecCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence            99999999999964  234688999999999999999999998   9999999999999999999999999998665432


Q ss_pred             Ccc--eeeccccCccchhhhcC-----CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCc
Q 013636          309 SRN--VKISGTLGYVAPEYLLE-----GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPN  381 (439)
Q Consensus       309 ~~~--~~~~gt~~y~aPE~~~~-----~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  381 (439)
                      ...  ....||+.|+|||++..     ..++.++|||||||++|||++|+.||...+..+....+..    ......++.
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~----~~~~~~~~~  231 (331)
T cd05597         156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN----HKEHFQFPP  231 (331)
T ss_pred             CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHc----CCCcccCCC
Confidence            221  22458999999999873     4578899999999999999999999987654332211110    000011111


Q ss_pred             cCCchhcCccCHHHHHHHHHHHHHhcCC--CCCCCCCHHHHHHh
Q 013636          382 IVDPVIRDTMDLKHLYQVAAVAVLCIQP--EPSYRPLITDVLHS  423 (439)
Q Consensus       382 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~--dP~~RPt~~evl~~  423 (439)
                      .     ....    ...+.+++.+|+..  ++..||++.+++++
T Consensus       232 ~-----~~~~----~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         232 D-----VTDV----SEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             c-----cCCC----CHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            0     0011    22345566666544  44458899999977

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-38  Score=297.92  Aligned_cols=245  Identities=29%  Similarity=0.451  Sum_probs=200.1

Q ss_pred             ceecccCcEEEEEEEECCccEEEEEEecCCCch-HHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEeccCCChh
Q 013636          159 NVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHD-AEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLE  237 (439)
Q Consensus       159 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~  237 (439)
                      ++||+|+||.||++...++..+++|........ ....+.+|++++++++|+||+++++++...+..++|+||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            469999999999999887889999988765443 4567999999999999999999999999999999999999999999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCcc---eee
Q 013636          238 KQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN---VKI  314 (439)
Q Consensus       238 ~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~~---~~~  314 (439)
                      +++...  ...+++..+..++.+++.|++|||+.   +++||||+|+||+++.++.+||+|||++.........   ...
T Consensus        81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence            999642  33588999999999999999999998   9999999999999999999999999998755422111   111


Q ss_pred             ccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCccCH
Q 013636          315 SGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDL  393 (439)
Q Consensus       315 ~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  393 (439)
                      ..+..|+|||.+.++.++.++|+||||+++|||++ |..||....+......+...     .....+            .
T Consensus       156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~-----~~~~~~------------~  218 (251)
T cd05041         156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESG-----YRMPAP------------Q  218 (251)
T ss_pred             cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcC-----CCCCCC------------c
Confidence            23567999999998899999999999999999999 89999876654333222110     000011            1


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCCCHHHHHHhcc
Q 013636          394 KHLYQVAAVAVLCIQPEPSYRPLITDVLHSLI  425 (439)
Q Consensus       394 ~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  425 (439)
                      .....+.+++.+|++.+|++|||+.|+++.|+
T Consensus       219 ~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         219 LCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             cCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            12346788999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.7e-39  Score=309.64  Aligned_cols=261  Identities=26%  Similarity=0.416  Sum_probs=203.4

Q ss_pred             cCCCccceecccCcEEEEEEEEC-----CccEEEEEEecCCCch-HHHHHHHHHHHHHhcCCCceeeeeeEEEe--CCee
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-----EKLLAAVKRIDDAGHD-AEREFNNEVNWLTKIRHQNIISLLGYCIH--AETR  224 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~  224 (439)
                      +.|+..+.||+|+||.||+++..     .+..+|+|.+...... ..+.|.+|+++++.++|+|++++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            35667789999999999999864     3578999998765543 45689999999999999999999999887  5578


Q ss_pred             EEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccc
Q 013636          225 FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT  304 (439)
Q Consensus       225 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~  304 (439)
                      +++|||+++++|.+++...  ...+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++..
T Consensus        84 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             EEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence            9999999999999999743  23589999999999999999999997   999999999999999999999999999977


Q ss_pred             cCCCCcce----eeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhh--------hhHhhhhcc
Q 013636          305 AGTQSRNV----KISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQ--------SMVTWAMPQ  372 (439)
Q Consensus       305 ~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~--------~~~~~~~~~  372 (439)
                      ........    ...++..|+|||.+.+..++.++||||||+++|||++|+.|+.........        .........
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05038         159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL  238 (284)
T ss_pred             cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence            65322211    122456799999999899999999999999999999999998653322100        000000000


Q ss_pred             cccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccC
Q 013636          373 LTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLV  428 (439)
Q Consensus       373 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~  428 (439)
                      +.....          .........++.+++.+||+.+|++|||+.||++.|+.++
T Consensus       239 ~~~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~  284 (284)
T cd05038         239 LKEGER----------LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR  284 (284)
T ss_pred             HHcCCc----------CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence            000000          0001122356888999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=9e-39  Score=302.03  Aligned_cols=249  Identities=26%  Similarity=0.423  Sum_probs=199.4

Q ss_pred             CCCccceecccCcEEEEEEEECCccEEEEEEecCCCc------hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEE
Q 013636          154 NFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGH------DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLV  227 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  227 (439)
                      +|+..+.||+|+||+||+|...++..+|+|.+.....      .....+.+|++++++++|+|++++++++...+..+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            4677899999999999999988888999998864321      1224588999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCC
Q 013636          228 YEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT  307 (439)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~  307 (439)
                      +||+++++|.+++...   ..+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          81 MEFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            9999999999999642   3578999999999999999999998   999999999999999999999999999865421


Q ss_pred             C-------CcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCC
Q 013636          308 Q-------SRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLP  380 (439)
Q Consensus       308 ~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  380 (439)
                      .       .......++..|+|||.+.+..++.++||||||+++|||++|+.||...+..........      .....+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~------~~~~~~  228 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGA------HRGLMP  228 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhh------ccCCCC
Confidence            1       111223578899999999988899999999999999999999999976553321111110      000111


Q ss_pred             ccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          381 NIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       381 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      .     +..    .....+.+++.+||+.+|++||++.+++++
T Consensus       229 ~-----~~~----~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  262 (265)
T cd06631         229 R-----LPD----SFSAAAIDFVTSCLTRDQHERPSALQLLRH  262 (265)
T ss_pred             C-----CCC----CCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            1     111    123456779999999999999999999863

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=4e-39  Score=340.53  Aligned_cols=259  Identities=22%  Similarity=0.330  Sum_probs=201.7

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC---chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      ++|++.++||+|+||.||+|... .+..+|+|++....   ....++|.+|+.++++++||||+++++++.+++..+++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57888999999999999999876 47889999986432   223457899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhcCCC--------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecc
Q 013636          229 EMMQNGSLEKQLHGPT--------HGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFG  300 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfG  300 (439)
                      ||+++|+|.+++....        ....+++..+++++.|+++||+|||+.   +++||||||+||+++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence            9999999999986411        123467788899999999999999998   99999999999999999999999999


Q ss_pred             cccccCCCC-------------------cceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhh
Q 013636          301 LSVTAGTQS-------------------RNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQ  361 (439)
Q Consensus       301 ls~~~~~~~-------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~  361 (439)
                      ++.......                   ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            997552110                   0112358999999999999999999999999999999999999997644322


Q ss_pred             hhhhHhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHhccccCC
Q 013636          362 CQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRP-LITDVLHSLIPLVP  429 (439)
Q Consensus       362 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~evl~~L~~l~~  429 (439)
                      ....     .........    .+      .......+.+++.+|++.||++|| +++++.+.|++...
T Consensus       239 i~~~-----~~i~~P~~~----~p------~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq  292 (932)
T PRK13184        239 ISYR-----DVILSPIEV----AP------YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ  292 (932)
T ss_pred             hhhh-----hhccChhhc----cc------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            1100     000000000    00      001123567799999999999996 56777777766543

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.4e-39  Score=315.68  Aligned_cols=237  Identities=27%  Similarity=0.352  Sum_probs=187.2

Q ss_pred             ceecccCcEEEEEEEECC-ccEEEEEEecCCC---chHHHHHHHHH-HHHHhcCCCceeeeeeEEEeCCeeEEEEEeccC
Q 013636          159 NVIGEGGRGHVYKARFNE-KLLAAVKRIDDAG---HDAEREFNNEV-NWLTKIRHQNIISLLGYCIHAETRFLVYEMMQN  233 (439)
Q Consensus       159 ~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  233 (439)
                      +.||+|+||+||+++... +..+|+|.+....   ......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            369999999999998864 5778999986432   12223444444 456788999999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCC-CCcce
Q 013636          234 GSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT-QSRNV  312 (439)
Q Consensus       234 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~-~~~~~  312 (439)
                      |+|.+++..   ...+++.....++.|+++||+|||+.   +++||||||+|||+++++.+||+|||++..... .....
T Consensus        81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~  154 (325)
T cd05602          81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTS  154 (325)
T ss_pred             CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcc
Confidence            999999964   34578888889999999999999998   999999999999999999999999999875322 22233


Q ss_pred             eeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCccC
Q 013636          313 KISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMD  392 (439)
Q Consensus       313 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  392 (439)
                      ...||+.|+|||.+.+..++.++|||||||++|||++|+.||...+..+....+.      ......    .+    .. 
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~------~~~~~~----~~----~~-  219 (325)
T cd05602         155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL------NKPLQL----KP----NI-  219 (325)
T ss_pred             cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHH------hCCcCC----CC----CC-
Confidence            4569999999999999999999999999999999999999998766543222211      001111    11    11 


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 013636          393 LKHLYQVAAVAVLCIQPEPSYRPLITD  419 (439)
Q Consensus       393 ~~~~~~l~~l~~~cl~~dP~~RPt~~e  419 (439)
                         ...+.+++..|++.||.+||++.+
T Consensus       220 ---~~~~~~li~~~l~~~p~~R~~~~~  243 (325)
T cd05602         220 ---TNSARHLLEGLLQKDRTKRLGAKD  243 (325)
T ss_pred             ---CHHHHHHHHHHcccCHHHCCCCCC
Confidence               234667899999999999998763

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=9e-39  Score=300.21  Aligned_cols=248  Identities=25%  Similarity=0.446  Sum_probs=200.8

Q ss_pred             CCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC-----chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEE
Q 013636          154 NFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG-----HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLV  227 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  227 (439)
                      +|+..+.||+|+||.||+|... ++..+++|.+....     ....+.+.+|+.+++.++|+|++++++++...+..+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4667789999999999999886 67889999875432     23446789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCC
Q 013636          228 YEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT  307 (439)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~  307 (439)
                      +||+++++|.+++...   ..+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.+||+|||++.....
T Consensus        81 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          81 LELVPGGSLAKLLKKY---GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             EEecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            9999999999999642   3588999999999999999999998   999999999999999999999999999876544


Q ss_pred             CCcceeeccccCccchhhhcCCC-CCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCch
Q 013636          308 QSRNVKISGTLGYVAPEYLLEGK-LTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPV  386 (439)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  386 (439)
                      ........++..|+|||.+.... ++.++|+||||+++|+|++|+.||....+........    .......++..+   
T Consensus       155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~----~~~~~~~~~~~~---  227 (258)
T cd06632         155 FSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIG----RSKELPPIPDHL---  227 (258)
T ss_pred             cccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHH----hcccCCCcCCCc---
Confidence            33233445889999999998776 8999999999999999999999997655322111111    001111111111   


Q ss_pred             hcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          387 IRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       387 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                               ...+.+++.+||+.+|++||++.+++++
T Consensus       228 ---------~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         228 ---------SDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             ---------CHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence                     2345678999999999999999999864

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=7.6e-39  Score=308.16  Aligned_cols=250  Identities=22%  Similarity=0.378  Sum_probs=203.4

Q ss_pred             hcCCCccceecccCcEEEEEEEE-CCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEe
Q 013636          152 TNNFQESNVIGEGGRGHVYKARF-NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      .++|+..+.||+|+||.||++.. .++..+|+|.+........+.+.+|+.+++.++|+|++++++++..++..++||||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            36788899999999999999987 46888999998765555567789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR  310 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~  310 (439)
                      +++++|.+++..    ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++........
T Consensus        98 ~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~  170 (297)
T cd06656          98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (297)
T ss_pred             cCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence            999999999853    3478999999999999999999998   999999999999999999999999999876543322


Q ss_pred             -ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcC
Q 013636          311 -NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRD  389 (439)
Q Consensus       311 -~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  389 (439)
                       .....+++.|+|||.+.+..++.++|+|||||++|++++|+.||...++.......       . ....+....+    
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~-------~-~~~~~~~~~~----  238 (297)
T cd06656         171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-------A-TNGTPELQNP----  238 (297)
T ss_pred             CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee-------c-cCCCCCCCCc----
Confidence             12345788999999999989999999999999999999999999765442211100       0 0000010011    


Q ss_pred             ccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          390 TMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       390 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                         ......+.+++.+||+.+|++||++.+++++
T Consensus       239 ---~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (297)
T cd06656         239 ---ERLSAVFRDFLNRCLEMDVDRRGSAKELLQH  269 (297)
T ss_pred             ---cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               0112346678999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.5e-38  Score=302.16  Aligned_cols=254  Identities=26%  Similarity=0.429  Sum_probs=202.1

Q ss_pred             cCCCccceecccCcEEEEEEEEC------CccEEEEEEecCCCch-HHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN------EKLLAAVKRIDDAGHD-AEREFNNEVNWLTKIRHQNIISLLGYCIHAETRF  225 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  225 (439)
                      ++|+....||+|+||.||+|+..      +...+++|.+...... ....+.+|++++++++|+|++++++++...+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            56788899999999999999864      2457888988764433 4467999999999999999999999999989999


Q ss_pred             EEEEeccCCChhhhhcCCCCC------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEec
Q 013636          226 LVYEMMQNGSLEKQLHGPTHG------SNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDF  299 (439)
Q Consensus       226 lV~e~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~Df  299 (439)
                      +||||+++|+|.+++......      ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence            999999999999999753322      2589999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCCc--ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccC
Q 013636          300 GLSVTAGTQSR--NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDR  376 (439)
Q Consensus       300 Gls~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~  376 (439)
                      |++........  .....++..|+|||.+.+...+.++||||||+++|+|++ |..||..............        
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~--------  233 (275)
T cd05046         162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQA--------  233 (275)
T ss_pred             ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHc--------
Confidence            99864432211  112235678999999998889999999999999999999 8889976544332222110        


Q ss_pred             CCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhcc
Q 013636          377 SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLI  425 (439)
Q Consensus       377 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  425 (439)
                      .... +..   ..    .....+.+++.+||+.+|++|||+.|++..|.
T Consensus       234 ~~~~-~~~---~~----~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         234 GKLE-LPV---PE----GCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             CCcC-CCC---CC----CCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            0000 000   01    11236778999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.1e-39  Score=316.13  Aligned_cols=236  Identities=25%  Similarity=0.319  Sum_probs=188.1

Q ss_pred             ceecccCcEEEEEEEEC-CccEEEEEEecCCC---chHHHHHHHHHH-HHHhcCCCceeeeeeEEEeCCeeEEEEEeccC
Q 013636          159 NVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG---HDAEREFNNEVN-WLTKIRHQNIISLLGYCIHAETRFLVYEMMQN  233 (439)
Q Consensus       159 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  233 (439)
                      +.||+|+||+||+++.. ++..+|+|.+....   ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            36999999999999875 57889999986431   223345555654 46778999999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCC-CCcce
Q 013636          234 GSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT-QSRNV  312 (439)
Q Consensus       234 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~-~~~~~  312 (439)
                      |+|..++..   ...+++..+..++.|++.||+|||+.   +++||||||+|||+++++.+||+|||++..... .....
T Consensus        81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~  154 (325)
T cd05604          81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTT  154 (325)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcc
Confidence            999988853   34689999999999999999999998   999999999999999999999999999875322 22223


Q ss_pred             eeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCccC
Q 013636          313 KISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMD  392 (439)
Q Consensus       313 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  392 (439)
                      ...||+.|+|||.+.+..++.++|||||||++|||++|+.||...+..+....+.      .....    ..+    .  
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~------~~~~~----~~~----~--  218 (325)
T cd05604         155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNIL------HKPLV----LRP----G--  218 (325)
T ss_pred             cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHH------cCCcc----CCC----C--
Confidence            4568999999999999999999999999999999999999998765443222211      00100    111    1  


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCHH
Q 013636          393 LKHLYQVAAVAVLCIQPEPSYRPLIT  418 (439)
Q Consensus       393 ~~~~~~l~~l~~~cl~~dP~~RPt~~  418 (439)
                        ....+.+++..|++.||++||++.
T Consensus       219 --~~~~~~~ll~~ll~~~p~~R~~~~  242 (325)
T cd05604         219 --ASLTAWSILEELLEKDRQRRLGAK  242 (325)
T ss_pred             --CCHHHHHHHHHHhccCHHhcCCCC
Confidence              123456789999999999999885

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1e-38  Score=307.08  Aligned_cols=249  Identities=22%  Similarity=0.389  Sum_probs=203.6

Q ss_pred             cCCCccceecccCcEEEEEEEE-CCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEec
Q 013636          153 NNFQESNVIGEGGRGHVYKARF-NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMM  231 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  231 (439)
                      .+|+..+.||.|+||.||+|.. .++..+++|.+........+.+.+|+.+++.++|||++++++++...+..++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            4688889999999999999986 457889999987655555677899999999999999999999999999999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc-
Q 013636          232 QNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR-  310 (439)
Q Consensus       232 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~-  310 (439)
                      ++++|.+++..    ..+++.++..++.|++.|++|||+.   +++||||+|+||+++.++.+||+|||++........ 
T Consensus        99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~  171 (296)
T cd06655          99 AGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK  171 (296)
T ss_pred             CCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence            99999998853    2489999999999999999999998   999999999999999999999999999876543322 


Q ss_pred             ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCc
Q 013636          311 NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDT  390 (439)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  390 (439)
                      .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...++......+..   .  ...   ....+   . 
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~---~--~~~---~~~~~---~-  239 (296)
T cd06655         172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT---N--GTP---ELQNP---E-  239 (296)
T ss_pred             CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---c--CCc---ccCCc---c-
Confidence            1234588899999999998899999999999999999999999987665432221110   0  000   00000   0 


Q ss_pred             cCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          391 MDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       391 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                         .....+.+++.+||+.||++||++.+++++
T Consensus       240 ---~~~~~~~~li~~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         240 ---KLSPIFRDFLNRCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             ---cCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence               112346678999999999999999999854

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2.1e-38  Score=297.89  Aligned_cols=250  Identities=24%  Similarity=0.376  Sum_probs=203.8

Q ss_pred             CCCccceecccCcEEEEEEEEC-CccEEEEEEecCC--CchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEe
Q 013636          154 NFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDA--GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      +|+..+.||+|+||.||.++.. ++..+++|.+...  .....+++.+|+.++++++|+|++++++++...+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            4778899999999999999864 4678899987643  234456788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCC-
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS-  309 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~-  309 (439)
                      +++|+|.+++.... ...+++..+..++.|+++|++|||+.   +++|+||+|+||++++++.+||+|||++....... 
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~  156 (256)
T cd08221          81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS  156 (256)
T ss_pred             cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence            99999999997532 45689999999999999999999997   99999999999999999999999999987654333 


Q ss_pred             cceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcC
Q 013636          310 RNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRD  389 (439)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  389 (439)
                      ......+++.|+|||.+.+..++.++||||||+++|||++|..||...++.+....+.        ........     .
T Consensus       157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~--------~~~~~~~~-----~  223 (256)
T cd08221         157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIV--------QGNYTPVV-----S  223 (256)
T ss_pred             cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH--------cCCCCCCc-----c
Confidence            2223458899999999998889999999999999999999999998765443222211        01111100     1


Q ss_pred             ccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhc
Q 013636          390 TMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL  424 (439)
Q Consensus       390 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  424 (439)
                          .....+.+++.+||+.+|++||++.++++++
T Consensus       224 ----~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         224 ----VYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             ----ccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence                1234577799999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=8.8e-39  Score=308.15  Aligned_cols=264  Identities=23%  Similarity=0.334  Sum_probs=199.0

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEe
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG-HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      ++|+..+.||+|+||.||+|+.. ++..+|+|.+.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            46888899999999999999875 46789999886432 22334677899999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR  310 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~  310 (439)
                      ++ ++|.+++...  ...+++..+..++.|+++||+|||+.   +++|+||||+||++++++.+||+|||++........
T Consensus        86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  159 (301)
T cd07873          86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  159 (301)
T ss_pred             cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence            97 5899888642  34688999999999999999999998   999999999999999999999999999865433221


Q ss_pred             -ceeeccccCccchhhhcCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcc--------cccC----
Q 013636          311 -NVKISGTLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQ--------LTDR----  376 (439)
Q Consensus       311 -~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~--------~~~~----  376 (439)
                       .....+++.|+|||.+.+. .++.++|||||||++|||++|+.||...+..+...........        ....    
T Consensus       160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (301)
T cd07873         160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK  239 (301)
T ss_pred             cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence             1223468899999998754 5788999999999999999999999876543322111111000        0000    


Q ss_pred             -CCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          377 -SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       377 -~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                       ...+....+.+.. ........+.+++.+|++.||.+|||+.|++++
T Consensus       240 ~~~~~~~~~~~~~~-~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h  286 (301)
T cd07873         240 SYNYPKYRADCLHN-HAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH  286 (301)
T ss_pred             ccccCccccccHHh-hcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence             0011111100000 000112356789999999999999999999975

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.5e-38  Score=298.52  Aligned_cols=249  Identities=25%  Similarity=0.380  Sum_probs=202.2

Q ss_pred             CCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEe
Q 013636          154 NFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      +|+..+.||+|+||.||++... ++..+++|.+....  ....+.+.+|+.++++++|||++++++.+..++..++|+||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            4778899999999999999874 57788999886532  33456789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC-CcEEEEecccccccCCCC
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS-FNAKLSDFGLSVTAGTQS  309 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~-~~~kl~DfGls~~~~~~~  309 (439)
                      +++++|.+++... .+..+++..+.+++.++++|++|||++   +++|+||+|+||+++++ +.+||+|||++.......
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence            9999999999752 244589999999999999999999998   99999999999999855 468999999998765544


Q ss_pred             cceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcC
Q 013636          310 RNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRD  389 (439)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  389 (439)
                      ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...+..........     .....++.        
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~--------  223 (256)
T cd08220         157 KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMS-----GTFAPISD--------  223 (256)
T ss_pred             cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHh-----cCCCCCCC--------
Confidence            43445688999999999988899999999999999999999999987654332111110     00011111        


Q ss_pred             ccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          390 TMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       390 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                          .....+.+++.+||+.+|++|||+.|++++
T Consensus       224 ----~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         224 ----RYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             ----CcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence                113356779999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.6e-38  Score=300.46  Aligned_cols=247  Identities=24%  Similarity=0.426  Sum_probs=197.8

Q ss_pred             CCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCch---------HHHHHHHHHHHHHhcCCCceeeeeeEEEeCCe
Q 013636          154 NFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHD---------AEREFNNEVNWLTKIRHQNIISLLGYCIHAET  223 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  223 (439)
                      +|.+...||+|+||.||+|... ++..+++|.+......         ..+.+.+|+.++++++||||+++++++...+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            3667889999999999999875 4678899988643221         12468899999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccccc
Q 013636          224 RFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSV  303 (439)
Q Consensus       224 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~  303 (439)
                      .++++||+++++|.+++..   ...+++..+..++.|++.||+|||+.   +++||||+|+||++++++.++|+|||.+.
T Consensus        81 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~  154 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISK  154 (267)
T ss_pred             cEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCc
Confidence            9999999999999999964   24588999999999999999999997   99999999999999999999999999987


Q ss_pred             ccCCCCc-------ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccC
Q 013636          304 TAGTQSR-------NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDR  376 (439)
Q Consensus       304 ~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~  376 (439)
                      .......       .....|+..|+|||.+.+..++.++|+||||+++|||++|+.||...+.........   .  ...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~--~~~  229 (267)
T cd06628         155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIG---E--NAS  229 (267)
T ss_pred             ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHh---c--cCC
Confidence            6542111       112347889999999999899999999999999999999999998654322111000   0  001


Q ss_pred             CCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          377 SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       377 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      ..++        .    .....+.+++.+||+.||++||++.+++++
T Consensus       230 ~~~~--------~----~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         230 PEIP--------S----NISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             CcCC--------c----ccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence            1111        1    123456779999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-39  Score=312.99  Aligned_cols=253  Identities=26%  Similarity=0.309  Sum_probs=212.1

Q ss_pred             HHhcCCCccceecccCcEEEEEEEECC-ccEEEEEEecCCCch---HHHHHHHHHHHHHhcC-CCceeeeeeEEEeCCee
Q 013636          150 AATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHD---AEREFNNEVNWLTKIR-HQNIISLLGYCIHAETR  224 (439)
Q Consensus       150 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~  224 (439)
                      ...+.|+..+.||+|.||.||+++... +..+|+|.+.+....   ....+.+|+.+|+++. |||+|.+.+.+++.+..
T Consensus        32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~  111 (382)
T KOG0032|consen   32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV  111 (382)
T ss_pred             cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence            345678888999999999999999876 889999999765432   3457899999999998 99999999999999999


Q ss_pred             EEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC----CcEEEEecc
Q 013636          225 FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS----FNAKLSDFG  300 (439)
Q Consensus       225 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~----~~~kl~DfG  300 (439)
                      ++|||++.+|.|.+.+...    .+++.....++.|++.+++|||+.   +++||||||+|+|+...    +.+|++|||
T Consensus       112 ~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG  184 (382)
T KOG0032|consen  112 YLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFG  184 (382)
T ss_pred             EEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence            9999999999999999754    399999999999999999999998   99999999999999643    579999999


Q ss_pred             cccccCCCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCC
Q 013636          301 LSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLP  380 (439)
Q Consensus       301 ls~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  380 (439)
                      ++............+||+.|+|||++....|+.++||||+||++|.|++|..||...+.......+...      ...+.
T Consensus       185 la~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~------~~~f~  258 (382)
T KOG0032|consen  185 LAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRG------DFDFT  258 (382)
T ss_pred             CceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcC------CCCCC
Confidence            999887755666788999999999999999999999999999999999999999988755433322211      11111


Q ss_pred             ccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          381 NIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       381 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      .-.-    +    ......-+++..|+..||..|+|+.++++|
T Consensus       259 ~~~w----~----~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  259 SEPW----D----DISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             CCCc----c----ccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence            1111    1    113345678999999999999999999997

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.6e-38  Score=302.53  Aligned_cols=247  Identities=23%  Similarity=0.426  Sum_probs=202.8

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEe
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG-HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      ..|+..+.||+|+||.||+|... .+..+|+|.+.... ......+.+|+.++++++|||++++++++.+++..++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            34666788999999999999875 47788999886443 34456789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR  310 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~  310 (439)
                      +++|+|.+++..    ..+++.....++.|++.|++|||+.   +++|+||+|+||+++.++.++|+|||++........
T Consensus        84 ~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06640          84 LGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence            999999999863    3588999999999999999999997   999999999999999999999999999966543221


Q ss_pred             -ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcC
Q 013636          311 -NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRD  389 (439)
Q Consensus       311 -~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  389 (439)
                       .....++..|+|||.+.+..++.++|+||||+++|||++|..||....+........        ...         ..
T Consensus       157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~--------~~~---------~~  219 (277)
T cd06640         157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIP--------KNN---------PP  219 (277)
T ss_pred             ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhh--------cCC---------CC
Confidence             122357889999999998889999999999999999999999998765443221110        000         01


Q ss_pred             ccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          390 TMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       390 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      .........+.+++..||+.+|++||++.+++++
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            1122344567889999999999999999999876

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=6e-39  Score=314.00  Aligned_cols=258  Identities=26%  Similarity=0.419  Sum_probs=205.8

Q ss_pred             hcCCCccceecccCcEEEEEEEEC--------CccEEEEEEecCCC-chHHHHHHHHHHHHHhc-CCCceeeeeeEEEeC
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN--------EKLLAAVKRIDDAG-HDAEREFNNEVNWLTKI-RHQNIISLLGYCIHA  221 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  221 (439)
                      ..+|++.+.||+|+||.||+++..        ....+|+|.+.... ....+++.+|+.+++++ +||||++++++|...
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   90 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence            356888999999999999999752        12468899887543 23446789999999999 899999999999999


Q ss_pred             CeeEEEEEeccCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE
Q 013636          222 ETRFLVYEMMQNGSLEKQLHGPT-------------HGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILL  288 (439)
Q Consensus       222 ~~~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl  288 (439)
                      +..++++||+++|+|.+++....             ....+++..+..++.|++.||+|||+.   +++||||||+||++
T Consensus        91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill  167 (334)
T cd05100          91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLV  167 (334)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEE
Confidence            99999999999999999986421             123588999999999999999999997   99999999999999


Q ss_pred             cCCCcEEEEecccccccCCCCcc---eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhh
Q 013636          289 DSSFNAKLSDFGLSVTAGTQSRN---VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQS  364 (439)
Q Consensus       289 ~~~~~~kl~DfGls~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~  364 (439)
                      ++++.+||+|||+++........   ....++..|+|||.+.+..++.++||||||+++|||++ |..||...+..+...
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~  247 (334)
T cd05100         168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK  247 (334)
T ss_pred             cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence            99999999999999765432211   11223567999999999999999999999999999998 899998766544332


Q ss_pred             hHhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCC
Q 013636          365 MVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVP  429 (439)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~  429 (439)
                      .+..       .... ..         .......+.+++.+||+.+|++|||+.|+++.|+++..
T Consensus       248 ~~~~-------~~~~-~~---------~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~  295 (334)
T cd05100         248 LLKE-------GHRM-DK---------PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT  295 (334)
T ss_pred             HHHc-------CCCC-CC---------CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence            2210       0000 00         00123467789999999999999999999999988874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=3.8e-39  Score=306.79  Aligned_cols=246  Identities=25%  Similarity=0.428  Sum_probs=199.4

Q ss_pred             CCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEec
Q 013636          154 NFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG-HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMM  231 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  231 (439)
                      .|+..+.||+|+||.||+|... ++..+|+|.+.... ....+.+.+|+.++++++|||++++++++..++..++|+||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            3555678999999999999875 46788999887443 334457899999999999999999999999999999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc-
Q 013636          232 QNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR-  310 (439)
Q Consensus       232 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~-  310 (439)
                      ++++|.+++..    ..+++..+..++.|+++|+.|||+.   +++|+||+|+||++++++.++|+|||++........ 
T Consensus        85 ~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~  157 (277)
T cd06642          85 GGGSALDLLKP----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK  157 (277)
T ss_pred             CCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcchh
Confidence            99999998853    3588999999999999999999997   999999999999999999999999999876543221 


Q ss_pred             ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCc
Q 013636          311 NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDT  390 (439)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  390 (439)
                      .....++..|+|||.+.+..++.++||||||+++|||++|+.|+....+......+       . ..     ..+.+.  
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~-------~-~~-----~~~~~~--  222 (277)
T cd06642         158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI-------P-KN-----SPPTLE--  222 (277)
T ss_pred             hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhh-------h-cC-----CCCCCC--
Confidence            12234788999999999989999999999999999999999999765443211111       0 00     011111  


Q ss_pred             cCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          391 MDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       391 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                        ......+.+++.+||+.+|++||++.+++++
T Consensus       223 --~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         223 --GQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             --cccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence              1223457789999999999999999999975

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.9e-38  Score=299.56  Aligned_cols=256  Identities=27%  Similarity=0.424  Sum_probs=204.2

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEe
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG-HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      ++|++.+.||.|+||+||+|... ++..+++|.+.... ......+.+|+..++.++|+|++++++.+...+..++++||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            46888999999999999999865 56788999886433 23456789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR  310 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~  310 (439)
                      +++++|.+++........+++.....++.|++.|++|||+.   +++||||+|+||++++++.++|+|||++........
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            99999999997533335689999999999999999999998   999999999999999999999999999865543222


Q ss_pred             c-----eeeccccCccchhhhcCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCC
Q 013636          311 N-----VKISGTLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVD  384 (439)
Q Consensus       311 ~-----~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  384 (439)
                      .     ....|+..|+|||.+... .++.++|+||||+++|||++|+.||...++....  ......   ....+.....
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~--~~~~~~---~~~~~~~~~~  232 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVL--MLTLQN---DPPSLETGAD  232 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhH--HHHhcC---CCCCcCCccc
Confidence            1     234588999999998877 7899999999999999999999999876543211  111000   0011100000


Q ss_pred             chhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          385 PVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       385 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                             .......+.+++..||+.||++||++.+++++
T Consensus       233 -------~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         233 -------YKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             -------cccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence                   01223467789999999999999999999875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=2.2e-38  Score=300.05  Aligned_cols=254  Identities=24%  Similarity=0.398  Sum_probs=200.9

Q ss_pred             CCCccceecccCcEEEEEEEECC--ccEEEEEEecCC----------CchHHHHHHHHHHHHHh-cCCCceeeeeeEEEe
Q 013636          154 NFQESNVIGEGGRGHVYKARFNE--KLLAAVKRIDDA----------GHDAEREFNNEVNWLTK-IRHQNIISLLGYCIH  220 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~  220 (439)
                      +|++.+.||+|+||.||+|....  +..+++|.+...          ......++.+|+.++.+ ++|||++++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            46778899999999999999865  678899987532          12233457788888875 799999999999999


Q ss_pred             CCeeEEEEEeccCCChhhhhcC-CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEec
Q 013636          221 AETRFLVYEMMQNGSLEKQLHG-PTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDF  299 (439)
Q Consensus       221 ~~~~~lV~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~Df  299 (439)
                      ++..+++|||+++++|.+++.. ......+++..+++++.|++.||.|||+.  .+++|+||+|+||++++++.+||+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEecc
Confidence            9999999999999999998753 12345689999999999999999999963  27999999999999999999999999


Q ss_pred             ccccccCCCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCC
Q 013636          300 GLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKL  379 (439)
Q Consensus       300 Gls~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  379 (439)
                      |++.............|+..|+|||.+.+..++.++||||||+++|||++|+.||...+.......+..        ...
T Consensus       159 g~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~--------~~~  230 (269)
T cd08528         159 GLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVE--------AVY  230 (269)
T ss_pred             cceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhh--------ccC
Confidence            999776544333344588999999999998999999999999999999999999976543321111110        000


Q ss_pred             CccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhcc
Q 013636          380 PNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLI  425 (439)
Q Consensus       380 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  425 (439)
                      ....    ..    .....+.+++.+||+.||++||++.|+..++.
T Consensus       231 ~~~~----~~----~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         231 EPLP----EG----MYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             CcCC----cc----cCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            0000    00    11245677999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=9.5e-39  Score=312.37  Aligned_cols=253  Identities=23%  Similarity=0.296  Sum_probs=195.3

Q ss_pred             cCCCccceecccCcEEEEEEEECC-ccEEEEEEecCCC---chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      ++|++.+.||+|+||.||+++..+ +..+|+|.+....   ......+.+|+.++..++|+||+++.+++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            468889999999999999998865 6778999886421   222345888999999999999999999999999999999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~  308 (439)
                      ||+++|+|.++++.  ....+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++......
T Consensus        81 ey~~~g~L~~~l~~--~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~  155 (332)
T cd05623          81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  155 (332)
T ss_pred             eccCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence            99999999999974  234689999999999999999999998   9999999999999999999999999998654332


Q ss_pred             Ccc--eeeccccCccchhhhc-----CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCc
Q 013636          309 SRN--VKISGTLGYVAPEYLL-----EGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPN  381 (439)
Q Consensus       309 ~~~--~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  381 (439)
                      ...  ....||+.|+|||++.     ...++.++|||||||++|||++|+.||...+..+....+...    ..+...+.
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~----~~~~~~p~  231 (332)
T cd05623         156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH----KERFQFPA  231 (332)
T ss_pred             CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCC----CccccCCC
Confidence            221  2245899999999986     346789999999999999999999999876644322222100    00111111


Q ss_pred             cCCchhcCccCHHHHHHHHHHHHHhcCCCCC--CCCCHHHHHHh
Q 013636          382 IVDPVIRDTMDLKHLYQVAAVAVLCIQPEPS--YRPLITDVLHS  423 (439)
Q Consensus       382 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~--~RPt~~evl~~  423 (439)
                      ..     ...    ...+.+++.+|+..+++  .||++.|++++
T Consensus       232 ~~-----~~~----s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         232 QV-----TDV----SEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             cc-----ccC----CHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            10     111    23455677777755444  47899999977

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=7.2e-39  Score=307.60  Aligned_cols=244  Identities=26%  Similarity=0.400  Sum_probs=198.6

Q ss_pred             cceecccCcEEEEEEEEC-CccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEeccCCCh
Q 013636          158 SNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSL  236 (439)
Q Consensus       158 ~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  236 (439)
                      ...||+|+||.||++... ++..+++|.+........+.+.+|+..++.++|+|++++++.+...+..++||||+++++|
T Consensus        27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L  106 (292)
T cd06658          27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL  106 (292)
T ss_pred             hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence            467999999999999875 4778999998765555667789999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc-ceeec
Q 013636          237 EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR-NVKIS  315 (439)
Q Consensus       237 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~-~~~~~  315 (439)
                      .+++..    ..+++..+..++.|++.||+|||+.   +++||||||+||++++++.++|+|||++........ .....
T Consensus       107 ~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~  179 (292)
T cd06658         107 TDIVTH----TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV  179 (292)
T ss_pred             HHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCceee
Confidence            998853    2488999999999999999999998   999999999999999999999999999865432222 22345


Q ss_pred             cccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCccCHHH
Q 013636          316 GTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKH  395 (439)
Q Consensus       316 gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  395 (439)
                      |+..|+|||.+.+..++.++||||||+++|||++|+.||...++......+....             .+.+...  ...
T Consensus       180 ~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~-------------~~~~~~~--~~~  244 (292)
T cd06658         180 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNL-------------PPRVKDS--HKV  244 (292)
T ss_pred             cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-------------CCccccc--ccc
Confidence            8899999999998899999999999999999999999998765433222211100             0000000  011


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          396 LYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       396 ~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      ...+.+++..|++.||++|||+.+++++
T Consensus       245 ~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         245 SSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            2346678899999999999999999976

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=8.7e-39  Score=312.51  Aligned_cols=253  Identities=23%  Similarity=0.291  Sum_probs=196.8

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC---chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      ++|++.+.||+|+||+||+++.. .+..+|+|.+....   ......+.+|..++..++|+||+++++++...+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47888999999999999999876 46788999886421   223345788999999999999999999999999999999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~  308 (439)
                      ||+++|+|.+++...  ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++......
T Consensus        81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            999999999999742  34688999999999999999999998   9999999999999999999999999999765433


Q ss_pred             Ccc--eeeccccCccchhhhcC-----CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCc
Q 013636          309 SRN--VKISGTLGYVAPEYLLE-----GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPN  381 (439)
Q Consensus       309 ~~~--~~~~gt~~y~aPE~~~~-----~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  381 (439)
                      ...  ....||+.|+|||.+.+     +.++.++|||||||++|||++|+.||...+..+....+..    ...+..++.
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~----~~~~~~~p~  231 (331)
T cd05624         156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN----HEERFQFPS  231 (331)
T ss_pred             CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHc----CCCcccCCC
Confidence            221  22458999999999875     5678899999999999999999999987654432221110    000111111


Q ss_pred             cCCchhcCccCHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHh
Q 013636          382 IVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSY--RPLITDVLHS  423 (439)
Q Consensus       382 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~evl~~  423 (439)
                      ...     .    ....+.+++.+|+..++++  |+++.+++++
T Consensus       232 ~~~-----~----~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         232 HIT-----D----VSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             ccc-----c----CCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            111     1    1235666888888765544  5688888866

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.2e-38  Score=307.55  Aligned_cols=255  Identities=27%  Similarity=0.481  Sum_probs=201.2

Q ss_pred             cCCCccceecccCcEEEEEEEECC-c----cEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNE-K----LLAAVKRIDDAGH-DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFL  226 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~-~----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  226 (439)
                      ++|+..+.||+|+||.||+|.+.. +    ..+++|.+..... ....++.+|+.+++.++||||++++++|... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            456778899999999999998642 3    2468888865433 3334688999999999999999999998754 5679


Q ss_pred             EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccC
Q 013636          227 VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAG  306 (439)
Q Consensus       227 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~  306 (439)
                      ++||+++|+|.+++..  ....+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||++....
T Consensus        86 v~e~~~~g~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~  160 (303)
T cd05110          86 VTQLMPHGCLLDYVHE--HKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLE  160 (303)
T ss_pred             eehhcCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccccccc
Confidence            9999999999999874  234688999999999999999999998   99999999999999999999999999997654


Q ss_pred             CCCcc---eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCcc
Q 013636          307 TQSRN---VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNI  382 (439)
Q Consensus       307 ~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  382 (439)
                      .....   ....++..|+|||.+.+..++.++||||||+++|||++ |+.||...........+..       ....+. 
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~-------~~~~~~-  232 (303)
T cd05110         161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEK-------GERLPQ-  232 (303)
T ss_pred             CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC-------CCCCCC-
Confidence            32221   11234678999999999999999999999999999997 9999987654443333221       111110 


Q ss_pred             CCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCC
Q 013636          383 VDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPT  430 (439)
Q Consensus       383 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~  430 (439)
                        +   .    .....+.+++..||..+|++||++.++++.|..+...
T Consensus       233 --~---~----~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~  271 (303)
T cd05110         233 --P---P----ICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD  271 (303)
T ss_pred             --C---C----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence              0   0    1123567899999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.4e-38  Score=299.44  Aligned_cols=248  Identities=26%  Similarity=0.390  Sum_probs=192.7

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC-----chHHHHHHHHHHHHHhcCCCceeeeeeEEEeC--Cee
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG-----HDAEREFNNEVNWLTKIRHQNIISLLGYCIHA--ETR  224 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  224 (439)
                      .+|+..+.||+|+||.||+|... .+..+++|.+....     ......+.+|+.++++++||||+++++++...  ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            47888999999999999999875 47788999875321     12335688999999999999999999988753  567


Q ss_pred             EEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccc
Q 013636          225 FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT  304 (439)
Q Consensus       225 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~  304 (439)
                      ++++||+++++|.+++..   ...+++.....++.|++.||+|||+.   +++||||+|+||+++.++.+||+|||++..
T Consensus        82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~  155 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR  155 (266)
T ss_pred             EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence            899999999999999964   23588999999999999999999987   999999999999999999999999999865


Q ss_pred             cCCC----CcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCC
Q 013636          305 AGTQ----SRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLP  380 (439)
Q Consensus       305 ~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  380 (439)
                      ....    .......++..|+|||.+.+..++.++|||||||++|||++|+.||.............    .......++
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~----~~~~~~~~~  231 (266)
T cd06651         156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIA----TQPTNPQLP  231 (266)
T ss_pred             cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHh----cCCCCCCCc
Confidence            4321    11122347889999999999899999999999999999999999997654322111100    000111111


Q ss_pred             ccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          381 NIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       381 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      ..++            ..+.+++ +||..+|++||+++|++++
T Consensus       232 ~~~~------------~~~~~li-~~~~~~p~~Rp~~~eil~h  261 (266)
T cd06651         232 SHIS------------EHARDFL-GCIFVEARHRPSAEELLRH  261 (266)
T ss_pred             hhcC------------HHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence            1111            1233344 6888999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.5e-38  Score=308.75  Aligned_cols=263  Identities=23%  Similarity=0.302  Sum_probs=193.3

Q ss_pred             ccceeccc--CcEEEEEEEEC-CccEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEec
Q 013636          157 ESNVIGEG--GRGHVYKARFN-EKLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMM  231 (439)
Q Consensus       157 ~~~~LG~G--~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  231 (439)
                      +.++||+|  +||+||+++.. ++..+|+|++....  ....+.+.+|+.+++.++||||+++++++..++..++|+||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            35779999  78999999875 57889999987542  233456778999999999999999999999999999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc-
Q 013636          232 QNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR-  310 (439)
Q Consensus       232 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~-  310 (439)
                      ++|+|.+++.... ...+++..+..++.|++.||+|||+.   +++||||||+|||++.++.++++||+.......... 
T Consensus        82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~  157 (327)
T cd08227          82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR  157 (327)
T ss_pred             CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence            9999999986422 33589999999999999999999998   999999999999999999999999986533211110 


Q ss_pred             -------ceeeccccCccchhhhcC--CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhh-hhHhhhhcccccC----
Q 013636          311 -------NVKISGTLGYVAPEYLLE--GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQ-SMVTWAMPQLTDR----  376 (439)
Q Consensus       311 -------~~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~-~~~~~~~~~~~~~----  376 (439)
                             .....++..|+|||++.+  ..++.++|||||||++|||++|+.||......... .......+...+.    
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (327)
T cd08227         158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIP  237 (327)
T ss_pred             ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchh
Confidence                   011236678999999976  46889999999999999999999999765432211 0000000000000    


Q ss_pred             --------------CCCCccCC-----c----hhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          377 --------------SKLPNIVD-----P----VIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       377 --------------~~~~~~~d-----~----~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                                    ....+...     +    .............+.+++.+||+.||++|||+.|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~  307 (327)
T cd08227         238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  307 (327)
T ss_pred             hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence                          00000000     0    00000111223467889999999999999999999864

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=8.8e-39  Score=302.63  Aligned_cols=248  Identities=29%  Similarity=0.493  Sum_probs=196.9

Q ss_pred             ceecccCcEEEEEEEECC-------ccEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEe
Q 013636          159 NVIGEGGRGHVYKARFNE-------KLLAAVKRIDDAG-HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       159 ~~LG~G~fg~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      +.||+|+||.||+|+..+       +..+++|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            369999999999998753       2468888876433 23456789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC-----cEEEEeccc
Q 013636          231 MQNGSLEKQLHGPT----HGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSF-----NAKLSDFGL  301 (439)
Q Consensus       231 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~-----~~kl~DfGl  301 (439)
                      +++|+|.+++....    ....+++..++.++.|++.|++|||+.   +++|+||+|+||+++.++     .++++|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            99999999996422    223588999999999999999999997   999999999999999887     899999999


Q ss_pred             ccccCCCCcc---eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCC
Q 013636          302 SVTAGTQSRN---VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRS  377 (439)
Q Consensus       302 s~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~  377 (439)
                      +.........   ....++..|+|||.+.++.++.++||||||+++|||++ |+.||...+..+....+.       ...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~-------~~~  230 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT-------AGG  230 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHh-------cCC
Confidence            8654332111   12235678999999999999999999999999999998 999997665433222211       011


Q ss_pred             CCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccc
Q 013636          378 KLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIP  426 (439)
Q Consensus       378 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  426 (439)
                      .. .         ........+.+++.+||+.+|++||++.++++.|++
T Consensus       231 ~~-~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         231 RL-Q---------KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             cc-C---------CcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            00 0         001123467789999999999999999999999863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-38  Score=304.60  Aligned_cols=265  Identities=25%  Similarity=0.348  Sum_probs=202.6

Q ss_pred             cCCCccceecccCcEEEEEEEECC-ccEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYE  229 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  229 (439)
                      ++|+..+.||+|+||.||+|...+ +..+++|.++...  ......+.+|++++++++|+|++++++++..++..+++||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            368888999999999999998864 6789999886432  2334678999999999999999999999999999999999


Q ss_pred             eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCC
Q 013636          230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS  309 (439)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~  309 (439)
                      |++++.+..+...   ...+++..+..++.|++.|++|||+.   +++|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~  154 (288)
T cd07833          81 YVERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARP  154 (288)
T ss_pred             cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence            9998777766542   34589999999999999999999998   99999999999999999999999999987665433


Q ss_pred             --cceeeccccCccchhhhcCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccc--------cCC-
Q 013636          310 --RNVKISGTLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLT--------DRS-  377 (439)
Q Consensus       310 --~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~--------~~~-  377 (439)
                        ......++..|+|||++.+. .++.++||||||+++|+|++|+.||...+..+.............        ... 
T Consensus       155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd07833         155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR  234 (288)
T ss_pred             cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcc
Confidence              22234578899999999888 889999999999999999999999976544322111111100000        000 


Q ss_pred             ----CCCccCCchh-cCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          378 ----KLPNIVDPVI-RDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       378 ----~~~~~~d~~l-~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                          ..++..++.. ...........+.+++.+||+.+|++||++++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence                1111111100 001111124678899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=8.3e-40  Score=291.63  Aligned_cols=254  Identities=27%  Similarity=0.383  Sum_probs=203.6

Q ss_pred             HHhcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC-----ch---HHHHHHHHHHHHHhc-CCCceeeeeeEEE
Q 013636          150 AATNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG-----HD---AEREFNNEVNWLTKI-RHQNIISLLGYCI  219 (439)
Q Consensus       150 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~---~~~~~~~E~~~l~~l-~h~niv~l~~~~~  219 (439)
                      ..-++|...++||.|..++|.+...+ .+...|+|++....     ..   -.+.-.+|+.+|+++ .||||+.+.++++
T Consensus        14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye   93 (411)
T KOG0599|consen   14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE   93 (411)
T ss_pred             hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence            34467777899999999999887654 46677888875321     11   123456899999998 6999999999999


Q ss_pred             eCCeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEec
Q 013636          220 HAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDF  299 (439)
Q Consensus       220 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~Df  299 (439)
                      .+...++|+|.|+.|.|.++|..   .-.++++...+|+.|+.+|++|||..   .|+||||||+|||+|++.++||+||
T Consensus        94 s~sF~FlVFdl~prGELFDyLts---~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDF  167 (411)
T KOG0599|consen   94 SDAFVFLVFDLMPRGELFDYLTS---KVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDF  167 (411)
T ss_pred             CcchhhhhhhhcccchHHHHhhh---heeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEecc
Confidence            99999999999999999999954   45699999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCCcceeeccccCccchhhhcC------CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhccc
Q 013636          300 GLSVTAGTQSRNVKISGTLGYVAPEYLLE------GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQL  373 (439)
Q Consensus       300 Gls~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~  373 (439)
                      |+|............||||+|+|||.+.-      .-|+...|+|+.||++|.|+.|.+||.....--...++....-++
T Consensus       168 GFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF  247 (411)
T KOG0599|consen  168 GFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQF  247 (411)
T ss_pred             ceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhccccc
Confidence            99999988888788999999999998863      347789999999999999999999998654322222222111111


Q ss_pred             ccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          374 TDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       374 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                          .-++|-|          .....-+++.+||+.||++|.|++|+|.+
T Consensus       248 ----~speWad----------is~~~KdLIsrlLqVdp~~Ritake~LaH  283 (411)
T KOG0599|consen  248 ----RSPEWAD----------ISATVKDLISRLLQVDPTKRITAKEALAH  283 (411)
T ss_pred             ----CCcchhh----------ccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence                1111111          12345569999999999999999999864

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=3.1e-38  Score=296.68  Aligned_cols=249  Identities=22%  Similarity=0.334  Sum_probs=201.8

Q ss_pred             CCCccceecccCcEEEEEEEEC-CccEEEEEEecCC--CchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEe
Q 013636          154 NFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDA--GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      +|+..+.||+|+||.+|+++.. ++..+++|.+...  .....+++.+|+.++++++|||++++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            4778899999999999999875 5778999988643  233446789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR  310 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~  310 (439)
                      +++++|.+++... ....+++..+.+++.|++.|++|||+.   +++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~  156 (256)
T cd08218          81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE  156 (256)
T ss_pred             CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence            9999999998642 234578999999999999999999997   999999999999999999999999999976543222


Q ss_pred             c-eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcC
Q 013636          311 N-VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRD  389 (439)
Q Consensus       311 ~-~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  389 (439)
                      . ....|++.|+|||.+.+..++.++|+||||+++++|++|+.||...+..+....+.  .   ......+         
T Consensus       157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~--~---~~~~~~~---------  222 (256)
T cd08218         157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKII--R---GSYPPVS---------  222 (256)
T ss_pred             hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHh--c---CCCCCCc---------
Confidence            1 22347889999999999999999999999999999999999997655433211110  0   0001111         


Q ss_pred             ccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          390 TMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       390 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                         ......+.+++.+||+.+|++||++.+|+++
T Consensus       223 ---~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         223 ---SHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             ---ccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence               1123457789999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.5e-38  Score=321.65  Aligned_cols=257  Identities=20%  Similarity=0.272  Sum_probs=194.7

Q ss_pred             hcCCCccceecccCcEEEEEEEECC-ccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEe
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      ..+|.+.+.||+|+||.||++.... +..||+|....      ..+.+|++++++++|+||+++++++...+..++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            3478999999999999999998865 67788885332      2457899999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR  310 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~  310 (439)
                      +. ++|.+++..  ....+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++.......
T Consensus       242 ~~-~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~  315 (461)
T PHA03211        242 YR-SDLYTYLGA--RLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS  315 (461)
T ss_pred             cC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence            95 689888863  234699999999999999999999998   999999999999999999999999999976533211


Q ss_pred             ---ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC--------hhhhhhhHhhhhcccccCCCC
Q 013636          311 ---NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMS--------PTQCQSMVTWAMPQLTDRSKL  379 (439)
Q Consensus       311 ---~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~--------~~~~~~~~~~~~~~~~~~~~~  379 (439)
                         .....||..|+|||++.+..++.++|||||||++|||++|..|+....        .......+.......   ...
T Consensus       316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~---~~~  392 (461)
T PHA03211        316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHV---DEF  392 (461)
T ss_pred             cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccc---ccC
Confidence               123468999999999999999999999999999999999876653221        112222222211100   000


Q ss_pred             CccCCchhc------------CccC-------HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          380 PNIVDPVIR------------DTMD-------LKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       380 ~~~~d~~l~------------~~~~-------~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      +......+.            ....       ......+.+++.+||+.||++|||+.|++++
T Consensus       393 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        393 PQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             CCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            000000000            0000       0011246779999999999999999999976

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.4e-38  Score=299.99  Aligned_cols=250  Identities=25%  Similarity=0.392  Sum_probs=188.7

Q ss_pred             eecccCcEEEEEEEECCc---cEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEeccCCC
Q 013636          160 VIGEGGRGHVYKARFNEK---LLAAVKRIDDAG-HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGS  235 (439)
Q Consensus       160 ~LG~G~fg~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  235 (439)
                      .||+|+||.||++...++   ..+++|.+.... ....+.|.+|+.+++.++|||++++++.|......++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            599999999999975433   345667665433 3345689999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCC---cc
Q 013636          236 LEKQLHGPT-HGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS---RN  311 (439)
Q Consensus       236 L~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~---~~  311 (439)
                      |.++++... .....++..+..++.|+++||+|||+.   +++||||||+|||++.++.+||+|||++.......   ..
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            999997532 224567778889999999999999997   99999999999999999999999999985432211   11


Q ss_pred             eeeccccCccchhhhcC-------CCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCccC
Q 013636          312 VKISGTLGYVAPEYLLE-------GKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV  383 (439)
Q Consensus       312 ~~~~gt~~y~aPE~~~~-------~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  383 (439)
                      ....++..|+|||++..       ..++.++||||||+++|||++ |..||...++.+....+.        ........
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~--------~~~~~~~~  230 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVI--------KDQQVKLF  230 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH--------hhcccccC
Confidence            23457889999998753       245789999999999999997 677887655433222111        01111223


Q ss_pred             CchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhcc
Q 013636          384 DPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLI  425 (439)
Q Consensus       384 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  425 (439)
                      ++.+....+    ..+.+++..|| .+|++||++++|++.|.
T Consensus       231 ~~~~~~~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         231 KPQLELPYS----ERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CCccCCCCc----HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            333322222    34566778899 57999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=5.4e-38  Score=295.06  Aligned_cols=249  Identities=22%  Similarity=0.354  Sum_probs=199.2

Q ss_pred             CCCccceecccCcEEEEEEEECC-ccEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCceeeeeeEEEeC-CeeEEEEE
Q 013636          154 NFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLLGYCIHA-ETRFLVYE  229 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lV~e  229 (439)
                      +|++.+.||+|++|.||+++... +..+++|.+....  ....+.+.+|++++++++|+|++++++.+... ...+++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            47788999999999999998754 6788999886432  23445688999999999999999999887643 46789999


Q ss_pred             eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCC
Q 013636          230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS  309 (439)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~  309 (439)
                      |+++++|.+++... ....+++.++..++.+++.|++|||+.   +++||||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~  156 (257)
T cd08223          81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC  156 (257)
T ss_pred             ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence            99999999999752 234589999999999999999999998   99999999999999999999999999987654322


Q ss_pred             -cceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhc
Q 013636          310 -RNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIR  388 (439)
Q Consensus       310 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  388 (439)
                       ......+++.|+|||.+.+..++.++||||||++++||++|+.||...+.........        ....+.     +.
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~--------~~~~~~-----~~  223 (257)
T cd08223         157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRII--------EGKLPP-----MP  223 (257)
T ss_pred             CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH--------hcCCCC-----Cc
Confidence             2223457899999999999999999999999999999999999998655432211110        011111     00


Q ss_pred             CccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          389 DTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       389 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                          ......+.+++.+|++.||++|||+.+++++
T Consensus       224 ----~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         224 ----KDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             ----cccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence                1123467789999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1e-38  Score=304.87  Aligned_cols=265  Identities=25%  Similarity=0.385  Sum_probs=200.2

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGH--DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYE  229 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  229 (439)
                      ++|+..+.||+|+||.||++... ++..+|+|.+.....  ...+.+.+|+++++.++|||++++++++...+..++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            46788899999999999999986 478899998764322  234568899999999999999999999999999999999


Q ss_pred             eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCC
Q 013636          230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS  309 (439)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~  309 (439)
                      |+++++|..+...   ...+++..+..++.|+++||+|||+.   +++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07846          81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  154 (286)
T ss_pred             cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence            9999999887753   23489999999999999999999998   99999999999999999999999999987653322


Q ss_pred             c-ceeeccccCccchhhhcC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccC--------CCC
Q 013636          310 R-NVKISGTLGYVAPEYLLE-GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDR--------SKL  379 (439)
Q Consensus       310 ~-~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~--------~~~  379 (439)
                      . .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+......+...        ...
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07846         155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF  234 (286)
T ss_pred             cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh
Confidence            2 123447889999999875 457889999999999999999999997654322111111111100000        000


Q ss_pred             CccCCchhcCcc-----CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          380 PNIVDPVIRDTM-----DLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       380 ~~~~d~~l~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      .....+......     .......+.+++.+||+.+|++||++.+++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence            000001000000     01123568889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.1e-38  Score=326.07  Aligned_cols=268  Identities=18%  Similarity=0.271  Sum_probs=196.0

Q ss_pred             HHHHHhcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCchHHHHHHHHHHHHHhcCC------CceeeeeeEEE
Q 013636          147 LLEAATNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRH------QNIISLLGYCI  219 (439)
Q Consensus       147 ~l~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~~  219 (439)
                      .++..+++|++.+.||+|+||+||+|... .+..+|||.++... ...+++..|+.+++.++|      .+++.+++++.
T Consensus       123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~  201 (467)
T PTZ00284        123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ  201 (467)
T ss_pred             ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence            34456788999999999999999999875 46789999986532 223445667777777654      45888988887


Q ss_pred             eC-CeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC------
Q 013636          220 HA-ETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSF------  292 (439)
Q Consensus       220 ~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~------  292 (439)
                      .. ...++|||++ +++|.+++..   ...+++..+..++.|++.||+|||+.  .+|+||||||+|||++.++      
T Consensus       202 ~~~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~  275 (467)
T PTZ00284        202 NETGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPV  275 (467)
T ss_pred             cCCceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccccc
Confidence            64 4688999988 6789888853   24689999999999999999999973  2899999999999998765      


Q ss_pred             ----------cEEEEecccccccCCCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhh
Q 013636          293 ----------NAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQC  362 (439)
Q Consensus       293 ----------~~kl~DfGls~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~  362 (439)
                                .+||+|||.+.....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+.
T Consensus       276 ~~~~~~~~~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~  353 (467)
T PTZ00284        276 TNRALPPDPCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEH  353 (467)
T ss_pred             cccccCCCCceEEECCCCccccCcc--ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence                      499999998864322  22345699999999999999999999999999999999999999987665433


Q ss_pred             hhhHhhhhccccc-----------------CCCCCccCCch-h---cC---ccCHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 013636          363 QSMVTWAMPQLTD-----------------RSKLPNIVDPV-I---RD---TMDLKHLYQVAAVAVLCIQPEPSYRPLIT  418 (439)
Q Consensus       363 ~~~~~~~~~~~~~-----------------~~~~~~~~d~~-l---~~---~~~~~~~~~l~~l~~~cl~~dP~~RPt~~  418 (439)
                      ...+......+..                 ...+....++. +   ..   .........+.+++..||+.||++|||++
T Consensus       354 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~  433 (467)
T PTZ00284        354 LHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNAR  433 (467)
T ss_pred             HHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHH
Confidence            2222211111000                 00000000110 0   00   00001124577999999999999999999


Q ss_pred             HHHHh
Q 013636          419 DVLHS  423 (439)
Q Consensus       419 evl~~  423 (439)
                      |+++|
T Consensus       434 e~L~H  438 (467)
T PTZ00284        434 QMTTH  438 (467)
T ss_pred             HHhcC
Confidence            99974

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.2e-38  Score=302.69  Aligned_cols=256  Identities=25%  Similarity=0.394  Sum_probs=202.3

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEe
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG-HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      ++|++.+.||+|+||+||++... ++..+|+|.+.... ....+.+.+|+++++.++||||+++++++...+..++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            46777889999999999999875 47788888876433 33456799999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR  310 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~  310 (439)
                      +++|+|.+++..   .+.+++.....++.+++.|+.|||+.  ++++||||+|+||++++++.++|+|||++........
T Consensus        85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~  159 (284)
T cd06620          85 MDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA  159 (284)
T ss_pred             CCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhhcc
Confidence            999999999864   24589999999999999999999973  2799999999999999999999999999865432221


Q ss_pred             ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhh-----hhhhHhhhhcccccCCCCCccCCc
Q 013636          311 NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQ-----CQSMVTWAMPQLTDRSKLPNIVDP  385 (439)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~d~  385 (439)
                       ....|+..|+|||.+.+..++.++|||||||++||+++|+.||....+..     ......+........  .+...  
T Consensus       160 -~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~--  234 (284)
T cd06620         160 -DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP--PPRLP--  234 (284)
T ss_pred             -CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc--CCCCC--
Confidence             23458999999999998899999999999999999999999998654321     111111111111100  00000  


Q ss_pred             hhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhc
Q 013636          386 VIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL  424 (439)
Q Consensus       386 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  424 (439)
                            .......+.+++.+|++.||++|||+.|++++.
T Consensus       235 ------~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         235 ------SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             ------chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence                  011234677899999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.4e-38  Score=337.67  Aligned_cols=256  Identities=25%  Similarity=0.409  Sum_probs=198.7

Q ss_pred             HHhcCCCccceecccCcEEEEEEEECC-ccEEEEEEecCC--CchHHHHHHHHHHHHHhcCCCceeeeeeEEEeC--Cee
Q 013636          150 AATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDA--GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHA--ETR  224 (439)
Q Consensus       150 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  224 (439)
                      ...++|++.+.||+|+||+||+++... +..+++|.+...  .......|..|+.++++++||||+++++++...  ...
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l   89 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL   89 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence            345689999999999999999998865 567788887643  233446789999999999999999999988643  468


Q ss_pred             EEEEEeccCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCC----CCeEecCCCCCCEEEcC---------
Q 013636          225 FLVYEMMQNGSLEKQLHGP-THGSNLTWHLRMKIAVDVARGLEYLHEHCN----HPVVHRDLKSSNILLDS---------  290 (439)
Q Consensus       225 ~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~----~~ivH~Dlk~~NiLl~~---------  290 (439)
                      ++||||+++|+|.++|... .....+++..++.|+.||+.||+|||+...    .+|+||||||+||||+.         
T Consensus        90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~  169 (1021)
T PTZ00266         90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT  169 (1021)
T ss_pred             EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence            9999999999999998642 223569999999999999999999998531    35999999999999964         


Q ss_pred             --------CCcEEEEecccccccCCCCcceeeccccCccchhhhcC--CCCCCchhhHHHHHHHHHHHhCCCCCCCCChh
Q 013636          291 --------SFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLE--GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPT  360 (439)
Q Consensus       291 --------~~~~kl~DfGls~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~  360 (439)
                              ...+||+|||++.............||+.|+|||++..  ..++.++|||||||+||||++|+.||...+..
T Consensus       170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~  249 (1021)
T PTZ00266        170 AQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF  249 (1021)
T ss_pred             ccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcH
Confidence                    33489999999977654444344569999999999864  45889999999999999999999999765432


Q ss_pred             hhhhhHhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 013636          361 QCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLH  422 (439)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  422 (439)
                      .  .+..    .+.....++      + .    .....+.+++..||+.+|.+||++.|++.
T Consensus       250 ~--qli~----~lk~~p~lp------i-~----~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        250 S--QLIS----ELKRGPDLP------I-K----GKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             H--HHHH----HHhcCCCCC------c-C----CCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            1  1111    011111110      0 0    11245778999999999999999999984

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=6.7e-38  Score=294.08  Aligned_cols=249  Identities=31%  Similarity=0.505  Sum_probs=201.3

Q ss_pred             CCccceecccCcEEEEEEEECC-----ccEEEEEEecCCCch-HHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEE
Q 013636          155 FQESNVIGEGGRGHVYKARFNE-----KLLAAVKRIDDAGHD-AEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       155 ~~~~~~LG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      |++.+.||+|+||.||+++..+     +..+|+|.+...... ..+.+.+|+..++.++|+|++++++++...+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            3456889999999999998865     478899999765443 5678999999999999999999999999999999999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~  308 (439)
                      ||+++++|.+++.... ...+++..+..++.|++.|++|||+.   +++|+||+|+||++++++.++|+|||++......
T Consensus        81 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       81 EYMEGGDLLDYLRKNR-PKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             eccCCCCHHHHHHhhh-hccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceecccc
Confidence            9999999999997422 12289999999999999999999998   9999999999999999999999999999765443


Q ss_pred             Ccce--eeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCc
Q 013636          309 SRNV--KISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDP  385 (439)
Q Consensus       309 ~~~~--~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  385 (439)
                      ....  ...+++.|+|||.+.+..++.++||||+|++++||++ |+.||...+.......+...     .....+.    
T Consensus       157 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~----  227 (258)
T smart00219      157 DYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKG-----YRLPKPE----  227 (258)
T ss_pred             cccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-----CCCCCCC----
Confidence            2211  1236789999999988889999999999999999998 88998775543322222110     0000011    


Q ss_pred             hhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhc
Q 013636          386 VIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL  424 (439)
Q Consensus       386 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  424 (439)
                              .....+.+++.+|++.||++|||+.|+++.|
T Consensus       228 --------~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      228 --------NCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             --------cCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                    1234577799999999999999999999865

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=3.1e-38  Score=302.67  Aligned_cols=262  Identities=29%  Similarity=0.446  Sum_probs=204.5

Q ss_pred             ccHHHHHHHhcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCchHHHHHHHHHHHHHhc-CCCceeeeeeEEEe
Q 013636          143 IEYELLEAATNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIH  220 (439)
Q Consensus       143 ~~~~~l~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  220 (439)
                      +....+..++++|++.+.||+|+||.||++... ++..+++|.+.... ....++.+|+.++.++ +|||++++++++..
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            334445566789999999999999999999885 57788999886542 2345678899999999 89999999999875


Q ss_pred             CC-----eeEEEEEeccCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcE
Q 013636          221 AE-----TRFLVYEMMQNGSLEKQLHGP-THGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA  294 (439)
Q Consensus       221 ~~-----~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~  294 (439)
                      .+     ..++|+||+++|+|.++++.. ..+..+++..+..++.|++.||+|||+.   +++||||||+||++++++.+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~  167 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGV  167 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCE
Confidence            43     579999999999999988642 2345689999999999999999999998   99999999999999999999


Q ss_pred             EEEecccccccCCCCc-ceeeccccCccchhhhcCC-----CCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhh
Q 013636          295 KLSDFGLSVTAGTQSR-NVKISGTLGYVAPEYLLEG-----KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTW  368 (439)
Q Consensus       295 kl~DfGls~~~~~~~~-~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~  368 (439)
                      ||+|||++........ .....|+..|+|||.+...     .++.++|||||||++|||++|+.||....+....  ...
T Consensus       168 kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~--~~~  245 (291)
T cd06639         168 KLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL--FKI  245 (291)
T ss_pred             EEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHH--HHH
Confidence            9999999876543221 1234578899999998653     3688999999999999999999999876543221  111


Q ss_pred             hhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          369 AMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       369 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      .      ....+...++       ......+.+++.+||+.+|++||++.|++++
T Consensus       246 ~------~~~~~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         246 P------RNPPPTLLHP-------EKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             h------cCCCCCCCcc-------cccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            0      0111111111       1123457889999999999999999999975

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=3.3e-38  Score=296.35  Aligned_cols=247  Identities=30%  Similarity=0.469  Sum_probs=198.2

Q ss_pred             cCCCccceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEecc
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQ  232 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  232 (439)
                      ++|++.+.||+|+||.||++.. .+..+++|......  ....+.+|+.++++++|||++++++++.. +..+++|||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcC-CCcEEEEECCC
Confidence            4578889999999999999975 45567899886532  34578899999999999999999999865 45799999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCcce
Q 013636          233 NGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV  312 (439)
Q Consensus       233 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~~~  312 (439)
                      +|+|.+++.... ...+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.+||+|||++........  
T Consensus        82 ~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~--  155 (254)
T cd05083          82 KGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD--  155 (254)
T ss_pred             CCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccCC--
Confidence            999999997532 34589999999999999999999997   999999999999999999999999999875432211  


Q ss_pred             eeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCcc
Q 013636          313 KISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTM  391 (439)
Q Consensus       313 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  391 (439)
                      ....+..|+|||.+.++.++.++|+||||+++|||++ |+.||...+..+.......       .... ..     ..  
T Consensus       156 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-------~~~~-~~-----~~--  220 (254)
T cd05083         156 NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEK-------GYRM-EP-----PE--  220 (254)
T ss_pred             CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhC-------CCCC-CC-----CC--
Confidence            2224567999999998999999999999999999998 9999987665443222211       0000 00     01  


Q ss_pred             CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccc
Q 013636          392 DLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIP  426 (439)
Q Consensus       392 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  426 (439)
                        .....+.+++.+||+.+|+.||++.++++.|+.
T Consensus       221 --~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         221 --GCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             --cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence              113456789999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.2e-38  Score=316.74  Aligned_cols=257  Identities=23%  Similarity=0.331  Sum_probs=196.7

Q ss_pred             hcCCCccceecccCcEEEEEEEECC---ccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFNE---KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      ..+|++.+.||+|+||.||++...+   +..+++|.+...     +...+|++++++++||||+++++++...+..+++|
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            4679999999999999999997643   467888887643     23567999999999999999999999999999999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~  308 (439)
                      |++. ++|.+++.   ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.++|+|||++......
T Consensus       166 e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        166 PKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH  238 (392)
T ss_pred             hhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence            9996 68888884   235689999999999999999999998   9999999999999999999999999999765432


Q ss_pred             Cc---ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhccccc-CCCCCc---
Q 013636          309 SR---NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTD-RSKLPN---  381 (439)
Q Consensus       309 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~-~~~~~~---  381 (439)
                      ..   .....||+.|+|||++....++.++|||||||++|||++|+.||.+................+.. ....+.   
T Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~  318 (392)
T PHA03207        239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS  318 (392)
T ss_pred             cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence            22   12346899999999999999999999999999999999999999765432111111100000000 000000   


Q ss_pred             ------------------cCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          382 ------------------IVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       382 ------------------~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                                        ...+.++..   .....+.+++..||+.||++|||+.|++.+
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        319 TNLCKHFKQYAIVLRPPYTIPPVIRKY---GMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             hhHHHHHHhhcccccCCccccchhhcc---CcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence                              000001000   112356678999999999999999999976

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=2.3e-38  Score=302.59  Aligned_cols=260  Identities=26%  Similarity=0.438  Sum_probs=201.9

Q ss_pred             HHHHHHhcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCchHHHHHHHHHHHHHhc-CCCceeeeeeEEE----
Q 013636          146 ELLEAATNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCI----  219 (439)
Q Consensus       146 ~~l~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~----  219 (439)
                      +.+..+.++|++.+.||+|+||.||++... .+..+++|.+.... ....++.+|+.+++++ +|||++++++++.    
T Consensus        11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   89 (286)
T cd06638          11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV   89 (286)
T ss_pred             ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence            344556789999999999999999999875 46788999876532 2345688899999999 6999999999884    


Q ss_pred             -eCCeeEEEEEeccCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEE
Q 013636          220 -HAETRFLVYEMMQNGSLEKQLHGP-THGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLS  297 (439)
Q Consensus       220 -~~~~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~  297 (439)
                       .++..++||||+++|+|.++++.. .....+++..+..++.|+++||.|||+.   +++||||||+||++++++.+||+
T Consensus        90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~  166 (286)
T cd06638          90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLV  166 (286)
T ss_pred             CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEc
Confidence             345689999999999999987642 2335688999999999999999999998   99999999999999999999999


Q ss_pred             ecccccccCCCC-cceeeccccCccchhhhcC-----CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhc
Q 013636          298 DFGLSVTAGTQS-RNVKISGTLGYVAPEYLLE-----GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP  371 (439)
Q Consensus       298 DfGls~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~  371 (439)
                      |||++....... ......|++.|+|||.+..     ..++.++||||+||++|||++|+.||....+........    
T Consensus       167 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~----  242 (286)
T cd06638         167 DFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIP----  242 (286)
T ss_pred             cCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcc----
Confidence            999987654322 1123358899999998753     457889999999999999999999998665422111100    


Q ss_pred             ccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhc
Q 013636          372 QLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL  424 (439)
Q Consensus       372 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  424 (439)
                          ....+...++..       ....+.+++.+||+.||++|||+.|++++.
T Consensus       243 ----~~~~~~~~~~~~-------~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         243 ----RNPPPTLHQPEL-------WSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             ----ccCCCcccCCCC-------cCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence                000011111111       123577899999999999999999999875

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=3.1e-38  Score=301.19  Aligned_cols=257  Identities=29%  Similarity=0.463  Sum_probs=200.3

Q ss_pred             HHHHHHhcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCchHHHHHHHHHHHHHhc-CCCceeeeeeEEEe---
Q 013636          146 ELLEAATNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIH---  220 (439)
Q Consensus       146 ~~l~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~---  220 (439)
                      ..+..+.+.|+..+.||+|+||.||+|+.. .+..+++|...... ....++..|+.+++++ +|+|++++++++..   
T Consensus         9 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~   87 (282)
T cd06636           9 SALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSP   87 (282)
T ss_pred             hhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccc
Confidence            334456678888999999999999999885 46788899876543 3345688899999998 79999999999853   


Q ss_pred             ---CCeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEE
Q 013636          221 ---AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLS  297 (439)
Q Consensus       221 ---~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~  297 (439)
                         .+..+++|||+++|+|.+++... ....+++..+..++.|++.|++|||+.   +++|+||+|+||++++++.++|+
T Consensus        88 ~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~  163 (282)
T cd06636          88 PGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLV  163 (282)
T ss_pred             cCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEe
Confidence               45789999999999999998642 234588888999999999999999998   99999999999999999999999


Q ss_pred             ecccccccCCC-CcceeeccccCccchhhhc-----CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhc
Q 013636          298 DFGLSVTAGTQ-SRNVKISGTLGYVAPEYLL-----EGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP  371 (439)
Q Consensus       298 DfGls~~~~~~-~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~  371 (439)
                      |||++...... .......|+..|+|||.+.     +..++.++|||||||++|||++|+.||....+........+   
T Consensus       164 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~---  240 (282)
T cd06636         164 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---  240 (282)
T ss_pred             eCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhh---
Confidence            99998754322 1223345889999999986     34678899999999999999999999976554322211110   


Q ss_pred             ccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          372 QLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       372 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                           .......        .......+.+++.+||+.||++|||+.|++++
T Consensus       241 -----~~~~~~~--------~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         241 -----NPPPKLK--------SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             -----CCCCCCc--------ccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence                 0000000        01123467889999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=6.7e-38  Score=295.29  Aligned_cols=252  Identities=24%  Similarity=0.429  Sum_probs=206.5

Q ss_pred             cCCCccceecccCcEEEEEEEECC-ccEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEe
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGH-DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      ++|++.+.||+|++|.||+++..+ +..+++|.+..... .....+.+|+..+.+++|+|++++++++...+..++|+||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            367888999999999999998875 88899999876544 4457899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCC
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHE-HCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS  309 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~-~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~  309 (439)
                      +++++|.+++...   ..+++..+..++.|+++|++|||+ .   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~  154 (264)
T cd06623          81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL  154 (264)
T ss_pred             cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence            9999999999642   568999999999999999999999 7   99999999999999999999999999997664433


Q ss_pred             cc-eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhc
Q 013636          310 RN-VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIR  388 (439)
Q Consensus       310 ~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  388 (439)
                      .. ....++..|+|||.+.+..++.++|+||||+++|||++|+.||.............+...     ...+.     +.
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-----~~~~~-----~~  224 (264)
T cd06623         155 DQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD-----GPPPS-----LP  224 (264)
T ss_pred             CcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc-----CCCCC-----CC
Confidence            32 234578899999999999999999999999999999999999977653222222222110     00000     00


Q ss_pred             CccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          389 DTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       389 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      ..   .....+.+++.+||+.+|++||++.+++++
T Consensus       225 ~~---~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         225 AE---EFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             cc---cCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            10   023467789999999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=3.1e-38  Score=297.34  Aligned_cols=253  Identities=26%  Similarity=0.402  Sum_probs=201.2

Q ss_pred             CCCccceecccCcEEEEEEEEC-CccEEEEEEecCC--CchHHHHHHHHHHHHHhcCCCceeeeeeEEEe--CCeeEEEE
Q 013636          154 NFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDA--GHDAEREFNNEVNWLTKIRHQNIISLLGYCIH--AETRFLVY  228 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~  228 (439)
                      +|++.+.||.|+||.||++... ++..+++|.+...  .....+++.+|+.++++++|||++++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4677889999999999999865 5678899988643  23344578899999999999999999998764  34679999


Q ss_pred             EeccCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCCeEecCCCCCCEEEcCCCcEEEEeccccccc
Q 013636          229 EMMQNGSLEKQLHGP-THGSNLTWHLRMKIAVDVARGLEYLHEHC--NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA  305 (439)
Q Consensus       229 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~~LH~~~--~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~  305 (439)
                      ||+++++|.+++... .....+++..+..++.|++.||+|||..+  ..+++|+||+|+||++++++.+||+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999998642 22457899999999999999999999332  239999999999999999999999999999876


Q ss_pred             CCCCc-ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCC
Q 013636          306 GTQSR-NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVD  384 (439)
Q Consensus       306 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  384 (439)
                      ..... .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+.        ....+.   
T Consensus       161 ~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~--------~~~~~~---  229 (265)
T cd08217         161 GHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIK--------EGKFRR---  229 (265)
T ss_pred             cCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHh--------cCCCCC---
Confidence            54433 233458899999999999899999999999999999999999998765332221111        111110   


Q ss_pred             chhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          385 PVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       385 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                        +    .......+.+++.+|++.+|++||++.+|+++
T Consensus       230 --~----~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         230 --I----PYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             --C----ccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence              1    11223467789999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-38  Score=304.19  Aligned_cols=251  Identities=25%  Similarity=0.324  Sum_probs=202.1

Q ss_pred             cCCCccceecccCcEEEEEEEECC-ccEEEEEEecCCCch---HHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      ++|+..+.||+|+||.||++...+ +..+++|.+......   ..+.+.+|+++++.++|+||+++++.+...+..++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            368888999999999999998865 788999988754322   3456889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~  308 (439)
                      ||+.+++|.+++... .+..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++......
T Consensus        81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence            999999999998742 345689999999999999999999998   9999999999999999999999999998654221


Q ss_pred             Cc------------------------------ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC
Q 013636          309 SR------------------------------NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMS  358 (439)
Q Consensus       309 ~~------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~  358 (439)
                      ..                              .....||..|+|||.+.+..++.++||||||+++|+|++|+.||...+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  236 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN  236 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            10                              012347889999999999999999999999999999999999998765


Q ss_pred             hhhhhhhHhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCC----HHHHHHh
Q 013636          359 PTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPL----ITDVLHS  423 (439)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt----~~evl~~  423 (439)
                      .......+.      ......+..          ......+.+++.+||+.||++||+    +.+++.+
T Consensus       237 ~~~~~~~~~------~~~~~~~~~----------~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~  289 (316)
T cd05574         237 RDETFSNIL------KKEVTFPGS----------PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH  289 (316)
T ss_pred             hHHHHHHHh------cCCccCCCc----------cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence            432211110      011111110          012356778999999999999999    8888864

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.1e-38  Score=307.70  Aligned_cols=195  Identities=27%  Similarity=0.407  Sum_probs=159.6

Q ss_pred             cceecccCcEEEEEEEEC---CccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEe--CCeeEEEEEecc
Q 013636          158 SNVIGEGGRGHVYKARFN---EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH--AETRFLVYEMMQ  232 (439)
Q Consensus       158 ~~~LG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~e~~~  232 (439)
                      .++||+|+||+||+|+..   .+..+|+|.+....  ....+.+|+.++++++||||+++++++..  ....++++||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            467999999999999865   45788999887543  23457789999999999999999998854  346789999986


Q ss_pred             CCChhhhhcCCC------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE----cCCCcEEEEecccc
Q 013636          233 NGSLEKQLHGPT------HGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILL----DSSFNAKLSDFGLS  302 (439)
Q Consensus       233 ~gsL~~~l~~~~------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl----~~~~~~kl~DfGls  302 (439)
                      + +|.+++....      ....+++..+..++.|++.||+|||+.   +++||||||+|||+    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            5 8888764211      123588999999999999999999998   99999999999999    45678999999999


Q ss_pred             cccCCCCc----ceeeccccCccchhhhcCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCC
Q 013636          303 VTAGTQSR----NVKISGTLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGRRPVEKMS  358 (439)
Q Consensus       303 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvll~elltG~~P~~~~~  358 (439)
                      ........    .....||+.|+|||++.+. .++.++||||+||++|||++|+.||....
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            76543221    1234589999999999874 58899999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=4e-38  Score=302.24  Aligned_cols=265  Identities=22%  Similarity=0.305  Sum_probs=199.6

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCceeeeeeEEEeC--CeeEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGH--DAEREFNNEVNWLTKIRHQNIISLLGYCIHA--ETRFLV  227 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV  227 (439)
                      ++|+..+.||+|+||.||+|+.. ++..+++|.++....  .....+.+|+.++++++|||++++++++...  +..++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            46778899999999999999986 477889998864332  2234577899999999999999999998877  789999


Q ss_pred             EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCC
Q 013636          228 YEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT  307 (439)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~  307 (439)
                      +||+++ +|.+++...  ...+++..+..++.|++.||+|||+.   +++|+||||+||++++++.+||+|||++.....
T Consensus        85 ~e~~~~-~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          85 MEYVEH-DLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGS  158 (293)
T ss_pred             ehhcCc-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence            999974 999988642  23689999999999999999999998   999999999999999999999999999976554


Q ss_pred             CC-cceeeccccCccchhhhcCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhc-----------ccc
Q 013636          308 QS-RNVKISGTLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP-----------QLT  374 (439)
Q Consensus       308 ~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~-----------~~~  374 (439)
                      .. ......+++.|+|||.+.+. .++.++|+||||+++|||++|+.||...+.......+.....           .+.
T Consensus       159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
T cd07843         159 PLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP  238 (293)
T ss_pred             CccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence            32 22233478899999998764 468899999999999999999999987654332211110000           000


Q ss_pred             --cCCCCCccCCchhcCccCHH-HHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          375 --DRSKLPNIVDPVIRDTMDLK-HLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       375 --~~~~~~~~~d~~l~~~~~~~-~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                        ............+...+... ....+.+++.+||+.||++|||+.|++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence              00001111111111111111 23456789999999999999999999864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.7e-38  Score=297.69  Aligned_cols=252  Identities=26%  Similarity=0.424  Sum_probs=197.1

Q ss_pred             CCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCc----------hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC
Q 013636          154 NFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGH----------DAEREFNNEVNWLTKIRHQNIISLLGYCIHAE  222 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  222 (439)
                      +|...+.||+|+||.||+|... ++..+|+|.++....          ...+.+.+|+.+++.++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4667789999999999999764 577899998753211          11245788999999999999999999999999


Q ss_pred             eeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccc
Q 013636          223 TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS  302 (439)
Q Consensus       223 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls  302 (439)
                      ..++|+||+++|+|.+++.+.   ..+++..+..++.|++.||.|||+.   +++||||+|+||++++++.++++|||++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~  155 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGIS  155 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccc
Confidence            999999999999999999643   4689999999999999999999997   9999999999999999999999999998


Q ss_pred             cccCCCCc---ceeeccccCccchhhhcCCC--CCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCC
Q 013636          303 VTAGTQSR---NVKISGTLGYVAPEYLLEGK--LTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRS  377 (439)
Q Consensus       303 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~--~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  377 (439)
                      ........   .....++..|+|||.+....  ++.++|+||||+++||+++|..||...+..+..  .....  .....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~--~~~~~--~~~~~  231 (272)
T cd06629         156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAM--FKLGN--KRSAP  231 (272)
T ss_pred             ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHH--HHhhc--cccCC
Confidence            76432211   12345788999999988754  789999999999999999999999754432211  11000  00011


Q ss_pred             CCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          378 KLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       378 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      ..    ++...    ......+.+++.+||+.+|++|||+.+++++
T Consensus       232 ~~----~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         232 PI----PPDVS----MNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             cC----Ccccc----ccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            11    11111    1123467779999999999999999999976

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-38  Score=301.87  Aligned_cols=265  Identities=24%  Similarity=0.365  Sum_probs=197.2

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEe
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGH-DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      ++|+..+.||+|++|.||+|+.. ++..+++|.+..... .....+.+|++++++++|+||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            57888899999999999999876 578899999864332 2234577899999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR  310 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~  310 (439)
                      +++ +|.+++...  ...+++.....++.|++.||.|||+.   +++||||||+||++++++.+||+|||+++.......
T Consensus        85 ~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  158 (291)
T cd07844          85 LDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK  158 (291)
T ss_pred             CCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence            985 999988643  23689999999999999999999998   999999999999999999999999999865432211


Q ss_pred             c-eeeccccCccchhhhcC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCh-hhhhhhHhhhhcc--------cccCCC-
Q 013636          311 N-VKISGTLGYVAPEYLLE-GKLTDKSDVYAFGVVLLELLMGRRPVEKMSP-TQCQSMVTWAMPQ--------LTDRSK-  378 (439)
Q Consensus       311 ~-~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvll~elltG~~P~~~~~~-~~~~~~~~~~~~~--------~~~~~~-  378 (439)
                      . ....++..|+|||.+.+ ..++.++||||+|+++|||++|+.||..... .+...........        ...... 
T Consensus       159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (291)
T cd07844         159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF  238 (291)
T ss_pred             cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence            1 12236788999999875 4578999999999999999999999976542 1111111110000        000000 


Q ss_pred             ----CCccCCchhcCcc-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          379 ----LPNIVDPVIRDTM-DLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       379 ----~~~~~d~~l~~~~-~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                          ........+.... .......+.+++.+||+.+|++|||+.+++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~  288 (291)
T cd07844         239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH  288 (291)
T ss_pred             ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence                0000000000000 00112566789999999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-39  Score=312.90  Aligned_cols=240  Identities=25%  Similarity=0.330  Sum_probs=187.9

Q ss_pred             ecccCcEEEEEEEEC-CccEEEEEEecCCCc---hHHHHHHHHHHHHHhc---CCCceeeeeeEEEeCCeeEEEEEeccC
Q 013636          161 IGEGGRGHVYKARFN-EKLLAAVKRIDDAGH---DAEREFNNEVNWLTKI---RHQNIISLLGYCIHAETRFLVYEMMQN  233 (439)
Q Consensus       161 LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lV~e~~~~  233 (439)
                      ||+|+||+||+|+.. .+..+|+|.+.....   .....+..|..++...   +||||+++++++...+..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999875 478899999864321   1223455677777665   699999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC-Ccce
Q 013636          234 GSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ-SRNV  312 (439)
Q Consensus       234 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~-~~~~  312 (439)
                      |+|.+++..   ...+++..+..++.|+++||+|||+.   +|+||||||+|||+++++.+||+|||++...... ....
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~  154 (330)
T cd05586          81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTN  154 (330)
T ss_pred             ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCcc
Confidence            999999863   34689999999999999999999998   9999999999999999999999999998654322 2223


Q ss_pred             eeccccCccchhhhcCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCcc
Q 013636          313 KISGTLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTM  391 (439)
Q Consensus       313 ~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  391 (439)
                      ...||+.|+|||.+.+. .++.++|||||||++|||++|+.||...+..+....+..      ....++.   .    ..
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~------~~~~~~~---~----~~  221 (330)
T cd05586         155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAF------GKVRFPK---N----VL  221 (330)
T ss_pred             CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHc------CCCCCCC---c----cC
Confidence            45699999999998765 478999999999999999999999987655433222211      0111111   0    01


Q ss_pred             CHHHHHHHHHHHHHhcCCCCCCCC----CHHHHHHh
Q 013636          392 DLKHLYQVAAVAVLCIQPEPSYRP----LITDVLHS  423 (439)
Q Consensus       392 ~~~~~~~l~~l~~~cl~~dP~~RP----t~~evl~~  423 (439)
                          ...+.+++.+||+.||++||    ++.+++++
T Consensus       222 ----~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h  253 (330)
T cd05586         222 ----SDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH  253 (330)
T ss_pred             ----CHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence                22456789999999999998    57777764

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.3e-38  Score=302.34  Aligned_cols=264  Identities=23%  Similarity=0.316  Sum_probs=194.9

Q ss_pred             CCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEe
Q 013636          154 NFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGH--DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      +|+..+.||+|+||.||+|+.. .+..+++|.+.....  .....+.+|+.++++++|||++++++++.+.+..++++||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4777889999999999999885 477889998864322  2234678899999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR  310 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~  310 (439)
                      ++ ++|.+++..  ....+++..+..++.|+++||.|||+.   +++||||||+||+++.++++||+|||++........
T Consensus        81 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  154 (284)
T cd07839          81 CD-QDLKKYFDS--CNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR  154 (284)
T ss_pred             CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence            97 488888763  234689999999999999999999998   999999999999999999999999999976543222


Q ss_pred             c-eeeccccCccchhhhcCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCh-hhhhhhHhhhh--------ccc---ccC
Q 013636          311 N-VKISGTLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGRRPVEKMSP-TQCQSMVTWAM--------PQL---TDR  376 (439)
Q Consensus       311 ~-~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvll~elltG~~P~~~~~~-~~~~~~~~~~~--------~~~---~~~  376 (439)
                      . ....++..|+|||.+.+. .++.++|||||||++|||++|..|+..... ......+....        +..   ...
T Consensus       155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07839         155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY  234 (284)
T ss_pred             CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence            1 223468899999998765 468999999999999999999988643322 11111110000        000   000


Q ss_pred             CCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          377 SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       377 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      ...+..................+.+++.+||+.||++|||+.+++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h  281 (284)
T cd07839         235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH  281 (284)
T ss_pred             cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence            00000000000000001123467789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-41  Score=301.83  Aligned_cols=248  Identities=23%  Similarity=0.388  Sum_probs=207.7

Q ss_pred             CCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEecc
Q 013636          154 NFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQ  232 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  232 (439)
                      -|.++++||+|+||.||+|..+ .|.++|+|.+.-.  .+..++..|+.+|++++.|++|+++|.+.....+++|||||.
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG  111 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG  111 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence            4566789999999999999775 4888999998653  466789999999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC-Ccc
Q 013636          233 NGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ-SRN  311 (439)
Q Consensus       233 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~-~~~  311 (439)
                      .|+..+.++  .+.+++++..+..+..+.++||+|||..   .-+|||||+.|||++.+|.+||+|||.+-...+. ...
T Consensus       112 AGSiSDI~R--~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKR  186 (502)
T KOG0574|consen  112 AGSISDIMR--ARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKR  186 (502)
T ss_pred             CCcHHHHHH--HhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHHhh
Confidence            999999997  4457899999999999999999999998   7899999999999999999999999999655432 223


Q ss_pred             eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCcc
Q 013636          312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTM  391 (439)
Q Consensus       312 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  391 (439)
                      .+..||+.|||||++..--|..++||||+|++..||..|++||....|-....++.        ...-+.+-.|.     
T Consensus       187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIP--------T~PPPTF~KPE-----  253 (502)
T KOG0574|consen  187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIP--------TKPPPTFKKPE-----  253 (502)
T ss_pred             CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEecc--------CCCCCCCCChH-----
Confidence            45669999999999999999999999999999999999999998776643322221        11111222222     


Q ss_pred             CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          392 DLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       392 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                        .-...+.+++..||-.+|++|-|+.+++++
T Consensus       254 --~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  254 --EWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             --hhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence              223457789999999999999999999976

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2.5e-38  Score=298.68  Aligned_cols=252  Identities=29%  Similarity=0.433  Sum_probs=201.5

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEe
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG-HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      ++|+..+.||+|+||.||++... ++..+++|.+.... ....+++.+|++++++++|||++++++.+...+..++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            35677789999999999999886 47788999887643 34456789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCC
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHE-HCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS  309 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~-~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~  309 (439)
                      +++++|.+++....  ..+++..+..++.|++.|++|||+ .   +++|+||+|+||++++++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~  155 (265)
T cd06605          81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL  155 (265)
T ss_pred             cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence            99999999997432  568899999999999999999999 6   99999999999999999999999999986553322


Q ss_pred             cceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh--hhhhhhHhhhhcccccCCCCCccCCchh
Q 013636          310 RNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSP--TQCQSMVTWAMPQLTDRSKLPNIVDPVI  387 (439)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~d~~l  387 (439)
                      .. ...++..|+|||.+.+..++.++||||||+++|+|++|+.||.....  ...........    ... .+...    
T Consensus       156 ~~-~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~-~~~~~----  225 (265)
T cd06605         156 AK-TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIV----NEP-PPRLP----  225 (265)
T ss_pred             hh-cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHh----cCC-CCCCC----
Confidence            22 25588899999999999999999999999999999999999976531  11111111110    000 00000    


Q ss_pred             cCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          388 RDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       388 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                       ..   .....+.+++.+||..||++|||+.+++.+
T Consensus       226 -~~---~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         226 -SG---KFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             -hh---hcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence             00   023457789999999999999999999865

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=5.1e-38  Score=299.99  Aligned_cols=263  Identities=23%  Similarity=0.288  Sum_probs=201.2

Q ss_pred             CCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEe
Q 013636          154 NFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      +|++.+.||+|+||.||+|+.. ++..+++|.+....  ......+.+|+.++++++|||++++++++...+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4777899999999999999875 57889999987543  23346789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR  310 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~  310 (439)
                      + +++|.+++....  ..+++..+..++.|+++||+|||+.   +++|+||||+||++++++.++|+|||++........
T Consensus        81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (286)
T cd07832          81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP  154 (286)
T ss_pred             c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence            9 999999986432  5689999999999999999999998   999999999999999999999999999976654321


Q ss_pred             --ceeeccccCccchhhhcCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhh-Hhhh-------hcccccCCCC
Q 013636          311 --NVKISGTLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSM-VTWA-------MPQLTDRSKL  379 (439)
Q Consensus       311 --~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~-~~~~-------~~~~~~~~~~  379 (439)
                        .....++..|+|||.+.+. .++.++||||+|+++|||++|+.||...+....... ....       .+........
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07832         155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY  234 (286)
T ss_pred             CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchh
Confidence              2234588999999998754 468899999999999999999888876543221111 1100       0000000000


Q ss_pred             CccCCc-----hhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          380 PNIVDP-----VIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       380 ~~~~d~-----~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      .....+     .+.. ...+....+.+++.+|++.+|++|||+++++++
T Consensus       235 ~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         235 NKITFPESKPIPLEE-IFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             hcccCCCCCcchHHH-hCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            000000     0000 001123678889999999999999999999976

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=3.4e-38  Score=303.62  Aligned_cols=244  Identities=26%  Similarity=0.363  Sum_probs=198.3

Q ss_pred             cceecccCcEEEEEEEEC-CccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEeccCCCh
Q 013636          158 SNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSL  236 (439)
Q Consensus       158 ~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  236 (439)
                      ...||+|+||.||++... ++..+++|.+........+.+.+|+.+++.++|||++++++++..++..++++||+++++|
T Consensus        26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L  105 (297)
T cd06659          26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL  105 (297)
T ss_pred             hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence            456999999999999875 5788999998765555566788999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc-ceeec
Q 013636          237 EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR-NVKIS  315 (439)
Q Consensus       237 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~-~~~~~  315 (439)
                      .+++..    ..+++..+..++.|++.||+|||+.   +++||||+|+||+++.++.+||+|||++........ .....
T Consensus       106 ~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~  178 (297)
T cd06659         106 TDIVSQ----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV  178 (297)
T ss_pred             HHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccccccccee
Confidence            998753    3488999999999999999999998   999999999999999999999999999865433221 22345


Q ss_pred             cccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCccCHHH
Q 013636          316 GTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKH  395 (439)
Q Consensus       316 gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  395 (439)
                      |+..|+|||.+.+..++.++||||||+++|||++|+.||...++.+....+..       .. ......   ..    ..
T Consensus       179 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~-------~~-~~~~~~---~~----~~  243 (297)
T cd06659         179 GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD-------SP-PPKLKN---AH----KI  243 (297)
T ss_pred             cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-------cC-CCCccc---cC----CC
Confidence            88999999999998999999999999999999999999986654432222110       00 000000   00    11


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          396 LYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       396 ~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      ...+.+++..||+.+|++||++.+++++
T Consensus       244 ~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         244 SPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             CHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            2346678999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.7e-37  Score=289.61  Aligned_cols=250  Identities=30%  Similarity=0.483  Sum_probs=206.1

Q ss_pred             CCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEecc
Q 013636          154 NFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQ  232 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  232 (439)
                      .|+..+.||+|++|.||++... ++..+++|.+..........+.+|+..+++++|+|++++++++...+..++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            3667789999999999999986 578899999977655566789999999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCcce
Q 013636          233 NGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV  312 (439)
Q Consensus       233 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~~~  312 (439)
                      +++|.+++....  ..+++..+..++.|++.+++|||+.   +++||||+|+||++++++.++|+|||.+..........
T Consensus        81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~  155 (253)
T cd05122          81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN  155 (253)
T ss_pred             CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccccc
Confidence            999999987532  5689999999999999999999997   99999999999999999999999999997765543233


Q ss_pred             eeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCccC
Q 013636          313 KISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMD  392 (439)
Q Consensus       313 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  392 (439)
                      ...++..|+|||.+....++.++||||||+++++|++|+.||...+..........        ...+...++.      
T Consensus       156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~------  221 (253)
T cd05122         156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT--------NGPPGLRNPE------  221 (253)
T ss_pred             ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh--------cCCCCcCccc------
Confidence            45588999999999988899999999999999999999999987644332211110        1111111110      


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          393 LKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       393 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                       .....+.+++.+||+.||++|||+.|++++
T Consensus       222 -~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         222 -KWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             -ccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence             013457789999999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=5.8e-38  Score=304.41  Aligned_cols=194  Identities=26%  Similarity=0.410  Sum_probs=159.0

Q ss_pred             cceecccCcEEEEEEEECC---ccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEe--CCeeEEEEEecc
Q 013636          158 SNVIGEGGRGHVYKARFNE---KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH--AETRFLVYEMMQ  232 (439)
Q Consensus       158 ~~~LG~G~fg~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~e~~~  232 (439)
                      ..+||+|+||+||+|+..+   +..+|+|.+....  ....+.+|+.++++++||||+++++++..  +...++|+||++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            3679999999999998753   4678999887543  23457889999999999999999998854  456799999987


Q ss_pred             CCChhhhhcCC------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE----cCCCcEEEEecccc
Q 013636          233 NGSLEKQLHGP------THGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILL----DSSFNAKLSDFGLS  302 (439)
Q Consensus       233 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl----~~~~~~kl~DfGls  302 (439)
                      + +|.+++...      .....+++..+..++.|++.||+|||+.   +++||||||+|||+    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            5 777776421      1223588999999999999999999998   99999999999999    56779999999999


Q ss_pred             cccCCCCc----ceeeccccCccchhhhcC-CCCCCchhhHHHHHHHHHHHhCCCCCCCC
Q 013636          303 VTAGTQSR----NVKISGTLGYVAPEYLLE-GKLTDKSDVYAFGVVLLELLMGRRPVEKM  357 (439)
Q Consensus       303 ~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvll~elltG~~P~~~~  357 (439)
                      +.......    .....+|+.|+|||.+.+ ..++.++|||||||++|||+||+.||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            76543221    123457899999999876 45789999999999999999999999754

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=7.3e-38  Score=301.07  Aligned_cols=264  Identities=27%  Similarity=0.313  Sum_probs=199.5

Q ss_pred             CCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCch-----HHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEE
Q 013636          154 NFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHD-----AEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLV  227 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  227 (439)
                      +|+..+.||+|+||.||+|... ++..+++|.+......     ....+.+|++++++++|+|++++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4677889999999999999875 5789999998754322     234577899999999999999999999999999999


Q ss_pred             EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCC
Q 013636          228 YEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT  307 (439)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~  307 (439)
                      |||+ +|+|.+++....  ..+++..+..++.|+++||+|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            9999 899999997532  3699999999999999999999998   999999999999999999999999999976644


Q ss_pred             CCcc-eeeccccCccchhhhcC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhccc-----ccCCCCC
Q 013636          308 QSRN-VKISGTLGYVAPEYLLE-GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQL-----TDRSKLP  380 (439)
Q Consensus       308 ~~~~-~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~-----~~~~~~~  380 (439)
                      .... ....++..|+|||.+.+ ..++.++|||||||++|||++|..||...++..............     .......
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (298)
T cd07841         155 PNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP  234 (298)
T ss_pred             CCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccc
Confidence            3221 22246788999998865 467899999999999999999988887655422111111000000     0000010


Q ss_pred             ccCCchhcCcc-----CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          381 NIVDPVIRDTM-----DLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       381 ~~~d~~l~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      ...........     .......+.+++.+||+.||++|||++|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            11100000000     01124567889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=9.3e-38  Score=294.49  Aligned_cols=250  Identities=29%  Similarity=0.494  Sum_probs=199.6

Q ss_pred             CCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEe
Q 013636          154 NFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGH--DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      +|+..+.||+|+||.||+|... ++..+++|.+.....  ...+.+.+|+.++++++|+||+++++.+...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            4777899999999999999875 578899999875543  2557899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR  310 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~  310 (439)
                      +++++|.+++..   +..+++..+..++.|+++|++|||+.   +++|+||+|+||++++++.+||+|||++........
T Consensus        81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~  154 (264)
T cd06626          81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT  154 (264)
T ss_pred             CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence            999999999964   23578999999999999999999998   999999999999999999999999999876543322


Q ss_pred             c-----eeeccccCccchhhhcCCC---CCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCcc
Q 013636          311 N-----VKISGTLGYVAPEYLLEGK---LTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNI  382 (439)
Q Consensus       311 ~-----~~~~gt~~y~aPE~~~~~~---~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  382 (439)
                      .     ....++..|+|||.+.+..   ++.++||||||+++||+++|+.||..........   +.... .....++..
T Consensus       155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~---~~~~~-~~~~~~~~~  230 (264)
T cd06626         155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIM---FHVGA-GHKPPIPDS  230 (264)
T ss_pred             cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHH---HHHhc-CCCCCCCcc
Confidence            1     1235788999999998766   8899999999999999999999997653221111   00000 111111111


Q ss_pred             CCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          383 VDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       383 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      .          .....+.+++.+||+.+|++|||+.|++.+
T Consensus       231 ~----------~~~~~~~~li~~~l~~~p~~R~~~~~i~~~  261 (264)
T cd06626         231 L----------QLSPEGKDFLDRCLESDPKKRPTASELLQH  261 (264)
T ss_pred             c----------ccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            0          112345679999999999999999998853

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.4e-38  Score=309.84  Aligned_cols=262  Identities=21%  Similarity=0.319  Sum_probs=196.0

Q ss_pred             HhcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCceeeeeeEEEeC------
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGH--DAEREFNNEVNWLTKIRHQNIISLLGYCIHA------  221 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  221 (439)
                      ..++|+..+.||+|+||.||+|... .+..+|+|.+.....  ...+.+.+|+.++++++||||+++++++...      
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF   92 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence            4578999999999999999999874 567899999875322  2335677899999999999999999887543      


Q ss_pred             CeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccc
Q 013636          222 ETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGL  301 (439)
Q Consensus       222 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGl  301 (439)
                      ...++++|++ +++|.+++..    ..+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||+
T Consensus        93 ~~~~~~~~~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~  164 (343)
T cd07878          93 NEVYLVTNLM-GADLNNIVKC----QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGL  164 (343)
T ss_pred             CcEEEEeecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCcc
Confidence            3468999988 7799888753    3589999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCCcceeeccccCccchhhhcC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhH-hhhh-------cc
Q 013636          302 SVTAGTQSRNVKISGTLGYVAPEYLLE-GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMV-TWAM-------PQ  372 (439)
Q Consensus       302 s~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~-~~~~-------~~  372 (439)
                      +.......  ....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+........ ....       ..
T Consensus       165 ~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (343)
T cd07878         165 ARQADDEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKK  242 (343)
T ss_pred             ceecCCCc--CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            97654322  23458999999999877 56889999999999999999999999765432211111 0000       00


Q ss_pred             ccc------CCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          373 LTD------RSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       373 ~~~------~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      +..      ...++......+..... .....+.+++.+|++.||++|||+.|++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         243 ISSEHARKYIQSLPHMPQQDLKKIFR-GANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             cchhhHHHHhhccccccchhHHHhcc-CCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            000      00000000000000000 011246789999999999999999999976

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.4e-37  Score=297.68  Aligned_cols=260  Identities=26%  Similarity=0.384  Sum_probs=201.3

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCceeeeeeEEEeC--CeeEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGH-DAEREFNNEVNWLTKIRHQNIISLLGYCIHA--ETRFLVY  228 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~  228 (439)
                      ++|+..+.||.|++|.||++... .+..+++|.+..... ....++.+|++++++++||||+++++++...  +..++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            36778899999999999999985 477889998874332 3456789999999999999999999988654  3689999


Q ss_pred             EeccCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCC
Q 013636          229 EMMQNGSLEKQLHGP-THGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT  307 (439)
Q Consensus       229 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~  307 (439)
                      ||+++++|.+++... .....+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            999999999887531 2345688999999999999999999998   999999999999999999999999999865433


Q ss_pred             CCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh--hhhhhhHhhhhcccccCCCCCccCCc
Q 013636          308 QSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSP--TQCQSMVTWAMPQLTDRSKLPNIVDP  385 (439)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~d~  385 (439)
                      ... ....++..|+|||.+.+..++.++||||+|+++|||++|+.||.....  ........+...     ...+...+.
T Consensus       158 ~~~-~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~  231 (287)
T cd06621         158 SLA-GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN-----MPNPELKDE  231 (287)
T ss_pred             ccc-ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc-----CCchhhccC
Confidence            222 234478899999999999999999999999999999999999976532  111122222111     000011000


Q ss_pred             hhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhc
Q 013636          386 VIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL  424 (439)
Q Consensus       386 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  424 (439)
                       ..  ........+.+++.+||+.+|++|||+.|++++-
T Consensus       232 -~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~  267 (287)
T cd06621         232 -PG--NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHP  267 (287)
T ss_pred             -CC--CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCc
Confidence             00  0011245678899999999999999999999753

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-39  Score=315.83  Aligned_cols=247  Identities=29%  Similarity=0.417  Sum_probs=206.1

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCch---HHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      +.|+..+.||.|+||.||-|++. +..+||||++.-.+.+   ...++..|+..|++++|||.+.+.|+|......||||
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM  105 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM  105 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence            34666788999999999999875 5678999999755443   3457999999999999999999999999999999999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~  308 (439)
                      |||-| |-.+++.  .+.+++-+..+..|+.+.+.||+|||+.   +.||||||+.|||+++.|.|||+|||.+......
T Consensus       106 EYClG-SAsDlle--VhkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA  179 (948)
T KOG0577|consen  106 EYCLG-SASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA  179 (948)
T ss_pred             HHHhc-cHHHHHH--HHhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCch
Confidence            99965 7777775  3456789999999999999999999998   9999999999999999999999999998776543


Q ss_pred             CcceeeccccCccchhhhc---CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCc
Q 013636          309 SRNVKISGTLGYVAPEYLL---EGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDP  385 (439)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  385 (439)
                         ..+.|||.|||||++.   .+.|+-|+||||+|++..||.-.++|+-.++.-.....+...     +.+.+   -  
T Consensus       180 ---nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQN-----esPtL---q--  246 (948)
T KOG0577|consen  180 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-----ESPTL---Q--  246 (948)
T ss_pred             ---hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhc-----CCCCC---C--
Confidence               3456999999999986   578999999999999999999999999988876555554321     11111   1  


Q ss_pred             hhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhc
Q 013636          386 VIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL  424 (439)
Q Consensus       386 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  424 (439)
                            ..+-...+..++..||+.-|++|||..+++.+-
T Consensus       247 ------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~  279 (948)
T KOG0577|consen  247 ------SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHR  279 (948)
T ss_pred             ------CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence                  123345677899999999999999999999764

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=8.8e-38  Score=296.44  Aligned_cols=253  Identities=25%  Similarity=0.414  Sum_probs=197.8

Q ss_pred             CCccceecccCcEEEEEEEEC----CccEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC------
Q 013636          155 FQESNVIGEGGRGHVYKARFN----EKLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE------  222 (439)
Q Consensus       155 ~~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  222 (439)
                      |.+.+.||+|+||.||+|...    .+..+|+|.+....  ....+++.+|+.++++++|||++++++++...+      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            456788999999999999764    35789999886532  334567889999999999999999999886543      


Q ss_pred             eeEEEEEeccCCChhhhhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEec
Q 013636          223 TRFLVYEMMQNGSLEKQLHGPT---HGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDF  299 (439)
Q Consensus       223 ~~~lV~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~Df  299 (439)
                      ..++++||+++|+|.+++....   ....+++....+++.|++.|++|||+.   +++||||||+||++++++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence            2378899999999998875321   123588999999999999999999997   9999999999999999999999999


Q ss_pred             ccccccCCCCcc---eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhccccc
Q 013636          300 GLSVTAGTQSRN---VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTD  375 (439)
Q Consensus       300 Gls~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~  375 (439)
                      |+++........   ....+++.|++||.+.+..++.++||||||+++|||++ |+.||...+.......+.   .    
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~---~----  230 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLI---K----  230 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHH---c----
Confidence            998765432211   12234578999999999999999999999999999999 899997665433222211   0    


Q ss_pred             CCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhcccc
Q 013636          376 RSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPL  427 (439)
Q Consensus       376 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l  427 (439)
                      ......  .        ......+.+++.+||+.+|++||++.++++.|+.+
T Consensus       231 ~~~~~~--~--------~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         231 GNRLKQ--P--------PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             CCcCCC--C--------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            001000  0        01234678899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=9.7e-38  Score=295.06  Aligned_cols=248  Identities=25%  Similarity=0.378  Sum_probs=194.4

Q ss_pred             cCCCccceecccCcEEEEEEEECC-ccEEEEEEecCCC-----chHHHHHHHHHHHHHhcCCCceeeeeeEEEeC--Cee
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAG-----HDAEREFNNEVNWLTKIRHQNIISLLGYCIHA--ETR  224 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  224 (439)
                      ++|++.+.||+|+||.||+|...+ +..+++|.+....     ....+.+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            478889999999999999998754 7889999875321     12335688999999999999999999988764  467


Q ss_pred             EEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccc
Q 013636          225 FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT  304 (439)
Q Consensus       225 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~  304 (439)
                      +++|||+++++|.+++...   ..+++....+++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++..
T Consensus        82 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~  155 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKR  155 (265)
T ss_pred             EEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccc
Confidence            8999999999999998632   3578899999999999999999998   999999999999999999999999999875


Q ss_pred             cCCC----CcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCC
Q 013636          305 AGTQ----SRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLP  380 (439)
Q Consensus       305 ~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  380 (439)
                      ....    .......++..|+|||.+.+..++.++||||||+++|||++|+.||.............       ....  
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~-------~~~~--  226 (265)
T cd06652         156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA-------TQPT--  226 (265)
T ss_pred             cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHh-------cCCC--
Confidence            4321    11122358889999999998889999999999999999999999997654332111110       0000  


Q ss_pred             ccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          381 NIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       381 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                         .+.    ........+.+++..|+. +|++||++.|++++
T Consensus       227 ---~~~----~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         227 ---NPV----LPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             ---CCC----CchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence               010    111223456678888885 99999999999865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-40  Score=319.07  Aligned_cols=251  Identities=25%  Similarity=0.449  Sum_probs=207.7

Q ss_pred             cCCCccceecccCcEEEEEEEECCc-cEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEec
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNEK-LLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMM  231 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  231 (439)
                      +-|.+...||-|+||.||+|..++. ...|.|.+...+....++|.-|+++|..+.||+||++++.|+..+.++++.|||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC  111 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC  111 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence            3445567899999999999988764 455778888877778889999999999999999999999999999999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccC-CCCc
Q 013636          232 QNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAG-TQSR  310 (439)
Q Consensus       232 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~-~~~~  310 (439)
                      .||-.+..+-.  -+..|++.++..++.|++.||.|||++   .|+|||||+.|||++-+|.++|+|||.+.... ....
T Consensus       112 ~GGAVDaimlE--L~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qk  186 (1187)
T KOG0579|consen  112 GGGAVDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQK  186 (1187)
T ss_pred             CCchHhHHHHH--hccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhHHhh
Confidence            99999988763  346799999999999999999999998   99999999999999999999999999985432 2223


Q ss_pred             ceeeccccCccchhhhc-----CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCc
Q 013636          311 NVKISGTLGYVAPEYLL-----EGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDP  385 (439)
Q Consensus       311 ~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  385 (439)
                      ...+.|||+|||||++.     ..+|+.++||||||++|.||..+.+|....++-.+.-.+.        ....|.++.|
T Consensus       187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKia--------KSePPTLlqP  258 (1187)
T KOG0579|consen  187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA--------KSEPPTLLQP  258 (1187)
T ss_pred             hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHh--------hcCCCcccCc
Confidence            34567999999999875     5689999999999999999999999998887754332222        2222333333


Q ss_pred             hhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          386 VIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       386 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      .       .-...+.++...||..||..||++.+++++
T Consensus       259 S-------~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  259 S-------HWSRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             c-------hhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence            2       123456678899999999999999999976

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.1e-37  Score=298.19  Aligned_cols=247  Identities=24%  Similarity=0.368  Sum_probs=200.6

Q ss_pred             CCccceecccCcEEEEEEEEC-CccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEeccC
Q 013636          155 FQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQN  233 (439)
Q Consensus       155 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  233 (439)
                      |...+.||+|++|.||++... ++..+++|.+........+.+.+|+.+++.++|||++++++++...+..++++||+++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~  100 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG  100 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence            344578999999999999864 5788999988765555566789999999999999999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc-ce
Q 013636          234 GSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR-NV  312 (439)
Q Consensus       234 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~-~~  312 (439)
                      ++|.+++..    ..+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.++|+|||.+........ ..
T Consensus       101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~  173 (285)
T cd06648         101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK  173 (285)
T ss_pred             CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccc
Confidence            999999864    3588999999999999999999998   999999999999999999999999998865433222 12


Q ss_pred             eeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCccC
Q 013636          313 KISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMD  392 (439)
Q Consensus       313 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  392 (439)
                      ...|+..|+|||.+.+..++.++||||||+++|||++|+.||...++...........     ....   ..+       
T Consensus       174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~-----~~~~---~~~-------  238 (285)
T cd06648         174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNL-----PPKL---KNL-------  238 (285)
T ss_pred             cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcC-----CCCC---ccc-------
Confidence            2458899999999998889999999999999999999999998765443222221110     0000   000       


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          393 LKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       393 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      ......+.+++.+||+.+|++|||+.+++++
T Consensus       239 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  269 (285)
T cd06648         239 HKVSPRLRSFLDRMLVRDPAQRATAAELLNH  269 (285)
T ss_pred             ccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence            0112467789999999999999999999964

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=7.6e-38  Score=300.01  Aligned_cols=245  Identities=26%  Similarity=0.379  Sum_probs=201.5

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC---chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      ++|+..+.||+|+||.||++... ++..+|+|.+....   ......+.+|++++++++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46888899999999999999876 47889999886432   223456889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~  308 (439)
                      ||+++++|.+++...   ..+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.+||+|||++......
T Consensus        81 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  154 (290)
T cd05580          81 EYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR  154 (290)
T ss_pred             ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence            999999999999642   4689999999999999999999997   9999999999999999999999999999776443


Q ss_pred             CcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhc
Q 013636          309 SRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIR  388 (439)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  388 (439)
                        .....+++.|+|||.+.+...+.++||||||+++|+|++|+.||...+.........      .....++...     
T Consensus       155 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~------~~~~~~~~~~-----  221 (290)
T cd05580         155 --TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL------EGKVRFPSFF-----  221 (290)
T ss_pred             --CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh------cCCccCCccC-----
Confidence              233458899999999998889999999999999999999999998765432221111      1111222222     


Q ss_pred             CccCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHh
Q 013636          389 DTMDLKHLYQVAAVAVLCIQPEPSYRP-----LITDVLHS  423 (439)
Q Consensus       389 ~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  423 (439)
                             ...+.+++.+||+.||++||     +++|++++
T Consensus       222 -------~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~  254 (290)
T cd05580         222 -------SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH  254 (290)
T ss_pred             -------CHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence                   23556799999999999999     78888754

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.2e-37  Score=301.17  Aligned_cols=247  Identities=29%  Similarity=0.436  Sum_probs=198.0

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC---chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      +.|+..+.||+|+||+||+|+.. ++..+++|.+....   .....++.+|+.+++.++|||++++.++|...+..++|+
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            55778899999999999999875 57889999886432   233356889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~  308 (439)
                      ||++ |++.+++..  ....+++..+..++.|++.||.|||+.   +++||||+|+||++++++.++|+|||++......
T Consensus        95 e~~~-g~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~  168 (307)
T cd06607          95 EYCL-GSASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA  168 (307)
T ss_pred             HhhC-CCHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence            9997 577777753  234589999999999999999999998   9999999999999999999999999998765432


Q ss_pred             CcceeeccccCccchhhhc---CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCc
Q 013636          309 SRNVKISGTLGYVAPEYLL---EGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDP  385 (439)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  385 (439)
                      .   ...++..|+|||.+.   .+.++.++||||||+++|||++|+.||...+..........        ...+...  
T Consensus       169 ~---~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~--------~~~~~~~--  235 (307)
T cd06607         169 N---SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--------NDSPTLS--  235 (307)
T ss_pred             C---CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc--------CCCCCCC--
Confidence            2   234788999999874   45688899999999999999999999987654432222211        0000100  


Q ss_pred             hhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhc
Q 013636          386 VIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL  424 (439)
Q Consensus       386 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  424 (439)
                            .......+.+++.+||+.||++||++.+++.+.
T Consensus       236 ------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  268 (307)
T cd06607         236 ------SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR  268 (307)
T ss_pred             ------chhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence                  011234678899999999999999999999753

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=7.1e-38  Score=300.80  Aligned_cols=249  Identities=22%  Similarity=0.373  Sum_probs=201.9

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEec
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMM  231 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  231 (439)
                      ++|.+.+.||+|+||.||++... ++..+++|.+........+.+.+|+.++++++|||++++++++...+..++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            57888899999999999999864 56789999987555555677899999999999999999999999999999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCcc
Q 013636          232 QNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN  311 (439)
Q Consensus       232 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~~  311 (439)
                      ++++|.+++..    ..+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.+||+|||++.........
T Consensus        99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~  171 (293)
T cd06647          99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  171 (293)
T ss_pred             CCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence            99999999864    2478999999999999999999998   9999999999999999999999999998655432221


Q ss_pred             -eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCc
Q 013636          312 -VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDT  390 (439)
Q Consensus       312 -~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  390 (439)
                       ....+++.|+|||.+....++.++|+||||+++||+++|+.||...++.......       ... ..+....      
T Consensus       172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~-------~~~-~~~~~~~------  237 (293)
T cd06647         172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-------ATN-GTPELQN------  237 (293)
T ss_pred             cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh-------hcC-CCCCCCC------
Confidence             2335888999999999888999999999999999999999999765442211100       000 0000000      


Q ss_pred             cCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          391 MDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       391 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                       .......+.+++.+||+.+|++||++.+++.+
T Consensus       238 -~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         238 -PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             -ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             01112356679999999999999999999976

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=7.7e-38  Score=295.85  Aligned_cols=251  Identities=23%  Similarity=0.418  Sum_probs=198.1

Q ss_pred             CCCccceecccCcEEEEEEEE-CCccEEEEEEecCCCc------hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEE
Q 013636          154 NFQESNVIGEGGRGHVYKARF-NEKLLAAVKRIDDAGH------DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFL  226 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  226 (439)
                      +|+..+.||+|+||.||+++. .++..+++|.+.....      ...+.+.+|+.++++++|+|++++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477789999999999999987 4577889998864321      124578899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC-cEEEEeccccccc
Q 013636          227 VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSF-NAKLSDFGLSVTA  305 (439)
Q Consensus       227 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~-~~kl~DfGls~~~  305 (439)
                      |+||+++++|.+++..   ...+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++ .+||+|||.+...
T Consensus        81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            9999999999999964   24688999999999999999999998   999999999999998776 5999999998665


Q ss_pred             CCCCc-----ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCC
Q 013636          306 GTQSR-----NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLP  380 (439)
Q Consensus       306 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  380 (439)
                      .....     .....++..|+|||.+.+..++.++||||+|+++|+|++|..||.............. .......... 
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~-  232 (268)
T cd06630         155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFK-IASATTAPSI-  232 (268)
T ss_pred             ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHH-HhccCCCCCC-
Confidence            43211     1123478899999999888899999999999999999999999975432211111110 0000001111 


Q ss_pred             ccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          381 NIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       381 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                                 .......+.+++.+|++.+|++||++.+++++
T Consensus       233 -----------~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~  264 (268)
T cd06630         233 -----------PEHLSPGLRDVTLRCLELQPEDRPPSRELLKH  264 (268)
T ss_pred             -----------chhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence                       11223456779999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.4e-37  Score=296.29  Aligned_cols=261  Identities=21%  Similarity=0.239  Sum_probs=195.8

Q ss_pred             CCccceecccCcEEEEEEEEC-CccEEEEEEecCCC-chHHHHHHHHHHHHHhcC-CCceeeeeeEEEeC--CeeEEEEE
Q 013636          155 FQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG-HDAEREFNNEVNWLTKIR-HQNIISLLGYCIHA--ETRFLVYE  229 (439)
Q Consensus       155 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lV~e  229 (439)
                      |++.+.||+|+||.||+|... ++..+|+|.+.... ........+|+..+.++. |+|++++++++.+.  +..++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            456788999999999999875 57888999887542 222334567888899885 99999999999987  88999999


Q ss_pred             eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCC
Q 013636          230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS  309 (439)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~  309 (439)
                      |++ |+|.+++...  ...+++..+..++.|++.||+|||+.   +++||||+|+||++++ +.+||+|||++.......
T Consensus        81 ~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~  153 (282)
T cd07831          81 LMD-MNLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP  153 (282)
T ss_pred             cCC-ccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence            997 5888887642  24689999999999999999999998   9999999999999999 999999999997765443


Q ss_pred             cceeeccccCccchhhhcC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhc--------cccc----C
Q 013636          310 RNVKISGTLGYVAPEYLLE-GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP--------QLTD----R  376 (439)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~--------~~~~----~  376 (439)
                      ......++..|+|||.+.. +.++.++|||||||++|||++|..||...++.+..........        ....    .
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
T cd07831         154 PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN  233 (282)
T ss_pred             CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence            3333457889999997654 5678899999999999999999999987654332111110000        0000    0


Q ss_pred             CCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          377 SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       377 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      ...+......+... .......+.+++.+||+.+|++||++.+++++
T Consensus       234 ~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         234 YNFPSKKGTGLRKL-LPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             ccCcccccccHHHH-cccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence            00111111111100 11235678899999999999999999999875

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-39  Score=316.62  Aligned_cols=242  Identities=29%  Similarity=0.463  Sum_probs=199.5

Q ss_pred             eecccCcEEEEEEEECC-ccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEeccCCChhh
Q 013636          160 VIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEK  238 (439)
Q Consensus       160 ~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~  238 (439)
                      +||+|.+|+||.|++.+ ...+|||-+..........+.+|+.+-+.++|.|||+++|.|.+++..-+.||-++||||.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            69999999999999865 56789999987766666678899999999999999999999999999999999999999999


Q ss_pred             hhcCCCCCCCC--CHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc-CCCcEEEEeccccccc-CCCCcceee
Q 013636          239 QLHGPTHGSNL--TWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLD-SSFNAKLSDFGLSVTA-GTQSRNVKI  314 (439)
Q Consensus       239 ~l~~~~~~~~l--~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~-~~~~~kl~DfGls~~~-~~~~~~~~~  314 (439)
                      +|+.  ..+++  ++..+-.+..||.+||.|||++   .|||||||-+||||+ -.|.+||+|||-++.. +-.....++
T Consensus       662 LLrs--kWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETF  736 (1226)
T KOG4279|consen  662 LLRS--KWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETF  736 (1226)
T ss_pred             HHHh--ccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCcccccc
Confidence            9974  34455  7788888999999999999998   999999999999996 5789999999999654 333344567


Q ss_pred             ccccCccchhhhcCC--CCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhh-hhHhhhhcccccCCCCCccCCchhcCcc
Q 013636          315 SGTLGYVAPEYLLEG--KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQ-SMVTWAMPQLTDRSKLPNIVDPVIRDTM  391 (439)
Q Consensus       315 ~gt~~y~aPE~~~~~--~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~l~~~~  391 (439)
                      .||.-|||||++..+  -|..++|||||||++.||.||++||......+.. ..+..    ....+.            +
T Consensus       737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGm----yKvHP~------------i  800 (1226)
T KOG4279|consen  737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGM----YKVHPP------------I  800 (1226)
T ss_pred             ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcc----eecCCC------------C
Confidence            799999999999876  4788999999999999999999999766433321 11111    111112            2


Q ss_pred             CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 013636          392 DLKHLYQVAAVAVLCIQPEPSYRPLITDVLH  422 (439)
Q Consensus       392 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  422 (439)
                      +.+...+...++.+|+.+||.+||+++++++
T Consensus       801 Peelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  801 PEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             cHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            2344556777999999999999999999984

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=4.3e-38  Score=296.22  Aligned_cols=248  Identities=25%  Similarity=0.344  Sum_probs=202.4

Q ss_pred             CCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCc---hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEE
Q 013636          154 NFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGH---DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYE  229 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  229 (439)
                      +|++.+.||+|+||.||+++.. .+..+++|.+.....   ...+.+.+|+.++++++|||++++++++...+..++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            5778899999999999999886 478899998865322   345678999999999999999999999999999999999


Q ss_pred             eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCC
Q 013636          230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS  309 (439)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~  309 (439)
                      |+++++|.+++...   ..+++..+..++.|+++||.|||+.   +++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  154 (258)
T cd05578          81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT  154 (258)
T ss_pred             CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence            99999999999642   4689999999999999999999998   99999999999999999999999999997765443


Q ss_pred             cceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcC
Q 013636          310 RNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRD  389 (439)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  389 (439)
                      ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...+...........   .......+..       
T Consensus       155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~-------  224 (258)
T cd05578         155 LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQ---ETADVLYPAT-------  224 (258)
T ss_pred             cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHh---ccccccCccc-------
Confidence            333455888999999999888999999999999999999999999876532111111110   0011111111       


Q ss_pred             ccCHHHHHHHHHHHHHhcCCCCCCCCCH--HHHHH
Q 013636          390 TMDLKHLYQVAAVAVLCIQPEPSYRPLI--TDVLH  422 (439)
Q Consensus       390 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~--~evl~  422 (439)
                           ....+.+++.+||+.||++||++  +|+++
T Consensus       225 -----~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~  254 (258)
T cd05578         225 -----WSTEAIDAINKLLERDPQKRLGDNLKDLKN  254 (258)
T ss_pred             -----CcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence                 12567789999999999999999  77764

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=3.5e-38  Score=300.74  Aligned_cols=253  Identities=25%  Similarity=0.390  Sum_probs=194.2

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC-chHHHHHHHHHHH-HHhcCCCceeeeeeEEEeCCeeEEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG-HDAEREFNNEVNW-LTKIRHQNIISLLGYCIHAETRFLVYE  229 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lV~e  229 (439)
                      ++|++.+.||+|+||.||+++.. ++..+|+|.++... .....++..|+.. ++..+|||++++++++..++..+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            46888899999999999999886 48899999987543 2334456666665 566789999999999999999999999


Q ss_pred             eccCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC
Q 013636          230 MMQNGSLEKQLHGP-THGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       230 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~  308 (439)
                      |++ |+|.+++... .....+++..+..++.|++.||+|||+.  .+++||||||+||++++++.+||+|||++......
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS  157 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            997 6888887542 2345689999999999999999999984  27999999999999999999999999999765433


Q ss_pred             CcceeeccccCccchhhhcC----CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCC
Q 013636          309 SRNVKISGTLGYVAPEYLLE----GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVD  384 (439)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  384 (439)
                      .......++..|+|||.+.+    ..++.++|+||||+++|||++|+.||....... ..... ...     ...+....
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~-~~~-----~~~~~~~~  230 (283)
T cd06617         158 VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF-QQLKQ-VVE-----EPSPQLPA  230 (283)
T ss_pred             cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH-HHHHH-HHh-----cCCCCCCc
Confidence            22233457889999998865    456889999999999999999999997532211 11111 000     00001100


Q ss_pred             chhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          385 PVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       385 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      .        .....+.+++.+||+.+|++||++.+++++
T Consensus       231 ~--------~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  261 (283)
T cd06617         231 E--------KFSPEFQDFVNKCLKKNYKERPNYPELLQH  261 (283)
T ss_pred             c--------ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0        112457789999999999999999999964

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.9e-37  Score=293.88  Aligned_cols=246  Identities=24%  Similarity=0.419  Sum_probs=199.7

Q ss_pred             CCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEec
Q 013636          154 NFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG-HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMM  231 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  231 (439)
                      -|+..+.||+|+||.||+|... ++..+|+|...... ......+.+|+.++++++|||++++++++..++..++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            4666788999999999999875 57789999876433 233457889999999999999999999999999999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc-
Q 013636          232 QNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR-  310 (439)
Q Consensus       232 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~-  310 (439)
                      ++++|.+++..    ..+++..+..++.|++.|+.|||+.   +++|+||+|+||++++++.++|+|||++........ 
T Consensus        85 ~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~  157 (277)
T cd06641          85 GGGSALDLLEP----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK  157 (277)
T ss_pred             CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchhh
Confidence            99999999863    3588999999999999999999997   999999999999999999999999999866543221 


Q ss_pred             ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCc
Q 013636          311 NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDT  390 (439)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  390 (439)
                      .....++..|+|||.+.+...+.++|+|||||++|+|++|..||....+......+..     .....+        .  
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-----~~~~~~--------~--  222 (277)
T cd06641         158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPK-----NNPPTL--------E--  222 (277)
T ss_pred             hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhc-----CCCCCC--------C--
Confidence            1223578899999999988899999999999999999999999976554322211110     001111        1  


Q ss_pred             cCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          391 MDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       391 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                        ......+.+++.+||+.+|++||++.+++++
T Consensus       223 --~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         223 --GNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             --cccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence              1123456779999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-37  Score=294.88  Aligned_cols=247  Identities=26%  Similarity=0.458  Sum_probs=198.5

Q ss_pred             CCCccceecccCcEEEEEEEE-CCccEEEEEEecCC-CchHHHHHHHHHHHHHhcC---CCceeeeeeEEEeCCeeEEEE
Q 013636          154 NFQESNVIGEGGRGHVYKARF-NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKIR---HQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV~  228 (439)
                      .|+..+.||+|+||.||+|.. .++..+++|.+... ......++.+|+.++++++   |||++++++++...+..++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            466778999999999999987 45788999988643 2334467889999999997   999999999999999999999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~  308 (439)
                      ||+++++|.+++..    ..+++.....++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++......
T Consensus        82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06917          82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN  154 (277)
T ss_pred             ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence            99999999999854    2589999999999999999999998   9999999999999999999999999999765443


Q ss_pred             Cc-ceeeccccCccchhhhcCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCch
Q 013636          309 SR-NVKISGTLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPV  386 (439)
Q Consensus       309 ~~-~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  386 (439)
                      .. .....|+..|+|||.+.++ .++.++|+||||+++|+|++|+.||.............        ....+.     
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~--------~~~~~~-----  221 (277)
T cd06917         155 SSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIP--------KSKPPR-----  221 (277)
T ss_pred             ccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccc--------cCCCCC-----
Confidence            22 2234588899999998764 46889999999999999999999997654432111110        001111     


Q ss_pred             hcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          387 IRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       387 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      +...   .....+.+++.+||+.||++||++.+++++
T Consensus       222 ~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         222 LEDN---GYSKLLREFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             CCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence            1110   123467789999999999999999999874

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=8.2e-38  Score=298.48  Aligned_cols=264  Identities=26%  Similarity=0.343  Sum_probs=197.7

Q ss_pred             CCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEe
Q 013636          154 NFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      +|+..+.||+|+||.||+|+.. ++..+++|.+....  ......+.+|++++++++|||++++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4778899999999999999875 57889999886432  22335788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR  310 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~  310 (439)
                      +. ++|.+++... ....+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.+||+|||++........
T Consensus        81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~  155 (284)
T cd07860          81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  155 (284)
T ss_pred             cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence            96 6899988653 245689999999999999999999998   999999999999999999999999999876543221


Q ss_pred             -ceeeccccCccchhhhcCCC-CCCchhhHHHHHHHHHHHhCCCCCCCCChhhh-hhhHhhhhcccc-----------cC
Q 013636          311 -NVKISGTLGYVAPEYLLEGK-LTDKSDVYAFGVVLLELLMGRRPVEKMSPTQC-QSMVTWAMPQLT-----------DR  376 (439)
Q Consensus       311 -~~~~~gt~~y~aPE~~~~~~-~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~-~~~~~~~~~~~~-----------~~  376 (439)
                       .....++..|+|||.+.+.. ++.++||||||+++|||+||+.||...+.... ............           ..
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd07860         156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYK  235 (284)
T ss_pred             ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHH
Confidence             12234678999999887644 58899999999999999999999976553221 111111000000           00


Q ss_pred             CCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          377 SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       377 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      ...+.+....+.... ......+.+++.+||+.||++|||+++++.+
T Consensus       236 ~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         236 PSFPKWARQDFSKVV-PPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             hhcccccccCHHHHc-ccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence            001111111110000 0112346689999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.4e-37  Score=300.50  Aligned_cols=253  Identities=24%  Similarity=0.318  Sum_probs=198.3

Q ss_pred             cCCCccceecccCcEEEEEEEECC-ccEEEEEEecCCC---chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      ++|+..+.||+|+||.||++.... +..+++|.+....   ......+.+|+++++.++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            468888999999999999998865 6788999886543   223456889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~  308 (439)
                      ||+++++|.+++..   ...+++..+..++.|++.|++|||+.   +++||||||+||++++++.+||+|||+++.....
T Consensus        81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~  154 (305)
T cd05609          81 EYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS  154 (305)
T ss_pred             ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence            99999999999954   24589999999999999999999997   9999999999999999999999999998632110


Q ss_pred             C----------------cceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcc
Q 013636          309 S----------------RNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQ  372 (439)
Q Consensus       309 ~----------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~  372 (439)
                      .                ......++..|+|||.+.+..++.++|+||||+++|||++|..||.+.++.+........   
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~---  231 (305)
T cd05609         155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD---  231 (305)
T ss_pred             ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---
Confidence            0                001134678899999999889999999999999999999999999876554432222110   


Q ss_pred             cccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccc
Q 013636          373 LTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIP  426 (439)
Q Consensus       373 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  426 (439)
                         ....     +....    .....+.+++.+||+.||++||+..++.+.|+.
T Consensus       232 ---~~~~-----~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         232 ---DIEW-----PEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             ---ccCC-----CCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence               0000     00000    112356789999999999999996545444433

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=3.2e-37  Score=288.96  Aligned_cols=249  Identities=25%  Similarity=0.433  Sum_probs=203.0

Q ss_pred             CCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCceeeeeeEEEeC--CeeEEEE
Q 013636          154 NFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGH--DAEREFNNEVNWLTKIRHQNIISLLGYCIHA--ETRFLVY  228 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~  228 (439)
                      +|+..+.||+|++|.||+|... ++..+++|.......  ...+.+.+|+..+++++|+|++++++.+...  +..++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4677889999999999999987 578899998865442  4456789999999999999999999999988  8899999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~  308 (439)
                      ||+++++|.+++...   ..+++..+..++.|+++|++|||+.   +++|+||+|+||++++++.++|+|||.+......
T Consensus        81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  154 (260)
T cd06606          81 EYVSGGSLSSLLKKF---GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI  154 (260)
T ss_pred             EecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence            999999999999643   2789999999999999999999997   9999999999999999999999999999776554


Q ss_pred             Cc---ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCc
Q 013636          309 SR---NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDP  385 (439)
Q Consensus       309 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  385 (439)
                      ..   .....++..|+|||.+.....+.++||||||+++++|++|+.||...... ....  +..........++..   
T Consensus       155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~--~~~~~~~~~~~~~~~---  228 (260)
T cd06606         155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP-MAAL--YKIGSSGEPPEIPEH---  228 (260)
T ss_pred             cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-HHHH--HhccccCCCcCCCcc---
Confidence            32   23345888999999999888999999999999999999999999876511 1111  111000111111111   


Q ss_pred             hhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          386 VIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       386 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                               ....+.+++.+|++.||++||++.|++.+
T Consensus       229 ---------~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         229 ---------LSEEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             ---------cCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence                     13467779999999999999999999865

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.9e-37  Score=305.73  Aligned_cols=264  Identities=23%  Similarity=0.323  Sum_probs=199.8

Q ss_pred             HhcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCC--CchHHHHHHHHHHHHHhcCCCceeeeeeEEEeC------
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDA--GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHA------  221 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  221 (439)
                      ..++|+..+.||+|+||.||+++.. ++..+|+|.+...  .......+.+|+.++++++|||++++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            4578999999999999999999875 5788999998643  223345678899999999999999999988643      


Q ss_pred             CeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccc
Q 013636          222 ETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGL  301 (439)
Q Consensus       222 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGl  301 (439)
                      ...++||||+.+ +|.+.+..     .+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||+
T Consensus        94 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~  164 (353)
T cd07850          94 QDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  164 (353)
T ss_pred             CcEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCcc
Confidence            346999999964 88888753     278899999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhh-hhHhh------------
Q 013636          302 SVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQ-SMVTW------------  368 (439)
Q Consensus       302 s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~-~~~~~------------  368 (439)
                      +.............++..|+|||.+.+..++.++|||||||++|+|++|+.||...+..... .....            
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (353)
T cd07850         165 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL  244 (353)
T ss_pred             ceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence            98765443333345788999999999999999999999999999999999999765432211 11000            


Q ss_pred             --hhc-ccccCC-----CCCccCCchhc----CccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          369 --AMP-QLTDRS-----KLPNIVDPVIR----DTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       369 --~~~-~~~~~~-----~~~~~~d~~l~----~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                        ... ......     .+.+.....+.    ..........+.+++.+||+.||++|||+.|++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         245 QPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             hhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence              000 000000     01111111110    00011234567789999999999999999999966

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=2.9e-37  Score=294.59  Aligned_cols=265  Identities=23%  Similarity=0.325  Sum_probs=200.9

Q ss_pred             CCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEec
Q 013636          154 NFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGH-DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMM  231 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  231 (439)
                      +|+..+.||+|++|.||+|+.. ++..+++|.+..... .....+.+|+.++++++|+|++++++++...+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            5778899999999999999986 478899998875432 23456778999999999999999999999999999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc-
Q 013636          232 QNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR-  310 (439)
Q Consensus       232 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~-  310 (439)
                      ++ +|.+++........+++..+..++.|++.||+|||+.   +++||||+|+||++++++.++|+|||++........ 
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~  156 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT  156 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc
Confidence            85 8988886544445689999999999999999999997   999999999999999999999999999965433211 


Q ss_pred             ceeeccccCccchhhhcCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhh-hHhhhhcc-------cccC----C
Q 013636          311 NVKISGTLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQS-MVTWAMPQ-------LTDR----S  377 (439)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~-~~~~~~~~-------~~~~----~  377 (439)
                      .....++..|++||.+.+. .++.++||||||+++|||++|+.||...+..+... ........       +...    .
T Consensus       157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd07836         157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP  236 (284)
T ss_pred             cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcc
Confidence            1223468899999998664 56889999999999999999999998765433211 11110000       0000    0


Q ss_pred             CCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          378 KLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       378 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      ..+...+... ..........+.+++..|++.||++||++.+++++
T Consensus       237 ~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         237 TFPRYPPQDL-QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             cccCCChHHH-HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            0011101000 01111223567789999999999999999999864

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=3.1e-37  Score=295.01  Aligned_cols=252  Identities=26%  Similarity=0.432  Sum_probs=204.9

Q ss_pred             HhcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEE
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYE  229 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  229 (439)
                      .+++|+..+.||+|+||.||+|..+ ++..+++|.+..... ....+.+|++.++.++|+|++++++++...+..++++|
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   95 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME   95 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence            4567888889999999999999987 577889999876543 56678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCC
Q 013636          230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS  309 (439)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~  309 (439)
                      |+++++|.+++....  ..+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  170 (286)
T cd06614          96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK  170 (286)
T ss_pred             ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence            999999999997532  4699999999999999999999997   99999999999999999999999999986543322


Q ss_pred             c-ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhc
Q 013636          310 R-NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIR  388 (439)
Q Consensus       310 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  388 (439)
                      . .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...++........  .      ...+...++   
T Consensus       171 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~--~------~~~~~~~~~---  239 (286)
T cd06614         171 SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLIT--T------KGIPPLKNP---  239 (286)
T ss_pred             hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--h------cCCCCCcch---
Confidence            1 123347889999999998889999999999999999999999998765432211111  0      001111111   


Q ss_pred             CccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          389 DTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       389 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                          ......+.+++.+|++.+|.+||++.+++++
T Consensus       240 ----~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         240 ----EKWSPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             ----hhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence                0012456779999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=2.4e-37  Score=296.51  Aligned_cols=266  Identities=26%  Similarity=0.323  Sum_probs=196.1

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGH-DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYE  229 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  229 (439)
                      +++|++.+.||+|+||.||+|... ++..+++|.+..... .....+.+|+.+++.++|+|++++.+++...+..++|+|
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e   83 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE   83 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence            467888999999999999999875 577899999865432 223467889999999999999999999999999999999


Q ss_pred             eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCC
Q 013636          230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS  309 (439)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~  309 (439)
                      |+. ++|.+++...  ...+++..+..++.|++.||+|||+.   +++|+||||+||+++.++++||+|||++.......
T Consensus        84 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  157 (291)
T cd07870          84 YMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPS  157 (291)
T ss_pred             ccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence            996 6777776532  24578888999999999999999998   99999999999999999999999999987543322


Q ss_pred             c-ceeeccccCccchhhhcCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccC------CCCCc
Q 013636          310 R-NVKISGTLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDR------SKLPN  381 (439)
Q Consensus       310 ~-~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~------~~~~~  381 (439)
                      . .....++..|+|||.+.+. .++.++||||||+++|||++|+.||...+.....-...|........      ..++.
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (291)
T cd07870         158 QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN  237 (291)
T ss_pred             CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccc
Confidence            1 1223478899999998764 57889999999999999999999998654321110000100000000      00000


Q ss_pred             cCCc--------hhcCcc-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          382 IVDP--------VIRDTM-DLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       382 ~~d~--------~l~~~~-~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      ....        .+.... .......+.+++.+|++.||++|||+.|++.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h  288 (291)
T cd07870         238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH  288 (291)
T ss_pred             ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence            0000        000000 00113456789999999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-37  Score=295.34  Aligned_cols=262  Identities=26%  Similarity=0.345  Sum_probs=199.9

Q ss_pred             CCccceecccCcEEEEEEEECC-ccEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCceeeeeeEEEeC--CeeEEEEE
Q 013636          155 FQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLLGYCIHA--ETRFLVYE  229 (439)
Q Consensus       155 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~e  229 (439)
                      |++.+.||+|+||.||+|+..+ +..+++|.+....  ......+.+|+.++++++|+|++++++++...  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            5667899999999999998864 7888999997653  23345688999999999999999999999988  78999999


Q ss_pred             eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCC
Q 013636          230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS  309 (439)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~  309 (439)
                      |+++ +|.+++...  ...+++..+..++.|+++||+|||+.   +++|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~  154 (287)
T cd07840          81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRN  154 (287)
T ss_pred             cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence            9975 898888643  24689999999999999999999998   99999999999999999999999999997664432


Q ss_pred             c--ceeeccccCccchhhhcC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCc-----
Q 013636          310 R--NVKISGTLGYVAPEYLLE-GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPN-----  381 (439)
Q Consensus       310 ~--~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  381 (439)
                      .  .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+.......+........ ....+.     
T Consensus       155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  233 (287)
T cd07840         155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPT-DENWPGVSKLP  233 (287)
T ss_pred             cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc-hhhccccccch
Confidence            1  122346788999998765 4578999999999999999999999987664332222211111000 000000     


Q ss_pred             ---------cCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          382 ---------IVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       382 ---------~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                               .....+.+.........+.+++.+||+.+|++||++.+++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence                     000111111111124578899999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=7.5e-37  Score=297.00  Aligned_cols=250  Identities=30%  Similarity=0.446  Sum_probs=197.7

Q ss_pred             CCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC---chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEE
Q 013636          154 NFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYE  229 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  229 (439)
                      .|+..+.||+|+||.||+++.. ++..+++|.+....   .....++.+|+.++++++|||++++++++...+..++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            3666788999999999999875 57788999886432   2334578899999999999999999999999999999999


Q ss_pred             eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCC
Q 013636          230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS  309 (439)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~  309 (439)
                      |++ |+|.+.+..  ....+++..+..++.|++.|+.|||+.   +++||||+|+||+++.++.+||+|||++.......
T Consensus       106 ~~~-g~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (317)
T cd06635         106 YCL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPAN  179 (317)
T ss_pred             CCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCcc
Confidence            997 488777753  234689999999999999999999998   99999999999999999999999999986544322


Q ss_pred             cceeeccccCccchhhhc---CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCch
Q 013636          310 RNVKISGTLGYVAPEYLL---EGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPV  386 (439)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  386 (439)
                         ...++..|+|||.+.   .+.++.++|||||||++|||++|+.||...+..........       .. .+...   
T Consensus       180 ---~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~-------~~-~~~~~---  245 (317)
T cd06635         180 ---SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-------NE-SPTLQ---  245 (317)
T ss_pred             ---cccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh-------cc-CCCCC---
Confidence               234788999999974   45788999999999999999999999976543322221110       00 00000   


Q ss_pred             hcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccC
Q 013636          387 IRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLV  428 (439)
Q Consensus       387 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~  428 (439)
                           .......+.+++.+||+.+|++||++.+++++...+.
T Consensus       246 -----~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  282 (317)
T cd06635         246 -----SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR  282 (317)
T ss_pred             -----CccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence                 0112235678999999999999999999998865433

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=9.6e-38  Score=309.62  Aligned_cols=202  Identities=27%  Similarity=0.368  Sum_probs=175.7

Q ss_pred             hcCCCccceecccCcEEEEEEEECC-ccEEEEEEecCCCchHHHHHHHHHHHHHhcC-C-----CceeeeeeEEEeCCee
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKIR-H-----QNIISLLGYCIHAETR  224 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~  224 (439)
                      .-+|.+.+.||+|+||.|.++.... +..||||.+++.. .-.++-..|+.+|..++ |     -|+|++++++..+++.
T Consensus       185 ~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl  263 (586)
T KOG0667|consen  185 AYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL  263 (586)
T ss_pred             EEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence            3478889999999999999997754 8899999998753 34456678999999997 3     4899999999999999


Q ss_pred             EEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC--CCcEEEEecccc
Q 013636          225 FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDS--SFNAKLSDFGLS  302 (439)
Q Consensus       225 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~--~~~~kl~DfGls  302 (439)
                      |||+|.+.. +|++++... +...++...+..++.||+.||.+||+.   +|||+||||+||||.+  ...+||+|||.|
T Consensus       264 ciVfELL~~-NLYellK~n-~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSS  338 (586)
T KOG0667|consen  264 CIVFELLST-NLYELLKNN-KFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSS  338 (586)
T ss_pred             eeeehhhhh-hHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccc
Confidence            999999866 999999873 345699999999999999999999998   9999999999999964  347999999999


Q ss_pred             cccCCCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhh
Q 013636          303 VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQ  361 (439)
Q Consensus       303 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~  361 (439)
                      ........  ....+..|+|||++.+.+|+.+.||||||||++||++|.+-|.+.++.+
T Consensus       339 c~~~q~vy--tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~D  395 (586)
T KOG0667|consen  339 CFESQRVY--TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYD  395 (586)
T ss_pred             cccCCcce--eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHH
Confidence            87654333  5557889999999999999999999999999999999998898877644

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-37  Score=294.06  Aligned_cols=254  Identities=32%  Similarity=0.493  Sum_probs=199.8

Q ss_pred             HhcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCchHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCC------
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAE------  222 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~------  222 (439)
                      ++++|++.+.||+|+||.||+|... ++..+++|.+..... ...++.+|+.+++++ +|+|++++++++....      
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            4678999999999999999999985 467888998875433 446789999999999 7999999999997654      


Q ss_pred             eeEEEEEeccCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccc
Q 013636          223 TRFLVYEMMQNGSLEKQLHGPT-HGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGL  301 (439)
Q Consensus       223 ~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGl  301 (439)
                      ..++||||+++++|.+++.... ....+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.+||+|||+
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~  159 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGV  159 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCcc
Confidence            4899999999999999986422 245689999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCCc-ceeeccccCccchhhhcC-----CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhccccc
Q 013636          302 SVTAGTQSR-NVKISGTLGYVAPEYLLE-----GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTD  375 (439)
Q Consensus       302 s~~~~~~~~-~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~  375 (439)
                      +........ .....++..|+|||.+..     ..++.++||||||+++|||++|+.||....+........        
T Consensus       160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~--------  231 (275)
T cd06608         160 SAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIP--------  231 (275)
T ss_pred             ceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhh--------
Confidence            865433221 223458889999998754     346789999999999999999999997654322111110        


Q ss_pred             CCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          376 RSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       376 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      ....+....+       ......+.+++.+||+.||++|||+.|++++
T Consensus       232 ~~~~~~~~~~-------~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         232 RNPPPTLKSP-------ENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             ccCCCCCCch-------hhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            0011111111       1123467789999999999999999999864

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2.1e-37  Score=290.95  Aligned_cols=249  Identities=26%  Similarity=0.402  Sum_probs=199.9

Q ss_pred             CCCccceecccCcEEEEEEEECC-ccEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEe
Q 013636          154 NFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      +|+..+.||+|+||.||++.... +..+++|.+....  ....+.+.+|+.+++.++|+|++++++.+...+..++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            47778999999999999998864 6778999886432  23445788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC-cEEEEecccccccCCCC
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSF-NAKLSDFGLSVTAGTQS  309 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~-~~kl~DfGls~~~~~~~  309 (439)
                      +++++|.+++... .+..+++..+..++.|+++|++|||+.   +++|+||+|+||++++++ .+||+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence            9999999998652 234589999999999999999999998   999999999999999885 46999999987654432


Q ss_pred             cc-eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhc
Q 013636          310 RN-VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIR  388 (439)
Q Consensus       310 ~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  388 (439)
                      .. ....|++.|+|||.+.+..++.++|+||||+++|||++|+.||...+........      .  ....... .+   
T Consensus       157 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~------~--~~~~~~~-~~---  224 (257)
T cd08225         157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKI------C--QGYFAPI-SP---  224 (257)
T ss_pred             ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH------h--cccCCCC-CC---
Confidence            22 2235888999999999889999999999999999999999999765433211110      0  0111111 11   


Q ss_pred             CccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          389 DTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       389 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                           .....+.+++.+|++.+|++|||+.|++.+
T Consensus       225 -----~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         225 -----NFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             -----CCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence                 112457789999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-39  Score=286.19  Aligned_cols=252  Identities=23%  Similarity=0.343  Sum_probs=199.7

Q ss_pred             hcCCCccceecccCcEEEEEEEE-CCccEEEEEEecCC--CchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARF-NEKLLAAVKRIDDA--GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      +++|++.+.||+|.|+.||+... ..++.+|+|.++..  +..+.+++.+|+.+.+.|+||||+++..........++|+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            45677788999999999999855 34667777776532  2335567889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC---CCcEEEEeccccccc
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDS---SFNAKLSDFGLSVTA  305 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~---~~~~kl~DfGls~~~  305 (439)
                      |+|.||+|..-+-.   ....++...-.++.||+++|.|+|.+   +|+|||+||+|+++.+   .--+||+|||++...
T Consensus        90 e~m~G~dl~~eIV~---R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l  163 (355)
T KOG0033|consen   90 DLVTGGELFEDIVA---REFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  163 (355)
T ss_pred             ecccchHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEe
Confidence            99999999765532   13366777788999999999999998   9999999999999953   445999999999888


Q ss_pred             CCCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCc
Q 013636          306 GTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDP  385 (439)
Q Consensus       306 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  385 (439)
                      +.........|||+|||||++...+|+..+|||+-||+||-|+.|+.||.+.+.......+.   .   ..-.    +++
T Consensus       164 ~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~---~---g~yd----~~~  233 (355)
T KOG0033|consen  164 NDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIK---A---GAYD----YPS  233 (355)
T ss_pred             CCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHh---c---cccC----CCC
Confidence            76555566789999999999999999999999999999999999999999865544322221   1   0111    111


Q ss_pred             hhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          386 VIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       386 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      .-.++..    .+..+++.+||..||.+|.|+.|.|.+
T Consensus       234 ~~w~~is----~~Ak~LvrrML~~dP~kRIta~EAL~H  267 (355)
T KOG0033|consen  234 PEWDTVT----PEAKSLIRRMLTVNPKKRITADEALKH  267 (355)
T ss_pred             cccCcCC----HHHHHHHHHHhccChhhhccHHHHhCC
Confidence            1112222    234568899999999999999999865

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=6.9e-37  Score=292.16  Aligned_cols=263  Identities=26%  Similarity=0.341  Sum_probs=198.3

Q ss_pred             CCccceecccCcEEEEEEEECC-ccEEEEEEecCCCc--hHHHHHHHHHHHHHhc---CCCceeeeeeEEEeCCe-----
Q 013636          155 FQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGH--DAEREFNNEVNWLTKI---RHQNIISLLGYCIHAET-----  223 (439)
Q Consensus       155 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~-----  223 (439)
                      |++.+.||+|+||.||+|+.+. +..+|+|.+.....  .....+.+|+.+++++   +|+|++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            5667899999999999999875 78899999874322  2234566788777666   59999999999988776     


Q ss_pred             eEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccccc
Q 013636          224 RFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSV  303 (439)
Q Consensus       224 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~  303 (439)
                      .+++|||+++ +|.+++.... ...+++..+..++.|+++||+|||+.   +++|+||+|+||++++++.+||+|||++.
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~  155 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLAR  155 (287)
T ss_pred             eEEEehhccc-CHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcce
Confidence            8999999975 8998886422 23589999999999999999999998   99999999999999999999999999997


Q ss_pred             ccCCCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhccccc--------
Q 013636          304 TAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTD--------  375 (439)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~--------  375 (439)
                      ............++..|+|||.+.+..++.++|+||||+++|||++|+.||...+..+....+.........        
T Consensus       156 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07838         156 IYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS  235 (287)
T ss_pred             eccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc
Confidence            765443333445788999999999999999999999999999999999999876544322111110000000        


Q ss_pred             --CCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          376 --RSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       376 --~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                        ....+....... ..........+.+++.+||+.||++||++.|++.+
T Consensus       236 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         236 LPRSSFPSYTPRSF-KSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             cchhhcccccccch-hhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence              000000000000 11111234567789999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-37  Score=325.13  Aligned_cols=262  Identities=27%  Similarity=0.471  Sum_probs=209.8

Q ss_pred             HHHHHhcCCCccceecccCcEEEEEEEEC--------CccEEEEEEecCCCc-hHHHHHHHHHHHHHhc-CCCceeeeee
Q 013636          147 LLEAATNNFQESNVIGEGGRGHVYKARFN--------EKLLAAVKRIDDAGH-DAEREFNNEVNWLTKI-RHQNIISLLG  216 (439)
Q Consensus       147 ~l~~~~~~~~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~  216 (439)
                      .++...++..+.+.||+|.||.|++|...        ....||||.+++... ...+.+..|+++|+.+ +|+|++.++|
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            45555566667779999999999999753        256789999986544 4556799999999999 6999999999


Q ss_pred             EEEeCCeeEEEEEeccCCChhhhhcCCC-----CC--------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 013636          217 YCIHAETRFLVYEMMQNGSLEKQLHGPT-----HG--------SNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKS  283 (439)
Q Consensus       217 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~-----~~--------~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~  283 (439)
                      +|..++..++|.||+..|+|.++|+...     ..        ..++..+.+.++.|||.|++||++.   +++||||.+
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAa  446 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAA  446 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhh
Confidence            9999999999999999999999998644     01        2389999999999999999999998   999999999


Q ss_pred             CCEEEcCCCcEEEEecccccccCCCCcceee--cc--ccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCC
Q 013636          284 SNILLDSSFNAKLSDFGLSVTAGTQSRNVKI--SG--TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMS  358 (439)
Q Consensus       284 ~NiLl~~~~~~kl~DfGls~~~~~~~~~~~~--~g--t~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~  358 (439)
                      +|||+.++..+||+|||+++...........  .|  ...|||||.+....|+.|+|||||||+||||+| |..||.+..
T Consensus       447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~  526 (609)
T KOG0200|consen  447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP  526 (609)
T ss_pred             hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence            9999999999999999999876554443211  12  346999999999999999999999999999999 999998754


Q ss_pred             -hhhhhhhHhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccC
Q 013636          359 -PTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLV  428 (439)
Q Consensus       359 -~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~  428 (439)
                       ..+.   ..+...  ..+...|+            .+..++.+++..||+.+|++||++.++.+.+...+
T Consensus       527 ~~~~l---~~~l~~--G~r~~~P~------------~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l  580 (609)
T KOG0200|consen  527 PTEEL---LEFLKE--GNRMEQPE------------HCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL  580 (609)
T ss_pred             cHHHH---HHHHhc--CCCCCCCC------------CCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence             2222   211110  11111122            22345667999999999999999999999887754

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-37  Score=290.01  Aligned_cols=261  Identities=23%  Similarity=0.356  Sum_probs=212.9

Q ss_pred             HHHHHhcCCCccceecccCcEEEEEEEEC------CccEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCceeeeeeEEE
Q 013636          147 LLEAATNNFQESNVIGEGGRGHVYKARFN------EKLLAAVKRIDDAG-HDAEREFNNEVNWLTKIRHQNIISLLGYCI  219 (439)
Q Consensus       147 ~l~~~~~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  219 (439)
                      ++.....+++...++-+|.||.||+|.+.      +.+.+.+|.+++.. .-....+..|.-.+..+.|||+.++.+.+.
T Consensus       278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i  357 (563)
T KOG1024|consen  278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSI  357 (563)
T ss_pred             hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence            34455677888899999999999999554      45566788876543 334467889999999999999999999886


Q ss_pred             eC-CeeEEEEEeccCCChhhhhc-----CCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCc
Q 013636          220 HA-ETRFLVYEMMQNGSLEKQLH-----GPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFN  293 (439)
Q Consensus       220 ~~-~~~~lV~e~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~  293 (439)
                      .. +..+++|.++.-|+|..+|.     +....+.++..+...++.|++.|++|||++   +++|.||.++|++||+...
T Consensus       358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~Lq  434 (563)
T KOG1024|consen  358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQ  434 (563)
T ss_pred             eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhhee
Confidence            54 57899999999999999998     444556788899999999999999999998   9999999999999999999


Q ss_pred             EEEEecccccccCCCCcce---eeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhh
Q 013636          294 AKLSDFGLSVTAGTQSRNV---KISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWA  369 (439)
Q Consensus       294 ~kl~DfGls~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~  369 (439)
                      +||+|-.+++..-..+.+.   .......||+||.+.+..|+.++|||||||+||||+| |+.||-..+|.+....+.- 
T Consensus       435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkd-  513 (563)
T KOG1024|consen  435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKD-  513 (563)
T ss_pred             EEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhc-
Confidence            9999999998764433221   1113568999999999999999999999999999999 9999999998876655432 


Q ss_pred             hcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhcccc
Q 013636          370 MPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPL  427 (439)
Q Consensus       370 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l  427 (439)
                            ..++.          .+..++.++..++.-||..+|++||+++|+++-|.+.
T Consensus       514 ------GyRla----------QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF  555 (563)
T KOG1024|consen  514 ------GYRLA----------QPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF  555 (563)
T ss_pred             ------cceec----------CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence                  11111          1123456788899999999999999999999888654

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.4e-37  Score=297.52  Aligned_cols=255  Identities=25%  Similarity=0.378  Sum_probs=194.2

Q ss_pred             CCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC-chHHHHHHHHHHHHHhcC-CCceeeeeeEEEeCCeeEEEEEe
Q 013636          154 NFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG-HDAEREFNNEVNWLTKIR-HQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      +|+..+.||+|+||.||++... ++..+|+|.+.... ......+.+|+.++.++. |+||+++++++...+..+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            4445678999999999999875 47889999886533 234567889999999996 99999999999999999999999


Q ss_pred             ccCCChhhhhcC--CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC
Q 013636          231 MQNGSLEKQLHG--PTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       231 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~  308 (439)
                      +.. ++.++...  ......+++..+.+++.|++.||+|||+.  .+++||||||+||++++++.+||+|||++......
T Consensus        85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  161 (288)
T cd06616          85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS  161 (288)
T ss_pred             ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence            864 55544321  11235689999999999999999999973  38999999999999999999999999999765443


Q ss_pred             CcceeeccccCccchhhhcCC---CCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCc
Q 013636          309 SRNVKISGTLGYVAPEYLLEG---KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDP  385 (439)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  385 (439)
                      .......|+..|+|||.+.+.   .++.++|||||||++|||++|+.||....... ......    ..  ...+.    
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~----~~--~~~~~----  230 (288)
T cd06616         162 IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVF-DQLTQV----VK--GDPPI----  230 (288)
T ss_pred             CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHH-HHHhhh----cC--CCCCc----
Confidence            333334588999999999876   68899999999999999999999997654210 111100    00  00001    


Q ss_pred             hhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          386 VIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       386 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                       +...........+.+++.+||+.||++|||+.+++++
T Consensus       231 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         231 -LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             -CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             1111111223467889999999999999999999975

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-37  Score=299.97  Aligned_cols=266  Identities=22%  Similarity=0.310  Sum_probs=196.4

Q ss_pred             CCCccceecccCcEEEEEEEECC---ccEEEEEEecCCC---chHHHHHHHHHHHHHhcCCCceeeeeeEEEeC--CeeE
Q 013636          154 NFQESNVIGEGGRGHVYKARFNE---KLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRHQNIISLLGYCIHA--ETRF  225 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~~---~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  225 (439)
                      +|++.+.||+|+||.||+|....   +..+|+|.+....   ......+.+|+.++++++|||++++++++...  +..+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            46778899999999999998854   6889999987632   23345678899999999999999999999988  7899


Q ss_pred             EEEEeccCCChhhhhcCCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC----CCcEEEEec
Q 013636          226 LVYEMMQNGSLEKQLHGPT--HGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDS----SFNAKLSDF  299 (439)
Q Consensus       226 lV~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~----~~~~kl~Df  299 (439)
                      +||||+++ +|.+++....  ....+++..+..++.|++.||+|||+.   +++||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 6776664321  223689999999999999999999998   9999999999999999    999999999


Q ss_pred             ccccccCCCCc----ceeeccccCccchhhhcCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCChhhh------hhhHhh
Q 013636          300 GLSVTAGTQSR----NVKISGTLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQC------QSMVTW  368 (439)
Q Consensus       300 Gls~~~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~------~~~~~~  368 (439)
                      |++........    .....++..|+|||.+.+. .++.++||||||++++||++|+.||........      ......
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99876543222    1223578899999988764 578999999999999999999999976543320      000000


Q ss_pred             hhccccc--------CCCCCccCC------------chhcCccCH--HHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          369 AMPQLTD--------RSKLPNIVD------------PVIRDTMDL--KHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       369 ~~~~~~~--------~~~~~~~~d------------~~l~~~~~~--~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      ....+..        ....++...            ..+....+.  .....+.+++.+||+.||++|||+.|++++
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            0000000        000000000            001000001  223467889999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-37  Score=294.33  Aligned_cols=263  Identities=25%  Similarity=0.334  Sum_probs=197.4

Q ss_pred             CCccceecccCcEEEEEEEEC-CccEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEec
Q 013636          155 FQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMM  231 (439)
Q Consensus       155 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  231 (439)
                      |+..+.||.|++|.||+|... ++..+++|++....  ......+.+|++++++++|||++++++++...+..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            566789999999999999875 68889999886432  223356889999999999999999999999999999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc-
Q 013636          232 QNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR-  310 (439)
Q Consensus       232 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~-  310 (439)
                      + ++|.+++.... ...+++..+..++.|+++||+|||+.   +++||||+|+||++++++.++|+|||++........ 
T Consensus        81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~  155 (283)
T cd07835          81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT  155 (283)
T ss_pred             C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence            5 69999986432 24689999999999999999999997   999999999999999999999999999975533221 


Q ss_pred             ceeeccccCccchhhhcCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCChhhh-hhhHhhhhccc-------cc----CC
Q 013636          311 NVKISGTLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQC-QSMVTWAMPQL-------TD----RS  377 (439)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~-~~~~~~~~~~~-------~~----~~  377 (439)
                      .....++..|+|||.+.+. .++.++||||||+++|||++|+.||...+.... ...........       ..    ..
T Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd07835         156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKP  235 (283)
T ss_pred             cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhh
Confidence            1222468899999988664 578899999999999999999999987654321 11111100000       00    00


Q ss_pred             CCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          378 KLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       378 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      ..+......... ........+.+++.+|++.||++|||++|++++
T Consensus       236 ~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         236 TFPKWARQDLSK-VVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             hcccccccchhh-hcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            011111111100 001122467789999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-38  Score=313.17  Aligned_cols=249  Identities=26%  Similarity=0.445  Sum_probs=197.1

Q ss_pred             cceecccCcEEEEEEEECC-ccEEEE--EEecCC--CchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCe--eEEEEEe
Q 013636          158 SNVIGEGGRGHVYKARFNE-KLLAAV--KRIDDA--GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAET--RFLVYEM  230 (439)
Q Consensus       158 ~~~LG~G~fg~Vy~~~~~~-~~~vav--K~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lV~e~  230 (439)
                      ..+||+|+|-+||+|.+.. |..||=  +++.+.  .....++|..|+.+|+.|+||||++++.++.+...  ..+|+|.
T Consensus        45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL  124 (632)
T KOG0584|consen   45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL  124 (632)
T ss_pred             hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence            4679999999999998754 555541  122222  22344789999999999999999999999987665  6789999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc-CCCcEEEEecccccccCCCC
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLD-SSFNAKLSDFGLSVTAGTQS  309 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~-~~~~~kl~DfGls~~~~~~~  309 (439)
                      +..|+|..|+.+.   +.++.+.+..|+.||++||.|||++ .++|+|||||.+||+|+ ..|.|||+|+|||.......
T Consensus       125 ~TSGtLr~Y~kk~---~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~  200 (632)
T KOG0584|consen  125 FTSGTLREYRKKH---RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH  200 (632)
T ss_pred             ccCCcHHHHHHHh---ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence            9999999999643   4588899999999999999999998 67999999999999997 46899999999998876543


Q ss_pred             cceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCC-CChhhhhhhHhhhhcccccCCCCCccCCchhc
Q 013636          310 RNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEK-MSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIR  388 (439)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  388 (439)
                      . ....|||.|||||+.. ..|+..+||||||++++||+|+.+||.. .++.+....+....    ....+..+-||.+ 
T Consensus       201 a-ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGi----KP~sl~kV~dPev-  273 (632)
T KOG0584|consen  201 A-KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGI----KPAALSKVKDPEV-  273 (632)
T ss_pred             c-ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCC----CHHHhhccCCHHH-
Confidence            3 3467999999999876 7899999999999999999999999964 35555544443221    1223444445544 


Q ss_pred             CccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCCC
Q 013636          389 DTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPTD  431 (439)
Q Consensus       389 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~~  431 (439)
                                 .+++..|+.. .++|||+.|+|..  ++++.+
T Consensus       274 -----------r~fIekCl~~-~~~R~sa~eLL~d--~Ff~~d  302 (632)
T KOG0584|consen  274 -----------REFIEKCLAT-KSERLSAKELLKD--PFFDED  302 (632)
T ss_pred             -----------HHHHHHHhcC-chhccCHHHHhhC--hhhccc
Confidence                       4588999999 9999999999953  444443

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.4e-37  Score=290.59  Aligned_cols=250  Identities=24%  Similarity=0.306  Sum_probs=203.3

Q ss_pred             CCCccceecccCcEEEEEEEECCc-cEEEEEEecCCCc---hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEE
Q 013636          154 NFQESNVIGEGGRGHVYKARFNEK-LLAAVKRIDDAGH---DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYE  229 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  229 (439)
                      .|+..+.||+|.-|+||.+++++. ...|+|.+.+..-   ....+...|-+||+.++||.+..|++.++.+...|++||
T Consensus        78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me  157 (459)
T KOG0610|consen   78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME  157 (459)
T ss_pred             HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence            455578899999999999999874 7889999986543   333467789999999999999999999999999999999


Q ss_pred             eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCC--
Q 013636          230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT--  307 (439)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~--  307 (439)
                      ||+||+|..++++ +.++.+++..+..++..+.-||+|||-.   |||.|||||+||||.++|++-|+||.|+.....  
T Consensus       158 yCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~P  233 (459)
T KOG0610|consen  158 YCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP  233 (459)
T ss_pred             cCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence            9999999998876 4467899999999999999999999998   999999999999999999999999999732100  


Q ss_pred             -------------------------------C-C-----------------------cceeeccccCccchhhhcCCCCC
Q 013636          308 -------------------------------Q-S-----------------------RNVKISGTLGYVAPEYLLEGKLT  332 (439)
Q Consensus       308 -------------------------------~-~-----------------------~~~~~~gt~~y~aPE~~~~~~~~  332 (439)
                                                     . .                       ....++||-.|.|||++.+.-.+
T Consensus       234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg  313 (459)
T KOG0610|consen  234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG  313 (459)
T ss_pred             eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence                                           0 0                       00123589999999999999999


Q ss_pred             CchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCC
Q 013636          333 DKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPS  412 (439)
Q Consensus       333 ~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~  412 (439)
                      .++|.|+|||++|||+.|..||.+.+..+....+-.      ....+++..          .-...+.++|...|.+||+
T Consensus       314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~------~~l~Fp~~~----------~vs~~akDLIr~LLvKdP~  377 (459)
T KOG0610|consen  314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVG------QPLKFPEEP----------EVSSAAKDLIRKLLVKDPS  377 (459)
T ss_pred             chhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhc------CCCcCCCCC----------cchhHHHHHHHHHhccChh
Confidence            999999999999999999999998876554333321      111221111          2245677899999999999


Q ss_pred             CCCC----HHHHHHh
Q 013636          413 YRPL----ITDVLHS  423 (439)
Q Consensus       413 ~RPt----~~evl~~  423 (439)
                      +|.-    +.||-+|
T Consensus       378 kRlg~~rGA~eIK~H  392 (459)
T KOG0610|consen  378 KRLGSKRGAAEIKRH  392 (459)
T ss_pred             hhhccccchHHhhcC
Confidence            9998    7777644

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=7.4e-37  Score=288.44  Aligned_cols=243  Identities=24%  Similarity=0.321  Sum_probs=195.9

Q ss_pred             ecccCcEEEEEEEECC-ccEEEEEEecCCC---chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEeccCCCh
Q 013636          161 IGEGGRGHVYKARFNE-KLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSL  236 (439)
Q Consensus       161 LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  236 (439)
                      ||+|+||.||+++... +..+++|.+....   ....+.+.+|+.+++.++|||++++++++.+++..++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            6999999999999864 7789999886432   23446789999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCcceeecc
Q 013636          237 EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG  316 (439)
Q Consensus       237 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~~~~~~g  316 (439)
                      .+++.+.   ..+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++.............+
T Consensus        81 ~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~  154 (262)
T cd05572          81 WTILRDR---GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCG  154 (262)
T ss_pred             HHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccC
Confidence            9999643   3489999999999999999999997   999999999999999999999999999977654433334468


Q ss_pred             ccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCccCHHHH
Q 013636          317 TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHL  396 (439)
Q Consensus       317 t~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  396 (439)
                      +..|+|||.+.+..++.++|+||+|+++|||++|..||........ ....... ........+...            .
T Consensus       155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~------------~  220 (262)
T cd05572         155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM-EIYNDIL-KGNGKLEFPNYI------------D  220 (262)
T ss_pred             CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH-HHHHHHh-ccCCCCCCCccc------------C
Confidence            8999999999888899999999999999999999999987652111 1111000 001111111111            3


Q ss_pred             HHHHHHHHHhcCCCCCCCCC-----HHHHHHh
Q 013636          397 YQVAAVAVLCIQPEPSYRPL-----ITDVLHS  423 (439)
Q Consensus       397 ~~l~~l~~~cl~~dP~~RPt-----~~evl~~  423 (439)
                      ..+.+++.+||+.+|++||+     ++|++++
T Consensus       221 ~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~  252 (262)
T cd05572         221 KAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH  252 (262)
T ss_pred             HHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence            46778999999999999999     7888763

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=5.9e-37  Score=294.30  Aligned_cols=243  Identities=25%  Similarity=0.395  Sum_probs=197.4

Q ss_pred             ceecccCcEEEEEEEEC-CccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEeccCCChh
Q 013636          159 NVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLE  237 (439)
Q Consensus       159 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~  237 (439)
                      ..||+|+||.||++... ++..+++|.+..........+.+|+.+++.++|+|++++++++...+..+++|||+++++|.
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  105 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT  105 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence            56999999999999885 57889999887655555667999999999999999999999999999999999999999999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc-ceeecc
Q 013636          238 KQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR-NVKISG  316 (439)
Q Consensus       238 ~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~-~~~~~g  316 (439)
                      +++..    ..+++.....++.|++.|++|||+.   +++||||+|+||++++++.++|+|||++........ .....+
T Consensus       106 ~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  178 (292)
T cd06657         106 DIVTH----TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVG  178 (292)
T ss_pred             HHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccccccccccc
Confidence            98753    2478999999999999999999998   999999999999999999999999999865543221 223458


Q ss_pred             ccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCccCHHHH
Q 013636          317 TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHL  396 (439)
Q Consensus       317 t~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  396 (439)
                      +..|+|||.+.+..++.++|+||||+++|||++|..||...+...........   ..  ..+..     + .    ...
T Consensus       179 ~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~---~~--~~~~~-----~-~----~~~  243 (292)
T cd06657         179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN---LP--PKLKN-----L-H----KVS  243 (292)
T ss_pred             CccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhh---CC--cccCC-----c-c----cCC
Confidence            89999999998888999999999999999999999999865543322222111   00  00000     0 0    112


Q ss_pred             HHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          397 YQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       397 ~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      ..+.+++.+||+.+|.+||++.+++++
T Consensus       244 ~~l~~li~~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         244 PSLKGFLDRLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             HHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence            345678999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=5.3e-37  Score=292.12  Aligned_cols=245  Identities=26%  Similarity=0.350  Sum_probs=193.2

Q ss_pred             ecccCcEEEEEEEEC-CccEEEEEEecCCC---chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEeccCCCh
Q 013636          161 IGEGGRGHVYKARFN-EKLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSL  236 (439)
Q Consensus       161 LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  236 (439)
                      ||+|+||+||++... ++..+++|.+....   ......+.+|++++++++|||++++++++...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            699999999999765 57788999886432   22344577899999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCcceeecc
Q 013636          237 EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG  316 (439)
Q Consensus       237 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~~~~~~g  316 (439)
                      .+++.... ...+++..+..++.|++.|+.|||+.   +++||||+|+||++++++.++|+|||++.............+
T Consensus        81 ~~~l~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  156 (277)
T cd05577          81 KYHIYNVG-EPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAG  156 (277)
T ss_pred             HHHHHHcC-cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccC
Confidence            99987532 24689999999999999999999998   999999999999999999999999999876543333333457


Q ss_pred             ccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCccCHHHH
Q 013636          317 TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHL  396 (439)
Q Consensus       317 t~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  396 (439)
                      +..|+|||.+.++.++.++||||||+++|+|++|+.||...........+...  ........+..+            .
T Consensus       157 ~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~------------~  222 (277)
T cd05577         157 TPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRR--TLEMAVEYPDKF------------S  222 (277)
T ss_pred             CCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhc--cccccccCCccC------------C
Confidence            88999999999888999999999999999999999999765432111111100  001111111111            3


Q ss_pred             HHHHHHHHHhcCCCCCCCC-----CHHHHHHh
Q 013636          397 YQVAAVAVLCIQPEPSYRP-----LITDVLHS  423 (439)
Q Consensus       397 ~~l~~l~~~cl~~dP~~RP-----t~~evl~~  423 (439)
                      ..+.+++.+||+.||++||     ++.+++.+
T Consensus       223 ~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h  254 (277)
T cd05577         223 PEAKDLCEALLQKDPEKRLGCRGGSADEVREH  254 (277)
T ss_pred             HHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence            3566799999999999999     77778754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=7.2e-37  Score=293.65  Aligned_cols=265  Identities=25%  Similarity=0.319  Sum_probs=196.3

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGH--DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYE  229 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  229 (439)
                      ++|+..+.||+|+||.||+|+.. ++..+++|.+.....  ...+.+.+|++++++++|||++++++++...+..++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46888899999999999999876 577899998864322  233568899999999999999999999999999999999


Q ss_pred             eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC-CCcEEEEecccccccCCC
Q 013636          230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDS-SFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~-~~~~kl~DfGls~~~~~~  308 (439)
                      |++ ++|.+++... ....+++..+..++.|++.||+|||+.   +++|+||+|+||++++ ++.+||+|||++......
T Consensus        82 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         82 YLD-LDLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP  156 (294)
T ss_pred             ccc-ccHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence            996 5888877542 233467888899999999999999998   9999999999999985 567999999999765432


Q ss_pred             Cc-ceeeccccCccchhhhcCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhh-hHhhhhcccc----cCCCCCc
Q 013636          309 SR-NVKISGTLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQS-MVTWAMPQLT----DRSKLPN  381 (439)
Q Consensus       309 ~~-~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~-~~~~~~~~~~----~~~~~~~  381 (439)
                      .. .....+++.|+|||.+.+. .++.++||||||+++|+|++|+.||...++.+... ..........    .-..+++
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (294)
T PLN00009        157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD  236 (294)
T ss_pred             ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence            21 1223468899999998764 57899999999999999999999998765432211 1111000000    0000000


Q ss_pred             c-------CCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          382 I-------VDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       382 ~-------~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      .       ....... ........+.+++.+|++.+|++||++.+++++
T Consensus       237 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~  284 (294)
T PLN00009        237 YKSAFPKWPPKDLAT-VVPTLEPAGVDLLSKMLRLDPSKRITARAALEH  284 (294)
T ss_pred             hhhhcccCCCCCHHH-hCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0       0000000 001123457789999999999999999999964

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=7.4e-37  Score=293.51  Aligned_cols=265  Identities=23%  Similarity=0.274  Sum_probs=196.6

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCc--hHHHHHHHHHHHHHhcC-CCceeeeeeEEEeCCe-----
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGH--DAEREFNNEVNWLTKIR-HQNIISLLGYCIHAET-----  223 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~-----  223 (439)
                      ++|+..+.||+|+||.||+|... ++..+|+|.......  .....+.+|+.+++.++ |||++++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46888899999999999999875 578899998764322  23356888999999995 6999999999887665     


Q ss_pred             eEEEEEeccCCChhhhhcCCCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC-CCcEEEEecc
Q 013636          224 RFLVYEMMQNGSLEKQLHGPTH--GSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDS-SFNAKLSDFG  300 (439)
Q Consensus       224 ~~lV~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~-~~~~kl~DfG  300 (439)
                      .++||||+++ +|.+++.....  ...+++..+..++.|+++||+|||+.   +++||||+|+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence            7999999986 89888864322  34689999999999999999999998   9999999999999998 8999999999


Q ss_pred             cccccCCCCc-ceeeccccCccchhhhcC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhh-hhHhhhhcccccC-
Q 013636          301 LSVTAGTQSR-NVKISGTLGYVAPEYLLE-GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQ-SMVTWAMPQLTDR-  376 (439)
Q Consensus       301 ls~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~-~~~~~~~~~~~~~-  376 (439)
                      ++........ .....+++.|+|||.+.+ ..++.++||||||+++|||++|..||...++.... ...... ...... 
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~-~~~~~~~  235 (295)
T cd07837         157 LGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLL-GTPTEQV  235 (295)
T ss_pred             cceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh-CCCChhh
Confidence            9875433211 122346788999998865 45789999999999999999999999876543221 111110 000000 


Q ss_pred             ----------CCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          377 ----------SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       377 ----------~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                                ...+......+.. ........+.+++.+||+.||++||++.|++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         236 WPGVSKLRDWHEFPQWKPQDLSR-AVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             CcchhhccchhhcCcccchhHHH-hccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence                      0000000000100 001123557889999999999999999999865

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-37  Score=293.33  Aligned_cols=263  Identities=24%  Similarity=0.340  Sum_probs=198.8

Q ss_pred             CCccceecccCcEEEEEEEECC-ccEEEEEEecCCCc-hHHHHHHHHHHHHHhcC-CCceeeeeeEEEeCCeeEEEEEec
Q 013636          155 FQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGH-DAEREFNNEVNWLTKIR-HQNIISLLGYCIHAETRFLVYEMM  231 (439)
Q Consensus       155 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~  231 (439)
                      |++.+.||+|+||+||+|+..+ +..+++|++..... .......+|+..+++++ |+|++++++++..++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            5667889999999999999864 67889998865432 22334567999999999 999999999999999999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCcc
Q 013636          232 QNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN  311 (439)
Q Consensus       232 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~~  311 (439)
                       +|+|.+++.... +..+++..+..++.|++.+|.|||+.   +++|+||+|+||++++++.++|+|||++.........
T Consensus        81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~  155 (283)
T cd07830          81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY  155 (283)
T ss_pred             -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCCc
Confidence             889999887532 34689999999999999999999997   9999999999999999999999999999766543333


Q ss_pred             eeeccccCccchhhhcC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhh-hhHhhhhcccc----c--------CC
Q 013636          312 VKISGTLGYVAPEYLLE-GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQ-SMVTWAMPQLT----D--------RS  377 (439)
Q Consensus       312 ~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~-~~~~~~~~~~~----~--------~~  377 (439)
                      ....++..|+|||.+.. ..++.++|+||||+++|||++|+.||...+..... ...........    .        ..
T Consensus       156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd07830         156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF  235 (283)
T ss_pred             CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccc
Confidence            34457889999998754 56789999999999999999999999766543211 11110000000    0        00


Q ss_pred             CCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          378 KLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       378 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      .++......+..... .....+.+++.+||+.||++|||++|++.+
T Consensus       236 ~~~~~~~~~~~~~~~-~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         236 RFPQFAPTSLHQLIP-NASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             cccccccccHHHHcc-cCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            000111111110000 113568899999999999999999999865

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=6.5e-37  Score=295.73  Aligned_cols=262  Identities=22%  Similarity=0.344  Sum_probs=196.0

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC-------
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE-------  222 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------  222 (439)
                      ++|+..+.||+|+||.||+|... ++..+|+|.+....  ......+.+|+.++++++|||+++++++|...+       
T Consensus        12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   91 (310)
T cd07865          12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK   91 (310)
T ss_pred             hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence            56888999999999999999875 47889999885432  222345678999999999999999999987654       


Q ss_pred             -eeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccc
Q 013636          223 -TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGL  301 (439)
Q Consensus       223 -~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGl  301 (439)
                       ..++||||+.+ +|.+++..  ....+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||+
T Consensus        92 ~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~  165 (310)
T cd07865          92 GSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGL  165 (310)
T ss_pred             ceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCC
Confidence             34999999975 88888764  234689999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCCcc-----eeeccccCccchhhhcCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhccccc
Q 013636          302 SVTAGTQSRN-----VKISGTLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTD  375 (439)
Q Consensus       302 s~~~~~~~~~-----~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~  375 (439)
                      +.........     ....++..|+|||.+.+. .++.++||||||+++|||++|+.||...++......+.........
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (310)
T cd07865         166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP  245 (310)
T ss_pred             cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            9755332211     123467889999988764 4688999999999999999999999876654433333322111110


Q ss_pred             C-----C--------CCCc----cCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          376 R-----S--------KLPN----IVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       376 ~-----~--------~~~~----~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      .     .        ..+.    .....+....   ....+.+++.+||+.||++|||+.+++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~---~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYV---KDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             hhcccccchhhhhhccCCCccchhhHHhccccc---CCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence            0     0        0000    0000000000   12346689999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.5e-36  Score=284.45  Aligned_cols=250  Identities=27%  Similarity=0.395  Sum_probs=204.7

Q ss_pred             CCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEe
Q 013636          154 NFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGH--DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      +|+..+.||+|+||.||++... ++..+++|.+.....  .....+.+|+++++.++|+|++++.+.+...+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4777889999999999999886 477889999875433  4556788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCC
Q 013636          231 MQNGSLEKQLHGPT-HGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS  309 (439)
Q Consensus       231 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~  309 (439)
                      +++++|.+++.... .+..+++..+..++.+++.||.|||+.   +++|+||+|+||++++++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999999997532 246799999999999999999999998   99999999999999999999999999997654433


Q ss_pred             -cceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhc
Q 013636          310 -RNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIR  388 (439)
Q Consensus       310 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  388 (439)
                       ......|++.|+|||...+..++.++|+||+|+++++|++|+.||...+.........   .  .....++.       
T Consensus       158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~---~--~~~~~~~~-------  225 (258)
T cd08215         158 DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKIL---K--GQYPPIPS-------  225 (258)
T ss_pred             ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHh---c--CCCCCCCC-------
Confidence             1223457889999999998899999999999999999999999997765433222111   0  00111111       


Q ss_pred             CccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          389 DTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       389 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                           .....+.+++.+||+.+|++|||+.+++++
T Consensus       226 -----~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         226 -----QYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             -----CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                 112456779999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=8.2e-37  Score=291.35  Aligned_cols=242  Identities=26%  Similarity=0.342  Sum_probs=186.2

Q ss_pred             eecccCcEEEEEEEEC-CccEEEEEEecCCC---chHHHHHHHHHHHHH---hcCCCceeeeeeEEEeCCeeEEEEEecc
Q 013636          160 VIGEGGRGHVYKARFN-EKLLAAVKRIDDAG---HDAEREFNNEVNWLT---KIRHQNIISLLGYCIHAETRFLVYEMMQ  232 (439)
Q Consensus       160 ~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~---~l~h~niv~l~~~~~~~~~~~lV~e~~~  232 (439)
                      +||+|+||.||++... ++..+|+|.+....   ......+.+|..+++   ..+|||++.+.+++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999875 47889999886432   122233445544443   3479999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCcce
Q 013636          233 NGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV  312 (439)
Q Consensus       233 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~~~  312 (439)
                      +|+|.+++..   ...+++..+..++.|++.||+|||+.   +++||||||+||++++++.++|+|||++........ .
T Consensus        81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~-~  153 (279)
T cd05633          81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-H  153 (279)
T ss_pred             CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc-c
Confidence            9999999863   24589999999999999999999998   999999999999999999999999999865543222 2


Q ss_pred             eeccccCccchhhhcC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCcc
Q 013636          313 KISGTLGYVAPEYLLE-GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTM  391 (439)
Q Consensus       313 ~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  391 (439)
                      ...||..|+|||.+.+ ..++.++||||+||++|||++|..||...............   ......++.          
T Consensus       154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~----------  220 (279)
T cd05633         154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---LTVNVELPD----------  220 (279)
T ss_pred             CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh---hcCCcCCcc----------
Confidence            3458999999999874 55789999999999999999999999765432211111100   011111111          


Q ss_pred             CHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHh
Q 013636          392 DLKHLYQVAAVAVLCIQPEPSYRP-----LITDVLHS  423 (439)
Q Consensus       392 ~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  423 (439)
                        .....+.+++..||+.||++||     ++++++++
T Consensus       221 --~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         221 --SFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             --ccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence              1234567789999999999999     69999986

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=8.2e-37  Score=295.55  Aligned_cols=265  Identities=28%  Similarity=0.361  Sum_probs=198.1

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCceeeeeeEEEeC--CeeEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGH--DAEREFNNEVNWLTKIRHQNIISLLGYCIHA--ETRFL  226 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  226 (439)
                      .++|+..+.||+|+||.||+|... .+..+|+|.+.....  .....+.+|+.++++++|+|++++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            367888999999999999999885 478899998864322  2223567899999999999999999998755  46899


Q ss_pred             EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccC
Q 013636          227 VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAG  306 (439)
Q Consensus       227 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~  306 (439)
                      ||||+.+ +|.+++...  ...+++..+..++.|+++||+|||+.   +++||||||+||++++++.+||+|||++....
T Consensus        86 v~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~  159 (309)
T cd07845          86 VMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYG  159 (309)
T ss_pred             EEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecC
Confidence            9999975 888888642  25689999999999999999999998   99999999999999999999999999997665


Q ss_pred             CCCcc-eeeccccCccchhhhcC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcc--------cccC
Q 013636          307 TQSRN-VKISGTLGYVAPEYLLE-GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQ--------LTDR  376 (439)
Q Consensus       307 ~~~~~-~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~--------~~~~  376 (439)
                      ..... ....++..|+|||.+.+ ..++.++||||+|+++|||++|+.||...++.+....+......        ....
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
T cd07845         160 LPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL  239 (309)
T ss_pred             CccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcc
Confidence            43221 22235788999999875 45789999999999999999999999877654433222211100        0000


Q ss_pred             C-----CCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          377 S-----KLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       377 ~-----~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      .     .+.......+... .......+.+++..|++.||++|||++|++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         240 PLVGKFTLPKQPYNNLKHK-FPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             cccccccccCCCCCchHHh-ccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            0     0000000000000 00113456789999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-36  Score=283.02  Aligned_cols=247  Identities=28%  Similarity=0.485  Sum_probs=201.7

Q ss_pred             CCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEe
Q 013636          154 NFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGH--DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      +|+..+.||+|++|.||+++.. ++..+++|.+.....  .....+.+|++++++++|+|++++++++...+..++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4677899999999999999876 467899999876543  3456799999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR  310 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~  310 (439)
                      +++++|.+++...   ..+++..+..++.|++.|+.|||+.   +++||||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (254)
T cd06627          81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK  154 (254)
T ss_pred             CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence            9999999998643   5689999999999999999999998   999999999999999999999999999976654332


Q ss_pred             -ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcC
Q 013636          311 -NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRD  389 (439)
Q Consensus       311 -~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  389 (439)
                       .....++..|+|||...+..++.++||||+|+++|+|++|+.||...++....  ..  ... ......+..+      
T Consensus       155 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~--~~--~~~-~~~~~~~~~~------  223 (254)
T cd06627         155 DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAAL--FR--IVQ-DDHPPLPEGI------  223 (254)
T ss_pred             cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHH--HH--Hhc-cCCCCCCCCC------
Confidence             12345788999999998888899999999999999999999999765432211  11  000 1111111111      


Q ss_pred             ccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          390 TMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       390 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                            ...+.+++.+||+.+|++|||+.+++.+
T Consensus       224 ------~~~~~~~i~~~l~~~p~~R~~~~~~l~~  251 (254)
T cd06627         224 ------SPELKDFLMQCFQKDPNLRPTAKQLLKH  251 (254)
T ss_pred             ------CHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence                  2356679999999999999999999853

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=9.3e-37  Score=293.33  Aligned_cols=253  Identities=28%  Similarity=0.469  Sum_probs=194.9

Q ss_pred             cCCCccceecccCcEEEEEEEECC-ccEEEEEEecCCCc-hHHHHHHHHHHHHHhcC-CCceeeeeeEEEeCCeeEEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGH-DAEREFNNEVNWLTKIR-HQNIISLLGYCIHAETRFLVYE  229 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e  229 (439)
                      ++|++.+.||+|+||.||+|..++ +..+|+|.+..... ....++..|+.++.+.. |||++++++++......+++||
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   94 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME   94 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence            567788999999999999999875 78899999875432 33455677887777775 9999999999999999999999


Q ss_pred             eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCC
Q 013636          230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS  309 (439)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~  309 (439)
                      |+++ +|.+++...  ...+++..+..++.|+++|++|||+.  ++++||||+|+||++++++.+||+|||++.......
T Consensus        95 ~~~~-~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~  169 (296)
T cd06618          95 LMST-CLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK  169 (296)
T ss_pred             ccCc-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence            9854 777766532  23689999999999999999999973  289999999999999999999999999987654333


Q ss_pred             cceeeccccCccchhhhcCCC----CCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCc
Q 013636          310 RNVKISGTLGYVAPEYLLEGK----LTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDP  385 (439)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  385 (439)
                      ......++..|+|||.+.+..    ++.++||||||+++|||++|+.||....... . ......   ...  .+.....
T Consensus       170 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~-~~~~~~---~~~--~~~~~~~  242 (296)
T cd06618         170 AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-E-VLTKIL---QEE--PPSLPPN  242 (296)
T ss_pred             cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH-H-HHHHHh---cCC--CCCCCCC
Confidence            333344778999999987654    7889999999999999999999997543221 1 111111   010  0011000


Q ss_pred             hhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhc
Q 013636          386 VIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL  424 (439)
Q Consensus       386 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  424 (439)
                      .       .....+.+++.+||+.||++||++.+++++-
T Consensus       243 ~-------~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~  274 (296)
T cd06618         243 E-------GFSPDFCSFVDLCLTKDHRKRPKYRELLQHP  274 (296)
T ss_pred             C-------CCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence            0       1234577899999999999999999999764

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=8.5e-37  Score=286.45  Aligned_cols=249  Identities=28%  Similarity=0.381  Sum_probs=203.8

Q ss_pred             CCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEe
Q 013636          154 NFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      +|++.+.||+|+||.||+++.. ++..+++|.+....  ......+.+|+.++++++|+||+++++++......++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4777899999999999999765 56788999886432  23345688999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCC
Q 013636          231 MQNGSLEKQLHGP-THGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS  309 (439)
Q Consensus       231 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~  309 (439)
                      +++++|.+++... .....+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.+||+|||++...... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            9999999998642 2235689999999999999999999998   9999999999999999999999999999776544 


Q ss_pred             cceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcC
Q 013636          310 RNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRD  389 (439)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  389 (439)
                      ......++..|+|||.+.+..++.++|+||||+++|||++|+.||...+.......+.        ....+..       
T Consensus       157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~--------~~~~~~~-------  221 (256)
T cd08530         157 MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQ--------RGKYPPI-------  221 (256)
T ss_pred             CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--------cCCCCCC-------
Confidence            2223457889999999999999999999999999999999999998766543222211        1111111       


Q ss_pred             ccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          390 TMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       390 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                        .......+.+++.+|++.+|++||++.+++++
T Consensus       222 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         222 --PPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             --chhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence              11223457889999999999999999999975

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-36  Score=290.19  Aligned_cols=262  Identities=26%  Similarity=0.351  Sum_probs=200.7

Q ss_pred             CCccceecccCcEEEEEEEEC-CccEEEEEEecCCCch--HHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEec
Q 013636          155 FQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHD--AEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMM  231 (439)
Q Consensus       155 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  231 (439)
                      |+..+.||+|++|.||++... ++..+++|.+......  ....+.+|+.++++++|+|++++++++..++..++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            456788999999999999875 5788899988654332  4467889999999999999999999999999999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCC-c
Q 013636          232 QNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS-R  310 (439)
Q Consensus       232 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~-~  310 (439)
                      ++ +|.+++...  ...+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||.+....... .
T Consensus        81 ~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~  154 (283)
T cd05118          81 DT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP  154 (283)
T ss_pred             CC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccc
Confidence            75 888888642  25689999999999999999999998   99999999999999999999999999997665433 1


Q ss_pred             ceeeccccCccchhhhcCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhc--------cccc-----C
Q 013636          311 NVKISGTLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP--------QLTD-----R  376 (439)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~--------~~~~-----~  376 (439)
                      .....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+..........        ....     .
T Consensus       155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd05118         155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK  234 (283)
T ss_pred             ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence            1223477889999999876 789999999999999999999999977654332111111000        0000     0


Q ss_pred             CCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          377 SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       377 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      ...+...+... ..........+.+++..||+.||++||++.+++.+
T Consensus       235 ~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         235 FSFPKKAGMPL-PKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             hhhccccccCH-HHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            00000000000 01112235678899999999999999999999864

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.3e-36  Score=292.17  Aligned_cols=254  Identities=19%  Similarity=0.225  Sum_probs=181.8

Q ss_pred             hcCCCccceecccCcEEEEEEEECCc----cEEEEEEecCCCchH--H---------HHHHHHHHHHHhcCCCceeeeee
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFNEK----LLAAVKRIDDAGHDA--E---------REFNNEVNWLTKIRHQNIISLLG  216 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~~~----~~vavK~~~~~~~~~--~---------~~~~~E~~~l~~l~h~niv~l~~  216 (439)
                      .++|++.++||+|+||+||+|...+.    ..+++|.........  +         .....+...+..++|+|++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            46889999999999999999987654    344555433221111  0         11223444566678999999999


Q ss_pred             EEEeCC----eeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC
Q 013636          217 YCIHAE----TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSF  292 (439)
Q Consensus       217 ~~~~~~----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~  292 (439)
                      ++....    ..++++|++.. ++.+.+..   ....++..+..++.|+++||+|||+.   +++||||||+|||++.++
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~  163 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNN  163 (294)
T ss_pred             eeeEecCCceEEEEEEehhcc-CHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCC
Confidence            776544    34677777644 66666643   22357888899999999999999998   999999999999999999


Q ss_pred             cEEEEecccccccCCCC--------cceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChh-hhh
Q 013636          293 NAKLSDFGLSVTAGTQS--------RNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPT-QCQ  363 (439)
Q Consensus       293 ~~kl~DfGls~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~-~~~  363 (439)
                      .++|+|||+|+......        ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ...
T Consensus       164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~  243 (294)
T PHA02882        164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI  243 (294)
T ss_pred             cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence            99999999997653211        112235899999999999999999999999999999999999999876322 111


Q ss_pred             hhHhh-hhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhc
Q 013636          364 SMVTW-AMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL  424 (439)
Q Consensus       364 ~~~~~-~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  424 (439)
                      ..... ....+... ..      .+.     .....+.+++..|++.+|++||++.++++.+
T Consensus       244 ~~~~~~~~~~~~~~-~~------~~~-----~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        244 HAAKCDFIKRLHEG-KI------KIK-----NANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HHhHHHHHHHhhhh-hh------ccC-----CCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            11110 01111110 00      000     1134577899999999999999999999876

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-37  Score=301.17  Aligned_cols=269  Identities=24%  Similarity=0.337  Sum_probs=198.4

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC-----ee
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG-HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE-----TR  224 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~  224 (439)
                      +++|++.+.||+|+||.||+|... ++..+|+|.+.... ......+.+|+.++++++|||++++++++...+     ..
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            468999999999999999999865 57889999986432 233456888999999999999999999876543     57


Q ss_pred             EEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccc
Q 013636          225 FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT  304 (439)
Q Consensus       225 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~  304 (439)
                      ++++||+.+ +|.+++..    ..+++..+..++.|+++||+|||+.   +++||||||+||++++++.+||+|||++..
T Consensus        84 ~lv~e~~~~-~l~~~~~~----~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~  155 (336)
T cd07849          84 YIVQELMET-DLYKLIKT----QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARI  155 (336)
T ss_pred             EEEehhccc-CHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceee
Confidence            999999975 88887753    3589999999999999999999998   999999999999999999999999999876


Q ss_pred             cCCCCcc----eeeccccCccchhhhcC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCC
Q 013636          305 AGTQSRN----VKISGTLGYVAPEYLLE-GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKL  379 (439)
Q Consensus       305 ~~~~~~~----~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  379 (439)
                      .......    ....||..|+|||.+.+ ..++.++|||||||++|||++|+.||...+............... .....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~-~~~~~  234 (336)
T cd07849         156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTP-SQEDL  234 (336)
T ss_pred             ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC-CHHHH
Confidence            5332211    22357899999998765 568899999999999999999999997654322111110000000 00000


Q ss_pred             CccCCchh---------cCccC-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh--ccccCC
Q 013636          380 PNIVDPVI---------RDTMD-----LKHLYQVAAVAVLCIQPEPSYRPLITDVLHS--LIPLVP  429 (439)
Q Consensus       380 ~~~~d~~l---------~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~l~~  429 (439)
                      ..+.+...         .....     ......+.+++.+||+.||++|||+.|++++  +.+..+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~  300 (336)
T cd07849         235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD  300 (336)
T ss_pred             HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence            00000000         00000     0113457889999999999999999999987  555543

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2.1e-36  Score=295.24  Aligned_cols=261  Identities=24%  Similarity=0.319  Sum_probs=192.8

Q ss_pred             ceeccc--CcEEEEEEEEC-CccEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEeccC
Q 013636          159 NVIGEG--GRGHVYKARFN-EKLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQN  233 (439)
Q Consensus       159 ~~LG~G--~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  233 (439)
                      ..||+|  +||+||+++.. .+..+|+|.+....  ....+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            346666  99999999875 68899999986432  23346788999999999999999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCcc--
Q 013636          234 GSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN--  311 (439)
Q Consensus       234 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~~--  311 (439)
                      |+|.+++.... ...+++..+..++.|++.||+|||+.   +++||||||+||++++++.++++||+.+.........  
T Consensus        84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~  159 (328)
T cd08226          84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK  159 (328)
T ss_pred             CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence            99999987532 23588999999999999999999997   9999999999999999999999999865322111110  


Q ss_pred             ------eeeccccCccchhhhcCC--CCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhh-hhHhhhh------cccc--
Q 013636          312 ------VKISGTLGYVAPEYLLEG--KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQ-SMVTWAM------PQLT--  374 (439)
Q Consensus       312 ------~~~~gt~~y~aPE~~~~~--~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~-~~~~~~~------~~~~--  374 (439)
                            ....++..|+|||.+.+.  .++.++|||||||++|||++|+.||......... .......      ....  
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (328)
T cd08226         160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE  239 (328)
T ss_pred             ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence                  011245679999999764  4789999999999999999999999765432211 1100000      0000  


Q ss_pred             --------------------cCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          375 --------------------DRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       375 --------------------~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                                          .........+..++..........+.+++.+||+.||++|||+.|++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~  308 (328)
T cd08226         240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH  308 (328)
T ss_pred             hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                                0000001111112222223455678899999999999999999999865

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.6e-36  Score=292.17  Aligned_cols=266  Identities=24%  Similarity=0.329  Sum_probs=198.6

Q ss_pred             HHhcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC----
Q 013636          150 AATNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE----  222 (439)
Q Consensus       150 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  222 (439)
                      ...++|++.+.||+|+||.||+|... ++..+++|.++...  ......+.+|+.++++++|||++++++++...+    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            45678899999999999999999986 46788999886432  223356788999999999999999999987655    


Q ss_pred             ------eeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEE
Q 013636          223 ------TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKL  296 (439)
Q Consensus       223 ------~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl  296 (439)
                            ..++|+||+++ ++.+.+...  ...+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.+||
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl  157 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKL  157 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEe
Confidence                  78999999986 777777542  34689999999999999999999998   9999999999999999999999


Q ss_pred             EecccccccCCCCc--ceeeccccCccchhhhcC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhccc
Q 013636          297 SDFGLSVTAGTQSR--NVKISGTLGYVAPEYLLE-GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQL  373 (439)
Q Consensus       297 ~DfGls~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~  373 (439)
                      +|||++........  .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+.......+.......
T Consensus       158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~  237 (302)
T cd07864         158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSP  237 (302)
T ss_pred             CcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            99999976543321  112235778999998865 457889999999999999999999998655433222221110000


Q ss_pred             ccCCCCCccC--------C------chhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          374 TDRSKLPNIV--------D------PVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       374 ~~~~~~~~~~--------d------~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      . ....+.+.        +      ..++.... .....+.+++..||+.||++||++.+++++
T Consensus       238 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         238 C-PAVWPDVIKLPYFNTMKPKKQYRRRLREEFS-FIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             C-hhhcccccccccccccccccccccchhhhcC-CCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            0 00000000        0      00000000 113467889999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=6.5e-37  Score=300.02  Aligned_cols=268  Identities=25%  Similarity=0.346  Sum_probs=199.7

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCC--CchHHHHHHHHHHHHHhcCCCceeeeeeEEEeC-----Ce
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDA--GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHA-----ET  223 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  223 (439)
                      .++|++.+.||+|+||+||+++.. .+..+++|.+...  .......+.+|+.+++.++|+|++++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            457888999999999999999875 4788999988653  223345677899999999999999999987654     24


Q ss_pred             eEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccccc
Q 013636          224 RFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSV  303 (439)
Q Consensus       224 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~  303 (439)
                      .++|+||+. ++|.+++..   ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.
T Consensus        84 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~  156 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRS---SQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLAR  156 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCcccc
Confidence            799999996 689888853   34689999999999999999999998   99999999999999999999999999997


Q ss_pred             ccCCCC-cceeeccccCccchhhhcC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccC-----
Q 013636          304 TAGTQS-RNVKISGTLGYVAPEYLLE-GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDR-----  376 (439)
Q Consensus       304 ~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~-----  376 (439)
                      ...... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+..................     
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
T cd07858         157 TTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFI  236 (337)
T ss_pred             ccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence            654331 1223357889999998875 468899999999999999999999997654322211111110000000     


Q ss_pred             --CC-------CCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh--cccc
Q 013636          377 --SK-------LPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS--LIPL  427 (439)
Q Consensus       377 --~~-------~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~l  427 (439)
                        ..       .+...++.... ........+.+++.+||+.+|++|||+++++++  +..+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         237 RNEKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             CchhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence              00       00000000000 001123557889999999999999999999987  5443

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.4e-36  Score=292.26  Aligned_cols=247  Identities=29%  Similarity=0.423  Sum_probs=195.5

Q ss_pred             CCCccceecccCcEEEEEEEEC-CccEEEEEEecCC---CchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEE
Q 013636          154 NFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDA---GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYE  229 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  229 (439)
                      .|+..+.||+|+||.||+|+.. ++..+++|.+...   ......++.+|+++++.++|+|++++.+++...+..++|+|
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   95 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence            4566788999999999999875 4677889987532   22334568899999999999999999999999999999999


Q ss_pred             eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCC
Q 013636          230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS  309 (439)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~  309 (439)
                      |+. |+|.+.+..  ....+++..+..++.|++.|+.|||+.   +++||||+|+||+++.++.++|+|||++.......
T Consensus        96 ~~~-~~l~~~~~~--~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~  169 (308)
T cd06634          96 YCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN  169 (308)
T ss_pred             ccC-CCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCcc
Confidence            996 588887753  234589999999999999999999998   99999999999999999999999999987654322


Q ss_pred             cceeeccccCccchhhhc---CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCch
Q 013636          310 RNVKISGTLGYVAPEYLL---EGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPV  386 (439)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  386 (439)
                         ...++..|+|||.+.   .+.++.++|||||||++|||++|+.||...+.........        ....+...   
T Consensus       170 ---~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~--------~~~~~~~~---  235 (308)
T cd06634         170 ---XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA--------QNESPALQ---  235 (308)
T ss_pred             ---cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHh--------hcCCCCcC---
Confidence               234788999999975   3567889999999999999999999997665433222111        00001100   


Q ss_pred             hcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhcc
Q 013636          387 IRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLI  425 (439)
Q Consensus       387 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  425 (439)
                           .......+.+++.+||+.+|++||++.+++++-.
T Consensus       236 -----~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~  269 (308)
T cd06634         236 -----SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF  269 (308)
T ss_pred             -----cccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence                 0112345678999999999999999999998753

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.3e-36  Score=286.33  Aligned_cols=242  Identities=26%  Similarity=0.380  Sum_probs=194.6

Q ss_pred             ecccCcEEEEEEEECC-ccEEEEEEecCCCc---hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEeccCCCh
Q 013636          161 IGEGGRGHVYKARFNE-KLLAAVKRIDDAGH---DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSL  236 (439)
Q Consensus       161 LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  236 (439)
                      ||+|+||.||++...+ +..+++|.+.....   ...+.+.+|++++++++|||++++++.+...+..++++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999999875 88899998865433   3445788999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCC-------
Q 013636          237 EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS-------  309 (439)
Q Consensus       237 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~-------  309 (439)
                      .+++.+.   ..+++..+..++.|+++||+|||+.   +++|+||+|+||++++++.++|+|||++.......       
T Consensus        81 ~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  154 (265)
T cd05579          81 ASLLENV---GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD  154 (265)
T ss_pred             HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence            9999642   2689999999999999999999998   99999999999999999999999999986543321       


Q ss_pred             --cceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchh
Q 013636          310 --RNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVI  387 (439)
Q Consensus       310 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  387 (439)
                        ......++..|+|||.......+.++||||||+++||+++|..||....+.+.......      .....+...    
T Consensus       155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~------~~~~~~~~~----  224 (265)
T cd05579         155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN------GKIEWPEDV----  224 (265)
T ss_pred             cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc------CCcCCCccc----
Confidence              11234578899999999988899999999999999999999999987665432222211      011111110    


Q ss_pred             cCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhc
Q 013636          388 RDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL  424 (439)
Q Consensus       388 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  424 (439)
                            .....+.+++.+||+.+|++|||+.++.+.|
T Consensus       225 ------~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l  255 (265)
T cd05579         225 ------EVSDEAIDLISKLLVPDPEKRLGAKSIEEIK  255 (265)
T ss_pred             ------cCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence                  0134567899999999999999995544444

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-36  Score=284.25  Aligned_cols=248  Identities=25%  Similarity=0.351  Sum_probs=195.5

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCC-----CchHHHHHHHHHHHHHhcCCCceeeeeeEEEeC--Cee
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDA-----GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHA--ETR  224 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  224 (439)
                      .+|++.+.||+|+||.||+|... ++..+++|.+...     .......+.+|+.++++++|+|++++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            47888999999999999999875 4788999987421     123345788999999999999999999998764  457


Q ss_pred             EEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccc
Q 013636          225 FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT  304 (439)
Q Consensus       225 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~  304 (439)
                      ++++||+++++|.+++..   ...+++....+++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++..
T Consensus        82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccc
Confidence            899999999999999863   23488999999999999999999998   999999999999999999999999999975


Q ss_pred             cCCC----CcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCC
Q 013636          305 AGTQ----SRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLP  380 (439)
Q Consensus       305 ~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  380 (439)
                      ....    .......++..|+|||.+.+..++.++|+|||||++|||++|+.||............  . . ......++
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--~-~-~~~~~~~p  231 (264)
T cd06653         156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKI--A-T-QPTKPMLP  231 (264)
T ss_pred             cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHH--H-c-CCCCCCCC
Confidence            4321    1112345788999999999888999999999999999999999999765433211111  0 0 00111111


Q ss_pred             ccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          381 NIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       381 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      .            .....+.+++.+|++ +|..||+..+++.+
T Consensus       232 ~------------~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~  261 (264)
T cd06653         232 D------------GVSDACRDFLKQIFV-EEKRRPTAEFLLRH  261 (264)
T ss_pred             c------------ccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence            1            122456778999999 57999999998875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.9e-37  Score=315.57  Aligned_cols=265  Identities=19%  Similarity=0.293  Sum_probs=186.9

Q ss_pred             HhcCCCccceecccCcEEEEEEEECCc--cEEEEE------------------EecCCCchHHHHHHHHHHHHHhcCCCc
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARFNEK--LLAAVK------------------RIDDAGHDAEREFNNEVNWLTKIRHQN  210 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~--~~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~h~n  210 (439)
                      ..++|++.+.||+|+||+||++..+..  ...+.|                  .+. ........+.+|+.++++++|||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence            457899999999999999999865431  111111                  111 11223456889999999999999


Q ss_pred             eeeeeeEEEeCCeeEEEEEeccCCChhhhhcCCCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE
Q 013636          211 IISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTH--GSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILL  288 (439)
Q Consensus       211 iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl  288 (439)
                      |+++++++...+..++|+|++. ++|.+++.....  ...........++.|++.||+|||+.   +|+||||||+|||+
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl  300 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFL  300 (501)
T ss_pred             cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence            9999999999999999999985 577777653221  12234566778999999999999998   99999999999999


Q ss_pred             cCCCcEEEEecccccccCCCCc--ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCC-CCCCCChhhhhhh
Q 013636          289 DSSFNAKLSDFGLSVTAGTQSR--NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRR-PVEKMSPTQCQSM  365 (439)
Q Consensus       289 ~~~~~~kl~DfGls~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~-P~~~~~~~~~~~~  365 (439)
                      +.++.+||+|||++........  .....||..|+|||++.+..++.++|||||||++|||++|.. |+..........+
T Consensus       301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~  380 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL  380 (501)
T ss_pred             CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence            9999999999999976644322  223568999999999999999999999999999999999875 4433221111111


Q ss_pred             HhhhhcccccCCCCCc-------------------cCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          366 VTWAMPQLTDRSKLPN-------------------IVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       366 ~~~~~~~~~~~~~~~~-------------------~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      .............+++                   .+.+.++..   .....+.+++.+||+.||++|||+.|++++
T Consensus       381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNL---GLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhc---CCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            1100000000000110                   011111110   011245667889999999999999999975

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=3.6e-36  Score=291.53  Aligned_cols=261  Identities=25%  Similarity=0.341  Sum_probs=191.5

Q ss_pred             cceecccCcEEEEEEEECCccEEEEEEecCC--CchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEeccCCC
Q 013636          158 SNVIGEGGRGHVYKARFNEKLLAAVKRIDDA--GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGS  235 (439)
Q Consensus       158 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  235 (439)
                      .+.+|.|+++.||+++. ++..+|+|++...  .....+.+.+|+.+++.++|+||+++++++...+..+++|||+++|+
T Consensus         7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~   85 (314)
T cd08216           7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS   85 (314)
T ss_pred             hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence            34455666666666655 5778999998654  33455679999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc-----
Q 013636          236 LEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR-----  310 (439)
Q Consensus       236 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~-----  310 (439)
                      |.+++... ....+++.....++.|+++||+|||+.   +++||||||+||+++.++.+||+|||.+........     
T Consensus        86 l~~~l~~~-~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~  161 (314)
T cd08216          86 CEDLLKTH-FPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV  161 (314)
T ss_pred             HHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence            99999753 234588999999999999999999998   999999999999999999999999998864422111     


Q ss_pred             ---ceeeccccCccchhhhcC--CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhh-hhHhhhhcccccCCC------
Q 013636          311 ---NVKISGTLGYVAPEYLLE--GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQ-SMVTWAMPQLTDRSK------  378 (439)
Q Consensus       311 ---~~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~-~~~~~~~~~~~~~~~------  378 (439)
                         .....++..|+|||.+..  ..++.++|||||||++|||++|+.||......... .......+.......      
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (314)
T cd08216         162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED  241 (314)
T ss_pred             ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcC
Confidence               112336778999999876  35789999999999999999999999865433211 000000000000000      


Q ss_pred             -CCc----cCCchhc----CccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          379 -LPN----IVDPVIR----DTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       379 -~~~----~~d~~l~----~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                       ...    ..++...    ..........+.+++.+||+.||++|||+++++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence             000    0111110    11112223467889999999999999999999975

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.3e-36  Score=297.92  Aligned_cols=264  Identities=26%  Similarity=0.349  Sum_probs=196.3

Q ss_pred             HhcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCC--CchHHHHHHHHHHHHHhc-CCCceeeeeeEEEeC--Cee
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDA--GHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHA--ETR  224 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~  224 (439)
                      ..++|++.+.||+|+||.||+|... ++..+++|++...  .......+.+|+.+++++ +||||+++++++...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            3467888899999999999999876 4778899988542  223345677899999999 999999999998654  367


Q ss_pred             EEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccc
Q 013636          225 FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT  304 (439)
Q Consensus       225 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~  304 (439)
                      ++||||++ ++|.+++...    .+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||++..
T Consensus        85 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~  156 (337)
T cd07852          85 YLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARS  156 (337)
T ss_pred             EEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence            99999997 5999888642    588999999999999999999997   999999999999999999999999999975


Q ss_pred             cCCCCc------ceeeccccCccchhhhcC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhccccc--
Q 013636          305 AGTQSR------NVKISGTLGYVAPEYLLE-GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTD--  375 (439)
Q Consensus       305 ~~~~~~------~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~--  375 (439)
                      ......      .....||..|+|||.+.+ ..++.++||||||+++|||++|+.||....+................  
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
T cd07852         157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED  236 (337)
T ss_pred             cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            533221      123457889999998765 45788999999999999999999999765543221111111000000  


Q ss_pred             --------CC----CCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          376 --------RS----KLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       376 --------~~----~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                              ..    .....-........ ......+.+++.+||+.||++|||+.+++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         237 IESIKSPFAATMLDSLPSRPRKPLDELL-PKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHhhhHHHhhhhcccccccchhhhc-cCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence                    00    00000000000000 0123567889999999999999999999976

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-37  Score=277.10  Aligned_cols=247  Identities=28%  Similarity=0.460  Sum_probs=196.4

Q ss_pred             ccceecccCcEEEEEEEECC-ccEEEEEEecCCC-chHHHHHHHHHHHHHhcC-CCceeeeeeEEEeCCeeEEEEEeccC
Q 013636          157 ESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAG-HDAEREFNNEVNWLTKIR-HQNIISLLGYCIHAETRFLVYEMMQN  233 (439)
Q Consensus       157 ~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~  233 (439)
                      ....||.|+.|.|++.+... +...|||.....+ .+..++++..++++...+ +|+||+.+||+..+...++.||.|..
T Consensus        96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~  175 (391)
T KOG0983|consen   96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST  175 (391)
T ss_pred             hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH
Confidence            35679999999999999875 7788999997654 345567888888887775 99999999999999999999999864


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCccee
Q 013636          234 GSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK  313 (439)
Q Consensus       234 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~~~~  313 (439)
                       .++.+|.+  ..+++++..+-++...+.+||.||.+.  ++|+|||+||+|||+|+.|++|+||||++-...+.....+
T Consensus       176 -C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAhtr  250 (391)
T KOG0983|consen  176 -CAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHTR  250 (391)
T ss_pred             -HHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceeeccccccc
Confidence             56666653  234688888999999999999999986  6999999999999999999999999999977655555556


Q ss_pred             eccccCccchhhhcC---CCCCCchhhHHHHHHHHHHHhCCCCCCCCChh-hhhhhHhhhhcccccCCCCCccCCchhcC
Q 013636          314 ISGTLGYVAPEYLLE---GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPT-QCQSMVTWAMPQLTDRSKLPNIVDPVIRD  389 (439)
Q Consensus       314 ~~gt~~y~aPE~~~~---~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  389 (439)
                      ..|-+.|||||.+.-   .+|+.++||||||+.++||.||+.||.+-+.+ +....+-      .   ..+    |.+..
T Consensus       251 sAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvl------n---~eP----P~L~~  317 (391)
T KOG0983|consen  251 SAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVL------N---EEP----PLLPG  317 (391)
T ss_pred             ccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHH------h---cCC----CCCCc
Confidence            668899999999874   46888999999999999999999999874322 2222221      1   111    22222


Q ss_pred             ccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          390 TMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       390 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      ...  ....+.++...||+.|+.+||...+++++
T Consensus       318 ~~g--FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  318 HMG--FSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             ccC--cCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence            111  23356778889999999999999999976

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1e-35  Score=288.57  Aligned_cols=244  Identities=29%  Similarity=0.457  Sum_probs=193.2

Q ss_pred             CCccceecccCcEEEEEEEEC-CccEEEEEEecCCC---chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEe
Q 013636          155 FQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       155 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      |...+.||+|+||+||+|+.. .+..+++|.+....   ......+.+|+.+++.++|||++++++++.+.+..++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            555678999999999999875 57788999886432   23335688999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR  310 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~  310 (439)
                      +. |+|.+++..  ....+++..+..++.|++.|++|||+.   +++|+||+|+||++++++.+||+|||++......  
T Consensus       103 ~~-~~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~--  174 (313)
T cd06633         103 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA--  174 (313)
T ss_pred             CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCCC--
Confidence            96 578877753  234689999999999999999999998   9999999999999999999999999998653322  


Q ss_pred             ceeeccccCccchhhhc---CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchh
Q 013636          311 NVKISGTLGYVAPEYLL---EGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVI  387 (439)
Q Consensus       311 ~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  387 (439)
                       ....|+..|+|||.+.   .+.++.++||||||+++|||++|..||...+..........        ...+....+  
T Consensus       175 -~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~--------~~~~~~~~~--  243 (313)
T cd06633         175 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--------NDSPTLQSN--  243 (313)
T ss_pred             -CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh--------cCCCCCCcc--
Confidence             2345888999999984   45688899999999999999999999977654332211110        011111111  


Q ss_pred             cCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          388 RDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       388 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                            .....+.+++.+||+.+|++||++.+++++
T Consensus       244 ------~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         244 ------EWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             ------ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                  112346779999999999999999999965

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=5.8e-36  Score=283.67  Aligned_cols=244  Identities=22%  Similarity=0.290  Sum_probs=187.0

Q ss_pred             hcCCCcccee--cccCcEEEEEEEEC-CccEEEEEEecCCCchHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeeEEE
Q 013636          152 TNNFQESNVI--GEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLV  227 (439)
Q Consensus       152 ~~~~~~~~~L--G~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV  227 (439)
                      .++|++.+.+  |+|+||.||++... ++..+++|..........     |+.....+ +|||++++++++...+..++|
T Consensus        13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv   87 (267)
T PHA03390         13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLI   87 (267)
T ss_pred             HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEE
Confidence            3566666665  99999999999875 467788888765322111     22222222 799999999999999999999


Q ss_pred             EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC-cEEEEecccccccC
Q 013636          228 YEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSF-NAKLSDFGLSVTAG  306 (439)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~-~~kl~DfGls~~~~  306 (439)
                      |||+++|+|.+++...   ..+++..+..++.|+++|+.|||+.   +++||||||+||+++.++ .++|+|||++....
T Consensus        88 ~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~  161 (267)
T PHA03390         88 MDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG  161 (267)
T ss_pred             EEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence            9999999999999642   3789999999999999999999998   899999999999999998 99999999987654


Q ss_pred             CCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCch
Q 013636          307 TQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPV  386 (439)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  386 (439)
                      ...   ...++..|+|||++.+..++.++||||||+++|||++|+.||........ ....+.... ........     
T Consensus       162 ~~~---~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~-~~~~~~~~-----  231 (267)
T PHA03390        162 TPS---CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL-DLESLLKRQ-QKKLPFIK-----  231 (267)
T ss_pred             CCc---cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh-hHHHHHHhh-cccCCccc-----
Confidence            332   23478999999999999999999999999999999999999985543221 111111110 11111111     


Q ss_pred             hcCccCHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHh
Q 013636          387 IRDTMDLKHLYQVAAVAVLCIQPEPSYRPL-ITDVLHS  423 (439)
Q Consensus       387 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-~~evl~~  423 (439)
                             .....+.+++.+||+.+|++||+ +++++++
T Consensus       232 -------~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h  262 (267)
T PHA03390        232 -------NVSKNANDFVQSMLKYNINYRLTNYNEIIKH  262 (267)
T ss_pred             -------ccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence                   12335677899999999999996 6998854

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-37  Score=292.79  Aligned_cols=248  Identities=24%  Similarity=0.356  Sum_probs=210.0

Q ss_pred             cCCCccceecccCcEEEEEEEE-CCccEEEEEEecCCCchH--HHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARF-NEKLLAAVKRIDDAGHDA--EREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYE  229 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  229 (439)
                      .-|...+.||+|.|..|-.|+. -.|..||||.+.+..-+.  ...+.+|++.|+..+|||||+++.+......+|||+|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            4455667899999999998875 467889999998654333  3578899999999999999999999999999999999


Q ss_pred             eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc-CCCcEEEEecccccccCCC
Q 013636          230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLD-SSFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~-~~~~~kl~DfGls~~~~~~  308 (439)
                      .-.+|+|++|+-+  +...+.+....+++.||..|+.|+|..   .+|||||||+||.+- .-|-+||.|||++..+...
T Consensus        98 LGD~GDl~DyImK--He~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG  172 (864)
T KOG4717|consen   98 LGDGGDLFDYIMK--HEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG  172 (864)
T ss_pred             ecCCchHHHHHHh--hhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence            9999999999974  445699999999999999999999998   999999999999885 5678999999999888777


Q ss_pred             CcceeeccccCccchhhhcCCCCC-CchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchh
Q 013636          309 SRNVKISGTLGYVAPEYLLEGKLT-DKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVI  387 (439)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  387 (439)
                      ....+.+|++.|-|||.+.+..|+ ++.||||+|||||-|++|+.||+..+..+...++-      .            .
T Consensus       173 ~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmIm------D------------C  234 (864)
T KOG4717|consen  173 KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIM------D------------C  234 (864)
T ss_pred             chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhh------c------------c
Confidence            777788999999999999998886 57899999999999999999999887665444431      1            1


Q ss_pred             cCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          388 RDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       388 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      +.+.+.....++.+++..||..||.+|.+.++++.+
T Consensus       235 KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~  270 (864)
T KOG4717|consen  235 KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST  270 (864)
T ss_pred             cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence            222223334567889999999999999999999854

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-36  Score=296.76  Aligned_cols=263  Identities=25%  Similarity=0.325  Sum_probs=201.7

Q ss_pred             CCCccceecccCcEEEEEEEECC-ccEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC-----eeE
Q 013636          154 NFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE-----TRF  225 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  225 (439)
                      +|++.+.||+|+||.||+|+..+ +..+++|.+....  ....+.+.+|+.+++.++|+||+++.+++...+     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            47788999999999999999864 7889999887643  334467899999999999999999999988765     789


Q ss_pred             EEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccccccc
Q 013636          226 LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA  305 (439)
Q Consensus       226 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~  305 (439)
                      ++|||+++ +|.+++..   ...+++..+..++.|++.||+|||+.   +++||||||+||++++++.++|+|||++...
T Consensus        81 lv~e~~~~-~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~  153 (330)
T cd07834          81 IVTELMET-DLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGV  153 (330)
T ss_pred             EEecchhh-hHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence            99999984 89988864   23799999999999999999999998   9999999999999999999999999999765


Q ss_pred             CCCC----cceeeccccCccchhhhcCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhccccc-----
Q 013636          306 GTQS----RNVKISGTLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTD-----  375 (439)
Q Consensus       306 ~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~-----  375 (439)
                      ....    ......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+....+.........     
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  233 (330)
T cd07834         154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF  233 (330)
T ss_pred             cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence            4432    12233478899999999887 7899999999999999999999999876654322222111110000     


Q ss_pred             --CCCCCccCCch-hcCc-----cCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          376 --RSKLPNIVDPV-IRDT-----MDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       376 --~~~~~~~~d~~-l~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                        .....+.+... ....     ........+.+++.+||+.+|++||++.+++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence              00000000000 0000     001123467889999999999999999999976

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-36  Score=282.85  Aligned_cols=242  Identities=23%  Similarity=0.304  Sum_probs=187.5

Q ss_pred             ceecccCcEEEEEEEEC-CccEEEEEEecCCCc---hHHHHHHHHHHHH-HhcCCCceeeeeeEEEeCCeeEEEEEeccC
Q 013636          159 NVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGH---DAEREFNNEVNWL-TKIRHQNIISLLGYCIHAETRFLVYEMMQN  233 (439)
Q Consensus       159 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  233 (439)
                      +.||+|+||.||+|... .+..+|+|.+.....   .....+..|..++ ...+|+|++++++++..++..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            46999999999999875 478899999865432   1223344554444 455899999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCccee
Q 013636          234 GSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK  313 (439)
Q Consensus       234 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~~~~  313 (439)
                      ++|.+++..   ...+++..+..++.|++.||.|||+.   +++||||+|+||++++++.+||+|||++......   ..
T Consensus        82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---~~  152 (260)
T cd05611          82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN---KK  152 (260)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceecccc---cc
Confidence            999999964   24588999999999999999999998   9999999999999999999999999998754331   23


Q ss_pred             eccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCccCH
Q 013636          314 ISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDL  393 (439)
Q Consensus       314 ~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  393 (439)
                      ..++..|+|||.+.+..++.++||||||+++|||++|..||...+...........      ....+..    ...    
T Consensus       153 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------~~~~~~~----~~~----  218 (260)
T cd05611         153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSR------RINWPEE----VKE----  218 (260)
T ss_pred             CCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc------ccCCCCc----ccc----
Confidence            34788999999999888999999999999999999999999876554332222110      0000000    000    


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          394 KHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       394 ~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      .....+.+++.+||+.||++||++.++.+.
T Consensus       219 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~  248 (260)
T cd05611         219 FCSPEAVDLINRLLCMDPAKRLGANGYQEI  248 (260)
T ss_pred             cCCHHHHHHHHHHccCCHHHccCCCcHHHH
Confidence            123457789999999999999977544443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=3.1e-36  Score=294.79  Aligned_cols=265  Identities=22%  Similarity=0.315  Sum_probs=197.8

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCceeeeeeEEEe----CCee
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLLGYCIH----AETR  224 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~  224 (439)
                      .++|++.+.||+|+||.||+|... ++..+++|++....  ......+.+|+.++++++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            367888899999999999999875 47889999887532  2334567889999999999999999988753    3467


Q ss_pred             EEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccc
Q 013636          225 FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT  304 (439)
Q Consensus       225 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~  304 (439)
                      ++|+||+. |+|.+++..   ...+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||++..
T Consensus        84 ~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~  156 (334)
T cd07855          84 YVVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARG  156 (334)
T ss_pred             EEEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEeccccccee
Confidence            99999996 689998864   23489999999999999999999997   999999999999999999999999999865


Q ss_pred             cCCCCcc-----eeeccccCccchhhhcC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhccccc---
Q 013636          305 AGTQSRN-----VKISGTLGYVAPEYLLE-GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTD---  375 (439)
Q Consensus       305 ~~~~~~~-----~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~---  375 (439)
                      .......     ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+.......+.........   
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~  236 (334)
T cd07855         157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL  236 (334)
T ss_pred             ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence            4332211     12357889999999866 46889999999999999999999999776543221111110000000   


Q ss_pred             ----CCC-------CCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhc
Q 013636          376 ----RSK-------LPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL  424 (439)
Q Consensus       376 ----~~~-------~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  424 (439)
                          ...       .+...+... ..........+.+++.+||+.+|++||++.+++.+-
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~  295 (334)
T cd07855         237 NRIGSDRVRKYIQNLPRKQPVPW-SKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP  295 (334)
T ss_pred             hhhchhhHHHHHhhcccCCCCCH-HHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence                000       000000000 000011245688899999999999999999999753

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=4.7e-36  Score=287.43  Aligned_cols=249  Identities=23%  Similarity=0.310  Sum_probs=194.5

Q ss_pred             CCCccceecccCcEEEEEEEE----CCccEEEEEEecCCCc----hHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCee
Q 013636          154 NFQESNVIGEGGRGHVYKARF----NEKLLAAVKRIDDAGH----DAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETR  224 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  224 (439)
                      +|++.+.||+|+||.||.++.    .++..+|+|.+.....    ...+.+.+|+.+++++ +|+||+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            467789999999999999986    3578899999865321    2335678899999999 599999999999998899


Q ss_pred             EEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccc
Q 013636          225 FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT  304 (439)
Q Consensus       225 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~  304 (439)
                      ++|+||+++++|.+++..   ...+++..+..++.|+++||.|||+.   +++||||+|+||++++++.+||+|||++..
T Consensus        81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            999999999999999964   24588999999999999999999997   999999999999999999999999999876


Q ss_pred             cCCCCc--ceeeccccCccchhhhcCC--CCCCchhhHHHHHHHHHHHhCCCCCCCCChhhh-hhhHhhhhcccccCCCC
Q 013636          305 AGTQSR--NVKISGTLGYVAPEYLLEG--KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQC-QSMVTWAMPQLTDRSKL  379 (439)
Q Consensus       305 ~~~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~-~~~~~~~~~~~~~~~~~  379 (439)
                      ......  .....|+..|+|||.+...  .++.++||||||+++|+|++|+.||........ .......   .......
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~  231 (290)
T cd05613         155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRI---LKSEPPY  231 (290)
T ss_pred             cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHh---hccCCCC
Confidence            543221  1234588999999998753  467899999999999999999999964332111 1111111   1111111


Q ss_pred             CccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHh
Q 013636          380 PNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRP-----LITDVLHS  423 (439)
Q Consensus       380 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  423 (439)
                      +..            ....+.+++.+||+.||++||     +..+++.+
T Consensus       232 ~~~------------~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         232 PQE------------MSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             Ccc------------CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence            111            123566799999999999997     77888765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=4e-36  Score=290.37  Aligned_cols=265  Identities=24%  Similarity=0.329  Sum_probs=195.4

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC------
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGH--DAEREFNNEVNWLTKIRHQNIISLLGYCIHAE------  222 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  222 (439)
                      .++|++.+.||+|+||.||+|... ++..+++|.+.....  .....+.+|++++++++||||+++++++....      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            468889999999999999999875 467889998854322  12345678999999999999999999875433      


Q ss_pred             --eeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecc
Q 013636          223 --TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFG  300 (439)
Q Consensus       223 --~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfG  300 (439)
                        ..++|+||+.+ +|...+..  ....+++..+..++.|+++||+|||+.   +++|+||||+||++++++.+||+|||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg  160 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFG  160 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCc
Confidence              46999999975 77777764  234699999999999999999999998   99999999999999999999999999


Q ss_pred             cccccCCCCcc------------eeeccccCccchhhhcCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHh
Q 013636          301 LSVTAGTQSRN------------VKISGTLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVT  367 (439)
Q Consensus       301 ls~~~~~~~~~------------~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~  367 (439)
                      ++.........            ....+++.|+|||.+.+. .++.++||||||+++|||++|+.||...+.......+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~  240 (311)
T cd07866         161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF  240 (311)
T ss_pred             cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            99654322111            122467889999988654 57899999999999999999999998765543222221


Q ss_pred             hhhcccc-----cCCCCCccC--------CchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          368 WAMPQLT-----DRSKLPNIV--------DPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       368 ~~~~~~~-----~~~~~~~~~--------d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      .......     ....++...        .+.+.... ......+.+++.+||+.||++|||+.|++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERF-GKLGPEGLDLLSKLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             HHhCCCChhhchhhhhcccccccccCCCCCccHHHHc-ccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence            1111000     000111111        11111000 0112467889999999999999999999864

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-37  Score=292.91  Aligned_cols=246  Identities=26%  Similarity=0.353  Sum_probs=199.0

Q ss_pred             cCCCccceecccCcEEEEEEEECC-ccEEEEEEecCCC---chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      +.|+.-++||+|+||.||-.+.++ |..+|.|++.+..   ...+.-.++|-.+|.+++.+.||.+-..++..+.+++|+
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL  264 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL  264 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence            667888999999999999987754 6777888876532   233345678999999999999999999999999999999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~  308 (439)
                      ..|.||+|.-++.... ...+++.....++.+|+.||++||+.   .||.||+||+|||+|+.|+++|+|.|+|..+...
T Consensus       265 tlMNGGDLkfHiyn~g-~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g  340 (591)
T KOG0986|consen  265 TLMNGGDLKFHIYNHG-NPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG  340 (591)
T ss_pred             EeecCCceeEEeeccC-CCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence            9999999998887533 25699999999999999999999998   9999999999999999999999999999888766


Q ss_pred             CcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhc
Q 013636          309 SRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIR  388 (439)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  388 (439)
                      .......||.+|||||++.++.|+...|.||+||+||||+.|+.||.......-..-++  ...+.+...+++-+.+   
T Consensus       341 ~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvd--rr~~~~~~ey~~kFS~---  415 (591)
T KOG0986|consen  341 KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVD--RRTLEDPEEYSDKFSE---  415 (591)
T ss_pred             CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHH--HHHhcchhhcccccCH---
Confidence            66556679999999999999999999999999999999999999997543322111111  1112233333333333   


Q ss_pred             CccCHHHHHHHHHHHHHhcCCCCCCCCC
Q 013636          389 DTMDLKHLYQVAAVAVLCIQPEPSYRPL  416 (439)
Q Consensus       389 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt  416 (439)
                               +...+....|+.||++|.-
T Consensus       416 ---------eakslc~~LL~Kdp~~RLG  434 (591)
T KOG0986|consen  416 ---------EAKSLCEGLLTKDPEKRLG  434 (591)
T ss_pred             ---------HHHHHHHHHHccCHHHhcc
Confidence                     3344677789999998863

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=4.8e-36  Score=293.57  Aligned_cols=264  Identities=23%  Similarity=0.279  Sum_probs=195.3

Q ss_pred             cCCC-ccceecccCcEEEEEEEEC-CccEEEEEEecCCCchH--------------HHHHHHHHHHHHhcCCCceeeeee
Q 013636          153 NNFQ-ESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDA--------------EREFNNEVNWLTKIRHQNIISLLG  216 (439)
Q Consensus       153 ~~~~-~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~~  216 (439)
                      ++|. +.+.||+|+||+||+|... .+..+|+|.+.......              ...+.+|+++++.++|+|++++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            4454 3477999999999999875 57889999886432211              124778999999999999999999


Q ss_pred             EEEeCCeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEE
Q 013636          217 YCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKL  296 (439)
Q Consensus       217 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl  296 (439)
                      ++...+..++||||++ |+|.+++..   ...+++.....++.|++.||+|||+.   +++|+||+|+||+++.++.+||
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl  160 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKI  160 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEE
Confidence            9999999999999997 699998853   34589999999999999999999997   9999999999999999999999


Q ss_pred             EecccccccCCC---------------CcceeeccccCccchhhhcCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCChh
Q 013636          297 SDFGLSVTAGTQ---------------SRNVKISGTLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGRRPVEKMSPT  360 (439)
Q Consensus       297 ~DfGls~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvll~elltG~~P~~~~~~~  360 (439)
                      +|||++......               .......++..|+|||.+.+. .++.++||||||+++|||++|+.||...++.
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~  240 (335)
T PTZ00024        161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI  240 (335)
T ss_pred             CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            999998655411               001112367889999998764 4689999999999999999999999876654


Q ss_pred             hhhhhHhhhhccccc-----CCCCC------ccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhc
Q 013636          361 QCQSMVTWAMPQLTD-----RSKLP------NIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL  424 (439)
Q Consensus       361 ~~~~~~~~~~~~~~~-----~~~~~------~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  424 (439)
                      +....+.........     ...++      ....+..... .......+.+++..||+.+|++|||+.|++.+-
T Consensus       241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~  314 (335)
T PTZ00024        241 DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTI-FPNASDDAIDLLQSLLKLNPLERISAKEALKHE  314 (335)
T ss_pred             HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHh-CcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence            322111111100000     00000      0000000000 011234677899999999999999999999653

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=3.2e-36  Score=286.29  Aligned_cols=247  Identities=26%  Similarity=0.361  Sum_probs=200.8

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCC---CchHHHHHHHHHHHHHhcC-CCceeeeeeEEEeCCeeEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDA---GHDAEREFNNEVNWLTKIR-HQNIISLLGYCIHAETRFLV  227 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV  227 (439)
                      ++|+..+.||+|+||.||++... ++..+++|.+...   .....+.+.+|..++++++ ||||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            46888899999999999999886 5788999988652   2233467889999999998 99999999999999999999


Q ss_pred             EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCC
Q 013636          228 YEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT  307 (439)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~  307 (439)
                      |||+++++|.+++...   ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          81 LEYAPNGELLQYIRKY---GSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            9999999999999642   3699999999999999999999998   999999999999999999999999999865433


Q ss_pred             CCc---------------------ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhH
Q 013636          308 QSR---------------------NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMV  366 (439)
Q Consensus       308 ~~~---------------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~  366 (439)
                      ...                     .....++..|+|||.+.+..++.++|+||||++++++++|+.||...+........
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~  234 (280)
T cd05581         155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKI  234 (280)
T ss_pred             ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence            221                     11234788999999999888999999999999999999999999876532211111


Q ss_pred             hhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCH----HHHHHh
Q 013636          367 TWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLI----TDVLHS  423 (439)
Q Consensus       367 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~----~evl~~  423 (439)
                         .   .....++..+            ...+.+++.+||+.+|++||++    .+++.+
T Consensus       235 ---~---~~~~~~~~~~------------~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~  277 (280)
T cd05581         235 ---L---KLEYSFPPNF------------PPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH  277 (280)
T ss_pred             ---H---hcCCCCCCcc------------CHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence               0   1111121111            3456789999999999999999    888765

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-36  Score=285.39  Aligned_cols=262  Identities=26%  Similarity=0.373  Sum_probs=199.1

Q ss_pred             CCccceecccCcEEEEEEEECC-ccEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEec
Q 013636          155 FQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMM  231 (439)
Q Consensus       155 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  231 (439)
                      |+..+.||+|+||.||+|+... +..+++|.+....  ......+.+|+.++++++|+|++++++++...+..++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            4556789999999999998865 7889999887643  223456788999999999999999999999999999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc-
Q 013636          232 QNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR-  310 (439)
Q Consensus       232 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~-  310 (439)
                      + ++|.+++....  ..+++..+..++.|+++||+|||+.   +++||||+|+||++++++.++|+|||++........ 
T Consensus        81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~  154 (282)
T cd07829          81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT  154 (282)
T ss_pred             C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCccc
Confidence            8 59999997532  4689999999999999999999998   999999999999999999999999999876544321 


Q ss_pred             ceeeccccCccchhhhcCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhh-hhHhhhh----------cccc-cCC
Q 013636          311 NVKISGTLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQ-SMVTWAM----------PQLT-DRS  377 (439)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~-~~~~~~~----------~~~~-~~~  377 (439)
                      .....++..|+|||.+.+. .++.++||||||+++||+++|+.||...+..... .......          .... ...
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
T cd07829         155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP  234 (282)
T ss_pred             cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence            1223357789999998876 8899999999999999999999999775532211 1111000          0000 000


Q ss_pred             CCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          378 KLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       378 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      ..+........... ......+.+++.+||+.||++||++.+++++
T Consensus       235 ~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         235 TFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             cccccCccchHHhc-ccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence            11111111110100 0114568899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=5.7e-36  Score=286.58  Aligned_cols=253  Identities=23%  Similarity=0.294  Sum_probs=196.3

Q ss_pred             CCCccceecccCcEEEEEEEEC----CccEEEEEEecCCC----chHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCee
Q 013636          154 NFQESNVIGEGGRGHVYKARFN----EKLLAAVKRIDDAG----HDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETR  224 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  224 (439)
                      +|++.+.||+|+||.||+++..    ++..+++|.+....    ....+.+.+|+.++.++ +|||++++++.+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            3677889999999999999753    46789999886432    12335688999999999 599999999999999999


Q ss_pred             EEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccc
Q 013636          225 FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT  304 (439)
Q Consensus       225 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~  304 (439)
                      ++||||+++|+|.+++..   ...+++..+..++.|+++||+|||+.   +++||||+|+||+++.++.++|+|||++..
T Consensus        81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccc
Confidence            999999999999999864   24588999999999999999999997   999999999999999999999999999876


Q ss_pred             cCCCCc--ceeeccccCccchhhhcCCC--CCCchhhHHHHHHHHHHHhCCCCCCCCChhhh-hhhHhhhhcccccCCCC
Q 013636          305 AGTQSR--NVKISGTLGYVAPEYLLEGK--LTDKSDVYAFGVVLLELLMGRRPVEKMSPTQC-QSMVTWAMPQLTDRSKL  379 (439)
Q Consensus       305 ~~~~~~--~~~~~gt~~y~aPE~~~~~~--~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~-~~~~~~~~~~~~~~~~~  379 (439)
                      ......  .....|+..|+|||.+.+..  .+.++||||||+++|||++|..||........ ......   ........
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~---~~~~~~~~  231 (288)
T cd05583         155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRR---ILKSKPPF  231 (288)
T ss_pred             cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHH---HHccCCCC
Confidence            433222  12245789999999987765  78899999999999999999999964322111 111111   01111112


Q ss_pred             CccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhcccc
Q 013636          380 PNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPL  427 (439)
Q Consensus       380 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l  427 (439)
                      +..+            ...+.+++.+||+.||++|||+.++.+.|...
T Consensus       232 ~~~~------------~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~  267 (288)
T cd05583         232 PKTM------------SAEARDFIQKLLEKDPKKRLGANGADEIKNHP  267 (288)
T ss_pred             Cccc------------CHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence            2111            13456789999999999999988887666544

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.1e-35  Score=283.35  Aligned_cols=242  Identities=26%  Similarity=0.333  Sum_probs=186.4

Q ss_pred             eecccCcEEEEEEEEC-CccEEEEEEecCCCc---hHHHHHHHHHH---HHHhcCCCceeeeeeEEEeCCeeEEEEEecc
Q 013636          160 VIGEGGRGHVYKARFN-EKLLAAVKRIDDAGH---DAEREFNNEVN---WLTKIRHQNIISLLGYCIHAETRFLVYEMMQ  232 (439)
Q Consensus       160 ~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~---~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  232 (439)
                      +||+|+||.||++... .+..+|+|.+.....   .....+.+|..   .++...|||++.+.+++...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999875 478899998865321   12223444443   4445579999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCcce
Q 013636          233 NGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV  312 (439)
Q Consensus       233 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~~~  312 (439)
                      +|+|.+++..   ...+++..+..++.|+++|++|||+.   +++||||||+||++++++.+||+|||++........ .
T Consensus        81 g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~-~  153 (278)
T cd05606          81 GGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-H  153 (278)
T ss_pred             CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC-c
Confidence            9999998853   34699999999999999999999997   999999999999999999999999999875533222 2


Q ss_pred             eeccccCccchhhhcCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCcc
Q 013636          313 KISGTLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTM  391 (439)
Q Consensus       313 ~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  391 (439)
                      ...|+..|+|||.+.++ .++.++||||+|+++|||++|+.||............. ..  ......++..         
T Consensus       154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~-~~--~~~~~~~~~~---------  221 (278)
T cd05606         154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR-MT--LTMAVELPDS---------  221 (278)
T ss_pred             CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHH-Hh--hccCCCCCCc---------
Confidence            34589999999999754 68999999999999999999999997653221111110 00  0001111111         


Q ss_pred             CHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHh
Q 013636          392 DLKHLYQVAAVAVLCIQPEPSYRP-----LITDVLHS  423 (439)
Q Consensus       392 ~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  423 (439)
                         ....+.+++.+|++.+|++||     ++.+++++
T Consensus       222 ---~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         222 ---FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             ---CCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence               124677789999999999999     99999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.6e-37  Score=295.80  Aligned_cols=250  Identities=26%  Similarity=0.428  Sum_probs=196.7

Q ss_pred             hcCCCccceecccCcEEEEEEEECCccEEEEEEecCC--CchHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeeEEEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDA--GHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      ...|++.+.||+||.+.||++...+...+|+|++...  ..+...-|.+|+..|.+| .|.+|+++++|-..++..|+||
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm  439 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM  439 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence            3567888999999999999999999888888887543  334456799999999999 4999999999999999999999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~  308 (439)
                      ||=+. +|.++|.... +....| .+..+..|++.++.+.|..   +|||.||||.|+|+-. |.+||+|||+|.....+
T Consensus       440 E~Gd~-DL~kiL~k~~-~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~D  512 (677)
T KOG0596|consen  440 ECGDI-DLNKILKKKK-SIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPD  512 (677)
T ss_pred             ecccc-cHHHHHHhcc-CCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccCcc
Confidence            98644 9999997533 223334 7778999999999999998   9999999999999965 58999999999877655


Q ss_pred             Ccc---eeeccccCccchhhhcCCC-----------CCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccc
Q 013636          309 SRN---VKISGTLGYVAPEYLLEGK-----------LTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLT  374 (439)
Q Consensus       309 ~~~---~~~~gt~~y~aPE~~~~~~-----------~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~  374 (439)
                      ...   ...+||+.||+||.+....           .+.++||||+|||||+|+.|+.||.....     ...       
T Consensus       513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-----~~a-------  580 (677)
T KOG0596|consen  513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-----QIA-------  580 (677)
T ss_pred             ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-----HHH-------
Confidence            443   3357999999999987432           45789999999999999999999975321     111       


Q ss_pred             cCCCCCccCCchhcCccC-HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          375 DRSKLPNIVDPVIRDTMD-LKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       375 ~~~~~~~~~d~~l~~~~~-~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                         ++..+.||.-.-++. ......+.+++..||+.||.+|||..++|++
T Consensus       581 ---Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  581 ---KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             ---HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence               112233332221111 1112238889999999999999999999975

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2e-35  Score=290.46  Aligned_cols=268  Identities=21%  Similarity=0.311  Sum_probs=198.8

Q ss_pred             HHHHHHHhcCCCccceecccCcEEEEEEEE-CCccEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCceeeeeeEEEeC
Q 013636          145 YELLEAATNNFQESNVIGEGGRGHVYKARF-NEKLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLLGYCIHA  221 (439)
Q Consensus       145 ~~~l~~~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  221 (439)
                      ...+...+++|++.+.||+|+||.||++.. .++..+|+|++....  ....+.+.+|+.++++++||||+++++++...
T Consensus         9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~   88 (345)
T cd07877           9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA   88 (345)
T ss_pred             HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence            344556778999999999999999999986 457889999987532  22345688899999999999999999988643


Q ss_pred             ------CeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEE
Q 013636          222 ------ETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAK  295 (439)
Q Consensus       222 ------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~k  295 (439)
                            ...+++++++ +++|.+++..    ..+++..+..++.|+++||+|||+.   +++||||||+||++++++.+|
T Consensus        89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~k  160 (345)
T cd07877          89 RSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELK  160 (345)
T ss_pred             ccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEE
Confidence                  3467888876 7799888753    2489999999999999999999998   999999999999999999999


Q ss_pred             EEecccccccCCCCcceeeccccCccchhhhcC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhh-Hhhhh---
Q 013636          296 LSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLE-GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSM-VTWAM---  370 (439)
Q Consensus       296 l~DfGls~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~-~~~~~---  370 (439)
                      |+|||++.......  ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+....... .....   
T Consensus       161 l~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  238 (345)
T cd07877         161 ILDFGLARHTDDEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG  238 (345)
T ss_pred             Eecccccccccccc--cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            99999987653322  23457889999999876 5688899999999999999999999976544321111 11000   


Q ss_pred             ----cccccC------CCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          371 ----PQLTDR------SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       371 ----~~~~~~------~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                          ..+...      ..++........... ......+.+++.+|++.||++||++.+++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         239 AELLKKISSESARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             HHHHhhcccHhHHHHHHHhcccCCcchhhhc-CCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence                000000      000000000000000 0113357789999999999999999999965

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-37  Score=303.81  Aligned_cols=200  Identities=31%  Similarity=0.444  Sum_probs=177.0

Q ss_pred             CCccceecccCcEEEEEEEEC-CccEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC------eeEE
Q 013636          155 FQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGH-DAEREFNNEVNWLTKIRHQNIISLLGYCIHAE------TRFL  226 (439)
Q Consensus       155 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~l  226 (439)
                      +...+.||+|+||.||+|+.+ .|..+|||.++.... ...+...+|+++|++++|+|||++++.-+...      ...+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            344678999999999999964 589999999987543 33456789999999999999999999866543      5689


Q ss_pred             EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc--CCC--cEEEEecccc
Q 013636          227 VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLD--SSF--NAKLSDFGLS  302 (439)
Q Consensus       227 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~--~~~--~~kl~DfGls  302 (439)
                      |||||.+|||...|.++.+...|++...+.+..+++.||.|||++   +|+||||||.||++-  ++|  .-||+|||.|
T Consensus        95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            999999999999999988888899999999999999999999987   999999999999993  333  4799999999


Q ss_pred             cccCCCCcceeeccccCccchhhhcC-CCCCCchhhHHHHHHHHHHHhCCCCCCCC
Q 013636          303 VTAGTQSRNVKISGTLGYVAPEYLLE-GKLTDKSDVYAFGVVLLELLMGRRPVEKM  357 (439)
Q Consensus       303 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvll~elltG~~P~~~~  357 (439)
                      +...+++......||..|.+||.... +.|+..+|.|||||++||..||..||..-
T Consensus       172 rel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~  227 (732)
T KOG4250|consen  172 RELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF  227 (732)
T ss_pred             ccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence            99988888888899999999999994 88999999999999999999999999653

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.5e-36  Score=296.83  Aligned_cols=248  Identities=25%  Similarity=0.355  Sum_probs=207.3

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCch--HHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHD--AEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      ...|.+...||+|.|++|..|+.. .+..||+|.+++...+  ....+.+|+++|..++|||||+++.+......+|+||
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~  134 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM  134 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence            467888899999999999999875 4789999999765433  2345889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~  308 (439)
                      ||+.+|.+++++...   +.+.+.....++.|+.++++|||++   .|+|||||++|+||+.+.++||+|||++..+...
T Consensus       135 eya~~ge~~~yl~~~---gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~  208 (596)
T KOG0586|consen  135 EYASGGELFDYLVKH---GRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDYG  208 (596)
T ss_pred             EeccCchhHHHHHhc---ccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeeccc
Confidence            999999999999743   3355578888999999999999998   9999999999999999999999999999988877


Q ss_pred             CcceeeccccCccchhhhcCCCC-CCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchh
Q 013636          309 SRNVKISGTLGYVAPEYLLEGKL-TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVI  387 (439)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  387 (439)
                      ....+.+|++.|.|||++.+..| ++++|+||+|++||-|+.|..||++.+-.+....      .+..+-+++..+..  
T Consensus       209 ~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~r------vl~gk~rIp~~ms~--  280 (596)
T KOG0586|consen  209 LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPR------VLRGKYRIPFYMSC--  280 (596)
T ss_pred             ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccch------heeeeecccceeec--
Confidence            77778899999999999998776 5799999999999999999999997553332211      12223333333332  


Q ss_pred             cCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          388 RDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       388 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                                .+-+++..++-.+|.+|++++++.+.
T Consensus       281 ----------dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  281 ----------DCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             ----------hhHHHHHHhhccCccccCCHHHhhhh
Confidence                      34458888999999999999998854

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=9.5e-36  Score=280.54  Aligned_cols=249  Identities=21%  Similarity=0.350  Sum_probs=193.0

Q ss_pred             CCCccceecccCcEEEEEEEECC-ccEEEEEEecC-----CCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEE
Q 013636          154 NFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDD-----AGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLV  227 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~-----~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  227 (439)
                      +|.+.+.||+|+||.||+++... +...++|.++.     .......++..|+.++++++|||++++++++.+.+..++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            47778999999999999998754 23344444432     1223344677899999999999999999999999999999


Q ss_pred             EEeccCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccC
Q 013636          228 YEMMQNGSLEKQLHGP-THGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAG  306 (439)
Q Consensus       228 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~  306 (439)
                      +||+++++|.+++... ..+..+++..+..++.|++.|+.|||+.   +++|+||+|+||++++ +.+||+|||++....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence            9999999999988642 2345799999999999999999999997   9999999999999976 569999999986653


Q ss_pred             CCCc-ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCc
Q 013636          307 TQSR-NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDP  385 (439)
Q Consensus       307 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  385 (439)
                      .... .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+........      .  ....+.    
T Consensus       157 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~------~--~~~~~~----  224 (260)
T cd08222         157 GSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRI------V--EGPTPS----  224 (260)
T ss_pred             CCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH------H--cCCCCC----
Confidence            3222 22345788999999998888899999999999999999999999754432211111      0  011111    


Q ss_pred             hhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          386 VIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       386 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                           ........+.+++.+||+.+|++||++.|++++
T Consensus       225 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         225 -----LPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             -----CcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence                 111223467789999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.3e-35  Score=291.30  Aligned_cols=263  Identities=22%  Similarity=0.318  Sum_probs=194.7

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeC----------
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHA----------  221 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----------  221 (439)
                      .+|+..+.||+|+||.||+|... .+..+++|.+........+.+.+|++++++++|||++++++++...          
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            67888999999999999999875 4788999998766555667789999999999999999999776543          


Q ss_pred             ----CeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc-CCCcEEE
Q 013636          222 ----ETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLD-SSFNAKL  296 (439)
Q Consensus       222 ----~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~-~~~~~kl  296 (439)
                          ...++|+||++ ++|.+++..    ..+++..+..++.|++.||.|||+.   +++||||||+||+++ +++.+||
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl  156 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKI  156 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEE
Confidence                35789999997 589888753    3488999999999999999999998   999999999999997 4567899


Q ss_pred             EecccccccCCCCcc----eeeccccCccchhhhcC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhc
Q 013636          297 SDFGLSVTAGTQSRN----VKISGTLGYVAPEYLLE-GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP  371 (439)
Q Consensus       297 ~DfGls~~~~~~~~~----~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~  371 (439)
                      +|||++.........    ....++..|+|||.+.. ..++.++|||||||++|||++|+.||...++...........+
T Consensus       157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~  236 (342)
T cd07854         157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP  236 (342)
T ss_pred             CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence            999999764322111    12246889999998754 5678899999999999999999999987664332221111100


Q ss_pred             ccc--cCCCCCccCCchhc-----CccC-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          372 QLT--DRSKLPNIVDPVIR-----DTMD-----LKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       372 ~~~--~~~~~~~~~d~~l~-----~~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      ...  +...........+.     ....     ......+.+++.+||+.||++|||+.+++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  300 (342)
T cd07854         237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH  300 (342)
T ss_pred             CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence            000  00000000000000     0000     0122457789999999999999999999964

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.5e-35  Score=289.35  Aligned_cols=266  Identities=22%  Similarity=0.297  Sum_probs=196.1

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC------
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE------  222 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  222 (439)
                      .++|...+.||+|+||.||+|... ++..+|+|.+....  ......+.+|+.+++.++||||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            468888999999999999999875 57889999886432  223356889999999999999999999986543      


Q ss_pred             eeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccc
Q 013636          223 TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS  302 (439)
Q Consensus       223 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls  302 (439)
                      ..++|+||+.. +|.++..     ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++
T Consensus        94 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~  164 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLA  164 (342)
T ss_pred             eEEEEeccccc-CHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCC
Confidence            46899999975 7776652     2488999999999999999999998   9999999999999999999999999998


Q ss_pred             cccCCCCcceeeccccCccchhhhcC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcc--------c
Q 013636          303 VTAGTQSRNVKISGTLGYVAPEYLLE-GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQ--------L  373 (439)
Q Consensus       303 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~--------~  373 (439)
                      .......  ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+.......+....+.        .
T Consensus       165 ~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (342)
T cd07879         165 RHADAEM--TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKL  242 (342)
T ss_pred             cCCCCCC--CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence            7653322  22347889999999876 46889999999999999999999999876532211111110000        0


Q ss_pred             ccC------CCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh--ccccCC
Q 013636          374 TDR------SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS--LIPLVP  429 (439)
Q Consensus       374 ~~~------~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~l~~  429 (439)
                      ...      ...+......+.... ......+.+++.+||+.||++||++.+++++  ++...+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         243 EDKAAKSYIKSLPKYPRKDFSTLF-PKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             cccchHHHHhhcCCcccchHHHHh-cCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence            000      000000000000000 0112457789999999999999999999976  544443

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=2.5e-35  Score=287.75  Aligned_cols=263  Identities=26%  Similarity=0.348  Sum_probs=197.3

Q ss_pred             HHhcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCceeeeeeEEEe-CCeeE
Q 013636          150 AATNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLLGYCIH-AETRF  225 (439)
Q Consensus       150 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~  225 (439)
                      ..+++|+..+.||+|+||.||++... ++..+++|++....  ....+.+.+|+.+++.++|||++++.+++.. .+..+
T Consensus         7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   86 (328)
T cd07856           7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY   86 (328)
T ss_pred             ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence            35688999999999999999999865 67889999875422  2334678899999999999999999998865 55789


Q ss_pred             EEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccccccc
Q 013636          226 LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA  305 (439)
Q Consensus       226 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~  305 (439)
                      +++||+ +++|.+++..    ..+++.....++.|+++||+|||+.   +++||||+|+||++++++.++|+|||++...
T Consensus        87 lv~e~~-~~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~  158 (328)
T cd07856          87 FVTELL-GTDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQ  158 (328)
T ss_pred             EEeehh-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccccc
Confidence            999998 5689888853    2478888889999999999999998   9999999999999999999999999998754


Q ss_pred             CCCCcceeeccccCccchhhhcC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcc--------cccC
Q 013636          306 GTQSRNVKISGTLGYVAPEYLLE-GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQ--------LTDR  376 (439)
Q Consensus       306 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~--------~~~~  376 (439)
                      ....  ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...++.............        ....
T Consensus       159 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (328)
T cd07856         159 DPQM--TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSE  236 (328)
T ss_pred             CCCc--CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccch
Confidence            3321  22346889999998766 56899999999999999999999999776543221111100000        0000


Q ss_pred             CCCCccCCc-hhcCccC-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          377 SKLPNIVDP-VIRDTMD-----LKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       377 ~~~~~~~d~-~l~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      ... +.+.. .......     ......+.+++.+||+.+|++|||+.+++.+
T Consensus       237 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         237 NTL-RFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             hhH-HHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            000 00000 0000000     0123567889999999999999999999976

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-35  Score=275.44  Aligned_cols=239  Identities=27%  Similarity=0.373  Sum_probs=194.0

Q ss_pred             ecccCcEEEEEEEECC-ccEEEEEEecCCCc---hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEeccCCCh
Q 013636          161 IGEGGRGHVYKARFNE-KLLAAVKRIDDAGH---DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSL  236 (439)
Q Consensus       161 LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  236 (439)
                      ||+|+||.||++...+ +..+++|.+.....   .....+.+|+.++++++|||++++++.+..++..+++|||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            6999999999998864 77889998865432   2445788999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCC-cceeec
Q 013636          237 EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS-RNVKIS  315 (439)
Q Consensus       237 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~-~~~~~~  315 (439)
                      .+++...   ..+++..+..++.|++.|+.|||+.   +++|+||+|+||++++++.++|+|||++....... ......
T Consensus        81 ~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~  154 (250)
T cd05123          81 FSHLSKE---GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC  154 (250)
T ss_pred             HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCc
Confidence            9999643   3589999999999999999999997   99999999999999999999999999997654431 223345


Q ss_pred             cccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCccCHHH
Q 013636          316 GTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKH  395 (439)
Q Consensus       316 gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  395 (439)
                      ++..|+|||...+...+.++|+||||+++||+++|+.||...+.......+.      .....++...            
T Consensus       155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~------~~~~~~~~~~------------  216 (250)
T cd05123         155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKIL------KDPLRFPEFL------------  216 (250)
T ss_pred             CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh------cCCCCCCCCC------------
Confidence            7889999999998889999999999999999999999997665422211111      0111222222            


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCH---HHHHHh
Q 013636          396 LYQVAAVAVLCIQPEPSYRPLI---TDVLHS  423 (439)
Q Consensus       396 ~~~l~~l~~~cl~~dP~~RPt~---~evl~~  423 (439)
                      ...+.+++.+||+.||++||++   .+++++
T Consensus       217 ~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~  247 (250)
T cd05123         217 SPEARDLISGLLQKDPTKRLGSGGAEEIKAH  247 (250)
T ss_pred             CHHHHHHHHHHhcCCHhhCCCcccHHHHHhC
Confidence            2355679999999999999999   666543

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.1e-35  Score=288.00  Aligned_cols=263  Identities=21%  Similarity=0.305  Sum_probs=196.5

Q ss_pred             HHhcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC----
Q 013636          150 AATNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE----  222 (439)
Q Consensus       150 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  222 (439)
                      ...++|++.+.||+|+||.||++... ++..+|+|.+....  ......+.+|+.++++++||||+++++++....    
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07880          12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR   91 (343)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence            35678999999999999999999864 57889999885432  223356889999999999999999999887554    


Q ss_pred             --eeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecc
Q 013636          223 --TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFG  300 (439)
Q Consensus       223 --~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfG  300 (439)
                        ..++||||+ +++|.+++..    ..+++..+..++.|+++||+|||+.   +++||||||+||++++++.+||+|||
T Consensus        92 ~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg  163 (343)
T cd07880          92 FHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG  163 (343)
T ss_pred             cceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecc
Confidence              358999999 6799888753    3589999999999999999999998   99999999999999999999999999


Q ss_pred             cccccCCCCcceeeccccCccchhhhcC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhh-hhhHhhhh-------c
Q 013636          301 LSVTAGTQSRNVKISGTLGYVAPEYLLE-GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQC-QSMVTWAM-------P  371 (439)
Q Consensus       301 ls~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~-~~~~~~~~-------~  371 (439)
                      ++.......  ....+++.|+|||.+.+ ..++.++|+||||+++|++++|+.||...+.... ........       .
T Consensus       164 ~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  241 (343)
T cd07880         164 LARQTDSEM--TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQ  241 (343)
T ss_pred             cccccccCc--cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            997654322  23357889999999876 4588999999999999999999999986543221 11111000       0


Q ss_pred             ccccC------CCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          372 QLTDR------SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       372 ~~~~~------~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      .+...      ..++......+.. ........+.+++.+|++.||++|||+.+++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~  298 (343)
T cd07880         242 KLQSEDAKNYVKKLPRFRKKDFRS-LLPNANPLAVNVLEKMLVLDAESRITAAEALAH  298 (343)
T ss_pred             hhcchhHHHHHHhccccCcchHHH-hccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00000      0001111111100 001122357789999999999999999999954

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-38  Score=326.92  Aligned_cols=253  Identities=29%  Similarity=0.452  Sum_probs=201.8

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEE-CCccEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeE
Q 013636          149 EAATNNFQESNVIGEGGRGHVYKARF-NEKLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRF  225 (439)
Q Consensus       149 ~~~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  225 (439)
                      ...+-+++....||.|.||.||.+.. ++|...|+|-+.-..  ........+|..++..++|||+|+++|+-.+++..+
T Consensus      1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred             ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence            34456788899999999999999976 457777888775332  233356789999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccccccc
Q 013636          226 LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA  305 (439)
Q Consensus       226 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~  305 (439)
                      |.||||++|+|.+.+.   ++...++.....+..|++.|++|||+.   +||||||||.||+++.+|.+|++|||.|...
T Consensus      1311 IFMEyC~~GsLa~ll~---~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLE---HGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred             HHHHHhccCcHHHHHH---hcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEe
Confidence            9999999999999994   455677777778899999999999998   9999999999999999999999999999776


Q ss_pred             CCCCcc-----eeeccccCccchhhhcCCC---CCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCC
Q 013636          306 GTQSRN-----VKISGTLGYVAPEYLLEGK---LTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRS  377 (439)
Q Consensus       306 ~~~~~~-----~~~~gt~~y~aPE~~~~~~---~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  377 (439)
                      ......     ....||+.|||||++.+..   ..-++||||+||++.||+||+.||...+..+. -+..-+   ....+
T Consensus      1385 ~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a-IMy~V~---~gh~P 1460 (1509)
T KOG4645|consen 1385 KNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA-IMYHVA---AGHKP 1460 (1509)
T ss_pred             cCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH-HHhHHh---ccCCC
Confidence            443211     2356999999999998643   34689999999999999999999987654332 111111   12233


Q ss_pred             CCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          378 KLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       378 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      .+|+-+.+            .-.+++.+||+.||++|.++.|++++
T Consensus      1461 q~P~~ls~------------~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1461 QIPERLSS------------EGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             CCchhhhH------------hHHHHHHHHHhcCchhhhHHHHHHHh
Confidence            44443332            33458889999999999999988865

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-35  Score=291.46  Aligned_cols=262  Identities=21%  Similarity=0.312  Sum_probs=197.3

Q ss_pred             HhcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCe----
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAET----  223 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  223 (439)
                      ..++|+..+.||+|+||.||+|+.. ++..+++|.+....  ......+.+|+.++++++|||++++.+++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            4578999999999999999999886 46789999886432  2233567889999999999999999988766554    


Q ss_pred             --eEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccc
Q 013636          224 --RFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGL  301 (439)
Q Consensus       224 --~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGl  301 (439)
                        .++|+||+ +++|.+++..    ..+++..+..++.|+++||+|||+.   +++||||+|+||++++++.+||+|||+
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~  164 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGL  164 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccccc
Confidence              89999998 5699998864    3589999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCCcceeeccccCccchhhhcC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhccccc----C
Q 013636          302 SVTAGTQSRNVKISGTLGYVAPEYLLE-GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTD----R  376 (439)
Q Consensus       302 s~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~----~  376 (439)
                      +......  .....++..|+|||.+.+ ..++.++||||||+++||+++|+.||...+.......+....+....    .
T Consensus       165 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  242 (343)
T cd07851         165 ARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQK  242 (343)
T ss_pred             ccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Confidence            9765433  223357889999999875 36788999999999999999999999766543221111100000000    0


Q ss_pred             C---C-------CCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          377 S---K-------LPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       377 ~---~-------~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      .   .       ++....+..... .......+.+++.+||+.||++|||+.+++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         243 ISSESARNYIQSLPQMPKKDFKEV-FSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             ccchhHHHHHHhccccCCCCHHHH-hccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence            0   0       000000000000 00124568899999999999999999999865

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=4.5e-36  Score=312.85  Aligned_cols=253  Identities=28%  Similarity=0.443  Sum_probs=189.1

Q ss_pred             HHhcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCceeeeeeEEEeC------
Q 013636          150 AATNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG-HDAEREFNNEVNWLTKIRHQNIISLLGYCIHA------  221 (439)
Q Consensus       150 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  221 (439)
                      ....+|+..++||+||||.||+++.+ ||..+|||++.-.. ......+.+|+..+++|+|||||+++..+.+.      
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            45567888899999999999999986 78999999997654 23335688999999999999999987322100      


Q ss_pred             --------------------------------------------------------------------------------
Q 013636          222 --------------------------------------------------------------------------------  221 (439)
Q Consensus       222 --------------------------------------------------------------------------------  221 (439)
                                                                                                      
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ---------------------------------CeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 013636          222 ---------------------------------ETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYL  268 (439)
Q Consensus       222 ---------------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~L  268 (439)
                                                       ..+||-||||+..+|.++++......  .....++++.+|++||+|+
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYI  713 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYI  713 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHH
Confidence                                             01367889999988888886533221  3567889999999999999


Q ss_pred             hhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccC------------------C-CCcceeeccccCccchhhhcCC
Q 013636          269 HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAG------------------T-QSRNVKISGTLGYVAPEYLLEG  329 (439)
Q Consensus       269 H~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~------------------~-~~~~~~~~gt~~y~aPE~~~~~  329 (439)
                      |++   ++|||||||.||++|+++.+||+|||++....                  . ........||.-|+|||.+.+.
T Consensus       714 H~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~  790 (1351)
T KOG1035|consen  714 HDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT  790 (1351)
T ss_pred             HhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence            999   99999999999999999999999999996611                  0 0112335699999999999865


Q ss_pred             ---CCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHh
Q 013636          330 ---KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLC  406 (439)
Q Consensus       330 ---~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~c  406 (439)
                         .|+.|+|+||+||+++||+.   ||...  -+....+.    .+. .+.++.-      ..+..+....-..++.++
T Consensus       791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts--MERa~iL~----~LR-~g~iP~~------~~f~~~~~~~e~slI~~L  854 (1351)
T KOG1035|consen  791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTS--MERASILT----NLR-KGSIPEP------ADFFDPEHPEEASLIRWL  854 (1351)
T ss_pred             ccccccchhhhHHHHHHHHHHhc---cCCch--HHHHHHHH----hcc-cCCCCCC------cccccccchHHHHHHHHH
Confidence               49999999999999999986   56432  12122222    122 2333322      111122334456799999


Q ss_pred             cCCCCCCCCCHHHHHHh
Q 013636          407 IQPEPSYRPLITDVLHS  423 (439)
Q Consensus       407 l~~dP~~RPt~~evl~~  423 (439)
                      ++.||++|||+.|+|.+
T Consensus       855 l~hdP~kRPtA~eLL~s  871 (1351)
T KOG1035|consen  855 LSHDPSKRPTATELLNS  871 (1351)
T ss_pred             hcCCCccCCCHHHHhhc
Confidence            99999999999999965

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=4.4e-35  Score=286.44  Aligned_cols=262  Identities=24%  Similarity=0.315  Sum_probs=191.0

Q ss_pred             CCCccceecccCcEEEEEEEECC---ccEEEEEEecCCC--chHHHHHHHHHHHHHhc-CCCceeeeeeEEEeC----Ce
Q 013636          154 NFQESNVIGEGGRGHVYKARFNE---KLLAAVKRIDDAG--HDAEREFNNEVNWLTKI-RHQNIISLLGYCIHA----ET  223 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~~---~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~  223 (439)
                      +|++.+.||+|+||.||+++...   +..+|+|.+....  ....+.+.+|+.+++++ +||||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            46778899999999999998754   5788999886432  22345688899999999 599999999876432    35


Q ss_pred             eEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccccc
Q 013636          224 RFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSV  303 (439)
Q Consensus       224 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~  303 (439)
                      .++++||+. ++|.+++..   ...+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||++.
T Consensus        81 ~~~~~e~~~-~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~  153 (332)
T cd07857          81 LYLYEELME-ADLHQIIRS---GQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLAR  153 (332)
T ss_pred             EEEEEeccc-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence            688889886 589998853   34689999999999999999999998   99999999999999999999999999997


Q ss_pred             ccCCCCc-----ceeeccccCccchhhhcC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcc-----
Q 013636          304 TAGTQSR-----NVKISGTLGYVAPEYLLE-GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQ-----  372 (439)
Q Consensus       304 ~~~~~~~-----~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~-----  372 (439)
                      .......     .....||..|+|||.+.+ ..++.++||||+|+++|++++|+.||...+..............     
T Consensus       154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (332)
T cd07857         154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET  233 (332)
T ss_pred             ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            5432211     122358899999998766 46889999999999999999999999865532211111100000     


Q ss_pred             ---cccCC------CCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          373 ---LTDRS------KLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       373 ---~~~~~------~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                         +....      .....-...+.. ........+.+++.+|++.||++|||+.+++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~  292 (332)
T cd07857         234 LSRIGSPKAQNYIRSLPNIPKKPFES-IFPNANPLALDLLEKLLAFDPTKRISVEEALEH  292 (332)
T ss_pred             HHhhhhhhHHHHHHhccccCCcchHh-hCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence               00000      000000000000 000113467789999999999999999999854

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-36  Score=274.25  Aligned_cols=239  Identities=25%  Similarity=0.331  Sum_probs=197.6

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC---chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      ++|...++||+|.||+|...+.+ .+..+|+|++++.-   .+....-..|-++|+..+||.+..+.-.+...+.+|.||
T Consensus       168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM  247 (516)
T KOG0690|consen  168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM  247 (516)
T ss_pred             chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence            67788899999999999999876 47788999997643   233345678999999999999999999999999999999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCC-
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT-  307 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~-  307 (439)
                      ||..||.|.-+|.+   ...+++.....+...|..||.|||++   +|+.||||.+|.|+|.+|++||+|||+++..-. 
T Consensus       248 eyanGGeLf~HLsr---er~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~  321 (516)
T KOG0690|consen  248 EYANGGELFFHLSR---ERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY  321 (516)
T ss_pred             EEccCceEeeehhh---hhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcccc
Confidence            99999999988854   45688888888999999999999998   999999999999999999999999999975433 


Q ss_pred             CCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchh
Q 013636          308 QSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVI  387 (439)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  387 (439)
                      ......+||||.|+|||++....|..+.|.|.+||++|||++|+.||...+......++-      ...-++|.-+.+..
T Consensus       322 g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl------~ed~kFPr~ls~eA  395 (516)
T KOG0690|consen  322 GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL------MEDLKFPRTLSPEA  395 (516)
T ss_pred             cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH------hhhccCCccCCHHH
Confidence            334456899999999999999999999999999999999999999998766544333332      12233444444332


Q ss_pred             cCccCHHHHHHHHHHHHHhcCCCCCCCC
Q 013636          388 RDTMDLKHLYQVAAVAVLCIQPEPSYRP  415 (439)
Q Consensus       388 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP  415 (439)
                                  ..+....|..||.+|.
T Consensus       396 ------------ktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  396 ------------KTLLSGLLKKDPKKRL  411 (516)
T ss_pred             ------------HHHHHHHhhcChHhhc
Confidence                        3366778999999995

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-37  Score=275.06  Aligned_cols=259  Identities=25%  Similarity=0.337  Sum_probs=196.9

Q ss_pred             HhcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCc-hHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeeEEE
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGH-DAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLV  227 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV  227 (439)
                      ..++.+....||.|+||+|+|-..+ .+...|||++..... ...++++.|.+...+- ++||||+++|.+...+..|+.
T Consensus        62 ~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiC  141 (361)
T KOG1006|consen   62 TSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWIC  141 (361)
T ss_pred             ccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeee
Confidence            3455566788999999999999876 478899999986554 4456788888766555 799999999999999999999


Q ss_pred             EEeccCCChhhhhcC--CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccccccc
Q 013636          228 YEMMQNGSLEKQLHG--PTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA  305 (439)
Q Consensus       228 ~e~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~  305 (439)
                      ||.|.- ||+.+...  ......+++..+-.|+.-..+||.||-+.  ..|+|||+||+|||++..|.+||||||++-..
T Consensus       142 MELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqL  218 (361)
T KOG1006|consen  142 MELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQL  218 (361)
T ss_pred             HHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhH
Confidence            999964 77655432  12345688999999999999999999875  58999999999999999999999999999665


Q ss_pred             CCCCcceeeccccCccchhhhcCC--CCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccC
Q 013636          306 GTQSRNVKISGTLGYVAPEYLLEG--KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV  383 (439)
Q Consensus       306 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  383 (439)
                      ...-......|-..|||||.+...  -|+.+|||||+|++|+|+.||+.||..++..  ...+..+   .  .+..+. +
T Consensus       219 v~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv--feql~~V---v--~gdpp~-l  290 (361)
T KOG1006|consen  219 VDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV--FEQLCQV---V--IGDPPI-L  290 (361)
T ss_pred             HHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH--HHHHHHH---H--cCCCCe-e
Confidence            443333334577899999998753  3788999999999999999999999987642  1111111   0  111111 1


Q ss_pred             CchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          384 DPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       384 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      ....   -.......+..++-.|+..|-++||...++.++
T Consensus       291 ~~~~---~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  291 LFDK---ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             cCcc---cccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            1111   112234567889999999999999999998854

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=8.3e-36  Score=270.49  Aligned_cols=268  Identities=23%  Similarity=0.311  Sum_probs=196.4

Q ss_pred             cCCCccceecccCcEEEEEEEEC---C--ccEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCceeeeeeEEEe-CCee
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN---E--KLLAAVKRIDDAGH--DAEREFNNEVNWLTKIRHQNIISLLGYCIH-AETR  224 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~---~--~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~  224 (439)
                      ..|+....||+|.+|.||+|.-.   +  ...+|+|+++....  .-.....+|+.+++.++|||++.+..++.. +...
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            46777899999999999999442   2  23679999875422  122346789999999999999999998877 6788


Q ss_pred             EEEEEeccCCChhhhhcC--CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC----CcEEEEe
Q 013636          225 FLVYEMMQNGSLEKQLHG--PTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS----FNAKLSD  298 (439)
Q Consensus       225 ~lV~e~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~----~~~kl~D  298 (439)
                      ++++||.+. +|.+.++-  ......++...+..|..||+.|+.|||++   -|+||||||.|||+..+    |.+||+|
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeec
Confidence            999999998 88888753  33446799999999999999999999998   99999999999999877    9999999


Q ss_pred             cccccccCCCCcc----eeeccccCccchhhhcCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCChhhh------hhhHh
Q 013636          299 FGLSVTAGTQSRN----VKISGTLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQC------QSMVT  367 (439)
Q Consensus       299 fGls~~~~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~------~~~~~  367 (439)
                      ||+++.+.+.-..    ....-|..|+|||.+.+. .||.+.|||+.|||+.||+|-.+-|.+....-.      .+.+.
T Consensus       180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~  259 (438)
T KOG0666|consen  180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD  259 (438)
T ss_pred             ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence            9999887654332    234568999999999875 689999999999999999998887765332110      01111


Q ss_pred             hh---h-----cccccCCCCCccCCc---hh---cCccCHH--------HHHHHHHHHHHhcCCCCCCCCCHHHHHHhc
Q 013636          368 WA---M-----PQLTDRSKLPNIVDP---VI---RDTMDLK--------HLYQVAAVAVLCIQPEPSYRPLITDVLHSL  424 (439)
Q Consensus       368 ~~---~-----~~~~~~~~~~~~~d~---~l---~~~~~~~--------~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  424 (439)
                      ..   .     ..+.+-..+++.-+.   .-   .+..+..        ....-.++...+|+.||-+|.|+++.+++.
T Consensus       260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~  338 (438)
T KOG0666|consen  260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP  338 (438)
T ss_pred             HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence            11   1     111111222222110   00   0111110        012266789999999999999999999875

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=4.2e-34  Score=302.81  Aligned_cols=145  Identities=31%  Similarity=0.433  Sum_probs=129.7

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC---chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      ++|++.+.||+|+||.||+|... .+..+|+|.+....   ......+.+|+.++..++||||+++++++...+..++||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            57888999999999999999886 57889999986532   223457889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccccc
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSV  303 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~  303 (439)
                      ||+++++|.+++...   ..+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~~---~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHIY---GYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999999642   3588899999999999999999997   99999999999999999999999999874

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-35  Score=244.75  Aligned_cols=264  Identities=24%  Similarity=0.318  Sum_probs=200.9

Q ss_pred             CCCccceecccCcEEEEEEEECC-ccEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEe
Q 013636          154 NFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      +|...++||+|.+|+|++|+..+ ...||+|+++-..  ..-.....+|+-+++.++|.|||++++....+....+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            34556789999999999998865 6788999886432  22234578999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR  310 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~  310 (439)
                      |.. +|..+...  -.+.++......++.|+.+||.++|++   ++.|||+||+|.||+.+|++|++|||+++..+-.-.
T Consensus        83 cdq-dlkkyfds--lng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvr  156 (292)
T KOG0662|consen   83 CDQ-DLKKYFDS--LNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR  156 (292)
T ss_pred             hhH-HHHHHHHh--cCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence            976 89888864  345689999999999999999999998   999999999999999999999999999987765433


Q ss_pred             c-eeeccccCccchhhhcCC-CCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCC--CCCccCCc
Q 013636          311 N-VKISGTLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRS--KLPNIVDP  385 (439)
Q Consensus       311 ~-~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~d~  385 (439)
                      . ....-|..|++|.++.+. -|++..|+||-||++.|+.. |++-|.+.+..+....+-|......+..  .+....|-
T Consensus       157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdy  236 (292)
T KOG0662|consen  157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDY  236 (292)
T ss_pred             eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCC
Confidence            2 223468999999999875 57899999999999999998 7777887776555555544433322211  11111111


Q ss_pred             hhcCcc---------CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          386 VIRDTM---------DLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       386 ~l~~~~---------~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      .....+         .+.....=.++....+.-+|..|.++++.+++
T Consensus       237 k~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  237 KPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             cccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence            111111         11112233466777788899999999998875

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.4e-33  Score=261.26  Aligned_cols=237  Identities=29%  Similarity=0.386  Sum_probs=193.4

Q ss_pred             CcEEEEEEEECC-ccEEEEEEecCCCchH-HHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEeccCCChhhhhcC
Q 013636          165 GRGHVYKARFNE-KLLAAVKRIDDAGHDA-EREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHG  242 (439)
Q Consensus       165 ~fg~Vy~~~~~~-~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~  242 (439)
                      +||.||+|...+ +..+++|.+....... .+.+.+|+..+++++|+|++++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            589999999875 7889999997655444 67899999999999999999999999999999999999999999999864


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCcceeeccccCccc
Q 013636          243 PTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA  322 (439)
Q Consensus       243 ~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~~~~~~gt~~y~a  322 (439)
                      ..   .+++..+..++.++++++.|||+.   +++|+||+|+||++++++.++|+|||.+.............++..|++
T Consensus        81 ~~---~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~  154 (244)
T smart00220       81 RG---RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMA  154 (244)
T ss_pred             cc---CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCC
Confidence            22   288999999999999999999998   999999999999999999999999999987655433334557889999


Q ss_pred             hhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCC-ChhhhhhhHhhhhcccccCCCCCccCCchhcCccCHHHHHHHHH
Q 013636          323 PEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKM-SPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAA  401 (439)
Q Consensus       323 PE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~  401 (439)
                      ||.+....++.++||||||++++++++|..||... +.........   ..   ....... ..        .....+.+
T Consensus       155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~---~~---~~~~~~~-~~--------~~~~~~~~  219 (244)
T smart00220      155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIG---KP---KPPFPPP-EW--------KISPEAKD  219 (244)
T ss_pred             HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh---cc---CCCCccc-cc--------cCCHHHHH
Confidence            99999888999999999999999999999999763 3222111111   00   0000000 00        02346778


Q ss_pred             HHHHhcCCCCCCCCCHHHHHH
Q 013636          402 VAVLCIQPEPSYRPLITDVLH  422 (439)
Q Consensus       402 l~~~cl~~dP~~RPt~~evl~  422 (439)
                      ++.+|+..+|++||++.++++
T Consensus       220 ~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      220 LIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHccCCchhccCHHHHhh
Confidence            999999999999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=5.2e-34  Score=265.40  Aligned_cols=219  Identities=22%  Similarity=0.240  Sum_probs=174.2

Q ss_pred             cCcEEEEEEEEC-CccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEeccCCChhhhhcC
Q 013636          164 GGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHG  242 (439)
Q Consensus       164 G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~  242 (439)
                      |.||.||+++.. ++..+|+|.+....     .+.+|...+....|||++++++++...+..+++|||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            899999999875 56789999987543     233455555566799999999999999999999999999999999864


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCcceeeccccCccc
Q 013636          243 PTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA  322 (439)
Q Consensus       243 ~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~~~~~~gt~~y~a  322 (439)
                      .   ..+++..+..++.|+++||+|||+.   +++||||||+||++++++.++++|||.+.......  ....++..|+|
T Consensus        79 ~---~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~y~a  150 (237)
T cd05576          79 F---LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC--DGEAVENMYCA  150 (237)
T ss_pred             h---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc--ccCCcCccccC
Confidence            2   3589999999999999999999998   99999999999999999999999999876554322  22335678999


Q ss_pred             hhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHH
Q 013636          323 PEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAV  402 (439)
Q Consensus       323 PE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l  402 (439)
                      ||......++.++||||+|+++|||++|+.|+...... ...         .....++..+            ...+.++
T Consensus       151 PE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-~~~---------~~~~~~~~~~------------~~~~~~l  208 (237)
T cd05576         151 PEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-INT---------HTTLNIPEWV------------SEEARSL  208 (237)
T ss_pred             CcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-ccc---------ccccCCcccC------------CHHHHHH
Confidence            99998888999999999999999999999887542211 000         0000111111            2356779


Q ss_pred             HHHhcCCCCCCCCCH
Q 013636          403 AVLCIQPEPSYRPLI  417 (439)
Q Consensus       403 ~~~cl~~dP~~RPt~  417 (439)
                      +.+|++.||++||++
T Consensus       209 i~~~l~~dp~~R~~~  223 (237)
T cd05576         209 LQQLLQFNPTERLGA  223 (237)
T ss_pred             HHHHccCCHHHhcCC
Confidence            999999999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-34  Score=290.57  Aligned_cols=261  Identities=29%  Similarity=0.462  Sum_probs=212.2

Q ss_pred             ccHHHHHHHhcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCchHHHHHHHHHHHHHhc-CCCceeeeeeEEEe
Q 013636          143 IEYELLEAATNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIH  220 (439)
Q Consensus       143 ~~~~~l~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  220 (439)
                      .+++.+-..++.|++.+.+|+|.+|.||+++.. +++.+|+|++.... +..+++..|.++++.. .|||++.++|++..
T Consensus         9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k   87 (953)
T KOG0587|consen    9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIK   87 (953)
T ss_pred             cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence            344445556788889999999999999999874 57788888876543 4445778889999888 69999999999864


Q ss_pred             -----CCeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEE
Q 013636          221 -----AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAK  295 (439)
Q Consensus       221 -----~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~k  295 (439)
                           ++.+|||||||.+||.-+++.+.. +..+.|..+..|+..+++|+++||..   .++|||+|-.|||++.++.+|
T Consensus        88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VK  163 (953)
T KOG0587|consen   88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVK  163 (953)
T ss_pred             ecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEE
Confidence                 468899999999999999998855 78899999999999999999999997   999999999999999999999


Q ss_pred             EEecccccccCCCC-cceeeccccCccchhhhcC-----CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhh
Q 013636          296 LSDFGLSVTAGTQS-RNVKISGTLGYVAPEYLLE-----GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWA  369 (439)
Q Consensus       296 l~DfGls~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~  369 (439)
                      |+|||++......- ...+..||+.|||||++.-     ..|+..+|+||+|++..||--|.+|+-++.|.-....+.  
T Consensus       164 LvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~Ip--  241 (953)
T KOG0587|consen  164 LVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP--  241 (953)
T ss_pred             EeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCC--
Confidence            99999997665432 2345679999999999863     357789999999999999999999998887654322221  


Q ss_pred             hcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          370 MPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       370 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                           .+      -.|.++.  ...-..++.+++..||..|-++||++.+++++
T Consensus       242 -----RN------PPPkLkr--p~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  242 -----RN------PPPKLKR--PKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             -----CC------CCccccc--hhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence                 11      1122211  22345678899999999999999999999865

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-34  Score=297.86  Aligned_cols=257  Identities=23%  Similarity=0.305  Sum_probs=201.5

Q ss_pred             HHHHHHhcCCCccceecccCcEEEEEEEECC-ccEEEEEEecC---CCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeC
Q 013636          146 ELLEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDD---AGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHA  221 (439)
Q Consensus       146 ~~l~~~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  221 (439)
                      ..++...++|.+.++||+|+||.|..++.+. +.++|.|++++   .......-|..|-++|..-+.+=|+.++-.|.+.
T Consensus        68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~  147 (1317)
T KOG0612|consen   68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE  147 (1317)
T ss_pred             HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence            3445556889999999999999999999865 67889999976   2233445688999999999999999999999999


Q ss_pred             CeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccc
Q 013636          222 ETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGL  301 (439)
Q Consensus       222 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGl  301 (439)
                      ..+|+|||||+||+|-.++...   ..+++.....++..+.-||.-||+.   |+|||||||+|||||.+|++||+|||.
T Consensus       148 ~~LYlVMdY~pGGDlltLlSk~---~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGs  221 (1317)
T KOG0612|consen  148 RYLYLVMDYMPGGDLLTLLSKF---DRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGS  221 (1317)
T ss_pred             cceEEEEecccCchHHHHHhhc---CCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchh
Confidence            9999999999999999999642   2799999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCCcc--eeeccccCccchhhhcC-----CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccc
Q 013636          302 SVTAGTQSRN--VKISGTLGYVAPEYLLE-----GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLT  374 (439)
Q Consensus       302 s~~~~~~~~~--~~~~gt~~y~aPE~~~~-----~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~  374 (439)
                      +..+..+...  ...+|||.|.+||++..     +.|+..+|.||+||++|||+.|..||...+-.+....+...    .
T Consensus       222 Clkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h----k  297 (1317)
T KOG0612|consen  222 CLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH----K  297 (1317)
T ss_pred             HHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch----h
Confidence            9777654433  23469999999999873     67899999999999999999999999865543322222111    0


Q ss_pred             cCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHh
Q 013636          375 DRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPL---ITDVLHS  423 (439)
Q Consensus       375 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt---~~evl~~  423 (439)
                      +.-.+|...|          -..+..+++.+.+. +|+.|..   +.++-.|
T Consensus       298 ~~l~FP~~~~----------VSeeakdLI~~ll~-~~e~RLgrngiedik~H  338 (1317)
T KOG0612|consen  298 ESLSFPDETD----------VSEEAKDLIEALLC-DREVRLGRNGIEDIKNH  338 (1317)
T ss_pred             hhcCCCcccc----------cCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence            1112221111          12234456666555 7777777   7776644

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1.7e-33  Score=291.48  Aligned_cols=259  Identities=18%  Similarity=0.217  Sum_probs=168.5

Q ss_pred             HhcCCCccceecccCcEEEEEEEECC-----ccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeE------EE
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARFNE-----KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGY------CI  219 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~  219 (439)
                      ..++|+..+.||+|+||.||+|++.+     +..+|+|++......  +....|  .+....+.++..++..      +.
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            45789999999999999999998864     578999988653321  111111  1222222232222211      24


Q ss_pred             eCCeeEEEEEeccCCChhhhhcCCCCC-----------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 013636          220 HAETRFLVYEMMQNGSLEKQLHGPTHG-----------------SNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLK  282 (439)
Q Consensus       220 ~~~~~~lV~e~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk  282 (439)
                      .....++|+||+++++|.++++.....                 .......+..++.|++.||+|||+.   +|+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence            566889999999999999998643210                 1112344567999999999999998   99999999


Q ss_pred             CCCEEEcC-CCcEEEEecccccccCCCC--cceeeccccCccchhhhcCC----------------------CCCCchhh
Q 013636          283 SSNILLDS-SFNAKLSDFGLSVTAGTQS--RNVKISGTLGYVAPEYLLEG----------------------KLTDKSDV  337 (439)
Q Consensus       283 ~~NiLl~~-~~~~kl~DfGls~~~~~~~--~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~Dv  337 (439)
                      |+|||+++ ++.+||+|||++.......  ......+|++|+|||.+...                      .++.++||
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV  362 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI  362 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence            99999986 6899999999997543221  12345689999999965432                      23456799


Q ss_pred             HHHHHHHHHHHhCCCCCCCCChhhh-------hhhHhhhhcccccCCCCCccCCchhcCccC--HHHHHHHHHHHHHhcC
Q 013636          338 YAFGVVLLELLMGRRPVEKMSPTQC-------QSMVTWAMPQLTDRSKLPNIVDPVIRDTMD--LKHLYQVAAVAVLCIQ  408 (439)
Q Consensus       338 wS~Gvll~elltG~~P~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~--~~~~~~l~~l~~~cl~  408 (439)
                      |||||+||||+++..|++.......       .....|...       ......+.+...++  ........+++.+||+
T Consensus       363 wSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~  435 (566)
T PLN03225        363 YSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKL-------VEPRASPDLRRGFEVLDLDGGAGWELLKSMMR  435 (566)
T ss_pred             HHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHh-------hccccchhhhhhhhhccccchHHHHHHHHHcc
Confidence            9999999999998776543211100       001111100       00000111110000  0011223479999999


Q ss_pred             CCCCCCCCHHHHHHh
Q 013636          409 PEPSYRPLITDVLHS  423 (439)
Q Consensus       409 ~dP~~RPt~~evl~~  423 (439)
                      .||++|||++|+++|
T Consensus       436 ~dP~kR~ta~e~L~H  450 (566)
T PLN03225        436 FKGRQRISAKAALAH  450 (566)
T ss_pred             CCcccCCCHHHHhCC
Confidence            999999999999986

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-34  Score=265.57  Aligned_cols=267  Identities=22%  Similarity=0.281  Sum_probs=203.5

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEECC-ccEEEEEEecCCCchHHHHHHHHHHHHHhcCC--C----ceeeeeeEEEeC
Q 013636          149 EAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRH--Q----NIISLLGYCIHA  221 (439)
Q Consensus       149 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~----niv~l~~~~~~~  221 (439)
                      ...+++|.+...+|+|.||.|...-++. +..+|+|++++...-. +.-.-|++++.++.+  |    -++.+.+++...
T Consensus        85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYr-eAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr  163 (415)
T KOG0671|consen   85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYR-EAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR  163 (415)
T ss_pred             cccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHh-hHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence            3447899999999999999999987654 6889999998754332 345668999999942  2    378888899999


Q ss_pred             CeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC-----------
Q 013636          222 ETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDS-----------  290 (439)
Q Consensus       222 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~-----------  290 (439)
                      +..|+|+|.+ |-|+.++|.. +...+++...+..|+.|++++++|||+.   +++|.||||+|||+.+           
T Consensus       164 ghiCivfell-G~S~~dFlk~-N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~  238 (415)
T KOG0671|consen  164 GHICIVFELL-GLSTFDFLKE-NNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKK  238 (415)
T ss_pred             CceEEEEecc-ChhHHHHhcc-CCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCC
Confidence            9999999988 5599999975 3346788999999999999999999998   9999999999999932           


Q ss_pred             ---------CCcEEEEecccccccCCCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhh
Q 013636          291 ---------SFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQ  361 (439)
Q Consensus       291 ---------~~~~kl~DfGls~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~  361 (439)
                               +..+|++|||.|+......  .....|..|+|||++.+-.++.++||||+||||.|+.+|..-|+.-+..+
T Consensus       239 ~~~~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E  316 (415)
T KOG0671|consen  239 KVCFIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE  316 (415)
T ss_pred             ccceeccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence                     3459999999998765544  45568999999999999999999999999999999999999997655333


Q ss_pred             hhhhHhhhhcccccC-------------CCC-----------CccCCchh----cCccCHHHHHHHHHHHHHhcCCCCCC
Q 013636          362 CQSMVTWAMPQLTDR-------------SKL-----------PNIVDPVI----RDTMDLKHLYQVAAVAVLCIQPEPSY  413 (439)
Q Consensus       362 ~~~~~~~~~~~~~~~-------------~~~-----------~~~~d~~l----~~~~~~~~~~~l~~l~~~cl~~dP~~  413 (439)
                      -..+.+...++++..             ..+           ....++..    .......+..++++++..||..||.+
T Consensus       317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~  396 (415)
T KOG0671|consen  317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR  396 (415)
T ss_pred             HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence            222222111111110             000           00011100    01112356678999999999999999


Q ss_pred             CCCHHHHHHh
Q 013636          414 RPLITDVLHS  423 (439)
Q Consensus       414 RPt~~evl~~  423 (439)
                      |+|+.|++++
T Consensus       397 RiTl~EAL~H  406 (415)
T KOG0671|consen  397 RITLREALSH  406 (415)
T ss_pred             cccHHHHhcC
Confidence            9999999865

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.6e-32  Score=277.99  Aligned_cols=259  Identities=22%  Similarity=0.316  Sum_probs=180.5

Q ss_pred             HhcCCCccceecccCcEEEEEEEE-----------------CCccEEEEEEecCCCchHHHHH--------------HHH
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARF-----------------NEKLLAAVKRIDDAGHDAEREF--------------NNE  199 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~~--------------~~E  199 (439)
                      ..++|++.++||+|+||.||+|..                 ..+..||||++........++|              ..|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            467899999999999999999964                 2346799999875443333333              346


Q ss_pred             HHHHHhcCCCce-----eeeeeEEEe--------CCeeEEEEEeccCCChhhhhcCCCC---------------------
Q 013636          200 VNWLTKIRHQNI-----ISLLGYCIH--------AETRFLVYEMMQNGSLEKQLHGPTH---------------------  245 (439)
Q Consensus       200 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lV~e~~~~gsL~~~l~~~~~---------------------  245 (439)
                      +.++.+++|.|+     ++++++|..        .+..+|||||+++|+|.+++++...                     
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777777776654     677777753        3568999999999999999975211                     


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCccee--eccccCccch
Q 013636          246 GSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK--ISGTLGYVAP  323 (439)
Q Consensus       246 ~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~~~~--~~gt~~y~aP  323 (439)
                      ...+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||++...........  ..+|+.|+||
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence            12356788899999999999999998   999999999999999999999999999966543222111  2247899999


Q ss_pred             hhhcCCCC----------------------CCchhhHHHHHHHHHHHhCCC-CCCCCChhh-----h-hhhHhhhhcccc
Q 013636          324 EYLLEGKL----------------------TDKSDVYAFGVVLLELLMGRR-PVEKMSPTQ-----C-QSMVTWAMPQLT  374 (439)
Q Consensus       324 E~~~~~~~----------------------~~~~DvwS~Gvll~elltG~~-P~~~~~~~~-----~-~~~~~~~~~~~~  374 (439)
                      |.+.....                      ..+.||||+||+++||++|.. |+.......     . .....|..- ..
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~-~~  458 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY-KG  458 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh-cc
Confidence            98764321                      234799999999999999875 765322110     0 111112110 00


Q ss_pred             cCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCC---CCCCCHHHHHHh
Q 013636          375 DRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEP---SYRPLITDVLHS  423 (439)
Q Consensus       375 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP---~~RPt~~evl~~  423 (439)
                      ....++      ..+.    ......+++..++..+|   .+|+|++|+++|
T Consensus       459 ~~~~~~------~~d~----~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        459 QKYDFS------LLDR----NKEAGWDLACKLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             cCCCcc------cccc----cChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence            011110      1111    12345568888888765   689999999976

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.8e-35  Score=257.19  Aligned_cols=263  Identities=21%  Similarity=0.321  Sum_probs=192.7

Q ss_pred             CCccceecccCcEEEEEEEECC-ccEEEEEEecC--CCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeC--------Ce
Q 013636          155 FQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDD--AGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHA--------ET  223 (439)
Q Consensus       155 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------~~  223 (439)
                      |....++|+|.||+||+|+..+ +..||+|+.--  ....--....+|+++|..++|+|++.++..|...        ..
T Consensus        19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t   98 (376)
T KOG0669|consen   19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT   98 (376)
T ss_pred             HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence            3345679999999999998754 55567766532  1122223457899999999999999999988543        34


Q ss_pred             eEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccccc
Q 013636          224 RFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSV  303 (439)
Q Consensus       224 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~  303 (439)
                      .++|+++|+. +|.-+|..  ....++...+.+++.++..||.|+|..   .|+|||+||.|+||+.++.+||+|||+++
T Consensus        99 ~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar  172 (376)
T KOG0669|consen   99 FYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLAR  172 (376)
T ss_pred             eeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecccccc
Confidence            7999999988 89888864  235688999999999999999999998   99999999999999999999999999996


Q ss_pred             ccCCCCcc-----eeeccccCccchhhhcC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCC
Q 013636          304 TAGTQSRN-----VKISGTLGYVAPEYLLE-GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRS  377 (439)
Q Consensus       304 ~~~~~~~~-----~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  377 (439)
                      ........     ....-|..|++||.+.+ ..|+++.|||.-||++.||+||.+-+.+.++......+.........+ 
T Consensus       173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke-  251 (376)
T KOG0669|consen  173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE-  251 (376)
T ss_pred             ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc-
Confidence            55432221     22335899999999886 579999999999999999999999888776655444443222211111 


Q ss_pred             CCCccCCchh----------cCccC--HHH------HHHHHHHHHHhcCCCCCCCCCHHHHHHhc
Q 013636          378 KLPNIVDPVI----------RDTMD--LKH------LYQVAAVAVLCIQPEPSYRPLITDVLHSL  424 (439)
Q Consensus       378 ~~~~~~d~~l----------~~~~~--~~~------~~~l~~l~~~cl~~dP~~RPt~~evl~~L  424 (439)
                      ..|+.-.-.+          +....  .+.      ....++++..++..||.+|+++.+++.+-
T Consensus       252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~  316 (376)
T KOG0669|consen  252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD  316 (376)
T ss_pred             cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence            0011100000          00000  011      12567889999999999999999998664

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-34  Score=256.41  Aligned_cols=250  Identities=23%  Similarity=0.310  Sum_probs=191.2

Q ss_pred             HhcCCCcc-ceecccCcEEEEEEEEC-CccEEEEEEecCCCchHHHHHHHHHHHHHhc-CCCceeeeeeEEEe----CCe
Q 013636          151 ATNNFQES-NVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIH----AET  223 (439)
Q Consensus       151 ~~~~~~~~-~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~  223 (439)
                      .+++|++. ++||-|-.|.|.....+ .+..+|+|.+.+..     ...+|+++--.. .|||||.+++++.+    ...
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~-----KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP-----KARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH-----HHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            35566654 57999999999888664 46778889887542     234567655444 69999999998764    346


Q ss_pred             eEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC---CCcEEEEecc
Q 013636          224 RFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDS---SFNAKLSDFG  300 (439)
Q Consensus       224 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~---~~~~kl~DfG  300 (439)
                      +++|||.|+||.|++.+... ....+++.+...|..||+.|+.|||+.   +|.||||||+|+|...   |..+||+|||
T Consensus       134 LLiVmE~meGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfG  209 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFG  209 (400)
T ss_pred             eEeeeecccchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccc
Confidence            68999999999999999753 345699999999999999999999998   9999999999999964   5569999999


Q ss_pred             cccccCCCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhh----hhhhHhhhhcccccC
Q 013636          301 LSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQ----CQSMVTWAMPQLTDR  376 (439)
Q Consensus       301 ls~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~----~~~~~~~~~~~~~~~  376 (439)
                      +|+.-.......+.+-|+.|.|||++...+|+...|+||+||++|-|++|.+||.......    ....+..      ..
T Consensus       210 FAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~------gq  283 (400)
T KOG0604|consen  210 FAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRT------GQ  283 (400)
T ss_pred             cccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhc------cC
Confidence            9987665444556678999999999999999999999999999999999999997543211    1111110      00


Q ss_pred             CCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          377 SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       377 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      -   ++-++...     .-.+..-+++..+|..+|++|.|+.+++.+
T Consensus       284 y---~FP~pEWs-----~VSe~aKdlIR~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  284 Y---EFPEPEWS-----CVSEAAKDLIRKLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             c---cCCChhHh-----HHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence            0   11112111     112334568889999999999999999865

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-33  Score=254.41  Aligned_cols=249  Identities=23%  Similarity=0.336  Sum_probs=193.0

Q ss_pred             cceecccCcEEEEEEE-ECCccEEEEEEecCCCchHHHHHHHHHHHHHhcC-CCceeeeeeEEEeCCeeEEEEEeccCCC
Q 013636          158 SNVIGEGGRGHVYKAR-FNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR-HQNIISLLGYCIHAETRFLVYEMMQNGS  235 (439)
Q Consensus       158 ~~~LG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~gs  235 (439)
                      .++||+|+++.|-... ...+..+|||++.+.....+.+..+|++++...+ |+||+++++++++++..|||||-|.||+
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp  162 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP  162 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence            4679999999998875 5678899999999887778888999999999994 9999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCc---EEEEecccccccC--CC--
Q 013636          236 LEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFN---AKLSDFGLSVTAG--TQ--  308 (439)
Q Consensus       236 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~---~kl~DfGls~~~~--~~--  308 (439)
                      |..+++..   ..+++...-++..+||.||.|||..   +|.||||||+|||......   +|||||.+..-..  .+  
T Consensus       163 lLshI~~~---~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s  236 (463)
T KOG0607|consen  163 LLSHIQKR---KHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS  236 (463)
T ss_pred             HHHHHHHh---hhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence            99999743   4589999999999999999999998   9999999999999976544   8999999873321  11  


Q ss_pred             ----CcceeeccccCccchhhhcC-----CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhh-----------hhhHhh
Q 013636          309 ----SRNVKISGTLGYVAPEYLLE-----GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQC-----------QSMVTW  368 (439)
Q Consensus       309 ----~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~-----------~~~~~~  368 (439)
                          ....+.+|+..|||||++.-     ..|+.+.|.||+|||||-|++|.+||.+.-..++           ++.+-.
T Consensus       237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFe  316 (463)
T KOG0607|consen  237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFE  316 (463)
T ss_pred             CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHH
Confidence                11133468889999998752     3578899999999999999999999976533221           211111


Q ss_pred             hhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 013636          369 AMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLH  422 (439)
Q Consensus       369 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  422 (439)
                      .++     ..--++.|.....     -....-+++...+-.|+.+|.++.++++
T Consensus       317 sIQ-----EGkYeFPdkdWah-----IS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  317 SIQ-----EGKYEFPDKDWAH-----ISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             HHh-----ccCCcCChhhhHH-----hhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            100     0111222221110     1223446778888899999999999987

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-33  Score=276.50  Aligned_cols=240  Identities=25%  Similarity=0.338  Sum_probs=189.2

Q ss_pred             HhcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCchHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeeEEEE
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      .++.|.....+|.|+|+.|-..... .+...++|++.....    +-.+|+.++... +|||++++.+.+.+..+.++||
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~  395 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM  395 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence            3567777888999999999888664 466779999876522    234566555555 7999999999999999999999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE-cCCCcEEEEecccccccCC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILL-DSSFNAKLSDFGLSVTAGT  307 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl-~~~~~~kl~DfGls~~~~~  307 (439)
                      |++.+|-+.+.+....    .....+..|+.+++.++.|||++   +++||||||+|||+ ++.++++|+|||.+.....
T Consensus       396 e~l~g~ell~ri~~~~----~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~  468 (612)
T KOG0603|consen  396 ELLDGGELLRRIRSKP----EFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER  468 (612)
T ss_pred             hhccccHHHHHHHhcc----hhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence            9999998887775432    22267778999999999999998   99999999999999 6999999999999987665


Q ss_pred             CCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChh-hhhhhHhhhhcccccCCCCCccCCch
Q 013636          308 QSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPT-QCQSMVTWAMPQLTDRSKLPNIVDPV  386 (439)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~d~~  386 (439)
                      .  ..+.+-|..|.|||++....|+.++|+||||++||+|++|+.||.....+ +....+.        .+...+.+.  
T Consensus       469 ~--~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~--------~~~~s~~vS--  536 (612)
T KOG0603|consen  469 S--CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQ--------MPKFSECVS--  536 (612)
T ss_pred             h--hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhc--------CCccccccC--
Confidence            4  23345688999999999999999999999999999999999999765433 1111111        111112222  


Q ss_pred             hcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          387 IRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       387 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                                ....+++.+||+.||.+||+|.++..+
T Consensus       537 ----------~~AKdLl~~LL~~dP~~Rl~~~~i~~h  563 (612)
T KOG0603|consen  537 ----------DEAKDLLQQLLQVDPALRLGADEIGAH  563 (612)
T ss_pred             ----------HHHHHHHHHhccCChhhCcChhhhccC
Confidence                      234468899999999999999999865

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-33  Score=267.25  Aligned_cols=269  Identities=26%  Similarity=0.361  Sum_probs=198.5

Q ss_pred             hcCCCccceecccCcEEEEEEEE-CCccEEEEEEecC-CCchHH------HHHHHHHHHHHhcCCCceeeeeeEEEe-CC
Q 013636          152 TNNFQESNVIGEGGRGHVYKARF-NEKLLAAVKRIDD-AGHDAE------REFNNEVNWLTKIRHQNIISLLGYCIH-AE  222 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~-~~~~~~------~~~~~E~~~l~~l~h~niv~l~~~~~~-~~  222 (439)
                      .++|-..++||+|||+.||+|.+ .+...||+|+-.- .++.++      +...+|.++-+.|.||.||++++|+.- .+
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd  541 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD  541 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence            35667788999999999999965 5577888887642 223222      235689999999999999999999864 45


Q ss_pred             eeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC---CCcEEEEec
Q 013636          223 TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDS---SFNAKLSDF  299 (439)
Q Consensus       223 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~---~~~~kl~Df  299 (439)
                      ..|-|+|||+|.+|+-||..   ...+++.....|+.||..||.||.+. +++|+|-||||.|||+.+   -|.+||.||
T Consensus       542 sFCTVLEYceGNDLDFYLKQ---hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDF  617 (775)
T KOG1151|consen  542 SFCTVLEYCEGNDLDFYLKQ---HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDF  617 (775)
T ss_pred             cceeeeeecCCCchhHHHHh---hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeec
Confidence            77899999999999999953   45699999999999999999999987 669999999999999954   578999999


Q ss_pred             ccccccCCCCcc--------eeeccccCccchhhhcCC----CCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHh
Q 013636          300 GLSVTAGTQSRN--------VKISGTLGYVAPEYLLEG----KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVT  367 (439)
Q Consensus       300 Gls~~~~~~~~~--------~~~~gt~~y~aPE~~~~~----~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~  367 (439)
                      |+++.+..++..        ....||.+|++||++.-+    +.+.|+||||.|||+|..+.|+.||......  +.++.
T Consensus       618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ--QdILq  695 (775)
T KOG1151|consen  618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ--QDILQ  695 (775)
T ss_pred             chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH--HHHHh
Confidence            999887665443        123589999999998754    5688999999999999999999999865432  22222


Q ss_pred             hhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh---ccccCCCCCCCcc
Q 013636          368 WAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS---LIPLVPTDLGGSL  436 (439)
Q Consensus       368 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~---L~~l~~~~~~~~~  436 (439)
                      ..- .+. ...+.--..|.+        ..+.-+++.+||+..-++|....++...   |-.+++....|++
T Consensus       696 eNT-Ilk-AtEVqFP~KPvV--------sseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh~rrs~s~gs~  757 (775)
T KOG1151|consen  696 ENT-ILK-ATEVQFPPKPVV--------SSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPHIRRSVSTGSP  757 (775)
T ss_pred             hhc-hhc-ceeccCCCCCcc--------CHHHHHHHHHHHHhhhhhhhhHHHHccCccccchhhhccccCCC
Confidence            110 000 000000011111        1234468999999999999988887643   2233344444443

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-33  Score=261.34  Aligned_cols=239  Identities=23%  Similarity=0.319  Sum_probs=190.3

Q ss_pred             cCCCccceecccCcEEEEEEEECC-ccEEEEEEecCCC---chHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeeEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAG---HDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLV  227 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV  227 (439)
                      .+|....+||+|+||+|..|.-++ ...+|||.+++.-   .++.+--..|-++|... +-|.+++++.++..-+.+|.|
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV  428 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV  428 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence            467778999999999999997654 5678999887532   12222234577777666 578899999999999999999


Q ss_pred             EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccC-
Q 013636          228 YEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAG-  306 (439)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~-  306 (439)
                      |||+.+|+|--++..   -+.+.+.....+|..||-||-+||++   +|+.||||.+||++|.+|++||+|||+++.-- 
T Consensus       429 MEyvnGGDLMyhiQQ---~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~  502 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQQ---VGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF  502 (683)
T ss_pred             EEEecCchhhhHHHH---hcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccccccc
Confidence            999999999888853   34577788889999999999999998   99999999999999999999999999996532 


Q ss_pred             CCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCch
Q 013636          307 TQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPV  386 (439)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  386 (439)
                      ......+++||+.|+|||.+...+|+..+|.|||||+||||+.|++||++.++++....+..      .+...+..+   
T Consensus       503 ~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~e------hnvsyPKsl---  573 (683)
T KOG0696|consen  503 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIME------HNVSYPKSL---  573 (683)
T ss_pred             CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH------ccCcCcccc---
Confidence            23344678999999999999999999999999999999999999999999887765443321      111222211   


Q ss_pred             hcCccCHHHHHHHHHHHHHhcCCCCCCCC
Q 013636          387 IRDTMDLKHLYQVAAVAVLCIQPEPSYRP  415 (439)
Q Consensus       387 l~~~~~~~~~~~l~~l~~~cl~~dP~~RP  415 (439)
                               ..+..+++...+..+|.+|.
T Consensus       574 ---------SkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  574 ---------SKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             ---------cHHHHHHHHHHhhcCCcccc
Confidence                     23445566777888888885

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-33  Score=240.80  Aligned_cols=208  Identities=27%  Similarity=0.417  Sum_probs=171.8

Q ss_pred             HHHHhcCCCccceecccCcEEEEEEEE-CCccEEEEEEecCC-CchHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCee
Q 013636          148 LEAATNNFQESNVIGEGGRGHVYKARF-NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETR  224 (439)
Q Consensus       148 l~~~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  224 (439)
                      ++...+.......||+|++|.|-+-++ .++...|+|++... +.+..++.++|+++..+. .+|.+|.++|...+....
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv  120 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV  120 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence            344445555567899999999988876 46888999999753 334556788899887766 799999999999999999


Q ss_pred             EEEEEeccCCChhhhhcC-CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccccc
Q 013636          225 FLVYEMMQNGSLEKQLHG-PTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSV  303 (439)
Q Consensus       225 ~lV~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~  303 (439)
                      ++.||.|.- ||+.+... ...+..+++..+-+|+..+.+||.|||++  ..++|||+||+||||+.+|++|+||||++-
T Consensus       121 wIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG  197 (282)
T KOG0984|consen  121 WICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISG  197 (282)
T ss_pred             EEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccce
Confidence            999999965 88777643 24567899999999999999999999997  589999999999999999999999999997


Q ss_pred             ccCCCCcceeeccccCccchhhhcC----CCCCCchhhHHHHHHHHHHHhCCCCCCCCC
Q 013636          304 TAGTQSRNVKISGTLGYVAPEYLLE----GKLTDKSDVYAFGVVLLELLMGRRPVEKMS  358 (439)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwS~Gvll~elltG~~P~~~~~  358 (439)
                      ...+.-......|-..|||||.+..    ..|+-|+||||+|+++.||.+++.||+.+.
T Consensus       198 ~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~  256 (282)
T KOG0984|consen  198 YLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG  256 (282)
T ss_pred             eehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence            6654332222347788999999863    368899999999999999999999998764

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-33  Score=271.11  Aligned_cols=248  Identities=23%  Similarity=0.358  Sum_probs=205.1

Q ss_pred             CCCccceecccCcEEEEEEEECCcc-EEEEEEecCC---CchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEE
Q 013636          154 NFQESNVIGEGGRGHVYKARFNEKL-LAAVKRIDDA---GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYE  229 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~~~~-~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  229 (439)
                      +++....||-|+||.|-.++.+... ..|+|.+++.   .....+.+..|-++|..++.|.||+++-.+.++...|+.||
T Consensus       421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE  500 (732)
T KOG0614|consen  421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME  500 (732)
T ss_pred             hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence            4455667999999999999887654 3677777653   33455678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCC
Q 013636          230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS  309 (439)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~  309 (439)
                      -|-||.|...|+.   .+.++......++..+.+|++|||+.   +|+.|||||+|.++|.+|-+||.|||+|+..+...
T Consensus       501 aClGGElWTiLrd---Rg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~  574 (732)
T KOG0614|consen  501 ACLGGELWTILRD---RGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR  574 (732)
T ss_pred             hhcCchhhhhhhh---cCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence            9999999999964   34578888888999999999999998   99999999999999999999999999999999988


Q ss_pred             cceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcC
Q 013636          310 RNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRD  389 (439)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  389 (439)
                      ...+++||+.|.|||.+.+.-.+..+|.||+|+++|||++|.+||.+.+|-...+++-.....+.    +|.        
T Consensus       575 KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~----~Pr--------  642 (732)
T KOG0614|consen  575 KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIE----FPR--------  642 (732)
T ss_pred             ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhh----ccc--------
Confidence            88999999999999999999999999999999999999999999999888665555432211111    111        


Q ss_pred             ccCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHh
Q 013636          390 TMDLKHLYQVAAVAVLCIQPEPSYRPL-----ITDVLHS  423 (439)
Q Consensus       390 ~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~  423 (439)
                          .-.....+++...+..+|.+|.-     ..|+-+|
T Consensus       643 ----~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH  677 (732)
T KOG0614|consen  643 ----RITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH  677 (732)
T ss_pred             ----ccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence                11223456788888889999975     4555544

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-33  Score=267.77  Aligned_cols=245  Identities=25%  Similarity=0.349  Sum_probs=195.1

Q ss_pred             cceecccCcEEEEEEEEC-CccEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEeccCC
Q 013636          158 SNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNG  234 (439)
Q Consensus       158 ~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  234 (439)
                      .+.||+|-||+||-|+.+ .|+.||||.+.+..  ...+.++.+|+.+|++++||.||.+--.|+..+..++|||-+.| 
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G-  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG-  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence            578999999999999875 58999999997643  34456799999999999999999999999999999999999965 


Q ss_pred             ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC---CcEEEEecccccccCCCCcc
Q 013636          235 SLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS---FNAKLSDFGLSVTAGTQSRN  311 (439)
Q Consensus       235 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~---~~~kl~DfGls~~~~~~~~~  311 (439)
                      +..+.+.. .+.+.+++.....+..||+.||.|||..   +|+|+||||+|||+.+.   -.+||||||+|+..+..+..
T Consensus       648 DMLEMILS-sEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR  723 (888)
T KOG4236|consen  648 DMLEMILS-SEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR  723 (888)
T ss_pred             hHHHHHHH-hhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence            55554433 3456799998899999999999999998   99999999999999654   46999999999999988887


Q ss_pred             eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCcc
Q 013636          312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTM  391 (439)
Q Consensus       312 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  391 (439)
                      ....||+.|+|||+++++-|...-|+||.|||+|--++|..||.....  ..+.++.+.          -++.+.-..++
T Consensus       724 rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd--IndQIQNAa----------FMyPp~PW~ei  791 (888)
T KOG4236|consen  724 RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED--INDQIQNAA----------FMYPPNPWSEI  791 (888)
T ss_pred             hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc--hhHHhhccc----------cccCCCchhhc
Confidence            888899999999999999999999999999999999999999975432  222222110          01111111112


Q ss_pred             CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          392 DLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       392 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      +    ....+++-..||..-.+|-+..+-+.+
T Consensus       792 s----~~AidlIn~LLqVkm~kRysvdk~lsh  819 (888)
T KOG4236|consen  792 S----PEAIDLINNLLQVKMRKRYSVDKSLSH  819 (888)
T ss_pred             C----HHHHHHHHHHHHHHHHHhcchHhhccc
Confidence            1    234557777777777788877765543

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-32  Score=277.04  Aligned_cols=245  Identities=27%  Similarity=0.400  Sum_probs=186.0

Q ss_pred             CCCccceecccCcEE-EEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeeEEEEEec
Q 013636          154 NFQESNVIGEGGRGH-VYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMM  231 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~  231 (439)
                      -|...+++|.|+-|+ ||+|..++ +.||||++-..   ......+|+..|+.- +|||||++++.-.++...|+..|.|
T Consensus       510 ~~~~~eilG~Gs~Gt~Vf~G~ye~-R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC  585 (903)
T KOG1027|consen  510 FFSPKEILGYGSNGTVVFRGVYEG-REVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC  585 (903)
T ss_pred             eeccHHHcccCCCCcEEEEEeeCC-ceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence            345567899999877 79999875 47899988642   333457899999988 6999999999999999999999999


Q ss_pred             cCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC-----CCcEEEEeccccccc
Q 013636          232 QNGSLEKQLHGP-THGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDS-----SFNAKLSDFGLSVTA  305 (439)
Q Consensus       232 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~-----~~~~kl~DfGls~~~  305 (439)
                      .. +|.+++... .......-........|++.||++||+.   +|+||||||.||||+.     ...++|+|||+++..
T Consensus       586 ~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl  661 (903)
T KOG1027|consen  586 AC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL  661 (903)
T ss_pred             hh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence            66 999999763 1111111133456788999999999998   9999999999999975     357999999999876


Q ss_pred             CCCCcc----eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCC
Q 013636          306 GTQSRN----VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLP  380 (439)
Q Consensus       306 ~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  380 (439)
                      ..+...    ....||-+|+|||.+....-+.++||||+||++|+.++ |.+||...-..+. +++.       ....+.
T Consensus       662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~-NIl~-------~~~~L~  733 (903)
T KOG1027|consen  662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA-NILT-------GNYTLV  733 (903)
T ss_pred             CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh-hhhc-------Ccccee
Confidence            544332    23569999999999999988999999999999999999 5999986543321 1211       111110


Q ss_pred             ccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          381 NIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       381 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      .     +....  ++  ...+++.+|++++|+.||++.+|+.|
T Consensus       734 ~-----L~~~~--d~--eA~dLI~~ml~~dP~~RPsa~~VL~H  767 (903)
T KOG1027|consen  734 H-----LEPLP--DC--EAKDLISRMLNPDPQLRPSATDVLNH  767 (903)
T ss_pred             e-----eccCc--hH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence            0     11111  11  56679999999999999999999964

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=7.2e-30  Score=230.52  Aligned_cols=210  Identities=37%  Similarity=0.559  Sum_probs=183.0

Q ss_pred             ecccCcEEEEEEEECC-ccEEEEEEecCCCch-HHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEeccCCChhh
Q 013636          161 IGEGGRGHVYKARFNE-KLLAAVKRIDDAGHD-AEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEK  238 (439)
Q Consensus       161 LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~  238 (439)
                      ||+|++|.||++...+ +..+++|........ ....+.+|+..++.++|++++++++++......++++||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999875 788899998765433 34679999999999999999999999999999999999999999999


Q ss_pred             hhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC-CCcEEEEecccccccCCCC-cceeecc
Q 013636          239 QLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDS-SFNAKLSDFGLSVTAGTQS-RNVKISG  316 (439)
Q Consensus       239 ~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~-~~~~kl~DfGls~~~~~~~-~~~~~~g  316 (439)
                      ++....  ..+++..+..++.++++++++||+.   +++|+||+|.||+++. ++.++|+|||.+....... ......+
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~  155 (215)
T cd00180          81 LLKENE--GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVG  155 (215)
T ss_pred             HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccC
Confidence            986432  4589999999999999999999998   9999999999999999 8999999999997664432 1222347


Q ss_pred             ccCccchhhhcCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCccCHHH
Q 013636          317 TLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKH  395 (439)
Q Consensus       317 t~~y~aPE~~~~~-~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  395 (439)
                      ...|++||..... ..+.++|+|++|++++++                                                
T Consensus       156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------  187 (215)
T cd00180         156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------  187 (215)
T ss_pred             CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence            7899999999887 888999999999999999                                                


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCHHHHHHhc
Q 013636          396 LYQVAAVAVLCIQPEPSYRPLITDVLHSL  424 (439)
Q Consensus       396 ~~~l~~l~~~cl~~dP~~RPt~~evl~~L  424 (439)
                       ..+.+++..|++.||++||++.++++++
T Consensus       188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 -PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             -HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence             3566788999999999999999999764

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=6.1e-31  Score=257.86  Aligned_cols=204  Identities=25%  Similarity=0.381  Sum_probs=172.3

Q ss_pred             CCCccceecccCcEEEEEEEECC-ccEEEEEEecCCCc---hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEE
Q 013636          154 NFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGH---DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYE  229 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  229 (439)
                      -|...+.||-|+||+|.+++-.+ ...+|.|.+++...   ........|-+||.....+=||+|+-.|.+++.+|+|||
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd  709 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD  709 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence            45667889999999999996544 56778999876543   233457789999999999999999999999999999999


Q ss_pred             eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccccccc----
Q 013636          230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA----  305 (439)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~----  305 (439)
                      |++||++-.+|-   +-+.+.+.....++..+..|+++.|..   |+|||||||+|||||.+|++||.||||+.-+    
T Consensus       710 YIPGGDmMSLLI---rmgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH  783 (1034)
T KOG0608|consen  710 YIPGGDMMSLLI---RMGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  783 (1034)
T ss_pred             ccCCccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceecc
Confidence            999999999985   345688888888999999999999998   9999999999999999999999999998321    


Q ss_pred             -----CCCCc----------------------------------ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHH
Q 013636          306 -----GTQSR----------------------------------NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLE  346 (439)
Q Consensus       306 -----~~~~~----------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~e  346 (439)
                           ...+.                                  .....||+.|+|||++...-|+.-+|.||.||||||
T Consensus       784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e  863 (1034)
T KOG0608|consen  784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE  863 (1034)
T ss_pred             ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence                 11000                                  011348999999999999999999999999999999


Q ss_pred             HHhCCCCCCCCChhhhh
Q 013636          347 LLMGRRPVEKMSPTQCQ  363 (439)
Q Consensus       347 lltG~~P~~~~~~~~~~  363 (439)
                      |+.|+.||-..++.+.+
T Consensus       864 m~~g~~pf~~~tp~~tq  880 (1034)
T KOG0608|consen  864 MLVGQPPFLADTPGETQ  880 (1034)
T ss_pred             HhhCCCCccCCCCCcce
Confidence            99999999888776544

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.6e-32  Score=242.86  Aligned_cols=259  Identities=24%  Similarity=0.339  Sum_probs=192.6

Q ss_pred             cceecccCcEEEEEEEE-CCccEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC-----eeEEEEE
Q 013636          158 SNVIGEGGRGHVYKARF-NEKLLAAVKRIDDAGH--DAEREFNNEVNWLTKIRHQNIISLLGYCIHAE-----TRFLVYE  229 (439)
Q Consensus       158 ~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lV~e  229 (439)
                      .+.||-|+||.||.+++ +++..++.|++.+.-.  ...+.+.+|+++|..++|.|++..++......     +.|+++|
T Consensus        58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE  137 (449)
T KOG0664|consen   58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE  137 (449)
T ss_pred             CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence            57799999999999977 5688899998875432  33467889999999999999999988765443     5678889


Q ss_pred             eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCC
Q 013636          230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS  309 (439)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~  309 (439)
                      .|.. +|.+.+-.   ...++.+.+.-+..||.+||.|||+.   +|.||||||.|.|+++|..+||||||+++.-..+.
T Consensus       138 LmQS-DLHKIIVS---PQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~  210 (449)
T KOG0664|consen  138 LMQS-DLHKIIVS---PQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD  210 (449)
T ss_pred             HHHh-hhhheecc---CCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchhh
Confidence            8865 78777743   34688888888999999999999998   99999999999999999999999999998755433


Q ss_pred             cc--eeeccccCccchhhhcC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhh--------hccccc---
Q 013636          310 RN--VKISGTLGYVAPEYLLE-GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWA--------MPQLTD---  375 (439)
Q Consensus       310 ~~--~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~--------~~~~~~---  375 (439)
                      ..  ....-|..|+|||.+.+ ..|+.+.||||.||++.|++..+.-|...+|-+...++...        ++...+   
T Consensus       211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk  290 (449)
T KOG0664|consen  211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAK  290 (449)
T ss_pred             hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhH
Confidence            22  22346889999999987 46899999999999999999999999877776544444321        111000   


Q ss_pred             -----C-CCCCccCCchhcCccC-HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhcc
Q 013636          376 -----R-SKLPNIVDPVIRDTMD-LKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLI  425 (439)
Q Consensus       376 -----~-~~~~~~~d~~l~~~~~-~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  425 (439)
                           . .+-+.  -+.+....+ ...-.+-..+.+.++..||+.|.+-.+.+.++.
T Consensus       291 ~H~LR~~~k~Ps--~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~  345 (449)
T KOG0664|consen  291 NHVLRAGLRAPD--TQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY  345 (449)
T ss_pred             HHhhccCCCCCC--ccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence                 0 00000  001110000 112233456777889999999999998887653

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=9.7e-31  Score=239.65  Aligned_cols=199  Identities=25%  Similarity=0.404  Sum_probs=171.0

Q ss_pred             hcCCCccceecccCcEEEEEEEECC-ccEEEEEEecCCC---chHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeeEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAG---HDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFL  226 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  226 (439)
                      -++|...++||+|++++|..+++.. .+.+|+|.+++.-   .++..=...|-.+..+. +||.+|.+..++.....+++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            3678899999999999999998865 5677888876432   12223355666666665 79999999999999999999


Q ss_pred             EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccccccc-
Q 013636          227 VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA-  305 (439)
Q Consensus       227 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~-  305 (439)
                      |.||+++|+|--++.   +...++++....+...|+-||.|||++   +|+.||||.+|||+|..|++||.|+|+++.. 
T Consensus       329 vieyv~ggdlmfhmq---rqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l  402 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL  402 (593)
T ss_pred             EEEEecCcceeeehh---hhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCC
Confidence            999999999977774   345689999999999999999999998   9999999999999999999999999999653 


Q ss_pred             CCCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCC
Q 013636          306 GTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEK  356 (439)
Q Consensus       306 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~  356 (439)
                      .......+++||+.|.|||.+.+..|....|.|++||+++||+.|+.||+.
T Consensus       403 ~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi  453 (593)
T KOG0695|consen  403 GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI  453 (593)
T ss_pred             CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence            444555678999999999999999999999999999999999999999974

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=3.2e-29  Score=229.85  Aligned_cols=197  Identities=34%  Similarity=0.470  Sum_probs=172.6

Q ss_pred             CCccceecccCcEEEEEEEECC-ccEEEEEEecCCCch-HHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEecc
Q 013636          155 FQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHD-AEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQ  232 (439)
Q Consensus       155 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  232 (439)
                      |...+.||+|++|.||++...+ +..+++|........ ..+.+.+|++.+++++|+|++++++++...+..++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            4557889999999999999876 788999999865544 56789999999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCC--c
Q 013636          233 NGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS--R  310 (439)
Q Consensus       233 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~--~  310 (439)
                      +++|.+++....  ..+++.....++.++++++.+||+.   +++|+|++|+||+++.++.++|+|||.+.......  .
T Consensus        81 ~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~  155 (225)
T smart00221       81 GGDLFDYLRKKG--GKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL  155 (225)
T ss_pred             CCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence            999999997432  1288999999999999999999998   99999999999999999999999999997765442  2


Q ss_pred             ceeeccccCccchhhh-cCCCCCCchhhHHHHHHHHHHHhCCCCCCC
Q 013636          311 NVKISGTLGYVAPEYL-LEGKLTDKSDVYAFGVVLLELLMGRRPVEK  356 (439)
Q Consensus       311 ~~~~~gt~~y~aPE~~-~~~~~~~~~DvwS~Gvll~elltG~~P~~~  356 (439)
                      .....++..|++||.+ ....++.++|+|+||++++||++|+.||..
T Consensus       156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            2334578899999998 667788899999999999999999999976

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=4.1e-30  Score=224.45  Aligned_cols=260  Identities=17%  Similarity=0.262  Sum_probs=194.6

Q ss_pred             hcCCCccceecccCcEEEEEEEE-CCccEEEEEEecCCCchHHHHHHHHHHHHHhcC-CCceeeeeeEEEeCC--eeEEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARF-NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR-HQNIISLLGYCIHAE--TRFLV  227 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~~lV  227 (439)
                      .++|++.+++|+|.+++|+.|.. .+...++||.++..   ..+.+.+|+.+|..|+ ||||+++++...+..  ...||
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            46788899999999999999974 55677889998763   4567899999999997 999999999987654  56899


Q ss_pred             EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC-CCcEEEEecccccccC
Q 013636          228 YEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDS-SFNAKLSDFGLSVTAG  306 (439)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~-~~~~kl~DfGls~~~~  306 (439)
                      +||+.+.+...+..      .++...+..+..+++.||.|+|+.   ||+|||+||.|++||. .-.++|+|+|+|.++.
T Consensus       114 FE~v~n~Dfk~ly~------tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH  184 (338)
T KOG0668|consen  114 FEYVNNTDFKQLYP------TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  184 (338)
T ss_pred             hhhhccccHHHHhh------hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcC
Confidence            99999977766552      477788889999999999999999   9999999999999985 5569999999999887


Q ss_pred             CCCcceeeccccCccchhhhcC-CCCCCchhhHHHHHHHHHHHhCCCCCCCC--ChhhhhhhH---------hhhhc-cc
Q 013636          307 TQSRNVKISGTLGYVAPEYLLE-GKLTDKSDVYAFGVVLLELLMGRRPVEKM--SPTQCQSMV---------TWAMP-QL  373 (439)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvll~elltG~~P~~~~--~~~~~~~~~---------~~~~~-~~  373 (439)
                      ..........+..|..||.+.+ ..|+..-|+|||||++..|+..+.||-..  +.++...+.         .+... ++
T Consensus       185 p~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i  264 (338)
T KOG0668|consen  185 PGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQI  264 (338)
T ss_pred             CCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHcc
Confidence            7666555557788999999876 46788899999999999999999998532  323221111         11000 00


Q ss_pred             ccCCCCCccCCchhcC----ccC----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          374 TDRSKLPNIVDPVIRD----TMD----LKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       374 ~~~~~~~~~~d~~l~~----~~~----~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      .-.+...+++..-.+.    ...    .-...+..+++...|..|-++|||++|.+.+
T Consensus       265 ~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H  322 (338)
T KOG0668|consen  265 DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH  322 (338)
T ss_pred             CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence            0111111111111110    000    0012467788999999999999999998865

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.96  E-value=5.9e-30  Score=233.62  Aligned_cols=260  Identities=23%  Similarity=0.308  Sum_probs=192.5

Q ss_pred             cCCCccceecccCcEEEEEEEE-CCccEEEEEEecCC--CchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC------e
Q 013636          153 NNFQESNVIGEGGRGHVYKARF-NEKLLAAVKRIDDA--GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE------T  223 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~  223 (439)
                      .+|.....+|.|.- .|..+.+ -.+..||+|+....  .....++..+|...+..++|+|+++++.++.-..      +
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            45666778888887 5555543 34678888887543  2334456788999999999999999999987543      4


Q ss_pred             eEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccccc
Q 013636          224 RFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSV  303 (439)
Q Consensus       224 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~  303 (439)
                      .|+|||||.. +|...++     -.++-..+.++..|++.|++|||+.   +|+||||||+||++..+..+||.|||+++
T Consensus        96 ~y~v~e~m~~-nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar  166 (369)
T KOG0665|consen   96 VYLVMELMDA-NLCQVIL-----MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLAR  166 (369)
T ss_pred             HHHHHHhhhh-HHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhc
Confidence            6899999965 8888876     2367788899999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhh----------------hhhhHh
Q 013636          304 TAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQ----------------CQSMVT  367 (439)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~----------------~~~~~~  367 (439)
                      ..+..-.......|..|.|||++.+..+.+.+||||.||++.||++|+.-|.+.+.-+                ...+..
T Consensus       167 ~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~  246 (369)
T KOG0665|consen  167 TEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQP  246 (369)
T ss_pred             ccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhH
Confidence            8766644455668999999999999889999999999999999999998887543111                001100


Q ss_pred             hh------hcccccCCCCCccC-CchhcCccC--HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          368 WA------MPQLTDRSKLPNIV-DPVIRDTMD--LKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       368 ~~------~~~~~~~~~~~~~~-d~~l~~~~~--~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      -+      +++-.. -...+.+ |........  .-......+++..||-.||++|-+.+++|+|
T Consensus       247 ~~r~yv~~~~~y~~-~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  247 TVRNYVENRPQYQA-ISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             HHHHHhhcChHhhc-cchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence            00      010000 0111111 111111111  1234456789999999999999999999976

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.96  E-value=4.7e-30  Score=246.82  Aligned_cols=275  Identities=20%  Similarity=0.213  Sum_probs=209.2

Q ss_pred             ccHHHHHHHhcCCCccceecccCcEEEEEEEECC-ccEEEEEEecCCCchHHHHHHHHHHHHHhcC------CCceeeee
Q 013636          143 IEYELLEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKIR------HQNIISLL  215 (439)
Q Consensus       143 ~~~~~l~~~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~  215 (439)
                      +.+...+....+|.+....|+|-|++|.+|+... +..||||++.+... -.+.=+.|+++|++|+      .-|.++++
T Consensus       422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~  500 (752)
T KOG0670|consen  422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLF  500 (752)
T ss_pred             EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence            3445567778899999999999999999998754 67999999987532 2234467999999995      35889999


Q ss_pred             eEEEeCCeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC-CcE
Q 013636          216 GYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS-FNA  294 (439)
Q Consensus       216 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~-~~~  294 (439)
                      -.|...+++|||+|-+.- +|.+.|........|....+..++.|+.-||..|-..   +|+|.||||+|||++++ ..+
T Consensus       501 r~F~hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iL  576 (752)
T KOG0670|consen  501 RHFKHKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNIL  576 (752)
T ss_pred             HHhhhcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCccee
Confidence            999999999999997744 9999998766666788889999999999999999987   99999999999999865 568


Q ss_pred             EEEecccccccCCCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccc
Q 013636          295 KLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLT  374 (439)
Q Consensus       295 kl~DfGls~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~  374 (439)
                      ||||||.|...+.+... .+.-+..|.|||++.+-+|+...|+||.||+||||.||+.-|++.+......+.......++
T Consensus       577 KLCDfGSA~~~~eneit-PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p  655 (752)
T KOG0670|consen  577 KLCDFGSASFASENEIT-PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFP  655 (752)
T ss_pred             eeccCcccccccccccc-HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCc
Confidence            99999999776654432 22245679999999999999999999999999999999999988765443222221111111


Q ss_pred             cC----CC---------------------------CCccCCc------hhcCc--c---CHHHHHHHHHHHHHhcCCCCC
Q 013636          375 DR----SK---------------------------LPNIVDP------VIRDT--M---DLKHLYQVAAVAVLCIQPEPS  412 (439)
Q Consensus       375 ~~----~~---------------------------~~~~~d~------~l~~~--~---~~~~~~~l~~l~~~cl~~dP~  412 (439)
                      ..    +.                           +-..+.|      .+...  .   ....+.++.+|...|+..||+
T Consensus       656 ~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~  735 (752)
T KOG0670|consen  656 NKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPE  735 (752)
T ss_pred             HHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChh
Confidence            00    00                           0000000      11110  1   123456788899999999999


Q ss_pred             CCCCHHHHHHh
Q 013636          413 YRPLITDVLHS  423 (439)
Q Consensus       413 ~RPt~~evl~~  423 (439)
                      +|.|..+.|.|
T Consensus       736 KRit~nqAL~H  746 (752)
T KOG0670|consen  736 KRITVNQALKH  746 (752)
T ss_pred             hcCCHHHHhcC
Confidence            99999999865

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.8e-28  Score=233.45  Aligned_cols=131  Identities=27%  Similarity=0.431  Sum_probs=110.1

Q ss_pred             cCCCccceecccCcEEEEEEEE-CCccEEEEEEecCCCchHHHHHHHHHHHHHhcC-----C---CceeeeeeEEEeC--
Q 013636          153 NNFQESNVIGEGGRGHVYKARF-NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR-----H---QNIISLLGYCIHA--  221 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~~~--  221 (439)
                      .+|.+.++||-|-|++||++.+ .+.+.||+|..+....- .+.-..|+++|++++     |   .+||+|++.|...  
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhY-tEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHY-TEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHH-HHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            7888999999999999999976 45788999998865432 234678999999984     2   4699999999754  


Q ss_pred             --CeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE
Q 013636          222 --ETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILL  288 (439)
Q Consensus       222 --~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl  288 (439)
                        .+.|+|+|+. |-+|..++... .-+.++...+.+|+.|++.||.|||..|  +|+|.||||+|||+
T Consensus       157 NG~HVCMVfEvL-GdnLLklI~~s-~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  157 NGQHVCMVFEVL-GDNLLKLIKYS-NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL  221 (590)
T ss_pred             CCcEEEEEehhh-hhHHHHHHHHh-CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence              4789999998 55888888653 3456899999999999999999999986  99999999999999

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.96  E-value=7.6e-30  Score=251.95  Aligned_cols=252  Identities=27%  Similarity=0.400  Sum_probs=205.0

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEe
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      .++|.....+|.|.+|.|||+++. .+..+|+|.++-...++..-..+|+-+++..+||||+.++|.+...+..++.|||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            356777889999999999999875 4778899999877777777788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC-C
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ-S  309 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~-~  309 (439)
                      |.+|+|.+..+.   ...+++.++...+....+|++|||+.   +-+|||||-.|||+++.|.+|++|||.+-.+... .
T Consensus        94 cgggslQdiy~~---TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati~  167 (829)
T KOG0576|consen   94 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATIA  167 (829)
T ss_pred             cCCCcccceeee---cccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhhh
Confidence            999999998874   34699999999999999999999998   8899999999999999999999999998766543 2


Q ss_pred             cceeeccccCccchhhhc---CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCch
Q 013636          310 RNVKISGTLGYVAPEYLL---EGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPV  386 (439)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  386 (439)
                      ....+.||+.|||||+..   .+-|..++|||+.|+...|+---+.|.-...+.....+...-      ..+-+..-|+.
T Consensus       168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS------~~qpp~lkDk~  241 (829)
T KOG0576|consen  168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKS------GFQPPTLKDKT  241 (829)
T ss_pred             hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhcc------CCCCCcccCCc
Confidence            334567999999999864   467889999999999999998888887666555443333211      11111122221


Q ss_pred             hcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 013636          387 IRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLH  422 (439)
Q Consensus       387 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  422 (439)
                             .-...+-+++..|+..+|..||+++.+++
T Consensus       242 -------kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  242 -------KWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             -------cchHHHHHHHHHHhcCCCccCCChhhhee
Confidence                   11234567888999999999999998886

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.96  E-value=7.1e-29  Score=241.51  Aligned_cols=197  Identities=25%  Similarity=0.353  Sum_probs=166.7

Q ss_pred             cCCCccceecccCcEEEEEEEECC-ccEEEEEEecCCC-----chH---HHHHHHHHHHHHhcC---CCceeeeeeEEEe
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAG-----HDA---EREFNNEVNWLTKIR---HQNIISLLGYCIH  220 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-----~~~---~~~~~~E~~~l~~l~---h~niv~l~~~~~~  220 (439)
                      ..|...+.+|+|+||.|+.+.++. ...|++|.+.+..     +..   .-....|+.+|..++   |+||+++++++++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            357888999999999999998865 4567788776432     111   112567999999997   9999999999999


Q ss_pred             CCeeEEEEEecc-CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEec
Q 013636          221 AETRFLVYEMMQ-NGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDF  299 (439)
Q Consensus       221 ~~~~~lV~e~~~-~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~Df  299 (439)
                      ++.+||+||-.. +-+|++++..   ...+++.....|+.|++.|+++||++   +|+|||||-+||.++.+|-+||+||
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~---kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidf  714 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEF---KPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDF  714 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhc---cCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeec
Confidence            999999999764 4589999954   45699999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCcceeeccccCccchhhhcCCCC-CCchhhHHHHHHHHHHHhCCCCCCC
Q 013636          300 GLSVTAGTQSRNVKISGTLGYVAPEYLLEGKL-TDKSDVYAFGVVLLELLMGRRPVEK  356 (439)
Q Consensus       300 Gls~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvll~elltG~~P~~~  356 (439)
                      |.+....+. ....+.||.+|.|||++.+.+| ...-|||++|++||.++....||.+
T Consensus       715 gsaa~~ksg-pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  715 GSAAYTKSG-PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             cchhhhcCC-CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            998665433 3345679999999999999877 4568999999999999999888864

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=3.5e-28  Score=217.23  Aligned_cols=248  Identities=23%  Similarity=0.355  Sum_probs=181.8

Q ss_pred             hcCCCccceecccCcEEEEEEEECC-ccEEEEEEecCCCchHHHHHHHHHHHHHhc-CCCceeeeeeE-EEeCCeeEEEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKI-RHQNIISLLGY-CIHAETRFLVY  228 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-~~~~~~~~lV~  228 (439)
                      .+.|.+.+.||+|.||.+-.+..+. ++.+++|-+... ....++|.+|...--.| .|.||+.-++. ++..+.+..++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            4678888999999999999999876 566777777643 45678899998765555 58999988764 56667888999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc--CCCcEEEEecccccccC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLD--SSFNAKLSDFGLSVTAG  306 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~--~~~~~kl~DfGls~~~~  306 (439)
                      ||++.|+|.+-+..    ..+-+....+++.|++.|+.|+|+.   .+||||||.+||||-  +..++||||||+++..+
T Consensus       102 E~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g  174 (378)
T KOG1345|consen  102 EFAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG  174 (378)
T ss_pred             ccCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccC
Confidence            99999999887753    3377888899999999999999998   999999999999993  44579999999998765


Q ss_pred             CCCcceeeccccCccchhhhcCC-----CCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCc
Q 013636          307 TQSRNVKISGTLGYVAPEYLLEG-----KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPN  381 (439)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  381 (439)
                      ..-..  ...+..|.+||.+...     ...+.+|+|.||++++.++||+.||..... .......|..-.-.....+|+
T Consensus       175 ~tV~~--~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~-~d~~Y~~~~~w~~rk~~~~P~  251 (378)
T KOG1345|consen  175 TTVKY--LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI-MDKPYWEWEQWLKRKNPALPK  251 (378)
T ss_pred             ceehh--hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc-cCchHHHHHHHhcccCccCch
Confidence            43332  2246779999987642     345689999999999999999999985432 223333333222223334444


Q ss_pred             cCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 013636          382 IVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITD  419 (439)
Q Consensus       382 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e  419 (439)
                      .+.+.         ..+...+-.+-+.++|++|=...+
T Consensus       252 ~F~~f---------s~~a~r~Fkk~lt~~~~drcki~~  280 (378)
T KOG1345|consen  252 KFNPF---------SEKALRLFKKSLTPRFKDRCKIWT  280 (378)
T ss_pred             hhccc---------CHHHHHHHHHhcCCcccccchhHH
Confidence            44331         123344556677888888843333

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.95  E-value=2e-28  Score=265.39  Aligned_cols=194  Identities=24%  Similarity=0.312  Sum_probs=138.5

Q ss_pred             hcCC-CceeeeeeEE-------EeCCeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 013636          205 KIRH-QNIISLLGYC-------IHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPV  276 (439)
Q Consensus       205 ~l~h-~niv~l~~~~-------~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~i  276 (439)
                      .++| +||.++++++       ...+..+.++||+ +++|.++|+..  ...+++..++.++.||++||+|||++   +|
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---gI  101 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQ---GI  101 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            3445 5788888877       2334567788887 55999999742  34599999999999999999999998   99


Q ss_pred             EecCCCCCCEEEcC-------------------CCcEEEEecccccccCCCC-----------------cceeeccccCc
Q 013636          277 VHRDLKSSNILLDS-------------------SFNAKLSDFGLSVTAGTQS-----------------RNVKISGTLGY  320 (439)
Q Consensus       277 vH~Dlk~~NiLl~~-------------------~~~~kl~DfGls~~~~~~~-----------------~~~~~~gt~~y  320 (439)
                      +||||||+||||+.                   ++.+|++|||+++......                 ......||+.|
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  181 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY  181 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence            99999999999965                   4456666666664321100                 00112478889


Q ss_pred             cchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCccCHHHHHHHH
Q 013636          321 VAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVA  400 (439)
Q Consensus       321 ~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~  400 (439)
                      +|||++.+..++.++|||||||+||||++|..|+......  ......  .      .    ..+..     ........
T Consensus       182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~--~~~~~~--~------~----~~~~~-----~~~~~~~~  242 (793)
T PLN00181        182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRT--MSSLRH--R------V----LPPQI-----LLNWPKEA  242 (793)
T ss_pred             EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHH--HHHHHH--h------h----cChhh-----hhcCHHHH
Confidence            9999999999999999999999999999998886532211  111100  0      0    01100     01123345


Q ss_pred             HHHHHhcCCCCCCCCCHHHHHHh
Q 013636          401 AVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       401 ~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      .++.+||+.+|.+||++.|++++
T Consensus       243 ~~~~~~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        243 SFCLWLLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             HHHHHhCCCChhhCcChHHHhhc
Confidence            77889999999999999999975

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=4.6e-27  Score=208.25  Aligned_cols=170  Identities=22%  Similarity=0.234  Sum_probs=126.1

Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCccee
Q 013636          234 GSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK  313 (439)
Q Consensus       234 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~~~~  313 (439)
                      |||.++++.  .+..+++..+..++.|+++||+|||+.   +      ||+|||++.++.+|+  ||++........   
T Consensus         1 GsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~~---   64 (176)
T smart00750        1 VSLADILEV--RGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQS---   64 (176)
T ss_pred             CcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeeccccC---
Confidence            789999973  245699999999999999999999997   4      999999999999999  999876544322   


Q ss_pred             eccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCccCH
Q 013636          314 ISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDL  393 (439)
Q Consensus       314 ~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  393 (439)
                       .||+.|+|||++.+..++.++|||||||++|||++|+.||.......  ...............    .+.  ......
T Consensus        65 -~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~----~~~--~~~~~~  135 (176)
T smart00750       65 -RVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--AILEILLNGMPADDP----RDR--SNLESV  135 (176)
T ss_pred             -CCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHHHHHHHhccCCc----ccc--ccHHHH
Confidence             48899999999999999999999999999999999999997543211  111111100000000    000  000000


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccC
Q 013636          394 KHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLV  428 (439)
Q Consensus       394 ~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~  428 (439)
                      .....+.+++.+||+.||++||++.|+++++..+.
T Consensus       136 ~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      136 SAARSFADFMRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             HhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence            11125888999999999999999999999886543

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.94  E-value=3.4e-27  Score=223.10  Aligned_cols=198  Identities=29%  Similarity=0.400  Sum_probs=165.3

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEEC----CccEEEEEEecCCCchHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCe
Q 013636          149 EAATNNFQESNVIGEGGRGHVYKARFN----EKLLAAVKRIDDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAET  223 (439)
Q Consensus       149 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  223 (439)
                      ....+.|...++||+|.|++||++.+.    ....+|+|.+...+..  ..+.+|+++|..+ .+.||+++.+++..++.
T Consensus        32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~  109 (418)
T KOG1167|consen   32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNNDQ  109 (418)
T ss_pred             hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence            344577888999999999999999764    3678899999865433  4588999999999 59999999999999999


Q ss_pred             eEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC-CCcEEEEecccc
Q 013636          224 RFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDS-SFNAKLSDFGLS  302 (439)
Q Consensus       224 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~-~~~~kl~DfGls  302 (439)
                      ..+|+||+++.+-.+++..      ++...+..+...+..||+++|..   ||+||||||+|+|.+. .+.-.|.|||++
T Consensus       110 v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA  180 (418)
T KOG1167|consen  110 VAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLA  180 (418)
T ss_pred             eEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhH
Confidence            9999999999999888853      66788999999999999999998   9999999999999974 567899999998


Q ss_pred             cccCC----------------C-----------------Cc------------ceeeccccCccchhhhcC-CCCCCchh
Q 013636          303 VTAGT----------------Q-----------------SR------------NVKISGTLGYVAPEYLLE-GKLTDKSD  336 (439)
Q Consensus       303 ~~~~~----------------~-----------------~~------------~~~~~gt~~y~aPE~~~~-~~~~~~~D  336 (439)
                      .....                .                 ..            .....||+||.|||++.. ...++++|
T Consensus       181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD  260 (418)
T KOG1167|consen  181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID  260 (418)
T ss_pred             HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence            61100                0                 00            001238999999999876 45688999


Q ss_pred             hHHHHHHHHHHHhCCCCCCCC
Q 013636          337 VYAFGVVLLELLMGRRPVEKM  357 (439)
Q Consensus       337 vwS~Gvll~elltG~~P~~~~  357 (439)
                      |||-|||++-+++++.||-..
T Consensus       261 iws~GVI~Lslls~~~PFf~a  281 (418)
T KOG1167|consen  261 IWSAGVILLSLLSRRYPFFKA  281 (418)
T ss_pred             eeeccceeehhhccccccccC
Confidence            999999999999999999643

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.2e-26  Score=207.61  Aligned_cols=248  Identities=21%  Similarity=0.375  Sum_probs=188.9

Q ss_pred             cceecccCcEEEEEEEECCccEEEEEEecC--CCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEeccCCC
Q 013636          158 SNVIGEGGRGHVYKARFNEKLLAAVKRIDD--AGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGS  235 (439)
Q Consensus       158 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  235 (439)
                      ..+|.+...|+.|+|++++... ++|.++-  ......++|.+|.-.|+.+.||||++++|.|.......++..||+.||
T Consensus       195 ~tkl~e~hsgelwrgrwqgndi-vakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs  273 (448)
T KOG0195|consen  195 ITKLAESHSGELWRGRWQGNDI-VAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS  273 (448)
T ss_pred             hhhhccCCCcccccccccCcch-hhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence            3468888999999999987544 4455543  223344689999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCcceeec
Q 013636          236 LEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS  315 (439)
Q Consensus       236 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~~~~~~  315 (439)
                      |+..||+.. +-.++..+..+++.++|+|++|||+. .+-|..--|++..|++|++.+++|+- +-.++.-..   ....
T Consensus       274 lynvlhe~t-~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~kfsfqe---~gr~  347 (448)
T KOG0195|consen  274 LYNVLHEQT-SVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTKFSFQE---VGRA  347 (448)
T ss_pred             HHHHHhcCc-cEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-ccceeeeec---cccc
Confidence            999999743 44577889999999999999999997 22344556899999999999988752 111111000   1112


Q ss_pred             cccCccchhhhcCCCCC---CchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCccC
Q 013636          316 GTLGYVAPEYLLEGKLT---DKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMD  392 (439)
Q Consensus       316 gt~~y~aPE~~~~~~~~---~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  392 (439)
                      -.+.|++||.++..+-+   ..+|+|||++++||+.|...||...++-++...+..        +        .++-.++
T Consensus       348 y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial--------e--------glrv~ip  411 (448)
T KOG0195|consen  348 YSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL--------E--------GLRVHIP  411 (448)
T ss_pred             cCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh--------c--------cccccCC
Confidence            46889999999876543   479999999999999999999999988877655431        1        1122222


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccC
Q 013636          393 LKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLV  428 (439)
Q Consensus       393 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~  428 (439)
                      +.-...+.+++.-|.+.||.+||.+..++-.|+++.
T Consensus       412 pgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  412 PGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             CCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            223446777888999999999999999998887653

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=3.9e-24  Score=207.98  Aligned_cols=258  Identities=22%  Similarity=0.224  Sum_probs=190.8

Q ss_pred             CCCccceecccCcEEEEEEEECCc--cEEEEEEecCCCchHHHHHHHHHHHHHhcCC----CceeeeeeEE-EeCCeeEE
Q 013636          154 NFQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHDAEREFNNEVNWLTKIRH----QNIISLLGYC-IHAETRFL  226 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~l  226 (439)
                      +|.+.+.||+|+||.||.+.....  ..+|+|............+..|..++..+..    +++..+++.. ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            788999999999999999997664  4677777665433222267778888888863    6888888888 46778899


Q ss_pred             EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC-----CcEEEEeccc
Q 013636          227 VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS-----FNAKLSDFGL  301 (439)
Q Consensus       227 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~-----~~~kl~DfGl  301 (439)
                      ||+.+ +.+|.++..... ...++..+.++++.|++.+|++||+.   +++||||||.|+++...     ..+.|.|||+
T Consensus        99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl  173 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL  173 (322)
T ss_pred             EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence            99987 669999875433 56799999999999999999999998   99999999999999765     4699999999


Q ss_pred             cc--ccCCCCc---------ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhh
Q 013636          302 SV--TAGTQSR---------NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAM  370 (439)
Q Consensus       302 s~--~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~  370 (439)
                      ++  .......         .....||.+|.++....+...+.+.|+||++.++.|++.|..||...........+....
T Consensus       174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~  253 (322)
T KOG1164|consen  174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP  253 (322)
T ss_pred             CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence            98  3211110         122459999999999999999999999999999999999999997665332211111110


Q ss_pred             cccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCC
Q 013636          371 PQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVP  429 (439)
Q Consensus       371 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~  429 (439)
                      .    ......      ...   .....+.++...+-..+..++|....+...+.....
T Consensus       254 ~----~~~~~~------~~~---~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~  299 (322)
T KOG1164|consen  254 R----KLLTDR------FGD---LKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFD  299 (322)
T ss_pred             h----hhcccc------ccC---CChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence            0    000000      011   112344445555556899999999999888765544

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.92  E-value=1.5e-24  Score=211.23  Aligned_cols=163  Identities=21%  Similarity=0.174  Sum_probs=127.2

Q ss_pred             HHhcCCCccceecccCcEEEEEEEEC--CccEEEEEEecCC-----CchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC
Q 013636          150 AATNNFQESNVIGEGGRGHVYKARFN--EKLLAAVKRIDDA-----GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE  222 (439)
Q Consensus       150 ~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  222 (439)
                      ...++|+..+.||+|+||+||+|+..  ++..+|+|++...     .....+.|.+|+++|++++|+|+++.+..   .+
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~   91 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TG   91 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cC
Confidence            44578999999999999999999875  4677899987532     12234568999999999999999863322   24


Q ss_pred             eeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC-CCCCEEEcCCCcEEEEeccc
Q 013636          223 TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDL-KSSNILLDSSFNAKLSDFGL  301 (439)
Q Consensus       223 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dl-k~~NiLl~~~~~~kl~DfGl  301 (439)
                      ..++||||+++++|.. ..  ..    .   ...++.+++++|+|||+.   +|+|||| ||+|||++.++++||+|||+
T Consensus        92 ~~~LVmE~~~G~~L~~-~~--~~----~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGl  158 (365)
T PRK09188         92 KDGLVRGWTEGVPLHL-AR--PH----G---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQL  158 (365)
T ss_pred             CcEEEEEccCCCCHHH-hC--cc----c---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECcc
Confidence            6799999999999963 21  11    1   146788999999999998   9999999 99999999999999999999


Q ss_pred             ccccCCCCcc---------eeeccccCccchhhhcC
Q 013636          302 SVTAGTQSRN---------VKISGTLGYVAPEYLLE  328 (439)
Q Consensus       302 s~~~~~~~~~---------~~~~gt~~y~aPE~~~~  328 (439)
                      |+........         ....+++.|+|||.+..
T Consensus       159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             ceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            9765443211         22347888999998864

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.91  E-value=2.6e-22  Score=192.88  Aligned_cols=255  Identities=29%  Similarity=0.391  Sum_probs=195.0

Q ss_pred             CCccceecccCcEEEEEEEECCccEEEEEEecCCCch---HHHHHHHHHHHHHhcCCC-ceeeeeeEEEeCCeeEEEEEe
Q 013636          155 FQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ-NIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       155 ~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lV~e~  230 (439)
                      |...+.||.|+||.||++...  ..+++|.+......   ....+.+|+..+..+.|+ +++++.+.+......+++++|
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            556788999999999999988  67788888654332   367799999999999988 799999999777778999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC-cEEEEecccccccCCCC
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSF-NAKLSDFGLSVTAGTQS  309 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~-~~kl~DfGls~~~~~~~  309 (439)
                      +.++++.+++........++......+..|++.++.|+|+.   +++|||+||+||+++..+ .++++|||.+.......
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            99999997775322113688899999999999999999998   899999999999999988 79999999987543322


Q ss_pred             -------cceeeccccCccchhhhcC---CCCCCchhhHHHHHHHHHHHhCCCCCCCCCh----hhhhhhHhhhhccccc
Q 013636          310 -------RNVKISGTLGYVAPEYLLE---GKLTDKSDVYAFGVVLLELLMGRRPVEKMSP----TQCQSMVTWAMPQLTD  375 (439)
Q Consensus       310 -------~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwS~Gvll~elltG~~P~~~~~~----~~~~~~~~~~~~~~~~  375 (439)
                             ......||..|+|||.+.+   ..++...|+||+|++++++++|..|+.....    ......+......   
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---  233 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP---  233 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc---
Confidence                   1244569999999999988   5788999999999999999999999776543    1212221111000   


Q ss_pred             CCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          376 RSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       376 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                        .......+...    ......+.+++..|+..+|..|.+..+....
T Consensus       234 --~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         234 --SLASPLSPSNP----ELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             --ccccccCcccc----chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence              00000111000    2223567778899999999999999887754

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.87  E-value=6.1e-23  Score=212.50  Aligned_cols=250  Identities=22%  Similarity=0.250  Sum_probs=179.0

Q ss_pred             ccceecccCcEEEEEEEECC-ccEEEEEEecC-C-CchHH----HHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEE
Q 013636          157 ESNVIGEGGRGHVYKARFNE-KLLAAVKRIDD-A-GHDAE----REFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYE  229 (439)
Q Consensus       157 ~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~-~-~~~~~----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  229 (439)
                      ..+++|.|.+|.|+...... ....+.|.... . .....    ..+..|+.+-..+.|+|++..+..+.+.....-.||
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            46789999999777665422 22222222110 0 11111    125678888888999999888887777666666699


Q ss_pred             eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCC
Q 013636          230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS  309 (439)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~  309 (439)
                      ||+. +|..++...   ..++...+-.++.|+..|+.|+|+.   ++.|||+|++|++++.++.+||+|||.+.......
T Consensus       402 ~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~  474 (601)
T KOG0590|consen  402 YCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW  474 (601)
T ss_pred             cccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence            9999 999998542   4578888999999999999999998   99999999999999999999999999986543322


Q ss_pred             c-----ceeeccccCccchhhhcCCCCCC-chhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccC
Q 013636          310 R-----NVKISGTLGYVAPEYLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV  383 (439)
Q Consensus       310 ~-----~~~~~gt~~y~aPE~~~~~~~~~-~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  383 (439)
                      .     ....+|+-.|+|||.+.+.+|.+ ..||||.|+++..|.+|+.||......+.....      ....... ...
T Consensus       475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~------~~~~~~~-~~~  547 (601)
T KOG0590|consen  475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT------NNYSDQR-NIF  547 (601)
T ss_pred             chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh------hcccccc-ccc
Confidence            2     24466899999999999999876 689999999999999999999765443221100      0000000 000


Q ss_pred             CchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 013636          384 DPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLH  422 (439)
Q Consensus       384 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  422 (439)
                      ..  ..............++.++|+.||.+|-|++++++
T Consensus       548 ~~--~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  548 EG--PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             cC--hHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            00  00011123445667899999999999999999985

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.87  E-value=5.9e-22  Score=180.01  Aligned_cols=173  Identities=16%  Similarity=0.183  Sum_probs=135.1

Q ss_pred             HHhcCCCccceecccCcEEEEEEEECCccEEEEEEecCCCchHHHH---------HHHHHHHHHhcCCCceeeeeeEEEe
Q 013636          150 AATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAERE---------FNNEVNWLTKIRHQNIISLLGYCIH  220 (439)
Q Consensus       150 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~  220 (439)
                      ...++|+..+++|.|+||.||.+.. ++..+|+|.+........+.         +.+|+..+.+++|++|..+.+++..
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            4568999999999999999999766 45679999997543333322         6799999999999999999888654


Q ss_pred             C--------CeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC
Q 013636          221 A--------ETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSF  292 (439)
Q Consensus       221 ~--------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~  292 (439)
                      .        +..+++|||++|.+|.++..       ++.    ....+++.++..+|+.   +++|||++|+|+++++++
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g  172 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG  172 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC
Confidence            3        35789999999999988742       222    2455999999999998   999999999999999988


Q ss_pred             cEEEEecccccccCCCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh
Q 013636          293 NAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM  349 (439)
Q Consensus       293 ~~kl~DfGls~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt  349 (439)
                       ++|+|||...........           ...+....+..++|+||||+++.-+..
T Consensus       173 -i~liDfg~~~~~~e~~a~-----------d~~vler~y~~~~di~~lg~~~~~~~~  217 (232)
T PRK10359        173 -LRIIDLSGKRCTAQRKAK-----------DRIDLERHYGIKNEIKDLGYYLLIYKK  217 (232)
T ss_pred             -EEEEECCCcccccchhhH-----------HHHHHHhHhcccccccceeEeehHHHH
Confidence             999999988654321111           114445556789999999998877643

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.87  E-value=1.1e-21  Score=175.76  Aligned_cols=140  Identities=19%  Similarity=0.179  Sum_probs=108.3

Q ss_pred             cceecccCcEEEEEEEECCccEEEEEEecCCCch--H-------H-----------------HHHHHHHHHHHhcCCCce
Q 013636          158 SNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHD--A-------E-----------------REFNNEVNWLTKIRHQNI  211 (439)
Q Consensus       158 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~E~~~l~~l~h~ni  211 (439)
                      .+.||+|+||.||+|...++..+|+|.++.....  .       .                 .....|+..+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            3679999999999999888899999998653211  0       0                 112359999999988776


Q ss_pred             eeeeeEEEeCCeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHH-hhcCCCCeEecCCCCCCEEEcC
Q 013636          212 ISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYL-HEHCNHPVVHRDLKSSNILLDS  290 (439)
Q Consensus       212 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~L-H~~~~~~ivH~Dlk~~NiLl~~  290 (439)
                      .....+..  ...++||||++++++.....   ....++......++.|++.+|.|+ |+.   +++||||||+|||++ 
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-  152 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-  152 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-
Confidence            44333222  23489999999987765432   123588999999999999999999 677   999999999999998 


Q ss_pred             CCcEEEEecccccccC
Q 013636          291 SFNAKLSDFGLSVTAG  306 (439)
Q Consensus       291 ~~~~kl~DfGls~~~~  306 (439)
                      ++.++|+|||+|....
T Consensus       153 ~~~v~LiDFG~a~~~~  168 (190)
T cd05147         153 DGKLYIIDVSQSVEHD  168 (190)
T ss_pred             CCcEEEEEccccccCC
Confidence            4789999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.86  E-value=1.1e-21  Score=194.69  Aligned_cols=215  Identities=27%  Similarity=0.448  Sum_probs=163.1

Q ss_pred             HHhcCCCceeeeeeEEEeCCeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCe-EecCC
Q 013636          203 LTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPV-VHRDL  281 (439)
Q Consensus       203 l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~i-vH~Dl  281 (439)
                      |+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+..  ....++|.....+..+++.||+|||+.   +| .|+.+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l   75 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGAL   75 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeee
Confidence            3568899999999999999999999999999999999974  456799999999999999999999986   44 99999


Q ss_pred             CCCCEEEcCCCcEEEEecccccccCCC---CcceeeccccCccchhhhcCC-------CCCCchhhHHHHHHHHHHHhCC
Q 013636          282 KSSNILLDSSFNAKLSDFGLSVTAGTQ---SRNVKISGTLGYVAPEYLLEG-------KLTDKSDVYAFGVVLLELLMGR  351 (439)
Q Consensus       282 k~~NiLl~~~~~~kl~DfGls~~~~~~---~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwS~Gvll~elltG~  351 (439)
                      +++|+++|....+||+|||+.......   .......-..-|.|||.+.+.       ..+.++||||||++++|+++.+
T Consensus        76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~  155 (484)
T KOG1023|consen   76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS  155 (484)
T ss_pred             ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence            999999999999999999998765321   111111134569999999864       2467899999999999999999


Q ss_pred             CCCCCCChhhh-hhhHhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCC
Q 013636          352 RPVEKMSPTQC-QSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPT  430 (439)
Q Consensus       352 ~P~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~  430 (439)
                      .||+....... ..++.+...      .-...+-|.+....  +....+..++..||..+|++||+++++-..+..+...
T Consensus       156 ~~~~~~~~~~~~~eii~~~~~------~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~  227 (484)
T KOG1023|consen  156 GPFDLRNLVEDPDEIILRVKK------GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG  227 (484)
T ss_pred             CccccccccCChHHHHHHHHh------cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence            99986432211 222222111      11112222222111  2223678899999999999999999999888777654

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.85  E-value=1.8e-21  Score=171.77  Aligned_cols=201  Identities=20%  Similarity=0.283  Sum_probs=166.0

Q ss_pred             hcCCCccceecccCcEEEEEEEE-CCccEEEEEEecCCCchHHHHHHHHHHHHHhcCC-CceeeeeeEEEeCCeeEEEEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARF-NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRH-QNIISLLGYCIHAETRFLVYE  229 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~e  229 (439)
                      ..+|...++||.|+||.+|.|.. .++..||+|.-.....  .-+...|..+.+.+++ ..|..+..+..+.+.-.+|||
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            46788899999999999999965 6789999998765432  2356778999999975 667777777788888899999


Q ss_pred             eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC---CCcEEEEecccccccC
Q 013636          230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDS---SFNAKLSDFGLSVTAG  306 (439)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~---~~~~kl~DfGls~~~~  306 (439)
                      .. +.||.+++.-.  ...++..+.+-++-|+..-++|+|.+   +++||||||+|+|..-   ...+.++|||+|+.+.
T Consensus        92 LL-GPsLEdLfnfC--~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   92 LL-GPSLEDLFNFC--SRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             cc-CccHHHHHHHH--hhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhc
Confidence            87 67999988632  24588899999999999999999998   9999999999999964   3469999999997654


Q ss_pred             CCCc--------ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChh
Q 013636          307 TQSR--------NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPT  360 (439)
Q Consensus       307 ~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~  360 (439)
                      +...        .....||.+|.+-....+...+.+.|+-|+|.+|..+--|..||.+..+.
T Consensus       166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~  227 (341)
T KOG1163|consen  166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA  227 (341)
T ss_pred             cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh
Confidence            3221        23456999999988888888889999999999999999999999987653

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.85  E-value=1.9e-20  Score=168.13  Aligned_cols=140  Identities=19%  Similarity=0.175  Sum_probs=111.2

Q ss_pred             cceecccCcEEEEEEEECCccEEEEEEecCCCch----------------------H----HHHHHHHHHHHHhcCCCce
Q 013636          158 SNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHD----------------------A----EREFNNEVNWLTKIRHQNI  211 (439)
Q Consensus       158 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----------------------~----~~~~~~E~~~l~~l~h~ni  211 (439)
                      .+.||+|+||.||+|+..++..+|+|.++.....                      .    ...+..|...+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            4679999999999999888999999998754211                      0    1124578999999999987


Q ss_pred             eeeeeEEEeCCeeEEEEEeccCCChhhh-hcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCCEEEc
Q 013636          212 ISLLGYCIHAETRFLVYEMMQNGSLEKQ-LHGPTHGSNLTWHLRMKIAVDVARGLEYLHE-HCNHPVVHRDLKSSNILLD  289 (439)
Q Consensus       212 v~l~~~~~~~~~~~lV~e~~~~gsL~~~-l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~-~~~~~ivH~Dlk~~NiLl~  289 (439)
                      .....+...  ..++||||++++++... +.    ...++......++.|++.++.++|+ .   +++||||||+||+++
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~----~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~  152 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK----DVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH  152 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhhh----hccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE
Confidence            554444332  34899999998865443 32    2347788899999999999999999 7   999999999999999


Q ss_pred             CCCcEEEEecccccccCC
Q 013636          290 SSFNAKLSDFGLSVTAGT  307 (439)
Q Consensus       290 ~~~~~kl~DfGls~~~~~  307 (439)
                       ++.++|+|||++.....
T Consensus       153 -~~~~~liDFG~a~~~~~  169 (190)
T cd05145         153 -DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             -CCCEEEEEcccceecCC
Confidence             88999999999976644

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.85  E-value=9.1e-21  Score=174.40  Aligned_cols=199  Identities=21%  Similarity=0.322  Sum_probs=165.6

Q ss_pred             cCCCccceecccCcEEEEEEEE-CCccEEEEEEecCCCchHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeeEEEEEe
Q 013636          153 NNFQESNVIGEGGRGHVYKARF-NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      -+|.+.++||+|+||..+.|+. -++..||||.-...+  ..-++..|.+..+.| ..++|...+-+-..+-.-.||+|.
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL  105 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL  105 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence            4788899999999999999964 567889999765433  233567788888887 468888888777777788899998


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC-----CcEEEEeccccccc
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS-----FNAKLSDFGLSVTA  305 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~-----~~~kl~DfGls~~~  305 (439)
                      . |-||++++.-  -+..++.+++..+|.|++.-++|+|++   .+|.|||||+|+||..-     ..+.++|||+|+.+
T Consensus       106 L-GPSLEDLFD~--CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y  179 (449)
T KOG1165|consen  106 L-GPSLEDLFDL--CGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY  179 (449)
T ss_pred             h-CcCHHHHHHH--hcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence            7 6699998863  345689999999999999999999998   99999999999999643     45999999999776


Q ss_pred             CCCCcc--------eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 013636          306 GTQSRN--------VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSP  359 (439)
Q Consensus       306 ~~~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~  359 (439)
                      .+....        ....||.+||+-....+.+-+.+.|+-|+|-++.+.+-|..||.+...
T Consensus       180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA  241 (449)
T KOG1165|consen  180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA  241 (449)
T ss_pred             cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence            543221        345699999999999999999999999999999999999999987654

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.84  E-value=5e-22  Score=206.46  Aligned_cols=246  Identities=22%  Similarity=0.265  Sum_probs=176.4

Q ss_pred             CCCccceecccCcEEEEEEEECCccEEEEEEecCCC-chHHHHHH---HHHHHHHhcCCCceeeeeeEEEeCCeeEEEEE
Q 013636          154 NFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAG-HDAEREFN---NEVNWLTKIRHQNIISLLGYCIHAETRFLVYE  229 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~---~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  229 (439)
                      ++...+.||.++|=+|.+++.++|. ++||.+-+.. .-..+.|.   .|++ ...++|||.+++.-+-......|||-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            5666788999999999999999988 6777664432 23334444   3444 555689999999877666667788889


Q ss_pred             eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccccccc--CC
Q 013636          230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA--GT  307 (439)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~--~~  307 (439)
                      |..+ +|+|.+.   .+.-+...+..-|+.|+..|+.-+|..   +|+|||||.+||||+.-+=+.|+||.--+..  ..
T Consensus       102 yvkh-nLyDRlS---TRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe  174 (1431)
T KOG1240|consen  102 YVKH-NLYDRLS---TRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE  174 (1431)
T ss_pred             HHhh-hhhhhhc---cchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCC
Confidence            9877 9999885   334577777888999999999999998   9999999999999999989999999865321  11


Q ss_pred             C--Ccceeec----cccCccchhhhcCC-----------CCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhh
Q 013636          308 Q--SRNVKIS----GTLGYVAPEYLLEG-----------KLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWA  369 (439)
Q Consensus       308 ~--~~~~~~~----gt~~y~aPE~~~~~-----------~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~  369 (439)
                      +  ....-+-    .-..|.|||.+...           ..+++.||||.||+++||++ |++||.-.      .+..+.
T Consensus       175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------QL~aYr  248 (1431)
T KOG1240|consen  175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------QLLAYR  248 (1431)
T ss_pred             CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------HHHhHh
Confidence            1  1111111    22469999987642           26779999999999999998 88888632      222221


Q ss_pred             hcc-cccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccc
Q 013636          370 MPQ-LTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIP  426 (439)
Q Consensus       370 ~~~-~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  426 (439)
                      ... ...+.-+.++-|.            .+..++..|++.||+.|.++++.|+....
T Consensus       249 ~~~~~~~e~~Le~Ied~------------~~Rnlil~Mi~rdPs~RlSAedyL~~yrG  294 (1431)
T KOG1240|consen  249 SGNADDPEQLLEKIEDV------------SLRNLILSMIQRDPSKRLSAEDYLQKYRG  294 (1431)
T ss_pred             ccCccCHHHHHHhCcCc------------cHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence            110 0000011111222            45668999999999999999999987543

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.84  E-value=4e-20  Score=164.60  Aligned_cols=185  Identities=16%  Similarity=0.089  Sum_probs=140.1

Q ss_pred             ccceecccCcEEEEEEEECCccEEEEEEecCCCchHH----HHHHHHHHHHHhcC-CCceeeeeeEEEeCCeeEEEEEec
Q 013636          157 ESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAE----REFNNEVNWLTKIR-HQNIISLLGYCIHAETRFLVYEMM  231 (439)
Q Consensus       157 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~----~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~  231 (439)
                      +...|++|+||+||.+.. ++..++.+.+.....-..    ..|.+|+++|++++ |+++.+++++    +..+++|||+
T Consensus         6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI   80 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL   80 (218)
T ss_pred             cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence            457899999999997765 666777777765544211    25789999999995 5889999886    4569999999


Q ss_pred             cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC-CCCCEEEcCCCcEEEEecccccccCCCCc
Q 013636          232 QNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDL-KSSNILLDSSFNAKLSDFGLSVTAGTQSR  310 (439)
Q Consensus       232 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dl-k~~NiLl~~~~~~kl~DfGls~~~~~~~~  310 (439)
                      .+.+|.+.+..          ....++.|++++++++|+.   +|+|||| ||+|||+++++.++|+|||++........
T Consensus        81 ~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~  147 (218)
T PRK12274         81 AGAAMYQRPPR----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR  147 (218)
T ss_pred             cCccHHhhhhh----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence            99998654321          1134778999999999998   9999999 79999999999999999999976544331


Q ss_pred             c--------------eeeccccCccchhhhcCC-CCC-CchhhHHHHHHHHHHHhCCCCCCCCCh
Q 013636          311 N--------------VKISGTLGYVAPEYLLEG-KLT-DKSDVYAFGVVLLELLMGRRPVEKMSP  359 (439)
Q Consensus       311 ~--------------~~~~gt~~y~aPE~~~~~-~~~-~~~DvwS~Gvll~elltG~~P~~~~~~  359 (439)
                      .              .....++.|++|+...-- ..+ ...+.++-|.-+|.++|++.|+..+++
T Consensus       148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~  212 (218)
T PRK12274        148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE  212 (218)
T ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence            0              011257788888754321 233 467899999999999999998876543

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.83  E-value=2.9e-20  Score=173.93  Aligned_cols=232  Identities=25%  Similarity=0.283  Sum_probs=148.3

Q ss_pred             CCccceecccCcEEEEEEEECC-ccEEEEEEecC---CCchHHHHHHHHHHHHHhcCC----------CceeeeeeEEE-
Q 013636          155 FQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDD---AGHDAEREFNNEVNWLTKIRH----------QNIISLLGYCI-  219 (439)
Q Consensus       155 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h----------~niv~l~~~~~-  219 (439)
                      +...+.||.|+|+.||.+++.+ +...|+|....   ......+++.+|.-....+.+          -.++-.++... 
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            4456889999999999999976 78889988743   223345667777655555332          12222222211 


Q ss_pred             --------eCC--------eeEEEEEeccCCChhhhhcC----CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEec
Q 013636          220 --------HAE--------TRFLVYEMMQNGSLEKQLHG----PTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHR  279 (439)
Q Consensus       220 --------~~~--------~~~lV~e~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~  279 (439)
                              ...        +.+++|+-+ .+||.+++..    ......+....++.+..|+++.+++||+.   +++|+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHg  169 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHG  169 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEES
T ss_pred             cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEec
Confidence                    111        236778877 4588877531    11122344556677889999999999998   99999


Q ss_pred             CCCCCCEEEcCCCcEEEEecccccccCCCCcceeeccccCccchhhhcCC--------CCCCchhhHHHHHHHHHHHhCC
Q 013636          280 DLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEG--------KLTDKSDVYAFGVVLLELLMGR  351 (439)
Q Consensus       280 Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~DvwS~Gvll~elltG~  351 (439)
                      ||+|+|++++++|.++|+||+.....+.....  ...+..|.+||.....        .++.+.|.|++|+++|.|++|.
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~  247 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR  247 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence            99999999999999999999877665442221  2356789999977442        4688999999999999999999


Q ss_pred             CCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCC
Q 013636          352 RPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYR  414 (439)
Q Consensus       352 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~R  414 (439)
                      .||+...+......                    .. ..+. +....+..++..+|+.||++|
T Consensus       248 lPf~~~~~~~~~~~--------------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  248 LPFGLSSPEADPEW--------------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             -STCCCGGGSTSGG--------------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCCCccccccc--------------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence            99987654321110                    11 1122 345567779999999999988

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.83  E-value=3.1e-20  Score=196.38  Aligned_cols=196  Identities=22%  Similarity=0.258  Sum_probs=158.7

Q ss_pred             HHHHhcCCCccceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcC---CCceeeeeeEEEeCCee
Q 013636          148 LEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR---HQNIISLLGYCIHAETR  224 (439)
Q Consensus       148 l~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~  224 (439)
                      .+...+.|.+.+.||+|+||+||+|...++..+|+|.-+..+.-.. .+.  ..++.+|+   -+.|..+..++.-.+..
T Consensus       693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEf-YI~--~q~~~RLk~~~~~~~~~~~~a~~~~~~S  769 (974)
T KOG1166|consen  693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEF-YIC--LQVMERLKPQMLPSIMHISSAHVFQNAS  769 (974)
T ss_pred             eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceee-eeh--HHHHHhhchhhhcchHHHHHHHccCCcc
Confidence            3445578889999999999999999999999999998876543211 111  22234444   34555555666667888


Q ss_pred             EEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc-------CCCcEEEE
Q 013636          225 FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLD-------SSFNAKLS  297 (439)
Q Consensus       225 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~-------~~~~~kl~  297 (439)
                      +||+||.+.|+|.++++   ..+.++|...+.++.|+++.+++||..   +||||||||+|+||.       ++..++|+
T Consensus       770 ~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lI  843 (974)
T KOG1166|consen  770 VLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLI  843 (974)
T ss_pred             eeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEE
Confidence            99999999999999996   456799999999999999999999998   999999999999994       24459999


Q ss_pred             eccccccc---CCCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCC
Q 013636          298 DFGLSVTA---GTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRR  352 (439)
Q Consensus       298 DfGls~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~  352 (439)
                      |||.|..+   .+........+|-.+-.+|+..++.++.++|.|.++-+++-|+.|++
T Consensus       844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            99999543   33334445668899999999999999999999999999999999975

>PRK10345 hypothetical protein; Provisional

Probab=99.81  E-value=3.5e-19  Score=161.23  Aligned_cols=135  Identities=16%  Similarity=0.208  Sum_probs=105.2

Q ss_pred             ccceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhc-----CCCceeeeeeEEEeCC---e-eEEE
Q 013636          157 ESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKI-----RHQNIISLLGYCIHAE---T-RFLV  227 (439)
Q Consensus       157 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~-~~lV  227 (439)
                      ..+.||+|+||.||.  ..+....+||..........+.+.+|+.+++.+     .||||++++|++.++.   . ..+|
T Consensus         6 ~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I   83 (210)
T PRK10345          6 EQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI   83 (210)
T ss_pred             CcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence            457899999999996  333333468887655444567899999999999     5799999999998874   3 3378


Q ss_pred             EEe--ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHH-HHHhhcCCCCeEecCCCCCCEEEcC----CCcEEEEecc
Q 013636          228 YEM--MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL-EYLHEHCNHPVVHRDLKSSNILLDS----SFNAKLSDFG  300 (439)
Q Consensus       228 ~e~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl-~~LH~~~~~~ivH~Dlk~~NiLl~~----~~~~kl~DfG  300 (439)
                      +||  +++|+|.+++...    .+++.  ..++.+++.++ +|||+.   +|+||||||+|||++.    +++++|+||+
T Consensus        84 ~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345         84 ADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             ecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            999  6689999999642    25554  35677888777 999998   9999999999999974    3479999954


Q ss_pred             cc
Q 013636          301 LS  302 (439)
Q Consensus       301 ls  302 (439)
                      .+
T Consensus       155 G~  156 (210)
T PRK10345        155 GE  156 (210)
T ss_pred             CC
Confidence            44

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.80  E-value=1.1e-20  Score=187.66  Aligned_cols=185  Identities=26%  Similarity=0.330  Sum_probs=152.3

Q ss_pred             ecccCcEEEEEEEE----CCccEEEEEEecCCCch--HHHHHHHHHHHHHhcC-CCceeeeeeEEEeCCeeEEEEEeccC
Q 013636          161 IGEGGRGHVYKARF----NEKLLAAVKRIDDAGHD--AEREFNNEVNWLTKIR-HQNIISLLGYCIHAETRFLVYEMMQN  233 (439)
Q Consensus       161 LG~G~fg~Vy~~~~----~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~  233 (439)
                      +|+|.||.|+.++-    +.+..++.|.+++....  .......|-.++...+ ||.++++...+..+...+++.+|..+
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg   81 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG   81 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence            79999999997632    33556666666543211  1114456777788886 99999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCccee
Q 013636          234 GSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK  313 (439)
Q Consensus       234 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~~~~  313 (439)
                      |+|...+..   ....+......+...++-+++++|+.   +++|||+|++||+++.+|++++.|||+++..-.....  
T Consensus        82 g~lft~l~~---~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~--  153 (612)
T KOG0603|consen   82 GDLFTRLSK---EVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA--  153 (612)
T ss_pred             chhhhcccc---CCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc--
Confidence            999888853   34566777777888999999999998   9999999999999999999999999999876544333  


Q ss_pred             eccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCC
Q 013636          314 ISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEK  356 (439)
Q Consensus       314 ~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~  356 (439)
                       +||..|||||++.  .....+|.||||++++||+||..||..
T Consensus       154 -cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  154 -CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             -ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence             7999999999988  567789999999999999999999986

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.78  E-value=3.6e-18  Score=155.83  Aligned_cols=134  Identities=20%  Similarity=0.323  Sum_probs=112.1

Q ss_pred             ceecccCcEEEEEEEECCccEEEEEEecCCCch--------HHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEe
Q 013636          159 NVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHD--------AEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       159 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      +.||+|++|.||+|... +..+++|........        ....+.+|+.++..++|+|+.....++...+..+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~~-~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDFL-GIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEeeC-CCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            57999999999999884 455777765532211        123578899999999999998888888778889999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccc
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT  304 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~  304 (439)
                      +++++|.+++...      .+ .+..++.+++.+|.++|+.   +++|||++|.||+++ ++.++++|||.+..
T Consensus        81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999998532      12 7888999999999999998   999999999999999 78999999999865

>smart00090 RIO RIO-like kinase

Probab=99.77  E-value=3.9e-18  Score=157.97  Aligned_cols=143  Identities=18%  Similarity=0.160  Sum_probs=110.9

Q ss_pred             CCCccceecccCcEEEEEEE--ECCccEEEEEEecCCCch------------------------HHHHHHHHHHHHHhcC
Q 013636          154 NFQESNVIGEGGRGHVYKAR--FNEKLLAAVKRIDDAGHD------------------------AEREFNNEVNWLTKIR  207 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~  207 (439)
                      .|++.+.||+|+||.||+|.  ..++..+|+|.+......                        ....+..|+..+.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            47778999999999999998  567899999988643210                        1123568999999997


Q ss_pred             CCc--eeeeeeEEEeCCeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC-eEecCCCCC
Q 013636          208 HQN--IISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHP-VVHRDLKSS  284 (439)
Q Consensus       208 h~n--iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~-ivH~Dlk~~  284 (439)
                      +.+  +.+.+++    ...++||||+++++|......   ...+.......++.|++.++++||+.   + ++||||||+
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~  178 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEY  178 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChh
Confidence            533  3344432    235899999999888765422   22355666788999999999999998   8 999999999


Q ss_pred             CEEEcCCCcEEEEecccccccCC
Q 013636          285 NILLDSSFNAKLSDFGLSVTAGT  307 (439)
Q Consensus       285 NiLl~~~~~~kl~DfGls~~~~~  307 (439)
                      ||+++ +++++|+|||.+...+.
T Consensus       179 NIli~-~~~i~LiDFg~a~~~~~  200 (237)
T smart00090      179 NILVH-DGKVVIIDVSQSVELDH  200 (237)
T ss_pred             hEEEE-CCCEEEEEChhhhccCC
Confidence            99999 88999999999875443

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.77  E-value=2.8e-18  Score=178.03  Aligned_cols=139  Identities=21%  Similarity=0.301  Sum_probs=113.9

Q ss_pred             hcCCCccceecccCcEEEEEEEECCccEEEEEEecCC-Cc------hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCee
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDA-GH------DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETR  224 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~-~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  224 (439)
                      ...|...+.||+|+||+||+|.+.+...++.++.... ..      ...+.+.+|+++++.++|+|++....++...+..
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~  411 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK  411 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence            3455667899999999999998876654443333221 11      1234688999999999999999888888887888


Q ss_pred             EEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccc
Q 013636          225 FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT  304 (439)
Q Consensus       225 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~  304 (439)
                      ++||||+++++|.+++.           ....++.+++++|.|||+.   +++||||||+|||+ +++.++|+|||+++.
T Consensus       412 ~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        412 TIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             EEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            99999999999999884           3567899999999999998   99999999999999 678999999999976


Q ss_pred             c
Q 013636          305 A  305 (439)
Q Consensus       305 ~  305 (439)
                      .
T Consensus       477 ~  477 (535)
T PRK09605        477 S  477 (535)
T ss_pred             C
Confidence            4

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.77  E-value=5.8e-18  Score=153.05  Aligned_cols=131  Identities=23%  Similarity=0.361  Sum_probs=106.5

Q ss_pred             eecccCcEEEEEEEECCccEEEEEEecCCCc--------hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEec
Q 013636          160 VIGEGGRGHVYKARFNEKLLAAVKRIDDAGH--------DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMM  231 (439)
Q Consensus       160 ~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  231 (439)
                      .||+|+||.||+|.+. +..+++|.......        ....++.+|++++..++|+++.....++...+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            3899999999999965 45677777543211        11245778999999999988766666666777789999999


Q ss_pred             cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccccccc
Q 013636          232 QNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA  305 (439)
Q Consensus       232 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~  305 (439)
                      ++++|.+++....   .       .++.+++.+|.+||+.   +++|||++|.||+++ ++.++++|||++...
T Consensus        80 ~g~~l~~~~~~~~---~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        80 EGKPLKDVIEEGN---D-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CCccHHHHHhhcH---H-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            9999999875311   0       7899999999999998   999999999999999 889999999998664

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.75  E-value=6.3e-18  Score=159.14  Aligned_cols=194  Identities=25%  Similarity=0.337  Sum_probs=136.0

Q ss_pred             CCCceeeeeeEEEeC---------------------------CeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHH
Q 013636          207 RHQNIISLLGYCIHA---------------------------ETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAV  259 (439)
Q Consensus       207 ~h~niv~l~~~~~~~---------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~  259 (439)
                      +|||||++.+++.+.                           ...|+||.-.+. +|..++...    ..+.....-+..
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~----~~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR----HRSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC----CCchHHHHHHHH
Confidence            599999999876532                           245889987766 899988642    356667777899


Q ss_pred             HHHHHHHHHhhcCCCCeEecCCCCCCEEEc--CCC--cEEEEecccccccCC-------CCcceeeccccCccchhhhcC
Q 013636          260 DVARGLEYLHEHCNHPVVHRDLKSSNILLD--SSF--NAKLSDFGLSVTAGT-------QSRNVKISGTLGYVAPEYLLE  328 (439)
Q Consensus       260 ~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~--~~~--~~kl~DfGls~~~~~-------~~~~~~~~gt~~y~aPE~~~~  328 (439)
                      |+.+|+.|||.+   ++.|||+|++|||+.  +|.  .+.++|||.+.-...       .+......|...-||||+...
T Consensus       349 QlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta  425 (598)
T KOG4158|consen  349 QLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA  425 (598)
T ss_pred             HHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence            999999999998   999999999999993  333  478999998743221       222344557888999998765


Q ss_pred             CCC------CCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHH
Q 013636          329 GKL------TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAV  402 (439)
Q Consensus       329 ~~~------~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l  402 (439)
                      .+.      -.|+|.|+.|.+.||+++..-||....+.. .+...+...+   -+.+++-+.            ..+.++
T Consensus       426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~-L~~r~Yqe~q---LPalp~~vp------------p~~rql  489 (598)
T KOG4158|consen  426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML-LDTRTYQESQ---LPALPSRVP------------PVARQL  489 (598)
T ss_pred             CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe-echhhhhhhh---CCCCcccCC------------hHHHHH
Confidence            322      358999999999999999999998633211 1111111111   112222222            245568


Q ss_pred             HHHhcCCCCCCCCCHHHHHHhc
Q 013636          403 AVLCIQPEPSYRPLITDVLHSL  424 (439)
Q Consensus       403 ~~~cl~~dP~~RPt~~evl~~L  424 (439)
                      +...|+.||++||+..-....|
T Consensus       490 V~~lL~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  490 VFDLLKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             HHHHhcCCccccCCccHHHhHH
Confidence            8889999999999876554443

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.75  E-value=1.5e-17  Score=150.28  Aligned_cols=138  Identities=17%  Similarity=0.116  Sum_probs=108.9

Q ss_pred             CCCccceecccCcEEEEEEEECCccEEEEEEecCCCc----------------------hHHHHHHHHHHHHHhcCCCc-
Q 013636          154 NFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGH----------------------DAEREFNNEVNWLTKIRHQN-  210 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~h~n-  210 (439)
                      .|...+.||+|+||.||++...++..+|||.+.....                      .....+..|..++..+.|++ 
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            4777899999999999999988899999998653220                      01123667899999998774 


Q ss_pred             -eeeeeeEEEeCCeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc
Q 013636          211 -IISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLD  289 (439)
Q Consensus       211 -iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~  289 (439)
                       +...++    ....++||||+++++|.+....         .....++.+++.++.++|+.   +++||||+|+||+++
T Consensus        96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~  159 (198)
T cd05144          96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVD  159 (198)
T ss_pred             CCCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEc
Confidence             444443    2456899999999999765421         23457889999999999997   999999999999999


Q ss_pred             CCCcEEEEecccccccCC
Q 013636          290 SSFNAKLSDFGLSVTAGT  307 (439)
Q Consensus       290 ~~~~~kl~DfGls~~~~~  307 (439)
                      +++.++|+|||++.....
T Consensus       160 ~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         160 DDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             CCCcEEEEECCccccCCC
Confidence            999999999999965543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.75  E-value=3.7e-19  Score=173.72  Aligned_cols=121  Identities=31%  Similarity=0.545  Sum_probs=108.5

Q ss_pred             eeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccc
Q 013636          223 TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS  302 (439)
Q Consensus       223 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls  302 (439)
                      ..++.|++|...+|.+++.+...+...++...+.++.|++.|+.|   +   +.+|+|+||.||+...+..+||+|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence            468999999999999999877777788999999999999999999   4   8999999999999999999999999998


Q ss_pred             cccCCCC-------cceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh
Q 013636          303 VTAGTQS-------RNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM  349 (439)
Q Consensus       303 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt  349 (439)
                      .......       ......||..||+||.+.+..|+.|+||||+|++|+|++.
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            6654433       2344569999999999999999999999999999999998

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.71  E-value=1.2e-17  Score=173.99  Aligned_cols=208  Identities=28%  Similarity=0.395  Sum_probs=142.9

Q ss_pred             hcCCCccceecccCcEEEEEEEECC-ccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEe
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      ..+|...+.+..|++|.||..+++. .+..|. ++++.+     -+.+-  ++.....|.               .|   
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~-----lilRn--ilt~a~npf---------------vv---  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQN-----LILRN--ILTFAGNPF---------------VV---  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhh-cccccc-----hhhhc--cccccCCcc---------------ee---
Confidence            3678888999999999999998875 345555 333221     11110  222223333               33   


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC--
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ--  308 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~--  308 (439)
                         |+=...+..   -+.++...        +.+++|||+.   +|+|||+||+|.+|+.-|++|+.|||+++.....  
T Consensus       136 ---gDc~tllk~---~g~lPvdm--------vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a  198 (1205)
T KOG0606|consen  136 ---GDCATLLKN---IGPLPVDM--------VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA  198 (1205)
T ss_pred             ---chhhhhccc---CCCCcchh--------hHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence               344444432   22333322        7899999998   9999999999999999999999999998542110  


Q ss_pred             --------------CcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccc
Q 013636          309 --------------SRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLT  374 (439)
Q Consensus       309 --------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~  374 (439)
                                    ......+||+.|.|||++...-|...+|.|++|+|+||.+-|+.||.+.++++....+-      .
T Consensus       199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vi------s  272 (1205)
T KOG0606|consen  199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI------S  272 (1205)
T ss_pred             chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhh------h
Confidence                          01123479999999999999999999999999999999999999999998877543332      1


Q ss_pred             cCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCH
Q 013636          375 DRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLI  417 (439)
Q Consensus       375 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~  417 (439)
                      +....++- |.        ....+..+++...|+.+|..|--.
T Consensus       273 d~i~wpE~-de--------a~p~Ea~dli~~LL~qnp~~Rlgt  306 (1205)
T KOG0606|consen  273 DDIEWPEE-DE--------ALPPEAQDLIEQLLRQNPLCRLGT  306 (1205)
T ss_pred             hhcccccc-Cc--------CCCHHHHHHHHHHHHhChHhhccc
Confidence            11111111 11        223456678888999999999633

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.70  E-value=2.9e-16  Score=134.35  Aligned_cols=135  Identities=19%  Similarity=0.164  Sum_probs=114.7

Q ss_pred             cceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcCC--CceeeeeeEEEeCCeeEEEEEeccCCC
Q 013636          158 SNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRH--QNIISLLGYCIHAETRFLVYEMMQNGS  235 (439)
Q Consensus       158 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lV~e~~~~gs  235 (439)
                      .+.||+|.++.||+++..+ ..+++|.......  ...+.+|+..+..++|  .++.+++++....+..++++||+++++
T Consensus         3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~   79 (155)
T cd05120           3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET   79 (155)
T ss_pred             ceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence            5779999999999999876 6778888865433  5678899999999976  589999988887788999999999877


Q ss_pred             hhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccccccc
Q 013636          236 LEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA  305 (439)
Q Consensus       236 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~  305 (439)
                      +..+          +......++.+++++++++|....++++|+|++|+||++++++.+++.|||.+...
T Consensus        80 ~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~  139 (155)
T cd05120          80 LDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG  139 (155)
T ss_pred             cccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence            7543          55677788999999999999865457999999999999999999999999988653

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.65  E-value=9.7e-16  Score=136.99  Aligned_cols=137  Identities=20%  Similarity=0.209  Sum_probs=98.4

Q ss_pred             cceecccCcEEEEEEEECCccEEEEEEecCCCchH--HHH----------------------HHHHHHHHHhcCCCc--e
Q 013636          158 SNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDA--ERE----------------------FNNEVNWLTKIRHQN--I  211 (439)
Q Consensus       158 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~E~~~l~~l~h~n--i  211 (439)
                      .+.||+|+||.||+|...++..+|+|.........  ...                      ...|...+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            46799999999999998888999999876432111  111                      134566666664432  3


Q ss_pred             eeeeeEEEeCCeeEEEEEeccCCChhhh-hcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCCEEEc
Q 013636          212 ISLLGYCIHAETRFLVYEMMQNGSLEKQ-LHGPTHGSNLTWHLRMKIAVDVARGLEYLHE-HCNHPVVHRDLKSSNILLD  289 (439)
Q Consensus       212 v~l~~~~~~~~~~~lV~e~~~~gsL~~~-l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~-~~~~~ivH~Dlk~~NiLl~  289 (439)
                      .+.+++    ...++||||++++++... +....    .. .....++.+++.++.++|+ .   +++|+||||+||+++
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE
Confidence            344432    346899999999654321 11100    11 5677899999999999998 6   999999999999999


Q ss_pred             CCCcEEEEecccccccCC
Q 013636          290 SSFNAKLSDFGLSVTAGT  307 (439)
Q Consensus       290 ~~~~~kl~DfGls~~~~~  307 (439)
                       ++.++++|||.+.....
T Consensus       150 -~~~~~liDfg~a~~~~~  166 (187)
T cd05119         150 -DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             -CCcEEEEECcccccccC
Confidence             89999999999965543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.63  E-value=4.8e-15  Score=137.58  Aligned_cols=136  Identities=18%  Similarity=0.209  Sum_probs=104.4

Q ss_pred             cceec-ccCcEEEEEEEECCccEEEEEEecCCC-------------chHHHHHHHHHHHHHhcCCCce--eeeeeEEEeC
Q 013636          158 SNVIG-EGGRGHVYKARFNEKLLAAVKRIDDAG-------------HDAEREFNNEVNWLTKIRHQNI--ISLLGYCIHA  221 (439)
Q Consensus       158 ~~~LG-~G~fg~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~  221 (439)
                      ...|| .|+.|+||.+... +..+++|+....+             ......+.+|+.++.+++|+++  ...+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            46788 8999999999886 4556777764311             1223457889999999998775  6677765433


Q ss_pred             C----eeEEEEEeccC-CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEE
Q 013636          222 E----TRFLVYEMMQN-GSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKL  296 (439)
Q Consensus       222 ~----~~~lV~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl  296 (439)
                      .    ..++|+||+++ .+|.+++..    ..++..    .+.+++.++.+||+.   +|+||||||.|||++.++.++|
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~L  183 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWL  183 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEE
Confidence            2    23599999997 689888853    234443    356899999999998   9999999999999999999999


Q ss_pred             Eeccccccc
Q 013636          297 SDFGLSVTA  305 (439)
Q Consensus       297 ~DfGls~~~  305 (439)
                      +|||.+...
T Consensus       184 IDfg~~~~~  192 (239)
T PRK01723        184 IDFDRGELR  192 (239)
T ss_pred             EECCCcccC
Confidence            999988664

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.61  E-value=8.7e-17  Score=166.86  Aligned_cols=251  Identities=24%  Similarity=0.346  Sum_probs=181.9

Q ss_pred             cCCCccceecccCcEEEEEEEECC--ccEEEEEEecCCC--chHHHHHHHHHHHHHhcC-CCceeeeeeEEEeCCeeEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNE--KLLAAVKRIDDAG--HDAEREFNNEVNWLTKIR-HQNIISLLGYCIHAETRFLV  227 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV  227 (439)
                      ..|...+.||+|+|+.|-......  ...+++|.+....  .........|..+-..+. |+|++.+++...+.+..++.
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            355566779999999998886633  4555666665443  223344556777777776 99999999999999999999


Q ss_pred             EEeccCCChhhhh-cCCCCCCCCCHHHHHHHHHHHHHHHHHHh-hcCCCCeEecCCCCCCEEEcCCC-cEEEEecccccc
Q 013636          228 YEMMQNGSLEKQL-HGPTHGSNLTWHLRMKIAVDVARGLEYLH-EHCNHPVVHRDLKSSNILLDSSF-NAKLSDFGLSVT  304 (439)
Q Consensus       228 ~e~~~~gsL~~~l-~~~~~~~~l~~~~~~~i~~~ia~gl~~LH-~~~~~~ivH~Dlk~~NiLl~~~~-~~kl~DfGls~~  304 (439)
                      .+|..+|++.+.+ +.  .....+....-.+..|+..++.|+| +.   ++.|+|+||+|.+++.++ ..+++|||+|..
T Consensus       100 ~~~s~g~~~f~~i~~~--~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~  174 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHP--DSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATA  174 (601)
T ss_pred             cCcccccccccccccC--CccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhcc
Confidence            9999999999888 42  2223555666778999999999999 65   999999999999999999 999999999976


Q ss_pred             cCC-CCcc---eeecc-ccCccchhhhcCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCC
Q 013636          305 AGT-QSRN---VKISG-TLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSK  378 (439)
Q Consensus       305 ~~~-~~~~---~~~~g-t~~y~aPE~~~~~-~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~  378 (439)
                      ... ....   ...+| ++.|+|||...+. ......|+||.|+++.-+++|..|+....... .....|.-.    ...
T Consensus       175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-~~~~~~~~~----~~~  249 (601)
T KOG0590|consen  175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-GRYSSWKSN----KGR  249 (601)
T ss_pred             ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-ccceeeccc----ccc
Confidence            655 2222   33458 9999999998884 55678999999999999999999998655433 111111100    000


Q ss_pred             CCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 013636          379 LPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVL  421 (439)
Q Consensus       379 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl  421 (439)
                      .    ........    ..+..++...++..+|+.|.+.+++-
T Consensus       250 ~----~~~~~~~~----~~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  250 F----TQLPWNSI----SDQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             c----ccCccccC----ChhhhhcccccccCCchhcccccccc
Confidence            0    00001111    12334456668889999999988775

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.56  E-value=5.7e-15  Score=136.39  Aligned_cols=202  Identities=21%  Similarity=0.317  Sum_probs=139.6

Q ss_pred             HHHHhcCCCceeeeeeEEEeC-----CeeEEEEEeccCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 013636          201 NWLTKIRHQNIISLLGYCIHA-----ETRFLVYEMMQNGSLEKQLHGP-THGSNLTWHLRMKIAVDVARGLEYLHEHCNH  274 (439)
Q Consensus       201 ~~l~~l~h~niv~l~~~~~~~-----~~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~  274 (439)
                      .-+-.+.|.|||+++.|+.+.     ....++.|||+.|++..+|++. ..+..+......+++.||..||.|||+. .+
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~P  197 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DP  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CC
Confidence            334556799999999987643     3568899999999999999862 3345688888889999999999999995 77


Q ss_pred             CeEecCCCCCCEEEcCCCcEEEEecccccccCC-----CCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh
Q 013636          275 PVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT-----QSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM  349 (439)
Q Consensus       275 ~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt  349 (439)
                      +++|+++..+.|++..++-+|++--.-......     ........+-++|.|||.=..-..+.++|||+||+..+||.-
T Consensus       198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai  277 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI  277 (458)
T ss_pred             ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence            999999999999999999888754221111100     011111235689999998766677889999999999999988


Q ss_pred             CCCCCCC-CChhhhhhhHhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhc
Q 013636          350 GRRPVEK-MSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL  424 (439)
Q Consensus       350 G~~P~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  424 (439)
                      |..--.. .+.......+..+.         -..-++.-++            ++..|++..|+.||+|++++.|.
T Consensus       278 lEiq~tnseS~~~~ee~ia~~i---------~~len~lqr~------------~i~kcl~~eP~~rp~ar~llfHp  332 (458)
T KOG1266|consen  278 LEIQSTNSESKVEVEENIANVI---------IGLENGLQRG------------SITKCLEGEPNGRPDARLLLFHP  332 (458)
T ss_pred             heeccCCCcceeehhhhhhhhe---------eeccCccccC------------cCcccccCCCCCCcchhhhhcCc
Confidence            7653221 11111111111100         0111111122            44459999999999999998765

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.51  E-value=1.3e-13  Score=139.00  Aligned_cols=142  Identities=18%  Similarity=0.163  Sum_probs=100.7

Q ss_pred             cceecccCcEEEEEEEECCccEEEEEEecCCCchH----------------------------------------HHHHH
Q 013636          158 SNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDA----------------------------------------EREFN  197 (439)
Q Consensus       158 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~~  197 (439)
                      .+.||.|++|.||+|++.+|..||||..+......                                        +-+|.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            36799999999999999999999999986532110                                        01244


Q ss_pred             HHHHHHHhcC----CCceeeeeeEE-EeCCeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHH-HHHHHhhc
Q 013636          198 NEVNWLTKIR----HQNIISLLGYC-IHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR-GLEYLHEH  271 (439)
Q Consensus       198 ~E~~~l~~l~----h~niv~l~~~~-~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-gl~~LH~~  271 (439)
                      +|...+.+++    |.+-+.+-..+ ...+..+|||||++|++|.+.......  ..   .+.+++..+++ .+..+|..
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~  276 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRD  276 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhC
Confidence            5665555552    33333332222 334567999999999999887642111  12   23456666665 46778886


Q ss_pred             CCCCeEecCCCCCCEEEcCCCcEEEEecccccccCC
Q 013636          272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT  307 (439)
Q Consensus       272 ~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~  307 (439)
                         +++|+|++|.||+++++++++++|||++.....
T Consensus       277 ---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       277 ---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             ---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence               999999999999999999999999999976643

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.38  E-value=7.2e-13  Score=132.25  Aligned_cols=244  Identities=26%  Similarity=0.287  Sum_probs=173.3

Q ss_pred             cCCCccceecc--cCcEEEEEEEE---CCccEEEEEEecCCCc--hHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCee
Q 013636          153 NNFQESNVIGE--GGRGHVYKARF---NEKLLAAVKRIDDAGH--DAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETR  224 (439)
Q Consensus       153 ~~~~~~~~LG~--G~fg~Vy~~~~---~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  224 (439)
                      ..|...+.+|.  |.+|.||.++.   .+...+|+|+-+....  .....=.+|+....++ .|+|.++....+..++..
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence            45666788999  99999999987   3466777777432221  2222234566666666 499999988889999999


Q ss_pred             EEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHH----HHHHHhhcCCCCeEecCCCCCCEEEcCC-CcEEEEec
Q 013636          225 FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR----GLEYLHEHCNHPVVHRDLKSSNILLDSS-FNAKLSDF  299 (439)
Q Consensus       225 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----gl~~LH~~~~~~ivH~Dlk~~NiLl~~~-~~~kl~Df  299 (439)
                      ++-+|++. .+|.++-+..  ...++.........+..+    |+.++|+.   .++|-|+||.||+...+ ...+++||
T Consensus       194 fiqtE~~~-~sl~~~~~~~--~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df  267 (524)
T KOG0601|consen  194 FIQTELCG-ESLQSYCHTP--CNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDF  267 (524)
T ss_pred             eeeecccc-chhHHhhhcc--cccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCc
Confidence            99999996 5888887742  234666677777777777    99999998   99999999999999999 89999999


Q ss_pred             ccccccCCCCcc-e-----eeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCC-ChhhhhhhHhhhhcc
Q 013636          300 GLSVTAGTQSRN-V-----KISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKM-SPTQCQSMVTWAMPQ  372 (439)
Q Consensus       300 Gls~~~~~~~~~-~-----~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~-~~~~~~~~~~~~~~~  372 (439)
                      |+...+...... .     ...|...|++||.. ++.++..+|+|++|.+..+..+|..+.... ...       |.   
T Consensus       268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~-------W~---  336 (524)
T KOG0601|consen  268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNSS-------WS---  336 (524)
T ss_pred             ceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCCC-------cc---
Confidence            998777654422 1     12477889999976 457788999999999999998876654321 111       11   


Q ss_pred             cccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 013636          373 LTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVL  421 (439)
Q Consensus       373 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl  421 (439)
                           .++....+   .++.......+...+.++++.+|-.|++.+.+.
T Consensus       337 -----~~r~~~ip---~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~  377 (524)
T KOG0601|consen  337 -----QLRQGYIP---LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT  377 (524)
T ss_pred             -----ccccccCc---hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence                 01111111   111111122344488889999999999877765

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.37  E-value=3e-12  Score=112.37  Aligned_cols=132  Identities=20%  Similarity=0.149  Sum_probs=96.2

Q ss_pred             cceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEeccCCChh
Q 013636          158 SNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLE  237 (439)
Q Consensus       158 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~  237 (439)
                      .+.|+.|.++.||+++.. +..+++|....... ....+..|+..++.+.+.++++-+-.+ ..+..++||||+++.++.
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~-~~~~~~lv~e~i~G~~l~   79 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYF-DPETGVLITEFIEGSELL   79 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEE-eCCCCeEEEEecCCCccc
Confidence            356899999999999876 55688888754321 223467899999988766655433232 334568999999998875


Q ss_pred             hhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCCeEecCCCCCCEEEcCCCcEEEEecccccc
Q 013636          238 KQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC--NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT  304 (439)
Q Consensus       238 ~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~--~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~  304 (439)
                      +..        .   ....+..+++++++.||+..  ...++|+|++|.||+++ ++.++++|||.+..
T Consensus        80 ~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          80 TED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             ccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            430        1   11235678999999999872  22369999999999999 66899999998764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.33  E-value=2.2e-12  Score=131.74  Aligned_cols=146  Identities=15%  Similarity=0.130  Sum_probs=94.2

Q ss_pred             HhcCCCccceecccCcEEEEEEEECC-ccEEEEEEecCCCch----------------------------------HHH-
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHD----------------------------------AER-  194 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----------------------------------~~~-  194 (439)
                      ....|+. +.||.|++|.||+|++.+ |..||||..+..-..                                  -.+ 
T Consensus       118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~  196 (537)
T PRK04750        118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT  196 (537)
T ss_pred             HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence            3456766 789999999999999987 999999998743110                                  011 


Q ss_pred             -----HHHHHHHHHHhcC----CCceeeeeeEEE-eCCeeEEEEEeccCCChhhhhcCCCCCC---CCCHHHHHHHHHHH
Q 013636          195 -----EFNNEVNWLTKIR----HQNIISLLGYCI-HAETRFLVYEMMQNGSLEKQLHGPTHGS---NLTWHLRMKIAVDV  261 (439)
Q Consensus       195 -----~~~~E~~~l~~l~----h~niv~l~~~~~-~~~~~~lV~e~~~~gsL~~~l~~~~~~~---~l~~~~~~~i~~~i  261 (439)
                           +|.+|+..+.+++    +.+.+.+-..+. ..+..+|||||++|+++.+.-.-...+.   .+.......++.|+
T Consensus       197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi  276 (537)
T PRK04750        197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV  276 (537)
T ss_pred             HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence                 2344444444442    333344333332 2456789999999999987421111111   12222222233333


Q ss_pred             HHHHHHHhhcCCCCeEecCCCCCCEEEcCCC----cEEEEecccccccCC
Q 013636          262 ARGLEYLHEHCNHPVVHRDLKSSNILLDSSF----NAKLSDFGLSVTAGT  307 (439)
Q Consensus       262 a~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~----~~kl~DfGls~~~~~  307 (439)
                             ...   +++|+|++|.||+++.++    .+++.|||+......
T Consensus       277 -------f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        277 -------FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             -------HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                   233   999999999999999888    999999999866543

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.28  E-value=3.3e-11  Score=121.65  Aligned_cols=165  Identities=21%  Similarity=0.242  Sum_probs=122.9

Q ss_pred             ECCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEeccCCChhhhhcCCCCCCCCCHHH
Q 013636          174 FNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHL  253 (439)
Q Consensus       174 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~  253 (439)
                      ..++..+.|...+..+........+-++.|+.++||||++++......+..|||+|-+.  .|..++..      +....
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~  105 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEE  105 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHH
Confidence            34556666666655544334456777888999999999999999999999999999875  56666653      23455


Q ss_pred             HHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc-ceeeccccCccchhhhcCCCCC
Q 013636          254 RMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR-NVKISGTLGYVAPEYLLEGKLT  332 (439)
Q Consensus       254 ~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~  332 (439)
                      ..-.+.||+.||.|||+.|  +++|++|.-..|++++.|+.||++|.++........ .....--..|..|+.+....  
T Consensus       106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--  181 (690)
T KOG1243|consen  106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--  181 (690)
T ss_pred             HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--
Confidence            6667899999999999764  899999999999999999999999998754432221 11111123467777554322  


Q ss_pred             CchhhHHHHHHHHHHHhC
Q 013636          333 DKSDVYAFGVVLLELLMG  350 (439)
Q Consensus       333 ~~~DvwS~Gvll~elltG  350 (439)
                      -..|.|.||++++|++.|
T Consensus       182 ~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  182 WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             cchhhhhHHHHHHHHhCc
Confidence            346999999999999999

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.25  E-value=1.7e-10  Score=102.77  Aligned_cols=137  Identities=18%  Similarity=0.183  Sum_probs=98.1

Q ss_pred             cceecccCcEEEEEEEECC-------ccEEEEEEecCCC----------------------chHHHHHH----HHHHHHH
Q 013636          158 SNVIGEGGRGHVYKARFNE-------KLLAAVKRIDDAG----------------------HDAEREFN----NEVNWLT  204 (439)
Q Consensus       158 ~~~LG~G~fg~Vy~~~~~~-------~~~vavK~~~~~~----------------------~~~~~~~~----~E~~~l~  204 (439)
                      ...||.|.-+.||.|...+       +..+|+|..+...                      ....+.+.    +|+..|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3568999999999997653       4788999763210                      11122333    7999999


Q ss_pred             hcCC--CceeeeeeEEEeCCeeEEEEEeccCCChhh-hhcCCCCCCCCCHHHHHHHHHHHHHHHHHH-hhcCCCCeEecC
Q 013636          205 KIRH--QNIISLLGYCIHAETRFLVYEMMQNGSLEK-QLHGPTHGSNLTWHLRMKIAVDVARGLEYL-HEHCNHPVVHRD  280 (439)
Q Consensus       205 ~l~h--~niv~l~~~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~ia~gl~~L-H~~~~~~ivH~D  280 (439)
                      ++..  -++...+++    ...++||||+.++.+.. .+..    ..++......+..+++.+|..| |+.   +++|||
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd----~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGD  150 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD----AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHAD  150 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc----cccCHHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence            9853  455555544    56789999998754422 2221    1244556677889999999999 776   999999


Q ss_pred             CCCCCEEEcCCCcEEEEecccccccC
Q 013636          281 LKSSNILLDSSFNAKLSDFGLSVTAG  306 (439)
Q Consensus       281 lk~~NiLl~~~~~~kl~DfGls~~~~  306 (439)
                      |++.||+++ ++.+.++|||.+....
T Consensus       151 Ls~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         151 LSEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             CCHHHEEEE-CCcEEEEECCCceeCC
Confidence            999999997 4689999999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.23  E-value=1.3e-10  Score=106.36  Aligned_cols=142  Identities=19%  Similarity=0.231  Sum_probs=110.1

Q ss_pred             ceecccCcEEEEEEEECCccEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCC--ceeeeeeEEEeCC---eeEEEEEecc
Q 013636          159 NVIGEGGRGHVYKARFNEKLLAAVKRIDDAGH-DAEREFNNEVNWLTKIRHQ--NIISLLGYCIHAE---TRFLVYEMMQ  232 (439)
Q Consensus       159 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~---~~~lV~e~~~  232 (439)
                      +.|+.|.++.||++...++..+++|....... ....++.+|..+++.+++.  ++.+++.+.....   ..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            56899999999999987767888888764322 1345688999999999763  4566777765532   5689999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC----------------------------------------
Q 013636          233 NGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC----------------------------------------  272 (439)
Q Consensus       233 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~----------------------------------------  272 (439)
                      +.++.+.+..    ..++......++.+++++|..||+..                                        
T Consensus        84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            9988776531    24677888888999999999998531                                        


Q ss_pred             -------------CCCeEecCCCCCCEEEcC--CCcEEEEecccccc
Q 013636          273 -------------NHPVVHRDLKSSNILLDS--SFNAKLSDFGLSVT  304 (439)
Q Consensus       273 -------------~~~ivH~Dlk~~NiLl~~--~~~~kl~DfGls~~  304 (439)
                                   ...++|+|+++.||++++  ++.+.++||+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                         235799999999999998  66789999998764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.21  E-value=2.4e-10  Score=98.69  Aligned_cols=133  Identities=24%  Similarity=0.351  Sum_probs=101.2

Q ss_pred             ceecccCcEEEEEEEECCccEEEEEEecCCCch-------HHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEec
Q 013636          159 NVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHD-------AEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMM  231 (439)
Q Consensus       159 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  231 (439)
                      ..+++|+-+.+|.+.+-+...+...++.+.-..       ....-.+|+.++.+++--.|....-+..+.+...|+|||+
T Consensus         2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I   81 (204)
T COG3642           2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI   81 (204)
T ss_pred             chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence            357899999999998765553333333322111       1234678999999997666666666677888899999999


Q ss_pred             cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccccccc
Q 013636          232 QNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA  305 (439)
Q Consensus       232 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~  305 (439)
                      ++-.|.+.+...          ...++..+-.-+.-||..   +|+|+||.++|+.+..+. +.++|||++...
T Consensus        82 ~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~s  141 (204)
T COG3642          82 EGELLKDALEEA----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEFS  141 (204)
T ss_pred             CChhHHHHHHhc----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCccccc
Confidence            999999888642          245677788888889998   999999999999998775 999999999754

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.16  E-value=2.6e-11  Score=121.20  Aligned_cols=247  Identities=19%  Similarity=0.205  Sum_probs=171.6

Q ss_pred             hcCCCccceecccCcEEEEEEEEC--CccEEEEEEecCCCchHHHH--HHHHHHHHHhc-CCCceeeeeeEEEeCCeeEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN--EKLLAAVKRIDDAGHDAERE--FNNEVNWLTKI-RHQNIISLLGYCIHAETRFL  226 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  226 (439)
                      ..+|..+..||.|.|+.|++...+  ++..+++|.+.+.......+  -..|+-+...+ .|.++++....+......++
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i  343 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI  343 (524)
T ss_pred             cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence            457788889999999999987654  57788888876544333222  23566666555 58888988877777778889


Q ss_pred             EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC-CcEEEEeccccccc
Q 013636          227 VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS-FNAKLSDFGLSVTA  305 (439)
Q Consensus       227 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~-~~~kl~DfGls~~~  305 (439)
                      --|||+++++....   .....++...++++..|++.++.++|+.   .++|+|++|+||++.++ +..+++|||.....
T Consensus       344 p~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~  417 (524)
T KOG0601|consen  344 PLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRL  417 (524)
T ss_pred             chhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccccccc
Confidence            99999999987766   2234577888899999999999999987   99999999999999886 88999999988642


Q ss_pred             CCCCcceeeccccCcc--chhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccC
Q 013636          306 GTQSRNVKISGTLGYV--APEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV  383 (439)
Q Consensus       306 ~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  383 (439)
                      .-.  ......+-++.  +++......+..+.|++|||.-+.|.++|..--+...        .|....   .+.++..-
T Consensus       418 ~~~--~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~--------~~~~i~---~~~~p~~~  484 (524)
T KOG0601|consen  418 AFS--SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV--------QSLTIR---SGDTPNLP  484 (524)
T ss_pred             cee--cccccccccccccchhhccccccccccccccccccccccccCcccCcccc--------cceeee---cccccCCC
Confidence            211  11112233444  5666667788899999999999999998764322111        111000   11111111


Q ss_pred             CchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhcccc
Q 013636          384 DPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPL  427 (439)
Q Consensus       384 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l  427 (439)
                           .    . ..++..+...+..+++..||.+.++..+....
T Consensus       485 -----~----~-~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  485 -----G----L-KLQLQVLLKVMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             -----c----h-HHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence                 1    0 12333455557889999999998887665443

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.15  E-value=6.7e-10  Score=95.61  Aligned_cols=145  Identities=21%  Similarity=0.243  Sum_probs=106.6

Q ss_pred             ccceecccCcEEEEEEEECCccEEEEEEecCCCc-------hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEE
Q 013636          157 ESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGH-------DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYE  229 (439)
Q Consensus       157 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  229 (439)
                      ...++-||+-+.|+++.+.+...+...++.+.-.       -..++..+|++.+.+++--.|.-..-++.+...-.|+||
T Consensus        11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME   90 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME   90 (229)
T ss_pred             cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence            3578999999999999998776655555543211       123457789999999875555555556667778889999


Q ss_pred             eccC-CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC---cEEEEeccccccc
Q 013636          230 MMQN-GSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSF---NAKLSDFGLSVTA  305 (439)
Q Consensus       230 ~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~---~~kl~DfGls~~~  305 (439)
                      |+++ .++.+++....... ........++..+-+.+.-||..   +++||||..+||++..++   .+.++|||++...
T Consensus        91 ~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen   91 FIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             eccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhcc
Confidence            9976 47778776432222 22233367888999999999998   999999999999996554   3689999998654

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.12  E-value=2.3e-09  Score=102.93  Aligned_cols=265  Identities=15%  Similarity=0.169  Sum_probs=158.5

Q ss_pred             ccceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhc-CCCceeeeeeE----EE--eCC-eeEEEE
Q 013636          157 ESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKI-RHQNIISLLGY----CI--HAE-TRFLVY  228 (439)
Q Consensus       157 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~----~~--~~~-~~~lV~  228 (439)
                      ..+.||+|+-+.+|..-.-.+.  +.|+..........+-   +..|... .||-+-.-+.+    ..  +.. ..-+.|
T Consensus        15 ~gr~LgqGgea~ly~l~e~~d~--VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm   89 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEVRDQ--VAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM   89 (637)
T ss_pred             CCccccCCccceeeecchhhch--hheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence            3577999999999965332222  3344333222222222   2222233 45543331211    11  112 245677


Q ss_pred             EeccCCC-hhhhhc---CCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccc
Q 013636          229 EMMQNGS-LEKQLH---GPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT  304 (439)
Q Consensus       229 e~~~~gs-L~~~l~---~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~  304 (439)
                      +.+++-. ...+++   +.......+|...++.+..+|.+.+-||+.   |.+-+|++++|+|+++++.+.|.|-..-..
T Consensus        90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi  166 (637)
T COG4248          90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQI  166 (637)
T ss_pred             ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceee
Confidence            7666532 222332   123345689999999999999999999998   889999999999999999999999654333


Q ss_pred             cCCCCcceeeccccCccchhhhc-----CCCCCCchhhHHHHHHHHHHHhC-CCCCCCCCh-----hhhhhhH-----hh
Q 013636          305 AGTQSRNVKISGTLGYVAPEYLL-----EGKLTDKSDVYAFGVVLLELLMG-RRPVEKMSP-----TQCQSMV-----TW  368 (439)
Q Consensus       305 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvll~elltG-~~P~~~~~~-----~~~~~~~-----~~  368 (439)
                      ..+........|...|.+||...     +..-+...|-|.+|+++++++.| ++||.+...     ......+     .+
T Consensus       167 ~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~y  246 (637)
T COG4248         167 NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAY  246 (637)
T ss_pred             ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeee
Confidence            33333334455889999999865     23456789999999999999885 999976421     1111111     11


Q ss_pred             hhccccc-CCCCCccCCchhcCccCHHHHHHHHHHHHHhcCC--CCCCCCCHHHHHHhccccCCCCCCCccc
Q 013636          369 AMPQLTD-RSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQP--EPSYRPLITDVLHSLIPLVPTDLGGSLR  437 (439)
Q Consensus       369 ~~~~~~~-~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~--dP~~RPt~~evl~~L~~l~~~~~~~~~~  437 (439)
                      +..+-.. ...-.++--..        ....+..+..+|+..  ++.-|||++-.+..|..+.++...++++
T Consensus       247 a~~~~~g~~p~P~~~P~~~--------Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~v~  310 (637)
T COG4248         247 ASDQRRGLKPPPRSIPLSM--------LPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCTVS  310 (637)
T ss_pred             chhccCCCCCCCCCCChhh--------cCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhhhc
Confidence            1110000 00000000000        112233455667653  3678999999999998888877766654

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.06  E-value=3.5e-11  Score=126.46  Aligned_cols=207  Identities=23%  Similarity=0.307  Sum_probs=145.7

Q ss_pred             HHhcCCCccceecccCcEEEEEEEECC-ccEEEEEE---ecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeE
Q 013636          150 AATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKR---IDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRF  225 (439)
Q Consensus       150 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~---~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  225 (439)
                      ...+.+.+.+-+-+|.|+.++.++-.. +...+.|.   .......+.+....+-.++-..++|-++.....+......+
T Consensus       801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~  880 (1205)
T KOG0606|consen  801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP  880 (1205)
T ss_pred             CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence            345667777788899999998875433 21112222   11111222223333333333345566666655555677889


Q ss_pred             EEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccccccc
Q 013636          226 LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA  305 (439)
Q Consensus       226 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~  305 (439)
                      |+++|..+++|...||...   ..+..........+..+++|||+.   .+.|+|++|.|.+...+++.+++|||.....
T Consensus       881 L~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v  954 (1205)
T KOG0606|consen  881 LVGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKV  954 (1205)
T ss_pred             hhhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccccc
Confidence            9999999999999998533   344444455666778899999997   6899999999999999999999999832110


Q ss_pred             C-------C---C------------------C----cceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCC
Q 013636          306 G-------T---Q------------------S----RNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP  353 (439)
Q Consensus       306 ~-------~---~------------------~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P  353 (439)
                      +       .   .                  .    ......||+.|.+||...+......+|.|+.|++++|.++|..|
T Consensus       955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen  955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred             ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence            0       0   0                  0    01123489999999999999999999999999999999999999


Q ss_pred             CCCCChhhh
Q 013636          354 VEKMSPTQC  362 (439)
Q Consensus       354 ~~~~~~~~~  362 (439)
                      |....+...
T Consensus      1035 ~na~tpq~~ 1043 (1205)
T KOG0606|consen 1035 FNAETPQQI 1043 (1205)
T ss_pred             CCCcchhhh
Confidence            988776543

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.94  E-value=2.6e-08  Score=93.75  Aligned_cols=141  Identities=15%  Similarity=0.131  Sum_probs=100.1

Q ss_pred             ceecccCcEEEEEEEECCccEEEEEEecCCCchH-HH----------HHHHHHHHHHhcCCC--ceeeeeeEEEe-----
Q 013636          159 NVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDA-ER----------EFNNEVNWLTKIRHQ--NIISLLGYCIH-----  220 (439)
Q Consensus       159 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~-~~----------~~~~E~~~l~~l~h~--niv~l~~~~~~-----  220 (439)
                      +.+-......|++..++ +..+.||+........ .+          .+.+|...+.++...  .....+++...     
T Consensus        28 e~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            44444444557777664 4568888775443221 11          377899888888433  33444556543     


Q ss_pred             CCeeEEEEEeccCC-ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC-------CC
Q 013636          221 AETRFLVYEMMQNG-SLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDS-------SF  292 (439)
Q Consensus       221 ~~~~~lV~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~-------~~  292 (439)
                      ....++|+|++++. +|.+++.... ....+......++.+++..+.-||+.   +++|+|++++|||++.       +.
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~  182 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDL  182 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCc
Confidence            23468999999986 8988875321 23345667778999999999999998   9999999999999975       57


Q ss_pred             cEEEEecccccc
Q 013636          293 NAKLSDFGLSVT  304 (439)
Q Consensus       293 ~~kl~DfGls~~  304 (439)
                      .+.++||+.+..
T Consensus       183 ~~~LIDl~r~~~  194 (268)
T PRK15123        183 KLSVIDLHRAQI  194 (268)
T ss_pred             eEEEEECCcccc
Confidence            899999998854

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.88  E-value=6.5e-08  Score=95.41  Aligned_cols=169  Identities=17%  Similarity=0.229  Sum_probs=126.5

Q ss_pred             cEEEEEEEE-CCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEE----eCCeeEEEEEeccC-CChhhh
Q 013636          166 RGHVYKARF-NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCI----HAETRFLVYEMMQN-GSLEKQ  239 (439)
Q Consensus       166 fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~lV~e~~~~-gsL~~~  239 (439)
                      -.+.||+.. .+|..+++|+++............-++.++++.|.|+|++..++.    .+...++||+|.++ ++|.++
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            367788865 478889999994332222222344577889999999999998876    34577999999885 467665


Q ss_pred             hcCC------------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCC
Q 013636          240 LHGP------------THGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT  307 (439)
Q Consensus       240 l~~~------------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~  307 (439)
                      -...            ..+...++..++.++.|++.||.++|+.   |+.-+-|.+++||++.+.+++|+..|.......
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            4321            1234578899999999999999999998   999999999999999999999999988765543


Q ss_pred             CCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCC
Q 013636          308 QSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP  353 (439)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P  353 (439)
                      +..           +|  +.   --.+-|.=.||.+++.|.||..-
T Consensus       446 d~~-----------~~--le---~~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  446 DPT-----------EP--LE---SQQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCC-----------cc--hh---HHhhhhHHHHHHHHHHHhhcccc
Confidence            321           01  11   12367888999999999999654

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.88  E-value=2.1e-08  Score=89.13  Aligned_cols=126  Identities=21%  Similarity=0.235  Sum_probs=82.0

Q ss_pred             EEEEEEECCccEEEEEEecCC---------------C---------c--hHHHHHHHHHHHHHhcCCC--ceeeeeeEEE
Q 013636          168 HVYKARFNEKLLAAVKRIDDA---------------G---------H--DAEREFNNEVNWLTKIRHQ--NIISLLGYCI  219 (439)
Q Consensus       168 ~Vy~~~~~~~~~vavK~~~~~---------------~---------~--~~~~~~~~E~~~l~~l~h~--niv~l~~~~~  219 (439)
                      .||.|...++..+|+|.....               .         +  .......+|.+.|.++..-  ++.+.+++  
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--   78 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY--   78 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence            489999988999999976421               0         0  0112366899999999765  44555544  


Q ss_pred             eCCeeEEEEEecc--CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHH-HhhcCCCCeEecCCCCCCEEEcCCCcEEE
Q 013636          220 HAETRFLVYEMMQ--NGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEY-LHEHCNHPVVHRDLKSSNILLDSSFNAKL  296 (439)
Q Consensus       220 ~~~~~~lV~e~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~-LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl  296 (439)
                        +...+||||++  +..+..+....     ++......++.+++..+.. +|+.   +++||||.+.||+++++ .+.+
T Consensus        79 --~~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~i  147 (188)
T PF01163_consen   79 --NRNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYI  147 (188)
T ss_dssp             --ETTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE
T ss_pred             --eCCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEE
Confidence              24579999999  55554433211     1123445677778776655 4676   99999999999999988 9999


Q ss_pred             EecccccccC
Q 013636          297 SDFGLSVTAG  306 (439)
Q Consensus       297 ~DfGls~~~~  306 (439)
                      +|||.+....
T Consensus       148 IDf~qav~~~  157 (188)
T PF01163_consen  148 IDFGQAVDSS  157 (188)
T ss_dssp             --GTTEEETT
T ss_pred             EecCcceecC
Confidence            9999887654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.76  E-value=9.9e-08  Score=87.55  Aligned_cols=136  Identities=18%  Similarity=0.152  Sum_probs=97.1

Q ss_pred             CccceecccCcEEEEEEEECCccEEEEEEecCC--------------------Cc--hHHHHHHHHHHHHHhcCCC--ce
Q 013636          156 QESNVIGEGGRGHVYKARFNEKLLAAVKRIDDA--------------------GH--DAEREFNNEVNWLTKIRHQ--NI  211 (439)
Q Consensus       156 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~--------------------~~--~~~~~~~~E~~~l~~l~h~--ni  211 (439)
                      .+.+.||.|.-+.||.|....+..+++|.-+..                    ++  .......+|.+.|.+|...  .+
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V  173 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV  173 (304)
T ss_pred             hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence            456889999999999999999999999965321                    10  1123356899999999655  66


Q ss_pred             eeeeeEEEeCCeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC
Q 013636          212 ISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS  291 (439)
Q Consensus       212 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~  291 (439)
                      .+.+++    +.-.+||||+++-.|...=        ++....-.++..|++-+.-+-..   |++|+|+++-||+++++
T Consensus       174 P~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~d  238 (304)
T COG0478         174 PKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTED  238 (304)
T ss_pred             CCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecC
Confidence            666655    4567999999986664321        12223333444444444444454   99999999999999999


Q ss_pred             CcEEEEecccccccC
Q 013636          292 FNAKLSDFGLSVTAG  306 (439)
Q Consensus       292 ~~~kl~DfGls~~~~  306 (439)
                      |.+.++||-.+....
T Consensus       239 g~~~vIDwPQ~v~~~  253 (304)
T COG0478         239 GDIVVIDWPQAVPIS  253 (304)
T ss_pred             CCEEEEeCcccccCC
Confidence            999999999876543

>PRK09902 hypothetical protein; Provisional

Probab=98.74  E-value=3.1e-07  Score=82.24  Aligned_cols=139  Identities=17%  Similarity=0.047  Sum_probs=102.9

Q ss_pred             ecccCcEEEEEEEECCccEEEEEEecCCC------chHHHHHHHHHHHHHhcCC--CceeeeeeEEEeCC----eeEEEE
Q 013636          161 IGEGGRGHVYKARFNEKLLAAVKRIDDAG------HDAEREFNNEVNWLTKIRH--QNIISLLGYCIHAE----TRFLVY  228 (439)
Q Consensus       161 LG~G~fg~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~----~~~lV~  228 (439)
                      -|+||-+.|++...++. .+.+|+-.+.-      ...+..|.+|+..+.++..  -++.+.+.......    .-+||+
T Consensus        26 ~~rgG~SgV~r~~~~g~-~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         26 YRRNGMSGVQCVERNGK-KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             cCCCCcceEEEEEeCCc-EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            47799999999888776 57888775321      2245679999999999853  33444442222222    358999


Q ss_pred             EeccC-CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCc--EEEEecccccc
Q 013636          229 EMMQN-GSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFN--AKLSDFGLSVT  304 (439)
Q Consensus       229 e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~--~kl~DfGls~~  304 (439)
                      |-+++ -||.+++.... ..+.+...+..+..+++..++-||+.   ++.|+|+.+.||+++.++.  ++++||.-++.
T Consensus       105 e~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        105 EDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            97763 38888875422 23567777889999999999999998   9999999999999986667  99999987654

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.66  E-value=6.8e-09  Score=105.61  Aligned_cols=148  Identities=22%  Similarity=0.334  Sum_probs=98.1

Q ss_pred             HHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCcc----------eeeccccCccchhhhcC
Q 013636          259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN----------VKISGTLGYVAPEYLLE  328 (439)
Q Consensus       259 ~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~~----------~~~~gt~~y~aPE~~~~  328 (439)
                      .+++.|+.|+|..  .++||++|.|++|.++.++..||+.|+.+.........          .-......|.|||++.+
T Consensus       106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            3455999999986  58999999999999999999999999988654332111          01123567999999999


Q ss_pred             CCCCCchhhHHHHHHHHHHHhCCCCC-CCCChhhhhhhHhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhc
Q 013636          329 GKLTDKSDVYAFGVVLLELLMGRRPV-EKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCI  407 (439)
Q Consensus       329 ~~~~~~~DvwS~Gvll~elltG~~P~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl  407 (439)
                      ...+.++|+||+|+++|.+..|..+. .............     ...+..         ....+..-..++.+=+.+++
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~-----~~~~~~---------~~~~s~~~p~el~~~l~k~l  249 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSR-----NLLNAG---------AFGYSNNLPSELRESLKKLL  249 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhh-----cccccc---------cccccccCcHHHHHHHHHHh
Confidence            88899999999999999999654443 2221111111100     000000         00001112334555667789


Q ss_pred             CCCCCCCCCHHHHHH
Q 013636          408 QPEPSYRPLITDVLH  422 (439)
Q Consensus       408 ~~dP~~RPt~~evl~  422 (439)
                      ..++.-||++.++..
T Consensus       250 ~~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  250 NGDSAVRPTLDLLLS  264 (700)
T ss_pred             cCCcccCcchhhhhc
Confidence            999999998777653

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.65  E-value=2.5e-07  Score=84.00  Aligned_cols=106  Identities=23%  Similarity=0.236  Sum_probs=83.1

Q ss_pred             HHHHHHHHHHHhcC--CCceeeeeeEEEeCC----eeEEEEEeccCC-ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHH
Q 013636          194 REFNNEVNWLTKIR--HQNIISLLGYCIHAE----TRFLVYEMMQNG-SLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE  266 (439)
Q Consensus       194 ~~~~~E~~~l~~l~--h~niv~l~~~~~~~~----~~~lV~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~  266 (439)
                      ....+|...+..+.  .-.....+++.....    ..++|+|++++. +|.+++....   ..+......++.++++.++
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~---~~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE---QLDPSQRRELLRALARLIA  132 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc---ccchhhHHHHHHHHHHHHH
Confidence            35677888777774  334555666665533    458999999985 7999886422   2566677889999999999


Q ss_pred             HHhhcCCCCeEecCCCCCCEEEcCCC---cEEEEeccccccc
Q 013636          267 YLHEHCNHPVVHRDLKSSNILLDSSF---NAKLSDFGLSVTA  305 (439)
Q Consensus       267 ~LH~~~~~~ivH~Dlk~~NiLl~~~~---~~kl~DfGls~~~  305 (439)
                      -||+.   +++|+|+++.|||++.+.   .+.++||+-+...
T Consensus       133 ~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  133 KLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            99998   999999999999999887   8999999987654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.54  E-value=6.3e-07  Score=91.36  Aligned_cols=147  Identities=19%  Similarity=0.194  Sum_probs=96.9

Q ss_pred             hcCCCccceecccCcEEEEEEEECCccEEEEEEecCCCch----------------------------------------
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHD----------------------------------------  191 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----------------------------------------  191 (439)
                      ...|+ .+.|+.++-|.||+|++.+|..||||..+..-..                                        
T Consensus       125 F~eF~-~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~  203 (517)
T COG0661         125 FSEFE-PEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLR  203 (517)
T ss_pred             HHHcC-CCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHH
Confidence            34454 3679999999999999999999999987643110                                        


Q ss_pred             HHHHHHHHHHHHHhcC-----CCceeeeeeEEEeCCeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHH-H
Q 013636          192 AEREFNNEVNWLTKIR-----HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG-L  265 (439)
Q Consensus       192 ~~~~~~~E~~~l~~l~-----h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~g-l  265 (439)
                      .+-++.+|..-+.+++     .+++.-..-|..-.+...|+|||++|-.+.+...-..  ...+.+.   ++..++++ +
T Consensus       204 ~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~---ia~~~~~~f~  278 (517)
T COG0661         204 EELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRKE---LAELLVRAFL  278 (517)
T ss_pred             HHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHHH---HHHHHHHHHH
Confidence            0112445555555552     3443333333344577899999999999988853222  2244333   33333332 1


Q ss_pred             HHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCC
Q 013636          266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT  307 (439)
Q Consensus       266 ~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~  307 (439)
                      ..+-..   +++|.|..|.||+++.++++.+.|||+......
T Consensus       279 ~q~~~d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         279 RQLLRD---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             HHHHhc---CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            222222   899999999999999999999999999866543

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.48  E-value=3.2e-06  Score=77.79  Aligned_cols=133  Identities=16%  Similarity=0.129  Sum_probs=83.2

Q ss_pred             ceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCc--eeeeeeEEEeCCeeEEEEEeccCCC-
Q 013636          159 NVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQN--IISLLGYCIHAETRFLVYEMMQNGS-  235 (439)
Q Consensus       159 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lV~e~~~~gs-  235 (439)
                      ..||+|..+.||+..   +...++|......  ......+|.++++.+..-.  +.+.++++...+...+|||+++|.+ 
T Consensus         7 ~~i~~G~t~~~y~~~---~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTHK---TGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEec---CCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            568999999999842   3345667665422  3345688999998886433  4566777777777889999999863 


Q ss_pred             hhhhhcCCCCCCCCCHHHHHHHHHHHHHH---------------------------------------HHHHhhc-CCCC
Q 013636          236 LEKQLHGPTHGSNLTWHLRMKIAVDVARG---------------------------------------LEYLHEH-CNHP  275 (439)
Q Consensus       236 L~~~l~~~~~~~~l~~~~~~~i~~~ia~g---------------------------------------l~~LH~~-~~~~  275 (439)
                      +...+.       .+......++.++++.                                       ..+|.+. ....
T Consensus        82 ~~~~~~-------~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~  154 (226)
T TIGR02172        82 FSRIIS-------DNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTST  154 (226)
T ss_pred             hhhhhc-------CCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCc
Confidence            211111       0001111111111111                                       2222211 1235


Q ss_pred             eEecCCCCCCEEEcCCCcEEEEecccccc
Q 013636          276 VVHRDLKSSNILLDSSFNAKLSDFGLSVT  304 (439)
Q Consensus       276 ivH~Dlk~~NiLl~~~~~~kl~DfGls~~  304 (439)
                      ++|+|+.|.||++++++ +.++||+.+..
T Consensus       155 ~~HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       155 CLHGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             eEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            78999999999999888 99999998754

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.41  E-value=2.5e-08  Score=100.59  Aligned_cols=188  Identities=19%  Similarity=0.152  Sum_probs=136.1

Q ss_pred             cCCCccceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCc-eeeeeeEEEeCCeeEEEEEec
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQN-IISLLGYCIHAETRFLVYEMM  231 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lV~e~~  231 (439)
                      ..+..-+-+++|+.++++|.+.........+.+...     ....-++++|.+++||| .+..++-+...+..+++++++
T Consensus       242 kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~  316 (829)
T KOG0576|consen  242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRIC  316 (829)
T ss_pred             cchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhh
Confidence            333444568999999999998765554445554432     33455788999999999 777777777777889999999


Q ss_pred             cCC-ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc
Q 013636          232 QNG-SLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR  310 (439)
Q Consensus       232 ~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~  310 (439)
                      ..| +-.....  .....+..-+...+...-+++++++|+.   .=+|+|    ||+..+ +..|..||+....+.....
T Consensus       317 s~~rs~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~  386 (829)
T KOG0576|consen  317 STGRSSALEMT--VSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTMK  386 (829)
T ss_pred             cCCccccccCC--hhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCcccc
Confidence            887 2211111  1111233334455666778899999986   457888    777766 6889999999877665544


Q ss_pred             ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCC
Q 013636          311 NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVE  355 (439)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~  355 (439)
                      .....+|+.|+|||+...+.+..+.|+|+.|+--.++--|-+|-.
T Consensus       387 ~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  387 PRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             cccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence            455679999999999999999999999999987777777777754

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.33  E-value=1.1e-05  Score=74.22  Aligned_cols=144  Identities=19%  Similarity=0.188  Sum_probs=85.1

Q ss_pred             cceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCC--ceeeeeeEEEe---CCeeEEEEEecc
Q 013636          158 SNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQ--NIISLLGYCIH---AETRFLVYEMMQ  232 (439)
Q Consensus       158 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~---~~~~~lV~e~~~  232 (439)
                      .+.++.|..+.||+....+ ..+++|.....  .....+.+|..+++.+...  .+.+++.++..   ....+++|++++
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            3579999999999999988 57788887654  4556788899988888533  34556654433   234689999999


Q ss_pred             CCChhh----------------hh---cCC-CCCCCCCHHH---------HHHH------------HHHHHH-HHHHHhh
Q 013636          233 NGSLEK----------------QL---HGP-THGSNLTWHL---------RMKI------------AVDVAR-GLEYLHE  270 (439)
Q Consensus       233 ~gsL~~----------------~l---~~~-~~~~~l~~~~---------~~~i------------~~~ia~-gl~~LH~  270 (439)
                      +.++..                .+   |.. .......+..         ....            ...+.+ .++.+++
T Consensus        79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (239)
T PF01636_consen   79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA  158 (239)
T ss_dssp             SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence            988877                11   111 0111111111         0000            111222 2333332


Q ss_pred             c----CCCCeEecCCCCCCEEEc-CCCcEEEEecccccc
Q 013636          271 H----CNHPVVHRDLKSSNILLD-SSFNAKLSDFGLSVT  304 (439)
Q Consensus       271 ~----~~~~ivH~Dlk~~NiLl~-~~~~~kl~DfGls~~  304 (439)
                      .    ....++|+|+.+.||+++ +++.+.|+||+.+..
T Consensus       159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence            1    234699999999999999 667778999987643

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.33  E-value=1.7e-05  Score=71.46  Aligned_cols=139  Identities=18%  Similarity=0.205  Sum_probs=91.3

Q ss_pred             HHhcCCCccceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHH---------HHHHHHHHhcC---CCceeeeeeE
Q 013636          150 AATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREF---------NNEVNWLTKIR---HQNIISLLGY  217 (439)
Q Consensus       150 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~---------~~E~~~l~~l~---h~niv~l~~~  217 (439)
                      ...++|...+++-......|.+-..++ ....+|...+.....++.|         .+++..+.+++   .-....++.+
T Consensus        28 i~~~~~~~~kv~k~~~r~~ValIei~~-~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~  106 (229)
T PF06176_consen   28 ILDNNYKIIKVFKNTKRNYVALIEIDG-KKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA  106 (229)
T ss_pred             HHhCCceEEEeecCCCccEEEEEEECC-cEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence            445788887888777777777777665 4567777665443333332         23344444443   2333333333


Q ss_pred             EEe-----CCeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC
Q 013636          218 CIH-----AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSF  292 (439)
Q Consensus       218 ~~~-----~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~  292 (439)
                      ...     ....+++|||++|-.|.+...       ++.    .++..+.+++.-||+.   |++|+|..|.|++++++ 
T Consensus       107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~-  171 (229)
T PF06176_consen  107 AEKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN-  171 (229)
T ss_pred             eeeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC-
Confidence            322     235578999999988866542       332    2445677889999998   99999999999999865 


Q ss_pred             cEEEEecccccc
Q 013636          293 NAKLSDFGLSVT  304 (439)
Q Consensus       293 ~~kl~DfGls~~  304 (439)
                      .+++.||+..+.
T Consensus       172 ~i~iID~~~k~~  183 (229)
T PF06176_consen  172 GIRIIDTQGKRM  183 (229)
T ss_pred             cEEEEECccccc
Confidence            499999986643

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.33  E-value=3.1e-06  Score=75.42  Aligned_cols=104  Identities=27%  Similarity=0.259  Sum_probs=83.1

Q ss_pred             HHHHHHHHhcCC-CceeeeeeEEEeCCeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 013636          197 NNEVNWLTKIRH-QNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHP  275 (439)
Q Consensus       197 ~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~  275 (439)
                      .+|..+++.+++ +++.+++|+|    ..+++.||...+++...-..-.+....+|..+.+||.++++.+.+|++.....
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            358888899976 6999999999    44789999998766432100011224689999999999999999999865557


Q ss_pred             eEecCCCCCCEEEcCCCcEEEEecccccc
Q 013636          276 VVHRDLKSSNILLDSSFNAKLSDFGLSVT  304 (439)
Q Consensus       276 ivH~Dlk~~NiLl~~~~~~kl~DfGls~~  304 (439)
                      +.-.|++++|+-+++++++|+.|......
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcch
Confidence            88899999999999999999999987644

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.27  E-value=1.5e-05  Score=74.26  Aligned_cols=140  Identities=16%  Similarity=0.126  Sum_probs=84.1

Q ss_pred             ecccCc-EEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcC-CCceeeeeeEEEeCCeeEEEEEeccCCChhh
Q 013636          161 IGEGGR-GHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR-HQNIISLLGYCIHAETRFLVYEMMQNGSLEK  238 (439)
Q Consensus       161 LG~G~f-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~  238 (439)
                      |-.|.. ..||+....+ ..+.+|......   .....+|+++++.+. +--+.+++++....+..++|||+++|.++..
T Consensus         6 ~~~g~~~~~v~~~~~~~-~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~   81 (244)
T cd05150           6 VTEGQSGATVYRLDGKN-PGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA   81 (244)
T ss_pred             cCCCCCcCeEEEEcCCC-CcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence            444444 8899997654 567778776543   335667888888874 3345566777666667899999999987764


Q ss_pred             hh-------------------cCCCC-CCCCCH--HHHHHHHH--------------------HHHHHHHHHhhc----C
Q 013636          239 QL-------------------HGPTH-GSNLTW--HLRMKIAV--------------------DVARGLEYLHEH----C  272 (439)
Q Consensus       239 ~l-------------------~~~~~-~~~l~~--~~~~~i~~--------------------~ia~gl~~LH~~----~  272 (439)
                      ..                   |.... ......  ........                    .+...+..|-+.    .
T Consensus        82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  161 (244)
T cd05150          82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE  161 (244)
T ss_pred             hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence            32                   21110 001110  00000000                    011112222111    1


Q ss_pred             CCCeEecCCCCCCEEEcCCCcEEEEecccccc
Q 013636          273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT  304 (439)
Q Consensus       273 ~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~  304 (439)
                      .+.++|+|+.|.||+++++....|+||+.+..
T Consensus       162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             ceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            24599999999999999988889999997753

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.23  E-value=2.3e-05  Score=71.42  Aligned_cols=150  Identities=21%  Similarity=0.232  Sum_probs=96.8

Q ss_pred             HHHHHHhcCCCccc---eecccCcEEEEEEEECCccEEEEEEecCCCch-------------------HHHH-----HHH
Q 013636          146 ELLEAATNNFQESN---VIGEGGRGHVYKARFNEKLLAAVKRIDDAGHD-------------------AERE-----FNN  198 (439)
Q Consensus       146 ~~l~~~~~~~~~~~---~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-------------------~~~~-----~~~  198 (439)
                      +.+.....+..+..   .|+.|.-+.||+|...++..+|+|+.......                   ..++     ..+
T Consensus        38 ~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~k  117 (268)
T COG1718          38 ETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARK  117 (268)
T ss_pred             HHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHH
Confidence            33444444444433   45677788899999988999999987543211                   1111     235


Q ss_pred             HHHHHHhcC--CCceeeeeeEEEeCCeeEEEEEeccCCCh-hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 013636          199 EVNWLTKIR--HQNIISLLGYCIHAETRFLVYEMMQNGSL-EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHP  275 (439)
Q Consensus       199 E~~~l~~l~--h~niv~l~~~~~~~~~~~lV~e~~~~gsL-~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~  275 (439)
                      |..-|+++.  +-.+.+.+++.    ...|||||+..... .-.|.    .-.+.......+..++.+.+.-|-..  .+
T Consensus       118 Ef~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~Lk----Dv~~e~~e~~~~~~~~v~~~~~l~~~--a~  187 (268)
T COG1718         118 EFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLK----DVPLELEEAEGLYEDVVEYMRRLYKE--AG  187 (268)
T ss_pred             HHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcc----cCCcCchhHHHHHHHHHHHHHHHHHh--cC
Confidence            666677663  34444445443    44799999875411 11111    11223335666777888888887763  29


Q ss_pred             eEecCCCCCCEEEcCCCcEEEEecccccccC
Q 013636          276 VVHRDLKSSNILLDSSFNAKLSDFGLSVTAG  306 (439)
Q Consensus       276 ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~  306 (439)
                      +||+||+.-|||+. ++.+.++|||.|....
T Consensus       188 LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         188 LVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             cccccchhhheEEE-CCeEEEEECccccccC
Confidence            99999999999999 8899999999997654

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.13  E-value=1.9e-05  Score=80.42  Aligned_cols=148  Identities=17%  Similarity=0.158  Sum_probs=93.0

Q ss_pred             hcCCCccceecccCcEEEEEEEECCccEEEEEEecCCCch-------------------------------------HHH
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHD-------------------------------------AER  194 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-------------------------------------~~~  194 (439)
                      ...|. .+.||.-+.|.||+|++++|..||||..+..-..                                     .+-
T Consensus       161 f~~f~-~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~EL  239 (538)
T KOG1235|consen  161 FSEFD-EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQEL  239 (538)
T ss_pred             HHhcC-cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhc
Confidence            34444 3679999999999999999999999987542111                                     011


Q ss_pred             HHHHHHHHHHhc----CCCce---eeeeeEE-EeCCeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHH
Q 013636          195 EFNNEVNWLTKI----RHQNI---ISLLGYC-IHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE  266 (439)
Q Consensus       195 ~~~~E~~~l~~l----~h~ni---v~l~~~~-~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~  266 (439)
                      +|.+|.+-..++    .|-+.   |.+=..+ .....+.|+||||+|..+.+.-.-..  ..++...+..-+.++..-+-
T Consensus       240 DF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~--~gi~~~~i~~~l~~~~~~qI  317 (538)
T KOG1235|consen  240 DFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDK--RGISPHDILNKLVEAYLEQI  317 (538)
T ss_pred             chHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHH--cCCCHHHHHHHHHHHHHHHH
Confidence            244454433333    34441   1122222 23457899999999997776543112  23555544443333322222


Q ss_pred             HHhhcCCCCeEecCCCCCCEEEc----CCCcEEEEecccccccCC
Q 013636          267 YLHEHCNHPVVHRDLKSSNILLD----SSFNAKLSDFGLSVTAGT  307 (439)
Q Consensus       267 ~LH~~~~~~ivH~Dlk~~NiLl~----~~~~~kl~DfGls~~~~~  307 (439)
                      +     ..|++|+|=.|.||+++    .++.+.+-|||+......
T Consensus       318 f-----~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  318 F-----KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             H-----hcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            2     23899999999999998    367899999999876543

>PLN02876 acyl-CoA dehydrogenase

Probab=98.10  E-value=5.9e-05  Score=82.59  Aligned_cols=79  Identities=13%  Similarity=0.250  Sum_probs=56.6

Q ss_pred             cceecccCcEEEEEEEECCc---cEEEEEEecCCC-chHHHHHHHHHHHHHhcC-CCce--eeeeeEEEeC---CeeEEE
Q 013636          158 SNVIGEGGRGHVYKARFNEK---LLAAVKRIDDAG-HDAEREFNNEVNWLTKIR-HQNI--ISLLGYCIHA---ETRFLV  227 (439)
Q Consensus       158 ~~~LG~G~fg~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~~~---~~~~lV  227 (439)
                      .+.++.|.++.+|+....++   ..+++|+..... ......+.+|..+++.+. |.++  .+++.+|.+.   +..++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            46789999999999887654   355666654322 123356889999999995 6654  7777887664   367899


Q ss_pred             EEeccCCCh
Q 013636          228 YEMMQNGSL  236 (439)
Q Consensus       228 ~e~~~~gsL  236 (439)
                      |||+++..+
T Consensus       123 ME~v~G~~~  131 (822)
T PLN02876        123 MEYLEGRIF  131 (822)
T ss_pred             EEecCCccc
Confidence            999987643

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.00  E-value=2.6e-05  Score=84.26  Aligned_cols=196  Identities=20%  Similarity=0.215  Sum_probs=136.7

Q ss_pred             HHHHHHHHHhcCCCceeeeeeEEEeCCeeE----EEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc
Q 013636          196 FNNEVNWLTKIRHQNIISLLGYCIHAETRF----LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH  271 (439)
Q Consensus       196 ~~~E~~~l~~l~h~niv~l~~~~~~~~~~~----lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~  271 (439)
                      -.-|...+.+..|+|++.+++|-..+...-    +..+++..-++...+.   +-..++......+..++.+|++|+|+.
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q---~v~~i~~~~~r~~~~~~~~GL~~~h~~  305 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ---SVGSIPLETLRILHQKLLEGLAYLHSL  305 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh---hccccCHHHHHHHHHHHhhhHHHHHHh
Confidence            345777788889999999999887655443    3447888888888774   334578888888999999999999997


Q ss_pred             CCCCeEecCCCCC---CEEEcCCCcEEEE--ecccccccCCCCcceeeccccCccchhhhcCCCCCC--chhhHHHHHHH
Q 013636          272 CNHPVVHRDLKSS---NILLDSSFNAKLS--DFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTD--KSDVYAFGVVL  344 (439)
Q Consensus       272 ~~~~ivH~Dlk~~---NiLl~~~~~~kl~--DfGls~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~DvwS~Gvll  344 (439)
                         ...|.-+..+   +--.+..+...++  ||+.+.............-+..|.+||......+..  ..|+|++|...
T Consensus       306 ---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~  382 (1351)
T KOG1035|consen  306 ---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL  382 (1351)
T ss_pred             ---ccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence               5556555555   5555677778877  999887766544443333456788888777655544  47999999999


Q ss_pred             HHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhc
Q 013636          345 LELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL  424 (439)
Q Consensus       345 ~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  424 (439)
                      ..+..|..+-.....                   ...+++...        ...+.+....|+..++++|++..+++.+.
T Consensus       383 ~~~~~~~~i~~~~~~-------------------~~~~l~~~~--------~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~  435 (1351)
T KOG1035|consen  383 LQLSQGEDISEKSAV-------------------PVSLLDVLS--------TSELLDALPKCLDEDSEERLSALELLTHP  435 (1351)
T ss_pred             hhhhhcCcccccccc-------------------hhhhhcccc--------chhhhhhhhhhcchhhhhccchhhhhhch
Confidence            999987654322110                   000111100        00234466679999999999999999765

>PRK10593 hypothetical protein; Provisional

Probab=97.99  E-value=0.00017  Score=69.27  Aligned_cols=77  Identities=12%  Similarity=0.070  Sum_probs=56.2

Q ss_pred             ccceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcCC---CceeeeeeEEEeC---CeeEEEEEe
Q 013636          157 ESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRH---QNIISLLGYCIHA---ETRFLVYEM  230 (439)
Q Consensus       157 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~---~~~~lV~e~  230 (439)
                      ..+.||.|..+.||+....++. +++|..+..  .....|.+|...|+.+.-   -.+.+++++|...   +..++|||+
T Consensus        18 ~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~   94 (297)
T PRK10593         18 RVECISEQPYAALWALYDSQGN-PMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER   94 (297)
T ss_pred             eeeecCCccceeEEEEEcCCCC-EEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence            3567999999999999876664 455654331  123478899999998853   3677788877543   568999999


Q ss_pred             ccCCCh
Q 013636          231 MQNGSL  236 (439)
Q Consensus       231 ~~~gsL  236 (439)
                      ++++++
T Consensus        95 i~G~~~  100 (297)
T PRK10593         95 LRGVSV  100 (297)
T ss_pred             cCCEec
Confidence            998765

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.91  E-value=0.00013  Score=63.13  Aligned_cols=130  Identities=15%  Similarity=0.176  Sum_probs=87.0

Q ss_pred             ccceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEeccCCCh
Q 013636          157 ESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSL  236 (439)
Q Consensus       157 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  236 (439)
                      ..+.|++|++|.||++.+.++ .+|+|.-...  .....+..|+++|..++-.++.+=+-.+   +.-++.|||+.|-.|
T Consensus        26 v~~~L~KG~~s~Vyl~~~~~~-~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~y---g~~~i~me~i~G~~L   99 (201)
T COG2112          26 VEKELAKGTTSVVYLGEWRGG-EVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFY---GEDFIRMEYIDGRPL   99 (201)
T ss_pred             hhhhhhcccccEEEEeeccCc-eEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEe---chhhhhhhhhcCcch
Confidence            357799999999999999877 4566655443  3456788999999999887776644333   233455999999888


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC-CCCEEEcCCCcEEEEeccccccc
Q 013636          237 EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLK-SSNILLDSSFNAKLSDFGLSVTA  305 (439)
Q Consensus       237 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk-~~NiLl~~~~~~kl~DfGls~~~  305 (439)
                      .+.-.+.      +-+.+.    .+++.---|...   +|-|+.|. |...+|.++..+.|+||.-|+.-
T Consensus       100 ~~~~~~~------~rk~l~----~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k  156 (201)
T COG2112         100 GKLEIGG------DRKHLL----RVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATFK  156 (201)
T ss_pred             hhhhhcc------cHHHHH----HHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence            7765421      223333    333332223333   89999987 44444444449999999988743

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.88  E-value=0.00018  Score=66.62  Aligned_cols=140  Identities=20%  Similarity=0.251  Sum_probs=75.0

Q ss_pred             ceecccCcE-EEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCC---ceeeeeeEEEeC---CeeEEEEEec
Q 013636          159 NVIGEGGRG-HVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQ---NIISLLGYCIHA---ETRFLVYEMM  231 (439)
Q Consensus       159 ~~LG~G~fg-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~---~~~~lV~e~~  231 (439)
                      +.++.|+.. .||+..    ..+++|.....  .....+.+|.+.+..+...   .+...++.....   ...+++|+++
T Consensus         3 ~~~~~gG~~n~vy~~~----~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i   76 (235)
T cd05155           3 EPVDSGGTDNATFRLG----DDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL   76 (235)
T ss_pred             eeccCCCcccceEEcC----CceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence            457777766 488762    23556654432  2345788899999887532   233333333222   2348899999


Q ss_pred             cCCChhhh------------------hcCCCCCC-C------------C-CHHHHH--HHH-------HHHHHH-HHH-H
Q 013636          232 QNGSLEKQ------------------LHGPTHGS-N------------L-TWHLRM--KIA-------VDVARG-LEY-L  268 (439)
Q Consensus       232 ~~gsL~~~------------------l~~~~~~~-~------------l-~~~~~~--~i~-------~~ia~g-l~~-L  268 (439)
                      +|.++.+.                  ||...... .            + .|....  .+.       .+.... .+. +
T Consensus        77 ~G~~l~~~~~~~~~~l~~~la~~l~~LH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  156 (235)
T cd05155          77 EGETATAAALSDPSEFAEDLADFLAALRQIDPSGGPPAGRHNFLRGGDLAVRDAETREAIEALEGVIDVDAARALWEAAL  156 (235)
T ss_pred             cCCCCCccccCCHHHHHHHHHHHHHHHhCCCcccCCccCCccccCCCChhHhhHHHHHHHHHcccccChHHHHHHHHHHh
Confidence            98776422                  22211000 0            0 011110  000       011111 111 1


Q ss_pred             hh--cCCCCeEecCCCCCCEEEcCCCcEEEEecccccc
Q 013636          269 HE--HCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT  304 (439)
Q Consensus       269 H~--~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~  304 (439)
                      +.  ...+.++|+|+.+.||+++++...-|+||+.+..
T Consensus       157 ~~~~~~~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         157 RAPWWGPPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             cccccCCceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            11  1233599999999999999776667999998754

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.85  E-value=0.00049  Score=61.71  Aligned_cols=132  Identities=23%  Similarity=0.327  Sum_probs=89.5

Q ss_pred             cceecccCcEEEEEEEECCccEEEEEEecCCC----------------chHHHHHHHHHHHHHhcC------CCceeeee
Q 013636          158 SNVIGEGGRGHVYKARFNEKLLAAVKRIDDAG----------------HDAEREFNNEVNWLTKIR------HQNIISLL  215 (439)
Q Consensus       158 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h~niv~l~  215 (439)
                      ...||+|+.-.||.--.+..  ..||......                ....++..+|+.....+.      +.+|.+++
T Consensus         6 ~~~i~~G~~R~cy~HP~dp~--~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    6 SDLIAQGGERDCYQHPDDPN--LCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             CcccccCCCceEEECCCCCC--eEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            56799999999997654444  3555554433                223456667777666665      88999999


Q ss_pred             eEEEeCCeeEEEEEeccCC------ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc
Q 013636          216 GYCIHAETRFLVYEMMQNG------SLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLD  289 (439)
Q Consensus       216 ~~~~~~~~~~lV~e~~~~g------sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~  289 (439)
                      |+.+++....+|+|.+.+.      +|.+++..    ..++. ...+   .+-+-..||-+.   .|+.+|++|.||++.
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~----~~~~~-~~~~---~L~~f~~~l~~~---~Iv~~dl~~~NIv~~  152 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE----GGLTE-ELRQ---ALDEFKRYLLDH---HIVIRDLNPHNIVVQ  152 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHc----CCccH-HHHH---HHHHHHHHHHHc---CCeecCCCcccEEEE
Confidence            9999999999999986542      56777742    22444 3333   333444566665   899999999999995


Q ss_pred             CCC----cEEEEe-cccc
Q 013636          290 SSF----NAKLSD-FGLS  302 (439)
Q Consensus       290 ~~~----~~kl~D-fGls  302 (439)
                      .+.    .+.|+| ||-.
T Consensus       153 ~~~~~~~~lvlIDG~G~~  170 (199)
T PF10707_consen  153 RRDSGEFRLVLIDGLGEK  170 (199)
T ss_pred             ecCCCceEEEEEeCCCCc
Confidence            332    577777 4543

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.84  E-value=0.00029  Score=65.10  Aligned_cols=141  Identities=16%  Similarity=0.196  Sum_probs=80.8

Q ss_pred             ceecccCcEEEEEEEECC--ccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeee-eeEEEeCCeeEEEEEeccCCC
Q 013636          159 NVIGEGGRGHVYKARFNE--KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISL-LGYCIHAETRFLVYEMMQNGS  235 (439)
Q Consensus       159 ~~LG~G~fg~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l-~~~~~~~~~~~lV~e~~~~gs  235 (439)
                      +.|..|-...+|+....+  +..+++|...... ...-...+|+.+++.+...++++- ++.+  .  ..++|||+++.+
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~-~~~~d~~~E~~~~~~l~~~gl~P~v~~~~--~--~~~l~e~i~G~~   78 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKT-ELIIDRERELRIHKLLSKHGLAPKLYATF--Q--NGLIYEFIPGRT   78 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCc-cceecHHHHHHHHHHHHhCCCCCeEEEEe--C--CcEEEEeeCCCc
Confidence            567888889999998764  5667777665322 111233468888888854444433 3322  1  248999999876


Q ss_pred             hhhh-----------------hcCCCCC--------CCCC-HHHHHHHHH----------------------HHHHHHHH
Q 013636          236 LEKQ-----------------LHGPTHG--------SNLT-WHLRMKIAV----------------------DVARGLEY  267 (439)
Q Consensus       236 L~~~-----------------l~~~~~~--------~~l~-~~~~~~i~~----------------------~ia~gl~~  267 (439)
                      +...                 +|.....        .... +..+..+..                      .+.+.+..
T Consensus        79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  158 (235)
T cd05157          79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW  158 (235)
T ss_pred             CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence            6321                 1221111        1111 222111111                      11111112


Q ss_pred             H----hhc-CCCCeEecCCCCCCEEEcC-CCcEEEEecccccc
Q 013636          268 L----HEH-CNHPVVHRDLKSSNILLDS-SFNAKLSDFGLSVT  304 (439)
Q Consensus       268 L----H~~-~~~~ivH~Dlk~~NiLl~~-~~~~kl~DfGls~~  304 (439)
                      |    ... ....++|+|+.+.|||+++ ++.+.++||..+..
T Consensus       159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~  201 (235)
T cd05157         159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY  201 (235)
T ss_pred             HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence            2    111 1236999999999999998 57899999998754

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.81  E-value=0.00018  Score=67.56  Aligned_cols=138  Identities=12%  Similarity=0.161  Sum_probs=77.1

Q ss_pred             ecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceee-eeeEEEeCCeeEEEEEeccCCChhhh
Q 013636          161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIIS-LLGYCIHAETRFLVYEMMQNGSLEKQ  239 (439)
Q Consensus       161 LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~~~~lV~e~~~~gsL~~~  239 (439)
                      +..|-.+.+|+.... +..+++|........-.-+..+|..+++.+....+++ +++.+    ..++|+||++|..+...
T Consensus         4 ~~~G~tn~~y~~~~~-~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~~~~~~   78 (256)
T TIGR02721         4 LSGGLTNRSWRIEHP-GISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGEVITLD   78 (256)
T ss_pred             CCCcCcCCeEEEEeC-CccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCcccccc
Confidence            556778899988744 4566777654322211123567888888886443433 33332    24799999998765421


Q ss_pred             -----------------hcCCCC-CCCCCHHHH-HHHHHHH---------HHHHHHHhhc-----CCCCeEecCCCCCCE
Q 013636          240 -----------------LHGPTH-GSNLTWHLR-MKIAVDV---------ARGLEYLHEH-----CNHPVVHRDLKSSNI  286 (439)
Q Consensus       240 -----------------l~~~~~-~~~l~~~~~-~~i~~~i---------a~gl~~LH~~-----~~~~ivH~Dlk~~Ni  286 (439)
                                       +|.... +..++.... ..+..++         .+-+..+-+.     ....++|+|+.|.||
T Consensus        79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni  158 (256)
T TIGR02721        79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL  158 (256)
T ss_pred             cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence                             232111 112222211 1111111         1112222111     123589999999999


Q ss_pred             EEcCCCcEEEEecccccc
Q 013636          287 LLDSSFNAKLSDFGLSVT  304 (439)
Q Consensus       287 Ll~~~~~~kl~DfGls~~  304 (439)
                      ++++++ +.++||..+..
T Consensus       159 l~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       159 VVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             EEeCCC-CEEEeccccCc
Confidence            999877 78999998854

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.65  E-value=0.00039  Score=66.65  Aligned_cols=143  Identities=17%  Similarity=0.174  Sum_probs=85.0

Q ss_pred             cceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCc--eeeeeeE------EEeCCeeEEEEE
Q 013636          158 SNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQN--IISLLGY------CIHAETRFLVYE  229 (439)
Q Consensus       158 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~------~~~~~~~~lV~e  229 (439)
                      .+.+..|....+|+....++ .+++|....   ....+...|+.++..+.+.+  +.+++..      ....+..+.+++
T Consensus        19 i~~i~~G~~n~~y~v~~~~~-~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTTDSG-RYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEeCCC-cEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            45677888889999877655 567787654   22345667787777774332  3444332      123445689999


Q ss_pred             eccCCChhh--------------hhcCCCC--------CCCCCHHHHH----------HHHHHHHHHHHHHhh----cCC
Q 013636          230 MMQNGSLEK--------------QLHGPTH--------GSNLTWHLRM----------KIAVDVARGLEYLHE----HCN  273 (439)
Q Consensus       230 ~~~~gsL~~--------------~l~~~~~--------~~~l~~~~~~----------~i~~~ia~gl~~LH~----~~~  273 (439)
                      |++|..+..              .+|....        .....|....          .....+...+.++.+    ...
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            999876532              1121000        0111222211          011123334445443    123


Q ss_pred             CCeEecCCCCCCEEEcCCCcEEEEecccccc
Q 013636          274 HPVVHRDLKSSNILLDSSFNAKLSDFGLSVT  304 (439)
Q Consensus       274 ~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~  304 (439)
                      ..++|+|+.|.|++++++..+.|.||+.+..
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            4799999999999999987789999998754

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.61  E-value=0.0013  Score=65.34  Aligned_cols=76  Identities=17%  Similarity=0.109  Sum_probs=52.6

Q ss_pred             cceecccCcEEEEEEEECCc-cEEEEEEecCC------C-chHHHHHHHHHHHHHhcC---CCceeeeeeEEEeCCeeEE
Q 013636          158 SNVIGEGGRGHVYKARFNEK-LLAAVKRIDDA------G-HDAEREFNNEVNWLTKIR---HQNIISLLGYCIHAETRFL  226 (439)
Q Consensus       158 ~~~LG~G~fg~Vy~~~~~~~-~~vavK~~~~~------~-~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~l  226 (439)
                      .+.||.|.+..||++...++ ..++||.-...      + .-..+++..|.+.|..+.   ..++.+++.+  +.+..++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            35799999999999999877 47888874311      1 123455677888888763   2345556655  4466789


Q ss_pred             EEEeccCCC
Q 013636          227 VYEMMQNGS  235 (439)
Q Consensus       227 V~e~~~~gs  235 (439)
                      ||||+++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999998754

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.57  E-value=0.0011  Score=59.31  Aligned_cols=125  Identities=24%  Similarity=0.399  Sum_probs=88.7

Q ss_pred             cCCCccceecccCc-EEEEEEEECCccEEEEEEecC---CC---------c---------hHHHHHHHHHHHHHhcC---
Q 013636          153 NNFQESNVIGEGGR-GHVYKARFNEKLLAAVKRIDD---AG---------H---------DAEREFNNEVNWLTKIR---  207 (439)
Q Consensus       153 ~~~~~~~~LG~G~f-g~Vy~~~~~~~~~vavK~~~~---~~---------~---------~~~~~~~~E~~~l~~l~---  207 (439)
                      .+++..+.||.|.- |.||+++..+. .+|+|.+..   ..         .         .-...|..|.+...+|+   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~g~-~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEIDGR-IYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEECCe-EEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            67778899999999 99999999866 789998321   00         0         01124888999888885   


Q ss_pred             CCce--eeeeeEEEeCC------------------eeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 013636          208 HQNI--ISLLGYCIHAE------------------TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEY  267 (439)
Q Consensus       208 h~ni--v~l~~~~~~~~------------------~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~  267 (439)
                      +.++  |+.+||..-..                  ...||.||.+...            .++..    -+.++.+-+..
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~~----~~~~~~~dl~~  179 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQIR----DIPQMLRDLKI  179 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccchh----HHHHHHHHHHH
Confidence            4566  89999874331                  2357888776532            12222    34466677788


Q ss_pred             HhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccc
Q 013636          268 LHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS  302 (439)
Q Consensus       268 LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls  302 (439)
                      +|..   +|+-+|+++.|..     .-||+|||.+
T Consensus       180 ~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  180 LHKL---GIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHC---CeeeccCcccccc-----CCEEEecccC
Confidence            8987   9999999999985     4589999864

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.49  E-value=0.001  Score=63.95  Aligned_cols=141  Identities=21%  Similarity=0.244  Sum_probs=82.2

Q ss_pred             ceecccCcEEEEEEEECC-------ccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCcee-eeeeEEEeCCeeEEEEEe
Q 013636          159 NVIGEGGRGHVYKARFNE-------KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNII-SLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       159 ~~LG~G~fg~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lV~e~  230 (439)
                      +.+..|-...+|+....+       +..+++|...... ....+..+|..++..+....+. ++++++.    -.+|+||
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e~   78 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEEF   78 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhhe
Confidence            456677778999988765       4667777765432 2223456788888887544343 3444432    2368999


Q ss_pred             ccCCChhhh-----------------hcCCCCCC------C--CCHHHHHH--------------------------HHH
Q 013636          231 MQNGSLEKQ-----------------LHGPTHGS------N--LTWHLRMK--------------------------IAV  259 (439)
Q Consensus       231 ~~~gsL~~~-----------------l~~~~~~~------~--l~~~~~~~--------------------------i~~  259 (439)
                      ++|.++...                 +|......      .  .-|....+                          +..
T Consensus        79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (302)
T cd05156          79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE  158 (302)
T ss_pred             eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence            988776431                 12211110      0  00111111                          011


Q ss_pred             HHHHHHHHHhh------cCCCCeEecCCCCCCEEEcCC----CcEEEEecccccc
Q 013636          260 DVARGLEYLHE------HCNHPVVHRDLKSSNILLDSS----FNAKLSDFGLSVT  304 (439)
Q Consensus       260 ~ia~gl~~LH~------~~~~~ivH~Dlk~~NiLl~~~----~~~kl~DfGls~~  304 (439)
                      .+..-+..+..      .....++|+|+.+.||+++++    +.++++||..+..
T Consensus       159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence            22222334432      134579999999999999985    8899999998854

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK05231 homoserine kinase; Provisional

Probab=97.45  E-value=0.0046  Score=59.97  Aligned_cols=142  Identities=13%  Similarity=0.165  Sum_probs=77.0

Q ss_pred             ceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcC-----CCceeeee-e--EEEeCCeeEEEEEe
Q 013636          159 NVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR-----HQNIISLL-G--YCIHAETRFLVYEM  230 (439)
Q Consensus       159 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~-~--~~~~~~~~~lV~e~  230 (439)
                      +.++.|....+|+....++ .+++|.....   .......|...+..|.     .|.++.-. |  +....+..++++||
T Consensus        28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~---~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~  103 (319)
T PRK05231         28 KGIAEGIENSNFFLTTTQG-EYVLTLFERL---TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF  103 (319)
T ss_pred             chhccccccceEEEEeCCC-cEEEEEeccC---ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence            4567777789999987766 4677876521   2233334555555542     33333211 0  12234567899999


Q ss_pred             ccCCChhh--------------hhcCCCCC--------CCCCH-HHHHHH------------H-HHHHHHHHHHhhc---
Q 013636          231 MQNGSLEK--------------QLHGPTHG--------SNLTW-HLRMKI------------A-VDVARGLEYLHEH---  271 (439)
Q Consensus       231 ~~~gsL~~--------------~l~~~~~~--------~~l~~-~~~~~i------------~-~~ia~gl~~LH~~---  271 (439)
                      ++|..+..              .+|....+        ..+.| .....-            . ..+...++.+.+.   
T Consensus       104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  183 (319)
T PRK05231        104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP  183 (319)
T ss_pred             cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence            99875421              11221110        11212 111110            1 1111222333211   


Q ss_pred             -CCCCeEecCCCCCCEEEcCCCcEEEEecccccc
Q 013636          272 -CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT  304 (439)
Q Consensus       272 -~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~  304 (439)
                       -..+++|+|+.+.||+++++...-++||+.+..
T Consensus       184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             cCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence             234899999999999999776668999998754

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.39  E-value=0.005  Score=59.45  Aligned_cols=144  Identities=18%  Similarity=0.208  Sum_probs=82.1

Q ss_pred             cceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCC--ceeeeeeEE------EeCCeeEEEEE
Q 013636          158 SNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQ--NIISLLGYC------IHAETRFLVYE  229 (439)
Q Consensus       158 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~------~~~~~~~lV~e  229 (439)
                      .+.++.|....+|+...+++ .+++|......  ...+...|.+++..|...  ++.+++...      ...+..++++|
T Consensus        27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e  103 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE  103 (307)
T ss_pred             ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence            35577777789999876655 45677664421  123445566777666322  233433321      22356789999


Q ss_pred             eccCCChhh--------------hhcCCCCC---------CCCCHHHHHH------------HHHHHHHHHHHHhh----
Q 013636          230 MMQNGSLEK--------------QLHGPTHG---------SNLTWHLRMK------------IAVDVARGLEYLHE----  270 (439)
Q Consensus       230 ~~~~gsL~~--------------~l~~~~~~---------~~l~~~~~~~------------i~~~ia~gl~~LH~----  270 (439)
                      |++|.++..              .+|....+         ..-.|.....            ....+.+.++++..    
T Consensus       104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~  183 (307)
T TIGR00938       104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR  183 (307)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence            998865421              12221110         0111211110            01123344555542    


Q ss_pred             cCCCCeEecCCCCCCEEEcCCCcEEEEecccccc
Q 013636          271 HCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT  304 (439)
Q Consensus       271 ~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~  304 (439)
                      ....+++|+|+++.|+++++++...++||+.+..
T Consensus       184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             cCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence            2245899999999999999988778999998744

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.19  E-value=0.0035  Score=59.72  Aligned_cols=74  Identities=15%  Similarity=0.242  Sum_probs=48.2

Q ss_pred             ccceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcC---CCceeeeeeEEEeCCeeEEEEEeccC
Q 013636          157 ESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR---HQNIISLLGYCIHAETRFLVYEMMQN  233 (439)
Q Consensus       157 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV~e~~~~  233 (439)
                      ..+.++.|....+|+.+ .++..+.||.-..   .....|..|.+-|+.|.   --.+.+.+++....+..+|++||++.
T Consensus        21 ~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~   96 (288)
T PF03881_consen   21 SIEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM   96 (288)
T ss_dssp             EEEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred             eeEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence            35678999999999988 6666788887763   23346788888888883   44577788888777788999999987


Q ss_pred             C
Q 013636          234 G  234 (439)
Q Consensus       234 g  234 (439)
                      +
T Consensus        97 ~   97 (288)
T PF03881_consen   97 G   97 (288)
T ss_dssp             -
T ss_pred             C
Confidence            7

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.16  E-value=6.7e-05  Score=83.03  Aligned_cols=159  Identities=16%  Similarity=0.008  Sum_probs=114.0

Q ss_pred             HHHHHHHHHhcCCCceeeeeeEEEe--CCeeEEEEEeccCCChhhhhcC-CCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 013636          196 FNNEVNWLTKIRHQNIISLLGYCIH--AETRFLVYEMMQNGSLEKQLHG-PTHGSNLTWHLRMKIAVDVARGLEYLHEHC  272 (439)
Q Consensus       196 ~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~  272 (439)
                      ...|.+.++...|+++.....-...  +.+-+.+++|+..|++.+.+-+ ..+...++.......-.+......-.|+..
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            3455555666788887765543332  2355899999999999998754 333344554444444444355555555443


Q ss_pred             C--CCeEecCCCCCCEEEcCCCcEEEEecccccccCCC-CcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh
Q 013636          273 N--HPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ-SRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM  349 (439)
Q Consensus       273 ~--~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt  349 (439)
                      +  +-.+|+++|+-|.+|..+.++|++++|+.+..... .......+++.|+.|+....-+++.++|+|+.|+.+|+..-
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSD 1435 (2724)
T ss_pred             cCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhc
Confidence            2  34789999999999999999999999999843332 22233457888999999888889989999999999999988


Q ss_pred             CCCCC
Q 013636          350 GRRPV  354 (439)
Q Consensus       350 G~~P~  354 (439)
                      |..+|
T Consensus      1436 ~n~~f 1440 (2724)
T KOG1826|consen 1436 GNAYF 1440 (2724)
T ss_pred             ccHHH
Confidence            88776

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.96  E-value=0.017  Score=55.61  Aligned_cols=129  Identities=16%  Similarity=0.192  Sum_probs=77.5

Q ss_pred             EEEEEECCccEEEEEEecC--CCchHHHHHHHHHHHHHhcCC--CceeeeeeEEEeCC--eeEEEEEeccCCChhhhhcC
Q 013636          169 VYKARFNEKLLAAVKRIDD--AGHDAEREFNNEVNWLTKIRH--QNIISLLGYCIHAE--TRFLVYEMMQNGSLEKQLHG  242 (439)
Q Consensus       169 Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~--~~~lV~e~~~~gsL~~~l~~  242 (439)
                      +|..... +...++. ...  ..........+|..+++.+.-  .-+-..+++|..+.  ..+.||+|+++....+.+..
T Consensus        41 t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~  118 (321)
T COG3173          41 TFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPP  118 (321)
T ss_pred             eEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCc
Confidence            4444433 5555555 321  112333456678888877742  33445567776665  67999999998544333221


Q ss_pred             CCCCCCCCHHHHHHHH-HHHHHHHHHHhh--------------------------------------------------c
Q 013636          243 PTHGSNLTWHLRMKIA-VDVARGLEYLHE--------------------------------------------------H  271 (439)
Q Consensus       243 ~~~~~~l~~~~~~~i~-~~ia~gl~~LH~--------------------------------------------------~  271 (439)
                      ..      ..  .+++ ..+++.|+-||+                                                  .
T Consensus       119 ~~------~~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~  190 (321)
T COG3173         119 ES------LG--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEAN  190 (321)
T ss_pred             cc------ch--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhc
Confidence            10      00  1111 244444444443                                                  2


Q ss_pred             -----CCCCeEecCCCCCCEEEcCCCcEEEEecccccccCC
Q 013636          272 -----CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT  307 (439)
Q Consensus       272 -----~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~  307 (439)
                           ..+.++|||+.+.|++++++.-+-+.||+++.....
T Consensus       191 ~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP  231 (321)
T COG3173         191 RPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP  231 (321)
T ss_pred             CCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence                 124699999999999999998899999999976543

>PLN02236 choline kinase

Probab=96.90  E-value=0.013  Score=57.51  Aligned_cols=141  Identities=15%  Similarity=0.202  Sum_probs=80.1

Q ss_pred             ceecccCcEEEEEEEECC-----ccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceee-eeeEEEeCCeeEEEEEecc
Q 013636          159 NVIGEGGRGHVYKARFNE-----KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIIS-LLGYCIHAETRFLVYEMMQ  232 (439)
Q Consensus       159 ~~LG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~~~~lV~e~~~  232 (439)
                      ..+-.|-...+|+....+     +..+++|....... ..-+-.+|..+++.+..-++.+ +++.+.. .   .|++|++
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~-~~idR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi~  116 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE-LFFDRDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFIH  116 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC-eeechHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEeeC
Confidence            445567788999987543     25677776654322 2122367888888886544443 4444422 2   5899998


Q ss_pred             CCChhhh-----------------hcCCC-CCC--CCCHHHHHHHHHH-----------------HHHHHHHHh----h-
Q 013636          233 NGSLEKQ-----------------LHGPT-HGS--NLTWHLRMKIAVD-----------------VARGLEYLH----E-  270 (439)
Q Consensus       233 ~gsL~~~-----------------l~~~~-~~~--~l~~~~~~~i~~~-----------------ia~gl~~LH----~-  270 (439)
                      +.++...                 +|... .+.  ...+..+.++..+                 +...+..|.    . 
T Consensus       117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~  196 (344)
T PLN02236        117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD  196 (344)
T ss_pred             CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence            7776421                 23211 111  1123333233211                 111222222    1 


Q ss_pred             cCCCCeEecCCCCCCEEEcC-CCcEEEEecccccc
Q 013636          271 HCNHPVVHRDLKSSNILLDS-SFNAKLSDFGLSVT  304 (439)
Q Consensus       271 ~~~~~ivH~Dlk~~NiLl~~-~~~~kl~DfGls~~  304 (439)
                      .....++|+|+++.||++++ ++.+.++||..+..
T Consensus       197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            12336899999999999986 46899999998754

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.79  E-value=0.028  Score=53.41  Aligned_cols=31  Identities=29%  Similarity=0.430  Sum_probs=26.0

Q ss_pred             CeEecCCCCCCEEEcCCCc-EEEEeccccccc
Q 013636          275 PVVHRDLKSSNILLDSSFN-AKLSDFGLSVTA  305 (439)
Q Consensus       275 ~ivH~Dlk~~NiLl~~~~~-~kl~DfGls~~~  305 (439)
                      .++|+|+++.||+++++++ .-|.||+.+...
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence            5899999999999997555 569999988653

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=96.60  E-value=0.004  Score=59.17  Aligned_cols=147  Identities=17%  Similarity=0.143  Sum_probs=94.8

Q ss_pred             cccHHHHHHHhc---CCCccceecccCcEEEEEEEECCccEEEEEEecCC--------------------Cch--HHHHH
Q 013636          142 VIEYELLEAATN---NFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDA--------------------GHD--AEREF  196 (439)
Q Consensus       142 ~~~~~~l~~~~~---~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~--------------------~~~--~~~~~  196 (439)
                      .++|-.++...+   -+.+.+.||-|.-+.+|.+-..+|.+.++|.-.-.                    +|.  .+-..
T Consensus        78 GyDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa  157 (465)
T KOG2268|consen   78 GYDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAA  157 (465)
T ss_pred             cchHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHH
Confidence            344444444433   34567899999999999999998888877743210                    111  11124


Q ss_pred             HHHHHHHHhcCC--CceeeeeeEEEeCCeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 013636          197 NNEVNWLTKIRH--QNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNH  274 (439)
Q Consensus       197 ~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~  274 (439)
                      .+|...|+.|..  --+.+.+++    +.-++|||++.+-.|...-+      ..+..++   ...+..-+.-|-..   
T Consensus       158 ~kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~------v~d~~~l---y~~lm~~Iv~la~~---  221 (465)
T KOG2268|consen  158 TKEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRH------VEDPPTL---YDDLMGLIVRLANH---  221 (465)
T ss_pred             HHHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeee------cCChHHH---HHHHHHHHHHHHHc---
Confidence            568888888742  234444444    45589999998877754422      1222332   23333334445444   


Q ss_pred             CeEecCCCCCCEEEcCCCcEEEEecccccc
Q 013636          275 PVVHRDLKSSNILLDSSFNAKLSDFGLSVT  304 (439)
Q Consensus       275 ~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~  304 (439)
                      |+||+|.+-=||++++++.++++||-....
T Consensus       222 GlIHgDFNEFNimv~dd~~i~vIDFPQmvS  251 (465)
T KOG2268|consen  222 GLIHGDFNEFNIMVKDDDKIVVIDFPQMVS  251 (465)
T ss_pred             CceecccchheeEEecCCCEEEeechHhhc
Confidence            999999999999999999999999986543

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.42  E-value=0.084  Score=50.81  Aligned_cols=30  Identities=27%  Similarity=0.365  Sum_probs=25.9

Q ss_pred             CCeEecCCCCCCEEEcCCCcEEEEecccccc
Q 013636          274 HPVVHRDLKSSNILLDSSFNAKLSDFGLSVT  304 (439)
Q Consensus       274 ~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~  304 (439)
                      .+++|+|+.+.||++++ +.+.++||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~  216 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI  216 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence            47999999999999988 6789999997643

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.23  E-value=0.13  Score=51.37  Aligned_cols=80  Identities=14%  Similarity=0.106  Sum_probs=50.8

Q ss_pred             cceecccCcEEEEEEEECCccEEEEEEecC----CCc---hHHHHHHHHHHHHHhcC---CCceeeeeeEEEeCCeeEEE
Q 013636          158 SNVIGEGGRGHVYKARFNEKLLAAVKRIDD----AGH---DAEREFNNEVNWLTKIR---HQNIISLLGYCIHAETRFLV  227 (439)
Q Consensus       158 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~----~~~---~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV  227 (439)
                      .+.||-|....||+....+ ..++||.-..    .+.   ....+-..|.+.|+.+.   ..++.+++.++.  +..+++
T Consensus        37 ~~eiggGn~N~VyrV~~~~-~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSSS-GSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEcCC-ccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence            4678999999999998754 4577877541    111   12223334566666553   346777887776  557889


Q ss_pred             EEeccC--CChhhhh
Q 013636          228 YEMMQN--GSLEKQL  240 (439)
Q Consensus       228 ~e~~~~--gsL~~~l  240 (439)
                      |||+++  ..+.+.+
T Consensus       114 ME~L~~~~~ilr~~L  128 (418)
T PLN02756        114 MRYLEPPHIILRKGL  128 (418)
T ss_pred             EeecCCcceehhhhh
Confidence            999977  3454443

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.08  E-value=0.058  Score=52.67  Aligned_cols=141  Identities=18%  Similarity=0.216  Sum_probs=78.3

Q ss_pred             ceecccCcEEEEEEEECCc----cEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceee-eeeEEEeCCeeEEEEEeccC
Q 013636          159 NVIGEGGRGHVYKARFNEK----LLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIIS-LLGYCIHAETRFLVYEMMQN  233 (439)
Q Consensus       159 ~~LG~G~fg~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~~~~lV~e~~~~  233 (439)
                      +.|..|-...+|+....+.    ..++++....... ..-+-.+|..+++.+..-++.+ +++++.  +.  +|.+|+++
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~--~G--~i~~fi~g   94 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFG--NG--MIQSFINA   94 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeC--Cc--EeehhhcC
Confidence            4565677788998876542    3667776654322 1223357888888886555543 444442  22  58999977


Q ss_pred             CChhh-----------------hhcCCC-CC-C-CCCHHHHHHHHHHH----------------------HHHHHHHhh-
Q 013636          234 GSLEK-----------------QLHGPT-HG-S-NLTWHLRMKIAVDV----------------------ARGLEYLHE-  270 (439)
Q Consensus       234 gsL~~-----------------~l~~~~-~~-~-~l~~~~~~~i~~~i----------------------a~gl~~LH~-  270 (439)
                      .+|..                 .+|... .. . .--|..+.++..++                      .+-+..+.. 
T Consensus        95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~  174 (330)
T PLN02421         95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI  174 (330)
T ss_pred             CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence            65521                 113211 01 1 11233332222221                      111222211 


Q ss_pred             ----cCCCCeEecCCCCCCEEEcC-CCcEEEEecccccc
Q 013636          271 ----HCNHPVVHRDLKSSNILLDS-SFNAKLSDFGLSVT  304 (439)
Q Consensus       271 ----~~~~~ivH~Dlk~~NiLl~~-~~~~kl~DfGls~~  304 (439)
                          ..+.-++|+|+.+.||++++ ++.++++||..|..
T Consensus       175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence                11224899999999999975 57899999998854

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.99  E-value=0.048  Score=49.27  Aligned_cols=136  Identities=19%  Similarity=0.140  Sum_probs=83.0

Q ss_pred             EEEEecCCCch-HHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHH
Q 013636          181 AVKRIDDAGHD-AEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAV  259 (439)
Q Consensus       181 avK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~  259 (439)
                      .+|++...... ...-|.++.+++.++.  .|+++..-  +.-..-++.|+|....            ....    .++.
T Consensus        89 ~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~------------i~~~----N~i~  148 (308)
T PF07387_consen   89 FLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK------------INFS----NFIT  148 (308)
T ss_pred             hhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc------------cchh----HHHH
Confidence            45555544433 3445778888887764  45666522  3335678999885311            1111    1222


Q ss_pred             HHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCcceeeccccCccchhhhcCCCCCCchhhHH
Q 013636          260 DVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYA  339 (439)
Q Consensus       260 ~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS  339 (439)
                      .=...|.-.|+. ..+.+|||..|+||+-|..|.+||.|-+.-..     ...      -|.--|   ....|.++.+=+
T Consensus       149 agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~-----~~V------~~vN~~---Y~~lT~~aE~~~  213 (308)
T PF07387_consen  149 AGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE-----NQV------NMVNIE---YESLTQEAEVKV  213 (308)
T ss_pred             HhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhhh-----hee------eEEeee---ccccChHHHHHH
Confidence            224677788865 34899999999999999999999999763211     111      121111   123567788888


Q ss_pred             HHHHHHHHHhCC
Q 013636          340 FGVVLLELLMGR  351 (439)
Q Consensus       340 ~Gvll~elltG~  351 (439)
                      |=.-++++....
T Consensus       214 fv~s~l~~v~~~  225 (308)
T PF07387_consen  214 FVKSCLKLVEKQ  225 (308)
T ss_pred             HHHHHHHHHHHH
Confidence            877777777643

The function of this family is unknown.

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.95  E-value=0.14  Score=49.78  Aligned_cols=140  Identities=17%  Similarity=0.246  Sum_probs=82.0

Q ss_pred             ecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcC---CCceee---eee----EEEeCCeeEEEEEe
Q 013636          161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR---HQNIIS---LLG----YCIHAETRFLVYEM  230 (439)
Q Consensus       161 LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~---l~~----~~~~~~~~~lV~e~  230 (439)
                      |.+ .-..+|+....++.. ++|..+..  ....++..|...+..+.   .+-.++   +-|    ........+-+++|
T Consensus        34 l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~  109 (331)
T COG2334          34 LNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY  109 (331)
T ss_pred             ccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence            444 456789998888877 66766554  34456667777777773   222222   111    11111367889999


Q ss_pred             ccCCChhh-h--------------hc----CCC-----CCCCCCHHH-------------HHHHHHHHHHHHHHHhhc--
Q 013636          231 MQNGSLEK-Q--------------LH----GPT-----HGSNLTWHL-------------RMKIAVDVARGLEYLHEH--  271 (439)
Q Consensus       231 ~~~gsL~~-~--------------l~----~~~-----~~~~l~~~~-------------~~~i~~~ia~gl~~LH~~--  271 (439)
                      ++|..+.. .              ||    +..     ......|..             -.....++...+..+.+.  
T Consensus       110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~  189 (331)
T COG2334         110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP  189 (331)
T ss_pred             cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence            99988872 1              11    110     111234431             011233344444444432  


Q ss_pred             --CCCC---eEecCCCCCCEEEcCCCc-EEEEecccccc
Q 013636          272 --CNHP---VVHRDLKSSNILLDSSFN-AKLSDFGLSVT  304 (439)
Q Consensus       272 --~~~~---ivH~Dlk~~NiLl~~~~~-~kl~DfGls~~  304 (439)
                        -...   ++|+|+.|.||+++.+.. +.+.|||-+..
T Consensus       190 ~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~  228 (331)
T COG2334         190 AHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY  228 (331)
T ss_pred             hhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence              1123   999999999999999885 99999997743

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=95.90  E-value=0.13  Score=50.27  Aligned_cols=80  Identities=18%  Similarity=0.149  Sum_probs=48.2

Q ss_pred             eecccCcEEEEEEEECCc-cEEEEEEecC------CC-chHHHHHHHHHHHHHhcC--CCceeeeeeEEEeCCeeEEEEE
Q 013636          160 VIGEGGRGHVYKARFNEK-LLAAVKRIDD------AG-HDAEREFNNEVNWLTKIR--HQNIISLLGYCIHAETRFLVYE  229 (439)
Q Consensus       160 ~LG~G~fg~Vy~~~~~~~-~~vavK~~~~------~~-~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lV~e  229 (439)
                      .||-|....||++...++ ..++||.-..      .+ .-...+..-|.+.|+...  .|..++-+ |+.+.+...+|||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~v-y~~D~e~~~~vME   80 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRI-FHFDTEMAVTVME   80 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeE-EEEccccceehHh
Confidence            479999999999998754 4678876431      11 122234445667776653  45444433 2335566779999


Q ss_pred             eccCC-Chhhhh
Q 013636          230 MMQNG-SLEKQL  240 (439)
Q Consensus       230 ~~~~g-sL~~~l  240 (439)
                      +++.. .|.+.|
T Consensus        81 dL~~~~ilR~~L   92 (370)
T TIGR01767        81 DLSHHKIARKGL   92 (370)
T ss_pred             hCccchHHHHHH
Confidence            98653 343444

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=95.87  E-value=0.14  Score=49.82  Aligned_cols=141  Identities=19%  Similarity=0.233  Sum_probs=92.0

Q ss_pred             cceecccCcEEEEEEEECCccEEEEEEecCCC----------------------chHHHH----HHHHHHHHHhcCCCce
Q 013636          158 SNVIGEGGRGHVYKARFNEKLLAAVKRIDDAG----------------------HDAERE----FNNEVNWLTKIRHQNI  211 (439)
Q Consensus       158 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~----------------------~~~~~~----~~~E~~~l~~l~h~ni  211 (439)
                      ...|..|.-+.||.+...+|..+|||+.+..-                      ...++-    ...|++-|.+++...|
T Consensus       149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI  228 (520)
T KOG2270|consen  149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI  228 (520)
T ss_pred             ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence            45688899999999999999999999764210                      000111    2356666777654332


Q ss_pred             eeeeeEEEeCCeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC
Q 013636          212 ISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS  291 (439)
Q Consensus       212 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~  291 (439)
                      .-.--...  ..-.|||+|+....-   -.-....-.++...+..+-.+++.-|.-|...|  ++||.||.--|+|+.+ 
T Consensus       229 P~PePIlL--k~hVLVM~FlGrdgw---~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyhd-  300 (520)
T KOG2270|consen  229 PCPEPILL--KNHVLVMEFLGRDGW---AAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYHD-  300 (520)
T ss_pred             CCCCceee--ecceEeeeeccCCCC---cCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEEC-
Confidence            21111111  123689999863211   111112234677777778888888888888775  8999999999999854 


Q ss_pred             CcEEEEecccccccC
Q 013636          292 FNAKLSDFGLSVTAG  306 (439)
Q Consensus       292 ~~~kl~DfGls~~~~  306 (439)
                      |.+.++|-+.|....
T Consensus       301 G~lyiIDVSQSVE~D  315 (520)
T KOG2270|consen  301 GKLYIIDVSQSVEHD  315 (520)
T ss_pred             CEEEEEEccccccCC
Confidence            589999999886543

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=95.76  E-value=0.14  Score=49.44  Aligned_cols=31  Identities=23%  Similarity=0.275  Sum_probs=28.1

Q ss_pred             CCeEecCCCCCCEEEcCCCcEEEEecccccc
Q 013636          274 HPVVHRDLKSSNILLDSSFNAKLSDFGLSVT  304 (439)
Q Consensus       274 ~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~  304 (439)
                      .+++|+|+.+.|+++++++.+.++||..+..
T Consensus       196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       196 TVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            4799999999999999999999999998754

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.57  E-value=0.36  Score=47.01  Aligned_cols=72  Identities=13%  Similarity=0.120  Sum_probs=44.0

Q ss_pred             cCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcCC--Cceeeee---e--EEEeCCeeEEEEEeccCCCh
Q 013636          164 GGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRH--QNIISLL---G--YCIHAETRFLVYEMMQNGSL  236 (439)
Q Consensus       164 G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~---~--~~~~~~~~~lV~e~~~~gsL  236 (439)
                      +.-..||+...+++..+++|..+... ....++..|+..+..+..  -.++...   |  ....++..+.++++++|...
T Consensus        36 s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~  114 (325)
T PRK11768         36 SYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP  114 (325)
T ss_pred             cccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence            34577999998888888888765322 234566677777776632  1122211   2  12234567889999987643

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.50  E-value=0.12  Score=50.13  Aligned_cols=86  Identities=23%  Similarity=0.220  Sum_probs=63.2

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCcceeeccccCccchhhhc
Q 013636          248 NLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLL  327 (439)
Q Consensus       248 ~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~~~~~~gt~~y~aPE~~~  327 (439)
                      .-.|.+...++.+.+.-+.-+...  .+.-|||+.-.||||+ +|++-|+||-+++....+..-    -..+.--|-.+.
T Consensus       317 ~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfklsRl~~~q~~i----sy~rldhp~lF~  389 (488)
T COG5072         317 ADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFKLSRLSYSQGII----SYNRLDHPDLFN  389 (488)
T ss_pred             cccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEeeeeecccCCcee----eccccCchhhhc
Confidence            356889999999998888888765  4788999999999999 999999999999854332221    112344455555


Q ss_pred             CCCCCCchhhHHHH
Q 013636          328 EGKLTDKSDVYAFG  341 (439)
Q Consensus       328 ~~~~~~~~DvwS~G  341 (439)
                       +.-+.+-|||-+-
T Consensus       390 -G~dd~QFeIYrlM  402 (488)
T COG5072         390 -GVDDYQFEIYRLM  402 (488)
T ss_pred             -CccceeeeHHHHH
Confidence             4447778888753

>PRK06148 hypothetical protein; Provisional

Probab=95.24  E-value=0.31  Score=54.88  Aligned_cols=142  Identities=20%  Similarity=0.273  Sum_probs=77.9

Q ss_pred             ceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhc-------CCCceeeee-e----EEEe-CC--e
Q 013636          159 NVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKI-------RHQNIISLL-G----YCIH-AE--T  223 (439)
Q Consensus       159 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-------~h~niv~l~-~----~~~~-~~--~  223 (439)
                      +.|+ |..-.+|+.+..++..+++|..+....  ......|...|..|       ..|.+++-. |    .... ++  .
T Consensus        31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~--~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~  107 (1013)
T PRK06148         31 TPLD-GERDLNFRLTTDDGADYILKIVNPSEP--RVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR  107 (1013)
T ss_pred             eecC-CcCCceEEEEeCCCCeEEEEEcCCccc--hhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence            4454 345788998888887889998875432  22333444555433       234444432 1    1111 12  3


Q ss_pred             eEEEEEeccCCChhhh-----------------hc----CCCC---CCCCCHHH-----------------HHHHHHHHH
Q 013636          224 RFLVYEMMQNGSLEKQ-----------------LH----GPTH---GSNLTWHL-----------------RMKIAVDVA  262 (439)
Q Consensus       224 ~~lV~e~~~~gsL~~~-----------------l~----~~~~---~~~l~~~~-----------------~~~i~~~ia  262 (439)
                      .+-+++|++|..+.+.                 +|    +...   ...+.|..                 ...++.++.
T Consensus       108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~  187 (1013)
T PRK06148        108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL  187 (1013)
T ss_pred             EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence            5678999999777541                 11    0000   11223321                 112222222


Q ss_pred             HHHH-----HHhhcCCCCeEecCCCCCCEEEcCCC--cEE-EEecccccc
Q 013636          263 RGLE-----YLHEHCNHPVVHRDLKSSNILLDSSF--NAK-LSDFGLSVT  304 (439)
Q Consensus       263 ~gl~-----~LH~~~~~~ivH~Dlk~~NiLl~~~~--~~k-l~DfGls~~  304 (439)
                      +...     .+.+ ...+++|+|+++.|||++.+.  ++. |+|||-+..
T Consensus       188 ~~~~~~v~p~l~~-Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        188 ARFERNVAPRLAA-LPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             HHHHHHHHHHHhc-CCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            2221     1222 234799999999999999875  454 999998754

>PTZ00384 choline kinase; Provisional

Probab=94.95  E-value=0.31  Score=48.53  Aligned_cols=75  Identities=12%  Similarity=0.129  Sum_probs=44.5

Q ss_pred             ceecccCcEEEEEEEECCcc--E-----EEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEec
Q 013636          159 NVIGEGGRGHVYKARFNEKL--L-----AAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMM  231 (439)
Q Consensus       159 ~~LG~G~fg~Vy~~~~~~~~--~-----vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  231 (439)
                      +.|..|-...+|++...++.  .     |.++. ........-+-.+|..+++.+...++.+-+-.+.   .-++++||+
T Consensus        56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~-~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f---~~g~l~efI  131 (383)
T PTZ00384         56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKK-SSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRF---GDFTIQEWV  131 (383)
T ss_pred             EEeCCcccceEEEEEecCCCCCccccceEEEEe-ccCCCceEeccHHHHHHHHHHHhCCCCCeEEEec---CCEEEEEEe
Confidence            45656888999999765431  1     33332 2221111122356888999997666665443332   236999999


Q ss_pred             cCCChh
Q 013636          232 QNGSLE  237 (439)
Q Consensus       232 ~~gsL~  237 (439)
                      ++.+|.
T Consensus       132 eGr~l~  137 (383)
T PTZ00384        132 EGNTMG  137 (383)
T ss_pred             ccccCC
Confidence            988764

>PRK12396 5-methylribose kinase; Reviewed

Probab=94.38  E-value=0.23  Score=49.29  Aligned_cols=75  Identities=15%  Similarity=0.182  Sum_probs=46.6

Q ss_pred             cceecccCcEEEEEEEECC-ccEEEEEEecC-----CC-chHHHHHHHHHHHHHhcC--CCceeeeeeEEEeCCeeEEEE
Q 013636          158 SNVIGEGGRGHVYKARFNE-KLLAAVKRIDD-----AG-HDAEREFNNEVNWLTKIR--HQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       158 ~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~-----~~-~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lV~  228 (439)
                      .+.||-|.-..||++.+.. +..++||.-..     .+ .-..++..-|.+.|+...  .|..++=+- +.+.+...+||
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy-~~D~e~~~~vM  112 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVY-LFDSVMNCCVM  112 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEE-EECcHHhhHHH
Confidence            4678999999999999852 45677775421     11 122344555677777663  454444332 23456667889


Q ss_pred             EeccC
Q 013636          229 EMMQN  233 (439)
Q Consensus       229 e~~~~  233 (439)
                      |+++.
T Consensus       113 EdL~~  117 (409)
T PRK12396        113 EDLSD  117 (409)
T ss_pred             HhCcc
Confidence            98854

>PF01102 Glycophorin_A: Glycophorin A; InterPro: IPR001195 Proteins in this group are responsible for the molecular basis of the blood group antigens, surface markers on the outside of the red blood cell membrane

Probab=94.01  E-value=0.055  Score=44.04  Aligned_cols=27  Identities=26%  Similarity=0.353  Sum_probs=12.2

Q ss_pred             eehhHHHHHHHHHHHHHHHHHHHhhhc
Q 013636           75 IALVVSSTLLGVLLLFLLCFWIYRWKR  101 (439)
Q Consensus        75 ~~~~~~~~~~~~~l~~~~~~~~~r~~r  101 (439)
                      ++.|+.++++++++++++++|+.||+|
T Consensus        66 i~~Ii~gv~aGvIg~Illi~y~irR~~   92 (122)
T PF01102_consen   66 IIGIIFGVMAGVIGIILLISYCIRRLR   92 (122)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHHS
T ss_pred             eeehhHHHHHHHHHHHHHHHHHHHHHh
Confidence            344444444444444444444444433

Most of these markers are proteins, but some are carbohydrates attached to lipids or proteins [Reid M.E., Lomas-Francis C. The Blood Group Antigen FactsBook Academic Press, London / San Diego, (1997)]. Glycophorin A (PAS-2) and glycophorin B (PAS-3) belong to the MNS blood group system and are associated with antigens that include M/N, S/s, U, He, Mi(a), M(c), Vw, Mur, M(g), Vr, M(e), Mt(a), St(a), Ri(a), Cl(a), Ny(a), Hut, Hil, M(v), Far, Mit, Dantu, Hop, Nob, En(a), ENKT, amongst others. Glycophorin A is the major sialoglycoprotein of the erythrocyte membrane []. Structurally, glycophorin A consists of an N-terminal extracellular domain, heavily glycosylated on serine and threonine residues, followed by a transmembrane region and a C-terminal cytoplasmic domain. Other glycophorins in this entry such as Glycophorin B and Glycophorin E represent minor sialoglycoproteins in the erythrocyte membrane.; GO: 0016021 integral to membrane; PDB: 2KPF_B 1AFO_B 2KPE_A.

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=94.00  E-value=0.69  Score=42.26  Aligned_cols=75  Identities=16%  Similarity=0.221  Sum_probs=50.3

Q ss_pred             ceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcC---CCceeeeeeEEEeCCeeEEEEEeccCCC
Q 013636          159 NVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR---HQNIISLLGYCIHAETRFLVYEMMQNGS  235 (439)
Q Consensus       159 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV~e~~~~gs  235 (439)
                      +.+.-|.--..|..... ...+.||.-..   .....|..|+.-|..|.   --++.+.+.+-...+..++|+||.+-|.
T Consensus        22 ~~v~gG~inea~~v~dg-~~~~FvK~n~~---~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~   97 (286)
T COG3001          22 EEVSGGDINEAWRLRDG-TDPFFVKCNQR---EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGP   97 (286)
T ss_pred             cccCCccccceeEeecC-CcceEEEecch---hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCC
Confidence            44555555555655443 34556675432   33456788887777764   4567777888888889999999999877


Q ss_pred             hh
Q 013636          236 LE  237 (439)
Q Consensus       236 L~  237 (439)
                      +.
T Consensus        98 ~d   99 (286)
T COG3001          98 LD   99 (286)
T ss_pred             CC
Confidence            65

>PF02439 Adeno_E3_CR2: Adenovirus E3 region protein CR2; InterPro: IPR003470 Early region 3 (E3) of human adenoviruses (Ads) codes for proteins that appear to control viral interactions with the host []

Probab=93.85  E-value=0.11  Score=32.44  Aligned_cols=30  Identities=13%  Similarity=0.389  Sum_probs=16.4

Q ss_pred             eeehhHHHHHHHHHHHHHHHHHHHhhhccc
Q 013636           74 LIALVVSSTLLGVLLLFLLCFWIYRWKRLK  103 (439)
Q Consensus        74 ~~~~~~~~~~~~~~l~~~~~~~~~r~~r~~  103 (439)
                      .+++++++++..+++++..+++.+++||.+
T Consensus         5 ~IaIIv~V~vg~~iiii~~~~YaCcykk~~   34 (38)
T PF02439_consen    5 TIAIIVAVVVGMAIIIICMFYYACCYKKHR   34 (38)
T ss_pred             hhhHHHHHHHHHHHHHHHHHHHHHHHcccc
Confidence            455666655555555555555555555543

This region called CR1 (conserved region 1) [] is found three times in Human adenovirus 19 (a subgroup D adenovirus) 49 kDa protein in the E3 region. CR1 is also found in the 20.1 Kd protein of subgroup B adenoviruses. The function of this 80 amino acid region is unknown. This region is probably a divergent immunoglobulin domain.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=93.74  E-value=0.12  Score=52.34  Aligned_cols=49  Identities=20%  Similarity=0.301  Sum_probs=37.8

Q ss_pred             HHHHHHHHHHHHhcCCCceeeeeeEEEeCC-eeEEEEEeccCCChhhhhcC
Q 013636          193 EREFNNEVNWLTKIRHQNIISLLGYCIHAE-TRFLVYEMMQNGSLEKQLHG  242 (439)
Q Consensus       193 ~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lV~e~~~~gsL~~~l~~  242 (439)
                      ..++.-...+++.+.|+|+...+.+..... ...+|+|++. .||++.+..
T Consensus        26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~   75 (725)
T KOG1093|consen   26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKT   75 (725)
T ss_pred             HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHh
Confidence            345667788899999999999998876544 4578899884 499988853

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	439
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		7e-50
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-49
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		3e-46
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		5e-46
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-39
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-39
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		4e-39
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-36
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		3e-32
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-32
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-24
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		6e-23
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		8e-23
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-22
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-22
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		4e-22
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		4e-22
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		4e-22
1fvr_A	327	Tie2 Kinase Domain Length = 327		4e-22
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		5e-22
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		5e-22
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		6e-22
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		6e-22
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		6e-22
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		6e-22
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		9e-22
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		9e-22
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-21
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-21
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-21
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-21
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-21
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-21
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-21
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-21
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-21
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-21
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-21
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-21
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-21
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-21
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-21
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-21
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-21
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-21
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-21
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-21
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-21
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		3e-21
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-21
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		4e-21
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		6e-21
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		7e-21
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		8e-21
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-20
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-20
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-20
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-20
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-20
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-20
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-20
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-20
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-20
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-20
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		4e-20
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		4e-20
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		4e-20
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		5e-20
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-19
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-19
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-19
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-19
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-19
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-19
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-19
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-19
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-19
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		4e-19
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		4e-19
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		4e-19
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		4e-19
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		4e-19
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		4e-19
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		4e-19
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		5e-19
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		5e-19
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		5e-19
2pl0_A	289	Lck Bound To Imatinib Length = 289		5e-19
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		7e-19
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		7e-19
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		8e-19
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		8e-19
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		9e-19
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		9e-19
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-19
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		9e-19
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		9e-19
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-18
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-18
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-18
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		1e-18
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		1e-18
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-18
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-18
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-18
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-18
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-18
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		1e-18
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-18
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-18
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-18
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-18
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-18
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-18
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-18
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-18
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-18
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-18
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-18
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-18
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-18
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		4e-18
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		4e-18
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-18
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		6e-18
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		6e-18
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		7e-18
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		7e-18
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		7e-18
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		7e-18
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		7e-18
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		8e-18
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		8e-18
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		8e-18
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		9e-18
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		9e-18
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-18
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		9e-18
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		9e-18
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		9e-18
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		9e-18
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-17
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-17
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-17
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-17
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-17
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-17
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-17
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-17
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-17
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-17
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-17
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-17
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-17
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-17
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-17
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-17
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-17
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-17
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-17
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-17
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-17
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-17
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-17
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-17
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-17
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-17
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-17
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-17
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-17
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-17
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		3e-17
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-17
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		3e-17
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-17
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-17
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		4e-17
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		4e-17
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		4e-17
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		4e-17
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		4e-17
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		4e-17
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		4e-17
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		4e-17
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		4e-17
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		4e-17
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		4e-17
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		4e-17
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		4e-17
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		5e-17
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		5e-17
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		5e-17
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		5e-17
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		5e-17
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		5e-17
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		5e-17
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		5e-17
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		5e-17
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		5e-17
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		5e-17
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		5e-17
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		5e-17
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		5e-17
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		5e-17
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		6e-17
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		6e-17
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		6e-17
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		6e-17
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		6e-17
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		6e-17
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		6e-17
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		7e-17
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		7e-17
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		8e-17
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		9e-17
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		9e-17
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		9e-17
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		9e-17
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-16
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-16
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-16
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-16
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-16
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-16
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-16
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-16
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-16
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-16
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-16
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-16
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-16
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-16
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-16
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-16
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-16
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-16
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-16
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-16
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-16
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-16
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-16
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-16
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-16
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-16
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-16
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-16
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-16
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-16
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-16
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-16
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-16
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-16
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-16
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-16
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-16
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		3e-16
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		3e-16
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-16
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-16
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-16
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-16
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		4e-16
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		4e-16
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		5e-16
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		5e-16
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-16
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		6e-16
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		6e-16
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		6e-16
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		6e-16
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		6e-16
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		6e-16
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		6e-16
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-16
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		6e-16
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		6e-16
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		6e-16
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		6e-16
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		6e-16
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		6e-16
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		6e-16
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		6e-16
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		7e-16
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		7e-16
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		7e-16
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		7e-16
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		7e-16
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		7e-16
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		7e-16
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		7e-16
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		7e-16
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		7e-16
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		8e-16
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		9e-16
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		9e-16
3a4o_X	286	Lyn Kinase Domain Length = 286		9e-16
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		9e-16
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		9e-16
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		9e-16
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		9e-16
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		9e-16
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-15
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-15
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-15
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		1e-15
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-15
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-15
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-15
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		1e-15
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-15
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-15
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-15
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-15
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-15
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		1e-15
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-15
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-15
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-15
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-15
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-15
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-15
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-15
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-15
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-15
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-15
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-15
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-15
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-15
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-15
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-15
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-15
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-15
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-15
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-15
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-15
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-15
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-15
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-15
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-15
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-15
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-15
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-15
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-15
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-15
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-15
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-15
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-15
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-15
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-15
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-15
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-15
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-15
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-15
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-15
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-15
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-15
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		3e-15
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-15
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-15
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-15
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-15
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-15
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-15
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		4e-15
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		5e-15
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		5e-15
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		5e-15
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		5e-15
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		5e-15
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-15
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		6e-15
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		6e-15
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		6e-15
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		6e-15
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		7e-15
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		7e-15
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		8e-15
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		9e-15
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		9e-15
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		9e-15
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		9e-15
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		9e-15
3a7f_A	303	Human Mst3 Kinase Length = 303		9e-15
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-14
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-14
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-14
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-14
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-14
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-14
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-14
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-14
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-14
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-14
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-14
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-14
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-14
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-14
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-14
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-14
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-14
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-14
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-14
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-14
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-14
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-14
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-14
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-14
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-14
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-14
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-14
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-14
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-14
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-14
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-14
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-14
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		3e-14
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-14
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-14
4fl3_A	635	Structural And Biophysical Characterization Of The		3e-14
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-14
3b2t_A	311	Structure Of Phosphotransferase Length = 311		3e-14
4fl2_A	636	Structural And Biophysical Characterization Of The		3e-14
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-14
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		4e-14
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-14
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		4e-14
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-14
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		4e-14
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		4e-14
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		5e-14
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-14
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		5e-14
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-14
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		6e-14
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-14
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-14
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		7e-14
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		7e-14
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		7e-14
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		8e-14
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		8e-14
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		8e-14
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		8e-14
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		8e-14
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		9e-14
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		9e-14
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		9e-14
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-13
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-13
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-13
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-13
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-13
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-13
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-13
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-13
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		1e-13
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-13
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-13
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-13
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-13
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-13
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-13
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-13
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-13
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-13
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-13
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-13
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-13
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-13
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-13
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-13
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-13
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		3e-13
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		3e-13
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		3e-13
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-13
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-13
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-13
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-13
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-13
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-13
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		4e-13
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		4e-13
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-13
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		4e-13
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		4e-13
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		4e-13
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		4e-13
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		5e-13
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		5e-13
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		5e-13
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		5e-13
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		6e-13
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		6e-13
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		6e-13
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		6e-13
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		6e-13
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		6e-13
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		6e-13
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-13
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-13
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-13
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-13
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		6e-13
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		6e-13
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		6e-13
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		6e-13
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		6e-13
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		6e-13
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		7e-13
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		7e-13
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		7e-13
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		7e-13
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		7e-13
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		7e-13
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		7e-13
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		8e-13
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		8e-13
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		8e-13
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		8e-13
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		8e-13
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		8e-13
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-12
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-12
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-12
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-12
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-12
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-12
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-12
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-12
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-12
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-12
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-12
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-12
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-12
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-12
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-12
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-12
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-12
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-12
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-12
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-12
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-12
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-12
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-12
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-12
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-12
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-12
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-12
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-12
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-12
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-12
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-12
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-12
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-12
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-12
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		3e-12
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-12
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-12
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-12
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-12
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-12
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		4e-12
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		4e-12
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-12
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		5e-12
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-12
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		5e-12
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		5e-12
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-12
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-12
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		6e-12
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		6e-12
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-12
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-12
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		6e-12
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		6e-12
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		6e-12
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		7e-12
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		7e-12
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		8e-12
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-11
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-11
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-11
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-11
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-11
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-11
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-11
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-11
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-11
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-11
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-11
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-11
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-11
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-11
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-11
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-11
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-11
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-11
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-11
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-11
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-11
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-11
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-11
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-11
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-11
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-11
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-11
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-11
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-11
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-11
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-11
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-11
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-11
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-11
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-11
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-11
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-11
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		3e-11
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		3e-11
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		3e-11
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		3e-11
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		4e-11
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		4e-11
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		4e-11
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		4e-11
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		4e-11
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		4e-11
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		4e-11
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		5e-11
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		5e-11
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		5e-11
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-11
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-11
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		6e-11
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		6e-11
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		6e-11
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		6e-11
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		7e-11
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		7e-11
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		7e-11
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-11
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		7e-11
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		8e-11
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		8e-11
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		8e-11
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		8e-11
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		8e-11
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		9e-11
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		9e-11
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		9e-11
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		9e-11
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		9e-11
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		9e-11
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-10
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-10
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-10
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-10
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-10
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-10
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-10
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-10
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-10
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-10
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-10
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-10
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-10
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-10
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-10
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-10
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-10
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-10
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-10
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-10
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-10
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-10
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-10
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-10
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-10
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-10
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-10
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		2e-10
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		3e-10
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-10
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		3e-10
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		3e-10
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		3e-10
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		3e-10
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-10
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		3e-10
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		4e-10
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-10
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		4e-10
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		4e-10
3soa_A	444	Full-Length Human Camkii Length = 444		5e-10
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		6e-10
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		7e-10
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		7e-10
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		7e-10
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		7e-10
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		8e-10
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		9e-10
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		9e-10
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-09
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		1e-09
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-09
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		1e-09
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-09
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-09
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-09
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-09
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-09
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-09
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-09
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-09
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-09
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-09
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-09
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-09
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-09
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-09
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-09
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-09
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-09
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-09
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-09
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-09
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-09
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-09
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-09
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-09
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-09
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-09
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-09
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-09
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-09
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-09
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-09
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-09
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-09
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-09
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-09
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-09
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-09
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-09
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-09
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-09
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-09
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-09
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-09
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-09
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-09
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-09
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-09
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-09
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-09
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-09
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-09
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-09
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-09
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-09
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-09
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-09
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-09
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-09
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-09
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		2e-09
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-09
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-09
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-09
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-09
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-09
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-09
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-09
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-09
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-09
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-09
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-09
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-09
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-09
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-09
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-09
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-09
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-09
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-09
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-09
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-09
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		3e-09
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		3e-09
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		3e-09
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		3e-09
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		3e-09
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		3e-09
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		4e-09
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		4e-09
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-09
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		4e-09
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		4e-09
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		5e-09
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		5e-09
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		5e-09
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		5e-09
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		5e-09
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		6e-09
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		6e-09
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		6e-09
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		6e-09
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		6e-09
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		6e-09
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		7e-09
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		7e-09
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		7e-09
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		7e-09
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		7e-09
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		7e-09
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		7e-09
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		7e-09
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		8e-09
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		8e-09
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		8e-09
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		8e-09
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		8e-09
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		8e-09
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		8e-09
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		9e-09
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		9e-09
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		9e-09
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		9e-09
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		9e-09
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		9e-09
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		9e-09
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		9e-09
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-08
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-08
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		1e-08
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-08
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-08
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-08
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-08
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-08
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-08
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-08
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-08
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-08
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-08
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-08
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-08
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-08
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-08
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-08
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-08
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-08
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-08
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-08
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		1e-08
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-08
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-08
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-08
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-08
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-08
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-08
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		2e-08
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-08
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-08
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-08
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-08
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-08
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-08
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-08
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-08
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-08
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-08
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-08
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-08
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		3e-08
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		3e-08
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		3e-08
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		3e-08
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		3e-08
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		3e-08
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		3e-08
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		3e-08
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		3e-08
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		3e-08
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		3e-08
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		3e-08
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-08
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		3e-08
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		3e-08
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-08
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		4e-08
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		4e-08
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		4e-08
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		4e-08
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		4e-08
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		5e-08
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		5e-08
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-08
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-08
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		5e-08
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		5e-08
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		5e-08
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		5e-08
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		5e-08
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		5e-08
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-08
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		5e-08
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		5e-08
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-08
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		5e-08
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		5e-08
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		5e-08
4ae9_A	343	Structure And Function Of The Human Sperm-specific		5e-08
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		5e-08
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		5e-08
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		5e-08
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		5e-08
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		5e-08
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		5e-08
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		5e-08
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		5e-08
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		5e-08
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-08
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		5e-08
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		5e-08
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		5e-08
4ae6_A	343	Structure And Function Of The Human Sperm-specific		6e-08
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		6e-08
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		6e-08
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		6e-08
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		6e-08
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		7e-08
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		7e-08
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		8e-08
4exu_A	371	Mapk13, Inactive Form Length = 371		8e-08
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		9e-08
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-07
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-07
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-07
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-07
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-07
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-07
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-07
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		1e-07
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		1e-07
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		1e-07
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		1e-07
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		1e-07
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		1e-07
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		1e-07
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-07
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		1e-07
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		1e-07
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		1e-07
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-07
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-07
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-07
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		2e-07
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-07
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		2e-07
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-07
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		2e-07
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-07
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-07
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-07
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-07
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		2e-07
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		2e-07
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-07
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-07
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-07
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-07
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-07
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-07
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-07
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-07
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		3e-07
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		3e-07
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-07
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		4e-07
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		4e-07
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		4e-07
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		5e-07
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		6e-07
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		6e-07
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		6e-07
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		6e-07
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		8e-07
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-06
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		1e-06
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		1e-06
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-06
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		1e-06
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		1e-06
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		2e-06
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		3e-06
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		3e-06
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		3e-06
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		3e-06
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		4e-06

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  194 bits (494), Expect = 7e-50,   Method: Compositional matrix adjust.
 Identities = 105/283 (37%), Positives = 167/283 (59%), Gaps = 7/283 (2%)
Query: 148 LEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRI-DDAGHDAEREFNNEVNWLTKI 206
           L+ A++NF   N++G GG G VYK R  +  L AVKR+ ++     E +F  EV  ++  
Sbjct: 33  LQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTEVEMISMA 92
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHG-PTHGSNLTWHLRMKIAVDVARGL 265
            H+N++ L G+C+    R LVY  M NGS+   L   P     L W  R +IA+  ARGL
Sbjct: 93  VHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGL 152
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK--ISGTLGYVAP 323
            YLH+HC+  ++HRD+K++NILLD  F A + DFGL+     +  +V   + GT+G++AP
Sbjct: 153 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIGHIAP 212
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELLMGRRPVE--KMSPTQCQSMVTWAMPQLTDRSKLPN 381
           EYL  GK ++K+DV+ +GV+LLEL+ G+R  +  +++      ++ W    L ++ KL  
Sbjct: 213 EYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK-KLEA 271
Query: 382 IVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
           +VD  ++     + + Q+  VA+LC Q  P  RP +++V+  L
Sbjct: 272 LVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 314

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  193 bits (490), Expect = 2e-49,   Method: Compositional matrix adjust.
 Identities = 104/283 (36%), Positives = 166/283 (58%), Gaps = 7/283 (2%)
Query: 148 LEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRI-DDAGHDAEREFNNEVNWLTKI 206
           L+ A++NF   N++G GG G VYK R  +  L AVKR+ ++     E +F  EV  ++  
Sbjct: 25  LQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTEVEMISMA 84
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHG-PTHGSNLTWHLRMKIAVDVARGL 265
            H+N++ L G+C+    R LVY  M NGS+   L   P     L W  R +IA+  ARGL
Sbjct: 85  VHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGL 144
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK--ISGTLGYVAP 323
            YLH+HC+  ++HRD+K++NILLD  F A + DFGL+     +  +V   + G +G++AP
Sbjct: 145 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXIGHIAP 204
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELLMGRRPVE--KMSPTQCQSMVTWAMPQLTDRSKLPN 381
           EYL  GK ++K+DV+ +GV+LLEL+ G+R  +  +++      ++ W    L ++ KL  
Sbjct: 205 EYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK-KLEA 263
Query: 382 IVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
           +VD  ++     + + Q+  VA+LC Q  P  RP +++V+  L
Sbjct: 264 LVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  182 bits (462), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 107/283 (37%), Positives = 160/283 (56%), Gaps = 12/283 (4%)
Query: 148 LEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR 207
           LE ATNNF    +IG G  G VYK    +    A+KR          EF  E+  L+  R
Sbjct: 34  LEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCR 93
Query: 208 HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHG---PTHGSNLTWHLRMKIAVDVARG 264
           H +++SL+G+C       L+Y+ M+NG+L++ L+G   PT   +++W  R++I +  ARG
Sbjct: 94  HPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPT--MSMSWEQRLEICIGAARG 151
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA---GTQSRNVKISGTLGYV 321
           L YLH      ++HRD+KS NILLD +F  K++DFG+S      G       + GTLGY+
Sbjct: 152 LHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYI 208
Query: 322 APEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPN 381
            PEY ++G+LT+KSDVY+FGVVL E+L  R  + +  P +  ++  WA+ +  +  +L  
Sbjct: 209 DPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAV-ESHNNGQLEQ 267
Query: 382 IVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
           IVDP + D +  + L +    AV C+      RP + DVL  L
Sbjct: 268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  182 bits (461), Expect = 5e-46,   Method: Compositional matrix adjust.
 Identities = 108/284 (38%), Positives = 162/284 (57%), Gaps = 14/284 (4%)
Query: 148 LEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR 207
           LE ATNNF    +IG G  G VYK    +    A+KR          EF  E+  L+  R
Sbjct: 34  LEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCR 93
Query: 208 HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHG---PTHGSNLTWHLRMKIAVDVARG 264
           H +++SL+G+C       L+Y+ M+NG+L++ L+G   PT   +++W  R++I +  ARG
Sbjct: 94  HPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPT--MSMSWEQRLEICIGAARG 151
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK----ISGTLGY 320
           L YLH      ++HRD+KS NILLD +F  K++DFG+S   GT+         + GTLGY
Sbjct: 152 LHYLH---TRAIIHRDVKSINILLDENFVPKITDFGIS-KKGTELDQTHLXXVVKGTLGY 207
Query: 321 VAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLP 380
           + PEY ++G+LT+KSDVY+FGVVL E+L  R  + +  P +  ++  WA+ +  +  +L 
Sbjct: 208 IDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAV-ESHNNGQLE 266
Query: 381 NIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
            IVDP + D +  + L +    AV C+      RP + DVL  L
Sbjct: 267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  159 bits (402), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 105/288 (36%), Positives = 159/288 (55%), Gaps = 20/288 (6%)
Query: 145 YELLEAATNNFQE------SNVIGEGGRGHVYKARFNEKLLAAVK---RIDDAGHDAERE 195
           YEL +  TNNF E       N +GEGG G VYK   N   +A  K    +D    + +++
Sbjct: 18  YEL-KNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQ 76
Query: 196 FNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRM 255
           F+ E+  + K +H+N++ LLG+    +   LVY  M NGSL  +L        L+WH+R 
Sbjct: 77  FDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRC 136
Query: 256 KIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV--- 312
           KIA   A G+ +LHE  NH  +HRD+KS+NILLD +F AK+SDFGL+  +   ++ V   
Sbjct: 137 KIAQGAANGINFLHE--NHH-IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXX 193
Query: 313 KISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQ 372
           +I GT  Y+APE  L G++T KSD+Y+FGVVLLE++ G   V++    Q   ++      
Sbjct: 194 RIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQL--LLDIKEEI 250
Query: 373 LTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDV 420
             +   + + +D  + D  D   +  + +VA  C+  + + RP I  V
Sbjct: 251 EDEEKTIEDYIDKKMNDA-DSTSVEAMYSVASQCLHEKKNKRPDIKKV 297

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  159 bits (402), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 105/288 (36%), Positives = 159/288 (55%), Gaps = 20/288 (6%)
Query: 145 YELLEAATNNFQE------SNVIGEGGRGHVYKARFNEKLLAAVK---RIDDAGHDAERE 195
           YEL +  TNNF E       N +GEGG G VYK   N   +A  K    +D    + +++
Sbjct: 18  YEL-KNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQ 76
Query: 196 FNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRM 255
           F+ E+  + K +H+N++ LLG+    +   LVY  M NGSL  +L        L+WH+R 
Sbjct: 77  FDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRC 136
Query: 256 KIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV--- 312
           KIA   A G+ +LHE  NH  +HRD+KS+NILLD +F AK+SDFGL+  +   ++ V   
Sbjct: 137 KIAQGAANGINFLHE--NHH-IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXS 193
Query: 313 KISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQ 372
           +I GT  Y+APE  L G++T KSD+Y+FGVVLLE++ G   V++    Q   ++      
Sbjct: 194 RIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQL--LLDIKEEI 250
Query: 373 LTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDV 420
             +   + + +D  + D  D   +  + +VA  C+  + + RP I  V
Sbjct: 251 EDEEKTIEDYIDKKMNDA-DSTSVEAMYSVASQCLHEKKNKRPDIKKV 297

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  158 bits (400), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 105/288 (36%), Positives = 159/288 (55%), Gaps = 20/288 (6%)
Query: 145 YELLEAATNNFQE------SNVIGEGGRGHVYKARFNEKLLAAVK---RIDDAGHDAERE 195
           YEL +  TNNF E       N +GEGG G VYK   N   +A  K    +D    + +++
Sbjct: 12  YEL-KNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQ 70
Query: 196 FNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRM 255
           F+ E+  + K +H+N++ LLG+    +   LVY  M NGSL  +L        L+WH+R 
Sbjct: 71  FDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRC 130
Query: 256 KIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV--- 312
           KIA   A G+ +LHE  NH  +HRD+KS+NILLD +F AK+SDFGL+  +   ++ V   
Sbjct: 131 KIAQGAANGINFLHE--NHH-IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXX 187
Query: 313 KISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQ 372
           +I GT  Y+APE  L G++T KSD+Y+FGVVLLE++ G   V++    Q   ++      
Sbjct: 188 RIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQL--LLDIKEEI 244
Query: 373 LTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDV 420
             +   + + +D  + D  D   +  + +VA  C+  + + RP I  V
Sbjct: 245 EDEEKTIEDYIDKKMNDA-DSTSVEAMYSVASQCLHEKKNKRPDIKKV 291

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 104/288 (36%), Positives = 152/288 (52%), Gaps = 20/288 (6%)
Query: 145 YELLEAATNNFQE------SNVIGEGGRGHVYKARFNEKLLAAVK---RIDDAGHDAERE 195
           YEL +  TNNF E       N  GEGG G VYK   N   +A  K    +D    + +++
Sbjct: 9   YEL-KNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQ 67
Query: 196 FNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRM 255
           F+ E+    K +H+N++ LLG+    +   LVY    NGSL  +L        L+WH R 
Sbjct: 68  FDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRC 127
Query: 256 KIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV--- 312
           KIA   A G+ +LHE  NH  +HRD+KS+NILLD +F AK+SDFGL+  +   ++ V   
Sbjct: 128 KIAQGAANGINFLHE--NHH-IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXS 184
Query: 313 KISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQ 372
           +I GT  Y APE  L G++T KSD+Y+FGVVLLE++ G   V++    Q   ++      
Sbjct: 185 RIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQL--LLDIKEEI 241
Query: 373 LTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDV 420
             +   + + +D    D  D   +    +VA  C+  + + RP I  V
Sbjct: 242 EDEEKTIEDYIDKKXNDA-DSTSVEAXYSVASQCLHEKKNKRPDIKKV 288

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  136 bits (342), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 93/271 (34%), Positives = 142/271 (52%), Gaps = 21/271 (7%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAER--EFNNEVNWLTKIRHQNIISLLGYC 218
           IG G  G V++A ++   +A VK + +    AER  EF  EV  + ++RH NI+  +G  
Sbjct: 45  IGAGSFGTVHRAEWHGSDVA-VKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 219 IHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVH 278
                  +V E +  GSL + LH       L    R+ +A DVA+G+ YLH   N P+VH
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIVH 162
Query: 279 RDLKSSNILLDSSFNAKLSDFGLS-VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDV 337
           R+LKS N+L+D  +  K+ DFGLS + A T   +   +GT  ++APE L +    +KSDV
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDV 222
Query: 338 YAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLY 397
           Y+FGV+L EL   ++P   ++P Q  + V +   +L    ++P  ++P            
Sbjct: 223 YSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL----EIPRNLNP------------ 266
Query: 398 QVAAVAVLCIQPEPSYRPLITDVLHSLIPLV 428
           QVAA+   C   EP  RP    ++  L PL+
Sbjct: 267 QVAAIIEGCWTNEPWKRPSFATIMDLLRPLI 297

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  136 bits (342), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 93/271 (34%), Positives = 141/271 (52%), Gaps = 21/271 (7%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAER--EFNNEVNWLTKIRHQNIISLLGYC 218
           IG G  G V++A ++   +A VK + +    AER  EF  EV  + ++RH NI+  +G  
Sbjct: 45  IGAGSFGTVHRAEWHGSDVA-VKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 219 IHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVH 278
                  +V E +  GSL + LH       L    R+ +A DVA+G+ YLH   N P+VH
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIVH 162
Query: 279 RDLKSSNILLDSSFNAKLSDFGLS-VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDV 337
           RDLKS N+L+D  +  K+ DFGLS + A     +   +GT  ++APE L +    +KSDV
Sbjct: 163 RDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPEVLRDEPSNEKSDV 222
Query: 338 YAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLY 397
           Y+FGV+L EL   ++P   ++P Q  + V +   +L    ++P  ++P            
Sbjct: 223 YSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL----EIPRNLNP------------ 266
Query: 398 QVAAVAVLCIQPEPSYRPLITDVLHSLIPLV 428
           QVAA+   C   EP  RP    ++  L PL+
Sbjct: 267 QVAAIIEGCWTNEPWKRPSFATIMDLLRPLI 297

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 86/291 (29%), Positives = 123/291 (42%), Gaps = 36/291 (12%)
Query: 147 LLEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNN---EVNWL 203
           LLE          +IG GG G VY+A +    +A      D   D  +   N   E    
Sbjct: 1   LLEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLF 60
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
             ++H NII+L G C+      LV E  + G L + L G      +   + +  AV +AR
Sbjct: 61  AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG----KRIPPDILVNWAVQIAR 116
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFN--------AKLSDFGLSVTAGTQSRNVKIS 315
           G+ YLH+    P++HRDLKSSNIL+              K++DFGL   A    R  K+S
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL---AREWHRTTKMS 173
Query: 316 --GTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQL 373
             G   ++APE +     +  SDV+++GV+L ELL G  P   +        V      L
Sbjct: 174 AAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLAL 233
Query: 374 TDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
              S  P     ++ D                C  P+P  RP  T++L  L
Sbjct: 234 PIPSTCPEPFAKLMED----------------CWNPDPHSRPSFTNILDQL 268

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 86/292 (29%), Positives = 141/292 (48%), Gaps = 42/292 (14%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARF-NEKLLAAVKRIDDAGHDAE-------REFNNEVNW 202
           A N  +    IG+GG G V+K R   +K + A+K +     + E       +EF  EV  
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 203 LTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
           ++ + H NI+ L G  +H   R +V E +  G L  +L    H   + W +++++ +D+A
Sbjct: 77  MSNLNHPNIVKLYG-LMHNPPR-MVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIA 132
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDS-----SFNAKLSDFGLSVTAGTQSRNVKISGT 317
            G+EY+    N P+VHRDL+S NI L S        AK++DFGLS     Q     +SG 
Sbjct: 133 LGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS-----QQSVHSVSGL 186
Query: 318 LG---YVAPEYL--LEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQ 372
           LG   ++APE +   E   T+K+D Y+F ++L  +L G  P ++ S  + + +       
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG 246
Query: 373 LTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
           L  R  +P    P +R+ ++            LC   +P  RP  + ++  L
Sbjct: 247 L--RPTIPEDCPPRLRNVIE------------LCWSGDPKKRPHFSYIVKEL 284

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 142/306 (46%), Gaps = 37/306 (12%)
Query: 129 NSLRLAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDA 188
           N +R  G++D+    E E  E        S  IG G  G VYK +++  +   + ++ D 
Sbjct: 17  NKIRPRGQRDSSYYWEIEASEVML-----STRIGSGSFGTVYKGKWHGDVAVKILKVVDP 71
Query: 189 GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSN 248
             +  + F NEV  L K RH NI+  +GY +  +   +V +  +  SL K LH     + 
Sbjct: 72  TPEQFQAFRNEVAVLRKTRHVNILLFMGY-MTKDNLAIVTQWCEGSSLYKHLH--VQETK 128
Query: 249 LTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ 308
                 + IA   A+G++YLH      ++HRD+KS+NI L      K+ DFGL+      
Sbjct: 129 FQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185
Query: 309 SRNVKI---SGTLGYVAPEYLL---EGKLTDKSDVYAFGVVLLELLMGRRPVEKM-SPTQ 361
           S + ++   +G++ ++APE +        + +SDVY++G+VL EL+ G  P   + +  Q
Sbjct: 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ 245
Query: 362 CQSMV--TWAMPQLTDRSK-LPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLIT 418
              MV   +A P L+   K  P  +  ++ D                C++     RPL  
Sbjct: 246 IIFMVGRGYASPDLSKLYKNCPKAMKRLVAD----------------CVKKVKEERPLFP 289
Query: 419 DVLHSL 424
            +L S+
Sbjct: 290 QILSSI 295

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 85/292 (29%), Positives = 140/292 (47%), Gaps = 42/292 (14%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARF-NEKLLAAVKRIDDAGHDAE-------REFNNEVNW 202
           A N  +    IG+GG G V+K R   +K + A+K +     + E       +EF  EV  
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 203 LTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
           ++ + H NI+ L G  +H   R +V E +  G L  +L    H   + W +++++ +D+A
Sbjct: 77  MSNLNHPNIVKLYG-LMHNPPR-MVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIA 132
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDS-----SFNAKLSDFGLSVTAGTQSRNVKISGT 317
            G+EY+    N P+VHRDL+S NI L S        AK++DFG S     Q     +SG 
Sbjct: 133 LGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTS-----QQSVHSVSGL 186
Query: 318 LG---YVAPEYL--LEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQ 372
           LG   ++APE +   E   T+K+D Y+F ++L  +L G  P ++ S  + + +       
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG 246
Query: 373 LTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
           L  R  +P    P +R+ ++            LC   +P  RP  + ++  L
Sbjct: 247 L--RPTIPEDCPPRLRNVIE------------LCWSGDPKKRPHFSYIVKEL 284

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 118/228 (51%), Gaps = 25/228 (10%)
Query: 161 IGEGGRGHVYKARF------NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISL 214
           +GEG  G V+ A         +K+L AVK + DA  +A ++F+ E   LT ++H++I+  
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 215 LGYCIHAETRFLVYEMMQNGSLEKQL--HGP--------THGSNLTWHLRMKIAVDVARG 264
            G C+  +   +V+E M++G L K L  HGP           + LT    + IA  +A G
Sbjct: 81  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAG 140
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG----TLGY 320
           + YL    +   VHRDL + N L+  +   K+ DFG+S    + +   ++ G     + +
Sbjct: 141 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYS-TDYYRVGGHTMLPIRW 196
Query: 321 VAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVT 367
           + PE ++  K T +SDV++ GVVL E+   G++P  ++S  +    +T
Sbjct: 197 MPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 244

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 92/333 (27%), Positives = 149/333 (44%), Gaps = 54/333 (16%)
Query: 116 GKGLSLSPILERFNSLRLAGKKDTVSVIEYELLEAATNNFQESNVI-----GEGGRGHVY 170
           G G SLSP   + + L    +   +   +Y   +A  ++ +  +++     GEG  G V+
Sbjct: 4   GSGSSLSPTEGKGSGL----QGHIIENPQY-FSDACVHHIKRRDIVLKWELGEGAFGKVF 58
Query: 171 KARFN------EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETR 224
            A  +      +K+L AVK + +A   A ++F  E   LT ++HQ+I+   G C      
Sbjct: 59  LAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118
Query: 225 FLVYEMMQNGSLEKQL--HGP-----THGSN-----LTWHLRMKIAVDVARGLEYLHEHC 272
            +V+E M++G L + L  HGP       G +     L     + +A  VA G+ YL    
Sbjct: 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---A 175
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG----TLGYVAPEYLLE 328
               VHRDL + N L+      K+ DFG+S      +   ++ G     + ++ PE +L 
Sbjct: 176 GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI-YSTDYYRVGGRTMLPIRWMPPESILY 234
Query: 329 GKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVI 387
            K T +SDV++FGVVL E+   G++P  ++S T+    +T        R+  P       
Sbjct: 235 RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPP------- 287
Query: 388 RDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDV 420
                     +V A+   C Q EP  R  I DV
Sbjct: 288 ----------EVYAIMRGCWQREPQQRHSIKDV 310

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 92/296 (31%), Positives = 142/296 (47%), Gaps = 49/296 (16%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNE---KLLAAVKRIDD-AGHDAEREFNNEVNWLTKI-R 207
           N+ +  +VIGEG  G V KAR  +   ++ AA+KR+ + A  D  R+F  E+  L K+  
Sbjct: 15  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 74
Query: 208 HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLH-------------GPTHGSNLTWHLR 254
           H NII+LLG C H    +L  E   +G+L   L                +  S L+    
Sbjct: 75  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 134
Query: 255 MKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKI 314
           +  A DVARG++YL +      +HRDL + NIL+  ++ AK++DFGLS     + + V +
Sbjct: 135 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLS-----RGQEVYV 186
Query: 315 SGTLG-----YVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTW 368
             T+G     ++A E L     T  SDV+++GV+L E++ +G  P   M+   C  +   
Sbjct: 187 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT---CAELYE- 242
Query: 369 AMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
            +PQ   R + P   D  + D M              C + +P  RP    +L SL
Sbjct: 243 KLPQ-GYRLEKPLNCDDEVYDLMR------------QCWREKPYERPSFAQILVSL 285

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 85/292 (29%), Positives = 140/292 (47%), Gaps = 42/292 (14%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARF-NEKLLAAVKRIDDAGHDAE-------REFNNEVNW 202
           A N  +    IG+GG G V+K R   +K + A+K +     + E       +EF  EV  
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 203 LTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
           ++ + H NI+ L G  +H   R +V E +  G L  +L    H   + W +++++ +D+A
Sbjct: 77  MSNLNHPNIVKLYG-LMHNPPR-MVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIA 132
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDS-----SFNAKLSDFGLSVTAGTQSRNVKISGT 317
            G+EY+    N P+VHRDL+S NI L S        AK++DF LS     Q     +SG 
Sbjct: 133 LGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLS-----QQSVHSVSGL 186
Query: 318 LG---YVAPEYL--LEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQ 372
           LG   ++APE +   E   T+K+D Y+F ++L  +L G  P ++ S  + + +       
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG 246
Query: 373 LTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
           L  R  +P    P +R+ ++            LC   +P  RP  + ++  L
Sbjct: 247 L--RPTIPEDCPPRLRNVIE------------LCWSGDPKKRPHFSYIVKEL 284

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 92/296 (31%), Positives = 142/296 (47%), Gaps = 49/296 (16%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNE---KLLAAVKRIDD-AGHDAEREFNNEVNWLTKIRH 208
           N+ +  +VIGEG  G V KAR  +   ++ AA+KR+ + A  D  R+F  E+  L K+ H
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 209 Q-NIISLLGYCIHAETRFLVYEMMQNGSLEKQLH-------------GPTHGSNLTWHLR 254
             NII+LLG C H    +L  E   +G+L   L                +  S L+    
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 255 MKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKI 314
           +  A DVARG++YL +      +HRDL + NIL+  ++ AK++DFGLS     + + V +
Sbjct: 145 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLS-----RGQEVYV 196
Query: 315 SGTLG-----YVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTW 368
             T+G     ++A E L     T  SDV+++GV+L E++ +G  P   M+   C  +   
Sbjct: 197 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT---CAELYE- 252
Query: 369 AMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
            +PQ   R + P   D  + D M              C + +P  RP    +L SL
Sbjct: 253 KLPQ-GYRLEKPLNCDDEVYDLMR------------QCWREKPYERPSFAQILVSL 295

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 85/280 (30%), Positives = 136/280 (48%), Gaps = 39/280 (13%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLT 204
           A  +F+    +G+G  G+VY AR  + K + A+K     +++ AG   E +   EV   +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQS 68
Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
            +RH NI+ L GY   A   +L+ E    G + K+L      S            ++A  
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQ---KLSKFDEQRTATYITELANA 125
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
           L Y H   +  V+HRD+K  N+LL S+   K++DFG SV A + SR   + GTL Y+ PE
Sbjct: 126 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPE 181
Query: 325 YLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
            ++EG++ D K D+++ GV+  E L+G+ P E  +  +    ++    + T     P+ V
Sbjct: 182 -MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFT----FPDFV 234
Query: 384 DPVIRDTMD--LKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
               RD +   LKH               PS RP++ +VL
Sbjct: 235 TEGARDLISRLLKH--------------NPSQRPMLREVL 260

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 83/283 (29%), Positives = 130/283 (45%), Gaps = 44/283 (15%)
Query: 161 IGEGGRGHVYKARFN------EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISL 214
           +GEG  G V+ A  +      +K+L AVK + +A   A ++F  E   LT ++HQ+I+  
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 215 LGYCIHAETRFLVYEMMQNGSLEKQL--HGP-----THGSN-----LTWHLRMKIAVDVA 262
            G C       +V+E M++G L + L  HGP       G +     L     + +A  VA
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG----TL 318
            G+ YL        VHRDL + N L+      K+ DFG+S    + +   ++ G     +
Sbjct: 140 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS-TDYYRVGGRTMLPI 195
Query: 319 GYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRS 377
            ++ PE +L  K T +SDV++FGVVL E+   G++P  ++S T+    +T        R+
Sbjct: 196 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRA 255
Query: 378 KLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDV 420
             P                 +V A+   C Q EP  R  I DV
Sbjct: 256 CPP-----------------EVYAIMRGCWQREPQQRHSIKDV 281

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 140/285 (49%), Gaps = 32/285 (11%)
Query: 139 TVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAERE-FN 197
           ++ +I+Y+ +E          V+G G  G V KA++  K +A +K+I+    ++ER+ F 
Sbjct: 1   SLHMIDYKEIEV-------EEVVGRGAFGVVCKAKWRAKDVA-IKQIES---ESERKAFI 49
Query: 198 NEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKI 257
            E+  L+++ H NI+ L G C++     LV E  + GSL   LHG       T    M  
Sbjct: 50  VELRQLSRVNHPNIVKLYGACLNPVC--LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW 107
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA-KLSDFGLSVTAGTQSRNVKISG 316
            +  ++G+ YLH      ++HRDLK  N+LL +     K+ DFG +    T   N K  G
Sbjct: 108 CLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK--G 165
Query: 317 TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDR 376
           +  ++APE       ++K DV+++G++L E++  R+P +++     + M  WA+   T  
Sbjct: 166 SAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM--WAVHNGTRP 223
Query: 377 SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
             + N+  P             + ++   C   +PS RP + +++
Sbjct: 224 PLIKNLPKP-------------IESLMTRCWSKDPSQRPSMEEIV 255

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 83/283 (29%), Positives = 130/283 (45%), Gaps = 44/283 (15%)
Query: 161 IGEGGRGHVYKARFN------EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISL 214
           +GEG  G V+ A  +      +K+L AVK + +A   A ++F  E   LT ++HQ+I+  
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 215 LGYCIHAETRFLVYEMMQNGSLEKQL--HGP-----THGSN-----LTWHLRMKIAVDVA 262
            G C       +V+E M++G L + L  HGP       G +     L     + +A  VA
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG----TL 318
            G+ YL        VHRDL + N L+      K+ DFG+S    + +   ++ G     +
Sbjct: 146 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS-TDYYRVGGRTMLPI 201
Query: 319 GYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRS 377
            ++ PE +L  K T +SDV++FGVVL E+   G++P  ++S T+    +T        R+
Sbjct: 202 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRA 261
Query: 378 KLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDV 420
             P                 +V A+   C Q EP  R  I DV
Sbjct: 262 CPP-----------------EVYAIMRGCWQREPQQRHSIKDV 287

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 85/280 (30%), Positives = 136/280 (48%), Gaps = 39/280 (13%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLT 204
           A  +F+    +G+G  G+VY AR  + K + A+K     +++ AG   E +   EV   +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQS 68
Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
            +RH NI+ L GY   A   +L+ E    G + K+L      S            ++A  
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKL---SKFDEQRTATYITELANA 125
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
           L Y H   +  V+HRD+K  N+LL S+   K++DFG SV A + SR   + GTL Y+ PE
Sbjct: 126 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRXXLXGTLDYLPPE 181
Query: 325 YLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
            ++EG++ D K D+++ GV+  E L+G+ P E  +  +    ++    + T     P+ V
Sbjct: 182 -MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFT----FPDFV 234
Query: 384 DPVIRDTMD--LKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
               RD +   LKH               PS RP++ +VL
Sbjct: 235 TEGARDLISRLLKH--------------NPSQRPMLREVL 260

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 140/285 (49%), Gaps = 32/285 (11%)
Query: 139 TVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAERE-FN 197
           ++ +I+Y+ +E          V+G G  G V KA++  K +A +K+I+    ++ER+ F 
Sbjct: 2   SLHMIDYKEIEV-------EEVVGRGAFGVVCKAKWRAKDVA-IKQIES---ESERKAFI 50
Query: 198 NEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKI 257
            E+  L+++ H NI+ L G C++     LV E  + GSL   LHG       T    M  
Sbjct: 51  VELRQLSRVNHPNIVKLYGACLNPVC--LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW 108
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA-KLSDFGLSVTAGTQSRNVKISG 316
            +  ++G+ YLH      ++HRDLK  N+LL +     K+ DFG +    T   N K  G
Sbjct: 109 CLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK--G 166
Query: 317 TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDR 376
           +  ++APE       ++K DV+++G++L E++  R+P +++     + M  WA+   T  
Sbjct: 167 SAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM--WAVHNGTRP 224
Query: 377 SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
             + N+  P             + ++   C   +PS RP + +++
Sbjct: 225 PLIKNLPKP-------------IESLMTRCWSKDPSQRPSMEEIV 256

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  101 bits (251), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 87/281 (30%), Positives = 138/281 (49%), Gaps = 41/281 (14%)
Query: 151 ATNNFQESNVIGEGGRGHVYKAR-FNEKLLAAVK-----RIDDAGHDAEREFNNEVNWLT 204
           A  +F+    +G+G  G+VY AR  N K + A+K     +++ AG   E +   EV   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAG--VEHQLRREVEIQS 63
Query: 205 KIRHQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
            +RH NI+ L GY  H  TR +L+ E    G++ ++L      S            ++A 
Sbjct: 64  HLRHPNILRLYGY-FHDSTRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELAN 119
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
            L Y H   +  V+HRD+K  N+LL S+   K++DFG SV A + SR   + GTL Y+ P
Sbjct: 120 ALSYCH---SKKVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRAALCGTLDYLPP 175
Query: 324 EYLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNI 382
           E ++EG++ D K D+++ GV+  E L+G+ P E  +       ++    + T     P+ 
Sbjct: 176 E-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRV--EFT----FPDF 228
Query: 383 VDPVIRDTMD--LKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
           V    RD +   LKH               PS RP++ +VL
Sbjct: 229 VTEGARDLISRLLKH--------------NPSQRPMLREVL 255

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  101 bits (251), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 84/280 (30%), Positives = 138/280 (49%), Gaps = 39/280 (13%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLT 204
           A  +F+    +G+G  G+VY AR  + K + A+K     +++ AG   E +   EV   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQS 63
Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
            +RH NI+ L GY   A   +L+ E    G++ ++L      S            ++A  
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANA 120
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
           L Y H   +  V+HRD+K  N+LL S+   K++DFG SV A + SR  ++ GTL Y+ PE
Sbjct: 121 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTELCGTLDYLPPE 176
Query: 325 YLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
            ++EG++ D K D+++ GV+  E L+G+ P E  +  +    ++    + T     P+ V
Sbjct: 177 -MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFT----FPDFV 229
Query: 384 DPVIRDTMD--LKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
               RD +   LKH               PS RP++ +VL
Sbjct: 230 TEGARDLISRLLKH--------------NPSQRPMLREVL 255

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 84/280 (30%), Positives = 137/280 (48%), Gaps = 39/280 (13%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLT 204
           A  +F+    +G+G  G+VY AR  + K + A+K     +++ AG   E +   EV   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQS 63
Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
            +RH NI+ L GY   A   +L+ E    G++ ++L      S            ++A  
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANA 120
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
           L Y H   +  V+HRD+K  N+LL S+   K++DFG SV A + SR   + GTL Y+ PE
Sbjct: 121 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRAALCGTLDYLPPE 176
Query: 325 YLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
            ++EG++ D K D+++ GV+  E L+G+ P E  +  +    ++    + T     P+ V
Sbjct: 177 -MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFT----FPDFV 229
Query: 384 DPVIRDTMD--LKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
               RD +   LKH               PS RP++ +VL
Sbjct: 230 TEGARDLISRLLKH--------------NPSQRPMLREVL 255

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 84/280 (30%), Positives = 137/280 (48%), Gaps = 39/280 (13%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLT 204
           A  +F+    +G+G  G+VY AR  + K + A+K     +++ AG   E +   EV   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQS 63
Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
            +RH NI+ L GY   A   +L+ E    G++ ++L      S            ++A  
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANA 120
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
           L Y H   +  V+HRD+K  N+LL S+   K++DFG SV A + SR   + GTL Y+ PE
Sbjct: 121 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTDLCGTLDYLPPE 176
Query: 325 YLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
            ++EG++ D K D+++ GV+  E L+G+ P E  +  +    ++    + T     P+ V
Sbjct: 177 -MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFT----FPDFV 229
Query: 384 DPVIRDTMD--LKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
               RD +   LKH               PS RP++ +VL
Sbjct: 230 TEGARDLISRLLKH--------------NPSQRPMLREVL 255

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 84/280 (30%), Positives = 137/280 (48%), Gaps = 39/280 (13%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLT 204
           A  +F+    +G+G  G+VY AR  + K + A+K     +++ AG   E +   EV   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQS 66
Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
            +RH NI+ L GY   A   +L+ E    G++ ++L      S            ++A  
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANA 123
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
           L Y H   +  V+HRD+K  N+LL S+   K++DFG SV A + SR   + GTL Y+ PE
Sbjct: 124 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPE 179
Query: 325 YLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
            ++EG++ D K D+++ GV+  E L+G+ P E  +  +    ++    + T     P+ V
Sbjct: 180 -MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFT----FPDFV 232
Query: 384 DPVIRDTMD--LKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
               RD +   LKH               PS RP++ +VL
Sbjct: 233 TEGARDLISRLLKH--------------NPSQRPMLREVL 258

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 84/280 (30%), Positives = 137/280 (48%), Gaps = 39/280 (13%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLT 204
           A  +F+    +G+G  G+VY AR  + K + A+K     +++ AG   E +   EV   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQS 63
Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
            +RH NI+ L GY   A   +L+ E    G++ ++L      S            ++A  
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANA 120
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
           L Y H   +  V+HRD+K  N+LL S+   K++DFG SV A + SR   + GTL Y+ PE
Sbjct: 121 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTXLCGTLDYLPPE 176
Query: 325 YLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
            ++EG++ D K D+++ GV+  E L+G+ P E  +  +    ++    + T     P+ V
Sbjct: 177 -MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFT----FPDFV 229
Query: 384 DPVIRDTMD--LKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
               RD +   LKH               PS RP++ +VL
Sbjct: 230 TEGARDLISRLLKH--------------NPSQRPMLREVL 255

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 84/280 (30%), Positives = 137/280 (48%), Gaps = 39/280 (13%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLT 204
           A  +F+    +G+G  G+VY AR  + K + A+K     +++ AG   E +   EV   +
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQS 67
Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
            +RH NI+ L GY   A   +L+ E    G++ ++L      S            ++A  
Sbjct: 68  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANA 124
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
           L Y H   +  V+HRD+K  N+LL S+   K++DFG SV A + SR   + GTL Y+ PE
Sbjct: 125 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPE 180
Query: 325 YLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
            ++EG++ D K D+++ GV+  E L+G+ P E  +  +    ++    + T     P+ V
Sbjct: 181 -MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFT----FPDFV 233
Query: 384 DPVIRDTMD--LKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
               RD +   LKH               PS RP++ +VL
Sbjct: 234 TEGARDLISRLLKH--------------NPSQRPMLREVL 259

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 84/280 (30%), Positives = 137/280 (48%), Gaps = 39/280 (13%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLT 204
           A  +F+    +G+G  G+VY AR  + K + A+K     +++ AG   E +   EV   +
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAG--VEHQLRREVEIQS 60
Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
            +RH NI+ L GY   A   +L+ E    G++ ++L      S            ++A  
Sbjct: 61  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANA 117
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
           L Y H   +  V+HRD+K  N+LL S+   K++DFG SV A + SR   + GTL Y+ PE
Sbjct: 118 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPE 173
Query: 325 YLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
            ++EG++ D K D+++ GV+  E L+G+ P E  +  +    ++    + T     P+ V
Sbjct: 174 -MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFT----FPDFV 226
Query: 384 DPVIRDTMD--LKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
               RD +   LKH               PS RP++ +VL
Sbjct: 227 TEGARDLISRLLKH--------------NPSQRPMLREVL 252

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 84/280 (30%), Positives = 137/280 (48%), Gaps = 39/280 (13%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLT 204
           A  +F+    +G+G  G+VY AR  + K + A+K     +++ AG   E +   EV   +
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQS 62
Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
            +RH NI+ L GY   A   +L+ E    G++ ++L      S            ++A  
Sbjct: 63  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK---LSKFDEQRTATYITELANA 119
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
           L Y H   +  V+HRD+K  N+LL S+   K++DFG SV A + SR   + GTL Y+ PE
Sbjct: 120 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPE 175
Query: 325 YLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
            ++EG++ D K D+++ GV+  E L+G+ P E  +  +    ++    + T     P+ V
Sbjct: 176 -MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFT----FPDFV 228
Query: 384 DPVIRDTMD--LKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
               RD +   LKH               PS RP++ +VL
Sbjct: 229 TEGARDLISRLLKH--------------NPSQRPMLREVL 254

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 84/280 (30%), Positives = 137/280 (48%), Gaps = 39/280 (13%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLT 204
           A  +F+    +G+G  G+VY AR  + K + A+K     +++ AG   E +   EV   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQS 63
Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
            +RH NI+ L GY   A   +L+ E    G++ ++L      S            ++A  
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANA 120
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
           L Y H   +  V+HRD+K  N+LL S+   K++DFG SV A + SR   + GTL Y+ PE
Sbjct: 121 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPE 176
Query: 325 YLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
            ++EG++ D K D+++ GV+  E L+G+ P E  +  +    ++    + T     P+ V
Sbjct: 177 -MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFT----FPDFV 229
Query: 384 DPVIRDTMD--LKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
               RD +   LKH               PS RP++ +VL
Sbjct: 230 TEGARDLISRLLKH--------------NPSQRPMLREVL 255

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 84/280 (30%), Positives = 137/280 (48%), Gaps = 39/280 (13%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLT 204
           A  +F+    +G+G  G+VY AR  + K + A+K     +++ AG   E +   EV   +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQS 64
Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
            +RH NI+ L GY   A   +L+ E    G++ ++L      S            ++A  
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANA 121
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
           L Y H   +  V+HRD+K  N+LL S+   K++DFG S  A + SR   +SGTL Y+ PE
Sbjct: 122 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSCHAPS-SRRTTLSGTLDYLPPE 177
Query: 325 YLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
            ++EG++ D K D+++ GV+  E L+G+ P E  +  +    ++    + T     P+ V
Sbjct: 178 -MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFT----FPDFV 230
Query: 384 DPVIRDTMD--LKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
               RD +   LKH               PS RP++ +VL
Sbjct: 231 TEGARDLISRLLKH--------------NPSQRPMLREVL 256

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 84/280 (30%), Positives = 137/280 (48%), Gaps = 39/280 (13%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLT 204
           A  +F+    +G+G  G+VY AR  + K + A+K     +++ AG   E +   EV   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQS 63
Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
            +RH NI+ L GY   A   +L+ E    G++ ++L      S            ++A  
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK---LSKFDEQRTATYITELANA 120
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
           L Y H   +  V+HRD+K  N+LL S+   K++DFG SV A + SR   + GTL Y+ PE
Sbjct: 121 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTDLCGTLDYLPPE 176
Query: 325 YLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
            ++EG++ D K D+++ GV+  E L+G+ P E  +  +    ++    + T     P+ V
Sbjct: 177 -MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFT----FPDFV 229
Query: 384 DPVIRDTMD--LKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
               RD +   LKH               PS RP++ +VL
Sbjct: 230 TEGARDLISRLLKH--------------NPSQRPMLREVL 255

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 91/296 (30%), Positives = 142/296 (47%), Gaps = 49/296 (16%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNE---KLLAAVKRIDD-AGHDAEREFNNEVNWLTKIRH 208
           N+ +  +VIGEG  G V KAR  +   ++ AA+KR+ + A  D  R+F  E+  L K+ H
Sbjct: 22  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 81
Query: 209 Q-NIISLLGYCIHAETRFLVYEMMQNGSLEKQLH-------------GPTHGSNLTWHLR 254
             NII+LLG C H    +L  E   +G+L   L                +  S L+    
Sbjct: 82  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 141
Query: 255 MKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKI 314
           +  A DVARG++YL +      +HR+L + NIL+  ++ AK++DFGLS     + + V +
Sbjct: 142 LHFAADVARGMDYLSQK---QFIHRNLAARNILVGENYVAKIADFGLS-----RGQEVYV 193
Query: 315 SGTLG-----YVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTW 368
             T+G     ++A E L     T  SDV+++GV+L E++ +G  P   M+   C  +   
Sbjct: 194 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT---CAELYE- 249
Query: 369 AMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
            +PQ   R + P   D  + D M              C + +P  RP    +L SL
Sbjct: 250 KLPQ-GYRLEKPLNCDDEVYDLMR------------QCWREKPYERPSFAQILVSL 292

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 84/280 (30%), Positives = 137/280 (48%), Gaps = 39/280 (13%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLT 204
           A  +F+    +G+G  G+VY AR  + K + A+K     +++ AG   E +   EV   +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQS 64
Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
            +RH NI+ L GY   A   +L+ E    G++ ++L      S            ++A  
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANA 121
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
           L Y H   +  V+HRD+K  N+LL S+   K++DFG SV A + SR   + GTL Y+ PE
Sbjct: 122 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTDLCGTLDYLPPE 177
Query: 325 YLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
            ++EG++ D K D+++ GV+  E L+G+ P E  +  +    ++    + T     P+ V
Sbjct: 178 -MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFT----FPDFV 230
Query: 384 DPVIRDTMD--LKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
               RD +   LKH               PS RP++ +VL
Sbjct: 231 TEGARDLISRLLKH--------------NPSQRPMLREVL 256

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 84/280 (30%), Positives = 137/280 (48%), Gaps = 39/280 (13%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLT 204
           A  +F+    +G+G  G+VY AR  + K + A+K     +++ AG   E +   EV   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQS 66
Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
            +RH NI+ L GY   A   +L+ E    G++ ++L      S            ++A  
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANA 123
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
           L Y H   +  V+HRD+K  N+LL S+   K++DFG SV A + SR   + GTL Y+ PE
Sbjct: 124 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPE 179
Query: 325 YLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
            ++EG++ D K D+++ GV+  E L+G+ P E  +  +    ++    + T     P+ V
Sbjct: 180 -MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFT----FPDFV 232
Query: 384 DPVIRDTMD--LKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
               RD +   LKH               PS RP++ +VL
Sbjct: 233 TEGARDLISRLLKH--------------NPSQRPMLREVL 258

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 84/280 (30%), Positives = 137/280 (48%), Gaps = 39/280 (13%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLT 204
           A  +F+    +G+G  G+VY AR  + K + A+K     +++ AG   E +   EV   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQS 66
Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
            +RH NI+ L GY   A   +L+ E    G++ ++L      S            ++A  
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANA 123
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
           L Y H   +  V+HRD+K  N+LL S+   K++DFG SV A + SR   + GTL Y+ PE
Sbjct: 124 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRAALCGTLDYLPPE 179
Query: 325 YLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
            ++EG++ D K D+++ GV+  E L+G+ P E  +  +    ++    + T     P+ V
Sbjct: 180 -MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFT----FPDFV 232
Query: 384 DPVIRDTMD--LKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
               RD +   LKH               PS RP++ +VL
Sbjct: 233 TEGARDLISRLLKH--------------NPSQRPMLREVL 258

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 84/280 (30%), Positives = 137/280 (48%), Gaps = 39/280 (13%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLT 204
           A  +F+    +G+G  G+VY AR  + K + A+K     +++ AG   E +   EV   +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQS 68
Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
            +RH NI+ L GY   A   +L+ E    G++ ++L      S            ++A  
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANA 125
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
           L Y H   +  V+HRD+K  N+LL S+   K++DFG SV A + SR   + GTL Y+ PE
Sbjct: 126 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPE 181
Query: 325 YLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
            ++EG++ D K D+++ GV+  E L+G+ P E  +  +    ++    + T     P+ V
Sbjct: 182 -MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFT----FPDFV 234
Query: 384 DPVIRDTMD--LKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
               RD +   LKH               PS RP++ +VL
Sbjct: 235 TEGARDLISRLLKH--------------NPSQRPMLREVL 260

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 84/280 (30%), Positives = 137/280 (48%), Gaps = 39/280 (13%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLT 204
           A  +F+    +G+G  G+VY AR  + K + A+K     +++ AG   E +   EV   +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQS 68
Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
            +RH NI+ L GY   A   +L+ E    G++ ++L      S            ++A  
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANA 125
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
           L Y H   +  V+HRD+K  N+LL S+   K++DFG SV A + SR   + GTL Y+ PE
Sbjct: 126 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTDLCGTLDYLPPE 181
Query: 325 YLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
            ++EG++ D K D+++ GV+  E L+G+ P E  +  +    ++    + T     P+ V
Sbjct: 182 -MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFT----FPDFV 234
Query: 384 DPVIRDTMD--LKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
               RD +   LKH               PS RP++ +VL
Sbjct: 235 TEGARDLISRLLKH--------------NPSQRPMLREVL 260

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 84/280 (30%), Positives = 137/280 (48%), Gaps = 39/280 (13%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLT 204
           A  +F+    +G+G  G+VY AR  + K + A+K     +++ AG   E +   EV   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQS 63
Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
            +RH NI+ L GY   A   +L+ E    G++ ++L      S            ++A  
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANA 120
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
           L Y H   +  V+HRD+K  N+LL S+   K++DFG SV A + SR   + GTL Y+ PE
Sbjct: 121 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRXXLCGTLDYLPPE 176
Query: 325 YLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
            ++EG++ D K D+++ GV+  E L+G+ P E  +  +    ++    + T     P+ V
Sbjct: 177 -MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFT----FPDFV 229
Query: 384 DPVIRDTMD--LKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
               RD +   LKH               PS RP++ +VL
Sbjct: 230 TEGARDLISRLLKH--------------NPSQRPMLREVL 255

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 84/280 (30%), Positives = 137/280 (48%), Gaps = 39/280 (13%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLT 204
           A  +F+    +G+G  G+VY AR  + K + A+K     +++ AG   E +   EV   +
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQS 80
Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
            +RH NI+ L GY   A   +L+ E    G++ ++L      S            ++A  
Sbjct: 81  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK---LSKFDEQRTATYITELANA 137
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
           L Y H   +  V+HRD+K  N+LL S+   K++DFG SV A + SR   + GTL Y+ PE
Sbjct: 138 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPE 193
Query: 325 YLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
            ++EG++ D K D+++ GV+  E L+G+ P E  +  +    ++    + T     P+ V
Sbjct: 194 -MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFT----FPDFV 246
Query: 384 DPVIRDTMD--LKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
               RD +   LKH               PS RP++ +VL
Sbjct: 247 TEGARDLISRLLKH--------------NPSQRPMLREVL 272

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 84/280 (30%), Positives = 137/280 (48%), Gaps = 39/280 (13%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLT 204
           A  +F+    +G+G  G+VY AR  + K + A+K     +++ AG   E +   EV   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQS 66
Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
            +RH NI+ L GY   A   +L+ E    G++ ++L      S            ++A  
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANA 123
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
           L Y H   +  V+HRD+K  N+LL S+   K++DFG SV A + SR   + GTL Y+ PE
Sbjct: 124 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRXXLCGTLDYLPPE 179
Query: 325 YLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
            ++EG++ D K D+++ GV+  E L+G+ P E  +  +    ++    + T     P+ V
Sbjct: 180 -MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFT----FPDFV 232
Query: 384 DPVIRDTMD--LKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
               RD +   LKH               PS RP++ +VL
Sbjct: 233 TEGARDLISRLLKH--------------NPSQRPMLREVL 258

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 84/280 (30%), Positives = 137/280 (48%), Gaps = 39/280 (13%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLT 204
           A  +F+    +G+G  G+VY AR  + K + A+K     +++ AG   E +   EV   +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQS 89
Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
            +RH NI+ L GY   A   +L+ E    G++ ++L      S            ++A  
Sbjct: 90  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANA 146
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
           L Y H   +  V+HRD+K  N+LL S+   K++DFG SV A + SR   + GTL Y+ PE
Sbjct: 147 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPE 202
Query: 325 YLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
            ++EG++ D K D+++ GV+  E L+G+ P E  +  +    ++    + T     P+ V
Sbjct: 203 -MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFT----FPDFV 255
Query: 384 DPVIRDTMD--LKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
               RD +   LKH               PS RP++ +VL
Sbjct: 256 TEGARDLISRLLKH--------------NPSQRPMLREVL 281

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 84/280 (30%), Positives = 137/280 (48%), Gaps = 39/280 (13%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLT 204
           A  +F+    +G+G  G+VY AR  + K + A+K     +++ AG   E +   EV   +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQS 65
Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
            +RH NI+ L GY   A   +L+ E    G++ ++L      S            ++A  
Sbjct: 66  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANA 122
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
           L Y H   +  V+HRD+K  N+LL S+   K++DFG SV A + SR   + GTL Y+ PE
Sbjct: 123 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRXXLCGTLDYLPPE 178
Query: 325 YLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
            ++EG++ D K D+++ GV+  E L+G+ P E  +  +    ++    + T     P+ V
Sbjct: 179 -MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFT----FPDFV 231
Query: 384 DPVIRDTMD--LKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
               RD +   LKH               PS RP++ +VL
Sbjct: 232 TEGARDLISRLLKH--------------NPSQRPMLREVL 257

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 83/280 (29%), Positives = 137/280 (48%), Gaps = 39/280 (13%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLT 204
           A  +F+    +G+G  G+VY AR  + K + A+K     +++ AG   E +   EV   +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQS 64
Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
            +RH NI+ L GY   A   +L+ E    G++ ++L      S            ++A  
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANA 121
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
           L Y H   +  V+HRD+K  N+LL S+   K++DFG SV A +  R+  + GTL Y+ PE
Sbjct: 122 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDT-LCGTLDYLPPE 177
Query: 325 YLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
            ++EG++ D K D+++ GV+  E L+G+ P E  +  +    ++    + T     P+ V
Sbjct: 178 -MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFT----FPDFV 230
Query: 384 DPVIRDTMD--LKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
               RD +   LKH               PS RP++ +VL
Sbjct: 231 TEGARDLISRLLKH--------------NPSQRPMLREVL 256

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 84/280 (30%), Positives = 137/280 (48%), Gaps = 39/280 (13%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLT 204
           A  +F+    +G+G  G+VY AR  + K + A+K     +++ AG   E +   EV   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQS 66
Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
            +RH NI+ L GY   A   +L+ E    G++ ++L      S            ++A  
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANA 123
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
           L Y H   +  V+HRD+K  N+LL S+   K++DFG SV A + SR   + GTL Y+ PE
Sbjct: 124 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRDDLCGTLDYLPPE 179
Query: 325 YLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
            ++EG++ D K D+++ GV+  E L+G+ P E  +  +    ++    + T     P+ V
Sbjct: 180 -MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFT----FPDFV 232
Query: 384 DPVIRDTMD--LKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
               RD +   LKH               PS RP++ +VL
Sbjct: 233 TEGARDLISRLLKH--------------NPSQRPMLREVL 258

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 84/280 (30%), Positives = 137/280 (48%), Gaps = 39/280 (13%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLT 204
           A  +F+    +G+G  G+VY AR  + K + A+K     +++ AG   E +   EV   +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQS 89
Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
            +RH NI+ L GY   A   +L+ E    G++ ++L      S            ++A  
Sbjct: 90  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANA 146
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
           L Y H   +  V+HRD+K  N+LL S+   K++DFG SV A + SR   + GTL Y+ PE
Sbjct: 147 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRDDLCGTLDYLPPE 202
Query: 325 YLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
            ++EG++ D K D+++ GV+  E L+G+ P E  +  +    ++    + T     P+ V
Sbjct: 203 -MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFT----FPDFV 255
Query: 384 DPVIRDTMD--LKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
               RD +   LKH               PS RP++ +VL
Sbjct: 256 TEGARDLISRLLKH--------------NPSQRPMLREVL 281

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 83/280 (29%), Positives = 137/280 (48%), Gaps = 39/280 (13%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLT 204
           A  +F+    +G+G  G+VY AR  + K + A+K     +++ AG   E +   EV   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQS 66
Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
            +RH NI+ L GY   A   +L+ E    G++ ++L      S            ++A  
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK---LSKFDEQRTATYITELANA 123
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
           L Y H   +  V+HRD+K  N+LL S+   K+++FG SV A + SR   + GTL Y+ PE
Sbjct: 124 LSYCH---SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPS-SRRTTLCGTLDYLPPE 179
Query: 325 YLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
            ++EG++ D K D+++ GV+  E L+G+ P E  +  +    ++    + T     P+ V
Sbjct: 180 -MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFT----FPDFV 232
Query: 384 DPVIRDTMD--LKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
               RD +   LKH               PS RP++ +VL
Sbjct: 233 TEGARDLISRLLKH--------------NPSQRPMLREVL 258

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 98.6 bits (244), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 83/280 (29%), Positives = 137/280 (48%), Gaps = 39/280 (13%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLT 204
           A  +F+    +G+G  G+VY AR  + K + A+K     +++ AG   E +   EV   +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQS 65
Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
            +RH NI+ L GY   A   +L+ E    G++ ++L      S            ++A  
Sbjct: 66  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANA 122
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
           L Y H   +  V+HRD+K  N+LL S+   K+++FG SV A + SR   + GTL Y+ PE
Sbjct: 123 LSYCH---SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPS-SRRTTLCGTLDYLPPE 178
Query: 325 YLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
            ++EG++ D K D+++ GV+  E L+G+ P E  +  +    ++    + T     P+ V
Sbjct: 179 -MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFT----FPDFV 231
Query: 384 DPVIRDTMD--LKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
               RD +   LKH               PS RP++ +VL
Sbjct: 232 TEGARDLISRLLKH--------------NPSQRPMLREVL 257

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 82/296 (27%), Positives = 138/296 (46%), Gaps = 48/296 (16%)
Query: 161 IGEGGRGHVYKARF------NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISL 214
           +GEG  G V+ A         +K+L AVK + D    A ++F  E   LT ++H++I+  
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 215 LGYCIHAETRFLVYEMMQNGSLEKQL--HGP-----------THGSNLTWHLRMKIAVDV 261
            G C   +   +V+E M++G L K L  HGP                L     + IA  +
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 262 ARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG----T 317
           A G+ YL    +   VHRDL + N L+ ++   K+ DFG+S    + +   ++ G     
Sbjct: 143 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYS-TDYYRVGGHTMLP 198
Query: 318 LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDR 376
           + ++ PE ++  K T +SDV++FGV+L E+   G++P  ++S T+    +T    ++ +R
Sbjct: 199 IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQG--RVLER 256
Query: 377 SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITD---VLHSLIPLVP 429
              P +    + D M            + C Q EP  R  I +   +LH+L    P
Sbjct: 257 ---PRVCPKEVYDVM------------LGCWQREPQQRLNIKEIYKILHALGKATP 297

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 86/312 (27%), Positives = 144/312 (46%), Gaps = 43/312 (13%)
Query: 126 ERFNSLRLAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRI 185
           E  N ++  G++D+    ++E+ +      Q    IG G  G VYK +++  +   +  +
Sbjct: 14  EDRNRMKTLGRRDSSD--DWEIPDGQITVGQR---IGSGSFGTVYKGKWHGDVAVKMLNV 68
Query: 186 DDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTH 245
                   + F NEV  L K RH NI+  +GY    +   +V +  +  SL   LH    
Sbjct: 69  TAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLA-IVTQWCEGSSLYHHLH--II 125
Query: 246 GSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA 305
            +       + IA   A+G++YLH      ++HRDLKS+NI L      K+ DFGL+   
Sbjct: 126 ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVK 182
Query: 306 GTQSRN---VKISGTLGYVAPEYLLEGKLTDK------SDVYAFGVVLLELLMGRRPVEK 356
              S +    ++SG++ ++APE +   ++ DK      SDVYAFG+VL EL+ G+ P   
Sbjct: 183 SRWSGSHQFEQLSGSILWMAPEVI---RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN 239
Query: 357 M-SPTQCQSMV--TWAMPQLTD-RSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPS 412
           + +  Q   MV   +  P L+  RS  P  +  ++ +                C++ +  
Sbjct: 240 INNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAE----------------CLKKKRD 283
Query: 413 YRPLITDVLHSL 424
            RPL   +L S+
Sbjct: 284 ERPLFPQILASI 295

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 105/204 (51%), Gaps = 22/204 (10%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           IG G  G VYK +++  +   +  +        + F NEV  L K RH NI+  +GY   
Sbjct: 20  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 79
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLR--MKIAVDVARGLEYLHEHCNHPVVH 278
            +   +V +  +  SL   L    H S   + ++  + IA   ARG++YLH      ++H
Sbjct: 80  PQLA-IVTQWCEGSSLYHHL----HASETKFEMKKLIDIARQTARGMDYLHAKS---IIH 131
Query: 279 RDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN---VKISGTLGYVAPEYLLEGKLTD-- 333
           RDLKS+NI L      K+ DFGL+      S +    ++SG++ ++APE +   ++ D  
Sbjct: 132 RDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI---RMQDSN 188
Query: 334 ----KSDVYAFGVVLLELLMGRRP 353
               +SDVYAFG+VL EL+ G+ P
Sbjct: 189 PYSFQSDVYAFGIVLYELMTGQLP 212

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 86/312 (27%), Positives = 144/312 (46%), Gaps = 43/312 (13%)
Query: 126 ERFNSLRLAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRI 185
           E  N ++  G++D+    ++E+ +      Q    IG G  G VYK +++  +   +  +
Sbjct: 13  EDRNRMKTLGRRDSSD--DWEIPDGQITVGQR---IGSGSFGTVYKGKWHGDVAVKMLNV 67
Query: 186 DDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTH 245
                   + F NEV  L K RH NI+  +GY    +   +V +  +  SL   LH    
Sbjct: 68  TAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLA-IVTQWCEGSSLYHHLH--II 124
Query: 246 GSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA 305
            +       + IA   A+G++YLH      ++HRDLKS+NI L      K+ DFGL+   
Sbjct: 125 ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVK 181
Query: 306 GTQSRN---VKISGTLGYVAPEYLLEGKLTDK------SDVYAFGVVLLELLMGRRPVEK 356
              S +    ++SG++ ++APE +   ++ DK      SDVYAFG+VL EL+ G+ P   
Sbjct: 182 SRWSGSHQFEQLSGSILWMAPEVI---RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN 238
Query: 357 M-SPTQCQSMV--TWAMPQLTD-RSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPS 412
           + +  Q   MV   +  P L+  RS  P  +  ++ +                C++ +  
Sbjct: 239 INNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAE----------------CLKKKRD 282
Query: 413 YRPLITDVLHSL 424
            RPL   +L S+
Sbjct: 283 ERPLFPQILASI 294

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 105/204 (51%), Gaps = 22/204 (10%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           IG G  G VYK +++  +   +  +        + F NEV  L K RH NI+  +GY   
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST- 90
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLR--MKIAVDVARGLEYLHEHCNHPVVH 278
           A    +V +  +  SL   L    H S   + ++  + IA   ARG++YLH      ++H
Sbjct: 91  APQLAIVTQWCEGSSLYHHL----HASETKFEMKKLIDIARQTARGMDYLHAKS---IIH 143
Query: 279 RDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN---VKISGTLGYVAPEYLLEGKLTD-- 333
           RDLKS+NI L      K+ DFGL+      S +    ++SG++ ++APE +   ++ D  
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI---RMQDSN 200
Query: 334 ----KSDVYAFGVVLLELLMGRRP 353
               +SDVYAFG+VL EL+ G+ P
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLP 224

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 85/309 (27%), Positives = 143/309 (46%), Gaps = 43/309 (13%)
Query: 129 NSLRLAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDA 188
           N ++  G++D+    ++E+ +      Q    IG G  G VYK +++  +   +  +   
Sbjct: 9   NRMKTLGRRDSSD--DWEIPDGQITVGQR---IGSGSFGTVYKGKWHGDVAVKMLNVTAP 63
Query: 189 GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSN 248
                + F NEV  L K RH NI+  +GY    +   +V +  +  SL   LH     + 
Sbjct: 64  TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLA-IVTQWCEGSSLYHHLH--IIETK 120
Query: 249 LTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ 308
                 + IA   A+G++YLH      ++HRDLKS+NI L      K+ DFGL+      
Sbjct: 121 FEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRW 177
Query: 309 SRN---VKISGTLGYVAPEYLLEGKLTDK------SDVYAFGVVLLELLMGRRPVEKM-S 358
           S +    ++SG++ ++APE +   ++ DK      SDVYAFG+VL EL+ G+ P   + +
Sbjct: 178 SGSHQFEQLSGSILWMAPEVI---RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 234
Query: 359 PTQCQSMV--TWAMPQLTD-RSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRP 415
             Q   MV   +  P L+  RS  P  +  ++ +                C++ +   RP
Sbjct: 235 RDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAE----------------CLKKKRDERP 278
Query: 416 LITDVLHSL 424
           L   +L S+
Sbjct: 279 LFPQILASI 287

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 86/312 (27%), Positives = 144/312 (46%), Gaps = 43/312 (13%)
Query: 126 ERFNSLRLAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRI 185
           E  N ++  G++D+    ++E+ +      Q    IG G  G VYK +++  +   +  +
Sbjct: 14  EDRNRMKTLGRRDSSD--DWEIPDGQITVGQR---IGSGSFGTVYKGKWHGDVAVKMLNV 68
Query: 186 DDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTH 245
                   + F NEV  L K RH NI+  +GY    +   +V +  +  SL   LH    
Sbjct: 69  TAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLA-IVTQWCEGSSLYHHLH--II 125
Query: 246 GSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA 305
            +       + IA   A+G++YLH      ++HRDLKS+NI L      K+ DFGL+   
Sbjct: 126 ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEK 182
Query: 306 GTQSRN---VKISGTLGYVAPEYLLEGKLTDK------SDVYAFGVVLLELLMGRRPVEK 356
              S +    ++SG++ ++APE +   ++ DK      SDVYAFG+VL EL+ G+ P   
Sbjct: 183 SRWSGSHQFEQLSGSILWMAPEVI---RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN 239
Query: 357 M-SPTQCQSMV--TWAMPQLTD-RSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPS 412
           + +  Q   MV   +  P L+  RS  P  +  ++ +                C++ +  
Sbjct: 240 INNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAE----------------CLKKKRD 283
Query: 413 YRPLITDVLHSL 424
            RPL   +L S+
Sbjct: 284 ERPLFPQILASI 295

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 84/280 (30%), Positives = 134/280 (47%), Gaps = 39/280 (13%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLT 204
           A  +F+    +G+G  G+VY AR  + K + A+K     +++ AG   E +   EV   +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQS 68
Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
            +RH NI+ L GY   A   +L+ E    G++ ++L      S            ++A  
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANA 125
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
           L Y H   +  V+HRD+K  N+LL S+   K++DFG SV A + SR   + GTL Y+ PE
Sbjct: 126 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPE 181
Query: 325 YLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
             +EG+  D K D+++ GV+  E L+G+ P E  +  +    ++    + T     P+ V
Sbjct: 182 -XIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFT----FPDFV 234
Query: 384 DPVIRDTMD--LKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
               RD +   LKH               PS RP + +VL
Sbjct: 235 TEGARDLISRLLKH--------------NPSQRPXLREVL 260

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 105/204 (51%), Gaps = 22/204 (10%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           IG G  G VYK +++  +   +  +        + F NEV  L K RH NI+  +GY   
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 91
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLR--MKIAVDVARGLEYLHEHCNHPVVH 278
            +   +V +  +  SL   L    H S   + ++  + IA   ARG++YLH      ++H
Sbjct: 92  PQLA-IVTQWCEGSSLYHHL----HASETKFEMKKLIDIARQTARGMDYLHAKS---IIH 143
Query: 279 RDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN---VKISGTLGYVAPEYLLEGKLTD-- 333
           RDLKS+NI L      K+ DFGL+      S +    ++SG++ ++APE +   ++ D  
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI---RMQDSN 200
Query: 334 ----KSDVYAFGVVLLELLMGRRP 353
               +SDVYAFG+VL EL+ G+ P
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLP 224

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 81/277 (29%), Positives = 129/277 (46%), Gaps = 38/277 (13%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           IG G  G VYK +++  +   +  +        + F NEV  L K RH NI+  +GY   
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST- 74
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
           A    +V +  +  SL   LH     +       + IA   A+G++YLH      ++HRD
Sbjct: 75  APQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRD 129
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRN---VKISGTLGYVAPEYLLEGKLTDK--- 334
           LKS+NI L      K+ DFGL+      S +    ++SG++ ++APE +   ++ DK   
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI---RMQDKNPY 186
Query: 335 ---SDVYAFGVVLLELLMGRRPVEKM-SPTQCQSMV--TWAMPQLTD-RSKLPNIVDPVI 387
              SDVYAFG+VL EL+ G+ P   + +  Q   MV   +  P L+  RS  P  +  ++
Sbjct: 187 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLM 246
Query: 388 RDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
            +                C++ +   RPL   +L S+
Sbjct: 247 AE----------------CLKKKRDERPLFPQILASI 267

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 102/202 (50%), Gaps = 18/202 (8%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           IG G  G VYK +++  +   +  +        + F NEV  L K RH NI+  +GY   
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 75
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
            +   +V +  +  SL   LH     +       + IA   A+G++YLH      ++HRD
Sbjct: 76  PQLA-IVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRD 129
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRN---VKISGTLGYVAPEYLLEGKLTDK--- 334
           LKS+NI L      K+ DFGL+      S +    ++SG++ ++APE +   ++ DK   
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI---RMQDKNPY 186
Query: 335 ---SDVYAFGVVLLELLMGRRP 353
              SDVYAFG+VL EL+ G+ P
Sbjct: 187 SFQSDVYAFGIVLYELMTGQLP 208

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 80/277 (28%), Positives = 129/277 (46%), Gaps = 38/277 (13%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           IG G  G VYK +++  +   +  +        + F NEV  L K RH NI+  +GY   
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 80
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
            +   +V +  +  SL   LH     +       + IA   A+G++YLH      ++HRD
Sbjct: 81  PQLA-IVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRD 134
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRN---VKISGTLGYVAPEYLLEGKLTDK--- 334
           LKS+NI L      K+ DFGL+      S +    ++SG++ ++APE +   ++ DK   
Sbjct: 135 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI---RMQDKNPY 191
Query: 335 ---SDVYAFGVVLLELLMGRRPVEKM-SPTQCQSMV--TWAMPQLTD-RSKLPNIVDPVI 387
              SDVYAFG+VL EL+ G+ P   + +  Q   MV   +  P L+  RS  P  +  ++
Sbjct: 192 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLM 251
Query: 388 RDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
            +                C++ +   RPL   +L S+
Sbjct: 252 AE----------------CLKKKRDERPLFPQILASI 272

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 80/277 (28%), Positives = 129/277 (46%), Gaps = 38/277 (13%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           IG G  G VYK +++  +   +  +        + F NEV  L K RH NI+  +GY   
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 80
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
            +   +V +  +  SL   LH     +       + IA   A+G++YLH      ++HRD
Sbjct: 81  PQLA-IVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRD 134
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRN---VKISGTLGYVAPEYLLEGKLTDK--- 334
           LKS+NI L      K+ DFGL+      S +    ++SG++ ++APE +   ++ DK   
Sbjct: 135 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI---RMQDKNPY 191
Query: 335 ---SDVYAFGVVLLELLMGRRPVEKM-SPTQCQSMV--TWAMPQLTD-RSKLPNIVDPVI 387
              SDVYAFG+VL EL+ G+ P   + +  Q   MV   +  P L+  RS  P  +  ++
Sbjct: 192 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLM 251
Query: 388 RDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
            +                C++ +   RPL   +L S+
Sbjct: 252 AE----------------CLKKKRDERPLFPQILASI 272

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 102/202 (50%), Gaps = 18/202 (8%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           IG G  G VYK +++  +   +  +        + F NEV  L K RH NI+  +GY   
Sbjct: 18  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 77
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
            +   +V +  +  SL   LH     +       + IA   A+G++YLH      ++HRD
Sbjct: 78  PQLA-IVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRD 131
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRN---VKISGTLGYVAPEYLLEGKLTDK--- 334
           LKS+NI L      K+ DFGL+      S +    ++SG++ ++APE +   ++ DK   
Sbjct: 132 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI---RMQDKNPY 188
Query: 335 ---SDVYAFGVVLLELLMGRRP 353
              SDVYAFG+VL EL+ G+ P
Sbjct: 189 SFQSDVYAFGIVLYELMTGQLP 210

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 80/277 (28%), Positives = 129/277 (46%), Gaps = 38/277 (13%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           IG G  G VYK +++  +   +  +        + F NEV  L K RH NI+  +GY   
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 75
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
            +   +V +  +  SL   LH     +       + IA   A+G++YLH      ++HRD
Sbjct: 76  PQLA-IVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRD 129
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRN---VKISGTLGYVAPEYLLEGKLTDK--- 334
           LKS+NI L      K+ DFGL+      S +    ++SG++ ++APE +   ++ DK   
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI---RMQDKNPY 186
Query: 335 ---SDVYAFGVVLLELLMGRRPVEKM-SPTQCQSMV--TWAMPQLTD-RSKLPNIVDPVI 387
              SDVYAFG+VL EL+ G+ P   + +  Q   MV   +  P L+  RS  P  +  ++
Sbjct: 187 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLM 246
Query: 388 RDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
            +                C++ +   RPL   +L S+
Sbjct: 247 AE----------------CLKKKRDERPLFPQILASI 267

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 102/216 (47%), Gaps = 19/216 (8%)
Query: 161 IGEGGRGHVYKARFN-EKLLAAVKRIDDA-GHDAEREFNNEVNWLTKIRHQNIISLLGYC 218
           IG G  G V+  R   +  L AVK   +    D + +F  E   L +  H NI+ L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 219 IHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVH 278
              +  ++V E++Q G     L   T G+ L     +++  D A G+EYL   C    +H
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLR--TEGARLRVKTLLQMVGDAAAGMEYLESKC---CIH 236
Query: 279 RDLKSSNILLDSSFNAKLSDFGLS-------VTAGTQSRNVKISGTLGYVAPEYLLEGKL 331
           RDL + N L+      K+SDFG+S         A    R V +     + APE L  G+ 
Sbjct: 237 RDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVK----WTAPEALNYGRY 292
Query: 332 TDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
           + +SDV++FG++L E   +G  P   +S  Q +  V
Sbjct: 293 SSESDVWSFGILLWETFSLGASPYPNLSNQQTREFV 328

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 102/216 (47%), Gaps = 19/216 (8%)
Query: 161 IGEGGRGHVYKARFN-EKLLAAVKRIDDA-GHDAEREFNNEVNWLTKIRHQNIISLLGYC 218
           IG G  G V+  R   +  L AVK   +    D + +F  E   L +  H NI+ L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 219 IHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVH 278
              +  ++V E++Q G     L   T G+ L     +++  D A G+EYL   C    +H
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLR--TEGARLRVKTLLQMVGDAAAGMEYLESKC---CIH 236
Query: 279 RDLKSSNILLDSSFNAKLSDFGLS-------VTAGTQSRNVKISGTLGYVAPEYLLEGKL 331
           RDL + N L+      K+SDFG+S         A    R V +     + APE L  G+ 
Sbjct: 237 RDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVK----WTAPEALNYGRY 292
Query: 332 TDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
           + +SDV++FG++L E   +G  P   +S  Q +  V
Sbjct: 293 SSESDVWSFGILLWETFSLGASPYPNLSNQQTREFV 328

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 108/201 (53%), Gaps = 9/201 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           +G G  G V+   +N     AVK +   G  +   F  E N + +++HQ ++ L    + 
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYA-VVT 78
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
            E  +++ E M+NGSL   L  P+ G  LT +  + +A  +A G+ ++ E  N+  +HRD
Sbjct: 79  QEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER-NY--IHRD 134
Query: 281 LKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVY 338
           L+++NIL+  + + K++DFGL+  +     +        + + APE +  G  T KSDV+
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 194
Query: 339 AFGVVLLELLM-GRRPVEKMS 358
           +FG++L E++  GR P   M+
Sbjct: 195 SFGILLTEIVTHGRIPYPGMT 215

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 110/210 (52%), Gaps = 17/210 (8%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLTKI 206
            +F     +G+G  G+VY AR  + K + A+K     +++ AG   E +   EV   + +
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAG--VEHQLRREVEIQSHL 69
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
           RH NI+ L GY   A   +L+ E    G++ ++L      S            ++A  L 
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL---SRFDEQRTATYITELANALS 126
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYL 326
           Y H   +  V+HRD+K  N+LL S+   K++DFG SV A + SR   + GTL Y+ PE +
Sbjct: 127 YCH---SKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPE-M 181
Query: 327 LEGKLTD-KSDVYAFGVVLLELLMGRRPVE 355
           +EG++ D K D+++ GV+  E L+G  P E
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVGMPPFE 211

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 108/201 (53%), Gaps = 9/201 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           +G G  G V+   +N     AVK +   G  +   F  E N + +++HQ ++ L    + 
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYA-VVT 87
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
            E  +++ E M+NGSL   L  P+ G  LT +  + +A  +A G+ ++ E  N+  +HRD
Sbjct: 88  QEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER-NY--IHRD 143
Query: 281 LKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVY 338
           L+++NIL+  + + K++DFGL+  +     +        + + APE +  G  T KSDV+
Sbjct: 144 LRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 203
Query: 339 AFGVVLLELLM-GRRPVEKMS 358
           +FG++L E++  GR P   M+
Sbjct: 204 SFGILLTEIVTHGRIPYPGMT 224

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 78/268 (29%), Positives = 125/268 (46%), Gaps = 26/268 (9%)
Query: 119 LSLSPILERFN-SLRLAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFN-- 175
           L  S I+  +N +   AGK  ++S    +L E    N      +G G  G VY+ + +  
Sbjct: 40  LRTSTIMTDYNPNYCFAGKTSSIS----DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGM 95
Query: 176 ----EKLLAAVKRIDD-AGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM 230
                 L  AVK + +      E +F  E   ++K  HQNI+  +G  + +  RF++ E+
Sbjct: 96  PNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLEL 155
Query: 231 MQNGSLEKQLHG----PTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNI 286
           M  G L+  L      P+  S+L     + +A D+A G +YL E  NH  +HRD+ + N 
Sbjct: 156 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NH-FIHRDIAARNC 212
Query: 287 LLDSSFN---AKLSDFGLS---VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAF 340
           LL        AK+ DFG++     AG   +       + ++ PE  +EG  T K+D ++F
Sbjct: 213 LLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSF 272
Query: 341 GVVLLELL-MGRRPVEKMSPTQCQSMVT 367
           GV+L E+  +G  P    S  +    VT
Sbjct: 273 GVLLWEIFSLGYMPYPSKSNQEVLEFVT 300

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 107/201 (53%), Gaps = 9/201 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           +G G  G V+   +N     AVK +   G  +   F  E N + +++HQ ++ L    + 
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYA-VVT 84
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
            E  +++ E M+NGSL   L  P+ G  LT +  + +A  +A G+ ++ E  N+  +HRD
Sbjct: 85  QEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER-NY--IHRD 140
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
           L+++NIL+  + + K++DFGL+          +      + + APE +  G  T KSDV+
Sbjct: 141 LRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 200
Query: 339 AFGVVLLELLM-GRRPVEKMS 358
           +FG++L E++  GR P   M+
Sbjct: 201 SFGILLTEIVTHGRIPYPGMT 221

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 78/268 (29%), Positives = 125/268 (46%), Gaps = 26/268 (9%)
Query: 119 LSLSPILERFN-SLRLAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFN-- 175
           L  S I+  +N +   AGK  ++S    +L E    N      +G G  G VY+ + +  
Sbjct: 17  LRTSTIMTDYNPNYCFAGKTSSIS----DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGM 72
Query: 176 ----EKLLAAVKRIDD-AGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM 230
                 L  AVK + +      E +F  E   ++K  HQNI+  +G  + +  RF++ E+
Sbjct: 73  PNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLEL 132
Query: 231 MQNGSLEKQLHG----PTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNI 286
           M  G L+  L      P+  S+L     + +A D+A G +YL E  NH  +HRD+ + N 
Sbjct: 133 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NH-FIHRDIAARNC 189
Query: 287 LLDSSFN---AKLSDFGLS---VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAF 340
           LL        AK+ DFG++     AG   +       + ++ PE  +EG  T K+D ++F
Sbjct: 190 LLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSF 249
Query: 341 GVVLLELL-MGRRPVEKMSPTQCQSMVT 367
           GV+L E+  +G  P    S  +    VT
Sbjct: 250 GVLLWEIFSLGYMPYPSKSNQEVLEFVT 277

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 107/201 (53%), Gaps = 9/201 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           +G G  G V+   +N     AVK +   G  +   F  E N + +++HQ ++ L    + 
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYA-VVT 80
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
            E  +++ E M+NGSL   L  P+ G  LT +  + +A  +A G+ ++ E  N+  +HRD
Sbjct: 81  QEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER-NY--IHRD 136
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
           L+++NIL+  + + K++DFGL+          +      + + APE +  G  T KSDV+
Sbjct: 137 LRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 196
Query: 339 AFGVVLLELLM-GRRPVEKMS 358
           +FG++L E++  GR P   M+
Sbjct: 197 SFGILLTEIVTHGRIPYPGMT 217

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 107/201 (53%), Gaps = 9/201 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           +G G  G V+   +N     AVK +   G  +   F  E N + +++HQ ++ L    + 
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYA-VVT 86
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
            E  +++ E M+NGSL   L  P+ G  LT +  + +A  +A G+ ++ E  N+  +HRD
Sbjct: 87  QEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER-NY--IHRD 142
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
           L+++NIL+  + + K++DFGL+          +      + + APE +  G  T KSDV+
Sbjct: 143 LRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 202
Query: 339 AFGVVLLELLM-GRRPVEKMS 358
           +FG++L E++  GR P   M+
Sbjct: 203 SFGILLTEIVTHGRIPYPGMT 223

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 108/201 (53%), Gaps = 9/201 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           +G G  G V+   +N     AVK +   G  +   F  E N + +++HQ ++ L    + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYA-VVT 78
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
            E  +++ E M+NGSL   L  P+ G  LT +  + +A  +A G+ ++ E  N+  +HRD
Sbjct: 79  QEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER-NY--IHRD 134
Query: 281 LKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVY 338
           L+++NIL+  + + K++DFGL+  +     +        + + APE +  G  T KSDV+
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 194
Query: 339 AFGVVLLELLM-GRRPVEKMS 358
           +FG++L E++  GR P   M+
Sbjct: 195 SFGILLTEIVTHGRIPYPGMT 215

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 107/201 (53%), Gaps = 9/201 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           +G G  G V+   +N     AVK +   G  +   F  E N + +++HQ ++ L    + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYA-VVT 78
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
            E  +++ E M+NGSL   L  P+ G  LT +  + +A  +A G+ ++ E  N+  +HRD
Sbjct: 79  QEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER-NY--IHRD 134
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
           L+++NIL+  + + K++DFGL+          +      + + APE +  G  T KSDV+
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 194
Query: 339 AFGVVLLELLM-GRRPVEKMS 358
           +FG++L E++  GR P   M+
Sbjct: 195 SFGILLTEIVTHGRIPYPGMT 215

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 110/210 (52%), Gaps = 17/210 (8%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLTKI 206
            +F     +G+G  G+VY AR  + K + A+K     +++ AG   E +   EV   + +
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAG--VEHQLRREVEIQSHL 69
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
           RH NI+ L GY   A   +L+ E    G++ ++L      S            ++A  L 
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL---SRFDEQRTATYITELANALS 126
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYL 326
           Y H   +  V+HRD+K  N+LL S+   K++DFG SV A +  R+  + GTL Y+ PE +
Sbjct: 127 YCH---SKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDT-LCGTLDYLPPE-M 181
Query: 327 LEGKLTD-KSDVYAFGVVLLELLMGRRPVE 355
           +EG++ D K D+++ GV+  E L+G  P E
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVGMPPFE 211

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 85/284 (29%), Positives = 131/284 (46%), Gaps = 39/284 (13%)
Query: 159 NVIGEGGRGHVYKARFN-----EKLLAAVKRIDDAGHDAER-EFNNEVNWLTKIRHQNII 212
            VIG G  G VYK         +++  A+K +     + +R +F  E   + +  H NII
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109
Query: 213 SLLGYCIHAETRFLVYEMMQNGSLEKQLH---GPTHGSNLTWHLRMKIAVDVARGLEYLH 269
            L G     +   ++ E M+NG+L+K L    G      L   LR      +A G++YL 
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLR-----GIAAGMKYL- 163
Query: 270 EHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS-VTAGTQSRNVKISG---TLGYVAPEY 325
              N   VHRDL + NIL++S+   K+SDFGLS V           SG    + + APE 
Sbjct: 164 --ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 221
Query: 326 LLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVD 384
           +   K T  SDV++FG+V+ E++  G RP  ++S  +        M  + D  +LP  +D
Sbjct: 222 ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-------VMKAINDGFRLPTPMD 274
Query: 385 PVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLV 428
                      +YQ   + + C Q E + RP   D++  L  L+
Sbjct: 275 CP-------SAIYQ---LMMQCWQQERARRPKFADIVSILDKLI 308

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 107/201 (53%), Gaps = 9/201 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           +G G  G V+   +N     AVK +   G  +   F  E N + +++HQ ++ L    + 
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYA-VVT 79
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
            E  +++ E M+NGSL   L  P+ G  LT +  + +A  +A G+ ++ E  N+  +HRD
Sbjct: 80  QEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER-NY--IHRD 135
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
           L+++NIL+  + + K++DFGL+          +      + + APE +  G  T KSDV+
Sbjct: 136 LRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 195
Query: 339 AFGVVLLELLM-GRRPVEKMS 358
           +FG++L E++  GR P   M+
Sbjct: 196 SFGILLTEIVTHGRIPYPGMT 216

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 107/201 (53%), Gaps = 9/201 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           +G G  G V+   +N     AVK +   G  +   F  E N + +++HQ ++ L    + 
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYA-VVT 84
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
            E  +++ E M+NGSL   L  P+ G  LT +  + +A  +A G+ ++ E  N+  +HRD
Sbjct: 85  QEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER-NY--IHRD 140
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
           L+++NIL+  + + K++DFGL+          +      + + APE +  G  T KSDV+
Sbjct: 141 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 200
Query: 339 AFGVVLLELLM-GRRPVEKMS 358
           +FG++L E++  GR P   M+
Sbjct: 201 SFGILLTEIVTHGRIPYPGMT 221

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 107/201 (53%), Gaps = 9/201 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           +G G  G V+   +N     AVK +   G  +   F  E N + +++HQ ++ L    + 
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYA-VVT 83
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
            E  +++ E M+NGSL   L  P+ G  LT +  + +A  +A G+ ++ E  N+  +HRD
Sbjct: 84  QEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER-NY--IHRD 139
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
           L+++NIL+  + + K++DFGL+          +      + + APE +  G  T KSDV+
Sbjct: 140 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 199
Query: 339 AFGVVLLELLM-GRRPVEKMS 358
           +FG++L E++  GR P   M+
Sbjct: 200 SFGILLTEIVTHGRIPYPGMT 220

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 107/201 (53%), Gaps = 9/201 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           +G G  G V+   +N     AVK +   G  +   F  E N + +++HQ ++ L    + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYA-VVT 78
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
            E  +++ E M+NGSL   L  P+ G  LT +  + +A  +A G+ ++ E  N+  +HRD
Sbjct: 79  QEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER-NY--IHRD 134
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
           L+++NIL+  + + K++DFGL+          +      + + APE +  G  T KSDV+
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 194
Query: 339 AFGVVLLELLM-GRRPVEKMS 358
           +FG++L E++  GR P   M+
Sbjct: 195 SFGILLTEIVTHGRIPYPGMT 215

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 107/201 (53%), Gaps = 9/201 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           +G G  G V+   +N     AVK +   G  +   F  E N + +++HQ ++ L    + 
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYA-VVT 73
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
            E  +++ E M+NGSL   L  P+ G  LT +  + +A  +A G+ ++ E  N+  +HRD
Sbjct: 74  QEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER-NY--IHRD 129
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
           L+++NIL+  + + K++DFGL+          +      + + APE +  G  T KSDV+
Sbjct: 130 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 189
Query: 339 AFGVVLLELLM-GRRPVEKMS 358
           +FG++L E++  GR P   M+
Sbjct: 190 SFGILLTEIVTHGRIPYPGMT 210

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 107/201 (53%), Gaps = 9/201 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           +G G  G V+   +N     AVK +   G  +   F  E N + +++HQ ++ L    + 
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYA-VVT 88
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
            E  +++ E M+NGSL   L  P+ G  LT +  + +A  +A G+ ++ E  N+  +HRD
Sbjct: 89  QEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER-NY--IHRD 144
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
           L+++NIL+  + + K++DFGL+          +      + + APE +  G  T KSDV+
Sbjct: 145 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 204
Query: 339 AFGVVLLELLM-GRRPVEKMS 358
           +FG++L E++  GR P   M+
Sbjct: 205 SFGILLTEIVTHGRIPYPGMT 225

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 74/275 (26%), Positives = 124/275 (45%), Gaps = 26/275 (9%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           IG G  G V+   +  K   A+K I + G  +E +F  E   + K+ H  ++ L G C+ 
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 76
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
                LV+E M++G L   L   T          + + +DV  G+ YL E C   V+HRD
Sbjct: 77  QAPICLVFEFMEHGCLSDYLR--TQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRD 131
Query: 281 LKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVY 338
           L + N L+  +   K+SDFG++  V     + +      + + +PE     + + KSDV+
Sbjct: 132 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 191
Query: 339 AFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLY 397
           +FGV++ E+   G+ P E  S ++           + D S    +  P +  T    H+Y
Sbjct: 192 SFGVLMWEVFSEGKIPYENRSNSEV----------VEDISTGFRLYKPRLAST----HVY 237
Query: 398 QVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPTDL 432
           Q+      C +  P  RP  + +L  L  +  + L
Sbjct: 238 QIMN---HCWRERPEDRPAFSRLLRQLAEIAESGL 269

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 74/275 (26%), Positives = 124/275 (45%), Gaps = 26/275 (9%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           IG G  G V+   +  K   A+K I + G  +E +F  E   + K+ H  ++ L G C+ 
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 71
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
                LV+E M++G L   L   T          + + +DV  G+ YL E C   V+HRD
Sbjct: 72  QAPICLVFEFMEHGCLSDYLR--TQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRD 126
Query: 281 LKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVY 338
           L + N L+  +   K+SDFG++  V     + +      + + +PE     + + KSDV+
Sbjct: 127 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 186
Query: 339 AFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLY 397
           +FGV++ E+   G+ P E  S ++           + D S    +  P +  T    H+Y
Sbjct: 187 SFGVLMWEVFSEGKIPYENRSNSEV----------VEDISTGFRLYKPRLAST----HVY 232
Query: 398 QVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPTDL 432
           Q+      C +  P  RP  + +L  L  +  + L
Sbjct: 233 QIMN---HCWKERPEDRPAFSRLLRQLAEIAESGL 264

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 78/268 (29%), Positives = 124/268 (46%), Gaps = 26/268 (9%)
Query: 119 LSLSPILERFN-SLRLAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFN-- 175
           L  S I+  +N +   AGK  ++S    +L E    N      +G G  G VY+ + +  
Sbjct: 6   LRTSTIMTDYNPNYSFAGKTSSIS----DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGM 61
Query: 176 ----EKLLAAVKRIDD-AGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM 230
                 L  AVK + +      E +F  E   ++K  HQNI+  +G  + +  RF++ E+
Sbjct: 62  PNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLEL 121
Query: 231 MQNGSLEKQLHG----PTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNI 286
           M  G L+  L      P+  S+L     + +A D+A G +YL E  NH  +HRD+ + N 
Sbjct: 122 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NH-FIHRDIAARNC 178
Query: 287 LLDSSFN---AKLSDFGLSVTAGTQSRNVKISGTL---GYVAPEYLLEGKLTDKSDVYAF 340
           LL        AK+ DFG++      S   K    +    ++ PE  +EG  T K+D ++F
Sbjct: 179 LLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSF 238
Query: 341 GVVLLELL-MGRRPVEKMSPTQCQSMVT 367
           GV+L E+  +G  P    S  +    VT
Sbjct: 239 GVLLWEIFSLGYMPYPSKSNQEVLEFVT 266

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 74/275 (26%), Positives = 124/275 (45%), Gaps = 26/275 (9%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           IG G  G V+   +  K   A+K I + G  +E +F  E   + K+ H  ++ L G C+ 
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
                LV+E M++G L   L   T          + + +DV  G+ YL E C   V+HRD
Sbjct: 74  QAPICLVFEFMEHGCLSDYLR--TQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRD 128
Query: 281 LKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVY 338
           L + N L+  +   K+SDFG++  V     + +      + + +PE     + + KSDV+
Sbjct: 129 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 188
Query: 339 AFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLY 397
           +FGV++ E+   G+ P E  S ++           + D S    +  P +  T    H+Y
Sbjct: 189 SFGVLMWEVFSEGKIPYENRSNSEV----------VEDISTGFRLYKPRLAST----HVY 234
Query: 398 QVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPTDL 432
           Q+      C +  P  RP  + +L  L  +  + L
Sbjct: 235 QIMN---HCWKERPEDRPAFSRLLRQLAEIAESGL 266

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 74/275 (26%), Positives = 124/275 (45%), Gaps = 26/275 (9%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           IG G  G V+   +  K   A+K I + G  +E +F  E   + K+ H  ++ L G C+ 
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIKE-GSMSEDDFIEEAEVMMKLSHPKLVQLYGVCLE 93
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
                LV+E M++G L   L   T          + + +DV  G+ YL E C   V+HRD
Sbjct: 94  QAPICLVFEFMEHGCLSDYLR--TQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRD 148
Query: 281 LKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVY 338
           L + N L+  +   K+SDFG++  V     + +      + + +PE     + + KSDV+
Sbjct: 149 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 208
Query: 339 AFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLY 397
           +FGV++ E+   G+ P E  S ++           + D S    +  P +  T    H+Y
Sbjct: 209 SFGVLMWEVFSEGKIPYENRSNSEV----------VEDISTGFRLYKPRLAST----HVY 254
Query: 398 QVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPTDL 432
           Q+      C +  P  RP  + +L  L  +  + L
Sbjct: 255 QIMN---HCWKERPEDRPAFSRLLRQLAEIAESGL 286

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 130/289 (44%), Gaps = 43/289 (14%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKARFN----EKLLAAVKRIDDAGHDAER-EFNNEVNWL 203
           E    N     V+G G  G V   R      +++  A+K +     + +R +F  E + +
Sbjct: 29  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 88
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
            +  H NII L G    ++   +V E M+NGSL+  L    H +  T    + +   +A 
Sbjct: 89  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR--KHDAQFTVIQLVGMLRGIAS 146
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT------AGTQSRNVKISGT 317
           G++YL +      VHRDL + NIL++S+   K+SDFGLS        A   +R  KI   
Sbjct: 147 GMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP-- 201
Query: 318 LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMS----------------PT 360
           + + +PE +   K T  SDV+++G+VL E++  G RP  +MS                P 
Sbjct: 202 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPM 261
Query: 361 QC-----QSMVTWAMPQLTDRSKLPNIV---DPVIRDTMDLKHLYQVAA 401
            C     Q M+        +R K   IV   D +IR+   LK +   AA
Sbjct: 262 DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAA 310

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 130/289 (44%), Gaps = 43/289 (14%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKARFN----EKLLAAVKRIDDAGHDAER-EFNNEVNWL 203
           E    N     V+G G  G V   R      +++  A+K +     + +R +F  E + +
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
            +  H NII L G    ++   +V E M+NGSL+  L    H +  T    + +   +A 
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLR--KHDAQFTVIQLVGMLRGIAS 158
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT------AGTQSRNVKISGT 317
           G++YL +      VHRDL + NIL++S+   K+SDFGLS        A   +R  KI   
Sbjct: 159 GMKYLSDMG---AVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP-- 213
Query: 318 LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMS----------------PT 360
           + + +PE +   K T  SDV+++G+VL E++  G RP  +MS                P 
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPM 273
Query: 361 QC-----QSMVTWAMPQLTDRSKLPNIV---DPVIRDTMDLKHLYQVAA 401
            C     Q M+        +R K   IV   D +IR+   LK +   AA
Sbjct: 274 DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAA 322

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 77/265 (29%), Positives = 124/265 (46%), Gaps = 26/265 (9%)
Query: 122 SPILERFN-SLRLAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFN----- 175
           S I+  +N +   AGK  ++S    +L E    N      +G G  G VY+ + +     
Sbjct: 3   STIMTDYNPNYSFAGKTSSIS----DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPND 58
Query: 176 -EKLLAAVKRIDD-AGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQN 233
              L  AVK + +      E +F  E   ++K+ HQNI+  +G  + +  RF++ E+M  
Sbjct: 59  PSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAG 118
Query: 234 GSLEKQLHG----PTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLD 289
           G L+  L      P+  S+L     + +A D+A G +YL E  NH  +HRD+ + N LL 
Sbjct: 119 GDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NH-FIHRDIAARNCLLT 175
Query: 290 SSFN---AKLSDFGLSVTAGTQSRNVKISGTL---GYVAPEYLLEGKLTDKSDVYAFGVV 343
                  AK+ DFG++      S   K    +    ++ PE  +EG  T K+D ++FGV+
Sbjct: 176 CPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVL 235
Query: 344 LLELL-MGRRPVEKMSPTQCQSMVT 367
           L E+  +G  P    S  +    VT
Sbjct: 236 LWEIFSLGYMPYPSKSNQEVLEFVT 260

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 78/268 (29%), Positives = 124/268 (46%), Gaps = 26/268 (9%)
Query: 119 LSLSPILERFN-SLRLAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFN-- 175
           L  S I+  +N +   AGK  ++S    +L E    N      +G G  G VY+ + +  
Sbjct: 26  LRTSTIMTDYNPNYSFAGKTSSIS----DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGM 81
Query: 176 ----EKLLAAVKRIDD-AGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM 230
                 L  AVK + +      E +F  E   ++K  HQNI+  +G  + +  RF++ E+
Sbjct: 82  PNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLEL 141
Query: 231 MQNGSLEKQLHG----PTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNI 286
           M  G L+  L      P+  S+L     + +A D+A G +YL E  NH  +HRD+ + N 
Sbjct: 142 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NH-FIHRDIAARNC 198
Query: 287 LLDSSFN---AKLSDFGLSVTAGTQSRNVKISGTL---GYVAPEYLLEGKLTDKSDVYAF 340
           LL        AK+ DFG++      S   K    +    ++ PE  +EG  T K+D ++F
Sbjct: 199 LLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSF 258
Query: 341 GVVLLELL-MGRRPVEKMSPTQCQSMVT 367
           GV+L E+  +G  P    S  +    VT
Sbjct: 259 GVLLWEIFSLGYMPYPSKSNQEVLEFVT 286

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 130/289 (44%), Gaps = 43/289 (14%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKARFN----EKLLAAVKRIDDAGHDAER-EFNNEVNWL 203
           E    N     V+G G  G V   R      +++  A+K +     + +R +F  E + +
Sbjct: 12  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 71
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
            +  H NII L G    ++   +V E M+NGSL+  L    H +  T    + +   +A 
Sbjct: 72  GQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLR--KHDAQFTVIQLVGMLRGIAS 129
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT------AGTQSRNVKISGT 317
           G++YL +      VHRDL + NIL++S+   K+SDFGLS        A   +R  KI   
Sbjct: 130 GMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP-- 184
Query: 318 LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMS----------------PT 360
           + + +PE +   K T  SDV+++G+VL E++  G RP  +MS                P 
Sbjct: 185 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPM 244
Query: 361 QC-----QSMVTWAMPQLTDRSKLPNIV---DPVIRDTMDLKHLYQVAA 401
            C     Q M+        +R K   IV   D +IR+   LK +   AA
Sbjct: 245 DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAA 293

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 130/289 (44%), Gaps = 43/289 (14%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKARFN----EKLLAAVKRIDDAGHDAER-EFNNEVNWL 203
           E    N     V+G G  G V   R      +++  A+K +     + +R +F  E + +
Sbjct: 12  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 71
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
            +  H NII L G    ++   +V E M+NGSL+  L    H +  T    + +   +A 
Sbjct: 72  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR--KHDAQFTVIQLVGMLRGIAS 129
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT------AGTQSRNVKISGT 317
           G++YL +      VHRDL + NIL++S+   K+SDFGLS        A   +R  KI   
Sbjct: 130 GMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP-- 184
Query: 318 LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMS----------------PT 360
           + + +PE +   K T  SDV+++G+VL E++  G RP  +MS                P 
Sbjct: 185 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPM 244
Query: 361 QC-----QSMVTWAMPQLTDRSKLPNIV---DPVIRDTMDLKHLYQVAA 401
            C     Q M+        +R K   IV   D +IR+   LK +   AA
Sbjct: 245 DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAA 293

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 130/289 (44%), Gaps = 43/289 (14%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKARFN----EKLLAAVKRIDDAGHDAER-EFNNEVNWL 203
           E    N     V+G G  G V   R      +++  A+K +     + +R +F  E + +
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
            +  H NII L G    ++   +V E M+NGSL+  L    H +  T    + +   +A 
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR--KHDAQFTVIQLVGMLRGIAS 158
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT------AGTQSRNVKISGT 317
           G++YL +      VHRDL + NIL++S+   K+SDFGLS        A   +R  KI   
Sbjct: 159 GMKYLSDMG---FVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP-- 213
Query: 318 LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMS----------------PT 360
           + + +PE +   K T  SDV+++G+VL E++  G RP  +MS                P 
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPM 273
Query: 361 QC-----QSMVTWAMPQLTDRSKLPNIV---DPVIRDTMDLKHLYQVAA 401
            C     Q M+        +R K   IV   D +IR+   LK +   AA
Sbjct: 274 DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAA 322

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 78/268 (29%), Positives = 124/268 (46%), Gaps = 26/268 (9%)
Query: 119 LSLSPILERFN-SLRLAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFN-- 175
           L  S I+  +N +   AGK  ++S    +L E    N      +G G  G VY+ + +  
Sbjct: 16  LRTSTIMTDYNPNYCFAGKTSSIS----DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGM 71
Query: 176 ----EKLLAAVKRIDD-AGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM 230
                 L  AVK + +      E +F  E   ++K  HQNI+  +G  + +  RF++ E+
Sbjct: 72  PNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLEL 131
Query: 231 MQNGSLEKQLHG----PTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNI 286
           M  G L+  L      P+  S+L     + +A D+A G +YL E  NH  +HRD+ + N 
Sbjct: 132 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NH-FIHRDIAARNC 188
Query: 287 LLDSSFN---AKLSDFGLSVTAGTQSRNVKISGTL---GYVAPEYLLEGKLTDKSDVYAF 340
           LL        AK+ DFG++      S   K    +    ++ PE  +EG  T K+D ++F
Sbjct: 189 LLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSF 248
Query: 341 GVVLLELL-MGRRPVEKMSPTQCQSMVT 367
           GV+L E+  +G  P    S  +    VT
Sbjct: 249 GVLLWEIFSLGYMPYPSKSNQEVLEFVT 276

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 77/265 (29%), Positives = 123/265 (46%), Gaps = 26/265 (9%)
Query: 122 SPILERFN-SLRLAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFN----- 175
           S I+  +N +   AGK  ++S    +L E    N      +G G  G VY+ + +     
Sbjct: 3   STIMTDYNPNYSFAGKTSSIS----DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPND 58
Query: 176 -EKLLAAVKRIDD-AGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQN 233
              L  AVK + +      E +F  E   ++K  HQNI+  +G  + +  RF++ E+M  
Sbjct: 59  PSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAG 118
Query: 234 GSLEKQLHG----PTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLD 289
           G L+  L      P+  S+L     + +A D+A G +YL E  NH  +HRD+ + N LL 
Sbjct: 119 GDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NH-FIHRDIAARNCLLT 175
Query: 290 SSFN---AKLSDFGLSVTAGTQSRNVKISGTL---GYVAPEYLLEGKLTDKSDVYAFGVV 343
                  AK+ DFG++      S   K    +    ++ PE  +EG  T K+D ++FGV+
Sbjct: 176 CPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVL 235
Query: 344 LLELL-MGRRPVEKMSPTQCQSMVT 367
           L E+  +G  P    S  +    VT
Sbjct: 236 LWEIFSLGYMPYPSKSNQEVLEFVT 260

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 74/253 (29%), Positives = 117/253 (46%), Gaps = 25/253 (9%)
Query: 133 LAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFN------EKLLAAVKRID 186
            AGK  ++S    +L E    N      +G G  G VY+ + +        L  AVK + 
Sbjct: 14  FAGKTSSIS----DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP 69
Query: 187 D-AGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHG--- 242
           +      E +F  E   ++K  HQNI+  +G  + +  RF++ E+M  G L+  L     
Sbjct: 70  EVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRP 129
Query: 243 -PTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFN---AKLSD 298
            P+  S+L     + +A D+A G +YL E  NH  +HRD+ + N LL        AK+ D
Sbjct: 130 RPSQPSSLAMLDLLHVARDIACGCQYLEE--NH-FIHRDIAARNCLLTCPGPGRVAKIGD 186
Query: 299 FGLSVTAGTQSRNVKISGTL---GYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPV 354
           FG++      S   K    +    ++ PE  +EG  T K+D ++FGV+L E+  +G  P 
Sbjct: 187 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 246
Query: 355 EKMSPTQCQSMVT 367
              S  +    VT
Sbjct: 247 PSKSNQEVLEFVT 259

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 77/265 (29%), Positives = 123/265 (46%), Gaps = 26/265 (9%)
Query: 122 SPILERFN-SLRLAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFN----- 175
           S I+  +N +   AGK  ++S    +L E    N      +G G  G VY+ + +     
Sbjct: 3   STIMTDYNPNYSFAGKTSSIS----DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPND 58
Query: 176 -EKLLAAVKRIDD-AGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQN 233
              L  AVK + +      E +F  E   ++K  HQNI+  +G  + +  RF++ E+M  
Sbjct: 59  PSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAG 118
Query: 234 GSLEKQLHG----PTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLD 289
           G L+  L      P+  S+L     + +A D+A G +YL E  NH  +HRD+ + N LL 
Sbjct: 119 GDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NH-FIHRDIAARNCLLT 175
Query: 290 SSFN---AKLSDFGLSVTAGTQSRNVKISGTL---GYVAPEYLLEGKLTDKSDVYAFGVV 343
                  AK+ DFG++      S   K    +    ++ PE  +EG  T K+D ++FGV+
Sbjct: 176 CPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVL 235
Query: 344 LLELL-MGRRPVEKMSPTQCQSMVT 367
           L E+  +G  P    S  +    VT
Sbjct: 236 LWEIFSLGYMPYPSKSNQEVLEFVT 260

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 130/289 (44%), Gaps = 43/289 (14%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKARFN----EKLLAAVKRIDDAGHDAER-EFNNEVNWL 203
           E    N     V+G G  G V   R      +++  A+K +     + +R +F  E + +
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
            +  H NII L G    ++   +V E M+NGSL+  L    H +  T    + +   +A 
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR--KHDAQFTVIQLVGMLRGIAS 158
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT------AGTQSRNVKISGT 317
           G++YL +      VHRDL + NIL++S+   K+SDFGLS        A   +R  KI   
Sbjct: 159 GMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP-- 213
Query: 318 LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMS----------------PT 360
           + + +PE +   K T  SDV+++G+VL E++  G RP  +MS                P 
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPM 273
Query: 361 QC-----QSMVTWAMPQLTDRSKLPNIV---DPVIRDTMDLKHLYQVAA 401
            C     Q M+        +R K   IV   D +IR+   LK +   AA
Sbjct: 274 DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAA 322

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 74/253 (29%), Positives = 118/253 (46%), Gaps = 25/253 (9%)
Query: 133 LAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFN------EKLLAAVKRID 186
            AGK  ++S    +L E    N      +G G  G VY+ + +        L  AVK + 
Sbjct: 29  FAGKTSSIS----DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP 84
Query: 187 D-AGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHG--- 242
           +      E +F  E   ++K+ HQNI+  +G  + +  RF++ E+M  G L+  L     
Sbjct: 85  EVCSEQDELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRP 144
Query: 243 -PTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFN---AKLSD 298
            P+  S+L     + +A D+A G +YL E  NH  +HRD+ + N LL        AK+ D
Sbjct: 145 RPSQPSSLAMLDLLHVARDIACGCQYLEE--NH-FIHRDIAARNCLLTCPGPGRVAKIGD 201
Query: 299 FGLSVTAGTQSRNVKISGTL---GYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPV 354
           FG++      S   K    +    ++ PE  +EG  T K+D ++FGV+L E+  +G  P 
Sbjct: 202 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 261
Query: 355 EKMSPTQCQSMVT 367
              S  +    VT
Sbjct: 262 PSKSNQEVLEFVT 274

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 74/253 (29%), Positives = 117/253 (46%), Gaps = 25/253 (9%)
Query: 133 LAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFN------EKLLAAVKRID 186
            AGK  ++S    +L E    N      +G G  G VY+ + +        L  AVK + 
Sbjct: 14  FAGKTSSIS----DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP 69
Query: 187 D-AGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHG--- 242
           +      E +F  E   ++K  HQNI+  +G  + +  RF++ E+M  G L+  L     
Sbjct: 70  EVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRP 129
Query: 243 -PTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFN---AKLSD 298
            P+  S+L     + +A D+A G +YL E  NH  +HRD+ + N LL        AK+ D
Sbjct: 130 RPSQPSSLAMLDLLHVARDIACGCQYLEE--NH-FIHRDIAARNCLLTCPGPGRVAKIGD 186
Query: 299 FGLSVTAGTQSRNVKISGTL---GYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPV 354
           FG++      S   K    +    ++ PE  +EG  T K+D ++FGV+L E+  +G  P 
Sbjct: 187 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 246
Query: 355 EKMSPTQCQSMVT 367
              S  +    VT
Sbjct: 247 PSKSNQEVLEFVT 259

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 74/253 (29%), Positives = 117/253 (46%), Gaps = 25/253 (9%)
Query: 133 LAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFN------EKLLAAVKRID 186
            AGK  ++S    +L E    N      +G G  G VY+ + +        L  AVK + 
Sbjct: 6   FAGKTSSIS----DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP 61
Query: 187 D-AGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHG--- 242
           +      E +F  E   ++K  HQNI+  +G  + +  RF++ E+M  G L+  L     
Sbjct: 62  EVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRP 121
Query: 243 -PTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFN---AKLSD 298
            P+  S+L     + +A D+A G +YL E  NH  +HRD+ + N LL        AK+ D
Sbjct: 122 RPSQPSSLAMLDLLHVARDIACGCQYLEE--NH-FIHRDIAARNCLLTCPGPGRVAKIGD 178
Query: 299 FGLSVTAGTQSRNVKISGTL---GYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPV 354
           FG++      S   K    +    ++ PE  +EG  T K+D ++FGV+L E+  +G  P 
Sbjct: 179 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 238
Query: 355 EKMSPTQCQSMVT 367
              S  +    VT
Sbjct: 239 PSKSNQEVLEFVT 251

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 130/289 (44%), Gaps = 43/289 (14%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKARFN----EKLLAAVKRIDDAGHDAER-EFNNEVNWL 203
           E    N     V+G G  G V   R      +++  A+K +     + +R +F  E + +
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
            +  H NII L G    ++   +V E M+NGSL+  L    H +  T    + +   +A 
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR--KHDAQFTVIQLVGMLRGIAS 158
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT------AGTQSRNVKISGT 317
           G++YL +      VHRDL + NIL++S+   K+SDFGLS        A   +R  KI   
Sbjct: 159 GMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP-- 213
Query: 318 LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMS----------------PT 360
           + + +PE +   K T  SDV+++G+VL E++  G RP  +MS                P 
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPM 273
Query: 361 QC-----QSMVTWAMPQLTDRSKLPNIV---DPVIRDTMDLKHLYQVAA 401
            C     Q M+        +R K   IV   D +IR+   LK +   AA
Sbjct: 274 DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAA 322

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 130/289 (44%), Gaps = 43/289 (14%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKARFN----EKLLAAVKRIDDAGHDAER-EFNNEVNWL 203
           E    N     V+G G  G V   R      +++  A+K +     + +R +F  E + +
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
            +  H NII L G    ++   +V E M+NGSL+  L    H +  T    + +   +A 
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR--KHDAQFTVIQLVGMLRGIAS 158
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT------AGTQSRNVKISGT 317
           G++YL +      VHRDL + NIL++S+   K+SDFGLS        A   +R  KI   
Sbjct: 159 GMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP-- 213
Query: 318 LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMS----------------PT 360
           + + +PE +   K T  SDV+++G+VL E++  G RP  +MS                P 
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPM 273
Query: 361 QC-----QSMVTWAMPQLTDRSKLPNIV---DPVIRDTMDLKHLYQVAA 401
            C     Q M+        +R K   IV   D +IR+   LK +   AA
Sbjct: 274 DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAA 322

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 130/289 (44%), Gaps = 43/289 (14%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKARFN----EKLLAAVKRIDDAGHDAER-EFNNEVNWL 203
           E    N     V+G G  G V   R      +++  A+K +     + +R +F  E + +
Sbjct: 39  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 98
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
            +  H NII L G    ++   +V E M+NGSL+  L    H +  T    + +   +A 
Sbjct: 99  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR--KHDAQFTVIQLVGMLRGIAS 156
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT------AGTQSRNVKISGT 317
           G++YL +      VHRDL + NIL++S+   K+SDFGLS        A   +R  KI   
Sbjct: 157 GMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP-- 211
Query: 318 LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMS----------------PT 360
           + + +PE +   K T  SDV+++G+VL E++  G RP  +MS                P 
Sbjct: 212 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPM 271
Query: 361 QC-----QSMVTWAMPQLTDRSKLPNIV---DPVIRDTMDLKHLYQVAA 401
            C     Q M+        +R K   IV   D +IR+   LK +   AA
Sbjct: 272 DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAA 320

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 130/289 (44%), Gaps = 43/289 (14%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKARFN----EKLLAAVKRIDDAGHDAER-EFNNEVNWL 203
           E    N     V+G G  G V   R      +++  A+K +     + +R +F  E + +
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
            +  H NII L G    ++   +V E M+NGSL+  L    H +  T    + +   +A 
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLR--KHDAQFTVIQLVGMLRGIAS 158
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT------AGTQSRNVKISGT 317
           G++YL +      VHRDL + NIL++S+   K+SDFGLS        A   +R  KI   
Sbjct: 159 GMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP-- 213
Query: 318 LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMS----------------PT 360
           + + +PE +   K T  SDV+++G+VL E++  G RP  +MS                P 
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPM 273
Query: 361 QC-----QSMVTWAMPQLTDRSKLPNIV---DPVIRDTMDLKHLYQVAA 401
            C     Q M+        +R K   IV   D +IR+   LK +   AA
Sbjct: 274 DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAA 322

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 121/274 (44%), Gaps = 26/274 (9%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           +G G  G V   ++  +   AVK I + G  +E EF  E   + K+ H  ++   G C  
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKE-GSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
               ++V E + NG L   L   +HG  L     +++  DV  G+ +L    +H  +HRD
Sbjct: 75  EYPIYIVTEYISNGCLLNYLR--SHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRD 129
Query: 281 LKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVY 338
           L + N L+D     K+SDFG++  V       +V     + + APE     K + KSDV+
Sbjct: 130 LAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVW 189
Query: 339 AFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLY 397
           AFG+++ E+  +G+ P +  + ++    V+        R   P++    I         Y
Sbjct: 190 AFGILMWEVFSLGKMPYDLYTNSEVVLKVSQG-----HRLYRPHLASDTI---------Y 235
Query: 398 QVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPTD 431
           Q+      C    P  RP    +L S+ PL   D
Sbjct: 236 QIMYS---CWHELPEKRPTFQQLLSSIEPLREKD 266

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 130/289 (44%), Gaps = 43/289 (14%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKARFN----EKLLAAVKRIDDAGHDAER-EFNNEVNWL 203
           E    N     V+G G  G V   R      +++  A+K +     + +R +F  E + +
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
            +  H NII L G    ++   +V E M+NGSL+  L    H +  T    + +   +A 
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR--KHDAQFTVIQLVGMLRGIAS 158
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT------AGTQSRNVKISGT 317
           G++YL +      VHRDL + NIL++S+   K+SDFGLS        A   +R  KI   
Sbjct: 159 GMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP-- 213
Query: 318 LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMS----------------PT 360
           + + +PE +   K T  SDV+++G+VL E++  G RP  +MS                P 
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPM 273
Query: 361 QC-----QSMVTWAMPQLTDRSKLPNIV---DPVIRDTMDLKHLYQVAA 401
            C     Q M+        +R K   IV   D +IR+   LK +   AA
Sbjct: 274 DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAA 322

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/253 (29%), Positives = 117/253 (46%), Gaps = 25/253 (9%)
Query: 133 LAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFN------EKLLAAVKRID 186
            AGK  ++S    +L E    N      +G G  G VY+ + +        L  AVK + 
Sbjct: 29  FAGKTSSIS----DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP 84
Query: 187 D-AGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHG--- 242
           +      E +F  E   ++K  HQNI+  +G  + +  RF++ E+M  G L+  L     
Sbjct: 85  EVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRP 144
Query: 243 -PTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFN---AKLSD 298
            P+  S+L     + +A D+A G +YL E  NH  +HRD+ + N LL        AK+ D
Sbjct: 145 RPSQPSSLAMLDLLHVARDIACGCQYLEE--NH-FIHRDIAARNCLLTCPGPGRVAKIGD 201
Query: 299 FGLSVTAGTQSRNVKISGTL---GYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPV 354
           FG++      S   K    +    ++ PE  +EG  T K+D ++FGV+L E+  +G  P 
Sbjct: 202 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 261
Query: 355 EKMSPTQCQSMVT 367
              S  +    VT
Sbjct: 262 PSKSNQEVLEFVT 274

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 107/201 (53%), Gaps = 9/201 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           +G G  G V+   +N     AVK +   G  +   F  E N + +++HQ ++ L    + 
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYA-VVT 74
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
            E  +++ E M+NGSL   L  P+ G  LT +  + +A  +A G+ ++ E  N+  +HR+
Sbjct: 75  QEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER-NY--IHRN 130
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
           L+++NIL+  + + K++DFGL+          +      + + APE +  G  T KSDV+
Sbjct: 131 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 190
Query: 339 AFGVVLLELLM-GRRPVEKMS 358
           +FG++L E++  GR P   M+
Sbjct: 191 SFGILLTEIVTHGRIPYPGMT 211

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/238 (31%), Positives = 111/238 (46%), Gaps = 19/238 (7%)
Query: 139 TVSVIEYELLEAATNNFQESNVIGEGGRGHVYKAR-FNEKLLAAVKRIDDAGHDAEREFN 197
           ++  I+   L      F+   ++G G  G VYK R      LAA+K +D  G D E E  
Sbjct: 10  SLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIK 68
Query: 198 NEVNWLTKI-RHQNIISLLGYCIHA------ETRFLVYEMMQNGSLEKQLHGPTHGSNLT 250
            E+N L K   H+NI +  G  I        +  +LV E    GS+   +   T G+ L 
Sbjct: 69  QEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN-TKGNTLK 127
Query: 251 WHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAG-TQS 309
                 I  ++ RGL +LH+H    V+HRD+K  N+LL  +   KL DFG+S     T  
Sbjct: 128 EEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG 184
Query: 310 RNVKISGTLGYVAPEYLLEGKLTD-----KSDVYAFGVVLLELLMGRRPVEKMSPTQC 362
           R     GT  ++APE +   +  D     KSD+++ G+  +E+  G  P+  M P + 
Sbjct: 185 RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA 242

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/253 (29%), Positives = 117/253 (46%), Gaps = 25/253 (9%)
Query: 133 LAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFN------EKLLAAVKRID 186
            AGK  ++S    +L E    N      +G G  G VY+ + +        L  AVK + 
Sbjct: 29  FAGKTSSIS----DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP 84
Query: 187 DA-GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHG--- 242
           +      E +F  E   ++K  HQNI+  +G  + +  RF++ E+M  G L+  L     
Sbjct: 85  EVYSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRP 144
Query: 243 -PTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFN---AKLSD 298
            P+  S+L     + +A D+A G +YL E  NH  +HRD+ + N LL        AK+ D
Sbjct: 145 RPSQPSSLAMLDLLHVARDIACGCQYLEE--NH-FIHRDIAARNCLLTCPGPGRVAKIGD 201
Query: 299 FGLSVTAGTQSRNVKISGTL---GYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPV 354
           FG++      S   K    +    ++ PE  +EG  T K+D ++FGV+L E+  +G  P 
Sbjct: 202 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 261
Query: 355 EKMSPTQCQSMVT 367
              S  +    VT
Sbjct: 262 PSKSNQEVLEFVT 274

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 83/289 (28%), Positives = 130/289 (44%), Gaps = 43/289 (14%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKARFN----EKLLAAVKRIDDAGHDAER-EFNNEVNWL 203
           E    N     V+G G  G V   R      +++  A+K +     + +R +F  E + +
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
            +  H NII L G    ++   +V E M+NGSL+  L    H +  T    + +   +A 
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR--KHDAQFTVIQLVGMLRGIAS 158
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT------AGTQSRNVKISGT 317
           G++YL +      VHRDL + NIL++S+   K+SDFGL+        A   +R  KI   
Sbjct: 159 GMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIP-- 213
Query: 318 LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMS----------------PT 360
           + + +PE +   K T  SDV+++G+VL E++  G RP  +MS                P 
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPM 273
Query: 361 QC-----QSMVTWAMPQLTDRSKLPNIV---DPVIRDTMDLKHLYQVAA 401
            C     Q M+        +R K   IV   D +IR+   LK +   AA
Sbjct: 274 DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAA 322

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 74/275 (26%), Positives = 123/275 (44%), Gaps = 26/275 (9%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           IG G  G V+   +  K   A+K I + G  +E +F  E   + K+ H  ++ L G C+ 
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
                LV E M++G L   L   T          + + +DV  G+ YL E C   V+HRD
Sbjct: 75  QAPICLVTEFMEHGCLSDYLR--TQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRD 129
Query: 281 LKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVY 338
           L + N L+  +   K+SDFG++  V     + +      + + +PE     + + KSDV+
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 189
Query: 339 AFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLY 397
           +FGV++ E+   G+ P E  S ++           + D S    +  P +  T    H+Y
Sbjct: 190 SFGVLMWEVFSEGKIPYENRSNSEV----------VEDISTGFRLYKPRLAST----HVY 235
Query: 398 QVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPTDL 432
           Q+      C +  P  RP  + +L  L  +  + L
Sbjct: 236 QIMN---HCWRERPEDRPAFSRLLRQLAEIAESGL 267

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 83/289 (28%), Positives = 129/289 (44%), Gaps = 43/289 (14%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKARFN----EKLLAAVKRIDDAGHDAER-EFNNEVNWL 203
           E    N     V+G G  G V   R      +++  A+K +     + +R +F  E + +
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
            +  H NII L G    ++   +V E M+NGSL+  L    H +  T    + +   +A 
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR--KHDAQFTVIQLVGMLRGIAS 158
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT------AGTQSRNVKISGT 317
           G++YL +      VHRDL + NIL++S+   K+SDFGL         A   +R  KI   
Sbjct: 159 GMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIP-- 213
Query: 318 LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMS----------------PT 360
           + + +PE +   K T  SDV+++G+VL E++  G RP  +MS                P 
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPM 273
Query: 361 QC-----QSMVTWAMPQLTDRSKLPNIV---DPVIRDTMDLKHLYQVAA 401
            C     Q M+        +R K   IV   D +IR+   LK +   AA
Sbjct: 274 DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAA 322

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 100/200 (50%), Gaps = 9/200 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           +G+G  G V+   +N     A+K +       E  F  E   + K+RH+ ++ L    + 
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYA-VVS 76
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
            E  ++V E M  GSL   L G T G  L     + +A  +A G+ Y+ E  N+  VHRD
Sbjct: 77  EEPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYV-ERMNY--VHRD 132
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
           L+++NIL+  +   K++DFGL+          +      + + APE  L G+ T KSDV+
Sbjct: 133 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 192
Query: 339 AFGVVLLELLM-GRRPVEKM 357
           +FG++L EL   GR P   M
Sbjct: 193 SFGILLTELTTKGRVPYPGM 212

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 100/204 (49%), Gaps = 9/204 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           +G G  G V   ++  +   A+K I + G  +E EF  E   +  + H+ ++ L G C  
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
               F++ E M NG L   L    H       L M    DV   +EYL    +   +HRD
Sbjct: 91  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM--CKDVCEAMEYLE---SKQFLHRD 145
Query: 281 LKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVY 338
           L + N L++     K+SDFGLS  V    ++ +V     + +  PE L+  K + KSD++
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 205
Query: 339 AFGVVLLELL-MGRRPVEKMSPTQ 361
           AFGV++ E+  +G+ P E+ + ++
Sbjct: 206 AFGVLMWEIYSLGKMPYERFTNSE 229

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 107/210 (50%), Gaps = 9/210 (4%)
Query: 161 IGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCI 219
           +G G  G VY+  + +  L  AVK + +   + E EF  E   + +I+H N++ LLG C 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 220 HAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHR 279
                +++ E M  G+L   L    +   ++  + + +A  ++  +EYL +      +HR
Sbjct: 78  REPPFYIIIEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHR 133
Query: 280 DLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDV 337
           DL + N L+  +   K++DFGLS  +T  T + +      + + APE L   K + KSDV
Sbjct: 134 DLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDV 193
Query: 338 YAFGVVLLEL-LMGRRPVEKMSPTQCQSMV 366
           +AFGV+L E+   G  P   + P+Q   ++
Sbjct: 194 WAFGVLLWEIATYGMSPYPGIDPSQVYELL 223

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 72/237 (30%), Positives = 114/237 (48%), Gaps = 20/237 (8%)
Query: 159 NVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYC 218
             IG+G  G V    +    +A     +DA   A   F  E + +T++RH N++ LLG  
Sbjct: 199 QTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVI 255
Query: 219 IHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVV 277
           +  +   ++V E M  GSL   L      S L     +K ++DV   +EYL     +  V
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLE---GNNFV 311
Query: 278 HRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDV 337
           HRDL + N+L+     AK+SDFGL+  A +     K+   + + APE L E K + KSDV
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP--VKWTAPEALREKKFSTKSDV 369
Query: 338 YAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRSKL--PNIVDPVIRDTM 391
           ++FG++L E+   GR P  ++            +P++    K+  P+   P + D M
Sbjct: 370 WSFGILLWEIYSFGRVPYPRIPLKD-------VVPRVEKGYKMDAPDGCPPAVYDVM 419

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 138/285 (48%), Gaps = 29/285 (10%)
Query: 153 NNFQESNVIGEGGRGHV---YKARFNEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRH 208
           ++++   VIG G    V   Y A   EK+  A+KRI+ +    +  E   E+  +++  H
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKV--AIKRINLEKCQTSMDELLKEIQAMSQCHH 67
Query: 209 QNIISLLGYCIHAETRFLVYEMMQNGS-LEKQLHGPTHGSNLTWHLR----MKIAVDVAR 263
            NI+S     +  +  +LV +++  GS L+   H    G + +  L       I  +V  
Sbjct: 68  PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 127
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS---VTAGTQSRN---VKISGT 317
           GLEYLH++     +HRD+K+ NILL    + +++DFG+S    T G  +RN       GT
Sbjct: 128 GLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 184
Query: 318 LGYVAPEYLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDR 376
             ++APE + + +  D K+D+++FG+  +EL  G  P  K  P +        +  LT +
Sbjct: 185 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK--------VLMLTLQ 236
Query: 377 SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
           +  P++   V    M  K+      +  LC+Q +P  RP   ++L
Sbjct: 237 NDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 281

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 138/285 (48%), Gaps = 29/285 (10%)
Query: 153 NNFQESNVIGEGGRGHV---YKARFNEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRH 208
           ++++   VIG G    V   Y A   EK+  A+KRI+ +    +  E   E+  +++  H
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKV--AIKRINLEKCQTSMDELLKEIQAMSQCHH 72
Query: 209 QNIISLLGYCIHAETRFLVYEMMQNGS-LEKQLHGPTHGSNLTWHLR----MKIAVDVAR 263
            NI+S     +  +  +LV +++  GS L+   H    G + +  L       I  +V  
Sbjct: 73  PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS---VTAGTQSRN---VKISGT 317
           GLEYLH++     +HRD+K+ NILL    + +++DFG+S    T G  +RN       GT
Sbjct: 133 GLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189
Query: 318 LGYVAPEYLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDR 376
             ++APE + + +  D K+D+++FG+  +EL  G  P  K  P +        +  LT +
Sbjct: 190 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK--------VLMLTLQ 241
Query: 377 SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
           +  P++   V    M  K+      +  LC+Q +P  RP   ++L
Sbjct: 242 NDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 286

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 76/246 (30%), Positives = 122/246 (49%), Gaps = 21/246 (8%)
Query: 122 SPILERFNSLRLAG-KKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARF----NE 176
           SP+L+    + L+    + V  +++ ++  ++     + VIG G  G VY         +
Sbjct: 17  SPLLQNTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGK 76
Query: 177 KLLAAVK---RIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE-TRFLVYEMMQ 232
           K+  AVK   RI D G  ++  F  E   +    H N++SLLG C+ +E +  +V   M+
Sbjct: 77  KIHCAVKSLNRITDIGEVSQ--FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMK 134
Query: 233 NGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSF 292
           +G L   +   TH  N T    +   + VA+G++YL    +   VHRDL + N +LD  F
Sbjct: 135 HGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKF 189
Query: 293 NAKLSDFGLSVTAGTQ---SRNVKISGTL--GYVAPEYLLEGKLTDKSDVYAFGVVLLEL 347
             K++DFGL+     +   S + K    L   ++A E L   K T KSDV++FGV+L EL
Sbjct: 190 TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 249
Query: 348 LMGRRP 353
           +    P
Sbjct: 250 MTRGAP 255

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 99/204 (48%), Gaps = 9/204 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           +G G  G V   ++  +   A+K I + G  +E EF  E   +  + H+ ++ L G C  
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
               F++ E M NG L   L    H       L M    DV   +EYL    +   +HRD
Sbjct: 71  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM--CKDVCEAMEYLE---SKQFLHRD 125
Query: 281 LKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVY 338
           L + N L++     K+SDFGLS  V     + +V     + +  PE L+  K + KSD++
Sbjct: 126 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 185
Query: 339 AFGVVLLELL-MGRRPVEKMSPTQ 361
           AFGV++ E+  +G+ P E+ + ++
Sbjct: 186 AFGVLMWEIYSLGKMPYERFTNSE 209

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 122/271 (45%), Gaps = 41/271 (15%)
Query: 160 VIGEGGRGHVYKARFN----EKLLAAVKRIDDAGHDAER-EFNNEVNWLTKIRHQNIISL 214
           VIG G  G V + R      ++   A+K +     + +R EF +E + + +  H NII L
Sbjct: 21  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 80
Query: 215 LGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNH 274
            G   ++    ++ E M+NG+L+  L    +    T    + +   +A G+ YL E    
Sbjct: 81  EGVVTNSMPVMILTEFMENGALDSFLR--LNDGQFTVIQLVGMLRGIASGMRYLAEMS-- 136
Query: 275 PVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLG------YVAPEYLLE 328
             VHRDL + NIL++S+   K+SDFGLS      S +   + +LG      + APE +  
Sbjct: 137 -YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAF 195
Query: 329 GKLTDKSDVYAFGVVLLELL-MGRRPVEKMS----------------PTQC-----QSMV 366
            K T  SD +++G+V+ E++  G RP   MS                P  C     Q M+
Sbjct: 196 RKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPPPPDCPTSLHQLML 255
Query: 367 TWAMPQLTDRSKLPNIV---DPVIRDTMDLK 394
                    R + P +V   D +IR+   LK
Sbjct: 256 DCWQKDRNARPRFPQVVSALDKMIRNPASLK 286

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 99/204 (48%), Gaps = 9/204 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           +G G  G V   ++  +   A+K I + G  +E EF  E   +  + H+ ++ L G C  
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 74
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
               F++ E M NG L   L    H       L M    DV   +EYL    +   +HRD
Sbjct: 75  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM--CKDVCEAMEYLE---SKQFLHRD 129
Query: 281 LKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVY 338
           L + N L++     K+SDFGLS  V     + +V     + +  PE L+  K + KSD++
Sbjct: 130 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 189
Query: 339 AFGVVLLELL-MGRRPVEKMSPTQ 361
           AFGV++ E+  +G+ P E+ + ++
Sbjct: 190 AFGVLMWEIYSLGKMPYERFTNSE 213

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 123/275 (44%), Gaps = 26/275 (9%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           IG G  G V+   +  K   A+K I + G  +E +F  E   + K+ H  ++ L G C+ 
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
                LV+E M++G L   L   T          + + +DV  G+ YL E     V+HRD
Sbjct: 74  QAPICLVFEFMEHGCLSDYLR--TQRGLFAAETLLGMCLDVCEGMAYLEE---ASVIHRD 128
Query: 281 LKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVY 338
           L + N L+  +   K+SDFG++  V     + +      + + +PE     + + KSDV+
Sbjct: 129 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 188
Query: 339 AFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLY 397
           +FGV++ E+   G+ P E  S ++           + D S    +  P +  T    H+Y
Sbjct: 189 SFGVLMWEVFSEGKIPYENRSNSEV----------VEDISTGFRLYKPRLAST----HVY 234
Query: 398 QVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPTDL 432
           Q+      C +  P  RP  + +L  L  +  + L
Sbjct: 235 QIMN---HCWKERPEDRPAFSRLLRQLAAIAASGL 266

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 99/204 (48%), Gaps = 9/204 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           +G G  G V   ++  +   A+K I + G  +E EF  E   +  + H+ ++ L G C  
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
               F++ E M NG L   L    H       L M    DV   +EYL    +   +HRD
Sbjct: 76  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM--CKDVCEAMEYLE---SKQFLHRD 130
Query: 281 LKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVY 338
           L + N L++     K+SDFGLS  V     + +V     + +  PE L+  K + KSD++
Sbjct: 131 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 190
Query: 339 AFGVVLLELL-MGRRPVEKMSPTQ 361
           AFGV++ E+  +G+ P E+ + ++
Sbjct: 191 AFGVLMWEIYSLGKMPYERFTNSE 214

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 102/201 (50%), Gaps = 11/201 (5%)
Query: 159 NVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYC 218
             IG+G  G V    +    +A     +DA   A   F  E + +T++RH N++ LLG  
Sbjct: 12  QTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVI 68
Query: 219 IHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVV 277
           +  +   ++V E M  GSL   L      S L     +K ++DV   +EYL     +  V
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLE---GNNFV 124
Query: 278 HRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDV 337
           HRDL + N+L+     AK+SDFGL+  A +     K+   + + APE L E K + KSDV
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP--VKWTAPEALREKKFSTKSDV 182
Query: 338 YAFGVVLLELL-MGRRPVEKM 357
           ++FG++L E+   GR P  ++
Sbjct: 183 WSFGILLWEIYSFGRVPYPRI 203

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 100/200 (50%), Gaps = 9/200 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           +G+G  G V+   +N     A+K +   G  +   F  E   + KIRH+ ++ L    + 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKIRHEKLVQLYA-VVS 83
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
            E  ++V E M  GSL   L G   G  L     + +A  +A G+ Y+ E  N+  VHRD
Sbjct: 84  EEPIYIVTEYMSKGSLLDFLKG-EMGKYLRLPQLVDMAAQIASGMAYV-ERMNY--VHRD 139
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
           L+++NIL+  +   K++DFGL+          +      + + APE  L G+ T KSDV+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 339 AFGVVLLELLM-GRRPVEKM 357
           +FG++L EL   GR P   M
Sbjct: 200 SFGILLTELTTKGRVPYPGM 219

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 101/200 (50%), Gaps = 9/200 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           +G+G  G V+   +N     A+K +   G  +   F  E   + K+RH+ ++ L    + 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 249
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
            E  ++V E M  GSL   L G T G  L     + +A  +A G+ Y+ E  N+  VHRD
Sbjct: 250 EEPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYV-ERMNY--VHRD 305
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
           L+++NIL+  +   K++DFGL+          +      + + APE  L G+ T KSDV+
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365
Query: 339 AFGVVLLELLM-GRRPVEKM 357
           +FG++L EL   GR P   M
Sbjct: 366 SFGILLTELTTKGRVPYPGM 385

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 106/210 (50%), Gaps = 9/210 (4%)
Query: 161 IGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCI 219
           +G G  G VY+  + +  L  AVK + +   + E EF  E   + +I+H N++ LLG C 
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 220 HAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHR 279
                +++ E M  G+L   L    +   ++  + + +A  ++  +EYL        +HR
Sbjct: 78  REPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHR 133
Query: 280 DLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDV 337
           DL + N L+  +   K++DFGLS  +T  T + +      + + APE L   K + KSDV
Sbjct: 134 DLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDV 193
Query: 338 YAFGVVLLEL-LMGRRPVEKMSPTQCQSMV 366
           +AFGV+L E+   G  P   + P+Q   ++
Sbjct: 194 WAFGVLLWEIATYGMSPYPGIDPSQVYELL 223

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 101/200 (50%), Gaps = 9/200 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           +G+G  G V+   +N     A+K +   G  +   F  E   + K+RH+ ++ L    + 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 249
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
            E  ++V E M  GSL   L G T G  L     + +A  +A G+ Y+ E  N+  VHRD
Sbjct: 250 EEPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYV-ERMNY--VHRD 305
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
           L+++NIL+  +   K++DFGL+          +      + + APE  L G+ T KSDV+
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365
Query: 339 AFGVVLLELLM-GRRPVEKM 357
           +FG++L EL   GR P   M
Sbjct: 366 SFGILLTELTTKGRVPYPGM 385

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 13/206 (6%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           +G G  G V   ++  +   A+K I + G  +E EF  E   +  + H+ ++ L G C  
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
               F++ E M NG L   L    H       L M    DV   +EYL    +   +HRD
Sbjct: 76  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM--CKDVCEAMEYLE---SKQFLHRD 130
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTA----GTQSRNVKISGTLGYVAPEYLLEGKLTDKSD 336
           L + N L++     K+SDFGLS        T SR  K    + +  PE L+  K + KSD
Sbjct: 131 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFP--VRWSPPEVLMYSKFSSKSD 188
Query: 337 VYAFGVVLLELL-MGRRPVEKMSPTQ 361
           ++AFGV++ E+  +G+ P E+ + ++
Sbjct: 189 IWAFGVLMWEIYSLGKMPYERFTNSE 214

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 76/246 (30%), Positives = 122/246 (49%), Gaps = 21/246 (8%)
Query: 122 SPILERFNSLRLAG-KKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARF----NE 176
           SP+L+    + L+    + V  +++ ++  ++     + VIG G  G VY         +
Sbjct: 16  SPLLQNTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGK 75
Query: 177 KLLAAVK---RIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE-TRFLVYEMMQ 232
           K+  AVK   RI D G  ++  F  E   +    H N++SLLG C+ +E +  +V   M+
Sbjct: 76  KIHCAVKSLNRITDIGEVSQ--FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMK 133
Query: 233 NGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSF 292
           +G L   +   TH  N T    +   + VA+G++YL    +   VHRDL + N +LD  F
Sbjct: 134 HGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKF 188
Query: 293 NAKLSDFGLSVTAGTQ---SRNVKISGTL--GYVAPEYLLEGKLTDKSDVYAFGVVLLEL 347
             K++DFGL+     +   S + K    L   ++A E L   K T KSDV++FGV+L EL
Sbjct: 189 TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 248
Query: 348 LMGRRP 353
           +    P
Sbjct: 249 MTRGAP 254

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 102/201 (50%), Gaps = 11/201 (5%)
Query: 159 NVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYC 218
             IG+G  G V    +    +A     +DA   A   F  E + +T++RH N++ LLG  
Sbjct: 27  QTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVI 83
Query: 219 IHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVV 277
           +  +   ++V E M  GSL   L      S L     +K ++DV   +EYL     +  V
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLE---GNNFV 139
Query: 278 HRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDV 337
           HRDL + N+L+     AK+SDFGL+  A +     K+   + + APE L E K + KSDV
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP--VKWTAPEALREKKFSTKSDV 197
Query: 338 YAFGVVLLELL-MGRRPVEKM 357
           ++FG++L E+   GR P  ++
Sbjct: 198 WSFGILLWEIYSFGRVPYPRI 218

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 104/209 (49%), Gaps = 14/209 (6%)
Query: 154 NFQESNVIGEGGRGHVYKAR-FNEKLLAAVKRIDD-AGHDAE--REFNNEVNWLTKIRHQ 209
           +F+  N++G+G    VY+A   +  L  A+K ID  A + A   +   NEV    +++H 
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHP 71
Query: 210 NIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTH--GSNLTWHLRMKIAVDVARGLEY 267
           +I+ L  Y   +   +LV EM  NG + + L         N   H   +I      G+ Y
Sbjct: 72  SILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIIT----GMLY 127
Query: 268 LHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT-QSRNVKISGTLGYVAPEYL 326
           LH   +H ++HRDL  SN+LL  + N K++DFGL+        ++  + GT  Y++PE  
Sbjct: 128 LH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIA 184
Query: 327 LEGKLTDKSDVYAFGVVLLELLMGRRPVE 355
                  +SDV++ G +   LL+GR P +
Sbjct: 185 TRSAHGLESDVWSLGCMFYTLLIGRPPFD 213

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 103/202 (50%), Gaps = 13/202 (6%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           +G+G  G V+   +N     A+K +   G  +   F  E   + K+RH+ ++ L    + 
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 80
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
            E  ++V E M  GSL   L G T G  L     + ++  +A G+ Y+ E  N+  VHRD
Sbjct: 81  EEPIYIVTEYMNKGSLLDFLKGET-GKYLRLPQLVDMSAQIASGMAYV-ERMNY--VHRD 136
Query: 281 LKSSNILLDSSFNAKLSDFGLSV----TAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSD 336
           L+++NIL+  +   K++DFGL+        T  +  K    + + APE  L G+ T KSD
Sbjct: 137 LRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFP--IKWTAPEAALYGRFTIKSD 194
Query: 337 VYAFGVVLLELLM-GRRPVEKM 357
           V++FG++L EL   GR P   M
Sbjct: 195 VWSFGILLTELTTKGRVPYPGM 216

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 114/219 (52%), Gaps = 17/219 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKI 206
              +   V+G G  G VYK  +       K+  A+K +++  G  A  EF +E   +  +
Sbjct: 38  TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM 97
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
            H +++ LLG C+ + T  LV ++M +G L + +H   H  N+   L +   V +A+G+ 
Sbjct: 98  DHPHLVRLLGVCL-SPTIQLVTQLMPHGCLLEYVH--EHKDNIGSQLLLNWCVQIAKGMM 154
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAP 323
           YL E     +VHRDL + N+L+ S  + K++DFGL+       +     G    + ++A 
Sbjct: 155 YLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMAL 211
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQ 361
           E +   K T +SDV+++GV + EL+  G +P + + PT+
Sbjct: 212 ECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI-PTR 249

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 101/200 (50%), Gaps = 9/200 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           +G+G  G V+   +N     A+K +   G  +   F  E   + K+RH+ ++ L    + 
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 80
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
            E  ++V E M  GSL   L G T G  L     + ++  +A G+ Y+ E  N+  VHRD
Sbjct: 81  EEPIYIVTEYMNKGSLLDFLKGET-GKYLRLPQLVDMSAQIASGMAYV-ERMNY--VHRD 136
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
           L+++NIL+  +   K++DFGL+          +      + + APE  L G+ T KSDV+
Sbjct: 137 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 196
Query: 339 AFGVVLLELLM-GRRPVEKM 357
           +FG++L EL   GR P   M
Sbjct: 197 SFGILLTELTTKGRVPYPGM 216

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 99/204 (48%), Gaps = 9/204 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           +G G  G V   ++  +   A+K I + G  +E EF  E   +  + H+ ++ L G C  
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
               F++ E M NG L   L    H       L M    DV   +EYL    +   +HRD
Sbjct: 91  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM--CKDVCEAMEYLE---SKQFLHRD 145
Query: 281 LKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVY 338
           L + N L++     K+SDFGLS  V     + +V     + +  PE L+  K + KSD++
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 205
Query: 339 AFGVVLLELL-MGRRPVEKMSPTQ 361
           AFGV++ E+  +G+ P E+ + ++
Sbjct: 206 AFGVLMWEIYSLGKMPYERFTNSE 229

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 99/204 (48%), Gaps = 9/204 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           +G G  G V   ++  +   A+K I + G  +E EF  E   +  + H+ ++ L G C  
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 81
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
               F++ E M NG L   L    H       L M    DV   +EYL    +   +HRD
Sbjct: 82  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM--CKDVCEAMEYLE---SKQFLHRD 136
Query: 281 LKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVY 338
           L + N L++     K+SDFGLS  V     + +V     + +  PE L+  K + KSD++
Sbjct: 137 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 196
Query: 339 AFGVVLLELL-MGRRPVEKMSPTQ 361
           AFGV++ E+  +G+ P E+ + ++
Sbjct: 197 AFGVLMWEIYSLGKMPYERFTNSE 220

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 100/200 (50%), Gaps = 9/200 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           +G+G  G V+   +N     A+K +   G  +   F  E   + K+RH+ ++ L    + 
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 73
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
            E   +V E M  GSL   L G T G  L     + +A  +A G+ Y+ E  N+  VHRD
Sbjct: 74  EEPIXIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYV-ERMNY--VHRD 129
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
           L+++NIL+  +   K++DFGL+          +      + + APE  L G+ T KSDV+
Sbjct: 130 LRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVW 189
Query: 339 AFGVVLLELLM-GRRPVEKM 357
           +FG++L EL   GR P   M
Sbjct: 190 SFGILLTELTTKGRVPYPGM 209

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 106/210 (50%), Gaps = 9/210 (4%)
Query: 161 IGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCI 219
           +G G  G VY+  + +  L  AVK + +   + E EF  E   + +I+H N++ LLG C 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 220 HAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHR 279
                +++ E M  G+L   L    +   ++  + + +A  ++  +EYL        +HR
Sbjct: 78  REPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHR 133
Query: 280 DLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDV 337
           DL + N L+  +   K++DFGLS  +T  T + +      + + APE L   K + KSDV
Sbjct: 134 DLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESLAYNKFSIKSDV 193
Query: 338 YAFGVVLLEL-LMGRRPVEKMSPTQCQSMV 366
           +AFGV+L E+   G  P   + P+Q   ++
Sbjct: 194 WAFGVLLWEIATYGMSPYPGIDPSQVYELL 223

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 100/200 (50%), Gaps = 9/200 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           +G+G  G V+   +N     A+K +   G  +   F  E   + K+RH+ ++ L    + 
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 72
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
            E  ++V E M  GSL   L G   G  L     + +A  +A G+ Y+ E  N+  VHRD
Sbjct: 73  EEPIYIVTEYMSKGSLLDFLKG-EMGKYLRLPQLVDMAAQIASGMAYV-ERMNY--VHRD 128
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
           L+++NIL+  +   K++DFGL+          +      + + APE  L G+ T KSDV+
Sbjct: 129 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 188
Query: 339 AFGVVLLELLM-GRRPVEKM 357
           +FG++L EL   GR P   M
Sbjct: 189 SFGILLTELTTKGRVPYPGM 208

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 123/272 (45%), Gaps = 43/272 (15%)
Query: 160 VIGEGGRGHVYKARFN----EKLLAAVKRIDDAGHDAER-EFNNEVNWLTKIRHQNIISL 214
           VIG G  G V   R       ++  A+K +     D +R +F +E + + +  H NII L
Sbjct: 36  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 95
Query: 215 LGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNH 274
            G     +   ++ E M+NGSL+  L    +    T    + +   +  G++YL +    
Sbjct: 96  EGVVTKCKPVMIITEYMENGSLDAFLR--KNDGRFTVIQLVGMLRGIGSGMKYLSDMS-- 151
Query: 275 PVVHRDLKSSNILLDSSFNAKLSDFGLSVT------AGTQSRNVKISGTLGYVAPEYLLE 328
             VHRDL + NIL++S+   K+SDFG+S        A   +R  KI   + + APE +  
Sbjct: 152 -AVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIP--IRWTAPEAIAY 208
Query: 329 GKLTDKSDVYAFGVVLLELL-MGRRPVEKMS----------------PTQC-----QSMV 366
            K T  SDV+++G+V+ E++  G RP   MS                P  C     Q M+
Sbjct: 209 RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPPPMDCPIALHQLML 268
Query: 367 TWAMPQLTDRSKLPNIV---DPVIRDTMDLKH 395
                + +DR K   IV   D +IR+   LK 
Sbjct: 269 DCWQKERSDRPKFGQIVNMLDKLIRNPNSLKR 300

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 101/200 (50%), Gaps = 9/200 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           +G+G  G V+   +N     A+K +   G  +   F  E   + K+RH+ ++ L    + 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 249
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
            E  ++V E M  GSL   L G T G  L     + +A  +A G+ Y+ E  N+  VHRD
Sbjct: 250 EEPIYIVGEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYV-ERMNY--VHRD 305
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
           L+++NIL+  +   K++DFGL+          +      + + APE  L G+ T KSDV+
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365
Query: 339 AFGVVLLELLM-GRRPVEKM 357
           +FG++L EL   GR P   M
Sbjct: 366 SFGILLTELTTKGRVPYPGM 385

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 100/200 (50%), Gaps = 9/200 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           +G+G  G V+   +N     A+K +   G  +   F  E   + K+RH+ ++ L    + 
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 74
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
            E  ++V E M  GSL   L G   G  L     + +A  +A G+ Y+ E  N+  VHRD
Sbjct: 75  EEPIYIVTEYMSKGSLLDFLKG-EMGKYLRLPQLVDMAAQIASGMAYV-ERMNY--VHRD 130
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
           L+++NIL+  +   K++DFGL+          +      + + APE  L G+ T KSDV+
Sbjct: 131 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 190
Query: 339 AFGVVLLELLM-GRRPVEKM 357
           +FG++L EL   GR P   M
Sbjct: 191 SFGILLTELTTKGRVPYPGM 210

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 101/200 (50%), Gaps = 9/200 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           +G+G  G V+   +N     A+K +   G  +   F  E   + K+RH+ ++ L    + 
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 332
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
            E  ++V E M  GSL   L G T G  L     + +A  +A G+ Y+ E  N+  VHRD
Sbjct: 333 EEPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYV-ERMNY--VHRD 388
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
           L+++NIL+  +   K++DFGL+          +      + + APE  L G+ T KSDV+
Sbjct: 389 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 448
Query: 339 AFGVVLLELLM-GRRPVEKM 357
           +FG++L EL   GR P   M
Sbjct: 449 SFGILLTELTTKGRVPYPGM 468

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/237 (30%), Positives = 114/237 (48%), Gaps = 21/237 (8%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLTKI 206
           ++F     +G+G  G+VY AR  + K + A+K     +++  G   E +   E+   + +
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEG--VEHQLRREIEIQSHL 72
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
           RH NI+ +  Y    +  +L+ E    G L K+L    HG             ++A  L 
Sbjct: 73  RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQ--KHG-RFDEQRSATFMEELADALH 129
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYL 326
           Y HE     V+HRD+K  N+L+      K++DFG SV A +  R   + GTL Y+ PE +
Sbjct: 130 YCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRX-MCGTLDYLPPE-M 184
Query: 327 LEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWA----MPQLTDRSK 378
           +EGK  D K D++  GV+  E L+G  P +  S T+    +        P L+D SK
Sbjct: 185 IEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSK 241

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 100/200 (50%), Gaps = 9/200 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           +G+G  G V+   +N     A+K +   G  +   F  E   + K+RH+ ++ L    + 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 83
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
            E  ++V E M  GSL   L G   G  L     + +A  +A G+ Y+ E  N+  VHRD
Sbjct: 84  EEPIYIVIEYMSKGSLLDFLKG-EMGKYLRLPQLVDMAAQIASGMAYV-ERMNY--VHRD 139
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
           L+++NIL+  +   K++DFGL+          +      + + APE  L G+ T KSDV+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 339 AFGVVLLELLM-GRRPVEKM 357
           +FG++L EL   GR P   M
Sbjct: 200 SFGILLTELTTKGRVPYPGM 219

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 100/200 (50%), Gaps = 9/200 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           +G+G  G V+   +N     A+K +   G  +   F  E   + K+RH+ ++ L    + 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 83
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
            E  ++V E M  GSL   L G   G  L     + +A  +A G+ Y+ E  N+  VHRD
Sbjct: 84  EEPIYIVIEYMSKGSLLDFLKG-EMGKYLRLPQLVDMAAQIASGMAYV-ERMNY--VHRD 139
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
           L+++NIL+  +   K++DFGL+          +      + + APE  L G+ T KSDV+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 339 AFGVVLLELLM-GRRPVEKM 357
           +FG++L EL   GR P   M
Sbjct: 200 SFGILLTELTTKGRVPYPGM 219

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 123/272 (45%), Gaps = 43/272 (15%)
Query: 160 VIGEGGRGHVYKARFN----EKLLAAVKRIDDAGHDAER-EFNNEVNWLTKIRHQNIISL 214
           VIG G  G V   R       ++  A+K +     D +R +F +E + + +  H NII L
Sbjct: 15  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 74
Query: 215 LGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNH 274
            G     +   ++ E M+NGSL+  L    +    T    + +   +  G++YL    + 
Sbjct: 75  EGVVTKCKPVMIITEYMENGSLDAFLR--KNDGRFTVIQLVGMLRGIGSGMKYLS---DM 129
Query: 275 PVVHRDLKSSNILLDSSFNAKLSDFGLSVT------AGTQSRNVKISGTLGYVAPEYLLE 328
             VHRDL + NIL++S+   K+SDFG+S        A   +R  KI   + + APE +  
Sbjct: 130 SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIP--IRWTAPEAIAY 187
Query: 329 GKLTDKSDVYAFGVVLLELL-MGRRPVEKMS----------------PTQC-----QSMV 366
            K T  SDV+++G+V+ E++  G RP   MS                P  C     Q M+
Sbjct: 188 RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPPPMDCPIALHQLML 247
Query: 367 TWAMPQLTDRSKLPNIV---DPVIRDTMDLKH 395
                + +DR K   IV   D +IR+   LK 
Sbjct: 248 DCWQKERSDRPKFGQIVNMLDKLIRNPNSLKR 279

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 114/219 (52%), Gaps = 17/219 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKI 206
              +   V+G G  G VYK  +       K+  A+K +++  G  A  EF +E   +  +
Sbjct: 15  TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM 74
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
            H +++ LLG C+ + T  LV ++M +G L + +H   H  N+   L +   V +A+G+ 
Sbjct: 75  DHPHLVRLLGVCL-SPTIQLVTQLMPHGCLLEYVH--EHKDNIGSQLLLNWCVQIAKGMM 131
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAP 323
           YL E     +VHRDL + N+L+ S  + K++DFGL+       +     G    + ++A 
Sbjct: 132 YLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMAL 188
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQ 361
           E +   K T +SDV+++GV + EL+  G +P + + PT+
Sbjct: 189 ECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI-PTR 226

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 122/271 (45%), Gaps = 41/271 (15%)
Query: 160 VIGEGGRGHVYKARFN----EKLLAAVKRIDDAGHDAER-EFNNEVNWLTKIRHQNIISL 214
           VIG G  G V + R      ++   A+K +     + +R EF +E + + +  H NII L
Sbjct: 23  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 82
Query: 215 LGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNH 274
            G   ++    ++ E M+NG+L+  L    +    T    + +   +A G+ YL E    
Sbjct: 83  EGVVTNSMPVMILTEFMENGALDSFLR--LNDGQFTVIQLVGMLRGIASGMRYLAEMS-- 138
Query: 275 PVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLG------YVAPEYLLE 328
             VHRDL + NIL++S+   K+SDFGLS      S +   + +LG      + APE +  
Sbjct: 139 -YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAF 197
Query: 329 GKLTDKSDVYAFGVVLLELL-MGRRPVEKMS----------------PTQC-----QSMV 366
            K T  SD +++G+V+ E++  G RP   MS                P  C     Q M+
Sbjct: 198 RKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPPPPDCPTSLHQLML 257
Query: 367 TWAMPQLTDRSKLPNIV---DPVIRDTMDLK 394
                    R + P +V   D +IR+   LK
Sbjct: 258 DCWQKDRNARPRFPQVVSALDKMIRNPASLK 288

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 123/272 (45%), Gaps = 43/272 (15%)
Query: 160 VIGEGGRGHVYKARFN----EKLLAAVKRIDDAGHDAER-EFNNEVNWLTKIRHQNIISL 214
           VIG G  G V   R       ++  A+K +     D +R +F +E + + +  H NII L
Sbjct: 21  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 80
Query: 215 LGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNH 274
            G     +   ++ E M+NGSL+  L    +    T    + +   +  G++YL    + 
Sbjct: 81  EGVVTKCKPVMIITEYMENGSLDAFLR--KNDGRFTVIQLVGMLRGIGSGMKYLS---DM 135
Query: 275 PVVHRDLKSSNILLDSSFNAKLSDFGLSVT------AGTQSRNVKISGTLGYVAPEYLLE 328
             VHRDL + NIL++S+   K+SDFG+S        A   +R  KI   + + APE +  
Sbjct: 136 SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIP--IRWTAPEAIAY 193
Query: 329 GKLTDKSDVYAFGVVLLELL-MGRRPVEKMS----------------PTQC-----QSMV 366
            K T  SDV+++G+V+ E++  G RP   MS                P  C     Q M+
Sbjct: 194 RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPPPMDCPIALHQLML 253
Query: 367 TWAMPQLTDRSKLPNIV---DPVIRDTMDLKH 395
                + +DR K   IV   D +IR+   LK 
Sbjct: 254 DCWQKERSDRPKFGQIVNMLDKLIRNPNSLKR 285

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 100/200 (50%), Gaps = 9/200 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           +G+G  G V+   +N     A+K +   G  +   F  E   + K+RH+ ++ L    + 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 83
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
            E  ++V E M  GSL   L G   G  L     + +A  +A G+ Y+ E  N+  VHRD
Sbjct: 84  EEPIYIVCEYMSKGSLLDFLKG-EMGKYLRLPQLVDMAAQIASGMAYV-ERMNY--VHRD 139
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
           L+++NIL+  +   K++DFGL+          +      + + APE  L G+ T KSDV+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 339 AFGVVLLELLM-GRRPVEKM 357
           +FG++L EL   GR P   M
Sbjct: 200 SFGILLTELTTKGRVPYPGM 219

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 112/242 (46%), Gaps = 35/242 (14%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKAR------FNEKLLAAVKRI-DDAGHDAEREFNNEVN 201
           E   NN +    IGEG  G V++AR      +    + AVK + ++A  D + +F  E  
Sbjct: 43  EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102
Query: 202 WLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPT-------HGSNLTWHLR 254
            + +  + NI+ LLG C   +   L++E M  G L + L   +         S+L+   R
Sbjct: 103 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162
Query: 255 MK--------------IAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFG 300
           +               IA  VA G+ YL E      VHRDL + N L+  +   K++DFG
Sbjct: 163 VSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFG 219
Query: 301 LS---VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEK 356
           LS    +A     +   +  + ++ PE +   + T +SDV+A+GVVL E+   G +P   
Sbjct: 220 LSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279
Query: 357 MS 358
           M+
Sbjct: 280 MA 281

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 100/200 (50%), Gaps = 9/200 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           +G+G  G V+   +N     A+K +   G  +   F  E   + K+RH+ ++ L    + 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 83
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
            E  ++V E M  GSL   L G   G  L     + +A  +A G+ Y+ E  N+  VHRD
Sbjct: 84  EEPIYIVTEYMSKGSLLDFLKG-EMGKYLRLPQLVDMAAQIASGMAYV-ERMNY--VHRD 139
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
           L+++NIL+  +   K++DFGL+          +      + + APE  L G+ T KSDV+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 339 AFGVVLLELLM-GRRPVEKM 357
           +FG++L EL   GR P   M
Sbjct: 200 SFGILLTELTTKGRVPYPGM 219

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 98/199 (49%), Gaps = 16/199 (8%)
Query: 161 IGEGGRGHVYKARF-----NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLL 215
           +G+G  G V   R+     N   + AVK++  +  +  R+F  E+  L  ++H NI+   
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 216 GYCIHAETR--FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
           G C  A  R   L+ E +  GSL + L    H   +     ++    + +G+EYL     
Sbjct: 81  GVCYSAGRRNLKLIMEFLPYGSLREYLQ--KHKERIDHIKLLQYTSQICKGMEYL---GT 135
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGT--LGYVAPEYLLEG 329
              +HRDL + NIL+++    K+ DFGL+  +    +   VK  G   + + APE L E 
Sbjct: 136 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 195
Query: 330 KLTDKSDVYAFGVVLLELL 348
           K +  SDV++FGVVL EL 
Sbjct: 196 KFSVASDVWSFGVVLYELF 214

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/242 (30%), Positives = 127/242 (52%), Gaps = 34/242 (14%)
Query: 161 IGEGGRGHVYKAR---FNEKLLAAVKRIDDAGHDAE---REFNNEVNWLTKIRHQNIISL 214
           +G GG   VY A     N K+  A+K I     + E   + F  EV+  +++ HQNI+S+
Sbjct: 19  LGGGGMSTVYLAEDTILNIKV--AIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 215 LGYCIHAETRFLVYEMMQNGSLEKQL--HGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
           +      +  +LV E ++  +L + +  HGP     L+    +     +  G+++ H   
Sbjct: 77  IDVDEEDDCYYLVMEYIEGPTLSEYIESHGP-----LSVDTAINFTNQILDGIKHAH--- 128
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFG----LSVTAGTQSRNVKISGTLGYVAPEYLLE 328
           +  +VHRD+K  NIL+DS+   K+ DFG    LS T+ TQ+ +V   GT+ Y +PE   +
Sbjct: 129 DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHV--LGTVQYFSPEQ-AK 185
Query: 329 GKLTDK-SDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVI 387
           G+ TD+ +D+Y+ G+VL E+L+G  P         ++ V+ A+  + D   +PN+   V 
Sbjct: 186 GEATDECTDIYSIGIVLYEMLVGEPPF------NGETAVSIAIKHIQD--SVPNVTTDVR 237
Query: 388 RD 389
           +D
Sbjct: 238 KD 239

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/201 (32%), Positives = 101/201 (50%), Gaps = 11/201 (5%)
Query: 159 NVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYC 218
             IG+G  G V    +    +A     +DA   A   F  E + +T++RH N++ LLG  
Sbjct: 18  QTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVI 74
Query: 219 IHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVV 277
           +  +   ++V E M  GSL   L      S L     +K ++DV   +EYL     +  V
Sbjct: 75  VEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLE---GNNFV 130
Query: 278 HRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDV 337
           HRDL + N+L+     AK+SDFGL+  A +     K+   + + APE L E   + KSDV
Sbjct: 131 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP--VKWTAPEALREAAFSTKSDV 188
Query: 338 YAFGVVLLELL-MGRRPVEKM 357
           ++FG++L E+   GR P  ++
Sbjct: 189 WSFGILLWEIYSFGRVPYPRI 209

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 108/222 (48%), Gaps = 17/222 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLTKI 206
           ++F     +G+G  G+VY AR  + K + A+K     +++  G   E +   E+   + +
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEG--VEHQLRREIEIQSHL 71
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
           RH NI+ +  Y    +  +L+ E    G L K+L    HG             ++A  L 
Sbjct: 72  RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQ--KHG-RFDEQRSATFMEELADALH 128
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYL 326
           Y HE     V+HRD+K  N+L+      K++DFG SV A +  R   + GTL Y+ PE +
Sbjct: 129 YCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRX-MCGTLDYLPPE-M 183
Query: 327 LEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVT 367
           +EGK  D K D++  GV+  E L+G  P +  S T+    + 
Sbjct: 184 IEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV 225

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 97/199 (48%), Gaps = 16/199 (8%)
Query: 161 IGEGGRGHVYKARF-----NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLL 215
           +G+G  G V   R+     N   + AVK++  +  +  R+F  E+  L  ++H NI+   
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 216 GYCIHAETR--FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
           G C  A  R   L+ E +  GSL   L    H   +     ++    + +G+EYL     
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYLQA--HAERIDHIKLLQYTSQICKGMEYL---GT 135
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGT--LGYVAPEYLLEG 329
              +HRDL + NIL+++    K+ DFGL+  +    +   VK  G   + + APE L E 
Sbjct: 136 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 195
Query: 330 KLTDKSDVYAFGVVLLELL 348
           K +  SDV++FGVVL EL 
Sbjct: 196 KFSVASDVWSFGVVLYELF 214

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/229 (31%), Positives = 113/229 (49%), Gaps = 20/229 (8%)
Query: 138 DTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARF----NEKLLAAVK---RIDDAGH 190
           + V  +++ ++  ++     + VIG G  G VY         +K+  AVK   RI D G 
Sbjct: 14  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 73
Query: 191 DAEREFNNEVNWLTKIRHQNIISLLGYCIHAE-TRFLVYEMMQNGSLEKQLHGPTHGSNL 249
            ++  F  E   +    H N++SLLG C+ +E +  +V   M++G L   +   TH  N 
Sbjct: 74  VSQ--FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NP 129
Query: 250 TWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS---VTAG 306
           T    +   + VA+G++YL    +   VHRDL + N +LD  F  K++DFGL+       
Sbjct: 130 TVKDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 186
Query: 307 TQSRNVKISGTL--GYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
             S + K    L   ++A E L   K T KSDV++FGV+L EL+    P
Sbjct: 187 XXSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 102/212 (48%), Gaps = 25/212 (11%)
Query: 154 NFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNII 212
           +F+E  +IG GG G V+KA+   +     +KR+      AERE    V  L K+ H NI+
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE----VKALAKLDHVNIV 67
Query: 213 SL----LGYCIHAETR------------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMK 256
                  G+    ET             F+  E    G+LE+ +     G  L   L ++
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE-KRRGEKLDKVLALE 126
Query: 257 IAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG 316
           +   + +G++Y+H   +  +++RDLK SNI L  +   K+ DFGL  +     +  +  G
Sbjct: 127 LFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRSKG 183
Query: 317 TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELL 348
           TL Y++PE +       + D+YA G++L ELL
Sbjct: 184 TLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/229 (31%), Positives = 114/229 (49%), Gaps = 20/229 (8%)
Query: 138 DTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARF----NEKLLAAVK---RIDDAGH 190
           + V  +++ ++  ++     + VIG G  G VY         +K+  AVK   RI D G 
Sbjct: 7   ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 66
Query: 191 DAEREFNNEVNWLTKIRHQNIISLLGYCIHAE-TRFLVYEMMQNGSLEKQLHGPTHGSNL 249
            ++  F  E   +    H N++SLLG C+ +E +  +V   M++G L   +   TH  N 
Sbjct: 67  VSQ--FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NP 122
Query: 250 TWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ- 308
           T    +   + VA+G++YL    +   VHRDL + N +LD  F  K++DFGL+     + 
Sbjct: 123 TVKDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 179
Query: 309 --SRNVKISGTL--GYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
             S + K    L   ++A E L   K T KSDV++FGV+L EL+    P
Sbjct: 180 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 228

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/229 (31%), Positives = 114/229 (49%), Gaps = 20/229 (8%)
Query: 138 DTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARF----NEKLLAAVK---RIDDAGH 190
           + V  +++ ++  ++     + VIG G  G VY         +K+  AVK   RI D G 
Sbjct: 12  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 71
Query: 191 DAEREFNNEVNWLTKIRHQNIISLLGYCIHAE-TRFLVYEMMQNGSLEKQLHGPTHGSNL 249
            ++  F  E   +    H N++SLLG C+ +E +  +V   M++G L   +   TH  N 
Sbjct: 72  VSQ--FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NP 127
Query: 250 TWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ- 308
           T    +   + VA+G++YL    +   VHRDL + N +LD  F  K++DFGL+     + 
Sbjct: 128 TVKDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184
Query: 309 --SRNVKISGTL--GYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
             S + K    L   ++A E L   K T KSDV++FGV+L EL+    P
Sbjct: 185 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 233

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 100/200 (50%), Gaps = 9/200 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           +G+G  G V+   +N     A+K +   G+ +   F  E   + K+RH+ ++ L    + 
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGNMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 250
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
            E  ++V E M  GSL   L G   G  L     + +A  +A G+ Y+ E  N+  VHRD
Sbjct: 251 EEPIYIVTEYMSKGSLLDFLKG-EMGKYLRLPQLVDMAAQIASGMAYV-ERMNY--VHRD 306
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
           L+++NIL+  +   K++DFGL           +      + + APE  L G+ T KSDV+
Sbjct: 307 LRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 366
Query: 339 AFGVVLLELLM-GRRPVEKM 357
           +FG++L EL   GR P   M
Sbjct: 367 SFGILLTELTTKGRVPYPGM 386

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/229 (31%), Positives = 114/229 (49%), Gaps = 20/229 (8%)
Query: 138 DTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARF----NEKLLAAVK---RIDDAGH 190
           + V  +++ ++  ++     + VIG G  G VY         +K+  AVK   RI D G 
Sbjct: 15  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 74
Query: 191 DAEREFNNEVNWLTKIRHQNIISLLGYCIHAE-TRFLVYEMMQNGSLEKQLHGPTHGSNL 249
            ++  F  E   +    H N++SLLG C+ +E +  +V   M++G L   +   TH  N 
Sbjct: 75  VSQ--FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NP 130
Query: 250 TWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ- 308
           T    +   + VA+G++YL    +   VHRDL + N +LD  F  K++DFGL+     + 
Sbjct: 131 TVKDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 187
Query: 309 --SRNVKISGTL--GYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
             S + K    L   ++A E L   K T KSDV++FGV+L EL+    P
Sbjct: 188 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 94/199 (47%), Gaps = 16/199 (8%)
Query: 161 IGEGGRGHVYKARF-----NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLL 215
           +G+G  G V   R+     N   + AVK++  +  +  R+F  E+  L  ++H NI+   
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 216 GYCIHAETR--FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
           G C  A  R   L+ E +  GSL   L    H   +     ++    + +G+EYL     
Sbjct: 82  GVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYL---GT 136
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKI----SGTLGYVAPEYLLEG 329
              +HRDL + NIL+++    K+ DFGL+          K+       + + APE L E 
Sbjct: 137 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 196
Query: 330 KLTDKSDVYAFGVVLLELL 348
           K +  SDV++FGVVL EL 
Sbjct: 197 KFSVASDVWSFGVVLYELF 215

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 97/199 (48%), Gaps = 16/199 (8%)
Query: 161 IGEGGRGHVYKARF-----NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLL 215
           +G+G  G V   R+     N   + AVK++  +  +  R+F  E+  L  ++H NI+   
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 216 GYCIHAETR--FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
           G C  A  R   L+ E +  GSL   L    H   +     ++    + +G+EYL     
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYL---GT 163
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGT--LGYVAPEYLLEG 329
              +HRDL + NIL+++    K+ DFGL+  +    +   VK  G   + + APE L E 
Sbjct: 164 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 223
Query: 330 KLTDKSDVYAFGVVLLELL 348
           K +  SDV++FGVVL EL 
Sbjct: 224 KFSVASDVWSFGVVLYELF 242

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 94/199 (47%), Gaps = 16/199 (8%)
Query: 161 IGEGGRGHVYKARF-----NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLL 215
           +G+G  G V   R+     N   + AVK++  +  +  R+F  E+  L  ++H NI+   
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 216 GYCIHAETR--FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
           G C  A  R   L+ E +  GSL   L    H   +     ++    + +G+EYL     
Sbjct: 77  GVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYL---GT 131
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKI----SGTLGYVAPEYLLEG 329
              +HRDL + NIL+++    K+ DFGL+          K+       + + APE L E 
Sbjct: 132 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 191
Query: 330 KLTDKSDVYAFGVVLLELL 348
           K +  SDV++FGVVL EL 
Sbjct: 192 KFSVASDVWSFGVVLYELF 210

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 97/199 (48%), Gaps = 16/199 (8%)
Query: 161 IGEGGRGHVYKARF-----NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLL 215
           +G+G  G V   R+     N   + AVK++  +  +  R+F  E+  L  ++H NI+   
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 216 GYCIHAETR--FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
           G C  A  R   L+ E +  GSL   L    H   +     ++    + +G+EYL     
Sbjct: 76  GVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYL---GT 130
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGT--LGYVAPEYLLEG 329
              +HRDL + NIL+++    K+ DFGL+  +    +   VK  G   + + APE L E 
Sbjct: 131 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 190
Query: 330 KLTDKSDVYAFGVVLLELL 348
           K +  SDV++FGVVL EL 
Sbjct: 191 KFSVASDVWSFGVVLYELF 209

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 72/229 (31%), Positives = 114/229 (49%), Gaps = 20/229 (8%)
Query: 138 DTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARF----NEKLLAAVK---RIDDAGH 190
           + V  +++ ++  ++     + VIG G  G VY         +K+  AVK   RI D G 
Sbjct: 15  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 74
Query: 191 DAEREFNNEVNWLTKIRHQNIISLLGYCIHAE-TRFLVYEMMQNGSLEKQLHGPTHGSNL 249
            ++  F  E   +    H N++SLLG C+ +E +  +V   M++G L   +   TH  N 
Sbjct: 75  VSQ--FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NP 130
Query: 250 TWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ- 308
           T    +   + VA+G++YL    +   VHRDL + N +LD  F  K++DFGL+     + 
Sbjct: 131 TVKDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 187
Query: 309 --SRNVKISGTL--GYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
             S + K    L   ++A E L   K T KSDV++FGV+L EL+    P
Sbjct: 188 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 9/200 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           +G+G  G V+   +N     A+K +   G  +   F  E   + K+RH+ ++ L    + 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 83
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
            E  ++V E M  GSL   L G   G  L     + +A  +A G+ Y+ E  N+  VHRD
Sbjct: 84  EEPIYIVTEYMSKGSLLDFLKG-EMGKYLRLPQLVDMAAQIASGMAYV-ERMNY--VHRD 139
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
           L ++NIL+  +   K++DFGL+          +      + + APE  L G+ T KSDV+
Sbjct: 140 LAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 339 AFGVVLLELLM-GRRPVEKM 357
           +FG++L EL   GR P   M
Sbjct: 200 SFGILLTELTTKGRVPYPGM 219

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 72/229 (31%), Positives = 114/229 (49%), Gaps = 20/229 (8%)
Query: 138 DTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARF----NEKLLAAVK---RIDDAGH 190
           + V  +++ ++  ++     + VIG G  G VY         +K+  AVK   RI D G 
Sbjct: 13  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 72
Query: 191 DAEREFNNEVNWLTKIRHQNIISLLGYCIHAE-TRFLVYEMMQNGSLEKQLHGPTHGSNL 249
            ++  F  E   +    H N++SLLG C+ +E +  +V   M++G L   +   TH  N 
Sbjct: 73  VSQ--FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NP 128
Query: 250 TWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ- 308
           T    +   + VA+G++YL    +   VHRDL + N +LD  F  K++DFGL+     + 
Sbjct: 129 TVKDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 185
Query: 309 --SRNVKISGTL--GYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
             S + K    L   ++A E L   K T KSDV++FGV+L EL+    P
Sbjct: 186 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 97/199 (48%), Gaps = 16/199 (8%)
Query: 161 IGEGGRGHVYKARF-----NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLL 215
           +G+G  G V   R+     N   + AVK++  +  +  R+F  E+  L  ++H NI+   
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 216 GYCIHAETR--FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
           G C  A  R   L+ E +  GSL   L    H   +     ++    + +G+EYL     
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYL---GT 132
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGT--LGYVAPEYLLEG 329
              +HRDL + NIL+++    K+ DFGL+  +    +   VK  G   + + APE L E 
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 192
Query: 330 KLTDKSDVYAFGVVLLELL 348
           K +  SDV++FGVVL EL 
Sbjct: 193 KFSVASDVWSFGVVLYELF 211

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 72/229 (31%), Positives = 114/229 (49%), Gaps = 20/229 (8%)
Query: 138 DTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARF----NEKLLAAVK---RIDDAGH 190
           + V  +++ ++  ++     + VIG G  G VY         +K+  AVK   RI D G 
Sbjct: 14  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 73
Query: 191 DAEREFNNEVNWLTKIRHQNIISLLGYCIHAE-TRFLVYEMMQNGSLEKQLHGPTHGSNL 249
            ++  F  E   +    H N++SLLG C+ +E +  +V   M++G L   +   TH  N 
Sbjct: 74  VSQ--FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NP 129
Query: 250 TWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ- 308
           T    +   + VA+G++YL    +   VHRDL + N +LD  F  K++DFGL+     + 
Sbjct: 130 TVKDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 186
Query: 309 --SRNVKISGTL--GYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
             S + K    L   ++A E L   K T KSDV++FGV+L EL+    P
Sbjct: 187 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 72/229 (31%), Positives = 114/229 (49%), Gaps = 20/229 (8%)
Query: 138 DTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARF----NEKLLAAVK---RIDDAGH 190
           + V  +++ ++  ++     + VIG G  G VY         +K+  AVK   RI D G 
Sbjct: 10  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 69
Query: 191 DAEREFNNEVNWLTKIRHQNIISLLGYCIHAE-TRFLVYEMMQNGSLEKQLHGPTHGSNL 249
            ++  F  E   +    H N++SLLG C+ +E +  +V   M++G L   +   TH  N 
Sbjct: 70  VSQ--FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NP 125
Query: 250 TWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ- 308
           T    +   + VA+G++YL    +   VHRDL + N +LD  F  K++DFGL+     + 
Sbjct: 126 TVKDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 182
Query: 309 --SRNVKISGTL--GYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
             S + K    L   ++A E L   K T KSDV++FGV+L EL+    P
Sbjct: 183 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 231

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 97/199 (48%), Gaps = 16/199 (8%)
Query: 161 IGEGGRGHVYKARF-----NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLL 215
           +G+G  G V   R+     N   + AVK++  +  +  R+F  E+  L  ++H NI+   
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 216 GYCIHAETR--FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
           G C  A  R   L+ E +  GSL   L    H   +     ++    + +G+EYL     
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYL---GT 132
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGT--LGYVAPEYLLEG 329
              +HRDL + NIL+++    K+ DFGL+  +    +   VK  G   + + APE L E 
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 192
Query: 330 KLTDKSDVYAFGVVLLELL 348
           K +  SDV++FGVVL EL 
Sbjct: 193 KFSVASDVWSFGVVLYELF 211

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 97/199 (48%), Gaps = 16/199 (8%)
Query: 161 IGEGGRGHVYKARF-----NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLL 215
           +G+G  G V   R+     N   + AVK++  +  +  R+F  E+  L  ++H NI+   
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 216 GYCIHAETR--FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
           G C  A  R   L+ E +  GSL   L    H   +     ++    + +G+EYL     
Sbjct: 85  GVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYL---GT 139
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGT--LGYVAPEYLLEG 329
              +HRDL + NIL+++    K+ DFGL+  +    +   VK  G   + + APE L E 
Sbjct: 140 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 199
Query: 330 KLTDKSDVYAFGVVLLELL 348
           K +  SDV++FGVVL EL 
Sbjct: 200 KFSVASDVWSFGVVLYELF 218

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 104/206 (50%), Gaps = 8/206 (3%)
Query: 145 YELLEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWL 203
           Y+  E    +    + +G G  G VY+  + +  L  AVK + +   + E EF  E   +
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVM 63
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
            +I+H N++ LLG C      +++ E M  G+L   L    +   ++  + + +A  ++ 
Sbjct: 64  KEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISS 122
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYV 321
            +EYL +      +HRDL + N L+  +   K++DFGLS  +T  T + +      + + 
Sbjct: 123 AMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 179
Query: 322 APEYLLEGKLTDKSDVYAFGVVLLEL 347
           APE L   K + KSDV+AFGV+L E+
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEI 205

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 97/199 (48%), Gaps = 16/199 (8%)
Query: 161 IGEGGRGHVYKARF-----NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLL 215
           +G+G  G V   R+     N   + AVK++  +  +  R+F  E+  L  ++H NI+   
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 216 GYCIHAETR--FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
           G C  A  R   L+ E +  GSL   L    H   +     ++    + +G+EYL     
Sbjct: 83  GVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYL---GT 137
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGT--LGYVAPEYLLEG 329
              +HRDL + NIL+++    K+ DFGL+  +    +   VK  G   + + APE L E 
Sbjct: 138 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 197
Query: 330 KLTDKSDVYAFGVVLLELL 348
           K +  SDV++FGVVL EL 
Sbjct: 198 KFSVASDVWSFGVVLYELF 216

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 97/199 (48%), Gaps = 16/199 (8%)
Query: 161 IGEGGRGHVYKARF-----NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLL 215
           +G+G  G V   R+     N   + AVK++  +  +  R+F  E+  L  ++H NI+   
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 216 GYCIHAETR--FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
           G C  A  R   L+ E +  GSL   L    H   +     ++    + +G+EYL     
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYL---GT 150
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGT--LGYVAPEYLLEG 329
              +HRDL + NIL+++    K+ DFGL+  +    +   VK  G   + + APE L E 
Sbjct: 151 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 210
Query: 330 KLTDKSDVYAFGVVLLELL 348
           K +  SDV++FGVVL EL 
Sbjct: 211 KFSVASDVWSFGVVLYELF 229

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 99/200 (49%), Gaps = 9/200 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           +G+G  G V+   +N     A+K +   G  +   F  E   + K+RH+ ++ L    + 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 83
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
            E  ++V E M  G L   L G   G  L     + +A  +A G+ Y+ E  N+  VHRD
Sbjct: 84  EEPIYIVMEYMSKGCLLDFLKG-EMGKYLRLPQLVDMAAQIASGMAYV-ERMNY--VHRD 139
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
           L+++NIL+  +   K++DFGL+          +      + + APE  L G+ T KSDV+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 339 AFGVVLLELLM-GRRPVEKM 357
           +FG++L EL   GR P   M
Sbjct: 200 SFGILLTELTTKGRVPYPGM 219

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 114/240 (47%), Gaps = 25/240 (10%)
Query: 161 IGEGGRGHVYKARF-----NEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNIISL 214
           +GEG  G V   R+     N     AVK +  ++G +   +   E+  L  + H+NI+  
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 215 LGYCIH--AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
            G C         L+ E + +GSL++ L  P + + +    ++K AV + +G++YL    
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLG--- 131
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKI----SGTLGYVAPEYLLE 328
           +   VHRDL + N+L++S    K+ DFGL+    T      +       + + APE L++
Sbjct: 132 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQ 191
Query: 329 GKLTDKSDVYAFGVVLLELLM----GRRP----VEKMSPTQCQSMVTWAMPQLTDRSKLP 380
            K    SDV++FGV L ELL        P    ++ + PT  Q  VT  +  L +  +LP
Sbjct: 192 SKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLP 251

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 97/199 (48%), Gaps = 16/199 (8%)
Query: 161 IGEGGRGHVYKARF-----NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLL 215
           +G+G  G V   R+     N   + AVK++  +  +  R+F  E+  L  ++H NI+   
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 216 GYCIHAETR--FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
           G C  A  R   L+ E +  GSL   L    H   +     ++    + +G+EYL     
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYL---GT 135
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGT--LGYVAPEYLLEG 329
              +HRDL + NIL+++    K+ DFGL+  +    +   VK  G   + + APE L E 
Sbjct: 136 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 195
Query: 330 KLTDKSDVYAFGVVLLELL 348
           K +  SDV++FGVVL EL 
Sbjct: 196 KFSVASDVWSFGVVLYELF 214

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 103/206 (50%), Gaps = 8/206 (3%)
Query: 145 YELLEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWL 203
           Y+  E    +    + +G G  G VY+  + +  L  AVK + +   + E EF  E   +
Sbjct: 6   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVM 64
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
            +I+H N++ LLG C      +++ E M  G+L   L    +   +   + + +A  ++ 
Sbjct: 65  KEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISS 123
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYV 321
            +EYL +      +HRDL + N L+  +   K++DFGLS  +T  T + +      + + 
Sbjct: 124 AMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWT 180
Query: 322 APEYLLEGKLTDKSDVYAFGVVLLEL 347
           APE L   K + KSDV+AFGV+L E+
Sbjct: 181 APESLAYNKFSIKSDVWAFGVLLWEI 206

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 97/199 (48%), Gaps = 16/199 (8%)
Query: 161 IGEGGRGHVYKARF-----NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLL 215
           +G+G  G V   R+     N   + AVK++  +  +  R+F  E+  L  ++H NI+   
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 216 GYCIHAETR--FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
           G C  A  R   L+ E +  GSL   L    H   +     ++    + +G+EYL     
Sbjct: 84  GVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYL---GT 138
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGT--LGYVAPEYLLEG 329
              +HRDL + NIL+++    K+ DFGL+  +    +   VK  G   + + APE L E 
Sbjct: 139 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 198
Query: 330 KLTDKSDVYAFGVVLLELL 348
           K +  SDV++FGVVL EL 
Sbjct: 199 KFSVASDVWSFGVVLYELF 217

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 114/240 (47%), Gaps = 25/240 (10%)
Query: 161 IGEGGRGHVYKARF-----NEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNIISL 214
           +GEG  G V   R+     N     AVK +  ++G +   +   E+  L  + H+NI+  
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 215 LGYCIH--AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
            G C         L+ E + +GSL++ L  P + + +    ++K AV + +G++YL    
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLG--- 143
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKI----SGTLGYVAPEYLLE 328
           +   VHRDL + N+L++S    K+ DFGL+    T      +       + + APE L++
Sbjct: 144 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQ 203
Query: 329 GKLTDKSDVYAFGVVLLELLM----GRRPV----EKMSPTQCQSMVTWAMPQLTDRSKLP 380
            K    SDV++FGV L ELL        P+    + + PT  Q  VT  +  L +  +LP
Sbjct: 204 SKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLP 263

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 103/206 (50%), Gaps = 8/206 (3%)
Query: 145 YELLEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWL 203
           Y+  E    +    + +G G  G VY+  + +  L  AVK + +   + E EF  E   +
Sbjct: 10  YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVM 68
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
            +I+H N++ LLG C      +++ E M  G+L   L    +   +   + + +A  ++ 
Sbjct: 69  KEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISS 127
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYV 321
            +EYL +      +HRDL + N L+  +   K++DFGLS  +T  T + +      + + 
Sbjct: 128 AMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 184
Query: 322 APEYLLEGKLTDKSDVYAFGVVLLEL 347
           APE L   K + KSDV+AFGV+L E+
Sbjct: 185 APESLAYNKFSIKSDVWAFGVLLWEI 210

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 104/206 (50%), Gaps = 8/206 (3%)
Query: 145 YELLEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWL 203
           Y+  E    +    + +G G  G VY+  + +  L  AVK + +   + E EF  E   +
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVM 63
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
            +I+H N++ LLG C      +++ E M  G+L   L    +   ++  + + +A  ++ 
Sbjct: 64  KEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISS 122
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYV 321
            +EYL +      +HRDL + N L+  +   K++DFGLS  +T  T + +      + + 
Sbjct: 123 AMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 179
Query: 322 APEYLLEGKLTDKSDVYAFGVVLLEL 347
           APE L   K + KSDV+AFGV+L E+
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEI 205

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 104/206 (50%), Gaps = 8/206 (3%)
Query: 145 YELLEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWL 203
           Y+  E    +    + +G G  G VY+  + +  L  AVK + +   + E EF  E   +
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVM 63
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
            +I+H N++ LLG C      +++ E M  G+L   L    +   ++  + + +A  ++ 
Sbjct: 64  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISS 122
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYV 321
            +EYL +      +HRDL + N L+  +   K++DFGLS  +T  T + +      + + 
Sbjct: 123 AMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 179
Query: 322 APEYLLEGKLTDKSDVYAFGVVLLEL 347
           APE L   K + KSDV+AFGV+L E+
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEI 205

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 104/206 (50%), Gaps = 8/206 (3%)
Query: 145 YELLEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWL 203
           Y+  E    +    + +G G  G VY+  + +  L  AVK + +   + E EF  E   +
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVM 63
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
            +I+H N++ LLG C      +++ E M  G+L   L    +   ++  + + +A  ++ 
Sbjct: 64  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISS 122
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYV 321
            +EYL +      +HRDL + N L+  +   K++DFGLS  +T  T + +      + + 
Sbjct: 123 AMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 179
Query: 322 APEYLLEGKLTDKSDVYAFGVVLLEL 347
           APE L   K + KSDV+AFGV+L E+
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEI 205

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 103/206 (50%), Gaps = 8/206 (3%)
Query: 145 YELLEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWL 203
           Y+  E    +    + +G G  G VY+  + +  L  AVK + +   + E EF  E   +
Sbjct: 10  YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVM 68
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
            +I+H N++ LLG C      +++ E M  G+L   L    +   +   + + +A  ++ 
Sbjct: 69  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISS 127
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYV 321
            +EYL +      +HRDL + N L+  +   K++DFGLS  +T  T + +      + + 
Sbjct: 128 AMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWT 184
Query: 322 APEYLLEGKLTDKSDVYAFGVVLLEL 347
           APE L   K + KSDV+AFGV+L E+
Sbjct: 185 APESLAYNKFSIKSDVWAFGVLLWEI 210

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 104/206 (50%), Gaps = 8/206 (3%)
Query: 145 YELLEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWL 203
           Y+  E    +    + +G G  G VY+  + +  L  AVK + +   + E EF  E   +
Sbjct: 10  YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVM 68
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
            +I+H N++ LLG C      +++ E M  G+L   L    +   ++  + + +A  ++ 
Sbjct: 69  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISS 127
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYV 321
            +EYL +      +HRDL + N L+  +   K++DFGLS  +T  T + +      + + 
Sbjct: 128 AMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 184
Query: 322 APEYLLEGKLTDKSDVYAFGVVLLEL 347
           APE L   K + KSDV+AFGV+L E+
Sbjct: 185 APESLAYNKFSIKSDVWAFGVLLWEI 210

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 99/200 (49%), Gaps = 9/200 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           +G+G  G V+   +N     A+K +   G  +   F  E   + K+RH+ ++ L    + 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 83
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
            E  ++V E M  G L   L G   G  L     + +A  +A G+ Y+ E  N+  VHRD
Sbjct: 84  EEPIYIVTEYMSKGCLLDFLKG-EMGKYLRLPQLVDMAAQIASGMAYV-ERMNY--VHRD 139
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
           L+++NIL+  +   K++DFGL+          +      + + APE  L G+ T KSDV+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 339 AFGVVLLELLM-GRRPVEKM 357
           +FG++L EL   GR P   M
Sbjct: 200 SFGILLTELTTKGRVPYPGM 219

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 94/199 (47%), Gaps = 16/199 (8%)
Query: 161 IGEGGRGHVYKARF-----NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLL 215
           +G+G  G V   R+     N   + AVK++  +  +  R+F  E+  L  ++H NI+   
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 216 GYCIHAETR--FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
           G C  A  R   L+ E +  GSL   L    H   +     ++    + +G+EYL     
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYL---GT 132
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKI----SGTLGYVAPEYLLEG 329
              +HRDL + NIL+++    K+ DFGL+          K+       + + APE L E 
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTES 192
Query: 330 KLTDKSDVYAFGVVLLELL 348
           K +  SDV++FGVVL EL 
Sbjct: 193 KFSVASDVWSFGVVLYELF 211

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 103/206 (50%), Gaps = 8/206 (3%)
Query: 145 YELLEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWL 203
           Y+  E    +    + +G G  G VY+  + +  L  AVK + +   + E EF  E   +
Sbjct: 10  YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVM 68
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
            +I+H N++ LLG C      +++ E M  G+L   L    +   +   + + +A  ++ 
Sbjct: 69  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISS 127
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYV 321
            +EYL +      +HRDL + N L+  +   K++DFGLS  +T  T + +      + + 
Sbjct: 128 AMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 184
Query: 322 APEYLLEGKLTDKSDVYAFGVVLLEL 347
           APE L   K + KSDV+AFGV+L E+
Sbjct: 185 APESLAYNKFSIKSDVWAFGVLLWEI 210

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 97/199 (48%), Gaps = 16/199 (8%)
Query: 161 IGEGGRGHVYKARF-----NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLL 215
           +G+G  G V   R+     N   + AVK++  +  +  R+F  E+  L  ++H NI+   
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 216 GYCIHAETR--FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
           G C  A  R   L+ E +  GSL   L    H   +     ++    + +G+EYL     
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYL---GT 150
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGT--LGYVAPEYLLEG 329
              +HRDL + NIL+++    K+ DFGL+  +    +   VK  G   + + APE L E 
Sbjct: 151 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 210
Query: 330 KLTDKSDVYAFGVVLLELL 348
           K +  SDV++FGVVL EL 
Sbjct: 211 KFSVASDVWSFGVVLYELF 229

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 103/206 (50%), Gaps = 8/206 (3%)
Query: 145 YELLEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWL 203
           Y+  E    +    + +G G  G VY+  + +  L  AVK + +   + E EF  E   +
Sbjct: 9   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVM 67
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
            +I+H N++ LLG C      +++ E M  G+L   L    +   +   + + +A  ++ 
Sbjct: 68  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISS 126
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYV 321
            +EYL +      +HRDL + N L+  +   K++DFGLS  +T  T + +      + + 
Sbjct: 127 AMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 183
Query: 322 APEYLLEGKLTDKSDVYAFGVVLLEL 347
           APE L   K + KSDV+AFGV+L E+
Sbjct: 184 APESLAYNKFSIKSDVWAFGVLLWEI 209

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 103/206 (50%), Gaps = 8/206 (3%)
Query: 145 YELLEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWL 203
           Y+  E    +    + +G G  G VY+  + +  L  AVK + +   + E EF  E   +
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVM 63
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
            +I+H N++ LLG C      +++ E M  G+L   L    +   +   + + +A  ++ 
Sbjct: 64  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISS 122
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYV 321
            +EYL +      +HRDL + N L+  +   K++DFGLS  +T  T + +      + + 
Sbjct: 123 AMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 179
Query: 322 APEYLLEGKLTDKSDVYAFGVVLLEL 347
           APE L   K + KSDV+AFGV+L E+
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEI 205

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 103/206 (50%), Gaps = 8/206 (3%)
Query: 145 YELLEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWL 203
           Y+  E    +    + +G G  G VY+  + +  L  AVK + +   + E EF  E   +
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVM 63
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
            +I+H N++ LLG C      +++ E M  G+L   L    +   +   + + +A  ++ 
Sbjct: 64  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISS 122
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYV 321
            +EYL +      +HRDL + N L+  +   K++DFGLS  +T  T + +      + + 
Sbjct: 123 AMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 179
Query: 322 APEYLLEGKLTDKSDVYAFGVVLLEL 347
           APE L   K + KSDV+AFGV+L E+
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEI 205

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 127/272 (46%), Gaps = 33/272 (12%)
Query: 160 VIGEGGRGHVYKAR-FNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYC 218
           V+G+G  G VY  R  + ++  A+K I +      +  + E+     ++H+NI+  LG  
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS- 87
Query: 219 IHAETRFL--VYEMMQNGSLEKQLH---GPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
             +E  F+    E +  GSL   L    GP   +  T     K    +  GL+YLH   +
Sbjct: 88  -FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK---QILEGLKYLH---D 140
Query: 274 HPVVHRDLKSSNILLDS-SFNAKLSDFGLSVT-AGTQSRNVKISGTLGYVAPEYLLEGK- 330
           + +VHRD+K  N+L+++ S   K+SDFG S   AG        +GTL Y+APE + +G  
Sbjct: 141 NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPR 200
Query: 331 -LTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRD 389
                +D+++ G  ++E+  G+ P  ++   Q  +M    M +          V P I +
Sbjct: 201 GYGKAADIWSLGCTIIEMATGKPPFYELGEPQA-AMFKVGMFK----------VHPEIPE 249
Query: 390 TMDLKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
           +M      +  A  + C +P+P  R    D+L
Sbjct: 250 SMSA----EAKAFILKCFEPDPDKRACANDLL 277

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 71/229 (31%), Positives = 114/229 (49%), Gaps = 20/229 (8%)
Query: 138 DTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARF----NEKLLAAVK---RIDDAGH 190
           + V  +++ ++  ++     + VIG G  G VY         +K+  AVK   RI D G 
Sbjct: 16  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 75
Query: 191 DAEREFNNEVNWLTKIRHQNIISLLGYCIHAE-TRFLVYEMMQNGSLEKQLHGPTHGSNL 249
            ++  F  E   +    H N++SLLG C+ +E +  +V   M++G L   +   TH  N 
Sbjct: 76  VSQ--FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NP 131
Query: 250 TWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS---VTAG 306
           T    +   + VA+G+++L    +   VHRDL + N +LD  F  K++DFGL+   +   
Sbjct: 132 TVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKE 188
Query: 307 TQSRNVKISGTL--GYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
             S + K    L   ++A E L   K T KSDV++FGV+L EL+    P
Sbjct: 189 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 127/272 (46%), Gaps = 33/272 (12%)
Query: 160 VIGEGGRGHVYKAR-FNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYC 218
           V+G+G  G VY  R  + ++  A+K I +      +  + E+     ++H+NI+  LG  
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS- 73
Query: 219 IHAETRFL--VYEMMQNGSLEKQLH---GPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
             +E  F+    E +  GSL   L    GP   +  T     K    +  GL+YLH   +
Sbjct: 74  -FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK---QILEGLKYLH---D 126
Query: 274 HPVVHRDLKSSNILLDS-SFNAKLSDFGLSVT-AGTQSRNVKISGTLGYVAPEYLLEGK- 330
           + +VHRD+K  N+L+++ S   K+SDFG S   AG        +GTL Y+APE + +G  
Sbjct: 127 NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPR 186
Query: 331 -LTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRD 389
                +D+++ G  ++E+  G+ P  ++   Q  +M    M +          V P I +
Sbjct: 187 GYGKAADIWSLGCTIIEMATGKPPFYELGEPQA-AMFKVGMFK----------VHPEIPE 235
Query: 390 TMDLKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
           +M      +  A  + C +P+P  R    D+L
Sbjct: 236 SMSA----EAKAFILKCFEPDPDKRACANDLL 263

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 103/206 (50%), Gaps = 8/206 (3%)
Query: 145 YELLEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWL 203
           Y+  E    +    + +G G  G VY+  + +  L  AVK + +   + E EF  E   +
Sbjct: 10  YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVM 68
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
            +I+H N++ LLG C      +++ E M  G+L   L    +   +   + + +A  ++ 
Sbjct: 69  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISS 127
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYV 321
            +EYL +      +HRDL + N L+  +   K++DFGLS  +T  T + +      + + 
Sbjct: 128 AMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 184
Query: 322 APEYLLEGKLTDKSDVYAFGVVLLEL 347
           APE L   K + KSDV+AFGV+L E+
Sbjct: 185 APESLAYNKFSIKSDVWAFGVLLWEI 210

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 103/206 (50%), Gaps = 8/206 (3%)
Query: 145 YELLEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWL 203
           Y+  E    +    + +G G  G VY+  + +  L  AVK + +   + E EF  E   +
Sbjct: 7   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVM 65
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
            +I+H N++ LLG C      +++ E M  G+L   L    +   +   + + +A  ++ 
Sbjct: 66  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISS 124
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYV 321
            +EYL +      +HRDL + N L+  +   K++DFGLS  +T  T + +      + + 
Sbjct: 125 AMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 181
Query: 322 APEYLLEGKLTDKSDVYAFGVVLLEL 347
           APE L   K + KSDV+AFGV+L E+
Sbjct: 182 APESLAYNKFSIKSDVWAFGVLLWEI 207

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 159 NVIGEGGRGHVYKARF----NEKLLAAVKRIDDAGHD--AEREFNNEVNWLTKIRHQNII 212
            +IG G  G V   R        +  A+K +  AG+     R+F +E + + +  H NII
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALK-AGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 213 SLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
            L G         +V E M+NGSL+  L   TH    T    + +   V  G+ YL    
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLR--THDGQFTIMQLVGMLRGVGAGMRYL---S 168
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT------AGTQSRNVKISGTLGYVAPEYL 326
           +   VHRDL + N+L+DS+   K+SDFGLS        A   +   KI   + + APE +
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIP--IRWTAPEAI 226
Query: 327 LEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMS 358
                +  SDV++FGVV+ E+L  G RP   M+
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT 259

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 103/206 (50%), Gaps = 8/206 (3%)
Query: 145 YELLEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWL 203
           Y+  E    +    + +G G  G VY+  + +  L  AVK + +   + E EF  E   +
Sbjct: 18  YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVM 76
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
            +I+H N++ LLG C      +++ E M  G+L   L    +   +   + + +A  ++ 
Sbjct: 77  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISS 135
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYV 321
            +EYL +      +HRDL + N L+  +   K++DFGLS  +T  T + +      + + 
Sbjct: 136 AMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 192
Query: 322 APEYLLEGKLTDKSDVYAFGVVLLEL 347
           APE L   K + KSDV+AFGV+L E+
Sbjct: 193 APESLAYNKFSIKSDVWAFGVLLWEI 218

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 103/206 (50%), Gaps = 8/206 (3%)
Query: 145 YELLEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWL 203
           Y+  E    +    + +G G  G VY+  + +  L  AVK + +   + E EF  E   +
Sbjct: 7   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVM 65
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
            +I+H N++ LLG C      +++ E M  G+L   L    +   +   + + +A  ++ 
Sbjct: 66  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISS 124
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYV 321
            +EYL +      +HRDL + N L+  +   K++DFGLS  +T  T + +      + + 
Sbjct: 125 AMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 181
Query: 322 APEYLLEGKLTDKSDVYAFGVVLLEL 347
           APE L   K + KSDV+AFGV+L E+
Sbjct: 182 APESLAYNKFSIKSDVWAFGVLLWEI 207

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 114/229 (49%), Gaps = 20/229 (8%)
Query: 138 DTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARF----NEKLLAAVK---RIDDAGH 190
           + V  +++ ++  ++     + VIG G  G VY         +K+  AVK   RI D G 
Sbjct: 20  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 79
Query: 191 DAEREFNNEVNWLTKIRHQNIISLLGYCIHAE-TRFLVYEMMQNGSLEKQLHGPTHGSNL 249
            ++  F  E   +    H N++SLLG C+ +E +  +V   M++G L   +   TH  N 
Sbjct: 80  VSQ--FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NP 135
Query: 250 TWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS 309
           T    +   + VA+G+++L    +   VHRDL + N +LD  F  K++DFGL+     + 
Sbjct: 136 TVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 192
Query: 310 RNVKISGT-----LGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
            +   + T     + ++A E L   K T KSDV++FGV+L EL+    P
Sbjct: 193 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 241

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 114/229 (49%), Gaps = 20/229 (8%)
Query: 138 DTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARF----NEKLLAAVK---RIDDAGH 190
           + V  +++ ++  ++     + VIG G  G VY         +K+  AVK   RI D G 
Sbjct: 15  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 74
Query: 191 DAEREFNNEVNWLTKIRHQNIISLLGYCIHAE-TRFLVYEMMQNGSLEKQLHGPTHGSNL 249
            ++  F  E   +    H N++SLLG C+ +E +  +V   M++G L   +   TH  N 
Sbjct: 75  VSQ--FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NP 130
Query: 250 TWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS 309
           T    +   + VA+G+++L    +   VHRDL + N +LD  F  K++DFGL+     + 
Sbjct: 131 TVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 187
Query: 310 RNVKISGT-----LGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
            +   + T     + ++A E L   K T KSDV++FGV+L EL+    P
Sbjct: 188 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 114/229 (49%), Gaps = 20/229 (8%)
Query: 138 DTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARF----NEKLLAAVK---RIDDAGH 190
           + V  +++ ++  ++     + VIG G  G VY         +K+  AVK   RI D G 
Sbjct: 74  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 133
Query: 191 DAEREFNNEVNWLTKIRHQNIISLLGYCIHAE-TRFLVYEMMQNGSLEKQLHGPTHGSNL 249
            ++  F  E   +    H N++SLLG C+ +E +  +V   M++G L   +   TH  N 
Sbjct: 134 VSQ--FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NP 189
Query: 250 TWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS 309
           T    +   + VA+G+++L    +   VHRDL + N +LD  F  K++DFGL+     + 
Sbjct: 190 TVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246
Query: 310 RNVKISGT-----LGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
            +   + T     + ++A E L   K T KSDV++FGV+L EL+    P
Sbjct: 247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 295

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 114/229 (49%), Gaps = 20/229 (8%)
Query: 138 DTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARF----NEKLLAAVK---RIDDAGH 190
           + V  +++ ++  ++     + VIG G  G VY         +K+  AVK   RI D G 
Sbjct: 15  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 74
Query: 191 DAEREFNNEVNWLTKIRHQNIISLLGYCIHAE-TRFLVYEMMQNGSLEKQLHGPTHGSNL 249
            ++  F  E   +    H N++SLLG C+ +E +  +V   M++G L   +   TH  N 
Sbjct: 75  VSQ--FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NP 130
Query: 250 TWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS 309
           T    +   + VA+G+++L    +   VHRDL + N +LD  F  K++DFGL+     + 
Sbjct: 131 TVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 187
Query: 310 RNVKISGT-----LGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
            +   + T     + ++A E L   K T KSDV++FGV+L EL+    P
Sbjct: 188 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 114/229 (49%), Gaps = 20/229 (8%)
Query: 138 DTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARF----NEKLLAAVK---RIDDAGH 190
           + V  +++ ++  ++     + VIG G  G VY         +K+  AVK   RI D G 
Sbjct: 16  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 75
Query: 191 DAEREFNNEVNWLTKIRHQNIISLLGYCIHAE-TRFLVYEMMQNGSLEKQLHGPTHGSNL 249
            ++  F  E   +    H N++SLLG C+ +E +  +V   M++G L   +   TH  N 
Sbjct: 76  VSQ--FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NP 131
Query: 250 TWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS 309
           T    +   + VA+G+++L    +   VHRDL + N +LD  F  K++DFGL+     + 
Sbjct: 132 TVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 188
Query: 310 RNVKISGT-----LGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
            +   + T     + ++A E L   K T KSDV++FGV+L EL+    P
Sbjct: 189 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 114/229 (49%), Gaps = 20/229 (8%)
Query: 138 DTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARF----NEKLLAAVK---RIDDAGH 190
           + V  +++ ++  ++     + VIG G  G VY         +K+  AVK   RI D G 
Sbjct: 13  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 72
Query: 191 DAEREFNNEVNWLTKIRHQNIISLLGYCIHAE-TRFLVYEMMQNGSLEKQLHGPTHGSNL 249
            ++  F  E   +    H N++SLLG C+ +E +  +V   M++G L   +   TH  N 
Sbjct: 73  VSQ--FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NP 128
Query: 250 TWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS 309
           T    +   + VA+G+++L    +   VHRDL + N +LD  F  K++DFGL+     + 
Sbjct: 129 TVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 185
Query: 310 RNVKISGT-----LGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
            +   + T     + ++A E L   K T KSDV++FGV+L EL+    P
Sbjct: 186 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 101/209 (48%), Gaps = 26/209 (12%)
Query: 159 NVIGEGGRGHVYKARFNEK----LLAAVK--RIDDAGHDAEREFNNEVNWLTKIRHQNII 212
            ++GEG  G V +    ++    L  AVK  ++D++      EF +E   +    H N+I
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 213 SLLGYCIHAETR-----FLVYEMMQNGSLEKQL------HGPTHGSNLTWHLRMKIAVDV 261
            LLG CI   ++      ++   M+ G L   L       GP H   +     +K  VD+
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKH---IPLQTLLKFMVDI 156
Query: 262 ARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGT-L 318
           A G+EYL    N   +HRDL + N +L       ++DFGLS  + +G   R  +I+   +
Sbjct: 157 ALGMEYLS---NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 213
Query: 319 GYVAPEYLLEGKLTDKSDVYAFGVVLLEL 347
            ++A E L +   T KSDV+AFGV + E+
Sbjct: 214 KWIAIESLADRVYTSKSDVWAFGVTMWEI 242

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 76/244 (31%), Positives = 123/244 (50%), Gaps = 36/244 (14%)
Query: 148 LEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAERE-----FNNEVNW 202
            +     +Q+   +GEG  G VYKA+ ++  + A+KRI     DAE E        E++ 
Sbjct: 16  FQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR---LDAEDEGIPSTAIREISL 72
Query: 203 LTKIRHQNIISLLGYCIHAETRF-LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAV-D 260
           L ++ H NI+SL+   IH+E    LV+E M+   L+K L     G   +   ++KI +  
Sbjct: 73  LKELHHPNIVSLID-VIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDS---QIKIYLYQ 127
Query: 261 VARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLG 319
           + RG+ + H+H    ++HRDLK  N+L++S    KL+DFGL+   G   R+      TL 
Sbjct: 128 LLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLW 184
Query: 320 YVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSK 378
           Y AP+ L+  K    S D+++ G +  E++ G +P+                P +TD  +
Sbjct: 185 YRAPDVLMGSKKYSTSVDIWSIGCIFAEMITG-KPL---------------FPGVTDDDQ 228
Query: 379 LPNI 382
           LP I
Sbjct: 229 LPKI 232

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 76/244 (31%), Positives = 123/244 (50%), Gaps = 36/244 (14%)
Query: 148 LEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAERE-----FNNEVNW 202
            +     +Q+   +GEG  G VYKA+ ++  + A+KRI     DAE E        E++ 
Sbjct: 16  FQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR---LDAEDEGIPSTAIREISL 72
Query: 203 LTKIRHQNIISLLGYCIHAETRF-LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAV-D 260
           L ++ H NI+SL+   IH+E    LV+E M+   L+K L     G   +   ++KI +  
Sbjct: 73  LKELHHPNIVSLID-VIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDS---QIKIYLYQ 127
Query: 261 VARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLG 319
           + RG+ + H+H    ++HRDLK  N+L++S    KL+DFGL+   G   R+      TL 
Sbjct: 128 LLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLW 184
Query: 320 YVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSK 378
           Y AP+ L+  K    S D+++ G +  E++ G +P+                P +TD  +
Sbjct: 185 YRAPDVLMGSKKYSTSVDIWSIGCIFAEMITG-KPL---------------FPGVTDDDQ 228
Query: 379 LPNI 382
           LP I
Sbjct: 229 LPKI 232

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 102/206 (49%), Gaps = 8/206 (3%)
Query: 145 YELLEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWL 203
           Y+  E    +    + +G G  G VY+  + +  L  AVK + +   + E EF  E   +
Sbjct: 6   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVM 64
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
            +I+H N++ LLG C      +++ E M  G+L   L    +   +   + + +A  ++ 
Sbjct: 65  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISS 123
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYV 321
            +EYL +      +HRDL + N L+  +   K++DFGLS  +T  T +        + + 
Sbjct: 124 AMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWT 180
Query: 322 APEYLLEGKLTDKSDVYAFGVVLLEL 347
           APE L   K + KSDV+AFGV+L E+
Sbjct: 181 APESLAYNKFSIKSDVWAFGVLLWEI 206

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 159 NVIGEGGRGHVYKARF----NEKLLAAVKRIDDAGHD--AEREFNNEVNWLTKIRHQNII 212
            +IG G  G V   R        +  A+K +  AG+     R+F +E + + +  H NII
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALK-AGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 213 SLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
            L G         +V E M+NGSL+  L   TH    T    + +   V  G+ YL    
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLR--THDGQFTIMQLVGMLRGVGAGMRYL---S 168
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT------AGTQSRNVKISGTLGYVAPEYL 326
           +   VHRDL + N+L+DS+   K+SDFGLS        A   +   KI   + + APE +
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIP--IRWTAPEAI 226
Query: 327 LEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMS 358
                +  SDV++FGVV+ E+L  G RP   M+
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT 259

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 102/206 (49%), Gaps = 8/206 (3%)
Query: 145 YELLEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWL 203
           Y+  E    +    + +G G  G VY+  + +  L  AVK + +   + E EF  E   +
Sbjct: 7   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVM 65
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
            +I+H N++ LLG C      +++ E M  G+L   L    +   +   + + +A  ++ 
Sbjct: 66  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISS 124
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYV 321
            +EYL +      +HRDL + N L+  +   K++DFGLS  +T  T +        + + 
Sbjct: 125 AMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWT 181
Query: 322 APEYLLEGKLTDKSDVYAFGVVLLEL 347
           APE L   K + KSDV+AFGV+L E+
Sbjct: 182 APESLAYNKFSIKSDVWAFGVLLWEI 207

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 114/224 (50%), Gaps = 16/224 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKI 206
             F++  V+G G  G VYK  +       K+  A+K + +A    A +E  +E   +  +
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
            + ++  LLG C+ +  + L+ ++M  G L   +    H  N+     +   V +A+G+ 
Sbjct: 76  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMN 132
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAP 323
           YL    +  +VHRDL + N+L+ +  + K++DFGL+   G + +     G    + ++A 
Sbjct: 133 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 189
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
           E +L    T +SDV+++GV + EL+  G +P + +  ++  S++
Sbjct: 190 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 233

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 114/224 (50%), Gaps = 16/224 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKI 206
             F++  V+G G  G VYK  +       K+  A+K + +A    A +E  +E   +  +
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
            + ++  LLG C+ +  + L+ ++M  G L   +    H  N+     +   V +A+G+ 
Sbjct: 79  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMN 135
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAP 323
           YL    +  +VHRDL + N+L+ +  + K++DFGL+   G + +     G    + ++A 
Sbjct: 136 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 192
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
           E +L    T +SDV+++GV + EL+  G +P + +  ++  S++
Sbjct: 193 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 236

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/277 (24%), Positives = 130/277 (46%), Gaps = 29/277 (10%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKI 206
             F++  V+G G  G VYK  +       K+  A+K + +A    A +E  +E   +  +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
            + ++  LLG C+ +  + L+ ++M  G L   +    H  N+     +   V +A+G+ 
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMN 131
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAP 323
           YL    +  +VHRDL + N+L+ +  + K++DFGL+   G + +     G    + ++A 
Sbjct: 132 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNI 382
           E +L    T +SDV+++GV + EL+  G +P + +  ++  S+       L    +LP  
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-------LEKGERLPQP 241
Query: 383 VDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITD 419
               I   M ++  + + A         P +R LI +
Sbjct: 242 PICTIDVYMIMRKCWMIDA------DSRPKFRELIIE 272

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 114/224 (50%), Gaps = 16/224 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKI 206
             F++  V+G G  G VYK  +       K+  A+K + +A    A +E  +E   +  +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
            + ++  LLG C+ +  + L+ ++M  G L   +    H  N+     +   V +A+G+ 
Sbjct: 78  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMN 134
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAP 323
           YL    +  +VHRDL + N+L+ +  + K++DFGL+   G + +     G    + ++A 
Sbjct: 135 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 191
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
           E +L    T +SDV+++GV + EL+  G +P + +  ++  S++
Sbjct: 192 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 235

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 114/224 (50%), Gaps = 16/224 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKI 206
             F++  V+G G  G VYK  +       K+  A+K + +A    A +E  +E   +  +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
            + ++  LLG C+ +  + L+ ++M  G L   +    H  N+     +   V +A+G+ 
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMN 131
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAP 323
           YL    +  +VHRDL + N+L+ +  + K++DFGL+   G + +     G    + ++A 
Sbjct: 132 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
           E +L    T +SDV+++GV + EL+  G +P + +  ++  S++
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 114/224 (50%), Gaps = 16/224 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKI 206
             F++  V+G G  G VYK  +       K+  A+K + +A    A +E  +E   +  +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
            + ++  LLG C+ +  + L+ ++M  G L   +    H  N+     +   V +A+G+ 
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMN 133
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAP 323
           YL    +  +VHRDL + N+L+ +  + K++DFGL+   G + +     G    + ++A 
Sbjct: 134 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
           E +L    T +SDV+++GV + EL+  G +P + +  ++  S++
Sbjct: 191 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 234

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 102/225 (45%), Gaps = 38/225 (16%)
Query: 154 NFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNII 212
           +F+E  +IG GG G V+KA+   +     ++R+      AERE    V  L K+ H NI+
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAERE----VKALAKLDHVNIV 68
Query: 213 SL----LGYCIHAETR-------------------------FLVYEMMQNGSLEKQLHGP 243
                  G+    ET                          F+  E    G+LE+ +   
Sbjct: 69  HYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIE-K 127
Query: 244 THGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSV 303
             G  L   L +++   + +G++Y+H   +  ++HRDLK SNI L  +   K+ DFGL  
Sbjct: 128 RRGEKLDKVLALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKIGDFGLVT 184
Query: 304 TAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELL 348
           +     +  +  GTL Y++PE +       + D+YA G++L ELL
Sbjct: 185 SLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 80/276 (28%), Positives = 135/276 (48%), Gaps = 29/276 (10%)
Query: 148 LEAATNNFQESNVIGEGGRGHVYKAR-FNEKLLAAVKRIDDAGHDAE------REFNNEV 200
           +++    +++ + +GEG    VYKAR  N   + A+K+I   GH +E      R    E+
Sbjct: 5   VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIK-LGHRSEAKDGINRTALREI 63
Query: 201 NWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTW---HLRMKI 257
             L ++ H NII LL    H     LV++ M     E  L      ++L     H++  +
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNISLVFDFM-----ETDLEVIIKDNSLVLTPSHIKAYM 118
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-G 316
            + + +GLEYLH+H    ++HRDLK +N+LLD +   KL+DFGL+ + G+ +R       
Sbjct: 119 LMTL-QGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV 174
Query: 317 TLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLM------GRRPVEKMSPTQCQSMVTWA 369
           T  Y APE L   ++     D++A G +L ELL+      G   +++++    +++ T  
Sbjct: 175 TRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI-FETLGTPT 233
Query: 370 MPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVL 405
             Q  D   LP+ V       + L H++  A   +L
Sbjct: 234 EEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLL 269

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 104/216 (48%), Gaps = 9/216 (4%)
Query: 146 ELLEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTK 205
           ++ E    + Q    +G G  G V+   +N     A+K +   G  +   F  E   + K
Sbjct: 2   DVWEIPRESLQLIKRLGNGQFGEVWMGTWNGNTKVAIKTLK-PGTMSPESFLEEAQIMKK 60
Query: 206 IRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
           ++H  ++ L    +  E  ++V E M  GSL   L     G  L     + +A  VA G+
Sbjct: 61  LKHDKLVQLYA-VVSEEPIYIVTEYMNKGSLLDFLKD-GEGRALKLPNLVDMAAQVAAGM 118
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAP 323
            Y+ E  N+  +HRDL+S+NIL+ +    K++DFGL+          +      + + AP
Sbjct: 119 AYI-ERMNY--IHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAP 175
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMS 358
           E  L G+ T KSDV++FG++L EL+  GR P   M+
Sbjct: 176 EAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN 211

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 114/224 (50%), Gaps = 16/224 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKI 206
             F++  V+G G  G VYK  +       K+  A+K + +A    A +E  +E   +  +
Sbjct: 25  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 84
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
            + ++  LLG C+ +  + L+ ++M  G L   +    H  N+     +   V +A+G+ 
Sbjct: 85  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMN 141
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAP 323
           YL    +  +VHRDL + N+L+ +  + K++DFGL+   G + +     G    + ++A 
Sbjct: 142 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 198
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
           E +L    T +SDV+++GV + EL+  G +P + +  ++  S++
Sbjct: 199 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 242

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 114/224 (50%), Gaps = 16/224 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKI 206
             F++  V+G G  G VYK  +       K+  A+K + +A    A +E  +E   +  +
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
            + ++  LLG C+ +  + L+ ++M  G L   +    H  N+     +   V +A+G+ 
Sbjct: 69  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMN 125
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAP 323
           YL    +  +VHRDL + N+L+ +  + K++DFGL+   G + +     G    + ++A 
Sbjct: 126 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
           E +L    T +SDV+++GV + EL+  G +P + +  ++  S++
Sbjct: 183 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 226

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 114/224 (50%), Gaps = 16/224 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKI 206
             F++  V+G G  G VYK  +       K+  A+K + +A    A +E  +E   +  +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
            + ++  LLG C+ +  + L+ ++M  G L   +    H  N+     +   V +A+G+ 
Sbjct: 78  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMN 134
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAP 323
           YL    +  +VHRDL + N+L+ +  + K++DFGL+   G + +     G    + ++A 
Sbjct: 135 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 191
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
           E +L    T +SDV+++GV + EL+  G +P + +  ++  S++
Sbjct: 192 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 235

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 114/224 (50%), Gaps = 16/224 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKI 206
             F++  V+G G  G VYK  +       K+  A+K + +A    A +E  +E   +  +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
            + ++  LLG C+ +  + L+ ++M  G L   +    H  N+     +   V +A+G+ 
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMN 131
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAP 323
           YL    +  +VHRDL + N+L+ +  + K++DFGL+   G + +     G    + ++A 
Sbjct: 132 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
           E +L    T +SDV+++GV + EL+  G +P + +  ++  S++
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 114/224 (50%), Gaps = 16/224 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKI 206
             F++  V+G G  G VYK  +       K+  A+K + +A    A +E  +E   +  +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
            + ++  LLG C+ +  + L+ ++M  G L   +    H  N+     +   V +A+G+ 
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMN 133
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAP 323
           YL    +  +VHRDL + N+L+ +  + K++DFGL+   G + +     G    + ++A 
Sbjct: 134 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
           E +L    T +SDV+++GV + EL+  G +P + +  ++  S++
Sbjct: 191 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 234

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 114/224 (50%), Gaps = 16/224 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKI 206
             F++  V+G G  G VYK  +       K+  A+K + +A    A +E  +E   +  +
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
            + ++  LLG C+ +  + L+ ++M  G L   +    H  N+     +   V +A+G+ 
Sbjct: 76  DNPHVCRLLGICLTSTVQ-LIMQLMPFGXLLDYVR--EHKDNIGSQYLLNWCVQIAKGMN 132
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAP 323
           YL    +  +VHRDL + N+L+ +  + K++DFGL+   G + +     G    + ++A 
Sbjct: 133 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 189
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
           E +L    T +SDV+++GV + EL+  G +P + +  ++  S++
Sbjct: 190 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 233

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 114/224 (50%), Gaps = 16/224 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKI 206
             F++  V+G G  G VYK  +       K+  A+K + +A    A +E  +E   +  +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
            + ++  LLG C+ +  + L+ ++M  G L   +    H  N+     +   V +A+G+ 
Sbjct: 78  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMN 134
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAP 323
           YL    +  +VHRDL + N+L+ +  + K++DFGL+   G + +     G    + ++A 
Sbjct: 135 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 191
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
           E +L    T +SDV+++GV + EL+  G +P + +  ++  S++
Sbjct: 192 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 235

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 114/224 (50%), Gaps = 16/224 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKI 206
             F++  V+G G  G VYK  +       K+  A+K + +A    A +E  +E   +  +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
            + ++  LLG C+ +  + L+ ++M  G L   +    H  N+     +   V +A+G+ 
Sbjct: 78  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMN 134
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAP 323
           YL    +  +VHRDL + N+L+ +  + K++DFGL+   G + +     G    + ++A 
Sbjct: 135 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 191
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
           E +L    T +SDV+++GV + EL+  G +P + +  ++  S++
Sbjct: 192 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 235

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 94/199 (47%), Gaps = 16/199 (8%)
Query: 161 IGEGGRGHVYKARF-----NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLL 215
           +G+G  G V   R+     N   + AVK++  +  +  R+F  E+  L  ++H NI+   
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 216 GYCIHAETR--FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
           G C  A  R   L+ E +  GSL   L    H   +     ++    + +G+EYL     
Sbjct: 79  GVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYL---GT 133
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKI----SGTLGYVAPEYLLEG 329
              +HR+L + NIL+++    K+ DFGL+          K+       + + APE L E 
Sbjct: 134 KRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTES 193
Query: 330 KLTDKSDVYAFGVVLLELL 348
           K +  SDV++FGVVL EL 
Sbjct: 194 KFSVASDVWSFGVVLYELF 212

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 114/224 (50%), Gaps = 16/224 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKI 206
             F++  V+G G  G VYK  +       K+  A+K + +A    A +E  +E   +  +
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
            + ++  LLG C+ +  + L+ ++M  G L   +    H  N+     +   V +A+G+ 
Sbjct: 82  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMN 138
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAP 323
           YL    +  +VHRDL + N+L+ +  + K++DFGL+   G + +     G    + ++A 
Sbjct: 139 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 195
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
           E +L    T +SDV+++GV + EL+  G +P + +  ++  S++
Sbjct: 196 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 239

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 114/224 (50%), Gaps = 16/224 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKI 206
             F++  V+G G  G VYK  +       K+  A+K + +A    A +E  +E   +  +
Sbjct: 21  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 80
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
            + ++  LLG C+ +  + L+ ++M  G L   +    H  N+     +   V +A+G+ 
Sbjct: 81  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMN 137
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAP 323
           YL    +  +VHRDL + N+L+ +  + K++DFGL+   G + +     G    + ++A 
Sbjct: 138 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 194
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
           E +L    T +SDV+++GV + EL+  G +P + +  ++  S++
Sbjct: 195 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 238

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 114/224 (50%), Gaps = 16/224 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKI 206
             F++  V+G G  G VYK  +       K+  A+K + +A    A +E  +E   +  +
Sbjct: 40  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 99
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
            + ++  LLG C+ +  + L+ ++M  G L   +    H  N+     +   V +A+G+ 
Sbjct: 100 DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMN 156
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAP 323
           YL    +  +VHRDL + N+L+ +  + K++DFGL+   G + +     G    + ++A 
Sbjct: 157 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 213
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
           E +L    T +SDV+++GV + EL+  G +P + +  ++  S++
Sbjct: 214 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 257

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/281 (27%), Positives = 126/281 (44%), Gaps = 47/281 (16%)
Query: 160 VIGEGGRGHVYKARFN----EKLLAAVKRIDDAGHDAER-EFNNEVNWLTKIRHQNIISL 214
           VIG G  G V           ++  A+K +     + +R +F +E + + +  H N+I L
Sbjct: 40  VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHL 99
Query: 215 LGYCIHAETRFLVYEMMQNGSLE---KQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
            G    +    ++ E M+NGSL+   +Q  G      L   LR      +A G++YL   
Sbjct: 100 EGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLR-----GIAAGMKYL--- 151
Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLG------YVAPEY 325
            +   VHRDL + NIL++S+   K+SDFGLS      + +   +  LG      + APE 
Sbjct: 152 ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA 211
Query: 326 LLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMS----------------PTQCQSMVTW 368
           +   K T  SDV+++G+V+ E++  G RP   M+                P  C S +  
Sbjct: 212 IQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQ 271
Query: 369 AMPQL--TDRSKLP------NIVDPVIRDTMDLKHLYQVAA 401
            M      DR+  P      N +D +IR+   LK +  +++
Sbjct: 272 LMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNSLKAMAPLSS 312

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 114/224 (50%), Gaps = 16/224 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKI 206
             F++  V+G G  G VYK  +       K+  A+K + +A    A +E  +E   +  +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
            + ++  LLG C+ +  + L+ ++M  G L   +    H  N+     +   V +A+G+ 
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGXLLDYVR--EHKDNIGSQYLLNWCVQIAKGMN 131
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAP 323
           YL    +  +VHRDL + N+L+ +  + K++DFGL+   G + +     G    + ++A 
Sbjct: 132 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
           E +L    T +SDV+++GV + EL+  G +P + +  ++  S++
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/290 (24%), Positives = 127/290 (43%), Gaps = 24/290 (8%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNEK-LLAAVKRIDDAGHD--AEREFNNEVNWLTKIR 207
           +   ++   ++GEG  G V K R  +   + A+K+  ++  D   ++    E+  L ++R
Sbjct: 23  SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR 82
Query: 208 HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEY 267
           H+N+++LL  C   +  +LV+E + +  L+     P   + L + +  K    +  G+ +
Sbjct: 83  HENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFP---NGLDYQVVQKYLFQIINGIGF 139
Query: 268 LHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPEYL 326
            H   +H ++HRD+K  NIL+  S   KL DFG + T             T  Y APE L
Sbjct: 140 CH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELL 196
Query: 327 L-EGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSK------- 378
           + + K     DV+A G ++ E+ MG       S       +   +  L  R +       
Sbjct: 197 VGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP 256
Query: 379 -LPNIVDPVIRDTMDLKHLYQ-----VAAVAVLCIQPEPSYRPLITDVLH 422
               +  P I++   L+  Y      V  +A  C+  +P  RP   ++LH
Sbjct: 257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 100/201 (49%), Gaps = 9/201 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           +G G  G V+ A +N+    AVK +       E  F  E N +  ++H  ++ L    + 
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHA-VVT 80
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
            E  +++ E M  GSL   L     GS       +  +  +A G+ ++ E  N+  +HRD
Sbjct: 81  KEPIYIITEFMAKGSLLDFLKS-DEGSKQPLPKLIDFSAQIAEGMAFI-EQRNY--IHRD 136
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
           L+++NIL+ +S   K++DFGL+          +      + + APE +  G  T KSDV+
Sbjct: 137 LRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 196
Query: 339 AFGVVLLELLM-GRRPVEKMS 358
           +FG++L+E++  GR P   MS
Sbjct: 197 SFGILLMEIVTYGRIPYPGMS 217

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 135/285 (47%), Gaps = 44/285 (15%)
Query: 160 VIGEGGRGHVYKARFN----EKLLAAVKRIDDAGHDAER-EFNNEVNWLTKIRHQNIISL 214
           VIG G  G V   R       +L  A+K +     + +R +F  E + + +  H NII L
Sbjct: 29  VIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHL 88
Query: 215 LGYCIHAETRFLVYEMMQNGSLE---KQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
            G    ++   +V E M+NGSL+   K+  G      L   LR      ++ G++YL + 
Sbjct: 89  EGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLR-----GISAGMKYLSDM 143
Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT------AGTQSRNVKISGTLGYVAPEY 325
                VHRDL + NIL++S+   K+SDFGLS        A   +R  KI   + + APE 
Sbjct: 144 G---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP--IRWTAPEA 198
Query: 326 LLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVD 384
           +   K T  SDV+++G+V+ E++  G RP  +M+           +  + +  +LP+ +D
Sbjct: 199 IAFRKFTSASDVWSYGIVMWEVVSYGERPYWEMTNQD-------VIKAVEEGYRLPSPMD 251
Query: 385 -PVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLV 428
            P          LYQ   + + C Q E + RP   ++++ L  L+
Sbjct: 252 CPAA--------LYQ---LMLDCWQKERNSRPKFDEIVNMLDKLI 285

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 113/224 (50%), Gaps = 16/224 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKI 206
             F++  V+G G  G VYK  +       K+  A+K + +A    A +E  +E   +  +
Sbjct: 12  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 71
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
            + ++  LLG C+ +  + L+ ++M  G L   +    H  N+     +   V +A G+ 
Sbjct: 72  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAEGMN 128
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAP 323
           YL    +  +VHRDL + N+L+ +  + K++DFGL+   G + +     G    + ++A 
Sbjct: 129 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 185
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
           E +L    T +SDV+++GV + EL+  G +P + +  ++  S++
Sbjct: 186 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 229

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 111/243 (45%), Gaps = 28/243 (11%)
Query: 161 IGEGGRGHVYKARFNEKLLA---AVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGY 217
           IGEG  G V  A   EK      AVK++D           NEV  +    H N++ +   
Sbjct: 53  IGEGSTGIVCIA--TEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSS 110
Query: 218 CIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMK------IAVDVARGLEYLHEH 271
            +  +  ++V E ++ G+L          +++  H RM       + + V R L YLH  
Sbjct: 111 YLVGDELWVVMEFLEGGAL----------TDIVTHTRMNEEQIATVCLSVLRALSYLH-- 158
Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK-ISGTLGYVAPEYLLEGK 330
            N  V+HRD+KS +ILL S    KLSDFG       +    K + GT  ++APE +    
Sbjct: 159 -NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLP 217
Query: 331 LTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDT 390
              + D+++ G++++E++ G  P     P Q    +  ++P    R K  + V  V+R  
Sbjct: 218 YGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDSLP---PRVKDLHKVSSVLRGF 274
Query: 391 MDL 393
           +DL
Sbjct: 275 LDL 277

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 107/210 (50%), Gaps = 20/210 (9%)
Query: 161 IGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCI 219
           +G+G  G VYKA+  E  +LAA K ID    +   ++  E++ L    H NI+ LL    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 220 HAETRFLVYEMMQNGSLEK---QLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPV 276
           +    +++ E    G+++    +L  P   S +   +  K  +D    L YLH   ++ +
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQI--QVVCKQTLD---ALNYLH---DNKI 156
Query: 277 VHRDLKSSNILLDSSFNAKLSDFGLSV--TAGTQSRNVKISGTLGYVAPEYLLEGKLTD- 333
           +HRDLK+ NIL     + KL+DFG+S   T   Q R+  I GT  ++APE ++     D 
Sbjct: 157 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDR 215
Query: 334 ----KSDVYAFGVVLLELLMGRRPVEKMSP 359
               K+DV++ G+ L+E+     P  +++P
Sbjct: 216 PYDYKADVWSLGITLIEMAEIEPPHHELNP 245

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 107/210 (50%), Gaps = 20/210 (9%)
Query: 161 IGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCI 219
           +G+G  G VYKA+  E  +LAA K ID    +   ++  E++ L    H NI+ LL    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 220 HAETRFLVYEMMQNGSLEK---QLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPV 276
           +    +++ E    G+++    +L  P   S +   +  K  +D    L YLH   ++ +
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQI--QVVCKQTLD---ALNYLH---DNKI 156
Query: 277 VHRDLKSSNILLDSSFNAKLSDFGLSV--TAGTQSRNVKISGTLGYVAPEYLLEGKLTD- 333
           +HRDLK+ NIL     + KL+DFG+S   T   Q R+  I GT  ++APE ++     D 
Sbjct: 157 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFI-GTPYWMAPEVVMCETSKDR 215
Query: 334 ----KSDVYAFGVVLLELLMGRRPVEKMSP 359
               K+DV++ G+ L+E+     P  +++P
Sbjct: 216 PYDYKADVWSLGITLIEMAEIEPPHHELNP 245

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 101/205 (49%), Gaps = 12/205 (5%)
Query: 153 NNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKIRHQ 209
            NFQ+   IGEG  G VYKAR     +++A  K R+D            E++ L ++ H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 210 NIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYL 268
           NI+ LL   IH E + +LV+E +      K+    +  + +   L       + +GL + 
Sbjct: 63  NIVKLLD-VIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 269 HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPEYLL 327
           H   +H V+HRDLK  N+L+++    KL+DFGL+   G   R       TL Y APE LL
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 176
Query: 328 EGKLTDKS-DVYAFGVVLLELLMGR 351
             K    + D+++ G +  E++  R
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 101/205 (49%), Gaps = 12/205 (5%)
Query: 153 NNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKIRHQ 209
            NFQ+   IGEG  G VYKAR     +++A  K R+D            E++ L ++ H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 210 NIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYL 268
           NI+ LL   IH E + +LV+E +      K+    +  + +   L       + +GL + 
Sbjct: 62  NIVKLLD-VIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 269 HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPEYLL 327
           H   +H V+HRDLK  N+L+++    KL+DFGL+   G   R       TL Y APE LL
Sbjct: 119 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175
Query: 328 EGKLTDKS-DVYAFGVVLLELLMGR 351
             K    + D+++ G +  E++  R
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 107/210 (50%), Gaps = 20/210 (9%)
Query: 161 IGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCI 219
           +G+G  G VYKA+  E  +LAA K ID    +   ++  E++ L    H NI+ LL    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 220 HAETRFLVYEMMQNGSLEK---QLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPV 276
           +    +++ E    G+++    +L  P   S +   +  K  +D    L YLH   ++ +
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQI--QVVCKQTLD---ALNYLH---DNKI 156
Query: 277 VHRDLKSSNILLDSSFNAKLSDFGLSV--TAGTQSRNVKISGTLGYVAPEYLLEGKLTD- 333
           +HRDLK+ NIL     + KL+DFG+S   T   Q R+  I GT  ++APE ++     D 
Sbjct: 157 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFI-GTPYWMAPEVVMCETSKDR 215
Query: 334 ----KSDVYAFGVVLLELLMGRRPVEKMSP 359
               K+DV++ G+ L+E+     P  +++P
Sbjct: 216 PYDYKADVWSLGITLIEMAEIEPPHHELNP 245

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 100/199 (50%), Gaps = 15/199 (7%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           +G G  G V+ A +N+    AVK +       E  F  E N +  ++H  ++ L    + 
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHA-VVT 247
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
            E  +++ E M  GSL   L     GS       +  +  +A G+ ++ E  N+  +HRD
Sbjct: 248 KEPIYIITEFMAKGSLLDFLKS-DEGSKQPLPKLIDFSAQIAEGMAFI-EQRNY--IHRD 303
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAF 340
           L+++NIL+ +S   K++DFGL+         V     + + APE +  G  T KSDV++F
Sbjct: 304 LRAANILVSASLVCKIADFGLA--------RVGAKFPIKWTAPEAINFGSFTIKSDVWSF 355
Query: 341 GVVLLELLM-GRRPVEKMS 358
           G++L+E++  GR P   MS
Sbjct: 356 GILLMEIVTYGRIPYPGMS 374

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 12/208 (5%)
Query: 150 AATNNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKI 206
            +  NFQ+   IGEG  G VYKAR     +++A  K R+D            E++ L ++
Sbjct: 4   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 63
Query: 207 RHQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
            H NI+ LL   IH E + +LV+E +      K+    +  + +   L       + +GL
Sbjct: 64  NHPNIVKLLD-VIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGL 120
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPE 324
            + H   +H V+HRDLK  N+L+++    KL+DFGL+   G   R       TL Y APE
Sbjct: 121 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 177
Query: 325 YLLEGKLTDKS-DVYAFGVVLLELLMGR 351
            LL  K    + D+++ G +  E++  R
Sbjct: 178 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 101/205 (49%), Gaps = 12/205 (5%)
Query: 153 NNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKIRHQ 209
            NFQ+   IGEG  G VYKAR     +++A  K R+D            E++ L ++ H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 210 NIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYL 268
           NI+ LL   IH E + +LV+E +      K+    +  + +   L       + +GL + 
Sbjct: 63  NIVKLLD-VIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLSFC 119
Query: 269 HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPEYLL 327
           H   +H V+HRDLK  N+L+++    KL+DFGL+   G   R       TL Y APE LL
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 176
Query: 328 EGKLTDKS-DVYAFGVVLLELLMGR 351
             K    + D+++ G +  E++  R
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 12/208 (5%)
Query: 150 AATNNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKI 206
            +  NFQ+   IGEG  G VYKAR     +++A  K R+D            E++ L ++
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 207 RHQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
            H NI+ LL   IH E + +LV+E +      K+    +  + +   L       + +GL
Sbjct: 63  NHPNIVKLLD-VIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPE 324
            + H   +H V+HRDLK  N+L+++    KL+DFGL+   G   R       TL Y APE
Sbjct: 120 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 176
Query: 325 YLLEGKLTDKS-DVYAFGVVLLELLMGR 351
            LL  K    + D+++ G +  E++  R
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 12/208 (5%)
Query: 150 AATNNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKI 206
            +  NFQ+   IGEG  G VYKAR     +++A  K R+D            E++ L ++
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 207 RHQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
            H NI+ LL   IH E + +LV+E +      K+    +  + +   L       + +GL
Sbjct: 62  NHPNIVKLLD-VIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGL 118
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPE 324
            + H   +H V+HRDLK  N+L+++    KL+DFGL+   G   R       TL Y APE
Sbjct: 119 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 175
Query: 325 YLLEGKLTDKS-DVYAFGVVLLELLMGR 351
            LL  K    + D+++ G +  E++  R
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 12/208 (5%)
Query: 150 AATNNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKI 206
            +  NFQ+   IGEG  G VYKAR     +++A  K R+D            E++ L ++
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 207 RHQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
            H NI+ LL   IH E + +LV+E +      K+    +  + +   L       + +GL
Sbjct: 61  NHPNIVKLLD-VIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGL 117
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPE 324
            + H   +H V+HRDLK  N+L+++    KL+DFGL+   G   R       TL Y APE
Sbjct: 118 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 174
Query: 325 YLLEGKLTDKS-DVYAFGVVLLELLMGR 351
            LL  K    + D+++ G +  E++  R
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 102/207 (49%), Gaps = 12/207 (5%)
Query: 151 ATNNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKIR 207
           +  NFQ+   IGEG  G VYKAR     +++A  K R+D            E++ L ++ 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 208 HQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
           H NI+ LL   IH E + +LV+E +      K+    +  + +   L       + +GL 
Sbjct: 61  HPNIVKLLD-VIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPEY 325
           + H   +H V+HRDLK  N+L+++    KL+DFGL+   G   R       TL Y APE 
Sbjct: 118 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 174
Query: 326 LLEGKLTDKS-DVYAFGVVLLELLMGR 351
           LL  K    + D+++ G +  E++  R
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 102/207 (49%), Gaps = 12/207 (5%)
Query: 151 ATNNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKIR 207
           +  NFQ+   IGEG  G VYKAR     +++A  K R+D            E++ L ++ 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 208 HQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
           H NI+ LL   IH E + +LV+E +      K+    +  + +   L       + +GL 
Sbjct: 61  HPNIVKLLD-VIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPEY 325
           + H   +H V+HRDLK  N+L+++    KL+DFGL+   G   R       TL Y APE 
Sbjct: 118 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 174
Query: 326 LLEGKLTDKS-DVYAFGVVLLELLMGR 351
           LL  K    + D+++ G +  E++  R
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 12/208 (5%)
Query: 150 AATNNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKI 206
            +  NFQ+   IGEG  G VYKAR     +++A  K R+D            E++ L ++
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 207 RHQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
            H NI+ LL   IH E + +LV+E +      K+    +  + +   L       + +GL
Sbjct: 61  NHPNIVKLLD-VIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGL 117
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPE 324
            + H   +H V+HRDLK  N+L+++    KL+DFGL+   G   R       TL Y APE
Sbjct: 118 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 174
Query: 325 YLLEGKLTDKS-DVYAFGVVLLELLMGR 351
            LL  K    + D+++ G +  E++  R
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 12/208 (5%)
Query: 150 AATNNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKI 206
            +  NFQ+   IGEG  G VYKAR     +++A  K R+D            E++ L ++
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 207 RHQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
            H NI+ LL   IH E + +LV+E +      K+    +  + +   L       + +GL
Sbjct: 62  NHPNIVKLLD-VIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGL 118
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPE 324
            + H   +H V+HRDLK  N+L+++    KL+DFGL+   G   R       TL Y APE
Sbjct: 119 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 175
Query: 325 YLLEGKLTDKS-DVYAFGVVLLELLMGR 351
            LL  K    + D+++ G +  E++  R
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 12/208 (5%)
Query: 150 AATNNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKI 206
            +  NFQ+   IGEG  G VYKAR     +++A  K R+D            E++ L ++
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 207 RHQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
            H NI+ LL   IH E + +LV+E +      K+    +  + +   L       + +GL
Sbjct: 62  NHPNIVKLLD-VIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGL 118
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPE 324
            + H   +H V+HRDLK  N+L+++    KL+DFGL+   G   R       TL Y APE
Sbjct: 119 AFCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 175
Query: 325 YLLEGKLTDKS-DVYAFGVVLLELLMGR 351
            LL  K    + D+++ G +  E++  R
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 102/207 (49%), Gaps = 12/207 (5%)
Query: 151 ATNNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKIR 207
           +  NFQ+   IGEG  G VYKAR     +++A  K R+D            E++ L ++ 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 208 HQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
           H NI+ LL   IH E + +LV+E +      K+    +  + +   L       + +GL 
Sbjct: 61  HPNIVKLLD-VIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPEY 325
           + H   +H V+HRDLK  N+L+++    KL+DFGL+   G   R       TL Y APE 
Sbjct: 118 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 174
Query: 326 LLEGKLTDKS-DVYAFGVVLLELLMGR 351
           LL  K    + D+++ G +  E++  R
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 101/205 (49%), Gaps = 12/205 (5%)
Query: 153 NNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKIRHQ 209
            NFQ+   IGEG  G VYKAR     +++A  K R+D            E++ L ++ H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 210 NIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYL 268
           NI+ LL   IH E + +LV+E +      K+    +  + +   L       + +GL + 
Sbjct: 63  NIVKLLD-VIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 269 HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPEYLL 327
           H   +H V+HRDLK  N+L+++    KL+DFGL+   G   R       TL Y APE LL
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 176
Query: 328 EGKLTDKS-DVYAFGVVLLELLMGR 351
             K    + D+++ G +  E++  R
Sbjct: 177 GXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 101/205 (49%), Gaps = 12/205 (5%)
Query: 153 NNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKIRHQ 209
            NFQ+   IGEG  G VYKAR     +++A  K R+D            E++ L ++ H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 210 NIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYL 268
           NI+ LL   IH E + +LV+E +      K+    +  + +   L       + +GL + 
Sbjct: 70  NIVKLLD-VIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 126
Query: 269 HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPEYLL 327
           H   +H V+HRDLK  N+L+++    KL+DFGL+   G   R       TL Y APE LL
Sbjct: 127 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 183
Query: 328 EGKLTDKS-DVYAFGVVLLELLMGR 351
             K    + D+++ G +  E++  R
Sbjct: 184 GCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 101/205 (49%), Gaps = 12/205 (5%)
Query: 153 NNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKIRHQ 209
            NFQ+   IGEG  G VYKAR     +++A  K R+D            E++ L ++ H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 210 NIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYL 268
           NI+ LL   IH E + +LV+E +      K+    +  + +   L       + +GL + 
Sbjct: 62  NIVKLLD-VIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 269 HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPEYLL 327
           H   +H V+HRDLK  N+L+++    KL+DFGL+   G   R       TL Y APE LL
Sbjct: 119 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 175
Query: 328 EGKLTDKS-DVYAFGVVLLELLMGR 351
             K    + D+++ G +  E++  R
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 101/205 (49%), Gaps = 12/205 (5%)
Query: 153 NNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKIRHQ 209
            NFQ+   IGEG  G VYKAR     +++A  K R+D            E++ L ++ H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 210 NIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYL 268
           NI+ LL   IH E + +LV+E +      K+    +  + +   L       + +GL + 
Sbjct: 63  NIVKLLD-VIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 269 HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPEYLL 327
           H   +H V+HRDLK  N+L+++    KL+DFGL+   G   R       TL Y APE LL
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 176
Query: 328 EGKLTDKS-DVYAFGVVLLELLMGR 351
             K    + D+++ G +  E++  R
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 101/205 (49%), Gaps = 12/205 (5%)
Query: 153 NNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKIRHQ 209
            NFQ+   IGEG  G VYKAR     +++A  K R+D            E++ L ++ H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 210 NIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYL 268
           NI+ LL   IH E + +LV+E +      K+    +  + +   L       + +GL + 
Sbjct: 62  NIVKLLD-VIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 269 HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPEYLL 327
           H   +H V+HRDLK  N+L+++    KL+DFGL+   G   R       TL Y APE LL
Sbjct: 119 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 175
Query: 328 EGKLTDKS-DVYAFGVVLLELLMGR 351
             K    + D+++ G +  E++  R
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 101/205 (49%), Gaps = 12/205 (5%)
Query: 153 NNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKIRHQ 209
            NFQ+   IGEG  G VYKAR     +++A  K R+D            E++ L ++ H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 210 NIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYL 268
           NI+ LL   IH E + +LV+E +      K+    +  + +   L       + +GL + 
Sbjct: 70  NIVKLLD-VIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 126
Query: 269 HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPEYLL 327
           H   +H V+HRDLK  N+L+++    KL+DFGL+   G   R       TL Y APE LL
Sbjct: 127 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 183
Query: 328 EGKLTDKS-DVYAFGVVLLELLMGR 351
             K    + D+++ G +  E++  R
Sbjct: 184 GXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 101/205 (49%), Gaps = 12/205 (5%)
Query: 153 NNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKIRHQ 209
            NFQ+   IGEG  G VYKAR     +++A  K R+D            E++ L ++ H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 210 NIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYL 268
           NI+ LL   IH E + +LV+E +      K+    +  + +   L       + +GL + 
Sbjct: 62  NIVKLLD-VIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 269 HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPEYLL 327
           H   +H V+HRDLK  N+L+++    KL+DFGL+   G   R       TL Y APE LL
Sbjct: 119 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175
Query: 328 EGKLTDKS-DVYAFGVVLLELLMGR 351
             K    + D+++ G +  E++  R
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 101/205 (49%), Gaps = 12/205 (5%)
Query: 153 NNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKIRHQ 209
            NFQ+   IGEG  G VYKAR     +++A  K R+D            E++ L ++ H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 210 NIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYL 268
           NI+ LL   IH E + +LV+E +      K+    +  + +   L       + +GL + 
Sbjct: 62  NIVKLLD-VIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 269 HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPEYLL 327
           H   +H V+HRDLK  N+L+++    KL+DFGL+   G   R       TL Y APE LL
Sbjct: 119 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175
Query: 328 EGKLTDKS-DVYAFGVVLLELLMGR 351
             K    + D+++ G +  E++  R
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 104/206 (50%), Gaps = 8/206 (3%)
Query: 145 YELLEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWL 203
           Y+  E    +    + +G G  G VY+  + +  L  AVK + +   + E EF  E   +
Sbjct: 212 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVM 270
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
            +I+H N++ LLG C      +++ E M  G+L   L    +   ++  + + +A  ++ 
Sbjct: 271 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISS 329
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYV 321
            +EYL +      +HR+L + N L+  +   K++DFGLS  +T  T + +      + + 
Sbjct: 330 AMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 386
Query: 322 APEYLLEGKLTDKSDVYAFGVVLLEL 347
           APE L   K + KSDV+AFGV+L E+
Sbjct: 387 APESLAYNKFSIKSDVWAFGVLLWEI 412

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 87/323 (26%), Positives = 146/323 (45%), Gaps = 57/323 (17%)
Query: 139 TVSVIEYELLEAATNNFQESNVI-----GEGGRGHVYKAR-FNEKLLA-----AVKRIDD 187
           ++SV  +++LE     F   N++     GEG  G V KA  F+ K  A     AVK + +
Sbjct: 4   SLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKE 63
Query: 188 AGHDAE-REFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSL-----EKQLH 241
               +E R+  +E N L ++ H ++I L G C       L+ E  + GSL     E +  
Sbjct: 64  NASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKV 123
Query: 242 GPTH----------------GSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSN 285
           GP +                   LT    +  A  +++G++YL E     +VHRDL + N
Sbjct: 124 GPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMS---LVHRDLAARN 180
Query: 286 ILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAPEYLLEGKLTDKSDVYAFGV 342
           IL+      K+SDFGLS     +   VK S     + ++A E L +   T +SDV++FGV
Sbjct: 181 ILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGV 240
Query: 343 VLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAA 401
           +L E++ +G  P   + P +  +++     +   R + P+            + +Y+   
Sbjct: 241 LLWEIVTLGGNPYPGIPPERLFNLL-----KTGHRMERPDNCS---------EEMYR--- 283
Query: 402 VAVLCIQPEPSYRPLITDVLHSL 424
           + + C + EP  RP+  D+   L
Sbjct: 284 LMLQCWKQEPDKRPVFADISKDL 306

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 12/208 (5%)
Query: 150 AATNNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKI 206
            +  NFQ+   IGEG  G VYKAR     +++A  K R+D            E++ L ++
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 207 RHQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
            H NI+ LL   IH E + +LV+E +      K+    +  + +   L       + +GL
Sbjct: 63  NHPNIVKLLD-VIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPE 324
            + H   +H V+HRDLK  N+L+++    KL+DFGL+   G   R       TL Y APE
Sbjct: 120 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 176
Query: 325 YLLEGKLTDKS-DVYAFGVVLLELLMGR 351
            LL  K    + D+++ G +  E++  R
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 101/205 (49%), Gaps = 12/205 (5%)
Query: 153 NNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKIRHQ 209
            NFQ+   IGEG  G VYKAR     +++A  K R+D            E++ L ++ H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 210 NIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYL 268
           NI+ LL   IH E + +LV+E +      K+    +  + +   L       + +GL + 
Sbjct: 63  NIVKLLD-VIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 269 HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPEYLL 327
           H   +H V+HRDLK  N+L+++    KL+DFGL+   G   R       TL Y APE LL
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 176
Query: 328 EGKLTDKS-DVYAFGVVLLELLMGR 351
             K    + D+++ G +  E++  R
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 132/297 (44%), Gaps = 44/297 (14%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA------RFNEKLLAAVKRIDDAGHDAER-EFNNEVN 201
           E A      S  +G+G  G VY+       +   +   A+K +++A    ER EF NE +
Sbjct: 11  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 70
Query: 202 WLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHG--PTHGSNL-----TWHLR 254
            + +    +++ LLG     +   ++ E+M  G L+  L    P   +N      +    
Sbjct: 71  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 130
Query: 255 MKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKI 314
           +++A ++A G+ YL+ +     VHRDL + N ++   F  K+ DFG+  T      +   
Sbjct: 131 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGM--TRDIYETDYYR 185
Query: 315 SGTLG-----YVAPEYLLEGKLTDKSDVYAFGVVLLEL-LMGRRPVEKMSPTQCQSMVTW 368
            G  G     +++PE L +G  T  SDV++FGVVL E+  +  +P + +S  Q    V  
Sbjct: 186 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 245
Query: 369 AMPQLTDR-SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
               L D+    P+++  ++R                +C Q  P  RP   +++ S+
Sbjct: 246 G--GLLDKPDNCPDMLFELMR----------------MCWQYNPKMRPSFLEIISSI 284

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 59/190 (31%), Positives = 97/190 (51%), Gaps = 8/190 (4%)
Query: 161 IGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCI 219
           +G G  G VY   + +  L  AVK + +   + E EF  E   + +I+H N++ LLG C 
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 98
Query: 220 HAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHR 279
                ++V E M  G+L   L    +   +T  + + +A  ++  +EYL +      +HR
Sbjct: 99  LEPPFYIVTEYMPYGNLLDYLR-ECNREEVTAVVLLYMATQISSAMEYLEK---KNFIHR 154
Query: 280 DLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDV 337
           DL + N L+  +   K++DFGLS  +T  T + +      + + APE L     + KSDV
Sbjct: 155 DLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDV 214
Query: 338 YAFGVVLLEL 347
           +AFGV+L E+
Sbjct: 215 WAFGVLLWEI 224

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 12/208 (5%)
Query: 150 AATNNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKI 206
            +  NFQ+   IGEG  G VYKAR     +++A  K R+D            E++ L ++
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 207 RHQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
            H NI+ LL   IH E + +LV+E +      K+    +  + +   L       + +GL
Sbjct: 61  NHPNIVKLLD-VIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGL 117
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPE 324
            + H   +H V+HRDLK  N+L+++    KL+DFGL+   G   R       TL Y APE
Sbjct: 118 AFCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 174
Query: 325 YLLEGKLTDKS-DVYAFGVVLLELLMGR 351
            LL  K    + D+++ G +  E++  R
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 101/205 (49%), Gaps = 12/205 (5%)
Query: 153 NNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKIRHQ 209
            NFQ+   IGEG  G VYKAR     +++A  K R+D            E++ L ++ H 
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 210 NIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYL 268
           NI+ LL   IH E + +LV+E +      K+    +  + +   L       + +GL + 
Sbjct: 67  NIVKLLD-VIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 123
Query: 269 HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPEYLL 327
           H   +H V+HRDLK  N+L+++    KL+DFGL+   G   R       TL Y APE LL
Sbjct: 124 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 180
Query: 328 EGKLTDKS-DVYAFGVVLLELLMGR 351
             K    + D+++ G +  E++  R
Sbjct: 181 GCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 102/207 (49%), Gaps = 12/207 (5%)
Query: 151 ATNNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKIR 207
           +  NFQ+   IGEG  G VYKAR     +++A  K R+D            E++ L ++ 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 208 HQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
           H NI+ LL   IH E + +LV+E +      K+    +  + +   L       + +GL 
Sbjct: 61  HPNIVKLLD-VIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPEY 325
           + H   +H V+HRDLK  N+L+++    KL+DFGL+   G   R       TL Y APE 
Sbjct: 118 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 174
Query: 326 LLEGKLTDKS-DVYAFGVVLLELLMGR 351
           LL  K    + D+++ G +  E++  R
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 113/224 (50%), Gaps = 16/224 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKI 206
             F++  V+G G  G VYK  +       K+  A+K + +A    A +E  +E   +  +
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
            + ++  LLG C+ +  + L+ ++M  G L   +    H  N+     +   V +A+G+ 
Sbjct: 79  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMN 135
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAP 323
           YL    +  +VHRDL + N+L+ +  + K++DFG +   G + +     G    + ++A 
Sbjct: 136 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 192
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
           E +L    T +SDV+++GV + EL+  G +P + +  ++  S++
Sbjct: 193 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 236

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 101/205 (49%), Gaps = 12/205 (5%)
Query: 153 NNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKIRHQ 209
            NFQ+   IGEG  G VYKAR     +++A  K R+D            E++ L ++ H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 210 NIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYL 268
           NI+ LL   IH E + +LV+E +      K+    +  + +   L       + +GL + 
Sbjct: 64  NIVKLLD-VIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 269 HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPEYLL 327
           H   +H V+HRDLK  N+L+++    KL+DFGL+   G   R       TL Y APE LL
Sbjct: 121 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 177
Query: 328 EGKLTDKS-DVYAFGVVLLELLMGR 351
             K    + D+++ G +  E++  R
Sbjct: 178 GCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 132/297 (44%), Gaps = 44/297 (14%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA------RFNEKLLAAVKRIDDAGHDAER-EFNNEVN 201
           E A      S  +G+G  G VY+       +   +   A+K +++A    ER EF NE +
Sbjct: 21  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 80
Query: 202 WLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHG--PTHGSNL-----TWHLR 254
            + +    +++ LLG     +   ++ E+M  G L+  L    P   +N      +    
Sbjct: 81  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 140
Query: 255 MKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKI 314
           +++A ++A G+ YL+    +  VHRDL + N ++   F  K+ DFG+  T      +   
Sbjct: 141 IQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGM--TRDIYETDYYR 195
Query: 315 SGTLG-----YVAPEYLLEGKLTDKSDVYAFGVVLLEL-LMGRRPVEKMSPTQCQSMVTW 368
            G  G     +++PE L +G  T  SDV++FGVVL E+  +  +P + +S  Q    V  
Sbjct: 196 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 255
Query: 369 AMPQLTDR-SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
               L D+    P+++  ++R                +C Q  P  RP   +++ S+
Sbjct: 256 G--GLLDKPDNCPDMLFELMR----------------MCWQYNPKMRPSFLEIISSI 294

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 121/268 (45%), Gaps = 26/268 (9%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           +G G  G V+   +N     AVK +   G  + + F  E N +  ++H  ++ L      
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTR 79
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
            E  +++ E M  GSL   L     G  L   L +  +  +A G+ Y+ E  N+  +HRD
Sbjct: 80  EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKL-IDFSAQIAEGMAYI-ERKNY--IHRD 135
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
           L+++N+L+  S   K++DFGL+          +      + + APE +  G  T KSDV+
Sbjct: 136 LRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSDVW 195
Query: 339 AFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLY 397
           +FG++L E++  G+ P     P +  + V  A+ Q     ++ N  D           LY
Sbjct: 196 SFGILLYEIVTYGKIPY----PGRTNADVMTALSQGYRMPRVENCPD----------ELY 241
Query: 398 QVAAVAVLCIQPEPSYRPLITDVLHSLI 425
            +     +C + +   RP   D L S++
Sbjct: 242 DIMK---MCWKEKAEERPTF-DYLQSVL 265

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 113/224 (50%), Gaps = 16/224 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKI 206
             F++  V+G G  G VYK  +       K+  A+K + +A    A +E  +E   +  +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
            + ++  LLG C+ +  + L+ ++M  G L   +    H  N+     +   V +A+G+ 
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMN 131
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAP 323
           YL    +  +VHRDL + N+L+ +  + K++DFG +   G + +     G    + ++A 
Sbjct: 132 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
           E +L    T +SDV+++GV + EL+  G +P + +  ++  S++
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 105/209 (50%), Gaps = 14/209 (6%)
Query: 150 AATNNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKI 206
            +  NFQ+   IGEG  G VYKAR     +++A  K R+D            E++ L ++
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 207 RHQNIISLLGYCIHAETR-FLVYEMMQNGSLE-KQLHGPTHGSNLTWHLRMKIAVDVARG 264
            H NI+ LL   IH E + +LV+E +   S++ K+    +  + +   L       + +G
Sbjct: 63  NHPNIVKLLD-VIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQG 118
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAP 323
           L + H   +H V+HRDLK  N+L+++    KL+DFGL+   G   R       TL Y AP
Sbjct: 119 LAFCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAP 175
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           E LL  K    + D+++ G +  E++  R
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 101/207 (48%), Gaps = 12/207 (5%)
Query: 151 ATNNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKIR 207
           +  NFQ+   IGEG  G VYKAR     +++A  K R+D            E++ L ++ 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 208 HQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
           H NI+ LL   IH E + +LV+E +      K     +  + +   L       + +GL 
Sbjct: 61  HPNIVKLLD-VIHTENKLYLVFEFLHQDL--KDFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPEY 325
           + H   +H V+HRDLK  N+L+++    KL+DFGL+   G   R       TL Y APE 
Sbjct: 118 FCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 174
Query: 326 LLEGKLTDKS-DVYAFGVVLLELLMGR 351
           LL  K    + D+++ G +  E++  R
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 113/224 (50%), Gaps = 16/224 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKI 206
             F++  V+G G  G VYK  +       K+  A+K + +A    A +E  +E   +  +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
            + ++  LLG C+ +  + L+ ++M  G L   +    H  N+     +   V +A+G+ 
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMN 133
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAP 323
           YL    +  +VHRDL + N+L+ +  + K++DFG +   G + +     G    + ++A 
Sbjct: 134 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
           E +L    T +SDV+++GV + EL+  G +P + +  ++  S++
Sbjct: 191 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 234

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 113/224 (50%), Gaps = 16/224 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKI 206
             F++  V+  G  G VYK  +       K+  A+K + +A    A +E  +E   +  +
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
            + ++  LLG C+ +  + L+ ++M  G L   +    H  N+     +   V +A+G+ 
Sbjct: 82  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMN 138
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAP 323
           YL    +  +VHRDL + N+L+ +  + K++DFGL+   G + +     G    + ++A 
Sbjct: 139 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 195
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
           E +L    T +SDV+++GV + EL+  G +P + +  ++  S++
Sbjct: 196 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 239

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/252 (27%), Positives = 112/252 (44%), Gaps = 24/252 (9%)
Query: 126 ERFNSLRLAGKKDTVSVIEYELLEAATNNFQES---------NVIGEGGRGHVYKARF-- 174
           E +   +  G K  +    YE    A + F +           VIG G  G V   R   
Sbjct: 7   ELYFHFKFPGTKTYIDPETYEDPNRAVHQFAKELDASCIKIERVIGAGEFGEVCSGRLKL 66
Query: 175 -NEKLLAAVKRIDDAGHDAE--REFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMM 231
             ++ +A   +    G+  +  R+F  E + + +  H N++ L G     +   +V E M
Sbjct: 67  PGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFM 126
Query: 232 QNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS 291
           +NG+L+  L    H    T    + +   +A G+ YL    +   VHRDL + NIL++S+
Sbjct: 127 ENGALDAFLR--KHDGQFTVIQLVGMLRGIAAGMRYL---ADMGYVHRDLAARNILVNSN 181
Query: 292 FNAKLSDFGLSVTAGTQSRNVKISG----TLGYVAPEYLLEGKLTDKSDVYAFGVVLLEL 347
              K+SDFGLS         V  +      + + APE +   K T  SDV+++G+V+ E+
Sbjct: 182 LVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEV 241
Query: 348 L-MGRRPVEKMS 358
           +  G RP   MS
Sbjct: 242 MSYGERPYWDMS 253

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 101/208 (48%), Gaps = 12/208 (5%)
Query: 150 AATNNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKI 206
            +  NFQ+   IGEG  G VYKAR     +++A  K R+D            E++ L ++
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 207 RHQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
            H NI+ LL   IH E + +LV+E +      K     +  + +   L       + +GL
Sbjct: 63  NHPNIVKLLD-VIHTENKLYLVFEFLHQDL--KTFMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPE 324
            + H   +H V+HRDLK  N+L+++    KL+DFGL+   G   R       TL Y APE
Sbjct: 120 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 176
Query: 325 YLLEGKLTDKS-DVYAFGVVLLELLMGR 351
            LL  K    + D+++ G +  E++  R
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 100/201 (49%), Gaps = 9/201 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           +G G  G V+ A +N+    AVK +       E  F  E N +  ++H  ++ L    + 
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHA-VVT 253
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
            E  +++ E M  GSL   L     GS       +  +  +A G+ ++ E  N+  +HRD
Sbjct: 254 KEPIYIITEFMAKGSLLDFLKS-DEGSKQPLPKLIDFSAQIAEGMAFI-EQRNY--IHRD 309
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
           L+++NIL+ +S   K++DFGL+          +      + + APE +  G  T KSDV+
Sbjct: 310 LRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 369
Query: 339 AFGVVLLELLM-GRRPVEKMS 358
           +FG++L+E++  GR P   MS
Sbjct: 370 SFGILLMEIVTYGRIPYPGMS 390

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 113/224 (50%), Gaps = 16/224 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKI 206
             F++  V+G G  G VYK  +       K+  A+K + +A    A +E  +E   +  +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
            + ++  LLG C+ +  + L+ ++M  G L   +    H  N+     +   V +A+G+ 
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMN 133
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAP 323
           YL    +  +VHRDL + N+L+ +  + K++DFG +   G + +     G    + ++A 
Sbjct: 134 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
           E +L    T +SDV+++GV + EL+  G +P + +  ++  S++
Sbjct: 191 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 234

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 113/224 (50%), Gaps = 16/224 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKI 206
             F++  V+G G  G VYK  +       K+  A+  + +A    A +E  +E   +  +
Sbjct: 49  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASV 108
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
            + ++  LLG C+ +  + L+ ++M  G L   +    H  N+     +   V +A+G+ 
Sbjct: 109 DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMN 165
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAP 323
           YL    +  +VHRDL + N+L+ +  + K++DFGL+   G + +     G    + ++A 
Sbjct: 166 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 222
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
           E +L    T +SDV+++GV + EL+  G +P + +  ++  S++
Sbjct: 223 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 266

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 132/297 (44%), Gaps = 44/297 (14%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA------RFNEKLLAAVKRIDDAGHDAER-EFNNEVN 201
           E A      S  +G+G  G VY+       +   +   A+K +++A    ER EF NE +
Sbjct: 15  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 74
Query: 202 WLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHG--PTHGSNL-----TWHLR 254
            + +    +++ LLG     +   ++ E+M  G L+  L    P   +N      +    
Sbjct: 75  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 134
Query: 255 MKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKI 314
           +++A ++A G+ YL+ +     VHRDL + N ++   F  K+ DFG+  T      +   
Sbjct: 135 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGM--TRDIXETDXXR 189
Query: 315 SGTLG-----YVAPEYLLEGKLTDKSDVYAFGVVLLEL-LMGRRPVEKMSPTQCQSMVTW 368
            G  G     +++PE L +G  T  SDV++FGVVL E+  +  +P + +S  Q    V  
Sbjct: 190 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 249
Query: 369 AMPQLTDR-SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
               L D+    P+++  ++R                +C Q  P  RP   +++ S+
Sbjct: 250 G--GLLDKPDNCPDMLFELMR----------------MCWQYNPKMRPSFLEIISSI 288

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 105/209 (50%), Gaps = 14/209 (6%)
Query: 150 AATNNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKI 206
            +  NFQ+   IGEG  G VYKAR     +++A  K R+D            E++ L ++
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 207 RHQNIISLLGYCIHAETR-FLVYEMMQNGSLE-KQLHGPTHGSNLTWHLRMKIAVDVARG 264
            H NI+ LL   IH E + +LV+E +   S++ K+    +  + +   L       + +G
Sbjct: 61  NHPNIVKLLD-VIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQG 116
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAP 323
           L + H   +H V+HRDLK  N+L+++    KL+DFGL+   G   R       TL Y AP
Sbjct: 117 LAFCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAP 173
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           E LL  K    + D+++ G +  E++  R
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 113/224 (50%), Gaps = 16/224 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKI 206
             F++  V+  G  G VYK  +       K+  A+K + +A    A +E  +E   +  +
Sbjct: 15  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
            + ++  LLG C+ +  + L+ ++M  G L   +    H  N+     +   V +A+G+ 
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMN 131
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAP 323
           YL    +  +VHRDL + N+L+ +  + K++DFGL+   G + +     G    + ++A 
Sbjct: 132 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
           E +L    T +SDV+++GV + EL+  G +P + +  ++  S++
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 87/323 (26%), Positives = 146/323 (45%), Gaps = 57/323 (17%)
Query: 139 TVSVIEYELLEAATNNFQESNVI-----GEGGRGHVYKAR-FNEKLLA-----AVKRIDD 187
           ++SV  +++LE     F   N++     GEG  G V KA  F+ K  A     AVK + +
Sbjct: 4   SLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKE 63
Query: 188 AGHDAE-REFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSL-----EKQLH 241
               +E R+  +E N L ++ H ++I L G C       L+ E  + GSL     E +  
Sbjct: 64  NASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKV 123
Query: 242 GPTH----------------GSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSN 285
           GP +                   LT    +  A  +++G++YL E     +VHRDL + N
Sbjct: 124 GPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARN 180
Query: 286 ILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAPEYLLEGKLTDKSDVYAFGV 342
           IL+      K+SDFGLS     +   VK S     + ++A E L +   T +SDV++FGV
Sbjct: 181 ILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGV 240
Query: 343 VLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAA 401
           +L E++ +G  P   + P +  +++     +   R + P+            + +Y+   
Sbjct: 241 LLWEIVTLGGNPYPGIPPERLFNLL-----KTGHRMERPDNCS---------EEMYR--- 283
Query: 402 VAVLCIQPEPSYRPLITDVLHSL 424
           + + C + EP  RP+  D+   L
Sbjct: 284 LMLQCWKQEPDKRPVFADISKDL 306

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 124/276 (44%), Gaps = 30/276 (10%)
Query: 155 FQESNVIGEGGRGHVYKARFNE-KLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNII 212
           F + + IG+G  G VYK   N  K + A+K ID +   D   +   E+  L++     I 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 213 SLLGYCIHAETRFLVYEMMQNGS-LEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
              G  + +   +++ E +  GS L+    GP   + +   LR     ++ +GL+YLH  
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIATILR-----EILKGLDYLHSE 135
Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLS-VTAGTQSRNVKISGTLGYVAPEYLLEGK 330
                +HRD+K++N+LL    + KL+DFG++     TQ +     GT  ++APE + +  
Sbjct: 136 RK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSA 192
Query: 331 LTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDT 390
              K+D+++ G+  +EL  G  P   + P +   ++    P                  T
Sbjct: 193 YDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPP-----------------T 235
Query: 391 MDLKHLYQVAAVAVLCIQPEPSYRPLITDVL-HSLI 425
           ++ +H          C+  +P +RP   ++L H  I
Sbjct: 236 LEGQHSKPFKEFVEACLNKDPRFRPTAKELLKHKFI 271

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 113/224 (50%), Gaps = 16/224 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKI 206
             F++  V+  G  G VYK  +       K+  A+K + +A    A +E  +E   +  +
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
            + ++  LLG C+ +  + L+ ++M  G L   +    H  N+     +   V +A+G+ 
Sbjct: 82  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMN 138
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAP 323
           YL    +  +VHRDL + N+L+ +  + K++DFGL+   G + +     G    + ++A 
Sbjct: 139 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 195
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
           E +L    T +SDV+++GV + EL+  G +P + +  ++  S++
Sbjct: 196 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 239

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 113/224 (50%), Gaps = 16/224 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKI 206
             F++  V+G G  G VYK  +       K+  A+K + +A    A +E  +E   +  +
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
            + ++  LLG C+ +  + L+ ++M  G L   +    H  N+     +   V +A+G+ 
Sbjct: 82  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMN 138
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAP 323
           YL    +  +VHRDL + N+L+ +  + K++DFG +   G + +     G    + ++A 
Sbjct: 139 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 195
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
           E +L    T +SDV+++GV + EL+  G +P + +  ++  S++
Sbjct: 196 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 239

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 113/224 (50%), Gaps = 16/224 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKI 206
             F++  V+G G  G VYK  +       K+  A+K + +A    A +E  +E   +  +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
            + ++  LLG C+ +  + L+ ++M  G L   +    H  N+     +   V +A+G+ 
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMN 133
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAP 323
           YL    +  +VHRDL + N+L+ +  + K++DFG +   G + +     G    + ++A 
Sbjct: 134 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
           E +L    T +SDV+++GV + EL+  G +P + +  ++  S++
Sbjct: 191 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 234

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/244 (29%), Positives = 116/244 (47%), Gaps = 38/244 (15%)
Query: 144 EYEL-LEAATNNFQESNVIGEGGRGHVYKA------RFNEKLLAAVKRIDDAGHDAERE- 195
           EY+L  E    N +   V+G G  G V  A      +    +  AVK + +    +ERE 
Sbjct: 35  EYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREA 94
Query: 196 FNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMMQNGSL------------------ 236
             +E+  +T++  H+NI++LLG C  +   +L++E    G L                  
Sbjct: 95  LMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEY 154
Query: 237 --EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA 294
             +K+L      + LT+   +  A  VA+G+E+L        VHRDL + N+L+      
Sbjct: 155 ENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVV 211
Query: 295 KLSDFGLSVTAGTQSRNVKISGT----LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-M 349
           K+ DFGL+    + S N  + G     + ++APE L EG  T KSDV+++G++L E+  +
Sbjct: 212 KICDFGLARDIMSDS-NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL 270
Query: 350 GRRP 353
           G  P
Sbjct: 271 GVNP 274

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 87/323 (26%), Positives = 146/323 (45%), Gaps = 57/323 (17%)
Query: 139 TVSVIEYELLEAATNNFQESNVI-----GEGGRGHVYKAR-FNEKLLA-----AVKRIDD 187
           ++SV  +++LE     F   N++     GEG  G V KA  F+ K  A     AVK + +
Sbjct: 4   SLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKE 63
Query: 188 AGHDAE-REFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSL-----EKQLH 241
               +E R+  +E N L ++ H ++I L G C       L+ E  + GSL     E +  
Sbjct: 64  NASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKV 123
Query: 242 GPTH----------------GSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSN 285
           GP +                   LT    +  A  +++G++YL E     +VHRDL + N
Sbjct: 124 GPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARN 180
Query: 286 ILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAPEYLLEGKLTDKSDVYAFGV 342
           IL+      K+SDFGLS     +   VK S     + ++A E L +   T +SDV++FGV
Sbjct: 181 ILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGV 240
Query: 343 VLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAA 401
           +L E++ +G  P   + P +  +++     +   R + P+            + +Y+   
Sbjct: 241 LLWEIVTLGGNPYPGIPPERLFNLL-----KTGHRMERPDNCS---------EEMYR--- 283
Query: 402 VAVLCIQPEPSYRPLITDVLHSL 424
           + + C + EP  RP+  D+   L
Sbjct: 284 LMLQCWKQEPDKRPVFADISKDL 306

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 103/206 (50%), Gaps = 8/206 (3%)
Query: 145 YELLEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWL 203
           Y+  E    +    + +G G  G VY+  + +  L  AVK + +   + E EF  E   +
Sbjct: 251 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVM 309
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
            +I+H N++ LLG C      +++ E M  G+L   L    +   +   + + +A  ++ 
Sbjct: 310 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISS 368
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYV 321
            +EYL +      +HR+L + N L+  +   K++DFGLS  +T  T + +      + + 
Sbjct: 369 AMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 425
Query: 322 APEYLLEGKLTDKSDVYAFGVVLLEL 347
           APE L   K + KSDV+AFGV+L E+
Sbjct: 426 APESLAYNKFSIKSDVWAFGVLLWEI 451

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 132/297 (44%), Gaps = 44/297 (14%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA------RFNEKLLAAVKRIDDAGHDAER-EFNNEVN 201
           E A      S  +G+G  G VY+       +   +   A+K +++A    ER EF NE +
Sbjct: 6   EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 65
Query: 202 WLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHG--PTHGSNL-----TWHLR 254
            + +    +++ LLG     +   ++ E+M  G L+  L    P   +N      +    
Sbjct: 66  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 125
Query: 255 MKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKI 314
           +++A ++A G+ YL+    +  VHRDL + N ++   F  K+ DFG+  T      +   
Sbjct: 126 IQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGM--TRDIXETDXXR 180
Query: 315 SGTLG-----YVAPEYLLEGKLTDKSDVYAFGVVLLEL-LMGRRPVEKMSPTQCQSMVTW 368
            G  G     +++PE L +G  T  SDV++FGVVL E+  +  +P + +S  Q    V  
Sbjct: 181 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 240
Query: 369 AMPQLTDR-SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
               L D+    P+++  ++R                +C Q  P  RP   +++ S+
Sbjct: 241 G--GLLDKPDNCPDMLLELMR----------------MCWQYNPKMRPSFLEIISSI 279

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 104/209 (49%), Gaps = 14/209 (6%)
Query: 150 AATNNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKI 206
            +  NFQ+   IGEG  G VYKAR     +++A  K R+D            E++ L ++
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 207 RHQNIISLLGYCIHAETR-FLVYEMMQNGSLE-KQLHGPTHGSNLTWHLRMKIAVDVARG 264
            H NI+ LL   IH E + +LV+E +   S++ K     +  + +   L       + +G
Sbjct: 62  NHPNIVKLLD-VIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQG 117
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAP 323
           L + H   +H V+HRDLK  N+L+++    KL+DFGL+   G   R       TL Y AP
Sbjct: 118 LAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAP 174
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           E LL  K    + D+++ G +  E++  R
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/248 (29%), Positives = 113/248 (45%), Gaps = 18/248 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKAR-FNEKLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRH 208
           N+F    +IG GG G VY  R  +   + A+K +D         E    NE   L+ +  
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 209 QN--IISLLGYCIHAETRF-LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
            +   I  + Y  H   +   + ++M  G L    H   HG      +R   A ++  GL
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDL--HYHLSQHGVFSEADMRF-YAAEIILGL 305
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEY 325
           E++H   N  VV+RDLK +NILLD   + ++SD GL+     +  +  + GT GY+APE 
Sbjct: 306 EHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEV 361
Query: 326 LLEGKLTDKS-DVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVD 384
           L +G   D S D ++ G +L +LL G  P  +        +       LT   +LP+   
Sbjct: 362 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---LTMAVELPDSFS 418
Query: 385 PVIRDTMD 392
           P +R  ++
Sbjct: 419 PELRSLLE 426

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/248 (29%), Positives = 113/248 (45%), Gaps = 18/248 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKAR-FNEKLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRH 208
           N+F    +IG GG G VY  R  +   + A+K +D         E    NE   L+ +  
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 209 QN--IISLLGYCIHAETRF-LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
            +   I  + Y  H   +   + ++M  G L    H   HG      +R   A ++  GL
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDL--HYHLSQHGVFSEADMRF-YAAEIILGL 305
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEY 325
           E++H   N  VV+RDLK +NILLD   + ++SD GL+     +  +  + GT GY+APE 
Sbjct: 306 EHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEV 361
Query: 326 LLEGKLTDKS-DVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVD 384
           L +G   D S D ++ G +L +LL G  P  +        +       LT   +LP+   
Sbjct: 362 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---LTMAVELPDSFS 418
Query: 385 PVIRDTMD 392
           P +R  ++
Sbjct: 419 PELRSLLE 426

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 104/209 (49%), Gaps = 14/209 (6%)
Query: 150 AATNNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKI 206
            +  NFQ+   IGEG  G VYKAR     +++A  K R+D            E++ L ++
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 207 RHQNIISLLGYCIHAETR-FLVYEMMQNGSLE-KQLHGPTHGSNLTWHLRMKIAVDVARG 264
            H NI+ LL   IH E + +LV+E +   S++ K     +  + +   L       + +G
Sbjct: 63  NHPNIVKLLD-VIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQG 118
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAP 323
           L + H   +H V+HRDLK  N+L+++    KL+DFGL+   G   R       TL Y AP
Sbjct: 119 LAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAP 175
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           E LL  K    + D+++ G +  E++  R
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 82/259 (31%), Positives = 122/259 (47%), Gaps = 20/259 (7%)
Query: 179 LAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNIISLLGYC--IHAETRFLVYEMMQNGS 235
           + AVK +  DAG      +  E++ L  + H++II   G C    A +  LV E +  GS
Sbjct: 62  MVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGS 121
Query: 236 LEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAK 295
           L   L  P H   L   L    A  +  G+ YLH    H  +HRDL + N+LLD+    K
Sbjct: 122 LRDYL--PRHSIGLAQLLL--FAQQICEGMAYLH--AQH-YIHRDLAARNVLLDNDRLVK 174
Query: 296 LSDFGL--SVTAGTQSRNVKISG--TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGR 351
           + DFGL  +V  G +   V+  G   + + APE L E K    SDV++FGV L ELL   
Sbjct: 175 IGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT-H 233
Query: 352 RPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEP 411
               +  PT+   ++  A  Q+T   +L  +++   R     K   +V  +   C + E 
Sbjct: 234 CDSSQSPPTKFLELIGIAQGQMT-VLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEA 292
Query: 412 SYRPLITDVLHSLIPLVPT 430
           S+RP       +LIP++ T
Sbjct: 293 SFRP----TFENLIPILKT 307

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 161 IGEGGRGHVYKA--RFNEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNIISLLGY 217
           +GEG  G V  A  R  E+ +A VK +D     D       E+     + H+N++   G+
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVA-VKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 72
Query: 218 CIHAETRFLVYEMMQNGSL----EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
                 ++L  E    G L    E  +  P   +   +H  M        G+ YLH    
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-------GVVYLH---G 122
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV---KISGTLGYVAPEYLLEGK 330
             + HRD+K  N+LLD   N K+SDFGL+      +R     K+ GTL YVAPE L   +
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 331 L-TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTW 368
              +  DV++ G+VL  +L G  P ++ S + CQ    W
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-CQEYSDW 220

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 161 IGEGGRGHVYKA--RFNEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNIISLLGY 217
           +GEG  G V  A  R  E+ +A VK +D     D       E+     + H+N++   G+
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVA-VKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 218 CIHAETRFLVYEMMQNGSL----EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
                 ++L  E    G L    E  +  P   +   +H  M        G+ YLH    
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-------GVVYLH---G 123
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV---KISGTLGYVAPEYLLEGK 330
             + HRD+K  N+LLD   N K+SDFGL+      +R     K+ GTL YVAPE L   +
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 331 L-TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTW 368
              +  DV++ G+VL  +L G  P ++ S + CQ    W
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-CQEYSDW 221

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 161 IGEGGRGHVYKA--RFNEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNIISLLGY 217
           +GEG  G V  A  R  E+ +A VK +D     D       E+     + H+N++   G+
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVA-VKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 218 CIHAETRFLVYEMMQNGSL----EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
                 ++L  E    G L    E  +  P   +   +H  M        G+ YLH    
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-------GVVYLH---G 122
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV---KISGTLGYVAPEYLLEGK 330
             + HRD+K  N+LLD   N K+SDFGL+      +R     K+ GTL YVAPE L   +
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 331 L-TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTW 368
              +  DV++ G+VL  +L G  P ++ S + CQ    W
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-CQEYSDW 220

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 132/297 (44%), Gaps = 44/297 (14%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA------RFNEKLLAAVKRIDDAGHDAER-EFNNEVN 201
           E A      S  +G+G  G VY+       +   +   A+K +++A    ER EF NE +
Sbjct: 14  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 73
Query: 202 WLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHG--PTHGSNL-----TWHLR 254
            + +    +++ LLG     +   ++ E+M  G L+  L    P   +N      +    
Sbjct: 74  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 133
Query: 255 MKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKI 314
           +++A ++A G+ YL+ +     VHRDL + N ++   F  K+ DFG+  T      +   
Sbjct: 134 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGM--TRDIYETDYYR 188
Query: 315 SGTLG-----YVAPEYLLEGKLTDKSDVYAFGVVLLEL-LMGRRPVEKMSPTQCQSMVTW 368
            G  G     +++PE L +G  T  SDV++FGVVL E+  +  +P + +S  Q    V  
Sbjct: 189 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 248
Query: 369 AMPQLTDR-SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
               L D+    P+++  ++R                +C Q  P  RP   +++ S+
Sbjct: 249 G--GLLDKPDNCPDMLFELMR----------------MCWQYNPKMRPSFLEIISSI 287

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 132/297 (44%), Gaps = 44/297 (14%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA------RFNEKLLAAVKRIDDAGHDAER-EFNNEVN 201
           E A      S  +G+G  G VY+       +   +   A+K +++A    ER EF NE +
Sbjct: 15  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 74
Query: 202 WLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHG--PTHGSNL-----TWHLR 254
            + +    +++ LLG     +   ++ E+M  G L+  L    P   +N      +    
Sbjct: 75  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 134
Query: 255 MKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKI 314
           +++A ++A G+ YL+    +  VHRDL + N ++   F  K+ DFG+  T      +   
Sbjct: 135 IQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGM--TRDIYETDYYR 189
Query: 315 SGTLG-----YVAPEYLLEGKLTDKSDVYAFGVVLLEL-LMGRRPVEKMSPTQCQSMVTW 368
            G  G     +++PE L +G  T  SDV++FGVVL E+  +  +P + +S  Q    V  
Sbjct: 190 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 249
Query: 369 AMPQLTDR-SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
               L D+    P+++  ++R                +C Q  P  RP   +++ S+
Sbjct: 250 G--GLLDKPDNCPDMLFELMR----------------MCWQYNPKMRPSFLEIISSI 288

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 132/297 (44%), Gaps = 44/297 (14%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA------RFNEKLLAAVKRIDDAGHDAER-EFNNEVN 201
           E A      S  +G+G  G VY+       +   +   A+K +++A    ER EF NE +
Sbjct: 12  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 71
Query: 202 WLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHG--PTHGSNL-----TWHLR 254
            + +    +++ LLG     +   ++ E+M  G L+  L    P   +N      +    
Sbjct: 72  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 131
Query: 255 MKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKI 314
           +++A ++A G+ YL+    +  VHRDL + N ++   F  K+ DFG+  T      +   
Sbjct: 132 IQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGM--TRDIYETDYYR 186
Query: 315 SGTLG-----YVAPEYLLEGKLTDKSDVYAFGVVLLEL-LMGRRPVEKMSPTQCQSMVTW 368
            G  G     +++PE L +G  T  SDV++FGVVL E+  +  +P + +S  Q    V  
Sbjct: 187 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 246
Query: 369 AMPQLTDR-SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
               L D+    P+++  ++R                +C Q  P  RP   +++ S+
Sbjct: 247 G--GLLDKPDNCPDMLFELMR----------------MCWQYNPKMRPSFLEIISSI 285

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 161 IGEGGRGHVYKA--RFNEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNIISLLGY 217
           +GEG  G V  A  R  E+ +A VK +D     D       E+     + H+N++   G+
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVA-VKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 218 CIHAETRFLVYEMMQNGSL----EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
                 ++L  E    G L    E  +  P   +   +H  M        G+ YLH    
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-------GVVYLH---G 122
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV---KISGTLGYVAPEYLLEGK 330
             + HRD+K  N+LLD   N K+SDFGL+      +R     K+ GTL YVAPE L   +
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 331 L-TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTW 368
              +  DV++ G+VL  +L G  P ++ S + CQ    W
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-CQEYSDW 220

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 12/208 (5%)
Query: 150 AATNNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKI 206
            +  NFQ+   IGEG  G VYKAR     +++A  K R+D            E++ L ++
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 207 RHQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
            H NI+ LL   IH E + +LV+E +      K+    +  + +   L       + +GL
Sbjct: 63  NHPNIVKLLD-VIHTENKLYLVFEHVDQDL--KKFMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPE 324
            + H   +H V+HRDLK  N+L+++    KL+DFGL+   G   R       TL Y APE
Sbjct: 120 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 176
Query: 325 YLLEGKLTDKS-DVYAFGVVLLELLMGR 351
            LL  K    + D+++ G +  E++  R
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 111/230 (48%), Gaps = 17/230 (7%)
Query: 134 AGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFNEK-LLAAVKRIDDAGHDA 192
           +GK+     I  +  +A  N+ +    +G G  G V+K RF +   + AVK++  +G+  
Sbjct: 6   SGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKE 65
Query: 193 E-REFNNEVNWLTKIRH-QNIISLLGYCIHAETRFLVYEMMQNGS--LEKQLHGPTHGSN 248
           E +    +++ + K      I+   G  I     F+  E+M   +  L+K++ GP     
Sbjct: 66  ENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGP----- 120
Query: 249 LTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ 308
           +   +  K+ V + + L YL E   H V+HRD+K SNILLD     KL DFG+S      
Sbjct: 121 IPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178
Query: 309 SRNVKISGTLGYVAPEYLLEGKLTD-----KSDVYAFGVVLLELLMGRRP 353
               + +G   Y+APE +     T      ++DV++ G+ L+EL  G+ P
Sbjct: 179 KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 161 IGEGGRGHVYKA--RFNEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNIISLLGY 217
           +GEG  G V  A  R  E+ +A VK +D     D       E+     + H+N++   G+
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVA-VKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 73
Query: 218 CIHAETRFLVYEMMQNGSL----EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
                 ++L  E    G L    E  +  P   +   +H  M        G+ YLH    
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-------GVVYLH---G 123
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV---KISGTLGYVAPEYLLEGK 330
             + HRD+K  N+LLD   N K+SDFGL+      +R     K+ GTL YVAPE L   +
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 183
Query: 331 L-TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTW 368
              +  DV++ G+VL  +L G  P ++ S + CQ    W
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-CQEYSDW 221

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 161 IGEGGRGHVYKA--RFNEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNIISLLGY 217
           +GEG  G V  A  R  E+ +A VK +D     D       E+     + H+N++   G+
Sbjct: 14  LGEGAAGEVQLAVNRVTEEAVA-VKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 218 CIHAETRFLVYEMMQNGSL----EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
                 ++L  E    G L    E  +  P   +   +H  M        G+ YLH    
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-------GVVYLH---G 122
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV---KISGTLGYVAPEYLLEGK 330
             + HRD+K  N+LLD   N K+SDFGL+      +R     K+ GTL YVAPE L   +
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 331 L-TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTW 368
              +  DV++ G+VL  +L G  P ++ S + CQ    W
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-CQEYSDW 220

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 161 IGEGGRGHVYKA--RFNEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNIISLLGY 217
           +GEG  G V  A  R  E+ +A VK +D     D       E+     + H+N++   G+
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVA-VKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 72
Query: 218 CIHAETRFLVYEMMQNGSL----EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
                 ++L  E    G L    E  +  P   +   +H  M        G+ YLH    
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-------GVVYLH---G 122
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV---KISGTLGYVAPEYLLEGK 330
             + HRD+K  N+LLD   N K+SDFGL+      +R     K+ GTL YVAPE L   +
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 331 L-TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTW 368
              +  DV++ G+VL  +L G  P ++ S + CQ    W
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-CQEYSDW 220

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 161 IGEGGRGHVYKA--RFNEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNIISLLGY 217
           +GEG  G V  A  R  E+ +A VK +D     D       E+     + H+N++   G+
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVA-VKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGH 73
Query: 218 CIHAETRFLVYEMMQNGSL----EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
                 ++L  E    G L    E  +  P   +   +H  M        G+ YLH    
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-------GVVYLH---G 123
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV---KISGTLGYVAPEYLLEGK 330
             + HRD+K  N+LLD   N K+SDFGL+      +R     K+ GTL YVAPE L   +
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 331 L-TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTW 368
              +  DV++ G+VL  +L G  P ++ S + CQ    W
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-CQEYSDW 221

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/248 (29%), Positives = 113/248 (45%), Gaps = 18/248 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKAR-FNEKLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRH 208
           N+F    +IG GG G VY  R  +   + A+K +D         E    NE   L+ +  
Sbjct: 188 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 247
Query: 209 QN--IISLLGYCIHAETRF-LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
            +   I  + Y  H   +   + ++M  G L    H   HG      +R   A ++  GL
Sbjct: 248 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDL--HYHLSQHGVFSEADMRF-YAAEIILGL 304
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEY 325
           E++H   N  VV+RDLK +NILLD   + ++SD GL+     +  +  + GT GY+APE 
Sbjct: 305 EHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEV 360
Query: 326 LLEGKLTDKS-DVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVD 384
           L +G   D S D ++ G +L +LL G  P  +        +       LT   +LP+   
Sbjct: 361 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---LTMAVELPDSFS 417
Query: 385 PVIRDTMD 392
           P +R  ++
Sbjct: 418 PELRSLLE 425

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/248 (29%), Positives = 113/248 (45%), Gaps = 18/248 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKAR-FNEKLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRH 208
           N+F    +IG GG G VY  R  +   + A+K +D         E    NE   L+ +  
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 209 QN--IISLLGYCIHAETRF-LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
            +   I  + Y  H   +   + ++M  G L    H   HG      +R   A ++  GL
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDL--HYHLSQHGVFSEADMRF-YAAEIILGL 305
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEY 325
           E++H   N  VV+RDLK +NILLD   + ++SD GL+     +  +  + GT GY+APE 
Sbjct: 306 EHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEV 361
Query: 326 LLEGKLTDKS-DVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVD 384
           L +G   D S D ++ G +L +LL G  P  +        +       LT   +LP+   
Sbjct: 362 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---LTMAVELPDSFS 418
Query: 385 PVIRDTMD 392
           P +R  ++
Sbjct: 419 PELRSLLE 426

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 132/297 (44%), Gaps = 44/297 (14%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA------RFNEKLLAAVKRIDDAGHDAER-EFNNEVN 201
           E A      S  +G+G  G VY+       +   +   A+K +++A    ER EF NE +
Sbjct: 14  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 73
Query: 202 WLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHG--PTHGSNL-----TWHLR 254
            + +    +++ LLG     +   ++ E+M  G L+  L    P   +N      +    
Sbjct: 74  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 133
Query: 255 MKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKI 314
           +++A ++A G+ YL+    +  VHRDL + N ++   F  K+ DFG+  T      +   
Sbjct: 134 IQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGM--TRDIYETDYYR 188
Query: 315 SGTLG-----YVAPEYLLEGKLTDKSDVYAFGVVLLEL-LMGRRPVEKMSPTQCQSMVTW 368
            G  G     +++PE L +G  T  SDV++FGVVL E+  +  +P + +S  Q    V  
Sbjct: 189 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 248
Query: 369 AMPQLTDR-SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
               L D+    P+++  ++R                +C Q  P  RP   +++ S+
Sbjct: 249 G--GLLDKPDNCPDMLFELMR----------------MCWQYNPKMRPSFLEIISSI 287

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 99/221 (44%), Gaps = 23/221 (10%)
Query: 159 NVIGEGGRGHVYKA--RFNEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNIISLL 215
             +GEG  G V  A  R  E+ +A VK +D     D       E+     + H+N++   
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVA-VKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 216 GYCIHAETRFLVYEMMQNGSL----EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
           G+      ++L  E    G L    E  +  P   +   +H  M        G+ YLH  
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-------GVVYLH-- 122
Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV---KISGTLGYVAPEYLLE 328
               + HRD+K  N+LLD   N K+SDFGL+      +R     K+ GTL YVAPE L  
Sbjct: 123 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 329 GKL-TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTW 368
            +   +  DV++ G+VL  +L G  P ++ S + CQ    W
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-CQEYSDW 221

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 99/221 (44%), Gaps = 23/221 (10%)
Query: 159 NVIGEGGRGHVYKA--RFNEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNIISLL 215
             +GEG  G V  A  R  E+ +A VK +D     D       E+     + H+N++   
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVA-VKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 216 GYCIHAETRFLVYEMMQNGSL----EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
           G+      ++L  E    G L    E  +  P   +   +H  M        G+ YLH  
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-------GVVYLH-- 122
Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV---KISGTLGYVAPEYLLE 328
               + HRD+K  N+LLD   N K+SDFGL+      +R     K+ GTL YVAPE L  
Sbjct: 123 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 329 GKL-TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTW 368
            +   +  DV++ G+VL  +L G  P ++ S + CQ    W
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-CQEYSDW 221

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 132/297 (44%), Gaps = 44/297 (14%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA------RFNEKLLAAVKRIDDAGHDAER-EFNNEVN 201
           E A      S  +G+G  G VY+       +   +   A+K +++A    ER EF NE +
Sbjct: 8   EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 67
Query: 202 WLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHG--PTHGSNL-----TWHLR 254
            + +    +++ LLG     +   ++ E+M  G L+  L    P   +N      +    
Sbjct: 68  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 127
Query: 255 MKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKI 314
           +++A ++A G+ YL+    +  VHRDL + N ++   F  K+ DFG+  T      +   
Sbjct: 128 IQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGM--TRDIYETDYYR 182
Query: 315 SGTLG-----YVAPEYLLEGKLTDKSDVYAFGVVLLEL-LMGRRPVEKMSPTQCQSMVTW 368
            G  G     +++PE L +G  T  SDV++FGVVL E+  +  +P + +S  Q    V  
Sbjct: 183 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 242
Query: 369 AMPQLTDR-SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
               L D+    P+++  ++R                +C Q  P  RP   +++ S+
Sbjct: 243 G--GLLDKPDNCPDMLFELMR----------------MCWQYNPKMRPSFLEIISSI 281

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 161 IGEGGRGHVYKA--RFNEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNIISLLGY 217
           +GEG  G V  A  R  E+ +A VK +D     D       E+     + H+N++   G+
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVA-VKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 218 CIHAETRFLVYEMMQNGSL----EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
                 ++L  E    G L    E  +  P   +   +H  M        G+ YLH    
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-------GVVYLH---G 122
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV---KISGTLGYVAPEYLLEGK 330
             + HRD+K  N+LLD   N K+SDFGL+      +R     K+ GTL YVAPE L   +
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 331 L-TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTW 368
              +  DV++ G+VL  +L G  P ++ S + CQ    W
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-CQEYSDW 220

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 99/221 (44%), Gaps = 23/221 (10%)
Query: 159 NVIGEGGRGHVYKA--RFNEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNIISLL 215
             +GEG  G V  A  R  E+ +A VK +D     D       E+     + H+N++   
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVA-VKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 216 GYCIHAETRFLVYEMMQNGSL----EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
           G+      ++L  E    G L    E  +  P   +   +H  M        G+ YLH  
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-------GVVYLH-- 122
Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV---KISGTLGYVAPEYLLE 328
               + HRD+K  N+LLD   N K+SDFGL+      +R     K+ GTL YVAPE L  
Sbjct: 123 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 329 GKL-TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTW 368
            +   +  DV++ G+VL  +L G  P ++ S + CQ    W
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-CQEYSDW 221

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 161 IGEGGRGHVYKA--RFNEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNIISLLGY 217
           +GEG  G V  A  R  E+ +A VK +D     D       E+     + H+N++   G+
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVA-VKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 218 CIHAETRFLVYEMMQNGSL----EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
                 ++L  E    G L    E  +  P   +   +H  M        G+ YLH    
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-------GVVYLH---G 123
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV---KISGTLGYVAPEYLLEGK 330
             + HRD+K  N+LLD   N K+SDFGL+      +R     K+ GTL YVAPE L   +
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 331 L-TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTW 368
              +  DV++ G+VL  +L G  P ++ S + CQ    W
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-CQEYSDW 221

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 122/276 (44%), Gaps = 47/276 (17%)
Query: 160 VIGEGGRGHVYKARFN----EKLLAAVKRIDDAGHDAER-EFNNEVNWLTKIRHQNIISL 214
           VIG G  G V           ++  A+K +     + +R +F +E + + +  H N+I L
Sbjct: 14  VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHL 73
Query: 215 LGYCIHAETRFLVYEMMQNGSLE---KQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
            G    +    ++ E M+NGSL+   +Q  G      L   LR      +A G++YL   
Sbjct: 74  EGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLR-----GIAAGMKYL--- 125
Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLG------YVAPEY 325
            +   VHR L + NIL++S+   K+SDFGLS      + +   +  LG      + APE 
Sbjct: 126 ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA 185
Query: 326 LLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMS----------------PTQCQSMVTW 368
           +   K T  SDV+++G+V+ E++  G RP   M+                P  C S +  
Sbjct: 186 IQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQ 245
Query: 369 AMPQL--TDRSKLP------NIVDPVIRDTMDLKHL 396
            M      DR+  P      N +D +IR+   LK +
Sbjct: 246 LMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNSLKAM 281

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 161 IGEGGRGHVYKA--RFNEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNIISLLGY 217
           +GEG  G V  A  R  E+ +A VK +D     D       E+     + H+N++   G+
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVA-VKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 218 CIHAETRFLVYEMMQNGSL----EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
                 ++L  E    G L    E  +  P   +   +H  M        G+ YLH    
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-------GVVYLH---G 122
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV---KISGTLGYVAPEYLLEGK 330
             + HRD+K  N+LLD   N K+SDFGL+      +R     K+ GTL YVAPE L   +
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 331 L-TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTW 368
              +  DV++ G+VL  +L G  P ++ S + CQ    W
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-CQEYSDW 220

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 99/220 (45%), Gaps = 23/220 (10%)
Query: 160 VIGEGGRGHVYKA--RFNEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNIISLLG 216
            +GEG  G V  A  R  E+ +A VK +D     D       E+     + H+N++   G
Sbjct: 12  TLGEGAYGEVQLAVNRVTEEAVA-VKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 217 YCIHAETRFLVYEMMQNGSL----EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
           +      ++L  E    G L    E  +  P   +   +H  M        G+ YLH   
Sbjct: 71  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-------GVVYLH--- 120
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV---KISGTLGYVAPEYLLEG 329
              + HRD+K  N+LLD   N K+SDFGL+      +R     K+ GTL YVAPE L   
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 330 KL-TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTW 368
           +   +  DV++ G+VL  +L G  P ++ S + CQ    W
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-CQEYSDW 219

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 121/268 (45%), Gaps = 26/268 (9%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           +G G  G V+   +N     AVK +   G  + + F  E N +  ++H  ++ L      
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 78
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
            E  +++ E M  GSL   L     G  L   L +  +  +A G+ Y+ E  N+  +HRD
Sbjct: 79  EEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKL-IDFSAQIAEGMAYI-ERKNY--IHRD 134
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
           L+++N+L+  S   K++DFGL+          +      + + APE +  G  T KS+V+
Sbjct: 135 LRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSNVW 194
Query: 339 AFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLY 397
           +FG++L E++  G+ P     P +  + V  A+ Q     ++ N  D           LY
Sbjct: 195 SFGILLYEIVTYGKIPY----PGRTNADVMSALSQGYRMPRMENCPD----------ELY 240
Query: 398 QVAAVAVLCIQPEPSYRPLITDVLHSLI 425
            +     +C + +   RP   D L S++
Sbjct: 241 DIMK---MCWKEKAEERPTF-DYLQSVL 264

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 161 IGEGGRGHVYKA--RFNEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNIISLLGY 217
           +GEG  G V  A  R  E+ +A VK +D     D       E+     + H+N++   G+
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVA-VKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 218 CIHAETRFLVYEMMQNGSL----EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
                 ++L  E    G L    E  +  P   +   +H  M        G+ YLH    
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-------GVVYLH---G 122
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV---KISGTLGYVAPEYLLEGK 330
             + HRD+K  N+LLD   N K+SDFGL+      +R     K+ GTL YVAPE L   +
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 331 L-TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTW 368
              +  DV++ G+VL  +L G  P ++ S + CQ    W
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-CQEYSDW 220

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 132/297 (44%), Gaps = 44/297 (14%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA------RFNEKLLAAVKRIDDAGHDAER-EFNNEVN 201
           E A      S  +G+G  G VY+       +   +   A+K +++A    ER EF NE +
Sbjct: 21  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 80
Query: 202 WLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHG--PTHGSNL-----TWHLR 254
            + +    +++ LLG     +   ++ E+M  G L+  L    P   +N      +    
Sbjct: 81  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 140
Query: 255 MKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKI 314
           +++A ++A G+ YL+    +  VHRDL + N ++   F  K+ DFG+  T      +   
Sbjct: 141 IQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGM--TRDIYETDYYR 195
Query: 315 SGTLG-----YVAPEYLLEGKLTDKSDVYAFGVVLLEL-LMGRRPVEKMSPTQCQSMVTW 368
            G  G     +++PE L +G  T  SDV++FGVVL E+  +  +P + +S  Q    V  
Sbjct: 196 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 255
Query: 369 AMPQLTDR-SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
               L D+    P+++  ++R                +C Q  P  RP   +++ S+
Sbjct: 256 G--GLLDKPDNCPDMLFELMR----------------MCWQYNPKMRPSFLEIISSI 294

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 161 IGEGGRGHVYKA--RFNEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNIISLLGY 217
           +GEG  G V  A  R  E+ +A VK +D     D       E+     + H+N++   G+
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVA-VKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 218 CIHAETRFLVYEMMQNGSL----EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
                 ++L  E    G L    E  +  P   +   +H  M        G+ YLH    
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-------GVVYLH---G 122
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV---KISGTLGYVAPEYLLEGK 330
             + HRD+K  N+LLD   N K+SDFGL+      +R     K+ GTL YVAPE L   +
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 331 L-TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTW 368
              +  DV++ G+VL  +L G  P ++ S + CQ    W
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-CQEYSDW 220

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 132/297 (44%), Gaps = 44/297 (14%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA------RFNEKLLAAVKRIDDAGHDAER-EFNNEVN 201
           E A      S  +G+G  G VY+       +   +   A+K +++A    ER EF NE +
Sbjct: 43  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 102
Query: 202 WLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHG--PTHGSNL-----TWHLR 254
            + +    +++ LLG     +   ++ E+M  G L+  L    P   +N      +    
Sbjct: 103 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 162
Query: 255 MKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKI 314
           +++A ++A G+ YL+ +     VHRDL + N ++   F  K+ DFG+  T      +   
Sbjct: 163 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGM--TRDIYETDYYR 217
Query: 315 SGTLG-----YVAPEYLLEGKLTDKSDVYAFGVVLLEL-LMGRRPVEKMSPTQCQSMVTW 368
            G  G     +++PE L +G  T  SDV++FGVVL E+  +  +P + +S  Q    V  
Sbjct: 218 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 277
Query: 369 AMPQLTDR-SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
               L D+    P+++  ++R                +C Q  P  RP   +++ S+
Sbjct: 278 G--GLLDKPDNCPDMLFELMR----------------MCWQYNPKMRPSFLEIISSI 316

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 161 IGEGGRGHVYKA--RFNEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNIISLLGY 217
           +GEG  G V  A  R  E+ +A VK +D     D       E+     + H+N++   G+
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVA-VKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 218 CIHAETRFLVYEMMQNGSL----EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
                 ++L  E    G L    E  +  P   +   +H  M        G+ YLH    
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-------GVVYLH---G 122
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV---KISGTLGYVAPEYLLEGK 330
             + HRD+K  N+LLD   N K+SDFGL+      +R     K+ GTL YVAPE L   +
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 331 L-TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTW 368
              +  DV++ G+VL  +L G  P ++ S + CQ    W
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-CQEYSDW 220

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 79/302 (26%), Positives = 130/302 (43%), Gaps = 63/302 (20%)
Query: 161 IGEGGRGHVYKARFNE------KLLAAVKRIDDAGHDAER-EFNNEVNWLTKIRHQNIIS 213
           +G+G  G VY+    +      +   AVK ++++    ER EF NE + +      +++ 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 214 LLGYCIHAETRFLVYEMMQNGSLEKQLHG--PTHGSNL-----TWHLRMKIAVDVARGLE 266
           LLG     +   +V E+M +G L+  L    P   +N      T    +++A ++A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLG-----YV 321
           YL+       VHRDL + N ++   F  K+ DFG+  T      +    G  G     ++
Sbjct: 145 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGM--TRDIXETDXXRKGGKGLLPVRWM 199
Query: 322 APEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLP 380
           APE L +G  T  SD+++FGVVL E+  +  +P + +S  Q                   
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ------------------- 240
Query: 381 NIVDPVIRDTMDLKHLYQ-------VAAVAVLCIQPEPSYRP-------LITDVLHSLIP 426
                V++  MD  +L Q       V  +  +C Q  P+ RP       L+ D LH   P
Sbjct: 241 -----VLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDDLHPSFP 295
Query: 427 LV 428
            V
Sbjct: 296 EV 297

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 99/220 (45%), Gaps = 23/220 (10%)
Query: 160 VIGEGGRGHVYKA--RFNEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNIISLLG 216
            +GEG  G V  A  R  E+ +A VK +D     D       E+     + H+N++   G
Sbjct: 13  TLGEGAYGEVQLAVNRVTEEAVA-VKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 217 YCIHAETRFLVYEMMQNGSL----EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
           +      ++L  E    G L    E  +  P   +   +H  M        G+ YLH   
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-------GVVYLH--- 121
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV---KISGTLGYVAPEYLLEG 329
              + HRD+K  N+LLD   N K+SDFGL+      +R     K+ GTL YVAPE L   
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 330 KL-TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTW 368
           +   +  DV++ G+VL  +L G  P ++ S + CQ    W
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-CQEYSDW 220

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 99/220 (45%), Gaps = 23/220 (10%)
Query: 160 VIGEGGRGHVYKA--RFNEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNIISLLG 216
            +GEG  G V  A  R  E+ +A VK +D     D       E+     + H+N++   G
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVA-VKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 217 YCIHAETRFLVYEMMQNGSL----EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
           +      ++L  E    G L    E  +  P   +   +H  M        G+ YLH   
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-------GVVYLH--- 122
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV---KISGTLGYVAPEYLLEG 329
              + HRD+K  N+LLD   N K+SDFGL+      +R     K+ GTL YVAPE L   
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 330 KL-TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTW 368
           +   +  DV++ G+VL  +L G  P ++ S + CQ    W
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-CQEYSDW 221

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 79/302 (26%), Positives = 129/302 (42%), Gaps = 63/302 (20%)
Query: 161 IGEGGRGHVYKARFNE------KLLAAVKRIDDAGHDAER-EFNNEVNWLTKIRHQNIIS 213
           +G+G  G VY+    +      +   AVK ++++    ER EF NE + +      +++ 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 214 LLGYCIHAETRFLVYEMMQNGSLEKQLHG--PTHGSNL-----TWHLRMKIAVDVARGLE 266
           LLG     +   +V E+M +G L+  L    P   +N      T    +++A ++A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLG-----YV 321
           YL+       VHRDL + N ++   F  K+ DFG+  T      +    G  G     ++
Sbjct: 145 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGM--TRDIXETDXXRKGGKGLLPVRWM 199
Query: 322 APEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLP 380
           APE L +G  T  SD+++FGVVL E+  +  +P + +S  Q                   
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ------------------- 240
Query: 381 NIVDPVIRDTMDLKHLYQ-------VAAVAVLCIQPEPSYRP-------LITDVLHSLIP 426
                V++  MD  +L Q       V  +  +C Q  P  RP       L+ D LH   P
Sbjct: 241 -----VLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 295
Query: 427 LV 428
            V
Sbjct: 296 EV 297

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 79/302 (26%), Positives = 129/302 (42%), Gaps = 63/302 (20%)
Query: 161 IGEGGRGHVYKARFNE------KLLAAVKRIDDAGHDAER-EFNNEVNWLTKIRHQNIIS 213
           +G+G  G VY+    +      +   AVK ++++    ER EF NE + +      +++ 
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 214 LLGYCIHAETRFLVYEMMQNGSLEKQLHG--PTHGSNL-----TWHLRMKIAVDVARGLE 266
           LLG     +   +V E+M +G L+  L    P   +N      T    +++A ++A G+ 
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLG-----YV 321
           YL+       VHRDL + N ++   F  K+ DFG+  T      +    G  G     ++
Sbjct: 142 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGM--TRDIXETDXXRKGGKGLLPVRWM 196
Query: 322 APEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLP 380
           APE L +G  T  SD+++FGVVL E+  +  +P + +S  Q                   
Sbjct: 197 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ------------------- 237
Query: 381 NIVDPVIRDTMDLKHLYQ-------VAAVAVLCIQPEPSYRP-------LITDVLHSLIP 426
                V++  MD  +L Q       V  +  +C Q  P  RP       L+ D LH   P
Sbjct: 238 -----VLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 292
Query: 427 LV 428
            V
Sbjct: 293 EV 294

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 12/205 (5%)
Query: 153 NNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKIRHQ 209
            NFQ+   IGEG  G VYKAR     +++A  K R+D            E++ L ++ H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 210 NIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYL 268
           NI+ LL   IH E + +LV+E +      K     +  + +   L       + +GL + 
Sbjct: 62  NIVKLLD-VIHTENKLYLVFEHVHQDL--KTFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 269 HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPEYLL 327
           H   +H V+HRDLK  N+L+++    KL+DFGL+   G   R       TL Y APE LL
Sbjct: 119 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175
Query: 328 EGKLTDKS-DVYAFGVVLLELLMGR 351
             K    + D+++ G +  E++  R
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 102/213 (47%), Gaps = 17/213 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNEK-LLAAVK-----RIDDAGHDAEREFNNEVNWLTKI 206
           ++F+    +G+G  G+VY AR  +   + A+K     +I+  G   E +   E+     +
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEG--VEHQLRREIEIQAHL 80
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
            H NI+ L  Y       +L+ E    G L K+L                I  ++A  L 
Sbjct: 81  HHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQK---SCTFDEQRTATIMEELADALM 137
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYL 326
           Y H      V+HRD+K  N+LL      K++DFG SV A +  R   + GTL Y+ PE +
Sbjct: 138 YCH---GKKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKT-MCGTLDYLPPE-M 192
Query: 327 LEGKL-TDKSDVYAFGVVLLELLMGRRPVEKMS 358
           +EG++  +K D++  GV+  ELL+G  P E  S
Sbjct: 193 IEGRMHNEKVDLWCIGVLCYELLVGNPPFESAS 225

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 125/276 (45%), Gaps = 30/276 (10%)
Query: 155 FQESNVIGEGGRGHVYKARFNE-KLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNII 212
           F +   IG+G  G V+K   N  + + A+K ID +   D   +   E+  L++     + 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 213 SLLGYCIHAETRFLVYEMMQNGS-LEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
              G  +     +++ E +  GS L+    GP     +   L+     ++ +GL+YLH  
Sbjct: 85  KYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK-----EILKGLDYLHSE 139
Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT-AGTQSRNVKISGTLGYVAPEYLLEGK 330
                +HRD+K++N+LL    + KL+DFG++     TQ +     GT  ++APE + +  
Sbjct: 140 KK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSA 196
Query: 331 LTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDT 390
              K+D+++ G+  +EL  G  P   M P +    V + +P    ++  P +V      T
Sbjct: 197 YDSKADIWSLGITAIELAKGEPPNSDMHPMR----VLFLIP----KNNPPTLVGDF---T 245
Query: 391 MDLKHLYQVAAVAVLCIQPEPSYRPLITDVL-HSLI 425
              K           C+  +PS+RP   ++L H  I
Sbjct: 246 KSFKEFIDA------CLNKDPSFRPTAKELLKHKFI 275

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 69/253 (27%), Positives = 113/253 (44%), Gaps = 37/253 (14%)
Query: 130 SLRLAGKKDT---VSVIEYELLEAATNNFQESNV-----IGEGGRGHVY--------KAR 173
           + RL+   DT     V EYEL E     F    +     +GEG  G V         K +
Sbjct: 50  TTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDK 109
Query: 174 FNEKLLAAVKRI-DDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMM 231
             E +  AVK + DDA      +  +E+  +  I +H+NII+LLG C      +++ E  
Sbjct: 110 PKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 169
Query: 232 QNGSLEKQLHGP-------------THGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVH 278
             G+L + L                     +T+   +     +ARG+EYL    +   +H
Sbjct: 170 SKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIH 226
Query: 279 RDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAPEYLLEGKLTDKS 335
           RDL + N+L+  +   K++DFGL+          K +     + ++APE L +   T +S
Sbjct: 227 RDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQS 286
Query: 336 DVYAFGVVLLELL 348
           DV++FGV++ E+ 
Sbjct: 287 DVWSFGVLMWEIF 299

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 99/199 (49%), Gaps = 16/199 (8%)
Query: 161 IGEGGRGHVYKARF-----NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLL 215
           +G+G  G V   R+     N   L AVK++  +G D +R+F  E+  L  +    I+   
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 78
Query: 216 G--YCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
           G  Y    ++  LV E + +G L   L    H + L     +  +  + +G+EYL    +
Sbjct: 79  GVSYGPGRQSLRLVMEYLPSGCLRDFLQ--RHRARLDASRLLLYSSQICKGMEYLG---S 133
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGT--LGYVAPEYLLEG 329
              VHRDL + NIL++S  + K++DFGL+  +        V+  G   + + APE L + 
Sbjct: 134 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN 193
Query: 330 KLTDKSDVYAFGVVLLELL 348
             + +SDV++FGVVL EL 
Sbjct: 194 IFSRQSDVWSFGVVLYELF 212

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 131/297 (44%), Gaps = 44/297 (14%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA------RFNEKLLAAVKRIDDAGHDAER-EFNNEVN 201
           E A      S  +G+G  G VY+       +   +   A+K +++A    ER EF NE +
Sbjct: 8   EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 67
Query: 202 WLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHG--PTHGSNL-----TWHLR 254
            + +    +++ LLG     +   ++ E+M  G L+  L    P   +N      +    
Sbjct: 68  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 127
Query: 255 MKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKI 314
           +++A ++A G+ YL+    +  VHRDL + N  +   F  K+ DFG+  T      +   
Sbjct: 128 IQMAGEIADGMAYLN---ANKFVHRDLAARNCXVAEDFTVKIGDFGM--TRDIYETDYYR 182
Query: 315 SGTLG-----YVAPEYLLEGKLTDKSDVYAFGVVLLEL-LMGRRPVEKMSPTQCQSMVTW 368
            G  G     +++PE L +G  T  SDV++FGVVL E+  +  +P + +S  Q    V  
Sbjct: 183 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 242
Query: 369 AMPQLTDR-SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
               L D+    P+++  ++R                +C Q  P  RP   +++ S+
Sbjct: 243 G--GLLDKPDNCPDMLLELMR----------------MCWQYNPKMRPSFLEIISSI 281

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 98/200 (49%), Gaps = 18/200 (9%)
Query: 161 IGEGGRGHVYKARF-----NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLL 215
           +G+G  G V   R+     N   L AVK++  +G D +R+F  E+  L  +    I+   
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 216 GYCI---HAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
           G        E R LV E + +G L   L    H + L     +  +  + +G+EYL    
Sbjct: 75  GVSYGPGRPELR-LVMEYLPSGCLRDFLQ--RHRARLDASRLLLYSSQICKGMEYLG--- 128
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGT--LGYVAPEYLLE 328
           +   VHRDL + NIL++S  + K++DFGL+  +        V+  G   + + APE L +
Sbjct: 129 SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSD 188
Query: 329 GKLTDKSDVYAFGVVLLELL 348
              + +SDV++FGVVL EL 
Sbjct: 189 NIFSRQSDVWSFGVVLYELF 208

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 99/199 (49%), Gaps = 16/199 (8%)
Query: 161 IGEGGRGHVYKARF-----NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLL 215
           +G+G  G V   R+     N   L AVK++  +G D +R+F  E+  L  +    I+   
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 216 G--YCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
           G  Y    ++  LV E + +G L   L    H + L     +  +  + +G+EYL    +
Sbjct: 91  GVSYGPGRQSLRLVMEYLPSGCLRDFLQ--RHRARLDASRLLLYSSQICKGMEYLG---S 145
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGT--LGYVAPEYLLEG 329
              VHRDL + NIL++S  + K++DFGL+  +        V+  G   + + APE L + 
Sbjct: 146 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN 205
Query: 330 KLTDKSDVYAFGVVLLELL 348
             + +SDV++FGVVL EL 
Sbjct: 206 IFSRQSDVWSFGVVLYELF 224

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 79/302 (26%), Positives = 129/302 (42%), Gaps = 63/302 (20%)
Query: 161 IGEGGRGHVYKARFNE------KLLAAVKRIDDAGHDAER-EFNNEVNWLTKIRHQNIIS 213
           +G+G  G VY+    +      +   AVK ++++    ER EF NE + +      +++ 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 214 LLGYCIHAETRFLVYEMMQNGSLEKQLHG--PTHGSNL-----TWHLRMKIAVDVARGLE 266
           LLG     +   +V E+M +G L+  L    P   +N      T    +++A ++A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLG-----YV 321
           YL+       VHRDL + N ++   F  K+ DFG+  T      +    G  G     ++
Sbjct: 145 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGM--TRDIYETDYYRKGGKGLLPVRWM 199
Query: 322 APEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLP 380
           APE L +G  T  SD+++FGVVL E+  +  +P + +S  Q                   
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ------------------- 240
Query: 381 NIVDPVIRDTMDLKHLYQ-------VAAVAVLCIQPEPSYRP-------LITDVLHSLIP 426
                V++  MD  +L Q       V  +  +C Q  P  RP       L+ D LH   P
Sbjct: 241 -----VLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 295
Query: 427 LV 428
            V
Sbjct: 296 EV 297

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 99/199 (49%), Gaps = 16/199 (8%)
Query: 161 IGEGGRGHVYKARF-----NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLL 215
           +G+G  G V   R+     N   L AVK++  +G D +R+F  E+  L  +    I+   
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 77
Query: 216 G--YCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
           G  Y    ++  LV E + +G L   L    H + L     +  +  + +G+EYL    +
Sbjct: 78  GVSYGPGRQSLRLVMEYLPSGCLRDFLQ--RHRARLDASRLLLYSSQICKGMEYLG---S 132
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGT--LGYVAPEYLLEG 329
              VHRDL + NIL++S  + K++DFGL+  +        V+  G   + + APE L + 
Sbjct: 133 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN 192
Query: 330 KLTDKSDVYAFGVVLLELL 348
             + +SDV++FGVVL EL 
Sbjct: 193 IFSRQSDVWSFGVVLYELF 211

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 100/211 (47%), Gaps = 16/211 (7%)
Query: 155 FQESNVIGEGGRGHVYKAR-FNEKLLAAVKRIDDAGHDAEREFNN---EVNWLTKIRHQN 210
           F +   IG G  G VY AR      + A+K++  +G  +  ++ +   EV +L K+RH N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 211 IISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHE 270
            I   G  +   T +LV E    GS    L    H   L       +     +GL YLH 
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCL-GSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYLH- 171
Query: 271 HCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLL--- 327
             +H ++HRD+K+ NILL      KL DFG   +A   +      GT  ++APE +L   
Sbjct: 172 --SHNMIHRDVKAGNILLSEPGLVKLGDFG---SASIMAPANXFVGTPYWMAPEVILAMD 226
Query: 328 EGKLTDKSDVYAFGVVLLELLMGRRPVEKMS 358
           EG+   K DV++ G+  +EL   + P+  M+
Sbjct: 227 EGQYDGKVDVWSLGITCIELAERKPPLFNMN 257

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 71/276 (25%), Positives = 125/276 (45%), Gaps = 30/276 (10%)
Query: 155 FQESNVIGEGGRGHVYKARFNE-KLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNII 212
           F +   IG+G  G V+K   N  + + A+K ID +   D   +   E+  L++     + 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 213 SLLGYCIHAETRFLVYEMMQNGSLEKQLH-GPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
              G  +     +++ E +  GS    L  GP   + +   LR     ++ +GL+YLH  
Sbjct: 89  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR-----EILKGLDYLHSE 143
Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT-AGTQSRNVKISGTLGYVAPEYLLEGK 330
                +HRD+K++N+LL      KL+DFG++     TQ +     GT  ++APE + +  
Sbjct: 144 KK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA 200
Query: 331 LTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDT 390
              K+D+++ G+  +EL  G  P  ++ P +    V + +P+    +   N   P     
Sbjct: 201 YDSKADIWSLGITAIELARGEPPHSELHPMK----VLFLIPKNNPPTLEGNYSKP----- 251
Query: 391 MDLKHLYQVAAVAVLCIQPEPSYRPLITDVL-HSLI 425
             LK   +       C+  EPS+RP   ++L H  I
Sbjct: 252 --LKEFVEA------CLNKEPSFRPTAKELLKHKFI 279

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 129/300 (43%), Gaps = 59/300 (19%)
Query: 161 IGEGGRGHVYKARFNE------KLLAAVKRIDDAGHDAER-EFNNEVNWLTKIRHQNIIS 213
           +G+G  G VY+    +      +   AVK ++++    ER EF NE + +      +++ 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 214 LLGYCIHAETRFLVYEMMQNGSLEKQLHG--PTHGSNL-----TWHLRMKIAVDVARGLE 266
           LLG     +   +V E+M +G L+  L    P   +N      T    +++A ++A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS---VTAGTQSRNVKISGTLGYVAP 323
           YL+       VHRDL + N ++   F  K+ DFG++          +  K    + ++AP
Sbjct: 145 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMAP 201
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNI 382
           E L +G  T  SD+++FGVVL E+  +  +P + +S  Q                     
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ--------------------- 240
Query: 383 VDPVIRDTMDLKHLYQ-------VAAVAVLCIQPEPSYRP-------LITDVLHSLIPLV 428
              V++  MD  +L Q       V  +  +C Q  P  RP       L+ D LH   P V
Sbjct: 241 ---VLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 297

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 100/211 (47%), Gaps = 16/211 (7%)
Query: 155 FQESNVIGEGGRGHVYKAR-FNEKLLAAVKRIDDAGHDAEREFNN---EVNWLTKIRHQN 210
           F +   IG G  G VY AR      + A+K++  +G  +  ++ +   EV +L K+RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 211 IISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHE 270
            I   G  +   T +LV E    GS    L    H   L       +     +GL YLH 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCL-GSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYLH- 132
Query: 271 HCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLL--- 327
             +H ++HRD+K+ NILL      KL DFG   +A   +      GT  ++APE +L   
Sbjct: 133 --SHNMIHRDVKAGNILLSEPGLVKLGDFG---SASIMAPANXFVGTPYWMAPEVILAMD 187
Query: 328 EGKLTDKSDVYAFGVVLLELLMGRRPVEKMS 358
           EG+   K DV++ G+  +EL   + P+  M+
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNMN 218

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 79/302 (26%), Positives = 129/302 (42%), Gaps = 63/302 (20%)
Query: 161 IGEGGRGHVYKARFNE------KLLAAVKRIDDAGHDAER-EFNNEVNWLTKIRHQNIIS 213
           +G+G  G VY+    +      +   AVK ++++    ER EF NE + +      +++ 
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 214 LLGYCIHAETRFLVYEMMQNGSLEKQLHG--PTHGSNL-----TWHLRMKIAVDVARGLE 266
           LLG     +   +V E+M +G L+  L    P   +N      T    +++A ++A G+ 
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLG-----YV 321
           YL+       VHRDL + N ++   F  K+ DFG+  T      +    G  G     ++
Sbjct: 144 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGM--TRDIYETDYYRKGGKGLLPVRWM 198
Query: 322 APEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLP 380
           APE L +G  T  SD+++FGVVL E+  +  +P + +S  Q                   
Sbjct: 199 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ------------------- 239
Query: 381 NIVDPVIRDTMDLKHLYQ-------VAAVAVLCIQPEPSYRP-------LITDVLHSLIP 426
                V++  MD  +L Q       V  +  +C Q  P  RP       L+ D LH   P
Sbjct: 240 -----VLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 294
Query: 427 LV 428
            V
Sbjct: 295 EV 296

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 71/276 (25%), Positives = 125/276 (45%), Gaps = 30/276 (10%)
Query: 155 FQESNVIGEGGRGHVYKARFNE-KLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNII 212
           F +   IG+G  G V+K   N  + + A+K ID +   D   +   E+  L++     + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 213 SLLGYCIHAETRFLVYEMMQNGSLEKQLH-GPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
              G  +     +++ E +  GS    L  GP   + +   LR     ++ +GL+YLH  
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR-----EILKGLDYLHSE 123
Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT-AGTQSRNVKISGTLGYVAPEYLLEGK 330
                +HRD+K++N+LL      KL+DFG++     TQ +     GT  ++APE + +  
Sbjct: 124 KK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA 180
Query: 331 LTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDT 390
              K+D+++ G+  +EL  G  P  ++ P +    V + +P+    +   N   P     
Sbjct: 181 YDSKADIWSLGITAIELARGEPPHSELHPMK----VLFLIPKNNPPTLEGNYSKP----- 231
Query: 391 MDLKHLYQVAAVAVLCIQPEPSYRPLITDVL-HSLI 425
             LK   +       C+  EPS+RP   ++L H  I
Sbjct: 232 --LKEFVEA------CLNKEPSFRPTAKELLKHKFI 259

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 71/276 (25%), Positives = 125/276 (45%), Gaps = 30/276 (10%)
Query: 155 FQESNVIGEGGRGHVYKARFNE-KLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNII 212
           F +   IG+G  G V+K   N  + + A+K ID +   D   +   E+  L++     + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 213 SLLGYCIHAETRFLVYEMMQNGSLEKQLH-GPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
              G  +     +++ E +  GS    L  GP   + +   LR     ++ +GL+YLH  
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR-----EILKGLDYLHSE 123
Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT-AGTQSRNVKISGTLGYVAPEYLLEGK 330
                +HRD+K++N+LL      KL+DFG++     TQ +     GT  ++APE + +  
Sbjct: 124 KK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSA 180
Query: 331 LTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDT 390
              K+D+++ G+  +EL  G  P  ++ P +    V + +P+    +   N   P     
Sbjct: 181 YDSKADIWSLGITAIELARGEPPHSELHPMK----VLFLIPKNNPPTLEGNYSKP----- 231
Query: 391 MDLKHLYQVAAVAVLCIQPEPSYRPLITDVL-HSLI 425
             LK   +       C+  EPS+RP   ++L H  I
Sbjct: 232 --LKEFVEA------CLNKEPSFRPTAKELLKHKFI 259

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 97/200 (48%), Gaps = 13/200 (6%)
Query: 160 VIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFN--NEVNWLTKIRHQNIISLLG 216
           ++G+G  G V K +    +   AVK I+ A    +       EV  L K+ H NI+ L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 217 YCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPV 276
               + + ++V E+   G L  ++         + H   +I   V  G+ Y+H+H    +
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEI---IKRKRFSEHDAARIIKQVFSGITYMHKH---NI 142
Query: 277 VHRDLKSSNILLDS---SFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTD 333
           VHRDLK  NILL+S     + K+ DFGLS      ++     GT  Y+APE +L G   +
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPE-VLRGTYDE 201
Query: 334 KSDVYAFGVVLLELLMGRRP 353
           K DV++ GV+L  LL G  P
Sbjct: 202 KCDVWSAGVILYILLSGTPP 221

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 104/216 (48%), Gaps = 21/216 (9%)
Query: 158 SNVIGEGGRGHVYKARF----NEKLLAAVKRIDDAGHDAERE-FNNEVNWLTKIRHQNII 212
             VIG+G  G VY   +      ++  A+K +       + E F  E   +  + H N++
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 213 SLLGYCIHAE-TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
           +L+G  +  E    ++   M +G L + +  P    N T    +   + VARG+EYL E 
Sbjct: 86  ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQ--RNPTVKDLISFGLQVARGMEYLAEQ 143
Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLS-------VTAGTQSRNVKISGTLGYVAPE 324
                VHRDL + N +LD SF  K++DFGL+         +  Q R+ ++   + + A E
Sbjct: 144 ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLP--VKWTALE 198
Query: 325 YLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSP 359
            L   + T KSDV++FGV+L ELL  G  P   + P
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP 234

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 107/240 (44%), Gaps = 34/240 (14%)
Query: 140 VSVIEYELLEAATNNFQESNV-----IGEGGRGHVY--------KARFNEKLLAAVKRI- 185
             V EYEL E     F    +     +GEG  G V         K +  E +  AVK + 
Sbjct: 17  AGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK 76
Query: 186 DDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGP- 243
           DDA      +  +E+  +  I +H+NII+LLG C      +++ E    G+L + L    
Sbjct: 77  DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARR 136
Query: 244 ------------THGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS 291
                            +T+   +     +ARG+EYL    +   +HRDL + N+L+  +
Sbjct: 137 PPGMEXSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTEN 193
Query: 292 FNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELL 348
              K++DFGL+          K +     + ++APE L +   T +SDV++FGV++ E+ 
Sbjct: 194 NVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 97/200 (48%), Gaps = 13/200 (6%)
Query: 160 VIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFN--NEVNWLTKIRHQNIISLLG 216
           ++G+G  G V K +    +   AVK I+ A    +       EV  L K+ H NI+ L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 217 YCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPV 276
               + + ++V E+   G L  ++         + H   +I   V  G+ Y+H+H    +
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEI---IKRKRFSEHDAARIIKQVFSGITYMHKH---NI 142
Query: 277 VHRDLKSSNILLDS---SFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTD 333
           VHRDLK  NILL+S     + K+ DFGLS      ++     GT  Y+APE +L G   +
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPE-VLRGTYDE 201
Query: 334 KSDVYAFGVVLLELLMGRRP 353
           K DV++ GV+L  LL G  P
Sbjct: 202 KCDVWSAGVILYILLSGTPP 221

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 71/276 (25%), Positives = 125/276 (45%), Gaps = 30/276 (10%)
Query: 155 FQESNVIGEGGRGHVYKARFNE-KLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNII 212
           F +   IG+G  G V+K   N  + + A+K ID +   D   +   E+  L++     + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 213 SLLGYCIHAETRFLVYEMMQNGSLEKQLH-GPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
              G  +     +++ E +  GS    L  GP   + +   LR     ++ +GL+YLH  
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR-----EILKGLDYLHSE 138
Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT-AGTQSRNVKISGTLGYVAPEYLLEGK 330
                +HRD+K++N+LL      KL+DFG++     TQ +     GT  ++APE + +  
Sbjct: 139 KK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSA 195
Query: 331 LTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDT 390
              K+D+++ G+  +EL  G  P  ++ P +    V + +P+    +   N   P     
Sbjct: 196 YDSKADIWSLGITAIELARGEPPHSELHPMK----VLFLIPKNNPPTLEGNYSKP----- 246
Query: 391 MDLKHLYQVAAVAVLCIQPEPSYRPLITDVL-HSLI 425
             LK   +       C+  EPS+RP   ++L H  I
Sbjct: 247 --LKEFVEA------CLNKEPSFRPTAKELLKHKFI 274

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 107/240 (44%), Gaps = 34/240 (14%)
Query: 140 VSVIEYELLEAATNNFQESNV-----IGEGGRGHVY--------KARFNEKLLAAVKRI- 185
             V EYEL E     F    +     +GEG  G V         K +  E +  AVK + 
Sbjct: 17  AGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK 76
Query: 186 DDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGP- 243
           DDA      +  +E+  +  I +H+NII+LLG C      +++ E    G+L + L    
Sbjct: 77  DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARR 136
Query: 244 ------------THGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS 291
                            +T+   +     +ARG+EYL    +   +HRDL + N+L+  +
Sbjct: 137 PPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTEN 193
Query: 292 FNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELL 348
              K++DFGL+          K +     + ++APE L +   T +SDV++FGV++ E+ 
Sbjct: 194 NVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 108/240 (45%), Gaps = 34/240 (14%)
Query: 140 VSVIEYELLEAATNNFQESNV-----IGEGGRGHVY--------KARFNEKLLAAVKRI- 185
             V EYEL E     F    +     +GEG  G V         K +  E +  AVK + 
Sbjct: 17  AGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK 76
Query: 186 DDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGP- 243
           DDA  +   +  +E+  +  I +H+NII+LLG C      +++ E    G+L + L    
Sbjct: 77  DDATEEDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARR 136
Query: 244 ------------THGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS 291
                            +T+   +     +ARG+EYL    +   +HRDL + N+L+  +
Sbjct: 137 PPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTEN 193
Query: 292 FNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELL 348
              K++DFGL+          K +     + ++APE L +   T +SDV++FGV++ E+ 
Sbjct: 194 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 97/200 (48%), Gaps = 13/200 (6%)
Query: 160 VIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFN--NEVNWLTKIRHQNIISLLG 216
           ++G+G  G V K +    +   AVK I+ A    +       EV  L K+ H NI+ L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 217 YCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPV 276
               + + ++V E+   G L  ++         + H   +I   V  G+ Y+H+H    +
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEI---IKRKRFSEHDAARIIKQVFSGITYMHKH---NI 142
Query: 277 VHRDLKSSNILLDS---SFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTD 333
           VHRDLK  NILL+S     + K+ DFGLS      ++     GT  Y+APE +L G   +
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPE-VLRGTYDE 201
Query: 334 KSDVYAFGVVLLELLMGRRP 353
           K DV++ GV+L  LL G  P
Sbjct: 202 KCDVWSAGVILYILLSGTPP 221

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 107/240 (44%), Gaps = 34/240 (14%)
Query: 140 VSVIEYELLEAATNNFQESNV-----IGEGGRGHVY--------KARFNEKLLAAVKRI- 185
             V EYEL E     F    +     +GEG  G V         K +  E +  AVK + 
Sbjct: 17  AGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK 76
Query: 186 DDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGP- 243
           DDA      +  +E+  +  I +H+NII+LLG C      +++ E    G+L + L    
Sbjct: 77  DDATEKDLSDLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARR 136
Query: 244 ------------THGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS 291
                            +T+   +     +ARG+EYL    +   +HRDL + N+L+  +
Sbjct: 137 PPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTEN 193
Query: 292 FNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELL 348
              K++DFGL+          K +     + ++APE L +   T +SDV++FGV++ E+ 
Sbjct: 194 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 199 EVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIA 258
           E N + ++ +  I+ ++G C  AE+  LV EM + G L K L    H  +      +++ 
Sbjct: 58  EANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKN---IIELV 113
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTL 318
             V+ G++YL E      VHRDL + N+LL +   AK+SDFGLS  A     N   + T 
Sbjct: 114 HQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLS-KALRADENYYKAQTH 169
Query: 319 G-----YVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQ 372
           G     + APE +   K + KSDV++FGV++ E    G++P   M  ++  +M+     +
Sbjct: 170 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-----E 224
Query: 373 LTDRSKLPNIVDPVIRDTMDLKHLYQV 399
             +R   P      + D M+L   Y V
Sbjct: 225 KGERMGCPAGCPREMYDLMNLCWTYDV 251

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 103/220 (46%), Gaps = 23/220 (10%)
Query: 161 IGEGGRGHVYKA--RFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYC 218
           IGEG  G V  A  R + KL+A VK++D           NEV  +   +H+N++ +    
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVA-VKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 97
Query: 219 IHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMK------IAVDVARGLEYLHEHC 272
           +  +  ++V E ++ G+L          +++  H RM       + + V + L  LH   
Sbjct: 98  LVGDELWVVMEFLEGGAL----------TDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG 147
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ-SRNVKISGTLGYVAPEYLLEGKL 331
              V+HRD+KS +ILL      KLSDFG       +  R   + GT  ++APE +     
Sbjct: 148 ---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY 204
Query: 332 TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
             + D+++ G++++E++ G  P     P +   M+   +P
Sbjct: 205 GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP 244

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 103/220 (46%), Gaps = 23/220 (10%)
Query: 161 IGEGGRGHVYKA--RFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYC 218
           IGEG  G V  A  R + KL+A VK++D           NEV  +   +H+N++ +    
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVA-VKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 219 IHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMK------IAVDVARGLEYLHEHC 272
           +  +  ++V E ++ G+L          +++  H RM       + + V + L  LH   
Sbjct: 87  LVGDELWVVMEFLEGGAL----------TDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG 136
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ-SRNVKISGTLGYVAPEYLLEGKL 331
              V+HRD+KS +ILL      KLSDFG       +  R   + GT  ++APE +     
Sbjct: 137 ---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY 193
Query: 332 TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
             + D+++ G++++E++ G  P     P +   M+   +P
Sbjct: 194 GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP 233

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 102/206 (49%), Gaps = 17/206 (8%)
Query: 199 EVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIA 258
           E N + ++ +  I+ ++G C  AE+  LV EM + G L K L    H  +      +++ 
Sbjct: 62  EANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKN---IIELV 117
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISG 316
             V+ G++YL E      VHRDL + N+LL +   AK+SDFGLS  + A       +  G
Sbjct: 118 HQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHG 174
Query: 317 T--LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQL 373
              + + APE +   K + KSDV++FGV++ E    G++P   M  ++  +M+     + 
Sbjct: 175 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-----EK 229
Query: 374 TDRSKLPNIVDPVIRDTMDLKHLYQV 399
            +R   P      + D M+L   Y V
Sbjct: 230 GERMGCPAGCPREMYDLMNLCWTYDV 255

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 199 EVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIA 258
           E N + ++ +  I+ ++G C  AE+  LV EM + G L K L    H  +      +++ 
Sbjct: 56  EANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKN---IIELV 111
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTL 318
             V+ G++YL E      VHRDL + N+LL +   AK+SDFGLS  A     N   + T 
Sbjct: 112 HQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLS-KALRADENYYKAQTH 167
Query: 319 G-----YVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQ 372
           G     + APE +   K + KSDV++FGV++ E    G++P   M  ++  +M+     +
Sbjct: 168 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-----E 222
Query: 373 LTDRSKLPNIVDPVIRDTMDLKHLYQV 399
             +R   P      + D M+L   Y V
Sbjct: 223 KGERMGCPAGCPREMYDLMNLCWTYDV 249

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 103/220 (46%), Gaps = 23/220 (10%)
Query: 161 IGEGGRGHVYKA--RFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYC 218
           IGEG  G V  A  R + KL+A VK++D           NEV  +   +H+N++ +    
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVA-VKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 95
Query: 219 IHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMK------IAVDVARGLEYLHEHC 272
           +  +  ++V E ++ G+L          +++  H RM       + + V + L  LH   
Sbjct: 96  LVGDELWVVMEFLEGGAL----------TDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG 145
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ-SRNVKISGTLGYVAPEYLLEGKL 331
              V+HRD+KS +ILL      KLSDFG       +  R   + GT  ++APE +     
Sbjct: 146 ---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY 202
Query: 332 TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
             + D+++ G++++E++ G  P     P +   M+   +P
Sbjct: 203 GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP 242

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 199 EVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIA 258
           E N + ++ +  I+ ++G C  AE+  LV EM + G L K L    H  +      +++ 
Sbjct: 62  EANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKN---IIELV 117
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTL 318
             V+ G++YL E      VHRDL + N+LL +   AK+SDFGLS  A     N   + T 
Sbjct: 118 HQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLS-KALRADENYYKAQTH 173
Query: 319 G-----YVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQ 372
           G     + APE +   K + KSDV++FGV++ E    G++P   M  ++  +M+     +
Sbjct: 174 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-----E 228
Query: 373 LTDRSKLPNIVDPVIRDTMDLKHLYQV 399
             +R   P      + D M+L   Y V
Sbjct: 229 KGERMGCPAGCPREMYDLMNLCWTYDV 255

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 99/208 (47%), Gaps = 8/208 (3%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKARFNEK-LLAAVKRIDDAGHDAER-EFNNEVNWLTKI 206
           E   ++F+  + +G G  G V K +     L+ A K I      A R +   E+  L + 
Sbjct: 12  ELKDDDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 71
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
               I+   G         +  E M  GSL++ L        +   +  K+++ V RGL 
Sbjct: 72  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KEAKRIPEEILGKVSIAVLRGLA 128
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYL 326
           YL E   H ++HRD+K SNIL++S    KL DFG+S        N    GT  Y+APE L
Sbjct: 129 YLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMAPERL 185
Query: 327 LEGKLTDKSDVYAFGVVLLELLMGRRPV 354
                + +SD+++ G+ L+EL +GR P+
Sbjct: 186 QGTHYSVQSDIWSMGLSLVELAVGRYPI 213

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 199 EVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIA 258
           E N + ++ +  I+ ++G C  AE+  LV EM + G L K L    H  +      +++ 
Sbjct: 68  EANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKN---IIELV 123
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTL 318
             V+ G++YL E      VHRDL + N+LL +   AK+SDFGLS  A     N   + T 
Sbjct: 124 HQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLS-KALRADENYYKAQTH 179
Query: 319 G-----YVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQ 372
           G     + APE +   K + KSDV++FGV++ E    G++P   M  ++  +M+     +
Sbjct: 180 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-----E 234
Query: 373 LTDRSKLPNIVDPVIRDTMDLKHLYQV 399
             +R   P      + D M+L   Y V
Sbjct: 235 KGERMGCPAGCPREMYDLMNLCWTYDV 261

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 8/209 (3%)
Query: 148 LEAATNNFQESNVIGEGGRGHVYKARFNEK-LLAAVKRIDDAGHDAER-EFNNEVNWLTK 205
           +E   ++F++ + +G G  G V+K       L+ A K I      A R +   E+  L +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 206 IRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
                I+   G         +  E M  GSL++ L        +   +  K+++ V +GL
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGL 117
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEY 325
            YL E   H ++HRD+K SNIL++S    KL DFG+S        N    GT  Y++PE 
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPER 174
Query: 326 LLEGKLTDKSDVYAFGVVLLELLMGRRPV 354
           L     + +SD+++ G+ L+E+ +GR P+
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 8/209 (3%)
Query: 148 LEAATNNFQESNVIGEGGRGHVYKARFNEK-LLAAVKRIDDAGHDAER-EFNNEVNWLTK 205
           +E   ++F++ + +G G  G V+K       L+ A K I      A R +   E+  L +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 206 IRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
                I+   G         +  E M  GSL++ L        +   +  K+++ V +GL
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGL 117
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEY 325
            YL E   H ++HRD+K SNIL++S    KL DFG+S        N    GT  Y++PE 
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPER 174
Query: 326 LLEGKLTDKSDVYAFGVVLLELLMGRRPV 354
           L     + +SD+++ G+ L+E+ +GR P+
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 199 EVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIA 258
           E N + ++ +  I+ ++G C  AE+  LV EM + G L K L    H  +      +++ 
Sbjct: 78  EANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKN---IIELV 133
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTL 318
             V+ G++YL E      VHRDL + N+LL +   AK+SDFGLS  A     N   + T 
Sbjct: 134 HQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLS-KALRADENYYKAQTH 189
Query: 319 G-----YVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQ 372
           G     + APE +   K + KSDV++FGV++ E    G++P   M  ++  +M+     +
Sbjct: 190 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-----E 244
Query: 373 LTDRSKLPNIVDPVIRDTMDLKHLYQV 399
             +R   P      + D M+L   Y V
Sbjct: 245 KGERMGCPAGCPREMYDLMNLCWTYDV 271

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 199 EVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIA 258
           E N + ++ +  I+ ++G C  AE+  LV EM + G L K L    H  +      +++ 
Sbjct: 78  EANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKN---IIELV 133
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTL 318
             V+ G++YL E      VHRDL + N+LL +   AK+SDFGLS  A     N   + T 
Sbjct: 134 HQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLS-KALRADENYYKAQTH 189
Query: 319 G-----YVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQ 372
           G     + APE +   K + KSDV++FGV++ E    G++P   M  ++  +M+     +
Sbjct: 190 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-----E 244
Query: 373 LTDRSKLPNIVDPVIRDTMDLKHLYQV 399
             +R   P      + D M+L   Y V
Sbjct: 245 KGERMGCPAGCPREMYDLMNLCWTYDV 271

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 199 EVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIA 258
           E N + ++ +  I+ ++G C  AE+  LV EM + G L K L    H  +      +++ 
Sbjct: 76  EANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKN---IIELV 131
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTL 318
             V+ G++YL E      VHRDL + N+LL +   AK+SDFGLS  A     N   + T 
Sbjct: 132 HQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLS-KALRADENYYKAQTH 187
Query: 319 G-----YVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQ 372
           G     + APE +   K + KSDV++FGV++ E    G++P   M  ++  +M+     +
Sbjct: 188 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-----E 242
Query: 373 LTDRSKLPNIVDPVIRDTMDLKHLYQV 399
             +R   P      + D M+L   Y V
Sbjct: 243 KGERMGCPAGCPREMYDLMNLCWTYDV 269

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 78/302 (25%), Positives = 130/302 (43%), Gaps = 63/302 (20%)
Query: 161 IGEGGRGHVYKARFNE------KLLAAVKRIDDAGHDAER-EFNNEVNWLTKIRHQNIIS 213
           +G+G  G VY+    +      +   AVK ++++    ER EF NE + +      +++ 
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 214 LLGYCIHAETRFLVYEMMQNGSLEKQLHG--PTHGSNL-----TWHLRMKIAVDVARGLE 266
           LLG     +   +V E+M +G L+  L    P   +N      T    +++A ++A G+ 
Sbjct: 86  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 145
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLG-----YV 321
           YL+       VHR+L + N ++   F  K+ DFG+  T      +    G  G     ++
Sbjct: 146 YLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGM--TRDIYETDYYRKGGKGLLPVRWM 200
Query: 322 APEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLP 380
           APE L +G  T  SD+++FGVVL E+  +  +P + +S  Q                   
Sbjct: 201 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ------------------- 241
Query: 381 NIVDPVIRDTMDLKHLYQ-------VAAVAVLCIQPEPSYRP-------LITDVLHSLIP 426
                V++  MD  +L Q       V  +  +C Q  P+ RP       L+ D LH   P
Sbjct: 242 -----VLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDDLHPSFP 296
Query: 427 LV 428
            V
Sbjct: 297 EV 298

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 8/209 (3%)
Query: 148 LEAATNNFQESNVIGEGGRGHVYKARFNEK-LLAAVKRIDDAGHDAER-EFNNEVNWLTK 205
           +E   ++F++ + +G G  G V+K       L+ A K I      A R +   E+  L +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 206 IRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
                I+   G         +  E M  GSL++ L        +   +  K+++ V +GL
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGL 117
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEY 325
            YL E   H ++HRD+K SNIL++S    KL DFG+S        N    GT  Y++PE 
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPER 174
Query: 326 LLEGKLTDKSDVYAFGVVLLELLMGRRPV 354
           L     + +SD+++ G+ L+E+ +GR P+
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 78/302 (25%), Positives = 130/302 (43%), Gaps = 63/302 (20%)
Query: 161 IGEGGRGHVYKARFNE------KLLAAVKRIDDAGHDAER-EFNNEVNWLTKIRHQNIIS 213
           +G+G  G VY+    +      +   AVK ++++    ER EF NE + +      +++ 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 214 LLGYCIHAETRFLVYEMMQNGSLEKQLHG--PTHGSNL-----TWHLRMKIAVDVARGLE 266
           LLG     +   +V E+M +G L+  L    P   +N      T    +++A ++A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLG-----YV 321
           YL+       VHR+L + N ++   F  K+ DFG+  T      +    G  G     ++
Sbjct: 145 YLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGM--TRDIYETDYYRKGGKGLLPVRWM 199
Query: 322 APEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLP 380
           APE L +G  T  SD+++FGVVL E+  +  +P + +S  Q                   
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ------------------- 240
Query: 381 NIVDPVIRDTMDLKHLYQ-------VAAVAVLCIQPEPSYRP-------LITDVLHSLIP 426
                V++  MD  +L Q       V  +  +C Q  P+ RP       L+ D LH   P
Sbjct: 241 -----VLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDDLHPSFP 295
Query: 427 LV 428
            V
Sbjct: 296 EV 297

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 103/220 (46%), Gaps = 23/220 (10%)
Query: 161 IGEGGRGHVYKA--RFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYC 218
           IGEG  G V  A  R + KL+A VK++D           NEV  +   +H+N++ +    
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVA-VKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 140
Query: 219 IHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMK------IAVDVARGLEYLHEHC 272
           +  +  ++V E ++ G+L          +++  H RM       + + V + L  LH   
Sbjct: 141 LVGDELWVVMEFLEGGAL----------TDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG 190
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ-SRNVKISGTLGYVAPEYLLEGKL 331
              V+HRD+KS +ILL      KLSDFG       +  R   + GT  ++APE +     
Sbjct: 191 ---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY 247
Query: 332 TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
             + D+++ G++++E++ G  P     P +   M+   +P
Sbjct: 248 GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP 287

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 8/209 (3%)
Query: 148 LEAATNNFQESNVIGEGGRGHVYKARFNEK-LLAAVKRIDDAGHDAER-EFNNEVNWLTK 205
           +E   ++F++ + +G G  G V+K       L+ A K I      A R +   E+  L +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 206 IRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
                I+   G         +  E M  GSL++ L        +   +  K+++ V +GL
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGL 117
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEY 325
            YL E   H ++HRD+K SNIL++S    KL DFG+S        N    GT  Y++PE 
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPER 174
Query: 326 LLEGKLTDKSDVYAFGVVLLELLMGRRPV 354
           L     + +SD+++ G+ L+E+ +GR P+
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 103/220 (46%), Gaps = 23/220 (10%)
Query: 161 IGEGGRGHVYKA--RFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYC 218
           IGEG  G V  A  R + KL+A VK++D           NEV  +   +H+N++ +    
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVA-VKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 90
Query: 219 IHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMK------IAVDVARGLEYLHEHC 272
           +  +  ++V E ++ G+L          +++  H RM       + + V + L  LH   
Sbjct: 91  LVGDELWVVMEFLEGGAL----------TDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG 140
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ-SRNVKISGTLGYVAPEYLLEGKL 331
              V+HRD+KS +ILL      KLSDFG       +  R   + GT  ++APE +     
Sbjct: 141 ---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY 197
Query: 332 TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
             + D+++ G++++E++ G  P     P +   M+   +P
Sbjct: 198 GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP 237

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 8/209 (3%)
Query: 148 LEAATNNFQESNVIGEGGRGHVYKARFNEK-LLAAVKRIDDAGHDAER-EFNNEVNWLTK 205
           +E   ++F++ + +G G  G V+K       L+ A K I      A R +   E+  L +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 206 IRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
                I+   G         +  E M  GSL++ L        +   +  K+++ V +GL
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGL 117
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEY 325
            YL E   H ++HRD+K SNIL++S    KL DFG+S        N    GT  Y++PE 
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPER 174
Query: 326 LLEGKLTDKSDVYAFGVVLLELLMGRRPV 354
           L     + +SD+++ G+ L+E+ +GR P+
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 120/263 (45%), Gaps = 33/263 (12%)
Query: 161 IGEGGRGHVYKA--RFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYC 218
           IGEG  G V  A  R + KL+A VK++D           NEV  +   +H+N++ +    
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVA-VKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 217
Query: 219 IHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMK------IAVDVARGLEYLHEHC 272
           +  +  ++V E ++ G+L          +++  H RM       + + V + L  LH   
Sbjct: 218 LVGDELWVVMEFLEGGAL----------TDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG 267
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ-SRNVKISGTLGYVAPEYLLEGKL 331
              V+HRD+KS +ILL      KLSDFG       +  R   + GT  ++APE +     
Sbjct: 268 ---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY 324
Query: 332 TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNI--VDPVIRD 389
             + D+++ G++++E++ G  P     P +   M+   +P      +L N+  V P ++ 
Sbjct: 325 GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-----PRLKNLHKVSPSLKG 379
Query: 390 TMD---LKHLYQVAAVAVLCIQP 409
            +D   ++   Q A  A L   P
Sbjct: 380 FLDRLLVRDPAQRATAAELLKHP 402

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 104/214 (48%), Gaps = 8/214 (3%)
Query: 147 LLEAATNNFQESNVIGEGGRGHVYKARFNEK-LLAAVKRIDDAGHDAER-EFNNEVNWLT 204
           L E   ++F++ + +G G  G V+K       L+ A K I      A R +   E+  L 
Sbjct: 3   LGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLH 62
Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
           +     I+   G         +  E M  GSL++ L        +   +  K+++ V +G
Sbjct: 63  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKG 119
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
           L YL E   H ++HRD+K SNIL++S    KL DFG+S     +  N +  GT  Y++PE
Sbjct: 120 LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMAN-EFVGTRSYMSPE 176
Query: 325 YLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMS 358
            L     + +SD+++ G+ L+E+ +GR P   M+
Sbjct: 177 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPRPPMA 210

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 84/353 (23%), Positives = 144/353 (40%), Gaps = 70/353 (19%)
Query: 98  RWKRLKNTNGNSKQTIDGGKGLSLSPILERFNSLRLAGKKDTVSVIEYELLEAATNNFQE 157
           RWK +++  GNS   ID        P    +N                E  E   NN Q 
Sbjct: 15  RWKIIESYEGNSYTFID--------PTQLPYN----------------EKWEFPRNNLQF 50
Query: 158 SNVIGEGGRGHVYKA------RFNEKLLAAVKRIDDAGHDAERE-FNNEVNWLTKI-RHQ 209
              +G G  G V +A      + +  L  AVK +    H  E+E   +E+  ++ + +H+
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 210 NIISLLGYCIHAETRFLVYEMMQNGSLEKQL-----------HGPTHG--SNLTWHLRMK 256
           NI++LLG C H     ++ E    G L   L           + P+H     L+    + 
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLH 170
Query: 257 IAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG 316
            +  VA+G+ +L    +   +HRD+ + N+LL +   AK+ DFGL+      S N  + G
Sbjct: 171 FSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS-NYIVKG 226
Query: 317 T----LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMP 371
                + ++APE + +   T +SDV+++G++L E+  +G  P                 P
Sbjct: 227 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP----------------YP 270
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
            +   SK   +V    +          + ++   C   EP++RP    +   L
Sbjct: 271 GILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL 323

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 104/210 (49%), Gaps = 19/210 (9%)
Query: 166 RGHVYKARFNEKLLAAVKRIDDAGHDAE-REFNNEVNWLTKIRHQNIISLLGYCIHAETR 224
           R  VY+ R  +++  A+K +      A+  E   E   + ++ +  I+ L+G C  AE  
Sbjct: 27  RQGVYRMR-KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEAL 84
Query: 225 FLVYEMMQNGSLEKQLHGPTHG---SNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDL 281
            LV EM   G L K L G       SN+      ++   V+ G++YL E      VHRDL
Sbjct: 85  MLVMEMAGGGPLHKFLVGKREEIPVSNVA-----ELLHQVSMGMKYLEEK---NFVHRDL 136
Query: 282 KSSNILLDSSFNAKLSDFGLSVTAGTQSR--NVKISGT--LGYVAPEYLLEGKLTDKSDV 337
            + N+LL +   AK+SDFGLS   G        + +G   L + APE +   K + +SDV
Sbjct: 137 AARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDV 196
Query: 338 YAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
           +++GV + E L  G++P +KM   +  + +
Sbjct: 197 WSYGVTMWEALSYGQKPYKKMKGPEVMAFI 226

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 98/208 (47%), Gaps = 27/208 (12%)
Query: 160 VIGEGGRGHVYKARFNEK----LLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLL 215
           V+G+G  G   K    E     ++  + R D+   + +R F  EV  +  + H N++  +
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFDE---ETQRTFLKEVKVMRCLEHPNVLKFI 73
Query: 216 GYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHP 275
           G     +    + E ++ G+L   +   +  S   W  R+  A D+A G+ YLH   +  
Sbjct: 74  GVLYKDKRLNFITEYIKGGTLRGIIK--SMDSQYPWSQRVSFAKDIASGMAYLH---SMN 128
Query: 276 VVHRDLKSSNILLDSSFNAKLSDFGLS---VTAGTQSRNVK------------ISGTLGY 320
           ++HRDL S N L+  + N  ++DFGL+   V   TQ   ++            + G   +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 321 VAPEYLLEGKLTDKSDVYAFGVVLLELL 348
           +APE +      +K DV++FG+VL E++
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEII 216

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 96/215 (44%), Gaps = 17/215 (7%)
Query: 151 ATNNFQESNVIGEGGRGHVYKAR-FNEKLLAAVK--RIDDAGHDAEREFNNEVNWLTKIR 207
           AT+ ++    IG G  G VYKAR  +     A+K  R+ +           EV  L ++ 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 208 ---HQNIISLLGYCIHAETR-----FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAV 259
              H N++ L+  C  + T       LV+E +           P  G  L       +  
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG--LPAETIKDLMR 119
Query: 260 DVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLG 319
              RGL++LH +C   +VHRDLK  NIL+ S    KL+DFGL+     Q     +  TL 
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVVTLW 176
Query: 320 YVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPV 354
           Y APE LL+       D+++ G +  E+   R+P+
Sbjct: 177 YRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 110/242 (45%), Gaps = 38/242 (15%)
Query: 140 VSVIEYELLEAATNNFQESNVI-----GEGGRGHVY--------KARFNEKLLAAVKRI- 185
             V EYEL E          ++     GEG  G V         K + N     AVK + 
Sbjct: 10  AGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK 69
Query: 186 DDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHG-- 242
            DA      +  +E+  +  I +H+NII+LLG C      +++ E    G+L + L    
Sbjct: 70  SDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARR 129
Query: 243 ---------PTHG--SNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS 291
                    P+H     L+    +  A  VARG+EYL    +   +HRDL + N+L+   
Sbjct: 130 PPGLEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTED 186
Query: 292 FNAKLSDFGLS-----VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLE 346
              K++DFGL+     +    ++ N ++   + ++APE L +   T +SDV++FGV+L E
Sbjct: 187 NVMKIADFGLARDIHHIDXXKKTTNGRLP--VKWMAPEALFDRIYTHQSDVWSFGVLLWE 244
Query: 347 LL 348
           + 
Sbjct: 245 IF 246

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 78/259 (30%), Positives = 120/259 (46%), Gaps = 20/259 (7%)
Query: 179 LAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFL--VYEMMQNGS 235
           + AVK +  D G      +  E++ L  + H++II   G C     + L  V E +  GS
Sbjct: 45  MVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGS 104
Query: 236 LEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAK 295
           L   L  P H   L   L    A  +  G+ YLH   +   +HR+L + N+LLD+    K
Sbjct: 105 LRDYL--PRHSIGLAQLLL--FAQQICEGMAYLH---SQHYIHRNLAARNVLLDNDRLVK 157
Query: 296 LSDFGL--SVTAGTQSRNVKISG--TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGR 351
           + DFGL  +V  G +   V+  G   + + APE L E K    SDV++FGV L ELL   
Sbjct: 158 IGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT-H 216
Query: 352 RPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEP 411
               +  PT+   ++  A  Q+T   +L  +++   R     K   +V  +   C + E 
Sbjct: 217 CDSSQSPPTKFLELIGIAQGQMT-VLRLTELLERGERLPRPDKCPCEVYHLMKNCWETEA 275
Query: 412 SYRPLITDVLHSLIPLVPT 430
           S+RP       +LIP++ T
Sbjct: 276 SFRP----TFENLIPILKT 290

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 96/215 (44%), Gaps = 17/215 (7%)
Query: 151 ATNNFQESNVIGEGGRGHVYKAR-FNEKLLAAVK--RIDDAGHDAEREFNNEVNWLTKIR 207
           AT+ ++    IG G  G VYKAR  +     A+K  R+ +           EV  L ++ 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 208 ---HQNIISLLGYCIHAETR-----FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAV 259
              H N++ L+  C  + T       LV+E +           P  G  L       +  
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG--LPAETIKDLMR 119
Query: 260 DVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLG 319
              RGL++LH +C   +VHRDLK  NIL+ S    KL+DFGL+     Q     +  TL 
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVVTLW 176
Query: 320 YVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPV 354
           Y APE LL+       D+++ G +  E+   R+P+
Sbjct: 177 YRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 85/350 (24%), Positives = 143/350 (40%), Gaps = 70/350 (20%)
Query: 98  RWKRLKNTNGNSKQTIDGGKGLSLSPILERFNSLRLAGKKDTVSVIEYELLEAATNNFQE 157
           RWK +++  GNS   ID        P    +N                E  E   NN Q 
Sbjct: 7   RWKIIESYEGNSYTFID--------PTQLPYN----------------EKWEFPRNNLQF 42
Query: 158 SNVIGEGGRGHVYKA------RFNEKLLAAVKRIDDAGHDAERE-FNNEVNWLTKI-RHQ 209
              +G G  G V +A      + +  L  AVK +    H  E+E   +E+  ++ + +H+
Sbjct: 43  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 102
Query: 210 NIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTH-------GSNLTWHLRMKIAVDVA 262
           NI++LLG C H     ++ E    G L   L            G  L     +  +  VA
Sbjct: 103 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVA 162
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT----L 318
           +G+ +L    +   +HRD+ + N+LL +   AK+ DFGL+      S N  + G     +
Sbjct: 163 QGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS-NYIVKGNARLPV 218
Query: 319 GYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRS 377
            ++APE + +   T +SDV+++G++L E+  +G  P                 P +   S
Sbjct: 219 KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP----------------YPGILVNS 262
Query: 378 KLPNIVD---PVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
           K   +V     + +     K++Y +      C   EP++RP    +   L
Sbjct: 263 KFYKLVKDGYQMAQPAFAPKNIYSIMQA---CWALEPTHRPTFQQICSFL 309

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 199 EVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIA 258
           E N + ++ +  I+ ++G C  AE+  LV EM + G L K L    H  +      +++ 
Sbjct: 420 EANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI---IELV 475
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTL 318
             V+ G++YL E      VHRDL + N+LL +   AK+SDFGLS  A     N   + T 
Sbjct: 476 HQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLS-KALRADENYYKAQTH 531
Query: 319 G-----YVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQ 372
           G     + APE +   K + KSDV++FGV++ E    G++P   M  ++  +M+     +
Sbjct: 532 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-----E 586
Query: 373 LTDRSKLPNIVDPVIRDTMDLKHLYQV 399
             +R   P      + D M+L   Y V
Sbjct: 587 KGERMGCPAGCPREMYDLMNLCWTYDV 613

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/248 (27%), Positives = 110/248 (44%), Gaps = 37/248 (14%)
Query: 135 GKKDT---VSVIEYELLEAATNNFQESNV-----IGEGGRGHVY--------KARFNEKL 178
           G  DT     V EYEL E     F    +     +GEG  G V         K +  E +
Sbjct: 1   GAMDTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAV 60
Query: 179 LAAVKRI-DDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMMQNGSL 236
             AVK + DDA      +  +E+  +  I +H+NII+LLG C      +++ E    G+L
Sbjct: 61  TVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 120
Query: 237 EKQLHGP-------------THGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKS 283
            + L                     +T+   +     +ARG+EYL    +   +HRDL +
Sbjct: 121 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAA 177
Query: 284 SNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAPEYLLEGKLTDKSDVYAF 340
            N+L+  +   K++DFGL+          K +     + ++APE L +   T +SDV++F
Sbjct: 178 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 237
Query: 341 GVVLLELL 348
           GV++ E+ 
Sbjct: 238 GVLMWEIF 245

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 107/240 (44%), Gaps = 34/240 (14%)
Query: 140 VSVIEYELLEAATNNFQESNV-----IGEGGRGHVY--------KARFNEKLLAAVKRI- 185
             V EYEL E     F    +     +GEG  G V         K +  E +  AVK + 
Sbjct: 4   AGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK 63
Query: 186 DDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGP- 243
           DDA      +  +E+  +  I +H+NII+LLG C      +++ E    G+L + L    
Sbjct: 64  DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARR 123
Query: 244 ------------THGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS 291
                            +T+   +     +ARG+EYL    +   +HRDL + N+L+  +
Sbjct: 124 PPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLTARNVLVTEN 180
Query: 292 FNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELL 348
              K++DFGL+          K +     + ++APE L +   T +SDV++FGV++ E+ 
Sbjct: 181 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 240

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 199 EVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIA 258
           E N + ++ +  I+ ++G C  AE+  LV EM + G L K L    H  +      +++ 
Sbjct: 421 EANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI---IELV 476
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTL 318
             V+ G++YL E      VHRDL + N+LL +   AK+SDFGLS  A     N   + T 
Sbjct: 477 HQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLS-KALRADENYYKAQTH 532
Query: 319 G-----YVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQ 372
           G     + APE +   K + KSDV++FGV++ E    G++P   M  ++  +M+     +
Sbjct: 533 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-----E 587
Query: 373 LTDRSKLPNIVDPVIRDTMDLKHLYQV 399
             +R   P      + D M+L   Y V
Sbjct: 588 KGERMGCPAGCPREMYDLMNLCWTYDV 614

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 106/240 (44%), Gaps = 34/240 (14%)
Query: 140 VSVIEYELLEAATNNFQESNV-----IGEGGRGHVY--------KARFNEKLLAAVKRI- 185
             V EYEL E     F    +     +GEG  G V         K +  E +  AVK + 
Sbjct: 17  AGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK 76
Query: 186 DDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGP- 243
           DDA      +  +E+  +  I +H+NII LLG C      +++ E    G+L + L    
Sbjct: 77  DDATEKDLSDLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARR 136
Query: 244 ------------THGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS 291
                            +T+   +     +ARG+EYL    +   +HRDL + N+L+  +
Sbjct: 137 PPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTEN 193
Query: 292 FNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELL 348
              K++DFGL+          K +     + ++APE L +   T +SDV++FGV++ E+ 
Sbjct: 194 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 107/240 (44%), Gaps = 34/240 (14%)
Query: 140 VSVIEYELLEAATNNFQESNV-----IGEGGRGHVY--------KARFNEKLLAAVKRI- 185
             V EYEL E     F    +     +GEG  G V         K +  E +  AVK + 
Sbjct: 6   AGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK 65
Query: 186 DDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGP- 243
           DDA      +  +E+  +  I +H+NII+LLG C      +++ E    G+L + L    
Sbjct: 66  DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARR 125
Query: 244 ------------THGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS 291
                            +T+   +     +ARG+EYL    +   +HRDL + N+L+  +
Sbjct: 126 PPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTEN 182
Query: 292 FNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELL 348
              K++DFGL+          K +     + ++APE L +   T +SDV++FGV++ E+ 
Sbjct: 183 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 242

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 107/240 (44%), Gaps = 34/240 (14%)
Query: 140 VSVIEYELLEAATNNFQESNV-----IGEGGRGHVY--------KARFNEKLLAAVKRI- 185
             V EYEL E     F    +     +GEG  G V         K +  E +  AVK + 
Sbjct: 17  AGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK 76
Query: 186 DDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGP- 243
           DDA      +  +E+  +  I +H+NII+LLG C      +++ E    G+L + L    
Sbjct: 77  DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARR 136
Query: 244 ------------THGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS 291
                            +T+   +     +ARG+EYL    +   +HRDL + N+L+  +
Sbjct: 137 PPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTEN 193
Query: 292 FNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELL 348
              +++DFGL+          K +     + ++APE L +   T +SDV++FGV++ E+ 
Sbjct: 194 NVMRIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 85/350 (24%), Positives = 143/350 (40%), Gaps = 70/350 (20%)
Query: 98  RWKRLKNTNGNSKQTIDGGKGLSLSPILERFNSLRLAGKKDTVSVIEYELLEAATNNFQE 157
           RWK +++  GNS   ID        P    +N                E  E   NN Q 
Sbjct: 15  RWKIIESYEGNSYTFID--------PTQLPYN----------------EKWEFPRNNLQF 50
Query: 158 SNVIGEGGRGHVYKA------RFNEKLLAAVKRIDDAGHDAERE-FNNEVNWLTKI-RHQ 209
              +G G  G V +A      + +  L  AVK +    H  E+E   +E+  ++ + +H+
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 210 NIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTH-------GSNLTWHLRMKIAVDVA 262
           NI++LLG C H     ++ E    G L   L            G  L     +  +  VA
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVA 170
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT----L 318
           +G+ +L    +   +HRD+ + N+LL +   AK+ DFGL+      S N  + G     +
Sbjct: 171 QGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS-NYIVKGNARLPV 226
Query: 319 GYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRS 377
            ++APE + +   T +SDV+++G++L E+  +G  P                 P +   S
Sbjct: 227 KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP----------------YPGILVNS 270
Query: 378 KLPNIVD---PVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
           K   +V     + +     K++Y +      C   EP++RP    +   L
Sbjct: 271 KFYKLVKDGYQMAQPAFAPKNIYSIMQA---CWALEPTHRPTFQQICSFL 317

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 110/242 (45%), Gaps = 38/242 (15%)
Query: 140 VSVIEYELLEAATNNFQESNV-----IGEGGRGHVY--------KARFNEKLLAAVKRI- 185
             V EYEL E     F    +     +GEG  G V         K +  E +  AVK + 
Sbjct: 17  AGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK 76
Query: 186 DDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGP- 243
           DDA      +  +E+  +  I +H+NII+LLG C      +++ E    G+L + L    
Sbjct: 77  DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARR 136
Query: 244 ------------THGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS 291
                            +T+   +     +ARG+EYL    +   +HRDL + N+L+  +
Sbjct: 137 PPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTEN 193
Query: 292 FNAKLSDFGLS-----VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLE 346
              K++DFGL+     +     + N ++   + ++APE L +   T +SDV++FGV++ E
Sbjct: 194 NVMKIADFGLARDINNIDYYKNTTNGRLP--VKWMAPEALFDRVYTHQSDVWSFGVLMWE 251
Query: 347 LL 348
           + 
Sbjct: 252 IF 253

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 85/354 (24%), Positives = 145/354 (40%), Gaps = 74/354 (20%)
Query: 98  RWKRLKNTNGNSKQTIDGGKGLSLSPILERFNSLRLAGKKDTVSVIEYELLEAATNNFQE 157
           RWK +++  GNS   ID        P    +N                E  E   NN Q 
Sbjct: 15  RWKIIESYEGNSYTFID--------PTQLPYN----------------EKWEFPRNNLQF 50
Query: 158 SNVIGEGGRGHVYKA------RFNEKLLAAVKRIDDAGHDAERE-FNNEVNWLTKI-RHQ 209
              +G G  G V +A      + +  L  AVK +    H  E+E   +E+  ++ + +H+
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 210 NIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTH-----------GSNLTWHLRMKIA 258
           NI++LLG C H     ++ E    G L   L   +             S L+    +  +
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFS 170
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT- 317
             VA+G+ +L    +   +HRD+ + N+LL +   AK+ DFGL+      S N  + G  
Sbjct: 171 SQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS-NYIVKGNA 226
Query: 318 ---LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQL 373
              + ++APE + +   T +SDV+++G++L E+  +G  P                 P +
Sbjct: 227 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP----------------YPGI 270
Query: 374 TDRSKLPNIVD---PVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
              SK   +V     + +     K++Y +      C   EP++RP    +   L
Sbjct: 271 LVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQA---CWALEPTHRPTFQQICSFL 321

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 8/208 (3%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKARFNEK-LLAAVKRIDDAGHDAER-EFNNEVNWLTKI 206
           E   ++F++ + +G G  G V+K       L+ A K I      A R +   E+  L + 
Sbjct: 64  ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 123
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
               I+   G         +  E M  GSL++ L        +   +  K+++ V +GL 
Sbjct: 124 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLT 180
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYL 326
           YL E   H ++HRD+K SNIL++S    KL DFG+S        N  + GT  Y++PE L
Sbjct: 181 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-GTRSYMSPERL 237
Query: 327 LEGKLTDKSDVYAFGVVLLELLMGRRPV 354
                + +SD+++ G+ L+E+ +GR P+
Sbjct: 238 QGTHYSVQSDIWSMGLSLVEMAVGRYPI 265

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 98/219 (44%), Gaps = 23/219 (10%)
Query: 161 IGEGGRGHVYKA--RFNEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNIISLLGY 217
           +GEG  G V  A  R  E+ +A VK +D     D       E+     + H+N++   G+
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVA-VKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 218 CIHAETRFLVYEMMQNGSL----EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
                 ++L  E    G L    E  +  P   +   +H  M        G+ YLH    
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-------GVVYLH---G 122
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV---KISGTLGYVAPEYLLEGK 330
             + HRD+K  N+LLD   N K+SDFGL+      +R     K+ GTL YVAPE L   +
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 331 L-TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTW 368
              +  DV++ G+VL  +L G  P ++ S +  Q    W
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSX-QEYSDW 220

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 8/208 (3%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKARFNEK-LLAAVKRIDDAGHDAER-EFNNEVNWLTKI 206
           E   ++F++ + +G G  G V+K       L+ A K I      A R +   E+  L + 
Sbjct: 29  ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 88
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
               I+   G         +  E M  GSL++ L        +   +  K+++ V +GL 
Sbjct: 89  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLT 145
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYL 326
           YL E   H ++HRD+K SNIL++S    KL DFG+S        N    GT  Y++PE L
Sbjct: 146 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERL 202
Query: 327 LEGKLTDKSDVYAFGVVLLELLMGRRPV 354
                + +SD+++ G+ L+E+ +GR P+
Sbjct: 203 QGTHYSVQSDIWSMGLSLVEMAVGRYPI 230

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 78/259 (30%), Positives = 119/259 (45%), Gaps = 20/259 (7%)
Query: 179 LAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFL--VYEMMQNGS 235
           + AVK +  D G      +  E++ L  + H++II   G C     + L  V E +  GS
Sbjct: 45  MVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGS 104
Query: 236 LEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAK 295
           L   L  P H   L   L    A  +  G+ YLH       +HR+L + N+LLD+    K
Sbjct: 105 LRDYL--PRHSIGLAQLLL--FAQQICEGMAYLH---AQHYIHRNLAARNVLLDNDRLVK 157
Query: 296 LSDFGL--SVTAGTQSRNVKISG--TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGR 351
           + DFGL  +V  G +   V+  G   + + APE L E K    SDV++FGV L ELL   
Sbjct: 158 IGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT-H 216
Query: 352 RPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEP 411
               +  PT+   ++  A  Q+T   +L  +++   R     K   +V  +   C + E 
Sbjct: 217 CDSSQSPPTKFLELIGIAQGQMT-VLRLTELLERGERLPRPDKCPCEVYHLMKNCWETEA 275
Query: 412 SYRPLITDVLHSLIPLVPT 430
           S+RP       +LIP++ T
Sbjct: 276 SFRP----TFENLIPILKT 290

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 111/242 (45%), Gaps = 38/242 (15%)
Query: 140 VSVIEYELLEAATNNFQESNVI-----GEGGRGHVY--------KARFNEKLLAAVKRI- 185
             V EYEL E          ++     GEG  G V         K + N     AVK + 
Sbjct: 10  AGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK 69
Query: 186 DDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQL---- 240
            DA      +  +E+  +  I +H+NII+LLG C      +++ E    G+L + L    
Sbjct: 70  SDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARR 129
Query: 241 -------HGPTHG--SNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS 291
                  + P+H     L+    +  A  VARG+EYL    +   +HRDL + N+L+   
Sbjct: 130 PPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTED 186
Query: 292 FNAKLSDFGLS-----VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLE 346
              K++DFGL+     +    ++ N ++   + ++APE L +   T +SDV++FGV+L E
Sbjct: 187 NVMKIADFGLARDIHHIDYYKKTTNGRLP--VKWMAPEALFDRIYTHQSDVWSFGVLLWE 244
Query: 347 LL 348
           + 
Sbjct: 245 IF 246

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 71/274 (25%), Positives = 128/274 (46%), Gaps = 21/274 (7%)
Query: 161 IGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCI 219
           IG+G  G VY A         A+++++      +    NE+  + + ++ NI++ L   +
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 220 HAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAV---DVARGLEYLHEHCNHPV 276
             +  ++V E +  GSL       T     T     +IA    +  + LE+LH   ++ V
Sbjct: 88  VGDELWVVMEYLAGGSL-------TDVVTETCMDEGQIAAVCRECLQALEFLH---SNQV 137
Query: 277 VHRDLKSSNILLDSSFNAKLSDFGLSVT-AGTQSRNVKISGTLGYVAPEYLLEGKLTDKS 335
           +HRD+KS NILL    + KL+DFG        QS+  ++ GT  ++APE +       K 
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKAYGPKV 197
Query: 336 DVYAFGVVLLELLMGRRPVEKMSPTQCQSMV-TWAMPQLTDRSKLPNIVDPVIRDTMDLK 394
           D+++ G++ +E++ G  P    +P +   ++ T   P+L +  KL  I    +   +D+ 
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMD 257
Query: 395 HLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLV 428
              + +A  +L  Q     +P     L SL PL+
Sbjct: 258 VEKRGSAKELLQHQFLKIAKP-----LSSLTPLI 286

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 68/243 (27%), Positives = 111/243 (45%), Gaps = 38/243 (15%)
Query: 139 TVSVIEYELLEAATNNFQESNVI-----GEGGRGHVY--------KARFNEKLLAAVKRI 185
              V EYEL E          ++     GEG  G V         K + N     AVK +
Sbjct: 2   VAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML 61
Query: 186 -DDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQL--- 240
             DA      +  +E+  +  I +H+NII+LLG C      +++ E    G+L + L   
Sbjct: 62  KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAR 121
Query: 241 --------HGPTHG--SNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDS 290
                   + P+H     L+    +  A  VARG+EYL    +   +HRDL + N+L+  
Sbjct: 122 RPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTE 178
Query: 291 SFNAKLSDFGLS-----VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLL 345
               K++DFGL+     +    ++ N ++   + ++APE L +   T +SDV++FGV+L 
Sbjct: 179 DNVMKIADFGLARDIHHIDYYKKTTNGRLP--VKWMAPEALFDRIYTHQSDVWSFGVLLW 236
Query: 346 ELL 348
           E+ 
Sbjct: 237 EIF 239

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 96/215 (44%), Gaps = 17/215 (7%)
Query: 151 ATNNFQESNVIGEGGRGHVYKAR-FNEKLLAAVK--RIDDAGHDAEREFNNEVNWLTKIR 207
           AT+ ++    IG G  G VYKAR  +     A+K  R+ +           EV  L ++ 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 208 ---HQNIISLLGYCIHAETR-----FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAV 259
              H N++ L+  C  + T       LV+E +           P  G  L       +  
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG--LPAETIKDLMR 119
Query: 260 DVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLG 319
              RGL++LH +C   +VHRDLK  NIL+ S    KL+DFGL+     Q     +  TL 
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVVTLW 176
Query: 320 YVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPV 354
           Y APE LL+       D+++ G +  E+   R+P+
Sbjct: 177 YRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 111/242 (45%), Gaps = 38/242 (15%)
Query: 140 VSVIEYELLEAATNNFQESNVI-----GEGGRGHVY--------KARFNEKLLAAVKRI- 185
             V EYEL E          ++     GEG  G V         K + N     AVK + 
Sbjct: 10  AGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK 69
Query: 186 DDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQL---- 240
            DA      +  +E+  +  I +H+NII+LLG C      +++ E    G+L + L    
Sbjct: 70  SDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARR 129
Query: 241 -------HGPTHG--SNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS 291
                  + P+H     L+    +  A  VARG+EYL    +   +HRDL + N+L+   
Sbjct: 130 PPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTED 186
Query: 292 FNAKLSDFGLS-----VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLE 346
              K++DFGL+     +    ++ N ++   + ++APE L +   T +SDV++FGV+L E
Sbjct: 187 NVMKIADFGLARDIHHIDYYKKTTNGRLP--VKWMAPEALFDRIYTHQSDVWSFGVLLWE 244
Query: 347 LL 348
           + 
Sbjct: 245 IF 246

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 69/244 (28%), Positives = 109/244 (44%), Gaps = 32/244 (13%)
Query: 161 IGEGGRGHVYKARFNEK-LLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCI 219
           IGEG  G V  AR        AVK +D           NEV  +   +H N++ +    +
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 220 HAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMK------IAVDVARGLEYLHEHCN 273
             E  +++ E +Q G+L          +++   +R+       +   V + L YLH    
Sbjct: 113 VGEELWVLMEFLQGGAL----------TDIVSQVRLNEEQIATVCEAVLQALAYLHAQG- 161
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK-ISGTLGYVAPEYLLEGKLT 332
             V+HRD+KS +ILL      KLSDFG            K + GT  ++APE +      
Sbjct: 162 --VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISRSLYA 219
Query: 333 DKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDR--SKLPNI--VDPVIR 388
            + D+++ G++++E++ G  P    SP Q       AM +L D    KL N   V PV+R
Sbjct: 220 TEVDIWSLGIMVIEMVDGEPPYFSDSPVQ-------AMKRLRDSPPPKLKNSHKVSPVLR 272
Query: 389 DTMD 392
           D ++
Sbjct: 273 DFLE 276

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 103/209 (49%), Gaps = 14/209 (6%)
Query: 161 IGEGGRGHVYKARFNEK-LLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCI 219
           +G+G  G VYKA+  E   LAA K I+    +   ++  E+  L    H  I+ LLG   
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 220 HAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHR 279
           H    +++ E    G+++  +     G  LT      +   +   L +LH   +  ++HR
Sbjct: 79  HDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVVCRQMLEALNFLH---SKRIIHR 133
Query: 280 DLKSSNILLDSSFNAKLSDFGLSVT--AGTQSRNVKISGTLGYVAPEYLLEGKLTD---- 333
           DLK+ N+L+    + +L+DFG+S       Q R+  I GT  ++APE ++   + D    
Sbjct: 134 DLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMCETMKDTPYD 192
Query: 334 -KSDVYAFGVVLLELLMGRRPVEKMSPTQ 361
            K+D+++ G+ L+E+     P  +++P +
Sbjct: 193 YKADIWSLGITLIEMAQIEPPHHELNPMR 221

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 8/208 (3%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAER-EFNNEVNWLTKI 206
           E   ++F++ + +G G  G V+K       L+ A K I      A R +   E+  L + 
Sbjct: 21  ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 80
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
               I+   G         +  E M  GSL++ L        +   +  K+++ V +GL 
Sbjct: 81  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLT 137
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYL 326
           YL E   H ++HRD+K SNIL++S    KL DFG+S        N    GT  Y++PE L
Sbjct: 138 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERL 194
Query: 327 LEGKLTDKSDVYAFGVVLLELLMGRRPV 354
                + +SD+++ G+ L+E+ +GR P+
Sbjct: 195 QGTHYSVQSDIWSMGLSLVEMAVGRYPI 222

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 111/242 (45%), Gaps = 38/242 (15%)
Query: 140 VSVIEYELLEAATNNFQESNVI-----GEGGRGHVY--------KARFNEKLLAAVKRI- 185
             V EYEL E          ++     GEG  G V         K + N     AVK + 
Sbjct: 10  AGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK 69
Query: 186 DDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQL---- 240
            DA      +  +E+  +  I +H+NII+LLG C      +++ E    G+L + L    
Sbjct: 70  SDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARE 129
Query: 241 -------HGPTHG--SNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS 291
                  + P+H     L+    +  A  VARG+EYL    +   +HRDL + N+L+   
Sbjct: 130 PPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTED 186
Query: 292 FNAKLSDFGLS-----VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLE 346
              K++DFGL+     +    ++ N ++   + ++APE L +   T +SDV++FGV+L E
Sbjct: 187 NVMKIADFGLARDIHHIDYYKKTTNGRLP--VKWMAPEALFDRIYTHQSDVWSFGVLLWE 244
Query: 347 LL 348
           + 
Sbjct: 245 IF 246

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 22/212 (10%)
Query: 151 ATNNFQESNVIGEG--GRGHVYKARFNEKLLAA-------VKRIDDAGHDAEREFNNEVN 201
           +  +FQ    +G G  GR H+ ++R N +  A        V R+    H      N+E  
Sbjct: 4   SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHT-----NDERL 58
Query: 202 WLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDV 261
            L+ + H  II + G    A+  F++ + ++ G L   L       N         A +V
Sbjct: 59  MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF---YAAEV 115
Query: 262 ARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYV 321
              LEYLH   +  +++RDLK  NILLD + + K++DFG +      +    + GT  Y+
Sbjct: 116 CLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT--YXLCGTPDYI 170
Query: 322 APEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
           APE +         D ++FG+++ E+L G  P
Sbjct: 171 APEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 70/248 (28%), Positives = 114/248 (45%), Gaps = 39/248 (15%)
Query: 140 VSVIEYELLEAATNNFQESNVI-----GEGGRGHVY--------KARFNEKLLAAVKRI- 185
             V EYEL E          ++     GEG  G V         K + N     AVK + 
Sbjct: 51  AGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK 110
Query: 186 DDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQL---- 240
            DA      +  +E+  +  I +H+NII+LLG C      +++ E    G+L + L    
Sbjct: 111 SDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARR 170
Query: 241 -------HGPTHG--SNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS 291
                  + P+H     L+    +  A  VARG+EYL    +   +HRDL + N+L+   
Sbjct: 171 PPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTED 227
Query: 292 FNAKLSDFGLS-----VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLE 346
              K++DFGL+     +    ++ N ++   + ++APE L +   T +SDV++FGV+L E
Sbjct: 228 NVMKIADFGLARDIHHIDYYKKTTNGRLP--VKWMAPEALFDRIYTHQSDVWSFGVLLWE 285
Query: 347 LL-MGRRP 353
           +  +G  P
Sbjct: 286 IFTLGGSP 293

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 111/242 (45%), Gaps = 38/242 (15%)
Query: 140 VSVIEYELLEAATNNFQESNVI-----GEGGRGHVY--------KARFNEKLLAAVKRI- 185
             V EYEL E          ++     GEG  G V         K + N     AVK + 
Sbjct: 2   AGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK 61
Query: 186 DDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQL---- 240
            DA      +  +E+  +  I +H+NII+LLG C      +++ E    G+L + L    
Sbjct: 62  SDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARR 121
Query: 241 -------HGPTHG--SNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS 291
                  + P+H     L+    +  A  VARG+EYL    +   +HRDL + N+L+   
Sbjct: 122 PPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTED 178
Query: 292 FNAKLSDFGLS-----VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLE 346
              K++DFGL+     +    ++ N ++   + ++APE L +   T +SDV++FGV+L E
Sbjct: 179 NVMKIADFGLARDIHHIDYYKKTTNGRLP--VKWMAPEALFDRIYTHQSDVWSFGVLLWE 236
Query: 347 LL 348
           + 
Sbjct: 237 IF 238

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 101/221 (45%), Gaps = 13/221 (5%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNN---EVNWLTKIRH 208
           ++F+    IG+G  G V   + N+ K + A+K ++        E  N   E+  +  + H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 209 QNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYL 268
             +++L       E  F+V +++  G L   L    H    T  L      ++   L+YL
Sbjct: 75  PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKL---FICELVMALDYL 131
Query: 269 HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLE 328
               N  ++HRD+K  NILLD   +  ++DF ++     +++   ++GT  Y+APE    
Sbjct: 132 Q---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSS 188
Query: 329 GKLTDKS---DVYAFGVVLLELLMGRRPVEKMSPTQCQSMV 366
            K    S   D ++ GV   ELL GRRP    S T  + +V
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV 229

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 87/354 (24%), Positives = 146/354 (41%), Gaps = 74/354 (20%)
Query: 98  RWKRLKNTNGNSKQTIDGGKGLSLSPILERFNSLRLAGKKDTVSVIEYELLEAATNNFQE 157
           RWK +++  GNS   ID        P    +N                E  E   NN Q 
Sbjct: 15  RWKIIESYEGNSYTFID--------PTQLPYN----------------EKWEFPRNNLQF 50
Query: 158 SNVIGEGGRGHVYKA------RFNEKLLAAVKRIDDAGHDAERE-FNNEVNWLTKI-RHQ 209
              +G G  G V +A      + +  L  AVK +    H  E+E   +E+  ++ + +H+
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 210 NIISLLGYCIHAETRFLVYEMMQNGSLEKQLH--------GPTHG-SNLTWHLR--MKIA 258
           NI++LLG C H     ++ E    G L   L          P    +N T   R  +  +
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT- 317
             VA+G+ +L    +   +HRD+ + N+LL +   AK+ DFGL+      S N  + G  
Sbjct: 171 SQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS-NYIVKGNA 226
Query: 318 ---LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQL 373
              + ++APE + +   T +SDV+++G++L E+  +G  P                 P +
Sbjct: 227 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP----------------YPGI 270
Query: 374 TDRSKLPNIVD---PVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
              SK   +V     + +     K++Y +      C   EP++RP    +   L
Sbjct: 271 LVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQA---CWALEPTHRPTFQQICSFL 321

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 103/209 (49%), Gaps = 14/209 (6%)
Query: 161 IGEGGRGHVYKARFNEK-LLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCI 219
           +G+G  G VYKA+  E   LAA K I+    +   ++  E+  L    H  I+ LLG   
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 220 HAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHR 279
           H    +++ E    G+++  +     G  LT      +   +   L +LH   +  ++HR
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVVCRQMLEALNFLH---SKRIIHR 141
Query: 280 DLKSSNILLDSSFNAKLSDFGLSVT--AGTQSRNVKISGTLGYVAPEYLLEGKLTD---- 333
           DLK+ N+L+    + +L+DFG+S       Q R+  I GT  ++APE ++   + D    
Sbjct: 142 DLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMCETMKDTPYD 200
Query: 334 -KSDVYAFGVVLLELLMGRRPVEKMSPTQ 361
            K+D+++ G+ L+E+     P  +++P +
Sbjct: 201 YKADIWSLGITLIEMAQIEPPHHELNPMR 229

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/274 (25%), Positives = 127/274 (46%), Gaps = 21/274 (7%)
Query: 161 IGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCI 219
           IG+G  G VY A         A+++++      +    NE+  + + ++ NI++ L   +
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 220 HAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAV---DVARGLEYLHEHCNHPV 276
             +  ++V E +  GSL       T     T     +IA    +  + LE+LH   ++ V
Sbjct: 88  VGDELWVVMEYLAGGSL-------TDVVTETCMDEGQIAAVCRECLQALEFLH---SNQV 137
Query: 277 VHRDLKSSNILLDSSFNAKLSDFGLSVT-AGTQSRNVKISGTLGYVAPEYLLEGKLTDKS 335
           +HRD+KS NILL    + KL+DFG        QS+   + GT  ++APE +       K 
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 197
Query: 336 DVYAFGVVLLELLMGRRPVEKMSPTQCQSMV-TWAMPQLTDRSKLPNIVDPVIRDTMDLK 394
           D+++ G++ +E++ G  P    +P +   ++ T   P+L +  KL  I    +   +D+ 
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMD 257
Query: 395 HLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLV 428
              + +A  +L  Q     +P     L SL PL+
Sbjct: 258 VEKRGSAKELLQHQFLKIAKP-----LSSLTPLI 286

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 106/240 (44%), Gaps = 34/240 (14%)
Query: 140 VSVIEYELLEAATNNFQESNV-----IGEGGRGHVY--------KARFNEKLLAAVKRI- 185
             V EYEL E     F    +     +GEG  G V         K +  E +  AVK + 
Sbjct: 17  AGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK 76
Query: 186 DDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGP- 243
           DDA      +  +E+  +  I +H+NII+LLG C      +++      G+L + L    
Sbjct: 77  DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARR 136
Query: 244 ------------THGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS 291
                            +T+   +     +ARG+EYL    +   +HRDL + N+L+  +
Sbjct: 137 PPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTEN 193
Query: 292 FNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELL 348
              K++DFGL+          K +     + ++APE L +   T +SDV++FGV++ E+ 
Sbjct: 194 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/229 (30%), Positives = 104/229 (45%), Gaps = 20/229 (8%)
Query: 143 IEYELLEAATNNFQESNVIGEGGRGHVYKAR--FNEKLLAAVKRID-DAGHDAE-----R 194
           +E + L  A   ++    IGEG  G V+KAR   N     A+KR+    G +       R
Sbjct: 1   MEKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR 60
Query: 195 EFNNEVNWLTKIRHQNIISLLGYCIHA----ETRF-LVYEMMQNGSLEKQLHGPTHGSNL 249
           E    +  L    H N++ L   C  +    ET+  LV+E +           P  G  +
Sbjct: 61  EVAV-LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--V 117
Query: 250 TWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS 309
                  +   + RGL++LH   +H VVHRDLK  NIL+ SS   KL+DFGL+     Q 
Sbjct: 118 PTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM 174
Query: 310 RNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMS 358
               +  TL Y APE LL+       D+++ G +  E+   R+P+ + S
Sbjct: 175 ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGS 222

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 110/238 (46%), Gaps = 38/238 (15%)
Query: 144 EYELLEAATNNFQESNVI-----GEGGRGHVY--------KARFNEKLLAAVKRI-DDAG 189
           EYEL E          ++     GEG  G V         K + N     AVK +  DA 
Sbjct: 3   EYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT 62
Query: 190 HDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQL-------- 240
                +  +E+  +  I +H+NII+LLG C      +++ E    G+L + L        
Sbjct: 63  EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 122
Query: 241 ---HGPTHG--SNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAK 295
              + P+H     L+    +  A  VARG+EYL    +   +HRDL + N+L+      K
Sbjct: 123 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMK 179
Query: 296 LSDFGLS-----VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELL 348
           ++DFGL+     +    ++ N ++   + ++APE L +   T +SDV++FGV+L E+ 
Sbjct: 180 IADFGLARDIHHIDYYKKTTNGRLP--VKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 235

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/229 (30%), Positives = 104/229 (45%), Gaps = 20/229 (8%)
Query: 143 IEYELLEAATNNFQESNVIGEGGRGHVYKAR--FNEKLLAAVKRID-DAGHDAE-----R 194
           +E + L  A   ++    IGEG  G V+KAR   N     A+KR+    G +       R
Sbjct: 1   MEKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR 60
Query: 195 EFNNEVNWLTKIRHQNIISLLGYCIHA----ETRF-LVYEMMQNGSLEKQLHGPTHGSNL 249
           E    +  L    H N++ L   C  +    ET+  LV+E +           P  G  +
Sbjct: 61  EVAV-LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--V 117
Query: 250 TWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS 309
                  +   + RGL++LH   +H VVHRDLK  NIL+ SS   KL+DFGL+     Q 
Sbjct: 118 PTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM 174
Query: 310 RNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMS 358
               +  TL Y APE LL+       D+++ G +  E+   R+P+ + S
Sbjct: 175 ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGS 222

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/250 (28%), Positives = 117/250 (46%), Gaps = 29/250 (11%)
Query: 126 ERFNSLRLAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRI 185
           E     +L  K+D + + + EL      NF          R  VY+ R  +++  A+K +
Sbjct: 323 EELKDKKLFLKRDNLLIADIEL---GCGNFGSV-------RQGVYRMR-KKQIDVAIKVL 371
Query: 186 DDAGHDAE-REFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPT 244
                 A+  E   E   + ++ +  I+ L+G C  AE   LV EM   G L K L G  
Sbjct: 372 KQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKR 430
Query: 245 HG---SNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGL 301
                SN+      ++   V+ G++YL E      VHR+L + N+LL +   AK+SDFGL
Sbjct: 431 EEIPVSNVA-----ELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGL 482
Query: 302 SVTAGTQSR--NVKISGT--LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEK 356
           S   G        + +G   L + APE +   K + +SDV+++GV + E L  G++P +K
Sbjct: 483 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK 542
Query: 357 MSPTQCQSMV 366
           M   +  + +
Sbjct: 543 MKGPEVMAFI 552

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/229 (30%), Positives = 104/229 (45%), Gaps = 20/229 (8%)
Query: 143 IEYELLEAATNNFQESNVIGEGGRGHVYKAR--FNEKLLAAVKRID-DAGHDAE-----R 194
           +E + L  A   ++    IGEG  G V+KAR   N     A+KR+    G +       R
Sbjct: 1   MEKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR 60
Query: 195 EFNNEVNWLTKIRHQNIISLLGYCIHA----ETRF-LVYEMMQNGSLEKQLHGPTHGSNL 249
           E    +  L    H N++ L   C  +    ET+  LV+E +           P  G  +
Sbjct: 61  EVAV-LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--V 117
Query: 250 TWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS 309
                  +   + RGL++LH   +H VVHRDLK  NIL+ SS   KL+DFGL+     Q 
Sbjct: 118 PTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM 174
Query: 310 RNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMS 358
               +  TL Y APE LL+       D+++ G +  E+   R+P+ + S
Sbjct: 175 ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGS 222

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/245 (27%), Positives = 113/245 (46%), Gaps = 20/245 (8%)
Query: 119 LSLSPILERFNSLRLAGKKDTVSVIEYELLEA---ATNNFQESNVIGEGGRGHVYKARFN 175
           L  +P  E  +SL        +  ++++ LEA     + F +  V+G GG G V+  +  
Sbjct: 154 LGQAPFQEFLDSLYF------LRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMK 207
Query: 176 EK-LLAAVKRIDDAGHDAEREFNN---EVNWLTKIRHQNIISLLGYCIHAETRF-LVYEM 230
               L A K+++       + +     E   L K+  + I+SL  Y    +T   LV  +
Sbjct: 208 ATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL-AYAFETKTDLCLVMTI 266
Query: 231 MQNGSLEKQLHGPTHGSNLTWHLR-MKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLD 289
           M  G +   ++     +      R +     +  GLE+LH+     +++RDLK  N+LLD
Sbjct: 267 MNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLD 323
Query: 290 SSFNAKLSDFGLSVT-AGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELL 348
              N ++SD GL+V     Q++    +GT G++APE LL  +     D +A GV L E++
Sbjct: 324 DDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMI 383
Query: 349 MGRRP 353
             R P
Sbjct: 384 AARGP 388

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 76/228 (33%), Positives = 107/228 (46%), Gaps = 41/228 (17%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVN--WLTKIRHQN 210
           +N +   +IG G  G VYK   +E+ +A VK    A     + F NE N   +  + H N
Sbjct: 13  DNLKLLELIGRGRYGAVYKGSLDERPVA-VKVFSFANR---QNFINEKNIYRVPLMEHDN 68
Query: 211 IISLL--GYCIHAETR---FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
           I   +     + A+ R    LV E   NGSL K L    H S+  W    ++A  V RGL
Sbjct: 69  IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS--LHTSD--WVSSCRLAHSVTRGL 124
Query: 266 EYLH------EHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--------VTAGTQSRN 311
            YLH      +H    + HRDL S N+L+ +     +SDFGLS        V  G +  N
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEED-N 183
Query: 312 VKIS--GTLGYVAPEYLLEGKLT--------DKSDVYAFGVVLLELLM 349
             IS  GT+ Y+APE +LEG +          + D+YA G++  E+ M
Sbjct: 184 AAISEVGTIRYMAPE-VLEGAVNLRDXESALKQVDMYALGLIYWEIFM 230

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 100/213 (46%), Gaps = 14/213 (6%)
Query: 148 LEAATNNFQESNVIGEGGRGHVY----KARFNEKLLAAVKRIDDAGHDAEREFNNEVNWL 203
            +  ++ +Q    +G G  G V     K    E+ +  +K+             +EV  L
Sbjct: 16  FQGLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVL 75
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
            ++ H NI+ L  +       +LV E+ + G L  ++      S +   + MK    V  
Sbjct: 76  KQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMK---QVLS 132
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDS-SFNA--KLSDFGLSVTAGTQSRNVKISGTLGY 320
           G  YLH+H    +VHRDLK  N+LL+S S +A  K+ DFGLS       +  +  GT  Y
Sbjct: 133 GTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYY 189
Query: 321 VAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
           +APE +L  K  +K DV++ GV+L  LL G  P
Sbjct: 190 IAPE-VLRKKYDEKCDVWSCGVILYILLCGYPP 221

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 99/216 (45%), Gaps = 16/216 (7%)
Query: 150 AATNNFQESNVIGEGGRGHV---YKARFNEKL-LAAVKRIDDAGHDAEREFNNEVNWLTK 205
           A   N+Q    +GEG  G V   Y     +K+ L  + +   A  D +     E+++L  
Sbjct: 5   AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRL 64
Query: 206 IRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
           +RH +II L       +   +V E   N   +  +        ++     +    +   +
Sbjct: 65  LRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQR----DKMSEQEARRFFQQIISAV 120
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPE 324
           EY H H    +VHRDLK  N+LLD   N K++DFGLS    T    +K S G+  Y APE
Sbjct: 121 EYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLS-NIMTDGNFLKTSCGSPNYAAPE 176
Query: 325 YLLEGKLT--DKSDVYAFGVVLLELLMGRRPVEKMS 358
            ++ GKL    + DV++ GV+L  +L  R P +  S
Sbjct: 177 -VISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES 211

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 99/216 (45%), Gaps = 16/216 (7%)
Query: 150 AATNNFQESNVIGEGGRGHV---YKARFNEKL-LAAVKRIDDAGHDAEREFNNEVNWLTK 205
           A   N+Q    +GEG  G V   Y     +K+ L  + +   A  D +     E+++L  
Sbjct: 1   AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRL 60
Query: 206 IRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
           +RH +II L       +   +V E   N   +  +        ++     +    +   +
Sbjct: 61  LRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQR----DKMSEQEARRFFQQIISAV 116
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPE 324
           EY H H    +VHRDLK  N+LLD   N K++DFGLS    T    +K S G+  Y APE
Sbjct: 117 EYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLS-NIMTDGNFLKTSCGSPNYAAPE 172
Query: 325 YLLEGKLT--DKSDVYAFGVVLLELLMGRRPVEKMS 358
            ++ GKL    + DV++ GV+L  +L  R P +  S
Sbjct: 173 -VISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES 207

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 161 IGEGGRGHVY----KARFNEKLLAAVK-------RIDDAGHDAER---EFNNEVNWLTKI 206
           +G G  G V     K   +EK +  +K       R  D   + E+   E  NE++ L  +
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
            H NII L       +  +LV E  + G L +Q+              MK    +  G+ 
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMK---QILSGIC 160
Query: 267 YLHEHCNHPVVHRDLKSSNILLD---SSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           YLH+   H +VHRD+K  NILL+   S  N K+ DFGLS       +     GT  Y+AP
Sbjct: 161 YLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAP 217
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
           E +L+ K  +K DV++ GV++  LL G  P
Sbjct: 218 E-VLKKKYNEKCDVWSCGVIMYILLCGYPP 246

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 33/216 (15%)
Query: 161 IGEGGRGHVY--------KARFNEKLLAAVKRI-DDAGHDAEREFNNEVNWLTKI-RHQN 210
           +GEG  G V         K + N     AVK +  DA      +  +E+  +  I +H+N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 211 IISLLGYCIHAETRFLVYEMMQNGSLEKQL-----------HGPTHG--SNLTWHLRMKI 257
           II+LLG C      +++ E    G+L + L           + P+H     L+    +  
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS-----VTAGTQSRNV 312
           A  VARG+EYL    +   +HRDL + N+L+      K++DFGL+     +    ++ N 
Sbjct: 141 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 313 KISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELL 348
           ++   + ++APE L +   T +SDV++FGV+L E+ 
Sbjct: 198 RLP--VKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 231

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/245 (27%), Positives = 113/245 (46%), Gaps = 20/245 (8%)
Query: 119 LSLSPILERFNSLRLAGKKDTVSVIEYELLEA---ATNNFQESNVIGEGGRGHVYKARFN 175
           L  +P  E  +SL        +  ++++ LEA     + F +  V+G GG G V+  +  
Sbjct: 154 LGQAPFQEFLDSLYF------LRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMK 207
Query: 176 EK-LLAAVKRIDDAGHDAEREFNN---EVNWLTKIRHQNIISLLGYCIHAETRF-LVYEM 230
               L A K+++       + +     E   L K+  + I+SL  Y    +T   LV  +
Sbjct: 208 ATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL-AYAFETKTDLCLVMTI 266
Query: 231 MQNGSLEKQLHGPTHGSNLTWHLR-MKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLD 289
           M  G +   ++     +      R +     +  GLE+LH+     +++RDLK  N+LLD
Sbjct: 267 MNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLD 323
Query: 290 SSFNAKLSDFGLSVT-AGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELL 348
              N ++SD GL+V     Q++    +GT G++APE LL  +     D +A GV L E++
Sbjct: 324 DDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMI 383
Query: 349 MGRRP 353
             R P
Sbjct: 384 AARGP 388

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/245 (27%), Positives = 113/245 (46%), Gaps = 20/245 (8%)
Query: 119 LSLSPILERFNSLRLAGKKDTVSVIEYELLEA---ATNNFQESNVIGEGGRGHVYKARFN 175
           L  +P  E  +SL        +  ++++ LEA     + F +  V+G GG G V+  +  
Sbjct: 154 LGQAPFQEFLDSLYF------LRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMK 207
Query: 176 EK-LLAAVKRIDDAGHDAEREFNN---EVNWLTKIRHQNIISLLGYCIHAETRF-LVYEM 230
               L A K+++       + +     E   L K+  + I+SL  Y    +T   LV  +
Sbjct: 208 ATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL-AYAFETKTDLCLVMTI 266
Query: 231 MQNGSLEKQLHGPTHGSNLTWHLR-MKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLD 289
           M  G +   ++     +      R +     +  GLE+LH+     +++RDLK  N+LLD
Sbjct: 267 MNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLD 323
Query: 290 SSFNAKLSDFGLSVT-AGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELL 348
              N ++SD GL+V     Q++    +GT G++APE LL  +     D +A GV L E++
Sbjct: 324 DDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMI 383
Query: 349 MGRRP 353
             R P
Sbjct: 384 AARGP 388

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 106/240 (44%), Gaps = 34/240 (14%)
Query: 140 VSVIEYELLEAATNNFQESNV-----IGEGGRGHVY--------KARFNEKLLAAVKRI- 185
             V EYEL E     F    +     +GEG  G V         K +  E +  AVK + 
Sbjct: 17  AGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK 76
Query: 186 DDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGP- 243
           DDA      +  +E+  +  I +H+NII+LLG C      +++      G+L + L    
Sbjct: 77  DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARR 136
Query: 244 ------------THGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS 291
                            +T+   +     +ARG+EYL    +   +HRDL + N+L+  +
Sbjct: 137 PPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTEN 193
Query: 292 FNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELL 348
              K++DFGL+          K +     + ++APE L +   T +SDV++FGV++ E+ 
Sbjct: 194 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 94/199 (47%), Gaps = 15/199 (7%)
Query: 165 GRGHVYKARFNEKLLA----AVKRIDDAGHDAE--REFNNEVNWLTKIRHQNIISLLGYC 218
           G+G+  K +    +L     AVK ID    ++   ++   EV  +  + H NI+ L    
Sbjct: 23  GKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVI 82
Query: 219 IHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVH 278
              +T +LV E    G +   L    HG       R K    +   ++Y H+     +VH
Sbjct: 83  ETEKTLYLVMEYASGGEVFDYL--VAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVH 136
Query: 279 RDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTD--KSD 336
           RDLK+ N+LLD+  N K++DFG S      ++     G+  Y APE L +GK  D  + D
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPE-LFQGKKYDGPEVD 195
Query: 337 VYAFGVVLLELLMGRRPVE 355
           V++ GV+L  L+ G  P +
Sbjct: 196 VWSLGVILYTLVSGSLPFD 214

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/247 (27%), Positives = 113/247 (45%), Gaps = 21/247 (8%)
Query: 119 LSLSPILERFNSLRLAGKKDTVSVIEYELLE---AATNNFQESNVIGEGGRGHVY--KAR 173
           LS++P  +  +S+           ++++ LE      N F++  V+G+GG G V   + R
Sbjct: 153 LSVAPFADYLDSIYFN------RFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVR 206
Query: 174 FNEKLLAAVKRIDDAGHDAEREFN--NEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMM 231
              K+ A  K         + E    NE   L K+  + ++SL       +   LV  +M
Sbjct: 207 ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLM 266
Query: 232 QNGSLEKQLHGPTHGSNLTWHLRMKI--AVDVARGLEYLHEHCNHPVVHRDLKSSNILLD 289
             G L+  ++   H     +     +  A ++  GLE LH      +V+RDLK  NILLD
Sbjct: 267 NGGDLKFHIY---HMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLD 320
Query: 290 SSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM 349
              + ++SD GL+V            GT+GY+APE +   + T   D +A G +L E++ 
Sbjct: 321 DHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIA 380
Query: 350 GRRPVEK 356
           G+ P ++
Sbjct: 381 GQSPFQQ 387

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 94/199 (47%), Gaps = 15/199 (7%)
Query: 165 GRGHVYKARFNEKLLA----AVKRIDDAGHDAE--REFNNEVNWLTKIRHQNIISLLGYC 218
           G+G+  K +    +L     AVK ID    ++   ++   EV  +  + H NI+ L    
Sbjct: 23  GKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVI 82
Query: 219 IHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVH 278
              +T +LV E    G +   L    HG       R K    +   ++Y H+     +VH
Sbjct: 83  ETEKTLYLVMEYASGGEVFDYL--VAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVH 136
Query: 279 RDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTD--KSD 336
           RDLK+ N+LLD+  N K++DFG S      ++     G+  Y APE L +GK  D  + D
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPE-LFQGKKYDGPEVD 195
Query: 337 VYAFGVVLLELLMGRRPVE 355
           V++ GV+L  L+ G  P +
Sbjct: 196 VWSLGVILYTLVSGSLPFD 214

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 99/216 (45%), Gaps = 16/216 (7%)
Query: 150 AATNNFQESNVIGEGGRGHV---YKARFNEKL-LAAVKRIDDAGHDAEREFNNEVNWLTK 205
           A   N+Q    +GEG  G V   Y     +K+ L  + +   A  D +     E+++L  
Sbjct: 10  AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRL 69
Query: 206 IRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
           +RH +II L       +   +V E   N   +  +        ++     +    +   +
Sbjct: 70  LRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQR----DKMSEQEARRFFQQIISAV 125
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPE 324
           EY H H    +VHRDLK  N+LLD   N K++DFGLS    T    +K S G+  Y APE
Sbjct: 126 EYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLS-NIMTDGNFLKTSCGSPNYAAPE 181
Query: 325 YLLEGKLT--DKSDVYAFGVVLLELLMGRRPVEKMS 358
            ++ GKL    + DV++ GV+L  +L  R P +  S
Sbjct: 182 -VISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES 216

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 99/216 (45%), Gaps = 16/216 (7%)
Query: 150 AATNNFQESNVIGEGGRGHV---YKARFNEKL-LAAVKRIDDAGHDAEREFNNEVNWLTK 205
           A   N+Q    +GEG  G V   Y     +K+ L  + +   A  D +     E+++L  
Sbjct: 11  AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRL 70
Query: 206 IRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
           +RH +II L       +   +V E   N   +  +        ++     +    +   +
Sbjct: 71  LRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQR----DKMSEQEARRFFQQIISAV 126
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPE 324
           EY H H    +VHRDLK  N+LLD   N K++DFGLS    T    +K S G+  Y APE
Sbjct: 127 EYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLS-NIMTDGNFLKTSCGSPNYAAPE 182
Query: 325 YLLEGKLT--DKSDVYAFGVVLLELLMGRRPVEKMS 358
            ++ GKL    + DV++ GV+L  +L  R P +  S
Sbjct: 183 -VISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES 217

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/247 (27%), Positives = 113/247 (45%), Gaps = 21/247 (8%)
Query: 119 LSLSPILERFNSLRLAGKKDTVSVIEYELLE---AATNNFQESNVIGEGGRGHVY--KAR 173
           LS++P  +  +S+           ++++ LE      N F++  V+G+GG G V   + R
Sbjct: 153 LSVAPFADYLDSIYFN------RFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVR 206
Query: 174 FNEKLLAAVKRIDDAGHDAEREFN--NEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMM 231
              K+ A  K         + E    NE   L K+  + ++SL       +   LV  +M
Sbjct: 207 ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLM 266
Query: 232 QNGSLEKQLHGPTHGSNLTWHLRMKI--AVDVARGLEYLHEHCNHPVVHRDLKSSNILLD 289
             G L+  ++   H     +     +  A ++  GLE LH      +V+RDLK  NILLD
Sbjct: 267 NGGDLKFHIY---HMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLD 320
Query: 290 SSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM 349
              + ++SD GL+V            GT+GY+APE +   + T   D +A G +L E++ 
Sbjct: 321 DHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIA 380
Query: 350 GRRPVEK 356
           G+ P ++
Sbjct: 381 GQSPFQQ 387

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 95/199 (47%), Gaps = 15/199 (7%)
Query: 165 GRGHVYKARFNEKLLA----AVKRIDDAGHDAE--REFNNEVNWLTKIRHQNIISLLGYC 218
           G+G+  K +    +L     AV+ ID    ++   ++   EV  +  + H NI+ L    
Sbjct: 23  GKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVI 82
Query: 219 IHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVH 278
              +T +LV E    G +   L    HG       R K    +   ++Y H+     +VH
Sbjct: 83  ETEKTLYLVMEYASGGEVFDYL--VAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVH 136
Query: 279 RDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTD--KSD 336
           RDLK+ N+LLD+  N K++DFG S      ++  +  G+  Y APE L +GK  D  + D
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPE-LFQGKKYDGPEVD 195
Query: 337 VYAFGVVLLELLMGRRPVE 355
           V++ GV+L  L+ G  P +
Sbjct: 196 VWSLGVILYTLVSGSLPFD 214

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 93/199 (46%), Gaps = 15/199 (7%)
Query: 165 GRGHVYKARFNEKLLA----AVKRIDDAGHDAE--REFNNEVNWLTKIRHQNIISLLGYC 218
           G+G+  K +    +L     AVK ID    ++   ++   EV  +  + H NI+ L    
Sbjct: 23  GKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVI 82
Query: 219 IHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVH 278
              +T +LV E    G +   L    HG       R K    +   ++Y H+     +VH
Sbjct: 83  ETEKTLYLVMEYASGGEVFDYL--VAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVH 136
Query: 279 RDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTD--KSD 336
           RDLK+ N+LLD+  N K++DFG S      ++     G   Y APE L +GK  D  + D
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPE-LFQGKKYDGPEVD 195
Query: 337 VYAFGVVLLELLMGRRPVE 355
           V++ GV+L  L+ G  P +
Sbjct: 196 VWSLGVILYTLVSGSLPFD 214

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 98/204 (48%), Gaps = 22/204 (10%)
Query: 161 IGEGGRGHVYKARFN-EKLLAAVKRIDDAGHD--AEREFNNEVNWLTKIRHQNIISLLGY 217
           IGEG  G V  A  N  K+  A+K+I    H    +R    E+  L + RH+NII     
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIG---- 105
Query: 218 CIHAETRFLVYEMMQNGSLEKQLHGPTHGSNL-TWHLR----MKIAVDVARGLEYLHEHC 272
            I+   R    E M++  L   L G      L T HL           + RGL+Y+H   
Sbjct: 106 -INDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH--- 161
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN----VKISGTLGYVAPEYLLE 328
           +  V+HRDLK SN+LL+++ + K+ DFGL+  A     +     +   T  Y APE +L 
Sbjct: 162 SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 221
Query: 329 GKLTDKS-DVYAFGVVLLELLMGR 351
            K   KS D+++ G +L E+L  R
Sbjct: 222 SKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 73/280 (26%), Positives = 120/280 (42%), Gaps = 41/280 (14%)
Query: 161 IGEGGRGHVYKARFNEKLLA-AVKRIDDAGHDAERE-FNNEVNWLTKIRHQNIISLLGYC 218
            G+  +GH++     E+  A A+K + D      RE F +E     +++H N++ LLG  
Sbjct: 22  FGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVV 81
Query: 219 IHAETRFLVYEMMQNGSLEKQL--HGP-----------THGSNLTWHLRMKIAVDVARGL 265
              +   +++    +G L + L    P           T  S L     + +   +A G+
Sbjct: 82  TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGM 141
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTL---GYVA 322
           EYL    +H VVH+DL + N+L+    N K+SD GL            +  +L    ++A
Sbjct: 142 EYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMA 198
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPN 381
           PE ++ GK +  SD++++GVVL E+   G +P    S      M+        +R  LP 
Sbjct: 199 PEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI-------RNRQVLPC 251
Query: 382 IVD-PVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDV 420
             D P             V A+ + C    PS RP   D+
Sbjct: 252 PDDCPA-----------WVYALMIECWNEFPSRRPRFKDI 280

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 73/280 (26%), Positives = 120/280 (42%), Gaps = 41/280 (14%)
Query: 161 IGEGGRGHVYKARFNEKLLA-AVKRIDDAGHDAERE-FNNEVNWLTKIRHQNIISLLGYC 218
            G+  +GH++     E+  A A+K + D      RE F +E     +++H N++ LLG  
Sbjct: 39  FGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVV 98
Query: 219 IHAETRFLVYEMMQNGSLEKQL--HGP-----------THGSNLTWHLRMKIAVDVARGL 265
              +   +++    +G L + L    P           T  S L     + +   +A G+
Sbjct: 99  TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGM 158
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTL---GYVA 322
           EYL    +H VVH+DL + N+L+    N K+SD GL            +  +L    ++A
Sbjct: 159 EYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMA 215
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPN 381
           PE ++ GK +  SD++++GVVL E+   G +P    S      M+        +R  LP 
Sbjct: 216 PEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI-------RNRQVLPC 268
Query: 382 IVD-PVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDV 420
             D P             V A+ + C    PS RP   D+
Sbjct: 269 PDDCPA-----------WVYALMIECWNEFPSRRPRFKDI 297

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 109/228 (47%), Gaps = 16/228 (7%)
Query: 161 IGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCI 219
           IG+G  G VY A         A+++++      +    NE+  + + ++ NI++ L   +
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 220 HAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAV---DVARGLEYLHEHCNHPV 276
             +  ++V E +  GSL       T     T     +IA    +  + LE+LH   ++ V
Sbjct: 88  VGDELWVVMEYLAGGSL-------TDVVTETCMDEGQIAAVCRECLQALEFLH---SNQV 137
Query: 277 VHRDLKSSNILLDSSFNAKLSDFGLSVT-AGTQSRNVKISGTLGYVAPEYLLEGKLTDKS 335
           +HRD+KS NILL    + KL+DFG        QS+   + GT  ++APE +       K 
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKV 197
Query: 336 DVYAFGVVLLELLMGRRPVEKMSPTQCQSMV-TWAMPQLTDRSKLPNI 382
           D+++ G++ +E++ G  P    +P +   ++ T   P+L +  KL  I
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI 245

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 109/228 (47%), Gaps = 16/228 (7%)
Query: 161 IGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCI 219
           IG+G  G VY A         A+++++      +    NE+  + + ++ NI++ L   +
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 220 HAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAV---DVARGLEYLHEHCNHPV 276
             +  ++V E +  GSL       T     T     +IA    +  + LE+LH   ++ V
Sbjct: 89  VGDELWVVMEYLAGGSL-------TDVVTETCMDEGQIAAVCRECLQALEFLH---SNQV 138
Query: 277 VHRDLKSSNILLDSSFNAKLSDFGLSVT-AGTQSRNVKISGTLGYVAPEYLLEGKLTDKS 335
           +HRD+KS NILL    + KL+DFG        QS+   + GT  ++APE +       K 
Sbjct: 139 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKV 198
Query: 336 DVYAFGVVLLELLMGRRPVEKMSPTQCQSMV-TWAMPQLTDRSKLPNI 382
           D+++ G++ +E++ G  P    +P +   ++ T   P+L +  KL  I
Sbjct: 199 DIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI 246

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 94/199 (47%), Gaps = 15/199 (7%)
Query: 165 GRGHVYKARFNEKLLA----AVKRIDDAGHDAE--REFNNEVNWLTKIRHQNIISLLGYC 218
           G+G+  K +    +L     AVK ID    ++   ++   EV  +  + H NI+ L    
Sbjct: 16  GKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVI 75
Query: 219 IHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVH 278
              +T +LV E    G +   L    HG       R K    +   ++Y H+     +VH
Sbjct: 76  ETEKTLYLVMEYASGGEVFDYL--VAHGWMKEKEARAKFR-QIVSAVQYCHQKF---IVH 129
Query: 279 RDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTD--KSD 336
           RDLK+ N+LLD+  N K++DFG S      ++     G+  Y APE L +GK  D  + D
Sbjct: 130 RDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPE-LFQGKKYDGPEVD 188
Query: 337 VYAFGVVLLELLMGRRPVE 355
           V++ GV+L  L+ G  P +
Sbjct: 189 VWSLGVILYTLVSGSLPFD 207

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 96/218 (44%), Gaps = 20/218 (9%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNEK----LLAAVKRIDDAGHDAEREFNN--EVNWLT 204
           AT+ ++    IG G  G VYKAR         L +V+  +  G       +   EV  L 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 205 KIR---HQNIISLLGYCIHAETR-----FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMK 256
           ++    H N++ L+  C  + T       LV+E +           P  G  L       
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG--LPAETIKD 124
Query: 257 IAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG 316
           +     RGL++LH +C   +VHRDLK  NIL+ S    KL+DFGL+     Q     +  
Sbjct: 125 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVV 181
Query: 317 TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPV 354
           TL Y APE LL+       D+++ G +  E+   R+P+
Sbjct: 182 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 218

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 116/238 (48%), Gaps = 22/238 (9%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKAR----FNEKLLAAVKRIDDAGHDAEREFNN--EVNW 202
           +A  + F+   V+G+G  G V+  +     + + L A+K +  A            E + 
Sbjct: 20  KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 79
Query: 203 LTKIRHQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGS--NLTWHLRMKIAV 259
           L ++ H  I+ L  Y    E + +L+ + ++ G L  +L      +  ++ ++L      
Sbjct: 80  LVEVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL-----A 133
Query: 260 DVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA-GTQSRNVKISGTL 318
           ++A  L++LH   +  +++RDLK  NILLD   + KL+DFGLS  +   + +     GT+
Sbjct: 134 ELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTV 190
Query: 319 GYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWA---MPQL 373
            Y+APE +     T  +D ++FGV++ E+L G  P +     +  +M+  A   MPQ 
Sbjct: 191 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQF 248

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 116/238 (48%), Gaps = 22/238 (9%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKAR----FNEKLLAAVKRIDDAGHDAEREFNN--EVNW 202
           +A  + F+   V+G+G  G V+  +     + + L A+K +  A            E + 
Sbjct: 20  KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 79
Query: 203 LTKIRHQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGS--NLTWHLRMKIAV 259
           L ++ H  I+ L  Y    E + +L+ + ++ G L  +L      +  ++ ++L      
Sbjct: 80  LVEVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL-----A 133
Query: 260 DVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA-GTQSRNVKISGTL 318
           ++A  L++LH   +  +++RDLK  NILLD   + KL+DFGLS  +   + +     GT+
Sbjct: 134 ELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTV 190
Query: 319 GYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWA---MPQL 373
            Y+APE +     T  +D ++FGV++ E+L G  P +     +  +M+  A   MPQ 
Sbjct: 191 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQF 248

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 116/238 (48%), Gaps = 22/238 (9%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKAR----FNEKLLAAVKRIDDAGHDAEREFNN--EVNW 202
           +A  + F+   V+G+G  G V+  +     + + L A+K +  A            E + 
Sbjct: 21  KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 80
Query: 203 LTKIRHQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGS--NLTWHLRMKIAV 259
           L ++ H  I+ L  Y    E + +L+ + ++ G L  +L      +  ++ ++L      
Sbjct: 81  LVEVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL-----A 134
Query: 260 DVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA-GTQSRNVKISGTL 318
           ++A  L++LH   +  +++RDLK  NILLD   + KL+DFGLS  +   + +     GT+
Sbjct: 135 ELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTV 191
Query: 319 GYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWA---MPQL 373
            Y+APE +     T  +D ++FGV++ E+L G  P +     +  +M+  A   MPQ 
Sbjct: 192 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQF 249

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 86/290 (29%), Positives = 132/290 (45%), Gaps = 60/290 (20%)
Query: 160 VIGEGGRGHVYKARF-NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYC 218
           V   G  G V+KA+  NE +   +  I D     + E+  EV  L  ++H+NI+  +G  
Sbjct: 31  VKARGRFGCVWKAQLLNEYVAVKIFPIQDK-QSWQNEY--EVYSLPGMKHENILQFIG-- 85
Query: 219 IHAETR--------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHE 270
             AE R        +L+    + GSL   L        ++W+    IA  +ARGL YLHE
Sbjct: 86  --AEKRGTSVDVDLWLITAFHEKGSLSDFLKANV----VSWNELCHIAETMARGLAYLHE 139
Query: 271 HC------NHPVV-HRDLKSSNILLDSSFNAKLSDFGLSVT--AGTQSRNVKIS-GTLGY 320
                   + P + HRD+KS N+LL ++  A ++DFGL++   AG  + +     GT  Y
Sbjct: 140 DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRY 199
Query: 321 VAPEYLLEGKLTDKS------DVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLT 374
           +APE +LEG +  +       D+YA G+VL EL    R      P        + +P   
Sbjct: 200 MAPE-VLEGAINFQRDAFLRIDMYAMGLVLWEL--ASRCTAADGPVD-----EYMLPFEE 251
Query: 375 DRSKLPNIVD-----------PVIRDTMDLKHLYQVAAVAVLCIQPEPSY 413
           +  + P++ D           PV+RD    KH    A +A+LC   E  +
Sbjct: 252 EIGQHPSLEDMQEVVVHKKKRPVLRDYWQ-KH----AGMAMLCETIEECW 296

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 94/199 (47%), Gaps = 15/199 (7%)
Query: 165 GRGHVYKARFNEKLLA----AVKRIDDAGHDAE--REFNNEVNWLTKIRHQNIISLLGYC 218
           G+G+  K +    +L     AV+ ID    ++   ++   EV  +  + H NI+ L    
Sbjct: 23  GKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVI 82
Query: 219 IHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVH 278
              +T +LV E    G +   L    HG       R K    +   ++Y H+     +VH
Sbjct: 83  ETEKTLYLVMEYASGGEVFDYL--VAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVH 136
Query: 279 RDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTD--KSD 336
           RDLK+ N+LLD+  N K++DFG S      ++     G+  Y APE L +GK  D  + D
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPE-LFQGKKYDGPEVD 195
Query: 337 VYAFGVVLLELLMGRRPVE 355
           V++ GV+L  L+ G  P +
Sbjct: 196 VWSLGVILYTLVSGSLPFD 214

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 77/316 (24%), Positives = 135/316 (42%), Gaps = 61/316 (19%)
Query: 146 ELLEAATNNFQESNVIGEGGRGHVYKA------RFNEKLLAAVKRIDDAGHDAERE-FNN 198
           E  E   NN Q    +G G  G V +A      + +  L  AVK +    H  E+E   +
Sbjct: 24  EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS 83
Query: 199 EVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMMQNGSL-------EKQLHGPT------ 244
           E+  ++ + +H+NI++LLG C H     ++ E    G L        + + GP+      
Sbjct: 84  ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQD 143
Query: 245 -------HGSNLTWHLRMKIAVDVARGLEYL-HEHCNHPVVHRDLKSSNILLDSSFNAKL 296
                   G  L     +  +  VA+G+ +L  ++C    +HRD+ + N+LL +   AK+
Sbjct: 144 PEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKI 199
Query: 297 SDFGLSVTAGTQSRNVKISGT----LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGR 351
            DFGL+      S N  + G     + ++APE + +   T +SDV+++G++L E+  +G 
Sbjct: 200 GDFGLARDIMNDS-NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGL 258
Query: 352 RPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVD---PVIRDTMDLKHLYQVAAVAVLCIQ 408
            P                 P +   SK   +V     + +     K++Y +      C  
Sbjct: 259 NP----------------YPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQA---CWA 299
Query: 409 PEPSYRPLITDVLHSL 424
            EP++RP    +   L
Sbjct: 300 LEPTHRPTFQQICSFL 315

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 67/245 (27%), Positives = 113/245 (46%), Gaps = 20/245 (8%)
Query: 119 LSLSPILERFNSLRLAGKKDTVSVIEYELLEA---ATNNFQESNVIGEGGRGHVYKARFN 175
           L  +P  E  +S      K  +  ++++ LEA     + F +  V+G GG G V+  +  
Sbjct: 154 LGQAPFQEFLDS------KYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMK 207
Query: 176 EK-LLAAVKRIDDAGHDAEREFNN---EVNWLTKIRHQNIISLLGYCIHAETRF-LVYEM 230
               L A K+++       + +     E   L K+  + I+SL  Y    +T   LV  +
Sbjct: 208 ATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL-AYAFETKTDLCLVMTI 266
Query: 231 MQNGSLEKQLHGPTHGSNLTWHLR-MKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLD 289
           M  G +   ++     +      R +     +  GLE+LH+     +++RDLK  N+LLD
Sbjct: 267 MNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLD 323
Query: 290 SSFNAKLSDFGLSVT-AGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELL 348
              N ++SD GL+V     Q++    +GT G++APE LL  +     D +A GV L E++
Sbjct: 324 DDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMI 383
Query: 349 MGRRP 353
             R P
Sbjct: 384 AARGP 388

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 37/231 (16%)
Query: 199 EVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSL------EKQLHGPTHGSNLTWH 252
           E++    + HQ+++   G+    +  F+V E+ +  SL       K L  P       ++
Sbjct: 65  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEP----EARYY 120
Query: 253 LRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV 312
           LR      +  G +YLH    + V+HRDLK  N+ L+     K+ DFGL+          
Sbjct: 121 LR-----QIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK 172
Query: 313 KI-SGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
           K+  GT  Y+APE L +   + + DV++ G ++  LL+G+ P E    T C       + 
Sbjct: 173 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE----TSCLKETYLRIK 228
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLH 422
           +  +   +P  ++PV             A++    +Q +P+ RP I ++L+
Sbjct: 229 K--NEYSIPKHINPV------------AASLIQKMLQTDPTARPTINELLN 265

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 11/209 (5%)
Query: 161 IGEGGRGHVYKARFNEK-LLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCI 219
           +GEG  G VYKA   E   + A+K++        +E   E++ + +    +++   G   
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQV--PVESDLQEIIKEISIMQQCDSPHVVKYYGSYF 94
Query: 220 HAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHR 279
                ++V E    GS+   +        LT      I     +GLEYLH       +HR
Sbjct: 95  KNTDLWIVMEYCGAGSVSDIIR--LRNKTLTEDEIATILQSTLKGLEYLHFMRK---IHR 149
Query: 280 DLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDV 337
           D+K+ NILL++  +AKL+DFG++  +T     RN  I GT  ++APE + E      +D+
Sbjct: 150 DIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVI-GTPFWMAPEVIQEIGYNCVADI 208
Query: 338 YAFGVVLLELLMGRRPVEKMSPTQCQSMV 366
           ++ G+  +E+  G+ P   + P +   M+
Sbjct: 209 WSLGITAIEMAEGKPPYADIHPMRAIFMI 237

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 99/204 (48%), Gaps = 22/204 (10%)
Query: 161 IGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFN-NEVNWLTKIRHQNIISLLGYC 218
           IGEG  G V  A  N  K+  A+K+I    H    +    E+  L + RH+NII +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGI-NDI 93
Query: 219 IHAET------RFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
           I A T       ++V ++M     E  L+      +L+          + RGL+Y+H   
Sbjct: 94  IRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH--- 145
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN----VKISGTLGYVAPEYLLE 328
           +  V+HRDLK SN+LL+++ + K+ DFGL+  A     +     +   T  Y APE +L 
Sbjct: 146 SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 329 GKLTDKS-DVYAFGVVLLELLMGR 351
            K   KS D+++ G +L E+L  R
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 37/231 (16%)
Query: 199 EVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSL------EKQLHGPTHGSNLTWH 252
           E++    + HQ+++   G+    +  F+V E+ +  SL       K L  P       ++
Sbjct: 89  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEP----EARYY 144
Query: 253 LRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV 312
           LR      +  G +YLH    + V+HRDLK  N+ L+     K+ DFGL+          
Sbjct: 145 LR-----QIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK 196
Query: 313 KI-SGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
           K+  GT  Y+APE L +   + + DV++ G ++  LL+G+ P E    T C       + 
Sbjct: 197 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE----TSCLKETYLRIK 252
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLH 422
           +  +   +P  ++PV             A++    +Q +P+ RP I ++L+
Sbjct: 253 K--NEYSIPKHINPV------------AASLIQKMLQTDPTARPTINELLN 289

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 92/199 (46%), Gaps = 15/199 (7%)
Query: 165 GRGHVYKARFNEKLLA----AVKRIDDAGHDAE--REFNNEVNWLTKIRHQNIISLLGYC 218
           G+G+  K +    +L     AVK ID    +    ++   EV  +  + H NI+ L    
Sbjct: 24  GKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI 83
Query: 219 IHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVH 278
              +T +LV E    G +   L    HG       R K    +   ++Y H+     +VH
Sbjct: 84  ETEKTLYLVMEYASGGEVFDYL--VAHGRMKEKEARAKFR-QIVSAVQYCHQKY---IVH 137
Query: 279 RDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTD--KSD 336
           RDLK+ N+LLD   N K++DFG S      ++     G+  Y APE L +GK  D  + D
Sbjct: 138 RDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPE-LFQGKKYDGPEVD 196
Query: 337 VYAFGVVLLELLMGRRPVE 355
           V++ GV+L  L+ G  P +
Sbjct: 197 VWSLGVILYTLVSGSLPFD 215

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 98/204 (48%), Gaps = 22/204 (10%)
Query: 161 IGEGGRGHVYKARFN-EKLLAAVKRIDDAGHD--AEREFNNEVNWLTKIRHQNIISLLGY 217
           IGEG  G V  A  N  K+  A+K+I    H    +R    E+  L + RH+NII     
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIG---- 85
Query: 218 CIHAETRFLVYEMMQN-----GSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
            I+   R    E M++       +E  L+      +L+          + RGL+Y+H   
Sbjct: 86  -INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH--- 141
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN----VKISGTLGYVAPEYLLE 328
           +  V+HRDLK SN+LL+++ + K+ DFGL+  A     +     +   T  Y APE +L 
Sbjct: 142 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 201
Query: 329 GKLTDKS-DVYAFGVVLLELLMGR 351
            K   KS D+++ G +L E+L  R
Sbjct: 202 SKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 91/205 (44%), Gaps = 21/205 (10%)
Query: 159 NVIGEGGRGHVYKA--RFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLG 216
           +V+G G    V  A  +  +KL+A      +A    E    NE+  L KI+H NI++L  
Sbjct: 24  DVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDD 83
Query: 217 YCIHAETRFLVYEMMQNGSL-----EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
                   +L+ +++  G L     EK  +     S L +         V   ++YLH  
Sbjct: 84  IYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQ--------VLDAVKYLH-- 133
Query: 272 CNHPVVHRDLKSSNIL---LDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLE 328
            +  +VHRDLK  N+L   LD      +SDFGLS      S      GT GYVAPE L +
Sbjct: 134 -DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ 192
Query: 329 GKLTDKSDVYAFGVVLLELLMGRRP 353
              +   D ++ GV+   LL G  P
Sbjct: 193 KPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 87/197 (44%), Gaps = 9/197 (4%)
Query: 160 VIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAERE---FNNEVNWLTKIRHQNIISLLG 216
            IG G  G   K R        V +  D G   E E     +EVN L +++H NI+    
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 217 YCIHAE--TRFLVYEMMQNGSLEKQL-HGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
             I     T ++V E  + G L   +  G      L     +++   +   L+  H   +
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 274 --HPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK-ISGTLGYVAPEYLLEGK 330
             H V+HRDLK +N+ LD   N KL DFGL+      +   K   GT  Y++PE +    
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMS 192
Query: 331 LTDKSDVYAFGVVLLEL 347
             +KSD+++ G +L EL
Sbjct: 193 YNEKSDIWSLGCLLYEL 209

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 87/197 (44%), Gaps = 9/197 (4%)
Query: 160 VIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAERE---FNNEVNWLTKIRHQNIISLLG 216
            IG G  G   K R        V +  D G   E E     +EVN L +++H NI+    
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 217 YCIHAE--TRFLVYEMMQNGSLEKQL-HGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
             I     T ++V E  + G L   +  G      L     +++   +   L+  H   +
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 274 --HPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK-ISGTLGYVAPEYLLEGK 330
             H V+HRDLK +N+ LD   N KL DFGL+      +   K   GT  Y++PE +    
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMS 192
Query: 331 LTDKSDVYAFGVVLLEL 347
             +KSD+++ G +L EL
Sbjct: 193 YNEKSDIWSLGCLLYEL 209

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 37/231 (16%)
Query: 199 EVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSL------EKQLHGPTHGSNLTWH 252
           E++    + HQ+++   G+    +  F+V E+ +  SL       K L  P       ++
Sbjct: 71  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEP----EARYY 126
Query: 253 LRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ-SRN 311
           LR      +  G +YLH    + V+HRDLK  N+ L+     K+ DFGL+        R 
Sbjct: 127 LR-----QIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK 178
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
             + GT  Y+APE L +   + + DV++ G ++  LL+G+ P E    T C       + 
Sbjct: 179 KTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE----TSCLKETYLRIK 234
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLH 422
           +  +   +P  ++PV             A++    +Q +P+ RP I ++L+
Sbjct: 235 K--NEYSIPKHINPV------------AASLIQKMLQTDPTARPTINELLN 271

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 37/231 (16%)
Query: 199 EVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSL------EKQLHGPTHGSNLTWH 252
           E++    + HQ+++   G+    +  F+V E+ +  SL       K L  P       ++
Sbjct: 91  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEP----EARYY 146
Query: 253 LRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV 312
           LR      +  G +YLH    + V+HRDLK  N+ L+     K+ DFGL+          
Sbjct: 147 LR-----QIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK 198
Query: 313 KI-SGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
           K+  GT  Y+APE L +   + + DV++ G ++  LL+G+ P E    T C       + 
Sbjct: 199 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE----TSCLKETYLRIK 254
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLH 422
           +  +   +P  ++PV             A++    +Q +P+ RP I ++L+
Sbjct: 255 K--NEYSIPKHINPV------------AASLIQKMLQTDPTARPTINELLN 291

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 98/204 (48%), Gaps = 22/204 (10%)
Query: 161 IGEGGRGHVYKARFN-EKLLAAVKRIDDAGHD--AEREFNNEVNWLTKIRHQNIISLLGY 217
           IGEG  G V  A  N  K+  A+K+I    H    +R    E+  L + RH+NII     
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIG---- 89
Query: 218 CIHAETRFLVYEMMQN-----GSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
            I+   R    E M++       +E  L+      +L+          + RGL+Y+H   
Sbjct: 90  -INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIH--- 145
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN----VKISGTLGYVAPEYLLE 328
           +  V+HRDLK SN+LL+++ + K+ DFGL+  A     +     +   T  Y APE +L 
Sbjct: 146 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 329 GKLTDKS-DVYAFGVVLLELLMGR 351
            K   KS D+++ G +L E+L  R
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 24/205 (11%)
Query: 161 IGEGGRGHVYKARFN-EKLLAAVKRIDDAGHD--AEREFNNEVNWLTKIRHQNIISLLGY 217
           IGEG  G V  A  N  K+  A+K+I    H    +R    E+  L + RH+NII +   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGI-ND 88
Query: 218 CIHAET------RFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
            I A T       ++V ++M     E  L+      +L+          + RGL+Y+H  
Sbjct: 89  IIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH-- 141
Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN----VKISGTLGYVAPEYLL 327
            +  V+HRDLK SN+LL+++ + K+ DFGL+  A     +     +   T  Y APE +L
Sbjct: 142 -SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 328 EGKLTDKS-DVYAFGVVLLELLMGR 351
             K   KS D+++ G +L E+L  R
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 37/231 (16%)
Query: 199 EVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSL------EKQLHGPTHGSNLTWH 252
           E++    + HQ+++   G+    +  F+V E+ +  SL       K L  P       ++
Sbjct: 67  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEP----EARYY 122
Query: 253 LRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ-SRN 311
           LR      +  G +YLH    + V+HRDLK  N+ L+     K+ DFGL+        R 
Sbjct: 123 LR-----QIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK 174
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
             + GT  Y+APE L +   + + DV++ G ++  LL+G+ P E    T C       + 
Sbjct: 175 KTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE----TSCLKETYLRIK 230
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLH 422
           +  +   +P  ++PV             A++    +Q +P+ RP I ++L+
Sbjct: 231 K--NEYSIPKHINPV------------AASLIQKMLQTDPTARPTINELLN 267

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 37/231 (16%)
Query: 199 EVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSL------EKQLHGPTHGSNLTWH 252
           E++    + HQ+++   G+    +  F+V E+ +  SL       K L  P       ++
Sbjct: 67  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEP----EARYY 122
Query: 253 LRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ-SRN 311
           LR      +  G +YLH    + V+HRDLK  N+ L+     K+ DFGL+        R 
Sbjct: 123 LR-----QIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK 174
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
             + GT  Y+APE L +   + + DV++ G ++  LL+G+ P E    T C       + 
Sbjct: 175 KTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE----TSCLKETYLRIK 230
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLH 422
           +  +   +P  ++PV             A++    +Q +P+ RP I ++L+
Sbjct: 231 K--NEYSIPKHINPV------------AASLIQKMLQTDPTARPTINELLN 267

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 15/210 (7%)
Query: 165 GRGHVYKARFNEKLLA----AVKRIDDAGHDAE--REFNNEVNWLTKIRHQNIISLLGYC 218
           G+G+  K +    +L     AVK ID    ++   ++   EV     + H NI+ L    
Sbjct: 23  GKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEVI 82
Query: 219 IHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVH 278
              +T +LV E    G +   L    HG       R K    +   ++Y H+     +VH
Sbjct: 83  ETEKTLYLVXEYASGGEVFDYL--VAHGRXKEKEARAKFR-QIVSAVQYCHQKF---IVH 136
Query: 279 RDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTD--KSD 336
           RDLK+ N+LLD+  N K++DFG S      ++     G   Y APE L +GK  D  + D
Sbjct: 137 RDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPE-LFQGKKYDGPEVD 195
Query: 337 VYAFGVVLLELLMGRRPVEKMSPTQCQSMV 366
           V++ GV+L  L+ G  P +  +  + +  V
Sbjct: 196 VWSLGVILYTLVSGSLPFDGQNLKELRERV 225

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 98/204 (48%), Gaps = 22/204 (10%)
Query: 161 IGEGGRGHVYKARFN-EKLLAAVKRIDDAGHD--AEREFNNEVNWLTKIRHQNIISLLGY 217
           IGEG  G V  A  N  K+  A+K+I    H    +R    E+  L + RH+NII     
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIG---- 87
Query: 218 CIHAETRFLVYEMMQN-----GSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
            I+   R    E M++       +E  L+      +L+          + RGL+Y+H   
Sbjct: 88  -INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH--- 143
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN----VKISGTLGYVAPEYLLE 328
           +  V+HRDLK SN+LL+++ + K+ DFGL+  A     +     +   T  Y APE +L 
Sbjct: 144 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 203
Query: 329 GKLTDKS-DVYAFGVVLLELLMGR 351
            K   KS D+++ G +L E+L  R
Sbjct: 204 SKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 98/204 (48%), Gaps = 22/204 (10%)
Query: 161 IGEGGRGHVYKARFN-EKLLAAVKRIDDAGHD--AEREFNNEVNWLTKIRHQNIISLLGY 217
           IGEG  G V  A  N  K+  A+K+I    H    +R    E+  L + RH+NII     
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIG---- 83
Query: 218 CIHAETRFLVYEMMQN-----GSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
            I+   R    E M++       +E  L+      +L+          + RGL+Y+H   
Sbjct: 84  -INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH--- 139
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN----VKISGTLGYVAPEYLLE 328
           +  V+HRDLK SN+LL+++ + K+ DFGL+  A     +     +   T  Y APE +L 
Sbjct: 140 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 199
Query: 329 GKLTDKS-DVYAFGVVLLELLMGR 351
            K   KS D+++ G +L E+L  R
Sbjct: 200 SKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 55/158 (34%), Positives = 76/158 (48%), Gaps = 10/158 (6%)
Query: 199 EVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIA 258
           EV  L  + H NI+ L  +       +LV E  + G L  ++    H           I 
Sbjct: 86  EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEI---IHRMKFNEVDAAVII 142
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA---KLSDFGLSVTAGTQSRNVKIS 315
             V  G+ YLH+H    +VHRDLK  N+LL+S       K+ DFGLS     Q +  +  
Sbjct: 143 KQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL 199
Query: 316 GTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
           GT  Y+APE +L  K  +K DV++ GV+L  LL G  P
Sbjct: 200 GTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYPP 236

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 98/204 (48%), Gaps = 22/204 (10%)
Query: 161 IGEGGRGHVYKARFN-EKLLAAVKRIDDAGHD--AEREFNNEVNWLTKIRHQNIISLLGY 217
           IGEG  G V  A  N  K+  A+K+I    H    +R    E+  L + RH+NII     
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIG---- 90
Query: 218 CIHAETRFLVYEMMQN-----GSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
            I+   R    E M++       +E  L+      +L+          + RGL+Y+H   
Sbjct: 91  -INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH--- 146
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN----VKISGTLGYVAPEYLLE 328
           +  V+HRDLK SN+LL+++ + K+ DFGL+  A     +     +   T  Y APE +L 
Sbjct: 147 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 206
Query: 329 GKLTDKS-DVYAFGVVLLELLMGR 351
            K   KS D+++ G +L E+L  R
Sbjct: 207 SKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 98/204 (48%), Gaps = 22/204 (10%)
Query: 161 IGEGGRGHVYKARFN-EKLLAAVKRIDDAGHD--AEREFNNEVNWLTKIRHQNIISLLGY 217
           IGEG  G V  A  N  K+  A+K+I    H    +R    E+  L + RH+NII     
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIG---- 91
Query: 218 CIHAETRFLVYEMMQN-----GSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
            I+   R    E M++       +E  L+      +L+          + RGL+Y+H   
Sbjct: 92  -INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH--- 147
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN----VKISGTLGYVAPEYLLE 328
           +  V+HRDLK SN+LL+++ + K+ DFGL+  A     +     +   T  Y APE +L 
Sbjct: 148 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 207
Query: 329 GKLTDKS-DVYAFGVVLLELLMGR 351
            K   KS D+++ G +L E+L  R
Sbjct: 208 SKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 98/204 (48%), Gaps = 22/204 (10%)
Query: 161 IGEGGRGHVYKARFN-EKLLAAVKRIDDAGHD--AEREFNNEVNWLTKIRHQNIISLLGY 217
           IGEG  G V  A  N  K+  A+K+I    H    +R    E+  L + RH+NII     
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIG---- 82
Query: 218 CIHAETRFLVYEMMQN-----GSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
            I+   R    E M++       +E  L+      +L+          + RGL+Y+H   
Sbjct: 83  -INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH--- 138
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN----VKISGTLGYVAPEYLLE 328
           +  V+HRDLK SN+LL+++ + K+ DFGL+  A     +     +   T  Y APE +L 
Sbjct: 139 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 198
Query: 329 GKLTDKS-DVYAFGVVLLELLMGR 351
            K   KS D+++ G +L E+L  R
Sbjct: 199 SKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 98/204 (48%), Gaps = 22/204 (10%)
Query: 161 IGEGGRGHVYKARFN-EKLLAAVKRIDDAGHD--AEREFNNEVNWLTKIRHQNIISLLGY 217
           IGEG  G V  A  N  K+  A+K+I    H    +R    E+  L + RH+NII     
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIG---- 89
Query: 218 CIHAETRFLVYEMMQN-----GSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
            I+   R    E M++       +E  L+      +L+          + RGL+Y+H   
Sbjct: 90  -INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH--- 145
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN----VKISGTLGYVAPEYLLE 328
           +  V+HRDLK SN+LL+++ + K+ DFGL+  A     +     +   T  Y APE +L 
Sbjct: 146 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 329 GKLTDKS-DVYAFGVVLLELLMGR 351
            K   KS D+++ G +L E+L  R
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 24/205 (11%)
Query: 161 IGEGGRGHVYKARFN-EKLLAAVKRIDDAGHD--AEREFNNEVNWLTKIRHQNIISLLGY 217
           IGEG  G V  A  N  K+  A+K+I    H    +R    E+  L + RH+NII +   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGI-ND 88
Query: 218 CIHAET------RFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
            I A T       ++V ++M     E  L+      +L+          + RGL+Y+H  
Sbjct: 89  IIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH-- 141
Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN----VKISGTLGYVAPEYLL 327
            +  V+HRDLK SN+LL+++ + K+ DFGL+  A     +     +   T  Y APE +L
Sbjct: 142 -SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 328 EGKLTDKS-DVYAFGVVLLELLMGR 351
             K   KS D+++ G +L E+L  R
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 98/204 (48%), Gaps = 22/204 (10%)
Query: 161 IGEGGRGHVYKARFN-EKLLAAVKRIDDAGHD--AEREFNNEVNWLTKIRHQNIISLLGY 217
           IGEG  G V  A  N  K+  A+K+I    H    +R    E+  L + RH+NII     
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIG---- 93
Query: 218 CIHAETRFLVYEMMQN-----GSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
            I+   R    E M++       +E  L+      +L+          + RGL+Y+H   
Sbjct: 94  -INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH--- 149
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN----VKISGTLGYVAPEYLLE 328
           +  V+HRDLK SN+LL+++ + K+ DFGL+  A     +     +   T  Y APE +L 
Sbjct: 150 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 209
Query: 329 GKLTDKS-DVYAFGVVLLELLMGR 351
            K   KS D+++ G +L E+L  R
Sbjct: 210 SKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 98/204 (48%), Gaps = 22/204 (10%)
Query: 161 IGEGGRGHVYKARFN-EKLLAAVKRIDDAGHD--AEREFNNEVNWLTKIRHQNIISLLGY 217
           IGEG  G V  A  N  K+  A+K+I    H    +R    E+  L + RH+NII     
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIG---- 85
Query: 218 CIHAETRFLVYEMMQN-----GSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
            I+   R    E M++       +E  L+      +L+          + RGL+Y+H   
Sbjct: 86  -INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH--- 141
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN----VKISGTLGYVAPEYLLE 328
           +  V+HRDLK SN+LL+++ + K+ DFGL+  A     +     +   T  Y APE +L 
Sbjct: 142 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 201
Query: 329 GKLTDKS-DVYAFGVVLLELLMGR 351
            K   KS D+++ G +L E+L  R
Sbjct: 202 SKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 98/204 (48%), Gaps = 22/204 (10%)
Query: 161 IGEGGRGHVYKARFN-EKLLAAVKRIDDAGHD--AEREFNNEVNWLTKIRHQNIISLLGY 217
           IGEG  G V  A  N  K+  A+K+I    H    +R    E+  L + RH+NII     
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIG---- 83
Query: 218 CIHAETRFLVYEMMQN-----GSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
            I+   R    E M++       +E  L+      +L+          + RGL+Y+H   
Sbjct: 84  -INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH--- 139
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN----VKISGTLGYVAPEYLLE 328
           +  V+HRDLK SN+LL+++ + K+ DFGL+  A     +     +   T  Y APE +L 
Sbjct: 140 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 199
Query: 329 GKLTDKS-DVYAFGVVLLELLMGR 351
            K   KS D+++ G +L E+L  R
Sbjct: 200 SKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 24/205 (11%)
Query: 161 IGEGGRGHVYKARFN-EKLLAAVKRIDDAGHD--AEREFNNEVNWLTKIRHQNIISLLGY 217
           IGEG  G V  A  N  K+  A+K+I    H    +R    E+  L + RH+NII +   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGI-ND 92
Query: 218 CIHAET------RFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
            I A T       ++V ++M     E  L+      +L+          + RGL+Y+H  
Sbjct: 93  IIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH-- 145
Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN----VKISGTLGYVAPEYLL 327
            +  V+HRDLK SN+LL+++ + K+ DFGL+  A     +     +   T  Y APE +L
Sbjct: 146 -SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 328 EGKLTDKS-DVYAFGVVLLELLMGR 351
             K   KS D+++ G +L E+L  R
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 99/209 (47%), Gaps = 14/209 (6%)
Query: 152 TNNFQESNVIGEGGRGHVY----KARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR 207
           ++ +Q    +G G  G V     K    E+ +  +K+             +EV  L ++ 
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 62
Query: 208 HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEY 267
           H NI+ L  +       +LV E+ + G L  ++      S +   + MK    V  G  Y
Sbjct: 63  HPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMK---QVLSGTTY 119
Query: 268 LHEHCNHPVVHRDLKSSNILLDS-SFNA--KLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
           LH+H    +VHRDLK  N+LL+S S +A  K+ DFGLS       +  +  GT  Y+APE
Sbjct: 120 LHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPE 176
Query: 325 YLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
            +L  K  +K DV++ GV+L  LL G  P
Sbjct: 177 -VLRKKYDEKCDVWSCGVILYILLCGYPP 204

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 24/205 (11%)
Query: 161 IGEGGRGHVYKARFN-EKLLAAVKRIDDAGHD--AEREFNNEVNWLTKIRHQNIISLLGY 217
           IGEG  G V  A  N  K+  A+K+I    H    +R    E+  L + RH+NII +   
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGI-ND 108
Query: 218 CIHAET------RFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
            I A T       ++V ++M     E  L+      +L+          + RGL+Y+H  
Sbjct: 109 IIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH-- 161
Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN----VKISGTLGYVAPEYLL 327
            +  V+HRDLK SN+LL+++ + K+ DFGL+  A     +     +   T  Y APE +L
Sbjct: 162 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 328 EGKLTDKS-DVYAFGVVLLELLMGR 351
             K   KS D+++ G +L E+L  R
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 66/273 (24%), Positives = 120/273 (43%), Gaps = 23/273 (8%)
Query: 154 NFQESNVIGEGGRGHVYKAR-FNEKLLAAVKRI---DDAGHDAEREFNNEVNWLTKIRHQ 209
           NF+    IG G    VY+A    + +  A+K++   D     A  +   E++ L ++ H 
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 210 NIISLLGYCIHAETRFLVYEMMQNGSLEKQL-HGPTHGSNLTWHLRMKIAVDVARGLEYL 268
           N+I      I      +V E+   G L + + H       +      K  V +   LE++
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM 152
Query: 269 HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV-KISGTLGYVAPEYLL 327
           H   +  V+HRD+K +N+ + ++   KL D GL     +++     + GT  Y++PE + 
Sbjct: 153 H---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 209
Query: 328 EGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVI 387
           E     KSD+++ G +L E+          SP     M  +++ +  ++   P +  P  
Sbjct: 210 ENGYNFKSDIWSLGCLLYEM------AALQSPFYGDKMNLYSLCKKIEQCDYPPL--PSD 261
Query: 388 RDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDV 420
             + +L+ L        +CI P+P  RP +T V
Sbjct: 262 HYSEELRQLVN------MCINPDPEKRPDVTYV 288

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 91/205 (44%), Gaps = 21/205 (10%)
Query: 159 NVIGEGGRGHVYKA--RFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLG 216
           +V+G G    V  A  +  +KL+A      +A    E    NE+  L KI+H NI++L  
Sbjct: 24  DVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDD 83
Query: 217 YCIHAETRFLVYEMMQNGSL-----EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
                   +L+ +++  G L     EK  +     S L +         V   ++YLH  
Sbjct: 84  IYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQ--------VLDAVKYLH-- 133
Query: 272 CNHPVVHRDLKSSNIL---LDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLE 328
            +  +VHRDLK  N+L   LD      +SDFGLS      S      GT GYVAPE L +
Sbjct: 134 -DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ 192
Query: 329 GKLTDKSDVYAFGVVLLELLMGRRP 353
              +   D ++ GV+   LL G  P
Sbjct: 193 KPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 91/205 (44%), Gaps = 21/205 (10%)
Query: 159 NVIGEGGRGHVYKA--RFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLG 216
           +V+G G    V  A  +  +KL+A      +A    E    NE+  L KI+H NI++L  
Sbjct: 24  DVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDD 83
Query: 217 YCIHAETRFLVYEMMQNGSL-----EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
                   +L+ +++  G L     EK  +     S L +         V   ++YLH  
Sbjct: 84  IYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQ--------VLDAVKYLH-- 133
Query: 272 CNHPVVHRDLKSSNIL---LDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLE 328
            +  +VHRDLK  N+L   LD      +SDFGLS      S      GT GYVAPE L +
Sbjct: 134 -DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ 192
Query: 329 GKLTDKSDVYAFGVVLLELLMGRRP 353
              +   D ++ GV+   LL G  P
Sbjct: 193 KPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 24/205 (11%)
Query: 161 IGEGGRGHVYKARFN-EKLLAAVKRIDDAGHD--AEREFNNEVNWLTKIRHQNIISLLGY 217
           IGEG  G V  A  N  K+  A+K+I    H    +R    E+  L + RH+NII +   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGI-ND 92
Query: 218 CIHAET------RFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
            I A T       ++V ++M     E  L+      +L+          + RGL+Y+H  
Sbjct: 93  IIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH-- 145
Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV----KISGTLGYVAPEYLL 327
            +  V+HRDLK SN+LL+++ + K+ DFGL+  A     +     +   T  Y APE +L
Sbjct: 146 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIML 204
Query: 328 EGKLTDKS-DVYAFGVVLLELLMGR 351
             K   KS D+++ G +L E+L  R
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 24/205 (11%)
Query: 161 IGEGGRGHVYKARFN-EKLLAAVKRIDDAGHD--AEREFNNEVNWLTKIRHQNIISLLGY 217
           IGEG  G V  A  N  K+  A+K+I    H    +R    E+  L + RH+NII +   
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGI-ND 93
Query: 218 CIHAET------RFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
            I A T       ++V ++M     E  L+      +L+          + RGL+Y+H  
Sbjct: 94  IIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH-- 146
Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV----KISGTLGYVAPEYLL 327
            +  V+HRDLK SN+LL+++ + K+ DFGL+  A     +     +   T  Y APE +L
Sbjct: 147 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIML 205
Query: 328 EGKLTDKS-DVYAFGVVLLELLMGR 351
             K   KS D+++ G +L E+L  R
Sbjct: 206 NSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 24/205 (11%)
Query: 161 IGEGGRGHVYKARFN-EKLLAAVKRIDDAGHD--AEREFNNEVNWLTKIRHQNIISLLGY 217
           IGEG  G V  A  N  K+  A+K+I    H    +R    E+  L + RH+NII +   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGI-ND 88
Query: 218 CIHAET------RFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
            I A T       ++V ++M     E  L+      +L+          + RGL+Y+H  
Sbjct: 89  IIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH-- 141
Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN----VKISGTLGYVAPEYLL 327
            +  V+HRDLK SN+LL+++ + K+ DFGL+  A     +     +   T  Y APE +L
Sbjct: 142 -SANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 328 EGKLTDKS-DVYAFGVVLLELLMGR 351
             K   KS D+++ G +L E+L  R
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 92/199 (46%), Gaps = 15/199 (7%)
Query: 165 GRGHVYKARFNEKLLA----AVKRIDDAGHDAE--REFNNEVNWLTKIRHQNIISLLGYC 218
           G+G+  K +    +L     A+K ID    +    ++   EV  +  + H NI+ L    
Sbjct: 21  GKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI 80
Query: 219 IHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVH 278
              +T +L+ E    G +   L    HG       R K    +   ++Y H+     +VH
Sbjct: 81  ETEKTLYLIMEYASGGEVFDYL--VAHGRMKEKEARSKFR-QIVSAVQYCHQK---RIVH 134
Query: 279 RDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTD--KSD 336
           RDLK+ N+LLD+  N K++DFG S       +     G+  Y APE L +GK  D  + D
Sbjct: 135 RDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPE-LFQGKKYDGPEVD 193
Query: 337 VYAFGVVLLELLMGRRPVE 355
           V++ GV+L  L+ G  P +
Sbjct: 194 VWSLGVILYTLVSGSLPFD 212

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 101/222 (45%), Gaps = 31/222 (13%)
Query: 153 NNFQESNVIGEGG----RGHVYKARFNEKLLAAVKRIDDAG---HDAE-----REFN-NE 199
            N++   ++G G     R  ++K    E    AVK ID  G     AE     RE    E
Sbjct: 4   ENYEPKEILGRGVSSVVRRCIHKPTCKE---YAVKIIDVTGGGSFSAEEVQELREATLKE 60
Query: 200 VNWLTKIR-HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIA 258
           V+ L K+  H NII L          FLV+++M+ G L   L      S       M+  
Sbjct: 61  VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 120
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTL 318
           ++V   L  L+      +VHRDLK  NILLD   N KL+DFG S       +  ++ GT 
Sbjct: 121 LEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTP 174
Query: 319 GYVAPEYLLEGKLTD-------KSDVYAFGVVLLELLMGRRP 353
            Y+APE ++E  + D       + D+++ GV++  LL G  P
Sbjct: 175 SYLAPE-IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 215

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/244 (26%), Positives = 119/244 (48%), Gaps = 34/244 (13%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKAR----------FNEKLL--AAVKRIDDAGHDAEREF 196
           +A  ++F+   V+G+G  G V+  R          +  K+L  A +K  D      ER+ 
Sbjct: 24  KADPSHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDI 83
Query: 197 NNEVNWLTKIRHQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGS--NLTWHL 253
             +VN      H  ++ L  Y    E + +L+ + ++ G L  +L      +  ++ ++L
Sbjct: 84  LADVN------HPFVVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL 136
Query: 254 RMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA-GTQSRNV 312
                 ++A GL++LH   +  +++RDLK  NILLD   + KL+DFGLS  A   + +  
Sbjct: 137 -----AELALGLDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAY 188
Query: 313 KISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWA--- 369
              GT+ Y+APE +     +  +D +++GV++ E+L G  P +     +  +++  A   
Sbjct: 189 SFCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLG 248
Query: 370 MPQL 373
           MPQ 
Sbjct: 249 MPQF 252

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/276 (26%), Positives = 126/276 (45%), Gaps = 33/276 (11%)
Query: 158 SNVIGEGGRGHVYKARFN----EKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNII 212
           + ++GEG  G VY+  +     EK+  AVK    D   D + +F +E   +  + H +I+
Sbjct: 13  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 72
Query: 213 SLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
            L+G  I  E  +++ E+   G L   L    + ++L     +  ++ + + + YL E  
Sbjct: 73  KLIGI-IEEEPTWIIMELYPYGELGHYLE--RNKNSLKVLTLVLYSLQICKAMAYL-ESI 128
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT---LGYVAPEYLLEG 329
           N   VHRD+   NIL+ S    KL DFGLS     +    K S T   + +++PE +   
Sbjct: 129 N--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY-YKASVTRLPIKWMSPESINFR 185
Query: 330 KLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIR 388
           + T  SDV+ F V + E+L  G++P   +       ++     +  DR   P++  PV+ 
Sbjct: 186 RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL-----EKGDRLPKPDLCPPVLY 240
Query: 389 DTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
             M              C   +PS RP  T+++ SL
Sbjct: 241 TLM------------TRCWDYDPSDRPRFTELVCSL 264

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/276 (26%), Positives = 126/276 (45%), Gaps = 33/276 (11%)
Query: 158 SNVIGEGGRGHVYKARFN----EKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNII 212
           + ++GEG  G VY+  +     EK+  AVK    D   D + +F +E   +  + H +I+
Sbjct: 29  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 88
Query: 213 SLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
            L+G  I  E  +++ E+   G L   L    + ++L     +  ++ + + + YL E  
Sbjct: 89  KLIGI-IEEEPTWIIMELYPYGELGHYLE--RNKNSLKVLTLVLYSLQICKAMAYL-ESI 144
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT---LGYVAPEYLLEG 329
           N   VHRD+   NIL+ S    KL DFGLS     +    K S T   + +++PE +   
Sbjct: 145 N--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY-YKASVTRLPIKWMSPESINFR 201
Query: 330 KLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIR 388
           + T  SDV+ F V + E+L  G++P   +       ++     +  DR   P++  PV+ 
Sbjct: 202 RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL-----EKGDRLPKPDLCPPVLY 256
Query: 389 DTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
             M              C   +PS RP  T+++ SL
Sbjct: 257 TLM------------TRCWDYDPSDRPRFTELVCSL 280

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 91/199 (45%), Gaps = 15/199 (7%)
Query: 165 GRGHVYKARFNEKLLA----AVKRIDDAGHDAE--REFNNEVNWLTKIRHQNIISLLGYC 218
           G+G+  K +    +L     A+K ID    +    ++   EV  +  + H NI+ L    
Sbjct: 24  GKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI 83
Query: 219 IHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVH 278
              +T +L+ E    G +   L    HG       R K    +   ++Y H+     +VH
Sbjct: 84  ETEKTLYLIMEYASGGEVFDYL--VAHGRMKEKEARSKFR-QIVSAVQYCHQK---RIVH 137
Query: 279 RDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTD--KSD 336
           RDLK+ N+LLD+  N K++DFG S       +     G   Y APE L +GK  D  + D
Sbjct: 138 RDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPE-LFQGKKYDGPEVD 196
Query: 337 VYAFGVVLLELLMGRRPVE 355
           V++ GV+L  L+ G  P +
Sbjct: 197 VWSLGVILYTLVSGSLPFD 215

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 86/197 (43%), Gaps = 9/197 (4%)
Query: 160 VIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAERE---FNNEVNWLTKIRHQNIISLLG 216
            IG G  G   K R        V +  D G   E E     +EVN L +++H NI+    
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 217 YCIHAE--TRFLVYEMMQNGSLEKQL-HGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
             I     T ++V E  + G L   +  G      L     +++   +   L+  H   +
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 274 --HPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK-ISGTLGYVAPEYLLEGK 330
             H V+HRDLK +N+ LD   N KL DFGL+          K   GT  Y++PE +    
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYMSPEQMNRMS 192
Query: 331 LTDKSDVYAFGVVLLEL 347
             +KSD+++ G +L EL
Sbjct: 193 YNEKSDIWSLGCLLYEL 209

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/276 (26%), Positives = 126/276 (45%), Gaps = 33/276 (11%)
Query: 158 SNVIGEGGRGHVYKARFN----EKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNII 212
           + ++GEG  G VY+  +     EK+  AVK    D   D + +F +E   +  + H +I+
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 213 SLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
            L+G  I  E  +++ E+   G L   L    + ++L     +  ++ + + + YL E  
Sbjct: 77  KLIGI-IEEEPTWIIMELYPYGELGHYLE--RNKNSLKVLTLVLYSLQICKAMAYL-ESI 132
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT---LGYVAPEYLLEG 329
           N   VHRD+   NIL+ S    KL DFGLS     +    K S T   + +++PE +   
Sbjct: 133 N--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY-YKASVTRLPIKWMSPESINFR 189
Query: 330 KLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIR 388
           + T  SDV+ F V + E+L  G++P   +       ++     +  DR   P++  PV+ 
Sbjct: 190 RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL-----EKGDRLPKPDLCPPVLY 244
Query: 389 DTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
             M              C   +PS RP  T+++ SL
Sbjct: 245 TLM------------TRCWDYDPSDRPRFTELVCSL 268

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 109/228 (47%), Gaps = 16/228 (7%)
Query: 161 IGEGGRGHVYKAR-FNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCI 219
           IG+G  G VY A         A+++++      +    NE+  + + ++ NI++ L   +
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 220 HAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAV---DVARGLEYLHEHCNHPV 276
             +  ++V E +  GSL       T     T     +IA    +  + LE+LH   ++ V
Sbjct: 89  VGDELWVVMEYLAGGSL-------TDVVTETCMDEGQIAAVCRECLQALEFLH---SNQV 138
Query: 277 VHRDLKSSNILLDSSFNAKLSDFGLSVT-AGTQSRNVKISGTLGYVAPEYLLEGKLTDKS 335
           +HR++KS NILL    + KL+DFG        QS+   + GT  ++APE +       K 
Sbjct: 139 IHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 198
Query: 336 DVYAFGVVLLELLMGRRPVEKMSPTQCQSMV-TWAMPQLTDRSKLPNI 382
           D+++ G++ +E++ G  P    +P +   ++ T   P+L +  KL  I
Sbjct: 199 DIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI 246

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 98/204 (48%), Gaps = 22/204 (10%)
Query: 161 IGEGGRGHVYKARFN-EKLLAAVKRIDDAGHD--AEREFNNEVNWLTKIRHQNIISLLGY 217
           IGEG  G V  A  N  K+  A+++I    H    +R    E+  L + RH+NII     
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLR-EIKILLRFRHENIIG---- 89
Query: 218 CIHAETRFLVYEMMQN-----GSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
            I+   R    E M++       +E  L+      +L+          + RGL+Y+H   
Sbjct: 90  -INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH--- 145
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN----VKISGTLGYVAPEYLLE 328
           +  V+HRDLK SN+LL+++ + K+ DFGL+  A     +     +   T  Y APE +L 
Sbjct: 146 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 329 GKLTDKS-DVYAFGVVLLELLMGR 351
            K   KS D+++ G +L E+L  R
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 104/205 (50%), Gaps = 15/205 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDD-AGHDAEREFNNEVNWLTKI 206
              ++  V+G G  G V+K  +     + K+   +K I+D +G  + +   + +  +  +
Sbjct: 13  TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
            H +I+ LLG C  +  + LV + +  GSL    H   H   L   L +   V +A+G+ 
Sbjct: 73  DHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLD--HVRQHRGALGPQLLLNWGVQIAKGMY 129
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT---LGYVAP 323
           YL EH    +VHR+L + N+LL S    +++DFG++       + +  S     + ++A 
Sbjct: 130 YLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 186
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL 348
           E +  GK T +SDV+++GV + EL+
Sbjct: 187 ESIHFGKYTHQSDVWSYGVTVWELM 211

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 17/211 (8%)
Query: 191 DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLT 250
           D   +   E+  L   RH +II L          F+V E +  G L   +    HG    
Sbjct: 53  DVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYI--CKHGRVEE 110
Query: 251 WHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR 310
              R ++   +   ++Y H H    VVHRDLK  N+LLD+  NAK++DFGLS        
Sbjct: 111 MEAR-RLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 166
Query: 311 NVKISGTLGYVAPEYLLEGKLT--DKSDVYAFGVVLLELLMGRRPV-EKMSPTQCQSMV- 366
                G+  Y APE ++ G+L    + D+++ GV+L  LL G  P  ++  PT  + +  
Sbjct: 167 LRDSCGSPNYAAPE-VISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRG 225
Query: 367 -TWAMPQLTDRSKLPNI-----VDPVIRDTM 391
             + +P+  +RS    +     VDP+ R T+
Sbjct: 226 GVFYIPEYLNRSVATLLMHMLQVDPLKRATI 256

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 75/290 (25%), Positives = 122/290 (42%), Gaps = 47/290 (16%)
Query: 161 IGEGGRGHVYKA------RFNEKLLAAVKRIDD-AGHDAEREFNNEVNWLTKIRHQ-NII 212
           +G G  G V +A      +       AVK + + A H   R   +E+  L  I H  N++
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 213 SLLGYCIHAETRFLV-YEMMQNGSLEKQLHGPT-----------HGSNLTWHLRMKIAVD 260
           +LLG C       +V  E  + G+L   L               +   LT    +  +  
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 261 VARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--- 317
           VA+G+E+L    +   +HRDL + NILL      K+ DFGL+         V+       
Sbjct: 157 VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 213
Query: 318 LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVE--KMSPTQCQSMVTWAMPQLT 374
           L ++APE + +   T +SDV++FGV+L E+  +G  P    K+    C+ +      +  
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL------KEG 267
Query: 375 DRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
            R + P+   P +  TM            + C   EPS RP  ++++  L
Sbjct: 268 TRMRAPDYTTPEMYQTM------------LDCWHGEPSQRPTFSELVEHL 305

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 99/205 (48%), Gaps = 24/205 (11%)
Query: 161 IGEGGRGHVYKARFN-EKLLAAVKRIDDAGHD--AEREFNNEVNWLTKIRHQNIISLLGY 217
           IGEG  G V  A  N  K+  A+K+I    H    +R    E+  L   RH+NII +   
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLAFRHENIIGI-ND 90
Query: 218 CIHAET------RFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
            I A T       ++V ++M     E  L+      +L+          + RGL+Y+H  
Sbjct: 91  IIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH-- 143
Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN----VKISGTLGYVAPEYLL 327
            +  V+HRDLK SN+LL+++ + K+ DFGL+  A     +     +   T  Y APE +L
Sbjct: 144 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 328 EGKLTDKS-DVYAFGVVLLELLMGR 351
             K   KS D+++ G +L E+L  R
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 17/211 (8%)
Query: 191 DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLT 250
           D   +   E+  L   RH +II L          F+V E +  G L   +    HG    
Sbjct: 53  DVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYI--CKHGRVEE 110
Query: 251 WHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR 310
              R ++   +   ++Y H H    VVHRDLK  N+LLD+  NAK++DFGLS        
Sbjct: 111 MEAR-RLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 166
Query: 311 NVKISGTLGYVAPEYLLEGKLT--DKSDVYAFGVVLLELLMGRRPV-EKMSPTQCQSMV- 366
                G+  Y APE ++ G+L    + D+++ GV+L  LL G  P  ++  PT  + +  
Sbjct: 167 LRTSCGSPNYAAPE-VISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRG 225
Query: 367 -TWAMPQLTDRSKLPNI-----VDPVIRDTM 391
             + +P+  +RS    +     VDP+ R T+
Sbjct: 226 GVFYIPEYLNRSVATLLMHMLQVDPLKRATI 256

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 101/222 (45%), Gaps = 31/222 (13%)
Query: 153 NNFQESNVIGEGG----RGHVYKARFNEKLLAAVKRIDDAG---HDAE-----REFN-NE 199
            N++   ++G G     R  ++K    E    AVK ID  G     AE     RE    E
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKE---YAVKIIDVTGGGSFSAEEVQELREATLKE 73
Query: 200 VNWLTKIR-HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIA 258
           V+ L K+  H NII L          FLV+++M+ G L   L      S       M+  
Sbjct: 74  VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 133
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTL 318
           ++V   L  L+      +VHRDLK  NILLD   N KL+DFG S       +  ++ GT 
Sbjct: 134 LEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTP 187
Query: 319 GYVAPEYLLEGKLTD-------KSDVYAFGVVLLELLMGRRP 353
            Y+APE ++E  + D       + D+++ GV++  LL G  P
Sbjct: 188 SYLAPE-IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 77/167 (46%), Gaps = 9/167 (5%)
Query: 191 DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLT 250
           D   +   E+  L   RH +II L          F+V E +  G L   +        L 
Sbjct: 58  DVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYI---CKNGRLD 114
Query: 251 WHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR 310
                ++   +  G++Y H H    VVHRDLK  N+LLD+  NAK++DFGLS        
Sbjct: 115 EKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 171
Query: 311 NVKISGTLGYVAPEYLLEGKLT--DKSDVYAFGVVLLELLMGRRPVE 355
                G+  Y APE ++ G+L    + D+++ GV+L  LL G  P +
Sbjct: 172 LRXSCGSPNYAAPE-VISGRLYAGPEVDIWSSGVILYALLCGTLPFD 217

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 123/288 (42%), Gaps = 45/288 (15%)
Query: 161 IGEGGRGHVYKA------RFNEKLLAAVKRIDD-AGHDAEREFNNEVNWLTKIRHQ-NII 212
           +G G  G V +A      +       AVK + + A H   R   +E+  L  I H  N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 213 SLLGYCIHAETRFLV-YEMMQNGSLEKQL---------HGPTHGSNLTWHLRMKIAVDVA 262
           +LLG C       +V  E  + G+L   L         +   +   LT    +  +  VA
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVA 154
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT---LG 319
           +G+E+L    +   +HRDL + NILL      K+ DFGL+         V+       L 
Sbjct: 155 KGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 320 YVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVE--KMSPTQCQSMVTWAMPQLTDR 376
           ++APE + +   T +SDV++FGV+L E+  +G  P    K+    C+ +      +   R
Sbjct: 212 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL------KEGTR 265
Query: 377 SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
            + P+   P +  TM            + C   EPS RP  ++++  L
Sbjct: 266 MRAPDYTTPEMYQTM------------LDCWHGEPSQRPTFSELVEHL 301

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 90/205 (43%), Gaps = 21/205 (10%)
Query: 159 NVIGEGGRGHVYKA--RFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLG 216
           +V+G G    V  A  +  +KL+A       A    E    NE+  L KI+H NI++L  
Sbjct: 24  DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 83
Query: 217 YCIHAETRFLVYEMMQNGSL-----EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
                   +L+ +++  G L     EK  +     S L +         V   ++YLH  
Sbjct: 84  IYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQ--------VLDAVKYLH-- 133
Query: 272 CNHPVVHRDLKSSNIL---LDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLE 328
            +  +VHRDLK  N+L   LD      +SDFGLS      S      GT GYVAPE L +
Sbjct: 134 -DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ 192
Query: 329 GKLTDKSDVYAFGVVLLELLMGRRP 353
              +   D ++ GV+   LL G  P
Sbjct: 193 KPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 107/230 (46%), Gaps = 29/230 (12%)
Query: 158 SNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGY 217
             +IG+G  G VY  R++ ++   +  I+    D  + F  EV    + RH+N++  +G 
Sbjct: 38  GELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97
Query: 218 CIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLR--MKIAVDVARGLEYLHEHCNHP 275
           C+      ++  + +     + L+     + +   +    +IA ++ +G+ YLH      
Sbjct: 98  CMSPPHLAIITSLCKG----RTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG--- 150
Query: 276 VVHRDLKSSNILLDSSFNAKLSDFGL-----SVTAGTQSRNVKI-SGTLGYVAPEYLL-- 327
           ++H+DLKS N+  D+     ++DFGL      + AG +   ++I +G L ++APE +   
Sbjct: 151 ILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209
Query: 328 -----EGKL--TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAM 370
                E KL  +  SDV+A G +  EL     P +    TQ    + W M
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK----TQPAEAIIWQM 255

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 104/205 (50%), Gaps = 15/205 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDD-AGHDAEREFNNEVNWLTKI 206
              ++  V+G G  G V+K  +     + K+   +K I+D +G  + +   + +  +  +
Sbjct: 31  TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 90
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
            H +I+ LLG C  +  + LV + +  GSL    H   H   L   L +   V +A+G+ 
Sbjct: 91  DHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLD--HVRQHRGALGPQLLLNWGVQIAKGMY 147
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT---LGYVAP 323
           YL EH    +VHR+L + N+LL S    +++DFG++       + +  S     + ++A 
Sbjct: 148 YLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 204
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL 348
           E +  GK T +SDV+++GV + EL+
Sbjct: 205 ESIHFGKYTHQSDVWSYGVTVWELM 229

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/269 (26%), Positives = 117/269 (43%), Gaps = 27/269 (10%)
Query: 161 IGEGGRG--HVYKARFNEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNIISLLGY 217
           +G G  G  H+ + R +  L   +K I+ D       +   E+  L  + H NII +   
Sbjct: 30  LGSGAFGDVHLVEER-SSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 218 CIHAETRFLVYEMMQNGSL-EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPV 276
                  ++V E  + G L E+ +     G  L+     ++   +   L Y H   +  V
Sbjct: 89  FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHV 145
Query: 277 VHRDLKSSNILL-DSSFNA--KLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTD 333
           VH+DLK  NIL  D+S ++  K+ DFGL+    +   +   +GT  Y+APE + +  +T 
Sbjct: 146 VHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPE-VFKRDVTF 204
Query: 334 KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDL 393
           K D+++ GVV+  LL G  P    S  + Q   T+  P      +      P+    +DL
Sbjct: 205 KCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECR------PLTPQAVDL 258
Query: 394 KHLYQVAAVAVLCIQPEPSYRPLITDVLH 422
             L Q+       +  +P  RP    VLH
Sbjct: 259 --LKQM-------LTKDPERRPSAAQVLH 278

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 98/204 (48%), Gaps = 14/204 (6%)
Query: 160 VIGEGGRGHVYKARF----NEKLLAAVKRIDDAGHDAERE-FNNEVNWLTKIRHQNIISL 214
            IGEG  G V++  +    N  L  A+K   +   D+ RE F  E   + +  H +I+ L
Sbjct: 17  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 76
Query: 215 LGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNH 274
           +G  I     +++ E+   G L   L    +  +L     +  A  ++  L YL    + 
Sbjct: 77  IGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLA--SLILYAYQLSTALAYLE---SK 130
Query: 275 PVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLT 332
             VHRD+ + N+L+ S+   KL DFGLS  +   T  +  K    + ++APE +   + T
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 333 DKSDVYAFGVVLLELLM-GRRPVE 355
             SDV+ FGV + E+LM G +P +
Sbjct: 191 SASDVWMFGVCMWEILMHGVKPFQ 214

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 100/222 (45%), Gaps = 31/222 (13%)
Query: 153 NNFQESNVIGEGG----RGHVYKARFNEKLLAAVKRIDDAG---HDAE-----REFN-NE 199
            N++   ++G G     R  ++K    E    AVK ID  G     AE     RE    E
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKE---YAVKIIDVTGGGSFSAEEVQELREATLKE 73
Query: 200 VNWLTKIR-HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIA 258
           V+ L K+  H NII L          FLV+++M+ G L   L      S       M+  
Sbjct: 74  VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 133
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTL 318
           ++V   L  L+      +VHRDLK  NILLD   N KL+DFG S       +   + GT 
Sbjct: 134 LEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSVCGTP 187
Query: 319 GYVAPEYLLEGKLTD-------KSDVYAFGVVLLELLMGRRP 353
            Y+APE ++E  + D       + D+++ GV++  LL G  P
Sbjct: 188 SYLAPE-IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 98/204 (48%), Gaps = 14/204 (6%)
Query: 160 VIGEGGRGHVYKARF----NEKLLAAVKRIDDAGHDAERE-FNNEVNWLTKIRHQNIISL 214
            IGEG  G V++  +    N  L  A+K   +   D+ RE F  E   + +  H +I+ L
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 215 LGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNH 274
           +G  I     +++ E+   G L   L    +  +L     +  A  ++  L YL    + 
Sbjct: 74  IGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLA--SLILYAYQLSTALAYLE---SK 127
Query: 275 PVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLT 332
             VHRD+ + N+L+ S+   KL DFGLS  +   T  +  K    + ++APE +   + T
Sbjct: 128 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 187
Query: 333 DKSDVYAFGVVLLELLM-GRRPVE 355
             SDV+ FGV + E+LM G +P +
Sbjct: 188 SASDVWMFGVCMWEILMHGVKPFQ 211

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 98/204 (48%), Gaps = 14/204 (6%)
Query: 160 VIGEGGRGHVYKARF----NEKLLAAVKRIDDAGHDAERE-FNNEVNWLTKIRHQNIISL 214
            IGEG  G V++  +    N  L  A+K   +   D+ RE F  E   + +  H +I+ L
Sbjct: 45  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 104
Query: 215 LGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNH 274
           +G  I     +++ E+   G L   L    +  +L     +  A  ++  L YL    + 
Sbjct: 105 IG-VITENPVWIIMELCTLGELRSFLQVRKYSLDLA--SLILYAYQLSTALAYLE---SK 158
Query: 275 PVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLT 332
             VHRD+ + N+L+ S+   KL DFGLS  +   T  +  K    + ++APE +   + T
Sbjct: 159 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 218
Query: 333 DKSDVYAFGVVLLELLM-GRRPVE 355
             SDV+ FGV + E+LM G +P +
Sbjct: 219 SASDVWMFGVCMWEILMHGVKPFQ 242

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 13/206 (6%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK-LLAAVKRI--DDAGHDAEREFNNEVNWLTKIRHQNI 211
           +++   IGEG  G V+KA+  E   + A+KR+  DD           E+  L +++H+NI
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 212 ISLLGYCIHAETRF-LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHE 270
           + L    +H++ +  LV+E   +  L+K     +   +L   +       + +GL + H 
Sbjct: 64  VRLHD-VLHSDKKLTLVFEFC-DQDLKKYFD--SCNGDLDPEIVKSFLFQLLKGLGFCH- 118
Query: 271 HCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPEYLLEG 329
             +  V+HRDLK  N+L++ +   KL+DFGL+   G   R       TL Y  P+ L   
Sbjct: 119 --SRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 330 KLTDKS-DVYAFGVVLLELLMGRRPV 354
           KL   S D+++ G +  EL    RP+
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAARPL 202

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 99/205 (48%), Gaps = 24/205 (11%)
Query: 161 IGEGGRGHVYKARFN-EKLLAAVKRIDDAGHD--AEREFNNEVNWLTKIRHQNIISLLGY 217
           IGEG  G V  A  N  K+  A+K+I    H    +R    E+  L   RH+NII +   
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLAFRHENIIGI-ND 90
Query: 218 CIHAET------RFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
            I A T       ++V ++M     E  L+      +L+          + RGL+Y+H  
Sbjct: 91  IIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH-- 143
Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN----VKISGTLGYVAPEYLL 327
            +  V+HRDLK SN+LL+++ + K+ DFGL+  A     +     +   T  Y APE +L
Sbjct: 144 -SANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 328 EGKLTDKS-DVYAFGVVLLELLMGR 351
             K   KS D+++ G +L E+L  R
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 93/213 (43%), Gaps = 16/213 (7%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNEK-LLAAVK--RIDDAGHDAEREFN-NEVNWLTKI 206
             +NF+   V+G+G  G V  AR  E   L AVK  + D    D + E    E   L+  
Sbjct: 21  GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLA 80
Query: 207 RHQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
           R+   ++ L  C     R F V E +  G L   +                 A ++   L
Sbjct: 81  RNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF---YAAEIISAL 137
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGL---SVTAGTQSRNVKISGTLGYVA 322
            +LH   +  +++RDLK  N+LLD   + KL+DFG+    +  G  +      GT  Y+A
Sbjct: 138 MFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTT--ATFCGTPDYIA 192
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVE 355
           PE L E       D +A GV+L E+L G  P E
Sbjct: 193 PEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFE 225

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 98/204 (48%), Gaps = 14/204 (6%)
Query: 160 VIGEGGRGHVYKARF----NEKLLAAVKRIDDAGHDAERE-FNNEVNWLTKIRHQNIISL 214
            IGEG  G V++  +    N  L  A+K   +   D+ RE F  E   + +  H +I+ L
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 215 LGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNH 274
           +G  I     +++ E+   G L   L    +  +L     +  A  ++  L YL    + 
Sbjct: 82  IGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLA--SLILYAYQLSTALAYLE---SK 135
Query: 275 PVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLT 332
             VHRD+ + N+L+ S+   KL DFGLS  +   T  +  K    + ++APE +   + T
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 195
Query: 333 DKSDVYAFGVVLLELLM-GRRPVE 355
             SDV+ FGV + E+LM G +P +
Sbjct: 196 SASDVWMFGVCMWEILMHGVKPFQ 219

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 160 VIGEGGRGHVY--KARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGY 217
           V+G G    V+  K R   KL A +K I  +    +    NE+  L KI+H+NI++L   
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFA-LKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74
Query: 218 CIHAETRFLVYEMMQNGSL-----EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
                  +LV +++  G L     E+ ++     S         +   V   ++YLHE+ 
Sbjct: 75  YESTTHYYLVMQLVSGGELFDRILERGVYTEKDAS--------LVIQQVLSAVKYLHEN- 125
Query: 273 NHPVVHRDLKSSNIL-LDSSFNAKL--SDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEG 329
              +VHRDLK  N+L L    N+K+  +DFGLS        +    GT GYVAPE L + 
Sbjct: 126 --GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTA-CGTPGYVAPEVLAQK 182
Query: 330 KLTDKSDVYAFGVVLLELLMGRRP 353
             +   D ++ GV+   LL G  P
Sbjct: 183 PYSKAVDCWSIGVITYILLCGYPP 206

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 98/210 (46%), Gaps = 18/210 (8%)
Query: 154 NFQESNVIGEGGRGHVYKARFNEK----LLAAVKR----IDDAGHDAEREFNNEVNWLTK 205
           +F+   ++G+G  G V+ A F +      + A+K+    +DD   D E     +      
Sbjct: 19  DFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDD---DVECTMVEKRVLSLA 75
Query: 206 IRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
             H  +  +       E  F V E +  G L   +    H  +L+       A ++  GL
Sbjct: 76  WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS-CHKFDLS--RATFYAAEIILGL 132
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT-QSRNVKISGTLGYVAPE 324
           ++LH   +  +V+RDLK  NILLD   + K++DFG+        ++  +  GT  Y+APE
Sbjct: 133 QFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPE 189
Query: 325 YLLEGKLTDKSDVYAFGVVLLELLMGRRPV 354
            LL  K     D ++FGV+L E+L+G+ P 
Sbjct: 190 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 219

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 98/204 (48%), Gaps = 14/204 (6%)
Query: 160 VIGEGGRGHVYKARF----NEKLLAAVKRIDDAGHDAERE-FNNEVNWLTKIRHQNIISL 214
            IGEG  G V++  +    N  L  A+K   +   D+ RE F  E   + +  H +I+ L
Sbjct: 19  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 78
Query: 215 LGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNH 274
           +G  I     +++ E+   G L   L    +  +L     +  A  ++  L YL    + 
Sbjct: 79  IGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLA--SLILYAYQLSTALAYLE---SK 132
Query: 275 PVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLT 332
             VHRD+ + N+L+ S+   KL DFGLS  +   T  +  K    + ++APE +   + T
Sbjct: 133 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 192
Query: 333 DKSDVYAFGVVLLELLM-GRRPVE 355
             SDV+ FGV + E+LM G +P +
Sbjct: 193 SASDVWMFGVCMWEILMHGVKPFQ 216

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 103/210 (49%), Gaps = 13/210 (6%)
Query: 150 AATNNFQESNVIGEGGRGHVYKA-RFNEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIR 207
           ++++ F++   +G G    VYK       +  A+K +  D+          E++ + +++
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61
Query: 208 HQNIISLLGYCIHAETRF-LVYEMMQNGSLEKQLHGPTHGSN---LTWHLRMKIAVDVAR 263
           H+NI+ L    IH E +  LV+E M N  L+K +   T G+    L  +L       + +
Sbjct: 62  HENIVRLYD-VIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVA 322
           GL + HE+    ++HRDLK  N+L++     KL DFGL+   G           TL Y A
Sbjct: 120 GLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRA 176
Query: 323 PEYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           P+ L+  +    S D+++ G +L E++ G+
Sbjct: 177 PDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 74/291 (25%), Positives = 121/291 (41%), Gaps = 48/291 (16%)
Query: 161 IGEGGRGHVYKA-RFNEKLLAAVKRI------DDAGHDAEREFNNEVNWLTKIRHQ-NII 212
           +G G  G V +A  F     A  + +      + A H   R   +E+  L  I H  N++
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 213 SLLGYCIHAETRFLV-YEMMQNGSLEKQLHGPT------------HGSNLTWHLRMKIAV 259
           +LLG C       +V  E  + G+L   L                +   LT    +  + 
Sbjct: 96  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSF 155
Query: 260 DVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT-- 317
            VA+G+E+L    +   +HRDL + NILL      K+ DFGL+         V+      
Sbjct: 156 QVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 318 -LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVE--KMSPTQCQSMVTWAMPQL 373
            L ++APE + +   T +SDV++FGV+L E+  +G  P    K+    C+ +      + 
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL------KE 266
Query: 374 TDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
             R + P+   P +  TM            + C   EPS RP  ++++  L
Sbjct: 267 GTRMRAPDYTTPEMYQTM------------LDCWHGEPSQRPTFSELVEHL 305

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/152 (32%), Positives = 74/152 (48%), Gaps = 12/152 (7%)
Query: 208 HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEY 267
           H +II+L+     +   FLV+++M+ G L   L   T    L+      I   +   + +
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYL---TEKVALSEKETRSIMRSLLEAVSF 215
Query: 268 LHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYL- 326
           LH +    +VHRDLK  NILLD +   +LSDFG S       +  ++ GT GY+APE L 
Sbjct: 216 LHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILK 272
Query: 327 -----LEGKLTDKSDVYAFGVVLLELLMGRRP 353
                       + D++A GV+L  LL G  P
Sbjct: 273 CSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 98/204 (48%), Gaps = 14/204 (6%)
Query: 160 VIGEGGRGHVYKARF----NEKLLAAVKRIDDAGHDAERE-FNNEVNWLTKIRHQNIISL 214
            IGEG  G V++  +    N  L  A+K   +   D+ RE F  E   + +  H +I+ L
Sbjct: 20  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 79
Query: 215 LGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNH 274
           +G  I     +++ E+   G L   L    +  +L     +  A  ++  L YL    + 
Sbjct: 80  IGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLA--SLILYAYQLSTALAYLE---SK 133
Query: 275 PVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLT 332
             VHRD+ + N+L+ S+   KL DFGLS  +   T  +  K    + ++APE +   + T
Sbjct: 134 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 193
Query: 333 DKSDVYAFGVVLLELLM-GRRPVE 355
             SDV+ FGV + E+LM G +P +
Sbjct: 194 SASDVWMFGVCMWEILMHGVKPFQ 217

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 14/204 (6%)
Query: 160 VIGEGGRGHVYKARF----NEKLLAAVKRIDDAGHDAERE-FNNEVNWLTKIRHQNIISL 214
            IGEG  G V++  +    N  +  A+K   +   D+ RE F  E   + +  H +I+ L
Sbjct: 17  CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 76
Query: 215 LGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNH 274
           +G  I     +++ E+   G L   L    +  +L     +  A  ++  L YL    + 
Sbjct: 77  IGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLA--SLILYAYQLSTALAYLE---SK 130
Query: 275 PVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLT 332
             VHRD+ + N+L+ S+   KL DFGLS  +   T  +  K    + ++APE +   + T
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 333 DKSDVYAFGVVLLELLM-GRRPVE 355
             SDV+ FGV + E+LM G +P +
Sbjct: 191 SASDVWMFGVCMWEILMHGVKPFQ 214

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 121/292 (41%), Gaps = 49/292 (16%)
Query: 161 IGEGGRGHVYKA-RFNEKLLAAVKRI------DDAGHDAEREFNNEVNWLTKIRHQ-NII 212
           +G G  G V +A  F     A  + +      + A H   R   +E+  L  I H  N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 213 SLLGYCIHAETRFLV-YEMMQNGSLEKQLHGPT-------------HGSNLTWHLRMKIA 258
           +LLG C       +V  E  + G+L   L                 +   LT    +  +
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT- 317
             VA+G+E+L    +   +HRDL + NILL      K+ DFGL+         V+     
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 318 --LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVE--KMSPTQCQSMVTWAMPQ 372
             L ++APE + +   T +SDV++FGV+L E+  +G  P    K+    C+ +      +
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL------K 256
Query: 373 LTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
              R + P+   P +  TM            + C   EPS RP  ++++  L
Sbjct: 257 EGTRMRAPDYTTPEMYQTM------------LDCWHGEPSQRPTFSELVEHL 296

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 121/292 (41%), Gaps = 49/292 (16%)
Query: 161 IGEGGRGHVYKA-RFNEKLLAAVKRI------DDAGHDAEREFNNEVNWLTKIRHQ-NII 212
           +G G  G V +A  F     A  + +      + A H   R   +E+  L  I H  N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 213 SLLGYCIHAETRFLVY-EMMQNGSLEKQLHGPT-------------HGSNLTWHLRMKIA 258
           +LLG C       +V  E  + G+L   L                 +   LT    +  +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT- 317
             VA+G+E+L    +   +HRDL + NILL      K+ DFGL+         V+     
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 318 --LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVE--KMSPTQCQSMVTWAMPQ 372
             L ++APE + +   T +SDV++FGV+L E+  +G  P    K+    C+ +      +
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL------K 256
Query: 373 LTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
              R + P+   P +  TM            + C   EPS RP  ++++  L
Sbjct: 257 EGTRMRAPDYTTPEMYQTM------------LDCWHGEPSQRPTFSELVEHL 296

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 97/204 (47%), Gaps = 14/204 (6%)
Query: 160 VIGEGGRGHVYKARF----NEKLLAAVKRIDDAGHDAERE-FNNEVNWLTKIRHQNIISL 214
            IGEG  G V++  +    N  +  A+K   +   D+ RE F  E   + +  H +I+ L
Sbjct: 17  CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 76
Query: 215 LGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNH 274
           +G  I     +++ E+   G L   L       +L     +  A  ++  L YL    + 
Sbjct: 77  IGV-ITENPVWIIMELCTLGELRSFLQ--VRKFSLDLASLILYAYQLSTALAYLE---SK 130
Query: 275 PVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLT 332
             VHRD+ + N+L+ S+   KL DFGLS  +   T  +  K    + ++APE +   + T
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESINFRRFT 190
Query: 333 DKSDVYAFGVVLLELLM-GRRPVE 355
             SDV+ FGV + E+LM G +P +
Sbjct: 191 SASDVWMFGVCMWEILMHGVKPFQ 214

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 121/292 (41%), Gaps = 49/292 (16%)
Query: 161 IGEGGRGHVYKA-RFNEKLLAAVKRI------DDAGHDAEREFNNEVNWLTKIRHQ-NII 212
           +G G  G V +A  F     A  + +      + A H   R   +E+  L  I H  N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 213 SLLGYCIHAETRFLV-YEMMQNGSLEKQLHGPT-------------HGSNLTWHLRMKIA 258
           +LLG C       +V  E  + G+L   L                 +   LT    +  +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT- 317
             VA+G+E+L    +   +HRDL + NILL      K+ DFGL+         V+     
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 318 --LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVE--KMSPTQCQSMVTWAMPQ 372
             L ++APE + +   T +SDV++FGV+L E+  +G  P    K+    C+ +      +
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL------K 265
Query: 373 LTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
              R + P+   P +  TM            + C   EPS RP  ++++  L
Sbjct: 266 EGTRMRAPDYTTPEMYQTM------------LDCWHGEPSQRPTFSELVEHL 305

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 95/202 (47%), Gaps = 16/202 (7%)
Query: 161 IGEGGRGHVYKA-RFNEKLLAAVKRIDD---AGHDAEREFNNEVNWLTKIRHQNIISLLG 216
           +GEG  G V  A  +  +   A+K I        D       E+++L  +RH +II L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 217 YCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPV 276
             I   T  ++      G L   +        +T     +    +   +EY H    H +
Sbjct: 77  -VITTPTDIVMVIEYAGGELFDYI---VEKKRMTEDEGRRFFQQIICAIEYCH---RHKI 129
Query: 277 VHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPEYLLEGKLT--D 333
           VHRDLK  N+LLD + N K++DFGLS    T    +K S G+  Y APE ++ GKL    
Sbjct: 130 VHRDLKPENLLLDDNLNVKIADFGLS-NIMTDGNFLKTSCGSPNYAAPE-VINGKLYAGP 187
Query: 334 KSDVYAFGVVLLELLMGRRPVE 355
           + DV++ G+VL  +L+GR P +
Sbjct: 188 EVDVWSCGIVLYVMLVGRLPFD 209

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 78/261 (29%), Positives = 125/261 (47%), Gaps = 54/261 (20%)
Query: 135 GKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKA---RFNEKLLAAVKRIDDA--- 188
           G+ D   + +YEL++           +G+G  G V+K+   R  E  + AVK+I DA   
Sbjct: 1   GRVDRHVLRKYELVKK----------LGKGAYGIVWKSIDRRTGE--VVAVKKIFDAFQN 48
Query: 189 GHDAEREFNNEVNWLTKIR-HQNIISLLGYCIHAETR--FLVYEMMQNGSLEKQLHGPTH 245
             DA+R F  E+  LT++  H+NI++LL        R  +LV++ M     E  LH    
Sbjct: 49  STDAQRTFR-EIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM-----ETDLHAVIR 102
Query: 246 GSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--- 302
            + L    +  +   + + ++YLH   +  ++HRD+K SNILL++  + K++DFGLS   
Sbjct: 103 ANILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSF 159
Query: 303 VTAGTQSRNVKIS-------------------GTLGYVAPEYLL-EGKLTDKSDVYAFGV 342
           V     + N+ +S                    T  Y APE LL   K T   D+++ G 
Sbjct: 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGC 219
Query: 343 VLLELLMGRRPVEKMSPTQCQ 363
           +L E+L G +P+   S T  Q
Sbjct: 220 ILGEILCG-KPIFPGSSTMNQ 239

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 119/268 (44%), Gaps = 38/268 (14%)
Query: 179 LAAVKRIDD-AGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRF--LVYEMMQNGS 235
           + AVK + +  G      +  E+  L  + H++I+   G C     +   LV E +  GS
Sbjct: 40  MVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGS 99
Query: 236 LEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAK 295
           L   L  P H   L   L    A  +  G+ YLH       +HR L + N+LLD+    K
Sbjct: 100 LRDYL--PRHCVGLAQLLL--FAQQICEGMAYLH---AQHYIHRALAARNVLLDNDRLVK 152
Query: 296 LSDFGLS--VTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-- 349
           + DFGL+  V  G +   V+  G   + + APE L E K    SDV++FGV L ELL   
Sbjct: 153 IGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLTYC 212
Query: 350 --GRRPVEKMSP----TQCQSMVTWAMPQLTDR-SKLPNIVDPVIRDTMDLKHLYQVAAV 402
              + P  K +     TQ Q M    + +L +R  +LP       R   ++ HL +    
Sbjct: 213 DSNQSPHTKFTELIGHTQGQ-MTVLRLTELLERGERLPR----PDRCPCEIYHLMKN--- 264
Query: 403 AVLCIQPEPSYRPLITDVLHSLIPLVPT 430
              C + E S+RP       +L+P++ T
Sbjct: 265 ---CWETEASFRP----TFQNLVPILQT 285

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 121/292 (41%), Gaps = 49/292 (16%)
Query: 161 IGEGGRGHVYKA-RFNEKLLAAVKRI------DDAGHDAEREFNNEVNWLTKIRHQ-NII 212
           +G G  G V +A  F     A  + +      + A H   R   +E+  L  I H  N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 213 SLLGYCIHAETRFLV-YEMMQNGSLEKQLHGPT-------------HGSNLTWHLRMKIA 258
           +LLG C       +V  E  + G+L   L                 +   LT    +  +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT- 317
             VA+G+E+L    +   +HRDL + NILL      K+ DFGL+         V+     
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDAR 211
Query: 318 --LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVE--KMSPTQCQSMVTWAMPQ 372
             L ++APE + +   T +SDV++FGV+L E+  +G  P    K+    C+ +      +
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL------K 265
Query: 373 LTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
              R + P+   P +  TM            + C   EPS RP  ++++  L
Sbjct: 266 EGTRMRAPDYTTPEMYQTM------------LDCWHGEPSQRPTFSELVEHL 305

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 103/225 (45%), Gaps = 34/225 (15%)
Query: 152 TNNFQESNVIGEGGRGHVYKARFNEK-LLAAVKRID--DAGHDAEREFNNEVNWLTKIRH 208
           +++FQ  +++GEG  G V  A       + A+K+I+  D    A R    E+  L   +H
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKH 68
Query: 209 QNIISLLGYCIHAETRF-------LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDV 261
           +NII++    I     F       ++ E+MQ       LH       L+           
Sbjct: 69  ENIITIFN--IQRPDSFENFNEVYIIQELMQT-----DLHRVISTQMLSDDHIQYFIYQT 121
Query: 262 ARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGL-----------SVTAGTQSR 310
            R ++ LH      V+HRDLK SN+L++S+ + K+ DFGL           S   G QS 
Sbjct: 122 LRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 311 NVKISGTLGYVAPEYLL-EGKLTDKSDVYAFGVVLLELLMGRRPV 354
            V+   T  Y APE +L   K +   DV++ G +L EL + RRP+
Sbjct: 179 MVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPI 222

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 119/268 (44%), Gaps = 38/268 (14%)
Query: 179 LAAVKRIDD-AGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRF--LVYEMMQNGS 235
           + AVK + +  G      +  E+  L  + H++I+   G C     +   LV E +  GS
Sbjct: 39  MVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGS 98
Query: 236 LEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAK 295
           L   L  P H   L   L    A  +  G+ YLH       +HR L + N+LLD+    K
Sbjct: 99  LRDYL--PRHCVGLAQLLL--FAQQICEGMAYLH---AQHYIHRALAARNVLLDNDRLVK 151
Query: 296 LSDFGLS--VTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-- 349
           + DFGL+  V  G +   V+  G   + + APE L E K    SDV++FGV L ELL   
Sbjct: 152 IGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLTYC 211
Query: 350 --GRRPVEKMSP----TQCQSMVTWAMPQLTDR-SKLPNIVDPVIRDTMDLKHLYQVAAV 402
              + P  K +     TQ Q M    + +L +R  +LP       R   ++ HL +    
Sbjct: 212 DSNQSPHTKFTELIGHTQGQ-MTVLRLTELLERGERLPR----PDRCPCEIYHLMKN--- 263
Query: 403 AVLCIQPEPSYRPLITDVLHSLIPLVPT 430
              C + E S+RP       +L+P++ T
Sbjct: 264 ---CWETEASFRP----TFQNLVPILQT 284

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 121/292 (41%), Gaps = 49/292 (16%)
Query: 161 IGEGGRGHVYKA-RFNEKLLAAVKRI------DDAGHDAEREFNNEVNWLTKIRHQ-NII 212
           +G G  G V +A  F     A  + +      + A H   R   +E+  L  I H  N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 213 SLLGYCIHAETRFLVY-EMMQNGSLEKQLHGPT-------------HGSNLTWHLRMKIA 258
           +LLG C       +V  E  + G+L   L                 +   LT    +  +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT- 317
             VA+G+E+L    +   +HRDL + NILL      K+ DFGL+         V+     
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 318 --LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVE--KMSPTQCQSMVTWAMPQ 372
             L ++APE + +   T +SDV++FGV+L E+  +G  P    K+    C+ +      +
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL------K 256
Query: 373 LTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
              R + P+   P +  TM            + C   EPS RP  ++++  L
Sbjct: 257 EGTRMRAPDYTTPEMYQTM------------LDCWHGEPSQRPTFSELVEHL 296

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 100/217 (46%), Gaps = 32/217 (14%)
Query: 160 VIGEGGRGHVYKARFNEKLLAA--VKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGY 217
            +G+G  G V++  ++ + +A       D+     E E  N V     +RH NI+  +  
Sbjct: 15  CVGKGRYGEVWRGLWHGESVAVKIFSSRDEQSWFRETEIYNTV----LLRHDNILGFIAS 70
Query: 218 CIHAETR----FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLH---- 269
            + +       +L+    ++GSL   L   T    L  HL +++AV  A GL +LH    
Sbjct: 71  DMTSRNSSTQLWLITHYHEHGSLYDFLQRQT----LEPHLALRLAVSAACGLAHLHVEIF 126
Query: 270 -EHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-----GTLGYVAP 323
                  + HRD KS N+L+ S+    ++D GL+V     S  + I      GT  Y+AP
Sbjct: 127 GTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAP 186
Query: 324 EYLLEGKLTDK------SDVYAFGVVLLELLMGRRPV 354
           E L E   TD       +D++AFG+VL E+   RR +
Sbjct: 187 EVLDEQIRTDCFESYKWTDIWAFGLVLWEI--ARRTI 221

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 103/213 (48%), Gaps = 16/213 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRI-DDAGHDAEREFNNEVNWLTKI 206
              ++  V+G G  G VYK  +     N K+  A+K + ++    A +E  +E   +  +
Sbjct: 17  TELRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGV 76
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
               +  LLG C+ +  + LV ++M  G L    H   +   L     +   + +A+G+ 
Sbjct: 77  GSPYVSRLLGICLTSTVQ-LVTQLMPYGCLLD--HVRENRGRLGSQDLLNWCMQIAKGMS 133
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAP 323
           YL    +  +VHRDL + N+L+ S  + K++DFGL+             G    + ++A 
Sbjct: 134 YLE---DVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMAL 190
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVE 355
           E +L  + T +SDV+++GV + EL+  G +P +
Sbjct: 191 ESILRRRFTHQSDVWSYGVTVWELMTFGAKPYD 223

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 121/292 (41%), Gaps = 49/292 (16%)
Query: 161 IGEGGRGHVYKA-RFNEKLLAAVKRI------DDAGHDAEREFNNEVNWLTKIRHQ-NII 212
           +G G  G V +A  F     A  + +      + A H   R   +E+  L  I H  N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 213 SLLGYCIHAETRFLV-YEMMQNGSLEKQLHGPT-------------HGSNLTWHLRMKIA 258
           +LLG C       +V  E  + G+L   L                 +   LT    +  +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT- 317
             VA+G+E+L    +   +HRDL + NILL      K+ DFGL+         V+     
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211
Query: 318 --LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVE--KMSPTQCQSMVTWAMPQ 372
             L ++APE + +   T +SDV++FGV+L E+  +G  P    K+    C+ +      +
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL------K 265
Query: 373 LTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
              R + P+   P +  TM            + C   EPS RP  ++++  L
Sbjct: 266 EGTRMRAPDYTTPEMYQTM------------LDCWHGEPSQRPTFSELVEHL 305

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 121/292 (41%), Gaps = 49/292 (16%)
Query: 161 IGEGGRGHVYKA-RFNEKLLAAVKRI------DDAGHDAEREFNNEVNWLTKIRHQ-NII 212
           +G G  G V +A  F     A  + +      + A H   R   +E+  L  I H  N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 213 SLLGYCIHAETRFLVY-EMMQNGSLEKQLHGPT-------------HGSNLTWHLRMKIA 258
           +LLG C       +V  E  + G+L   L                 +   LT    +  +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT- 317
             VA+G+E+L    +   +HRDL + NILL      K+ DFGL+         V+     
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 318 --LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVE--KMSPTQCQSMVTWAMPQ 372
             L ++APE + +   T +SDV++FGV+L E+  +G  P    K+    C+ +      +
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL------K 256
Query: 373 LTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
              R + P+   P +  TM            + C   EPS RP  ++++  L
Sbjct: 257 EGTRMRAPDYTTPEMYQTM------------LDCWHGEPSQRPTFSELVEHL 296

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 116/280 (41%), Gaps = 38/280 (13%)
Query: 112 TIDGGKG-LSLSPILERFNSLRLAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVY 170
           + DGG G   L  +     +  L G  + V +  +ELL+          V+G G  G V+
Sbjct: 22  SADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLK----------VLGTGAYGKVF 71
Query: 171 KAR----------FNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
             R          +  K+L     +  A          E   L  IR    +  L Y   
Sbjct: 72  LVRKISGHDTGKLYAMKVLKKATIVQKA--KTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 129
Query: 221 AETRF-LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHR 279
            ET+  L+ + +  G L   L   +     T H       ++   LE+LH+     +++R
Sbjct: 130 TETKLHLILDYINGGELFTHL---SQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYR 183
Query: 280 DLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLT-DKS- 335
           D+K  NILLDS+ +  L+DFGLS    A    R     GT+ Y+AP+ +  G    DK+ 
Sbjct: 184 DIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAV 243
Query: 336 DVYAFGVVLLELLMGRRPV----EKMSPTQCQSMVTWAMP 371
           D ++ GV++ ELL G  P     EK S  +    +  + P
Sbjct: 244 DWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP 283

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 96/205 (46%), Gaps = 12/205 (5%)
Query: 155 FQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHD--AEREFNNEVNWLTKIRHQNI 211
           + +   IGEG  G V  A  +  K   A+K+I    H    +R    E+  L + RH+N+
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLR-EIQILLRFRHENV 103
Query: 212 ISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
           I +      +    +    +    +E  L+       L+          + RGL+Y+H  
Sbjct: 104 IGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIH-- 161
Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN----VKISGTLGYVAPEYLL 327
            +  V+HRDLK SN+L++++ + K+ DFGL+  A  +  +     +   T  Y APE +L
Sbjct: 162 -SANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIML 220
Query: 328 EGKLTDKS-DVYAFGVVLLELLMGR 351
             K   KS D+++ G +L E+L  R
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 121/292 (41%), Gaps = 49/292 (16%)
Query: 161 IGEGGRGHVYKA-RFNEKLLAAVKRI------DDAGHDAEREFNNEVNWLTKIRHQ-NII 212
           +G G  G V +A  F     A  + +      + A H   R   +E+  L  I H  N++
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 213 SLLGYCIHAETRFLV-YEMMQNGSLEKQLHGPT-------------HGSNLTWHLRMKIA 258
           +LLG C       +V  E  + G+L   L                 +   LT    +  +
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 191
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT- 317
             VA+G+E+L    +   +HRDL + NILL      K+ DFGL+         V+     
Sbjct: 192 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 248
Query: 318 --LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVE--KMSPTQCQSMVTWAMPQ 372
             L ++APE + +   T +SDV++FGV+L E+  +G  P    K+    C+ +      +
Sbjct: 249 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL------K 302
Query: 373 LTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
              R + P+   P +  TM            + C   EPS RP  ++++  L
Sbjct: 303 EGTRMRAPDYTTPEMYQTM------------LDCWHGEPSQRPTFSELVEHL 342

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 121/292 (41%), Gaps = 49/292 (16%)
Query: 161 IGEGGRGHVYKA-RFNEKLLAAVKRI------DDAGHDAEREFNNEVNWLTKIRHQ-NII 212
           +G G  G V +A  F     A  + +      + A H   R   +E+  L  I H  N++
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 213 SLLGYCIHAETRFLV-YEMMQNGSLEKQLHGPT-------------HGSNLTWHLRMKIA 258
           +LLG C       +V  E  + G+L   L                 +   LT    +  +
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYS 156
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT- 317
             VA+G+E+L    +   +HRDL + NILL      K+ DFGL+         V+     
Sbjct: 157 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 213
Query: 318 --LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVE--KMSPTQCQSMVTWAMPQ 372
             L ++APE + +   T +SDV++FGV+L E+  +G  P    K+    C+ +      +
Sbjct: 214 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL------K 267
Query: 373 LTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
              R + P+   P +  TM            + C   EPS RP  ++++  L
Sbjct: 268 EGTRMRAPDYTTPEMYQTM------------LDCWHGEPSQRPTFSELVEHL 307

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 75/169 (44%), Gaps = 19/169 (11%)
Query: 193 EREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSL-----EKQLHGPTHGS 247
           E    NE+  L KI+H+NI++L          +LV +++  G L     EK  +     S
Sbjct: 64  ESSIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDAS 123
Query: 248 NLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILL---DSSFNAKLSDFGLSVT 304
            L   +R      V   + YLH      +VHRDLK  N+L    D      +SDFGLS  
Sbjct: 124 TL---IRQ-----VLDAVYYLH---RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKM 172
Query: 305 AGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
            G         GT GYVAPE L +   +   D ++ GV+   LL G  P
Sbjct: 173 EGKGDVMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 221

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 45/133 (33%), Positives = 69/133 (51%), Gaps = 7/133 (5%)
Query: 222 ETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDL 281
           E  F V E +  G L   +    H  +L+       A ++  GL++LH   +  +V+RDL
Sbjct: 91  ENLFFVMEYLNGGDLMYHIQS-CHKFDLS--RATFYAAEIILGLQFLH---SKGIVYRDL 144
Query: 282 KSSNILLDSSFNAKLSDFGLSVTAGT-QSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAF 340
           K  NILLD   + K++DFG+        ++     GT  Y+APE LL  K     D ++F
Sbjct: 145 KLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLGQKYNHSVDWWSF 204
Query: 341 GVVLLELLMGRRP 353
           GV+L E+L+G+ P
Sbjct: 205 GVLLYEMLIGQSP 217

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 97/204 (47%), Gaps = 14/204 (6%)
Query: 160 VIGEGGRGHVYKARF----NEKLLAAVKRIDDAGHDAERE-FNNEVNWLTKIRHQNIISL 214
            IGEG  G V++  +    N  +  A+K   +   D+ RE F  E   + +  H +I+ L
Sbjct: 17  CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 76
Query: 215 LGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNH 274
           +G  I     +++ E+   G L   L       +L     +  A  ++  L YL    + 
Sbjct: 77  IGV-ITENPVWIIMELCTLGELRSFLQ--VRKFSLDLASLILYAYQLSTALAYLE---SK 130
Query: 275 PVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLT 332
             VHRD+ + N+L+ ++   KL DFGLS  +   T  +  K    + ++APE +   + T
Sbjct: 131 RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 333 DKSDVYAFGVVLLELLM-GRRPVE 355
             SDV+ FGV + E+LM G +P +
Sbjct: 191 SASDVWMFGVCMWEILMHGVKPFQ 214

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 100/224 (44%), Gaps = 30/224 (13%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKARFNEKLL--AAVKRIDD------AGHDAEREFN--N 198
           +A  + +  S  +G G  G V K  F  K     A+K I        +  +A+   N   
Sbjct: 6   KALRDEYIMSKTLGSGACGEV-KLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVET 64
Query: 199 EVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHL---RM 255
           E+  L K+ H  II +  +   AE  ++V E+M+ G L  ++ G       T  L   +M
Sbjct: 65  EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123
Query: 256 KIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFN---AKLSDFGLSVTAGTQSRNV 312
            +AV      +YLHE+    ++HRDLK  N+LL S       K++DFG S   G  S   
Sbjct: 124 LLAV------QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR 174
Query: 313 KISGTLGYVAPEYLLE---GKLTDKSDVYAFGVVLLELLMGRRP 353
            + GT  Y+APE L+           D ++ GV+L   L G  P
Sbjct: 175 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 99/223 (44%), Gaps = 40/223 (17%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAA--VKRIDDAGHDAEREFNNEVNWLTKIRHQN 210
            + Q   +   G  G V+KA+     +A       D     +ERE  +       ++H+N
Sbjct: 15  GSLQLLEIKARGRFGCVWKAQLMNDFVAVKIFPLQDKQSWQSEREIFSTPG----MKHEN 70
Query: 211 IISLLGYCIHAETR--------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
           ++      I AE R        +L+      GSL   L G    + +TW+    +A  ++
Sbjct: 71  LLQF----IAAEKRGSNLEVELWLITAFHDKGSLTDYLKG----NIITWNELCHVAETMS 122
Query: 263 RGLEYLHEH---CNH-----PVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKI 314
           RGL YLHE    C        + HRD KS N+LL S   A L+DFGL+V           
Sbjct: 123 RGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDT 182
Query: 315 SGTLG---YVAPEYLLEGKLTDKS------DVYAFGVVLLELL 348
            G +G   Y+APE +LEG +  +       D+YA G+VL EL+
Sbjct: 183 HGQVGTRRYMAPE-VLEGAINFQRDAFLRIDMYAMGLVLWELV 224

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 103/207 (49%), Gaps = 22/207 (10%)
Query: 155 FQESNVIGEGGRGHVYKARFNEKL--LAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
           +Q+   IG G +G V  A F+  L    AVK++     +   A+R +  E+  L  + H+
Sbjct: 24  YQQLKPIGSGAQGIVCAA-FDTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHK 81
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           NIISLL      +T       +LV E+M + +L + +H       +++ L   +      
Sbjct: 82  NIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIHMELDHERMSYLLYQMLC----- 135
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           G+++LH   +  ++HRDLK SNI++ S    K+ DFGL+ TA T         T  Y AP
Sbjct: 136 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVVTRYYRAP 192
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELLMG 350
           E +L     +  D+++ G ++ EL+ G
Sbjct: 193 EVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 100/224 (44%), Gaps = 30/224 (13%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKARFNEKLL--AAVKRIDD------AGHDAEREFN--N 198
           +A  + +  S  +G G  G V K  F  K     A+K I        +  +A+   N   
Sbjct: 6   KALRDEYIMSKTLGSGACGEV-KLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVET 64
Query: 199 EVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHL---RM 255
           E+  L K+ H  II +  +   AE  ++V E+M+ G L  ++ G       T  L   +M
Sbjct: 65  EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123
Query: 256 KIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFN---AKLSDFGLSVTAGTQSRNV 312
            +AV      +YLHE+    ++HRDLK  N+LL S       K++DFG S   G  S   
Sbjct: 124 LLAV------QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR 174
Query: 313 KISGTLGYVAPEYLLE---GKLTDKSDVYAFGVVLLELLMGRRP 353
            + GT  Y+APE L+           D ++ GV+L   L G  P
Sbjct: 175 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 100/224 (44%), Gaps = 30/224 (13%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKARFNEKLL--AAVKRIDD------AGHDAEREFN--N 198
           +A  + +  S  +G G  G V K  F  K     A+K I        +  +A+   N   
Sbjct: 6   KALRDEYIMSKTLGSGACGEV-KLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVET 64
Query: 199 EVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHL---RM 255
           E+  L K+ H  II +  +   AE  ++V E+M+ G L  ++ G       T  L   +M
Sbjct: 65  EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123
Query: 256 KIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFN---AKLSDFGLSVTAGTQSRNV 312
            +AV      +YLHE+    ++HRDLK  N+LL S       K++DFG S   G  S   
Sbjct: 124 LLAV------QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR 174
Query: 313 KISGTLGYVAPEYLLE---GKLTDKSDVYAFGVVLLELLMGRRP 353
            + GT  Y+APE L+           D ++ GV+L   L G  P
Sbjct: 175 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 104/221 (47%), Gaps = 20/221 (9%)
Query: 152 TNNFQESNVIGEGGRGHVYKAR---FNEKLLAAVKRIDDAGHDA-EREFNNEVNWLTKIR 207
           ++ ++   ++G GG   V+ AR    +  +   V R D A   +    F  E      + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 208 HQNIISLLGYCIHAETR-----FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
           H  I+++      AET      ++V E +   +L   +H  T G  +T    +++  D  
Sbjct: 71  HPAIVAVYATG-EAETPAGPLPYIVMEYVDGVTLRDIVH--TEGP-MTPKRAIEVIADAC 126
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSV----TAGTQSRNVKISGTL 318
           + L + H++    ++HRD+K +NI++ ++   K+ DFG++     +  + ++   + GT 
Sbjct: 127 QALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 319 GYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSP 359
            Y++PE      +  +SDVY+ G VL E+L G  P    SP
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 74/286 (25%), Positives = 122/286 (42%), Gaps = 41/286 (14%)
Query: 161 IGEGGRGHVYKA------RFNEKLLAAVKRIDD-AGHDAEREFNNEVNWLTKIRHQ-NII 212
           +G G  G V +A      +       AVK + + A H   R   +E+  L  I H  N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 213 SLLGYCIHAETRFLV-YEMMQNGSLEKQL---------HGPTHGSNLTWHLRMKIAVDVA 262
           +LLG C       +V  E  + G+L   L         +   +   LT    +  +  VA
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVA 154
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT---LG 319
           +G+E+L    +   +HRDL + NILL      K+ DFGL+         V+       L 
Sbjct: 155 KGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 320 YVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRSK 378
           ++APE + +   T +SDV++FGV+L E+  +G  P   +   +        + + T R +
Sbjct: 212 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV---KIDEEFXRRLKEGT-RMR 267
Query: 379 LPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
            P+   P +  TM            + C   EPS RP  ++++  L
Sbjct: 268 APDYTTPEMYQTM------------LDCWHGEPSQRPTFSELVEHL 301

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 14/209 (6%)
Query: 152 TNNFQESNVIGEGGRGHVY----KARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR 207
           ++ ++   V+G+G  G V     K    E  +  + +        +     EV  L ++ 
Sbjct: 31  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 90
Query: 208 HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEY 267
           H NI+ L  +       +LV E+   G L  ++      S +      +I   V  G+ Y
Sbjct: 91  HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVD---AARIIRQVLSGITY 147
Query: 268 LHEHCNHPVVHRDLKSSNILLDS---SFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
           +H++    +VHRDLK  N+LL+S     N ++ DFGLS       +     GT  Y+APE
Sbjct: 148 MHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE 204
Query: 325 YLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
            +L G   +K DV++ GV+L  LL G  P
Sbjct: 205 -VLHGTYDEKCDVWSTGVILYILLSGCPP 232

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 100/224 (44%), Gaps = 30/224 (13%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKARFNEKLL--AAVKRIDD------AGHDAEREFN--N 198
           +A  + +  S  +G G  G V K  F  K     A+K I        +  +A+   N   
Sbjct: 5   KALRDEYIMSKTLGSGACGEV-KLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVET 63
Query: 199 EVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHL---RM 255
           E+  L K+ H  II +  +   AE  ++V E+M+ G L  ++ G       T  L   +M
Sbjct: 64  EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 122
Query: 256 KIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFN---AKLSDFGLSVTAGTQSRNV 312
            +AV      +YLHE+    ++HRDLK  N+LL S       K++DFG S   G  S   
Sbjct: 123 LLAV------QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR 173
Query: 313 KISGTLGYVAPEYLLE---GKLTDKSDVYAFGVVLLELLMGRRP 353
            + GT  Y+APE L+           D ++ GV+L   L G  P
Sbjct: 174 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 217

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 105/228 (46%), Gaps = 14/228 (6%)
Query: 136 KKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARF----NEKLLAAVKRIDDAGHD 191
           ++DT ++      E      +    IGEG  G V++  +    N  +  A+K   +   D
Sbjct: 373 EEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSD 432
Query: 192 AERE-FNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLT 250
           + RE F  E   + +  H +I+ L+G  I     +++ E+   G L   L       +L 
Sbjct: 433 SVREKFLQEALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQ--VRKFSLD 489
Query: 251 WHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQ 308
               +  A  ++  L YL    +   VHRD+ + N+L+ S+   KL DFGLS  +   T 
Sbjct: 490 LASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 546
Query: 309 SRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVE 355
            +  K    + ++APE +   + T  SDV+ FGV + E+LM G +P +
Sbjct: 547 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 594

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 100/224 (44%), Gaps = 30/224 (13%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKARFNEKLL--AAVKRIDD------AGHDAEREFN--N 198
           +A  + +  S  +G G  G V K  F  K     A+K I        +  +A+   N   
Sbjct: 12  KALRDEYIMSKTLGSGACGEV-KLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVET 70
Query: 199 EVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHL---RM 255
           E+  L K+ H  II +  +   AE  ++V E+M+ G L  ++ G       T  L   +M
Sbjct: 71  EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 129
Query: 256 KIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFN---AKLSDFGLSVTAGTQSRNV 312
            +AV      +YLHE+    ++HRDLK  N+LL S       K++DFG S   G  S   
Sbjct: 130 LLAV------QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR 180
Query: 313 KISGTLGYVAPEYLLE---GKLTDKSDVYAFGVVLLELLMGRRP 353
            + GT  Y+APE L+           D ++ GV+L   L G  P
Sbjct: 181 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 224

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 13/206 (6%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK-LLAAVKRI--DDAGHDAEREFNNEVNWLTKIRHQNI 211
           +++   IGEG  G V+KA+  E   + A+KR+  DD           E+  L +++H+NI
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 212 ISLLGYCIHAETRF-LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHE 270
           + L    +H++ +  LV+E   +  L+K     +   +L   +       + +GL + H 
Sbjct: 64  VRLHD-VLHSDKKLTLVFEFC-DQDLKKYFD--SCNGDLDPEIVKSFLFQLLKGLGFCH- 118
Query: 271 HCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPEYLLEG 329
             +  V+HRDLK  N+L++ +   KL++FGL+   G   R       TL Y  P+ L   
Sbjct: 119 --SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 330 KLTDKS-DVYAFGVVLLELLMGRRPV 354
           KL   S D+++ G +  EL    RP+
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPL 202

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 101/218 (46%), Gaps = 35/218 (16%)
Query: 155 FQESNVIGEGGRGHVYKAR----------FNEKLLAA---VKRIDDAGH-DAEREFNNEV 200
           F+   V+G+GG G V++ R          F  K+L     V+   D  H  AER      
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAER------ 72
Query: 201 NWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLH--GPTHGSNLTWHLRMKIA 258
           N L +++H  I+ L+         +L+ E +  G L  QL   G        ++L     
Sbjct: 73  NILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYL----- 127
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGL---SVTAGTQSRNVKIS 315
            +++  L +LH+     +++RDLK  NI+L+   + KL+DFGL   S+  GT +      
Sbjct: 128 AEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FC 182
Query: 316 GTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
           GT+ Y+APE L+        D ++ G ++ ++L G  P
Sbjct: 183 GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 102/221 (46%), Gaps = 20/221 (9%)
Query: 152 TNNFQESNVIGEGGRGHVYKAR-FNEKLLAAVKRI-DDAGHDAE--REFNNEVNWLTKIR 207
           ++ ++   ++G GG   V+ AR   +    AVK +  D   D      F  E      + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 208 HQNIISLLGYCIHAETR-----FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
           H  I+++      AET      ++V E +   +L   +H  T G  +T    +++  D  
Sbjct: 71  HPAIVAVYDTG-EAETPAGPLPYIVMEYVDGVTLRDIVH--TEGP-MTPKRAIEVIADAC 126
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV----KISGTL 318
           + L + H++    ++HRD+K +NIL+ ++   K+ DFG++        +V     + GT 
Sbjct: 127 QALNFSHQNG---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTA 183
Query: 319 GYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSP 359
            Y++PE      +  +SDVY+ G VL E+L G  P    SP
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 104/221 (47%), Gaps = 20/221 (9%)
Query: 152 TNNFQESNVIGEGGRGHVYKAR---FNEKLLAAVKRIDDAGHDA-EREFNNEVNWLTKIR 207
           ++ ++   ++G GG   V+ AR    +  +   V R D A   +    F  E      + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 208 HQNIISLLGYCIHAETR-----FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
           H  I+++      AET      ++V E +   +L   +H  T G  +T    +++  D  
Sbjct: 71  HPAIVAVYDTG-EAETPAGPLPYIVMEYVDGVTLRDIVH--TEGP-MTPKRAIEVIADAC 126
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSV----TAGTQSRNVKISGTL 318
           + L + H++    ++HRD+K +NI++ ++   K+ DFG++     +  + ++   + GT 
Sbjct: 127 QALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 319 GYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSP 359
            Y++PE      +  +SDVY+ G VL E+L G  P    SP
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 114/243 (46%), Gaps = 33/243 (13%)
Query: 119 LSLSPILERFNSLRLAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFNEKL 178
           +S S +  +F S+ +A    TV              +Q+   IG G +G V  A F+  L
Sbjct: 1   MSKSKVDNQFYSVEVADSTFTV-----------LKRYQQLKPIGSGAQGIVCAA-FDTVL 48
Query: 179 --LAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQNIISLLGYCIHAETR------FLV 227
               AVK++     +   A+R +  E+  L  + H+NIISLL      +T       +LV
Sbjct: 49  GINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLV 107
Query: 228 YEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNIL 287
            E+M + +L + +H       +++ L   +      G+++LH   +  ++HRDLK SNI+
Sbjct: 108 MELM-DANLCQVIHMELDHERMSYLLYQMLC-----GIKHLH---SAGIIHRDLKPSNIV 158
Query: 288 LDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLEL 347
           + S    K+ DFGL+ TA T         T  Y APE +L        D+++ G ++ EL
Sbjct: 159 VKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGEL 218
Query: 348 LMG 350
           + G
Sbjct: 219 VKG 221

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/158 (32%), Positives = 78/158 (49%), Gaps = 10/158 (6%)
Query: 199 EVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIA 258
           EV  L ++ H NI+ L  +       +LV E+   G L  ++      S +      +I 
Sbjct: 76  EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVD---AARII 132
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDS---SFNAKLSDFGLSVTAGTQSRNVKIS 315
             V  G+ Y+H++    +VHRDLK  N+LL+S     N ++ DFGLS       +     
Sbjct: 133 RQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI 189
Query: 316 GTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
           GT  Y+APE +L G   +K DV++ GV+L  LL G  P
Sbjct: 190 GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPP 226

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 97/231 (41%), Gaps = 44/231 (19%)
Query: 152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAER--EFNNEVNWLTKIRH 208
            ++F+E  V+G+G  G V KAR   +    A+K+I    H  E+     +EV  L  + H
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI---RHTEEKLSTILSEVMLLASLNH 61
Query: 209 Q-------------NIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPT--HGSNLTWHL 253
           Q             N +  +       T F+  E  +NG+L   +H        +  W L
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 254 RMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA-------- 305
             +I       L Y+H   +  ++HRDLK  NI +D S N K+ DFGL+           
Sbjct: 122 FRQIL----EALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 306 -------GTQSRNVKISGTLGYVAPEYLL-EGKLTDKSDVYAFGVVLLELL 348
                  G+        GT  YVA E L   G   +K D+Y+ G++  E++
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 94/213 (44%), Gaps = 22/213 (10%)
Query: 152 TNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNN---EVNWLTKIRH 208
           ++N+     +G+G    V +       L    +I +    + R+F     E     K++H
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 209 QNIISLLGYCIHAETRFLVYEMMQNGSL-----EKQLHGPTHGSNLTWHLRMKIAVDVAR 263
            NI+ L          +LV++++  G L      ++ +     S+    +   IA     
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIA----- 118
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNA---KLSDFGLSVTAGTQSRNVKISGTLGY 320
              Y H   ++ +VHR+LK  N+LL S       KL+DFGL++           +GT GY
Sbjct: 119 ---YCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGY 172
Query: 321 VAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
           ++PE L +   +   D++A GV+L  LL+G  P
Sbjct: 173 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 205

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 105/228 (46%), Gaps = 14/228 (6%)
Query: 136 KKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARF----NEKLLAAVKRIDDAGHD 191
           ++DT ++      E      +    IGEG  G V++  +    N  +  A+K   +   D
Sbjct: 373 EEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSD 432
Query: 192 AERE-FNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLT 250
           + RE F  E   + +  H +I+ L+G  I     +++ E+   G L   L       +L 
Sbjct: 433 SVREKFLQEALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQ--VRKFSLD 489
Query: 251 WHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQ 308
               +  A  ++  L YL    +   VHRD+ + N+L+ ++   KL DFGLS  +   T 
Sbjct: 490 LASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTY 546
Query: 309 SRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVE 355
            +  K    + ++APE +   + T  SDV+ FGV + E+LM G +P +
Sbjct: 547 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 594

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 102/225 (45%), Gaps = 34/225 (15%)
Query: 152 TNNFQESNVIGEGGRGHVYKARFNEK-LLAAVKRID--DAGHDAEREFNNEVNWLTKIRH 208
           +++FQ  +++GEG  G V  A       + A+K+I+  D    A R    E+  L   +H
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKH 68
Query: 209 QNIISLLGYCIHAETRF-------LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDV 261
           +NII++    I     F       ++ E+MQ       LH       L+           
Sbjct: 69  ENIITIFN--IQRPDSFENFNEVYIIQELMQT-----DLHRVISTQMLSDDHIQYFIYQT 121
Query: 262 ARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGL-----------SVTAGTQSR 310
            R ++ LH      V+HRDLK SN+L++S+ + K+ DFGL           S   G QS 
Sbjct: 122 LRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 311 NVKISGTLGYVAPEYLL-EGKLTDKSDVYAFGVVLLELLMGRRPV 354
             +   T  Y APE +L   K +   DV++ G +L EL + RRP+
Sbjct: 179 MTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPI 222

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 94/213 (44%), Gaps = 22/213 (10%)
Query: 152 TNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNN---EVNWLTKIRH 208
           ++N+     +G+G    V +       L    +I +    + R+F     E     K++H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 209 QNIISLLGYCIHAETRFLVYEMMQNGSL-----EKQLHGPTHGSNLTWHLRMKIAVDVAR 263
            NI+ L          +LV++++  G L      ++ +     S+    +   IA     
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIA----- 119
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNA---KLSDFGLSVTAGTQSRNVKISGTLGY 320
              Y H   ++ +VHR+LK  N+LL S       KL+DFGL++           +GT GY
Sbjct: 120 ---YCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGY 173
Query: 321 VAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
           ++PE L +   +   D++A GV+L  LL+G  P
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 101/218 (46%), Gaps = 35/218 (16%)
Query: 155 FQESNVIGEGGRGHVYKAR----------FNEKLLAA---VKRIDDAGH-DAEREFNNEV 200
           F+   V+G+GG G V++ R          F  K+L     V+   D  H  AER      
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAER------ 72
Query: 201 NWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLH--GPTHGSNLTWHLRMKIA 258
           N L +++H  I+ L+         +L+ E +  G L  QL   G        ++L     
Sbjct: 73  NILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYL----- 127
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGL---SVTAGTQSRNVKIS 315
            +++  L +LH+     +++RDLK  NI+L+   + KL+DFGL   S+  GT +      
Sbjct: 128 AEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHX--FC 182
Query: 316 GTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
           GT+ Y+APE L+        D ++ G ++ ++L G  P
Sbjct: 183 GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 102/225 (45%), Gaps = 34/225 (15%)
Query: 152 TNNFQESNVIGEGGRGHVYKARFNEK-LLAAVKRID--DAGHDAEREFNNEVNWLTKIRH 208
           +++FQ  +++GEG  G V  A       + A+K+I+  D    A R    E+  L   +H
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKH 68
Query: 209 QNIISLLGYCIHAETRF-------LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDV 261
           +NII++    I     F       ++ E+MQ       LH       L+           
Sbjct: 69  ENIITIFN--IQRPDSFENFNEVYIIQELMQT-----DLHRVISTQMLSDDHIQYFIYQT 121
Query: 262 ARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGL-----------SVTAGTQSR 310
            R ++ LH      V+HRDLK SN+L++S+ + K+ DFGL           S   G QS 
Sbjct: 122 LRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 311 NVKISGTLGYVAPEYLL-EGKLTDKSDVYAFGVVLLELLMGRRPV 354
             +   T  Y APE +L   K +   DV++ G +L EL + RRP+
Sbjct: 179 MTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPI 222

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 94/213 (44%), Gaps = 22/213 (10%)
Query: 152 TNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNN---EVNWLTKIRH 208
           ++N+     +G+G    V +       L    +I +    + R+F     E     K++H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 209 QNIISLLGYCIHAETRFLVYEMMQNGSL-----EKQLHGPTHGSNLTWHLRMKIAVDVAR 263
            NI+ L          +LV++++  G L      ++ +     S+    +   IA     
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIA----- 119
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNA---KLSDFGLSVTAGTQSRNVKISGTLGY 320
              Y H   ++ +VHR+LK  N+LL S       KL+DFGL++           +GT GY
Sbjct: 120 ---YCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGY 173
Query: 321 VAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
           ++PE L +   +   D++A GV+L  LL+G  P
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 104/221 (47%), Gaps = 20/221 (9%)
Query: 152 TNNFQESNVIGEGGRGHVYKAR-FNEKLLAAVKRI-DDAGHDAE--REFNNEVNWLTKIR 207
           ++ ++   ++G GG   V+ AR   +    AVK +  D   D      F  E      + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 208 HQNIISLLGYCIHAETR-----FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
           H  I+++      AET      ++V E +   +L   +H  T G  +T    +++  D  
Sbjct: 71  HPAIVAVYDTG-EAETPAGPLPYIVMEYVDGVTLRDIVH--TEGP-MTPKRAIEVIADAC 126
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSV----TAGTQSRNVKISGTL 318
           + L + H++    ++HRD+K +NI++ ++   K+ DFG++     +  + ++   + GT 
Sbjct: 127 QALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 319 GYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSP 359
            Y++PE      +  +SDVY+ G VL E+L G  P    SP
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 104/221 (47%), Gaps = 20/221 (9%)
Query: 152 TNNFQESNVIGEGGRGHVYKAR---FNEKLLAAVKRIDDAGHDA-EREFNNEVNWLTKIR 207
           ++ ++   ++G GG   V+ AR    +  +   V R D A   +    F  E      + 
Sbjct: 28  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 87
Query: 208 HQNIISLLGYCIHAETR-----FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
           H  I+++      AET      ++V E +   +L   +H  T G  +T    +++  D  
Sbjct: 88  HPAIVAVYDTG-EAETPAGPLPYIVMEYVDGVTLRDIVH--TEGP-MTPKRAIEVIADAC 143
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSV----TAGTQSRNVKISGTL 318
           + L + H++    ++HRD+K +NI++ ++   K+ DFG++     +  + ++   + GT 
Sbjct: 144 QALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 200
Query: 319 GYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSP 359
            Y++PE      +  +SDVY+ G VL E+L G  P    SP
Sbjct: 201 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 241

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 104/221 (47%), Gaps = 20/221 (9%)
Query: 152 TNNFQESNVIGEGGRGHVYKAR-FNEKLLAAVKRI-DDAGHDAE--REFNNEVNWLTKIR 207
           ++ ++   ++G GG   V+ AR   +    AVK +  D   D      F  E      + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 208 HQNIISLLGYCIHAETR-----FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
           H  I+++      AET      ++V E +   +L   +H  T G  +T    +++  D  
Sbjct: 71  HPAIVAVYDTG-EAETPAGPLPYIVMEYVDGVTLRDIVH--TEGP-MTPKRAIEVIADAC 126
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSV----TAGTQSRNVKISGTL 318
           + L + H++    ++HRD+K +NI++ ++   K+ DFG++     +  + ++   + GT 
Sbjct: 127 QALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 319 GYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSP 359
            Y++PE      +  +SDVY+ G VL E+L G  P    SP
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 97/222 (43%), Gaps = 39/222 (17%)
Query: 152 TNNFQESNVIGEGG-----------RGHVYKARF-NEKLLAAVKRIDDAGHDAEREFNNE 199
           T+ +Q    IG+G             GH Y A+  N K L+A            ++   E
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDH---------QKLERE 53
Query: 200 VNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAV 259
                 ++H NI+ L          +LV++++  G L + +    + S            
Sbjct: 54  ARICRLLKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSE----------A 103
Query: 260 DVARGLEYLHE---HCNH-PVVHRDLKSSNILLDSSFNA---KLSDFGLSV-TAGTQSRN 311
           D +  ++ + E   HC+   VVHRDLK  N+LL S       KL+DFGL++   G Q   
Sbjct: 104 DASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAW 163
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
              +GT GY++PE L +       D++A GV+L  LL+G  P
Sbjct: 164 FGFAGTPGYLSPEVLRKEAYGKPVDIWACGVILYILLVGYPP 205

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/278 (22%), Positives = 123/278 (44%), Gaps = 37/278 (13%)
Query: 153 NNFQESNVIGEGGRGHVYK-ARFNEKLLAAVKRIDDA----GHDAEREFNNEVNWLTKIR 207
             +     +G+GG    Y+    + K + A K +  +     H  E+  + E+     + 
Sbjct: 26  KRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEK-MSTEIAIHKSLD 84
Query: 208 HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHG---SNLTWHLRMKIAVDVARG 264
           + +++   G+    +  ++V E+ +  SL  +LH            + +R  I     +G
Sbjct: 85  NPHVVGFHGFFEDDDFVYVVLEICRRRSL-LELHKRRKAVTEPEARYFMRQTI-----QG 138
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ-SRNVKISGTLGYVAP 323
           ++YLH   N+ V+HRDLK  N+ L+   + K+ DFGL+        R   + GT  Y+AP
Sbjct: 139 VQYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAP 195
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
           E L +   + + D+++ G +L  LL+G+ P E    T C       + +  +   +P  +
Sbjct: 196 EVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE----TSCLKETYIRIKK--NEYSVPRHI 249
Query: 384 DPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
           +PV             +A+    +  +P+ RP + ++L
Sbjct: 250 NPV------------ASALIRRMLHADPTLRPSVAELL 275

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/158 (32%), Positives = 78/158 (49%), Gaps = 10/158 (6%)
Query: 199 EVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIA 258
           EV  L ++ H NI+ L  +       +LV E+   G L  ++      S +      +I 
Sbjct: 100 EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVD---AARII 156
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDS---SFNAKLSDFGLSVTAGTQSRNVKIS 315
             V  G+ Y+H++    +VHRDLK  N+LL+S     N ++ DFGLS       +     
Sbjct: 157 RQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI 213
Query: 316 GTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
           GT  Y+APE +L G   +K DV++ GV+L  LL G  P
Sbjct: 214 GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPP 250

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/158 (32%), Positives = 78/158 (49%), Gaps = 10/158 (6%)
Query: 199 EVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIA 258
           EV  L ++ H NI+ L  +       +LV E+   G L  ++      S +      +I 
Sbjct: 99  EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVD---AARII 155
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDS---SFNAKLSDFGLSVTAGTQSRNVKIS 315
             V  G+ Y+H++    +VHRDLK  N+LL+S     N ++ DFGLS       +     
Sbjct: 156 RQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI 212
Query: 316 GTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
           GT  Y+APE +L G   +K DV++ GV+L  LL G  P
Sbjct: 213 GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPP 249

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/278 (22%), Positives = 123/278 (44%), Gaps = 37/278 (13%)
Query: 153 NNFQESNVIGEGGRGHVYK-ARFNEKLLAAVKRIDDA----GHDAEREFNNEVNWLTKIR 207
             +     +G+GG    Y+    + K + A K +  +     H  E+  + E+     + 
Sbjct: 42  KRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEK-MSTEIAIHKSLD 100
Query: 208 HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHG---SNLTWHLRMKIAVDVARG 264
           + +++   G+    +  ++V E+ +  SL  +LH            + +R  I     +G
Sbjct: 101 NPHVVGFHGFFEDDDFVYVVLEICRRRSL-LELHKRRKAVTEPEARYFMRQTI-----QG 154
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ-SRNVKISGTLGYVAP 323
           ++YLH   N+ V+HRDLK  N+ L+   + K+ DFGL+        R   + GT  Y+AP
Sbjct: 155 VQYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAP 211
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
           E L +   + + D+++ G +L  LL+G+ P E    T C       + +  +   +P  +
Sbjct: 212 EVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE----TSCLKETYIRIKK--NEYSVPRHI 265
Query: 384 DPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
           +PV             +A+    +  +P+ RP + ++L
Sbjct: 266 NPV------------ASALIRRMLHADPTLRPSVAELL 291

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/278 (22%), Positives = 123/278 (44%), Gaps = 37/278 (13%)
Query: 153 NNFQESNVIGEGGRGHVYK-ARFNEKLLAAVKRIDDA----GHDAEREFNNEVNWLTKIR 207
             +     +G+GG    Y+    + K + A K +  +     H  E+  + E+     + 
Sbjct: 42  KRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEK-MSTEIAIHKSLD 100
Query: 208 HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHG---SNLTWHLRMKIAVDVARG 264
           + +++   G+    +  ++V E+ +  SL  +LH            + +R  I     +G
Sbjct: 101 NPHVVGFHGFFEDDDFVYVVLEICRRRSL-LELHKRRKAVTEPEARYFMRQTI-----QG 154
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ-SRNVKISGTLGYVAP 323
           ++YLH   N+ V+HRDLK  N+ L+   + K+ DFGL+        R   + GT  Y+AP
Sbjct: 155 VQYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAP 211
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
           E L +   + + D+++ G +L  LL+G+ P E    T C       + +  +   +P  +
Sbjct: 212 EVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE----TSCLKETYIRIKK--NEYSVPRHI 265
Query: 384 DPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
           +PV             +A+    +  +P+ RP + ++L
Sbjct: 266 NPV------------ASALIRRMLHADPTLRPSVAELL 291

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/126 (35%), Positives = 64/126 (50%), Gaps = 8/126 (6%)
Query: 256 KIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS 315
           KI +   + L +L E  N  ++HRD+K SNILLD S N KL DFG+S          + +
Sbjct: 129 KITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDA 186
Query: 316 GTLGYVAPEYLLEGKLTD----KSDVYAFGVVLLELLMGRRPVEKMSPT--QCQSMVTWA 369
           G   Y+APE +           +SDV++ G+ L EL  GR P  K +    Q   +V   
Sbjct: 187 GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGD 246
Query: 370 MPQLTD 375
            PQL++
Sbjct: 247 PPQLSN 252

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 92/210 (43%), Gaps = 12/210 (5%)
Query: 150 AATNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG---HDAEREFNNEVNWLTK 205
           A  ++F    VIG+G  G V  AR   E++  AVK +          E+   +E N L K
Sbjct: 35  AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLK 94
Query: 206 -IRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
            ++H  ++ L      A+  + V + +  G L   L        L    R   A ++A  
Sbjct: 95  NVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQ--RERCFLEPRARF-YAAEIASA 151
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGL-SVTAGTQSRNVKISGTLGYVAP 323
           L YLH      +V+RDLK  NILLDS  +  L+DFGL        S      GT  Y+AP
Sbjct: 152 LGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAP 208
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
           E L +       D +  G VL E+L G  P
Sbjct: 209 EVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/278 (22%), Positives = 123/278 (44%), Gaps = 37/278 (13%)
Query: 153 NNFQESNVIGEGGRGHVYK-ARFNEKLLAAVKRIDDA----GHDAEREFNNEVNWLTKIR 207
             +     +G+GG    Y+    + K + A K +  +     H  E+  + E+     + 
Sbjct: 42  KRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEK-MSTEIAIHKSLD 100
Query: 208 HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHG---SNLTWHLRMKIAVDVARG 264
           + +++   G+    +  ++V E+ +  SL  +LH            + +R  I     +G
Sbjct: 101 NPHVVGFHGFFEDDDFVYVVLEICRRRSL-LELHKRRKAVTEPEARYFMRQTI-----QG 154
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ-SRNVKISGTLGYVAP 323
           ++YLH   N+ V+HRDLK  N+ L+   + K+ DFGL+        R   + GT  Y+AP
Sbjct: 155 VQYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAP 211
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
           E L +   + + D+++ G +L  LL+G+ P E    T C       + +  +   +P  +
Sbjct: 212 EVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE----TSCLKETYIRIKK--NEYSVPRHI 265
Query: 384 DPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
           +PV             +A+    +  +P+ RP + ++L
Sbjct: 266 NPV------------ASALIRRMLHADPTLRPSVAELL 291

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 100/224 (44%), Gaps = 30/224 (13%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKARFNEK--------LLAAVKRIDDAGHDAEREFN--N 198
           +A  + +  S  +G G  G V K  F  K        +++  K    +  +A+   N   
Sbjct: 131 KALRDEYIMSKTLGSGACGEV-KLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVET 189
Query: 199 EVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHL---RM 255
           E+  L K+ H  II +  +   AE  ++V E+M+ G L  ++ G       T  L   +M
Sbjct: 190 EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 248
Query: 256 KIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFN---AKLSDFGLSVTAGTQSRNV 312
            +AV      +YLHE+    ++HRDLK  N+LL S       K++DFG S   G  S   
Sbjct: 249 LLAV------QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR 299
Query: 313 KISGTLGYVAPEYLLE---GKLTDKSDVYAFGVVLLELLMGRRP 353
            + GT  Y+APE L+           D ++ GV+L   L G  P
Sbjct: 300 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 100/224 (44%), Gaps = 30/224 (13%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKARFNEK--------LLAAVKRIDDAGHDAEREFN--N 198
           +A  + +  S  +G G  G V K  F  K        +++  K    +  +A+   N   
Sbjct: 145 KALRDEYIMSKTLGSGACGEV-KLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVET 203
Query: 199 EVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHL---RM 255
           E+  L K+ H  II +  +   AE  ++V E+M+ G L  ++ G       T  L   +M
Sbjct: 204 EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 262
Query: 256 KIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFN---AKLSDFGLSVTAGTQSRNV 312
            +AV      +YLHE+    ++HRDLK  N+LL S       K++DFG S   G  S   
Sbjct: 263 LLAV------QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR 313
Query: 313 KISGTLGYVAPEYLLE---GKLTDKSDVYAFGVVLLELLMGRRP 353
            + GT  Y+APE L+           D ++ GV+L   L G  P
Sbjct: 314 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 357

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 117/265 (44%), Gaps = 36/265 (13%)
Query: 161 IGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCI 219
           + E   G ++K R+    ++  V ++ D      R+FN E   L    H N++ +LG C 
Sbjct: 18  LNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQ 77
Query: 220 H--AETRFLVYEMMQNGSLEKQLHGPTHGSNLT--WHLRMKIAVDVARGLEYLHEHCNHP 275
              A    L+   M  GSL   LH    G+N        +K A+D+ARG+ +L  H   P
Sbjct: 78  SPPAPHPTLITHWMPYGSLYNVLH---EGTNFVVDQSQAVKFALDMARGMAFL--HTLEP 132
Query: 276 VVHRD-LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTD- 333
           ++ R  L S ++++D    A++S   +  +  +  R         +VAPE  L+ K  D 
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMY----APAWVAPEA-LQKKPEDT 187
Query: 334 ---KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDT 390
               +D+++F V+L EL+    P   +S  +    V  A+  L  R  +P  + P     
Sbjct: 188 NRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKV--ALEGL--RPTIPPGISP----- 238
Query: 391 MDLKHLYQVAAVAVLCIQPEPSYRP 415
                   V+ +  +C+  +P+ RP
Sbjct: 239 -------HVSKLMKICMNEDPAKRP 256

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 80/169 (47%), Gaps = 17/169 (10%)
Query: 197 NNEVNWLTKIRH-----QNIISLLGY--CIHAETR-FLVYEMMQNGSLEKQLHGPTHGSN 248
           + +++W+   +H      N   L+G   C   E+R F V E +  G L    H       
Sbjct: 50  DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKL 107
Query: 249 LTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ 308
              H R   + +++  L YLHE     +++RDLK  N+LLDS  + KL+D+G+    G +
Sbjct: 108 PEEHARF-YSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGM-CKEGLR 162
Query: 309 SRNV--KISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVE 355
             +      GT  Y+APE L         D +A GV++ E++ GR P +
Sbjct: 163 PGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 211

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 98/213 (46%), Gaps = 23/213 (10%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNII 212
            +F+   ++GEG    V  AR          +I +  H  +    N+V ++T  R ++++
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK---ENKVPYVT--RERDVM 91
Query: 213 SLLG--------YCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           S L         +C   + + +      +NG L K +     GS      R   A ++  
Sbjct: 92  SRLDHPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTA-EIVS 148
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS---GTLGY 320
            LEYLH      ++HRDLK  NILL+   + +++DFG +     +S+  + +   GT  Y
Sbjct: 149 ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 205
Query: 321 VAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
           V+PE L E      SD++A G ++ +L+ G  P
Sbjct: 206 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 238

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 80/169 (47%), Gaps = 17/169 (10%)
Query: 197 NNEVNWLTKIRH-----QNIISLLGY--CIHAETR-FLVYEMMQNGSLEKQLHGPTHGSN 248
           + +++W+   +H      N   L+G   C   E+R F V E +  G L    H       
Sbjct: 61  DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKL 118
Query: 249 LTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ 308
              H R   + +++  L YLHE     +++RDLK  N+LLDS  + KL+D+G+    G +
Sbjct: 119 PEEHARF-YSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGM-CKEGLR 173
Query: 309 SRNV--KISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVE 355
             +      GT  Y+APE L         D +A GV++ E++ GR P +
Sbjct: 174 PGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 222

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 80/169 (47%), Gaps = 17/169 (10%)
Query: 197 NNEVNWLTKIRH-----QNIISLLGY--CIHAETR-FLVYEMMQNGSLEKQLHGPTHGSN 248
           + +++W+   +H      N   L+G   C   E+R F V E +  G L    H       
Sbjct: 46  DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKL 103
Query: 249 LTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ 308
              H R   + +++  L YLHE     +++RDLK  N+LLDS  + KL+D+G+    G +
Sbjct: 104 PEEHARF-YSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGM-CKEGLR 158
Query: 309 SRNV--KISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVE 355
             +      GT  Y+APE L         D +A GV++ E++ GR P +
Sbjct: 159 PGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 207

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 101/225 (44%), Gaps = 26/225 (11%)
Query: 157 ESNVIGEGGRGHVYKA-RFNEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIR-HQNIIS 213
           + +V+GEG    V            AVK I+   GH   R F  EV  L + + H+N++ 
Sbjct: 17  QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFR-EVEMLYQCQGHRNVLE 75
Query: 214 LLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
           L+ +    +  +LV+E M+ GS+   +H   H + L   +   +  DVA  L++LH   N
Sbjct: 76  LIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV---VVQDVASALDFLH---N 129
Query: 274 HPVVHRDLKSSNILLDSSFN---AKLSDFGLSVTAGTQSRNVKIS--------GTLGYVA 322
             + HRDLK  NIL +        K+ DFGL            IS        G+  Y+A
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 323 PE----YLLEGKLTDK-SDVYAFGVVLLELLMGRRPVEKMSPTQC 362
           PE    +  E  + DK  D+++ GV+L  LL G  P      + C
Sbjct: 190 PEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDC 234

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 80/169 (47%), Gaps = 17/169 (10%)
Query: 197 NNEVNWLTKIRH-----QNIISLLGY--CIHAETR-FLVYEMMQNGSLEKQLHGPTHGSN 248
           + +++W+   +H      N   L+G   C   E+R F V E +  G L    H       
Sbjct: 93  DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKL 150
Query: 249 LTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ 308
              H R   + +++  L YLHE     +++RDLK  N+LLDS  + KL+D+G+    G +
Sbjct: 151 PEEHARF-YSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGM-CKEGLR 205
Query: 309 SRNV--KISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVE 355
             +      GT  Y+APE L         D +A GV++ E++ GR P +
Sbjct: 206 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 254

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 94/213 (44%), Gaps = 22/213 (10%)
Query: 152 TNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNN---EVNWLTKIRH 208
           ++N+     +G+G    V +       L    +I +    + R+F     E     K++H
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 209 QNIISLLGYCIHAETRFLVYEMMQNGSL-----EKQLHGPTHGSNLTWHLRMKIAVDVAR 263
            NI+ L          +LV++++  G L      ++ +     S+    +   IA     
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIA----- 142
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNA---KLSDFGLSVTAGTQSRNVKISGTLGY 320
              Y H   ++ +VHR+LK  N+LL S       KL+DFGL++           +GT GY
Sbjct: 143 ---YCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGY 196
Query: 321 VAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
           ++PE L +   +   D++A GV+L  LL+G  P
Sbjct: 197 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR----- 207
            +F+   ++GEG    V  AR          +I +  H  +    N+V ++T+ R     
Sbjct: 10  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK---ENKVPYVTRERDVMSR 66
Query: 208 --HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
             H   + L       E  +      +NG L K +     GS      R   A ++   L
Sbjct: 67  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTA-EIVSAL 123
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS---GTLGYVA 322
           EYLH      ++HRDLK  NILL+   + +++DFG +     +S+  + +   GT  YV+
Sbjct: 124 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 180
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
           PE L E      SD++A G ++ +L+ G  P
Sbjct: 181 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 211

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 94/211 (44%), Gaps = 19/211 (9%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR----- 207
            +F+   ++GEG    V  AR          +I +  H  +    N+V ++T+ R     
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK---ENKVPYVTRERDVMSR 88
Query: 208 --HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
             H   + L       E  +      +NG L K +     GS      R   A ++   L
Sbjct: 89  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIR--KIGSFDETCTRFYTA-EIVSAL 145
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS---GTLGYVA 322
           EYLH      ++HRDLK  NILL+   + +++DFG +     +S+  + +   GT  YV+
Sbjct: 146 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 202
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
           PE L E   +  SD++A G ++ +L+ G  P
Sbjct: 203 PELLTEKSASKSSDLWALGCIIYQLVAGLPP 233

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 94/196 (47%), Gaps = 20/196 (10%)
Query: 165 GRGHVYKARFNEKLLAAVKRIDDAGHDAERE-FNNEVNWLTKIRHQNIISLLGYCIHAET 223
           G G  Y A+F +K     +R+  +     RE    EVN L +IRH NII+L     +   
Sbjct: 35  GTGKEYAAKFIKK-----RRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD 89
Query: 224 RFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKS 283
             L+ E++  G L   L       +LT     +    +  G+ YLH   +  + H DLK 
Sbjct: 90  VVLILELVSGGELFDFL---AEKESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKP 143
Query: 284 SNI-LLDSSF---NAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDV 337
            NI LLD +      KL DFG++  + AG + +N  I GT  +VAPE +    L  ++D+
Sbjct: 144 ENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN--IFGTPEFVAPEIVNYEPLGLEADM 201
Query: 338 YAFGVVLLELLMGRRP 353
           ++ GV+   LL G  P
Sbjct: 202 WSIGVITYILLSGASP 217

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/158 (32%), Positives = 76/158 (48%), Gaps = 10/158 (6%)
Query: 199 EVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIA 258
           EV  L ++ H NI  L  +       +LV E+   G L  ++      S +      +I 
Sbjct: 76  EVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVD---AARII 132
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDS---SFNAKLSDFGLSVTAGTQSRNVKIS 315
             V  G+ Y H++    +VHRDLK  N+LL+S     N ++ DFGLS       +     
Sbjct: 133 RQVLSGITYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKI 189
Query: 316 GTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
           GT  Y+APE +L G   +K DV++ GV+L  LL G  P
Sbjct: 190 GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPP 226

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR----- 207
            +F+   ++GEG    V  AR          +I +  H  +    N+V ++T+ R     
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK---ENKVPYVTRERDVMSR 65
Query: 208 --HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
             H   + L       E  +      +NG L K +     GS      R   A ++   L
Sbjct: 66  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTA-EIVSAL 122
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS---GTLGYVA 322
           EYLH      ++HRDLK  NILL+   + +++DFG +     +S+  + +   GT  YV+
Sbjct: 123 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 179
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
           PE L E      SD++A G ++ +L+ G  P
Sbjct: 180 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 210

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR----- 207
            +F+   ++GEG    V  AR          +I +  H  +    N+V ++T+ R     
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK---ENKVPYVTRERDVMSR 63
Query: 208 --HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
             H   + L       E  +      +NG L K +     GS      R   A ++   L
Sbjct: 64  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTA-EIVSAL 120
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS---GTLGYVA 322
           EYLH      ++HRDLK  NILL+   + +++DFG +     +S+  + +   GT  YV+
Sbjct: 121 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 177
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
           PE L E      SD++A G ++ +L+ G  P
Sbjct: 178 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 208

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 99/224 (44%), Gaps = 32/224 (14%)
Query: 153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAERE-FNNEVNWLTKIRHQN 210
            +F+    +G GG G V++A+   +    A+KRI     +  RE    EV  L K+ H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 211 IISLLGYCIHAET---------RFLVYEMMQ---NGSLEKQLHGPTHGSNLTWHLRMKIA 258
           I+      +   T         +  +Y  MQ     +L+  ++G          + + I 
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ---------- 308
           + +A  +E+LH   +  ++HRDLK SNI        K+ DFGL VTA  Q          
Sbjct: 125 LQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGL-VTAMDQDEEEQTVLTP 180
Query: 309 ----SRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELL 348
               +R+    GT  Y++PE +     + K D+++ G++L ELL
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR----- 207
            +F+   ++GEG    V  AR          +I +  H  +    N+V ++T+ R     
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK---ENKVPYVTRERDVMSR 64
Query: 208 --HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
             H   + L       E  +      +NG L K +     GS      R   A ++   L
Sbjct: 65  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTA-EIVSAL 121
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS---GTLGYVA 322
           EYLH      ++HRDLK  NILL+   + +++DFG +     +S+  + +   GT  YV+
Sbjct: 122 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 178
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
           PE L E      SD++A G ++ +L+ G  P
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 209

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/195 (32%), Positives = 94/195 (48%), Gaps = 18/195 (9%)
Query: 165 GRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETR 224
           G G  Y A+F +K   +  R   +  + ERE    VN L +IRH NII+L     +    
Sbjct: 28  GTGKEYAAKFIKKRRLSSSRRGVSREEIERE----VNILREIRHPNIITLHDIFENKTDV 83
Query: 225 FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSS 284
            L+ E++  G L   L       +LT     +    +  G+ YLH   +  + H DLK  
Sbjct: 84  VLILELVSGGELFDFL---AEKESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPE 137
Query: 285 NI-LLDSSF---NAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVY 338
           NI LLD +      KL DFG++  + AG + +N  I GT  +VAPE +    L  ++D++
Sbjct: 138 NIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN--IFGTPEFVAPEIVNYEPLGLEADMW 195
Query: 339 AFGVVLLELLMGRRP 353
           + GV+   LL G  P
Sbjct: 196 SIGVITYILLSGASP 210

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR----- 207
            +F+   ++GEG    V  AR          +I +  H  +    N+V ++T+ R     
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK---ENKVPYVTRERDVMSR 88
Query: 208 --HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
             H   + L       E  +      +NG L K +     GS      R   A ++   L
Sbjct: 89  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTA-EIVSAL 145
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS---GTLGYVA 322
           EYLH      ++HRDLK  NILL+   + +++DFG +     +S+  + +   GT  YV+
Sbjct: 146 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 202
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
           PE L E      SD++A G ++ +L+ G  P
Sbjct: 203 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR----- 207
            +F+   ++GEG    V  AR          +I +  H  +    N+V ++T+ R     
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK---ENKVPYVTRERDVMSR 88
Query: 208 --HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
             H   + L       E  +      +NG L K +     GS      R   A ++   L
Sbjct: 89  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTA-EIVSAL 145
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS---GTLGYVA 322
           EYLH      ++HRDLK  NILL+   + +++DFG +     +S+  + +   GT  YV+
Sbjct: 146 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 202
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
           PE L E      SD++A G ++ +L+ G  P
Sbjct: 203 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR----- 207
            +F+   ++GEG    V  AR          +I +  H  +    N+V ++T+ R     
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK---ENKVPYVTRERDVMSR 89
Query: 208 --HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
             H   + L       E  +      +NG L K +     GS      R   A ++   L
Sbjct: 90  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTA-EIVSAL 146
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS---GTLGYVA 322
           EYLH      ++HRDLK  NILL+   + +++DFG +     +S+  + +   GT  YV+
Sbjct: 147 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 203
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
           PE L E      SD++A G ++ +L+ G  P
Sbjct: 204 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR----- 207
            +F+   ++GEG    V  AR          +I +  H  +    N+V ++T+ R     
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK---ENKVPYVTRERDVMSR 86
Query: 208 --HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
             H   + L       E  +      +NG L K +     GS      R   A ++   L
Sbjct: 87  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTA-EIVSAL 143
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS---GTLGYVA 322
           EYLH      ++HRDLK  NILL+   + +++DFG +     +S+  + +   GT  YV+
Sbjct: 144 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 200
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
           PE L E      SD++A G ++ +L+ G  P
Sbjct: 201 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR----- 207
            +F+   ++GEG    V  AR          +I +  H  +    N+V ++T+ R     
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK---ENKVPYVTRERDVMSR 89
Query: 208 --HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
             H   + L       E  +      +NG L K +     GS      R   A ++   L
Sbjct: 90  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTA-EIVSAL 146
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS---GTLGYVA 322
           EYLH      ++HRDLK  NILL+   + +++DFG +     +S+  + +   GT  YV+
Sbjct: 147 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 203
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
           PE L E      SD++A G ++ +L+ G  P
Sbjct: 204 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR----- 207
            +F+   ++GEG    V  AR          +I +  H  +    N+V ++T+ R     
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK---ENKVPYVTRERDVMSR 86
Query: 208 --HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
             H   + L       E  +      +NG L K +     GS      R   A ++   L
Sbjct: 87  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTA-EIVSAL 143
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS---GTLGYVA 322
           EYLH      ++HRDLK  NILL+   + +++DFG +     +S+  + +   GT  YV+
Sbjct: 144 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 200
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
           PE L E      SD++A G ++ +L+ G  P
Sbjct: 201 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR----- 207
            +F+   ++GEG    V  AR          +I +  H  +    N+V ++T+ R     
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK---ENKVPYVTRERDVMSR 70
Query: 208 --HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
             H   + L       E  +      +NG L K +     GS      R   A ++   L
Sbjct: 71  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTA-EIVSAL 127
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS---GTLGYVA 322
           EYLH      ++HRDLK  NILL+   + +++DFG +     +S+  + +   GT  YV+
Sbjct: 128 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 184
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
           PE L E      SD++A G ++ +L+ G  P
Sbjct: 185 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 215

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR----- 207
            +F+   ++GEG    V  AR          +I +  H  +    N+V ++T+ R     
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK---ENKVPYVTRERDVMSR 91
Query: 208 --HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
             H   + L       E  +      +NG L K +     GS      R   A ++   L
Sbjct: 92  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTA-EIVSAL 148
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS---GTLGYVA 322
           EYLH      ++HRDLK  NILL+   + +++DFG +     +S+  + +   GT  YV+
Sbjct: 149 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 205
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
           PE L E      SD++A G ++ +L+ G  P
Sbjct: 206 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 236

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR----- 207
            +F+   ++GEG    V  AR          +I +  H  +    N+V ++T+ R     
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK---ENKVPYVTRERDVMSR 88
Query: 208 --HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
             H   + L       E  +      +NG L K +     GS      R   A ++   L
Sbjct: 89  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTA-EIVSAL 145
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS---GTLGYVA 322
           EYLH      ++HRDLK  NILL+   + +++DFG +     +S+  + +   GT  YV+
Sbjct: 146 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 202
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
           PE L E      SD++A G ++ +L+ G  P
Sbjct: 203 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR----- 207
            +F+   ++GEG    V  AR          +I +  H  +    N+V ++T+ R     
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK---ENKVPYVTRERDVMSR 86
Query: 208 --HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
             H   + L       E  +      +NG L K +     GS      R   A ++   L
Sbjct: 87  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTA-EIVSAL 143
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS---GTLGYVA 322
           EYLH      ++HRDLK  NILL+   + +++DFG +     +S+  + +   GT  YV+
Sbjct: 144 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVS 200
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
           PE L E      SD++A G ++ +L+ G  P
Sbjct: 201 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 90/205 (43%), Gaps = 16/205 (7%)
Query: 161 IGEGGRGHVYK---ARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISL--- 214
           +G GG G+V +       E++     R + +  + ER +  E+  + K+ H N++S    
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRER-WCLEIQIMKKLNHPNVVSAREV 80
Query: 215 ---LGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
              L      +   L  E  + G L K L+   +   L       +  D++  L YLHE+
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 140
Query: 272 CNHPVVHRDLKSSNILLDSSFNA---KLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLE 328
               ++HRDLK  NI+L         K+ D G +          +  GTL Y+APE L +
Sbjct: 141 ---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQ 197
Query: 329 GKLTDKSDVYAFGVVLLELLMGRRP 353
            K T   D ++FG +  E + G RP
Sbjct: 198 KKYTVTVDYWSFGTLAFECITGFRP 222

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 90/205 (43%), Gaps = 16/205 (7%)
Query: 161 IGEGGRGHVYK---ARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISL--- 214
           +G GG G+V +       E++     R + +  + ER +  E+  + K+ H N++S    
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRER-WCLEIQIMKKLNHPNVVSAREV 81
Query: 215 ---LGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
              L      +   L  E  + G L K L+   +   L       +  D++  L YLHE+
Sbjct: 82  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 141
Query: 272 CNHPVVHRDLKSSNILLDSSFNA---KLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLE 328
               ++HRDLK  NI+L         K+ D G +          +  GTL Y+APE L +
Sbjct: 142 ---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQ 198
Query: 329 GKLTDKSDVYAFGVVLLELLMGRRP 353
            K T   D ++FG +  E + G RP
Sbjct: 199 KKYTVTVDYWSFGTLAFECITGFRP 223

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR----- 207
            +F+   ++GEG    V  AR          +I +  H  +    N+V ++T+ R     
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK---ENKVPYVTRERDVMSR 85
Query: 208 --HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
             H   + L       E  +      +NG L K +     GS      R   A ++   L
Sbjct: 86  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTA-EIVSAL 142
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS---GTLGYVA 322
           EYLH      ++HRDLK  NILL+   + +++DFG +     +S+  + +   GT  YV+
Sbjct: 143 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 199
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
           PE L E      SD++A G ++ +L+ G  P
Sbjct: 200 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 230

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 74/156 (47%), Gaps = 18/156 (11%)
Query: 206 IRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
           ++H NI+ L          +LV++++  G L + +    + S            D +  +
Sbjct: 87  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSE----------ADASHCI 136
Query: 266 EYLHEHCNH----PVVHRDLKSSNILLDSSFNA---KLSDFGLSV-TAGTQSRNVKISGT 317
             + E  NH     +VHRDLK  N+LL S       KL+DFGL++   G Q      +GT
Sbjct: 137 HQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGT 196
Query: 318 LGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
            GY++PE L +       D++A GV+L  LL+G  P
Sbjct: 197 PGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPP 232

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR----- 207
            +F+   ++GEG    V  AR          +I +  H  +    N+V ++T+ R     
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK---ENKVPYVTRERDVMSR 85
Query: 208 --HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
             H   + L       E  +      +NG L K +     GS      R   A ++   L
Sbjct: 86  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTA-EIVSAL 142
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS---GTLGYVA 322
           EYLH      ++HRDLK  NILL+   + +++DFG +     +S+  + +   GT  YV+
Sbjct: 143 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 199
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
           PE L E      SD++A G ++ +L+ G  P
Sbjct: 200 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 230

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 94/196 (47%), Gaps = 20/196 (10%)
Query: 165 GRGHVYKARFNEKLLAAVKRIDDAGHDAERE-FNNEVNWLTKIRHQNIISLLGYCIHAET 223
           G G  Y A+F +K     +R+  +     RE    EVN L +IRH NII+L     +   
Sbjct: 49  GTGKEYAAKFIKK-----RRLXSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD 103
Query: 224 RFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKS 283
             L+ E++  G L   L       +LT     +    +  G+ YLH   +  + H DLK 
Sbjct: 104 VVLILELVSGGELFDFL---AEKESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKP 157
Query: 284 SNI-LLDSSF---NAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDV 337
            NI LLD +      KL DFG++  + AG + +N  I GT  +VAPE +    L  ++D+
Sbjct: 158 ENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN--IFGTPEFVAPEIVNYEPLGLEADM 215
Query: 338 YAFGVVLLELLMGRRP 353
           ++ GV+   LL G  P
Sbjct: 216 WSIGVITYILLSGASP 231

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 54/98 (55%), Gaps = 6/98 (6%)
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS--- 315
            ++   LEYLH      ++HRDLK  NILL+   + +++DFG +     +S+  + +   
Sbjct: 137 AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 193
Query: 316 GTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
           GT  YV+PE L E      SD++A G ++ +L+ G  P
Sbjct: 194 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR----- 207
            +F+   ++GEG    V  AR          +I +  H  +    N+V ++T+ R     
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK---ENKVPYVTRERDVMSR 88
Query: 208 --HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
             H   + L       E  +      +NG L K +     GS      R   A ++   L
Sbjct: 89  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTA-EIVSAL 145
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS---GTLGYVA 322
           EYLH      ++HRDLK  NILL+   + +++DFG +     +S+  + +   GT  YV+
Sbjct: 146 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 202
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
           PE L E      SD++A G ++ +L+ G  P
Sbjct: 203 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 24/206 (11%)
Query: 155 FQESNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRH 208
           +Q    IG G +G V   Y A  +  +  A+K++     +   A+R +  E+  +  + H
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKXVNH 82
Query: 209 QNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
           +NIISLL      +T       +LV E+M + +L + +        +++ L   +     
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQMELDHERMSYLLYQMLC---- 137
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
            G+++LH   +  ++HRDLK SNI++ S    K+ DFGL+ TAGT         T  Y A
Sbjct: 138 -GIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELL 348
           PE +L     +  D+++ G ++ E++
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 75/156 (48%), Gaps = 18/156 (11%)
Query: 206 IRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
           ++H NI+ L          +LV++++  G L + +    + S            D +  +
Sbjct: 60  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSE----------ADASHCI 109
Query: 266 EYLHEHCNHP----VVHRDLKSSNILLDSSFNA---KLSDFGLSV-TAGTQSRNVKISGT 317
           + + E  NH     +VHRDLK  N+LL S       KL+DFGL++   G Q      +GT
Sbjct: 110 QQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGT 169
Query: 318 LGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
            GY++PE L +       D++A GV+L  LL+G  P
Sbjct: 170 PGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 24/206 (11%)
Query: 155 FQESNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRH 208
           +Q    IG G +G V   Y A  +  +  A+K++     +   A+R +  E+  +  + H
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKXVNH 82
Query: 209 QNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
           +NIISLL      +T       +LV E+M + +L + +        +++ L   +     
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQMELDHERMSYLLYQMLX---- 137
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
            G+++LH      ++HRDLK SNI++ S    K+ DFGL+ TAGT         T  Y A
Sbjct: 138 -GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELL 348
           PE +L     +  D+++ G ++ E++
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 75/156 (48%), Gaps = 18/156 (11%)
Query: 206 IRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
           ++H NI+ L          +LV++++  G L + +    + S            D +  +
Sbjct: 60  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSE----------ADASHCI 109
Query: 266 EYLHEHCNH----PVVHRDLKSSNILLDSSFNA---KLSDFGLSV-TAGTQSRNVKISGT 317
           + + E  NH     +VHRDLK  N+LL S       KL+DFGL++   G Q      +GT
Sbjct: 110 QQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGT 169
Query: 318 LGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
            GY++PE L +       D++A GV+L  LL+G  P
Sbjct: 170 PGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 98/216 (45%), Gaps = 28/216 (12%)
Query: 158 SNVIGEGGRGHVYKA-RFNEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIR-HQNIISL 214
           S ++GEG    V  A         AVK I+  AGH   R F  EV  L + + ++NI+ L
Sbjct: 18  SELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFR-EVETLYQCQGNKNILEL 76
Query: 215 LGYCIHAETRF-LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
           + +    +TRF LV+E +Q GS+   +    H          ++  DVA  L++LH    
Sbjct: 77  IEF-FEDDTRFYLVFEKLQGGSILAHIQKQKH---FNEREASRVVRDVAAALDFLH---T 129
Query: 274 HPVVHRDLKSSNILLDSSFN---AKLSDFGL--------SVTAGTQSRNVKISGTLGYVA 322
             + HRDLK  NIL +S       K+ DF L        S T  T        G+  Y+A
Sbjct: 130 KGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMA 189
Query: 323 PE----YLLEGKLTDK-SDVYAFGVVLLELLMGRRP 353
           PE    +  +    DK  D+++ GVVL  +L G  P
Sbjct: 190 PEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPP 225

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR----- 207
            +F+   ++GEG    V  AR          +I +  H  +    N+V ++T+ R     
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK---ENKVPYVTRERDVMSR 88
Query: 208 --HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
             H   + L       E  +      +NG L K +     GS      R   A ++   L
Sbjct: 89  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTA-EIVSAL 145
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS---GTLGYVA 322
           EYLH      ++HRDLK  NILL+   + +++DFG +     +S+  + +   GT  YV+
Sbjct: 146 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 202
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
           PE L E      SD++A G ++ +L+ G  P
Sbjct: 203 PELLTEKSAXKSSDLWALGCIIYQLVAGLPP 233

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 96/231 (41%), Gaps = 44/231 (19%)
Query: 152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAER--EFNNEVNWLTKIRH 208
            ++F+E  V+G+G  G V KAR   +    A+K+I    H  E+     +EV  L  + H
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI---RHTEEKLSTILSEVMLLASLNH 61
Query: 209 Q-------------NIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPT--HGSNLTWHL 253
           Q             N +  +       T F+  E  +N +L   +H        +  W L
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRL 121
Query: 254 RMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA-------- 305
             +I       L Y+H   +  ++HRDLK  NI +D S N K+ DFGL+           
Sbjct: 122 FRQIL----EALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 306 -------GTQSRNVKISGTLGYVAPEYLL-EGKLTDKSDVYAFGVVLLELL 348
                  G+        GT  YVA E L   G   +K D+Y+ G++  E++
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 24/221 (10%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNEK----LLAAVKRIDD---AGHDAEREFNNEVNWLTK 205
             F    ++G+G  G V +A+  ++    +  AVK +     A  D E EF  E   + +
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIE-EFLREAACMKE 81
Query: 206 IRHQNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSN---LTWHLRMK 256
             H ++  L+G  + +  +       ++   M++G L   L     G N   L     ++
Sbjct: 82  FDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVR 141
Query: 257 IAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKI 314
             VD+A G+EYL    +   +HRDL + N +L       ++DFGLS  + +G   R    
Sbjct: 142 FMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCA 198
Query: 315 SG-TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRP 353
           S   + ++A E L +   T  SDV+AFGV + E++  G+ P
Sbjct: 199 SKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 24/206 (11%)
Query: 155 FQESNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRH 208
           +Q    IG G +G V   Y A  +  +  A+K++     +   A+R +  E+  +  + H
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 75
Query: 209 QNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
           +NIISLL      +T       +LV E+M + +L + +        +++ L   +     
Sbjct: 76  KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQMELDHERMSYLLYQMLX---- 130
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
            G+++LH   +  ++HRDLK SNI++ S    K+ DFGL+ TAGT         T  Y A
Sbjct: 131 -GIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRA 186
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELL 348
           PE +L     +  D+++ G ++ E++
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 24/206 (11%)
Query: 155 FQESNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRH 208
           +Q    IG G +G V   Y A  +  +  A+K++     +   A+R +  E+  +  + H
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKXVNH 82
Query: 209 QNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
           +NIISLL      +T       +LV E+M + +L + +        +++ L   +     
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQMLC---- 137
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
            G+++LH   +  ++HRDLK SNI++ S    K+ DFGL+ TAGT         T  Y A
Sbjct: 138 -GIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELL 348
           PE +L     +  D+++ G ++ E++
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 24/206 (11%)
Query: 155 FQESNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRH 208
           +Q    IG G +G V   Y A  +  +  A+K++     +   A+R +  E+  +  + H
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 82
Query: 209 QNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
           +NIISLL      +T       +LV E+M + +L + +        +++ L   +     
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQMELDHERMSYLLYQMLX---- 137
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
            G+++LH   +  ++HRDLK SNI++ S    K+ DFGL+ TAGT         T  Y A
Sbjct: 138 -GIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELL 348
           PE +L     +  D+++ G ++ E++
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 24/206 (11%)
Query: 155 FQESNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRH 208
           +Q    IG G +G V   Y A  +  +  A+K++     +   A+R +  E+  +  + H
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 83
Query: 209 QNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
           +NIISLL      +T       +LV E+M + +L + +        +++ L   +     
Sbjct: 84  KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQMLC---- 138
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
            G+++LH   +  ++HRDLK SNI++ S    K+ DFGL+ TAGT         T  Y A
Sbjct: 139 -GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 194
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELL 348
           PE +L     +  D+++ G ++ E++
Sbjct: 195 PEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 24/206 (11%)
Query: 155 FQESNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRH 208
           +Q    IG G +G V   Y A  +  +  A+K++     +   A+R +  E+  +  + H
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 76
Query: 209 QNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
           +NIISLL      +T       +LV E+M + +L + +        +++ L   +     
Sbjct: 77  KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQMLC---- 131
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
            G+++LH   +  ++HRDLK SNI++ S    K+ DFGL+ TAGT         T  Y A
Sbjct: 132 -GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 187
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELL 348
           PE +L     +  D+++ G ++ E++
Sbjct: 188 PEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 24/206 (11%)
Query: 155 FQESNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRH 208
           +Q    IG G +G V   Y A  +  +  A+K++     +   A+R +  E+  +  + H
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 76
Query: 209 QNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
           +NIISLL      +T       +LV E+M + +L + +        +++ L   +     
Sbjct: 77  KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQMLC---- 131
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
            G+++LH   +  ++HRDLK SNI++ S    K+ DFGL+ TAGT         T  Y A
Sbjct: 132 -GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 187
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELL 348
           PE +L     +  D+++ G ++ E++
Sbjct: 188 PEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 24/206 (11%)
Query: 155 FQESNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRH 208
           +Q    IG G +G V   Y A  +  +  A+K++     +   A+R +  E+  +  + H
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 75
Query: 209 QNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
           +NIISLL      +T       +LV E+M + +L + +        +++ L   +     
Sbjct: 76  KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQMLC---- 130
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
            G+++LH   +  ++HRDLK SNI++ S    K+ DFGL+ TAGT         T  Y A
Sbjct: 131 -GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 186
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELL 348
           PE +L     +  D+++ G ++ E++
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 96/197 (48%), Gaps = 16/197 (8%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRI----DDAGHDAEREFNNEVNWLTKIRHQNIISLLG 216
           IGEG  G VYKA+ N     A+K+I    +D G  +      E++ L +++H NI+ L  
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTT--IREISILKELKHSNIVKLYD 67
Query: 217 YCIHAETRF-LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHP 275
             IH + R  LV+E +    L+K L     G  L         + +  G+ Y H   +  
Sbjct: 68  -VIHTKKRLVLVFEHLDQ-DLKKLLDVCEGG--LESVTAKSFLLQLLNGIAYCH---DRR 120
Query: 276 VVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPEYLL-EGKLTD 333
           V+HRDLK  N+L++     K++DFGL+   G   R       TL Y AP+ L+   K + 
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYST 180
Query: 334 KSDVYAFGVVLLELLMG 350
             D+++ G +  E++ G
Sbjct: 181 TIDIWSVGCIFAEMVNG 197

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 24/206 (11%)
Query: 155 FQESNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRH 208
           +Q    IG G +G V   Y A  +  +  A+K++     +   A+R +  E+  +  + H
Sbjct: 25  YQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 81
Query: 209 QNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
           +NIISLL      +T       +LV E+M + +L + +        +++ L   +     
Sbjct: 82  KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQMLC---- 136
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
            G+++LH   +  ++HRDLK SNI++ S    K+ DFGL+ TAGT         T  Y A
Sbjct: 137 -GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 192
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELL 348
           PE +L     +  D+++ G ++ E++
Sbjct: 193 PEVILGMGYKENVDIWSVGCIMGEMV 218

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 24/206 (11%)
Query: 155 FQESNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRH 208
           +Q    IG G +G V   Y A  +  +  A+K++     +   A+R +  E+  +  + H
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 82
Query: 209 QNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
           +NIISLL      +T       +LV E+M + +L + +        +++ L   +     
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQMLC---- 137
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
            G+++LH   +  ++HRDLK SNI++ S    K+ DFGL+ TAGT         T  Y A
Sbjct: 138 -GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELL 348
           PE +L     +  D+++ G ++ E++
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 24/206 (11%)
Query: 155 FQESNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRH 208
           +Q    IG G +G V   Y A  +  +  A+K++     +   A+R +  E+  +  + H
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 82
Query: 209 QNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
           +NIISLL      +T       +LV E+M + +L + +        +++ L   +     
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQMLC---- 137
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
            G+++LH   +  ++HRDLK SNI++ S    K+ DFGL+ TAGT         T  Y A
Sbjct: 138 -GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELL 348
           PE +L     +  D+++ G ++ E++
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 76/156 (48%), Gaps = 18/156 (11%)
Query: 206 IRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
           ++H NI+ L          +L+++++  G L + +    + S            D +  +
Sbjct: 78  LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSE----------ADASHCI 127
Query: 266 EYLHE---HCNH-PVVHRDLKSSNILLDSSFNA---KLSDFGLSV-TAGTQSRNVKISGT 317
           + + E   HC+   VVHRDLK  N+LL S       KL+DFGL++   G Q      +GT
Sbjct: 128 QQILEAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGT 187
Query: 318 LGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
            GY++PE L +       D++A GV+L  LL+G  P
Sbjct: 188 PGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 223

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 96/197 (48%), Gaps = 16/197 (8%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRI----DDAGHDAEREFNNEVNWLTKIRHQNIISLLG 216
           IGEG  G VYKA+ N     A+K+I    +D G  +      E++ L +++H NI+ L  
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTT--IREISILKELKHSNIVKLYD 67
Query: 217 YCIHAETRF-LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHP 275
             IH + R  LV+E +    L+K L     G  L         + +  G+ Y H   +  
Sbjct: 68  -VIHTKKRLVLVFEHLDQ-DLKKLLDVCEGG--LESVTAKSFLLQLLNGIAYCH---DRR 120
Query: 276 VVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPEYLL-EGKLTD 333
           V+HRDLK  N+L++     K++DFGL+   G   R       TL Y AP+ L+   K + 
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYST 180
Query: 334 KSDVYAFGVVLLELLMG 350
             D+++ G +  E++ G
Sbjct: 181 TIDIWSVGCIFAEMVNG 197

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 96/197 (48%), Gaps = 16/197 (8%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRI----DDAGHDAEREFNNEVNWLTKIRHQNIISLLG 216
           IGEG  G VYKA+ N     A+K+I    +D G  +      E++ L +++H NI+ L  
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTT--IREISILKELKHSNIVKLYD 67
Query: 217 YCIHAETRF-LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHP 275
             IH + R  LV+E +    L+K L     G  L         + +  G+ Y H   +  
Sbjct: 68  -VIHTKKRLVLVFEHLDQ-DLKKLLDVCEGG--LESVTAKSFLLQLLNGIAYCH---DRR 120
Query: 276 VVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPEYLL-EGKLTD 333
           V+HRDLK  N+L++     K++DFGL+   G   R       TL Y AP+ L+   K + 
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYST 180
Query: 334 KSDVYAFGVVLLELLMG 350
             D+++ G +  E++ G
Sbjct: 181 TIDIWSVGCIFAEMVNG 197

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 24/206 (11%)
Query: 155 FQESNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRH 208
           +Q    IG G +G V   Y A  +  +  A+K++     +   A+R +  E+  +  + H
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 83
Query: 209 QNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
           +NIISLL      +T       +LV E+M + +L + +        +++ L   +     
Sbjct: 84  KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQMLC---- 138
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
            G+++LH   +  ++HRDLK SNI++ S    K+ DFGL+ TAGT         T  Y A
Sbjct: 139 -GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 194
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELL 348
           PE +L     +  D+++ G ++ E++
Sbjct: 195 PEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 111/237 (46%), Gaps = 15/237 (6%)
Query: 148 LEAATNNFQESNVIGEGGRGHVYKAR-FNEKLLAAVKRIDDAGHDAERE---FNNEVNWL 203
            E   ++ +    +G G  G V K R      + AVKRI    +  E++    + +++  
Sbjct: 46  FEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 105
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPT-HGSNLTWHLRMKIAVDVA 262
           T +     ++  G        ++  E+M + SL+K        G  +   +  KIAV + 
Sbjct: 106 T-VDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIV 163
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
           + LE+LH   +  V+HRD+K SN+L+++    K+ DFG+S            +G   Y+A
Sbjct: 164 KALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMA 221
Query: 323 PEY----LLEGKLTDKSDVYAFGVVLLELLMGRRPVEKM-SP-TQCQSMVTWAMPQL 373
           PE     L +   + KSD+++ G+ ++EL + R P +   +P  Q + +V    PQL
Sbjct: 222 PERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQL 278

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 32/217 (14%)
Query: 160 VIGEGGRGHVYKARFNEKLLAA--VKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGY 217
            +G+G  G V++  +  + +A       D+     E E  N V     +RH+NI+  +  
Sbjct: 15  CVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTV----MLRHENILGFIAS 70
Query: 218 CI---HAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLH---- 269
            +   H+ T+ +L+    + GSL   L   T  +       ++I + +A GL +LH    
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSC----LRIVLSIASGLAHLHIEIF 126
Query: 270 -EHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-----GTLGYVAP 323
                  + HRDLKS NIL+  +    ++D GL+V     +  + +      GT  Y+AP
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 324 EYLLEGKLTD------KSDVYAFGVVLLELLMGRRPV 354
           E L E    D      + D++AFG+VL E+   RR V
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEV--ARRMV 221

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 24/206 (11%)
Query: 155 FQESNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRH 208
           +Q    IG G +G V   Y A  +  +  A+K++     +   A+R +  E+  +  + H
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 120
Query: 209 QNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
           +NIISLL      +T       +LV E+M + +L + +        +++ L   +     
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQMLC---- 175
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
            G+++LH   +  ++HRDLK SNI++ S    K+ DFGL+ TAGT         T  Y A
Sbjct: 176 -GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 231
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELL 348
           PE +L     +  D+++ G ++ E++
Sbjct: 232 PEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 92/224 (41%), Gaps = 16/224 (7%)
Query: 133 LAGKKDTVSVIEYELLEA-ATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHD 191
           LA  K  V++ E+E L+      F +  ++ E   G  Y  +  +K +   K  D+  H 
Sbjct: 138 LAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAK--DEVAHT 195
Query: 192 AEREFNNEVNWLTKIRHQNIISLLGYCIHAETRF-LVYEMMQNGSLEKQLHGPTHGSNLT 250
                  E   L   RH   ++ L Y      R   V E    G L   L      S   
Sbjct: 196 L-----TENRVLQNSRHP-FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDR 249
Query: 251 WHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR 310
                    ++   L+YLH   N  VV+RDLK  N++LD   + K++DFGL         
Sbjct: 250 ARF---YGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA 304
Query: 311 NVK-ISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
            +K   GT  Y+APE L +       D +  GVV+ E++ GR P
Sbjct: 305 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 32/217 (14%)
Query: 160 VIGEGGRGHVYKARFNEKLLAA--VKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGY 217
            +G+G  G V++  +  + +A       D+     E E  N V     +RH+NI+  +  
Sbjct: 15  CVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTV----MLRHENILGFIAS 70
Query: 218 CI---HAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLH---- 269
            +   H+ T+ +L+    + GSL   L   T  +       ++I + +A GL +LH    
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSC----LRIVLSIASGLAHLHIEIF 126
Query: 270 -EHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-----GTLGYVAP 323
                  + HRDLKS NIL+  +    ++D GL+V     +  + +      GT  Y+AP
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 324 EYLLEGKLTD------KSDVYAFGVVLLELLMGRRPV 354
           E L E    D      + D++AFG+VL E+   RR V
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEV--ARRMV 221

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 24/206 (11%)
Query: 155 FQESNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRH 208
           +Q    IG G +G V   Y A  +  +  A+K++     +   A+R +  E+  +  + H
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 120
Query: 209 QNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
           +NIISLL      +T       +LV E+M + +L + +        +++ L   +     
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQMLC---- 175
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
            G+++LH   +  ++HRDLK SNI++ S    K+ DFGL+ TAGT         T  Y A
Sbjct: 176 -GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 231
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELL 348
           PE +L     +  D+++ G ++ E++
Sbjct: 232 PEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 100/225 (44%), Gaps = 26/225 (11%)
Query: 157 ESNVIGEGGRGHVYKA-RFNEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIR-HQNIIS 213
           + +V+GEG    V            AVK I+   GH   R F  EV  L + + H+N++ 
Sbjct: 17  QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFR-EVEMLYQCQGHRNVLE 75
Query: 214 LLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
           L+ +    +  +LV+E M+ GS+   +H   H + L   +   +  DVA  L++LH   N
Sbjct: 76  LIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV---VVQDVASALDFLH---N 129
Query: 274 HPVVHRDLKSSNILLDSSFN---AKLSDFGLSVTAGTQSRNVKIS--------GTLGYVA 322
             + HRDLK  NIL +        K+ DF L            IS        G+  Y+A
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 323 PE----YLLEGKLTDK-SDVYAFGVVLLELLMGRRPVEKMSPTQC 362
           PE    +  E  + DK  D+++ GV+L  LL G  P      + C
Sbjct: 190 PEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDC 234

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 32/217 (14%)
Query: 160 VIGEGGRGHVYKARFNEKLLAA--VKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGY 217
            +G+G  G V++  +  + +A       D+     E E  N V     +RH+NI+  +  
Sbjct: 44  CVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTV----MLRHENILGFIAS 99
Query: 218 CI---HAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLH---- 269
            +   H+ T+ +L+    + GSL   L   T  +       ++I + +A GL +LH    
Sbjct: 100 DMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSC----LRIVLSIASGLAHLHIEIF 155
Query: 270 -EHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-----GTLGYVAP 323
                  + HRDLKS NIL+  +    ++D GL+V     +  + +      GT  Y+AP
Sbjct: 156 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 215
Query: 324 EYLLEGKLTD------KSDVYAFGVVLLELLMGRRPV 354
           E L E    D      + D++AFG+VL E+   RR V
Sbjct: 216 EVLDETIQVDCFDSYKRVDIWAFGLVLWEV--ARRMV 250

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 92/224 (41%), Gaps = 16/224 (7%)
Query: 133 LAGKKDTVSVIEYELLEA-ATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHD 191
           LA  K  V++ E+E L+      F +  ++ E   G  Y  +  +K +   K  D+  H 
Sbjct: 141 LAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAK--DEVAHT 198
Query: 192 AEREFNNEVNWLTKIRHQNIISLLGYCIHAETRF-LVYEMMQNGSLEKQLHGPTHGSNLT 250
                  E   L   RH   ++ L Y      R   V E    G L   L      S   
Sbjct: 199 L-----TENRVLQNSRHP-FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDR 252
Query: 251 WHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR 310
                    ++   L+YLH   N  VV+RDLK  N++LD   + K++DFGL         
Sbjct: 253 ARF---YGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA 307
Query: 311 NVK-ISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
            +K   GT  Y+APE L +       D +  GVV+ E++ GR P
Sbjct: 308 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 351

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 110/237 (46%), Gaps = 15/237 (6%)
Query: 148 LEAATNNFQESNVIGEGGRGHVYKAR-FNEKLLAAVKRIDDAGHDAERE---FNNEVNWL 203
           +E   ++ +    +G G  G V K R      + AVKRI    +  E++    + +++  
Sbjct: 2   MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPT-HGSNLTWHLRMKIAVDVA 262
           T +     ++  G        ++  E+M + SL+K        G  +   +  KIAV + 
Sbjct: 62  T-VDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIV 119
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
           + LE+LH   +  V+HRD+K SN+L+++    K+ DFG+S            +G   Y+A
Sbjct: 120 KALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMA 177
Query: 323 PEY----LLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSP--TQCQSMVTWAMPQL 373
           PE     L +   + KSD+++ G+ ++EL + R P +       Q + +V    PQL
Sbjct: 178 PERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQL 234

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 100/208 (48%), Gaps = 24/208 (11%)
Query: 155 FQESNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRH 208
           +Q    IG G +G V   Y A     +  A+K++     +   A+R +  E+  +  + H
Sbjct: 26  YQNLKPIGSGAQGIVVAAYDAILERNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKVVNH 82
Query: 209 QNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
           +NII LL      ++       ++V E+M + +L + +        +++ L   +     
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQMELDHERMSYLLYQMLV---- 137
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
            G+++LH      ++HRDLK SNI++ S    K+ DFGL+ TAGT         T  Y A
Sbjct: 138 -GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMG 350
           PE +L     +  D+++ GV++ E++ G
Sbjct: 194 PEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 100/208 (48%), Gaps = 24/208 (11%)
Query: 155 FQESNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRH 208
           +Q    IG G +G V   Y A     +  A+K++     +   A+R +  E+  +  + H
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKVVNH 82
Query: 209 QNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
           +NII LL      ++       ++V E+M + +L + +        +++ L   +     
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQMELDHERMSYLLYQMLV---- 137
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
            G+++LH      ++HRDLK SNI++ S    K+ DFGL+ TAGT         T  Y A
Sbjct: 138 -GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMG 350
           PE +L     +  D+++ GV++ E++ G
Sbjct: 194 PEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 101/208 (48%), Gaps = 24/208 (11%)
Query: 155 FQESNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRH 208
           +Q    IG G +G V   Y A     +  A+K++     +   A+R +  E+  +  + H
Sbjct: 28  YQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 84
Query: 209 QNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
           +NII LL      ++       ++V E+M + +L + +        +++ L   +     
Sbjct: 85  KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSYLLYQMLC---- 139
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
            G+++LH   +  ++HRDLK SNI++ S    K+ DFGL+ TAGT    V    T  Y A
Sbjct: 140 -GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVVTRYYRA 195
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMG 350
           PE +L     +  D+++ G ++ E++ G
Sbjct: 196 PEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/248 (25%), Positives = 103/248 (41%), Gaps = 29/248 (11%)
Query: 191 DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLT 250
           +A  +F  EVN +  + H+N+I L G  +    + +V E+   GSL  +L    H  +  
Sbjct: 63  EAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLR--KHQGHFL 119
Query: 251 WHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR 310
                + AV VA G+ YL    +   +HRDL + N+LL +    K+ DFGL + A  Q+ 
Sbjct: 120 LGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGL-MRALPQND 175
Query: 311 NVKISG-----TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQS 364
           +  +          + APE L     +  SD + FGV L E+   G+ P   ++ +Q   
Sbjct: 176 DHXVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH 235
Query: 365 MVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
            +     +L      P                  +  V V C   +P  RP    +   L
Sbjct: 236 KIDKEGERLPRPEDCPQ----------------DIYNVMVQCWAHKPEDRPTFVALRDFL 279
Query: 425 IPLVPTDL 432
           +   PTD+
Sbjct: 280 LEAQPTDM 287

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 96/220 (43%), Gaps = 30/220 (13%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNEKLLAA---------VKRIDDAGHDAEREFNNEVN 201
            T   +E  +  E G+G     R   K+LA           K++    H   ++   E  
Sbjct: 6   CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDH---QKLEREAR 62
Query: 202 WLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDV 261
               ++H NI+ L          +L+++++  G L + +    + S            D 
Sbjct: 63  ICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSE----------ADA 112
Query: 262 ARGLEYLHE---HCNH-PVVHRDLKSSNILLDSSFNA---KLSDFGLSV-TAGTQSRNVK 313
           +  ++ + E   HC+   VVHR+LK  N+LL S       KL+DFGL++   G Q     
Sbjct: 113 SHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG 172
Query: 314 ISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
            +GT GY++PE L +       D++A GV+L  LL+G  P
Sbjct: 173 FAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 64/248 (25%), Positives = 103/248 (41%), Gaps = 29/248 (11%)
Query: 191 DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLT 250
           +A  +F  EVN +  + H+N+I L G  +    + +V E+   GSL  +L    H  +  
Sbjct: 63  EAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLR--KHQGHFL 119
Query: 251 WHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR 310
                + AV VA G+ YL    +   +HRDL + N+LL +    K+ DFGL + A  Q+ 
Sbjct: 120 LGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGL-MRALPQND 175
Query: 311 NVKISG-----TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQS 364
           +  +          + APE L     +  SD + FGV L E+   G+ P   ++ +Q   
Sbjct: 176 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH 235
Query: 365 MVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
            +     +L      P                  +  V V C   +P  RP    +   L
Sbjct: 236 KIDKEGERLPRPEDCPQ----------------DIYNVMVQCWAHKPEDRPTFVALRDFL 279
Query: 425 IPLVPTDL 432
           +   PTD+
Sbjct: 280 LEAQPTDM 287

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 84/163 (51%), Gaps = 15/163 (9%)
Query: 198 NEVNWLTKIRHQNIISLLGYC--IHAETRFLVYEMMQNGS-LEKQLHGPTHGSNLTWHLR 254
            E+  L K+ H N++ L+      + +  ++V+E++  G  +E     P       ++ +
Sbjct: 85  QEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQ 144
Query: 255 MKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT-AGTQSRNVK 313
                D+ +G+EYLH      ++HRD+K SN+L+    + K++DFG+S    G+ +    
Sbjct: 145 -----DLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSN 196
Query: 314 ISGTLGYVAPEYLLEGK--LTDKS-DVYAFGVVLLELLMGRRP 353
             GT  ++APE L E +   + K+ DV+A GV L   + G+ P
Sbjct: 197 TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 64/248 (25%), Positives = 103/248 (41%), Gaps = 29/248 (11%)
Query: 191 DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLT 250
           +A  +F  EVN +  + H+N+I L G  +    + +V E+   GSL  +L    H  +  
Sbjct: 57  EAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLR--KHQGHFL 113
Query: 251 WHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR 310
                + AV VA G+ YL    +   +HRDL + N+LL +    K+ DFGL + A  Q+ 
Sbjct: 114 LGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGL-MRALPQND 169
Query: 311 NVKISGT-----LGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQS 364
           +  +          + APE L     +  SD + FGV L E+   G+ P   ++ +Q   
Sbjct: 170 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH 229
Query: 365 MVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
            +     +L      P                  +  V V C   +P  RP    +   L
Sbjct: 230 KIDKEGERLPRPEDCPQ----------------DIYNVMVQCWAHKPEDRPTFVALRDFL 273
Query: 425 IPLVPTDL 432
           +   PTD+
Sbjct: 274 LEAQPTDM 281

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 40/125 (32%), Positives = 67/125 (53%), Gaps = 18/125 (14%)
Query: 244 THGSNLTWHL----RMK------IAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFN 293
            +G +L +H+    R K       A ++A GL +L    +  +++RDLK  N++LDS  +
Sbjct: 103 VNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGH 159
Query: 294 AKLSDFGL---SVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMG 350
            K++DFG+   ++  G  ++     GT  Y+APE +         D +AFGV+L E+L G
Sbjct: 160 IKIADFGMCKENIWDGVTTKX--FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 217
Query: 351 RRPVE 355
           + P E
Sbjct: 218 QAPFE 222

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 37/125 (29%), Positives = 68/125 (54%), Gaps = 18/125 (14%)
Query: 244 THGSNLTWHLR----------MKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFN 293
            +G +L +H++          +  A +++ GL +LH+     +++RDLK  N++LDS  +
Sbjct: 102 VNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKRG---IIYRDLKLDNVMLDSEGH 158
Query: 294 AKLSDFGLS---VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMG 350
            K++DFG+    +  G  +R  +  GT  Y+APE +         D +A+GV+L E+L G
Sbjct: 159 IKIADFGMCKEHMMDGVTTR--EFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAG 216
Query: 351 RRPVE 355
           + P +
Sbjct: 217 QPPFD 221

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
           +Q  + +G G  G V  A F+ K  L  AVK++         A+R +  E+  L  ++H+
Sbjct: 24  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 81
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           N+I LL     A +       +LV  +M        L+       LT      +   + R
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           GL+Y+H   +  ++HRDLK SN+ ++     K+ DFGL+    T         T  Y AP
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 191
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           E +L     +++ D+++ G ++ ELL GR
Sbjct: 192 EIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 100/208 (48%), Gaps = 24/208 (11%)
Query: 155 FQESNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRH 208
           +Q    IG G +G V   Y A     +  A+K++     +   A+R +  E+  +  + H
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 82
Query: 209 QNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
           +NII LL      ++       ++V E+M + +L + +        +++ L   +     
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQMELDHERMSYLLYQMLC---- 137
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
            G+++LH   +  ++HRDLK SNI++ S    K+ DFGL+ TAGT         T  Y A
Sbjct: 138 -GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMG 350
           PE +L     +  D+++ G ++ E++ G
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 101/238 (42%), Gaps = 34/238 (14%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA------RFNEKLLAAVKRIDDAGHDAERE-FNNEVN 201
           E   N       +G G  G V +A      + +  +  AVK +  + H  ERE   +E+ 
Sbjct: 19  EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 78
Query: 202 WLTKI-RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLH-----------GPT----H 245
            L+ +  H NI++LLG C       ++ E    G L   L             P      
Sbjct: 79  VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138
Query: 246 GSNLTWHLRMKIAVDVARGLEYL-HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT 304
              L     +  +  VA+G+ +L  ++C    +HRDL + NILL      K+ DFGL+  
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARD 194
Query: 305 AGTQSRNVKISGT----LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKM 357
               S N  + G     + ++APE +     T +SDV+++G+ L EL  +G  P   M
Sbjct: 195 IKNDS-NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 101/238 (42%), Gaps = 34/238 (14%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA------RFNEKLLAAVKRIDDAGHDAERE-FNNEVN 201
           E   N       +G G  G V +A      + +  +  AVK +  + H  ERE   +E+ 
Sbjct: 37  EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 96
Query: 202 WLTKI-RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLH-----------GPT----H 245
            L+ +  H NI++LLG C       ++ E    G L   L             P      
Sbjct: 97  VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 156
Query: 246 GSNLTWHLRMKIAVDVARGLEYL-HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT 304
              L     +  +  VA+G+ +L  ++C    +HRDL + NILL      K+ DFGL+  
Sbjct: 157 ELALDLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARD 212
Query: 305 AGTQSRNVKISGT----LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKM 357
               S N  + G     + ++APE +     T +SDV+++G+ L EL  +G  P   M
Sbjct: 213 IKNDS-NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 269

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 101/238 (42%), Gaps = 34/238 (14%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA------RFNEKLLAAVKRIDDAGHDAERE-FNNEVN 201
           E   N       +G G  G V +A      + +  +  AVK +  + H  ERE   +E+ 
Sbjct: 35  EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 94
Query: 202 WLTKI-RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLH-----------GPT----H 245
            L+ +  H NI++LLG C       ++ E    G L   L             P      
Sbjct: 95  VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 154
Query: 246 GSNLTWHLRMKIAVDVARGLEYL-HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT 304
              L     +  +  VA+G+ +L  ++C    +HRDL + NILL      K+ DFGL+  
Sbjct: 155 ELALDLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARD 210
Query: 305 AGTQSRNVKISGT----LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKM 357
               S N  + G     + ++APE +     T +SDV+++G+ L EL  +G  P   M
Sbjct: 211 IKNDS-NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 267

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 101/238 (42%), Gaps = 34/238 (14%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA------RFNEKLLAAVKRIDDAGHDAERE-FNNEVN 201
           E   N       +G G  G V +A      + +  +  AVK +  + H  ERE   +E+ 
Sbjct: 42  EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 101
Query: 202 WLTKI-RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLH-----------GPT----H 245
            L+ +  H NI++LLG C       ++ E    G L   L             P      
Sbjct: 102 VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 161
Query: 246 GSNLTWHLRMKIAVDVARGLEYL-HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT 304
              L     +  +  VA+G+ +L  ++C    +HRDL + NILL      K+ DFGL+  
Sbjct: 162 ELALDLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARD 217
Query: 305 AGTQSRNVKISGT----LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKM 357
               S N  + G     + ++APE +     T +SDV+++G+ L EL  +G  P   M
Sbjct: 218 IKNDS-NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 274

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 107/222 (48%), Gaps = 36/222 (16%)
Query: 150 AATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQ 209
           A T   QES  IG+G  G V++ ++  + +A   +I  +  +       E+     +RH+
Sbjct: 41  ARTIVLQES--IGKGRFGEVWRGKWRGEEVAV--KIFSSREERSWFREAEIYQTVMLRHE 96
Query: 210 NIISLLGYCIHAETR--------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDV 261
           NI   LG+ I A+ +        +LV +  ++GSL   L+  T    +T    +K+A+  
Sbjct: 97  NI---LGF-IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALST 148
Query: 262 ARGLEYLH-----EHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS- 315
           A GL +LH           + HRDLKS NIL+  +    ++D GL+V   + +  + I+ 
Sbjct: 149 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP 208
Query: 316 ----GTLGYVAPEYLLEG------KLTDKSDVYAFGVVLLEL 347
               GT  Y+APE L +       +   ++D+YA G+V  E+
Sbjct: 209 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 51/97 (52%), Gaps = 3/97 (3%)
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK-ISG 316
             ++   L+YLH   N  VV+RDLK  N++LD   + K++DFGL          +K   G
Sbjct: 114 GAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCG 171
Query: 317 TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
           T  Y+APE L +       D +  GVV+ E++ GR P
Sbjct: 172 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 208

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 40/124 (32%), Positives = 67/124 (54%), Gaps = 18/124 (14%)
Query: 245 HGSNLTWHL----RMK------IAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA 294
           +G +L +H+    R K       A ++A GL +L    +  +++RDLK  N++LDS  + 
Sbjct: 425 NGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHI 481
Query: 295 KLSDFGL---SVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGR 351
           K++DFG+   ++  G  ++     GT  Y+APE +         D +AFGV+L E+L G+
Sbjct: 482 KIADFGMCKENIWDGVTTKX--FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
Query: 352 RPVE 355
            P E
Sbjct: 540 APFE 543

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 51/97 (52%), Gaps = 3/97 (3%)
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK-ISG 316
             ++   L+YLH   N  VV+RDLK  N++LD   + K++DFGL          +K   G
Sbjct: 116 GAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCG 173
Query: 317 TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
           T  Y+APE L +       D +  GVV+ E++ GR P
Sbjct: 174 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 210

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 102/247 (41%), Gaps = 29/247 (11%)
Query: 191 DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLT 250
           +A  +F  EVN +  + H+N+I L G  +    + +V E+   GSL  +L    H  +  
Sbjct: 53  EAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLR--KHQGHFL 109
Query: 251 WHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR 310
                + AV VA G+ YL    +   +HRDL + N+LL +    K+ DFGL + A  Q+ 
Sbjct: 110 LGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGL-MRALPQND 165
Query: 311 NVKISG-----TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQS 364
           +  +          + APE L     +  SD + FGV L E+   G+ P   ++ +Q   
Sbjct: 166 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH 225
Query: 365 MVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
            +     +L      P                  +  V V C   +P  RP    +   L
Sbjct: 226 KIDKEGERLPRPEDCPQ----------------DIYNVMVQCWAHKPEDRPTFVALRDFL 269
Query: 425 IPLVPTD 431
           +   PTD
Sbjct: 270 LEAQPTD 276

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 30/212 (14%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
           +Q  + +G G  G V  A F+ K  L  AVK++         A+R +  E+  L  ++H+
Sbjct: 24  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 81
Query: 210 NIISLLGYCIHAETR------FLVYEMMQ---NGSLEKQLHGPTHGSNLTWHLRMKIAVD 260
           N+I LL     A +       +LV  +M    N  ++ Q     H   L +         
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQ-------- 133
Query: 261 VARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGY 320
           + RGL+Y+H   +  ++HRDLK SN+ ++     K+ DFGL+    T         T  Y
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLA--RHTDDEMTGYVATRWY 188
Query: 321 VAPEYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
            APE +L     +++ D+++ G ++ ELL GR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 51/97 (52%), Gaps = 3/97 (3%)
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK-ISG 316
             ++   L+YLH   N  VV+RDLK  N++LD   + K++DFGL          +K   G
Sbjct: 115 GAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCG 172
Query: 317 TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
           T  Y+APE L +       D +  GVV+ E++ GR P
Sbjct: 173 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
           +Q  + IG G  G V  A F+ K  L  AVK++         A+R +  E+  L  ++H+
Sbjct: 29  YQNLSPIGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 86
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           N+I LL     A +       +LV  +M        L+       LT      +   + R
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 141
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           GL+Y+H   +  ++HRDLK SN+ ++     K+ DFGL+    T         T  Y AP
Sbjct: 142 GLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLA--RHTDDEMTGYVATRWYRAP 196
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           E +L     +++ D+++ G ++ ELL GR
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 30/212 (14%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
           +Q  + +G G  G V  A F+ K  L  AVK++         A+R +  E+  L  ++H+
Sbjct: 24  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 81
Query: 210 NIISLLGYCIHAETR------FLVYEMMQ---NGSLEKQLHGPTHGSNLTWHLRMKIAVD 260
           N+I LL     A +       +LV  +M    N  ++ Q     H   L +         
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQ-------- 133
Query: 261 VARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGY 320
           + RGL+Y+H   +  ++HRDLK SN+ ++     K+ DFGL+    T         T  Y
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWY 188
Query: 321 VAPEYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
            APE +L     +++ D+++ G ++ ELL GR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 100/208 (48%), Gaps = 24/208 (11%)
Query: 155 FQESNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRH 208
           +Q    IG G +G V   Y A     +  A+K++     +   A+R +  E+  +  + H
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 82
Query: 209 QNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
           +NII LL      ++       ++V E+M + +L + +        +++ L   +     
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQMELDHERMSYLLYQMLC---- 137
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
            G+++LH   +  ++HRDLK SNI++ S    K+ DFGL+ TAGT         T  Y A
Sbjct: 138 -GIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMG 350
           PE +L     +  D+++ G ++ E++ G
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 100/208 (48%), Gaps = 24/208 (11%)
Query: 155 FQESNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRH 208
           +Q    IG G +G V   Y A     +  A+K++     +   A+R +  E+  +  + H
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKVVNH 82
Query: 209 QNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
           +NII LL      ++       ++V E+M + +L + +        +++ L   +     
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQMELDHERMSYLLYQMLC---- 137
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
            G+++LH   +  ++HRDLK SNI++ S    K+ DFGL+ TAGT         T  Y A
Sbjct: 138 -GIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMG 350
           PE +L     +  D+++ G ++ E++ G
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
           +Q  + +G G  G V  A F+ K  L  AVK++         A+R +  E+  L  ++H+
Sbjct: 36  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSKPFQSIIHAKRTYR-ELRLLKHMKHE 93
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           N+I LL     A +       +LV  +M        L+       LT      +   + R
Sbjct: 94  NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 148
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           GL+Y+H   +  ++HRDLK SN+ ++     K+ DFGL+    T         T  Y AP
Sbjct: 149 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 203
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           E +L     +++ D+++ G ++ ELL GR
Sbjct: 204 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 107/222 (48%), Gaps = 36/222 (16%)
Query: 150 AATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQ 209
           A T   QES  IG+G  G V++ ++  + +A   +I  +  +       E+     +RH+
Sbjct: 28  ARTIVLQES--IGKGRFGEVWRGKWRGEEVAV--KIFSSREERSWFREAEIYQTVMLRHE 83
Query: 210 NIISLLGYCIHAETR--------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDV 261
           NI   LG+ I A+ +        +LV +  ++GSL   L+  T    +T    +K+A+  
Sbjct: 84  NI---LGF-IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALST 135
Query: 262 ARGLEYLH-----EHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS- 315
           A GL +LH           + HRDLKS NIL+  +    ++D GL+V   + +  + I+ 
Sbjct: 136 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP 195
Query: 316 ----GTLGYVAPEYLLEG------KLTDKSDVYAFGVVLLEL 347
               GT  Y+APE L +       +   ++D+YA G+V  E+
Sbjct: 196 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 80/173 (46%), Gaps = 27/173 (15%)
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT 317
           +  VA+G+E+L    +   +HRDL + NILL      K+ DFGL+         V+    
Sbjct: 197 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 253
Query: 318 ---LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVE--KMSPTQCQSMVTWAMP 371
              L ++APE + +   T +SDV++FGV+L E+  +G  P    K+    C+ +      
Sbjct: 254 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL------ 307
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
           +   R + P+   P +  TM            + C   EPS RP  ++++  L
Sbjct: 308 KEGTRMRAPDYTTPEMYQTM------------LDCWHGEPSQRPTFSELVEHL 348

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
           +Q  + +G G  G V  A F+ K  L  AVK++         A+R +  E+  L  ++H+
Sbjct: 24  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 81
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           N+I LL     A +       +LV  +M        L+       LT      +   + R
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           GL+Y+H   +  ++HRDLK SN+ ++     K+ DFGL+    T         T  Y AP
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 191
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           E +L     +++ D+++ G ++ ELL GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 101/238 (42%), Gaps = 34/238 (14%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA------RFNEKLLAAVKRIDDAGHDAERE-FNNEVN 201
           E   N       +G G  G V +A      + +  +  AVK +  + H  ERE   +E+ 
Sbjct: 42  EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 101
Query: 202 WLTKI-RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLH-----------GPT----H 245
            L+ +  H NI++LLG C       ++ E    G L   L             P      
Sbjct: 102 VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 161
Query: 246 GSNLTWHLRMKIAVDVARGLEYL-HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT 304
              L     +  +  VA+G+ +L  ++C    +HRDL + NILL      K+ DFGL+  
Sbjct: 162 ELALDLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARH 217
Query: 305 AGTQSRNVKISGT----LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKM 357
               S N  + G     + ++APE +     T +SDV+++G+ L EL  +G  P   M
Sbjct: 218 IKNDS-NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 274

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
           +Q  + +G G  G V  A F+ K  L  AVK++         A+R +  E+  L  ++H+
Sbjct: 24  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 81
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           N+I LL     A +       +LV  +M        L+       LT      +   + R
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           GL+Y+H   +  ++HRDLK SN+ ++     K+ DFGL+    T         T  Y AP
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 191
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           E +L     +++ D+++ G ++ ELL GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
           +Q  + +G G  G V  A F+ K  L  AVK++         A+R +  E+  L  ++H+
Sbjct: 24  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 81
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           N+I LL     A +       +LV  +M        L+       LT      +   + R
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           GL+Y+H   +  ++HRDLK SN+ ++     K+ DFGL+    T         T  Y AP
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGXVATRWYRAP 191
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           E +L     +++ D+++ G ++ ELL GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
           +Q  + +G G  G V  A F+ K  L  AVK++         A+R +  E+  L  ++H+
Sbjct: 20  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 77
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           N+I LL     A +       +LV  +M        L+       LT      +   + R
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 132
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           GL+Y+H   +  ++HRDLK SN+ ++     K+ DFGL+    T         T  Y AP
Sbjct: 133 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 187
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           E +L     +++ D+++ G ++ ELL GR
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 52/97 (53%), Gaps = 4/97 (4%)
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK-ISG 316
             ++   LEYLH   +  VV+RD+K  N++LD   + K++DFGL     +    +K   G
Sbjct: 116 GAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCG 172
Query: 317 TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
           T  Y+APE L +       D +  GVV+ E++ GR P
Sbjct: 173 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 111/265 (41%), Gaps = 36/265 (13%)
Query: 161 IGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCI 219
           + E   G ++K R+    ++  V ++ D      R+FN E   L    H N++ +LG C 
Sbjct: 18  LNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQ 77
Query: 220 H--AETRFLVYEMMQNGSLEKQLHGPTHGSNLT--WHLRMKIAVDVARGLEYLHEHCNHP 275
              A    L+      GSL   LH    G+N        +K A+D ARG  +L  H   P
Sbjct: 78  SPPAPHPTLITHWXPYGSLYNVLH---EGTNFVVDQSQAVKFALDXARGXAFL--HTLEP 132
Query: 276 VVHRD-LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTD- 333
           ++ R  L S ++ +D    A++S   +  +  +  R         +VAPE  L+ K  D 
Sbjct: 133 LIPRHALNSRSVXIDEDXTARISXADVKFSFQSPGRXY----APAWVAPE-ALQKKPEDT 187
Query: 334 ---KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDT 390
               +D ++F V+L EL+    P   +S  +    V  A+  L  R  +P  + P     
Sbjct: 188 NRRSADXWSFAVLLWELVTREVPFADLSNXEIGXKV--ALEGL--RPTIPPGISP----- 238
Query: 391 MDLKHLYQVAAVAVLCIQPEPSYRP 415
                   V+ +  +C   +P+ RP
Sbjct: 239 -------HVSKLXKICXNEDPAKRP 256

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
           +Q  + +G G  G V  A F+ K  L  AVK++         A+R +  E+  L  ++H+
Sbjct: 24  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 81
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           N+I LL     A +       +LV  +M        L+       LT      +   + R
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           GL+Y+H   +  ++HRDLK SN+ ++     K+ DFGL+    T         T  Y AP
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 191
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           E +L     +++ D+++ G ++ ELL GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 52/97 (53%), Gaps = 4/97 (4%)
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK-ISG 316
             ++   LEYLH   +  VV+RD+K  N++LD   + K++DFGL     +    +K   G
Sbjct: 111 GAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCG 167
Query: 317 TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
           T  Y+APE L +       D +  GVV+ E++ GR P
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 99/208 (47%), Gaps = 24/208 (11%)
Query: 155 FQESNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRH 208
           +Q    IG G +G V   Y A     +  A+K++     +   A+R +  E+  +  + H
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKVVNH 82
Query: 209 QNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
           +NII LL      ++       ++V E+M + +L + +        +++ L   +     
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQMELDHERMSYLLYQMLV---- 137
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
            G+++LH      ++HRDLK SNI++ S    K+ DFGL+ TAGT         T  Y A
Sbjct: 138 -GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMG 350
           PE +L     +  D+++ G ++ E++ G
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 91/203 (44%), Gaps = 11/203 (5%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNEK-LLAAVKRIDDAGHDA--EREFNNEVNWLTKIRHQ 209
             +++   IGEG  G V+K R  +   + A+K+  ++  D   ++    E+  L +++H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 210 NIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLH 269
           N+++LL          LV+E   +  L +      +   +  HL   I     + + + H
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCDHTVLHEL---DRYQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 270 EHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS-VTAGTQSRNVKISGTLGYVAPEYLL- 327
           +H     +HRD+K  NIL+      KL DFG + +  G          T  Y +PE L+ 
Sbjct: 120 KH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVG 176
Query: 328 EGKLTDKSDVYAFGVVLLELLMG 350
           + +     DV+A G V  ELL G
Sbjct: 177 DTQYGPPVDVWAIGCVFAELLSG 199

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
           +Q  + +G G  G V  A F+ K  L  AVK++         A+R +  E+  L  ++H+
Sbjct: 24  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 81
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           N+I LL     A +       +LV  +M        L+       LT      +   + R
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           GL+Y+H   +  ++HRDLK SN+ ++     K+ DFGL+    T         T  Y AP
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 191
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           E +L     +++ D+++ G ++ ELL GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
           +Q  + +G G  G V  A F+ K  L  AVK++         A+R +  E+  L  ++H+
Sbjct: 21  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 78
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           N+I LL     A +       +LV  +M        L+       LT      +   + R
Sbjct: 79  NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 133
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           GL+Y+H   +  ++HRDLK SN+ ++     K+ DFGL+    T         T  Y AP
Sbjct: 134 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 188
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           E +L     +++ D+++ G ++ ELL GR
Sbjct: 189 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 100/208 (48%), Gaps = 24/208 (11%)
Query: 155 FQESNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRH 208
           +Q    IG G +G V   Y A     +  A+K++     +   A+R +  E+  +  + H
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 82
Query: 209 QNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
           +NII LL      ++       ++V E+M + +L + +        +++ L   +     
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSYLLYQMLC---- 137
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
            G+++LH   +  ++HRDLK SNI++ S    K+ DFGL+ TAGT         T  Y A
Sbjct: 138 -GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMG 350
           PE +L     +  D+++ G ++ E++ G
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
           +Q  + +G G  G V  A F+ K  L  AVK++         A+R +  E+  L  ++H+
Sbjct: 24  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 81
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           N+I LL     A +       +LV  +M        L+       LT      +   + R
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           GL+Y+H   +  ++HRDLK SN+ ++     K+ DFGL+    T         T  Y AP
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 191
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           E +L     +++ D+++ G ++ ELL GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
           +Q  + +G G  G V  A F+ K  L  AVK++         A+R +  E+  L  ++H+
Sbjct: 22  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 79
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           N+I LL     A +       +LV  +M        L+       LT      +   + R
Sbjct: 80  NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 134
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           GL+Y+H   +  ++HRDLK SN+ ++     K+ DFGL+    T         T  Y AP
Sbjct: 135 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 189
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           E +L     +++ D+++ G ++ ELL GR
Sbjct: 190 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
           +Q  + +G G  G V  A F+ K  L  AVK++         A+R +  E+  L  ++H+
Sbjct: 21  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 78
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           N+I LL     A +       +LV  +M        L+       LT      +   + R
Sbjct: 79  NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 133
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           GL+Y+H   +  ++HRDLK SN+ ++     K+ DFGL+    T         T  Y AP
Sbjct: 134 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 188
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           E +L     +++ D+++ G ++ ELL GR
Sbjct: 189 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 80/173 (46%), Gaps = 27/173 (15%)
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT 317
           +  VA+G+E+L    +   +HRDL + NILL      K+ DFGL+         V+    
Sbjct: 199 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 255
Query: 318 ---LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVE--KMSPTQCQSMVTWAMP 371
              L ++APE + +   T +SDV++FGV+L E+  +G  P    K+    C+ +      
Sbjct: 256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL------ 309
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
           +   R + P+   P +  TM            + C   EPS RP  ++++  L
Sbjct: 310 KEGTRMRAPDYTTPEMYQTM------------LDCWHGEPSQRPTFSELVEHL 350

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
           +Q  + +G G  G V  A F+ K  L  AVK++         A+R +  E+  L  ++H+
Sbjct: 24  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 81
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           N+I LL     A +       +LV  +M        L+       LT      +   + R
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           GL+Y+H   +  ++HRDLK SN+ ++     K+ DFGL+    T         T  Y AP
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 191
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           E +L     +++ D+++ G ++ ELL GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
           +Q  + +G G  G V  A F+ K  L  AVK++         A+R +  E+  L  ++H+
Sbjct: 31  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 88
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           N+I LL     A +       +LV  +M        L+       LT      +   + R
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 143
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           GL+Y+H   +  ++HRDLK SN+ ++     K+ DFGL+    T         T  Y AP
Sbjct: 144 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 198
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           E +L     +++ D+++ G ++ ELL GR
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 107/222 (48%), Gaps = 36/222 (16%)
Query: 150 AATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQ 209
           A T   QES  IG+G  G V++ ++  + +A   +I  +  +       E+     +RH+
Sbjct: 8   ARTIVLQES--IGKGRFGEVWRGKWRGEEVAV--KIFSSREERSWFREAEIYQTVMLRHE 63
Query: 210 NIISLLGYCIHAETR--------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDV 261
           NI   LG+ I A+ +        +LV +  ++GSL   L+  T    +T    +K+A+  
Sbjct: 64  NI---LGF-IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALST 115
Query: 262 ARGLEYLH-----EHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS- 315
           A GL +LH           + HRDLKS NIL+  +    ++D GL+V   + +  + I+ 
Sbjct: 116 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP 175
Query: 316 ----GTLGYVAPEYLLEG------KLTDKSDVYAFGVVLLEL 347
               GT  Y+APE L +       +   ++D+YA G+V  E+
Sbjct: 176 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 107/222 (48%), Gaps = 36/222 (16%)
Query: 150 AATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQ 209
           A T   QES  IG+G  G V++ ++  + +A   +I  +  +       E+     +RH+
Sbjct: 2   ARTIVLQES--IGKGRFGEVWRGKWRGEEVAV--KIFSSREERSWFREAEIYQTVMLRHE 57
Query: 210 NIISLLGYCIHAETR--------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDV 261
           NI   LG+ I A+ +        +LV +  ++GSL   L+  T    +T    +K+A+  
Sbjct: 58  NI---LGF-IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALST 109
Query: 262 ARGLEYLH-----EHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS- 315
           A GL +LH           + HRDLKS NIL+  +    ++D GL+V   + +  + I+ 
Sbjct: 110 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP 169
Query: 316 ----GTLGYVAPEYLLEG------KLTDKSDVYAFGVVLLEL 347
               GT  Y+APE L +       +   ++D+YA G+V  E+
Sbjct: 170 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 82/203 (40%), Gaps = 16/203 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNII 212
             F +  ++ E   G  Y  +   K +   K  D+  H        E   L   RH   +
Sbjct: 16  GTFGKVILVREKATGRYYAMKILRKEVIIAK--DEVAHTV-----TESRVLQNTRHP-FL 67
Query: 213 SLLGYCIHAETRF-LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
           + L Y      R   V E    G L   L   +     T         ++   LEYLH  
Sbjct: 68  TALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYLH-- 122
Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK-ISGTLGYVAPEYLLEGK 330
            +  VV+RD+K  N++LD   + K++DFGL     +    +K   GT  Y+APE L +  
Sbjct: 123 -SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181
Query: 331 LTDKSDVYAFGVVLLELLMGRRP 353
                D +  GVV+ E++ GR P
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
           +Q  + +G G  G V  A F+ K  L  AVK++         A+R +  E+  L  ++H+
Sbjct: 26  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 83
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           N+I LL     A +       +LV  +M        L+       LT      +   + R
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 138
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           GL+Y+H   +  ++HRDLK SN+ ++     K+ DFGL+    T         T  Y AP
Sbjct: 139 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 193
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           E +L     +++ D+++ G ++ ELL GR
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 84/200 (42%), Gaps = 13/200 (6%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNEK-LLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNI 211
            +FQ  + +G G  G V+K R  E   L AVKR         R   +    L ++     
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKR----SMSPFRGPKDRARKLAEVGSHEK 112
Query: 212 ISLLGYCIHAETRF----LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEY 267
           +     C+  E  +    ++Y   +      Q H    G++L          D    L +
Sbjct: 113 VGQHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAH 172
Query: 268 LHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLL 327
           LH   +  +VH D+K +NI L      KL DFGL V  GT        G   Y+APE LL
Sbjct: 173 LH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPE-LL 228
Query: 328 EGKLTDKSDVYAFGVVLLEL 347
           +G     +DV++ G+ +LE+
Sbjct: 229 QGSYGTAADVFSLGLTILEV 248

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
           +Q  + +G G  G V  A F+ K  L  AVK++         A+R +  E+  L  ++H+
Sbjct: 29  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 86
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           N+I LL     A +       +LV  +M        L+       LT      +   + R
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 141
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           GL+Y+H   +  ++HRDLK SN+ ++     K+ DFGL+    T         T  Y AP
Sbjct: 142 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 196
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           E +L     +++ D+++ G ++ ELL GR
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 82/203 (40%), Gaps = 16/203 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNII 212
             F +  ++ E   G  Y  +   K +   K  D+  H        E   L   RH   +
Sbjct: 16  GTFGKVILVREKATGRYYAMKILRKEVIIAK--DEVAHTV-----TESRVLQNTRHP-FL 67
Query: 213 SLLGYCIHAETRF-LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
           + L Y      R   V E    G L   L   +     T         ++   LEYLH  
Sbjct: 68  TALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYLH-- 122
Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK-ISGTLGYVAPEYLLEGK 330
            +  VV+RD+K  N++LD   + K++DFGL     +    +K   GT  Y+APE L +  
Sbjct: 123 -SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDND 181
Query: 331 LTDKSDVYAFGVVLLELLMGRRP 353
                D +  GVV+ E++ GR P
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 85/199 (42%), Gaps = 11/199 (5%)
Query: 161 IGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCI 219
           IG G  G     R    K L AVK I+  G   +     E+     +RH NI+      +
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIE-RGAAIDENVQREIINHRSLRHPNIVRFKEVIL 86
Query: 220 HAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHR 279
                 ++ E    G L +++      S        +    +  G+ Y H   +  + HR
Sbjct: 87  TPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQ---QLLSGVSYCH---SMQICHR 140
Query: 280 DLKSSNILLDSSFNA--KLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDK-SD 336
           DLK  N LLD S     K+ DFG S ++   S+     GT  Y+APE LL  +   K +D
Sbjct: 141 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIAD 200
Query: 337 VYAFGVVLLELLMGRRPVE 355
           V++ GV L  +L+G  P E
Sbjct: 201 VWSCGVTLYVMLVGAYPFE 219

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
           +Q  + +G G  G V  A F+ K  L  AVK++         A+R +  E+  L  ++H+
Sbjct: 23  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 80
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           N+I LL     A +       +LV  +M        L+       LT      +   + R
Sbjct: 81  NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 135
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           GL+Y+H   +  ++HRDLK SN+ ++     K+ DFGL+    T         T  Y AP
Sbjct: 136 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 190
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           E +L     +++ D+++ G ++ ELL GR
Sbjct: 191 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
           +Q  + +G G  G V  A F+ K  L  AVK++         A+R +  E+  L  ++H+
Sbjct: 29  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 86
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           N+I LL     A +       +LV  +M        L+       LT      +   + R
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 141
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           GL+Y+H   +  ++HRDLK SN+ ++     K+ DFGL+    T         T  Y AP
Sbjct: 142 GLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLA--RHTDDEMTGYVATRWYRAP 196
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           E +L     +++ D+++ G ++ ELL GR
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 93/229 (40%), Gaps = 40/229 (17%)
Query: 152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAER--EFNNEVNWLTKIRH 208
            ++F+E  V+G+G  G V KAR   +    A+K+I    H  E+     +EV  L  + H
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI---RHTEEKLSTILSEVXLLASLNH 61
Query: 209 QNIISLLGYCIH-------------AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRM 255
           Q ++      +                T F+  E  +N +L   +H          + R+
Sbjct: 62  QYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRL 121
Query: 256 KIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA---------- 305
                +   L Y+H   +  ++HR+LK  NI +D S N K+ DFGL+             
Sbjct: 122 --FRQILEALSYIH---SQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 306 -----GTQSRNVKISGTLGYVAPEYLL-EGKLTDKSDVYAFGVVLLELL 348
                G+        GT  YVA E L   G   +K D Y+ G++  E +
Sbjct: 177 SQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 82/203 (40%), Gaps = 16/203 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNII 212
             F +  ++ E   G  Y  +   K +   K  D+  H        E   L   RH   +
Sbjct: 16  GTFGKVILVREKATGRYYAMKILRKEVIIAK--DEVAHTV-----TESRVLQNTRHP-FL 67
Query: 213 SLLGYCIHAETRF-LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
           + L Y      R   V E    G L   L   +     T         ++   LEYLH  
Sbjct: 68  TALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYLH-- 122
Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK-ISGTLGYVAPEYLLEGK 330
            +  VV+RD+K  N++LD   + K++DFGL     +    +K   GT  Y+APE L +  
Sbjct: 123 -SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDND 181
Query: 331 LTDKSDVYAFGVVLLELLMGRRP 353
                D +  GVV+ E++ GR P
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 100/208 (48%), Gaps = 24/208 (11%)
Query: 155 FQESNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRH 208
           +Q    IG G +G V   Y A     +  A+K++     +   A+R +  E+  +  + H
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 82
Query: 209 QNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
           +NII LL      ++       ++V E+M + +L + +        +++ L   +     
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSYLLYQMLC---- 137
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
            G+++LH   +  ++HRDLK SNI++ S    K+ DFGL+ TAGT         T  Y A
Sbjct: 138 -GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMG 350
           PE +L     +  D+++ G ++ E++ G
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
           +Q  + +G G  G V  A F+ K  L  AVK++         A+R +  E+  L  ++H+
Sbjct: 47  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 104
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           N+I LL     A +       +LV  +M        L+       LT      +   + R
Sbjct: 105 NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 159
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           GL+Y+H   +  ++HRDLK SN+ ++     K+ DFGL+    T         T  Y AP
Sbjct: 160 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 214
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           E +L     +++ D+++ G ++ ELL GR
Sbjct: 215 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 107/222 (48%), Gaps = 36/222 (16%)
Query: 150 AATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQ 209
           A T   QES  IG+G  G V++ ++  + +A   +I  +  +       E+     +RH+
Sbjct: 3   ARTIVLQES--IGKGRFGEVWRGKWRGEEVAV--KIFSSREERSWFREAEIYQTVMLRHE 58
Query: 210 NIISLLGYCIHAETR--------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDV 261
           NI   LG+ I A+ +        +LV +  ++GSL   L+  T    +T    +K+A+  
Sbjct: 59  NI---LGF-IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALST 110
Query: 262 ARGLEYLH-----EHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS- 315
           A GL +LH           + HRDLKS NIL+  +    ++D GL+V   + +  + I+ 
Sbjct: 111 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP 170
Query: 316 ----GTLGYVAPEYLLEG------KLTDKSDVYAFGVVLLEL 347
               GT  Y+APE L +       +   ++D+YA G+V  E+
Sbjct: 171 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
           +Q  + +G G  G V  A F+ K  L  AVK++         A+R +  E+  L  ++H+
Sbjct: 29  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 86
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           N+I LL     A +       +LV  +M        L+       LT      +   + R
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 141
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           GL+Y+H   +  ++HRDLK SN+ ++     K+ DFGL+    T         T  Y AP
Sbjct: 142 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 196
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           E +L     +++ D+++ G ++ ELL GR
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 82/203 (40%), Gaps = 16/203 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNII 212
             F +  ++ E   G  Y  +   K +   K  D+  H        E   L   RH   +
Sbjct: 16  GTFGKVILVREKATGRYYAMKILRKEVIIAK--DEVAHTV-----TESRVLQNTRHP-FL 67
Query: 213 SLLGYCIHAETRF-LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
           + L Y      R   V E    G L   L   +     T         ++   LEYLH  
Sbjct: 68  TALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYLH-- 122
Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK-ISGTLGYVAPEYLLEGK 330
            +  VV+RD+K  N++LD   + K++DFGL     +    +K   GT  Y+APE L +  
Sbjct: 123 -SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181
Query: 331 LTDKSDVYAFGVVLLELLMGRRP 353
                D +  GVV+ E++ GR P
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
           +Q  + +G G  G V  A F+ K  L  AVK++         A+R +  E+  L  ++H+
Sbjct: 26  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 83
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           N+I LL     A +       +LV  +M        L+       LT      +   + R
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 138
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           GL+Y+H   +  ++HRDLK SN+ ++     K+ DFGL+    T         T  Y AP
Sbjct: 139 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 193
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           E +L     +++ D+++ G ++ ELL GR
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
           +Q  + +G G  G V  A F+ K  L  AVK++         A+R +  E+  L  ++H+
Sbjct: 31  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 88
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           N+I LL     A +       +LV  +M        L+       LT      +   + R
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 143
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           GL+Y+H   +  ++HRDLK SN+ ++     K+ DFGL+    T         T  Y AP
Sbjct: 144 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTADEMTGYVATRWYRAP 198
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           E +L     +++ D+++ G ++ ELL GR
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 82/203 (40%), Gaps = 16/203 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNII 212
             F +  ++ E   G  Y  +   K +   K  D+  H        E   L   RH   +
Sbjct: 19  GTFGKVILVREKATGRYYAMKILRKEVIIAK--DEVAHTV-----TESRVLQNTRHP-FL 70
Query: 213 SLLGYCIHAETRF-LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
           + L Y      R   V E    G L   L   +     T         ++   LEYLH  
Sbjct: 71  TALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYLH-- 125
Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK-ISGTLGYVAPEYLLEGK 330
            +  VV+RD+K  N++LD   + K++DFGL     +    +K   GT  Y+APE L +  
Sbjct: 126 -SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 184
Query: 331 LTDKSDVYAFGVVLLELLMGRRP 353
                D +  GVV+ E++ GR P
Sbjct: 185 YGRAVDWWGLGVVMYEMMCGRLP 207

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 32/207 (15%)
Query: 161 IGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQNIISL 214
           +G G  G V   Y AR  +K+  AVK++         A R +  E+  L  ++H+N+I L
Sbjct: 28  VGSGAYGSVCSAYDARLRQKV--AVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGL 84
Query: 215 LGYCIHAET------RFLVYEMMQ---NGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
           L     A +       +LV  +M    N  ++ Q     H   L + L         RGL
Sbjct: 85  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQL--------LRGL 136
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEY 325
           +Y+H   +  ++HRDLK SN+ ++     ++ DFGL+  A  +        T  Y APE 
Sbjct: 137 KYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGY--VATRWYRAPEI 191
Query: 326 LLEGKLTDKS-DVYAFGVVLLELLMGR 351
           +L     +++ D+++ G ++ ELL G+
Sbjct: 192 MLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
           +Q  + +G G  G V  A F+ K  L  AVK++         A+R +  E+  L  ++H+
Sbjct: 30  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 87
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           N+I LL     A +       +LV  +M        L+       LT      +   + R
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 142
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           GL+Y+H   +  ++HRDLK SN+ ++     K+ DFGL+    T         T  Y AP
Sbjct: 143 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 197
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           E +L     +++ D+++ G ++ ELL GR
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
           +Q  + +G G  G V  A F+ K  L  AVK++         A+R +  E+  L  ++H+
Sbjct: 31  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 88
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           N+I LL     A +       +LV  +M        L+       LT      +   + R
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 143
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           GL+Y+H   +  ++HRDLK SN+ ++     K+ DFGL+    T         T  Y AP
Sbjct: 144 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTADEMTGYVATRWYRAP 198
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           E +L     +++ D+++ G ++ ELL GR
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 100/208 (48%), Gaps = 24/208 (11%)
Query: 155 FQESNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRH 208
           +Q    IG G +G V   Y A     +  A+K++     +   A+R +  E+  +  + H
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 83
Query: 209 QNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
           +NII LL      ++       ++V E+M + +L + +        +++ L   +     
Sbjct: 84  KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSYLLYQMLC---- 138
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
            G+++LH   +  ++HRDLK SNI++ S    K+ DFGL+ TAGT         T  Y A
Sbjct: 139 -GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 194
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMG 350
           PE +L     +  D+++ G ++ E++ G
Sbjct: 195 PEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
           +Q  + +G G  G V  A F+ K  L  AVK++         A+R +  E+  L  ++H+
Sbjct: 35  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 92
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           N+I LL     A +       +LV  +M        L+       LT      +   + R
Sbjct: 93  NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 147
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           GL+Y+H   +  ++HRDLK SN+ ++     K+ DFGL+    T         T  Y AP
Sbjct: 148 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 202
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           E +L     +++ D+++ G ++ ELL GR
Sbjct: 203 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 80/173 (46%), Gaps = 27/173 (15%)
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT 317
           +  VA+G+E+L    +   +HRDL + NILL      K+ DFGL+         V+    
Sbjct: 206 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 262
Query: 318 ---LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVE--KMSPTQCQSMVTWAMP 371
              L ++APE + +   T +SDV++FGV+L E+  +G  P    K+    C+ +      
Sbjct: 263 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL------ 316
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
           +   R + P+   P +  TM            + C   EPS RP  ++++  L
Sbjct: 317 KEGTRMRAPDYTTPEMYQTM------------LDCWHGEPSQRPTFSELVEHL 357

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/261 (22%), Positives = 115/261 (44%), Gaps = 37/261 (14%)
Query: 182 VKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLH 241
           +K +D A  +    F    + ++K+ H++++   G C+  +   LV E ++ GSL+  L 
Sbjct: 45  LKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLK 104
Query: 242 GPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFN-------- 293
              +  N+ W  ++++A  +A  + +L E+    ++H ++ + NILL    +        
Sbjct: 105 KNKNCINILW--KLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPF 159
Query: 294 AKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGK-LTDKSDVYAFGVVLLELLM-GR 351
            KLSD G+S+T   +     +   + +V PE +   K L   +D ++FG  L E+   G 
Sbjct: 160 IKLSDPGISITVLPKD---ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGD 216
Query: 352 RPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEP 411
           +P+  +   +        +    DR +LP                 ++A +   C+  EP
Sbjct: 217 KPLSALDSQR-------KLQFYEDRHQLP------------APKAAELANLINNCMDYEP 257
Query: 412 SYRPLITDVLHSLIPLVPTDL 432
            +RP    ++  L  L   DL
Sbjct: 258 DHRPSFRAIIRDLNSLFTPDL 278

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
           +Q  + +G G  G V  A F+ K  L  AVK++         A+R +  E+  L  ++H+
Sbjct: 24  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 81
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           N+I LL     A +       +LV  +M        L+       LT      +   + R
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           GL+Y+H   +  ++HRDLK SN+ ++     K+ DFGL+    T         T  Y AP
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 191
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           E +L     +++ D+++ G ++ ELL GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
           +Q  + +G G  G V  A F+ K  L  AVK++         A+R +  E+  L  ++H+
Sbjct: 43  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 100
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           N+I LL     A +       +LV  +M        L+       LT      +   + R
Sbjct: 101 NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 155
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           GL+Y+H   +  ++HRDLK SN+ ++     K+ DFGL+    T         T  Y AP
Sbjct: 156 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 210
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           E +L     +++ D+++ G ++ ELL GR
Sbjct: 211 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 107/222 (48%), Gaps = 36/222 (16%)
Query: 150 AATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQ 209
           A T   QES  IG+G  G V++ ++  + +A   +I  +  +       E+     +RH+
Sbjct: 5   ARTIVLQES--IGKGRFGEVWRGKWRGEEVAV--KIFSSREERSWFREAEIYQTVMLRHE 60
Query: 210 NIISLLGYCIHAETR--------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDV 261
           NI   LG+ I A+ +        +LV +  ++GSL   L+  T    +T    +K+A+  
Sbjct: 61  NI---LGF-IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALST 112
Query: 262 ARGLEYLH-----EHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS- 315
           A GL +LH           + HRDLKS NIL+  +    ++D GL+V   + +  + I+ 
Sbjct: 113 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP 172
Query: 316 ----GTLGYVAPEYLLEG------KLTDKSDVYAFGVVLLEL 347
               GT  Y+APE L +       +   ++D+YA G+V  E+
Sbjct: 173 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 32/207 (15%)
Query: 161 IGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQNIISL 214
           +G G  G V   Y AR  +K+  AVK++         A R +  E+  L  ++H+N+I L
Sbjct: 36  VGSGAYGSVCSAYDARLRQKV--AVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGL 92
Query: 215 LGYCIHAET------RFLVYEMMQ---NGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
           L     A +       +LV  +M    N  ++ Q     H   L + L         RGL
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQL--------LRGL 144
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEY 325
           +Y+H   +  ++HRDLK SN+ ++     ++ DFGL+  A  +        T  Y APE 
Sbjct: 145 KYIH---SAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEM--TGYVATRWYRAPEI 199
Query: 326 LLEGKLTDKS-DVYAFGVVLLELLMGR 351
           +L     +++ D+++ G ++ ELL G+
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
           +Q  + +G G  G V  A F+ K  L  AVK++         A+R +  E+  L  ++H+
Sbjct: 36  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 93
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           N+I LL     A +       +LV  +M        L+       LT      +   + R
Sbjct: 94  NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 148
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           GL+Y+H   +  ++HRDLK SN+ ++     K+ DFGL+    T         T  Y AP
Sbjct: 149 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 203
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           E +L     +++ D+++ G ++ ELL GR
Sbjct: 204 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
           +Q  + +G G  G V  A F+ K  L  AVK++         A+R +  E+  L  ++H+
Sbjct: 36  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 93
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           N+I LL     A +       +LV  +M        L+       LT      +   + R
Sbjct: 94  NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 148
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           GL+Y+H   +  ++HRDLK SN+ ++     K+ DFGL+    T         T  Y AP
Sbjct: 149 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 203
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           E +L     +++ D+++ G ++ ELL GR
Sbjct: 204 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
           +Q  + +G G  G V  A F+ K  L  AVK++         A+R +  E+  L  ++H+
Sbjct: 44  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 101
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           N+I LL     A +       +LV  +M        L+       LT      +   + R
Sbjct: 102 NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 156
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           GL+Y+H   +  ++HRDLK SN+ ++     K+ DFGL+    T         T  Y AP
Sbjct: 157 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 211
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           E +L     +++ D+++ G ++ ELL GR
Sbjct: 212 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 80/173 (46%), Gaps = 27/173 (15%)
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT 317
           +  VA+G+E+L    +   +HRDL + NILL      K+ DFGL+         V+    
Sbjct: 204 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 260
Query: 318 ---LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVE--KMSPTQCQSMVTWAMP 371
              L ++APE + +   T +SDV++FGV+L E+  +G  P    K+    C+ +      
Sbjct: 261 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL------ 314
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
           +   R + P+   P +  TM            + C   EPS RP  ++++  L
Sbjct: 315 KEGTRMRAPDYTTPEMYQTM------------LDCWHGEPSQRPTFSELVEHL 355

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 80/169 (47%), Gaps = 13/169 (7%)
Query: 191 DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLT 250
           +A  +F  EVN +  + H+N+I L G  +    + +V E+   GSL  +L    H  +  
Sbjct: 53  EAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLR--KHQGHFL 109
Query: 251 WHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR 310
                + AV VA G+ YL    +   +HRDL + N+LL +    K+ DFGL + A  Q+ 
Sbjct: 110 LGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGL-MRALPQND 165
Query: 311 NVKISG-----TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRP 353
           +  +          + APE L     +  SD + FGV L E+   G+ P
Sbjct: 166 DHXVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
           +Q  + +G G  G V  A F+ K  L  AVK++         A+R +  E+  L  ++H+
Sbjct: 31  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 88
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           N+I LL     A +       +LV  +M        L+       LT      +   + R
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 143
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           GL+Y+H   +  ++HRDLK SN+ ++     K+ DFGL+    T         T  Y AP
Sbjct: 144 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTADEMTGYVATRWYRAP 198
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           E +L     +++ D+++ G ++ ELL GR
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
           +Q  + +G G  G V  A F+ K  L  AVK++         A+R +  E+  L  ++H+
Sbjct: 35  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 92
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           N+I LL     A +       +LV  +M        L+       LT      +   + R
Sbjct: 93  NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 147
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           GL+Y+H   +  ++HRDLK SN+ ++     K+ DFGL+    T         T  Y AP
Sbjct: 148 GLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLA--RHTDDEMTGYVATRWYRAP 202
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           E +L     +++ D+++ G ++ ELL GR
Sbjct: 203 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 107/262 (40%), Gaps = 47/262 (17%)
Query: 161 IGEGGRGHVYKARFNEKLL--AAVKRIDDAGHDAERE-FNNEVNWLTKIRHQNIISLLG- 216
           IG G    VYK    E  +  A  +  D     +ER+ F  E   L  ++H NI+     
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYDS 93
Query: 217 --------YCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKI---------AV 259
                    CI      LV E+  +G+L+            T+  R K+           
Sbjct: 94  WESTVKGKKCI-----VLVTELXTSGTLK------------TYLKRFKVXKIKVLRSWCR 136
Query: 260 DVARGLEYLHEHCNHPVVHRDLKSSNILLDS-SFNAKLSDFGLSVTAGTQSRNVKISGTL 318
            + +GL++LH     P++HRDLK  NI +   + + K+ D GL+ T    S    + GT 
Sbjct: 137 QILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA-TLKRASFAKAVIGTP 194
Query: 319 GYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPV-EKMSPTQCQSMVTWAM-PQLTDR 376
            + APE   E K  +  DVYAFG   LE      P  E  +  Q    VT  + P   D+
Sbjct: 195 EFXAPE-XYEEKYDESVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPASFDK 253
Query: 377 SKLP---NIVDPVIRDTMDLKH 395
             +P    I++  IR   D ++
Sbjct: 254 VAIPEVKEIIEGCIRQNKDERY 275

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
           +Q  + +G G  G V  A F+ K  L  AVK++         A+R +  E+  L  ++H+
Sbjct: 26  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 83
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           N+I LL     A +       +LV  +M        L+       LT      +   + R
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 138
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           GL+Y+H   +  ++HRDLK SN+ ++     K+ DFGL+    T         T  Y AP
Sbjct: 139 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 193
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           E +L     +++ D+++ G ++ ELL GR
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 79/180 (43%), Gaps = 10/180 (5%)
Query: 179 LAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEK 238
           L AVK I+  G   +     E+     +RH NI+      +      +V E    G L +
Sbjct: 45  LVAVKYIE-RGEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 103
Query: 239 QLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA--KL 296
           ++      S        +    +  G+ Y H      V HRDLK  N LLD S     K+
Sbjct: 104 RICNAGRFSEDEARFFFQ---QLISGVSYCHAM---QVCHRDLKLENTLLDGSPAPRLKI 157
Query: 297 SDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDK-SDVYAFGVVLLELLMGRRPVE 355
            DFG S ++   S+     GT  Y+APE LL+ +   K +DV++ GV L  +L+G  P E
Sbjct: 158 CDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFE 217

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 100/208 (48%), Gaps = 24/208 (11%)
Query: 155 FQESNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRH 208
           +Q    IG G +G V   Y A     +  A+K++     +   A+R +  E+  +  + H
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 82
Query: 209 QNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
           +NII LL      ++       ++V E+M + +L + +        +++ L   +     
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSYLLYQMLC---- 137
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
            G+++LH   +  ++HRDLK SNI++ S    K+ DFGL+ TAGT         T  Y A
Sbjct: 138 -GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEVVTRYYRA 193
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMG 350
           PE +L     +  D+++ G ++ E++ G
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 18/208 (8%)
Query: 154 NFQESNVIGEGGRGHVYKARFNE--KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNI 211
           ++ ++ VIG G  G VY+A+  +  +L+A  K + D     +R  N E+  + K+ H NI
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 75
Query: 212 ISLLGYCIHA-ETRFLVY-EMMQNGSLEKQLHGPTHGSNLTWHLRMKIA----VDVARGL 265
           + L  +   + E + +VY  ++ +   E       H S     L +         + R L
Sbjct: 76  VRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNA-KLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
            Y+H   +  + HRD+K  N+LLD      KL DFG +        NV    +  Y APE
Sbjct: 136 AYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPE 192
Query: 325 YLLEG-KLTDKSDVYAFGVVLLELLMGR 351
            +      T   DV++ G VL ELL+G+
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
           +Q  + +G G  G V  A F+ K  L  AVK++         A+R +  E+  L  ++H+
Sbjct: 26  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 83
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           N+I LL     A +       +LV  +M        L+       LT      +   + R
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 138
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           GL+Y+H   +  ++HRDLK SN+ ++     K+ DFGL+    T         T  Y AP
Sbjct: 139 GLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLA--RHTDDEMTGYVATRWYRAP 193
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           E +L     +++ D+++ G ++ ELL GR
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
           +Q  + +G G  G V  A F+ K  L  AVK++         A+R +  E+  L  ++H+
Sbjct: 24  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 81
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           N+I LL     A +       +LV  +M        L+       LT      +   + R
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKSQKLTDDHVQFLIYQILR 136
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           GL+Y+H   +  ++HRDLK SN+ ++     K+ DFGL     T         T  Y AP
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGL--CRHTDDEMTGYVATRWYRAP 191
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           E +L     +++ D+++ G ++ ELL GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
           +Q  + +G G  G V  A F+ K  L  AVK++         A+R +  E+  L  ++H+
Sbjct: 30  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 87
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           N+I LL     A +       +LV  +M        L+       LT      +   + R
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 142
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           GL+Y+H   +  ++HRDLK SN+ ++     K+ DFGL+    T         T  Y AP
Sbjct: 143 GLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLA--RHTDDEMTGYVATRWYRAP 197
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           E +L     +++ D+++ G ++ ELL GR
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 81/167 (48%), Gaps = 12/167 (7%)
Query: 195 EFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEK-QLHGPTHGSNLTWHL 253
           +F NE+  +T I+++  ++  G   + +  +++YE M+N S+ K   +      N T  +
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 254 RMK----IAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS 309
            ++    I   V     Y+H   N  + HRD+K SNIL+D +   KLSDFG S       
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGES--EYMVD 204
Query: 310 RNVKIS-GTLGYVAPEYLLEGKLTD--KSDVYAFGVVLLELLMGRRP 353
           + +K S GT  ++ PE+       +  K D+++ G+ L  +     P
Sbjct: 205 KKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
           +Q  + +G G  G V  A F+ K  L  AVK++         A+R +  E+  L  ++H+
Sbjct: 47  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 104
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           N+I LL     A +       +LV  +M        L+       LT      +   + R
Sbjct: 105 NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 159
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           GL+Y+H   +  ++HRDLK SN+ ++     K+ DFGL+    T         T  Y AP
Sbjct: 160 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMXGYVATRWYRAP 214
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           E +L     +++ D+++ G ++ ELL GR
Sbjct: 215 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
           +Q  + +G G  G V  A F+ K  L  AVK++         A+R +  E+  L  ++H+
Sbjct: 30  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 87
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           N+I LL     A +       +LV  +M        L+       LT      +   + R
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 142
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           GL+Y+H   +  ++HRDLK SN+ ++     K+ DFGL+    T         T  Y AP
Sbjct: 143 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 197
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           E +L     +++ D+++ G ++ ELL GR
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 28/214 (13%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
           IG+G  G V+  ++  + +A   ++     +A      E+     +RH+NI+  +   I 
Sbjct: 45  IGKGRYGEVWMGKWRGEKVAV--KVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIK 102
Query: 221 AETR----FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC---- 272
                   +L+ +  +NGSL   L   T    L     +K+A     GL +LH       
Sbjct: 103 GTGSWTQLYLITDYHENGSLYDYLKSTT----LDAKSMLKLAYSSVSGLCHLHTEIFSTQ 158
Query: 273 -NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-----GTLGYVAPEYL 326
               + HRDLKS NIL+  +    ++D GL+V   + +  V I      GT  Y+ PE L
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVL 218
Query: 327 LEGKLTDK------SDVYAFGVVLLELLMGRRPV 354
            E    +       +D+Y+FG++L E+   RR V
Sbjct: 219 DESLNRNHFQSYIMADMYSFGLILWEV--ARRCV 250

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 80/169 (47%), Gaps = 13/169 (7%)
Query: 191 DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLT 250
           +A  +F  EVN +  + H+N+I L G  +    + +V E+   GSL  +L    H  +  
Sbjct: 57  EAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLR--KHQGHFL 113
Query: 251 WHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR 310
                + AV VA G+ YL    +   +HRDL + N+LL +    K+ DFGL + A  Q+ 
Sbjct: 114 LGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGL-MRALPQND 169
Query: 311 NVKISGT-----LGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRP 353
           +  +          + APE L     +  SD + FGV L E+   G+ P
Sbjct: 170 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 80/169 (47%), Gaps = 13/169 (7%)
Query: 191 DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLT 250
           +A  +F  EVN +  + H+N+I L G  +    + +V E+   GSL  +L    H  +  
Sbjct: 53  EAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLR--KHQGHFL 109
Query: 251 WHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR 310
                + AV VA G+ YL    +   +HRDL + N+LL +    K+ DFGL + A  Q+ 
Sbjct: 110 LGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGL-MRALPQND 165
Query: 311 NVKISGT-----LGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRP 353
           +  +          + APE L     +  SD + FGV L E+   G+ P
Sbjct: 166 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 32/207 (15%)
Query: 161 IGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQNIISL 214
           +G G  G V   Y AR  +K+  AVK++         A R +  E+  L  ++H+N+I L
Sbjct: 36  VGSGAYGSVCSAYDARLRQKV--AVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGL 92
Query: 215 LGYCIHAET------RFLVYEMMQ---NGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
           L     A +       +LV  +M    N  ++ Q     H   L + L         RGL
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQL--------LRGL 144
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEY 325
           +Y+H   +  ++HRDLK SN+ ++     ++ DFGL+  A  +        T  Y APE 
Sbjct: 145 KYIH---SAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGY--VATRWYRAPEI 199
Query: 326 LLEGKLTDKS-DVYAFGVVLLELLMGR 351
           +L     +++ D+++ G ++ ELL G+
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/261 (22%), Positives = 114/261 (43%), Gaps = 37/261 (14%)
Query: 182 VKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLH 241
           +K +D A  +    F    + ++K+ H++++   G C   +   LV E ++ GSL+  L 
Sbjct: 45  LKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLK 104
Query: 242 GPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA------- 294
              +  N+ W  ++++A  +A  + +L E+    ++H ++ + NILL    +        
Sbjct: 105 KNKNCINILW--KLEVAKQLAWAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPF 159
Query: 295 -KLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGK-LTDKSDVYAFGVVLLELLM-GR 351
            KLSD G+S+T   +     +   + +V PE +   K L   +D ++FG  L E+   G 
Sbjct: 160 IKLSDPGISITVLPKD---ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGD 216
Query: 352 RPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEP 411
           +P+  +   +        +    DR +LP                 ++A +   C+  EP
Sbjct: 217 KPLSALDSQR-------KLQFYEDRHQLP------------APKAAELANLINNCMDYEP 257
Query: 412 SYRPLITDVLHSLIPLVPTDL 432
            +RP    ++  L  L   DL
Sbjct: 258 DHRPSFRAIIRDLNSLFTPDL 278

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 79/180 (43%), Gaps = 10/180 (5%)
Query: 179 LAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEK 238
           L AVK I+  G   +     E+     +RH NI+      +      +V E    G L +
Sbjct: 46  LVAVKYIE-RGEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 104
Query: 239 QLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA--KL 296
           ++      S        +    +  G+ Y H      V HRDLK  N LLD S     K+
Sbjct: 105 RICNAGRFSEDEARFFFQ---QLISGVSYAHAMQ---VAHRDLKLENTLLDGSPAPRLKI 158
Query: 297 SDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDK-SDVYAFGVVLLELLMGRRPVE 355
           +DFG S  +   S+     GT  Y+APE LL+ +   K +DV++ GV L  +L+G  P E
Sbjct: 159 ADFGYSKASVLHSQPKSAVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFE 218

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
           +Q  + +G G  G V  A F+ K  L  AVK++         A+R +  E+  L  ++H+
Sbjct: 24  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 81
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           N+I LL     A +       +LV  +M        L+       LT      +   + R
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           GL+Y+H   +  ++HRDLK SN+ ++     K+ D+GL+    T         T  Y AP
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDYGLA--RHTDDEMTGYVATRWYRAP 191
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           E +L     +++ D+++ G ++ ELL GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 103/226 (45%), Gaps = 36/226 (15%)
Query: 144 EYELLEAATNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGH---DAEREFNNE 199
           EYE++E           IG G  G V  AR        A+K+I +A     +A+R    E
Sbjct: 56  EYEIIE----------TIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLR-E 104
Query: 200 VNWLTKIRHQNIIS----LLGYCIHAETR--FLVYEMMQNGSLEKQLHGPTHGSN-LTWH 252
           +  L   +H NII+    L     + E +  ++V ++M     E  LH   H S  LT  
Sbjct: 105 LKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLM-----ESDLHQIIHSSQPLTLE 159
Query: 253 LRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGL-----SVTAGT 307
                   + RGL+Y+H   +  V+HRDLK SN+L++ +   K+ DFG+     +  A  
Sbjct: 160 HVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEH 216
Query: 308 QSRNVKISGTLGYVAPEYLLE-GKLTDKSDVYAFGVVLLELLMGRR 352
           Q    +   T  Y APE +L   + T   D+++ G +  E+L  R+
Sbjct: 217 QYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 91/212 (42%), Gaps = 13/212 (6%)
Query: 159 NVIGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGY 217
           N IG G  G V  A +   ++  A K+I     +    F  E+  +  + H NII L   
Sbjct: 15  NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET 74
Query: 218 CIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVV 277
                  +LV E+   G L +++    H          +I  DV   + Y H+     V 
Sbjct: 75  FEDNTDIYLVMELCTGGELFERV---VHKRVFRESDAARIMKDVLSAVAYCHKLN---VA 128
Query: 278 HRDLKSSNILL--DSSFNA-KLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDK 334
           HRDLK  N L   DS  +  KL DFGL+             GT  YV+P+ +LEG    +
Sbjct: 129 HRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQ-VLEGLYGPE 187
Query: 335 SDVYAFGVVLLELLMGRRPVEKMSPTQCQSMV 366
            D ++ GV++  LL G  P    +PT  + M+
Sbjct: 188 CDEWSAGVMMYVLLCGYPPFS--APTDXEVML 217

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEKL--LAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
           +Q  + +G G  G V  A F+ K     AVK++         A+R +  E+  L  ++H+
Sbjct: 20  YQNLSPVGSGAYGSVCAA-FDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 77
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           N+I LL     A +       +LV  +M        L+     + LT      +   + R
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCAKLTDDHVQFLIYQILR 132
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           GL+Y+H   +  ++HRDLK SN+ ++     K+ DFGL+    T         T  Y AP
Sbjct: 133 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 187
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           E +L     +++ D+++ G ++ ELL GR
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 87/207 (42%), Gaps = 18/207 (8%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKR---IDDAGHDAEREFNNEVNWLTKIRHQNIISLLGY 217
           IGEG  G     +  E     V +   I         E   EV  L  ++H NI+     
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRES 91
Query: 218 CIHAETRFLVYEMMQNGSLEKQLHGPT-----HGSNLTWHLRMKIAVDVARGLEYLHEHC 272
                + ++V +  + G L K+++            L W +++ +A      L+++H   
Sbjct: 92  FEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLA------LKHVH--- 142
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLS-VTAGTQSRNVKISGTLGYVAPEYLLEGKL 331
           +  ++HRD+KS NI L      +L DFG++ V   T        GT  Y++PE       
Sbjct: 143 DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPY 202
Query: 332 TDKSDVYAFGVVLLELLMGRRPVEKMS 358
            +KSD++A G VL EL   +   E  S
Sbjct: 203 NNKSDIWALGCVLYELCTLKHAFEAGS 229

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 103/226 (45%), Gaps = 36/226 (15%)
Query: 144 EYELLEAATNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGH---DAEREFNNE 199
           EYE++E           IG G  G V  AR        A+K+I +A     +A+R    E
Sbjct: 55  EYEIIE----------TIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLR-E 103
Query: 200 VNWLTKIRHQNIIS----LLGYCIHAETR--FLVYEMMQNGSLEKQLHGPTHGSN-LTWH 252
           +  L   +H NII+    L     + E +  ++V ++M     E  LH   H S  LT  
Sbjct: 104 LKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLM-----ESDLHQIIHSSQPLTLE 158
Query: 253 LRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGL-----SVTAGT 307
                   + RGL+Y+H   +  V+HRDLK SN+L++ +   K+ DFG+     +  A  
Sbjct: 159 HVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEH 215
Query: 308 QSRNVKISGTLGYVAPEYLLE-GKLTDKSDVYAFGVVLLELLMGRR 352
           Q    +   T  Y APE +L   + T   D+++ G +  E+L  R+
Sbjct: 216 QYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEKL--LAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
           +Q  + +G G  G V  A F+ K     AVK++         A+R +  E+  L  ++H+
Sbjct: 20  YQNLSPVGSGAYGSVCAA-FDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 77
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           N+I LL     A +       +LV  +M        L+       LT      +   + R
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 132
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           GL+Y+H   +  ++HRDLK SN+ ++     K+ DFGL+    T         T  Y AP
Sbjct: 133 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMAGFVATRWYRAP 187
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           E +L     +++ D+++ G ++ ELL GR
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEKL--LAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
           +Q  + +G G  G V  A F+ K     AVK++         A+R +  E+  L  ++H+
Sbjct: 24  YQNLSPVGSGAYGSVCAA-FDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 81
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           N+I LL     A +       +LV  +M        L+       LT      +   + R
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           GL+Y+H   +  ++HRDLK SN+ ++     K+ DFGL+    T         T  Y AP
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMAGFVATRWYRAP 191
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           E +L     +++ D+++ G ++ ELL GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 91/212 (42%), Gaps = 13/212 (6%)
Query: 159 NVIGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGY 217
           N IG G  G V  A +   ++  A K+I     +    F  E+  +  + H NII L   
Sbjct: 32  NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET 91
Query: 218 CIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVV 277
                  +LV E+   G L +++    H          +I  DV   + Y H+     V 
Sbjct: 92  FEDNTDIYLVMELCTGGELFERV---VHKRVFRESDAARIMKDVLSAVAYCHKLN---VA 145
Query: 278 HRDLKSSNILL--DSSFNA-KLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDK 334
           HRDLK  N L   DS  +  KL DFGL+             GT  YV+P+ +LEG    +
Sbjct: 146 HRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQ-VLEGLYGPE 204
Query: 335 SDVYAFGVVLLELLMGRRPVEKMSPTQCQSMV 366
            D ++ GV++  LL G  P    +PT  + M+
Sbjct: 205 CDEWSAGVMMYVLLCGYPPFS--APTDXEVML 234

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 92/197 (46%), Gaps = 18/197 (9%)
Query: 163 EGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE 222
           E   G  Y A+F +K      R   +  D ERE    V+ L +I+H N+I+L     +  
Sbjct: 32  EKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE----VSILKEIQHPNVITLHEVYENKT 87
Query: 223 TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLK 282
              L+ E++  G L   L       +LT     +    +  G+ YLH   +  + H DLK
Sbjct: 88  DVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLK 141
Query: 283 SSNI-LLDSSF---NAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSD 336
             NI LLD +      K+ DFGL+  +  G + +N  I GT  +VAPE +    L  ++D
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPAFVAPEIVNYEPLGLEAD 199
Query: 337 VYAFGVVLLELLMGRRP 353
           +++ GV+   LL G  P
Sbjct: 200 MWSIGVITYILLSGASP 216

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEKL--LAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
           +Q  + +G G  G V  A F+ K     AVK++         A+R +  E+  L  ++H+
Sbjct: 24  YQNLSPVGSGAYGSVCAA-FDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 81
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           N+I LL     A +       +LV  +M        L+       LT      +   + R
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           GL+Y+H   +  ++HRDLK SN+ ++     K+ DFGL+    T         T  Y AP
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMAGFVATRWYRAP 191
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           E +L     +++ D+++ G ++ ELL GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 90/202 (44%), Gaps = 17/202 (8%)
Query: 161 IGEG--GRGHVYKARFNEKLLAA--VKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLG 216
           IG G  G   + + + + +L+A   ++R +    + +RE  N       +RH NI+    
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINH----RSLRHPNIVRFKE 82
Query: 217 YCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPV 276
             +      +V E    G L +++      S        +    +  G+ Y H      V
Sbjct: 83  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ---QLISGVSYCHAM---QV 136
Query: 277 VHRDLKSSNILLDSSFNA--KLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDK 334
            HRDLK  N LLD S     K+ DFG S ++   S+     GT  Y+APE LL+ +   K
Sbjct: 137 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 196
Query: 335 -SDVYAFGVVLLELLMGRRPVE 355
            +DV++ GV L  +L+G  P E
Sbjct: 197 VADVWSCGVTLYVMLVGAYPFE 218

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 34/216 (15%)
Query: 154 NFQESNVIGEGGRGHVYKARFNE--KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNI 211
           ++ ++ VIG G  G VY+A+  +  +L+A  K + D     +R  N E+  + K+ H NI
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 75
Query: 212 ISLLGYCIHAETR----FL----------VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKI 257
           + L  +   +  +    +L          VY + ++ S  KQ     +     + L    
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL---- 131
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA-KLSDFGLSVTAGTQSRNVKISG 316
                R L Y+H   +  + HRD+K  N+LLD      KL DFG +        NV    
Sbjct: 132 ----FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 184
Query: 317 TLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGR 351
           +  Y APE +      T   DV++ G VL ELL+G+
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 34/216 (15%)
Query: 154 NFQESNVIGEGGRGHVYKARFNE--KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNI 211
           ++ ++ VIG G  G VY+A+  +  +L+A  K + D     +R  N E+  + K+ H NI
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 75
Query: 212 ISLLGYCIHAETR----FL----------VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKI 257
           + L  +   +  +    +L          VY + ++ S  KQ     +     + L    
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL---- 131
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA-KLSDFGLSVTAGTQSRNVKISG 316
                R L Y+H   +  + HRD+K  N+LLD      KL DFG +        NV    
Sbjct: 132 ----FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 184
Query: 317 TLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGR 351
           +  Y APE +      T   DV++ G VL ELL+G+
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 34/216 (15%)
Query: 154 NFQESNVIGEGGRGHVYKARFNE--KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNI 211
           ++ ++ VIG G  G VY+A+  +  +L+A  K + D     +R  N E+  + K+ H NI
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 76
Query: 212 ISLLGYCIHAETR----FL----------VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKI 257
           + L  +   +  +    +L          VY + ++ S  KQ     +     + L    
Sbjct: 77  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL---- 132
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA-KLSDFGLSVTAGTQSRNVKISG 316
                R L Y+H   +  + HRD+K  N+LLD      KL DFG +        NV    
Sbjct: 133 ----FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 185
Query: 317 TLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGR 351
           +  Y APE +      T   DV++ G VL ELL+G+
Sbjct: 186 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 34/216 (15%)
Query: 154 NFQESNVIGEGGRGHVYKARFNE--KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNI 211
           ++ ++ VIG G  G VY+A+  +  +L+A  K + D     +R  N E+  + K+ H NI
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 75
Query: 212 ISLLGYCIHAETR----FL----------VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKI 257
           + L  +   +  +    +L          VY + ++ S  KQ     +     + L    
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL---- 131
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA-KLSDFGLSVTAGTQSRNVKISG 316
                R L Y+H   +  + HRD+K  N+LLD      KL DFG +        NV    
Sbjct: 132 ----FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 184
Query: 317 TLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGR 351
           +  Y APE +      T   DV++ G VL ELL+G+
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 34/216 (15%)
Query: 154 NFQESNVIGEGGRGHVYKARFNE--KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNI 211
           ++ ++ VIG G  G VY+A+  +  +L+A  K + D     +R  N E+  + K+ H NI
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 83
Query: 212 ISLLGYCIHAETR----FL----------VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKI 257
           + L  +   +  +    +L          VY + ++ S  KQ     +     + L    
Sbjct: 84  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL---- 139
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA-KLSDFGLSVTAGTQSRNVKISG 316
                R L Y+H   +  + HRD+K  N+LLD      KL DFG +        NV    
Sbjct: 140 ----FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 192
Query: 317 TLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGR 351
           +  Y APE +      T   DV++ G VL ELL+G+
Sbjct: 193 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 34/216 (15%)
Query: 154 NFQESNVIGEGGRGHVYKARFNE--KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNI 211
           ++ ++ VIG G  G VY+A+  +  +L+A  K + D     +R  N E+  + K+ H NI
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 94
Query: 212 ISLLGYCIHAETR----FL----------VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKI 257
           + L  +   +  +    +L          VY + ++ S  KQ     +     + L    
Sbjct: 95  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL---- 150
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA-KLSDFGLSVTAGTQSRNVKISG 316
                R L Y+H   +  + HRD+K  N+LLD      KL DFG +        NV    
Sbjct: 151 ----FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 203
Query: 317 TLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGR 351
           +  Y APE +      T   DV++ G VL ELL+G+
Sbjct: 204 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 41/134 (30%), Positives = 66/134 (49%), Gaps = 8/134 (5%)
Query: 246 GSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA 305
           G  +   +  KIAV + + LE+LH   +  V+HRD+K SN+L+++    K  DFG+S   
Sbjct: 130 GQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKXCDFGISGYL 187
Query: 306 GTQSRNVKISGTLGYVAPEY----LLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSP-- 359
                    +G   Y APE     L +   + KSD+++ G+  +EL + R P +      
Sbjct: 188 VDDVAKDIDAGCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPF 247
Query: 360 TQCQSMVTWAMPQL 373
            Q + +V    PQL
Sbjct: 248 QQLKQVVEEPSPQL 261

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 34/216 (15%)
Query: 154 NFQESNVIGEGGRGHVYKARFNE--KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNI 211
           ++ ++ VIG G  G VY+A+  +  +L+A  K + D     +R  N E+  + K+ H NI
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 88
Query: 212 ISLLGYCIHAETR----FL----------VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKI 257
           + L  +   +  +    +L          VY + ++ S  KQ     +     + L    
Sbjct: 89  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL---- 144
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA-KLSDFGLSVTAGTQSRNVKISG 316
                R L Y+H   +  + HRD+K  N+LLD      KL DFG +        NV    
Sbjct: 145 ----FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 197
Query: 317 TLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGR 351
           +  Y APE +      T   DV++ G VL ELL+G+
Sbjct: 198 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 34/216 (15%)
Query: 154 NFQESNVIGEGGRGHVYKARFNE--KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNI 211
           ++ ++ VIG G  G VY+A+  +  +L+A  K + D     +R  N E+  + K+ H NI
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 79
Query: 212 ISLLGYCIHAETR----FL----------VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKI 257
           + L  +   +  +    +L          VY + ++ S  KQ     +     + L    
Sbjct: 80  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL---- 135
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA-KLSDFGLSVTAGTQSRNVKISG 316
                R L Y+H   +  + HRD+K  N+LLD      KL DFG +        NV    
Sbjct: 136 ----FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 188
Query: 317 TLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGR 351
           +  Y APE +      T   DV++ G VL ELL+G+
Sbjct: 189 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 34/216 (15%)
Query: 154 NFQESNVIGEGGRGHVYKARFNE--KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNI 211
           ++ ++ VIG G  G VY+A+  +  +L+A  K + D     +R  N E+  + K+ H NI
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 87
Query: 212 ISLLGYCIHAETR----FL----------VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKI 257
           + L  +   +  +    +L          VY + ++ S  KQ     +     + L    
Sbjct: 88  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL---- 143
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA-KLSDFGLSVTAGTQSRNVKISG 316
                R L Y+H   +  + HRD+K  N+LLD      KL DFG +        NV    
Sbjct: 144 ----FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 196
Query: 317 TLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGR 351
           +  Y APE +      T   DV++ G VL ELL+G+
Sbjct: 197 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 78/287 (27%), Positives = 118/287 (41%), Gaps = 63/287 (21%)
Query: 160 VIGEGGRGHVYKARFNE-KLLAAVKRIDDAG------HDAEREFNNEVNWLTKIRHQNII 212
            IG+G  G V  A  N+ + + A+K ++          D ER    EV  + K+ H NI 
Sbjct: 33  AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVER-IKTEVRLMKKLHHPNIA 91
Query: 213 SLLGYCIHAETRF--LVYEMMQNGSL-------------------------------EKQ 239
            L  Y ++ + ++  LV E+   G L                               E+ 
Sbjct: 92  RL--YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149
Query: 240 LHGPTHG--SNLTWHLRMKIAVDVAR----GLEYLHEHCNHPVVHRDLKSSNILL--DSS 291
           ++G  HG   +L +  R K+  ++ R     L YLH   N  + HRD+K  N L   + S
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKS 206
Query: 292 FNAKLSDFGLS-----VTAGTQSRNVKISGTLGYVAPEYL--LEGKLTDKSDVYAFGVVL 344
           F  KL DFGLS     +  G        +GT  +VAPE L         K D ++ GV+L
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
Query: 345 LELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTM 391
             LLMG  P   ++     S V     +L   +   N++ P+ RD +
Sbjct: 267 HLLLMGAVPFPGVNDADTISQVL--NKKLCFENPNYNVLSPLARDLL 311

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEKL--LAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
           +Q  + +G G  G V  A F+ K     AVK++         A+R +  E+  L  ++H+
Sbjct: 20  YQNLSPVGSGAYGSVCAA-FDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 77
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           N+I LL     A +       +LV  +M        L+       LT      +   + R
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 132
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           GL+Y+H   +  ++HRDLK SN+ ++     K+ DFGL+    T         T  Y AP
Sbjct: 133 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 187
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           E +L     +++ D+++ G ++ ELL GR
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 34/216 (15%)
Query: 154 NFQESNVIGEGGRGHVYKARFNE--KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNI 211
           ++ ++ VIG G  G VY+A+  +  +L+A  K + D     +R  N E+  + K+ H NI
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 87
Query: 212 ISLLGYCIHAETR----FL----------VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKI 257
           + L  +   +  +    +L          VY + ++ S  KQ     +     + L    
Sbjct: 88  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL---- 143
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA-KLSDFGLSVTAGTQSRNVKISG 316
                R L Y+H   +  + HRD+K  N+LLD      KL DFG +        NV    
Sbjct: 144 ----FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 196
Query: 317 TLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGR 351
           +  Y APE +      T   DV++ G VL ELL+G+
Sbjct: 197 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 94/212 (44%), Gaps = 18/212 (8%)
Query: 149 EAATNNFQESNVIGEGGRGHVY--KARFNEK--LLAAVKRIDDAGHDAEREFNNEVNWLT 204
           +A ++ F+  + +G G    VY  K +  +K   L  +K+  D     ++    E+  L 
Sbjct: 49  DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD-----KKIVRTEIGVLL 103
Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
           ++ H NII L           LV E++  G L  ++    + S       +K    +   
Sbjct: 104 RLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVK---QILEA 160
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDS---SFNAKLSDFGLSVTAGTQSRNVKISGTLGYV 321
           + YLHE+    +VHRDLK  N+L  +       K++DFGLS     Q     + GT GY 
Sbjct: 161 VAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYC 217
Query: 322 APEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
           APE L       + D+++ G++   LL G  P
Sbjct: 218 APEILRGCAYGPEVDMWSVGIITYILLCGFEP 249

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEKL--LAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
           +Q  + +G G  G V  A F+ K     AVK++         A+R +  E+  L  ++H+
Sbjct: 24  YQNLSPVGSGAYGSVCAA-FDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 81
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           N+I LL     A +       +LV  +M        L+       LT      +   + R
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           GL+Y+H   +  ++HRDLK SN+ ++     K+ DFGL+    T         T  Y AP
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 191
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           E +L     +++ D+++ G ++ ELL GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 92/197 (46%), Gaps = 18/197 (9%)
Query: 163 EGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE 222
           E   G  Y A+F +K      R   +  D ERE    V+ L +I+H N+I+L     +  
Sbjct: 32  EKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE----VSILKEIQHPNVITLHEVYENKT 87
Query: 223 TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLK 282
              L+ E++  G L   L       +LT     +    +  G+ YLH   +  + H DLK
Sbjct: 88  DVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLK 141
Query: 283 SSNI-LLDSSF---NAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSD 336
             NI LLD +      K+ DFGL+  +  G + +N  I GT  +VAPE +    L  ++D
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFVAPEIVNYEPLGLEAD 199
Query: 337 VYAFGVVLLELLMGRRP 353
           +++ GV+   LL G  P
Sbjct: 200 MWSIGVITYILLSGASP 216

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEKL--LAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
           +Q  + +G G  G V  A F+ K     AVK++         A+R +  E+  L  ++H+
Sbjct: 43  YQNLSPVGSGAYGSVCAA-FDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 100
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           N+I LL     A +       +LV  +M        L+       LT      +   + R
Sbjct: 101 NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 155
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           GL+Y+H   +  ++HRDLK SN+ ++     K+ DFGL+    T         T  Y AP
Sbjct: 156 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 210
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           E +L     +++ D+++ G ++ ELL GR
Sbjct: 211 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 92/197 (46%), Gaps = 18/197 (9%)
Query: 163 EGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE 222
           E   G  Y A+F +K      R   +  D ERE    V+ L +I+H N+I+L     +  
Sbjct: 31  EKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE----VSILKEIQHPNVITLHEVYENKT 86
Query: 223 TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLK 282
              L+ E++  G L   L       +LT     +    +  G+ YLH   +  + H DLK
Sbjct: 87  DVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLK 140
Query: 283 SSNI-LLDSSF---NAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSD 336
             NI LLD +      K+ DFGL+  +  G + +N  I GT  +VAPE +    L  ++D
Sbjct: 141 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFVAPEIVNYEPLGLEAD 198
Query: 337 VYAFGVVLLELLMGRRP 353
           +++ GV+   LL G  P
Sbjct: 199 MWSIGVITYILLSGASP 215

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEKL--LAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
           +Q  + +G G  G V  A F+ K     AVK++         A+R +  E+  L  ++H+
Sbjct: 44  YQNLSPVGSGAYGSVCAA-FDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 101
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           N+I LL     A +       +LV  +M        L+       LT      +   + R
Sbjct: 102 NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 156
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           GL+Y+H   +  ++HRDLK SN+ ++     K+ DFGL+    T         T  Y AP
Sbjct: 157 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 211
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           E +L     +++ D+++ G ++ ELL GR
Sbjct: 212 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 92/197 (46%), Gaps = 18/197 (9%)
Query: 163 EGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE 222
           E   G  Y A+F +K      R   +  D ERE    V+ L +I+H N+I+L     +  
Sbjct: 32  EKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE----VSILKEIQHPNVITLHEVYENKT 87
Query: 223 TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLK 282
              L+ E++  G L   L       +LT     +    +  G+ YLH   +  + H DLK
Sbjct: 88  DVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLK 141
Query: 283 SSNI-LLDSSF---NAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSD 336
             NI LLD +      K+ DFGL+  +  G + +N  I GT  +VAPE +    L  ++D
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFVAPEIVNYEPLGLEAD 199
Query: 337 VYAFGVVLLELLMGRRP 353
           +++ GV+   LL G  P
Sbjct: 200 MWSIGVITYILLSGASP 216

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 92/197 (46%), Gaps = 18/197 (9%)
Query: 163 EGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE 222
           E   G  Y A+F +K      R   +  D ERE    V+ L +I+H N+I+L     +  
Sbjct: 32  EKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE----VSILKEIQHPNVITLHEVYENKT 87
Query: 223 TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLK 282
              L+ E++  G L   L       +LT     +    +  G+ YLH   +  + H DLK
Sbjct: 88  DVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLK 141
Query: 283 SSNI-LLDSSF---NAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSD 336
             NI LLD +      K+ DFGL+  +  G + +N  I GT  +VAPE +    L  ++D
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFVAPEIVNYEPLGLEAD 199
Query: 337 VYAFGVVLLELLMGRRP 353
           +++ GV+   LL G  P
Sbjct: 200 MWSIGVITYILLSGASP 216

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 92/197 (46%), Gaps = 18/197 (9%)
Query: 163 EGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE 222
           E   G  Y A+F +K      R   +  D ERE    V+ L +I+H N+I+L     +  
Sbjct: 32  EKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE----VSILKEIQHPNVITLHEVYENKT 87
Query: 223 TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLK 282
              L+ E++  G L   L       +LT     +    +  G+ YLH   +  + H DLK
Sbjct: 88  DVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLK 141
Query: 283 SSNI-LLDSSF---NAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSD 336
             NI LLD +      K+ DFGL+  +  G + +N  I GT  +VAPE +    L  ++D
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFVAPEIVNYEPLGLEAD 199
Query: 337 VYAFGVVLLELLMGRRP 353
           +++ GV+   LL G  P
Sbjct: 200 MWSIGVITYILLSGASP 216

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 92/197 (46%), Gaps = 18/197 (9%)
Query: 163 EGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE 222
           E   G  Y A+F +K      R   +  D ERE    V+ L +I+H N+I+L     +  
Sbjct: 32  EKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE----VSILKEIQHPNVITLHEVYENKT 87
Query: 223 TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLK 282
              L+ E++  G L   L       +LT     +    +  G+ YLH   +  + H DLK
Sbjct: 88  DVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLK 141
Query: 283 SSNI-LLDSSF---NAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSD 336
             NI LLD +      K+ DFGL+  +  G + +N  I GT  +VAPE +    L  ++D
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFVAPEIVNYEPLGLEAD 199
Query: 337 VYAFGVVLLELLMGRRP 353
           +++ GV+   LL G  P
Sbjct: 200 MWSIGVITYILLSGASP 216

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 34/216 (15%)
Query: 154 NFQESNVIGEGGRGHVYKARFNE--KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNI 211
           ++ ++ VIG G  G VY+A+  +  +L+A  K + D     +R  N E+  + K+ H NI
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 103
Query: 212 ISLLGYCIHAETR----FL----------VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKI 257
           + L  +   +  +    +L          VY + ++ S  KQ     +     + L    
Sbjct: 104 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL---- 159
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA-KLSDFGLSVTAGTQSRNVKISG 316
                R L Y+H   +  + HRD+K  N+LLD      KL DFG +        NV    
Sbjct: 160 ----FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 212
Query: 317 TLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGR 351
           +  Y APE +      T   DV++ G VL ELL+G+
Sbjct: 213 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 92/197 (46%), Gaps = 18/197 (9%)
Query: 163 EGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE 222
           E   G  Y A+F +K      R   +  D ERE    V+ L +I+H N+I+L     +  
Sbjct: 32  EKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE----VSILKEIQHPNVITLHEVYENKT 87
Query: 223 TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLK 282
              L+ E++  G L   L       +LT     +    +  G+ YLH   +  + H DLK
Sbjct: 88  DVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLK 141
Query: 283 SSNI-LLDSSF---NAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSD 336
             NI LLD +      K+ DFGL+  +  G + +N  I GT  +VAPE +    L  ++D
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFVAPEIVNYEPLGLEAD 199
Query: 337 VYAFGVVLLELLMGRRP 353
           +++ GV+   LL G  P
Sbjct: 200 MWSIGVITYILLSGASP 216

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 92/197 (46%), Gaps = 18/197 (9%)
Query: 163 EGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE 222
           E   G  Y A+F +K      R   +  D ERE    V+ L +I+H N+I+L     +  
Sbjct: 31  EKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE----VSILKEIQHPNVITLHEVYENKT 86
Query: 223 TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLK 282
              L+ E++  G L   L       +LT     +    +  G+ YLH   +  + H DLK
Sbjct: 87  DVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLK 140
Query: 283 SSNI-LLDSSF---NAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSD 336
             NI LLD +      K+ DFGL+  +  G + +N  I GT  +VAPE +    L  ++D
Sbjct: 141 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFVAPEIVNYEPLGLEAD 198
Query: 337 VYAFGVVLLELLMGRRP 353
           +++ GV+   LL G  P
Sbjct: 199 MWSIGVITYILLSGASP 215

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 34/216 (15%)
Query: 154 NFQESNVIGEGGRGHVYKARFNE--KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNI 211
           ++ ++ VIG G  G VY+A+  +  +L+A  K + D     +R  N E+  + K+ H NI
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 80
Query: 212 ISLLGYCIHAETR----FL----------VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKI 257
           + L  +   +  +    +L          VY + ++ S  KQ     +     + L    
Sbjct: 81  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL---- 136
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA-KLSDFGLSVTAGTQSRNVKISG 316
                R L Y+H   +  + HRD+K  N+LLD      KL DFG +        NV    
Sbjct: 137 ----FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 189
Query: 317 TLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGR 351
           +  Y APE +      T   DV++ G VL ELL+G+
Sbjct: 190 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 93/224 (41%), Gaps = 32/224 (14%)
Query: 160 VIGEGGRGHVYKAR-FNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR-HQNIISLLGY 217
           V+ EGG   VY+A+        A+KR+     +  R    EV ++ K+  H NI+    +
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQ---F 91
Query: 218 CIHA----------ETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEY 267
           C  A          +  FL+   +  G L + L        L+    +KI     R +++
Sbjct: 92  CSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQH 151
Query: 268 LHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA--------GTQSR-----NVKI 314
           +H     P++HRDLK  N+LL +    KL DFG + T           Q R      +  
Sbjct: 152 MHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210
Query: 315 SGTLGYVAPEYL---LEGKLTDKSDVYAFGVVLLELLMGRRPVE 355
           + T  Y  PE +       + +K D++A G +L  L   + P E
Sbjct: 211 NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE 254

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 92/197 (46%), Gaps = 18/197 (9%)
Query: 163 EGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE 222
           E   G  Y A+F +K      R   +  D ERE    V+ L +I+H N+I+L     +  
Sbjct: 32  EKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE----VSILKEIQHPNVITLHEVYENKT 87
Query: 223 TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLK 282
              L+ E++  G L   L       +LT     +    +  G+ YLH   +  + H DLK
Sbjct: 88  DVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLK 141
Query: 283 SSNI-LLDSSF---NAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSD 336
             NI LLD +      K+ DFGL+  +  G + +N  I GT  +VAPE +    L  ++D
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFVAPEIVNYEPLGLEAD 199
Query: 337 VYAFGVVLLELLMGRRP 353
           +++ GV+   LL G  P
Sbjct: 200 MWSIGVITYILLSGASP 216

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 34/216 (15%)
Query: 154 NFQESNVIGEGGRGHVYKARFNE--KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNI 211
           ++ ++ VIG G  G VY+A+  +  +L+A  K + D     +R  N E+  + K+ H NI
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 109
Query: 212 ISLLGYCIHAETR----FL----------VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKI 257
           + L  +   +  +    +L          VY + ++ S  KQ     +     + L    
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL---- 165
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA-KLSDFGLSVTAGTQSRNVKISG 316
                R L Y+H   +  + HRD+K  N+LLD      KL DFG +        NV    
Sbjct: 166 ----FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 218
Query: 317 TLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGR 351
           +  Y APE +      T   DV++ G VL ELL+G+
Sbjct: 219 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 99/206 (48%), Gaps = 24/206 (11%)
Query: 155 FQESNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRH 208
           +Q    IG G +G V   Y A     +  A+K++     +   A+R +  E+  +  + H
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 76
Query: 209 QNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
           +NII LL      ++       ++V E+M + +L + +        +++ L   +     
Sbjct: 77  KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSYLLYQMLC---- 131
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
            G+++LH   +  ++HRDLK SNI++ S    K+ DFGL+ TAGT         T  Y A
Sbjct: 132 -GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 187
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELL 348
           PE +L     +  D+++ G ++ E++
Sbjct: 188 PEVILGMGYKENVDLWSVGCIMGEMV 213

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 92/197 (46%), Gaps = 18/197 (9%)
Query: 163 EGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE 222
           E   G  Y A+F +K      R   +  D ERE    V+ L +I+H N+I+L     +  
Sbjct: 32  EKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE----VSILKEIQHPNVITLHEVYENKT 87
Query: 223 TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLK 282
              L+ E++  G L   L       +LT     +    +  G+ YLH   +  + H DLK
Sbjct: 88  DVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLK 141
Query: 283 SSNI-LLDSSF---NAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSD 336
             NI LLD +      K+ DFGL+  +  G + +N  I GT  +VAPE +    L  ++D
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFVAPEIVNYEPLGLEAD 199
Query: 337 VYAFGVVLLELLMGRRP 353
           +++ GV+   LL G  P
Sbjct: 200 MWSIGVITYILLSGASP 216

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 34/216 (15%)
Query: 154 NFQESNVIGEGGRGHVYKARFNE--KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNI 211
           ++ ++ VIG G  G VY+A+  +  +L+A  K + D     +R  N E+  + K+ H NI
Sbjct: 57  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 111
Query: 212 ISLLGYCIHAETR----FL----------VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKI 257
           + L  +   +  +    +L          VY + ++ S  KQ     +     + L    
Sbjct: 112 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL---- 167
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA-KLSDFGLSVTAGTQSRNVKISG 316
                R L Y+H   +  + HRD+K  N+LLD      KL DFG +        NV    
Sbjct: 168 ----FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 220
Query: 317 TLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGR 351
           +  Y APE +      T   DV++ G VL ELL+G+
Sbjct: 221 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 34/216 (15%)
Query: 154 NFQESNVIGEGGRGHVYKARFNE--KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNI 211
           ++ ++ VIG G  G VY+A+  +  +L+A  K + D     +R  N E+  + K+ H NI
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 109
Query: 212 ISLLGYCIHAETR----FL----------VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKI 257
           + L  +   +  +    +L          VY + ++ S  KQ     +     + L    
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL---- 165
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA-KLSDFGLSVTAGTQSRNVKISG 316
                R L Y+H   +  + HRD+K  N+LLD      KL DFG +        NV    
Sbjct: 166 ----FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 218
Query: 317 TLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGR 351
           +  Y APE +      T   DV++ G VL ELL+G+
Sbjct: 219 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEKL--LAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
           +Q  + +G G  G V  A F+ K     AVK++         A+R +  E+  L  ++H+
Sbjct: 44  YQNLSPVGSGAYGSVCAA-FDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 101
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           N+I LL     A +       +LV  +M        L+       LT      +   + R
Sbjct: 102 NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 156
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           GL+Y+H   +  ++HRDLK SN+ ++     K+ DFGL+    T         T  Y AP
Sbjct: 157 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMXGXVATRWYRAP 211
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           E +L     +++ D+++ G ++ ELL GR
Sbjct: 212 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 92/197 (46%), Gaps = 18/197 (9%)
Query: 163 EGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE 222
           E   G  Y A+F +K      R   +  D ERE    V+ L +I+H N+I+L     +  
Sbjct: 32  EKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE----VSILKEIQHPNVITLHEVYENKT 87
Query: 223 TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLK 282
              L+ E++  G L   L       +LT     +    +  G+ YLH   +  + H DLK
Sbjct: 88  DVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLK 141
Query: 283 SSNI-LLDSSF---NAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSD 336
             NI LLD +      K+ DFGL+  +  G + +N  I GT  +VAPE +    L  ++D
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFVAPEIVNYEPLGLEAD 199
Query: 337 VYAFGVVLLELLMGRRP 353
           +++ GV+   LL G  P
Sbjct: 200 MWSIGVITYILLSGASP 216

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 99/206 (48%), Gaps = 24/206 (11%)
Query: 155 FQESNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRH 208
           +Q    IG G +G V   Y A     +  A+K++     +   A+R +  E+  +  + H
Sbjct: 31  YQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 87
Query: 209 QNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
           +NII LL      ++       ++V E+M + +L + +        +++ L   +     
Sbjct: 88  KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSYLLYQMLC---- 142
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
            G+++LH   +  ++HRDLK SNI++ S    K+ DFGL+ TAGT         T  Y A
Sbjct: 143 -GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 198
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELL 348
           PE +L     +  D+++ G ++ E++
Sbjct: 199 PEVILGMGYKENVDLWSVGCIMGEMV 224

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 34/216 (15%)
Query: 154 NFQESNVIGEGGRGHVYKARFNE--KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNI 211
           ++ ++ VIG G  G VY+A+  +  +L+A  K + D     +R  N E+  + K+ H NI
Sbjct: 59  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 113
Query: 212 ISLLGYCIHAETR----FL----------VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKI 257
           + L  +   +  +    +L          VY + ++ S  KQ     +     + L    
Sbjct: 114 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL---- 169
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA-KLSDFGLSVTAGTQSRNVKISG 316
                R L Y+H   +  + HRD+K  N+LLD      KL DFG +        NV    
Sbjct: 170 ----FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 222
Query: 317 TLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGR 351
           +  Y APE +      T   DV++ G VL ELL+G+
Sbjct: 223 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 112/265 (42%), Gaps = 48/265 (18%)
Query: 154 NFQESNVIGEGGRGHV--YKARFNEKLLAA--------VKRIDDAGHDAEREF--NNEVN 201
           +F+   VIG G  G V   K +  +K+ A         +KR + A    ER+   N +  
Sbjct: 75  DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSK 134
Query: 202 WLTKIRH-----QNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMK 256
           W+T + +      N+  ++ Y +  +   L+         E +L  P   +   +   M 
Sbjct: 135 WITTLHYAFQDDNNLYLVMDYYVGGDLLTLL------SKFEDRL--PEEMARF-YLAEMV 185
Query: 257 IAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT---AGTQSRNVK 313
           IA+D    L Y         VHRD+K  NIL+D + + +L+DFG  +     GT   +V 
Sbjct: 186 IAIDSVHQLHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA 236
Query: 314 ISGTLGYVAPEYLL-----EGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTW 368
           + GT  Y++PE L      +G+   + D ++ GV + E+L G  P    S  +    +  
Sbjct: 237 V-GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM- 294
Query: 369 AMPQLTDRSKLPNIVDPVIRDTMDL 393
                 +R + P  V  V  +  DL
Sbjct: 295 ---NHKERFQFPTQVTDVSENAKDL 316

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 78/175 (44%), Gaps = 16/175 (9%)
Query: 225 FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSS 284
           ++V E M  G +   L      S    H R   A  +    EYLH   +  +++RDLK  
Sbjct: 117 YMVMEYMPGGDMFSHLRRIGRFSEP--HARF-YAAQIVLTFEYLH---SLDLIYRDLKPE 170
Query: 285 NILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVL 344
           N+L+D     K++DFG +     + R   + GT  Y+APE +L        D +A GV++
Sbjct: 171 NLLIDQQGYIKVADFGFA--KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 345 LELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
            E+  G  P     P Q    +      ++ + + P+     ++D   L++L QV
Sbjct: 229 YEMAAGYPPFFADQPIQIYEKI------VSGKVRFPSHFSSDLKDL--LRNLLQV 275

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 78/175 (44%), Gaps = 16/175 (9%)
Query: 225 FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSS 284
           ++V E M  G +   L      S    H R   A  +    EYLH   +  +++RDLK  
Sbjct: 117 YMVMEYMPGGDMFSHLRRIGRFSEP--HARF-YAAQIVLTFEYLH---SLDLIYRDLKPE 170
Query: 285 NILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVL 344
           N+L+D     K++DFG +     + R   + GT  Y+APE +L        D +A GV++
Sbjct: 171 NLLIDQQGYIKVADFGFA--KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 345 LELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
            E+  G  P     P Q    +      ++ + + P+     ++D   L++L QV
Sbjct: 229 YEMAAGYPPFFADQPIQIYEKI------VSGKVRFPSHFSSDLKDL--LRNLLQV 275

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 93/200 (46%), Gaps = 20/200 (10%)
Query: 161 IGEGGRGHVYKARFNEKL---LAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNIISLLG 216
           +GEG    VYK +   KL   L A+K I  +    A      EV+ L  ++H NI++L  
Sbjct: 10  LGEGTYATVYKGK--SKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 67
Query: 217 YCIHAETRF-LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHP 275
             IH E    LV+E + +  L++ L     G+ +  H        + RGL Y H      
Sbjct: 68  -IIHTEKSLTLVFEYL-DKDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCH---RQK 120
Query: 276 VVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPEYLLEGKLTDK 334
           V+HRDLK  N+L++     KL+DFGL+      ++       TL Y  P+ LL    TD 
Sbjct: 121 VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGS--TDY 178
Query: 335 S---DVYAFGVVLLELLMGR 351
           S   D++  G +  E+  GR
Sbjct: 179 STQIDMWGVGCIFYEMATGR 198

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEKL--LAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
           +Q  + +G G  G V  A F+ K     AVK++         A+R +  E+  L  ++H+
Sbjct: 30  YQNLSPVGSGAYGSVCAA-FDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 87
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           N+I LL     A +       +LV  +M        L+       LT      +   + R
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 142
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           GL+Y+H   +  ++HRDLK SN+ ++     K+ DFGL+    T         T  Y AP
Sbjct: 143 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 197
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           E +L     +++ D+++ G ++ ELL GR
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
           +Q  + +G G  G V  A F+ K  L  AVK++         A+R +  E+  L  ++H+
Sbjct: 24  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 81
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           N+I LL     A +       +LV  +M        L+       LT      +   + R
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           GL+Y+H   +  ++HRDLK SN+ ++     K+  FGL+    T         T  Y AP
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILGFGLA--RHTDDEMTGYVATRWYRAP 191
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           E +L     +++ D+++ G ++ ELL GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 85/187 (45%), Gaps = 32/187 (17%)
Query: 181 AVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQL 240
           AVK ID +  D   E    + +    +H NII+L       +  +LV E+M+ G L  ++
Sbjct: 56  AVKVIDKSKRDPSEEIEILLRY---GQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKI 112
Query: 241 HGPTHGSNLTWHLRMKIAVD---------VARGLEYLHEHCNHPVVHRDLKSSNIL-LDS 290
                       LR K   +         + + +EYLH   +  VVHRDLK SNIL +D 
Sbjct: 113 ------------LRQKFFSEREASFVLHTIGKTVEYLH---SQGVVHRDLKPSNILYVDE 157
Query: 291 SFNA---KLSDFGLSVTAGTQSRNVKISG-TLGYVAPEYLLEGKLTDKSDVYAFGVVLLE 346
           S N    ++ DFG +     ++  +     T  +VAPE L      +  D+++ G++L  
Sbjct: 158 SGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYT 217
Query: 347 LLMGRRP 353
           +L G  P
Sbjct: 218 MLAGYTP 224

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEKL--LAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
           +Q    +G G  G V  A F+ K     AVK++         A+R +  E+  L  ++H+
Sbjct: 34  YQNLAPVGSGAYGSVCAA-FDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 91
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           N+I LL     A +       +LV  +M        L+       LT      +   + R
Sbjct: 92  NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 146
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           GL+Y+H   +  ++HRDLK SN+ ++     K+ DFGL+    T         T  Y AP
Sbjct: 147 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 201
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           E +L     +++ D+++ G ++ ELL GR
Sbjct: 202 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 34/216 (15%)
Query: 154 NFQESNVIGEGGRGHVYKARFNE--KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNI 211
           ++ ++ VIG G  G VY+A+  +  +L+A  K + D     +R  N E+  + K+ H NI
Sbjct: 100 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 154
Query: 212 ISLLGYCIHAETR----FL----------VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKI 257
           + L  +   +  +    +L          VY + ++ S  KQ     +     + L    
Sbjct: 155 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL---- 210
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA-KLSDFGLSVTAGTQSRNVKISG 316
                R L Y+H      + HRD+K  N+LLD      KL DFG +        NV    
Sbjct: 211 ----FRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 263
Query: 317 TLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGR 351
           +  Y APE +      T   DV++ G VL ELL+G+
Sbjct: 264 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/115 (34%), Positives = 59/115 (51%), Gaps = 5/115 (4%)
Query: 277 VHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS---GTLGYVAPEYLLEGKLTD 333
            HRD+K  NIL+ +   A L DFG++ +A T  +  ++    GTL Y APE   E   T 
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIA-SATTDEKLTQLGNTVGTLYYXAPERFSESHATY 214
Query: 334 KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQ-LTDRSKLPNIVDPVI 387
           ++D+YA   VL E L G  P +    +   + +  A+P+  T R  +P   D VI
Sbjct: 215 RADIYALTCVLYECLTGSPPYQGDQLSVXGAHINQAIPRPSTVRPGIPVAFDAVI 269

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 70/148 (47%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
           H R   A  +    EYLH   +  +++RDLK  N+++D     K++DFGL+     + R 
Sbjct: 142 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGLA--KRVKGRT 195
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
             + GT  Y+APE +L        D +A GV++ E+  G  P     P Q    +     
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 250
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
            ++ + + P+     ++D   L++L QV
Sbjct: 251 -VSGKVRFPSHFSSDLKDL--LRNLLQV 275

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/188 (29%), Positives = 89/188 (47%), Gaps = 34/188 (18%)
Query: 181 AVKRIDDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQ 239
           AVK ID +    +R+ + E+  L +  +H NII+L       +  +LV E+M+ G L  +
Sbjct: 56  AVKVIDKS----KRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDK 111
Query: 240 LHGPTHGSNLTWHLRMKIAVD---------VARGLEYLHEHCNHPVVHRDLKSSNIL-LD 289
           +            LR K   +         + + +EYLH   +  VVHRDLK SNIL +D
Sbjct: 112 I------------LRQKFFSEREASFVLHTIGKTVEYLH---SQGVVHRDLKPSNILYVD 156
Query: 290 SSFNA---KLSDFGLSVTAGTQSRNVKISG-TLGYVAPEYLLEGKLTDKSDVYAFGVVLL 345
            S N    ++ DFG +     ++  +     T  +VAPE L      +  D+++ G++L 
Sbjct: 157 ESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLY 216
Query: 346 ELLMGRRP 353
            +L G  P
Sbjct: 217 TMLAGYTP 224

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 92/197 (46%), Gaps = 18/197 (9%)
Query: 163 EGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE 222
           E   G  Y A+F +K      R   +  D ERE    V+ L +I+H N+I+L     +  
Sbjct: 32  EKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE----VSILKEIQHPNVITLHEVYENKT 87
Query: 223 TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLK 282
              L+ E++  G L   L       +LT     +    +  G+ YLH   +  + H DLK
Sbjct: 88  DVILIGELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLK 141
Query: 283 SSNI-LLDSSF---NAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSD 336
             NI LLD +      K+ DFGL+  +  G + +N  I GT  +VAPE +    L  ++D
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFVAPEIVNYEPLGLEAD 199
Query: 337 VYAFGVVLLELLMGRRP 353
           +++ GV+   LL G  P
Sbjct: 200 MWSIGVITYILLSGASP 216

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
           +Q  + +G G  G V  A F+ K  L  AVK++         A+R +  E+  L  ++H+
Sbjct: 24  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 81
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           N+I LL     A +       +LV  +M        L+       LT      +   + R
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           GL+Y+H   +  ++HRDLK SN+ ++     K+ D GL+    T         T  Y AP
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDAGLA--RHTDDEMTGYVATRWYRAP 191
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           E +L     +++ D+++ G ++ ELL GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 92/197 (46%), Gaps = 18/197 (9%)
Query: 163 EGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE 222
           E   G  Y A+F +K      R   +  D ERE    V+ L +I+H N+I+L     +  
Sbjct: 32  EKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE----VSILKEIQHPNVITLHEVYENKT 87
Query: 223 TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLK 282
              L+ E++  G L   L       +LT     +    +  G+ YLH   +  + H DLK
Sbjct: 88  DVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLK 141
Query: 283 SSNI-LLDSSF---NAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSD 336
             NI LLD +      K+ DFGL+  +  G + +N  I GT  +VAPE +    L  ++D
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFVAPEIVNYEPLGLEAD 199
Query: 337 VYAFGVVLLELLMGRRP 353
           +++ GV+   LL G  P
Sbjct: 200 MWSIGVITYILLSGASP 216

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
           H R   A  +    EYLH   +  +++RDLK  N+L+D     K++DFG +     + R 
Sbjct: 142 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFA--KRVKGRT 195
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
             + GT  Y+APE +L        D +A GV++ E+  G  P     P Q    +     
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 250
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
            ++ + + P+     ++D   L++L QV
Sbjct: 251 -VSGKVRFPSHFSSDLKDL--LRNLLQV 275

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 78/180 (43%), Gaps = 10/180 (5%)
Query: 179 LAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEK 238
           L AVK I+  G   +     E+     +RH NI+      +      +V E    G L +
Sbjct: 46  LVAVKYIE-RGEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 104
Query: 239 QLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA--KL 296
           ++      S        +    +  G+ Y H      V HRDLK  N LLD S     K+
Sbjct: 105 RICNAGRFSEDEARFFFQ---QLISGVSYCHAM---QVCHRDLKLENTLLDGSPAPRLKI 158
Query: 297 SDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDK-SDVYAFGVVLLELLMGRRPVE 355
             FG S ++   S+     GT  Y+APE LL+ +   K +DV++ GV L  +L+G  P E
Sbjct: 159 CAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFE 218

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
           H R   A  +    EYLH   +  +++RDLK  N+L+D     K++DFG +     + R 
Sbjct: 143 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKR--VKGRT 196
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
             + GT  Y+APE +L        D +A GV++ E+  G  P     P Q    +     
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 251
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
            ++ + + P+     ++D   L++L QV
Sbjct: 252 -VSGKVRFPSHFSSDLKDL--LRNLLQV 276

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 80/173 (46%), Gaps = 27/173 (15%)
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT 317
           +  VARG+E+L    +   +HRDL + NILL  +   K+ DFGL+         V+   T
Sbjct: 205 SFQVARGMEFLS---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDT 261
Query: 318 ---LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVE--KMSPTQCQSMVTWAMP 371
              L ++APE + +   + KSDV+++GV+L E+  +G  P    +M    C S +   M 
Sbjct: 262 RLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDEDFC-SRLREGM- 319
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
               R + P    P I         YQ   + + C   +P  RP   +++  L
Sbjct: 320 ----RMRAPEYSTPEI---------YQ---IMLDCWHRDPKERPRFAELVEKL 356

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 91/197 (46%), Gaps = 18/197 (9%)
Query: 163 EGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE 222
           E   G  Y A+F +K  +   R   +  + ERE    V+ L ++ H N+I+L     +  
Sbjct: 33  EKSTGLEYAAKFIKKRQSRASRRGVSREEIERE----VSILRQVLHHNVITLHDVYENRT 88
Query: 223 TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLK 282
              L+ E++  G L   L       +L+          +  G+ YLH      + H DLK
Sbjct: 89  DVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLK 142
Query: 283 SSNI-LLDSSF---NAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSD 336
             NI LLD +    + KL DFGL+  +  G + +N  I GT  +VAPE +    L  ++D
Sbjct: 143 PENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--IFGTPEFVAPEIVNYEPLGLEAD 200
Query: 337 VYAFGVVLLELLMGRRP 353
           +++ GV+   LL G  P
Sbjct: 201 MWSIGVITYILLSGASP 217

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
           +Q  + +G G  G V  A F+ K  L  AVK++         A+R +  E+  L  ++H+
Sbjct: 24  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 81
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           N+I LL     A +       +LV  +M        L+       LT      +   + R
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           GL+Y+H   +  ++HRDLK SN+ ++     K+ D GL+    T         T  Y AP
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDRGLA--RHTDDEMTGYVATRWYRAP 191
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           E +L     +++ D+++ G ++ ELL GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 91/197 (46%), Gaps = 18/197 (9%)
Query: 163 EGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE 222
           E   G  Y A+F +K  +   R   +  + ERE    V+ L ++ H N+I+L     +  
Sbjct: 33  EKSTGLEYAAKFIKKRQSRASRRGVSREEIERE----VSILRQVLHHNVITLHDVYENRT 88
Query: 223 TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLK 282
              L+ E++  G L   L       +L+          +  G+ YLH      + H DLK
Sbjct: 89  DVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLK 142
Query: 283 SSNI-LLDSSF---NAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSD 336
             NI LLD +    + KL DFGL+  +  G + +N  I GT  +VAPE +    L  ++D
Sbjct: 143 PENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--IFGTPEFVAPEIVNYEPLGLEAD 200
Query: 337 VYAFGVVLLELLMGRRP 353
           +++ GV+   LL G  P
Sbjct: 201 MWSIGVITYILLSGASP 217

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 78/180 (43%), Gaps = 10/180 (5%)
Query: 179 LAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEK 238
           L AVK I+  G   +     E+     +RH NI+      +      +V E    G L +
Sbjct: 46  LVAVKYIE-RGEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 104
Query: 239 QLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA--KL 296
           ++      S        +    +  G+ Y H      V HRDLK  N LLD S     K+
Sbjct: 105 RICNAGRFSEDEARFFFQ---QLISGVSYCHAM---QVCHRDLKLENTLLDGSPAPRLKI 158
Query: 297 SDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDK-SDVYAFGVVLLELLMGRRPVE 355
             FG S ++   S+     GT  Y+APE LL+ +   K +DV++ GV L  +L+G  P E
Sbjct: 159 CAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFE 218

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 91/197 (46%), Gaps = 18/197 (9%)
Query: 163 EGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE 222
           E   G  Y A+F +K  +   R   +  + ERE    V+ L ++ H N+I+L     +  
Sbjct: 33  EKSTGLEYAAKFIKKRQSRASRRGVSREEIERE----VSILRQVLHHNVITLHDVYENRT 88
Query: 223 TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLK 282
              L+ E++  G L   L       +L+          +  G+ YLH      + H DLK
Sbjct: 89  DVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLK 142
Query: 283 SSNI-LLDSSF---NAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSD 336
             NI LLD +    + KL DFGL+  +  G + +N  I GT  +VAPE +    L  ++D
Sbjct: 143 PENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--IFGTPEFVAPEIVNYEPLGLEAD 200
Query: 337 VYAFGVVLLELLMGRRP 353
           +++ GV+   LL G  P
Sbjct: 201 MWSIGVITYILLSGASP 217

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
           +Q  + +G G  G V  A F+ K  L  AVK++         A+R +  E+  L  ++H+
Sbjct: 24  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 81
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           N+I LL     A +       +LV  +M        L+       LT      +   + R
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           GL+Y+H   +  ++HRDLK SN+ ++     K+ D GL+    T         T  Y AP
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDGGLA--RHTDDEMTGYVATRWYRAP 191
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           E +L     +++ D+++ G ++ ELL GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 99/206 (48%), Gaps = 24/206 (11%)
Query: 155 FQESNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRH 208
           +Q    IG G +G V   Y A     +  A+K++     +   A+R +  E+  +  + H
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 82
Query: 209 QNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
           +NII LL      ++       ++V E+M + +L + +        +++ L   +     
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSYLLYQMLC---- 137
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
            G+++LH   +  ++HRDLK SNI++ S    K+ DFGL+ TAGT         T  Y A
Sbjct: 138 -GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRA 193
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELL 348
           PE +L     +  D+++ G ++ E++
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 91/197 (46%), Gaps = 18/197 (9%)
Query: 163 EGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE 222
           E   G  Y A+F +K  +   R   +  + ERE    V+ L ++ H N+I+L     +  
Sbjct: 33  EKSTGLEYAAKFIKKRQSRASRRGVSREEIERE----VSILRQVLHHNVITLHDVYENRT 88
Query: 223 TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLK 282
              L+ E++  G L   L       +L+          +  G+ YLH      + H DLK
Sbjct: 89  DVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLK 142
Query: 283 SSNI-LLDSSF---NAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSD 336
             NI LLD +    + KL DFGL+  +  G + +N  I GT  +VAPE +    L  ++D
Sbjct: 143 PENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--IFGTPEFVAPEIVNYEPLGLEAD 200
Query: 337 VYAFGVVLLELLMGRRP 353
           +++ GV+   LL G  P
Sbjct: 201 MWSIGVITYILLSGASP 217

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 93/216 (43%), Gaps = 34/216 (15%)
Query: 154 NFQESNVIGEGGRGHVYKARF-NEKLLAAVKRIDDAGHDAEREFNN-EVNWLTKIRHQNI 211
           ++ ++ VIG G  G VY+A+  +   L A+K++        + F N E+  + K+ H NI
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQG-----KAFKNRELQIMRKLDHCNI 75
Query: 212 ISLLGYCIHAETR--------------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKI 257
           + L  +   +  +                VY + ++ S  KQ     +     + L    
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQL---- 131
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA-KLSDFGLSVTAGTQSRNVKISG 316
                R L Y+H   +  + HRD+K  N+LLD      KL DFG +        NV    
Sbjct: 132 ----FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 184
Query: 317 TLGYVAPEYLLEGK-LTDKSDVYAFGVVLLELLMGR 351
           +  Y APE +      T   DV++ G VL ELL+G+
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 91/197 (46%), Gaps = 18/197 (9%)
Query: 163 EGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE 222
           E   G  Y A+F +K  +   R   +  + ERE    V+ L ++ H N+I+L     +  
Sbjct: 33  EKSTGLEYAAKFIKKRQSRASRRGVSREEIERE----VSILRQVLHHNVITLHDVYENRT 88
Query: 223 TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLK 282
              L+ E++  G L   L       +L+          +  G+ YLH      + H DLK
Sbjct: 89  DVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLK 142
Query: 283 SSNI-LLDSSF---NAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSD 336
             NI LLD +    + KL DFGL+  +  G + +N  I GT  +VAPE +    L  ++D
Sbjct: 143 PENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--IFGTPEFVAPEIVNYEPLGLEAD 200
Query: 337 VYAFGVVLLELLMGRRP 353
           +++ GV+   LL G  P
Sbjct: 201 MWSIGVITYILLSGASP 217

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/250 (24%), Positives = 109/250 (43%), Gaps = 55/250 (22%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRI--DDAGHDAEREFNNEVNWLTKIRHQN--IISLLG 216
           IG GG   V++    +K + A+K +  ++A +     + NE+ +L K++  +  II L  
Sbjct: 20  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 79
Query: 217 YCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDV-------ARGLEYLH 269
           Y I   T   +Y +M+ G+++           L   L+ K ++D           LE +H
Sbjct: 80  YEI---TDQYIYMVMECGNID-----------LNSWLKKKKSIDPWERKSYWKNMLEAVH 125
Query: 270 EHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV---KISGTLGYVAPEYL 326
               H +VH DLK +N L+      KL DFG++      + +V      GT+ Y+ PE +
Sbjct: 126 TIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 184
Query: 327 LEGKLTDKS-----------DVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTD 375
            +   + ++           DV++ G +L  +  G+ P +++               +  
Sbjct: 185 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI---------------INQ 229
Query: 376 RSKLPNIVDP 385
            SKL  I+DP
Sbjct: 230 ISKLHAIIDP 239

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 95/216 (43%), Gaps = 34/216 (15%)
Query: 154 NFQESNVIGEGGRGHVYKARF-NEKLLAAVKRIDDAGHDAEREFNN-EVNWLTKIRHQNI 211
           ++ ++ VIG G  G VY+A+  +   L A+K++        + F N E+  + K+ H NI
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQG-----KAFKNRELQIMRKLDHCNI 75
Query: 212 ISLLGYCIHAETR----FL----------VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKI 257
           + L  +   +  +    +L          VY + ++ S  KQ     +     + L    
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL---- 131
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA-KLSDFGLSVTAGTQSRNVKISG 316
                R L Y+H   +  + HRD+K  N+LLD      KL DFG +        NV    
Sbjct: 132 ----FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 184
Query: 317 TLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGR 351
           +  Y APE +      T   DV++ G VL ELL+G+
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 95/216 (43%), Gaps = 34/216 (15%)
Query: 154 NFQESNVIGEGGRGHVYKARF-NEKLLAAVKRIDDAGHDAEREFNN-EVNWLTKIRHQNI 211
           ++ ++ VIG G  G VY+A+  +   L A+K++        + F N E+  + K+ H NI
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQG-----KAFKNRELQIMRKLDHCNI 75
Query: 212 ISLLGYCIHAETR----FL----------VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKI 257
           + L  +   +  +    +L          VY + ++ S  KQ     +     + L    
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL---- 131
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA-KLSDFGLSVTAGTQSRNVKISG 316
                R L Y+H   +  + HRD+K  N+LLD      KL DFG +        NV    
Sbjct: 132 ----FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 184
Query: 317 TLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGR 351
           +  Y APE +      T   DV++ G VL ELL+G+
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 110/268 (41%), Gaps = 54/268 (20%)
Query: 154 NFQESNVIGEGGRGHV--YKARFNEKLLAA--------VKRIDDAGHDAEREF--NNEVN 201
           +F+   VIG G  G V   K +  E++ A         +KR + A    ER+   N +  
Sbjct: 75  DFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQ 134
Query: 202 WLTKIRHQNIISLLGYCIHAETR-FLVYEMMQNGSL-------EKQLHGPTHGSNLTWHL 253
           W+T          L Y    E   +LV +    G L       E +L  P   +   +  
Sbjct: 135 WITA---------LHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKL--PEDMARF-YIG 182
Query: 254 RMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA---GTQSR 310
            M +A+D    L Y         VHRD+K  N+LLD + + +L+DFG  +     GT   
Sbjct: 183 EMVLAIDSIHQLHY---------VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQS 233
Query: 311 NVKISGTLGYVAPEYLLE-----GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSM 365
           +V + GT  Y++PE L       GK   + D ++ GV + E+L G  P    S  +    
Sbjct: 234 SVAV-GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK 292
Query: 366 VTWAMPQLTDRSKLPNIVDPVIRDTMDL 393
           +        +R + P+ V  V  +  DL
Sbjct: 293 IM----NHEERFQFPSHVTDVSEEAKDL 316

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/250 (24%), Positives = 109/250 (43%), Gaps = 55/250 (22%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRI--DDAGHDAEREFNNEVNWLTKIRHQN--IISLLG 216
           IG GG   V++    +K + A+K +  ++A +     + NE+ +L K++  +  II L  
Sbjct: 36  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95
Query: 217 YCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDV-------ARGLEYLH 269
           Y I   T   +Y +M+ G+++           L   L+ K ++D           LE +H
Sbjct: 96  YEI---TDQYIYMVMECGNID-----------LNSWLKKKKSIDPWERKSYWKNMLEAVH 141
Query: 270 EHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV---KISGTLGYVAPEYL 326
               H +VH DLK +N L+      KL DFG++      + +V      GT+ Y+ PE +
Sbjct: 142 TIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 200
Query: 327 LEGKLTDKS-----------DVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTD 375
            +   + ++           DV++ G +L  +  G+ P +++               +  
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI---------------INQ 245
Query: 376 RSKLPNIVDP 385
            SKL  I+DP
Sbjct: 246 ISKLHAIIDP 255

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 110/268 (41%), Gaps = 54/268 (20%)
Query: 154 NFQESNVIGEGGRGHV--YKARFNEKLLAA--------VKRIDDAGHDAEREF--NNEVN 201
           +F+   VIG G  G V   K +  E++ A         +KR + A    ER+   N +  
Sbjct: 91  DFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQ 150
Query: 202 WLTKIRHQNIISLLGYCIHAETR-FLVYEMMQNGSL-------EKQLHGPTHGSNLTWHL 253
           W+T          L Y    E   +LV +    G L       E +L  P   +   +  
Sbjct: 151 WITA---------LHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKL--PEDMARF-YIG 198
Query: 254 RMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA---GTQSR 310
            M +A+D    L Y         VHRD+K  N+LLD + + +L+DFG  +     GT   
Sbjct: 199 EMVLAIDSIHQLHY---------VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQS 249
Query: 311 NVKISGTLGYVAPEYLLE-----GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSM 365
           +V + GT  Y++PE L       GK   + D ++ GV + E+L G  P    S  +    
Sbjct: 250 SVAV-GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK 308
Query: 366 VTWAMPQLTDRSKLPNIVDPVIRDTMDL 393
           +        +R + P+ V  V  +  DL
Sbjct: 309 IM----NHEERFQFPSHVTDVSEEAKDL 332

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
           H R   A  +    EYLH   +  +++RDLK  N+++D     K++DFG +     + R 
Sbjct: 142 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFA--KRVKGRT 195
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
             + GT  Y+APE +L        D +A GV++ E+  G  P     P Q    +     
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 250
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
            ++ + + P+     ++D   L++L QV
Sbjct: 251 -VSGKVRFPSHFSSDLKDL--LRNLLQV 275

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 92/210 (43%), Gaps = 17/210 (8%)
Query: 150 AATNNFQESNVIGEGGRGHVYKA---RFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKI 206
            + + ++    +GEG  G VYKA     NE +     R++            EV+ L ++
Sbjct: 31  TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKEL 90
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
           +H+NII L     H     L++E  +N  L+K +       +++  +       +  G+ 
Sbjct: 91  QHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYM---DKNPDVSMRVIKSFLYQLINGVN 146
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNA-----KLSDFGLSVTAGTQSRNVKIS-GTLGY 320
           + H   +   +HRDLK  N+LL  S  +     K+ DFGL+   G   R       TL Y
Sbjct: 147 FCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWY 203
Query: 321 VAPEYLLEGKLTDKS-DVYAFGVVLLELLM 349
             PE LL  +    S D+++   +  E+LM
Sbjct: 204 RPPEILLGSRHYSTSVDIWSIACIWAEMLM 233

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 70/148 (47%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
           H R   A  +    EYLH   +  +++RDLK  N+L+D     +++DFG +     + R 
Sbjct: 142 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 195
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
             ++GT  Y+APE +L        D +A GV++ E+  G  P     P Q    +     
Sbjct: 196 WXLAGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 250
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
            ++ + + P+     ++D   L++L QV
Sbjct: 251 -VSGKVRFPSHFSSDLKDL--LRNLLQV 275

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
           H R   A  +    EYLH   +  +++RDLK  N+++D     K++DFG +     + R 
Sbjct: 143 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFA--KRVKGRT 196
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
             + GT  Y+APE +L        D +A GV++ E+  G  P     P Q    +     
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 251
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
            ++ + + P+     ++D   L++L QV
Sbjct: 252 -VSGKVRFPSHFSSDLKDL--LRNLLQV 276

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
           H R   A  +    EYLH   +  +++RDLK  N+++D     K++DFG +     + R 
Sbjct: 143 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFA--KRVKGRT 196
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
             + GT  Y+APE +L        D +A GV++ E+  G  P     P Q    +     
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 251
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
            ++ + + P+     ++D   L++L QV
Sbjct: 252 -VSGKVRFPSHFSSDLKDL--LRNLLQV 276

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
           H R   A  +    EYLH   +  +++RDLK  N+++D     K++DFG +     + R 
Sbjct: 143 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFA--KRVKGRT 196
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
             + GT  Y+APE +L        D +A GV++ E+  G  P     P Q    +     
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 251
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
            ++ + + P+     ++D   L++L QV
Sbjct: 252 -VSGKVRFPSHFSSDLKDL--LRNLLQV 276

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
           H R   A  +    EYLH   +  +++RDLK  N+++D     K++DFG +     + R 
Sbjct: 143 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFA--KRVKGRT 196
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
             + GT  Y+APE +L        D +A GV++ E+  G  P     P Q    +     
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 251
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
            ++ + + P+     ++D   L++L QV
Sbjct: 252 -VSGKVRFPSHFSSDLKDL--LRNLLQV 276

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
           H R   A  +    EYLH   +  +++RDLK  N+++D     K++DFG +     + R 
Sbjct: 142 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFA--KRVKGRT 195
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
             + GT  Y+APE +L        D +A GV++ E+  G  P     P Q    +     
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 250
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
            ++ + + P+     ++D   L++L QV
Sbjct: 251 -VSGKVRFPSHFSSDLKDL--LRNLLQV 275

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 90/197 (45%), Gaps = 18/197 (9%)
Query: 163 EGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE 222
           E   G  Y A+F +K  +   R      + ERE    V+ L ++ H NII+L     +  
Sbjct: 33  EKSTGLEYAAKFIKKRQSRASRRGVCREEIERE----VSILRQVLHPNIITLHDVYENRT 88
Query: 223 TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLK 282
              L+ E++  G L   L       +L+          +  G+ YLH      + H DLK
Sbjct: 89  DVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLK 142
Query: 283 SSNI-LLDSSF---NAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSD 336
             NI LLD +    + KL DFGL+  +  G + +N  I GT  +VAPE +    L  ++D
Sbjct: 143 PENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--IFGTPEFVAPEIVNYEPLGLEAD 200
Query: 337 VYAFGVVLLELLMGRRP 353
           +++ GV+   LL G  P
Sbjct: 201 MWSIGVITYILLSGASP 217

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 111/250 (44%), Gaps = 55/250 (22%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRI--DDAGHDAEREFNNEVNWLTKIRHQN--IISLLG 216
           IG GG   V++    +K + A+K +  ++A +     + NE+ +L K++  +  II L  
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 217 YCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDV-------ARGLEYLH 269
           Y I   T   +Y +M+ G+++           L   L+ K ++D           LE +H
Sbjct: 124 YEI---TDQYIYMVMECGNID-----------LNSWLKKKKSIDPWERKSYWKNMLEAVH 169
Query: 270 EHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN-VKIS--GTLGYVAPEYL 326
               H +VH DLK +N L+      KL DFG++      + + VK S  GT+ Y+ PE +
Sbjct: 170 TIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 228
Query: 327 LEGKLTDKS-----------DVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTD 375
            +   + ++           DV++ G +L  +  G+ P +++               +  
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI---------------INQ 273
Query: 376 RSKLPNIVDP 385
            SKL  I+DP
Sbjct: 274 ISKLHAIIDP 283

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 69/290 (23%), Positives = 122/290 (42%), Gaps = 35/290 (12%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNN------EVN 201
           E   + +Q   ++G GG G VY   R ++ L  A+K ++        E  N      EV 
Sbjct: 4   EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 63
Query: 202 WLTKIR--HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAV 259
            L K+      +I LL +    ++  L+ E M+   ++      T    L   L      
Sbjct: 64  LLKKVSSGFSGVIRLLDWFERPDSFVLILERME--PVQDLFDFITERGALQEELARSFFW 121
Query: 260 DVARGLEYLHEHCNHPVVHRDLKSSNILLD-SSFNAKLSDFGLSVTAGTQSRNVKISGTL 318
            V   + + H   N  V+HRD+K  NIL+D +    KL DFG S      +      GT 
Sbjct: 122 QVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTR 177
Query: 319 GYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRPVE-------------KMSPTQCQS 364
            Y  PE++   +   +S  V++ G++L +++ G  P E             +   ++CQ 
Sbjct: 178 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQH 237
Query: 365 MVTWAMP-QLTDRSKLPNIVD-PVIRDTMDLKHLYQVAAVAVLCIQPEPS 412
           ++ W +  + +DR     I + P ++D +  +   + A + +  + P PS
Sbjct: 238 LIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ---ETAEIHLHSLSPGPS 284

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/250 (24%), Positives = 109/250 (43%), Gaps = 55/250 (22%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRI--DDAGHDAEREFNNEVNWLTKIRHQN--IISLLG 216
           IG GG   V++    +K + A+K +  ++A +     + NE+ +L K++  +  II L  
Sbjct: 16  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 75
Query: 217 YCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDV-------ARGLEYLH 269
           Y I   T   +Y +M+ G+++           L   L+ K ++D           LE +H
Sbjct: 76  YEI---TDQYIYMVMECGNID-----------LNSWLKKKKSIDPWERKSYWKNMLEAVH 121
Query: 270 EHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV---KISGTLGYVAPEYL 326
               H +VH DLK +N L+      KL DFG++      + +V      GT+ Y+ PE +
Sbjct: 122 TIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 180
Query: 327 LEGKLTDKS-----------DVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTD 375
            +   + ++           DV++ G +L  +  G+ P +++               +  
Sbjct: 181 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI---------------INQ 225
Query: 376 RSKLPNIVDP 385
            SKL  I+DP
Sbjct: 226 ISKLHAIIDP 235

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 70/148 (47%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
           H R   A  +    EYLH   +  +++RDLK  N+++D     +++DFGL+     + R 
Sbjct: 142 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIQVTDFGLA--KRVKGRT 195
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
             + GT  Y+APE +L        D +A GV++ E+  G  P     P Q    +     
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 250
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
            ++ + + P+     ++D   L++L QV
Sbjct: 251 -VSGKVRFPSHFSSDLKDL--LRNLLQV 275

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 99/206 (48%), Gaps = 24/206 (11%)
Query: 155 FQESNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRH 208
           +Q    IG G +G V   Y A     +  A+K++     +   A+R +  E+  +  + H
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 82
Query: 209 QNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
           +NII LL      ++       ++V E+M + +L + +        +++ L   +     
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSYLLYQMLC---- 137
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
            G+++LH   +  ++HRDLK SNI++ S    K+ DFGL+ TAGT         T  Y A
Sbjct: 138 -GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRA 193
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELL 348
           PE +L     +  D+++ G ++ E++
Sbjct: 194 PEVILGMGYKENVDLWSVGCIMGEMV 219

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/250 (24%), Positives = 109/250 (43%), Gaps = 55/250 (22%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRI--DDAGHDAEREFNNEVNWLTKIRHQN--IISLLG 216
           IG GG   V++    +K + A+K +  ++A +     + NE+ +L K++  +  II L  
Sbjct: 17  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 76
Query: 217 YCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDV-------ARGLEYLH 269
           Y I   T   +Y +M+ G+++           L   L+ K ++D           LE +H
Sbjct: 77  YEI---TDQYIYMVMECGNID-----------LNSWLKKKKSIDPWERKSYWKNMLEAVH 122
Query: 270 EHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV---KISGTLGYVAPEYL 326
               H +VH DLK +N L+      KL DFG++      + +V      GT+ Y+ PE +
Sbjct: 123 TIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181
Query: 327 LEGKLTDKS-----------DVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTD 375
            +   + ++           DV++ G +L  +  G+ P +++               +  
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI---------------INQ 226
Query: 376 RSKLPNIVDP 385
            SKL  I+DP
Sbjct: 227 ISKLHAIIDP 236

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
           H R   A  +    EYLH   +  +++RDLK  N+L+D     +++DFG +     + R 
Sbjct: 142 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 195
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
             + GT  Y+APE +L        D +A GV++ E+  G  P     P Q    +     
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 250
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
            ++ + + P+     ++D   L++L QV
Sbjct: 251 -VSGKVRFPSHFSSDLKDL--LRNLLQV 275

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
           H R   A  +    EYLH   +  +++RDLK  N+L+D     +++DFG +     + R 
Sbjct: 142 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 195
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
             + GT  Y+APE +L        D +A GV++ E+  G  P     P Q    +     
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 250
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
            ++ + + P+     ++D   L++L QV
Sbjct: 251 -VSGKVRFPSHFSSDLKDL--LRNLLQV 275

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
           H R   A  +    EYLH   +  +++RDLK  N+L+D     +++DFG +     + R 
Sbjct: 143 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 196
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
             + GT  Y+APE +L        D +A GV++ E+  G  P     P Q    +     
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 251
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
            ++ + + P+     ++D   L++L QV
Sbjct: 252 -VSGKVRFPSHFSSDLKDL--LRNLLQV 276

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
           H R   A  +    EYLH   +  +++RDLK  N+L+D     +++DFG +     + R 
Sbjct: 142 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 195
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
             + GT  Y+APE +L        D +A GV++ E+  G  P     P Q    +     
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 250
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
            ++ + + P+     ++D   L++L QV
Sbjct: 251 -VSGKVRFPSHFSSDLKDL--LRNLLQV 275

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
           H R   A  +    EYLH   +  +++RDLK  N+L+D     +++DFG +     + R 
Sbjct: 142 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 195
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
             + GT  Y+APE +L        D +A GV++ E+  G  P     P Q    +     
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 250
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
            ++ + + P+     ++D   L++L QV
Sbjct: 251 -VSGKVRFPSHFSSDLKDL--LRNLLQV 275

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
           H R   A  +    EYLH   +  +++RDLK  N+L+D     +++DFG +     + R 
Sbjct: 142 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 195
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
             + GT  Y+APE +L        D +A GV++ E+  G  P     P Q    +     
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 250
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
            ++ + + P+     ++D   L++L QV
Sbjct: 251 -VSGKVRFPSHFSSDLKDL--LRNLLQV 275

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
           H R   A  +    EYLH   +  +++RDLK  N+L+D     +++DFG +     + R 
Sbjct: 142 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 195
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
             + GT  Y+APE +L        D +A GV++ E+  G  P     P Q    +     
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 250
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
            ++ + + P+     ++D   L++L QV
Sbjct: 251 -VSGKVRFPSHFSSDLKDL--LRNLLQV 275

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
           H R   A  +    EYLH   +  +++RDLK  N+L+D     +++DFG +     + R 
Sbjct: 142 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 195
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
             + GT  Y+APE +L        D +A GV++ E+  G  P     P Q    +     
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 250
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
            ++ + + P+     ++D   L++L QV
Sbjct: 251 -VSGKVRFPSHFSSDLKDL--LRNLLQV 275

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
           H R   A  +    EYLH   +  +++RDLK  N+L+D     +++DFG +     + R 
Sbjct: 142 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 195
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
             + GT  Y+APE +L        D +A GV++ E+  G  P     P Q    +     
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 250
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
            ++ + + P+     ++D   L++L QV
Sbjct: 251 -VSGKVRFPSHFSSDLKDL--LRNLLQV 275

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
           H R   A  +    EYLH   +  +++RDLK  N+L+D     +++DFG +     + R 
Sbjct: 129 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDEQGYIQVTDFGFA--KRVKGRT 182
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
             + GT  Y+APE +L        D +A GV++ E+  G  P     P Q    +     
Sbjct: 183 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 237
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
            ++ + + P+     ++D   L++L QV
Sbjct: 238 -VSGKVRFPSHFSSDLKDL--LRNLLQV 262

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
           H R   A  +    EYLH   +  +++RDLK  N+L+D     +++DFG +     + R 
Sbjct: 143 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 196
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
             + GT  Y+APE +L        D +A GV++ E+  G  P     P Q    +     
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 251
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
            ++ + + P+     ++D   L++L QV
Sbjct: 252 -VSGKVRFPSHFSSDLKDL--LRNLLQV 276

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
           H R   A  +    EYLH   +  +++RDLK  N+L+D     +++DFG +     + R 
Sbjct: 142 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 195
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
             + GT  Y+APE +L        D +A GV++ E+  G  P     P Q    +     
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 250
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
            ++ + + P+     ++D   L++L QV
Sbjct: 251 -VSGKVRFPSHFSSDLKDL--LRNLLQV 275

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
           H R   A  +    EYLH   +  +++RDLK  N+L+D     +++DFG +     + R 
Sbjct: 143 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 196
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
             + GT  Y+APE +L        D +A GV++ E+  G  P     P Q    +     
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 251
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
            ++ + + P+     ++D   L++L QV
Sbjct: 252 -VSGKVRFPSHFSSDLKDL--LRNLLQV 276

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
           H R   A  +    EYLH   +  +++RDLK  N+L+D     +++DFG +     + R 
Sbjct: 143 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 196
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
             + GT  Y+APE +L        D +A GV++ E+  G  P     P Q    +     
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 251
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
            ++ + + P+     ++D   L++L QV
Sbjct: 252 -VSGKVRFPSHFSSDLKDL--LRNLLQV 276

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 111/250 (44%), Gaps = 55/250 (22%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRI--DDAGHDAEREFNNEVNWLTKIRHQN--IISLLG 216
           IG GG   V++    +K + A+K +  ++A +     + NE+ +L K++  +  II L  
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 217 YCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDV-------ARGLEYLH 269
           Y I   T   +Y +M+ G+++           L   L+ K ++D           LE +H
Sbjct: 124 YEI---TDQYIYMVMECGNID-----------LNSWLKKKKSIDPWERKSYWKNMLEAVH 169
Query: 270 EHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN-VKIS--GTLGYVAPEYL 326
               H +VH DLK +N L+      KL DFG++      + + VK S  GT+ Y+ PE +
Sbjct: 170 TIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 228
Query: 327 LEGKLTDKS-----------DVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTD 375
            +   + ++           DV++ G +L  +  G+ P +++               +  
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI---------------INQ 273
Query: 376 RSKLPNIVDP 385
            SKL  I+DP
Sbjct: 274 ISKLHAIIDP 283

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 155 FQESNVIGEGGRGHVYKAR-FNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQN 210
           +Q  + +G G  G V  +      L  AVK++         A+R +  E+  L  ++H+N
Sbjct: 53  YQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHEN 111
Query: 211 IISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
           +I LL     A +       +LV  +M        L+       LT      +   + RG
Sbjct: 112 VIGLLDVFTPATSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILRG 166
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
           L+Y+H   +  ++HRDLK SN+ ++     K+ DFGL+    T         T  Y APE
Sbjct: 167 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAPE 221
Query: 325 YLLEGKLTDKS-DVYAFGVVLLELLMGR 351
            +L     + + D+++ G ++ ELL GR
Sbjct: 222 IMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
           H R   A  +    EYLH   +  +++RDLK  N+L+D     +++DFG +     + R 
Sbjct: 142 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 195
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
             + GT  Y+APE +L        D +A GV++ E+  G  P     P Q    +     
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 250
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
            ++ + + P+     ++D   L++L QV
Sbjct: 251 -VSGKVRFPSHFSSDLKDL--LRNLLQV 275

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
           H R   A  +    EYLH   +  +++RDLK  N+L+D     +++DFG +     + R 
Sbjct: 135 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 188
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
             + GT  Y+APE +L        D +A GV++ E+  G  P     P Q    +     
Sbjct: 189 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 243
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
            ++ + + P+     ++D   L++L QV
Sbjct: 244 -VSGKVRFPSHFSSDLKDL--LRNLLQV 268

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
           H R   A  +    EYLH   +  +++RDLK  N+L+D     +++DFG +     + R 
Sbjct: 142 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 195
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
             + GT  Y+APE +L        D +A GV++ E+  G  P     P Q    +     
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 250
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
            ++ + + P+     ++D   L++L QV
Sbjct: 251 -VSGKVRFPSHFSSDLKDL--LRNLLQV 275

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 96/211 (45%), Gaps = 11/211 (5%)
Query: 149 EAATNNF---QESNVIGEGGRGHVYKARFNEKLLA-AVKRIDDAGHDAEREFNNEVNWLT 204
           + A N+F    ++ ++G G  G V+K       L  A K I   G   + E  NE++ + 
Sbjct: 82  QGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMN 141
Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
           ++ H N+I L           LV E +  G L  ++   ++  NLT    +     +  G
Sbjct: 142 QLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESY--NLTELDTILFMKQICEG 199
Query: 265 LEYLHEHCNHPVVHRDLKSSNILL--DSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
           + ++H+     ++H DLK  NIL     +   K+ DFGL+     + +     GT  ++A
Sbjct: 200 IRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLA 256
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
           PE +    ++  +D+++ GV+   LL G  P
Sbjct: 257 PEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
           H R   A  +    EYLH   +  +++RDLK  N+L+D     +++DFG +     + R 
Sbjct: 137 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 190
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
             + GT  Y+APE +L        D +A GV++ E+  G  P     P Q    +     
Sbjct: 191 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 245
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
            ++ + + P+     ++D   L++L QV
Sbjct: 246 -VSGKVRFPSHFSSDLKDL--LRNLLQV 270

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
           H R   A  +    EYLH   +  +++RDLK  N+L+D     +++DFG +     + R 
Sbjct: 142 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 195
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
             + GT  Y+APE +L        D +A GV++ E+  G  P     P Q    +     
Sbjct: 196 WXLXGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 250
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
            ++ + + P+     ++D   L++L QV
Sbjct: 251 -VSGKVRFPSHFSSDLKDL--LRNLLQV 275

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
           H R   A  +    EYLH   +  +++RDLK  N+L+D     +++DFG +     + R 
Sbjct: 142 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 195
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
             + GT  Y+APE +L        D +A GV++ E+  G  P     P Q    +     
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 250
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
            ++ + + P+     ++D   L++L QV
Sbjct: 251 -VSGKVRFPSHFSSDLKDL--LRNLLQV 275

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
           H R   A  +    EYLH   +  +++RDLK  N+L+D     +++DFG +     + R 
Sbjct: 142 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 195
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
             + GT  Y+APE +L        D +A GV++ E+  G  P     P Q    +     
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 250
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
            ++ + + P+     ++D   L++L QV
Sbjct: 251 -VSGKVRFPSHFSSDLKDL--LRNLLQV 275

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
           H R   A  +    EYLH   +  +++RDLK  N+L+D     +++DFG +     + R 
Sbjct: 128 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 181
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
             + GT  Y+APE +L        D +A GV++ E+  G  P     P Q    +     
Sbjct: 182 WTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 236
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
            ++ + + P+     ++D   L++L QV
Sbjct: 237 -VSGKVRFPSHFSSDLKDL--LRNLLQV 261

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
           H R   A  +    EYLH   +  +++RDLK  N+L+D     +++DFG +     + R 
Sbjct: 142 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 195
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
             + GT  Y+APE +L        D +A GV++ E+  G  P     P Q    +     
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADEPIQIYEKI----- 250
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
            ++ + + P+     ++D   L++L QV
Sbjct: 251 -VSGKVRFPSHFSSDLKDL--LRNLLQV 275

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
           H R   A  +    EYLH   +  +++RDLK  N+L+D     +++DFG +     + R 
Sbjct: 143 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 196
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
             + GT  Y+APE +L        D +A GV++ E+  G  P     P Q    +     
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 251
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
            ++ + + P+     ++D   L++L QV
Sbjct: 252 -VSGKVRFPSHFSSDLKDL--LRNLLQV 276

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
           H R   A  +    EYLH   +  +++RDLK  N+L+D     +++DFG +     + R 
Sbjct: 143 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 196
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
             + GT  Y+APE +L        D +A GV++ E+  G  P     P Q    +     
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 251
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
            ++ + + P+     ++D   L++L QV
Sbjct: 252 -VSGKVRFPSHFSSDLKDL--LRNLLQV 276

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
           H R   A  +    EYLH   +  +++RDLK  N+L+D     +++DFG +     + R 
Sbjct: 142 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 195
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
             + GT  Y+APE +L        D +A GV++ E+  G  P     P Q    +     
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 250
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
            ++ + + P+     ++D   L++L QV
Sbjct: 251 -VSGKVRFPSHFSSDLKDL--LRNLLQV 275

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
           H R   A  +    EYLH   +  +++RDLK  N+L+D     +++DFG +     + R 
Sbjct: 142 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 195
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
             + GT  Y+APE +L        D +A GV++ E+  G  P     P Q    +     
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 250
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
            ++ + + P+     ++D   L++L QV
Sbjct: 251 -VSGKVRFPSHFSSDLKDL--LRNLLQV 275

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
           H R   A  +    EYLH   +  +++RDLK  N+L+D     +++DFG +     + R 
Sbjct: 143 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 196
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
             + GT  Y+APE +L        D +A GV++ E+  G  P     P Q    +     
Sbjct: 197 WTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 251
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
            ++ + + P+     ++D   L++L QV
Sbjct: 252 -VSGKVRFPSHFSSDLKDL--LRNLLQV 276

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
           H R   A  +    EYLH   +  +++RDLK  N+L+D     +++DFG +     + R 
Sbjct: 135 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 188
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
             + GT  Y+APE +L        D +A GV++ E+  G  P     P Q    +     
Sbjct: 189 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 243
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
            ++ + + P+     ++D   L++L QV
Sbjct: 244 -VSGKVRFPSHFSSDLKDL--LRNLLQV 268

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
           H R   A  +    EYLH   +  +++RDLK  N+L+D     +++DFG +     + R 
Sbjct: 142 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 195
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
             + GT  Y+APE +L        D +A GV++ E+  G  P     P Q    +     
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 250
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
            ++ + + P+     ++D   L++L QV
Sbjct: 251 -VSGKVRFPSHFSSDLKDL--LRNLLQV 275

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
           H R   A  +    EYLH   +  +++RDLK  N+L+D     +++DFG +     + R 
Sbjct: 142 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 195
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
             + GT  Y+APE +L        D +A GV++ E+  G  P     P Q    +     
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 250
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
            ++ + + P+     ++D   L++L QV
Sbjct: 251 -VSGKVRFPSHFSSDLKDL--LRNLLQV 275

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
           H R   A  +    EYLH   +  +++RDLK  N+L+D     +++DFG +     + R 
Sbjct: 163 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT 216
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
             + GT  Y+APE +L        D +A GV++ E+  G  P     P Q    +     
Sbjct: 217 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 271
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
            ++ + + P+     ++D   L++L QV
Sbjct: 272 -VSGKVRFPSHFSSDLKDL--LRNLLQV 296

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
           H R   A  +    EYLH   +  +++RDLK  N+L+D     +++DFG +     + R 
Sbjct: 163 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT 216
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
             + GT  Y+APE +L        D +A GV++ E+  G  P     P Q    +     
Sbjct: 217 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 271
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
            ++ + + P+     ++D   L++L QV
Sbjct: 272 -VSGKVRFPSHFSSDLKDL--LRNLLQV 296

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 60/250 (24%), Positives = 107/250 (42%), Gaps = 55/250 (22%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRI--DDAGHDAEREFNNEVNWLTKIRHQN--IISLLG 216
           IG GG   V++    +K + A+K +  ++A +     + NE+ +L K++  +  II L  
Sbjct: 36  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95
Query: 217 YCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDV-------ARGLEYLH 269
           Y I   T   +Y +M+ G+++           L   L+ K ++D           LE +H
Sbjct: 96  YEI---TDQYIYMVMECGNID-----------LNSWLKKKKSIDPWERKSYWKNMLEAVH 141
Query: 270 EHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV---KISGTLGYVAPEYL 326
               H +VH DLK +N L+      KL DFG++         V      GT+ Y+ PE +
Sbjct: 142 TIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAI 200
Query: 327 LEGKLTDKS-----------DVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTD 375
            +   + ++           DV++ G +L  +  G+ P +++               +  
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI---------------INQ 245
Query: 376 RSKLPNIVDP 385
            SKL  I+DP
Sbjct: 246 ISKLHAIIDP 255

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEKL--LAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
           +Q  + +G G  G V  A F+ K     AVK++         A+R +  E+  L  ++H+
Sbjct: 24  YQNLSPVGSGAYGSVCAA-FDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 81
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           N+I LL     A +       +LV  +M        L+       LT      +   + R
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           GL+Y+H   +  ++HRDLK SN+ ++     K+ DF L+    T         T  Y AP
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFYLA--RHTDDEMTGYVATRWYRAP 191
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           E +L     +++ D+++ G ++ ELL GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 39/148 (26%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
           H R   A  +    EYLH   +  +++RDLK  N+++D     +++DFG +     + R 
Sbjct: 142 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIQVTDFGFA--KRVKGRT 195
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
             + GT  Y+APE +L        D +A GV++ E+  G  P     P Q    +     
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 250
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
            ++ + + P+     ++D   L++L QV
Sbjct: 251 -VSGKVRFPSHFSSDLKDL--LRNLLQV 275

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 97/204 (47%), Gaps = 27/204 (13%)
Query: 161 IGEGGRGHVYKA---RFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQNIISL 214
           +G G  G V  A   R  EK+  A+K++         A+R +  E+  L  ++H+N+I L
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKV--AIKKLSRPFQSEIFAKRAYR-ELLLLKHMQHENVIGL 106
Query: 215 LGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYL 268
           L     A +       +LV   MQ   L+K +     G   +      +   + +GL+Y+
Sbjct: 107 LDVFTPASSLRNFYDFYLVMPFMQT-DLQKIM-----GMEFSEEKIQYLVYQMLKGLKYI 160
Query: 269 HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLE 328
           H   +  VVHRDLK  N+ ++     K+ DFGL+  A  +     +  T  Y APE +L 
Sbjct: 161 H---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV--TRWYRAPEVILS 215
Query: 329 GKLTDKS-DVYAFGVVLLELLMGR 351
               +++ D+++ G ++ E+L G+
Sbjct: 216 WMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/188 (29%), Positives = 86/188 (45%), Gaps = 34/188 (18%)
Query: 181 AVKRIDDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQ 239
           AVK ID +    +R+   E+  L +  +H NII+L       +  ++V E+M+ G L  +
Sbjct: 51  AVKIIDKS----KRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDK 106
Query: 240 LHGPTHGSNLTWHLRMK---------IAVDVARGLEYLHEHCNHPVVHRDLKSSNIL-LD 289
           +            LR K         +   + + +EYLH      VVHRDLK SNIL +D
Sbjct: 107 I------------LRQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVD 151
Query: 290 SSFNA---KLSDFGLSVTAGTQSRNVKISG-TLGYVAPEYLLEGKLTDKSDVYAFGVVLL 345
            S N    ++ DFG +     ++  +     T  +VAPE L         D+++ GV+L 
Sbjct: 152 ESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLY 211
Query: 346 ELLMGRRP 353
            +L G  P
Sbjct: 212 TMLTGYTP 219

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 97/204 (47%), Gaps = 27/204 (13%)
Query: 161 IGEGGRGHVYKA---RFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQNIISL 214
           +G G  G V  A   R  EK+  A+K++         A+R +  E+  L  ++H+N+I L
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKV--AIKKLSRPFQSEIFAKRAYR-ELLLLKHMQHENVIGL 88
Query: 215 LGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYL 268
           L     A +       +LV   MQ   L+K +     G   +      +   + +GL+Y+
Sbjct: 89  LDVFTPASSLRNFYDFYLVMPFMQT-DLQKIM-----GLKFSEEKIQYLVYQMLKGLKYI 142
Query: 269 HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLE 328
           H   +  VVHRDLK  N+ ++     K+ DFGL+  A  +     +  T  Y APE +L 
Sbjct: 143 H---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV--TRWYRAPEVILS 197
Query: 329 GKLTDKS-DVYAFGVVLLELLMGR 351
               +++ D+++ G ++ E+L G+
Sbjct: 198 WMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 83/205 (40%), Gaps = 15/205 (7%)
Query: 155 FQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISL 214
           +    VIG G  G V++A+  E    A+K++       +R  N E+  +  ++H N++ L
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIKKV----LQDKRFKNRELQIMRIVKHPNVVDL 97
Query: 215 LGYCIHAETRF------LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYL 268
             +      +       LV E +         H       +   L       + R L Y+
Sbjct: 98  KAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYI 157
Query: 269 HEHCNHPVVHRDLKSSNILLDSSFNA-KLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLL 327
           H      + HRD+K  N+LLD      KL DFG +        NV    +  Y APE + 
Sbjct: 158 HSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRYYRAPELIF 214
Query: 328 EG-KLTDKSDVYAFGVVLLELLMGR 351
                T   D+++ G V+ EL+ G+
Sbjct: 215 GATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 90/214 (42%), Gaps = 22/214 (10%)
Query: 161 IGEGGRGHVYKAR-FNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCI 219
           +GEGG  +V      ++    A+KRI         E   E +      H NI+ L+ YC+
Sbjct: 37  LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCL 96
Query: 220 H----AETRFLVYEMMQNGSLEKQLHG-PTHGSNLTWHLRMKIAVDVARGLEYLHEHCNH 274
                    +L+    + G+L  ++      G+ LT    + + + + RGLE +H     
Sbjct: 97  RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK--- 153
Query: 275 PVVHRDLKSSNILLDSSFNAKLSDFG------LSVTAGTQSRNVK----ISGTLGYVAPE 324
              HRDLK +NILL       L D G      + V    Q+  ++       T+ Y APE
Sbjct: 154 GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPE 213
Query: 325 YL---LEGKLTDKSDVYAFGVVLLELLMGRRPVE 355
                    + +++DV++ G VL  ++ G  P +
Sbjct: 214 LFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD 247

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 54/102 (52%), Gaps = 6/102 (5%)
Query: 255 MKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSF---NAKLSDFGLSVTAGTQSRN 311
           +++   +  G+ YLH++    +VH DLK  NILL S +   + K+ DFG+S   G     
Sbjct: 134 IRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL 190
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
            +I GT  Y+APE L    +T  +D++  G++   LL    P
Sbjct: 191 REIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/148 (26%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
           H R   A  +    EYLH   +  +++RDLK  N+L+D     +++DFG +     + R 
Sbjct: 142 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 195
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
             + GT  Y+APE +L        D +A GV++ ++  G  P     P Q    +     
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAGYPPFFADQPIQIYEKI----- 250
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
            ++ + + P+     ++D   L++L QV
Sbjct: 251 -VSGKVRFPSHFSSDLKDL--LRNLLQV 275

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 69/302 (22%), Positives = 126/302 (41%), Gaps = 59/302 (19%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNN------EVN 201
           E   + +Q   ++G GG G VY   R ++ L  A+K ++        E  N      EV 
Sbjct: 5   EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 64
Query: 202 WLTKIR--HQNIISLLGYCIHAETRFLVYE-----------MMQNGSLEKQLHGPTHGSN 248
            L K+      +I LL +    ++  L+ E           + + G+L+++L       +
Sbjct: 65  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-----ARS 119
Query: 249 LTWHLRMKIAVDVARGLEYLHEHC-NHPVVHRDLKSSNILLD-SSFNAKLSDFGLSVTAG 306
             W +   +             HC N  V+HRD+K  NIL+D +    KL DFG S    
Sbjct: 120 FFWQVLEAV------------RHCHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALL 166
Query: 307 TQSRNVKISGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRPVE---------- 355
             +      GT  Y  PE++   +   +S  V++ G++L +++ G  P E          
Sbjct: 167 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV 226
Query: 356 ---KMSPTQCQSMVTWAMP-QLTDRSKLPNIVD-PVIRDTMDLKHLYQVAAVAVLCIQPE 410
              +   ++CQ ++ W +  + +DR     I + P ++D +  +   + A + +  + P 
Sbjct: 227 FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ---ETAEIHLHSLSPG 283
Query: 411 PS 412
           PS
Sbjct: 284 PS 285

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 69/302 (22%), Positives = 126/302 (41%), Gaps = 59/302 (19%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNN------EVN 201
           E   + +Q   ++G GG G VY   R ++ L  A+K ++        E  N      EV 
Sbjct: 5   EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 64
Query: 202 WLTKIRH--QNIISLLGYCIHAETRFLVYE-----------MMQNGSLEKQLHGPTHGSN 248
            L K+      +I LL +    ++  L+ E           + + G+L+++L       +
Sbjct: 65  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-----ARS 119
Query: 249 LTWHLRMKIAVDVARGLEYLHEHC-NHPVVHRDLKSSNILLD-SSFNAKLSDFGLSVTAG 306
             W +   +             HC N  V+HRD+K  NIL+D +    KL DFG S    
Sbjct: 120 FFWQVLEAV------------RHCHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALL 166
Query: 307 TQSRNVKISGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRPVE---------- 355
             +      GT  Y  PE++   +   +S  V++ G++L +++ G  P E          
Sbjct: 167 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV 226
Query: 356 ---KMSPTQCQSMVTWAMP-QLTDRSKLPNIVD-PVIRDTMDLKHLYQVAAVAVLCIQPE 410
              +   ++CQ ++ W +  + +DR     I + P ++D +  +   + A + +  + P 
Sbjct: 227 FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ---ETAEIHLHSLSPG 283
Query: 411 PS 412
           PS
Sbjct: 284 PS 285

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 69/302 (22%), Positives = 126/302 (41%), Gaps = 59/302 (19%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNN------EVN 201
           E   + +Q   ++G GG G VY   R ++ L  A+K ++        E  N      EV 
Sbjct: 32  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 91
Query: 202 WLTKIRH--QNIISLLGYCIHAETRFLVYE-----------MMQNGSLEKQLHGPTHGSN 248
            L K+      +I LL +    ++  L+ E           + + G+L+++L       +
Sbjct: 92  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-----ARS 146
Query: 249 LTWHLRMKIAVDVARGLEYLHEHC-NHPVVHRDLKSSNILLD-SSFNAKLSDFGLSVTAG 306
             W +   +             HC N  V+HRD+K  NIL+D +    KL DFG S    
Sbjct: 147 FFWQVLEAV------------RHCHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALL 193
Query: 307 TQSRNVKISGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRPVE---------- 355
             +      GT  Y  PE++   +   +S  V++ G++L +++ G  P E          
Sbjct: 194 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQV 253
Query: 356 ---KMSPTQCQSMVTWAMP-QLTDRSKLPNIVD-PVIRDTMDLKHLYQVAAVAVLCIQPE 410
              +   ++CQ ++ W +  + +DR     I + P ++D +  +   + A + +  + P 
Sbjct: 254 FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ---ETAEIHLHSLSPG 310
Query: 411 PS 412
           PS
Sbjct: 311 PS 312

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 69/302 (22%), Positives = 126/302 (41%), Gaps = 59/302 (19%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNN------EVN 201
           E   + +Q   ++G GG G VY   R ++ L  A+K ++        E  N      EV 
Sbjct: 32  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 91
Query: 202 WLTKIRH--QNIISLLGYCIHAETRFLVYE-----------MMQNGSLEKQLHGPTHGSN 248
            L K+      +I LL +    ++  L+ E           + + G+L+++L       +
Sbjct: 92  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-----ARS 146
Query: 249 LTWHLRMKIAVDVARGLEYLHEHC-NHPVVHRDLKSSNILLD-SSFNAKLSDFGLSVTAG 306
             W +   +             HC N  V+HRD+K  NIL+D +    KL DFG S    
Sbjct: 147 FFWQVLEAV------------RHCHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALL 193
Query: 307 TQSRNVKISGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRPVE---------- 355
             +      GT  Y  PE++   +   +S  V++ G++L +++ G  P E          
Sbjct: 194 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQV 253
Query: 356 ---KMSPTQCQSMVTWAMP-QLTDRSKLPNIVD-PVIRDTMDLKHLYQVAAVAVLCIQPE 410
              +   ++CQ ++ W +  + +DR     I + P ++D +  +   + A + +  + P 
Sbjct: 254 FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ---ETAEIHLHSLSPG 310
Query: 411 PS 412
           PS
Sbjct: 311 PS 312

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 77/333 (23%), Positives = 137/333 (41%), Gaps = 64/333 (19%)
Query: 123 PILERFNSL---RLAGKKD--TVSVIEYELLEAATNNFQESNVIGEGGRGHVYKA-RFNE 176
           P+L + NSL   R A   D     +   +  E   + +Q   ++G GG G VY   R ++
Sbjct: 16  PLLSKINSLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSD 75
Query: 177 KLLAAVKRIDDAGHDAEREFNN------EVNWLTKIRH--QNIISLLGYCIHAETRFLVY 228
            L  A+K ++        E  N      EV  L K+      +I LL +    ++  L+ 
Sbjct: 76  NLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL 135
Query: 229 E-----------MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC-NHPV 276
           E           + + G+L+++L       +  W +   +             HC N  V
Sbjct: 136 ERPEPVQDLFDFITERGALQEEL-----ARSFFWQVLEAV------------RHCHNCGV 178
Query: 277 VHRDLKSSNILLD-SSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKS 335
           +HRD+K  NIL+D +    KL DFG S      +      GT  Y  PE++   +   +S
Sbjct: 179 LHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRS 237
Query: 336 -DVYAFGVVLLELLMGRRPVE-------------KMSPTQCQSMVTWAMP-QLTDRSKLP 380
             V++ G++L +++ G  P E             +    +CQ ++ W +  + +DR    
Sbjct: 238 AAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQHLIRWCLALRPSDRPTFE 297
Query: 381 NIVD-PVIRDTMDLKHLYQVAAVAVLCIQPEPS 412
            I + P ++D +  +   + A + +  + P PS
Sbjct: 298 EIQNHPWMQDVLLPQ---ETAEIHLHSLSPGPS 327

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 98/218 (44%), Gaps = 31/218 (14%)
Query: 158 SNVIGEGGRGHVYKARFNEKL-LAAVKRIDDAGH----DAE-REFNNEVNWLTKIRHQNI 211
           S+++G+G   +V++ R  +   L A+K  ++       D + REF  EV  L K+ H+NI
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREF--EV--LKKLNHKNI 69
Query: 212 ISLLGYCIHAET----RFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEY 267
           + L  + I  ET    + L+ E    GSL   L  P++   L     + +  DV  G+ +
Sbjct: 70  VKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 268 LHEHCNHPVVHRDLKSSNILL----DSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           L E+    +VHR++K  NI+     D     KL+DFG +       + V + GT  Y+ P
Sbjct: 128 LRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEEYLHP 184
Query: 324 EYLL--------EGKLTDKSDVYAFGVVLLELLMGRRP 353
           +           + K     D+++ GV       G  P
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 69/302 (22%), Positives = 126/302 (41%), Gaps = 59/302 (19%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNN------EVN 201
           E   + +Q   ++G GG G VY   R ++ L  A+K ++        E  N      EV 
Sbjct: 4   EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 63
Query: 202 WLTKIR--HQNIISLLGYCIHAETRFLVYE-----------MMQNGSLEKQLHGPTHGSN 248
            L K+      +I LL +    ++  L+ E           + + G+L+++L       +
Sbjct: 64  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-----ARS 118
Query: 249 LTWHLRMKIAVDVARGLEYLHEHC-NHPVVHRDLKSSNILLD-SSFNAKLSDFGLSVTAG 306
             W +   +             HC N  V+HRD+K  NIL+D +    KL DFG S    
Sbjct: 119 FFWQVLEAV------------RHCHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALL 165
Query: 307 TQSRNVKISGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRPVE---------- 355
             +      GT  Y  PE++   +   +S  V++ G++L +++ G  P E          
Sbjct: 166 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV 225
Query: 356 ---KMSPTQCQSMVTWAMP-QLTDRSKLPNIVD-PVIRDTMDLKHLYQVAAVAVLCIQPE 410
              +   ++CQ ++ W +  + +DR     I + P ++D +  +   + A + +  + P 
Sbjct: 226 FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ---ETAEIHLHSLSPG 282
Query: 411 PS 412
           PS
Sbjct: 283 PS 284

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 69/302 (22%), Positives = 126/302 (41%), Gaps = 59/302 (19%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNN------EVN 201
           E   + +Q   ++G GG G VY   R ++ L  A+K ++        E  N      EV 
Sbjct: 19  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 78
Query: 202 WLTKIRH--QNIISLLGYCIHAETRFLVYE-----------MMQNGSLEKQLHGPTHGSN 248
            L K+      +I LL +    ++  L+ E           + + G+L+++L       +
Sbjct: 79  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-----ARS 133
Query: 249 LTWHLRMKIAVDVARGLEYLHEHC-NHPVVHRDLKSSNILLD-SSFNAKLSDFGLSVTAG 306
             W +   +             HC N  V+HRD+K  NIL+D +    KL DFG S    
Sbjct: 134 FFWQVLEAV------------RHCHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALL 180
Query: 307 TQSRNVKISGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRPVE---------- 355
             +      GT  Y  PE++   +   +S  V++ G++L +++ G  P E          
Sbjct: 181 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV 240
Query: 356 ---KMSPTQCQSMVTWAMP-QLTDRSKLPNIVD-PVIRDTMDLKHLYQVAAVAVLCIQPE 410
              +   ++CQ ++ W +  + +DR     I + P ++D +  +   + A + +  + P 
Sbjct: 241 FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ---ETAEIHLHSLSPG 297
Query: 411 PS 412
           PS
Sbjct: 298 PS 299

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 71/152 (46%), Gaps = 10/152 (6%)
Query: 208 HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEY 267
           H NI+ L          FLV E++  G L +++    H S       M+  V     + +
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVS---AVSH 121
Query: 268 LHEHCNHPVVHRDLKSSNILL---DSSFNAKLSDFGLSVTAGTQSRNVKISG-TLGYVAP 323
           +H+     VVHRDLK  N+L    + +   K+ DFG +      ++ +K    TL Y AP
Sbjct: 122 MHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAP 178
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELLMGRRPVE 355
           E L +    +  D+++ GV+L  +L G+ P +
Sbjct: 179 ELLNQNGYDESCDLWSLGVILYTMLSGQVPFQ 210

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 103/240 (42%), Gaps = 37/240 (15%)
Query: 133 LAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKAR-------FNEKLLAA---V 182
           L+  KDT++ I    L     +++   VIG G  G V   R       +  KLL+    +
Sbjct: 56  LSRYKDTINKIR--DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI 113
Query: 183 KRIDDAGHDAEREFNNEVN--WLTKIRHQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQ 239
           KR D A    ER+     N  W+ +         L Y    +   ++V E M  G L   
Sbjct: 114 KRSDSAFFWEERDIMAFANSPWVVQ---------LFYAFQDDRYLYMVMEYMPGGDLVNL 164
Query: 240 LHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDF 299
           +    +     W  R   A +V   L+ +H   +   +HRD+K  N+LLD S + KL+DF
Sbjct: 165 MS--NYDVPEKWA-RFYTA-EVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADF 217
Query: 300 GLSVTAGTQS--RNVKISGTLGYVAPEYLL----EGKLTDKSDVYAFGVVLLELLMGRRP 353
           G  +    +   R     GT  Y++PE L     +G    + D ++ GV L E+L+G  P
Sbjct: 218 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 69/302 (22%), Positives = 126/302 (41%), Gaps = 59/302 (19%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNN------EVN 201
           E   + +Q   ++G GG G VY   R ++ L  A+K ++        E  N      EV 
Sbjct: 32  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 91
Query: 202 WLTKIRH--QNIISLLGYCIHAETRFLVYE-----------MMQNGSLEKQLHGPTHGSN 248
            L K+      +I LL +    ++  L+ E           + + G+L+++L       +
Sbjct: 92  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-----ARS 146
Query: 249 LTWHLRMKIAVDVARGLEYLHEHC-NHPVVHRDLKSSNILLD-SSFNAKLSDFGLSVTAG 306
             W +   +             HC N  V+HRD+K  NIL+D +    KL DFG S    
Sbjct: 147 FFWQVLEAV------------RHCHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALL 193
Query: 307 TQSRNVKISGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRPVE---------- 355
             +      GT  Y  PE++   +   +S  V++ G++L +++ G  P E          
Sbjct: 194 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV 253
Query: 356 ---KMSPTQCQSMVTWAMP-QLTDRSKLPNIVD-PVIRDTMDLKHLYQVAAVAVLCIQPE 410
              +   ++CQ ++ W +  + +DR     I + P ++D +  +   + A + +  + P 
Sbjct: 254 FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ---ETAEIHLHSLSPG 310
Query: 411 PS 412
           PS
Sbjct: 311 PS 312

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 69/302 (22%), Positives = 126/302 (41%), Gaps = 59/302 (19%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNN------EVN 201
           E   + +Q   ++G GG G VY   R ++ L  A+K ++        E  N      EV 
Sbjct: 20  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 79
Query: 202 WLTKIRH--QNIISLLGYCIHAETRFLVYE-----------MMQNGSLEKQLHGPTHGSN 248
            L K+      +I LL +    ++  L+ E           + + G+L+++L       +
Sbjct: 80  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-----ARS 134
Query: 249 LTWHLRMKIAVDVARGLEYLHEHC-NHPVVHRDLKSSNILLD-SSFNAKLSDFGLSVTAG 306
             W +   +             HC N  V+HRD+K  NIL+D +    KL DFG S    
Sbjct: 135 FFWQVLEAV------------RHCHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALL 181
Query: 307 TQSRNVKISGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRPVE---------- 355
             +      GT  Y  PE++   +   +S  V++ G++L +++ G  P E          
Sbjct: 182 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV 241
Query: 356 ---KMSPTQCQSMVTWAMP-QLTDRSKLPNIVD-PVIRDTMDLKHLYQVAAVAVLCIQPE 410
              +   ++CQ ++ W +  + +DR     I + P ++D +  +   + A + +  + P 
Sbjct: 242 FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ---ETAEIHLHSLSPG 298
Query: 411 PS 412
           PS
Sbjct: 299 PS 300

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 69/302 (22%), Positives = 126/302 (41%), Gaps = 59/302 (19%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNN------EVN 201
           E   + +Q   ++G GG G VY   R ++ L  A+K ++        E  N      EV 
Sbjct: 39  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 98
Query: 202 WLTKIRH--QNIISLLGYCIHAETRFLVYE-----------MMQNGSLEKQLHGPTHGSN 248
            L K+      +I LL +    ++  L+ E           + + G+L+++L       +
Sbjct: 99  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-----ARS 153
Query: 249 LTWHLRMKIAVDVARGLEYLHEHC-NHPVVHRDLKSSNILLD-SSFNAKLSDFGLSVTAG 306
             W +   +             HC N  V+HRD+K  NIL+D +    KL DFG S    
Sbjct: 154 FFWQVLEAV------------RHCHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALL 200
Query: 307 TQSRNVKISGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRPVE---------- 355
             +      GT  Y  PE++   +   +S  V++ G++L +++ G  P E          
Sbjct: 201 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV 260
Query: 356 ---KMSPTQCQSMVTWAMP-QLTDRSKLPNIVD-PVIRDTMDLKHLYQVAAVAVLCIQPE 410
              +   ++CQ ++ W +  + +DR     I + P ++D +  +   + A + +  + P 
Sbjct: 261 FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ---ETAEIHLHSLSPG 317
Query: 411 PS 412
           PS
Sbjct: 318 PS 319

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 81/168 (48%), Gaps = 20/168 (11%)
Query: 192 AEREFNNEVNWLTKIRHQNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTH 245
           A+R +  E+  L  +RH+N+I LL      ET       +LV   M    L K +     
Sbjct: 68  AKRAYR-ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKL 125
Query: 246 GSNLTWHLRMKIAV-DVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT 304
           G +     R++  V  + +GL Y+H      ++HRDLK  N+ ++     K+ DFGL+  
Sbjct: 126 GED-----RIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQ 177
Query: 305 AGTQSRNVKISGTLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGR 351
           A ++     +  T  Y APE +L   + T   D+++ G ++ E++ G+
Sbjct: 178 ADSEMXGXVV--TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 69/302 (22%), Positives = 126/302 (41%), Gaps = 59/302 (19%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNN------EVN 201
           E   + +Q   ++G GG G VY   R ++ L  A+K ++        E  N      EV 
Sbjct: 47  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 106
Query: 202 WLTKIRH--QNIISLLGYCIHAETRFLVYE-----------MMQNGSLEKQLHGPTHGSN 248
            L K+      +I LL +    ++  L+ E           + + G+L+++L       +
Sbjct: 107 LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-----ARS 161
Query: 249 LTWHLRMKIAVDVARGLEYLHEHC-NHPVVHRDLKSSNILLD-SSFNAKLSDFGLSVTAG 306
             W +   +             HC N  V+HRD+K  NIL+D +    KL DFG S    
Sbjct: 162 FFWQVLEAV------------RHCHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALL 208
Query: 307 TQSRNVKISGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRPVE---------- 355
             +      GT  Y  PE++   +   +S  V++ G++L +++ G  P E          
Sbjct: 209 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV 268
Query: 356 ---KMSPTQCQSMVTWAMP-QLTDRSKLPNIVD-PVIRDTMDLKHLYQVAAVAVLCIQPE 410
              +   ++CQ ++ W +  + +DR     I + P ++D +  +   + A + +  + P 
Sbjct: 269 FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ---ETAEIHLHSLSPG 325
Query: 411 PS 412
           PS
Sbjct: 326 PS 327

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 69/302 (22%), Positives = 126/302 (41%), Gaps = 59/302 (19%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNN------EVN 201
           E   + +Q   ++G GG G VY   R ++ L  A+K ++        E  N      EV 
Sbjct: 33  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 92
Query: 202 WLTKIRH--QNIISLLGYCIHAETRFLVYE-----------MMQNGSLEKQLHGPTHGSN 248
            L K+      +I LL +    ++  L+ E           + + G+L+++L       +
Sbjct: 93  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-----ARS 147
Query: 249 LTWHLRMKIAVDVARGLEYLHEHC-NHPVVHRDLKSSNILLD-SSFNAKLSDFGLSVTAG 306
             W +   +             HC N  V+HRD+K  NIL+D +    KL DFG S    
Sbjct: 148 FFWQVLEAV------------RHCHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALL 194
Query: 307 TQSRNVKISGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRPVE---------- 355
             +      GT  Y  PE++   +   +S  V++ G++L +++ G  P E          
Sbjct: 195 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQV 254
Query: 356 ---KMSPTQCQSMVTWAMP-QLTDRSKLPNIVD-PVIRDTMDLKHLYQVAAVAVLCIQPE 410
              +   ++CQ ++ W +  + +DR     I + P ++D +  +   + A + +  + P 
Sbjct: 255 FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ---ETAEIHLHSLSPG 311
Query: 411 PS 412
           PS
Sbjct: 312 PS 313

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 69/302 (22%), Positives = 126/302 (41%), Gaps = 59/302 (19%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNN------EVN 201
           E   + +Q   ++G GG G VY   R ++ L  A+K ++        E  N      EV 
Sbjct: 5   EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 64
Query: 202 WLTKIRH--QNIISLLGYCIHAETRFLVYE-----------MMQNGSLEKQLHGPTHGSN 248
            L K+      +I LL +    ++  L+ E           + + G+L+++L       +
Sbjct: 65  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-----ARS 119
Query: 249 LTWHLRMKIAVDVARGLEYLHEHC-NHPVVHRDLKSSNILLD-SSFNAKLSDFGLSVTAG 306
             W +   +             HC N  V+HRD+K  NIL+D +    KL DFG S    
Sbjct: 120 FFWQVLEAV------------RHCHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALL 166
Query: 307 TQSRNVKISGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRPVE---------- 355
             +      GT  Y  PE++   +   +S  V++ G++L +++ G  P E          
Sbjct: 167 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV 226
Query: 356 ---KMSPTQCQSMVTWAMP-QLTDRSKLPNIVD-PVIRDTMDLKHLYQVAAVAVLCIQPE 410
              +   ++CQ ++ W +  + +DR     I + P ++D +  +   + A + +  + P 
Sbjct: 227 FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ---ETAEIHLHSLSPG 283
Query: 411 PS 412
           PS
Sbjct: 284 PS 285

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 98/218 (44%), Gaps = 31/218 (14%)
Query: 158 SNVIGEGGRGHVYKARFNEKL-LAAVKRIDDAGH----DAE-REFNNEVNWLTKIRHQNI 211
           S+++G+G   +V++ R  +   L A+K  ++       D + REF  EV  L K+ H+NI
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREF--EV--LKKLNHKNI 69
Query: 212 ISLLGYCIHAET----RFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEY 267
           + L  + I  ET    + L+ E    GSL   L  P++   L     + +  DV  G+ +
Sbjct: 70  VKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 268 LHEHCNHPVVHRDLKSSNILL----DSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           L E+    +VHR++K  NI+     D     KL+DFG +       + V + GT  Y+ P
Sbjct: 128 LRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184
Query: 324 EYL--------LEGKLTDKSDVYAFGVVLLELLMGRRP 353
           +           + K     D+++ GV       G  P
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/273 (23%), Positives = 106/273 (38%), Gaps = 50/273 (18%)
Query: 148 LEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAE-----------REF 196
           L A  + +     I  G  G V     +E +  A+KR+ +   D             +  
Sbjct: 17  LHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRV 76
Query: 197 NNEVNWLTKIRHQNIISLLGYCIHAETR-----FLVYEMMQNGSLEKQLH------GPTH 245
             E+  L    H NI+ L    +H E       +LV E+M+   L + +H       P H
Sbjct: 77  LREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQH 135
Query: 246 GSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA 305
                +H+ +        GL  LHE     VVHRDL   NILL  + +  + DF L+   
Sbjct: 136 IQYFMYHILL--------GLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLARED 184
Query: 306 GTQSRNVKISGTLGYVAPEYLLEGK-LTDKSDVYAFGVVLLELLMGR------------- 351
              +          Y APE +++ K  T   D+++ G V+ E+   +             
Sbjct: 185 TADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLN 244
Query: 352 RPVEKMSPTQCQSMVTWAMPQLTD--RSKLPNI 382
           + VE +   + + +V ++ P   D  R+ L N+
Sbjct: 245 KIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNV 277

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 69/302 (22%), Positives = 126/302 (41%), Gaps = 59/302 (19%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNN------EVN 201
           E   + +Q   ++G GG G VY   R ++ L  A+K ++        E  N      EV 
Sbjct: 33  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 92
Query: 202 WLTKIRH--QNIISLLGYCIHAETRFLVYE-----------MMQNGSLEKQLHGPTHGSN 248
            L K+      +I LL +    ++  L+ E           + + G+L+++L       +
Sbjct: 93  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-----ARS 147
Query: 249 LTWHLRMKIAVDVARGLEYLHEHC-NHPVVHRDLKSSNILLD-SSFNAKLSDFGLSVTAG 306
             W +   +             HC N  V+HRD+K  NIL+D +    KL DFG S    
Sbjct: 148 FFWQVLEAV------------RHCHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALL 194
Query: 307 TQSRNVKISGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRPVE---------- 355
             +      GT  Y  PE++   +   +S  V++ G++L +++ G  P E          
Sbjct: 195 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQV 254
Query: 356 ---KMSPTQCQSMVTWAMP-QLTDRSKLPNIVD-PVIRDTMDLKHLYQVAAVAVLCIQPE 410
              +   ++CQ ++ W +  + +DR     I + P ++D +  +   + A + +  + P 
Sbjct: 255 FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ---ETAEIHLHSLSPG 311
Query: 411 PS 412
           PS
Sbjct: 312 PS 313

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/273 (23%), Positives = 106/273 (38%), Gaps = 50/273 (18%)
Query: 148 LEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAE-----------REF 196
           L A  + +     I  G  G V     +E +  A+KR+ +   D             +  
Sbjct: 17  LHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRV 76
Query: 197 NNEVNWLTKIRHQNIISLLGYCIHAETR-----FLVYEMMQNGSLEKQLH------GPTH 245
             E+  L    H NI+ L    +H E       +LV E+M+   L + +H       P H
Sbjct: 77  LREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQH 135
Query: 246 GSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA 305
                +H+ +        GL  LHE     VVHRDL   NILL  + +  + DF L+   
Sbjct: 136 IQYFMYHILL--------GLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLARED 184
Query: 306 GTQSRNVKISGTLGYVAPEYLLEGK-LTDKSDVYAFGVVLLELLMGR------------- 351
              +          Y APE +++ K  T   D+++ G V+ E+   +             
Sbjct: 185 TADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLN 244
Query: 352 RPVEKMSPTQCQSMVTWAMPQLTD--RSKLPNI 382
           + VE +   + + +V ++ P   D  R+ L N+
Sbjct: 245 KIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNV 277

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 103/240 (42%), Gaps = 37/240 (15%)
Query: 133 LAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKAR-------FNEKLLAA---V 182
           L+  KDT++ I    L     +++   VIG G  G V   R       +  KLL+    +
Sbjct: 51  LSRYKDTINKIR--DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI 108
Query: 183 KRIDDAGHDAEREFNNEVN--WLTKIRHQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQ 239
           KR D A    ER+     N  W+ +         L Y    +   ++V E M  G L   
Sbjct: 109 KRSDSAFFWEERDIMAFANSPWVVQ---------LFYAFQDDRYLYMVMEYMPGGDLVNL 159
Query: 240 LHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDF 299
           +    +     W  R   A +V   L+ +H   +   +HRD+K  N+LLD S + KL+DF
Sbjct: 160 MS--NYDVPEKW-ARFYTA-EVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADF 212
Query: 300 GLSVTAGTQS--RNVKISGTLGYVAPEYLL----EGKLTDKSDVYAFGVVLLELLMGRRP 353
           G  +    +   R     GT  Y++PE L     +G    + D ++ GV L E+L+G  P
Sbjct: 213 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 38/148 (25%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
           H R   A  +    EYLH   +  +++RDLK  N+++D     +++DFG +     + R 
Sbjct: 142 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLIIDQQGYIQVTDFGFA--KRVKGRT 195
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
             + GT  Y+APE ++        D +A GV++ E+  G  P     P Q    +     
Sbjct: 196 WXLCGTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 250
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
            ++ + + P+     ++D   L++L QV
Sbjct: 251 -VSGKVRFPSHFSSDLKDL--LRNLLQV 275

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 103/240 (42%), Gaps = 37/240 (15%)
Query: 133 LAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKAR-------FNEKLLAA---V 182
           L+  KDT++ I    L     +++   VIG G  G V   R       +  KLL+    +
Sbjct: 56  LSRYKDTINKIR--DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI 113
Query: 183 KRIDDAGHDAEREFNNEVN--WLTKIRHQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQ 239
           KR D A    ER+     N  W+ +         L Y    +   ++V E M  G L   
Sbjct: 114 KRSDSAFFWEERDIMAFANSPWVVQ---------LFYAFQDDRYLYMVMEYMPGGDLVNL 164
Query: 240 LHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDF 299
           +    +     W  R   A +V   L+ +H   +   +HRD+K  N+LLD S + KL+DF
Sbjct: 165 MS--NYDVPEKW-ARFYTA-EVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADF 217
Query: 300 GLSVTAGTQS--RNVKISGTLGYVAPEYLL----EGKLTDKSDVYAFGVVLLELLMGRRP 353
           G  +    +   R     GT  Y++PE L     +G    + D ++ GV L E+L+G  P
Sbjct: 218 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 90/215 (41%), Gaps = 24/215 (11%)
Query: 155 FQESNVIGEGGRGHVYKA-------RFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR 207
           ++   VIG+G    V +        +F  K++   K     G   E +   E +    ++
Sbjct: 26  YELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTE-DLKREASICHMLK 84
Query: 208 HQNIISLLGYCIHAETRFLVYEMMQNGSL-----EKQLHGPTHGSNLTWHLRMKIAVDVA 262
           H +I+ LL         ++V+E M    L     ++   G  +   +  H   +I     
Sbjct: 85  HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL---- 140
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA---KLSDFGLSVTAGTQSRNVKIS-GTL 318
             L Y H   ++ ++HRD+K  N+LL S  N+   KL DFG+++  G          GT 
Sbjct: 141 EALRYCH---DNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTP 197
Query: 319 GYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
            ++APE +         DV+  GV+L  LL G  P
Sbjct: 198 HFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/250 (24%), Positives = 110/250 (44%), Gaps = 55/250 (22%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRI--DDAGHDAEREFNNEVNWLTKIRHQN--IISLLG 216
           IG GG   V++    +K + A+K +  ++A +     + NE+ +L K++  +  II L  
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 217 YCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDV-------ARGLEYLH 269
           Y I   T   +Y +M+ G+++           L   L+ K ++D           LE +H
Sbjct: 124 YEI---TDQYIYMVMECGNID-----------LNSWLKKKKSIDPWERKSYWKNMLEAVH 169
Query: 270 EHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN-VKIS--GTLGYVAPEYL 326
               H +VH DLK +N L+      KL DFG++      + + VK S  G + Y+ PE +
Sbjct: 170 TIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAI 228
Query: 327 LEGKLTDKS-----------DVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTD 375
            +   + ++           DV++ G +L  +  G+ P +++               +  
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI---------------INQ 273
Query: 376 RSKLPNIVDP 385
            SKL  I+DP
Sbjct: 274 ISKLHAIIDP 283

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 69/302 (22%), Positives = 125/302 (41%), Gaps = 59/302 (19%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNN------EVN 201
           E   + +Q   ++G GG G VY   R ++ L  A+K ++        E  N      EV 
Sbjct: 27  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 86
Query: 202 WLTKIR--HQNIISLLGYCIHAETRFLVYE-----------MMQNGSLEKQLHGPTHGSN 248
            L K+      +I LL +    ++  L+ E           + + G+L+++L       +
Sbjct: 87  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-----ARS 141
Query: 249 LTWHLRMKIAVDVARGLEYLHEHC-NHPVVHRDLKSSNILLD-SSFNAKLSDFGLSVTAG 306
             W +   +             HC N  V+HRD+K  NIL+D +    KL DFG S    
Sbjct: 142 FFWQVLEAV------------RHCHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALL 188
Query: 307 TQSRNVKISGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRPVE---------- 355
             +      GT  Y  PE++   +   +S  V++ G++L +++ G  P E          
Sbjct: 189 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV 248
Query: 356 ---KMSPTQCQSMVTWAMP-QLTDRSKLPNIVD-PVIRDTMDLKHLYQVAAVAVLCIQPE 410
              +    +CQ ++ W +  + +DR     I + P ++D +  +   + A + +  + P 
Sbjct: 249 FFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ---ETAEIHLHSLSPG 305
Query: 411 PS 412
           PS
Sbjct: 306 PS 307

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 69/302 (22%), Positives = 125/302 (41%), Gaps = 59/302 (19%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNN------EVN 201
           E   + +Q   ++G GG G VY   R ++ L  A+K ++        E  N      EV 
Sbjct: 19  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 78
Query: 202 WLTKIRH--QNIISLLGYCIHAETRFLVYE-----------MMQNGSLEKQLHGPTHGSN 248
            L K+      +I LL +    ++  L+ E           + + G+L+++L       +
Sbjct: 79  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-----ARS 133
Query: 249 LTWHLRMKIAVDVARGLEYLHEHC-NHPVVHRDLKSSNILLD-SSFNAKLSDFGLSVTAG 306
             W +   +             HC N  V+HRD+K  NIL+D +    KL DFG S    
Sbjct: 134 FFWQVLEAV------------RHCHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALL 180
Query: 307 TQSRNVKISGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRPVE---------- 355
             +      GT  Y  PE++   +   +S  V++ G++L +++ G  P E          
Sbjct: 181 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV 240
Query: 356 ---KMSPTQCQSMVTWAMP-QLTDRSKLPNIVD-PVIRDTMDLKHLYQVAAVAVLCIQPE 410
              +    +CQ ++ W +  + +DR     I + P ++D +  +   + A + +  + P 
Sbjct: 241 FFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ---ETAEIHLHSLSPG 297
Query: 411 PS 412
           PS
Sbjct: 298 PS 299

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 69/302 (22%), Positives = 125/302 (41%), Gaps = 59/302 (19%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNN------EVN 201
           E   + +Q   ++G GG G VY   R ++ L  A+K ++        E  N      EV 
Sbjct: 32  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 91
Query: 202 WLTKIRH--QNIISLLGYCIHAETRFLVYE-----------MMQNGSLEKQLHGPTHGSN 248
            L K+      +I LL +    ++  L+ E           + + G+L+++L       +
Sbjct: 92  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-----ARS 146
Query: 249 LTWHLRMKIAVDVARGLEYLHEHC-NHPVVHRDLKSSNILLD-SSFNAKLSDFGLSVTAG 306
             W +   +             HC N  V+HRD+K  NIL+D +    KL DFG S    
Sbjct: 147 FFWQVLEAV------------RHCHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALL 193
Query: 307 TQSRNVKISGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRPVE---------- 355
             +      GT  Y  PE++   +   +S  V++ G++L +++ G  P E          
Sbjct: 194 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQV 253
Query: 356 ---KMSPTQCQSMVTWAMP-QLTDRSKLPNIVD-PVIRDTMDLKHLYQVAAVAVLCIQPE 410
              +    +CQ ++ W +  + +DR     I + P ++D +  +   + A + +  + P 
Sbjct: 254 FFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ---ETAEIHLHSLSPG 310
Query: 411 PS 412
           PS
Sbjct: 311 PS 312

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 69/302 (22%), Positives = 125/302 (41%), Gaps = 59/302 (19%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNN------EVN 201
           E   + +Q   ++G GG G VY   R ++ L  A+K ++        E  N      EV 
Sbjct: 33  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 92
Query: 202 WLTKIRH--QNIISLLGYCIHAETRFLVYE-----------MMQNGSLEKQLHGPTHGSN 248
            L K+      +I LL +    ++  L+ E           + + G+L+++L       +
Sbjct: 93  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-----ARS 147
Query: 249 LTWHLRMKIAVDVARGLEYLHEHC-NHPVVHRDLKSSNILLD-SSFNAKLSDFGLSVTAG 306
             W +   +             HC N  V+HRD+K  NIL+D +    KL DFG S    
Sbjct: 148 FFWQVLEAV------------RHCHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALL 194
Query: 307 TQSRNVKISGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRPVE---------- 355
             +      GT  Y  PE++   +   +S  V++ G++L +++ G  P E          
Sbjct: 195 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQV 254
Query: 356 ---KMSPTQCQSMVTWAMP-QLTDRSKLPNIVD-PVIRDTMDLKHLYQVAAVAVLCIQPE 410
              +    +CQ ++ W +  + +DR     I + P ++D +  +   + A + +  + P 
Sbjct: 255 FFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ---ETAEIHLHSLSPG 311
Query: 411 PS 412
           PS
Sbjct: 312 PS 313

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 69/302 (22%), Positives = 125/302 (41%), Gaps = 59/302 (19%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNN------EVN 201
           E   + +Q   ++G GG G VY   R ++ L  A+K ++        E  N      EV 
Sbjct: 33  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 92
Query: 202 WLTKIRH--QNIISLLGYCIHAETRFLVYE-----------MMQNGSLEKQLHGPTHGSN 248
            L K+      +I LL +    ++  L+ E           + + G+L+++L       +
Sbjct: 93  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-----ARS 147
Query: 249 LTWHLRMKIAVDVARGLEYLHEHC-NHPVVHRDLKSSNILLD-SSFNAKLSDFGLSVTAG 306
             W +   +             HC N  V+HRD+K  NIL+D +    KL DFG S    
Sbjct: 148 FFWQVLEAV------------RHCHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALL 194
Query: 307 TQSRNVKISGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRPVE---------- 355
             +      GT  Y  PE++   +   +S  V++ G++L +++ G  P E          
Sbjct: 195 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQV 254
Query: 356 ---KMSPTQCQSMVTWAMP-QLTDRSKLPNIVD-PVIRDTMDLKHLYQVAAVAVLCIQPE 410
              +    +CQ ++ W +  + +DR     I + P ++D +  +   + A + +  + P 
Sbjct: 255 FFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ---ETAEIHLHSLSPG 311
Query: 411 PS 412
           PS
Sbjct: 312 PS 313

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 69/302 (22%), Positives = 125/302 (41%), Gaps = 59/302 (19%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNN------EVN 201
           E   + +Q   ++G GG G VY   R ++ L  A+K ++        E  N      EV 
Sbjct: 20  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 79
Query: 202 WLTKIRH--QNIISLLGYCIHAETRFLVYE-----------MMQNGSLEKQLHGPTHGSN 248
            L K+      +I LL +    ++  L+ E           + + G+L+++L       +
Sbjct: 80  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-----ARS 134
Query: 249 LTWHLRMKIAVDVARGLEYLHEHC-NHPVVHRDLKSSNILLD-SSFNAKLSDFGLSVTAG 306
             W +   +             HC N  V+HRD+K  NIL+D +    KL DFG S    
Sbjct: 135 FFWQVLEAV------------RHCHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALL 181
Query: 307 TQSRNVKISGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRPVE---------- 355
             +      GT  Y  PE++   +   +S  V++ G++L +++ G  P E          
Sbjct: 182 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV 241
Query: 356 ---KMSPTQCQSMVTWAMP-QLTDRSKLPNIVD-PVIRDTMDLKHLYQVAAVAVLCIQPE 410
              +    +CQ ++ W +  + +DR     I + P ++D +  +   + A + +  + P 
Sbjct: 242 FFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ---ETAEIHLHSLSPG 298
Query: 411 PS 412
           PS
Sbjct: 299 PS 300

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 109/233 (46%), Gaps = 44/233 (18%)
Query: 153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHD--AEREFNNEVNWLTKIRHQ 209
           + ++  ++IG G  GHV +A    EK + A+K+I     D    +    E+  L ++ H 
Sbjct: 53  DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHD 112
Query: 210 NIISLLGYCIHAETR-----FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
           +++ +L   I  +       ++V E+  +   +K    P + + L  H++  +  ++  G
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTEL--HIKT-LLYNLLVG 168
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAG------------------ 306
           ++Y+H   +  ++HRDLK +N L++   + K+ DFGL+ T                    
Sbjct: 169 VKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225
Query: 307 -----TQSRNVK--ISG---TLGYVAPEY-LLEGKLTDKSDVYAFGVVLLELL 348
                  ++N+K  ++G   T  Y APE  LL+   T+  DV++ G +  ELL
Sbjct: 226 NLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 69/302 (22%), Positives = 125/302 (41%), Gaps = 59/302 (19%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNN------EVN 201
           E   + +Q   ++G GG G VY   R ++ L  A+K ++        E  N      EV 
Sbjct: 52  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 111
Query: 202 WLTKIRH--QNIISLLGYCIHAETRFLVYE-----------MMQNGSLEKQLHGPTHGSN 248
            L K+      +I LL +    ++  L+ E           + + G+L+++L       +
Sbjct: 112 LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-----ARS 166
Query: 249 LTWHLRMKIAVDVARGLEYLHEHC-NHPVVHRDLKSSNILLD-SSFNAKLSDFGLSVTAG 306
             W +   +             HC N  V+HRD+K  NIL+D +    KL DFG S    
Sbjct: 167 FFWQVLEAV------------RHCHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALL 213
Query: 307 TQSRNVKISGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRPVE---------- 355
             +      GT  Y  PE++   +   +S  V++ G++L +++ G  P E          
Sbjct: 214 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV 273
Query: 356 ---KMSPTQCQSMVTWAMP-QLTDRSKLPNIVD-PVIRDTMDLKHLYQVAAVAVLCIQPE 410
              +    +CQ ++ W +  + +DR     I + P ++D +  +   + A + +  + P 
Sbjct: 274 FFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ---ETAEIHLHSLSPG 330
Query: 411 PS 412
           PS
Sbjct: 331 PS 332

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/148 (26%), Positives = 68/148 (45%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
           H R   A  +    EYLH   +  +++RDLK  N+L+D     +++DFG +     + R 
Sbjct: 142 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 195
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
             + GT  Y+AP  +L        D +A GV++ E+  G  P     P Q    +     
Sbjct: 196 WXLCGTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 250
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
            ++ + + P+     ++D   L++L QV
Sbjct: 251 -VSGKVRFPSHFSSDLKDL--LRNLLQV 275

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 62/258 (24%), Positives = 112/258 (43%), Gaps = 31/258 (12%)
Query: 161 IGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISL----- 214
           +G GG G V+ A  N+     A+K+I      + +    E+  + ++ H NI+ +     
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 215 ---------LGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
                    +G      + ++V E M+         GP     L  H R+     + RGL
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPL----LEEHARL-FMYQLLRGL 133
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDS-SFNAKLSDFGLS-VTAGTQSRNVKISGTL---GY 320
           +Y+H   +  V+HRDLK +N+ +++     K+ DFGL+ +     S    +S  L    Y
Sbjct: 134 KYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWY 190
Query: 321 VAPEYLLE-GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQL--TDRS 377
            +P  LL     T   D++A G +  E+L G+         +   ++  ++P +   DR 
Sbjct: 191 RSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQ 250
Query: 378 KLPNIVDPVIRDTMDLKH 395
           +L +++   IR+ M   H
Sbjct: 251 ELLSVIPVYIRNDMTEPH 268

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 65/281 (23%), Positives = 117/281 (41%), Gaps = 56/281 (19%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNN------EVN 201
           E   + +Q   ++G GG G VY   R ++ L  A+K ++        E  N      EV 
Sbjct: 3   EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 62
Query: 202 WLTKIR--HQNIISLLGYCIHAETRFLVYE-----------MMQNGSLEKQLHGPTHGSN 248
            L K+      +I LL +    ++  L+ E           + + G+L+++L       +
Sbjct: 63  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-----ARS 117
Query: 249 LTWHLRMKIAVDVARGLEYLHEHC-NHPVVHRDLKSSNILLD-SSFNAKLSDFGLSVTAG 306
             W +   +             HC N  V+HRD+K  NIL+D +    KL DFG S    
Sbjct: 118 FFWQVLEAV------------RHCHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALL 164
Query: 307 TQSRNVKISGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRPVE---------- 355
             +      GT  Y  PE++   +   +S  V++ G++L +++ G  P E          
Sbjct: 165 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV 224
Query: 356 ---KMSPTQCQSMVTWAMP-QLTDRSKLPNIVD-PVIRDTM 391
              +   ++CQ ++ W +  + +DR     I + P ++D +
Sbjct: 225 FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 265

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 70/150 (46%), Gaps = 18/150 (12%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQS 309
           H R   A  +    EYLH   +  +++RDLK  N+L+D     +++DFG +  V   T +
Sbjct: 163 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWT 218
Query: 310 RNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWA 369
               + GT  Y+APE +L        D +A GV++ E+  G  P     P Q    +   
Sbjct: 219 ----LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI--- 271
Query: 370 MPQLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
              ++ + + P+     ++D   L++L QV
Sbjct: 272 ---VSGKVRFPSHFSSDLKDL--LRNLLQV 296

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 69/302 (22%), Positives = 124/302 (41%), Gaps = 59/302 (19%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNN------EVN 201
           E   + +Q   ++G GG G VY   R ++ L  A+K ++        E  N      EV 
Sbjct: 20  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 79
Query: 202 WLTKIRH--QNIISLLGYCIHAETRFLVYE-----------MMQNGSLEKQLHGPTHGSN 248
            L K+      +I LL +    ++  L+ E           + + G+L+++L       +
Sbjct: 80  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-----ARS 134
Query: 249 LTWHLRMKIAVDVARGLEYLHEHC-NHPVVHRDLKSSNILLD-SSFNAKLSDFGLSVTAG 306
             W +   +             HC N  V+HRD+K  NIL+D +    KL DFG S    
Sbjct: 135 FFWQVLEAV------------RHCHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALL 181
Query: 307 TQSRNVKISGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRPVE---------- 355
             +      GT  Y  PE++   +   +S  V++ G++L +++ G  P E          
Sbjct: 182 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV 241
Query: 356 ---KMSPTQCQSMVTWAMP-QLTDRSKLPNIVD-PVIRDTMDLKHLYQVAAVAVLCIQPE 410
              +    +CQ ++ W +  +  DR     I + P ++D +  +   + A + +  + P 
Sbjct: 242 FFRQRVSXECQHLIRWCLALRPXDRPTFEEIQNHPWMQDVLLPQ---ETAEIHLHSLSPG 298
Query: 411 PS 412
           PS
Sbjct: 299 PS 300

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 62/133 (46%), Gaps = 28/133 (21%)
Query: 230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLD 289
           M +  SLE + HG          + + I + +A  +E+LH   +  ++HRDLK SNI   
Sbjct: 152 MNRRCSLEDREHG----------VCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFT 198
Query: 290 SSFNAKLSDFGLSVTAGTQSRNVKIS--------------GTLGYVAPEYLLEGKLTDKS 335
                K+ DFGL VTA  Q    +                GT  Y++PE +     + K 
Sbjct: 199 MDDVVKVGDFGL-VTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKV 257
Query: 336 DVYAFGVVLLELL 348
           D+++ G++L ELL
Sbjct: 258 DIFSLGLILFELL 270

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 64/277 (23%), Positives = 116/277 (41%), Gaps = 56/277 (20%)
Query: 153 NNFQESNVIGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNN------EVNWLTK 205
           + +Q   ++G GG G VY   R ++ L  A+K ++        E  N      EV  L K
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 206 IR--HQNIISLLGYCIHAETRFLVYE-----------MMQNGSLEKQLHGPTHGSNLTWH 252
           +      +I LL +    ++  L+ E           + + G+L+++L       +  W 
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-----ARSFFWQ 118
Query: 253 LRMKIAVDVARGLEYLHEHC-NHPVVHRDLKSSNILLD-SSFNAKLSDFGLSVTAGTQSR 310
           +   +             HC N  V+HRD+K  NIL+D +    KL DFG S      + 
Sbjct: 119 VLEAV------------RHCHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTV 165
Query: 311 NVKISGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRPVE-------------K 356
                GT  Y  PE++   +   +S  V++ G++L +++ G  P E             +
Sbjct: 166 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQ 225
Query: 357 MSPTQCQSMVTWAMP-QLTDRSKLPNIVD-PVIRDTM 391
              ++CQ ++ W +  + +DR     I + P ++D +
Sbjct: 226 RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 64/277 (23%), Positives = 116/277 (41%), Gaps = 56/277 (20%)
Query: 153 NNFQESNVIGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNN------EVNWLTK 205
           + +Q   ++G GG G VY   R ++ L  A+K ++        E  N      EV  L K
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 206 IR--HQNIISLLGYCIHAETRFLVYE-----------MMQNGSLEKQLHGPTHGSNLTWH 252
           +      +I LL +    ++  L+ E           + + G+L+++L       +  W 
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-----ARSFFWQ 118
Query: 253 LRMKIAVDVARGLEYLHEHC-NHPVVHRDLKSSNILLD-SSFNAKLSDFGLSVTAGTQSR 310
           +   +             HC N  V+HRD+K  NIL+D +    KL DFG S      + 
Sbjct: 119 VLEAV------------RHCHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTV 165
Query: 311 NVKISGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRPVE-------------K 356
                GT  Y  PE++   +   +S  V++ G++L +++ G  P E             +
Sbjct: 166 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQ 225
Query: 357 MSPTQCQSMVTWAMP-QLTDRSKLPNIVD-PVIRDTM 391
              ++CQ ++ W +  + +DR     I + P ++D +
Sbjct: 226 RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 101/231 (43%), Gaps = 42/231 (18%)
Query: 153 NNFQESNVIGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHD--AEREFNNEVNWLTKIRHQ 209
           +N++  ++IG G  G+VY A   N     A+K+++    D    +    E+  L +++  
Sbjct: 28  DNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 87
Query: 210 NIISLLGYCI-----HAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
            II L    I       +  ++V E+  +  L+K    P     LT      I  ++  G
Sbjct: 88  YIIRLHDLIIPEDLLKFDELYIVLEI-ADSDLKKLFKTPIF---LTEQHVKTILYNLLLG 143
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT-------------------- 304
            +++HE     ++HRDLK +N LL+   + K+ DFGL+ T                    
Sbjct: 144 EKFIHESG---IIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENE 200
Query: 305 -AGTQSRNVKIS-----GTLGYVAPEY-LLEGKLTDKSDVYAFGVVLLELL 348
             G  ++N+K        T  Y APE  LL+   T+  D+++ G +  ELL
Sbjct: 201 EPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELL 251

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 39/148 (26%), Positives = 68/148 (45%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
           H R   A  +    EYLH   +  +++RDLK  N+L+D     +++DFG +     + R 
Sbjct: 142 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 195
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
             + GT   +APE +L        D +A GV++ E+  G  P     P Q    +     
Sbjct: 196 WXLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 250
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
            ++ + + P+     ++D   L++L QV
Sbjct: 251 -VSGKVRFPSHFSSDLKDL--LRNLLQV 275

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 64/277 (23%), Positives = 115/277 (41%), Gaps = 56/277 (20%)
Query: 153 NNFQESNVIGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNN------EVNWLTK 205
           + +Q   ++G GG G VY   R ++ L  A+K ++        E  N      EV  L K
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 206 IR--HQNIISLLGYCIHAETRFLVYE-----------MMQNGSLEKQLHGPTHGSNLTWH 252
           +      +I LL +    ++  L+ E           + + G+L+++L       +  W 
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-----ARSFFWQ 118
Query: 253 LRMKIAVDVARGLEYLHEHC-NHPVVHRDLKSSNILLD-SSFNAKLSDFGLSVTAGTQSR 310
           +   +             HC N  V+HRD+K  NIL+D +    KL DFG S      + 
Sbjct: 119 VLEAV------------RHCHNXGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTV 165
Query: 311 NVKISGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRPVE-------------K 356
                GT  Y  PE++   +   +S  V++ G++L +++ G  P E             +
Sbjct: 166 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQ 225
Query: 357 MSPTQCQSMVTWAMP-QLTDRSKLPNIVD-PVIRDTM 391
               +CQ ++ W +  + +DR     I + P ++D +
Sbjct: 226 RVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 82/171 (47%), Gaps = 16/171 (9%)
Query: 190 HDAERE-FNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQL---HGPTH 245
           H++++E    E+  ++ +RH  +++L           ++YE M  G L +++   H    
Sbjct: 194 HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMS 253
Query: 246 GSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDS--SFNAKLSDFGLSV 303
                 ++R      V +GL ++HE+     VH DLK  NI+  +  S   KL DFGL+ 
Sbjct: 254 EDEAVEYMRQ-----VCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTA 305
Query: 304 TAGTQSRNVKISGTLGYVAPEYLLEGK-LTDKSDVYAFGVVLLELLMGRRP 353
               +      +GT  + APE + EGK +   +D+++ GV+   LL G  P
Sbjct: 306 HLDPKQSVKVTTGTAEFAAPE-VAEGKPVGYYTDMWSVGVLSYILLSGLSP 355

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 82/171 (47%), Gaps = 16/171 (9%)
Query: 190 HDAERE-FNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQL---HGPTH 245
           H++++E    E+  ++ +RH  +++L           ++YE M  G L +++   H    
Sbjct: 88  HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMS 147
Query: 246 GSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDS--SFNAKLSDFGLSV 303
                 ++R      V +GL ++HE+     VH DLK  NI+  +  S   KL DFGL+ 
Sbjct: 148 EDEAVEYMRQ-----VCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTA 199
Query: 304 TAGTQSRNVKISGTLGYVAPEYLLEGK-LTDKSDVYAFGVVLLELLMGRRP 353
               +      +GT  + APE + EGK +   +D+++ GV+   LL G  P
Sbjct: 200 HLDPKQSVKVTTGTAEFAAPE-VAEGKPVGYYTDMWSVGVLSYILLSGLSP 249

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/188 (28%), Positives = 84/188 (44%), Gaps = 34/188 (18%)
Query: 181 AVKRIDDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQ 239
           AVK ID +    +R+   E+  L +  +H NII+L       +  ++V E+ + G L  +
Sbjct: 51  AVKIIDKS----KRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDK 106
Query: 240 LHGPTHGSNLTWHLRMK---------IAVDVARGLEYLHEHCNHPVVHRDLKSSNIL-LD 289
           +            LR K         +   + + +EYLH      VVHRDLK SNIL +D
Sbjct: 107 I------------LRQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVD 151
Query: 290 SSFNA---KLSDFGLSVTAGTQSRNVKISG-TLGYVAPEYLLEGKLTDKSDVYAFGVVLL 345
            S N    ++ DFG +     ++  +     T  +VAPE L         D+++ GV+L 
Sbjct: 152 ESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFVAPEVLERQGYDAACDIWSLGVLLY 211
Query: 346 ELLMGRRP 353
             L G  P
Sbjct: 212 TXLTGYTP 219

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/132 (29%), Positives = 61/132 (46%), Gaps = 8/132 (6%)
Query: 225 FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSS 284
            ++ E M+ G L  ++         T     +I  D+   +++LH   +H + HRD+K  
Sbjct: 83  LIIMECMEGGELFSRIQ-ERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPE 138
Query: 285 NILLDSSFNA---KLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFG 341
           N+L  S       KL+DFG +    TQ+       T  YVAPE L   K     D+++ G
Sbjct: 139 NLLYTSKEKDAVLKLTDFGFA-KETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLG 197
Query: 342 VVLLELLMGRRP 353
           V++  LL G  P
Sbjct: 198 VIMYILLCGFPP 209

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/245 (25%), Positives = 102/245 (41%), Gaps = 35/245 (14%)
Query: 122 SPILERFNSLRLAGKKDTVSVIEYELLEA-ATNNFQESNVIGEGGRGHVYKARFNEKLLA 180
            PI+ R   +RL  ++D     ++E+L+      F E  V+     G VY  +   K   
Sbjct: 47  EPIVVRLKEVRL--QRD-----DFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKW-D 98
Query: 181 AVKRIDDAGHDAEREF--NNEVNWLTKIRHQNIISLLGYCIHAETR-FLVYEMMQNGSLE 237
            +KR + +    ER+   N +  W+T+         L +    E   +LV E    G L 
Sbjct: 99  MLKRGEVSCFREERDVLVNGDRRWITQ---------LHFAFQDENYLYLVMEYYVGGDLL 149
Query: 238 KQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLS 297
             L     G  +   +      ++   ++ +H       VHRD+K  NILLD   + +L+
Sbjct: 150 TLLS--KFGERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLA 204
Query: 298 DFG--LSVTAGTQSRNVKISGTLGYVAPEYL-------LEGKLTDKSDVYAFGVVLLELL 348
           DFG  L + A    R++   GT  Y++PE L         G    + D +A GV   E+ 
Sbjct: 205 DFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMF 264
Query: 349 MGRRP 353
            G+ P
Sbjct: 265 YGQTP 269

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 96/230 (41%), Gaps = 45/230 (19%)
Query: 148 LEAATNNFQESNVIGEGGRGHVYKAR-------FNEKLLAA---VKRIDDAGHDAEREFN 197
           L+    ++    VIG G  G V   R       +  KLL+    +KR D A    ER+  
Sbjct: 70  LQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIM 129
Query: 198 NEVN--WLTKIRHQNIISLLGYCIHAETRFL--VYEMMQNGSLEKQLHG---PTHGSNLT 250
              N  W+ ++          +C   + ++L  V E M  G L   +     P   +   
Sbjct: 130 AFANSPWVVQL----------FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKF- 178
Query: 251 WHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT---AGT 307
                    +V   L+ +H   +  ++HRD+K  N+LLD   + KL+DFG  +     G 
Sbjct: 179 ------YTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM 229
Query: 308 QSRNVKISGTLGYVAPEYLL----EGKLTDKSDVYAFGVVLLELLMGRRP 353
              +  + GT  Y++PE L     +G    + D ++ GV L E+L+G  P
Sbjct: 230 VHCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 278

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/132 (29%), Positives = 61/132 (46%), Gaps = 8/132 (6%)
Query: 225 FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSS 284
            ++ E M+ G L  ++         T     +I  D+   +++LH   +H + HRD+K  
Sbjct: 102 LIIMECMEGGELFSRIQ-ERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPE 157
Query: 285 NILLDSSFNA---KLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFG 341
           N+L  S       KL+DFG +    TQ+       T  YVAPE L   K     D+++ G
Sbjct: 158 NLLYTSKEKDAVLKLTDFGFAKET-TQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLG 216
Query: 342 VVLLELLMGRRP 353
           V++  LL G  P
Sbjct: 217 VIMYILLCGFPP 228

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 101/229 (44%), Gaps = 41/229 (17%)
Query: 153 NNFQESNVIGEGGRGHVYKA--RFNEKLLA--AVKRIDDAGHDAEREFNNEVNWLTKIRH 208
           +N+   ++IG G  G+VY A  +  EK +A   V R+ +   D +R    E+  L +++ 
Sbjct: 26  DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR-EITILNRLKS 84
Query: 209 QNIISLLGYCI-----HAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
             II L    I       +  ++V E+  +  L+K    P     LT      I  ++  
Sbjct: 85  DYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIF---LTEEHIKTILYNLLL 140
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT------------------A 305
           G  ++HE     ++HRDLK +N LL+   + K+ DFGL+ T                   
Sbjct: 141 GENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEP 197
Query: 306 GTQSRNVKIS-----GTLGYVAPEY-LLEGKLTDKSDVYAFGVVLLELL 348
           G  ++N+K        T  Y APE  LL+   T   D+++ G +  ELL
Sbjct: 198 GPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 93/205 (45%), Gaps = 18/205 (8%)
Query: 158 SNVIGEGGRG---HVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNW-LTKIRHQNIIS 213
           S V+G G  G    ++  R  EK   A+K + D    A RE   E++W  ++  H   I 
Sbjct: 21  SQVLGLGINGKVLQIFNKRTQEKF--ALKMLQDCP-KARREV--ELHWRASQCPHIVRIV 75
Query: 214 LLGYCIHAETRFL--VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
            +   ++A  + L  V E +  G L  ++      +  T     +I   +   ++YLH  
Sbjct: 76  DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIGEAIQYLH-- 132
Query: 272 CNHPVVHRDLKSSNILLDSSF-NA--KLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLE 328
            +  + HRD+K  N+L  S   NA  KL+DFG +    + +   +   T  YVAPE L  
Sbjct: 133 -SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAPEVLGP 191
Query: 329 GKLTDKSDVYAFGVVLLELLMGRRP 353
            K     D+++ GV++  LL G  P
Sbjct: 192 EKYDKSCDMWSLGVIMYILLCGYPP 216

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 18/205 (8%)
Query: 158 SNVIGEGGRG---HVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNW-LTKIRHQNIIS 213
           S V+G G  G    ++  R  EK   A+K + D    A RE   E++W  ++  H   I 
Sbjct: 27  SQVLGLGINGKVLQIFNKRTQEKF--ALKMLQDCP-KARREV--ELHWRASQCPHIVRIV 81
Query: 214 LLGYCIHAETRFL--VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
            +   ++A  + L  V E +  G L  ++         T     +I   +   ++YLH  
Sbjct: 82  DVYENLYAGRKCLLIVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLH-- 138
Query: 272 CNHPVVHRDLKSSNILLDSSF-NA--KLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLE 328
            +  + HRD+K  N+L  S   NA  KL+DFG +    + +       T  YVAPE L  
Sbjct: 139 -SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP 197
Query: 329 GKLTDKSDVYAFGVVLLELLMGRRP 353
            K     D+++ GV++  LL G  P
Sbjct: 198 EKYDKSCDMWSLGVIMYILLCGYPP 222

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 18/205 (8%)
Query: 158 SNVIGEGGRG---HVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNW-LTKIRHQNIIS 213
           S V+G G  G    ++  R  EK   A+K + D    A RE   E++W  ++  H   I 
Sbjct: 29  SQVLGLGINGKVLQIFNKRTQEKF--ALKMLQDCP-KARREV--ELHWRASQCPHIVRIV 83
Query: 214 LLGYCIHAETRFL--VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
            +   ++A  + L  V E +  G L  ++         T     +I   +   ++YLH  
Sbjct: 84  DVYENLYAGRKCLLIVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLH-- 140
Query: 272 CNHPVVHRDLKSSNILLDSSF-NA--KLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLE 328
            +  + HRD+K  N+L  S   NA  KL+DFG +    + +       T  YVAPE L  
Sbjct: 141 -SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP 199
Query: 329 GKLTDKSDVYAFGVVLLELLMGRRP 353
            K     D+++ GV++  LL G  P
Sbjct: 200 EKYDKSCDMWSLGVIMYILLCGYPP 224

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 18/205 (8%)
Query: 158 SNVIGEGGRG---HVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNW-LTKIRHQNIIS 213
           S V+G G  G    ++  R  EK   A+K + D    A RE   E++W  ++  H   I 
Sbjct: 28  SQVLGLGINGKVLQIFNKRTQEKF--ALKMLQDCP-KARREV--ELHWRASQCPHIVRIV 82
Query: 214 LLGYCIHAETRFL--VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
            +   ++A  + L  V E +  G L  ++         T     +I   +   ++YLH  
Sbjct: 83  DVYENLYAGRKCLLIVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLH-- 139
Query: 272 CNHPVVHRDLKSSNILLDSSF-NA--KLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLE 328
            +  + HRD+K  N+L  S   NA  KL+DFG +    + +       T  YVAPE L  
Sbjct: 140 -SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP 198
Query: 329 GKLTDKSDVYAFGVVLLELLMGRRP 353
            K     D+++ GV++  LL G  P
Sbjct: 199 EKYDKSCDMWSLGVIMYILLCGYPP 223

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 18/205 (8%)
Query: 158 SNVIGEGGRG---HVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNW-LTKIRHQNIIS 213
           S V+G G  G    ++  R  EK   A+K + D    A RE   E++W  ++  H   I 
Sbjct: 23  SQVLGLGINGKVLQIFNKRTQEKF--ALKMLQDCP-KARREV--ELHWRASQCPHIVRIV 77
Query: 214 LLGYCIHAETRFL--VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
            +   ++A  + L  V E +  G L  ++      +  T     +I   +   ++YLH  
Sbjct: 78  DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIGEAIQYLH-- 134
Query: 272 CNHPVVHRDLKSSNILLDSSF-NA--KLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLE 328
            +  + HRD+K  N+L  S   NA  KL+DFG +    + +       T  YVAPE L  
Sbjct: 135 -SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP 193
Query: 329 GKLTDKSDVYAFGVVLLELLMGRRP 353
            K     D+++ GV++  LL G  P
Sbjct: 194 EKYDKSCDMWSLGVIMYILLCGYPP 218

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 18/205 (8%)
Query: 158 SNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHDAEREFNNEVNW-LTKIRHQNIIS 213
           S V+G G  G V   +  R  EK   A+K + D    A RE   E++W  ++  H   I 
Sbjct: 22  SQVLGLGINGKVLQIFNKRTQEKF--ALKMLQDCP-KARREV--ELHWRASQCPHIVRIV 76
Query: 214 LLGYCIHAETRFL--VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
            +   ++A  + L  V E +  G L  ++      +  T     +I   +   ++YLH  
Sbjct: 77  DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIGEAIQYLH-- 133
Query: 272 CNHPVVHRDLKSSNILLDSSF-NA--KLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLE 328
            +  + HRD+K  N+L  S   NA  KL+DFG +    + +       T  YVAPE L  
Sbjct: 134 -SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP 192
Query: 329 GKLTDKSDVYAFGVVLLELLMGRRP 353
            K     D+++ GV++  LL G  P
Sbjct: 193 EKYDKSCDMWSLGVIMYILLCGYPP 217
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	439
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-126
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-123
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-121
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-77
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-72
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-68
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	4e-64
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-63
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-63
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-60
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-60
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	8e-60
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	5e-59
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-57
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	7e-54
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-52
3q4u_A	301	Activin receptor type-1; structural genomics conso	4e-52
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	4e-52
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-41
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-40
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-39
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	4e-39
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-38
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-38
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-38
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	4e-38
2a19_B	284	Interferon-induced, double-stranded RNA-activated	4e-38
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	8e-38
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	8e-38
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-37
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-37
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-37
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-37
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-37
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-37
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-37
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-37
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-37
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-37
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	4e-37
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	4e-37
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	5e-37
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	5e-37
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	7e-37
4aoj_A	329	High affinity nerve growth factor receptor; transf	7e-37
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	8e-37
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-36
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-36
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-36
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-36
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	3e-36
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-36
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-36
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	4e-36
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	6e-36
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	6e-36
3pls_A	298	Macrophage-stimulating protein receptor; protein k	7e-36
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	7e-36
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	8e-36
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	9e-36
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	9e-36
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-35
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-35
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-35
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-35
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	3e-35
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	5e-35
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	8e-35
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	9e-35
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-34
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-34
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-34
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-34
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-34
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-34
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-34
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	4e-34
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	7e-34
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	8e-34
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-33
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-33
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-33
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-33
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	4e-33
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	4e-33
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	4e-33
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	5e-33
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	7e-33
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-32
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-32
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-32
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	4e-32
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	4e-32
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	5e-32
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-31
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-31
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-31
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-31
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	3e-31
3aln_A	327	Dual specificity mitogen-activated protein kinase;	4e-31
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-30
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-30
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-30
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	3e-30
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-30
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	4e-30
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	9e-30
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-29
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-29
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-29
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-29
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-28
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-28
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-28
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-28
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-28
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-27
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-27
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-27
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-27
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	4e-27
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	7e-27
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-26
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-26
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-26
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-26
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	7e-26
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-25
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-25
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-25
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-25
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-25
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	5e-25
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	9e-25
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-24
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-24
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-24
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-24
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-24
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-24
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	5e-24
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	7e-24
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	9e-24
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-23
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-23
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-23
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-23
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	3e-23
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-23
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	6e-23
3uqc_A	286	Probable conserved transmembrane protein; structur	6e-23
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	7e-23
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	7e-23
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	7e-23
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	9e-23
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	9e-23
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-22
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-22
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-22
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-22
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-22
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-22
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-22
3bhy_A	283	Death-associated protein kinase 3; death associate	3e-22
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	4e-22
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	4e-22
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	4e-22
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	6e-22
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	7e-22
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	7e-22
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	9e-22
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-21
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-21
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-21
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-21
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-21
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-21
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	3e-21
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	4e-21
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	6e-21
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	6e-21
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	8e-21
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	9e-21
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-20
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-20
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-20
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-20
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-20
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	4e-20
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	4e-20
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	5e-19
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	7e-19
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-18
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-18
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-18
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-18
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-07
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	7e-18
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-17
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-17
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-17
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-17
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-17
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	4e-17
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	6e-17
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	7e-17
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	8e-17
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-16
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-16
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-16
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-16
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-16
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-16
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	4e-16
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-15
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-15
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-15
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-15
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-15
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-15
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	4e-15
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	6e-15
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-13
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-12
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	7e-11
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	7e-11
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	7e-11
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	5e-10
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	6e-07
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	5e-06
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	7e-06
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-05
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	8e-05
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	9e-05
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-04
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	5e-04

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  366 bits (942), Expect = e-126
 Identities = 107/285 (37%), Positives = 160/285 (56%), Gaps = 10/285 (3%)

Query: 145 YELLEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLT 204
              LE ATNNF    +IG G  G VYK    +    A+KR          EF  E+  L+
Sbjct: 31  LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLS 90

Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGP-THGSNLTWHLRMKIAVDVAR 263
             RH +++SL+G+C       L+Y+ M+NG+L++ L+G      +++W  R++I +  AR
Sbjct: 91  FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR 150

Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS----GTLG 319
           GL YLH      ++HRD+KS NILLD +F  K++DFG+S   GT+     +S    GTLG
Sbjct: 151 GLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGIS-KKGTELDQTHLSTVVKGTLG 206

Query: 320 YVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKL 379
           Y+ PEY ++G+LT+KSDVY+FGVVL E+L  R  + +  P +  ++  WA+    +  +L
Sbjct: 207 YIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG-QL 265

Query: 380 PNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
             IVDP + D +  + L +    AV C+      RP + DVL  L
Sbjct: 266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  358 bits (922), Expect = e-123
 Identities = 104/286 (36%), Positives = 165/286 (57%), Gaps = 7/286 (2%)

Query: 145 YELLEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDA-EREFNNEVNWL 203
              L+ A++NF   N++G GG G VYK R  +  L AVKR+ +      E +F  EV  +
Sbjct: 22  LRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMI 81

Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHG-SNLTWHLRMKIAVDVA 262
           +   H+N++ L G+C+    R LVY  M NGS+   L         L W  R +IA+  A
Sbjct: 82  SMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSA 141

Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV--KISGTLGY 320
           RGL YLH+HC+  ++HRD+K++NILLD  F A + DFGL+     +  +V   + GT+G+
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 201

Query: 321 VAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVE--KMSPTQCQSMVTWAMPQLTDRSK 378
           +APEYL  GK ++K+DV+ +GV+LLEL+ G+R  +  +++      ++ W    L ++ K
Sbjct: 202 IAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK-K 260

Query: 379 LPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
           L  +VD  ++     + + Q+  VA+LC Q  P  RP +++V+  L
Sbjct: 261 LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  354 bits (910), Expect = e-121
 Identities = 103/299 (34%), Positives = 162/299 (54%), Gaps = 21/299 (7%)

Query: 145 YELLEAATNNFQE------SNVIGEGGRGHVYKARFNEKLLAAVKR----IDDAGHDAER 194
           +  L+  TNNF E       N +GEGG G VYK   N   +A VK+    +D    + ++
Sbjct: 17  FYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVA-VKKLAAMVDITTEELKQ 75

Query: 195 EFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLR 254
           +F+ E+  + K +H+N++ LLG+    +   LVY  M NGSL  +L        L+WH+R
Sbjct: 76  QFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMR 135

Query: 255 MKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV-- 312
            KIA   A G+ +LHE+     +HRD+KS+NILLD +F AK+SDFGL+  +   ++ V  
Sbjct: 136 CKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMT 192

Query: 313 -KISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
            +I GT  Y+APE  L G++T KSD+Y+FGVVLLE++ G   V++      Q ++     
Sbjct: 193 SRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP--QLLLDIKEE 249

Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPT 430
              +   + + +D  + D  D   +  + +VA  C+  + + RP I  V   L  +  +
Sbjct: 250 IEDEEKTIEDYIDKKMNDA-DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  243 bits (622), Expect = 1e-77
 Identities = 73/311 (23%), Positives = 115/311 (36%), Gaps = 30/311 (9%)

Query: 141 SVIEYELLEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEV 200
             +  E L   +   Q   V   G  G V+KA+   +   AVK           +   EV
Sbjct: 12  VDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEY-VAVKIFP-IQDKQSWQNEYEV 69

Query: 201 NWLTKIRHQNIISLLGYCIHAET----RFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMK 256
             L  ++H+NI+  +G      +     +L+    + GSL   L        ++W+    
Sbjct: 70  YSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV----VSWNELCH 125

Query: 257 IAVDVARGLEYLHEH-------CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS 309
           IA  +ARGL YLHE            + HRD+KS N+LL ++  A ++DFGL++      
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185

Query: 310 RNVKIS---GTLGYVAPEYL-----LEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQ 361
                    GT  Y+APE L      +     + D+YA G+VL EL       +      
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245

Query: 362 CQ--SMVTWAMPQLTDRSKL--PNIVDPVIRDTMD-LKHLYQVAAVAVLCIQPEPSYRPL 416
                      P L D  ++       PV+RD       +  +      C   +   R  
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305

Query: 417 ITDVLHSLIPL 427
              V   +  +
Sbjct: 306 AGCVGERITQM 316

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  229 bits (586), Expect = 2e-72
 Identities = 86/285 (30%), Positives = 140/285 (49%), Gaps = 21/285 (7%)

Query: 143 IEYELLEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRI--DDAGHDAEREFNNEV 200
           ++ + ++    +      IG G  G V++A ++   +A VK +   D   +   EF  EV
Sbjct: 27  MDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVA-VKILMEQDFHAERVNEFLREV 85

Query: 201 NWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVD 260
             + ++RH NI+  +G         +V E +  GSL + LH       L    R+ +A D
Sbjct: 86  AIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYD 145

Query: 261 VARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS-VTAGTQSRNVKISGTLG 319
           VA+G+ YLH + N P+VHR+LKS N+L+D  +  K+ DFGLS + A T   +   +GT  
Sbjct: 146 VAKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPE 204

Query: 320 YVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKL 379
           ++APE L +    +KSDVY+FGV+L EL   ++P   ++P Q    V  A+     R ++
Sbjct: 205 WMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ----VVAAVGFKCKRLEI 260

Query: 380 PNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
           P  ++P +   +              C   EP  RP    ++  L
Sbjct: 261 PRNLNPQVAAII------------EGCWTNEPWKRPSFATIMDLL 293

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  218 bits (558), Expect = 2e-68
 Identities = 73/273 (26%), Positives = 126/273 (46%), Gaps = 23/273 (8%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNII 212
              +   V+G G  G V KA++  K +A +K+I+       + F  E+  L+++ H NI+
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKWRAKDVA-IKQIESE--SERKAFIVELRQLSRVNHPNIV 64

Query: 213 SLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
            L G C++     LV E  + GSL   LHG       T    M   +  ++G+ YLH   
Sbjct: 65  KLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122

Query: 273 NHPVVHRDLKSSNILLDSSFN-AKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKL 331
              ++HRDLK  N+LL +     K+ DFG +    T   N K  G+  ++APE       
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK--GSAAWMAPEVFEGSNY 180

Query: 332 TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTM 391
           ++K DV+++G++L E++  R+P +++     +  + WA+     R  L   +   I   M
Sbjct: 181 SEKCDVFSWGIILWEVITRRKPFDEIGGPAFR--IMWAVHN-GTRPPLIKNLPKPIESLM 237

Query: 392 DLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
                         C   +PS RP + +++  +
Sbjct: 238 ------------TRCWSKDPSQRPSMEEIVKIM 258

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  206 bits (527), Expect = 4e-64
 Identities = 78/279 (27%), Positives = 118/279 (42%), Gaps = 36/279 (12%)

Query: 159 NVIGEGGRGHVYKARFNEKLLAAVKRI----DDAGHDAEREFNNEVNWLTKIRHQNIISL 214
            +IG GG G VY+A +    +A VK      D+           E      ++H NII+L
Sbjct: 13  EIIGIGGFGKVYRAFWIGDEVA-VKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71

Query: 215 LGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNH 274
            G C+      LV E  + G L + L G      +   + +  AV +ARG+ YLH+    
Sbjct: 72  RGVCLKEPNLCLVMEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAIV 127

Query: 275 PVVHRDLKSSNILLDSSF--------NAKLSDFGLS-VTAGTQSRNVKISGTLGYVAPEY 325
           P++HRDLKSSNIL+              K++DFGL+     T   +    G   ++APE 
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA--GAYAWMAPEV 185

Query: 326 LLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDP 385
           +     +  SDV+++GV+L ELL G  P   +        V + +        +P+    
Sbjct: 186 IRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA----VAYGVAMNKLALPIPSTCPE 241

Query: 386 VIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
                M              C  P+P  RP  T++L  L
Sbjct: 242 PFAKLM------------EDCWNPDPHSRPSFTNILDQL 268

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  205 bits (523), Expect = 1e-63
 Identities = 63/290 (21%), Positives = 114/290 (39%), Gaps = 39/290 (13%)

Query: 143 IEYELLEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRI--DDAGHDAEREFNNEV 200
           I+++ L            + E   G ++K R+    +  VK +   D      R+FN E 
Sbjct: 7   IDFKQLN-------FLTKLNENHSGELWKGRWQGNDIV-VKVLKVRDWSTRKSRDFNEEC 58

Query: 201 NWLTKIRHQNIISLLGYCIHAETRFL--VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIA 258
             L    H N++ +LG C          +   M  GSL   LH  T    +     +K A
Sbjct: 59  PRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGT-NFVVDQSQAVKFA 117

Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTL 318
           +D+ARG+ +LH      +    L S ++++D    A++S   +  +  +  R        
Sbjct: 118 LDMARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR----MYAP 172

Query: 319 GYVAPEYLLEGK----LTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLT 374
            +VAPE  L+ K        +D+++F V+L EL+    P   +S  +    +   +    
Sbjct: 173 AWVAPE-ALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME----IGMKVALEG 227

Query: 375 DRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
            R  +P  + P +   M             +C+  +P+ RP    ++  L
Sbjct: 228 LRPTIPPGISPHVSKLMK------------ICMNEDPAKRPKFDMIVPIL 265

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  205 bits (524), Expect = 2e-63
 Identities = 80/297 (26%), Positives = 140/297 (47%), Gaps = 38/297 (12%)

Query: 144 EYELLEAATNNFQESNVIGEGGRGHVYKARF-NEKLLAAVKRIDDAGHDAE-------RE 195
           +  L   A N  +    IG+GG G V+K R   +K + A+K +     + E       +E
Sbjct: 10  KSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQE 69

Query: 196 FNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRM 255
           F  EV  ++ + H NI+ L G         +V E +  G L  +L    H   + W +++
Sbjct: 70  FQREVFIMSNLNHPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAH--PIKWSVKL 125

Query: 256 KIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS-----FNAKLSDFGLS-VTAGTQS 309
           ++ +D+A G+EY+  + N P+VHRDL+S NI L S        AK++DFGLS  +  + S
Sbjct: 126 RLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVS 184

Query: 310 RNVKISGTLGYVAPEYLLEGKL--TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVT 367
             +   G   ++APE +   +   T+K+D Y+F ++L  +L G  P ++ S  + + +  
Sbjct: 185 GLL---GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI-- 239

Query: 368 WAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
             + +   R  +P    P +R+ +             LC   +P  RP  + ++  L
Sbjct: 240 NMIREEGLRPTIPEDCPPRLRNVI------------ELCWSGDPKKRPHFSYIVKEL 284

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  199 bits (508), Expect = 1e-60
 Identities = 67/312 (21%), Positives = 128/312 (41%), Gaps = 41/312 (13%)

Query: 130 SLRLAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAG 189
           S R   +K + + I  +  +      +   +IG+G  G VY  R++ ++  A++ ID   
Sbjct: 10  SARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHGEV--AIRLIDIER 67

Query: 190 HDAE--REFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGS 247
            + +  + F  EV    + RH+N++  +G C+      ++  + +  +L   +       
Sbjct: 68  DNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDA--KI 125

Query: 248 NLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS----- 302
            L  +   +IA ++ +G+ YLH      ++H+DLKS N+  D +    ++DFGL      
Sbjct: 126 VLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181

Query: 303 VTAGTQSRNVKIS-GTLGYVAPEYLLEGKL---------TDKSDVYAFGVVLLELLMGRR 352
           + AG +   ++I  G L ++APE + +            +  SDV+A G +  EL     
Sbjct: 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREW 241

Query: 353 PVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPS 412
           P +          + W M      +     +   I D +            + C   E  
Sbjct: 242 PFKTQPAEA----IIWQMGTGMKPNLSQIGMGKEISDIL------------LFCWAFEQE 285

Query: 413 YRPLITDVLHSL 424
            RP  T ++  L
Sbjct: 286 ERPTFTKLMDML 297

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  197 bits (502), Expect = 3e-60
 Identities = 75/278 (26%), Positives = 119/278 (42%), Gaps = 40/278 (14%)

Query: 161 IGEGGRGHVYKARFNEKLLAAVKRI--DDAGHDAEREFNNEVNWLTKIRHQNIISLLGYC 218
           IG G  G VYK +++  +  AVK +          + F NEV  L K RH NI+  +GY 
Sbjct: 32  IGSGSFGTVYKGKWHGDV--AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89

Query: 219 IHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVH 278
                  +V +  +  SL   LH     +       + IA   ARG++YLH      ++H
Sbjct: 90  TA-PQLAIVTQWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLH---AKSIIH 143

Query: 279 RDLKSSNILLDSSFNAKLSDFGLS-VTAGTQSRNVKIS--GTLGYVAPEYLL---EGKLT 332
           RDLKS+NI L      K+ DFGL+   +     +      G++ ++APE +        +
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS 203

Query: 333 DKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWA------MPQLTDRSKLPNIVDPV 386
            +SDVYAFG+VL EL+ G+ P   ++       +          P L   SK+ +     
Sbjct: 204 FQSDVYAFGIVLYELMTGQLPYSNINNRD---QIIEMVGRGSLSPDL---SKVRSNCPKR 257

Query: 387 IRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
           ++  M              C++ +   RP    +L  +
Sbjct: 258 MKRLM------------AECLKKKRDERPSFPRILAEI 283

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  195 bits (497), Expect = 5e-59
 Identities = 78/327 (23%), Positives = 113/327 (34%), Gaps = 53/327 (16%)

Query: 143 IEYELLEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVN- 201
                     +N +   +IG G  G VYK   +E+   AVK          + F NE N 
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERP-VAVKVFSF---ANRQNFINEKNI 58

Query: 202 -WLTKIRHQNIISLLGYCIHAETR-----FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRM 255
             +  + H NI   +               LV E   NGSL K L   T      W    
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSC 114

Query: 256 KIAVDVARGLEYLHE------HCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS 309
           ++A  V RGL YLH       H    + HRDL S N+L+ +     +SDFGLS+      
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174

Query: 310 RNVKIS---------GTLGYVAPEYL-------LEGKLTDKSDVYAFGVVLLELLMG--- 350
                          GT+ Y+APE L              + D+YA G++  E+ M    
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234

Query: 351 RRPVEKMSPTQC--QSMVTWAMPQLTDRSKL-------PNIVDPVIRDTMDLKHLYQVAA 401
             P E +   Q   Q+ V    P   D   L       P   +    +++ ++ L     
Sbjct: 235 LFPGESVPEYQMAFQTEV-GNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSL---KE 290

Query: 402 VAVLCIQPEPSYRPLITDVLHSLIPLV 428
               C   +   R         +  L+
Sbjct: 291 TIEDCWDQDAEARLTAQXAEERMAELM 317

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  191 bits (486), Expect = 1e-57
 Identities = 64/282 (22%), Positives = 107/282 (37%), Gaps = 36/282 (12%)

Query: 159 NVIGEGGRGHVYKARFNEKLLA-AVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGY 217
            V+G+G  G   K    E      +K +     + +R F  EV  +  + H N++  +G 
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75

Query: 218 CIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVV 277
               +    + E ++ G+L   +   +  S   W  R+  A D+A G+ YLH      ++
Sbjct: 76  LYKDKRLNFITEYIKGGTLRGIIK--SMDSQYPWSQRVSFAKDIASGMAYLHS---MNII 130

Query: 278 HRDLKSSNILLDSSFNAKLSDFGLS------VTAGTQSRNVKIS---------GTLGYVA 322
           HRDL S N L+  + N  ++DFGL+       T     R++K           G   ++A
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190

Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNI 382
           PE +      +K DV++FG+VL E++          P      +     +       P  
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV---RGFLDRYCPPN 247

Query: 383 VDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
             P                  V C   +P  RP    + H L
Sbjct: 248 CPPSFFPIT------------VRCCDLDPEKRPSFVKLEHWL 277

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  182 bits (463), Expect = 7e-54
 Identities = 69/299 (23%), Positives = 117/299 (39%), Gaps = 36/299 (12%)

Query: 156 QESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLL 215
           Q    IG+G  G V+  ++  + +A VK       +A      E+     +RH+NI+  +
Sbjct: 40  QMVKQIGKGRYGEVWMGKWRGEKVA-VKVFFT-TEEASWFRETEIYQTVLMRHENILGFI 97

Query: 216 GYCIHAETR----FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHE- 270
              I         +L+ +  +NGSL   L   T    L     +K+A     GL +LH  
Sbjct: 98  AADIKGTGSWTQLYLITDYHENGSLYDYLKSTT----LDAKSMLKLAYSSVSGLCHLHTE 153

Query: 271 ----HCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-----GTLGYV 321
                    + HRDLKS NIL+  +    ++D GL+V   + +  V I      GT  Y+
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213

Query: 322 APEYLLEGKL-------TDKSDVYAFGVVLLELLMGRRPVEKMSPTQ-CQSMVTWAMPQL 373
            PE +L+  L          +D+Y+FG++L E+         +   Q     +  + P  
Sbjct: 214 PPE-VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSY 272

Query: 374 TDRSKLPNIVD----PVIRDTMDLKH-LYQVAAVAVLCIQPEPSYRPLITDVLHSLIPL 427
            D  ++  +      P   +       L Q+  +   C    P+ R     V  +L  +
Sbjct: 273 EDMREI--VCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  176 bits (448), Expect = 4e-52
 Identities = 63/309 (20%), Positives = 115/309 (37%), Gaps = 62/309 (20%)

Query: 159 NVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNE--VNWLTKIRHQNIISLLG 216
             +G+G  G V++  +  + +A VK         E+ +  E  +     +RH+NI+  + 
Sbjct: 14  ECVGKGRYGEVWRGSWQGENVA-VKIFSS---RDEKSWFRETELYNTVMLRHENILGFIA 69

Query: 217 YCIHAETR----FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHE-- 270
             + +       +L+    + GSL   L   T    L     ++I + +A GL +LH   
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT----LDTVSCLRIVLSIASGLAHLHIEI 125

Query: 271 ---HCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-----GTLGYVA 322
                   + HRDLKS NIL+  +    ++D GL+V     +  + +      GT  Y+A
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185

Query: 323 PEYLLEGKL-------TDKSDVYAFGVVLLELLMG----------RRPVEKMSPTQCQSM 365
           PE +L+  +         + D++AFG+VL E+             + P   + P      
Sbjct: 186 PE-VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 244

Query: 366 VTWAM-------PQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLIT 418
               +       P + +R    +     +   M              C    PS R    
Sbjct: 245 DMRKVVCVDQQRPNIPNRWF-SDPTLTSLAKLM------------KECWYQNPSARLTAL 291

Query: 419 DVLHSLIPL 427
            +  +L  +
Sbjct: 292 RIKKTLTKI 300

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  177 bits (451), Expect = 4e-52
 Identities = 68/298 (22%), Positives = 124/298 (41%), Gaps = 40/298 (13%)

Query: 159 NVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNE--VNWLTKIRHQNIISLLG 216
             IG+G  G V++ ++  + +A VK         ER +  E  +     +RH+NI+  + 
Sbjct: 48  ESIGKGRFGEVWRGKWRGEEVA-VKIFSS---REERSWFREAEIYQTVMLRHENILGFIA 103

Query: 217 YCIHAETR----FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHE-- 270
                       +LV +  ++GSL   L+  T    +T    +K+A+  A GL +LH   
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEI 159

Query: 271 ---HCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-----GTLGYVA 322
                   + HRDLKS NIL+  +    ++D GL+V   + +  + I+     GT  Y+A
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219

Query: 323 PEYLLEGKL-------TDKSDVYAFGVVLLELLMGRRPVEKMSPTQ-CQSMVTWAMPQLT 374
           PE +L+  +         ++D+YA G+V  E+             Q     +  + P + 
Sbjct: 220 PE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 278

Query: 375 DRSKLPNIVD----PVIRDT-MDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPL 427
           +  K+  + +    P I +     + L  +A +   C     + R     +  +L  L
Sbjct: 279 EMRKV--VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  150 bits (380), Expect = 2e-41
 Identities = 67/218 (30%), Positives = 100/218 (45%), Gaps = 19/218 (8%)

Query: 160 VIGEGGRGHVYKARFN-EKLLAAVKRI-DDAGHDAEREFNNEVNWLTKIRHQNIISLLGY 217
            IG G  G V+  R   +  L AVK   +    D + +F  E   L +  H NI+ L+G 
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180

Query: 218 CIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVV 277
           C   +  ++V E++Q G     L   T G+ L     +++  D A G+EYL        +
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFLR--TEGARLRVKTLLQMVGDAAAGMEYLES---KCCI 235

Query: 278 HRDLKSSNILLDSSFNAKLSDFGLS-------VTAGTQSRNVKISGTLGYVAPEYLLEGK 330
           HRDL + N L+      K+SDFG+S         A    R V +  T    APE L  G+
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT----APEALNYGR 291

Query: 331 LTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVT 367
            + +SDV++FG++L E    G  P   +S  Q +  V 
Sbjct: 292 YSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE 329

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  145 bits (368), Expect = 1e-40
 Identities = 66/280 (23%), Positives = 112/280 (40%), Gaps = 40/280 (14%)

Query: 160 VIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHDAE--REFNNEVNWLTKIRHQNIISLL 215
            IG G    VYK   + +  +  A   + D        + F  E   L  ++H NI+   
Sbjct: 33  EIGRGSFKTVYKG-LDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91

Query: 216 GYCIHAETR----FLVYEMMQNGSLEKQL--HGPTHGSNLTWHLRMKIAVDVARGLEYLH 269
                         LV E+M +G+L+  L          +   +       + +GL++LH
Sbjct: 92  DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-----MKIKVLRSWCRQILKGLQFLH 146

Query: 270 EHCNHPVVHRDLKSSNILLDSSF-NAKLSDFGLS-VTAGTQSRNVKISGTLGYVAPEYLL 327
                P++HRDLK  NI +     + K+ D GL+ +   + ++ V   GT  ++APE   
Sbjct: 147 TR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI--GTPEFMAPEM-Y 202

Query: 328 EGKLTDKSDVYAFGVVLLELLMGRRP-VEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPV 386
           E K  +  DVYAFG+ +LE+     P  E  +  Q    VT  +   +       +  P 
Sbjct: 203 EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS----FDKVAIPE 258

Query: 387 IRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVL-HSLI 425
           +++ ++             CI+     R  I D+L H+  
Sbjct: 259 VKEIIE------------GCIRQNKDERYSIKDLLNHAFF 286

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  142 bits (361), Expect = 3e-39
 Identities = 57/218 (26%), Positives = 107/218 (49%), Gaps = 16/218 (7%)

Query: 159 NVIGEGGRGHVYKARF-----NEKLLAAVKRI-DDAGHDAEREFNNEVNWLTKIRHQNII 212
            V+G G  G VYK  +       K+  A+K + +     A +E  +E   +  + + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 213 SLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
            LLG C+   T  L+ ++M  G L   +    H  N+     +   V +A+G+ YL +  
Sbjct: 81  RLLGICL-TSTVQLITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137

Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYV---APEYLLEG 329
              +VHRDL + N+L+ +  + K++DFGL+   G + +     G    +   A E +L  
Sbjct: 138 ---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194

Query: 330 KLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMV 366
             T +SDV+++GV + EL+  G +P + +  ++  S++
Sbjct: 195 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  142 bits (360), Expect = 4e-39
 Identities = 65/293 (22%), Positives = 107/293 (36%), Gaps = 47/293 (16%)

Query: 154 NFQESNVIGEGGRGHVYKAR-FNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNII 212
           ++     +GEGG  +V      ++    A+KRI         E   E +      H NI+
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89

Query: 213 SLLGYCIHAETR----FLVYEMMQNGSLEKQL-HGPTHGSNLTWHLRMKIAVDVARGLEY 267
            L+ YC+         +L+    + G+L  ++      G+ LT    + + + + RGLE 
Sbjct: 90  RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149

Query: 268 LHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS----------GT 317
           +H        HRDLK +NILL       L D G    A       + +           T
Sbjct: 150 IHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206

Query: 318 LGYVAPEYLLEGK----LTDKSDVYAFGVVLLELLMGRRP----VEKMSPTQCQSMVTWA 369
           + Y APE L   +    + +++DV++ G VL  ++ G  P     +K            +
Sbjct: 207 ISYRAPE-LFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLS 265

Query: 370 MPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLH 422
           +PQ    S               L  L          +  +P  RP I  +L 
Sbjct: 266 IPQSPRHSS-------------ALWQLLNS------MMTVDPHQRPHIPLLLS 299

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  139 bits (353), Expect = 1e-38
 Identities = 75/284 (26%), Positives = 118/284 (41%), Gaps = 44/284 (15%)

Query: 160 VIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCI 219
            +G G  G V   ++  +   AVK I + G  +E EF  E   + K+ H  ++   G C 
Sbjct: 15  ELGSGQFGVVKLGKWKGQYDVAVKMIKE-GSMSEDEFFQEAQTMMKLSHPKLVKFYGVCS 73

Query: 220 HAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHR 279
                ++V E + NG L   L   +HG  L     +++  DV  G+ +L  H     +HR
Sbjct: 74  KEYPIYIVTEYISNGCLLNYLR--SHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHR 128

Query: 280 DLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV------KISGTLGYV---APEYLLEGK 330
           DL + N L+D     K+SDFG++       R V         GT   V   APE     K
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMT-------RYVLDDQYVSSVGTKFPVKWSAPEVFHYFK 181

Query: 331 LTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVT--WAMPQLTDRSKLPNIVDPVI 387
            + KSDV+AFG+++ E+   G+ P +  + ++    V+    + +       P++    I
Sbjct: 182 YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYR-------PHLASDTI 234

Query: 388 RDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPTD 431
              M              C    P  RP    +L S+ PL   D
Sbjct: 235 YQIM------------YSCWHELPEKRPTFQQLLSSIEPLREKD 266

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  138 bits (351), Expect = 2e-38
 Identities = 73/286 (25%), Positives = 121/286 (42%), Gaps = 44/286 (15%)

Query: 159 NVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYC 218
             IG G  G V+   +  K   A+K I + G  +E +F  E   + K+ H  ++ L G C
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72

Query: 219 IHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVH 278
           +      LV E M++G L   L   T          + + +DV  G+ YL E C   V+H
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYLR--TQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 127

Query: 279 RDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV------KISGTLGYV---APEYLLEG 329
           RDL + N L+  +   K+SDFG+       +R V        +GT   V   +PE     
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGM-------TRFVLDDQYTSSTGTKFPVKWASPEVFSFS 180

Query: 330 KLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVT--WAMPQLTDRSKLPNIVDPV 386
           + + KSDV++FGV++ E+   G+ P E  S ++    ++  + + +       P +    
Sbjct: 181 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-------PRLASTH 233

Query: 387 IRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPTDL 432
           +   M              C +  P  RP  + +L  L  +  + L
Sbjct: 234 VYQIM------------NHCWRERPEDRPAFSRLLRQLAEIAESGL 267

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  139 bits (353), Expect = 3e-38
 Identities = 64/277 (23%), Positives = 115/277 (41%), Gaps = 27/277 (9%)

Query: 153 NNFQESNVIGEGGRGHVYKAR-FNEKLLAAVKRIDDAGHDAERE---FNNEVNWLTKIRH 208
            NF+    IG G    VY+A    + +  A+K++        +       E++ L ++ H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 209 QNIISLLGYCIHAETRFLVYEMMQNGSLEKQL-HGPTHGSNLTWHLRMKIAVDVARGLEY 267
            N+I      I      +V E+   G L + + H       +      K  V +   LE+
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151

Query: 268 LHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS-VTAGTQSRNVKISGTLGYVAPEYL 326
           +H      V+HRD+K +N+ + ++   KL D GL    +   +    + GT  Y++PE +
Sbjct: 152 MHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 208

Query: 327 LEGKLTDKSDVYAFGVVLLELLMGRRP--VEKMSPTQCQSMVTWAMPQLTDRSKLPNIVD 384
            E     KSD+++ G +L E+   + P   +KM+       +         +   P +  
Sbjct: 209 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE--------QCDYPPL-- 258

Query: 385 PVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
           P    + +L+ L        +CI P+P  RP +T V 
Sbjct: 259 PSDHYSEELRQLVN------MCINPDPEKRPDVTYVY 289

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  143 bits (362), Expect = 4e-38
 Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 9/213 (4%)

Query: 159 NVIGEGGRGHVYKARFNEK-LLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGY 217
           + +G G  G VY+  + +  L  AVK + +   + E EF  E   + +I+H N++ LLG 
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 284

Query: 218 CIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVV 277
           C      +++ E M  G+L   L        ++  + + +A  ++  +EYL +      +
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FI 340

Query: 278 HRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGY--VAPEYLLEGKLTDKS 335
           HR+L + N L+  +   K++DFGLS      +              APE L   K + KS
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 400

Query: 336 DVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVT 367
           DV+AFGV+L E+   G  P   +  +Q   ++ 
Sbjct: 401 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 433

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  138 bits (350), Expect = 4e-38
 Identities = 72/290 (24%), Positives = 119/290 (41%), Gaps = 47/290 (16%)

Query: 153 NNFQESNVIGEGGRGHVYKAR-FNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNI 211
            +F+E  +IG GG G V+KA+   +     +KR+      AERE    V  L K+ H NI
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE----VKALAKLDHVNI 66

Query: 212 ISLLGYCIHAETR----------------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRM 255
           +   G     +                  F+  E    G+LE+ +     G  L   L +
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK-RRGEKLDKVLAL 125

Query: 256 KIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS 315
           ++   + +G++Y+H      +++RDLK SNI L  +   K+ DFGL  +     +  +  
Sbjct: 126 ELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK 182

Query: 316 GTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTD 375
           GTL Y++PE +       + D+YA G++L ELL       + S                 
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLR---------- 232

Query: 376 RSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLI 425
              + +I D         K L Q        +  +P  RP  +++L +L 
Sbjct: 233 DGIISDIFDK------KEKTLLQ------KLLSKKPEDRPNTSEILRTLT 270

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  138 bits (349), Expect = 8e-38
 Identities = 76/298 (25%), Positives = 124/298 (41%), Gaps = 61/298 (20%)

Query: 159 NVIGEGGRGHVYKARFN------EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNII 212
             +GEG  G V+ A         +K+L AVK + D    A ++F  E   LT ++H++I+
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80

Query: 213 SLLGYCIHAETRFLVYEMMQNGSL-------------EKQLHGPTHGSNLTWHLRMKIAV 259
              G C   +   +V+E M++G L                         L     + IA 
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140

Query: 260 DVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV------- 312
            +A G+ YL        VHRDL + N L+ ++   K+ DFG+       SR+V       
Sbjct: 141 QIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGM-------SRDVYSTDYYR 190

Query: 313 KISGTLGYV---APEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTW 368
               T+  +    PE ++  K T +SDV++FGV+L E+   G++P  ++S T+       
Sbjct: 191 VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE------- 243

Query: 369 AMPQLTDRSKL--PNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
            +  +T    L  P +    + D M            + C Q EP  R  I ++   L
Sbjct: 244 VIECITQGRVLERPRVCPKEVYDVM------------LGCWQREPQQRLNIKEIYKIL 289

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  141 bits (358), Expect = 8e-38
 Identities = 57/212 (26%), Positives = 98/212 (46%), Gaps = 9/212 (4%)

Query: 159 NVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYC 218
             +G G  G V+ A +N+    AVK +   G  +   F  E N +  ++H  ++ L    
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKP-GSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252

Query: 219 IHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVH 278
              E  +++ E M  GSL   L     GS       +  +  +A G+ ++ +      +H
Sbjct: 253 TK-EPIYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIH 307

Query: 279 RDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGY--VAPEYLLEGKLTDKSD 336
           RDL+++NIL+ +S   K++DFGL+          +          APE +  G  T KSD
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 367

Query: 337 VYAFGVVLLELLM-GRRPVEKMSPTQCQSMVT 367
           V++FG++L+E++  GR P   MS  +    + 
Sbjct: 368 VWSFGILLMEIVTYGRIPYPGMSNPEVIRALE 399

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  137 bits (348), Expect = 1e-37
 Identities = 66/285 (23%), Positives = 116/285 (40%), Gaps = 44/285 (15%)

Query: 159 NVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYC 218
             +G G  G V   ++  +   A+K I + G  +E EF  E   +  + H+ ++ L G C
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88

Query: 219 IHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVH 278
                 F++ E M NG L   L              +++  DV   +EYL        +H
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLR--EMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLH 143

Query: 279 RDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV------KISGTLGYV---APEYLLEG 329
           RDL + N L++     K+SDFGL       SR V         G+   V    PE L+  
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGL-------SRYVLDDEYTSSVGSKFPVRWSPPEVLMYS 196

Query: 330 KLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVT--WAMPQLTDRSKLPNIVDPV 386
           K + KSD++AFGV++ E+   G+ P E+ + ++    +     + +       P++    
Sbjct: 197 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR-------PHLASEK 249

Query: 387 IRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPTD 431
           +   M              C   +   RP    +L +++ ++  +
Sbjct: 250 VYTIM------------YSCWHEKADERPTFKILLSNILDVMDEE 282

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  138 bits (350), Expect = 1e-37
 Identities = 67/301 (22%), Positives = 124/301 (41%), Gaps = 56/301 (18%)

Query: 159 NVIGEGGRGHVYKARFN------EKLLAAVKRI-DDAGHDAEREFNNEVNWLTKIRHQNI 211
             +G+G  G VY+           +   A+K + + A      EF NE + + +    ++
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90

Query: 212 ISLLGYCIHAETRFLVYEMMQNGSLEKQL--HGPTHGSN-----LTWHLRMKIAVDVARG 264
           + LLG     +   ++ E+M  G L+  L    P   +N      +    +++A ++A G
Sbjct: 91  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150

Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK-----ISGTLG 319
           + YL+    +  VHRDL + N ++   F  K+ DFG+       +R++        G  G
Sbjct: 151 MAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGM-------TRDIYETDYYRKGGKG 200

Query: 320 YV-----APEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVT--WAMP 371
            +     +PE L +G  T  SDV++FGVVL E+     +P + +S  Q    V     + 
Sbjct: 201 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD 260

Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPTD 431
           +       P+    ++ + M             +C Q  P  RP   +++ S+   +   
Sbjct: 261 K-------PDNCPDMLFELM------------RMCWQYNPKMRPSFLEIISSIKEEMEPG 301

Query: 432 L 432
            
Sbjct: 302 F 302

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  139 bits (351), Expect = 2e-37
 Identities = 71/309 (22%), Positives = 123/309 (39%), Gaps = 54/309 (17%)

Query: 138 DTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARF----NEKLLAAVKRI-DDAGHDA 192
           + V  +++ ++  ++     + VIG G  G VY         +K+  AVK +        
Sbjct: 74  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 133

Query: 193 EREFNNEVNWLTKIRHQNIISLLGYCIHAET-RFLVYEMMQNGSLEKQLHGPTHGSNLTW 251
             +F  E   +    H N++SLLG C+ +E    +V   M++G L   +       N T 
Sbjct: 134 VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR--NETHNPTV 191

Query: 252 HLRMKIAVDVARGLEYLHE-HCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR 310
              +   + VA+G+++L         VHRDL + N +LD  F  K++DFGL       +R
Sbjct: 192 KDLIGFGLQVAKGMKFLASKKF----VHRDLAARNCMLDEKFTVKVADFGL-------AR 240

Query: 311 NVKISGTLGYV------------APEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKM 357
           ++                     A E L   K T KSDV++FGV+L EL+  G  P   +
Sbjct: 241 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 300

Query: 358 SPTQCQSMVT--WAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRP 415
           +       +     + Q       P      + + M            + C  P+   RP
Sbjct: 301 NTFDITVYLLQGRRLLQ-------PEYCPDPLYEVM------------LKCWHPKAEMRP 341

Query: 416 LITDVLHSL 424
             ++++  +
Sbjct: 342 SFSELVSRI 350

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  139 bits (351), Expect = 2e-37
 Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 29/226 (12%)

Query: 159 NVIGEGGRGHVYKARFN----EKLLAAVKRI-DDAGHDAEREFNNEVNWLTKIRHQNIIS 213
            V+G G  G V   R      +++  A+K +         R+F  E + + +  H NII 
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110

Query: 214 LLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
           L G    ++   +V E M+NGSL+  L    H +  T    + +   +A G++YL +   
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLR--KHDAQFTVIQLVGMLRGIASGMKYLSDMG- 167

Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYV-----------A 322
              VHRDL + NIL++S+   K+SDFGL        R ++      Y            +
Sbjct: 168 --YVHRDLAARNILINSNLVCKVSDFGL-------GRVLEDDPEAAYTTRGGKIPIRWTS 218

Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVT 367
           PE +   K T  SDV+++G+VL E++  G RP  +MS       V 
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD 264

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  140 bits (355), Expect = 2e-37
 Identities = 63/212 (29%), Positives = 97/212 (45%), Gaps = 9/212 (4%)

Query: 159 NVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYC 218
             +G+G  G V+   +N     A+K +   G  +   F  E   + K+RH+ ++ L    
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248

Query: 219 IHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVH 278
              E  ++V E M  GSL   L G T G  L     + +A  +A G+ Y+        VH
Sbjct: 249 SE-EPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVH 303

Query: 279 RDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGY--VAPEYLLEGKLTDKSD 336
           RDL+++NIL+  +   K++DFGL+          +          APE  L G+ T KSD
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363

Query: 337 VYAFGVVLLELLM-GRRPVEKMSPTQCQSMVT 367
           V++FG++L EL   GR P   M   +    V 
Sbjct: 364 VWSFGILLTELTTKGRVPYPGMVNREVLDQVE 395

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  136 bits (345), Expect = 2e-37
 Identities = 64/290 (22%), Positives = 112/290 (38%), Gaps = 38/290 (13%)

Query: 148 LEAATNNFQESNVIGEGGRGHVYKAR-FNEKLLAAVKRIDDAGHDA-EREF-NNEVNWLT 204
           + +   +++    IG G  G   K R  ++  +   K +D       E++   +EVN L 
Sbjct: 1   MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLR 60

Query: 205 KIRHQNIISLLGYCIHAETRFL--VYEMMQNGSLEKQL-HGPTHGSNLTWHLRMKIAVDV 261
           +++H NI+      I      L  V E  + G L   +  G      L     +++   +
Sbjct: 61  ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 120

Query: 262 ARGLEYLHE--HCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS-VTAGTQSRNVKISGTL 318
              L+  H      H V+HRDLK +N+ LD   N KL DFGL+ +     S      GT 
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTP 180

Query: 319 GYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDR-- 376
            Y++PE +      +KSD+++ G +L EL     P    S             +L  +  
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS-----------QKELAGKIR 229

Query: 377 ----SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLH 422
                ++P           +L  +          +  +  +RP + ++L 
Sbjct: 230 EGKFRRIPYRYSD------ELNEIIT------RMLNLKDYHRPSVEEILE 267

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  137 bits (348), Expect = 2e-37
 Identities = 68/226 (30%), Positives = 98/226 (43%), Gaps = 29/226 (12%)

Query: 159 NVIGEGGRGHVYKARF----NEKLLAAVKRI-DDAGHDAEREFNNEVNWLTKIRHQNIIS 213
            +IG G  G V   R        +  A+K +         R+F +E + + +  H NII 
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114

Query: 214 LLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
           L G         +V E M+NGSL+  L   TH    T    + +   V  G+ YL +   
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLR--THDGQFTIMQLVGMLRGVGAGMRYLSDLG- 171

Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYV-----------A 322
              VHRDL + N+L+DS+   K+SDFGL       SR ++      Y            A
Sbjct: 172 --YVHRDLAARNVLVDSNLVCKVSDFGL-------SRVLEDDPDAAYTTTGGKIPIRWTA 222

Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVT 367
           PE +     +  SDV++FGVV+ E+L  G RP   M+     S V 
Sbjct: 223 PEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE 268

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  137 bits (348), Expect = 2e-37
 Identities = 57/218 (26%), Positives = 107/218 (49%), Gaps = 16/218 (7%)

Query: 159 NVIGEGGRGHVYKARF-----NEKLLAAVKRI-DDAGHDAEREFNNEVNWLTKIRHQNII 212
            V+G G  G VYK  +       K+  A+K + +     A +E  +E   +  + + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 213 SLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
            LLG C+   T  L+ ++M  G L   +    H  N+     +   V +A+G+ YL +  
Sbjct: 81  RLLGICL-TSTVQLITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137

Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYV---APEYLLEG 329
              +VHRDL + N+L+ +  + K++DFGL+   G + +     G    +   A E +L  
Sbjct: 138 ---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194

Query: 330 KLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMV 366
             T +SDV+++GV + EL+  G +P + +  ++  S++
Sbjct: 195 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  141 bits (358), Expect = 3e-37
 Identities = 63/212 (29%), Positives = 97/212 (45%), Gaps = 9/212 (4%)

Query: 159 NVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYC 218
             +G+G  G V+   +N     A+K +   G  +   F  E   + K+RH+ ++ L    
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331

Query: 219 IHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVH 278
              E  ++V E M  GSL   L G T G  L     + +A  +A G+ Y+        VH
Sbjct: 332 SE-EPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVH 386

Query: 279 RDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGY--VAPEYLLEGKLTDKSD 336
           RDL+++NIL+  +   K++DFGL+          +          APE  L G+ T KSD
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 446

Query: 337 VYAFGVVLLELLM-GRRPVEKMSPTQCQSMVT 367
           V++FG++L EL   GR P   M   +    V 
Sbjct: 447 VWSFGILLTELTTKGRVPYPGMVNREVLDQVE 478

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  138 bits (349), Expect = 3e-37
 Identities = 60/278 (21%), Positives = 103/278 (37%), Gaps = 26/278 (9%)

Query: 153 NNFQESNVIGEGGRGHVYKAR-FNEKLLAAVKRIDDAGHDAE--REFNNEVNWLTKIRHQ 209
             +     IGEG  G     +   +     +K I+ +   ++   E   EV  L  ++H 
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83

Query: 210 NIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLH 269
           NI+          + ++V +  + G L K+++    G        +   V +   L+++H
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRIN-AQKGVLFQEDQILDWFVQICLALKHVH 142

Query: 270 EHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS-VTAGTQSRNVKISGTLGYVAPEYLLE 328
           +     ++HRD+KS NI L      +L DFG++ V   T        GT  Y++PE    
Sbjct: 143 DR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICEN 199

Query: 329 GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIR 388
               +KSD++A G VL EL   +   E  S       +            +         
Sbjct: 200 KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKI-----ISGSFPPVSLHYSY--- 251

Query: 389 DTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVL-HSLI 425
              DL+ L           +  P  RP +  +L    I
Sbjct: 252 ---DLRSLVS------QLFKRNPRDRPSVNSILEKGFI 280

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  136 bits (344), Expect = 4e-37
 Identities = 73/302 (24%), Positives = 125/302 (41%), Gaps = 40/302 (13%)

Query: 138 DTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARF----NEKLLAAVKRI-DDAGHDA 192
           + V  +++ ++  ++     + VIG G  G VY         +K+  AVK +        
Sbjct: 10  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 69

Query: 193 EREFNNEVNWLTKIRHQNIISLLGYCIHAE-TRFLVYEMMQNGSLEKQLHGPTHGSNLTW 251
             +F  E   +    H N++SLLG C+ +E +  +V   M++G L   +       N T 
Sbjct: 70  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR--NETHNPTV 127

Query: 252 HLRMKIAVDVARGLEYLHE-HCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQ 308
              +   + VA+G++YL         VHRDL + N +LD  F  K++DFGL+  +     
Sbjct: 128 KDLIGFGLQVAKGMKYLASKKF----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 183

Query: 309 SRNVKISGTLGYV---APEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQS 364
                 +G    V   A E L   K T KSDV++FGV+L EL+  G  P   ++      
Sbjct: 184 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 243

Query: 365 MVT--WAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLH 422
            +     + Q       P      + + M            + C  P+   RP  ++++ 
Sbjct: 244 YLLQGRRLLQ-------PEYCPDPLYEVM------------LKCWHPKAEMRPSFSELVS 284

Query: 423 SL 424
            +
Sbjct: 285 RI 286

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  139 bits (353), Expect = 4e-37
 Identities = 67/210 (31%), Positives = 102/210 (48%), Gaps = 11/210 (5%)

Query: 159 NVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYC 218
             IG+G  G V    +      AVK I +      + F  E + +T++RH N++ LLG  
Sbjct: 199 QTIGKGEFGDVMLGDYRGNK-VAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVI 255

Query: 219 IHAETRF-LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVV 277
           +  +    +V E M  GSL   L      S L     +K ++DV   +EYL  +     V
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FV 311

Query: 278 HRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDV 337
           HRDL + N+L+     AK+SDFGL+  A +     K+   + + APE L E K + KSDV
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL--PVKWTAPEALREKKFSTKSDV 369

Query: 338 YAFGVVLLELLM-GRRPVEKMSPTQCQSMV 366
           ++FG++L E+   GR P  ++        V
Sbjct: 370 WSFGILLWEIYSFGRVPYPRIPLKDVVPRV 399

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  136 bits (345), Expect = 5e-37
 Identities = 68/314 (21%), Positives = 130/314 (41%), Gaps = 51/314 (16%)

Query: 127 RFNSLRLAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRID 186
              +  L  +  +V    Y +L+           IG GG   V++    +K + A+K ++
Sbjct: 12  DLGTENLYFQSMSVKGRIYSILK----------QIGSGGSSKVFQVLNEKKQIYAIKYVN 61

Query: 187 DAGHDAE--REFNNEVNWLTKIRHQN--IISLLGYCIHAETRFLVYEMMQNGSLEKQLHG 242
               D +    + NE+ +L K++  +  II L  Y I  +  ++V E   N  L   L  
Sbjct: 62  LEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLK- 119

Query: 243 PTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS 302
               S +    R     ++   +  +H+H    +VH DLK +N L+      KL DFG++
Sbjct: 120 -KKKS-IDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIA 173

Query: 303 VTAGTQSRNVKIS---GTLGYVAPEYLLE-----------GKLTDKSDVYAFGVVLLELL 348
                 + +V      GT+ Y+ PE + +            K++ KSDV++ G +L  + 
Sbjct: 174 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT 233

Query: 349 MGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQ 408
            G+ P +++   Q   +   A+       + P+I +  ++D +              C++
Sbjct: 234 YGKTPFQQII-NQISKLH--AIIDPNHEIEFPDIPEKDLQDVLK------------CCLK 278

Query: 409 PEPSYRPLITDVLH 422
            +P  R  I ++L 
Sbjct: 279 RDPKQRISIPELLA 292

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  137 bits (346), Expect = 5e-37
 Identities = 63/226 (27%), Positives = 101/226 (44%), Gaps = 30/226 (13%)

Query: 160 VIGEGGRGHVYKARFN-----EKLLAAVKRI-DDAGHDAEREFNNEVNWLTKIRHQNIIS 213
           VIG G  G VYK         +++  A+K +          +F  E   + +  H NII 
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110

Query: 214 LLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
           L G     +   ++ E M+NG+L+K L         +    + +   +A G++YL     
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLR--EKDGEFSVLQLVGMLRGIAAGMKYLANMN- 167

Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYV-----------A 322
              VHRDL + NIL++S+   K+SDFGL       SR ++      Y            A
Sbjct: 168 --YVHRDLAARNILVNSNLVCKVSDFGL-------SRVLEDDPEATYTTSGGKIPIRWTA 218

Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVT 367
           PE +   K T  SDV++FG+V+ E++  G RP  ++S  +    + 
Sbjct: 219 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN 264

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  136 bits (345), Expect = 7e-37
 Identities = 75/227 (33%), Positives = 115/227 (50%), Gaps = 32/227 (14%)

Query: 159 NVIGEGGRGHVYKARFN---EKLLAAVKRI-DDAGHDAEREFNNEVNWLTKI-RHQNIIS 213
           +VIGEG  G V KAR      ++ AA+KR+ + A  D  R+F  E+  L K+  H NII+
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90

Query: 214 LLGYCIHAETRFLVYEMMQNGSL-------------EKQLHGPTHGSNLTWHLRMKIAVD 260
           LLG C H    +L  E   +G+L                    +  S L+    +  A D
Sbjct: 91  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150

Query: 261 VARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGY 320
           VARG++YL +      +HRDL + NIL+  ++ AK++DFGLS     + + V +  T+G 
Sbjct: 151 VARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLS-----RGQEVYVKKTMGR 202

Query: 321 V-----APEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQ 361
           +     A E L     T  SDV+++GV+L E++ +G  P   M+  +
Sbjct: 203 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 249

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  136 bits (345), Expect = 7e-37
 Identities = 70/232 (30%), Positives = 109/232 (46%), Gaps = 39/232 (16%)

Query: 159 NVIGEGGRGHVYKARFN------EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNII 212
             +GEG  G V+ A  +      +K+L AVK + +A   A ++F  E   LT ++HQ+I+
Sbjct: 47  WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106

Query: 213 SLLGYCIHAETRFLVYEMMQNGSLEKQL--HGP----------THGSNLTWHLRMKIAVD 260
              G C       +V+E M++G L + L  HGP               L     + +A  
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166

Query: 261 VARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS----- 315
           VA G+ YL        VHRDL + N L+      K+ DFG+       SR++  +     
Sbjct: 167 VAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGM-------SRDIYSTDYYRV 216

Query: 316 GTLGYV-----APEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQ 361
           G    +      PE +L  K T +SDV++FGVVL E+   G++P  ++S T+
Sbjct: 217 GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE 268

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  135 bits (342), Expect = 8e-37
 Identities = 63/236 (26%), Positives = 103/236 (43%), Gaps = 37/236 (15%)

Query: 159 NVIGEGGRGHVYKARF-----NEKLLAAVKRI-DDAGHDAEREFNNEVNWLTKIRHQNII 212
             +GEG  G V   R+     N     AVK +  ++G +   +   E+  L  + H+NI+
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86

Query: 213 SLLGYCIHAETR--FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHE 270
              G C         L+ E + +GSL++ L  P + + +    ++K AV + +G++YL  
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLGS 144

Query: 271 -HCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYV-------- 321
                  VHRDL + N+L++S    K+ DFGL       ++ ++ +    Y         
Sbjct: 145 RQY----VHRDLAARNVLVESEHQVKIGDFGL-------TKAIE-TDKEYYTVKDDRDSP 192

Query: 322 ----APEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVT-WAMP 371
               APE L++ K    SDV++FGV L ELL         M+        T   M 
Sbjct: 193 VFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMT 248

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  135 bits (343), Expect = 1e-36
 Identities = 58/213 (27%), Positives = 102/213 (47%), Gaps = 16/213 (7%)

Query: 159 NVIGEGGRGHVYKARF-----NEKLLAAVKRI-DDAGHDAEREFNNEVNWLTKIRHQNII 212
            V+G G  G V+K  +     + K+   +K I D +G  + +   + +  +  + H +I+
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78

Query: 213 SLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
            LLG C    +  LV + +  GSL   +    H   L   L +   V +A+G+ YL EH 
Sbjct: 79  RLLGLCP-GSSLQLVTQYLPLGSLLDHVR--QHRGALGPQLLLNWGVQIAKGMYYLEEHG 135

Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYV---APEYLLEG 329
              +VHR+L + N+LL S    +++DFG++       + +  S     +   A E +  G
Sbjct: 136 ---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG 192

Query: 330 KLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQ 361
           K T +SDV+++GV + EL+  G  P   +   +
Sbjct: 193 KYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE 225

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  134 bits (340), Expect = 1e-36
 Identities = 59/297 (19%), Positives = 115/297 (38%), Gaps = 57/297 (19%)

Query: 160 VIGEGGRGHVYKARFNEKLLA--------AVKRIDDAGHDAEREFNNEVNWLTKIRHQNI 211
            +G+G    ++K    E             +K +D A  +    F    + ++K+ H+++
Sbjct: 15  SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74

Query: 212 ISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
           +   G C+  +   LV E ++ GSL+  L    + + +    ++++A  +A  + +L E+
Sbjct: 75  VLNYGVCVCGDENILVQEFVKFGSLDTYLK--KNKNCINILWKLEVAKQLAAAMHFLEEN 132

Query: 272 CNHPVVHRDLKSSNILLDSSFN--------AKLSDFGLSVTAGTQSRNVKISGTLGY--- 320
               ++H ++ + NILL    +         KLSD G+       S  V           
Sbjct: 133 T---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGI-------SITVLPKD--ILQER 180

Query: 321 ---VAPEYLLEGKL-TDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTD 375
              V PE +   K     +D ++FG  L E+   G +P+  +   +        +    D
Sbjct: 181 IPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR-------KLQFYED 233

Query: 376 RSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPTDL 432
           R +LP      + + +              C+  EP +RP    ++  L  L   DL
Sbjct: 234 RHQLPAPKAAELANLI------------NNCMDYEPDHRPSFRAIIRDLNSLFTPDL 278

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  134 bits (340), Expect = 2e-36
 Identities = 71/290 (24%), Positives = 117/290 (40%), Gaps = 44/290 (15%)

Query: 160 VIGEGGRGHVYKARFN----EKLLAAVKRI---DDAGHDAEREFNNEVNWLTKIRHQNII 212
            +G+G  G V +  ++    + +  AVK +     +  +A  +F  EVN +  + H+N+I
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84

Query: 213 SLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
            L G  +      +V E+   GSL  +L    H  +       + AV VA G+ YL    
Sbjct: 85  RLYGVVL-TPPMKMVTELAPLGSLLDRLR--KHQGHFLLGTLSRYAVQVAEGMGYLESKR 141

Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAG----TQSRNVKISGTLGYVAPEYL 326
               +HRDL + N+LL +    K+ DFGL   +           + K+     + APE L
Sbjct: 142 ---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP--FAWCAPESL 196

Query: 327 LEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWA---MPQLTDRSKLPNI 382
                +  SD + FGV L E+   G+ P   ++ +Q    +      +P+       P  
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR-------PED 249

Query: 383 VDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPTDL 432
               I + M            V C   +P  RP    +   L+   PTD+
Sbjct: 250 CPQDIYNVM------------VQCWAHKPEDRPTFVALRDFLLEAQPTDM 287

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  135 bits (341), Expect = 2e-36
 Identities = 66/277 (23%), Positives = 105/277 (37%), Gaps = 31/277 (11%)

Query: 154 NFQESNVIGEGGRGHVYKARFNE-KLLAAVKRI--DDAGHDAEREFNNEVNWLTKI-RHQ 209
           +FQ  + +G G  G V+K R  E   L AVKR      G         EV    K+ +H 
Sbjct: 58  SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117

Query: 210 NIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLH 269
             + L          +L  E+    SL++       G++L          D    L +LH
Sbjct: 118 CCVRLEQAWEEGGILYLQTELCG-PSLQQHCE--AWGASLPEAQVWGYLRDTLLALAHLH 174

Query: 270 EHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEG 329
                 +VH D+K +NI L      KL DFGL V  GT        G   Y+APE LL+G
Sbjct: 175 SQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPE-LLQG 230

Query: 330 KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRD 389
                +DV++ G+ +LE+           P   +      + Q     +    +      
Sbjct: 231 SYGTAADVFSLGLTILEVACNMEL-----PHGGEGWQ--QLRQGYLPPEFTAGLSS---- 279

Query: 390 TMDLKHLYQVAAVAVLCIQPEPSYRPLITDVL-HSLI 425
             +L+ +        + ++P+P  R     +L   ++
Sbjct: 280 --ELRSVLV------MMLEPDPKLRATAEALLALPVL 308

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  135 bits (341), Expect = 3e-36
 Identities = 61/216 (28%), Positives = 97/216 (44%), Gaps = 35/216 (16%)

Query: 159 NVIGEGGRGHVYKARF-----NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIIS 213
           + +G+G  G V   R+     N   L AVK++  +G D +R+F  E+  L  +    I+ 
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88

Query: 214 LLGYCIHAETR--FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHE- 270
             G       +   LV E + +G L   L    H + L     +  +  + +G+EYL   
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGSR 146

Query: 271 HCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYV--------- 321
            C    VHRDL + NIL++S  + K++DFGL       ++ +       YV         
Sbjct: 147 RC----VHRDLAARNILVESEAHVKIADFGL-------AKLLP-LDKDYYVVREPGQSPI 194

Query: 322 ---APEYLLEGKLTDKSDVYAFGVVLLELLM-GRRP 353
              APE L +   + +SDV++FGVVL EL     + 
Sbjct: 195 FWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS 230

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  133 bits (337), Expect = 3e-36
 Identities = 67/208 (32%), Positives = 102/208 (49%), Gaps = 23/208 (11%)

Query: 159 NVIGEGGRGHVYKARFNEKLLAAVKRI-DDAGHDAEREFNNEVNWLTKIRHQNIISLLGY 217
             IG+G  G V    +      AVK I +DA     + F  E + +T++RH N++ LLG 
Sbjct: 27  QTIGKGEFGDVMLGDYRGNK-VAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGV 82

Query: 218 CIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPV 276
            +  +   ++V E M  GSL   L      S L     +K ++DV   +EYL  +     
Sbjct: 83  IVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---F 138

Query: 277 VHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYV-----APEYLLEGKL 331
           VHRDL + N+L+     AK+SDFGL       ++    +   G +     APE L E K 
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGL-------TKEASSTQDTGKLPVKWTAPEALREKKF 191

Query: 332 TDKSDVYAFGVVLLELLM-GRRPVEKMS 358
           + KSDV++FG++L E+   GR P  ++ 
Sbjct: 192 STKSDVWSFGILLWEIYSFGRVPYPRIP 219

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  133 bits (338), Expect = 3e-36
 Identities = 61/213 (28%), Positives = 103/213 (48%), Gaps = 21/213 (9%)

Query: 159 NVIGEGGRGHVYKARFNEKLLA-AVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGY 217
           + +G G  G VY+  + +  L  AVK + +       EF  E   + +I+H N++ LLG 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77

Query: 218 CIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVV 277
           C      +++ E M  G+L   L    +   ++  + + +A  ++  +EYL +      +
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FI 133

Query: 278 HRDLKSSNILLDSSFNAKLSDFGLS-------VTAGTQSRN-VKISGTLGYVAPEYLLEG 329
           HRDL + N L+  +   K++DFGLS        TA   ++  +K      + APE L   
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK------WTAPESLAYN 187

Query: 330 KLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQ 361
           K + KSDV+AFGV+L E+   G  P   +  +Q
Sbjct: 188 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 220

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  135 bits (342), Expect = 4e-36
 Identities = 79/370 (21%), Positives = 137/370 (37%), Gaps = 67/370 (18%)

Query: 92  LCFWIYRWKRLKNTNGNSKQTIDGGKGLSLSPILERFNSLRLAGKKDTV-SVIEYELLEA 150
           + ++ +      +          G  G  L     + + LR +           +    +
Sbjct: 1   MSYYHHHHHHDYDIPTTENLYFQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTS 60

Query: 151 ATNNFQE--------SNVIGEGGRGHVYKARFN------EKLLAAVKRI-DDAGHDAERE 195
           + ++ +E           +G G  G VY+ + +        L  AVK + +      E +
Sbjct: 61  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 120

Query: 196 FNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQL--HGPTHGSNLTWHL 253
           F  E   ++K  HQNI+  +G  + +  RF++ E+M  G L+  L    P      +  +
Sbjct: 121 FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 180

Query: 254 R--MKIAVDVARGLEYLHE-HCNHPVVHRDLKSSNILLDSS---FNAKLSDFGLSVTAGT 307
              + +A D+A G +YL E H     +HRD+ + N LL        AK+ DFG+      
Sbjct: 181 LDLLHVARDIACGCQYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGM------ 230

Query: 308 QSRNVK-----ISGTLGYV-----APEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEK 356
            +R++        G    +      PE  +EG  T K+D ++FGV+L E+  +G  P   
Sbjct: 231 -ARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 289

Query: 357 MSPTQCQSMVT--WAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYR 414
            S  +    VT    M         P      +   M              C Q +P  R
Sbjct: 290 KSNQEVLEFVTSGGRMDP-------PKNCPGPVYRIM------------TQCWQHQPEDR 330

Query: 415 PLITDVLHSL 424
           P    +L  +
Sbjct: 331 PNFAIILERI 340

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  134 bits (339), Expect = 6e-36
 Identities = 67/302 (22%), Positives = 127/302 (42%), Gaps = 51/302 (16%)

Query: 139 TVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAE--REF 196
           +V    Y +L+           IG GG   V++    +K + A+K ++    D +    +
Sbjct: 5   SVKGRIYSILK----------QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSY 54

Query: 197 NNEVNWLTKIRHQN--IISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLR 254
            NE+ +L K++  +  II L  Y I  +  ++V E   N  L   L      S +    R
Sbjct: 55  RNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLK--KKKS-IDPWER 110

Query: 255 MKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKI 314
                ++   +  +H+H    +VH DLK +N L+      KL DFG++      + +V  
Sbjct: 111 KSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVK 166

Query: 315 S---GTLGYVAPEYLLE-----------GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPT 360
               GT+ Y+ PE + +            K++ KSDV++ G +L  +  G+ P +++   
Sbjct: 167 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-N 225

Query: 361 QCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDV 420
           Q   +   A+       + P+I +  ++D +              C++ +P  R  I ++
Sbjct: 226 QISKLH--AIIDPNHEIEFPDIPEKDLQDVLK------------CCLKRDPKQRISIPEL 271

Query: 421 LH 422
           L 
Sbjct: 272 LA 273

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  132 bits (335), Expect = 6e-36
 Identities = 60/212 (28%), Positives = 103/212 (48%), Gaps = 9/212 (4%)

Query: 159 NVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYC 218
             +G G  G V+   +N     AVK +   G  +   F  E N + +++HQ ++ L    
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77

Query: 219 IHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVH 278
              E  +++ E M+NGSL   L  P  G  LT +  + +A  +A G+ ++ E      +H
Sbjct: 78  TQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIH 132

Query: 279 RDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGY--VAPEYLLEGKLTDKSD 336
           RDL+++NIL+  + + K++DFGL+          +          APE +  G  T KSD
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 192

Query: 337 VYAFGVVLLELLM-GRRPVEKMSPTQCQSMVT 367
           V++FG++L E++  GR P   M+  +    + 
Sbjct: 193 VWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  133 bits (336), Expect = 7e-36
 Identities = 65/223 (29%), Positives = 101/223 (45%), Gaps = 27/223 (12%)

Query: 156 QESNVIGEGGRGHVYKARF----NEKLLAAVKRI-DDAGHDAEREFNNEVNWLTKIRHQN 210
               VIG+G  G VY   +      ++  A+K +           F  E   +  + H N
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPN 83

Query: 211 IISLLGYCIHAE-TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLH 269
           +++L+G  +  E    ++   M +G L + +   +   N T    +   + VARG+EYL 
Sbjct: 84  VLALIGIMLPPEGLPHVLLPYMCHGDLLQFIR--SPQRNPTVKDLISFGLQVARGMEYLA 141

Query: 270 E-HCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS-------VTAGTQSRNVK--ISGTLG 319
           E       VHRDL + N +LD SF  K++DFGL+         +  Q R+ +  +  T  
Sbjct: 142 EQKF----VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT-- 195

Query: 320 YVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQ 361
             A E L   + T KSDV++FGV+L ELL  G  P   + P  
Sbjct: 196 --ALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD 236

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  133 bits (338), Expect = 7e-36
 Identities = 75/294 (25%), Positives = 119/294 (40%), Gaps = 58/294 (19%)

Query: 159 NVIGEGGRGHVYKARFN------EKLLAAVKRI-DDAGHDAEREFNNEVNWLTKIRHQNI 211
             +G G  G VY+ + +        L  AVK + +      E +F  E   ++K  HQNI
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95

Query: 212 ISLLGYCIHAETRFLVYEMMQNGSLEKQL----HGPTHGSNLTWHLRMKIAVDVARGLEY 267
           +  +G  + +  RF++ E+M  G L+  L      P+  S+L     + +A D+A G +Y
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155

Query: 268 LHE-HCNHPVVHRDLKSSNILLDSS---FNAKLSDFGLSVTAGTQSRNVK-----ISGTL 318
           L E H     +HRD+ + N LL        AK+ DFG++       R++        G  
Sbjct: 156 LEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMA-------RDIYRASYYRKGGC 204

Query: 319 GYV-----APEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVT--WAM 370
             +      PE  +EG  T K+D ++FGV+L E+  +G  P    S  +    VT    M
Sbjct: 205 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM 264

Query: 371 PQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
                    P      +   M              C Q +P  RP    +L  +
Sbjct: 265 DP-------PKNCPGPVYRIM------------TQCWQHQPEDRPNFAIILERI 299

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  132 bits (335), Expect = 8e-36
 Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 31/215 (14%)

Query: 161 IGEGGRGHVYKARFN---EKLLAAVKRI-DDAGHDAEREFNNEVNWLTKIRHQNIISLLG 216
           +G G  G V +  +    +++  A+K +          E   E   + ++ +  I+ L+G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77

Query: 217 YCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPV 276
            C  AE   LV EM   G L K L G      +      ++   V+ G++YL E      
Sbjct: 78  VCQ-AEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---F 131

Query: 277 VHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYV------------APE 324
           VHRDL + N+LL +   AK+SDFGL       S+ +    +  Y             APE
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGL-------SKALGADDSY-YTARSAGKWPLKWYAPE 183

Query: 325 YLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMS 358
            +   K + +SDV+++GV + E L  G++P +KM 
Sbjct: 184 CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 218

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  132 bits (335), Expect = 9e-36
 Identities = 60/241 (24%), Positives = 97/241 (40%), Gaps = 43/241 (17%)

Query: 159 NVIGEGGRGHVYKARFN------EKLLAAVKRI-DDAGHDAEREFNNEVNWLTKIRHQNI 211
             +GE   G VYK          +    A+K + D A      EF +E     +++H N+
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74

Query: 212 ISLLGYCIHAETRFLVYEMMQNGSL-------------EKQLHGPTHGSNLTWHLRMKIA 258
           + LLG     +   +++    +G L                    T  S L     + + 
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134

Query: 259 VDVARGLEYLHE-HCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV----- 312
             +A G+EYL   H     VH+DL + N+L+    N K+SD GL        R V     
Sbjct: 135 AQIAAGMEYLSSHHV----VHKDLATRNVLVYDKLNVKISDLGL-------FREVYAADY 183

Query: 313 --KISGTLGYV---APEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMV 366
              +  +L  +   APE ++ GK +  SD++++GVVL E+   G +P    S      M+
Sbjct: 184 YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI 243

Query: 367 T 367
            
Sbjct: 244 R 244

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  132 bits (334), Expect = 9e-36
 Identities = 58/223 (26%), Positives = 99/223 (44%), Gaps = 28/223 (12%)

Query: 160 VIGEGGRGHVYKARFN----EKLLAAVKRI-DDAGHDAEREFNNEVNWLTKIRHQNIISL 214
           ++GEG  G VY+  +     EK+  AVK    D   D + +F +E   +  + H +I+ L
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78

Query: 215 LGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNH 274
           +G     E  +++ E+   G L   L    + ++L     +  ++ + + + YL      
Sbjct: 79  IGIIE-EEPTWIIMELYPYGELGHYLE--RNKNSLKVLTLVLYSLQICKAMAYLESIN-- 133

Query: 275 PVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV------KISGTLGYV---APEY 325
             VHRD+   NIL+ S    KL DFGLS       R +      K S T   +   +PE 
Sbjct: 134 -CVHRDIAVRNILVASPECVKLGDFGLS-------RYIEDEDYYKASVTRLPIKWMSPES 185

Query: 326 LLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVT 367
           +   + T  SDV+ F V + E+L  G++P   +       ++ 
Sbjct: 186 INFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE 228

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  134 bits (340), Expect = 1e-35
 Identities = 66/305 (21%), Positives = 127/305 (41%), Gaps = 51/305 (16%)

Query: 136 KKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAE-- 193
           +  +V    Y +L+           IG GG   V++    +K + A+K ++    D +  
Sbjct: 49  ECISVKGRIYSILK----------QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL 98

Query: 194 REFNNEVNWLTKIRHQN--IISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTW 251
             + NE+ +L K++  +  II L  Y I  +  ++V E   N  L   L      S +  
Sbjct: 99  DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLK--KKKS-IDP 154

Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
             R     ++   +  +H+H    +VH DLK +N L+      KL DFG++      + +
Sbjct: 155 WERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTS 210

Query: 312 VKIS---GTLGYVAPEYLLE-----------GKLTDKSDVYAFGVVLLELLMGRRPVEKM 357
           V      G + Y+ PE + +            K++ KSDV++ G +L  +  G+ P +++
Sbjct: 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 270

Query: 358 SPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLI 417
              Q   +   A+       + P+I +  ++D +              C++ +P  R  I
Sbjct: 271 I-NQISKLH--AIIDPNHEIEFPDIPEKDLQDVLK------------CCLKRDPKQRISI 315

Query: 418 TDVLH 422
            ++L 
Sbjct: 316 PELLA 320

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  132 bits (335), Expect = 2e-35
 Identities = 63/317 (19%), Positives = 110/317 (34%), Gaps = 56/317 (17%)

Query: 133 LAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKAR-FNEKLLAAVKRIDDAGHD 191
             G+   +  +   +            V+ EGG   VY+A+        A+KR+     +
Sbjct: 18  FVGQTVELGELRLRVRR----------VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEE 67

Query: 192 AEREFNNEVNWLTKIR-HQNIISLLGYCIHA-----ETRFLVYEMMQ--NGSLEKQLHGP 243
             R    EV ++ K+  H NI+                +     + +   G L + L   
Sbjct: 68  KNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKM 127

Query: 244 THGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSV 303
                L+    +KI     R ++++H     P++HRDLK  N+LL +    KL DFG + 
Sbjct: 128 ESRGPLSCDTVLKIFYQTCRAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSAT 186

Query: 304 TAGTQSRNVKIS-------------GTLGYVAPEYL-LEGKL--TDKSDVYAFGVVLLEL 347
           T          +              T  Y  PE + L       +K D++A G +L  L
Sbjct: 187 TISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLL 246

Query: 348 LMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCI 407
              + P E  +  +  +   +++P    +                   L +        +
Sbjct: 247 CFRQHPFEDGAKLRIVN-GKYSIPPHDTQYT-------------VFHSLIRA------ML 286

Query: 408 QPEPSYRPLITDVLHSL 424
           Q  P  R  I +V+H L
Sbjct: 287 QVNPEERLSIAEVVHQL 303

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  132 bits (334), Expect = 2e-35
 Identities = 60/210 (28%), Positives = 93/210 (44%), Gaps = 34/210 (16%)

Query: 159 NVIGEGGRGHVYKARF-----NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIIS 213
             +G+G  G V   R+     N   + AVK++  +  +  R+F  E+  L  ++H NI+ 
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106

Query: 214 LLGYCIHAETR--FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHE- 270
             G C  A  R   L+ E +  GSL   L    H   +     ++    + +G+EYL   
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGTK 164

Query: 271 HCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYV--------- 321
                 +HRDL + NIL+++    K+ DFGL       ++ +       Y          
Sbjct: 165 RY----IHRDLATRNILVENENRVKIGDFGL-------TKVLP-QDKEYYKVKEPGESPI 212

Query: 322 ---APEYLLEGKLTDKSDVYAFGVVLLELL 348
              APE L E K +  SDV++FGVVL EL 
Sbjct: 213 FWYAPESLTESKFSVASDVWSFGVVLYELF 242

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  131 bits (332), Expect = 2e-35
 Identities = 59/210 (28%), Positives = 93/210 (44%), Gaps = 34/210 (16%)

Query: 159 NVIGEGGRGHVYKARF-----NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIIS 213
             +G+G  G V   R+     N   + AVK++  +  +  R+F  E+  L  ++H NI+ 
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75

Query: 214 LLGYCIHAETR--FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHE- 270
             G C  A  R   L+ E +  GSL   L    H   +     ++    + +G+EYL   
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGTK 133

Query: 271 HCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYV--------- 321
                 +HRDL + NIL+++    K+ DFGL       ++ +       +          
Sbjct: 134 RY----IHRDLATRNILVENENRVKIGDFGL-------TKVLP-QDKEFFKVKEPGESPI 181

Query: 322 ---APEYLLEGKLTDKSDVYAFGVVLLELL 348
              APE L E K +  SDV++FGVVL EL 
Sbjct: 182 FWYAPESLTESKFSVASDVWSFGVVLYELF 211

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  132 bits (333), Expect = 3e-35
 Identities = 60/228 (26%), Positives = 94/228 (41%), Gaps = 35/228 (15%)

Query: 159 NVIGEGGRGHVYKARFN----EKLLAAVK--RIDDAGHDAEREFNNEVNWLTKIRHQNII 212
            ++GEG  G V +          L  AVK  ++D++      EF +E   +    H N+I
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99

Query: 213 SLLGYCIHAETR-----FLVYEMMQNGSLE---KQLHGPTHGSNLTWHLRMKIAVDVARG 264
            LLG CI   ++      ++   M+ G L          T   ++     +K  VD+A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159

Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV-------KISGT 317
           +EYL        +HRDL + N +L       ++DFGL       S+ +       +    
Sbjct: 160 MEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGL-------SKKIYSGDYYRQGRIA 209

Query: 318 LGYV---APEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQ 361
              V   A E L +   T KSDV+AFGV + E+   G  P   +   +
Sbjct: 210 KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE 257

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  131 bits (331), Expect = 5e-35
 Identities = 64/225 (28%), Positives = 91/225 (40%), Gaps = 38/225 (16%)

Query: 159 NVIGEGGRGHVYKARFN-----EKLLAAVKRI-DDAGHDAEREFNNEVNWLTKIRHQNII 212
             +GEG  G V    ++        + AVK +  DAG      +  E++ L  + H++II
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96

Query: 213 SLLGYCIHAETR--FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHE 270
              G C  A      LV E +  GSL   L       ++     +  A  +  G+ YLH 
Sbjct: 97  KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHA 152

Query: 271 -HCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYV-------- 321
            H     +HRDL + N+LLD+    K+ DFGL       ++ V   G   Y         
Sbjct: 153 QHY----IHRDLAARNVLLDNDRLVKIGDFGL-------AKAVP-EGHEYYRVREDGDSP 200

Query: 322 ----APEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQ 361
               APE L E K    SDV++FGV L ELL          +   
Sbjct: 201 VFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL 245

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  129 bits (327), Expect = 8e-35
 Identities = 68/282 (24%), Positives = 108/282 (38%), Gaps = 49/282 (17%)

Query: 160 VIGEGGRGHVYKARF----NEKLLAAVKRI-DDAGHDAEREFNNEVNWLTKIRHQNIISL 214
            IGEG  G V++  +    N  L  A+K   +        +F  E   + +  H +I+ L
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81

Query: 215 LGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNH 274
           +G        +++ E+   G L   L       +L     +  A  ++  L YL      
Sbjct: 82  IGVIT-ENPVWIIMELCTLGELRSFLQ--VRKYSLDLASLILYAYQLSTALAYLESKR-- 136

Query: 275 PVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV------KISGTLGYV---APEY 325
             VHRD+ + N+L+ S+   KL DFGLS       R +      K S     +   APE 
Sbjct: 137 -FVHRDIAARNVLVSSNDCVKLGDFGLS-------RYMEDSTYYKASKGKLPIKWMAPES 188

Query: 326 LLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVT--WAMPQLTDRSKLPNI 382
           +   + T  SDV+ FGV + E+LM G +P + +        +     +P        P  
Sbjct: 189 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM-------PPN 241

Query: 383 VDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
             P +   M              C   +PS RP  T++   L
Sbjct: 242 CPPTLYSLM------------TKCWAYDPSRRPRFTELKAQL 271

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  131 bits (331), Expect = 9e-35
 Identities = 65/243 (26%), Positives = 103/243 (42%), Gaps = 51/243 (20%)

Query: 159 NVIGEGGRGHVYKAR------FNEKLLAAVKRI-DDAGHDAEREFNNEVNWLTKIRHQNI 211
             IGEG  G V++AR      +    + AVK + ++A  D + +F  E   + +  + NI
Sbjct: 53  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112

Query: 212 ISLLGYCIHAETRFLVYEMMQNGSL---------------------EKQLHGPTHGSNLT 250
           + LLG C   +   L++E M  G L                      +          L+
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172

Query: 251 WHLRMKIAVDVARGLEYLHE-HCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS 309
              ++ IA  VA G+ YL E       VHRDL + N L+  +   K++DFGL       S
Sbjct: 173 CAEQLCIARQVAAGMAYLSERKF----VHRDLATRNCLVGENMVVKIADFGL-------S 221

Query: 310 RNVKIS-----GTLGYV-----APEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMS 358
           RN+  +          +      PE +   + T +SDV+A+GVVL E+   G +P   M+
Sbjct: 222 RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281

Query: 359 PTQ 361
             +
Sbjct: 282 HEE 284

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  135 bits (342), Expect = 1e-34
 Identities = 63/291 (21%), Positives = 109/291 (37%), Gaps = 31/291 (10%)

Query: 94  FWIYRWKRLKNTNGNSKQTIDGGKGLSLSPILERFNSLRLAGKKDTVSVIEYELLEAATN 153
           F I   K  +    +  +  +  K    S  +    +   A   D      Y +      
Sbjct: 328 FIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDT--YTMPSTRDY 385

Query: 154 NFQESNV-----IGEGGRGHVYKARF----NEKLLAAVKRI-DDAGHDAEREFNNEVNWL 203
             Q   +     IGEG  G V++  +    N  +  A+K   +        +F  E   +
Sbjct: 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 445

Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
            +  H +I+ L+G        +++ E+   G L   L       +L     +  A  ++ 
Sbjct: 446 RQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQ--VRKFSLDLASLILYAYQLST 502

Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS-------VTAGTQSRNVKISG 316
            L YL        VHRD+ + N+L+ S+   KL DFGLS           ++ + + I  
Sbjct: 503 ALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK-LPIKW 558

Query: 317 TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMV 366
                APE +   + T  SDV+ FGV + E+LM G +P + +        +
Sbjct: 559 M----APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 605

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  130 bits (329), Expect = 1e-34
 Identities = 64/295 (21%), Positives = 111/295 (37%), Gaps = 59/295 (20%)

Query: 159 NVIGEGGRGHVYKARFN----EKLLAAVK--RIDDAGHDAEREFNNEVNWLTKIRHQNII 212
            ++G+G  G V +A+        +  AVK  + D        EF  E   + +  H ++ 
Sbjct: 29  RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88

Query: 213 SLLGYCIHAETR------FLVYEMMQNGSLE---KQLHGPTHGSNLTWHLRMKIAVDVAR 263
            L+G  + +  +       ++   M++G L           +  NL     ++  VD+A 
Sbjct: 89  KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148

Query: 264 GLEYLHE-HCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV-------KIS 315
           G+EYL   +     +HRDL + N +L       ++DFGL       SR +       +  
Sbjct: 149 GMEYLSSRNF----IHRDLAARNCMLAEDMTVCVADFGL-------SRKIYSGDYYRQGC 197

Query: 316 GTLGYV---APEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVT--WA 369
            +   V   A E L +   T  SDV+AFGV + E++  G+ P   +   +  + +     
Sbjct: 198 ASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR 257

Query: 370 MPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
           + Q       P      + D M              C   +P  RP  T +   L
Sbjct: 258 LKQ-------PPECMEEVYDLM------------YQCWSADPKQRPSFTCLRMEL 293

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  129 bits (326), Expect = 1e-34
 Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 33/217 (15%)

Query: 160 VIGEGGRGHVYKARFNEKLLA---AVK--RIDDAGHDAEREFNNEVNWLTKIRHQNIISL 214
            +G G  G V K  +  K +    AVK  + +      + E   E N + ++ +  I+ +
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 215 LGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNH 274
           +G C  AE+  LV EM + G L K L       ++     +++   V+ G++YL E    
Sbjct: 84  IGICE-AESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESN-- 137

Query: 275 PVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYV------------A 322
             VHRDL + N+LL +   AK+SDFGL       S+ ++ +    Y             A
Sbjct: 138 -FVHRDLAARNVLLVTQHYAKISDFGL-------SKALR-ADENYYKAQTHGKWPVKWYA 188

Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMS 358
           PE +   K + KSDV++FGV++ E    G++P   M 
Sbjct: 189 PECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 225

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  130 bits (328), Expect = 1e-34
 Identities = 66/245 (26%), Positives = 99/245 (40%), Gaps = 55/245 (22%)

Query: 159 NVIGEGGRGHVYKAR------FNEKLLAAVKRI-DDAGHDAEREFNNEVNWLTKIRHQNI 211
             +GEG  G V KA              AVK + ++A     R+  +E N L ++ H ++
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88

Query: 212 ISLLGYCIHAETRFLVYEMMQNGSL---------------------EKQLHGPTHGSNLT 250
           I L G C       L+ E  + GSL                                 LT
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148

Query: 251 WHLRMKIAVDVARGLEYLHE-HCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS 309
               +  A  +++G++YL E       VHRDL + NIL+      K+SDFGL       S
Sbjct: 149 MGDLISFAWQISQGMQYLAEMKL----VHRDLAARNILVAEGRKMKISDFGL-------S 197

Query: 310 RNVKISGTLGYV------------APEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEK 356
           R+V    +  YV            A E L +   T +SDV++FGV+L E++ +G  P   
Sbjct: 198 RDVYEEDS--YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255

Query: 357 MSPTQ 361
           + P +
Sbjct: 256 IPPER 260

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  129 bits (325), Expect = 3e-34
 Identities = 62/300 (20%), Positives = 112/300 (37%), Gaps = 53/300 (17%)

Query: 153 NNFQESNVIGEGGRGHVYKAR-FNEKLLAAVKRIDDAGHDAERE-FNNEVNWLTKIRHQN 210
            +F+    +G GG G V++A+   +    A+KRI     +  RE    EV  L K+ H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 211 IISLLGYCIHAETR------------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIA 258
           I+      +   T             ++  ++ +  +L+  ++G          + + I 
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124

Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS-------------VTA 305
           + +A  +E+LH      ++HRDLK SNI        K+ DFGL                 
Sbjct: 125 LQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181

Query: 306 GTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSM 365
              +R+    GT  Y++PE +     + K D+++ G++L ELL          P   Q  
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---------PFSTQME 232

Query: 366 VTWAMPQLTDRS--KLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS 423
               +  + +     L     P          + Q        + P P  RP   +++ +
Sbjct: 233 RVRTLTDVRNLKFPPLFTQKYP------CEYVMVQ------DMLSPSPMERPEAINIIEN 280

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  129 bits (327), Expect = 3e-34
 Identities = 70/305 (22%), Positives = 116/305 (38%), Gaps = 71/305 (23%)

Query: 159 NVIGEGGRGHVYKA--------RFNEKLLAAVKRI-DDAGHDAEREFNNEVNWLTKI-RH 208
             +GEG  G V  A        +  E +  AVK + DDA      +  +E+  +  I +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100

Query: 209 QNIISLLGYCIHAETRFLVYEMMQNGSL-------------EKQLHGPTHGSNLTWHLRM 255
           +NII+LLG C      +++ E    G+L                         +T+   +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160

Query: 256 KIAVDVARGLEYLHE-HCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKI 314
                +ARG+EYL    C    +HRDL + N+L+  +   K++DFGL       +R++  
Sbjct: 161 SCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGL-------ARDINN 209

Query: 315 SGTLGYV------------APEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQ 361
                Y             APE L +   T +SDV++FGV++ E+  +G  P   +   +
Sbjct: 210 IDY--YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 267

Query: 362 CQSMVT--WAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITD 419
              ++     M +       P      +   M              C    PS RP    
Sbjct: 268 LFKLLKEGHRMDK-------PANCTNELYMMM------------RDCWHAVPSQRPTFKQ 308

Query: 420 VLHSL 424
           ++  L
Sbjct: 309 LVEDL 313

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  129 bits (327), Expect = 3e-34
 Identities = 56/228 (24%), Positives = 100/228 (43%), Gaps = 46/228 (20%)

Query: 159 NVIGEGGRGHVYKA------RFNEKLLAAVKRI-DDAGHDAEREFNNEVNWLTKI-RHQN 210
             +G G  G V +A      + +  L  AVK +   A  D +    +E+  ++ + +H+N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111

Query: 211 IISLLGYCIHAETRFLVYEMMQNGSL-----------EKQLHGPTHGSNLTWHLRMKIAV 259
           I++LLG C H     ++ E    G L           E         S  +    +  + 
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171

Query: 260 DVARGLEYLHE-HCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTL 318
            VA+G+ +L   +C    +HRD+ + N+LL +   AK+ DFGL       +R++      
Sbjct: 172 QVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGL-------ARDIMNDSN- 219

Query: 319 GYV------------APEYLLEGKLTDKSDVYAFGVVLLELL-MGRRP 353
            Y+            APE + +   T +SDV+++G++L E+  +G  P
Sbjct: 220 -YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  129 bits (327), Expect = 4e-34
 Identities = 71/303 (23%), Positives = 118/303 (38%), Gaps = 67/303 (22%)

Query: 159 NVIGEGGRGHVYKA--------RFNEKLLAAVKRI-DDAGHDAEREFNNEVNWLTKI-RH 208
             +GEG  G V  A        +  E +  AVK + DDA      +  +E+  +  I +H
Sbjct: 87  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146

Query: 209 QNIISLLGYCIHAETRFLVYEMMQNGSL-------------EKQLHGPTHGSNLTWHLRM 255
           +NII+LLG C      +++ E    G+L                         +T+   +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206

Query: 256 KIAVDVARGLEYLHE-HCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK- 313
                +ARG+EYL    C    +HRDL + N+L+  +   K++DFGL       +R++  
Sbjct: 207 SCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGL-------ARDINN 255

Query: 314 ----ISGTLGYV-----APEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQ 363
                  T G +     APE L +   T +SDV++FGV++ E+  +G  P   +   +  
Sbjct: 256 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 315

Query: 364 SMVT--WAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
            ++     M +       P      +   M              C    PS RP    ++
Sbjct: 316 KLLKEGHRMDK-------PANCTNELYMMM------------RDCWHAVPSQRPTFKQLV 356

Query: 422 HSL 424
             L
Sbjct: 357 EDL 359

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  127 bits (321), Expect = 7e-34
 Identities = 62/273 (22%), Positives = 113/273 (41%), Gaps = 25/273 (9%)

Query: 149 EAATNNFQESNVIGEGGRGHVYKAR-FNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR 207
           +   +   +  V+G+G  G VY  R  + ++  A+K I +      +  + E+     ++
Sbjct: 18  DYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLK 77

Query: 208 HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEY 267
           H+NI+  LG         +  E +  GSL   L                    +  GL+Y
Sbjct: 78  HKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKY 137

Query: 268 LHEHCNHPVVHRDLKSSNILLDS-SFNAKLSDFGLS-VTAGTQSRNVKISGTLGYVAPEY 325
           LH++    +VHRD+K  N+L+++ S   K+SDFG S   AG        +GTL Y+APE 
Sbjct: 138 LHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEI 194

Query: 326 LLEGKL--TDKSDVYAFGVVLLELLMGRRP-VEKMSPTQCQSMVTWAMPQLTDRSKLPNI 382
           + +G       +D+++ G  ++E+  G+ P  E   P        + +       ++P  
Sbjct: 195 IDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA----AMFKVGMFKVHPEIPES 250

Query: 383 VDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRP 415
           +    +  +              C +P+P  R 
Sbjct: 251 MSAEAKAFIL------------KCFEPDPDKRA 271

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  132 bits (334), Expect = 8e-34
 Identities = 61/218 (27%), Positives = 101/218 (46%), Gaps = 19/218 (8%)

Query: 160 VIGEGGRGHVYKARF---NEKLLAAVKRI-DDAGHDAEREFNNEVNWLTKIRHQNIISLL 215
            +G G  G V +  +    +++  A+K +          E   E   + ++ +  I+ L+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402

Query: 216 GYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHP 275
           G C  AE   LV EM   G L K L        +      ++   V+ G++YL E     
Sbjct: 403 GVCQ-AEALMLVMEMAGGGPLHKFLV--GKREEIPVSNVAELLHQVSMGMKYLEEKN--- 456

Query: 276 VVHRDLKSSNILLDSSFNAKLSDFGLS--VTAG----TQSRNVKISGTLGYVAPEYLLEG 329
            VHR+L + N+LL +   AK+SDFGLS  + A     T     K    L + APE +   
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW--PLKWYAPECINFR 514

Query: 330 KLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMV 366
           K + +SDV+++GV + E L  G++P +KM   +  + +
Sbjct: 515 KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 552

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  127 bits (321), Expect = 1e-33
 Identities = 57/230 (24%), Positives = 95/230 (41%), Gaps = 38/230 (16%)

Query: 152 TNNFQESNVIGEGGRGHVYKAR-FNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQN 210
            ++F+E  V+G+G  G V KAR   +    A+K+I     +      +EV  L  + HQ 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQY 63

Query: 211 IISLLGYCIHAETR-------------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKI 257
           ++      +                  F+  E  +NG+L   +H  +   N       ++
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH--SENLNQQRDEYWRL 121

Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-- 315
              +   L Y+H      ++HRDLK  NI +D S N K+ DFGL+         +K+   
Sbjct: 122 FRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178

Query: 316 -------------GTLGYVAPEYLLEGKLTD--KSDVYAFGVVLLELLMG 350
                        GT  YVA E +L+G      K D+Y+ G++  E++  
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFEMIYP 227

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  128 bits (323), Expect = 1e-33
 Identities = 36/315 (11%), Positives = 70/315 (22%), Gaps = 52/315 (16%)

Query: 160 VIGEGGRGHVYKARFNE-KLLAAVKRIDDAGH---DAEREFNNEVNWLTKIRHQNIISLL 215
            +  G R  V+  R  E     A+K                +       ++  ++     
Sbjct: 69  PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128

Query: 216 GYC--------------------------IHAETRFLVYEMMQNGSLEKQL----HGPTH 245
                                               L+        LE            
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVF 187

Query: 246 GSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA 305
             +        +   + R    L       +VH      N+ +       L D       
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKV 244

Query: 306 GTQSRNVKISGTLGYVAPEYLL--EGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQ 363
           GT+      S  + Y   E+L       T   + +  G+ +  +     P   ++P    
Sbjct: 245 GTRGPAS--SVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI-- 300

Query: 364 SMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVL-H 422
              +W  P L                   +K L          +  +   R L  + +  
Sbjct: 301 -KGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIG------RFLNFDRRRRLLPLEAMET 353

Query: 423 SLIPLVPTDLGGSLR 437
                +  ++  SL 
Sbjct: 354 PEFLQLQNEISSSLS 368

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  126 bits (318), Expect = 2e-33
 Identities = 67/207 (32%), Positives = 108/207 (52%), Gaps = 15/207 (7%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDA---GHDAEREFNNEVNWLTKIRH 208
            +F+    +G+G  G+VY AR  + K + A+K +  A       E +   EV   + +RH
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68

Query: 209 QNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEY 267
            NI+ L GY  H  TR +L+ E    G++ ++L      S            ++A  L Y
Sbjct: 69  PNILRLYGY-FHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSY 124

Query: 268 LHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLL 327
            H      V+HRD+K  N+LL S+   K++DFG SV A +  R   + GTL Y+ PE ++
Sbjct: 125 CHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD-LCGTLDYLPPE-MI 179

Query: 328 EGKLTDKS-DVYAFGVVLLELLMGRRP 353
           EG++ D+  D+++ GV+  E L+G+ P
Sbjct: 180 EGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  131 bits (332), Expect = 2e-33
 Identities = 48/218 (22%), Positives = 84/218 (38%), Gaps = 33/218 (15%)

Query: 145 YELLEAATNNFQESNVIGEGGRGHVYKARFNEKLLA---AVKRIDDAGHDAERE-FNNEV 200
           YE+             I  GG G +Y A  +  +      +K +  +G    +     E 
Sbjct: 82  YEVKG----------CIAHGGLGWIYLAL-DRNVNGRPVVLKGLVHSGDAEAQAMAMAER 130

Query: 201 NWLTKIRHQNIISLLGYCIHAETR-----FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRM 255
            +L ++ H +I+ +  +  H +       ++V E +   SL++          L     +
Sbjct: 131 QFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAI 185

Query: 256 KIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS 315
              +++   L YLH      +V+ DLK  NI+L      KL D G  V+       +   
Sbjct: 186 AYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGA-VSRINSFGYL--Y 238

Query: 316 GTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
           GT G+ APE ++    T  +D+Y  G  L  L +    
Sbjct: 239 GTPGFQAPE-IVRTGPTVATDIYTVGRTLAALTLDLPT 275

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  131 bits (330), Expect = 4e-33
 Identities = 57/208 (27%), Positives = 88/208 (42%), Gaps = 16/208 (7%)

Query: 160 VIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAERE-FNNEVNWLTKIRHQNIISLL-- 215
            +G GG G+V +    +     A+K+         RE +  E+  + K+ H N++S    
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80

Query: 216 ----GYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
                     +   L  E  + G L K L+   +   L       +  D++  L YLHE+
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 140

Query: 272 CNHPVVHRDLKSSNILLDSSFNA---KLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLE 328
               ++HRDLK  NI+L         K+ D G +          +  GTL Y+APE LLE
Sbjct: 141 R---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPE-LLE 196

Query: 329 GKL-TDKSDVYAFGVVLLELLMGRRPVE 355
            K  T   D ++FG +  E + G RP  
Sbjct: 197 QKKYTVTVDYWSFGTLAFECITGFRPFL 224

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  124 bits (315), Expect = 4e-33
 Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 14/208 (6%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDA---GHDAEREFNNEVNWLTKIRH 208
            +F+  N++G+G    VY+A      L  A+K ID          +   NEV    +++H
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70

Query: 209 QNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEY 267
            +I+ L  Y        +LV EM  NG + + L         + +        +  G+ Y
Sbjct: 71  PSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLK--NRVKPFSENEARHFMHQIITGMLY 127

Query: 268 LHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPEYL 326
           LH H    ++HRDL  SN+LL  + N K++DFGL+              GT  Y++PE +
Sbjct: 128 LHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPE-I 183

Query: 327 LEGKLTD-KSDVYAFGVVLLELLMGRRP 353
                   +SDV++ G +   LL+GR P
Sbjct: 184 ATRSAHGLESDVWSLGCMFYTLLIGRPP 211

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  125 bits (317), Expect = 4e-33
 Identities = 57/232 (24%), Positives = 90/232 (38%), Gaps = 50/232 (21%)

Query: 159 NVIGEGGRGHVYKA------RFNEKLLAAVKRI-DDAGHDAEREFNNEVNWLTKI-RHQN 210
             +G G  G V +A      + +  +  AVK +   A         +E+  L+ +  H N
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88

Query: 211 IISLLGYCIHAETRFLVYEMMQNGSL---------------EKQLHGPTHGSNLTWHLRM 255
           I++LLG C       ++ E    G L                           L     +
Sbjct: 89  IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148

Query: 256 KIAVDVARGLEYLHE-HCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKI 314
             +  VA+G+ +L   +C    +HRDL + NILL      K+ DFGL+       R++K 
Sbjct: 149 SFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLA-------RDIKN 197

Query: 315 SGTLGYV------------APEYLLEGKLTDKSDVYAFGVVLLELL-MGRRP 353
                YV            APE +     T +SDV+++G+ L EL  +G  P
Sbjct: 198 DSN--YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  126 bits (317), Expect = 5e-33
 Identities = 51/211 (24%), Positives = 86/211 (40%), Gaps = 21/211 (9%)

Query: 160 VIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAERE-FNNEVNWLTKIRHQNIISLLGY 217
           ++G+G   +V++ R  +   L A+K  ++       +    E   L K+ H+NI+ L   
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA- 74

Query: 218 CIHAETR---FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNH 274
                T     L+ E    GSL   L  P++   L     + +  DV  G+ +L E+   
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG-- 132

Query: 275 PVVHRDLKSSNILL----DSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGK 330
            +VHR++K  NI+     D     KL+DFG +       + V + GT  Y+ P+      
Sbjct: 133 -IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAV 191

Query: 331 LTD--------KSDVYAFGVVLLELLMGRRP 353
           L            D+++ GV       G  P
Sbjct: 192 LRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  125 bits (317), Expect = 7e-33
 Identities = 65/237 (27%), Positives = 103/237 (43%), Gaps = 55/237 (23%)

Query: 159 NVIGEGGRGHVYKAR------FNEKLLAAVKRI-DDAGHDAEREFNNEVNWLTKI-RHQN 210
            V+G G  G V  A           +  AVK + + A         +E+  +T++  H+N
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110

Query: 211 IISLLGYCIHAETRFLVYEMMQNGSL--------------------EKQLHGPTHGSNLT 250
           I++LLG C  +   +L++E    G L                    +K+L      + LT
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170

Query: 251 WHLRMKIAVDVARGLEYLHE-HCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS 309
           +   +  A  VA+G+E+L    C    VHRDL + N+L+      K+ DFGL       +
Sbjct: 171 FEDLLCFAYQVAKGMEFLEFKSC----VHRDLAARNVLVTHGKVVKICDFGL-------A 219

Query: 310 RNVKISGTLGYV------------APEYLLEGKLTDKSDVYAFGVVLLELL-MGRRP 353
           R++       YV            APE L EG  T KSDV+++G++L E+  +G  P
Sbjct: 220 RDIMSDSN--YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  126 bits (318), Expect = 1e-32
 Identities = 51/212 (24%), Positives = 88/212 (41%), Gaps = 23/212 (10%)

Query: 160 VIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAERE-FNNEVNWLTKIRHQNIISLLGY 217
           ++G+G   +V++ R  +   L A+K  ++       +    E   L K+ H+NI+ L   
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA- 74

Query: 218 CIHAETR---FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNH 274
                T     L+ E    GSL   L  P++   L     + +  DV  G+ +L E+   
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG-- 132

Query: 275 PVVHRDLKSSNILL----DSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGK 330
            +VHR++K  NI+     D     KL+DFG +       + V + GT  Y+ P+ + E  
Sbjct: 133 -IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPD-MYERA 190

Query: 331 LTD---------KSDVYAFGVVLLELLMGRRP 353
           +             D+++ GV       G  P
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  124 bits (314), Expect = 1e-32
 Identities = 62/231 (26%), Positives = 95/231 (41%), Gaps = 49/231 (21%)

Query: 159 NVIGEGGRGHVYKARFN------EKLLAAVKRI-DDAGHDAEREFNNEVNWLTKI-RHQN 210
             +G G  G V +A              AVK + + A H   R   +E+  L  I  H N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92

Query: 211 IISLLGYCIHAET-RFLVYEMMQNGSL-------------EKQLHGPTHGSNLTWHLRMK 256
           +++LLG C        ++ E  + G+L              K      +   LT    + 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152

Query: 257 IAVDVARGLEYLHE-HCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS 315
            +  VA+G+E+L    C    +HRDL + NILL      K+ DFGL       +R++   
Sbjct: 153 YSFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGL-------ARDIYKD 201

Query: 316 GTLGYV------------APEYLLEGKLTDKSDVYAFGVVLLELL-MGRRP 353
               YV            APE + +   T +SDV++FGV+L E+  +G  P
Sbjct: 202 PD--YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  125 bits (315), Expect = 3e-32
 Identities = 63/240 (26%), Positives = 98/240 (40%), Gaps = 50/240 (20%)

Query: 159 NVIGEGGRGHVYKA--------RFNEKLLAAVKRI-DDAGHDAEREFNNEVNWLTKI-RH 208
             +GEG  G V  A        + N     AVK +  DA      +  +E+  +  I +H
Sbjct: 75  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134

Query: 209 QNIISLLGYCIHAETRFLVYEMMQNGSL-------------EKQLHGPTHGSNLTWHLRM 255
           +NII+LLG C      +++ E    G+L                         L+    +
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194

Query: 256 KIAVDVARGLEYLHE-HCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKI 314
             A  VARG+EYL    C    +HRDL + N+L+      K++DFGL+       R++  
Sbjct: 195 SCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLA-------RDIHH 243

Query: 315 SGTLGYV------------APEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQ 361
                Y             APE L +   T +SDV++FGV+L E+  +G  P   +   +
Sbjct: 244 IDY--YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 301

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  124 bits (312), Expect = 4e-32
 Identities = 47/227 (20%), Positives = 90/227 (39%), Gaps = 32/227 (14%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRID-----------------DAGHDAERE 195
           N+++    + +G    +     + K   A+K+ +                  +      +
Sbjct: 31  NDYRIIRTLNQGKFNKIILCEKDNKF-YALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89

Query: 196 FNNEVNWLTKIRHQNIISLLGYCIHAETR-FLVYEMMQNGSL-----EKQLHGPTHGSNL 249
           F NE+  +T I+++  ++  G  I      +++YE M+N S+        +    +   +
Sbjct: 90  FKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148

Query: 250 TWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS 309
              +   I   V     Y+H   N  + HRD+K SNIL+D +   KLSDFG S     + 
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK 206

Query: 310 RNVKISGTLGYVAPEYLLEGKLT---DKSDVYAFGVVLLELLMGRRP 353
                 GT  ++ PE     + +    K D+++ G+ L  +     P
Sbjct: 207 IK-GSRGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  122 bits (308), Expect = 4e-32
 Identities = 63/207 (30%), Positives = 100/207 (48%), Gaps = 15/207 (7%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDA---GHDAEREFNNEVNWLTKIRH 208
           ++F     +G+G  G+VY AR  + K + A+K +  +       E +   E+   + +RH
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73

Query: 209 QNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEY 267
            NI+ +  Y  H   R +L+ E    G L K+L                   ++A  L Y
Sbjct: 74  PNILRMYNY-FHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATFMEELADALHY 129

Query: 268 LHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLL 327
            HE     V+HRD+K  N+L+      K++DFG SV A +  R   + GTL Y+ PE ++
Sbjct: 130 CHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRT-MCGTLDYLPPE-MI 184

Query: 328 EGKLTDKS-DVYAFGVVLLELLMGRRP 353
           EGK  D+  D++  GV+  E L+G  P
Sbjct: 185 EGKTHDEKVDLWCAGVLCYEFLVGMPP 211

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  124 bits (312), Expect = 5e-32
 Identities = 59/220 (26%), Positives = 104/220 (47%), Gaps = 8/220 (3%)

Query: 136 KKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRID-DAGHDAE 193
           + +     + ++ E   ++F++ + +G G  G V+K       L+ A K I  +      
Sbjct: 16  RLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIR 75

Query: 194 REFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHL 253
            +   E+  L +     I+   G         +  E M  GSL++ L        +   +
Sbjct: 76  NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQI 132

Query: 254 RMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK 313
             K+++ V +GL YL E   H ++HRD+K SNIL++S    KL DFG+S        N  
Sbjct: 133 LGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 190

Query: 314 ISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
           + GT  Y++PE L     + +SD+++ G+ L+E+ +GR P
Sbjct: 191 V-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  122 bits (308), Expect = 1e-31
 Identities = 72/295 (24%), Positives = 122/295 (41%), Gaps = 51/295 (17%)

Query: 155 FQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIIS 213
                 IGEG  G V  AR        AVK +D           NEV  +   +H N++ 
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106

Query: 214 LLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMK---IAV---DVARGLEY 267
           +    +  E  +++ E +Q G+L          +++   +R+    IA     V + L Y
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGAL----------TDIVSQVRLNEEQIATVCEAVLQALAY 156

Query: 268 LHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEY 325
           LH      V+HRD+KS +ILL      KLSDFG    ++     R   + GT  ++APE 
Sbjct: 157 LH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEV 212

Query: 326 LLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMV-TWAMPQLTDRSKLPNIVD 384
           +       + D+++ G++++E++ G  P    SP Q    +     P+L +  K+     
Sbjct: 213 ISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVS---- 268

Query: 385 PVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLH-----------SLIPLV 428
           PV+RD ++              +  +P  R    ++L             L+PL+
Sbjct: 269 PVLRDFLE------------RMLVRDPQERATAQELLDHPFLLQTGLPECLVPLI 311

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  121 bits (305), Expect = 2e-31
 Identities = 67/297 (22%), Positives = 131/297 (44%), Gaps = 48/297 (16%)

Query: 145 YELLEAATNNFQESNVIGEGGRGHVYKARFNEKL--LAAVKRID-DAGHDAE--REFNNE 199
           Y++++           +G GG   VY A  +  L    A+K I        E  + F  E
Sbjct: 13  YKIVD----------KLGGGGMSTVYLAE-DTILNIKVAIKAIFIPPREKEETLKRFERE 61

Query: 200 VNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQL--HGPTHGSNLTWHLRMKI 257
           V+  +++ HQNI+S++      +  +LV E ++  +L + +  HGP     L+    +  
Sbjct: 62  VHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP-----LSVDTAINF 116

Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGL--SVTAGTQSRNVKIS 315
              +  G+++ H+     +VHRD+K  NIL+DS+   K+ DFG+  +++  + ++   + 
Sbjct: 117 TNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVL 173

Query: 316 GTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTD 375
           GT+ Y +PE        + +D+Y+ G+VL E+L+G  P    +       V+ A+  + D
Sbjct: 174 GTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA------VSIAIKHIQD 227

Query: 376 RS-KLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRP-----LITDVLHSLIP 426
               +   V   I  ++          V +   + + + R      +  D+   L  
Sbjct: 228 SVPNVTTDVRKDIPQSLS--------NVILRATEKDKANRYKTIQEMKDDLSSVLHE 276

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  121 bits (306), Expect = 2e-31
 Identities = 60/257 (23%), Positives = 101/257 (39%), Gaps = 29/257 (11%)

Query: 145 YELLEAATNNFQESNVIGEGGRGHVYKARFNEKL--LAAVKRID-DAGHDAE--REFNNE 199
           Y L            ++G GG G VY+A  +     + A+K +      D         E
Sbjct: 36  YRLRR----------LVGRGGMGDVYEAE-DTVRERIVALKLMSETLSSDPVFRTRMQRE 84

Query: 200 VNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQL--HGPTHGSNLTWHLRMKI 257
                +++  +++ +  +       ++   ++    L   L   GP     L     + I
Sbjct: 85  ARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP-----LAPPRAVAI 139

Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGL--SVTAGTQSRNVKIS 315
              +   L+  H        HRD+K  NIL+ +   A L DFG+  + T    ++     
Sbjct: 140 VRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV 196

Query: 316 GTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTD 375
           GTL Y+APE   E   T ++D+YA   VL E L G  P +    +   + +  A+P+ + 
Sbjct: 197 GTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPST 256

Query: 376 -RSKLPNIVDPVIRDTM 391
            R  +P   D VI   M
Sbjct: 257 VRPGIPVAFDAVIARGM 273

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  121 bits (305), Expect = 2e-31
 Identities = 67/262 (25%), Positives = 114/262 (43%), Gaps = 21/262 (8%)

Query: 130 SLRLAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRID-D 187
           S   +GK+     I  +  +A  N+ +    +G G  G V+K RF +   + AVK++   
Sbjct: 2   SSGSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS 61

Query: 188 AGHDAEREFNNEVNWLTK-IRHQNIISLLGYCIHAETRFLVYEMMQNGSLE--KQLHGPT 244
              +  +    +++ + K      I+   G  I     F+  E+M   + +  K++ GP 
Sbjct: 62  GNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPI 121

Query: 245 HGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS-V 303
               L      K+ V + + L YL E   H V+HRD+K SNILLD     KL DFG+S  
Sbjct: 122 PERILG-----KMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGR 174

Query: 304 TAGTQSRNVKISGTLGYVAPEYLLEGKLTD-----KSDVYAFGVVLLELLMGRRPVEKMS 358
               ++++    G   Y+APE +     T      ++DV++ G+ L+EL  G+ P +   
Sbjct: 175 LVDDKAKDRSA-GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK 233

Query: 359 PT--QCQSMVTWAMPQLTDRSK 378
                   ++    P L     
Sbjct: 234 TDFEVLTKVLQEEPPLLPGHMG 255

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  120 bits (303), Expect = 3e-31
 Identities = 68/295 (23%), Positives = 129/295 (43%), Gaps = 51/295 (17%)

Query: 155 FQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIIS 213
           +     IG+G  G VY A         A+++++      +    NE+  + + ++ NI++
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 214 LLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMK---IAV---DVARGLEY 267
            L   +  +  ++V E +  GSL          +++     M    IA    +  + LE+
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSL----------TDVVTETCMDEGQIAAVCRECLQALEF 131

Query: 268 LHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEY 325
           LH   ++ V+HRD+KS NILL    + KL+DFG    +T     R+  + GT  ++APE 
Sbjct: 132 LH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEV 187

Query: 326 LLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMV-TWAMPQLTDRSKLPNIVD 384
           +       K D+++ G++ +E++ G  P    +P +   ++ T   P+L +  KL     
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLS---- 243

Query: 385 PVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLH-----------SLIPLV 428
            + RD ++             C++ +   R    ++L            SL PL+
Sbjct: 244 AIFRDFLN------------RCLEMDVEKRGSAKELLQHQFLKIAKPLSSLTPLI 286

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  120 bits (304), Expect = 4e-31
 Identities = 64/254 (25%), Positives = 109/254 (42%), Gaps = 20/254 (7%)

Query: 136 KKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRID-DAGHDAE 193
               + +   +  +    + ++   IG G  G V K        + AVKRI        +
Sbjct: 5   SSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQ 64

Query: 194 REFNNEVNWLTK-IRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLH--GPTHGSNLT 250
           ++   +++ + +      I+   G        ++  E+M + S +K            + 
Sbjct: 65  KQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIP 123

Query: 251 WHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS---VTAGT 307
             +  KI +   + L +L E  N  ++HRD+K SNILLD S N KL DFG+S   V +  
Sbjct: 124 EEILGKITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA 181

Query: 308 QSRNVKISGTLGYVAPEYLLEGKLTD----KSDVYAFGVVLLELLMGRRPVEKMSP--TQ 361
           ++R+    G   Y+APE +           +SDV++ G+ L EL  GR P  K +    Q
Sbjct: 182 KTRDA---GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ 238

Query: 362 CQSMVTWAMPQLTD 375
              +V    PQL++
Sbjct: 239 LTQVVKGDPPQLSN 252

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  121 bits (304), Expect = 1e-30
 Identities = 63/256 (24%), Positives = 98/256 (38%), Gaps = 36/256 (14%)

Query: 145 YELLEAATNNFQESNVIGEGGR--GHVYKARFNE-KLLAAVKRID--DAGHDAEREFNNE 199
           YELL           VIG+G      V  AR+        V+RI+     ++       E
Sbjct: 27  YELLT----------VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGE 76

Query: 200 VNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAV 259
           ++      H NI+      I     ++V   M  GS  K L        +     + IA 
Sbjct: 77  LHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSA-KDLICTHFMDGMN---ELAIAY 132

Query: 260 ---DVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKI 314
               V + L+Y+H       VHR +K+S+IL+       LS    +  + +  Q + V  
Sbjct: 133 ILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVH 189

Query: 315 S------GTLGYVAPEYLLEGKL--TDKSDVYAFGVVLLELLMGRRPVEKMSPTQC-QSM 365
                    L +++PE L +       KSD+Y+ G+   EL  G  P + M  TQ     
Sbjct: 190 DFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK 249

Query: 366 VTWAMPQLTDRSKLPN 381
           +   +P L D S +P 
Sbjct: 250 LNGTVPCLLDTSTIPA 265

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  121 bits (304), Expect = 2e-30
 Identities = 64/287 (22%), Positives = 102/287 (35%), Gaps = 39/287 (13%)

Query: 154 NFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKI-RHQNII 212
           +F   +V+G G  G +      +    AVKRI             EV  L +   H N+I
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD---REVQLLRESDEHPNVI 81

Query: 213 SLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
                    + +++  E+    +L++ +              + +      GL +LH   
Sbjct: 82  RYFCTEKDRQFQYIAIELCA-ATLQEYVEQK--DFAHLGLEPITLLQQTTSGLAHLHSLN 138

Query: 273 NHPVVHRDLKSSNILL-----DSSFNAKLSDFGLSV----TAGTQSRNVKISGTLGYVAP 323
              +VHRDLK  NIL+          A +SDFGL         + SR   + GT G++AP
Sbjct: 139 ---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195

Query: 324 EYLLE---GKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRSKL 379
           E L E      T   D+++ G V   ++  G  P  K    Q   ++      L      
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL--GACSLDCLHPE 253

Query: 380 PNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVL-HSLI 425
            +         +  + L +        I  +P  RP    VL H   
Sbjct: 254 KHE-------DVIARELIE------KMIAMDPQKRPSAKHVLKHPFF 287

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  118 bits (297), Expect = 2e-30
 Identities = 54/232 (23%), Positives = 93/232 (40%), Gaps = 41/232 (17%)

Query: 137 KDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDA---GHDA 192
            D  S   Y               +G+GG    ++    + K + A K +  +       
Sbjct: 9   VDPRSRRRYVRGR----------FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQ 58

Query: 193 EREFNNEVNWLTKIRHQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTW 251
             + + E++    + HQ+++   G+        F+V E+ +  SL +             
Sbjct: 59  REKMSMEISIHRSLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKR--------- 108

Query: 252 HLRMKIAVDVAR--------GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSV 303
             R  +    AR        G +YLH +    V+HRDLK  N+ L+     K+ DFGL+ 
Sbjct: 109 --RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLAT 163

Query: 304 TAGTQSRNVKIS-GTLGYVAPEYLLEGKLTD-KSDVYAFGVVLLELLMGRRP 353
                    K+  GT  Y+APE +L  K    + DV++ G ++  LL+G+ P
Sbjct: 164 KVEYDGERKKVLCGTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKPP 214

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  118 bits (298), Expect = 3e-30
 Identities = 51/215 (23%), Positives = 91/215 (42%), Gaps = 31/215 (14%)

Query: 154 NFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDA---GHDAEREFNNEVNWLTKIRHQ 209
            +     +G+GG    ++    + K + A K +  +         + + E++    + HQ
Sbjct: 42  RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 101

Query: 210 NIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR----- 263
           +++   G+        F+V E+ +  SL +               R  +    AR     
Sbjct: 102 HVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKR-----------RKALTEPEARYYLRQ 149

Query: 264 ---GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK-ISGTLG 319
              G +YLH +    V+HRDLK  N+ L+     K+ DFGL+          K + GT  
Sbjct: 150 IVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN 206

Query: 320 YVAPEYLLEGKLTD-KSDVYAFGVVLLELLMGRRP 353
           Y+APE +L  K    + DV++ G ++  LL+G+ P
Sbjct: 207 YIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  118 bits (297), Expect = 3e-30
 Identities = 54/273 (19%), Positives = 99/273 (36%), Gaps = 36/273 (13%)

Query: 152 TNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQN 210
            +       +G G  G V++ +  +     AVK++       E     E+     +    
Sbjct: 57  VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR-----LEVFRVEELVACAGLSSPR 111

Query: 211 IISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHE 270
           I+ L G         +  E+++ GSL + +        L     +        GLEYLH 
Sbjct: 112 IVPLYGAVREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHT 168

Query: 271 HCNHPVVHRDLKSSNILLDSS-FNAKLSDFGLS------VTAGTQSRNVKISGTLGYVAP 323
                ++H D+K+ N+LL S    A L DFG +          +      I GT  ++AP
Sbjct: 169 RR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 225

Query: 324 EYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQ-CQSMVTWAMPQLTDRSKLPNI 382
           E ++      K D+++   ++L +L G  P  +      C  + +   P      ++P  
Sbjct: 226 EVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIR----EIPPS 281

Query: 383 VDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRP 415
             P+    +               ++ EP +R 
Sbjct: 282 CAPLTAQAIQ------------EGLRKEPVHRA 302

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  118 bits (298), Expect = 4e-30
 Identities = 40/229 (17%), Positives = 75/229 (32%), Gaps = 27/229 (11%)

Query: 148 LEAATNNFQESNVIGEGGRGHVYKARFNE------KLLAAVKRIDDAGHDAEREFNNEVN 201
            +  +      +++GEG    VY+A   +      K    +K    A           + 
Sbjct: 60  FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLME 119

Query: 202 WLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEK--QLHGPTHGSNLTWHLRMKIAV 259
            L        +      +      LV E+   G+L     L+  T    +   L +  A+
Sbjct: 120 RLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAM 179

Query: 260 DVARGLEYLHEHCNHPVVHRDLKSSNILL-----------DSSFNAKLSDFGLSVTAGTQ 308
            +   +E +H+     ++H D+K  N +L           D S    L D G S+     
Sbjct: 180 RMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLF 236

Query: 309 SRNVKIS---GTLGYVAPEYLLEGKLTD-KSDVYAFGVVLLELLMGRRP 353
            +    +    T G+   E +L  K  + + D +     +  +L G   
Sbjct: 237 PKGTIFTAKCETSGFQCVE-MLSNKPWNYQIDYFGVAATVYCMLFGTYM 284

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  116 bits (293), Expect = 9e-30
 Identities = 55/215 (25%), Positives = 101/215 (46%), Gaps = 24/215 (11%)

Query: 155 FQESNVIGEGGRGHVYKARFNE-KLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNII 212
           F +   IG+G  G V+K   N  + + A+K ID +   D   +   E+  L++     + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 213 SLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMK---IAV---DVARGLE 266
              G  +     +++ E +  GS            +L     +    IA    ++ +GL+
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSA----------LDLLEPGPLDETQIATILREILKGLD 133

Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPE 324
           YLH   +   +HRD+K++N+LL      KL+DFG++  +T     RN  + GT  ++APE
Sbjct: 134 YLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPE 189

Query: 325 YLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSP 359
            + +     K+D+++ G+  +EL  G  P  ++ P
Sbjct: 190 VIKQSAYDSKADIWSLGITAIELARGEPPHSELHP 224

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  116 bits (292), Expect = 1e-29
 Identities = 83/297 (27%), Positives = 136/297 (45%), Gaps = 36/297 (12%)

Query: 144 EYELLEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRID-DAGHDAEREFNNEVN 201
           +YEL E          VIG G    V  A     K   A+KRI+ +    +  E   E+ 
Sbjct: 16  DYELQE----------VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQ 65

Query: 202 WLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQL-HGPTHGSNLTWHLR-MKIAV 259
            +++  H NI+S     +  +  +LV +++  GS+   + H    G + +  L    IA 
Sbjct: 66  AMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIAT 125

Query: 260 ---DVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS---VTAGTQSRNVK 313
              +V  GLEYLH    +  +HRD+K+ NILL    + +++DFG+S    T G  +RN  
Sbjct: 126 ILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKV 182

Query: 314 ---ISGTLGYVAPEYLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWA 369
                GT  ++APE + + +  D K+D+++FG+  +EL  G  P  K  P          
Sbjct: 183 RKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPP-------MKV 235

Query: 370 MPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVL-HSLI 425
           +  LT ++  P++   V    M  K+      +  LC+Q +P  RP   ++L H   
Sbjct: 236 L-MLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFF 291

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  115 bits (290), Expect = 2e-29
 Identities = 61/300 (20%), Positives = 102/300 (34%), Gaps = 52/300 (17%)

Query: 152 TNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRID--DAGHDAEREFNNEVNWLTKI-R 207
           T  F E   IG G  G V+K        + A+KR     AG   E+    EV     + +
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 208 HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQL-HGPTHGSNLTWHLRMKIAVDVARGLE 266
           H +++         +   +  E    GSL   +       S         + + V RGL 
Sbjct: 70  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129

Query: 267 YLHEHCNHPVVHRDLKSSNILLD-------------------SSFNAKLSDFGLSVTAGT 307
           Y+H      +VH D+K SNI +                    +    K+ D G       
Sbjct: 130 YIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR--I 184

Query: 308 QSRNVKISGTLGYVAPEYLLEGKL-TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMV 366
            S  V+  G   ++A E L E      K+D++A  + ++             P       
Sbjct: 185 SSPQVEE-GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL-----PRNGDQW- 237

Query: 367 TWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVL-HSLI 425
                    + +LP I   +   + +   L +      + I P+P  RP    ++ HS++
Sbjct: 238 -----HEIRQGRLPRIPQVL---SQEFTELLK------VMIHPDPERRPSAMALVKHSVL 283

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  115 bits (290), Expect = 2e-29
 Identities = 68/309 (22%), Positives = 123/309 (39%), Gaps = 59/309 (19%)

Query: 145 YELLEAATNNFQESNVIGEGGRGHVYKARFNEKLLA---AVK--RIDDAGHDAE--REFN 197
           YEL E          ++G GG   V+ AR  +       AVK  R D A  D      F 
Sbjct: 14  YELGE----------ILGFGGMSEVHLAR--DLRDHRDVAVKVLRADLA-RDPSFYLRFR 60

Query: 198 NEVNWLTKIRHQNIISLLGY----CIHAETRFLVYEMMQNGSLEKQL---HGPTHGSNLT 250
            E      + H  I+++              ++V E +   +L + +    GP     +T
Sbjct: 61  REAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTL-RDIVHTEGP-----MT 114

Query: 251 WHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGL----SVTAG 306
               +++  D  + L + H++    ++HRD+K +NI++ ++   K+ DFG+    + +  
Sbjct: 115 PKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 171

Query: 307 TQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMV 366
           + ++   + GT  Y++PE      +  +SDVY+ G VL E+L G  P    SP      V
Sbjct: 172 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------V 225

Query: 367 TWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRP-----LITDVL 421
           + A   + +    P+     +   +D        AV +  +   P  R      +  D++
Sbjct: 226 SVAYQHVREDPIPPSARHEGLSADLD--------AVVLKALAKNPENRYQTAAEMRADLV 277

Query: 422 HSLIPLVPT 430
                  P 
Sbjct: 278 RVHNGEPPE 286

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  114 bits (288), Expect = 3e-29
 Identities = 60/241 (24%), Positives = 108/241 (44%), Gaps = 19/241 (7%)

Query: 148 LEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRID-DAGHDAEREFNNEVN-WLT 204
           +E   ++ +    +G G  G V K R      + AVKRI        ++    +++  + 
Sbjct: 2   MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61

Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQL-HGPTHGSNLTWHLRMKIAVDVAR 263
            +     ++  G        ++  E+M + SL+K        G  +   +  KIAV + +
Sbjct: 62  TVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 120

Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS---VTAGTQSRNVKISGTLGY 320
            LE+LH      V+HRD+K SN+L+++    K+ DFG+S   V    +  +    G   Y
Sbjct: 121 ALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA---GCKPY 175

Query: 321 VAPE----YLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSP--TQCQSMVTWAMPQLT 374
           +APE     L +   + KSD+++ G+ ++EL + R P +       Q + +V    PQL 
Sbjct: 176 MAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLP 235

Query: 375 D 375
            
Sbjct: 236 A 236

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  113 bits (284), Expect = 1e-28
 Identities = 57/216 (26%), Positives = 103/216 (47%), Gaps = 20/216 (9%)

Query: 155 FQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIIS 213
           ++    +G+G  G VYKA+  E   LAA K I+    +   ++  E+  L    H  I+ 
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 214 LLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAV---DVARGLEYLHE 270
           LLG   H    +++ E    G+++  +     G          I V    +   L +LH 
Sbjct: 81  LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ-----IQVVCRQMLEALNFLH- 134

Query: 271 HCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLE 328
             +  ++HRDLK+ N+L+    + +L+DFG+S       Q R+  I GT  ++APE ++ 
Sbjct: 135 --SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMC 191

Query: 329 GKLTD-----KSDVYAFGVVLLELLMGRRPVEKMSP 359
             + D     K+D+++ G+ L+E+     P  +++P
Sbjct: 192 ETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP 227

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  112 bits (282), Expect = 2e-28
 Identities = 54/200 (27%), Positives = 85/200 (42%), Gaps = 10/200 (5%)

Query: 160 VIGEGGRGHVYKARFNE-KLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNIISLLGY 217
            +G G  G V+        L   +K I+ D       +   E+  L  + H NII +   
Sbjct: 29  KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88

Query: 218 CIHAETRFLVYEMMQNGSL-EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPV 276
                  ++V E  + G L E+ +     G  L+     ++   +   L Y H      V
Sbjct: 89  FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HV 145

Query: 277 VHRDLKSSNILLDS---SFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTD 333
           VH+DLK  NIL          K+ DFGL+    +   +   +GT  Y+APE + +  +T 
Sbjct: 146 VHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPE-VFKRDVTF 204

Query: 334 KSDVYAFGVVLLELLMGRRP 353
           K D+++ GVV+  LL G  P
Sbjct: 205 KCDIWSAGVVMYFLLTGCLP 224

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  112 bits (282), Expect = 3e-28
 Identities = 69/282 (24%), Positives = 116/282 (41%), Gaps = 35/282 (12%)

Query: 152 TNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQN 210
              F     +GEG  G VYKA   E   + A+K++        +E   E++ + +    +
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85

Query: 211 IISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAV---DVARGLEY 267
           ++   G        ++V E    GS+   +        LT     +IA       +GLEY
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIR--LRNKTLT---EDEIATILQSTLKGLEY 140

Query: 268 LHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEY 325
           LH       +HRD+K+ NILL++  +AKL+DFG++  +T     RN  I GT  ++APE 
Sbjct: 141 LH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEV 196

Query: 326 LLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMV-TWAMPQLTDRSKLPNIVD 384
           + E      +D+++ G+  +E+  G+ P   + P +   M+ T   P             
Sbjct: 197 IQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELW----S 252

Query: 385 PVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVL-HSLI 425
               D +              C+   P  R   T +L H  +
Sbjct: 253 DNFTDFVK------------QCLVKSPEQRATATQLLQHPFV 282

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  114 bits (288), Expect = 3e-28
 Identities = 55/232 (23%), Positives = 89/232 (38%), Gaps = 38/232 (16%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKI-RHQNI 211
           N      ++G G  G V      +    AVKR+     D       E+  LT+   H N+
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDI---ALMEIKLLTESDDHPNV 71

Query: 212 ISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR----GLEY 267
           I            ++  E+  N +L+  +             +    + + R    G+ +
Sbjct: 72  IRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130

Query: 268 LHEHCNHPVVHRDLKSSNILLDSS-------------FNAKLSDFGLS--VTAGTQSRNV 312
           LH      ++HRDLK  NIL+ +S                 +SDFGL   + +G  S   
Sbjct: 131 LHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187

Query: 313 KIS---GTLGYVAPEYLLEG-------KLTDKSDVYAFGVVLLELL-MGRRP 353
            ++   GT G+ APE L E        +LT   D+++ G V   +L  G+ P
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  112 bits (282), Expect = 1e-27
 Identities = 52/325 (16%), Positives = 95/325 (29%), Gaps = 77/325 (23%)

Query: 160 VIGEGGRGHVYKARFNE-------KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNII 212
           V+G+       +A   E        +    +R         +E    +  L  I++Q   
Sbjct: 85  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 213 SLLGYCIHA------------------------ETRFLVYEMMQNGSLEKQL-----HGP 243
            +    I                           +RF +Y  MQ  +L+        H  
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSHSS 203

Query: 244 THGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSV 303
           TH S L  H R+++ + V R L  LH +    +VH  L+  +I+LD      L+ F   V
Sbjct: 204 THKS-LVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV 259

Query: 304 TAGTQSRNVKISGTLGYVAPEYL----------LEGKLTDKSDVYAFGVVLLELLMGRRP 353
             G  + +       G+  PE                +T   D +  G+ +  +     P
Sbjct: 260 RDGASAVS---PIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316

Query: 354 VEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSY 413
               +       +            +P  V  ++                   ++     
Sbjct: 317 NTDDAALGGSEWI------FRSCKNIPQPVRALLEG----------------FLRYPKED 354

Query: 414 RPLITDVL-HSLIPLVPTDLGGSLR 437
           R L    +       + T+L  +L 
Sbjct: 355 RLLPLQAMETPEYEQLRTELSAALP 379

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  113 bits (285), Expect = 1e-27
 Identities = 64/228 (28%), Positives = 93/228 (40%), Gaps = 17/228 (7%)

Query: 136 KKDTVSVIEYELLEAATNNFQE----SNVIGEGGRGHVYKARFNE-KLLAAVKRID--DA 188
            +  +       + +   +  E       +G G  G V   R     +  A+K I     
Sbjct: 16  FQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSV 75

Query: 189 GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSN 248
              +  +   EV  L  + H NI+ L  +       +LV E  + G L        H   
Sbjct: 76  STSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL---FDEIIHRMK 132

Query: 249 LTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS---FNAKLSDFGLSVTA 305
                   I   V  G+ YLH+H    +VHRDLK  N+LL+S       K+ DFGLS   
Sbjct: 133 FNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189

Query: 306 GTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
             Q +  +  GT  Y+APE +L  K  +K DV++ GV+L  LL G  P
Sbjct: 190 ENQKKMKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYPP 236

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  112 bits (280), Expect = 1e-27
 Identities = 52/309 (16%), Positives = 95/309 (30%), Gaps = 77/309 (24%)

Query: 160 VIGEGGRGHVYKARFNE-KLLAAVKRID-------DAGHDAERE---------------- 195
           V+G+       +A   E      V           +A    + E                
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 196 -----FNNEVNWLTKIRHQNIISLLGYC--IHAETRFLVYEMMQNGSLEKQL-----HGP 243
                F    + +   + + +I +      +   +RF +Y  MQ  +L+        H  
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSHSS 198

Query: 244 THGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSV 303
           TH S L  H R+++ + V R L  LH +    +VH  L+  +I+LD      L+ F   V
Sbjct: 199 THKS-LVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV 254

Query: 304 TAGTQSRNVKISGTLGYVAPEYLL-----------EGKLTDKSDVYAFGVVLLELLMGRR 352
             G +      S + G+  PE                 +T   D +A G+V+  +     
Sbjct: 255 RDGARVV---SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311

Query: 353 PVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPS 412
           P+ K +       +            +P  V  ++                   ++    
Sbjct: 312 PITKDAALGGSEWI------FRSCKNIPQPVRALLEG----------------FLRYPKE 349

Query: 413 YRPLITDVL 421
            R L    +
Sbjct: 350 DRLLPLQAM 358

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  108 bits (273), Expect = 3e-27
 Identities = 55/207 (26%), Positives = 79/207 (38%), Gaps = 29/207 (14%)

Query: 160 VIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYC 218
            IG G  G V  A     ++  A K+I     +    F  E+  +  + H NII L    
Sbjct: 16  TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75

Query: 219 IHAETRFLVYEMMQNGSL-----EKQLHGPTHGSNLTWHLRMKIAVDVAR----GLEYLH 269
                 +LV E+   G L      K+              R   A  + +     + Y H
Sbjct: 76  EDNTDIYLVMELCTGGELFERVVHKR------------VFRESDAARIMKDVLSAVAYCH 123

Query: 270 EHCNHPVVHRDLKSSNILLDSS---FNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYL 326
           +     V HRDLK  N L  +       KL DFGL+             GT  YV+P+ +
Sbjct: 124 KL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQ-V 179

Query: 327 LEGKLTDKSDVYAFGVVLLELLMGRRP 353
           LEG    + D ++ GV++  LL G  P
Sbjct: 180 LEGLYGPECDEWSAGVMMYVLLCGYPP 206

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  112 bits (281), Expect = 4e-27
 Identities = 62/227 (27%), Positives = 95/227 (41%), Gaps = 36/227 (15%)

Query: 147 LLEAATNNFQE----SNVIGEGGRGHVYKARFNE-KLLAAVKRID---DAGHDAEREFNN 198
            ++ +T  F +      V+G+G  G V   +        AVK I          +     
Sbjct: 16  FVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR 75

Query: 199 EVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSL-----EKQLHGPTHGSNLTWHL 253
           EV  L ++ H NI+ L  +       +LV E+   G L      ++              
Sbjct: 76  EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK------------RF 123

Query: 254 RMKIAVDVAR----GLEYLHEHCNHPVVHRDLKSSNILLDSS---FNAKLSDFGLSVTAG 306
               A  + R    G+ Y+H++    +VHRDLK  N+LL+S     N ++ DFGLS    
Sbjct: 124 SEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180

Query: 307 TQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
              +     GT  Y+APE +L G   +K DV++ GV+L  LL G  P
Sbjct: 181 ASKKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPP 226

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  111 bits (279), Expect = 7e-27
 Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 31/210 (14%)

Query: 159 NVIGEGGRGHVYKARFNE-KLLAAVKRID--DAGHDAEREFNNEVNWLTKIRHQNIISLL 215
            ++G+G  G V K +    +   AVK I+   A +        EV  L K+ H NI+ L 
Sbjct: 28  CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87

Query: 216 GYCIHAETRFLVYEMMQNGSL-----EKQLHGPTHGSNLTWHLRMKIAVDVAR----GLE 266
                + + ++V E+   G L     +++                  A  + +    G+ 
Sbjct: 88  EILEDSSSFYIVGELYTGGELFDEIIKRK------------RFSEHDAARIIKQVFSGIT 135

Query: 267 YLHEHCNHPVVHRDLKSSNILLDSS---FNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           Y+H+H    +VHRDLK  NILL+S     + K+ DFGLS      ++     GT  Y+AP
Sbjct: 136 YMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAP 192

Query: 324 EYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
           E +L G   +K DV++ GV+L  LL G  P
Sbjct: 193 E-VLRGTYDEKCDVWSAGVILYILLSGTPP 221

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  107 bits (270), Expect = 1e-26
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 33/210 (15%)

Query: 160 VIGEGGRGHVYKARFNE-KLLAAVKRIDDA---GHDAEREFNNEVNWLTKIRHQNIISLL 215
           ++G+G  G V K +    +   AVK I+ A     D       EV  L K+ H NI+ L 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST-ILREVELLKKLDHPNIMKLF 87

Query: 216 GYCIHAETRFLVYEMMQNGSL-----EKQLHGPTHGSNLTWHLRMKIAVDVAR----GLE 266
                + + ++V E+   G L     +++                  A  + +    G+ 
Sbjct: 88  EILEDSSSFYIVGELYTGGELFDEIIKRK------------RFSEHDAARIIKQVFSGIT 135

Query: 267 YLHEHCNHPVVHRDLKSSNILLDS---SFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           Y+H+H    +VHRDLK  NILL+S     + K+ DFGLS      ++     GT  Y+AP
Sbjct: 136 YMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAP 192

Query: 324 EYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
           E +L G   +K DV++ GV+L  LL G  P
Sbjct: 193 E-VLRGTYDEKCDVWSAGVILYILLSGTPP 221

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  108 bits (271), Expect = 1e-26
 Identities = 77/248 (31%), Positives = 114/248 (45%), Gaps = 27/248 (10%)

Query: 130 SLRLAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDA 188
           S+       ++  I+   L      F+   ++G G  G VYK R  +   LAA+K +D  
Sbjct: 1   SMASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT 60

Query: 189 GHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRF------LVYEMMQNGSLEKQLH 241
           G D E E   E+N L K   H+NI +  G  I            LV E    GS+   + 
Sbjct: 61  G-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK 119

Query: 242 GPTHGSNLTWHLRMKIAV---DVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSD 298
             T G+ L       IA    ++ RGL +LH+H    V+HRD+K  N+LL  +   KL D
Sbjct: 120 -NTKGNTLK---EEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVD 172

Query: 299 FGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTD-----KSDVYAFGVVLLELLMGR 351
           FG+S  +      RN  I GT  ++APE +   +  D     KSD+++ G+  +E+  G 
Sbjct: 173 FGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231

Query: 352 RPVEKMSP 359
            P+  M P
Sbjct: 232 PPLCDMHP 239

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  110 bits (277), Expect = 2e-26
 Identities = 61/212 (28%), Positives = 90/212 (42%), Gaps = 24/212 (11%)

Query: 159 NVIGEGGRGHVYKARFNE-KLLAAVKRID-------------DAGHDAEREFNNEVNWLT 204
             +G G  G V   +        A+K I                      E  NE++ L 
Sbjct: 42  RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101

Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
            + H NII L       +  +LV E  + G L +Q+    +           I   +  G
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI---INRHKFDECDAANIMKQILSG 158

Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSS---FNAKLSDFGLSVTAGTQSRNVKISGTLGYV 321
           + YLH+H    +VHRD+K  NILL++     N K+ DFGLS       +     GT  Y+
Sbjct: 159 ICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYI 215

Query: 322 APEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
           APE +L+ K  +K DV++ GV++  LL G  P
Sbjct: 216 APE-VLKKKYNEKCDVWSCGVIMYILLCGYPP 246

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  106 bits (268), Expect = 2e-26
 Identities = 64/233 (27%), Positives = 93/233 (39%), Gaps = 45/233 (19%)

Query: 151 ATNNFQE----SNVIGEGGRGHVYKARFNE-KLLAAVKRID---------DAGHDAEREF 196
           +T+ F E      ++G G    V +          AVK ID         +   +     
Sbjct: 11  STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70

Query: 197 NNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMMQNGSL-----EKQLHGPTHGSNLT 250
             EV+ L K+  H NII L          FLV+++M+ G L     EK            
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV----------- 119

Query: 251 WHLRMKIAVDVAR----GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAG 306
             L  K    + R     +  LH+     +VHRDLK  NILLD   N KL+DFG S    
Sbjct: 120 -TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLD 175

Query: 307 TQSRNVKISGTLGYVAPEYLLEGKLTDKS------DVYAFGVVLLELLMGRRP 353
              +  ++ GT  Y+APE +      +        D+++ GV++  LL G  P
Sbjct: 176 PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  107 bits (268), Expect = 7e-26
 Identities = 61/219 (27%), Positives = 92/219 (42%), Gaps = 40/219 (18%)

Query: 160 VIGEGGRGHVYKARFNE-KLLAAVKRID--------DAGHDAEREFNNEVNWLTKIR-HQ 209
           VIG G    V +          AVK ++        +   +       E + L ++  H 
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160

Query: 210 NIISLLGYCIHAETRFLVYEMMQNGSL-----EKQLHGPTHGSNLTWHLRMKIAVDVAR- 263
           +II+L+     +   FLV+++M+ G L     EK              L  K    + R 
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKV------------ALSEKETRSIMRS 208

Query: 264 ---GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGY 320
               + +LH +    +VHRDLK  NILLD +   +LSDFG S       +  ++ GT GY
Sbjct: 209 LLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGY 265

Query: 321 VAPEYLLEGKLTD------KSDVYAFGVVLLELLMGRRP 353
           +APE L             + D++A GV+L  LL G  P
Sbjct: 266 LAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  104 bits (263), Expect = 1e-25
 Identities = 65/210 (30%), Positives = 106/210 (50%), Gaps = 24/210 (11%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAERE-FNN----EVNWLTKIR 207
             +Q+   +GEG  G VYKA+ ++  + A+KRI     DAE E   +    E++ L ++ 
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR---LDAEDEGIPSTAIREISLLKELH 77

Query: 208 HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEY 267
           H NI+SL+          LV+E M+   L+K L    + + L           + RG+ +
Sbjct: 78  HPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLD--ENKTGLQDSQIKIYLYQLLRGVAH 134

Query: 268 LHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN-----VKISGTLGYVA 322
            H+H    ++HRDLK  N+L++S    KL+DFGL+   G   R+     V    TL Y A
Sbjct: 135 CHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV----TLWYRA 187

Query: 323 PEYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           P+ L+  K    S D+++ G +  E++ G+
Sbjct: 188 PDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  104 bits (261), Expect = 2e-25
 Identities = 53/222 (23%), Positives = 90/222 (40%), Gaps = 36/222 (16%)

Query: 152 TNNFQE----SNVIGEGGRGHVYKARFNE-KLLAAVKRID---DAGHDAEREFNNEVNWL 203
           +  F +       +G+G    V +       L  A K I+    +  D ++    E    
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-LEREARIC 59

Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSL-----EKQLHGPTHGSNLTWHLRMKIA 258
            K++H NI+ L          +LV++++  G L      ++                  A
Sbjct: 60  RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE------------FYSEADA 107

Query: 259 VDVAR----GLEYLHEHCNHPVVHRDLKSSNILLDSSFNA---KLSDFGLSVTAGTQSRN 311
               +     + Y H +    +VHR+LK  N+LL S       KL+DFGL++        
Sbjct: 108 SHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW 164

Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
              +GT GY++PE L +   +   D++A GV+L  LL+G  P
Sbjct: 165 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  104 bits (261), Expect = 2e-25
 Identities = 59/213 (27%), Positives = 97/213 (45%), Gaps = 25/213 (11%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAERE-FNN----EVNWLTKI 206
             +++   IGEG  G V+KA+  E   + A+KR+     D + E   +    E+  L ++
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR---LDDDDEGVPSSALREICLLKEL 58

Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
           +H+NI+ L       +   LV+E      L+K     +   +L   +       + +GL 
Sbjct: 59  KHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFD--SCNGDLDPEIVKSFLFQLLKGLG 115

Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN-----VKISGTLGYV 321
           + H      V+HRDLK  N+L++ +   KL++FGL+   G   R      V    TL Y 
Sbjct: 116 FCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV----TLWYR 168

Query: 322 APEYLLEGKLTDKS-DVYAFGVVLLELLMGRRP 353
            P+ L   KL   S D+++ G +  EL    RP
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  106 bits (266), Expect = 2e-25
 Identities = 57/220 (25%), Positives = 85/220 (38%), Gaps = 44/220 (20%)

Query: 160 VIGEGGRGHVYKARFNEKL---LAAVKRID--------DAGHDAEREFNNEVNWLTKIRH 208
            +G G  G V  A   E+      A++ I             D       E+  L K+ H
Sbjct: 142 TLGSGACGEVKLAF--ERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH 199

Query: 209 QNIISLLGYCIHAETRFLVYEMMQNGSL-----EKQLHGPTHGSNLTWHLRMKIAVDVAR 263
             II +  +   AE  ++V E+M+ G L       +             L+         
Sbjct: 200 PCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNK------------RLKEATCKLYFY 246

Query: 264 ----GLEYLHEHCNHPVVHRDLKSSNILLDSS---FNAKLSDFGLSVTAGTQSRNVKISG 316
                ++YLHE+    ++HRDLK  N+LL S       K++DFG S   G  S    + G
Sbjct: 247 QMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCG 303

Query: 317 TLGYVAPEYLLEGKL---TDKSDVYAFGVVLLELLMGRRP 353
           T  Y+APE L+           D ++ GV+L   L G  P
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  104 bits (261), Expect = 3e-25
 Identities = 58/220 (26%), Positives = 85/220 (38%), Gaps = 44/220 (20%)

Query: 160 VIGEGGRGHVYKARFNEKL---LAAVKRID--------DAGHDAEREFNNEVNWLTKIRH 208
            +G G  G V  A   E+      A+K I             D       E+  L K+ H
Sbjct: 17  TLGSGACGEVKLAF--ERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74

Query: 209 QNIISLLGYCIHAETRFLVYEMMQNGSL-----EKQLHGPTHGSNLTWHLRMKIAVDVAR 263
             II +  +   AE  ++V E+M+ G L       +             L+         
Sbjct: 75  PCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNK------------RLKEATCKLYFY 121

Query: 264 ----GLEYLHEHCNHPVVHRDLKSSNILLDSS---FNAKLSDFGLSVTAGTQSRNVKISG 316
                ++YLHE+    ++HRDLK  N+LL S       K++DFG S   G  S    + G
Sbjct: 122 QMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCG 178

Query: 317 TLGYVAPEYLLEGKL---TDKSDVYAFGVVLLELLMGRRP 353
           T  Y+APE L+           D ++ GV+L   L G  P
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  104 bits (260), Expect = 5e-25
 Identities = 67/215 (31%), Positives = 101/215 (46%), Gaps = 22/215 (10%)

Query: 155 FQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFN---NEVNWLTKIRHQN 210
           F +   IG G  G VY AR      + A+K++  +G  +  ++     EV +L K+RH N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 211 IISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAV---DVARGLEY 267
            I   G  +   T +LV E    GS    L    H   L     ++IA       +GL Y
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCL-GSASDLLE--VHKKPLQ---EVEIAAVTHGALQGLAY 169

Query: 268 LHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE--- 324
           LH   +H ++HRD+K+ NILL      KL DFG    +     N  + GT  ++APE   
Sbjct: 170 LH---SHNMIHRDVKAGNILLSEPGLVKLGDFG--SASIMAPANSFV-GTPYWMAPEVIL 223

Query: 325 YLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSP 359
            + EG+   K DV++ G+  +EL   + P+  M+ 
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 258

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  103 bits (260), Expect = 9e-25
 Identities = 55/228 (24%), Positives = 94/228 (41%), Gaps = 36/228 (15%)

Query: 146 ELLEAATNNFQES----NVIGEGGRGHVYKARFNE-KLLAAVKRID---DAGHDAEREFN 197
           E +  A+  F ++      +G+G    V +       L  A K I+    +  D ++   
Sbjct: 18  EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-LE 76

Query: 198 NEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSL-----EKQLHGPTHGSNLTWH 252
            E     K++H NI+ L          +LV++++  G L      ++             
Sbjct: 77  REARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE------------F 124

Query: 253 LRMKIAVDVAR----GLEYLHEHCNHPVVHRDLKSSNILLDSSFNA---KLSDFGLSVTA 305
                A    +     + Y H +    +VHR+LK  N+LL S       KL+DFGL++  
Sbjct: 125 YSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181

Query: 306 GTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
                    +GT GY++PE L +   +   D++A GV+L  LL+G  P
Sbjct: 182 NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  103 bits (259), Expect = 1e-24
 Identities = 51/206 (24%), Positives = 82/206 (39%), Gaps = 16/206 (7%)

Query: 160 VIGEGGRGHVYKARFNE-KLLAAVKRID------DAGHDAEREFNNEVNWLTKIRHQNII 212
           VIG+G    V +    E     AVK +D        G   E     E +    ++H +I+
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTED-LKREASICHMLKHPHIV 89

Query: 213 SLLGYCIHAETRFLVYEMMQNGSL-EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
            LL         ++V+E M    L  + +     G   +  +       +   L Y H++
Sbjct: 90  ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN 149

Query: 272 CNHPVVHRDLKSSNILLDS---SFNAKLSDFGLSVT-AGTQSRNVKISGTLGYVAPEYLL 327
               ++HRD+K   +LL S   S   KL  FG+++    +        GT  ++APE + 
Sbjct: 150 N---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVK 206

Query: 328 EGKLTDKSDVYAFGVVLLELLMGRRP 353
                   DV+  GV+L  LL G  P
Sbjct: 207 REPYGKPVDVWGCGVILFILLSGCLP 232

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  102 bits (256), Expect = 1e-24
 Identities = 50/219 (22%), Positives = 83/219 (37%), Gaps = 43/219 (19%)

Query: 160 VIGEGGRGHVYKARFNE-KLLAAVKRID----DAGHDAEREFNNEVNWLTKIRHQNIISL 214
           ++GEG  G V +   +E     AVK +         + E     E+  L ++RH+N+I L
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71

Query: 215 LGY-CIHAETR---FLVYEMMQNGSLE---KQLHGPTHGSNLTWHLRMKIAVDVAR---- 263
                ++ E +   ++V E    G  E                   R  +    A     
Sbjct: 72  --VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK-----------RFPV--CQAHGYFC 116

Query: 264 ----GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS---G 316
               GLEYLH      +VH+D+K  N+LL +    K+S  G++      + +       G
Sbjct: 117 QLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQG 173

Query: 317 TLGYVAPEYLLEGKLTD--KSDVYAFGVVLLELLMGRRP 353
           +  +  PE           K D+++ GV L  +  G  P
Sbjct: 174 SPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  102 bits (256), Expect = 1e-24
 Identities = 58/210 (27%), Positives = 94/210 (44%), Gaps = 24/210 (11%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAERE-FNN----EVNWLTKIR 207
             +     IGEG  G VYKA+ N     A+K+I     + E E   +    E++ L +++
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR---LEKEDEGIPSTTIREISILKELK 58

Query: 208 HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEY 267
           H NI+ L       +   LV+E +    L+K L        L         + +  G+ Y
Sbjct: 59  HSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLD--VCEGGLESVTAKSFLLQLLNGIAY 115

Query: 268 LHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN-----VKISGTLGYVA 322
            H+     V+HRDLK  N+L++     K++DFGL+   G   R      V    TL Y A
Sbjct: 116 CHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV----TLWYRA 168

Query: 323 PEYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           P+ L+  K    + D+++ G +  E++ G 
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  101 bits (253), Expect = 2e-24
 Identities = 60/212 (28%), Positives = 89/212 (41%), Gaps = 38/212 (17%)

Query: 161 IGEGGRGHVYKARFNE-KLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNIISLLGYC 218
           +GEG  G V  A     +   AVK +D     D       E+     + H+N++   G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-- 72

Query: 219 IHAETR---FLVYEMMQNGSL-EKQLHGPTHGSNLTWHLRMKIAVDVAR--------GLE 266
            H       +L  E    G L ++          +   + M      A+        G+ 
Sbjct: 73  -HRREGNIQYLFLEYCSGGELFDR----------IEPDIGMP--EPDAQRFFHQLMAGVV 119

Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS---GTLGYVAP 323
           YLH      + HRD+K  N+LLD   N K+SDFGL+      +R   ++   GTL YVAP
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

Query: 324 EYLLEGKLTD--KSDVYAFGVVLLELLMGRRP 353
           E LL+ +       DV++ G+VL  +L G  P
Sbjct: 177 E-LLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  101 bits (255), Expect = 2e-24
 Identities = 58/207 (28%), Positives = 89/207 (42%), Gaps = 29/207 (14%)

Query: 160 VIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYC 218
           V+G G    V+  +      L A+K I  +    +    NE+  L KI+H+NI++L    
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75

Query: 219 IHAETRFLVYEMMQNGSL-----EKQLHGPTHGSNLTWHLRMKIAVDVAR----GLEYLH 269
                 +LV +++  G L     E+                 K A  V +     ++YLH
Sbjct: 76  ESTTHYYLVMQLVSGGELFDRILERG------------VYTEKDASLVIQQVLSAVKYLH 123

Query: 270 EHCNHPVVHRDLKSSNILLDSSFNA---KLSDFGLSVTAGTQSRNVKISGTLGYVAPEYL 326
           E+    +VHRDLK  N+L  +        ++DFGLS        +    GT GYVAPE L
Sbjct: 124 ENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMS-TACGTPGYVAPEVL 179

Query: 327 LEGKLTDKSDVYAFGVVLLELLMGRRP 353
            +   +   D ++ GV+   LL G  P
Sbjct: 180 AQKPYSKAVDCWSIGVITYILLCGYPP 206

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  101 bits (254), Expect = 3e-24
 Identities = 54/344 (15%), Positives = 113/344 (32%), Gaps = 96/344 (27%)

Query: 153 NNFQESNVIGEGGRGHVYKAR--------------------FNEKLLAAVKRIDDAGH-- 190
            +F+    +G GG G V++A+                      EK++  VK +    H  
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

Query: 191 -------------------------------------DAEREFNNEVNWLTKIRHQNIIS 213
                                                      + ++  +     +N + 
Sbjct: 66  IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125

Query: 214 LLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
            L         ++  ++ +  +L+  ++      +    + + I + +A  +E+LH    
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG- 184

Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-------------GTLGY 320
             ++HRDLK SNI        K+ DFGL            +              GT  Y
Sbjct: 185 --LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242

Query: 321 VAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSK-L 379
           ++PE +     + K D+++ G++L ELL                   ++     +R + +
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELL-------------------YSFSTQMERVRII 283

Query: 380 PNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS 423
            ++ +         K+  Q   +    + P P+ RP  TD++ +
Sbjct: 284 TDVRNLKFPLLFTQKY-PQEHMMVQDMLSPSPTERPEATDIIEN 326

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  100 bits (252), Expect = 5e-24
 Identities = 60/212 (28%), Positives = 89/212 (41%), Gaps = 38/212 (17%)

Query: 161 IGEGGRGHVYKARFNE-KLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNIISLLGYC 218
           +GEG  G V  A     +   AVK +D     D       E+     + H+N++   G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-- 72

Query: 219 IHAETR---FLVYEMMQNGSL-EKQLHGPTHGSNLTWHLRMKIAVDVAR--------GLE 266
            H       +L  E    G L ++          +   + M      A+        G+ 
Sbjct: 73  -HRREGNIQYLFLEYCSGGELFDR----------IEPDIGMP--EPDAQRFFHQLMAGVV 119

Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS---GTLGYVAP 323
           YLH      + HRD+K  N+LLD   N K+SDFGL+      +R   ++   GTL YVAP
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

Query: 324 EYLLEGKLTD--KSDVYAFGVVLLELLMGRRP 353
           E LL+ +       DV++ G+VL  +L G  P
Sbjct: 177 E-LLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  100 bits (252), Expect = 7e-24
 Identities = 56/207 (27%), Positives = 88/207 (42%), Gaps = 30/207 (14%)

Query: 160 VIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYC 218
            +G G    VY+ +    +   A+K +       ++    E+  L ++ H NII L    
Sbjct: 60  ELGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIF 117

Query: 219 IHAETRFLVYEMMQNGSL-----EKQLHGPTHGSNLTWHLRMKIAVDVAR----GLEYLH 269
                  LV E++  G L     EK             +   + A D  +     + YLH
Sbjct: 118 ETPTEISLVLELVTGGELFDRIVEKG------------YYSERDAADAVKQILEAVAYLH 165

Query: 270 EHCNHPVVHRDLKSSNILLDS-SFNA--KLSDFGLSVTAGTQSRNVKISGTLGYVAPEYL 326
           E+    +VHRDLK  N+L  + + +A  K++DFGLS     Q     + GT GY APE L
Sbjct: 166 ENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEIL 222

Query: 327 LEGKLTDKSDVYAFGVVLLELLMGRRP 353
                  + D+++ G++   LL G  P
Sbjct: 223 RGCAYGPEVDMWSVGIITYILLCGFEP 249

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  100 bits (251), Expect = 9e-24
 Identities = 54/212 (25%), Positives = 96/212 (45%), Gaps = 27/212 (12%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAERE-FNN----EVNWLTKI 206
             ++   ++GEG  G V K R  +   + A+K+  +     + +        E+  L ++
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLE---SDDDKMVKKIAMREIKLLKQL 81

Query: 207 RHQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
           RH+N+++LL      + R +LV+E + + ++   L      + L + +  K    +  G+
Sbjct: 82  RHENLVNLLE-VCKKKKRWYLVFEFVDH-TILDDLE--LFPNGLDYQVVQKYLFQIINGI 137

Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN-----VKISGTLGY 320
            + H H    ++HRD+K  NIL+  S   KL DFG + T                 T  Y
Sbjct: 138 GFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA----TRWY 190

Query: 321 VAPEYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
            APE L+      K+ DV+A G ++ E+ MG 
Sbjct: 191 RAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =   99 bits (250), Expect = 1e-23
 Identities = 57/213 (26%), Positives = 91/213 (42%), Gaps = 29/213 (13%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRI----DDAGHD--AEREFNNEVNWLTK 205
             +++   IGEG  G V+K R  +   + A+K+     DD      A RE    +  L +
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALRE----IRMLKQ 58

Query: 206 IRHQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
           ++H N+++LL      + R  LV+E   + ++  +L    +   +  HL   I     + 
Sbjct: 59  LKHPNLVNLLE-VFRRKRRLHLVFEYCDH-TVLHELD--RYQRGVPEHLVKSITWQTLQA 114

Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN-----VKISGTLG 319
           + + H+H     +HRD+K  NIL+      KL DFG +      S            T  
Sbjct: 115 VNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA----TRW 167

Query: 320 YVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           Y +PE L+         DV+A G V  ELL G 
Sbjct: 168 YRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  100 bits (250), Expect = 1e-23
 Identities = 40/206 (19%), Positives = 76/206 (36%), Gaps = 27/206 (13%)

Query: 160 VIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYC 218
            +G G  G V++      K     K +   G D       E++ L   RH+NI+ L    
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV-LVKKEISILNIARHRNILHLHESF 70

Query: 219 IHAETRFLVYEMMQNGSL-----EKQLHGPTHGSNLTWHLRMKIAVDVAR----GLEYLH 269
              E   +++E +    +                   + L  +  V         L++LH
Sbjct: 71  ESMEELVMIFEFISGLDIFERINTSA-----------FELNEREIVSYVHQVCEALQFLH 119

Query: 270 EHCNHPVVHRDLKSSNILLDSSFNA--KLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLL 327
            H    + H D++  NI+  +  ++  K+ +FG +           +     Y APE   
Sbjct: 120 SH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQ 176

Query: 328 EGKLTDKSDVYAFGVVLLELLMGRRP 353
              ++  +D+++ G ++  LL G  P
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGINP 202

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 99.7 bits (249), Expect = 2e-23
 Identities = 64/209 (30%), Positives = 91/209 (43%), Gaps = 34/209 (16%)

Query: 161 IGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFN--NEVNWLTKIRHQNIISLLGY 217
           IG+G    V  AR        A+K ID    +         EV  +  + H NI+ L   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 218 CIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR--------GLEYLH 269
               +T +L+ E    G +   L    HG       RMK     AR         ++Y H
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLV--AHG-------RMK--EKEARSKFRQIVSAVQYCH 131

Query: 270 EHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS---GTLGYVAPEYL 326
           +     +VHRDLK+ N+LLD+  N K++DFG S      +   K+    G   Y APE L
Sbjct: 132 QKR---IVHRDLKAENLLLDADMNIKIADFGFS---NEFTVGGKLDAFCGAPPYAAPE-L 184

Query: 327 LEGKLTD--KSDVYAFGVVLLELLMGRRP 353
            +GK  D  + DV++ GV+L  L+ G  P
Sbjct: 185 FQGKKYDGPEVDVWSLGVILYTLVSGSLP 213

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 98.8 bits (247), Expect = 3e-23
 Identities = 58/211 (27%), Positives = 92/211 (43%), Gaps = 26/211 (12%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRI---DDAGHD--AEREFNNEVNWLTKI 206
             + + + +GEG    VYK +      L A+K I    + G    A RE    V+ L  +
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIRE----VSLLKDL 57

Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
           +H NI++L       ++  LV+E +    L++ L     G+ +  H        + RGL 
Sbjct: 58  KHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLD--DCGNIINMHNVKLFLFQLLRGLA 114

Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN-----VKISGTLGYV 321
           Y H      V+HRDLK  N+L++     KL+DFGL+      ++      V    TL Y 
Sbjct: 115 YCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV----TLWYR 167

Query: 322 APEYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
            P+ LL         D++  G +  E+  GR
Sbjct: 168 PPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 99.7 bits (249), Expect = 3e-23
 Identities = 58/255 (22%), Positives = 106/255 (41%), Gaps = 38/255 (14%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDA---GHDAEREFNNEVNWLTKIRH 208
           ++F+    IG+G  G V   + N+ K + A+K ++       +  R    E+  +  + H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74

Query: 209 QNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLR--MKIAVDVAR-- 263
             +++L  Y    E   F+V +++  G L              +HL+  +    +  +  
Sbjct: 75  PFLVNLW-YSFQDEEDMFMVVDLLLGGDL-------------RYHLQQNVHFKEETVKLF 120

Query: 264 ------GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT 317
                  L+YL       ++HRD+K  NILLD   +  ++DF ++     +++   ++GT
Sbjct: 121 ICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGT 177

Query: 318 LGYVAPEYLLEGKLT--DKS-DVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLT 374
             Y+APE     K      + D ++ GV   ELL GRRP    S T  + +V       T
Sbjct: 178 KPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVH---TFET 234

Query: 375 DRSKLPNIVDPVIRD 389
                P+     +  
Sbjct: 235 TVVTYPSAWSQEMVS 249

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 99.7 bits (249), Expect = 6e-23
 Identities = 50/211 (23%), Positives = 86/211 (40%), Gaps = 33/211 (15%)

Query: 160 VIGEGGRGHVYKARFNE-KLLAAVKRID---DAGHDAEREFNNEVNWLTKIRHQNIISLL 215
            +G+G    V +          A   I+    +  D ++    E      ++H NI+ L 
Sbjct: 18  ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQK-LEREARICRLLKHPNIVRLH 76

Query: 216 GYCIHAETRFLVYEMMQNGSL-----EKQLHGPTHGSNLTWHLRMKIAVDVAR----GLE 266
                    +L+++++  G L      ++            +     A    +     + 
Sbjct: 77  DSISEEGHHYLIFDLVTGGELFEDIVARE------------YYSEADASHCIQQILEAVL 124

Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNA---KLSDFGLSVT-AGTQSRNVKISGTLGYVA 322
           + H+     VVHR+LK  N+LL S       KL+DFGL++   G Q      +GT GY++
Sbjct: 125 HCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLS 181

Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
           PE L +       D++A GV+L  LL+G  P
Sbjct: 182 PEVLRKDPYGKPVDLWACGVILYILLVGYPP 212

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 97.1 bits (242), Expect = 6e-23
 Identities = 39/277 (14%), Positives = 78/277 (28%), Gaps = 63/277 (22%)

Query: 145 YELLEAATNNFQESNVIGEGGRGHVYKARFNEKLLA---AVKRID-DAGHDAE--REFNN 198
           Y LL             G       ++A   +  L    A+  +D       +  +E  +
Sbjct: 33  YRLLI----------FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLS 80

Query: 199 EVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIA 258
               L++I    +  +L          +V E ++ GSL++           +    ++  
Sbjct: 81  RTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS-----PSPVGAIRAM 135

Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTL 318
             +A   +  H      V       S + +    +  L+                     
Sbjct: 136 QSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYP------------------- 173

Query: 319 GYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSK 378
             +            + D+   G  L  LL+ R P+ +      +S +  A      +  
Sbjct: 174 ATMPDA-------NPQDDIRGIGASLYALLVNRWPLPEAGV---RSGLAPAERDTAGQPI 223

Query: 379 LPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRP 415
            P  +D  I   +         AVA   +Q +   R 
Sbjct: 224 EPADIDRDIPFQIS--------AVAARSVQGDGGIRS 252

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 97.7 bits (244), Expect = 7e-23
 Identities = 53/215 (24%), Positives = 95/215 (44%), Gaps = 23/215 (10%)

Query: 150 AATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNN----EVNWLT 204
           ++++ F++   +G G    VYK       +  A+K +     D+E    +    E++ + 
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK---LDSEEGTPSTAIREISLMK 58

Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQN--GSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
           +++H+NI+ L           LV+E M N                 L  +L       + 
Sbjct: 59  ELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118

Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN-----VKISGT 317
           +GL + HE+    ++HRDLK  N+L++     KL DFGL+   G          V    T
Sbjct: 119 QGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV----T 171

Query: 318 LGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           L Y AP+ L+  +    S D+++ G +L E++ G+
Sbjct: 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 98.6 bits (246), Expect = 7e-23
 Identities = 45/224 (20%), Positives = 89/224 (39%), Gaps = 12/224 (5%)

Query: 137 KDTVSVIEYELLEAATNNFQE----SNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHD 191
           +D       + +E    +  +       +G G  G V++        +   K I+     
Sbjct: 31  EDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL 90

Query: 192 AEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTW 251
            +    NE++ + ++ H  +I+L           L+ E +  G L  ++        ++ 
Sbjct: 91  DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI--AAEDYKMSE 148

Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA--KLSDFGLSVTAGTQS 309
              +        GL+++HEH    +VH D+K  NI+ ++   +  K+ DFGL+       
Sbjct: 149 AEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205

Query: 310 RNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
                + T  + APE +    +   +D++A GV+   LL G  P
Sbjct: 206 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  100 bits (250), Expect = 7e-23
 Identities = 53/254 (20%), Positives = 101/254 (39%), Gaps = 19/254 (7%)

Query: 103 KNTNGNSKQTIDGGKGLSLSPILERFNSLRLAGKKDTVSVIEYELLEAATNNFQESNVIG 162
           +      K T+       +  I +++    +  K D V    Y++ E           +G
Sbjct: 118 QGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDH-YDIHE----------ELG 166

Query: 163 EGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHA 221
            G  G V++          A K +       +     E+  ++ +RH  +++L       
Sbjct: 167 TGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD 226

Query: 222 ETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDL 281
               ++YE M  G L +++      + ++    ++    V +GL ++HE   +  VH DL
Sbjct: 227 NEMVMIYEFMSGGELFEKV--ADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDL 281

Query: 282 KSSNILLDSSFNA--KLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYA 339
           K  NI+  +  +   KL DFGL+     +      +GT  + APE      +   +D+++
Sbjct: 282 KPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWS 341

Query: 340 FGVVLLELLMGRRP 353
            GV+   LL G  P
Sbjct: 342 VGVLSYILLSGLSP 355

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 97.6 bits (244), Expect = 9e-23
 Identities = 65/212 (30%), Positives = 104/212 (49%), Gaps = 24/212 (11%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAERE-FNN----EVNWLTKI 206
             +++ + +GEG    VYKAR      + A+K+I        ++  N     E+  L ++
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69

Query: 207 RHQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
            H NII LL      ++   LV++ M+   LE  +    +   LT        +   +GL
Sbjct: 70  SHPNIIGLLD-AFGHKSNISLVFDFMET-DLEVIIK--DNSLVLTPSHIKAYMLMTLQGL 125

Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN-----VKISGTLGY 320
           EYLH+H    ++HRDLK +N+LLD +   KL+DFGL+ + G+ +R      V    T  Y
Sbjct: 126 EYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV----TRWY 178

Query: 321 VAPEYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
            APE L   ++     D++A G +L ELL+  
Sbjct: 179 RAPELLFGARMYGVGVDMWAVGCILAELLLRV 210

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 99.9 bits (249), Expect = 9e-23
 Identities = 59/208 (28%), Positives = 93/208 (44%), Gaps = 11/208 (5%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDA---GHDAEREFNNEVNWLTKIRH 208
           + F +  V+G GG G V+  +      L A K+++          +    E   L K+  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244

Query: 209 QNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKI-AVDVARGLE 266
           + I+SL  Y    +T   LV  +M  G +   ++     +      R       +  GLE
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303

Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPEY 325
           +LH+     +++RDLK  N+LLD   N ++SD GL+V         K   GT G++APE 
Sbjct: 304 HLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360

Query: 326 LLEGKLTDKSDVYAFGVVLLELLMGRRP 353
           LL  +     D +A GV L E++  R P
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGP 388

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 97.3 bits (243), Expect = 1e-22
 Identities = 58/216 (26%), Positives = 93/216 (43%), Gaps = 31/216 (14%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAERE-FNN----EVNWLTKI 206
           + ++    +GEG  G VYKA         A+KRI     + E E        EV+ L ++
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR---LEHEEEGVPGTAIREVSLLKEL 90

Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
           +H+NII L     H     L++E  +N  L+K +       +++  +       +  G+ 
Sbjct: 91  QHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMD---KNPDVSMRVIKSFLYQLINGVN 146

Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNA-----KLSDFGLSVTAGTQSRN-----VKISG 316
           + H       +HRDLK  N+LL  S  +     K+ DFGL+   G   R      +    
Sbjct: 147 FCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII---- 199

Query: 317 TLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           TL Y  PE LL  +    S D+++   +  E+LM  
Sbjct: 200 TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 96.6 bits (241), Expect = 1e-22
 Identities = 45/164 (27%), Positives = 77/164 (46%), Gaps = 19/164 (11%)

Query: 199 EVNWLTKIRHQNIISLLGYC-IHAETR---FLVYEMMQNGSL-EKQLHGPTHGSNLTWHL 253
           E+  L K+ H N++ L     +        ++V+E++  G + E     P     L+   
Sbjct: 86  EIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP-----LSEDQ 138

Query: 254 RMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK 313
                 D+ +G+EYLH      ++HRD+K SN+L+    + K++DFG+S         + 
Sbjct: 139 ARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLS 195

Query: 314 IS-GTLGYVAPEYLLEGKLT---DKSDVYAFGVVLLELLMGRRP 353
            + GT  ++APE L E +        DV+A GV L   + G+ P
Sbjct: 196 NTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 97.8 bits (244), Expect = 1e-22
 Identities = 56/267 (20%), Positives = 105/267 (39%), Gaps = 28/267 (10%)

Query: 103 KNTNGNSKQTIDGGKGLSLSPILERFNSLRLAGKKDTVSVIEYELLEAATNNFQE----- 157
           ++ +  +K+           P+  +  S          +  ++ ++ A            
Sbjct: 33  RSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVS 92

Query: 158 -SNVIGEGGRGHVYKARFNEK---LLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIIS 213
            + ++G G  G V+K    E    L  A K I   G   + E  NE++ + ++ H N+I 
Sbjct: 93  KTEILGGGRFGQVHKCE--ETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150

Query: 214 LLGYCIHAETRFLVYEMMQNGSL-----EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYL 268
           L           LV E +  G L     ++         NLT    +     +  G+ ++
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGELFDRIIDE-------SYNLTELDTILFMKQICEGIRHM 203

Query: 269 HEHCNHPVVHRDLKSSNILLDSSFNA--KLSDFGLSVTAGTQSRNVKISGTLGYVAPEYL 326
           H+     ++H DLK  NIL  +      K+ DFGL+     + +     GT  ++APE +
Sbjct: 204 HQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVV 260

Query: 327 LEGKLTDKSDVYAFGVVLLELLMGRRP 353
               ++  +D+++ GV+   LL G  P
Sbjct: 261 NYDFVSFPTDMWSVGVIAYMLLSGLSP 287

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 99.1 bits (247), Expect = 1e-22
 Identities = 61/207 (29%), Positives = 96/207 (46%), Gaps = 12/207 (5%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDA---GHDAEREFNNEVNWLTKIRH 208
           N F++  V+G+GG G V   +      + A K+++         E    NE   L K+  
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243

Query: 209 QNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKI-AVDVARGLE 266
           + ++SL  Y    +    LV  +M  G L+  ++    G       R    A ++  GLE
Sbjct: 244 RFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIY--HMGQAGFPEARAVFYAAEICCGLE 300

Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYL 326
            LH      +V+RDLK  NILLD   + ++SD GL+V            GT+GY+APE +
Sbjct: 301 DLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV 357

Query: 327 LEGKLTDKSDVYAFGVVLLELLMGRRP 353
              + T   D +A G +L E++ G+ P
Sbjct: 358 KNERYTFSPDWWALGCLLYEMIAGQSP 384

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 96.8 bits (241), Expect = 2e-22
 Identities = 57/254 (22%), Positives = 83/254 (32%), Gaps = 55/254 (21%)

Query: 152 TNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRID-----DAGHDAEREFNNEVNWLTK 205
              +     IG+G  G V  A  N+ + + A+K ++                 EV  + K
Sbjct: 25  QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84

Query: 206 IRHQNIISLLGYCIHAETRFLVYEMMQNGSL-----EKQLHGPTHGSNLTWHLRM----- 255
           + H NI  L       +   LV E+   G L               +      ++     
Sbjct: 85  LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144

Query: 256 ---------------------------KIAVDVARGLEYLHEHCNHPVVHRDLKSSNILL 288
                                       I   +   L YLH      + HRD+K  N L 
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLF 201

Query: 289 DSSFNA--KLSDFGLSV-----TAGTQSRNVKISGTLGYVAPEYLLEG--KLTDKSDVYA 339
            ++ +   KL DFGLS        G        +GT  +VAPE L         K D ++
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261

Query: 340 FGVVLLELLMGRRP 353
            GV+L  LLMG  P
Sbjct: 262 AGVLLHLLLMGAVP 275

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 97.4 bits (243), Expect = 2e-22
 Identities = 60/255 (23%), Positives = 99/255 (38%), Gaps = 34/255 (13%)

Query: 115 GGKGLSLSPIL-ERFNSLRLAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKAR 173
           G   +S +P+   + N L    K   V   + +  E     +    VIG G  G V++A+
Sbjct: 1   GSFTMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAK 60

Query: 174 FNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETR-------FL 226
             E    A+K++     D   + N E+  +  ++H N++ L     ++           L
Sbjct: 61  LVESDEVAIKKVLQ---DKRFK-NRELQIMRIVKHPNVVDLK-AFFYSNGDKKDEVFLNL 115

Query: 227 VYE--------MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVH 278
           V E          ++ +  KQ           + L         R L Y+H      + H
Sbjct: 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQL--------LRSLAYIHSIG---ICH 164

Query: 279 RDLKSSNILLDSSFNA-KLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKL-TDKSD 336
           RD+K  N+LLD      KL DFG +        NV    +  Y APE +      T   D
Sbjct: 165 RDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNID 224

Query: 337 VYAFGVVLLELLMGR 351
           +++ G V+ EL+ G+
Sbjct: 225 IWSTGCVMAELMQGQ 239

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 95.4 bits (238), Expect = 2e-22
 Identities = 63/213 (29%), Positives = 95/213 (44%), Gaps = 41/213 (19%)

Query: 161 IGEGGRGHVYKARFNE-KLLAAVKRID----DAGHDAEREFNNEVNWLTKIRHQNIISLL 215
           +G G  G V            AVK ++     +     +    E+  L   RH +II L 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR-EIQNLKLFRHPHIIKL- 76

Query: 216 GYCIHAETR---FLVYEMMQNGSL-EKQLHGPTHGSNLTWHLRMKIAVDVAR-------- 263
            Y +   T    F+V E +  G L +           +  H R++     AR        
Sbjct: 77  -YQV-ISTPTDFFMVMEYVSGGELFDY----------ICKHGRVEE--MEARRLFQQILS 122

Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVA 322
            ++Y H H    VVHRDLK  N+LLD+  NAK++DFGLS    +    ++ S G+  Y A
Sbjct: 123 AVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRTSCGSPNYAA 178

Query: 323 PEYLLEGKLTD--KSDVYAFGVVLLELLMGRRP 353
           PE ++ G+L    + D+++ GV+L  LL G  P
Sbjct: 179 PE-VISGRLYAGPEVDIWSCGVILYALLCGTLP 210

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 94.9 bits (237), Expect = 3e-22
 Identities = 62/217 (28%), Positives = 87/217 (40%), Gaps = 41/217 (18%)

Query: 160 VIGEGGRGHVYKARFNEK---LLAAVKRID-------DAGHDAEREFNNEVNWLTKIRHQ 209
            +G G    V K R  +K      A K I          G   E E   EVN L +IRH 
Sbjct: 12  ELGSGQFAIVRKCR--QKGTGKEYAAKFIKKRRLSSSRRGVSRE-EIEREVNILREIRHP 68

Query: 210 NIISLLGYCIHAETRFLVYEMMQNGSL-----EKQLHGPTHGSNLTWHLRMKIAVDVAR- 263
           NII+L     +     L+ E++  G L     EK+             L    A    + 
Sbjct: 69  NIITLHDIFENKTDVVLILELVSGGELFDFLAEKE------------SLTEDEATQFLKQ 116

Query: 264 ---GLEYLHEHCNHPVVHRDLKSSNILLDS----SFNAKLSDFGLSVTAGTQSRNVKISG 316
              G+ YLH      + H DLK  NI+L      +   KL DFG++      +    I G
Sbjct: 117 ILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFG 173

Query: 317 TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
           T  +VAPE +    L  ++D+++ GV+   LL G  P
Sbjct: 174 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 95.4 bits (238), Expect = 4e-22
 Identities = 58/216 (26%), Positives = 86/216 (39%), Gaps = 39/216 (18%)

Query: 160 VIGEGGRGHVYKARFNEK---LLAAVKRID------DAGHDAEREFNNEVNWLTKIRHQN 210
            +G G    V K R  EK   L  A K I            +  E   EV+ L ++ H N
Sbjct: 19  ELGSGQFAIVKKCR--EKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76

Query: 211 IISLLGYCIHAETRFLVYEMMQNGSL-----EKQLHGPTHGSNLTWHLRMKIAVDVAR-- 263
           +I+L     +     L+ E++  G L     +K+             L  + A    +  
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGELFDFLAQKE------------SLSEEEATSFIKQI 124

Query: 264 --GLEYLHEHCNHPVVHRDLKSSNILLDS----SFNAKLSDFGLSVTAGTQSRNVKISGT 317
             G+ YLH      + H DLK  NI+L        + KL DFGL+           I GT
Sbjct: 125 LDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGT 181

Query: 318 LGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
             +VAPE +    L  ++D+++ GV+   LL G  P
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 96.8 bits (241), Expect = 4e-22
 Identities = 57/217 (26%), Positives = 99/217 (45%), Gaps = 38/217 (17%)

Query: 161 IGEGGRGHVYKARFNEKL---LAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLL 215
           +G G  GHVYKA+  +       A+K+I+  G    A RE    +  L +++H N+ISL 
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACRE----IALLRELKHPNVISLQ 84

Query: 216 GYCI-HAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA--------RGL 265
              + HA+ + +L+++  ++  L   +    H ++      +++   +          G+
Sbjct: 85  KVFLSHADRKVWLLFDYAEH-DLWHIIK--FHRASKANKKPVQLPRGMVKSLLYQILDGI 141

Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNA----KLSDFGLS------VTAGTQSRNVKIS 315
            YLH +    V+HRDLK +NIL+          K++D G +      +        V + 
Sbjct: 142 HYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV- 197

Query: 316 GTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
            T  Y APE LL  +   K+ D++A G +  ELL   
Sbjct: 198 -TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 96.7 bits (241), Expect = 4e-22
 Identities = 64/248 (25%), Positives = 100/248 (40%), Gaps = 40/248 (16%)

Query: 128 FNSLRLAGKKDTVSVIEYELLEAATNNFQES------NVIGEGGRGHVYKARFNE-KLLA 180
           F S++++  KD   V           +  +        VIG G  G VY+A+  +   L 
Sbjct: 23  FGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELV 82

Query: 181 AVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETR-------FLVYEMMQ- 232
           A+K++     D   + N E+  + K+ H NI+ L  Y  ++           LV + +  
Sbjct: 83  AIKKVLQ---DKRFK-NRELQIMRKLDHCNIVRLR-YFFYSSGEKKDEVYLNLVLDYVPE 137

Query: 233 -------NGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSN 285
                  + S  KQ     +     + L         R L Y+H   +  + HRD+K  N
Sbjct: 138 TVYRVARHYSRAKQTLPVIYVKLYMYQL--------FRSLAYIH---SFGICHRDIKPQN 186

Query: 286 ILLDSSFNA-KLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKL-TDKSDVYAFGVV 343
           +LLD      KL DFG +        NV    +  Y APE +      T   DV++ G V
Sbjct: 187 LLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCV 246

Query: 344 LLELLMGR 351
           L ELL+G+
Sbjct: 247 LAELLLGQ 254

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 95.5 bits (238), Expect = 6e-22
 Identities = 61/217 (28%), Positives = 87/217 (40%), Gaps = 41/217 (18%)

Query: 160 VIGEGGRGHVYKARFNEK---LLAAVKRID-------DAGHDAEREFNNEVNWLTKIRHQ 209
            +G G    V K R  EK   L  A K I          G   E E   EV+ L ++ H 
Sbjct: 19  ELGSGQFAIVKKCR--EKSTGLEYAAKFIKKRQSRASRRGVCRE-EIEREVSILRQVLHP 75

Query: 210 NIISLLGYCIHAETRFLVYEMMQNGSL-----EKQLHGPTHGSNLTWHLRMKIAVDVAR- 263
           NII+L     +     L+ E++  G L     +K+             L  + A    + 
Sbjct: 76  NIITLHDVYENRTDVVLILELVSGGELFDFLAQKE------------SLSEEEATSFIKQ 123

Query: 264 ---GLEYLHEHCNHPVVHRDLKSSNILLDS----SFNAKLSDFGLSVTAGTQSRNVKISG 316
              G+ YLH      + H DLK  NI+L        + KL DFGL+           I G
Sbjct: 124 ILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFG 180

Query: 317 TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
           T  +VAPE +    L  ++D+++ GV+   LL G  P
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 97.3 bits (242), Expect = 7e-22
 Identities = 65/213 (30%), Positives = 98/213 (46%), Gaps = 23/213 (10%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRH 208
           N+F    +IG GG G VY  R  +   + A+K +D         E    NE   L+ +  
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248

Query: 209 QN---IISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
            +   I+ +  Y  H   +   + ++M  G L   L    HG      +R   A ++  G
Sbjct: 249 GDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLS--QHGVFSEADMRFYAA-EIILG 304

Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSV---TAGTQSRNVKISGTLGYV 321
           LE++H      VV+RDLK +NILLD   + ++SD GL+         +      GT GY+
Sbjct: 305 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYM 357

Query: 322 APEYLLEGKLTDKS-DVYAFGVVLLELLMGRRP 353
           APE L +G   D S D ++ G +L +LL G  P
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 95.4 bits (238), Expect = 7e-22
 Identities = 46/227 (20%), Positives = 83/227 (36%), Gaps = 16/227 (7%)

Query: 137 KDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAERE 195
               +    E      + FQ   + G+G  G V   +     +  A+K++        RE
Sbjct: 7   SLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE 66

Query: 196 FNNEVNWLTKIRHQNIISLLGYCIHAETR--------FLVYEMMQNGSLEKQL-HGPTHG 246
               +  L  + H NI+ L     +             +V E + + +L +   +     
Sbjct: 67  LQ-IMQDLAVLHHPNIVQLQ-SYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQ 123

Query: 247 SNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA-KLSDFGLSVTA 305
                 L       + R +  LH      V HRD+K  N+L++ +    KL DFG +   
Sbjct: 124 VAPPPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182

Query: 306 GTQSRNVKISGTLGYVAPEYLLEGKL-TDKSDVYAFGVVLLELLMGR 351
                NV    +  Y APE +   +  T   D+++ G +  E+++G 
Sbjct: 183 SPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 94.2 bits (235), Expect = 9e-22
 Identities = 57/261 (21%), Positives = 98/261 (37%), Gaps = 53/261 (20%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNE-------KLL--AAVKRIDDAGHDAEREFNNEVNWL 203
            +F+   ++GEG    V  AR          K+L    + + +   +        E + +
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY-----VTRERDVM 84

Query: 204 TKIRHQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRM--KIAVD 260
           +++ H   + L  +    + + +      +NG L               ++R        
Sbjct: 85  SRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGEL-------------LKYIRKIGSFDET 130

Query: 261 VAR--------GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS---VTAGTQS 309
             R         LEYLH      ++HRDLK  NILL+   + +++DFG +        Q+
Sbjct: 131 CTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 187

Query: 310 RNVKISGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTW 368
           R     GT  YV+PE LL  K   KS D++A G ++ +L+ G  P    +       +  
Sbjct: 188 RANSFVGTAQYVSPE-LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI-- 244

Query: 369 AMPQLTDRSKLPNIVDPVIRD 389
               +      P    P  RD
Sbjct: 245 ----IKLEYDFPEKFFPKARD 261

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 94.2 bits (235), Expect = 1e-21
 Identities = 50/212 (23%), Positives = 82/212 (38%), Gaps = 33/212 (15%)

Query: 160 VIGEGGRGHVYKARFNEK---LLAAVKRID--DAGHDAEREFNNEVNWLTKIRHQ-NIIS 213
            +G G    V +     K      A K +     G D   E  +E+  L   +    +I+
Sbjct: 36  ELGRGKFAVVRQCI--SKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVIN 93

Query: 214 LLGYCIHAETRFLVYEMMQNGSL-----EKQLHGPTHGSNLTWHLRMKIAVDVAR----G 264
           L     +     L+ E    G +      +              +     + + +    G
Sbjct: 94  LHEVYENTSEIILILEYAAGGEIFSLCLPELAE----------MVSENDVIRLIKQILEG 143

Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSF---NAKLSDFGLSVTAGTQSRNVKISGTLGYV 321
           + YLH++    +VH DLK  NILL S +   + K+ DFG+S   G      +I GT  Y+
Sbjct: 144 VYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYL 200

Query: 322 APEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
           APE L    +T  +D++  G++   LL    P
Sbjct: 201 APEILNYDPITTATDMWNIGIIAYMLLTHTSP 232

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 94.4 bits (235), Expect = 1e-21
 Identities = 52/213 (24%), Positives = 83/213 (38%), Gaps = 35/213 (16%)

Query: 161 IGEGGRGHVYKARFNE-KLLAAVKRID--------DAGHDAEREFNNEVNWLTKIRHQNI 211
           +G G  G V+ A   E      VK I                 +   E+  L+++ H NI
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 212 ISLLGYCIHAETR---FLVYEMMQNGS-----LEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           I +L      E +    LV E   +G      +++      H   L   L   I   +  
Sbjct: 92  IKVLDI---FENQGFFQLVMEKHGSGLDLFAFIDR------HP-RLDEPLASYIFRQLVS 141

Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVA 322
            + YL       ++HRD+K  NI++   F  KL DFG +     + +      GT+ Y A
Sbjct: 142 AVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSA-AYLERGKLFYTFCGTIEYCA 197

Query: 323 PEYLLEGKLTD--KSDVYAFGVVLLELLMGRRP 353
           PE +L G      + ++++ GV L  L+    P
Sbjct: 198 PE-VLMGNPYRGPELEMWSLGVTLYTLVFEENP 229

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 93.9 bits (234), Expect = 1e-21
 Identities = 57/210 (27%), Positives = 85/210 (40%), Gaps = 35/210 (16%)

Query: 160 VIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKIR-HQNIISLLGY 217
            +GEG      K    +     AVK I        +    E+  L     H NI+ L   
Sbjct: 18  PLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ---KEITALKLCEGHPNIVKLHEV 74

Query: 218 CIHAETRFLVYEMMQNGSL-----EKQLHGPTHGSNLTWHLRMKIAVDVAR----GLEYL 268
                  FLV E++  G L     +K+            H     A  + R     + ++
Sbjct: 75  FHDQLHTFLVMELLNGGELFERIKKKK------------HFSETEASYIMRKLVSAVSHM 122

Query: 269 HEHCNHPVVHRDLKSSNILLDS-SFNA--KLSDFGLSVTAGTQSRNVK-ISGTLGYVAPE 324
           H+     VVHRDLK  N+L    + N   K+ DFG +      ++ +K    TL Y APE
Sbjct: 123 HDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPE 179

Query: 325 YLLEGKLTDKS-DVYAFGVVLLELLMGRRP 353
            LL     D+S D+++ GV+L  +L G+ P
Sbjct: 180 -LLNQNGYDESCDLWSLGVILYTMLSGQVP 208

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 94.3 bits (235), Expect = 1e-21
 Identities = 63/243 (25%), Positives = 100/243 (41%), Gaps = 48/243 (19%)

Query: 129 NSLRLAGKKDTVSVIE-YELLEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRID 186
           +S+     ++++   + YE+ E           IG G      +       +  AVK ID
Sbjct: 7   HSIVQQLHRNSIQFTDGYEVKE----------DIGVGSYSVCKRCIHKATNMEFAVKIID 56

Query: 187 DAGHDAEREFNNEVNWLTK-IRHQNIISLLGYCIHAETRFLVYEMMQNGSL-----EKQL 240
            +  D       E+  L +  +H NII+L       +  ++V E+M+ G L      ++ 
Sbjct: 57  KSKRDPTE----EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK- 111

Query: 241 HGPTHGSNLTWHLRMKIAVDVAR----GLEYLHEHCNHPVVHRDLKSSNILL-DSSFNA- 294
                          + A  V       +EYLH      VVHRDLK SNIL  D S N  
Sbjct: 112 -----------FFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPE 157

Query: 295 --KLSDFGLSV-TAGTQSRNVKISGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMG 350
             ++ DFG +          +    T  +VAPE +LE +  D + D+++ GV+L  +L G
Sbjct: 158 SIRICDFGFAKQLRAENGLLMTPCYTANFVAPE-VLERQGYDAACDIWSLGVLLYTMLTG 216

Query: 351 RRP 353
             P
Sbjct: 217 YTP 219

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 93.9 bits (234), Expect = 2e-21
 Identities = 54/232 (23%), Positives = 93/232 (40%), Gaps = 38/232 (16%)

Query: 143 IEYELLEAATNNFQE-----SNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREF 196
           + ++  E       +       V+G G  G V +          A+K + D+   A +E 
Sbjct: 14  VLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-PKARQE- 71

Query: 197 NNEVNWLTKI-RHQNIISLLGYC---IHAETRF-LVYEMMQNGSL-----EKQLHGPT-- 244
              V+   +     +I+ +L       H +    ++ E M+ G L     E+     T  
Sbjct: 72  ---VDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTER 128

Query: 245 HGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDS-SFNA--KLSDFGL 301
             + +     M+   D+   +++LH H    + HRD+K  N+L  S   +A  KL+DFG 
Sbjct: 129 EAAEI-----MR---DIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF 177

Query: 302 SVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
           +      +       T  YVAPE L   K     D+++ GV++  LL G  P
Sbjct: 178 AKETTQNALQ-TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 93.5 bits (233), Expect = 2e-21
 Identities = 58/216 (26%), Positives = 88/216 (40%), Gaps = 39/216 (18%)

Query: 160 VIGEGGRGHVYKARFNEK---LLAAVKRID------DAGHDAEREFNNEVNWLTKIRHQN 210
            +G G    V K R  EK   L  A K I            +  +   EV+ L +I+H N
Sbjct: 18  ELGSGQFAVVKKCR--EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75

Query: 211 IISLLGYCIHAETRFLVYEMMQNGSL-----EKQLHGPTHGSNLTWHLRMKIAVDVAR-- 263
           +I+L     +     L+ E++  G L     EK+             L  + A +  +  
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKE------------SLTEEEATEFLKQI 123

Query: 264 --GLEYLHEHCNHPVVHRDLKSSNILLDS----SFNAKLSDFGLSVTAGTQSRNVKISGT 317
             G+ YLH      + H DLK  NI+L          K+ DFGL+      +    I GT
Sbjct: 124 LNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180

Query: 318 LGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
             +VAPE +    L  ++D+++ GV+   LL G  P
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 93.2 bits (232), Expect = 3e-21
 Identities = 64/330 (19%), Positives = 113/330 (34%), Gaps = 72/330 (21%)

Query: 102 LKNTNGNSKQTIDGGKGLSLSPILERFNSLRLAGKKDTVSVI-EYELLEAATNNFQESNV 160
           + +++ +   +       S        ++ +LA  K+   +  +Y++            +
Sbjct: 1   MGSSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGP----------L 50

Query: 161 IGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNN------EVNWLTKIRHQ--NI 211
           +G GG G VY        L  A+K ++        E  N      EV  L K+      +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 212 ISLLGYCIHAETRFLVYEMMQNGSLEKQL------HGPTHGSNLTWHLRMKIAVDVARGL 265
           I LL +    E       +++     + L       G      L   L       V   +
Sbjct: 111 IRLLDWF---ERPDSFVLILERPEPVQDLFDFITERG-----ALQEELARSFFWQVLEAV 162

Query: 266 EYLHEHCNHPVVHRDLKSSNILLDS-SFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAP 323
            + H      V+HRD+K  NIL+D      KL DFG    A  +        GT  Y  P
Sbjct: 163 RHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG--ALLKDTVYTDFDGTRVYSPP 217

Query: 324 EYLLEGKLTD--KSDVYAFGVVLLELLMGRRPVE--------------KMSPTQCQSMVT 367
           E  +         + V++ G++L +++ G  P E              ++S  +CQ ++ 
Sbjct: 218 E-WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSS-ECQHLIR 275

Query: 368 WAMPQLTDRSKLPNIVDPVIRDTMD--LKH 395
           W +            + P  R T +    H
Sbjct: 276 WCL-----------ALRPSDRPTFEEIQNH 294

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 92.7 bits (231), Expect = 4e-21
 Identities = 54/221 (24%), Positives = 84/221 (38%), Gaps = 42/221 (19%)

Query: 160 VIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKIR-HQNIISLLGY 217
           V+GEG    V            AVK I+            EV  L + + H+N++ L+ +
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79

Query: 218 CIHAETRFLVYEMMQNGSL-----EKQLHGPTHGSNLTWHLRMKIAVDVAR----GLEYL 268
               +  +LV+E M+ GS+     +++            H     A  V +     L++L
Sbjct: 80  FEEEDRFYLVFEKMRGGSILSHIHKRR------------HFNELEASVVVQDVASALDFL 127

Query: 269 HEHCNHPVVHRDLKSSNILL---DSSFNAKLSDFGLSVTAGTQSRNVKIS--------GT 317
           H      + HRDLK  NIL    +     K+ DF L            IS        G+
Sbjct: 128 HNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGS 184

Query: 318 LGYVAPEYLLEGKLTDKS-----DVYAFGVVLLELLMGRRP 353
             Y+APE +              D+++ GV+L  LL G  P
Sbjct: 185 AEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 93.3 bits (232), Expect = 6e-21
 Identities = 53/216 (24%), Positives = 84/216 (38%), Gaps = 44/216 (20%)

Query: 160 VIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKI-RHQNIISLLGY 217
           V+G G  G V +      +   A+K + D    A RE    V    +  +  +I+ ++  
Sbjct: 69  VLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARRE----VELHWRASQCPHIVRIVDV 123

Query: 218 C---IHAETRF-LVYEMMQNGSL-------------EKQLHGPTHGSNLTWHLRMKIAVD 260
                       +V E +  G L             E++       S +     MK    
Sbjct: 124 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE------ASEI-----MK---S 169

Query: 261 VARGLEYLHEHCNHPVVHRDLKSSNILLDS-SFNA--KLSDFGLSVTAGTQSRNVKISGT 317
           +   ++YLH      + HRD+K  N+L  S   NA  KL+DFG +    + +       T
Sbjct: 170 IGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 226

Query: 318 LGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
             YVAPE L   K     D+++ GV++  LL G  P
Sbjct: 227 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 91.9 bits (229), Expect = 6e-21
 Identities = 60/222 (27%), Positives = 92/222 (41%), Gaps = 33/222 (14%)

Query: 151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKIR-- 207
           AT+ ++    IG G  G VYKAR        A+K +              +  ++ +R  
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR---VPNGGGGGGGLP-ISTVREV 62

Query: 208 ----------HQNIISLLGYCIHAETR-----FLVYEMMQNGSLEKQLHGPTHGSNLTWH 252
                     H N++ L+  C  + T       LV+E +    L   L        L   
Sbjct: 63  ALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDK-APPPGLPAE 120

Query: 253 LRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV 312
               +     RGL++LH +C   +VHRDLK  NIL+ S    KL+DFGL   A   S  +
Sbjct: 121 TIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGL---ARIYSYQM 174

Query: 313 KISG---TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGR 351
            ++    TL Y APE LL+       D+++ G +  E+   +
Sbjct: 175 ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 92.4 bits (230), Expect = 8e-21
 Identities = 57/214 (26%), Positives = 93/214 (43%), Gaps = 28/214 (13%)

Query: 152 TNNFQESNVIGEGGRGHVYKA---RFNEKLLAAVKRIDDA---GHDAEREFNNEVNWLTK 205
              +Q    IG G +G V  A        +  A+K++         A+R +  E+  +  
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKC 80

Query: 206 IRHQNIISLLGYCIHAETRF-------LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMK-I 257
           + H+NII LL      +          +V E+M     +  L        L  H RM  +
Sbjct: 81  VNHKNIIGLL-NVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQ-MELD-HERMSYL 132

Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT 317
              +  G+++LH      ++HRDLK SNI++ S    K+ DFGL+ TAGT         T
Sbjct: 133 LYQMLCGIKHLHS-AG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVT 189

Query: 318 LGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGR 351
             Y APE +L     +  D+++ G ++ E++ G 
Sbjct: 190 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 93.3 bits (232), Expect = 9e-21
 Identities = 62/212 (29%), Positives = 95/212 (44%), Gaps = 39/212 (18%)

Query: 161 IGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNN---EVNWLTKIRHQNIISLLG 216
           +G G  G V   +        AVK ++     +         E+  L   RH +II L  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL-- 81

Query: 217 YCIHAETR---FLVYEMMQNGSL-EKQLHGPTHGSNLTWHLRMKIAVDVAR--------G 264
           Y +   T    F+V E +  G L +           +  + R+      +R        G
Sbjct: 82  YQV-ISTPSDIFMVMEYVSGGELFDY----------ICKNGRLDE--KESRRLFQQILSG 128

Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAP 323
           ++Y H H    VVHRDLK  N+LLD+  NAK++DFGLS    +    ++ S G+  Y AP
Sbjct: 129 VDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRTSCGSPNYAAP 184

Query: 324 EYLLEGKLTD--KSDVYAFGVVLLELLMGRRP 353
           E ++ G+L    + D+++ GV+L  LL G  P
Sbjct: 185 E-VISGRLYAGPEVDIWSSGVILYALLCGTLP 215

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 91.6 bits (228), Expect = 1e-20
 Identities = 66/212 (31%), Positives = 98/212 (46%), Gaps = 40/212 (18%)

Query: 161 IGEGGRGHVYKARFNE-KLLAAVKRID----DAGHDAEREFNNEVNWLTKIRHQNIISLL 215
           +GEG  G V  A   + +   A+K I            R    E+++L  +RH +II L 
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVER-EISYLKLLRHPHIIKL- 74

Query: 216 GYCIHAETRFLVYEMMQ--NGSL-EKQLHGPTHGSNLTWHLRMKIAVDVAR--------G 264
            Y +   T   +  +++   G L +           +    RM    D  R         
Sbjct: 75  -YDV-ITTPTDIVMVIEYAGGELFDY----------IVEKKRMTE--DEGRRFFQQIICA 120

Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAP 323
           +EY H H    +VHRDLK  N+LLD + N K++DFGLS    T    +K S G+  Y AP
Sbjct: 121 IEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIM-TDGNFLKTSCGSPNYAAP 176

Query: 324 EYLLEGKLTD--KSDVYAFGVVLLELLMGRRP 353
           E ++ GKL    + DV++ G+VL  +L+GR P
Sbjct: 177 E-VINGKLYAGPEVDVWSCGIVLYVMLVGRLP 207

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 91.1 bits (227), Expect = 2e-20
 Identities = 64/221 (28%), Positives = 94/221 (42%), Gaps = 37/221 (16%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNEKL---LAAVKRIDDAGHDAERE-FNN----EVNWLT 204
             ++    IGEG  G V+KAR + K      A+KR+         E        EV  L 
Sbjct: 11  QQYECVAEIGEGAYGKVFKAR-DLKNGGRFVALKRVR---VQTGEEGMPLSTIREVAVLR 66

Query: 205 KIR---HQNIISLLGYCIHAETR-----FLVYEMMQN---GSLEKQLHGPTHGSNLTWHL 253
            +    H N++ L   C  + T       LV+E +       L+K          +   +
Sbjct: 67  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM 126

Query: 254 RMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK 313
                  + RGL++LH H    VVHRDLK  NIL+ SS   KL+DFGL   A   S  + 
Sbjct: 127 FQ-----LLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL---ARIYSFQMA 175

Query: 314 ISG---TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGR 351
           ++    TL Y APE LL+       D+++ G +  E+   +
Sbjct: 176 LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 91.3 bits (227), Expect = 2e-20
 Identities = 61/210 (29%), Positives = 84/210 (40%), Gaps = 37/210 (17%)

Query: 161 IGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCI 219
           IG G  G     R    K L AVK I+      E     E+     +RH NI+      +
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN-VQREIINHRSLRHPNIVRF--KEV 84

Query: 220 HAETR---FLVYEMMQNGSL-EKQLHGPTHGSNLTWHLRMKIAVDVAR--------GLEY 267
              T     ++ E    G L E+          +    R     D AR        G+ Y
Sbjct: 85  -ILTPTHLAIIMEYASGGELYER----------ICNAGRFS--EDEARFFFQQLLSGVSY 131

Query: 268 LHEHCNHPVVHRDLKSSNILLDSSF--NAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEY 325
            H      + HRDLK  N LLD S     K+ DFG S ++   S+     GT  Y+APE 
Sbjct: 132 CHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE- 187

Query: 326 LLEGKLTD--KSDVYAFGVVLLELLMGRRP 353
           +L  +  D   +DV++ GV L  +L+G  P
Sbjct: 188 VLLRQEYDGKIADVWSCGVTLYVMLVGAYP 217

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 90.1 bits (224), Expect = 3e-20
 Identities = 57/240 (23%), Positives = 84/240 (35%), Gaps = 43/240 (17%)

Query: 134 AGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDA 192
            GK       EY L            ++G+GG G V+       +L  A+K I       
Sbjct: 22  GGKDREAFEAEYRLGP----------LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLG 71

Query: 193 EREFNN------EVNWLTKIR----HQNIISLLGYCIHAETRFLVYEMMQNGS-----LE 237
               ++      EV  L K+     H  +I LL +    E   LV E           + 
Sbjct: 72  WSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYIT 131

Query: 238 KQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDS-SFNAKL 296
           +       G  L           V   +++ H      VVHRD+K  NIL+D     AKL
Sbjct: 132 E------KG-PLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKL 181

Query: 297 SDFGLSVTAGTQSRNVKIS-GTLGYVAPEYLLEGKLTD--KSDVYAFGVVLLELLMGRRP 353
            DFG    A           GT  Y  PE  +         + V++ G++L +++ G  P
Sbjct: 182 IDFGSG--ALLHDEPYTDFDGTRVYSPPE-WISRHQYHALPATVWSLGILLYDMVCGDIP 238

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 90.4 bits (225), Expect = 4e-20
 Identities = 50/219 (22%), Positives = 97/219 (44%), Gaps = 29/219 (13%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAERE-FNN----EVNWLTKI 206
           + +++   IG+G  G V+KAR  +     A+K++     + E+E F      E+  L  +
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL---MENEKEGFPITALREIKILQLL 73

Query: 207 RHQNIISLLGYCIHAETR--------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIA 258
           +H+N+++L+  C    +         +LV++  ++  L   L         T     ++ 
Sbjct: 74  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNV--LVKFTLSEIKRVM 130

Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG-- 316
             +  GL Y+H +    ++HRD+K++N+L+      KL+DFGL+        +       
Sbjct: 131 QMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 187

Query: 317 ---TLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
              TL Y  PE LL  +      D++  G ++ E+    
Sbjct: 188 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 91.4 bits (227), Expect = 4e-20
 Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 28/214 (13%)

Query: 152 TNNFQESNVIGEGGRGHVYKA---RFNEKLLAAVKRIDDA---GHDAEREFNNEVNWLTK 205
              +Q    IG G +G V  A     +  +  A+K++         A+R +  E+  +  
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKC 117

Query: 206 IRHQNIISLLGYCIHAETR------FLVYEMMQN--GSLEKQLHGPTHGSNLTWHLRMKI 257
           + H+NIISLL      +T       +LV E+M      + +        S L + +    
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM---- 173

Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT 317
                 G+++LH      ++HRDLK SNI++ S    K+ DFGL+ TAGT         T
Sbjct: 174 ----LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVT 226

Query: 318 LGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGR 351
             Y APE +L     +  D+++ G ++ E++  +
Sbjct: 227 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 87.3 bits (217), Expect = 5e-19
 Identities = 67/220 (30%), Positives = 105/220 (47%), Gaps = 36/220 (16%)

Query: 152 TNNFQESNVIGEGGRGHVYKA---RFNEKLLAAVKRIDDAGH--DAEREFNNEVNWLTKI 206
              +   + IGEG  G V  A       ++  A+K+I    H    +R    E+  L + 
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRV--AIKKISPFEHQTYCQRTLR-EIKILLRF 82

Query: 207 RHQNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLT-WHLRMKIAV 259
           RH+NII +    I A T       ++V ++M     E  L+      +L+  H+      
Sbjct: 83  RHENIIGIND-IIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICY-FLY 135

Query: 260 DVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTL- 318
            + RGL+Y+H   N  V+HRDLK SN+LL+++ + K+ DFGL+  A     +   +G L 
Sbjct: 136 QILRGLKYIHS-AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH---TGFLT 189

Query: 319 GYV------APEYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
            YV      APE +L  K   KS D+++ G +L E+L  R
Sbjct: 190 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 86.6 bits (215), Expect = 7e-19
 Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 43/221 (19%)

Query: 152 TNNFQESNVIGEGGRGHVYKA---RFNEKLLAAVKRIDDA---GHDAEREFNNEVNWLTK 205
              +     +G G  G V  A   R  EK+  A+K++         A+R +  E+  L  
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKV--AIKKLSRPFQSEIFAKRAYR-ELLLLKH 79

Query: 206 IRHQNIISLLGYCIHAETR------FLVYEMMQN--GSLEKQLHGPTHGSNLTWHLRMKI 257
           ++H+N+I LL     A +       +LV   MQ     +            L + +    
Sbjct: 80  MQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQM---- 135

Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT 317
                +GL+Y+H      VVHRDLK  N+ ++     K+ DFGL       +R+     T
Sbjct: 136 ----LKGLKYIHS-AG--VVHRDLKPGNLAVNEDCELKILDFGL-------ARHADAEMT 181

Query: 318 LGYV------APEYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
            GYV      APE +L     +++ D+++ G ++ E+L G+
Sbjct: 182 -GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 86.2 bits (214), Expect = 1e-18
 Identities = 54/227 (23%), Positives = 85/227 (37%), Gaps = 43/227 (18%)

Query: 152 TNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAE--REFNN---------EV 200
            + +     I  G  G V     +E +  A+KR+ +   D       ++         E+
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 201 NWLTKIRHQNIISLLGYCIHAETR-----FLVYEMMQNGSLEKQLHGPTHGSNLTW---H 252
             L    H NI+ L    +H E       +LV E+M        L    H   +     H
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-----RTDLAQVIHDQRIVISPQH 135

Query: 253 LRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV 312
           ++      +  GL  LHE     VVHRDL   NILL  + +  + DF L       +R  
Sbjct: 136 IQY-FMYHILLGLHVLHE-AG--VVHRDLHPGNILLADNNDITICDFNL-------ARED 184

Query: 313 KISGTL-GYV------APEYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
                   YV      APE +++ K   K  D+++ G V+ E+   +
Sbjct: 185 TADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 85.5 bits (212), Expect = 2e-18
 Identities = 54/220 (24%), Positives = 93/220 (42%), Gaps = 40/220 (18%)

Query: 152 TNNFQESNVIGEGGRGHVYKA---RFNEKLLAAVKRIDDA---GHDAEREFNNEVNWLTK 205
              +++   +G G  G V  A   R   K+  A+K++         A+R +  E+  L  
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKV--AIKKLYRPFQSELFAKRAYR-ELRLLKH 80

Query: 206 IRHQNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTW-HLRMKIA 258
           +RH+N+I LL      ET       +LV   M        L        L    ++  + 
Sbjct: 81  MRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-----GTDLGKLMKHEKLGEDRIQF-LV 134

Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTL 318
             + +GL Y+H      ++HRDLK  N+ ++     K+ DFGL       +R      T 
Sbjct: 135 YQMLKGLRYIHA-AG--IIHRDLKPGNLAVNEDCELKILDFGL-------ARQADSEMT- 183

Query: 319 GYV------APEYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           GYV      APE +L      ++ D+++ G ++ E++ G+
Sbjct: 184 GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 84.7 bits (210), Expect = 3e-18
 Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 36/218 (16%)

Query: 152 TNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDA---GHDAEREFNNEVNWLTKIR 207
              +Q  + +G G  G V  A   +  L  AVK++         A+R +  E+  L  ++
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK 86

Query: 208 HQNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLT-WHLRMKIAVD 260
           H+N+I LL     A +       +LV  +M        L+       LT  H++  +   
Sbjct: 87  HENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDDHVQF-LIYQ 140

Query: 261 VARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGY 320
           + RGL+Y+H   +  ++HRDLK SN+ ++     K+ DFGL       +R+     T GY
Sbjct: 141 ILRGLKYIHS-AD--IIHRDLKPSNLAVNEDCELKILDFGL-------ARHTADEMT-GY 189

Query: 321 V------APEYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
           V      APE +L     +++ D+++ G ++ ELL GR
Sbjct: 190 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 84.6 bits (209), Expect = 3e-18
 Identities = 38/146 (26%), Positives = 65/146 (44%), Gaps = 7/146 (4%)

Query: 212 ISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
           +  +     + +   V E   +   E++     +   LT    +  +  VA+G+E+L   
Sbjct: 153 LDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR 212

Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYV---APEYLLE 328
                +HRDL + NILL      K+ DFGL+         V+       +   APE + +
Sbjct: 213 ---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD 269

Query: 329 GKLTDKSDVYAFGVVLLELL-MGRRP 353
              T +SDV++FGV+L E+  +G  P
Sbjct: 270 RVYTIQSDVWSFGVLLWEIFSLGASP 295

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 33/153 (21%), Positives = 53/153 (34%), Gaps = 19/153 (12%)

Query: 159 NVIGEGGRGHVYKARFN------EKLLAAVKRI-DDAGHDAEREFNNEVNWLTKI-RHQN 210
             +G G  G V +A              AVK + + A H   R   +E+  L  I  H N
Sbjct: 28  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87

Query: 211 IISLLGYCI-HAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLH 269
           +++LLG C        ++ E  + G+L   L    +                 +G +Y+ 
Sbjct: 88  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTK----GARFRQGKDYVG 143

Query: 270 EHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS 302
                     DLK     + SS ++  S F   
Sbjct: 144 AI------PVDLKRRLDSITSSQSSASSGFVEE 170

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 83.5 bits (207), Expect = 7e-18
 Identities = 52/223 (23%), Positives = 87/223 (39%), Gaps = 48/223 (21%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNE-------KLL--AAVKRIDDAGHDAEREFNNEVNWL 203
           + F     +G G  G V   +  E       K+L    V ++    H       NE   L
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH-----TLNEKRIL 95

Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRM--KIAVDV 261
             +    ++ L          ++V E +  G +               HLR   + +   
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM-------------FSHLRRIGRFSEPH 142

Query: 262 AR--------GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRN 311
           AR          EYLH      +++RDLK  N+L+D     +++DFG +  V   T +  
Sbjct: 143 ARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-- 197

Query: 312 VKISGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRP 353
             + GT   +APE ++  K  +K+ D +A GV++ E+  G  P
Sbjct: 198 --LCGTPEALAPE-IILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 82.2 bits (204), Expect = 1e-17
 Identities = 61/224 (27%), Positives = 98/224 (43%), Gaps = 50/224 (22%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNE-------KLL--AAVKRIDDAGHDAEREFNNEVNWL 203
            +FQ    +G G  G V+  R          K+L    V R+    H      N+E   L
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEH-----TNDERLML 60

Query: 204 TKIRHQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRM--KIAVD 260
           + + H  II +         + F++ + ++ G L                LR   +    
Sbjct: 61  SIVTHPFIIRMW-GTFQDAQQIFMIMDYIEGGEL-------------FSLLRKSQRFPNP 106

Query: 261 VAR--------GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSR 310
           VA+         LEYLH      +++RDLK  NILLD + + K++DFG +  V   T + 
Sbjct: 107 VAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT- 162

Query: 311 NVKISGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRP 353
              + GT  Y+APE ++  K  +KS D ++FG+++ E+L G  P
Sbjct: 163 ---LCGTPDYIAPE-VVSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 83.6 bits (207), Expect = 1e-17
 Identities = 59/225 (26%), Positives = 88/225 (39%), Gaps = 48/225 (21%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNE-------KLL--AAVKRIDDAGH-DAEREFNNEVNW 202
           N F+   ++G+G  G V   +          K+L    +   D+  H   E         
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTEN------RV 201

Query: 203 LTKIRHQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHL-------- 253
           L   RH  + +L  Y      R   V E                G  L +HL        
Sbjct: 202 LQNSRHPFLTALK-YSFQTHDRLCFVMEYAN-------------GGELFFHLSRERVFSE 247

Query: 254 -RMKI-AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS---VTAGTQ 308
            R +    ++   L+YLH   N  VV+RDLK  N++LD   + K++DFGL    +  G  
Sbjct: 248 DRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT 305

Query: 309 SRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
            +     GT  Y+APE L +       D +  GVV+ E++ GR P
Sbjct: 306 MKT--FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 82.3 bits (204), Expect = 2e-17
 Identities = 58/224 (25%), Positives = 103/224 (45%), Gaps = 37/224 (16%)

Query: 152 TNNFQESNVIGEGGRGHVYKA---RFNEKLLAAVKRID--DAGHDAEREFNNEVNWLTKI 206
           +++FQ  +++GEG  G V  A      E +  A+K+I+  D    A R    E+  L   
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIV--AIKKIEPFDKPLFALRTLR-EIKILKHF 66

Query: 207 RHQNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLT-WHLRMKIAV 259
           +H+NII++       ++       +++ E+M     +  LH       L+  H++     
Sbjct: 67  KHENIITIF-NIQRPDSFENFNEVYIIQELM-----QTDLHRVISTQMLSDDHIQY-FIY 119

Query: 260 DVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTL- 318
              R ++ LH   N  V+HRDLK SN+L++S+ + K+ DFGL+      + +        
Sbjct: 120 QTLRAVKVLHG-SN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176

Query: 319 ----GYV------APEYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
                +V      APE +L      ++ DV++ G +L EL + R
Sbjct: 177 SGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 81.5 bits (202), Expect = 3e-17
 Identities = 61/230 (26%), Positives = 89/230 (38%), Gaps = 59/230 (25%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRI--------DDAGH-DAEREFNNEVNW 202
           N+F    ++G+G  G V   R        A+K +        D+  H   E         
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTES------RV 58

Query: 203 LTKIRHQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHL-------- 253
           L   RH  + +L  Y      R   V E                G  L +HL        
Sbjct: 59  LQNTRHPFLTALK-YAFQTHDRLCFVMEYAN-------------GGELFFHLSRERVFTE 104

Query: 254 -RMKI-AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS-------VT 304
            R +    ++   LEYLH      VV+RD+K  N++LD   + K++DFGL         T
Sbjct: 105 ERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 161

Query: 305 AGTQSRNVKISGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRP 353
             T        GT  Y+APE +LE     ++ D +  GVV+ E++ GR P
Sbjct: 162 MKT------FCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 82.1 bits (203), Expect = 3e-17
 Identities = 50/231 (21%), Positives = 82/231 (35%), Gaps = 52/231 (22%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNE-------KLL--AAVKRIDDAGHDAEREFNNEVNWL 203
           ++F+   VIG G    V   +  +       K++    + +  +        F  E + L
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSC-----FREERDVL 115

Query: 204 TKIRHQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLR---MKIAV 259
                + I  L  +    E   +LV E                G +L   L     +I  
Sbjct: 116 VNGDRRWITQLH-FAFQDENYLYLVMEYYV-------------GGDLLTLLSKFGERIPA 161

Query: 260 DVAR--------GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
           ++AR         ++ +H       VHRD+K  NILLD   + +L+DFG  +        
Sbjct: 162 EMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV 218

Query: 312 VKIS--GTLGYVAPEYLLEGKLTDKSDVY-------AFGVVLLELLMGRRP 353
             +   GT  Y++PE L        +  Y       A GV   E+  G+ P
Sbjct: 219 RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 81.0 bits (201), Expect = 4e-17
 Identities = 59/230 (25%), Positives = 98/230 (42%), Gaps = 55/230 (23%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNE----------KLL---AAVKRIDDAGH-DAEREFNN 198
             F+   V+G+GG G V++ R             K+L     V+   D  H  AER    
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAER---- 72

Query: 199 EVNWLTKIRHQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRM-- 255
             N L +++H  I+ L+ Y      + +L+ E +  G L                L    
Sbjct: 73  --NILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGEL-------------FMQLEREG 116

Query: 256 KIAVDVAR--------GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS---VT 304
               D A          L +LH+     +++RDLK  NI+L+   + KL+DFGL    + 
Sbjct: 117 IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH 173

Query: 305 AGTQSRNVKISGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRP 353
            GT +      GT+ Y+APE +L     +++ D ++ G ++ ++L G  P
Sbjct: 174 DGTVTHT--FCGTIEYMAPE-ILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 80.9 bits (200), Expect = 6e-17
 Identities = 47/246 (19%), Positives = 86/246 (34%), Gaps = 50/246 (20%)

Query: 148 LEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKI 206
           LE ++  +     +G G  G V +    E     A+K++     D   + N E++ +  +
Sbjct: 2   LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ---DPRYK-NRELDIMKVL 57

Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDV----- 261
            H NII L+    +                 K        +N    + +  + +      
Sbjct: 58  DHVNIIKLV-DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116

Query: 262 ----------------------------------ARGLEYLHEHCNHPVVHRDLKSSNIL 287
                                              R + ++H   +  + HRD+K  N+L
Sbjct: 117 MEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLL 173

Query: 288 LDSSFNA-KLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKL-TDKSDVYAFGVVLL 345
           ++S  N  KL DFG +        +V    +  Y APE +L     T   D+++ G V  
Sbjct: 174 VNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG 233

Query: 346 ELLMGR 351
           EL++G+
Sbjct: 234 ELILGK 239

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 80.0 bits (198), Expect = 7e-17
 Identities = 53/241 (21%), Positives = 101/241 (41%), Gaps = 47/241 (19%)

Query: 139 TVSVIEYELLEAATNNFQESNVIGEGGRGHVYKA---RFNEKLLAAVKRID-DAGHDAER 194
           ++++  ++L     + + +   +G GG G V+ A     ++++  A+K+I        + 
Sbjct: 1   SMNIHGFDL----GSRYMDLKPLGCGGNGLVFSAVDNDCDKRV--AIKKIVLTDPQSVKH 54

Query: 195 EFNNEVNWLTKIRHQNIISLL----------GYCIHAETRF----LVYEMMQNGSLEKQL 240
               E+  + ++ H NI+ +              + + T      +V E M     E  L
Sbjct: 55  ALR-EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDL 108

Query: 241 HGPTHGSNLT-WHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSF-NAKLSD 298
                   L   H R+     + RGL+Y+H   N  V+HRDLK +N+ +++     K+ D
Sbjct: 109 ANVLEQGPLLEEHARL-FMYQLLRGLKYIHS-AN--VLHRDLKPANLFINTEDLVLKIGD 164

Query: 299 FGLSVTAGTQSRNVKISGTL-GYV------APEYLLEGKLTDKS-DVYAFGVVLLELLMG 350
           FGL+        +    G L   +      +P  LL      K+ D++A G +  E+L G
Sbjct: 165 FGLARIMDPHYSH---KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 221

Query: 351 R 351
           +
Sbjct: 222 K 222

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 80.9 bits (200), Expect = 8e-17
 Identities = 54/246 (21%), Positives = 103/246 (41%), Gaps = 47/246 (19%)

Query: 152 TNNFQESNVIGEGGRGHVYKA---RFNEKLLAAVKRIDDA---GHDAEREFNNEVNWLTK 205
            +N+   ++IG G  G+VY A      + +  A+K+++       D +R    E+  L +
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNV--AIKKVNRMFEDLIDCKRILR-EITILNR 81

Query: 206 IRHQNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAV 259
           ++   II L    I  +        ++V E+  +  L+K    P   +    H++  I  
Sbjct: 82  LKSDYIIRLYD-LIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEE--HIKT-ILY 136

Query: 260 DVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTL- 318
           ++  G  ++HE     ++HRDLK +N LL+   + K+ DFGL+ T  ++     ++    
Sbjct: 137 NLLLGENFIHE-SG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEE 193

Query: 319 ----------------GYV------APEYLLEGKLTDKS-DVYAFGVVLLELLMGRRPVE 355
                            +V      APE +L  +   KS D+++ G +  ELL   +   
Sbjct: 194 NEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253

Query: 356 KMSPTQ 361
                +
Sbjct: 254 NDPTNR 259

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 80.2 bits (198), Expect = 1e-16
 Identities = 49/229 (21%), Positives = 85/229 (37%), Gaps = 50/229 (21%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNE-------KLL--AAVKRIDDAGHDAEREFNNEVNWL 203
            +F+   VIG G  G V   +          K+L    + +  +        F  E + L
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETAC-----FREERDVL 128

Query: 204 TKIRHQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLR---MKIAV 259
                + I +L  Y    +   +LV +                G +L   L     ++  
Sbjct: 129 VNGDSKWITTLH-YAFQDDNNLYLVMDYYV-------------GGDLLTLLSKFEDRLPE 174

Query: 260 DVAR--------GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
           ++AR         ++ +H+      VHRD+K  NIL+D + + +L+DFG  +        
Sbjct: 175 EMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 231

Query: 312 VKIS--GTLGYVAPEYLLEGKLTDKS-----DVYAFGVVLLELLMGRRP 353
                 GT  Y++PE L   +          D ++ GV + E+L G  P
Sbjct: 232 QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 81.2 bits (200), Expect = 1e-16
 Identities = 58/219 (26%), Positives = 87/219 (39%), Gaps = 36/219 (16%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRI--------DDAGHD-AEREFNNEVNW 202
            +F    V+G+G  G V  +       L AVK +        DD      E+        
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG- 399

Query: 203 LTKIRHQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDV 261
               +   +  L   C     R + V E +  G L   +     G     H     A ++
Sbjct: 400 ----KPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQ--QVGRFKEPHAVFYAA-EI 451

Query: 262 ARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS-------VTAGTQSRNVKI 314
           A GL +L       +++RDLK  N++LDS  + K++DFG+        VT  T       
Sbjct: 452 AIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT------F 502

Query: 315 SGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
            GT  Y+APE +         D +AFGV+L E+L G+ P
Sbjct: 503 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 79.1 bits (196), Expect = 2e-16
 Identities = 54/222 (24%), Positives = 98/222 (44%), Gaps = 41/222 (18%)

Query: 153 NNFQESNVIGEGGRGHVYKAR----FNEKLLAAVKRI--DDAGHDAEREFNNEVNWLTKI 206
           + F+   V+G+G  G V+  +     + + L A+K +               E + L ++
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83

Query: 207 RHQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRM--KIAVDVAR 263
            H  I+ L  Y    E + +L+ + ++ G L                L        +  +
Sbjct: 84  NHPFIVKLH-YAFQTEGKLYLILDFLRGGDL-------------FTRLSKEVMFTEEDVK 129

Query: 264 --------GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS---VTAGTQSRNV 312
                    L++LH      +++RDLK  NILLD   + KL+DFGLS   +    ++ + 
Sbjct: 130 FYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS- 185

Query: 313 KISGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRP 353
              GT+ Y+APE ++  +   +S D ++FGV++ E+L G  P
Sbjct: 186 -FCGTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 80.3 bits (198), Expect = 2e-16
 Identities = 56/286 (19%), Positives = 112/286 (39%), Gaps = 52/286 (18%)

Query: 104 NTNGNSKQTIDGGKGLSLSPILERFNSLRLAGKKDTVSVIEYELLEAATNNFQESNVIGE 163
           +    ++Q   G +        E     +    K T S+          + ++  ++IG 
Sbjct: 4   HEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGT 63

Query: 164 GGRGHVYKA---RFNEKLLAAVKRIDDA---GHDAEREFNNEVNWLTKIRHQNIISLLGY 217
           G  GHV +A        +  A+K+I        D +R    E+  L ++ H +++ +L  
Sbjct: 64  GSYGHVCEAYDKLEKRVV--AIKKILRVFEDLIDCKRILR-EIAILNRLNHDHVVKVLD- 119

Query: 218 CIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
            +  +        ++V E+  +   +K    P + + L  H++  +  ++  G++Y+H  
Sbjct: 120 IVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTEL--HIKT-LLYNLLVGVKYVHSA 175

Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTL------------- 318
               ++HRDLK +N L++   + K+ DFGL+ T                           
Sbjct: 176 ---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPH 232

Query: 319 ---------GYV------APEYLLEGKLTDKS-DVYAFGVVLLELL 348
                    G+V      APE +L  +   ++ DV++ G +  ELL
Sbjct: 233 TKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 79.7 bits (197), Expect = 2e-16
 Identities = 54/226 (23%), Positives = 86/226 (38%), Gaps = 47/226 (20%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNE-------KLL--AAVKRIDDAGHDAEREFNNEVNWL 203
            +++   VIG G  G V   R          KLL    + +  D+       F  E + +
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF-----FWEERDIM 123

Query: 204 TKIRHQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
                  ++ L  Y    +   ++V E M  G L            +       +    A
Sbjct: 124 AFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDL------------VNLMSNYDVPEKWA 170

Query: 263 R--------GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNV 312
           R         L+ +H       +HRD+K  N+LLD S + KL+DFG    +      R  
Sbjct: 171 RFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCD 227

Query: 313 KISGTLGYVAPEYLLEGKLTDKS-----DVYAFGVVLLELLMGRRP 353
              GT  Y++PE +L+ +  D       D ++ GV L E+L+G  P
Sbjct: 228 TAVGTPDYISPE-VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 78.1 bits (193), Expect = 3e-16
 Identities = 52/213 (24%), Positives = 102/213 (47%), Gaps = 28/213 (13%)

Query: 152 TNNFQESNVIGEGGRGHVYKARF---NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR- 207
            +++Q    +G G    V++A     NEK+   VK +       +++   E+  L  +R 
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEAINITNNEKV--VVKILK---PVKKKKIKREIKILENLRG 89

Query: 208 HQNIISLLGYCIHAETRF---LVYEMMQNGSLEKQLHGPTHGSNLT-WHLRMKIAVDVAR 263
             NII+L    +         LV+E + N    KQL+       LT + +R  +  ++ +
Sbjct: 90  GPNIITLAD-IVKDPVSRTPALVFEHVNNTDF-KQLYQT-----LTDYDIRFYM-YEILK 141

Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNA-KLSDFGLS-VTAGTQSRNVKISGTLGYV 321
            L+Y H      ++HRD+K  N+++D      +L D+GL+      Q  NV+++ +  + 
Sbjct: 142 ALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA-SRYFK 197

Query: 322 APEYLLEGKLTDKS-DVYAFGVVLLELLMGRRP 353
            PE L++ ++ D S D+++ G +L  ++  + P
Sbjct: 198 GPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 78.1 bits (193), Expect = 4e-16
 Identities = 64/230 (27%), Positives = 94/230 (40%), Gaps = 51/230 (22%)

Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLA--------AVKRIDDAGH-DAEREFNN 198
            NF+   V+G G  G V+  R        KL A         V++     H   ER    
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER---- 109

Query: 199 EVNWLTKIRHQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRM-- 255
               L  IR    +  L Y    ET+  L+ + +  G L               HL    
Sbjct: 110 --QVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGEL-------------FTHLSQRE 154

Query: 256 KIAVDVAR--------GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTA 305
           +      +         LE+LH+     +++RD+K  NILLDS+ +  L+DFGLS    A
Sbjct: 155 RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 211

Query: 306 GTQSRNVKISGTLGYVAPEYLLEGKL-TDKS-DVYAFGVVLLELLMGRRP 353
               R     GT+ Y+AP+ +  G    DK+ D ++ GV++ ELL G  P
Sbjct: 212 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 78.4 bits (192), Expect = 1e-15
 Identities = 75/473 (15%), Positives = 150/473 (31%), Gaps = 140/473 (29%)

Query: 30  DTDISFVFGSLKEPISQFSAEMEAESPGIAEVRVVNHQDLNKKILIA------LVVSSTL 83
           D +        K+ +S F      E   +      + QD+ K IL        ++    +
Sbjct: 8   DFETGEHQYQYKDILSVF------EDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAV 61

Query: 84  LGVLLLF-LLC---------F----------WIYRWKRLKNTNGNSKQTIDGGKGLSLSP 123
            G L LF  L          F          ++     +K      +Q          S 
Sbjct: 62  SGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFL--MSPIKTEQ---RQP---------SM 107

Query: 124 ILERFNSLR--LAG-----KKDTVSVIE--YELLEAATNNFQESNVI--GEGGRGHVYKA 172
           +   +   R  L        K  VS ++   +L +A        NV+  G  G G     
Sbjct: 108 MTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSG----- 162

Query: 173 RFNEK--LLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM 230
               K  +   V       +  + + + ++ WL           L  C   E    V EM
Sbjct: 163 ----KTWVALDVCL----SYKVQCKMDFKIFWLN----------LKNCNSPE---TVLEM 201

Query: 231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDS 290
           +Q   L  Q+          W  R   + ++   +  +       +  +  ++  ++L +
Sbjct: 202 LQK--LLYQIDPN-------WTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLN 252

Query: 291 SFNAK-LSDFGLS----VTAGTQSRNVK---ISGTLGYVAPEYLLEGKLTDKS-DVYA-- 339
             NAK  + F LS    +T  T+ + V     + T  +++ ++       D+   +    
Sbjct: 253 VQNAKAWNAFNLSCKILLT--TRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKY 310

Query: 340 FGVVLLELLMGRRPVE--KMSPTQCQSMV---------TWAMPQLTDRSKLPNIVDPVIR 388
                 +L     P E    +P +  S++         TW   +  +  KL  I++  + 
Sbjct: 311 LDCRPQDL-----PREVLTTNPRRL-SIIAESIRDGLATWDNWKHVNCDKLTTIIESSLN 364

Query: 389 --DTMDLKHLYQVAAV---------AVLCI---QPEPSYRPLITDVLH--SLI 425
             +  + + ++   +V          +L +       S   ++ + LH  SL+
Sbjct: 365 VLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLV 417

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 77.0 bits (190), Expect = 2e-15
 Identities = 66/234 (28%), Positives = 109/234 (46%), Gaps = 47/234 (20%)

Query: 152 TNNFQESNVIGEGGRGHVYKA---RFNEKLLAAVKRIDDA---GHDAEREFNNEVNWLTK 205
              ++    +G+G  G V+K+   R  E +  AVK+I DA     DA+R F  E+  LT+
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVV--AVKKIFDAFQNSTDAQRTFR-EIMILTE 64

Query: 206 IR-HQNIISLLGYCIHAETR---FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMK-IAVD 260
           +  H+NI++LL   + A+     +LV++ M     E  LH     + L   +  + +   
Sbjct: 65  LSGHENIVNLLN-VLRADNDRDVYLVFDYM-----ETDLHAVIRANILE-PVHKQYVVYQ 117

Query: 261 VARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTL-- 318
           + + ++YLH      ++HRD+K SNILL++  + K++DFGLS +     R          
Sbjct: 118 LIKVIKYLHS-GG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSIN 174

Query: 319 --------------GYV------APEYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
                          YV      APE LL      K  D+++ G +L E+L G+
Sbjct: 175 ENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 76.1 bits (188), Expect = 2e-15
 Identities = 66/230 (28%), Positives = 97/230 (42%), Gaps = 58/230 (25%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRI--------DDAGH-DAEREFNNEVNW 202
           +NF+   V+G+G  G V  AR  E   L AVK +        DD      E+        
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEK------RI 76

Query: 203 LTKIRHQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRM--KIAV 259
           L+  R+   ++ L  C     R F V E +  G L              +H++   +   
Sbjct: 77  LSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDL-------------MFHIQKSRRFDE 123

Query: 260 DVAR--------GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS-------VT 304
             AR         L +LH+     +++RDLK  N+LLD   + KL+DFG+        VT
Sbjct: 124 ARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT 180

Query: 305 AGTQSRNVKISGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRP 353
             T        GT  Y+APE +L+  L   + D +A GV+L E+L G  P
Sbjct: 181 TAT------FCGTPDYIAPE-ILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 76.1 bits (188), Expect = 2e-15
 Identities = 61/230 (26%), Positives = 96/230 (41%), Gaps = 58/230 (25%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRI--------DDAGH-DAEREFNNEVNW 202
            +F    VIG G    V   R  +   + A+K +        +D      E+      + 
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEK------HV 62

Query: 203 LTKIRHQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRM--KIAV 259
             +  +   +  L  C   E+R F V E +              G +L +H++   K+  
Sbjct: 63  FEQASNHPFLVGLHSCFQTESRLFFVIEYVN-------------GGDLMFHMQRQRKLPE 109

Query: 260 DVAR--------GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS-------VT 304
           + AR         L YLHE     +++RDLK  N+LLDS  + KL+D+G+         T
Sbjct: 110 EHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT 166

Query: 305 AGTQSRNVKISGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRP 353
             T        GT  Y+APE +L G+    S D +A GV++ E++ GR P
Sbjct: 167 TST------FCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSP 209

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 75.7 bits (187), Expect = 3e-15
 Identities = 57/226 (25%), Positives = 94/226 (41%), Gaps = 50/226 (22%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNE-------KLL--AAVKRIDDAGH-DAEREFNNEVNW 202
            +F    V+G+G  G V  +           K+L    V + DD      E+        
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEK------RV 73

Query: 203 LTKIRHQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHL-------- 253
           L        ++ L  C     R + V E +              G +L +H+        
Sbjct: 74  LALPGKPPFLTQLHSCFQTMDRLYFVMEYVN-------------GGDLMYHIQQVGRFKE 120

Query: 254 -RMKI-AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS---VTAGTQ 308
                 A ++A GL +L       +++RDLK  N++LDS  + K++DFG+    +  G  
Sbjct: 121 PHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT 177

Query: 309 SRNVKISGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRP 353
           ++     GT  Y+APE ++  +   KS D +AFGV+L E+L G+ P
Sbjct: 178 TKT--FCGTPDYIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 75.3 bits (186), Expect = 3e-15
 Identities = 60/231 (25%), Positives = 94/231 (40%), Gaps = 60/231 (25%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNE-------KLL--AAVKRIDDAGH-DAEREFNNEVNW 202
            +F    ++G+G  G V+ A F +       K L    V   DD      E+        
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEK------RV 70

Query: 203 LTK-IRHQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRM--KIA 258
           L+    H  +  +       +   F V E +  G L              +H++   K  
Sbjct: 71  LSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLM-------------YHIQSCHKFD 116

Query: 259 VDVAR--------GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS-------V 303
           +  A         GL++LH      +V+RDLK  NILLD   + K++DFG+         
Sbjct: 117 LSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 173

Query: 304 TAGTQSRNVKISGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRP 353
              T        GT  Y+APE +L G+  + S D ++FGV+L E+L+G+ P
Sbjct: 174 KTNT------FCGTPDYIAPE-ILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 75.4 bits (186), Expect = 4e-15
 Identities = 66/231 (28%), Positives = 96/231 (41%), Gaps = 60/231 (25%)

Query: 153 NNFQESNVIGEGGRGHVYKARF-NEKLLAAVKRI--------DDAGH-DAEREFNNEVNW 202
           ++F    VIG+G  G V  AR   E++  AVK +         +  H  +ER      N 
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSER------NV 91

Query: 203 LTK-IRHQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRM--KIA 258
           L K ++H  ++ L  +      + + V + +              G  L +HL+      
Sbjct: 92  LLKNVKHPFLVGLH-FSFQTADKLYFVLDYIN-------------GGELFYHLQRERCFL 137

Query: 259 VDVAR--------GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS-------V 303
              AR         L YLH      +V+RDLK  NILLDS  +  L+DFGL         
Sbjct: 138 EPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS 194

Query: 304 TAGTQSRNVKISGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRP 353
           T  T        GT  Y+APE +L  +  D++ D +  G VL E+L G  P
Sbjct: 195 TTST------FCGTPEYLAPE-VLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 75.1 bits (185), Expect = 6e-15
 Identities = 60/230 (26%), Positives = 95/230 (41%), Gaps = 58/230 (25%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNE-------KLL--AAVKRIDDAGH-DAEREFNNEVNW 202
            +F    VIG G    V   R  +       +++    V   +D      E+      + 
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEK------HV 105

Query: 203 LTKIRHQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRM--KIAV 259
             +  +   +  L  C   E+R F V E +              G +L +H++   K+  
Sbjct: 106 FEQASNHPFLVGLHSCFQTESRLFFVIEYVN-------------GGDLMFHMQRQRKLPE 152

Query: 260 DVAR--------GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS-------VT 304
           + AR         L YLHE     +++RDLK  N+LLDS  + KL+D+G+         T
Sbjct: 153 EHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT 209

Query: 305 AGTQSRNVKISGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRP 353
             T        GT  Y+APE +L G+    S D +A GV++ E++ GR P
Sbjct: 210 TST------FCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSP 252

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 70.0 bits (172), Expect = 1e-13
 Identities = 46/212 (21%), Positives = 77/212 (36%), Gaps = 57/212 (26%)

Query: 160 VIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKI-RHQNIISLLGY 217
           V+G G  G V +      +   A+K + D    A RE    V    +  +  +I+ ++  
Sbjct: 25  VLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARRE----VELHWRASQCPHIVRIVDV 79

Query: 218 C----IHAETRFLVYEMMQNGSL-----EKQLHGPTHGSNLTWHLRMKIAVDVAR----G 264
                   +   +V E +  G L     ++     T           + A ++ +     
Sbjct: 80  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE----------REASEIMKSIGEA 129

Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDS-SFNA--KLSDFGLSVTAGTQSRNVKISGTLGYV 321
           ++YLH      + HRD+K  N+L  S   NA  KL+DFG                     
Sbjct: 130 IQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF-------------------- 166

Query: 322 APEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
           A E     K     D+++ GV++  LL G  P
Sbjct: 167 AKE-TTGEKYDKSCDMWSLGVIMYILLCGYPP 197

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 66.7 bits (163), Expect = 3e-12
 Identities = 45/223 (20%), Positives = 90/223 (40%), Gaps = 47/223 (21%)

Query: 160 VIGEGGRGHVYKAR-FNEKLLAAVKRI--DDAGHDAEREFNNEVNWLTKIR--------- 207
            +G G    V+ A+        A+K +  D    +A  +   E+  L ++          
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED---EIKLLQRVNDADNTKEDS 82

Query: 208 --HQNIISLLGYCIHAETR----FLVYEMMQNGSLEKQLHG-PTHGSNLTWHLRMKIAVD 260
               +I+ LL +  H         +V+E++   +L   +      G  L  +++ +I+  
Sbjct: 83  MGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLI-YVK-QISKQ 139

Query: 261 VARGLEYLHEHCNHPVVHRDLKSSNILLDSS------FNAKLSDFGLS------VTAGTQ 308
           +  GL+Y+H  C   ++H D+K  N+L++           K++D G +       T   Q
Sbjct: 140 LLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 197

Query: 309 SRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGR 351
           +R         Y +PE LL       +D+++   ++ EL+ G 
Sbjct: 198 TRE--------YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 62.8 bits (153), Expect = 7e-11
 Identities = 55/226 (24%), Positives = 86/226 (38%), Gaps = 49/226 (21%)

Query: 152 TNNFQESNVIGEGGRGHVYKAR-FNEKLLAAVKRI--DDAGHDAEREFNNEVNWLTKIRH 208
            + ++  ++IG+G  G V KA    E+   A+K I    A  +  +    EV  L  +  
Sbjct: 53  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQ---IEVRLLELMNK 109

Query: 209 Q------NIISLLGYCIHAETRFLVYEMM---------QNGSLEKQLHGPTHGSNLTWHL 253
                   I+ L  + +      LV+EM+                       G +L    
Sbjct: 110 HDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNF---------RGVSLN-LT 159

Query: 254 RMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA--KLSDFGLSVTAGT---- 307
           R K A  +   L +L       ++H DLK  NILL +   +  K+ DFG S   G     
Sbjct: 160 R-KFAQQMCTALLFLATPELS-IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQ 217

Query: 308 --QSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGR 351
             QSR         Y +PE LL        D+++ G +L+E+  G 
Sbjct: 218 YIQSRF--------YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 62.2 bits (150), Expect = 7e-11
 Identities = 39/250 (15%), Positives = 67/250 (26%), Gaps = 69/250 (27%)

Query: 151 ATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRI--------DDAGHDAEREFNNEVNW 202
            T   Q    IGEG  G V++    +    A+K I        + +      E   E+  
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 203 LTKI---------RHQNIISLLGYCIH------------------------------AET 223
             ++         R +  I L                                     + 
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 224 RFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKS 283
            F+V E    G   +Q+         +      I   +   L       +    HRDL  
Sbjct: 137 LFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHW 190

Query: 284 SNILLDSSFNAKLSDFGLSVTAGTQSRNVKI------------SGTLGY---VAPEYLLE 328
            N+LL  +   KL       ++   S  +++             G + +      E L  
Sbjct: 191 GNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFT 250

Query: 329 GKLTDKSDVY 338
           G    + D+Y
Sbjct: 251 GDGDYQFDIY 260

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 62.8 bits (153), Expect = 7e-11
 Identities = 57/209 (27%), Positives = 86/209 (41%), Gaps = 33/209 (15%)

Query: 160 VIGEGGRGHVYKAR-FNEKLLAAVKRI--DDAGHDAEREFNNEVNWLTKIRHQ------N 210
           VIG+G  G V KA         A+K +  +   H    E   E+  L  +R Q      N
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAE---EIRILEHLRKQDKDNTMN 160

Query: 211 IISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHE 270
           +I +L          + +E++     E        G +L   +R K A  + + L+ LH+
Sbjct: 161 VIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLP-LVR-KFAHSILQCLDALHK 218

Query: 271 HCNHPVVHRDLKSSNILLDSSFNA--KLSDFGLSVTAGT------QSRNVKISGTLGYVA 322
           +    ++H DLK  NILL     +  K+ DFG S           QSR         Y A
Sbjct: 219 NR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF--------YRA 267

Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMGR 351
           PE +L  +     D+++ G +L ELL G 
Sbjct: 268 PEVILGARYGMPIDMWSLGCILAELLTGY 296

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 59.9 bits (145), Expect = 5e-10
 Identities = 46/256 (17%), Positives = 82/256 (32%), Gaps = 71/256 (27%)

Query: 161 IGEGGRGHVYKAR-FNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLG--Y 217
           +G G    V+ +     K   A+K +  A H  E    +E+  L  +R+ +  +      
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSDP-NDPNREM 102

Query: 218 CIHAETRF-----------LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
            +     F           +V+E++ +  L K +    +   L      KI   V +GL+
Sbjct: 103 VVQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQG-LPLPCVKKIIQQVLQGLD 160

Query: 267 YLHEHCNHPVVHRDLKSSNILLDSS----------------------------------- 291
           YLH  C   ++H D+K  NILL  +                                   
Sbjct: 161 YLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218

Query: 292 --------------FNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDV 337
                            K++D G +     +     I  T  Y + E L+       +D+
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNA-CWVHKHFTEDIQ-TRQYRSLEVLIGSGYNTPADI 276

Query: 338 YAFGVVLLELLMGRRP 353
           ++   +  EL  G   
Sbjct: 277 WSTACMAFELATGDYL 292

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 50.1 bits (120), Expect = 6e-07
 Identities = 43/224 (19%), Positives = 89/224 (39%), Gaps = 37/224 (16%)

Query: 161 IGEGGRGHVYKAR---------FNEKLLAAVK------RIDDAGHDAEREFNNE--VNW- 202
                +G +Y+A            +K   ++K      R+ +  +  +R         W 
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 203 -LTKIRHQNIISLLGYCIHAET-RFLVYEMMQNG-SLEKQLHGPTHGSNLTWHLRMKIAV 259
            L       I + +G+ +H +  RFLV   +  G SL+      +    L+    +++A 
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQS-ALDVSPKHVLSERSVLQVAC 166

Query: 260 DVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAK--LSDFGLS---VTAGT-----QS 309
            +   LE+LHE+     VH ++ + NI +D    ++  L+ +G +     +G      + 
Sbjct: 167 RLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEG 223

Query: 310 RNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
                 G L +++ +       + +SD+ + G  +L+ L G  P
Sbjct: 224 SRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 47.3 bits (113), Expect = 5e-06
 Identities = 49/235 (20%), Positives = 81/235 (34%), Gaps = 69/235 (29%)

Query: 160 VIGEGGRGHVYKA--RFNEKLLAAVKRI--DDAGHDAEREFNNEVNWLTKIRHQ------ 209
            +GEG  G V +       K   A+K I       +A R    E+N L KI+ +      
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARL---EINVLKKIKEKDKENKF 82

Query: 210 NIISLLGYCIHAETRFLVYEMM---------QNGSLEKQLHGPTHGSNLTWHLRMKIAVD 260
             + +  +        + +E++         +N               L  H+R  +A  
Sbjct: 83  LCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNF---------QPYPLP-HVR-HMAYQ 131

Query: 261 VARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA-------------------KLSDFGL 301
           +   L +LHE+    + H DLK  NIL  +S                      +++DFG 
Sbjct: 132 LCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGS 188

Query: 302 SVTAGT------QSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMG 350
           +            +R+        Y  PE +LE       DV++ G +L E   G
Sbjct: 189 ATFDHEHHTTIVATRH--------YRPPEVILELGWAQPCDVWSIGCILFEYYRG 235

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 47.1 bits (112), Expect = 7e-06
 Identities = 46/226 (20%), Positives = 90/226 (39%), Gaps = 41/226 (18%)

Query: 161 IGEGGRGHVYKARFN------EKLLAAVKRIDDAGHD------------AEREFNNEVNW 202
           IG+GG G +Y A  N            VK ++ + +             A+ E   +   
Sbjct: 43  IGQGGFGCIYLADMNSSESVGSDAPCVVK-VEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 203 LTKIRHQNIISLLGYCIHAET----RFLVYEMMQNG-SLEKQLHGPTHGSNLTWHLRMKI 257
             K+++  +    G  +H +     RF++ +    G  L+K      +    +    +++
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYE--ANAKRFSRKTVLQL 157

Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAK--LSDFGLS---VTAGT----- 307
           ++ +   LEY+HEH     VH D+K+SN+LL+     +  L D+GL+      G      
Sbjct: 158 SLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYA 214

Query: 308 QSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
                   GT+ + + +       + + D+   G  +++ L G  P
Sbjct: 215 ADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 45.9 bits (109), Expect = 1e-05
 Identities = 37/168 (22%), Positives = 66/168 (39%), Gaps = 38/168 (22%)

Query: 161 IGEGGRGHVYKARF---NEKLLAAVKRIDDAGHD------------AEREFNNEVNWLTK 205
           IG GG G +Y A      EK    V +++   +             A+++   +     +
Sbjct: 45  IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104

Query: 206 IRHQNIISLLGYCIHAET----RFLVYEMMQNG-SLEKQLHGPTHGSNLTWHLRMK---- 256
           + +  I    G  +        RF+V E +  G  L+K               +      
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKIS-------GQNGTFKKSTVLQ 155

Query: 257 IAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAK--LSDFGLS 302
           + + +   LEY+HE+     VH D+K++N+LL      +  L+D+GLS
Sbjct: 156 LGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLS 200

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 43.5 bits (103), Expect = 8e-05
 Identities = 51/231 (22%), Positives = 89/231 (38%), Gaps = 57/231 (24%)

Query: 160 VIGEGGRGHVYKAR-FNEKLLAAVKRI--DDAGHDAEREFNNEVNWLTKIRHQ-----NI 211
            +G+G  G V   +  + K   AVK +        + +    E + L KI++      NI
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKI---EADILKKIQNDDINNNNI 98

Query: 212 ISLLGYCIHAETRFLVYEMM---------QNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
           +   G  ++ +   L++E +         +N           +G ++   ++    +++ 
Sbjct: 99  VKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNY---------NGFHIE-DIK-LYCIEIL 147

Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR-------NVKI- 314
           + L YL +     + H DLK  NILLD  +  K       VT G + +        +K+ 
Sbjct: 148 KALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLI 204

Query: 315 ---SGTLG------------YVAPEYLLEGKLTDKSDVYAFGVVLLELLMG 350
                T              Y APE +L       SD+++FG VL EL  G
Sbjct: 205 DFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 43.4 bits (103), Expect = 9e-05
 Identities = 49/227 (21%), Positives = 85/227 (37%), Gaps = 53/227 (23%)

Query: 160 VIGEGGRGHVYKARFNE--KLLAAVKRI--DDAGHDAEREFNNEVNWLTKIRHQ------ 209
            +GEG  G V +   ++      AVK +   D   +A R    E+  L  +         
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARS---EIQVLEHLNTTDPNSTF 77

Query: 210 NIISLLGYCIHAETRFLVYEMM---------QNGSLEKQLHGPTHGSNLTWHLRMKIAVD 260
             + +L +  H     +V+E++         +NG              L  H+R K+A  
Sbjct: 78  RCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGF---------LPFRLD-HIR-KMAYQ 126

Query: 261 VARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN-VKI----S 315
           + + + +LH +    + H DLK  NIL   S   +  +  +     T     +K+    S
Sbjct: 127 ICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGS 183

Query: 316 GTLG------------YVAPEYLLEGKLTDKSDVYAFGVVLLELLMG 350
            T              Y APE +L    +   DV++ G +L+E  +G
Sbjct: 184 ATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG 230

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 42.0 bits (99), Expect = 2e-04
 Identities = 26/170 (15%), Positives = 55/170 (32%), Gaps = 41/170 (24%)

Query: 153 NNFQESNVIGEGGRGHVYKAR-FNEKLLAAVKR-IDDAGHDAEREFNNEVNWLTKIRH-Q 209
            +++    IGEG  G +++          A+K     +      +  +E      +    
Sbjct: 10  VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA---PQLRDEYRTYKLLAGCT 66

Query: 210 NIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMK------------I 257
            I ++  +        LV +++              G +L   L                
Sbjct: 67  GIPNVYYFGQEGLHNVLVIDLL--------------GPSL-EDLLDLCGRKFSVKTVAMA 111

Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAK-----LSDFGLS 302
           A  +   ++ +HE     +V+RD+K  N L+    +       + DFG+ 
Sbjct: 112 AKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 41.2 bits (97), Expect = 5e-04
 Identities = 29/169 (17%), Positives = 57/169 (33%), Gaps = 39/169 (23%)

Query: 153 NNFQESNVIGEGGRGHVYKAR-FNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRH-QN 210
            NF+    IG G  G +   +        A+K   +       + + E  +  ++     
Sbjct: 9   PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKL--EPMKSRAPQLHLEYRFYKQLGSGDG 66

Query: 211 IISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMK------------IA 258
           I  +  +    +   +V E++              G +L   L               IA
Sbjct: 67  IPQVYYFGPCGKYNAMVLELL--------------GPSL-EDLFDLCDRTFSLKTVLMIA 111

Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAK-----LSDFGLS 302
           + +   +EY+H      +++RD+K  N L+    N       + DF L+
Sbjct: 112 IQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	439
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.96
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.91
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.81
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.67
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.38
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.25
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.12
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.01
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.69
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.57
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.51
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.46
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.36
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.35
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.11
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.03
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.98
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.91
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.64
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.43
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.38
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.14
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.12
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.05
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.77
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.72
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.63
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.6
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.44
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.72
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	95.31
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	94.9
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.49
2k1k_A	38	Ephrin type-A receptor 1; EPHA1, receptor tyrosine	91.64
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	86.76
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	85.34
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	84.45

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.4e-58  Score=448.47  Aligned_cols=257  Identities=31%  Similarity=0.483  Sum_probs=210.8

Q ss_pred             cCCCccceecccCcEEEEEEEEC------CccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN------EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFL  226 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  226 (439)
                      ++|...+.||+|+||+||+|++.      ++..||||.++.......++|.+|+++|++++|||||+++|+|.+.+..+|
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            56777889999999999999875      367899999988777777889999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcE
Q 013636          227 VYEMMQNGSLEKQLHGPT------------HGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA  294 (439)
Q Consensus       227 V~e~~~~gsL~~~l~~~~------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~  294 (439)
                      |||||++|+|.++++...            ....++|.++++|+.|+|+||+|||+.   +|+||||||+||||++++++
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcE
Confidence            999999999999997532            124699999999999999999999998   99999999999999999999


Q ss_pred             EEEecccccccCCCCc---ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhh
Q 013636          295 KLSDFGLSVTAGTQSR---NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAM  370 (439)
Q Consensus       295 kl~DfGls~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~  370 (439)
                      ||+|||+|+.......   .....||++|||||++.+..++.++|||||||+||||+| |+.||...+..+....+... 
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g-  276 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG-  276 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHT-
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-
Confidence            9999999986543322   233569999999999999999999999999999999999 99999988766544443321 


Q ss_pred             cccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCC
Q 013636          371 PQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVP  429 (439)
Q Consensus       371 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~  429 (439)
                          .+...+..+            ..++.+++.+||+.||++|||+.||+++|+.+..
T Consensus       277 ----~~~~~p~~~------------~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~  319 (329)
T 4aoj_A          277 ----RELERPRAC------------PPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ  319 (329)
T ss_dssp             ----CCCCCCTTC------------CHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ----CCCCCcccc------------cHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence                111222211            2356779999999999999999999999987653

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=3.5e-58  Score=439.81  Aligned_cols=256  Identities=30%  Similarity=0.494  Sum_probs=214.3

Q ss_pred             cCCCccceecccCcEEEEEEEEC------CccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN------EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFL  226 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  226 (439)
                      ++|.+.+.||+|+||+||+|++.      ++..||||+++.......++|.+|+++|++++|||||+++|+|.+++..++
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            56778899999999999999874      367899999988777777889999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhcCC----------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEE
Q 013636          227 VYEMMQNGSLEKQLHGP----------THGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKL  296 (439)
Q Consensus       227 V~e~~~~gsL~~~l~~~----------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl  296 (439)
                      |||||++|+|.++|+..          .....++|..+++++.|+|+||+|||++   +|+||||||+|||+++++++||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEE
Confidence            99999999999999742          2235799999999999999999999998   9999999999999999999999


Q ss_pred             EecccccccCCCCcc---eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcc
Q 013636          297 SDFGLSVTAGTQSRN---VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQ  372 (439)
Q Consensus       297 ~DfGls~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~  372 (439)
                      +|||+|+........   ....||++|||||++.++.++.++|||||||+||||+| |+.||...+..+....+...   
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~---  246 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG---  246 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHT---
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC---
Confidence            999999765443322   22458999999999999999999999999999999999 99999988776554443321   


Q ss_pred             cccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccC
Q 013636          373 LTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLV  428 (439)
Q Consensus       373 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~  428 (439)
                        .....+..            ...++.+++.+||+.||++|||+.||++.|+.+.
T Consensus       247 --~~~~~p~~------------~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~  288 (299)
T 4asz_A          247 --RVLQRPRT------------CPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA  288 (299)
T ss_dssp             --CCCCCCTT------------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --CCCCCCcc------------chHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence              11111211            1235678999999999999999999999887654

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=3.4e-57  Score=433.36  Aligned_cols=257  Identities=29%  Similarity=0.470  Sum_probs=203.5

Q ss_pred             HhcCCCccceecccCcEEEEEEEECCccEEEEEEecCC--CchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEE
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDA--GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      ..++++..+.||+|+||+||+|++++  .+|||.++..  .....++|.+|+.++++++|||||+++|+|.+ +..+|||
T Consensus        34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm  110 (307)
T 3omv_A           34 EASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT  110 (307)
T ss_dssp             CTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             cHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence            34678888999999999999999875  4788888643  33445789999999999999999999999864 5789999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~  308 (439)
                      |||++|+|.++|+.  ....++|..+.+|+.|+|+||+|||+.   +|+||||||+||||++++++||+|||+|+.....
T Consensus       111 Ey~~gGsL~~~l~~--~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~  185 (307)
T 3omv_A          111 QWCEGSSLYKHLHV--QETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW  185 (307)
T ss_dssp             ECCSSCBHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred             EcCCCCCHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence            99999999999974  335699999999999999999999998   9999999999999999999999999999765432


Q ss_pred             C---cceeeccccCccchhhhcC---CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhh-hhhHhhhhcccccCCCCCc
Q 013636          309 S---RNVKISGTLGYVAPEYLLE---GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQC-QSMVTWAMPQLTDRSKLPN  381 (439)
Q Consensus       309 ~---~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  381 (439)
                      .   .....+||+.|||||++.+   +.|+.++|||||||+||||+||+.||.+.+.... ...+...    ...+.++.
T Consensus       186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~----~~~p~~~~  261 (307)
T 3omv_A          186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRG----YASPDLSK  261 (307)
T ss_dssp             --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTT----CCCCCSTT
T ss_pred             CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcC----CCCCCccc
Confidence            2   2234579999999999964   4689999999999999999999999987654332 2222110    00111111


Q ss_pred             cCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccC
Q 013636          382 IVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLV  428 (439)
Q Consensus       382 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~  428 (439)
                           +..    .....+.+++.+||+.||++|||+.||+++|+.+.
T Consensus       262 -----~~~----~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~  299 (307)
T 3omv_A          262 -----LYK----NCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ  299 (307)
T ss_dssp             -----SCT----TSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred             -----ccc----cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence                 111    12345778999999999999999999999987654

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.1e-57  Score=436.18  Aligned_cols=255  Identities=26%  Similarity=0.392  Sum_probs=210.6

Q ss_pred             cCCCccceecccCcEEEEEEEEC------CccEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN------EKLLAAVKRIDDAG-HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRF  225 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  225 (439)
                      .+++..+.||+|+||+||+|++.      ++..||||+++... ....++|.+|+.++++++|||||+++|+|.+.+..+
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            34556788999999999999873      46789999997543 334578999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC
Q 013636          226 LVYEMMQNGSLEKQLHGPTH-------------GSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSF  292 (439)
Q Consensus       226 lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~  292 (439)
                      +|||||++|||.++|+....             ...++|..+++++.|+|+||+|||+.   +|+||||||+||||++++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCC
Confidence            99999999999999964321             24699999999999999999999998   999999999999999999


Q ss_pred             cEEEEecccccccCCCCc---ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhh
Q 013636          293 NAKLSDFGLSVTAGTQSR---NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTW  368 (439)
Q Consensus       293 ~~kl~DfGls~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~  368 (439)
                      ++||+|||+|+.......   .....||++|||||++.++.++.++|||||||+||||+| |+.||.+.+..+....+..
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~  262 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRN  262 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHT
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            999999999976543222   233468999999999999999999999999999999998 8999998877654444321


Q ss_pred             hhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhcccc
Q 013636          369 AMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPL  427 (439)
Q Consensus       369 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l  427 (439)
                      .     .....++            .....+.+++.+||+.||++|||+.||+++|+..
T Consensus       263 ~-----~~~~~p~------------~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          263 R-----QVLPCPD------------DCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             T-----CCCCCCT------------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             C-----CCCCCcc------------cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            1     0111111            1234577899999999999999999999999764

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.8e-55  Score=426.10  Aligned_cols=250  Identities=22%  Similarity=0.332  Sum_probs=204.2

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYE  229 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  229 (439)
                      ++|++.+.||+|+||+||+|+.. ++..||||.+....  ....+.|.+|+.+|++++|||||++++++.+.+..|+|||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            58999999999999999999875 58899999986542  3345679999999999999999999999999999999999


Q ss_pred             eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCC
Q 013636          230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS  309 (439)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~  309 (439)
                      ||++|+|.+++... .+..+++..+..++.|++.||+|||++   +|+||||||+||||++++++||+|||+|+......
T Consensus       104 y~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  179 (350)
T 4b9d_A          104 YCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV  179 (350)
T ss_dssp             CCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred             CCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence            99999999999642 344679999999999999999999998   99999999999999999999999999998765432


Q ss_pred             c-ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhc
Q 013636          310 R-NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIR  388 (439)
Q Consensus       310 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  388 (439)
                      . ....+||+.|||||++.+..|+.++|||||||++|||++|+.||...+..+....+...     .....+.       
T Consensus       180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~-----~~~~~~~-------  247 (350)
T 4b9d_A          180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISG-----SFPPVSL-------  247 (350)
T ss_dssp             HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT-----CCCCCCT-------
T ss_pred             ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC-----CCCCCCc-------
Confidence            2 23457999999999999999999999999999999999999999987765543332211     0111111       


Q ss_pred             CccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          389 DTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       389 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                       .+    ...+.+++.+||+.||++|||+.|++++
T Consensus       248 -~~----s~~~~~li~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          248 -HY----SYDLRSLVSQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             -TS----CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -cC----CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             11    2356779999999999999999999875

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=4.8e-55  Score=423.83  Aligned_cols=249  Identities=23%  Similarity=0.384  Sum_probs=211.2

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEec
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMM  231 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  231 (439)
                      +.|+..+.||+|+||+||+|+.. ++..||||+++.......+.+.+|+.+|++++|||||++++++.+.+..|||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            56888999999999999999986 58899999997655555567899999999999999999999999999999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC-Cc
Q 013636          232 QNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ-SR  310 (439)
Q Consensus       232 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~-~~  310 (439)
                      ++|+|.+++..    ..+++..+..++.|++.||+|||++   +|+||||||+||||++++++||+|||+|+..... ..
T Consensus       154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~  226 (346)
T 4fih_A          154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR  226 (346)
T ss_dssp             TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred             CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCCc
Confidence            99999999964    3499999999999999999999998   9999999999999999999999999999876543 33


Q ss_pred             ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCc
Q 013636          311 NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDT  390 (439)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  390 (439)
                      ....+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.++.+....+....     ...+..      ...
T Consensus       227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~-----~~~~~~------~~~  295 (346)
T 4fih_A          227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL-----PPRLKN------LHK  295 (346)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS-----CCCCSC------GGG
T ss_pred             ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC-----CCCCCc------ccc
Confidence            345789999999999999999999999999999999999999999877655444332110     001100      011


Q ss_pred             cCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          391 MDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       391 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      +    ...+.+++.+||+.||++|||+.|++++
T Consensus       296 ~----s~~~~dli~~~L~~dP~~R~ta~e~l~H  324 (346)
T 4fih_A          296 V----SPSLKGFLDRLLVRDPAQRATAAELLKH  324 (346)
T ss_dssp             S----CHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             C----CHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            1    2356679999999999999999999975

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.6e-55  Score=430.41  Aligned_cols=268  Identities=25%  Similarity=0.386  Sum_probs=217.8

Q ss_pred             ccHHHHHHHhcCCCccceecccCcEEEEEEEECC------ccEEEEEEecCCCc-hHHHHHHHHHHHHHhcCC-Cceeee
Q 013636          143 IEYELLEAATNNFQESNVIGEGGRGHVYKARFNE------KLLAAVKRIDDAGH-DAEREFNNEVNWLTKIRH-QNIISL  214 (439)
Q Consensus       143 ~~~~~l~~~~~~~~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h-~niv~l  214 (439)
                      ++...++...++|++.+.||+|+||+||+|++.+      ...||||.+..... ...++|.+|+.+|++++| ||||++
T Consensus        54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l  133 (353)
T 4ase_A           54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL  133 (353)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence            3445667778899999999999999999998643      35799999976543 345679999999999965 899999


Q ss_pred             eeEEEeC-CeeEEEEEeccCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 013636          215 LGYCIHA-ETRFLVYEMMQNGSLEKQLHGPT-------------HGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD  280 (439)
Q Consensus       215 ~~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~D  280 (439)
                      +|+|.+. +..++|||||++|+|.++|+...             ....+++..+..++.|+|+||+|||++   +|+|||
T Consensus       134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRD  210 (353)
T 4ase_A          134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD  210 (353)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCc
Confidence            9999765 56899999999999999997422             134589999999999999999999998   999999


Q ss_pred             CCCCCEEEcCCCcEEEEecccccccCCCCcc---eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCC
Q 013636          281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRN---VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEK  356 (439)
Q Consensus       281 lk~~NiLl~~~~~~kl~DfGls~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~  356 (439)
                      |||+|||+++++++||+|||+|+........   ....||++|||||++.++.|+.++|||||||+||||+| |+.||.+
T Consensus       211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~  290 (353)
T 4ase_A          211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  290 (353)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence            9999999999999999999999876543322   23568999999999999999999999999999999998 9999987


Q ss_pred             CChhh-hhhhHhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCC
Q 013636          357 MSPTQ-CQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPT  430 (439)
Q Consensus       357 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~  430 (439)
                      .+..+ ....+..     ..+...++..            ..++.+++..||+.||++|||+.|++++|+.++..
T Consensus       291 ~~~~~~~~~~i~~-----g~~~~~p~~~------------~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~  348 (353)
T 4ase_A          291 VKIDEEFCRRLKE-----GTRMRAPDYT------------TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  348 (353)
T ss_dssp             CCCSHHHHHHHHH-----TCCCCCCTTC------------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHc-----CCCCCCCccC------------CHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence            65332 2222211     0112222222            23566799999999999999999999999887653

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=9.3e-55  Score=418.07  Aligned_cols=268  Identities=24%  Similarity=0.299  Sum_probs=201.2

Q ss_pred             cCCCccceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC----eeEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE----TRFLVY  228 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lV~  228 (439)
                      ++|.+.+.||+|+||+||+|+++ +..||||+++... .....+..|+..+.+++|||||+++++|.+.+    ..+|||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            45677889999999999999985 6789999997542 22223445666677899999999999998764    579999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----CCCeEecCCCCCCEEEcCCCcEEEEeccccc
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC-----NHPVVHRDLKSSNILLDSSFNAKLSDFGLSV  303 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~-----~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~  303 (439)
                      |||++|+|.++|+..    .++|..+.+++.|+++||+|||+.+     .++|+||||||+||||++++++||+|||+|+
T Consensus        81 Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~  156 (303)
T 3hmm_A           81 DYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             ECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             cCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence            999999999999742    4899999999999999999999752     4589999999999999999999999999997


Q ss_pred             ccCCCCcc-----eeeccccCccchhhhcCC------CCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhh--------h
Q 013636          304 TAGTQSRN-----VKISGTLGYVAPEYLLEG------KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQ--------S  364 (439)
Q Consensus       304 ~~~~~~~~-----~~~~gt~~y~aPE~~~~~------~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~--------~  364 (439)
                      ........     ....||+.|||||++.+.      .++.++|||||||+||||+||+.|+......+..        .
T Consensus       157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~  236 (303)
T 3hmm_A          157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence            65443322     234699999999999764      3677999999999999999998877543211100        0


Q ss_pred             hHhhhhcccccCCCCCccCCchhcCc-cCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCCC
Q 013636          365 MVTWAMPQLTDRSKLPNIVDPVIRDT-MDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPTD  431 (439)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~~  431 (439)
                      ...........     ...+|.+... .+.+....+.+++.+||+.||++|||+.||++.|+++..++
T Consensus       237 ~~~~~~~~~~~-----~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~  299 (303)
T 3hmm_A          237 SVEEMRKVVCE-----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE  299 (303)
T ss_dssp             CHHHHHHHHTT-----SCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             hHHHHHHHHhc-----ccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence            00000000001     1112222111 12345677889999999999999999999999999887653

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=4.6e-54  Score=405.32  Aligned_cols=246  Identities=26%  Similarity=0.364  Sum_probs=193.7

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC---chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      ++|++.+.||+|+||+||+|+.. ++..+|+|.++...   ....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            57999999999999999999875 58899999986532   233457999999999999999999999999999999999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~  308 (439)
                      ||+ +|+|.+++..   ...+++..+..++.|++.||+|||++   +|+||||||+|||+++++++||+|||+|+.....
T Consensus        93 Ey~-~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  165 (275)
T 3hyh_A           93 EYA-GNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG  165 (275)
T ss_dssp             ECC-CEEHHHHHHH---SCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred             eCC-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence            999 6799999864   34699999999999999999999998   9999999999999999999999999999876655


Q ss_pred             CcceeeccccCccchhhhcCCCC-CCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchh
Q 013636          309 SRNVKISGTLGYVAPEYLLEGKL-TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVI  387 (439)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  387 (439)
                      ......+||+.|+|||++.+..+ +.++||||+||++|||++|+.||...+.......+..      ....++..++   
T Consensus       166 ~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~------~~~~~p~~~s---  236 (275)
T 3hyh_A          166 NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISN------GVYTLPKFLS---  236 (275)
T ss_dssp             ---------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------TCCCCCTTSC---
T ss_pred             CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc------CCCCCCCCCC---
Confidence            55556789999999999998876 5799999999999999999999988765544333321      1122232222   


Q ss_pred             cCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          388 RDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       388 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                               ..+.+++.+||+.||++|||+.|++++
T Consensus       237 ---------~~~~~li~~~L~~dP~~R~s~~eil~h  263 (275)
T 3hyh_A          237 ---------PGAAGLIKRMLIVNPLNRISIHEIMQD  263 (275)
T ss_dssp             ---------HHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred             ---------HHHHHHHHHHccCChhHCcCHHHHHcC
Confidence                     245679999999999999999999975

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=8.8e-54  Score=424.97  Aligned_cols=250  Identities=24%  Similarity=0.384  Sum_probs=212.2

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEe
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      .+.|+..+.||+|+||+||+|+.. .+..||||.+........+.+.+|+.+|++++|||||++++++.+.+..||||||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy  229 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  229 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence            357999999999999999999986 4789999999766555566789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC-C
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ-S  309 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~-~  309 (439)
                      |++|+|.+++..    ..+++..+..++.|++.||+|||++   +|+||||||+||||+.++++||+|||+|+..... .
T Consensus       230 ~~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~  302 (423)
T 4fie_A          230 LEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP  302 (423)
T ss_dssp             CTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred             CCCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence            999999999963    2499999999999999999999998   9999999999999999999999999999876543 3


Q ss_pred             cceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcC
Q 013636          310 RNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRD  389 (439)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  389 (439)
                      .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.++.+....+.....   .......        
T Consensus       303 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~---~~~~~~~--------  371 (423)
T 4fie_A          303 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP---PRLKNLH--------  371 (423)
T ss_dssp             CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC---CCCSCTT--------
T ss_pred             cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC---CCCcccc--------
Confidence            33456799999999999999999999999999999999999999998776654444322110   0000001        


Q ss_pred             ccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          390 TMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       390 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      .+    ...+.+++.+||+.||++|||+.|+++|
T Consensus       372 ~~----s~~~~dli~~~L~~dP~~R~ta~ell~H  401 (423)
T 4fie_A          372 KV----SPSLKGFLDRLLVRDPAQRATAAELLKH  401 (423)
T ss_dssp             SS----CHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             cC----CHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            11    2356679999999999999999999975

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=6.7e-54  Score=407.60  Aligned_cols=246  Identities=27%  Similarity=0.397  Sum_probs=196.7

Q ss_pred             CccceecccCcEEEEEEEECC-ccEEEEEEecCC--CchHHHHHHHHHHHHHhcCCCceeeeeeEEEe----CCeeEEEE
Q 013636          156 QESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDA--GHDAEREFNNEVNWLTKIRHQNIISLLGYCIH----AETRFLVY  228 (439)
Q Consensus       156 ~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~  228 (439)
                      +..+.||+|+||+||+|.... +..||+|.+...  .....+.|.+|++++++++|||||++++++..    .+..++||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            456789999999999998864 778999998643  33445679999999999999999999999865    24579999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC-CCcEEEEecccccccCC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDS-SFNAKLSDFGLSVTAGT  307 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~-~~~~kl~DfGls~~~~~  307 (439)
                      |||++|+|.+++..   ...+++..+..++.|++.||+|||++ .++|+||||||+||||+. ++++||+|||+|+....
T Consensus       109 Ey~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~  184 (290)
T 3fpq_A          109 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence            99999999999964   34699999999999999999999997 124999999999999984 79999999999976543


Q ss_pred             CCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChh-hhhhhHhhhhcccccCCCCCccCCch
Q 013636          308 QSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPT-QCQSMVTWAMPQLTDRSKLPNIVDPV  386 (439)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~d~~  386 (439)
                       ......+||+.|||||++.+ .|+.++|||||||++|||+||+.||...+.. .....+.       . ...+..    
T Consensus       185 -~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~-------~-~~~~~~----  250 (290)
T 3fpq_A          185 -SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT-------S-GVKPAS----  250 (290)
T ss_dssp             -TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHT-------T-TCCCGG----
T ss_pred             -CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHH-------c-CCCCCC----
Confidence             33445679999999998864 6999999999999999999999999765432 2221111       1 111111    


Q ss_pred             hcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          387 IRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       387 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      .....+    .++.+++.+||+.||++|||+.|+++|
T Consensus       251 ~~~~~~----~~~~~li~~~L~~dP~~R~s~~e~l~H  283 (290)
T 3fpq_A          251 FDKVAI----PEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             GGGCCC----HHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCccCC----HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            111111    246779999999999999999999976

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.8e-54  Score=418.52  Aligned_cols=250  Identities=21%  Similarity=0.261  Sum_probs=204.2

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEec
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMM  231 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  231 (439)
                      +.|+..+.||+|+||+||+|+.. .+..||||.++....     ..+|+.++++++|||||++++++.+.+..|||||||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  132 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL  132 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence            46777889999999999999985 478999999975322     246999999999999999999999999999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC-cEEEEecccccccCCCCc
Q 013636          232 QNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSF-NAKLSDFGLSVTAGTQSR  310 (439)
Q Consensus       232 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~-~~kl~DfGls~~~~~~~~  310 (439)
                      ++|+|.++++.   ...+++..+..++.|++.||+|||++   +|+||||||+||||+.++ ++||+|||+|+.......
T Consensus       133 ~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~  206 (336)
T 4g3f_A          133 EGGSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL  206 (336)
T ss_dssp             TTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred             CCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence            99999999964   34699999999999999999999998   999999999999999987 699999999987644321


Q ss_pred             c------eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCC
Q 013636          311 N------VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVD  384 (439)
Q Consensus       311 ~------~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  384 (439)
                      .      ...+||+.|||||++.+..|+.++|||||||++|||++|+.||...+..+....+....+..   ..++    
T Consensus       207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~---~~~~----  279 (336)
T 4g3f_A          207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPI---REIP----  279 (336)
T ss_dssp             -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGG---GGSC----
T ss_pred             ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCc---hhcC----
Confidence            1      23469999999999999999999999999999999999999998766544333322111000   0111    


Q ss_pred             chhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccC
Q 013636          385 PVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLV  428 (439)
Q Consensus       385 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~  428 (439)
                          ..+    ...+.+++.+||+.||++|||+.|++++|...+
T Consensus       280 ----~~~----s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l  315 (336)
T 4g3f_A          280 ----PSC----APLTAQAIQEGLRKEPVHRASAMELRRKVGKAL  315 (336)
T ss_dssp             ----TTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----ccC----CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence                111    235667999999999999999999999886554

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.5e-54  Score=414.40  Aligned_cols=245  Identities=22%  Similarity=0.305  Sum_probs=207.7

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC---chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      ++|++.+.||+|+||+||+|+.. ++..+|+|.+....   ....+.+.+|+++|++++|||||++++++.+.+..|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            57999999999999999999875 57899999996432   234467899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~  308 (439)
                      |||++|+|.+++..   .+.+++..+..++.|++.||+|||++   +|+||||||+|||+++++++||+|||+|+.....
T Consensus       112 Ey~~gG~L~~~i~~---~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          112 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            99999999999964   34699999999999999999999998   9999999999999999999999999999876433


Q ss_pred             C---cceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCc
Q 013636          309 S---RNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDP  385 (439)
Q Consensus       309 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  385 (439)
                      .   .....+||+.|||||++.+..|+.++||||+||++|||++|+.||...+..+....+..      ....+++.++ 
T Consensus       186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~------~~~~~p~~~s-  258 (311)
T 4aw0_A          186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIK------LEYDFPEKFF-  258 (311)
T ss_dssp             TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------TCCCCCTTCC-
T ss_pred             CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc------CCCCCCcccC-
Confidence            2   23456799999999999999999999999999999999999999988776554333321      1222332222 


Q ss_pred             hhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 013636          386 VIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVL  421 (439)
Q Consensus       386 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl  421 (439)
                                 .++.+++.+||+.||++|||++|++
T Consensus       259 -----------~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          259 -----------PKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             -----------HHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             -----------HHHHHHHHHHccCCHhHCcChHHHc
Confidence                       2456799999999999999999863

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=4.9e-54  Score=410.61  Aligned_cols=247  Identities=24%  Similarity=0.365  Sum_probs=200.4

Q ss_pred             cCCCccceecccCcEEEEEEEEC----CccEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN----EKLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFL  226 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  226 (439)
                      ++|++.+.||+|+||+||+|+..    .+..+|+|.++...  ......+.+|+++|++++|||||++++++.+.+..++
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            57899999999999999999863    36789999986532  2223468899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccC
Q 013636          227 VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAG  306 (439)
Q Consensus       227 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~  306 (439)
                      |||||++|+|.+++..   ...+++..+..++.|++.||+|||++   +|+||||||+|||+++++++||+|||+|+...
T Consensus       104 vmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  177 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESI  177 (304)
T ss_dssp             EECCCTTCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred             EEEcCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence            9999999999999964   34699999999999999999999998   99999999999999999999999999997653


Q ss_pred             C-CCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCc
Q 013636          307 T-QSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDP  385 (439)
Q Consensus       307 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  385 (439)
                      . .......+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.+..+....+..      .....+..++ 
T Consensus       178 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~------~~~~~p~~~s-  250 (304)
T 3ubd_A          178 DHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK------AKLGMPQFLS-  250 (304)
T ss_dssp             ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------CCCCCCTTSC-
T ss_pred             CCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHc------CCCCCCCcCC-
Confidence            3 2333456799999999999999999999999999999999999999998776654433321      1222333222 


Q ss_pred             hhcCccCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHh
Q 013636          386 VIRDTMDLKHLYQVAAVAVLCIQPEPSYRPL-----ITDVLHS  423 (439)
Q Consensus       386 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~  423 (439)
                                 ..+.+++.+||+.||++|||     ++|+++|
T Consensus       251 -----------~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H  282 (304)
T 3ubd_A          251 -----------PEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH  282 (304)
T ss_dssp             -----------HHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred             -----------HHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence                       24567999999999999998     4688764

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.4e-51  Score=394.58  Aligned_cols=249  Identities=24%  Similarity=0.405  Sum_probs=190.3

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCe-------
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGH-DAEREFNNEVNWLTKIRHQNIISLLGYCIHAET-------  223 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------  223 (439)
                      ++|++.+.||+|+||+||+|+.. ++..+|+|.++.... ...+.+.+|+.+|++++|||||++++++.+.+.       
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            45888999999999999999875 578999999875443 344679999999999999999999999876543       


Q ss_pred             -----eEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEe
Q 013636          224 -----RFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSD  298 (439)
Q Consensus       224 -----~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~D  298 (439)
                           .++|||||++|+|.+++.+.......++..+..++.|+++||+|||++   +|+||||||+|||++.++++||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEcc
Confidence                 689999999999999998655445567788899999999999999998   999999999999999999999999


Q ss_pred             cccccccCCCCc-------------ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhh
Q 013636          299 FGLSVTAGTQSR-------------NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSM  365 (439)
Q Consensus       299 fGls~~~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~  365 (439)
                      ||+|+.......             ....+||+.|||||++.+..|+.++|||||||++|||++   ||....  +....
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~--~~~~~  236 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM--ERVRT  236 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH--HHHHH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc--HHHHH
Confidence            999976543221             123469999999999999999999999999999999996   775421  11111


Q ss_pred             HhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          366 VTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      ....    . ....+...         ........+++.+||+.||++|||+.|++++
T Consensus       237 ~~~~----~-~~~~p~~~---------~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  280 (299)
T 4g31_A          237 LTDV----R-NLKFPPLF---------TQKYPCEYVMVQDMLSPSPMERPEAINIIEN  280 (299)
T ss_dssp             HHHH----H-TTCCCHHH---------HHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHH----h-cCCCCCCC---------cccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            1110    0 11111111         1122345679999999999999999999975

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-48  Score=388.23  Aligned_cols=260  Identities=24%  Similarity=0.333  Sum_probs=203.2

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCceeeeeeEEEeC------Ce
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLLGYCIHA------ET  223 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  223 (439)
                      ++|++.+.||+|+||+||+|+.. .+..||||+++...  ....+.+.+|+.+|+.++|||||++++++...      +.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            57999999999999999999885 58899999997543  23446788999999999999999999987643      57


Q ss_pred             eEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccccc
Q 013636          224 RFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSV  303 (439)
Q Consensus       224 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~  303 (439)
                      .|+|||||+ |+|.+++..   ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+|+
T Consensus       134 ~~ivmE~~~-g~L~~~i~~---~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~  206 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHS---SQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMAR  206 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTS---SSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEeCCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceee
Confidence            899999996 689999964   35699999999999999999999998   99999999999999999999999999997


Q ss_pred             ccCCC-----CcceeeccccCccchhhhcCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccC-
Q 013636          304 TAGTQ-----SRNVKISGTLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDR-  376 (439)
Q Consensus       304 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~-  376 (439)
                      .....     ......+||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.+..+....+.......... 
T Consensus       207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~  286 (398)
T 4b99_A          207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAV  286 (398)
T ss_dssp             CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred             ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence            65332     122346799999999998875 56899999999999999999999999877655433332211111000 


Q ss_pred             -C------------CCCccCC---chhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          377 -S------------KLPNIVD---PVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       377 -~------------~~~~~~d---~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                       .            .++....   ..+....    ..++.+++.+||+.||++|||+.|+++|
T Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----s~~~~dLl~~mL~~dP~~R~ta~e~L~H  345 (398)
T 4b99_A          287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGA----DRQALSLLGRMLRFEPSARISAAAALRH  345 (398)
T ss_dssp             TC-----CHHHHHHSSCCCCCCCHHHHSTTC----CHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCC----CHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence             0            0000000   0000111    2356789999999999999999999975

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=5.7e-49  Score=381.06  Aligned_cols=279  Identities=37%  Similarity=0.676  Sum_probs=240.3

Q ss_pred             HHHHHhcCCCccceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEE
Q 013636          147 LLEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFL  226 (439)
Q Consensus       147 ~l~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  226 (439)
                      +++..+++|+..+.||+|+||+||+|+.+++..+|+|.+........+.+.+|+.+++.++||||+++++++...+..++
T Consensus        33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  112 (321)
T 2qkw_B           33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL  112 (321)
T ss_dssp             CCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred             HHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence            34557789999999999999999999998899999999987766677889999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhcCCCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccccccc
Q 013636          227 VYEMMQNGSLEKQLHGPTH-GSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA  305 (439)
Q Consensus       227 V~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~  305 (439)
                      ||||+++|+|.+++..... ...+++..+..++.|+++||+|||+.   +++||||||+||+++.++.+||+|||++...
T Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  189 (321)
T 2qkw_B          113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKG  189 (321)
T ss_dssp             EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEEC
T ss_pred             EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence            9999999999999975332 34699999999999999999999998   9999999999999999999999999999764


Q ss_pred             CCCCc---ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCcc
Q 013636          306 GTQSR---NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNI  382 (439)
Q Consensus       306 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  382 (439)
                      .....   .....||+.|+|||.+.+..++.++||||||+++|||++|+.||....+.+......|.... .....+...
T Consensus       190 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  268 (321)
T 2qkw_B          190 TELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES-HNNGQLEQI  268 (321)
T ss_dssp             SSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHH-HTTTCCCSS
T ss_pred             ccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhc-cccccHHHh
Confidence            33221   22345899999999999999999999999999999999999999877665555555544322 234456677


Q ss_pred             CCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCC
Q 013636          383 VDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVP  429 (439)
Q Consensus       383 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~  429 (439)
                      .++.+...........+.+++.+||+.||++|||+.|++++|+.++.
T Consensus       269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~  315 (321)
T 2qkw_B          269 VDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR  315 (321)
T ss_dssp             SSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence            77777777788888999999999999999999999999999987764

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.8e-48  Score=404.71  Aligned_cols=253  Identities=20%  Similarity=0.269  Sum_probs=215.4

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEe
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      .++|++.+.||+|+||+||+|+.. .+..+|+|.+........+.+.+|+.+|+.++|||||++++++.+.+..++||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            368999999999999999999885 5789999999876666677899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC--CcEEEEecccccccCCC
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS--FNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~--~~~kl~DfGls~~~~~~  308 (439)
                      |++|+|.+++..  ....+++..+..++.||+.||+|||++   +|+||||||+|||++.+  +.+||+|||+|+.....
T Consensus       236 ~~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~  310 (573)
T 3uto_A          236 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  310 (573)
T ss_dssp             CCCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred             cCCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence            999999999963  335699999999999999999999998   99999999999999854  89999999999987766


Q ss_pred             CcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhc
Q 013636          309 SRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIR  388 (439)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  388 (439)
                      ......+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.+..+....+...      ....+    +...
T Consensus       311 ~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~------~~~~~----~~~~  380 (573)
T 3uto_A          311 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC------DWNMD----DSAF  380 (573)
T ss_dssp             SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT------CCCCC----SGGG
T ss_pred             CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhC------CCCCC----cccc
Confidence            6666678999999999999999999999999999999999999999987765544333211      11111    1111


Q ss_pred             CccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          389 DTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       389 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      ..++    ..+.+++.+||+.||++|||+.|+++|
T Consensus       381 ~~~s----~~~~dli~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          381 SGIS----EDGKDFIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             TTSC----HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             cCCC----HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            1122    246679999999999999999999986

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=3.8e-48  Score=380.36  Aligned_cols=197  Identities=26%  Similarity=0.378  Sum_probs=170.6

Q ss_pred             HhcCCCccceecccCcEEEEEEEEC----CccEEEEEEecCCCchHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeeE
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARFN----EKLLAAVKRIDDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRF  225 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  225 (439)
                      ..++|++.+.||+|+||+||+|+.+    .+..||+|.+....  ...++.+|+++|+.+ +||||+++++++.+.+..+
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~   96 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV   96 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence            4578999999999999999999763    46789999987643  345678999999998 6999999999999999999


Q ss_pred             EEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC-CcEEEEecccccc
Q 013636          226 LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS-FNAKLSDFGLSVT  304 (439)
Q Consensus       226 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~-~~~kl~DfGls~~  304 (439)
                      +||||+++|+|.+++.      .+++..+..++.|++.||+|||++   +|+||||||+|||++.+ +++||+|||+|+.
T Consensus        97 lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~  167 (361)
T 4f9c_A           97 IAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQG  167 (361)
T ss_dssp             EEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence            9999999999999984      388999999999999999999998   99999999999999877 7999999999975


Q ss_pred             cCCCC-----------------------------cceeeccccCccchhhhcCC-CCCCchhhHHHHHHHHHHHhCCCCC
Q 013636          305 AGTQS-----------------------------RNVKISGTLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGRRPV  354 (439)
Q Consensus       305 ~~~~~-----------------------------~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvll~elltG~~P~  354 (439)
                      .....                             .....+||+.|+|||++.+. .++.++||||+||++|||++|+.||
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf  247 (361)
T 4f9c_A          168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF  247 (361)
T ss_dssp             CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred             cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence            43221                             11234699999999999875 5899999999999999999999999


Q ss_pred             CCCC
Q 013636          355 EKMS  358 (439)
Q Consensus       355 ~~~~  358 (439)
                      ...+
T Consensus       248 ~~~~  251 (361)
T 4f9c_A          248 YKAS  251 (361)
T ss_dssp             SCCS
T ss_pred             CCCC
Confidence            6543

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=3.9e-48  Score=375.79  Aligned_cols=290  Identities=36%  Similarity=0.648  Sum_probs=241.2

Q ss_pred             cccccHHHHHHHhcCCCccceecccCcEEEEEEEECCccEEEEEEecCCCch-HHHHHHHHHHHHHhcCCCceeeeeeEE
Q 013636          140 VSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHD-AEREFNNEVNWLTKIRHQNIISLLGYC  218 (439)
Q Consensus       140 ~~~~~~~~l~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~  218 (439)
                      ...+...+++...++|+..+.||+|+||.||+|+..++..+|+|.+...... ....+.+|+.++++++||||+++++++
T Consensus        17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   96 (326)
T 3uim_A           17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC   96 (326)
T ss_dssp             CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred             cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence            4567788899999999999999999999999999888999999999764322 223689999999999999999999999


Q ss_pred             EeCCeeEEEEEeccCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEE
Q 013636          219 IHAETRFLVYEMMQNGSLEKQLHGPT-HGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLS  297 (439)
Q Consensus       219 ~~~~~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~  297 (439)
                      ...+..++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+.+.++++||||||+|||+++++.+||+
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~  176 (326)
T 3uim_A           97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG  176 (326)
T ss_dssp             CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred             ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence            99999999999999999999998643 34469999999999999999999999766799999999999999999999999


Q ss_pred             ecccccccCCCCcc--eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh--hhhhhhHhhhhccc
Q 013636          298 DFGLSVTAGTQSRN--VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSP--TQCQSMVTWAMPQL  373 (439)
Q Consensus       298 DfGls~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~--~~~~~~~~~~~~~~  373 (439)
                      |||++.........  ....||+.|+|||.+.+..++.++||||||+++|||++|+.||.....  ........|... .
T Consensus       177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~  255 (326)
T 3uim_A          177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG-L  255 (326)
T ss_dssp             CCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT-T
T ss_pred             cCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH-H
Confidence            99999866433322  234589999999999999999999999999999999999999963211  111222333322 2


Q ss_pred             ccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCC
Q 013636          374 TDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPT  430 (439)
Q Consensus       374 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~  430 (439)
                      ..........+..+...........+.+++.+||+.||++|||+.||+++|+.....
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~  312 (326)
T 3uim_A          256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA  312 (326)
T ss_dssp             TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCS
T ss_pred             hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchh
Confidence            334556677777777778888899999999999999999999999999999765443

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.4e-47  Score=397.15  Aligned_cols=249  Identities=25%  Similarity=0.349  Sum_probs=200.1

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC---chHHHHH---HHHHHHHHhcCCCceeeeeeEEEeCCeeE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG---HDAEREF---NNEVNWLTKIRHQNIISLLGYCIHAETRF  225 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~---~~E~~~l~~l~h~niv~l~~~~~~~~~~~  225 (439)
                      ++|++.++||+|+||+||+|+.. .+..+|+|.+....   ......+   ..++.+++.++|||||++++++.+.+..|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            67999999999999999999886 47899999986421   1112223   34466777889999999999999999999


Q ss_pred             EEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccccccc
Q 013636          226 LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA  305 (439)
Q Consensus       226 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~  305 (439)
                      +|||||+||+|.++|..   ...+++..+..++.||+.||+|||++   +|+||||||+||||+.+|++||+|||+|+..
T Consensus       269 lVmEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~  342 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDF  342 (689)
T ss_dssp             EEECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeec
Confidence            99999999999999964   34699999999999999999999998   9999999999999999999999999999876


Q ss_pred             CCCCcceeeccccCccchhhhcC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCC
Q 013636          306 GTQSRNVKISGTLGYVAPEYLLE-GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVD  384 (439)
Q Consensus       306 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  384 (439)
                      .... ....+||+.|||||++.. ..|+.++|+||+||++|||++|+.||...+......+....   ......++..++
T Consensus       343 ~~~~-~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i---~~~~~~~p~~~S  418 (689)
T 3v5w_A          343 SKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---LTMAVELPDSFS  418 (689)
T ss_dssp             SSCC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHH---HHCCCCCCTTSC
T ss_pred             CCCC-CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh---cCCCCCCCccCC
Confidence            5433 345679999999999975 57999999999999999999999999764332222221111   112223333333


Q ss_pred             chhcCccCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHh
Q 013636          385 PVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPL-----ITDVLHS  423 (439)
Q Consensus       385 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~  423 (439)
                      +            .+.+++..||+.||++|++     +.|+++|
T Consensus       419 ~------------~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H  450 (689)
T 3v5w_A          419 P------------ELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  450 (689)
T ss_dssp             H------------HHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred             H------------HHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence            2            4567999999999999998     6888754

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=9.2e-47  Score=363.94  Aligned_cols=263  Identities=32%  Similarity=0.510  Sum_probs=207.7

Q ss_pred             HHhcCCCccceecccCcEEEEEEEECCccEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEE
Q 013636          150 AATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLV  227 (439)
Q Consensus       150 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  227 (439)
                      ...++|++.+.||+|+||+||+|+.. +..+|+|.+....  ....+++.+|+.++++++||||+++++++...+..++|
T Consensus        34 i~~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 3p86_A           34 IPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV  112 (309)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred             CChhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence            34578889999999999999999874 6678999987544  33446799999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEecCCCCCCEEEcCCCcEEEEeccccccc
Q 013636          228 YEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHP--VVHRDLKSSNILLDSSFNAKLSDFGLSVTA  305 (439)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~--ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~  305 (439)
                      |||+++|+|.+++........+++..+..++.|+++||+|||+.   +  ++||||||+||++++++.+||+|||++...
T Consensus       113 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~  189 (309)
T 3p86_A          113 TEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK  189 (309)
T ss_dssp             EECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred             EecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence            99999999999997533333489999999999999999999998   7  999999999999999999999999999765


Q ss_pred             CCCCc-ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCC
Q 013636          306 GTQSR-NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVD  384 (439)
Q Consensus       306 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  384 (439)
                      ..... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...++.+....+...    .....++..++
T Consensus       190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~----~~~~~~~~~~~  265 (309)
T 3p86_A          190 ASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFK----CKRLEIPRNLN  265 (309)
T ss_dssp             ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHS----CCCCCCCTTSC
T ss_pred             cccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc----CCCCCCCccCC
Confidence            43322 23456899999999999999999999999999999999999999987765543333211    11122222222


Q ss_pred             chhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCCCC
Q 013636          385 PVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPTDL  432 (439)
Q Consensus       385 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~~~  432 (439)
                                  ..+.+++.+||+.||++|||+.++++.|++++....
T Consensus       266 ------------~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~  301 (309)
T 3p86_A          266 ------------PQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV  301 (309)
T ss_dssp             ------------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred             ------------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence                        356779999999999999999999999988876543

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.3e-46  Score=362.68  Aligned_cols=257  Identities=23%  Similarity=0.392  Sum_probs=210.3

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEec
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMM  231 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  231 (439)
                      ++|+..+.||+|+||+||+|... ++..+|+|.+........+.|.+|+.++++++||||+++++++.+.+..++||||+
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   89 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI   89 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence            57888999999999999999985 47889999987776677788999999999999999999999999999999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCcc
Q 013636          232 QNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN  311 (439)
Q Consensus       232 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~~  311 (439)
                      ++|+|.+++..  ....+++..+..++.|+++||+|||+.   +++||||||+||++++++.+||+|||++.........
T Consensus        90 ~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  164 (310)
T 3s95_A           90 KGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ  164 (310)
T ss_dssp             TTCBHHHHHHH--CCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred             CCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence            99999999974  245699999999999999999999998   9999999999999999999999999999765432221


Q ss_pred             ---------------eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccC
Q 013636          312 ---------------VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDR  376 (439)
Q Consensus       312 ---------------~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~  376 (439)
                                     ....||+.|+|||.+.+..++.++||||||+++|||++|..|+....+........         
T Consensus       165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~---------  235 (310)
T 3s95_A          165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN---------  235 (310)
T ss_dssp             ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC---------
T ss_pred             ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh---------
Confidence                           13468999999999999999999999999999999999999987643322110000         


Q ss_pred             CCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCC
Q 013636          377 SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVP  429 (439)
Q Consensus       377 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~  429 (439)
                            ................+.+++.+||+.||++|||+.++++.|+.+..
T Consensus       236 ------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~  282 (310)
T 3s95_A          236 ------VRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM  282 (310)
T ss_dssp             ------HHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------hhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence                  00000000000112246679999999999999999999999987754

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=3.6e-46  Score=362.74  Aligned_cols=248  Identities=23%  Similarity=0.361  Sum_probs=210.5

Q ss_pred             hcCCCccceecccCcEEEEEEEE-CCccEEEEEEecCC--CchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARF-NEKLLAAVKRIDDA--GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      .++|++.+.||+|+||.||+|+. .++..+|+|.+...  .....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            36789999999999999999998 56889999998654  2344567889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~  308 (439)
                      ||+++|+|.+++..   ...+++..+..++.|+++||+|||+.   +++||||||+|||++.++++||+|||++......
T Consensus        94 e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  167 (328)
T 3fe3_A           94 EYASGGEVFDYLVA---HGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG  167 (328)
T ss_dssp             CCCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred             ECCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence            99999999999964   24589999999999999999999998   9999999999999999999999999999876655


Q ss_pred             CcceeeccccCccchhhhcCCCCC-CchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchh
Q 013636          309 SRNVKISGTLGYVAPEYLLEGKLT-DKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVI  387 (439)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  387 (439)
                      ......+||+.|+|||.+.+..++ .++||||+||++|||++|+.||.+.+..+....+..      ....++....   
T Consensus       168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~------~~~~~p~~~s---  238 (328)
T 3fe3_A          168 GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR------GKYRIPFYMS---  238 (328)
T ss_dssp             CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------CCCCCCTTSC---
T ss_pred             CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh------CCCCCCCCCC---
Confidence            544556799999999999988875 789999999999999999999998776554433321      1122222222   


Q ss_pred             cCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          388 RDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       388 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                               ..+.+++.+||+.||++|||+.|++++
T Consensus       239 ---------~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          239 ---------TDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             ---------HHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             ---------HHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                     246679999999999999999999976

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.2e-45  Score=354.09  Aligned_cols=250  Identities=21%  Similarity=0.365  Sum_probs=209.4

Q ss_pred             hcCCCccceecccCcEEEEEEEE-CCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEe
Q 013636          152 TNNFQESNVIGEGGRGHVYKARF-NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      .++|+..+.||+|+||+||+|.. .++..+|+|.+........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            46899999999999999999986 45789999998766555667899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR  310 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~  310 (439)
                      +++|+|.+++...    .+++..+..++.|++.||+|||+.   +++||||||+|||++.++++||+|||++........
T Consensus        99 ~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  171 (297)
T 3fxz_A           99 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (297)
T ss_dssp             CTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             CCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence            9999999999642    489999999999999999999998   999999999999999999999999999976544322


Q ss_pred             -ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcC
Q 013636          311 -NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRD  389 (439)
Q Consensus       311 -~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  389 (439)
                       .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...++...........     ...   ...+   .
T Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~-----~~~---~~~~---~  240 (297)
T 3fxz_A          172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-----TPE---LQNP---E  240 (297)
T ss_dssp             CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC-----SCC---CSCG---G
T ss_pred             ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----CCC---CCCc---c
Confidence             234569999999999999999999999999999999999999998776544332221110     000   0000   1


Q ss_pred             ccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          390 TMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       390 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      .    ....+.+++.+||+.||++|||+.|++++
T Consensus       241 ~----~~~~~~~li~~~l~~dp~~Rps~~ell~h  270 (297)
T 3fxz_A          241 K----LSAIFRDFLNRCLEMDVEKRGSAKELLQH  270 (297)
T ss_dssp             G----SCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             c----cCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            1    12346779999999999999999999975

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2e-45  Score=353.46  Aligned_cols=282  Identities=35%  Similarity=0.579  Sum_probs=226.1

Q ss_pred             cccccHHHHHHHhcCCCcc------ceecccCcEEEEEEEECCccEEEEEEecCC----CchHHHHHHHHHHHHHhcCCC
Q 013636          140 VSVIEYELLEAATNNFQES------NVIGEGGRGHVYKARFNEKLLAAVKRIDDA----GHDAEREFNNEVNWLTKIRHQ  209 (439)
Q Consensus       140 ~~~~~~~~l~~~~~~~~~~------~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~  209 (439)
                      ...+.+.+++.++++|...      +.||+|+||.||+|+. ++..+|+|.+...    .....+.+.+|+.++++++||
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   90 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE   90 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence            4567888899999998877      8999999999999987 4678899988643    233456799999999999999


Q ss_pred             ceeeeeeEEEeCCeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc
Q 013636          210 NIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLD  289 (439)
Q Consensus       210 niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~  289 (439)
                      ||+++++++.+.+..++||||+++|+|.+++........+++..+..++.|++.||+|||+.   +++||||||+||+++
T Consensus        91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~  167 (307)
T 2nru_A           91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLD  167 (307)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEC
T ss_pred             CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEc
Confidence            99999999999999999999999999999997644456799999999999999999999998   999999999999999


Q ss_pred             CCCcEEEEecccccccCCCCcc---eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhH
Q 013636          290 SSFNAKLSDFGLSVTAGTQSRN---VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMV  366 (439)
Q Consensus       290 ~~~~~kl~DfGls~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~  366 (439)
                      +++.+||+|||++.........   ....||+.|+|||.+.+ .++.++||||||+++|||++|+.||...........+
T Consensus       168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~  246 (307)
T 2nru_A          168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI  246 (307)
T ss_dssp             TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHH
T ss_pred             CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHH
Confidence            9999999999999765443221   23458999999998764 5889999999999999999999999875433221111


Q ss_pred             hhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCC
Q 013636          367 TWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVP  429 (439)
Q Consensus       367 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~  429 (439)
                      ....  ......+...+++.+. .........+.+++..||+.||++|||+.+++++|+++..
T Consensus       247 ~~~~--~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          247 KEEI--EDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             HHHH--HTTSCCHHHHSCSSCS-CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             HHHh--hhhhhhhhhhcccccc-ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            1100  0111222233333222 2345567788999999999999999999999999988754

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.8e-45  Score=363.81  Aligned_cols=258  Identities=25%  Similarity=0.432  Sum_probs=212.2

Q ss_pred             hcCCCccceecccCcEEEEEEEEC--------CccEEEEEEecCCCc-hHHHHHHHHHHHHHhc-CCCceeeeeeEEEeC
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN--------EKLLAAVKRIDDAGH-DAEREFNNEVNWLTKI-RHQNIISLLGYCIHA  221 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  221 (439)
                      .++|++.+.||+|+||.||+|+..        ++..+|+|.++.... ...+.+.+|+.+++++ +||||++++++|...
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            467888999999999999999862        356799999976533 3446799999999999 899999999999999


Q ss_pred             CeeEEEEEeccCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE
Q 013636          222 ETRFLVYEMMQNGSLEKQLHGPT-------------HGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILL  288 (439)
Q Consensus       222 ~~~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl  288 (439)
                      +..++||||+++|+|.+++....             ....+++..+..++.|+++||+|||+.   +|+||||||+|||+
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEE
Confidence            99999999999999999997532             124589999999999999999999998   99999999999999


Q ss_pred             cCCCcEEEEecccccccCCCCc---ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhh
Q 013636          289 DSSFNAKLSDFGLSVTAGTQSR---NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQS  364 (439)
Q Consensus       289 ~~~~~~kl~DfGls~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~  364 (439)
                      +.++.+||+|||++........   .....+|+.|+|||.+.+..++.++|||||||++|||++ |+.||...+..+...
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~  316 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK  316 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            9999999999999976543222   122346789999999999999999999999999999999 999998876554333


Q ss_pred             hHhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCC
Q 013636          365 MVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVP  429 (439)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~  429 (439)
                      .+...     .....+.            .....+.+++..||+.||++|||+.|+++.|+.++.
T Consensus       317 ~~~~~-----~~~~~~~------------~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~  364 (370)
T 2psq_A          317 LLKEG-----HRMDKPA------------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  364 (370)
T ss_dssp             HHHTT-----CCCCCCT------------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHhcC-----CCCCCCC------------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            32211     0111111            112357779999999999999999999999988764

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.5e-45  Score=357.95  Aligned_cols=257  Identities=28%  Similarity=0.433  Sum_probs=211.1

Q ss_pred             hcCCCccceecccCcEEEEEEEEC----CccEEEEEEecCC-CchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN----EKLLAAVKRIDDA-GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFL  226 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  226 (439)
                      .++|++.+.||+|+||+||+|++.    .+..+|+|.+... .....+.|.+|+.++++++||||+++++++.+.+..++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            467888999999999999999984    4556999999764 33445679999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccC
Q 013636          227 VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAG  306 (439)
Q Consensus       227 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~  306 (439)
                      ||||+++|+|.+++..  ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++....
T Consensus       128 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          128 VTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE  202 (325)
T ss_dssp             EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             EeeCCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence            9999999999999974  335699999999999999999999998   99999999999999999999999999997764


Q ss_pred             CCCcc----eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCc
Q 013636          307 TQSRN----VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPN  381 (439)
Q Consensus       307 ~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  381 (439)
                      .....    ....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+....+...     .....+.
T Consensus       203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~  277 (325)
T 3kul_A          203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG-----YRLPAPM  277 (325)
T ss_dssp             ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT-----CCCCCCT
T ss_pred             cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-----CCCCCCC
Confidence            43221    12235778999999999999999999999999999999 99999887765543333211     0111111


Q ss_pred             cCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCC
Q 013636          382 IVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPT  430 (439)
Q Consensus       382 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~  430 (439)
                                  .....+.+++..||+.||++|||+.++++.|+.+...
T Consensus       278 ------------~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~  314 (325)
T 3kul_A          278 ------------GCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS  314 (325)
T ss_dssp             ------------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             ------------CcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence                        1123577899999999999999999999999888653

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=6.1e-45  Score=353.04  Aligned_cols=259  Identities=25%  Similarity=0.350  Sum_probs=213.1

Q ss_pred             ccHHHHHHHhcC----------CCccceecccCcEEEEEEEEC-CccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCce
Q 013636          143 IEYELLEAATNN----------FQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNI  211 (439)
Q Consensus       143 ~~~~~l~~~~~~----------~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni  211 (439)
                      ++.++++.+++.          |+..+.||+|+||.||+|+.. ++..||||.+........+.+.+|+.++++++||||
T Consensus        25 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni  104 (321)
T 2c30_A           25 VTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNV  104 (321)
T ss_dssp             CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTB
T ss_pred             CcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCc
Confidence            455555555543          666789999999999999986 688999999987666667789999999999999999


Q ss_pred             eeeeeEEEeCCeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC
Q 013636          212 ISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS  291 (439)
Q Consensus       212 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~  291 (439)
                      +++++++...+..++||||+++|+|.+++..    ..+++..+..++.|+++||+|||+.   +++||||||+||+++.+
T Consensus       105 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~  177 (321)
T 2c30_A          105 VEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLD  177 (321)
T ss_dssp             CCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT
T ss_pred             ceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCC
Confidence            9999999999999999999999999999864    3589999999999999999999998   99999999999999999


Q ss_pred             CcEEEEecccccccCCCC-cceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhh
Q 013636          292 FNAKLSDFGLSVTAGTQS-RNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAM  370 (439)
Q Consensus       292 ~~~kl~DfGls~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~  370 (439)
                      +.+||+|||++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...++.+....+... 
T Consensus       178 ~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~-  256 (321)
T 2c30_A          178 GRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS-  256 (321)
T ss_dssp             CCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-
T ss_pred             CcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-
Confidence            999999999997654432 223456999999999999999999999999999999999999999877654432222110 


Q ss_pred             cccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          371 PQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       371 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                        .  ....   ..   ....    ...+.+++.+||+.||++|||+.|++++
T Consensus       257 --~--~~~~---~~---~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          257 --P--PPKL---KN---SHKV----SPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             --S--CCCC---TT---GGGS----CHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             --C--CCCc---Cc---cccC----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              0  0000   00   0111    2356779999999999999999999976

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=2.3e-45  Score=346.19  Aligned_cols=257  Identities=27%  Similarity=0.438  Sum_probs=213.5

Q ss_pred             hcCCCccceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEec
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMM  231 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  231 (439)
                      .++|++.+.||+|+||.||+|+..++..+|+|.+..... ..+++.+|+.++++++||||+++++++.+.+..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            467888999999999999999999988999999976543 3467899999999999999999999999999999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCcc
Q 013636          232 QNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN  311 (439)
Q Consensus       232 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~~  311 (439)
                      ++|+|.+++..  .+..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++.........
T Consensus        86 ~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  160 (268)
T 3sxs_A           86 SNGCLLNYLRS--HGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV  160 (268)
T ss_dssp             TTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred             CCCcHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence            99999999964  234589999999999999999999998   9999999999999999999999999999765443322


Q ss_pred             --eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhc
Q 013636          312 --VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIR  388 (439)
Q Consensus       312 --~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  388 (439)
                        ....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...+.......+....     ....+...     
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~-----  230 (268)
T 3sxs_A          161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH-----RLYRPHLA-----  230 (268)
T ss_dssp             ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC-----CCCCCTTS-----
T ss_pred             cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCC-----CCCCCCcC-----
Confidence              22335678999999999899999999999999999999 999998776554332222110     11111111     


Q ss_pred             CccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCCC
Q 013636          389 DTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPTD  431 (439)
Q Consensus       389 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~~  431 (439)
                             ...+.+++..||+.||++|||+.|++++|+.+...+
T Consensus       231 -------~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~  266 (268)
T 3sxs_A          231 -------SDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD  266 (268)
T ss_dssp             -------CHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred             -------hHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence                   235677999999999999999999999999987653

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.4e-45  Score=348.09  Aligned_cols=255  Identities=25%  Similarity=0.421  Sum_probs=213.3

Q ss_pred             cCCCccceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEecc
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQ  232 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  232 (439)
                      ++|+..+.||+|+||.||+|+..++..+|+|.+..... ..+++.+|+.++++++||||+++++++.+.+..++||||++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   88 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence            57888999999999999999998888899999986543 34679999999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc--
Q 013636          233 NGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR--  310 (439)
Q Consensus       233 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~--  310 (439)
                      +|+|.+++..  ....+++..+..++.|+++||+|||+.   +++||||||+||+++.++.+||+|||++........  
T Consensus        89 ~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  163 (269)
T 4hcu_A           89 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS  163 (269)
T ss_dssp             TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred             CCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccccccc
Confidence            9999999974  335689999999999999999999998   999999999999999999999999999976543221  


Q ss_pred             ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcC
Q 013636          311 NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRD  389 (439)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  389 (439)
                      .....+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||...+..+....+...     .....+...      
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~------  232 (269)
T 4hcu_A          164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-----FRLYKPRLA------  232 (269)
T ss_dssp             TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-----CCCCCCTTS------
T ss_pred             ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC-----ccCCCCCcC------
Confidence            122346778999999999999999999999999999999 99999887665433332211     011111111      


Q ss_pred             ccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCC
Q 013636          390 TMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPT  430 (439)
Q Consensus       390 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~  430 (439)
                            ...+.+++..||+.||++|||+.+++++|+++...
T Consensus       233 ------~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          233 ------STHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             ------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             ------CHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence                  23567799999999999999999999999887654

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.7e-44  Score=355.34  Aligned_cols=252  Identities=25%  Similarity=0.282  Sum_probs=210.1

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCch------HHHHHHHHHHHHHhcCCCceeeeeeEEEeCCee
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHD------AEREFNNEVNWLTKIRHQNIISLLGYCIHAETR  224 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  224 (439)
                      .++|++.+.||+|+||.||+++.. ++..+|+|.+......      ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            467889999999999999999886 4788999998754321      346789999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC----cEEEEecc
Q 013636          225 FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSF----NAKLSDFG  300 (439)
Q Consensus       225 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~----~~kl~DfG  300 (439)
                      ++||||+++|+|.+++..   ...+++..+..++.|++.||+|||+.   +|+||||||+|||+++++    .+||+|||
T Consensus        91 ~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG  164 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (361)
T ss_dssp             EEEEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred             EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence            999999999999999953   34699999999999999999999998   999999999999998877    79999999


Q ss_pred             cccccCCCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCC
Q 013636          301 LSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLP  380 (439)
Q Consensus       301 ls~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  380 (439)
                      ++.............||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+...      ...  
T Consensus       165 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~------~~~--  236 (361)
T 2yab_A          165 LAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV------SYD--  236 (361)
T ss_dssp             SCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT------CCC--
T ss_pred             CceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc------CCC--
Confidence            998766554445567999999999999999999999999999999999999999887655433222211      011  


Q ss_pred             ccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          381 NIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       381 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                        +++......    ...+.+++..||+.||++|||+.|++++
T Consensus       237 --~~~~~~~~~----s~~~~~li~~~L~~dP~~R~t~~e~l~h  273 (361)
T 2yab_A          237 --FDEEFFSQT----SELAKDFIRKLLVKETRKRLTIQEALRH  273 (361)
T ss_dssp             --CCHHHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             --CCchhccCC----CHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence              111111222    2356789999999999999999999975

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=9.4e-45  Score=351.09  Aligned_cols=273  Identities=19%  Similarity=0.273  Sum_probs=214.9

Q ss_pred             hcCCCccceecccCcEEEEEEEECC-ccEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC--eeEEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAG-HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE--TRFLV  227 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lV  227 (439)
                      .++|++.+.||+|+||+||+|+... +..+|+|.+.... ....+.+.+|++++++++||||+++++++...+  ..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            3678889999999999999999865 7899999997543 233567889999999999999999999998765  77999


Q ss_pred             EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE----cCCCcEEEEeccccc
Q 013636          228 YEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILL----DSSFNAKLSDFGLSV  303 (439)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl----~~~~~~kl~DfGls~  303 (439)
                      |||+++|+|.+++........+++..+..++.|++.||+|||+.   +++||||||+|||+    +.++.+||+|||++.
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            99999999999998654445599999999999999999999998   99999999999999    788889999999998


Q ss_pred             ccCCCCcceeeccccCccchhhhc--------CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhh-hhhhHhhhhcccc
Q 013636          304 TAGTQSRNVKISGTLGYVAPEYLL--------EGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQ-CQSMVTWAMPQLT  374 (439)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~-~~~~~~~~~~~~~  374 (439)
                      ............||+.|+|||.+.        +..++.++|||||||++|||++|+.||....... .............
T Consensus       165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p  244 (319)
T 4euu_A          165 ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP  244 (319)
T ss_dssp             ECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCC
T ss_pred             ecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCC
Confidence            776655555567999999999986        5788999999999999999999999997543222 1111111110000


Q ss_pred             --------cCCCCCccCCc--hhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhcccc
Q 013636          375 --------DRSKLPNIVDP--VIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPL  427 (439)
Q Consensus       375 --------~~~~~~~~~d~--~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l  427 (439)
                              ......-..++  .............+.+++.+||+.||++|||+.|++++...-
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~  307 (319)
T 4euu_A          245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (319)
T ss_dssp             TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             cccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence                    00000000000  111234456677888999999999999999999999988643

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=3.3e-45  Score=362.23  Aligned_cols=256  Identities=28%  Similarity=0.439  Sum_probs=201.7

Q ss_pred             hcCCCccceecccCcEEEEEEEEC----CccEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN----EKLLAAVKRIDDAG-HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFL  226 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  226 (439)
                      .++|++.+.||+|+||.||+|+..    .+..+|+|.++... ....++|.+|+.++++++||||+++++++.+.+..++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            368899999999999999999875    56789999997543 3445679999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccC
Q 013636          227 VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAG  306 (439)
Q Consensus       227 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~  306 (439)
                      ||||+++|+|.++++.  .+..+++..+..++.|+++||+|||+.   +++||||||+|||++.++.+||+|||++....
T Consensus       124 v~e~~~~~sL~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          124 VTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLE  198 (373)
T ss_dssp             EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence            9999999999999974  345699999999999999999999998   99999999999999999999999999997654


Q ss_pred             CCCcc----eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCc
Q 013636          307 TQSRN----VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPN  381 (439)
Q Consensus       307 ~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  381 (439)
                      .....    ....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...+..+....+....     ....+ 
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~-----~~~~~-  272 (373)
T 2qol_A          199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY-----RLPPP-  272 (373)
T ss_dssp             ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTE-----ECCCC-
T ss_pred             cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-----CCCCC-
Confidence            33211    11235678999999999999999999999999999998 999998877654433332110     00000 


Q ss_pred             cCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCC
Q 013636          382 IVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVP  429 (439)
Q Consensus       382 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~  429 (439)
                                 ......+.+++.+||+.||++||++.++++.|+.+..
T Consensus       273 -----------~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~  309 (373)
T 2qol_A          273 -----------MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR  309 (373)
T ss_dssp             -----------TTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----------ccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence                       0123467789999999999999999999999987754

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.1e-44  Score=349.76  Aligned_cols=265  Identities=24%  Similarity=0.343  Sum_probs=204.5

Q ss_pred             hcCCCccceecccCcEEEEEEEECCccEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGH--DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYE  229 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  229 (439)
                      .++|++.+.||+|+||+||+|+..++..+|+|++.....  .....+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   99 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE   99 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence            478899999999999999999998899999999875332  234678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCC
Q 013636          230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS  309 (439)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~  309 (439)
                      |+++ +|.+++..  ....+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++.......
T Consensus       100 ~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  173 (311)
T 3niz_A          100 FMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPV  173 (311)
T ss_dssp             CCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred             CCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence            9985 88888864  334689999999999999999999998   99999999999999999999999999998765332


Q ss_pred             c-ceeeccccCccchhhhcC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCc------
Q 013636          310 R-NVKISGTLGYVAPEYLLE-GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPN------  381 (439)
Q Consensus       310 ~-~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~------  381 (439)
                      . .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...+..+....+........ ....+.      
T Consensus       174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~~~~~~  252 (311)
T 3niz_A          174 RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPN-PREWPQVQELPL  252 (311)
T ss_dssp             C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCC-TTTSGGGTTSHH
T ss_pred             ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCC-hHHhhhhhccch
Confidence            2 233468999999999876 5689999999999999999999999987655433222211110000 000000      


Q ss_pred             -------cCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          382 -------IVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       382 -------~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                             ..+.............++.+++.+||+.||++|||+.|++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  301 (311)
T 3niz_A          253 WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH  301 (311)
T ss_dssp             HHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             hhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence                   000000000001122467789999999999999999999975

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=6.7e-45  Score=354.94  Aligned_cols=247  Identities=23%  Similarity=0.328  Sum_probs=207.1

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCC---CchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDA---GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      ++|+..+.||+|+||+||+++.. ++..+|+|.++..   .......+.+|+.+++.++||||+++++++...+..++||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            57888999999999999999886 5788999998653   2234457889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCC-
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT-  307 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~-  307 (439)
                      ||+++|+|.+++..   ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++++||+|||++..... 
T Consensus        85 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  158 (337)
T 1o6l_A           85 EYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             ECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence            99999999999863   34589999999999999999999998   999999999999999999999999999976432 


Q ss_pred             CCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchh
Q 013636          308 QSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVI  387 (439)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  387 (439)
                      .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+..      ....++..++   
T Consensus       159 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~------~~~~~p~~~s---  229 (337)
T 1o6l_A          159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM------EEIRFPRTLS---  229 (337)
T ss_dssp             TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------CCCCCCTTSC---
T ss_pred             CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHc------CCCCCCCCCC---
Confidence            2233456799999999999999999999999999999999999999987765543332221      1122222222   


Q ss_pred             cCccCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHh
Q 013636          388 RDTMDLKHLYQVAAVAVLCIQPEPSYRP-----LITDVLHS  423 (439)
Q Consensus       388 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  423 (439)
                               ..+.+++.+||+.||++||     ++.|++++
T Consensus       230 ---------~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          230 ---------PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             ---------HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             ---------HHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence                     3466799999999999999     89999875

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=9e-46  Score=366.86  Aligned_cols=258  Identities=28%  Similarity=0.445  Sum_probs=212.5

Q ss_pred             HHhcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEE
Q 013636          150 AATNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGH-DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLV  227 (439)
Q Consensus       150 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  227 (439)
                      ...++|+..+.||+|+||.||+|++. ++..||+|.+..... ...++|.+|+.++++++||||+++++++...+..++|
T Consensus       111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  190 (377)
T 3cbl_A          111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV  190 (377)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence            34568888999999999999999986 678999999875432 3345689999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCC
Q 013636          228 YEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT  307 (439)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~  307 (439)
                      |||+++|+|.+++..  .+..+++..+..++.|+++||+|||+.   +++||||||+|||+++++.+||+|||+++....
T Consensus       191 ~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~  265 (377)
T 3cbl_A          191 MELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEAD  265 (377)
T ss_dssp             EECCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred             EEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence            999999999999973  334589999999999999999999998   999999999999999999999999999976443


Q ss_pred             CCcc---eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCccC
Q 013636          308 QSRN---VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV  383 (439)
Q Consensus       308 ~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  383 (439)
                      ....   ....+++.|+|||.+.++.++.++|||||||++|||++ |..||...+..+....+...     .....+.. 
T Consensus       266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~-  339 (377)
T 3cbl_A          266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG-----GRLPCPEL-  339 (377)
T ss_dssp             SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTT-----CCCCCCTT-
T ss_pred             CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-----CCCCCCCC-
Confidence            2211   11225678999999999999999999999999999998 99999987765544333211     01111111 


Q ss_pred             CchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCC
Q 013636          384 DPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVP  429 (439)
Q Consensus       384 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~  429 (439)
                                 ....+.+++.+||+.||++|||+.++++.|+.+..
T Consensus       340 -----------~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~  374 (377)
T 3cbl_A          340 -----------CPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK  374 (377)
T ss_dssp             -----------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----------CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence                       12356779999999999999999999999987653

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=8.3e-45  Score=347.65  Aligned_cols=263  Identities=23%  Similarity=0.392  Sum_probs=210.1

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC---chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLV  227 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  227 (439)
                      .++|++.+.||+|+||.||+++.. .+..+|+|.+....   ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            467899999999999999999875 57889999885432   33446789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCC
Q 013636          228 YEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT  307 (439)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~  307 (439)
                      |||+++|+|.+++..   ...+++..+..++.|+++||+|||+.   +++||||||+||+++.++++||+|||++.....
T Consensus        90 ~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  163 (294)
T 4eqm_A           90 MEYIEGPTLSEYIES---HGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE  163 (294)
T ss_dssp             EECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred             EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence            999999999999964   24689999999999999999999998   999999999999999999999999999976543


Q ss_pred             CCc--ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCc
Q 013636          308 QSR--NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDP  385 (439)
Q Consensus       308 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  385 (439)
                      ...  .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...+........      ..  ...+.. ..
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~------~~--~~~~~~-~~  234 (294)
T 4eqm_A          164 TSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKH------IQ--DSVPNV-TT  234 (294)
T ss_dssp             -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHH------HS--SCCCCH-HH
T ss_pred             ccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH------hh--ccCCCc-ch
Confidence            322  22346899999999999999999999999999999999999999877654321111      00  011110 01


Q ss_pred             hhcCccCHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHhccccCCCCCC
Q 013636          386 VIRDTMDLKHLYQVAAVAVLCIQPEPSYRP-LITDVLHSLIPLVPTDLG  433 (439)
Q Consensus       386 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~evl~~L~~l~~~~~~  433 (439)
                      .....    ....+.+++.+||+.||++|| +++++.+.|+.++.+...
T Consensus       235 ~~~~~----~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~  279 (294)
T 4eqm_A          235 DVRKD----IPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRA  279 (294)
T ss_dssp             HSCTT----SCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSST
T ss_pred             hcccC----CCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccC
Confidence            11111    234677899999999999998 999999999998876544

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.9e-45  Score=348.27  Aligned_cols=258  Identities=24%  Similarity=0.430  Sum_probs=212.6

Q ss_pred             HhcCCCccceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEe
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      ..++|++.+.||+|+||.||+++..++..+|+|.+..... ..+++.+|+.++++++||||+++++++.+.+..++||||
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  100 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY  100 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence            3468888999999999999999999988999999986543 346789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR  310 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~  310 (439)
                      +++|+|.+++...  ...+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||++........
T Consensus       101 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  175 (283)
T 3gen_A          101 MANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY  175 (283)
T ss_dssp             CTTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred             cCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence            9999999999742  34599999999999999999999998   999999999999999999999999999976543221


Q ss_pred             c--eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchh
Q 013636          311 N--VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVI  387 (439)
Q Consensus       311 ~--~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  387 (439)
                      .  ....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...+.......+....     ....+...    
T Consensus       176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~----  246 (283)
T 3gen_A          176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL-----RLYRPHLA----  246 (283)
T ss_dssp             HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC-----CCCCCTTC----
T ss_pred             ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhccc-----CCCCCCcC----
Confidence            1  22336788999999999999999999999999999998 999998877654333332110     11111111    


Q ss_pred             cCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCCC
Q 013636          388 RDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPTD  431 (439)
Q Consensus       388 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~~  431 (439)
                              ...+.+++.+||+.||++|||+.+++++|+.+..++
T Consensus       247 --------~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e  282 (283)
T 3gen_A          247 --------SEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE  282 (283)
T ss_dssp             --------CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             --------CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence                    235677999999999999999999999999887654

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.5e-45  Score=352.78  Aligned_cols=252  Identities=24%  Similarity=0.295  Sum_probs=208.9

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCc------hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCee
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGH------DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETR  224 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  224 (439)
                      .++|++.+.||+|+||.||+++.. ++..+|+|.+.....      ...+.+.+|+.++++++||||+++++++...+..
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            357888999999999999999986 478899998865332      1356799999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC----cEEEEecc
Q 013636          225 FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSF----NAKLSDFG  300 (439)
Q Consensus       225 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~----~~kl~DfG  300 (439)
                      ++||||+++|+|.+++..   ...+++..+..++.|++.||+|||+.   +++||||||+|||++.++    .+||+|||
T Consensus        90 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  163 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG  163 (326)
T ss_dssp             EEEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence            999999999999999964   34699999999999999999999998   999999999999999887    89999999


Q ss_pred             cccccCCCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCC
Q 013636          301 LSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLP  380 (439)
Q Consensus       301 ls~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  380 (439)
                      ++.............||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+...      .... 
T Consensus       164 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~------~~~~-  236 (326)
T 2y0a_A          164 LAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV------NYEF-  236 (326)
T ss_dssp             TCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHT------CCCC-
T ss_pred             CCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhc------CCCc-
Confidence            998765444444566999999999999999999999999999999999999999876654433222211      0011 


Q ss_pred             ccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          381 NIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       381 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                         .+......    ...+.+++.+||+.||++|||+.|++++
T Consensus       237 ---~~~~~~~~----~~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          237 ---EDEYFSNT----SALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             ---CHHHHTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             ---CccccccC----CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence               11111111    2356789999999999999999999976

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-44  Score=348.33  Aligned_cols=252  Identities=18%  Similarity=0.235  Sum_probs=210.5

Q ss_pred             hcCCCccceecccCcEEEEEEEECC-ccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEe
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      .++|++.+.||+|+||.||++.... +..+|+|.+.... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            4688999999999999999998864 7788999887543 4456789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC--CCcEEEEecccccccCCC
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDS--SFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~--~~~~kl~DfGls~~~~~~  308 (439)
                      +++|+|.+++..  ....+++..+..++.|++.||+|||+.   +++||||||+|||++.  ++.+||+|||++......
T Consensus        83 ~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~  157 (321)
T 1tki_A           83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence            999999999964  334699999999999999999999998   9999999999999987  789999999999877655


Q ss_pred             CcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhc
Q 013636          309 SRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIR  388 (439)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  388 (439)
                      .......||+.|+|||.+.+..++.++|||||||++|||++|..||...+..+....+...      ...    .++...
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~------~~~----~~~~~~  227 (321)
T 1tki_A          158 DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNA------EYT----FDEEAF  227 (321)
T ss_dssp             CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT------CCC----CCHHHH
T ss_pred             CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcC------CCC----CChhhh
Confidence            5555567999999999999988999999999999999999999999887654433222211      101    111111


Q ss_pred             CccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          389 DTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       389 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      ...    ...+.+++.+||+.||++|||+.|++++
T Consensus       228 ~~~----s~~~~~li~~~L~~dp~~Rpt~~e~l~h  258 (321)
T 1tki_A          228 KEI----SIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             TTS----CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ccC----CHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            111    2357789999999999999999999975

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-44  Score=357.23  Aligned_cols=253  Identities=20%  Similarity=0.267  Sum_probs=211.3

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEe
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      .++|++.+.||+|+||.||+|... ++..+|+|.+..........+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            468999999999999999999886 5788999999876655667899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC--CCcEEEEecccccccCCC
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDS--SFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~--~~~~kl~DfGls~~~~~~  308 (439)
                      +++|+|.+++..  ....+++..+..++.|++.||+|||+.   +++||||||+|||++.  ++.+||+|||++......
T Consensus       130 ~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~  204 (387)
T 1kob_A          130 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  204 (387)
T ss_dssp             CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence            999999999964  334689999999999999999999998   9999999999999974  577999999999877655


Q ss_pred             CcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhc
Q 013636          309 SRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIR  388 (439)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  388 (439)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+...      ....    ++...
T Consensus       205 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~------~~~~----~~~~~  274 (387)
T 1kob_A          205 EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC------DWEF----DEDAF  274 (387)
T ss_dssp             SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHC------CCCC----CSSTT
T ss_pred             cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhC------CCCC----Ccccc
Confidence            5545567999999999999999999999999999999999999999887654332222111      0011    11111


Q ss_pred             CccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          389 DTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       389 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      ...    ...+.+++..||+.||++|||+.|++++
T Consensus       275 ~~~----s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          275 SSV----SPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             TTS----CHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             ccC----CHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            111    2356789999999999999999999986

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=5.6e-46  Score=360.40  Aligned_cols=267  Identities=24%  Similarity=0.311  Sum_probs=205.0

Q ss_pred             hcCCCccceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC----eeEEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE----TRFLV  227 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lV  227 (439)
                      .++|++.+.||+|+||+||+|+.. +..||+|.+.... .....+..|+.++++++||||+++++++....    ..++|
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            368889999999999999999887 6789999997543 33445677999999999999999999998754    36999


Q ss_pred             EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-------CCCeEecCCCCCCEEEcCCCcEEEEecc
Q 013636          228 YEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC-------NHPVVHRDLKSSNILLDSSFNAKLSDFG  300 (439)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~-------~~~ivH~Dlk~~NiLl~~~~~~kl~DfG  300 (439)
                      |||+++|+|.+++..    ..+++..+..++.|+++||+|||+.+       .++++||||||+|||++.++.+||+|||
T Consensus       101 ~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg  176 (322)
T 3soc_A          101 TAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG  176 (322)
T ss_dssp             EECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             EecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence            999999999999964    24899999999999999999999851       2389999999999999999999999999


Q ss_pred             cccccCCCCc---ceeeccccCccchhhhcCC-----CCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhh----
Q 013636          301 LSVTAGTQSR---NVKISGTLGYVAPEYLLEG-----KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTW----  368 (439)
Q Consensus       301 ls~~~~~~~~---~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~----  368 (439)
                      ++........   .....||+.|+|||.+.+.     .++.++|||||||++|||++|+.||..............    
T Consensus       177 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~  256 (322)
T 3soc_A          177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH  256 (322)
T ss_dssp             TCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSS
T ss_pred             cccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccC
Confidence            9976543322   1224689999999999873     455688999999999999999999976543211111000    


Q ss_pred             -----hhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccC
Q 013636          369 -----AMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLV  428 (439)
Q Consensus       369 -----~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~  428 (439)
                           ...... ............   ........+.+++.+||+.||++|||+.|+++.|+++.
T Consensus       257 ~~~~~~~~~~~-~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~  317 (322)
T 3soc_A          257 PSLEDMQEVVV-HKKKRPVLRDYW---QKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ  317 (322)
T ss_dssp             CCHHHHHHHHT-TSCCCCCCCGGG---GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             Cchhhhhhhhh-cccCCCCccccc---cccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                 000000 011111111111   11234567889999999999999999999999998764

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=3e-45  Score=360.08  Aligned_cols=267  Identities=25%  Similarity=0.395  Sum_probs=214.2

Q ss_pred             ccHHHHHHHhcCCCccceecccCcEEEEEEEE------CCccEEEEEEecCCCc-hHHHHHHHHHHHHHhc-CCCceeee
Q 013636          143 IEYELLEAATNNFQESNVIGEGGRGHVYKARF------NEKLLAAVKRIDDAGH-DAEREFNNEVNWLTKI-RHQNIISL  214 (439)
Q Consensus       143 ~~~~~l~~~~~~~~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l  214 (439)
                      +....++...++|++.+.||+|+||.||+|++      .++..+|+|.+..... ...+.+.+|+.++.++ +||||+++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence            34455666778999999999999999999974      2457899999976433 3446799999999999 79999999


Q ss_pred             eeEEEeCCe-eEEEEEeccCCChhhhhcCCCC------------------------------------------------
Q 013636          215 LGYCIHAET-RFLVYEMMQNGSLEKQLHGPTH------------------------------------------------  245 (439)
Q Consensus       215 ~~~~~~~~~-~~lV~e~~~~gsL~~~l~~~~~------------------------------------------------  245 (439)
                      ++++...+. .++||||+++|+|.++++....                                                
T Consensus        92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (359)
T 3vhe_A           92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK  171 (359)
T ss_dssp             EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred             eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence            999987654 8999999999999999975332                                                


Q ss_pred             ---------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc
Q 013636          246 ---------------GSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR  310 (439)
Q Consensus       246 ---------------~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~  310 (439)
                                     ...+++..+..++.|+++||+|||+.   +++||||||+|||++.++.+||+|||++........
T Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  248 (359)
T 3vhe_A          172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD  248 (359)
T ss_dssp             ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred             ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence                           12289999999999999999999998   999999999999999999999999999976543322


Q ss_pred             ---ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhh-hhhHhhhhcccccCCCCCccCCc
Q 013636          311 ---NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQC-QSMVTWAMPQLTDRSKLPNIVDP  385 (439)
Q Consensus       311 ---~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~d~  385 (439)
                         .....||+.|+|||.+.+..++.++||||||+++|||++ |+.||........ ...+..     ......+...  
T Consensus       249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~--  321 (359)
T 3vhe_A          249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE-----GTRMRAPDYT--  321 (359)
T ss_dssp             CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHH-----TCCCCCCTTC--
T ss_pred             chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHc-----CCCCCCCCCC--
Confidence               123457899999999999999999999999999999998 9999987653321 111111     0111122211  


Q ss_pred             hhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCC
Q 013636          386 VIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVP  429 (439)
Q Consensus       386 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~  429 (439)
                                ...+.+++..||+.||++|||+.|++++|+.++.
T Consensus       322 ----------~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  355 (359)
T 3vhe_A          322 ----------TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  355 (359)
T ss_dssp             ----------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----------CHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence                      2356779999999999999999999999987764

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.5e-44  Score=346.12  Aligned_cols=258  Identities=25%  Similarity=0.380  Sum_probs=199.7

Q ss_pred             hcCCCccceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHh--cCCCceeeeeeEEEeC----CeeE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTK--IRHQNIISLLGYCIHA----ETRF  225 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~----~~~~  225 (439)
                      .++|++.+.||+|+||+||+|+. ++..+|+|.+...   ....+..|.+++..  ++||||+++++++...    +..+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~   82 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW   82 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence            46899999999999999999998 5778999998653   34556667777766  7999999999987653    4579


Q ss_pred             EEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHh--------hcCCCCeEecCCCCCCEEEcCCCcEEEE
Q 013636          226 LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLH--------EHCNHPVVHRDLKSSNILLDSSFNAKLS  297 (439)
Q Consensus       226 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH--------~~~~~~ivH~Dlk~~NiLl~~~~~~kl~  297 (439)
                      +||||+++|+|.++++.    ..+++..+.+++.|++.||+|||        +.   +++||||||+|||++.++.+||+
T Consensus        83 lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~  155 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIA  155 (301)
T ss_dssp             EEECCCTTCBHHHHHTT----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEEC
T ss_pred             EehhhccCCCHHHHHhh----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEe
Confidence            99999999999999953    35899999999999999999999        65   99999999999999999999999


Q ss_pred             ecccccccCCCCcc-----eeeccccCccchhhhcCC------CCCCchhhHHHHHHHHHHHhC----------CCCCCC
Q 013636          298 DFGLSVTAGTQSRN-----VKISGTLGYVAPEYLLEG------KLTDKSDVYAFGVVLLELLMG----------RRPVEK  356 (439)
Q Consensus       298 DfGls~~~~~~~~~-----~~~~gt~~y~aPE~~~~~------~~~~~~DvwS~Gvll~elltG----------~~P~~~  356 (439)
                      |||++.........     ....||+.|+|||.+.+.      .++.++||||||+++|||++|          +.||..
T Consensus       156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~  235 (301)
T 3q4u_A          156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD  235 (301)
T ss_dssp             CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence            99999765433222     123689999999999876      445799999999999999999          888865


Q ss_pred             CChhhhh-hhHhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhcccc
Q 013636          357 MSPTQCQ-SMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPL  427 (439)
Q Consensus       357 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l  427 (439)
                      ..+.... .......   ......+....    ..........+.+++.+||+.||++|||+.|+++.|+++
T Consensus       236 ~~~~~~~~~~~~~~~---~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          236 VVPNDPSFEDMRKVV---CVDQQRPNIPN----RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             TSCSSCCHHHHHHHH---TTSCCCCCCCG----GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCCCCcchhhhhHHH---hccCCCCCCCh----hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            4322111 1111100   01111111111    111224567888999999999999999999999999764

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.2e-44  Score=366.99  Aligned_cols=255  Identities=29%  Similarity=0.424  Sum_probs=209.8

Q ss_pred             HhcCCCccceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC-eeEEEEE
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE-TRFLVYE  229 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lV~e  229 (439)
                      ..++|+..+.||+|+||.||+|++. +..+|||.++...  ..+.|.+|+.++++++||||+++++++...+ ..++|||
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e  267 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE  267 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence            3467888999999999999999987 5589999998643  4567999999999999999999999988765 7899999


Q ss_pred             eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCC
Q 013636          230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS  309 (439)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~  309 (439)
                      |+++|+|.+++... ....+++..+..++.|+++||+|||+.   +++||||||+|||+++++.+||+|||+++......
T Consensus       268 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  343 (450)
T 1k9a_A          268 YMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ  343 (450)
T ss_dssp             CCTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             ecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc
Confidence            99999999999742 223479999999999999999999998   99999999999999999999999999997654322


Q ss_pred             cceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhc
Q 013636          310 RNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIR  388 (439)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  388 (439)
                      .  ...++..|+|||.+.+..++.++||||||+++|||++ |+.||...+..+....+...     .+...+.       
T Consensus       344 ~--~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~-----~~~~~p~-------  409 (450)
T 1k9a_A          344 D--TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-----YKMDAPD-------  409 (450)
T ss_dssp             -----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTT-----CCCCCCT-------
T ss_pred             c--CCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-----CCCCCCC-------
Confidence            2  2347889999999999999999999999999999998 99999887655443333211     0111111       


Q ss_pred             CccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCCC
Q 013636          389 DTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPTD  431 (439)
Q Consensus       389 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~~  431 (439)
                           .....+.+++..||+.||++|||+.++++.|+.+...+
T Consensus       410 -----~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~  447 (450)
T 1k9a_A          410 -----GCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHE  447 (450)
T ss_dssp             -----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             -----cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhh
Confidence                 11245777999999999999999999999998876544

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.8e-44  Score=340.54  Aligned_cols=254  Identities=30%  Similarity=0.502  Sum_probs=196.4

Q ss_pred             hcCCCccceecccCcEEEEEEEECCccEEEEEEecCCCc----hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGH----DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLV  227 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  227 (439)
                      .++|+..+.||+|+||.||+|+.. +..+|+|.+.....    ...+.+.+|+.+++.++||||+++++++...+..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            367888999999999999999986 67789999865432    2246788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC--------CCcEEEEec
Q 013636          228 YEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDS--------SFNAKLSDF  299 (439)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~--------~~~~kl~Df  299 (439)
                      |||+++|+|.+++.+    ..+++..+..++.|+++||+|||+....+++||||||+||+++.        ++.+||+||
T Consensus        85 ~e~~~~~~L~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           85 MEFARGGPLNRVLSG----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EECCTTEEHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EEcCCCCCHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            999999999999853    35899999999999999999999982223999999999999986        778999999


Q ss_pred             ccccccCCCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCC
Q 013636          300 GLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKL  379 (439)
Q Consensus       300 Gls~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  379 (439)
                      |++........ ....||+.|+|||.+.+..++.++||||||+++|||++|+.||...+...........    ......
T Consensus       161 g~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~----~~~~~~  235 (271)
T 3dtc_A          161 GLAREWHRTTK-MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMN----KLALPI  235 (271)
T ss_dssp             CC--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTS----CCCCCC
T ss_pred             Ccccccccccc-cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcC----CCCCCC
Confidence            99976544332 2446899999999999999999999999999999999999999877654432222111    001111


Q ss_pred             CccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhcccc
Q 013636          380 PNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPL  427 (439)
Q Consensus       380 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l  427 (439)
                      +.        .    ....+.+++.+||+.||++|||+.|++++|+.+
T Consensus       236 ~~--------~----~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          236 PS--------T----CPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             CT--------T----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             Cc--------c----cCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            11        1    123577899999999999999999999999764

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-44  Score=353.27  Aligned_cols=262  Identities=28%  Similarity=0.432  Sum_probs=214.3

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEECC------ccEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCceeeeeeEEEeC
Q 013636          149 EAATNNFQESNVIGEGGRGHVYKARFNE------KLLAAVKRIDDAG-HDAEREFNNEVNWLTKIRHQNIISLLGYCIHA  221 (439)
Q Consensus       149 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  221 (439)
                      +...++|++.+.||+|+||.||+|+..+      +..+|+|.+.... ....+.+.+|+.++++++||||+++++++...
T Consensus        43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  122 (343)
T 1luf_A           43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG  122 (343)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence            3456889999999999999999998853      4789999997643 33456799999999999999999999999999


Q ss_pred             CeeEEEEEeccCCChhhhhcCCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 013636          222 ETRFLVYEMMQNGSLEKQLHGPTH---------------------GSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD  280 (439)
Q Consensus       222 ~~~~lV~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~D  280 (439)
                      +..++||||+++|+|.+++.....                     ...+++..++.++.|+++||+|||+.   +++|||
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~D  199 (343)
T 1luf_A          123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRD  199 (343)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence            999999999999999999975221                     25699999999999999999999998   999999


Q ss_pred             CCCCCEEEcCCCcEEEEecccccccCCCCc---ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCC
Q 013636          281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSR---NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEK  356 (439)
Q Consensus       281 lk~~NiLl~~~~~~kl~DfGls~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~  356 (439)
                      |||+||++++++.+||+|||++........   .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  279 (343)
T 1luf_A          200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  279 (343)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence            999999999999999999999976533221   123457889999999999999999999999999999999 9999988


Q ss_pred             CChhhhhhhHhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCC
Q 013636          357 MSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPT  430 (439)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~  430 (439)
                      .+..+....+...     .....+..            ....+.+++.+||+.||++|||+.++++.|+++...
T Consensus       280 ~~~~~~~~~~~~~-----~~~~~~~~------------~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~  336 (343)
T 1luf_A          280 MAHEEVIYYVRDG-----NILACPEN------------CPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER  336 (343)
T ss_dssp             SCHHHHHHHHHTT-----CCCCCCTT------------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred             CChHHHHHHHhCC-----CcCCCCCC------------CCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence            7655433322210     00111111            123577899999999999999999999999988764

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=4.3e-45  Score=349.32  Aligned_cols=264  Identities=25%  Similarity=0.387  Sum_probs=206.2

Q ss_pred             hcCCCccceecccCcEEEEEEEE-----CCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeC--Cee
Q 013636          152 TNNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHA--ETR  224 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  224 (439)
                      .++|++.+.||+|+||+||++++     .++..+|+|++........+.+.+|+.++++++||||+++++++...  ...
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            36788899999999999999985     35789999999877666677899999999999999999999998654  458


Q ss_pred             EEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccc
Q 013636          225 FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT  304 (439)
Q Consensus       225 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~  304 (439)
                      ++||||+++|+|.+++...  ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++++||+|||++..
T Consensus        89 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~  163 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKV  163 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred             EEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence            9999999999999999742  34589999999999999999999998   999999999999999999999999999977


Q ss_pred             cCCCCcc----eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhh---------hhHhhhhc
Q 013636          305 AGTQSRN----VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQ---------SMVTWAMP  371 (439)
Q Consensus       305 ~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~---------~~~~~~~~  371 (439)
                      .......    ....+|..|+|||.+.+..++.++||||||+++|||++|..|+.........         ........
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (295)
T 3ugc_A          164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE  243 (295)
T ss_dssp             ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred             ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence            6443221    1233677899999999999999999999999999999999998653221100         00000011


Q ss_pred             ccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCC
Q 013636          372 QLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPT  430 (439)
Q Consensus       372 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~  430 (439)
                      ........+          ........+.+++.+||+.||++|||+.|+++.|+++...
T Consensus       244 ~~~~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~  292 (295)
T 3ugc_A          244 LLKNNGRLP----------RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN  292 (295)
T ss_dssp             HHHTTCCCC----------CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHhccCcCC----------CCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            111111110          0111234677899999999999999999999999887643

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=5.9e-45  Score=369.74  Aligned_cols=260  Identities=25%  Similarity=0.422  Sum_probs=215.7

Q ss_pred             HHHHhcCCCccceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEE
Q 013636          148 LEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLV  227 (439)
Q Consensus       148 l~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  227 (439)
                      ++...++|+..+.||+|+||+||+|+++++..||||.++... ...+.|.+|+.++++++||||+++++++. .+..++|
T Consensus       183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv  260 (454)
T 1qcf_A          183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII  260 (454)
T ss_dssp             SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence            445567889999999999999999999988899999998654 34678999999999999999999999986 6678999


Q ss_pred             EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCC
Q 013636          228 YEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT  307 (439)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~  307 (439)
                      |||+++|+|.++++.. .+..+++..+..++.|+++||+|||+.   +++||||||+|||+++++.+||+|||+++....
T Consensus       261 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~  336 (454)
T 1qcf_A          261 TEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIED  336 (454)
T ss_dssp             ECCCTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred             EeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence            9999999999999742 123588999999999999999999998   999999999999999999999999999987543


Q ss_pred             CCcc--eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCccCC
Q 013636          308 QSRN--VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVD  384 (439)
Q Consensus       308 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  384 (439)
                      ....  ....+|..|+|||.+..+.++.++|||||||++|||++ |+.||...+..+....+....     ....+.   
T Consensus       337 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~-----~~~~~~---  408 (454)
T 1qcf_A          337 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY-----RMPRPE---  408 (454)
T ss_dssp             HHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTC-----CCCCCT---
T ss_pred             CceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-----CCCCCC---
Confidence            2211  22336788999999999999999999999999999999 999999877655443332110     111111   


Q ss_pred             chhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCC
Q 013636          385 PVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPT  430 (439)
Q Consensus       385 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~  430 (439)
                               .....+.+++.+||+.||++|||+.+|++.|+.+...
T Consensus       409 ---------~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~  445 (454)
T 1qcf_A          409 ---------NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA  445 (454)
T ss_dssp             ---------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred             ---------CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence                     1134577899999999999999999999999988764

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.3e-44  Score=343.36  Aligned_cols=264  Identities=24%  Similarity=0.331  Sum_probs=202.2

Q ss_pred             cCCCccceecccCcEEEEEEEECCccEEEEEEecCCCch--HHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEe
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHD--AEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      ++|++.+.||+|+||+||+|+...+..+|+|++......  ..+.+.+|+.++++++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            578889999999999999999988899999998654322  236788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCC-
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS-  309 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~-  309 (439)
                      +++ +|.+++...  ...+++..+..++.|+++||+|||+.   +++||||||+||+++.++.+||+|||++....... 
T Consensus        82 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (288)
T 1ob3_A           82 LDQ-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (288)
T ss_dssp             CSE-EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             cCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence            986 999998742  35689999999999999999999998   99999999999999999999999999997654322 


Q ss_pred             cceeeccccCccchhhhcCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCc-----cC
Q 013636          310 RNVKISGTLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPN-----IV  383 (439)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~  383 (439)
                      ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||...+..+....+........ ....+.     ..
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  234 (288)
T 1ob3_A          156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPN-SKNWPNVTELPKY  234 (288)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC-TTTSTTGGGSTTC
T ss_pred             ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCC-hhhchhhhccccc
Confidence            22334589999999999764 589999999999999999999999987765433222211100000 000000     00


Q ss_pred             Cchhc-------CccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          384 DPVIR-------DTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       384 d~~l~-------~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      ++...       ..........+.+++.+||+.||++|||+.|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  281 (288)
T 1ob3_A          235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (288)
T ss_dssp             CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            00000       00001123456789999999999999999999975

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=5.1e-44  Score=352.29  Aligned_cols=253  Identities=23%  Similarity=0.349  Sum_probs=208.7

Q ss_pred             HhcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEE
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLV  227 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  227 (439)
                      ..++|++.+.||+|+||.||++... ++..+|+|.+....  ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            3568999999999999999999885 47889999986543  23446789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC---CcEEEEecccccc
Q 013636          228 YEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS---FNAKLSDFGLSVT  304 (439)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~---~~~kl~DfGls~~  304 (439)
                      |||+++|+|.+++..   ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.+   +.+||+|||++..
T Consensus       107 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~  180 (362)
T 2bdw_A          107 FDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE  180 (362)
T ss_dssp             ECCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred             EecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence            999999999999864   34689999999999999999999998   99999999999999865   4599999999987


Q ss_pred             cCCCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCC
Q 013636          305 AGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVD  384 (439)
Q Consensus       305 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  384 (439)
                      ...........||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+...      ....+.   
T Consensus       181 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~------~~~~~~---  251 (362)
T 2bdw_A          181 VNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG------AYDYPS---  251 (362)
T ss_dssp             CTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT------CCCCCT---
T ss_pred             ecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC------CCCCCc---
Confidence            76544444567999999999999999999999999999999999999999877654433322211      111110   


Q ss_pred             chhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          385 PVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       385 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      + .....    ...+.+++.+||+.||++|||+.|++++
T Consensus       252 ~-~~~~~----~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          252 P-EWDTV----TPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             T-GGGGS----CHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             c-cccCC----CHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            0 01111    2356779999999999999999999976

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.5e-44  Score=357.10  Aligned_cols=262  Identities=26%  Similarity=0.398  Sum_probs=215.0

Q ss_pred             HHhcCCCccceecccCcEEEEEEEEC--------CccEEEEEEecCCCc-hHHHHHHHHHHHHHhc-CCCceeeeeeEEE
Q 013636          150 AATNNFQESNVIGEGGRGHVYKARFN--------EKLLAAVKRIDDAGH-DAEREFNNEVNWLTKI-RHQNIISLLGYCI  219 (439)
Q Consensus       150 ~~~~~~~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  219 (439)
                      ...++|++.+.||+|+||+||+|+..        .+..+|+|++..... ...+++.+|+++++++ +||||+++++++.
T Consensus        66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  145 (382)
T 3tt0_A           66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT  145 (382)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence            34578899999999999999999862        346799999976433 3446799999999999 9999999999999


Q ss_pred             eCCeeEEEEEeccCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCE
Q 013636          220 HAETRFLVYEMMQNGSLEKQLHGPTH-------------GSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNI  286 (439)
Q Consensus       220 ~~~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~Ni  286 (439)
                      ..+..++||||+++|+|.+++.....             ...+++..+..++.|+++||+|||+.   +++||||||+||
T Consensus       146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NI  222 (382)
T 3tt0_A          146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV  222 (382)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred             cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceE
Confidence            99999999999999999999975321             24599999999999999999999998   999999999999


Q ss_pred             EEcCCCcEEEEecccccccCCCCc---ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhh
Q 013636          287 LLDSSFNAKLSDFGLSVTAGTQSR---NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQC  362 (439)
Q Consensus       287 Ll~~~~~~kl~DfGls~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~  362 (439)
                      |+++++.+||+|||++........   .....+|+.|+|||.+.+..++.++|||||||++|||++ |..||...+..+.
T Consensus       223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~  302 (382)
T 3tt0_A          223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL  302 (382)
T ss_dssp             EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred             EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            999999999999999976544321   122347889999999999999999999999999999999 9999988776554


Q ss_pred             hhhHhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCCC
Q 013636          363 QSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPTD  431 (439)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~~  431 (439)
                      ...+....     ....+.        .    ....+.+++.+||+.||++|||+.|++++|+.++...
T Consensus       303 ~~~~~~~~-----~~~~~~--------~----~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  354 (382)
T 3tt0_A          303 FKLLKEGH-----RMDKPS--------N----CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT  354 (382)
T ss_dssp             HHHHHTTC-----CCCCCS--------S----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred             HHHHHcCC-----CCCCCc--------c----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence            33332110     111111        1    1235777999999999999999999999998887543

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.1e-44  Score=345.09  Aligned_cols=253  Identities=23%  Similarity=0.427  Sum_probs=206.6

Q ss_pred             hcCCCccceecccCcEEEEEEEECC--------ccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCe
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFNE--------KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAET  223 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  223 (439)
                      .++|++.+.||+|+||+||+|+...        +..+|+|.+........+.+.+|+.++++++||||+++++++...+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            3678889999999999999998754        24689999987666677889999999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCc--------EE
Q 013636          224 RFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFN--------AK  295 (439)
Q Consensus       224 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~--------~k  295 (439)
                      .++||||+++|+|.+++..  ....+++..+..++.|+++||+|||+.   +++||||||+|||++.++.        +|
T Consensus        87 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKK--NKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             CEEEEECCCCCCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceee
Confidence            9999999999999999974  234489999999999999999999998   9999999999999998887        99


Q ss_pred             EEecccccccCCCCcceeeccccCccchhhhcC-CCCCCchhhHHHHHHHHHHHhC-CCCCCCCChhhhhhhHhhhhccc
Q 013636          296 LSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLE-GKLTDKSDVYAFGVVLLELLMG-RRPVEKMSPTQCQSMVTWAMPQL  373 (439)
Q Consensus       296 l~DfGls~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvll~elltG-~~P~~~~~~~~~~~~~~~~~~~~  373 (439)
                      |+|||++......   ....||+.|+|||.+.+ ..++.++||||||+++|||++| ..|+...+.........      
T Consensus       162 l~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~------  232 (289)
T 4fvq_A          162 LSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE------  232 (289)
T ss_dssp             ECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH------
T ss_pred             eccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhh------
Confidence            9999999765332   23458899999999987 7789999999999999999995 55555544333222211      


Q ss_pred             ccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCCC
Q 013636          374 TDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPTD  431 (439)
Q Consensus       374 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~~  431 (439)
                       .....+...++            .+.+++.+||+.||++|||+.|++++|+++....
T Consensus       233 -~~~~~~~~~~~------------~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~  277 (289)
T 4fvq_A          233 -DRHQLPAPKAA------------ELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD  277 (289)
T ss_dssp             -TTCCCCCCSSC------------TTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred             -ccCCCCCCCCH------------HHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence             11222222222            3556899999999999999999999999998654

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.3e-44  Score=351.49  Aligned_cols=254  Identities=25%  Similarity=0.468  Sum_probs=203.9

Q ss_pred             cCCCccceecccCcEEEEEEEECC-c----cEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNE-K----LLAAVKRIDDAG-HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFL  226 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~-~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  226 (439)
                      ++|+..+.||+|+||+||+|++.. +    ..+|+|.+.... ....++|.+|+.++++++||||++++++|... ..++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~   93 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   93 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEE
Confidence            578889999999999999998743 2    246888886432 34456899999999999999999999999875 4789


Q ss_pred             EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccC
Q 013636          227 VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAG  306 (439)
Q Consensus       227 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~  306 (439)
                      |+||+++|+|.+++..  ....+++..++.++.|+++||+|||+.   +++||||||+|||++.++++||+|||+++...
T Consensus        94 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  168 (327)
T 3poz_A           94 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             EEECCTTCBHHHHHHH--STTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred             EEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence            9999999999999974  335699999999999999999999998   99999999999999999999999999997654


Q ss_pred             CCCcc---eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCcc
Q 013636          307 TQSRN---VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNI  382 (439)
Q Consensus       307 ~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  382 (439)
                      .....   ....+|+.|+|||.+.+..++.++|||||||++|||++ |+.||...+.......+....     ....+. 
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~-  242 (327)
T 3poz_A          169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-----RLPQPP-  242 (327)
T ss_dssp             TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-----CCCCCT-
T ss_pred             CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCC-----CCCCCc-
Confidence            43322   22346789999999999999999999999999999999 999998877655444333211     011111 


Q ss_pred             CCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCC
Q 013636          383 VDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVP  429 (439)
Q Consensus       383 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~  429 (439)
                                 .....+.+++.+||+.||++|||+.+++++|+.+..
T Consensus       243 -----------~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          243 -----------ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             -----------TBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             -----------cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                       112357789999999999999999999999977654

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=8.6e-45  Score=356.42  Aligned_cols=248  Identities=26%  Similarity=0.345  Sum_probs=202.7

Q ss_pred             hcCCCccceecccCcEEEEEEEECC-ccEEEEEEecCCC---chHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeeEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAG---HDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFL  226 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  226 (439)
                      .++|++.+.||+|+||+||+|+... +..+|+|.+....   ....+.+.+|..+++.+ +||||+++++++.+.+..++
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            4789999999999999999998864 7889999987531   23345678999999988 79999999999999999999


Q ss_pred             EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccC
Q 013636          227 VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAG  306 (439)
Q Consensus       227 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~  306 (439)
                      ||||+++|+|.+++..   ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++++||+|||++....
T Consensus       102 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~  175 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQK---SRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI  175 (353)
T ss_dssp             EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence            9999999999999964   24589999999999999999999998   99999999999999999999999999997643


Q ss_pred             C-CCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCc
Q 013636          307 T-QSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDP  385 (439)
Q Consensus       307 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  385 (439)
                      . .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+..      .....+..++ 
T Consensus       176 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~------~~~~~p~~~~-  248 (353)
T 3txo_A          176 CNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN------DEVVYPTWLH-  248 (353)
T ss_dssp             C---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------CCCCCCTTSC-
T ss_pred             cCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHc------CCCCCCCCCC-
Confidence            2 2233456799999999999999999999999999999999999999998776554333321      1222222222 


Q ss_pred             hhcCccCHHHHHHHHHHHHHhcCCCCCCCCCH------HHHHHh
Q 013636          386 VIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLI------TDVLHS  423 (439)
Q Consensus       386 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~------~evl~~  423 (439)
                                 ..+.+++..||+.||++||++      .|++++
T Consensus       249 -----------~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h  281 (353)
T 3txo_A          249 -----------EDATGILKSFMTKNPTMRLGSLTQGGEHAILRH  281 (353)
T ss_dssp             -----------HHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred             -----------HHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence                       246679999999999999998      777754

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.8e-44  Score=342.10  Aligned_cols=248  Identities=23%  Similarity=0.347  Sum_probs=196.9

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCch--------------------------HHHHHHHHHHHHHh
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHD--------------------------AEREFNNEVNWLTK  205 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~  205 (439)
                      ++|++.+.||+|+||.||+|+.. ++..+|+|.+......                          ..+.+.+|+.++++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   92 (298)
T 2zv2_A           13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK   92 (298)
T ss_dssp             TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred             cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence            67888999999999999999875 5788999998653211                          12468899999999


Q ss_pred             cCCCceeeeeeEEEe--CCeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 013636          206 IRHQNIISLLGYCIH--AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKS  283 (439)
Q Consensus       206 l~h~niv~l~~~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~  283 (439)
                      ++||||+++++++..  .+..++||||+++|+|.+++.    ...+++..+..++.|+++||+|||+.   +++||||||
T Consensus        93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp  165 (298)
T 2zv2_A           93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT----LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKP  165 (298)
T ss_dssp             CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC----SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCG
T ss_pred             CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCH
Confidence            999999999999986  567899999999999988754    24699999999999999999999998   999999999


Q ss_pred             CCEEEcCCCcEEEEecccccccCCCCc-ceeeccccCccchhhhcCCC---CCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 013636          284 SNILLDSSFNAKLSDFGLSVTAGTQSR-NVKISGTLGYVAPEYLLEGK---LTDKSDVYAFGVVLLELLMGRRPVEKMSP  359 (439)
Q Consensus       284 ~NiLl~~~~~~kl~DfGls~~~~~~~~-~~~~~gt~~y~aPE~~~~~~---~~~~~DvwS~Gvll~elltG~~P~~~~~~  359 (439)
                      +|||++.++++||+|||++........ .....||+.|+|||.+.+..   ++.++|||||||++|||++|+.||...+.
T Consensus       166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~  245 (298)
T 2zv2_A          166 SNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI  245 (298)
T ss_dssp             GGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             HHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence            999999999999999999977654322 23356899999999998765   37789999999999999999999987654


Q ss_pred             hhhhhhHhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          360 TQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      ......+...      ....+.  .    ...    ...+.+++.+||+.||++|||+.|++++
T Consensus       246 ~~~~~~~~~~------~~~~~~--~----~~~----~~~l~~li~~~l~~dp~~R~s~~e~l~h  293 (298)
T 2zv2_A          246 MCLHSKIKSQ------ALEFPD--Q----PDI----AEDLKDLITRMLDKNPESRIVVPEIKLH  293 (298)
T ss_dssp             HHHHHHHHHC------CCCCCS--S----SCC----CHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred             HHHHHHHhcc------cCCCCC--c----ccc----CHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence            4332222111      111111  0    111    2356789999999999999999999865

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1e-44  Score=349.41  Aligned_cols=261  Identities=28%  Similarity=0.425  Sum_probs=213.9

Q ss_pred             HHhcCCCccceecccCcEEEEEEEE------CCccEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC
Q 013636          150 AATNNFQESNVIGEGGRGHVYKARF------NEKLLAAVKRIDDAG-HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE  222 (439)
Q Consensus       150 ~~~~~~~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  222 (439)
                      ...++|++.+.||+|+||.||+|..      .++..+|+|.+.... ....+.+.+|+.++++++||||+++++++...+
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   99 (314)
T 2ivs_A           20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG   99 (314)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence            3457888999999999999999986      345789999997543 344567999999999999999999999999999


Q ss_pred             eeEEEEEeccCCChhhhhcCCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 013636          223 TRFLVYEMMQNGSLEKQLHGPTH---------------------GSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDL  281 (439)
Q Consensus       223 ~~~lV~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dl  281 (439)
                      ..++||||+++|+|.+++.....                     ...+++..+..++.|+++||+|||+.   +++||||
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~di  176 (314)
T 2ivs_A          100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDL  176 (314)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred             ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCccccc
Confidence            99999999999999999975322                     23489999999999999999999998   9999999


Q ss_pred             CCCCEEEcCCCcEEEEecccccccCCCCcc---eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCC
Q 013636          282 KSSNILLDSSFNAKLSDFGLSVTAGTQSRN---VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKM  357 (439)
Q Consensus       282 k~~NiLl~~~~~~kl~DfGls~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~  357 (439)
                      ||+||++++++.+||+|||++.........   ....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  256 (314)
T 2ivs_A          177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI  256 (314)
T ss_dssp             SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999999766443322   22346788999999999999999999999999999999 99999887


Q ss_pred             ChhhhhhhHhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCC
Q 013636          358 SPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPT  430 (439)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~  430 (439)
                      +.......+....     ....+.        .    ....+.+++.+||+.||++|||+.|++++|+++...
T Consensus       257 ~~~~~~~~~~~~~-----~~~~~~--------~----~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          257 PPERLFNLLKTGH-----RMERPD--------N----CSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             CGGGHHHHHHTTC-----CCCCCT--------T----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CHHHHHHHhhcCC-----cCCCCc--------c----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence            7655433332110     111111        1    123577899999999999999999999999887643

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.6e-44  Score=370.26  Aligned_cols=260  Identities=26%  Similarity=0.420  Sum_probs=215.9

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEECC-ccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEE
Q 013636          149 EAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLV  227 (439)
Q Consensus       149 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  227 (439)
                      +...++|+..+.||+|+||.||+|++.. +..||+|.++... ...++|.+|+.+|++++||||++++++|...+..++|
T Consensus       216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  294 (495)
T 1opk_A          216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII  294 (495)
T ss_dssp             BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEE
Confidence            3445678889999999999999999876 7889999997654 3456899999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCC
Q 013636          228 YEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT  307 (439)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~  307 (439)
                      |||+++|+|.+++... ....+++..++.++.|+++||+|||+.   +|+||||||+|||+++++.+||+|||+++....
T Consensus       295 ~E~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  370 (495)
T 1opk_A          295 TEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTG  370 (495)
T ss_dssp             EECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred             EEccCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence            9999999999999752 235689999999999999999999998   999999999999999999999999999987643


Q ss_pred             CCcc--eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCccCC
Q 013636          308 QSRN--VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVD  384 (439)
Q Consensus       308 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  384 (439)
                      ....  ....+|..|+|||.+....++.++|||||||++|||++ |+.||...+..+....+...     .....+.   
T Consensus       371 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~---  442 (495)
T 1opk_A          371 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-----YRMERPE---  442 (495)
T ss_dssp             CCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT-----CCCCCCT---
T ss_pred             CceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-----CCCCCCC---
Confidence            3221  12235678999999999999999999999999999999 99999887765543333211     0111111   


Q ss_pred             chhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCC
Q 013636          385 PVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPT  430 (439)
Q Consensus       385 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~  430 (439)
                               .....+.+++.+||+.||++|||+.++++.|+.+...
T Consensus       443 ---------~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~  479 (495)
T 1opk_A          443 ---------GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  479 (495)
T ss_dssp             ---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred             ---------CCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence                     1124577799999999999999999999999988754

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=4.7e-44  Score=341.32  Aligned_cols=258  Identities=30%  Similarity=0.499  Sum_probs=197.0

Q ss_pred             HhcCCCccceecccCcEEEEEEEECCccEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEE
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      ..++|++.+.||+|+||+||+|+..+  .+|+|.++...  ....+.|.+|+.++++++||||+++++++ ..+..++||
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~   98 (289)
T 3og7_A           22 PDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT   98 (289)
T ss_dssp             CTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred             CccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence            35789999999999999999998765  38888886443  34456799999999999999999999965 556789999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~  308 (439)
                      ||+++++|.+++..  ....+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++......
T Consensus        99 e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  173 (289)
T 3og7_A           99 QWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW  173 (289)
T ss_dssp             ECCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred             EecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccccc
Confidence            99999999999964  345699999999999999999999998   9999999999999999999999999999755432


Q ss_pred             C---cceeeccccCccchhhhc---CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhh-hhhhHhhhhcccccCCCCCc
Q 013636          309 S---RNVKISGTLGYVAPEYLL---EGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQ-CQSMVTWAMPQLTDRSKLPN  381 (439)
Q Consensus       309 ~---~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  381 (439)
                      .   ......||+.|+|||.+.   +..++.++||||||+++|||++|+.||....... ....+...    ........
T Consensus       174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~  249 (289)
T 3og7_A          174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRG----SLSPDLSK  249 (289)
T ss_dssp             ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHT----SCCCCTTS
T ss_pred             cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhccc----ccCcchhh
Confidence            1   122345899999999987   5678889999999999999999999998755432 12221110    00111111


Q ss_pred             cCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCC
Q 013636          382 IVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVP  429 (439)
Q Consensus       382 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~  429 (439)
                           +..    .....+.+++.+||+.||++|||+.++++.|+++..
T Consensus       250 -----~~~----~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          250 -----VRS----NCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             -----SCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             -----ccc----cCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence                 111    123467789999999999999999999999998865

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=5.6e-44  Score=336.53  Aligned_cols=252  Identities=23%  Similarity=0.361  Sum_probs=205.9

Q ss_pred             cCCCccceecccCcEEEEEEEECCccEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCceeeeeeEEEeC--CeeEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLLGYCIHA--ETRFLVY  228 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~  228 (439)
                      ++|+..+.||+|+||.||+|+.+ +..+|+|.+....  ....+.+.+|+.++++++||||+++++++...  +..++||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT   88 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence            57888999999999999999986 6778999987543  34456799999999999999999999999877  6789999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEecCCCCCCEEEcCCCcEEEEecccccccC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHP--VVHRDLKSSNILLDSSFNAKLSDFGLSVTAG  306 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~--ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~  306 (439)
                      ||+++|+|.+++... ....+++..+..++.|++.||+|||+.   +  ++||||||+||++++++.++|+|||++....
T Consensus        89 e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~  164 (271)
T 3kmu_A           89 HWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ  164 (271)
T ss_dssp             ECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred             cccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence            999999999999753 233689999999999999999999997   6  9999999999999999999999999876533


Q ss_pred             CCCcceeeccccCccchhhhcCCCCCC---chhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccC
Q 013636          307 TQSRNVKISGTLGYVAPEYLLEGKLTD---KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV  383 (439)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  383 (439)
                      ..    ...||+.|+|||.+.+..++.   ++||||||+++|||++|+.||...+...........    ......+..+
T Consensus       165 ~~----~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~  236 (271)
T 3kmu_A          165 SP----GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALE----GLRPTIPPGI  236 (271)
T ss_dssp             CT----TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHS----CCCCCCCTTC
T ss_pred             cc----CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhc----CCCCCCCCCC
Confidence            22    234899999999998765554   799999999999999999999877654432222110    0111111111


Q ss_pred             CchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCC
Q 013636          384 DPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVP  429 (439)
Q Consensus       384 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~  429 (439)
                                  ...+.+++..||+.||++|||+.|+++.|+++..
T Consensus       237 ------------~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          237 ------------SPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             ------------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             ------------CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence                        2356779999999999999999999999987753

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.3e-44  Score=338.82  Aligned_cols=255  Identities=25%  Similarity=0.412  Sum_probs=212.2

Q ss_pred             cCCCccceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEecc
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQ  232 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  232 (439)
                      ++|+..+.||+|+||.||+++..++..+|+|.+..... ..+++.+|+.++++++||||+++++++.+.+..++||||++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME   86 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence            57888999999999999999998888999999986543 34678999999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc--
Q 013636          233 NGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR--  310 (439)
Q Consensus       233 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~--  310 (439)
                      +|+|.+++..  ....+++..+..++.|+++||+|||+.   +++||||||+||+++.++.+||+|||++........  
T Consensus        87 ~~~L~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~  161 (267)
T 3t9t_A           87 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS  161 (267)
T ss_dssp             TCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred             CCcHHHHHhh--CcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccccccc
Confidence            9999999974  234689999999999999999999998   999999999999999999999999999976543211  


Q ss_pred             ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcC
Q 013636          311 NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRD  389 (439)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  389 (439)
                      .....+|..|+|||.+.+..++.++||||||+++|||++ |+.||...+..+....+...     .....+...      
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~-----~~~~~~~~~------  230 (267)
T 3t9t_A          162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-----FRLYKPRLA------  230 (267)
T ss_dssp             TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-----CCCCCCTTS------
T ss_pred             cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcC-----CcCCCCccC------
Confidence            122346788999999999999999999999999999999 99999877654433222110     001111111      


Q ss_pred             ccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCC
Q 013636          390 TMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPT  430 (439)
Q Consensus       390 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~  430 (439)
                            ...+.+++.+||+.||++|||+.+++++|+++..+
T Consensus       231 ------~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (267)
T 3t9t_A          231 ------STHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  265 (267)
T ss_dssp             ------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             ------cHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence                  23567799999999999999999999999887654

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=8.7e-45  Score=353.92  Aligned_cols=246  Identities=26%  Similarity=0.359  Sum_probs=202.8

Q ss_pred             cCCCccceecccCcEEEEEEEE-CCccEEEEEEecCCC---chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARF-NEKLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      ++|++.+.||+|+||.||+|.. .++..+|+|.+....   ......+.+|+.+++.++||||+++++++...+..++||
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   88 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI   88 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            6788899999999999999997 467899999986431   122346889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~  308 (439)
                      ||+ +|+|.+++..   ...+++..+..++.|++.||+|||+.   +++||||||+|||+++++++||+|||++......
T Consensus        89 E~~-~g~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~  161 (336)
T 3h4j_B           89 EYA-GGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG  161 (336)
T ss_dssp             CCC-CEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred             ECC-CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence            999 6899998854   24599999999999999999999998   9999999999999999999999999999876655


Q ss_pred             CcceeeccccCccchhhhcCCCC-CCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchh
Q 013636          309 SRNVKISGTLGYVAPEYLLEGKL-TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVI  387 (439)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  387 (439)
                      ......+||+.|+|||.+.+..+ +.++|||||||++|||++|+.||...........+.      ......+..+    
T Consensus       162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~------~~~~~~p~~~----  231 (336)
T 3h4j_B          162 NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVN------SCVYVMPDFL----  231 (336)
T ss_dssp             BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCC------SSCCCCCTTS----
T ss_pred             cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHH------cCCCCCcccC----
Confidence            55555679999999999988776 689999999999999999999997654322111110      0011111111    


Q ss_pred             cCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          388 RDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       388 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                              ...+.+++.+||+.||++|||+.|++++
T Consensus       232 --------s~~~~~li~~~L~~dP~~Rpt~~eil~h  259 (336)
T 3h4j_B          232 --------SPGAQSLIRRMIVADPMQRITIQEIRRD  259 (336)
T ss_dssp             --------CHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred             --------CHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence                    2346679999999999999999999875

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2.3e-44  Score=349.45  Aligned_cols=254  Identities=25%  Similarity=0.418  Sum_probs=204.0

Q ss_pred             cCCCccceecccCcEEEEEEEECC-cc----EEEEEEecCCC-chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNE-KL----LAAVKRIDDAG-HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFL  226 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  226 (439)
                      ++|+..+.||+|+||+||+|+... +.    .+++|.+.... ......+.+|+.++++++||||+++++++. .+..++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            578889999999999999998753 32    37888875432 233346788999999999999999999986 567899


Q ss_pred             EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccC
Q 013636          227 VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAG  306 (439)
Q Consensus       227 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~  306 (439)
                      ||||+++|+|.+++...  ...+++..+..++.|++.||+|||+.   +++||||||+|||++.++++||+|||++....
T Consensus        92 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             EEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             EEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccC
Confidence            99999999999999742  34688999999999999999999998   99999999999999999999999999998764


Q ss_pred             CCCc---ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCcc
Q 013636          307 TQSR---NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNI  382 (439)
Q Consensus       307 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  382 (439)
                      ....   .....+|..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+...     .....+..
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~  241 (325)
T 3kex_A          167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG-----ERLAQPQI  241 (325)
T ss_dssp             CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTT-----CBCCCCTT
T ss_pred             cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcC-----CCCCCCCc
Confidence            4322   233457889999999999999999999999999999999 99999887655544443321     11111222


Q ss_pred             CCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCC
Q 013636          383 VDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVP  429 (439)
Q Consensus       383 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~  429 (439)
                      ..+            .+.+++.+||+.||++|||+.+++++|+.+..
T Consensus       242 ~~~------------~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          242 CTI------------DVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             BCT------------TTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             CcH------------HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            222            24558899999999999999999999987754

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.2e-44  Score=348.78  Aligned_cols=263  Identities=25%  Similarity=0.389  Sum_probs=209.0

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEE------CCccEEEEEEecCCC-chHHHHHHHHHHHHHhc-CCCceeeeeeEEEe
Q 013636          149 EAATNNFQESNVIGEGGRGHVYKARF------NEKLLAAVKRIDDAG-HDAEREFNNEVNWLTKI-RHQNIISLLGYCIH  220 (439)
Q Consensus       149 ~~~~~~~~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  220 (439)
                      +...++|+..+.||+|+||.||+|+.      ..+..+|+|.+.... ....+.+.+|+.+++++ +||||+++++++..
T Consensus        41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  120 (344)
T 1rjb_A           41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL  120 (344)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence            34567899999999999999999986      245689999997543 23346789999999999 89999999999999


Q ss_pred             CCeeEEEEEeccCCChhhhhcCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 013636          221 AETRFLVYEMMQNGSLEKQLHGPTH--------------------GSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD  280 (439)
Q Consensus       221 ~~~~~lV~e~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~D  280 (439)
                      .+..++||||+++|+|.+++.....                    ...+++..+..++.|+++||+|||+.   +++|||
T Consensus       121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~D  197 (344)
T 1rjb_A          121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRD  197 (344)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETT
T ss_pred             CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCC
Confidence            9999999999999999999975332                    13489999999999999999999998   999999


Q ss_pred             CCCCCEEEcCCCcEEEEecccccccCCCCcc---eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCC
Q 013636          281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRN---VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEK  356 (439)
Q Consensus       281 lk~~NiLl~~~~~~kl~DfGls~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~  356 (439)
                      |||+||+++.++.+||+|||++.........   ....+|+.|+|||.+.+..++.++||||||+++|||++ |..||..
T Consensus       198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  277 (344)
T 1rjb_A          198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG  277 (344)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence            9999999999999999999999765443322   22347889999999999999999999999999999998 9999987


Q ss_pred             CChhhh-hhhHhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCCC
Q 013636          357 MSPTQC-QSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPTD  431 (439)
Q Consensus       357 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~~  431 (439)
                      ...... ...+..   .  .....+..            ....+.+++.+||+.||++|||+.+++++|+.+....
T Consensus       278 ~~~~~~~~~~~~~---~--~~~~~~~~------------~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  336 (344)
T 1rjb_A          278 IPVDANFYKLIQN---G--FKMDQPFY------------ATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA  336 (344)
T ss_dssp             CCCSHHHHHHHHT---T--CCCCCCTT------------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             CCcHHHHHHHHhc---C--CCCCCCCC------------CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence            654321 111110   0  01111111            1235777999999999999999999999999887654

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-44  Score=356.37  Aligned_cols=257  Identities=28%  Similarity=0.422  Sum_probs=208.9

Q ss_pred             hcCCCccceecccCcEEEEEEEEC------CccEEEEEEecCC-CchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCee
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN------EKLLAAVKRIDDA-GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETR  224 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  224 (439)
                      .++|++.+.||+|+||+||+|++.      .+..+|+|.+... ......++.+|+.++++++||||+++++++...+..
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            467888999999999999999854      3568999999754 334556799999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC---cEEEE
Q 013636          225 FLVYEMMQNGSLEKQLHGPT----HGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSF---NAKLS  297 (439)
Q Consensus       225 ~lV~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~---~~kl~  297 (439)
                      ++||||+++|+|.+++....    ....+++..++.++.|+++||+|||+.   +|+||||||+|||++.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEEC
Confidence            99999999999999997422    224699999999999999999999998   999999999999999554   59999


Q ss_pred             ecccccccCC---CCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhccc
Q 013636          298 DFGLSVTAGT---QSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQL  373 (439)
Q Consensus       298 DfGls~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~  373 (439)
                      |||+++....   ........||+.|+|||.+.+..++.++|||||||++|||++ |..||...+..+....+....   
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~---  303 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG---  303 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC---
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC---
Confidence            9999964321   112223457899999999999999999999999999999998 999998877655433332110   


Q ss_pred             ccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccC
Q 013636          374 TDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLV  428 (439)
Q Consensus       374 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~  428 (439)
                        ....+..            ....+.+++.+||+.||++|||+.+++++|+.+.
T Consensus       304 --~~~~~~~------------~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~  344 (367)
T 3l9p_A          304 --RMDPPKN------------CPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  344 (367)
T ss_dssp             --CCCCCTT------------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --CCCCCcc------------CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence              1111111            1235678999999999999999999999997654

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2e-44  Score=365.67  Aligned_cols=259  Identities=27%  Similarity=0.419  Sum_probs=210.2

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEE
Q 013636          149 EAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       149 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      +...++|+..+.||+|+||.||+|.++++..+|+|.++... ...++|.+|+.++++++||||+++++++.+ +..++||
T Consensus       180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~  257 (452)
T 1fmk_A          180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT  257 (452)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             ccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEe
Confidence            34457788899999999999999999988889999998644 335679999999999999999999999876 6789999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~  308 (439)
                      ||+++|+|.+++... .+..+++..+..++.|++.||+|||+.   +++||||||+|||+++++.+||+|||+++.....
T Consensus       258 e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  333 (452)
T 1fmk_A          258 EYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN  333 (452)
T ss_dssp             CCCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred             hhhcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence            999999999999631 234589999999999999999999998   9999999999999999999999999999765432


Q ss_pred             Ccc--eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCc
Q 013636          309 SRN--VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDP  385 (439)
Q Consensus       309 ~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  385 (439)
                      ...  ....+|..|+|||.+.++.++.++||||||+++|||++ |+.||......+....+...     .....+.    
T Consensus       334 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~-----~~~~~~~----  404 (452)
T 1fmk_A          334 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-----YRMPCPP----  404 (452)
T ss_dssp             ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-----CCCCCCT----
T ss_pred             ceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-----CCCCCCC----
Confidence            211  22346789999999999999999999999999999999 99999987765543333211     0111111    


Q ss_pred             hhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCC
Q 013636          386 VIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPT  430 (439)
Q Consensus       386 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~  430 (439)
                              .....+.+++.+||+.||++|||+.++++.|+.+...
T Consensus       405 --------~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          405 --------ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             --------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             --------CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence                    1134577899999999999999999999999988754

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=2.4e-44  Score=341.83  Aligned_cols=256  Identities=25%  Similarity=0.386  Sum_probs=199.1

Q ss_pred             hcCCCccceecccCcEEEEEEEECC----ccEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFNE----KLLAAVKRIDDAG-HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFL  226 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  226 (439)
                      .++|++.+.||+|+||.||+|....    +..+|+|...... ....+.+.+|+.++++++||||+++++++. .+..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence            4688889999999999999998743    4578999987643 334567999999999999999999999984 567899


Q ss_pred             EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccC
Q 013636          227 VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAG  306 (439)
Q Consensus       227 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~  306 (439)
                      ||||+++|+|.+++..  ....+++..+..++.|+++||+|||+.   +++||||||+|||++.++.+||+|||++....
T Consensus        93 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  167 (281)
T 1mp8_A           93 IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  167 (281)
T ss_dssp             EEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccC
Confidence            9999999999999974  234689999999999999999999998   99999999999999999999999999997664


Q ss_pred             CCCcc--eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCccC
Q 013636          307 TQSRN--VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV  383 (439)
Q Consensus       307 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  383 (439)
                      .....  ....+|+.|+|||.+.+..++.++||||||+++|||++ |..||......+....+...     .....+.  
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~-----~~~~~~~--  240 (281)
T 1mp8_A          168 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-----ERLPMPP--  240 (281)
T ss_dssp             -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-----CCCCCCT--
T ss_pred             cccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcC-----CCCCCCC--
Confidence            43221  22346788999999999999999999999999999997 99999877654433222210     0111111  


Q ss_pred             CchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCC
Q 013636          384 DPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPT  430 (439)
Q Consensus       384 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~  430 (439)
                            .    ....+.+++..||+.||++|||+.|+++.|+.+..+
T Consensus       241 ------~----~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  277 (281)
T 1mp8_A          241 ------N----CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  277 (281)
T ss_dssp             ------T----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------C----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence                  1    123567799999999999999999999999887643

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.7e-44  Score=345.27  Aligned_cols=255  Identities=27%  Similarity=0.514  Sum_probs=199.6

Q ss_pred             cCCCccceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEecc
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQ  232 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  232 (439)
                      ++|++.+.||+|+||+||+++.. +..+|+|.+...  ...+.|.+|+.++++++||||+++++++.  +..++||||++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~   82 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE   82 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence            56888899999999999999986 567899998753  35568999999999999999999999886  45899999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCc-EEEEecccccccCCCCcc
Q 013636          233 NGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFN-AKLSDFGLSVTAGTQSRN  311 (439)
Q Consensus       233 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~-~kl~DfGls~~~~~~~~~  311 (439)
                      +|+|.+++........+++..++.++.|+++||+|||+.+..+++||||||+||+++.++. +||+|||++.......  
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~--  160 (307)
T 2eva_A           83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM--  160 (307)
T ss_dssp             TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred             CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc--
Confidence            9999999986544446889999999999999999999943348999999999999998886 7999999997654322  


Q ss_pred             eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCcc
Q 013636          312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTM  391 (439)
Q Consensus       312 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  391 (439)
                      ....||+.|+|||.+.+..++.++||||||+++|||++|+.||.........  ..+.... .......        ...
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~~~~~~-~~~~~~~--------~~~  229 (307)
T 2eva_A          161 TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR--IMWAVHN-GTRPPLI--------KNL  229 (307)
T ss_dssp             ----CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH--HHHHHHT-TCCCCCB--------TTC
T ss_pred             ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH--HHHHHhc-CCCCCcc--------ccc
Confidence            2335899999999999999999999999999999999999999865432211  1111110 0011111        111


Q ss_pred             CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCC
Q 013636          392 DLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVP  429 (439)
Q Consensus       392 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~  429 (439)
                          ...+.+++.+||+.||++|||+.++++.|+.+..
T Consensus       230 ----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  263 (307)
T 2eva_A          230 ----PKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR  263 (307)
T ss_dssp             ----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred             ----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence                2356779999999999999999999999977654

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=4.2e-44  Score=352.79  Aligned_cols=252  Identities=24%  Similarity=0.358  Sum_probs=193.6

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEe
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      .++|++.+.||+|+||+||+++.. ++..+|+|.+..... ..+.+.+|+.++++++||||+++++++...+..++||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            467899999999999999999986 578899999975432 335688999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCc--EEEEecccccccCCC
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFN--AKLSDFGLSVTAGTQ  308 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~--~kl~DfGls~~~~~~  308 (439)
                      +++|+|.+++..   ...+++..+..++.|+++||+|||+.   +++||||||+|||++.++.  +||+|||+++.....
T Consensus        98 ~~~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~  171 (361)
T 3uc3_A           98 ASGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  171 (361)
T ss_dssp             CCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred             CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence            999999999863   23589999999999999999999998   9999999999999987765  999999999755444


Q ss_pred             CcceeeccccCccchhhhcCCCCCCc-hhhHHHHHHHHHHHhCCCCCCCCChhh-hhhhHhhhhcccccCCCCCccCCch
Q 013636          309 SRNVKISGTLGYVAPEYLLEGKLTDK-SDVYAFGVVLLELLMGRRPVEKMSPTQ-CQSMVTWAMPQLTDRSKLPNIVDPV  386 (439)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwS~Gvll~elltG~~P~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~d~~  386 (439)
                      .......||+.|+|||.+.+..++.+ +|||||||++|||++|+.||....... .........   ......+...   
T Consensus       172 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~---~~~~~~~~~~---  245 (361)
T 3uc3_A          172 SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRIL---SVKYSIPDDI---  245 (361)
T ss_dssp             ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHH---TTCCCCCTTS---
T ss_pred             CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHh---cCCCCCCCcC---
Confidence            44445569999999999998888766 899999999999999999998754322 112211111   1111111100   


Q ss_pred             hcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          387 IRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       387 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                         ..    ...+.+++.+||+.||++|||+.|++++
T Consensus       246 ---~~----s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          246 ---RI----SPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             ---CC----CHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             ---CC----CHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence               01    2356789999999999999999999976

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.2e-43  Score=358.40  Aligned_cols=253  Identities=22%  Similarity=0.308  Sum_probs=206.3

Q ss_pred             HhcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEE
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGH--DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLV  227 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  227 (439)
                      ..++|++.+.||+|+||+||++... ++..+|+|.+.....  ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            4568999999999999999999874 578899999875432  3345789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc---CCCcEEEEecccccc
Q 013636          228 YEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLD---SSFNAKLSDFGLSVT  304 (439)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~---~~~~~kl~DfGls~~  304 (439)
                      |||+++|+|.+++..   ...+++..+..++.|++.||+|||+.   +|+||||||+|||++   +++.+||+|||++..
T Consensus        89 ~E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~  162 (444)
T 3soa_A           89 FDLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIE  162 (444)
T ss_dssp             ECCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred             EEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence            999999999999864   24599999999999999999999998   999999999999998   567899999999977


Q ss_pred             cCCCCc-ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccC
Q 013636          305 AGTQSR-NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV  383 (439)
Q Consensus       305 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  383 (439)
                      ...... .....||+.|+|||.+.+..++.++||||+||++|+|++|+.||...+.......+....      ...+.  
T Consensus       163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~------~~~~~--  234 (444)
T 3soa_A          163 VEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGA------YDFPS--  234 (444)
T ss_dssp             CCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC------CCCCT--
T ss_pred             ecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC------CCCCc--
Confidence            654332 234569999999999999999999999999999999999999998876554433332111      11110  


Q ss_pred             CchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          384 DPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       384 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                       +. ....    ...+.+++..||+.||++|||+.|++++
T Consensus       235 -~~-~~~~----s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          235 -PE-WDTV----TPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             -TT-TTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             -cc-cccC----CHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence             00 0111    2356679999999999999999999976

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.9e-44  Score=349.88  Aligned_cols=250  Identities=24%  Similarity=0.391  Sum_probs=199.5

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCe------
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG-HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAET------  223 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------  223 (439)
                      .++|++.+.||+|+||.||+|+.. ++..+|+|++.... ....+.+.+|+.++++++||||+++++++.+.+.      
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            357888999999999999999986 68899999987433 3455789999999999999999999999866542      


Q ss_pred             ---------------------------------------------------eEEEEEeccCCChhhhhcCCCCCCCCCHH
Q 013636          224 ---------------------------------------------------RFLVYEMMQNGSLEKQLHGPTHGSNLTWH  252 (439)
Q Consensus       224 ---------------------------------------------------~~lV~e~~~~gsL~~~l~~~~~~~~l~~~  252 (439)
                                                                         .++||||+++|+|.+++.........++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                               79999999999999999875555567888


Q ss_pred             HHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc-------------ceeeccccC
Q 013636          253 LRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR-------------NVKISGTLG  319 (439)
Q Consensus       253 ~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~-------------~~~~~gt~~  319 (439)
                      .+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++........             .....||+.
T Consensus       165 ~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            8999999999999999998   999999999999999999999999999977654321             123458999


Q ss_pred             ccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCccCHHHHHHH
Q 013636          320 YVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQV  399 (439)
Q Consensus       320 y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l  399 (439)
                      |+|||.+.+..++.++||||||+++|||++|..|+...     .......    . ....+.     .    .......+
T Consensus       242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-----~~~~~~~----~-~~~~~~-----~----~~~~~~~~  302 (332)
T 3qd2_B          242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-----VRIITDV----R-NLKFPL-----L----FTQKYPQE  302 (332)
T ss_dssp             GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-----HHHHHHH----H-TTCCCH-----H----HHHHCHHH
T ss_pred             ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-----HHHHHHh----h-ccCCCc-----c----cccCChhH
Confidence            99999999999999999999999999999987764211     1111100    0 111110     0    11223456


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          400 AAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       400 ~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      .+++.+||+.||++|||+.|++++
T Consensus       303 ~~li~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          303 HMMVQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             HHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHHccCCCCcCCCHHHHhhc
Confidence            789999999999999999999975

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=4.3e-44  Score=347.42  Aligned_cols=252  Identities=27%  Similarity=0.395  Sum_probs=201.7

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGH-DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYE  229 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  229 (439)
                      .++|++.+.||+|+||+||+|+.. ++..+|+|.+..... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            368899999999999999999886 678899999864432 234568899999999999999999999999999999999


Q ss_pred             eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCC
Q 013636          230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS  309 (439)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~  309 (439)
                      |+++|+|.+++..   ...+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++.......
T Consensus        86 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  159 (323)
T 3tki_A           86 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (323)
T ss_dssp             CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             cCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence            9999999999964   34599999999999999999999998   99999999999999999999999999997653222


Q ss_pred             c---ceeeccccCccchhhhcCCCC-CCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCc
Q 013636          310 R---NVKISGTLGYVAPEYLLEGKL-TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDP  385 (439)
Q Consensus       310 ~---~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  385 (439)
                      .   .....||+.|+|||.+.+..+ +.++|||||||++|||++|+.||...+.... ....+...    ....    .+
T Consensus       160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~----~~~~----~~  230 (323)
T 3tki_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKEK----KTYL----NP  230 (323)
T ss_dssp             EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHHHHTT----CTTS----TT
T ss_pred             cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHHhcc----cccC----Cc
Confidence            1   224568999999999988775 7789999999999999999999986554321 11111110    0000    00


Q ss_pred             hhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhc
Q 013636          386 VIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL  424 (439)
Q Consensus       386 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  424 (439)
                        ....    ...+.+++.+||+.||++|||+.|++++-
T Consensus       231 --~~~~----~~~~~~li~~~L~~dP~~R~t~~eil~h~  263 (323)
T 3tki_A          231 --WKKI----DSAPLALLHKILVENPSARITIPDIKKDR  263 (323)
T ss_dssp             --GGGS----CHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred             --cccC----CHHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence              0111    23456799999999999999999999763

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=8.3e-44  Score=349.10  Aligned_cols=251  Identities=24%  Similarity=0.326  Sum_probs=190.2

Q ss_pred             HhcCCCccceecccCcEEEEEEEECC-ccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEE
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYE  229 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  229 (439)
                      ..++|++.+.||+|+||.||+|+..+ +..+|+|.+....  ..+.+.+|+.++++++||||+++++++...+..++|||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            45789999999999999999999874 6789999987542  34568899999999999999999999999999999999


Q ss_pred             eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC---CCcEEEEecccccccC
Q 013636          230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDS---SFNAKLSDFGLSVTAG  306 (439)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~---~~~~kl~DfGls~~~~  306 (439)
                      |+++|+|.+++..   ...+++..+..++.|++.||+|||+.   +++||||||+|||++.   ++.+||+|||++....
T Consensus       129 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~  202 (349)
T 2w4o_A          129 LVTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE  202 (349)
T ss_dssp             CCCSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred             eCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence            9999999999964   34589999999999999999999998   9999999999999975   8899999999998765


Q ss_pred             CCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhh-hhhhHhhhhcccccCCCCCccCCc
Q 013636          307 TQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQ-CQSMVTWAMPQLTDRSKLPNIVDP  385 (439)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~d~  385 (439)
                      .........||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ....+.      ......   ..+
T Consensus       203 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~------~~~~~~---~~~  273 (349)
T 2w4o_A          203 HQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRIL------NCEYYF---ISP  273 (349)
T ss_dssp             ----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHH------TTCCCC---CTT
T ss_pred             cccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHH------hCCCcc---CCc
Confidence            5444445569999999999999999999999999999999999999997654432 111111      001000   000


Q ss_pred             hhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          386 VIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       386 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                       .....    ...+.+++.+||+.||++|||+.|++++
T Consensus       274 -~~~~~----~~~~~~li~~~L~~dP~~Rpt~~e~l~h  306 (349)
T 2w4o_A          274 -WWDEV----SLNAKDLVRKLIVLDPKKRLTTFQALQH  306 (349)
T ss_dssp             -TTTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -hhhhC----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             11111    2356789999999999999999999985

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=4.6e-44  Score=355.82  Aligned_cols=254  Identities=23%  Similarity=0.360  Sum_probs=201.3

Q ss_pred             hcCCCccceecccCcEEEEEEEECC-ccEEEEEEecCCCc---hHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeeEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGH---DAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFL  226 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  226 (439)
                      .++|++.+.||+|+||+||+++... +..+|+|.++....   ...+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            3678999999999999999999865 67899999875422   2234578899999887 89999999999999999999


Q ss_pred             EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccccccc-
Q 013636          227 VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA-  305 (439)
Q Consensus       227 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~-  305 (439)
                      ||||+++|+|.+++..   ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++++||+|||+++.. 
T Consensus       131 V~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~  204 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  204 (396)
T ss_dssp             EEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEcCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence            9999999999999964   24599999999999999999999998   9999999999999999999999999999763 


Q ss_pred             CCCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhh--hhhHhhhh-cccccCCCCCcc
Q 013636          306 GTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQC--QSMVTWAM-PQLTDRSKLPNI  382 (439)
Q Consensus       306 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~--~~~~~~~~-~~~~~~~~~~~~  382 (439)
                      .........+||+.|+|||++.+..++.++|||||||++|||++|+.||........  ........ ........++..
T Consensus       205 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~  284 (396)
T 4dc2_A          205 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS  284 (396)
T ss_dssp             CTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTT
T ss_pred             cCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCc
Confidence            233334456799999999999999999999999999999999999999975422110  00000000 011112223322


Q ss_pred             CCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCH------HHHHHh
Q 013636          383 VDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLI------TDVLHS  423 (439)
Q Consensus       383 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~------~evl~~  423 (439)
                      ++            ..+.+++.+||+.||++||++      .|++++
T Consensus       285 ~s------------~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H  319 (396)
T 4dc2_A          285 LS------------VKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  319 (396)
T ss_dssp             SC------------HHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred             CC------------HHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence            22            246679999999999999985      677654

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=3.6e-44  Score=354.77  Aligned_cols=247  Identities=23%  Similarity=0.301  Sum_probs=200.8

Q ss_pred             cceecccCcEEEEEEEEC-CccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEeccCCCh
Q 013636          158 SNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSL  236 (439)
Q Consensus       158 ~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  236 (439)
                      .+.||+|+||.||+|+.. ++..+|+|.+........+.+.+|+.++++++||||+++++++...+..++||||+++|+|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            568999999999999875 5789999999876666677899999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE--cCCCcEEEEecccccccCCCCcceee
Q 013636          237 EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILL--DSSFNAKLSDFGLSVTAGTQSRNVKI  314 (439)
Q Consensus       237 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl--~~~~~~kl~DfGls~~~~~~~~~~~~  314 (439)
                      .+++..  ....+++..+..++.|+++||+|||+.   +|+||||||+|||+  +.++.+||+|||++............
T Consensus       174 ~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~  248 (373)
T 2x4f_A          174 FDRIID--ESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN  248 (373)
T ss_dssp             HHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCC
T ss_pred             HHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccc
Confidence            998863  234589999999999999999999998   99999999999999  66789999999999877655444455


Q ss_pred             ccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCccCHH
Q 013636          315 SGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLK  394 (439)
Q Consensus       315 ~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  394 (439)
                      .||+.|+|||.+.+..++.++|||||||++|||++|+.||...+..+....+...      ....+   ++ .....   
T Consensus       249 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~------~~~~~---~~-~~~~~---  315 (373)
T 2x4f_A          249 FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILAC------RWDLE---DE-EFQDI---  315 (373)
T ss_dssp             CSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT------CCCSC---SG-GGTTS---
T ss_pred             cCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc------cCCCC---hh-hhccC---
Confidence            6999999999999999999999999999999999999999887654432222111      11110   00 11111   


Q ss_pred             HHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          395 HLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       395 ~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                       ...+.+++.+||+.||++|||+.|++++
T Consensus       316 -~~~~~~li~~~L~~dp~~Rps~~e~l~h  343 (373)
T 2x4f_A          316 -SEEAKEFISKLLIKEKSWRISASEALKH  343 (373)
T ss_dssp             -CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -CHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence             2357789999999999999999999974

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.3e-44  Score=361.35  Aligned_cols=261  Identities=21%  Similarity=0.277  Sum_probs=209.7

Q ss_pred             HHHHHHHhcCCCccceecccCcEEEEEEEECC-ccEEEEEEecCCCc---hHHHHHHHHHHHHHhcCCCceeeeeeEEEe
Q 013636          145 YELLEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGH---DAEREFNNEVNWLTKIRHQNIISLLGYCIH  220 (439)
Q Consensus       145 ~~~l~~~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  220 (439)
                      ...++...++|++.++||+|+||+||+|+..+ +..+|+|.+.....   .....+.+|..++..++||||+++++++.+
T Consensus        66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  145 (437)
T 4aw2_A           66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD  145 (437)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            34445567899999999999999999999875 67899999864221   112248899999999999999999999999


Q ss_pred             CCeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecc
Q 013636          221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFG  300 (439)
Q Consensus       221 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfG  300 (439)
                      .+..++||||+++|+|.+++..  ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++++||+|||
T Consensus       146 ~~~~~lV~Ey~~gg~L~~~l~~--~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFG  220 (437)
T 4aw2_A          146 DNNLYLVMDYYVGGDLLTLLSK--FEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFG  220 (437)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CCEEEEEEecCCCCcHHHHHHH--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchh
Confidence            9999999999999999999974  235699999999999999999999998   99999999999999999999999999


Q ss_pred             cccccCCCCcc--eeeccccCccchhhhc-----CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhccc
Q 013636          301 LSVTAGTQSRN--VKISGTLGYVAPEYLL-----EGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQL  373 (439)
Q Consensus       301 ls~~~~~~~~~--~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~  373 (439)
                      +++........  ...+||+.|+|||++.     .+.++.++|||||||++|||++|+.||...+..+....+.....  
T Consensus       221 la~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--  298 (437)
T 4aw2_A          221 SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE--  298 (437)
T ss_dssp             TCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH--
T ss_pred             hhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccc--
Confidence            99765443322  2356999999999997     56789999999999999999999999998776554333221111  


Q ss_pred             ccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHh
Q 013636          374 TDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSY--RPLITDVLHS  423 (439)
Q Consensus       374 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~evl~~  423 (439)
                        ...++...     ...    ...+.+++.+||..+|++  ||++.|++++
T Consensus       299 --~~~~p~~~-----~~~----s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          299 --RFQFPTQV-----TDV----SENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             --HCCCCSSC-----CCS----CHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             --cccCCccc-----ccC----CHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence              11111111     011    224567889999888888  9999999975

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=5e-44  Score=338.67  Aligned_cols=251  Identities=24%  Similarity=0.282  Sum_probs=208.3

Q ss_pred             hcCCCccceecccCcEEEEEEEECC-ccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEe
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      .++|++.+.||+|+||.||+|.... +..+|+|++........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL   87 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence            4678899999999999999999865 568899998766556677899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE---cCCCcEEEEecccccccCC
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILL---DSSFNAKLSDFGLSVTAGT  307 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl---~~~~~~kl~DfGls~~~~~  307 (439)
                      +++++|.+++..   ...+++..+..++.|++.||+|||+.   +++||||||+||++   +.++.+||+|||++.....
T Consensus        88 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~  161 (277)
T 3f3z_A           88 CTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP  161 (277)
T ss_dssp             CCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred             cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence            999999998864   34589999999999999999999998   99999999999999   7889999999999987665


Q ss_pred             CCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchh
Q 013636          308 QSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVI  387 (439)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  387 (439)
                      ........||+.|+|||.+.+ .++.++||||||+++|||++|+.||...+..+....+...      ....+.    ..
T Consensus       162 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------~~~~~~----~~  230 (277)
T 3f3z_A          162 GKMMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREG------TFTFPE----KD  230 (277)
T ss_dssp             TSCBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------CCCCCH----HH
T ss_pred             ccchhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC------CCCCCc----hh
Confidence            554455669999999998865 4899999999999999999999999887655433222211      111110    00


Q ss_pred             cCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          388 RDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       388 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      ....    ...+.+++.+||+.||++|||+.|++++
T Consensus       231 ~~~~----~~~~~~li~~~l~~dp~~R~s~~~~l~h  262 (277)
T 3f3z_A          231 WLNV----SPQAESLIRRLLTKSPKQRITSLQALEH  262 (277)
T ss_dssp             HTTS----CHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             hhcC----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0011    2357789999999999999999999864

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.4e-44  Score=347.21  Aligned_cols=246  Identities=26%  Similarity=0.327  Sum_probs=194.8

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCc--hHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeeEEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGH--DAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLV  227 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV  227 (439)
                      .++|+..++||+|+||+||+|+.. ++..+|||++.....  .....+..|+..+.++ +||||++++++|.+.+..++|
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv  135 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ  135 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence            467999999999999999999986 688999998865332  3334555666666555 899999999999999999999


Q ss_pred             EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCC
Q 013636          228 YEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT  307 (439)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~  307 (439)
                      |||+ +|+|.+++...  +..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++++||+|||++.....
T Consensus       136 ~e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~  209 (311)
T 3p1a_A          136 TELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT  209 (311)
T ss_dssp             EECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred             Eecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence            9999 67999988642  34699999999999999999999998   999999999999999999999999999987765


Q ss_pred             CCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchh
Q 013636          308 QSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVI  387 (439)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  387 (439)
                      ........||+.|+|||++.+ .++.++|||||||++|||++|..|+......  ....         ..    ...+.+
T Consensus       210 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~--~~~~---------~~----~~~~~~  273 (311)
T 3p1a_A          210 AGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGW--QQLR---------QG----YLPPEF  273 (311)
T ss_dssp             -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH--HHHT---------TT----CCCHHH
T ss_pred             CCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHH--HHHh---------cc----CCCccc
Confidence            544445569999999998875 7999999999999999999997766542211  1110         00    111112


Q ss_pred             cCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          388 RDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       388 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      ....    ...+.+++.+||+.||++|||+.|++++
T Consensus       274 ~~~~----~~~l~~li~~~L~~dP~~Rpt~~ell~h  305 (311)
T 3p1a_A          274 TAGL----SSELRSVLVMMLEPDPKLRATAEALLAL  305 (311)
T ss_dssp             HTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ccCC----CHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence            2222    2467789999999999999999999975

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=9.6e-44  Score=348.93  Aligned_cols=254  Identities=22%  Similarity=0.310  Sum_probs=204.2

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCC-----CchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDA-----GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRF  225 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  225 (439)
                      .++|++.+.||+|+||+||++... ++..+|+|.+...     .....+.+.+|+.+++.++||||+++++++...+..+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            357889999999999999999875 5789999998532     1123567999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCc---EEEEeccc
Q 013636          226 LVYEMMQNGSLEKQLHGP-THGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFN---AKLSDFGL  301 (439)
Q Consensus       226 lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~---~kl~DfGl  301 (439)
                      +||||+++|+|.+++... ..+..+++..+..++.|++.||+|||+.   +++||||||+|||++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            999999999998887532 2234589999999999999999999998   9999999999999987655   99999999


Q ss_pred             ccccCCCCc-ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCC
Q 013636          302 SVTAGTQSR-NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLP  380 (439)
Q Consensus       302 s~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  380 (439)
                      +........ .....||+.|+|||.+.+..++.++|||||||++|||++|+.||..............       ...  
T Consensus       180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i~~~-------~~~--  250 (351)
T 3c0i_A          180 AIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKG-------KYK--  250 (351)
T ss_dssp             CEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHHHHT-------CCC--
T ss_pred             eeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHHHcC-------CCC--
Confidence            977654332 2345699999999999999999999999999999999999999987533221111110       000  


Q ss_pred             ccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          381 NIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       381 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                        .++......    ...+.+++.+||+.||++|||+.|++++
T Consensus       251 --~~~~~~~~~----s~~~~~li~~~L~~dP~~R~s~~e~l~h  287 (351)
T 3c0i_A          251 --MNPRQWSHI----SESAKDLVRRMLMLDPAERITVYEALNH  287 (351)
T ss_dssp             --CCHHHHTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             --CCccccccC----CHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence              111111111    2356789999999999999999999964

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.7e-43  Score=340.49  Aligned_cols=267  Identities=25%  Similarity=0.311  Sum_probs=203.4

Q ss_pred             HhcCCCccceecccCcEEEEEEEE-CCccEEEEEEecCCC-----chHHHHHHHHHHHHHhc---CCCceeeeeeEEEeC
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARF-NEKLLAAVKRIDDAG-----HDAEREFNNEVNWLTKI---RHQNIISLLGYCIHA  221 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~  221 (439)
                      ..++|++.+.||+|+||+||+|+. .++..+|+|.+....     ......+.+|+.+++++   +||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            457899999999999999999997 457889999986322     11224566777777666   499999999999876


Q ss_pred             C-----eeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEE
Q 013636          222 E-----TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKL  296 (439)
Q Consensus       222 ~-----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl  296 (439)
                      .     ..++||||+. |+|.+++.... ...+++..+..++.|++.||+|||+.   +++||||||+|||++.++++||
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl  161 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKL  161 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEE
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEE
Confidence            5     4799999997 59999997532 34499999999999999999999998   9999999999999999999999


Q ss_pred             EecccccccCCCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccC
Q 013636          297 SDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDR  376 (439)
Q Consensus       297 ~DfGls~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~  376 (439)
                      +|||++.............||+.|+|||.+.+..++.++|||||||++|||++|+.||...+..+....+..........
T Consensus       162 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  241 (308)
T 3g33_A          162 ADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED  241 (308)
T ss_dssp             CSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             eeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            99999987665544455678999999999999999999999999999999999999998877654333322211111110


Q ss_pred             CCCCccC---CchhcC-------ccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          377 SKLPNIV---DPVIRD-------TMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       377 ~~~~~~~---d~~l~~-------~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                       ..+...   ......       ....+....+.+++.+||+.||++|||+.|++++
T Consensus       242 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  297 (308)
T 3g33_A          242 -DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH  297 (308)
T ss_dssp             -TSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             -hccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence             000000   000000       0001123467789999999999999999999976

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=9.1e-44  Score=344.29  Aligned_cols=245  Identities=25%  Similarity=0.352  Sum_probs=205.7

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC---chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      ++|++.+.||+|+||+||+++.. ++..+|+|.+....   ....+.+.+|..+++.++||||+++++++.+.+..++||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            57888999999999999999886 57899999986532   123456889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~  308 (439)
                      ||+++|+|.+++..   ...+++..+..++.|++.||+|||+.   +++||||||+|||++.++++||+|||++......
T Consensus        86 e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~  159 (318)
T 1fot_A           86 DYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  159 (318)
T ss_dssp             CCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence            99999999999964   34589999999999999999999998   9999999999999999999999999999875432


Q ss_pred             CcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhc
Q 013636          309 SRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIR  388 (439)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  388 (439)
                        ....+||+.|+|||.+.+..++.++|||||||++|||++|+.||...+.......+..      .....+..++    
T Consensus       160 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~------~~~~~p~~~~----  227 (318)
T 1fot_A          160 --TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN------AELRFPPFFN----  227 (318)
T ss_dssp             --BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH------CCCCCCTTSC----
T ss_pred             --cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh------CCCCCCCCCC----
Confidence              2345699999999999999999999999999999999999999987665443222211      1122222222    


Q ss_pred             CccCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHh
Q 013636          389 DTMDLKHLYQVAAVAVLCIQPEPSYRP-----LITDVLHS  423 (439)
Q Consensus       389 ~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  423 (439)
                              ..+.+++.+||+.||++||     ++.|++++
T Consensus       228 --------~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          228 --------EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             --------HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             --------HHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence                    3466799999999999999     89999865

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=6e-44  Score=353.72  Aligned_cols=249  Identities=24%  Similarity=0.389  Sum_probs=205.7

Q ss_pred             cCCCccceecccCcEEEEEEEECC-ccEEEEEEecCCC---chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      ++|++.+.||+|+||.||+++... +..+|+|.+....   ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            678889999999999999998865 7789999986432   233467889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~  308 (439)
                      ||+++|+|.+++..   ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++++||+|||++......
T Consensus        95 e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  168 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE  168 (384)
T ss_dssp             CCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence            99999999999964   34699999999999999999999998   9999999999999999999999999999877655


Q ss_pred             CcceeeccccCccchhhhcC---CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCc
Q 013636          309 SRNVKISGTLGYVAPEYLLE---GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDP  385 (439)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  385 (439)
                      .......||+.|+|||++..   ..++.++|||||||++|||++|+.||...+.............   .....+..+  
T Consensus       169 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~---~~~~~p~~~--  243 (384)
T 4fr4_A          169 TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET---TVVTYPSAW--  243 (384)
T ss_dssp             CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH---CCCCCCTTS--
T ss_pred             CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh---cccCCCCcC--
Confidence            55556779999999999974   4589999999999999999999999986544332222222111   111222222  


Q ss_pred             hhcCccCHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHH
Q 013636          386 VIRDTMDLKHLYQVAAVAVLCIQPEPSYRPL-ITDVLH  422 (439)
Q Consensus       386 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-~~evl~  422 (439)
                                ...+.+++..||+.||++||+ +.++++
T Consensus       244 ----------s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          244 ----------SQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             ----------CHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             ----------CHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence                      235677999999999999998 777765

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.8e-43  Score=340.51  Aligned_cols=265  Identities=23%  Similarity=0.319  Sum_probs=202.2

Q ss_pred             cCCCccceecccCcEEEEEEEECC-ccEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGH--DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYE  229 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  229 (439)
                      ++|++.+.||+|+||+||+|+... +..+|+|++.....  ...+.+.+|+.++++++||||+++++++...+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            678899999999999999999864 78899998865433  234668899999999999999999999999999999999


Q ss_pred             eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCC
Q 013636          230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS  309 (439)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~  309 (439)
                      |+++++|.+++..   ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++.......
T Consensus        83 ~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  156 (311)
T 4agu_A           83 YCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS  156 (311)
T ss_dssp             CCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             eCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence            9999999998863   34589999999999999999999998   99999999999999999999999999997765322


Q ss_pred             c-ceeeccccCccchhhhcC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcc-------------cc
Q 013636          310 R-NVKISGTLGYVAPEYLLE-GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQ-------------LT  374 (439)
Q Consensus       310 ~-~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~-------------~~  374 (439)
                      . .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...+..+....+......             ..
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (311)
T 4agu_A          157 DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF  236 (311)
T ss_dssp             ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred             cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence            2 234468999999999976 67899999999999999999999999887655433222211110             00


Q ss_pred             cCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          375 DRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       375 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      .....+...+..-...........+.+++..||+.||++|||+.|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            0111111000000000000123457789999999999999999999976

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.9e-44  Score=351.53  Aligned_cols=248  Identities=25%  Similarity=0.395  Sum_probs=205.6

Q ss_pred             HhcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC---chHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeeE
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG---HDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRF  225 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  225 (439)
                      ..++|++.+.||+|+||+||+|+.. ++..+|+|.++...   ......+..|..++..+ +||||+++++++.+.+..+
T Consensus        15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~   94 (345)
T 1xjd_A           15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF   94 (345)
T ss_dssp             -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence            4578999999999999999999986 47889999987532   22345678899999887 9999999999999999999


Q ss_pred             EEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccccccc
Q 013636          226 LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA  305 (439)
Q Consensus       226 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~  305 (439)
                      +||||+++|+|.+++..   ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++++||+|||+++..
T Consensus        95 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  168 (345)
T 1xjd_A           95 FVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKEN  168 (345)
T ss_dssp             EEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence            99999999999999964   23589999999999999999999998   9999999999999999999999999999764


Q ss_pred             CC-CCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCC
Q 013636          306 GT-QSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVD  384 (439)
Q Consensus       306 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  384 (439)
                      .. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+..      .....+..++
T Consensus       169 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~------~~~~~p~~~s  242 (345)
T 1xjd_A          169 MLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM------DNPFYPRWLE  242 (345)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------CCCCCCTTSC
T ss_pred             ccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh------CCCCCCcccC
Confidence            32 2233456799999999999999999999999999999999999999988776544333321      1122222222


Q ss_pred             chhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHH-HHHH
Q 013636          385 PVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLIT-DVLH  422 (439)
Q Consensus       385 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~-evl~  422 (439)
                                  ..+.+++.+||+.||++||++. ++++
T Consensus       243 ------------~~~~~li~~lL~~dp~~R~~~~~~i~~  269 (345)
T 1xjd_A          243 ------------KEAKDLLVKLFVREPEKRLGVRGDIRQ  269 (345)
T ss_dssp             ------------HHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             ------------HHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence                        3466799999999999999997 6664

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=6.4e-44  Score=343.62  Aligned_cols=261  Identities=24%  Similarity=0.390  Sum_probs=212.2

Q ss_pred             HHhcCCCccceecccCcEEEEEEEE------CCccEEEEEEecCCCc-hHHHHHHHHHHHHHhc-CCCceeeeeeEEEeC
Q 013636          150 AATNNFQESNVIGEGGRGHVYKARF------NEKLLAAVKRIDDAGH-DAEREFNNEVNWLTKI-RHQNIISLLGYCIHA  221 (439)
Q Consensus       150 ~~~~~~~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  221 (439)
                      ...++|+..+.||+|+||.||+|+.      .++..+|+|.+..... ...+.+.+|+.+++++ +||||+++++++...
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   99 (313)
T 1t46_A           20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (313)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence            3446888899999999999999985      3467899999976543 3456799999999999 999999999999999


Q ss_pred             CeeEEEEEeccCCChhhhhcCCCC---------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCE
Q 013636          222 ETRFLVYEMMQNGSLEKQLHGPTH---------------GSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNI  286 (439)
Q Consensus       222 ~~~~lV~e~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~Ni  286 (439)
                      +..++||||+++|+|.+++.....               ...+++..+..++.|+++||+|||+.   +++||||||+||
T Consensus       100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Ni  176 (313)
T 1t46_A          100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNI  176 (313)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred             CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceE
Confidence            999999999999999999975321               22589999999999999999999998   999999999999


Q ss_pred             EEcCCCcEEEEecccccccCCCCcc---eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhh-
Q 013636          287 LLDSSFNAKLSDFGLSVTAGTQSRN---VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQ-  361 (439)
Q Consensus       287 Ll~~~~~~kl~DfGls~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~-  361 (439)
                      +++.++.+||+|||++.........   ....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... 
T Consensus       177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~  256 (313)
T 1t46_A          177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK  256 (313)
T ss_dssp             EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred             EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH
Confidence            9999999999999999776544322   22346789999999999999999999999999999999 999998765332 


Q ss_pred             hhhhHhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCC
Q 013636          362 CQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPT  430 (439)
Q Consensus       362 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~  430 (439)
                      .........     ....+.            .....+.+++.+||+.||++|||+.|++++|++++.+
T Consensus       257 ~~~~~~~~~-----~~~~~~------------~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  308 (313)
T 1t46_A          257 FYKMIKEGF-----RMLSPE------------HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (313)
T ss_dssp             HHHHHHHTC-----CCCCCT------------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHhccCC-----CCCCcc------------cCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence            111111100     001111            1124577899999999999999999999999887653

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=4e-44  Score=347.07  Aligned_cols=259  Identities=24%  Similarity=0.400  Sum_probs=196.5

Q ss_pred             HhcCCCccceecccCcEEEEEEEECCcc----EEEEEEecCC--CchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCee
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARFNEKL----LAAVKRIDDA--GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETR  224 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~----~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  224 (439)
                      ..++|++.+.||+|+||+||+|+.....    .+|+|.+...  .....+.+.+|+.++++++||||+++++++...+..
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  100 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK  100 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence            3468999999999999999999876532    7899998754  344567899999999999999999999999877655


Q ss_pred             ------EEEEEeccCCChhhhhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEE
Q 013636          225 ------FLVYEMMQNGSLEKQLHGPT---HGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAK  295 (439)
Q Consensus       225 ------~lV~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~k  295 (439)
                            ++||||+++|+|.+++....   ....+++..+..++.|+++||+|||+.   +++||||||+|||+++++.+|
T Consensus       101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~k  177 (323)
T 3qup_A          101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVC  177 (323)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEE
T ss_pred             cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEE
Confidence                  99999999999999986422   223689999999999999999999998   999999999999999999999


Q ss_pred             EEecccccccCCCCcc---eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhc
Q 013636          296 LSDFGLSVTAGTQSRN---VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMP  371 (439)
Q Consensus       296 l~DfGls~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~  371 (439)
                      |+|||++.........   ....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...+..+....+.... 
T Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~-  256 (323)
T 3qup_A          178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN-  256 (323)
T ss_dssp             ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-
T ss_pred             EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCC-
Confidence            9999999765433221   22346788999999999999999999999999999999 999998876554333322110 


Q ss_pred             ccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCC
Q 013636          372 QLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVP  429 (439)
Q Consensus       372 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~  429 (439)
                          ....+.            .....+.+++.+||+.||++|||+.++++.|++++.
T Consensus       257 ----~~~~~~------------~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~  298 (323)
T 3qup_A          257 ----RLKQPP------------ECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG  298 (323)
T ss_dssp             ----CCCCCT------------TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----CCCCCC------------ccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence                011111            112357789999999999999999999999987764

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=3.3e-43  Score=340.67  Aligned_cols=252  Identities=24%  Similarity=0.275  Sum_probs=209.4

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCc------hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCee
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGH------DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETR  224 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  224 (439)
                      .++|++.+.||+|+||.||+++.. ++..+|+|.+.....      ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            467888999999999999999986 478899999865332      1356799999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC----cEEEEecc
Q 013636          225 FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSF----NAKLSDFG  300 (439)
Q Consensus       225 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~----~~kl~DfG  300 (439)
                      ++||||+++|+|.+++..   ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++    .+||+|||
T Consensus        91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg  164 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (321)
T ss_dssp             EEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred             EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence            999999999999999964   34689999999999999999999998   999999999999999888    79999999


Q ss_pred             cccccCCCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCC
Q 013636          301 LSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLP  380 (439)
Q Consensus       301 ls~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  380 (439)
                      ++.............||+.|+|||.+.+..++.++||||||+++|||++|+.||...+..+....+...      ..   
T Consensus       165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~------~~---  235 (321)
T 2a2a_A          165 LAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV------SY---  235 (321)
T ss_dssp             TCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT------CC---
T ss_pred             cceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc------cc---
Confidence            998766544444556999999999999999999999999999999999999999876654432222110      00   


Q ss_pred             ccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          381 NIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       381 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                       ..++......    ...+.+++.+||+.||++|||+.|++++
T Consensus       236 -~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          236 -DFDEEFFSHT----SELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             -CCCHHHHTTC----CHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             -ccChhhhccc----CHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence             1111121222    2356789999999999999999999975

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.7e-43  Score=337.90  Aligned_cols=265  Identities=22%  Similarity=0.309  Sum_probs=200.1

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYE  229 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  229 (439)
                      ++|++.+.||+|+||+||+|+.. ++..+|+|.+....  ......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            57888999999999999999986 47889999986432  3344678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCC
Q 013636          230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS  309 (439)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~  309 (439)
                      |+++ +|.+++..  ....+++..+..++.|++.||+|||+.   +++||||||+|||++.++++||+|||++.......
T Consensus        82 ~~~~-~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  155 (292)
T 3o0g_A           82 FCDQ-DLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSE-EHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred             cCCC-CHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence            9986 55555542  235699999999999999999999998   99999999999999999999999999997664332


Q ss_pred             c-ceeeccccCccchhhhcCCC-CCCchhhHHHHHHHHHHHhCCCCC-CCCChhhhhhhHhhhhcccccC----------
Q 013636          310 R-NVKISGTLGYVAPEYLLEGK-LTDKSDVYAFGVVLLELLMGRRPV-EKMSPTQCQSMVTWAMPQLTDR----------  376 (439)
Q Consensus       310 ~-~~~~~gt~~y~aPE~~~~~~-~~~~~DvwS~Gvll~elltG~~P~-~~~~~~~~~~~~~~~~~~~~~~----------  376 (439)
                      . .....||+.|+|||.+.+.. ++.++|||||||++|||++|..|+ ...+..+....+..........          
T Consensus       156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  235 (292)
T 3o0g_A          156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD  235 (292)
T ss_dssp             SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred             ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccc
Confidence            2 23346899999999998766 799999999999999999988885 4433332222211111000000          


Q ss_pred             -CCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          377 -SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       377 -~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                       ...+..................+.+++.+||+.||++|||+.|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  283 (292)
T 3o0g_A          236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence             00000000000000111223456789999999999999999999975

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.2e-43  Score=343.21  Aligned_cols=268  Identities=22%  Similarity=0.322  Sum_probs=192.9

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGH-DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYE  229 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  229 (439)
                      .++|++.+.||+|+||+||+|... ++..+|+|.+..... ...+.+.+|+.++++++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            357888999999999999999875 478899999865432 233678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhcCC---CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccC
Q 013636          230 MMQNGSLEKQLHGP---THGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAG  306 (439)
Q Consensus       230 ~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~  306 (439)
                      |++ |+|.+++...   .....+++..+..++.|+++||+|||+.   +++||||||+|||++.++.+||+|||++....
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            998 5999988642   2224589999999999999999999998   99999999999999999999999999997764


Q ss_pred             CCC-cceeeccccCccchhhhcC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhccc--------ccC
Q 013636          307 TQS-RNVKISGTLGYVAPEYLLE-GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQL--------TDR  376 (439)
Q Consensus       307 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~--------~~~  376 (439)
                      ... ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...+..+....+.......        ...
T Consensus       160 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  239 (317)
T 2pmi_A          160 IPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL  239 (317)
T ss_dssp             SCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGC
T ss_pred             CCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhh
Confidence            332 2233468999999999976 468999999999999999999999998876554332222111100        000


Q ss_pred             C----CCC----ccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          377 S----KLP----NIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       377 ~----~~~----~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      .    .+.    ..+...+...........+.+++.+||+.||++|||+.|++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  294 (317)
T 2pmi_A          240 PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH  294 (317)
T ss_dssp             TTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence            0    000    0000001100011122467889999999999999999999975

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=9.8e-44  Score=345.45  Aligned_cols=248  Identities=23%  Similarity=0.332  Sum_probs=196.7

Q ss_pred             hcCCCccceecccCcEEEEEEEE----CCccEEEEEEecCCC----chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCe
Q 013636          152 TNNFQESNVIGEGGRGHVYKARF----NEKLLAAVKRIDDAG----HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAET  223 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  223 (439)
                      .++|++.+.||+|+||.||+++.    .++..+|+|.++...    ......+.+|+.++++++||||+++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            36788899999999999999987    468899999987542    2234567899999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccccc
Q 013636          224 RFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSV  303 (439)
Q Consensus       224 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~  303 (439)
                      .++||||+++|+|.+++..   ...+++..+..++.|++.||+|||+.   +++||||||+|||++.++++||+|||++.
T Consensus        96 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  169 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK  169 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred             EEEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence            9999999999999999964   23588999999999999999999998   99999999999999999999999999997


Q ss_pred             ccCCCC-cceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCcc
Q 013636          304 TAGTQS-RNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNI  382 (439)
Q Consensus       304 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  382 (439)
                      ...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...+.......+..      ....++..
T Consensus       170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~------~~~~~p~~  243 (327)
T 3a62_A          170 ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK------CKLNLPPY  243 (327)
T ss_dssp             ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH------TCCCCCTT
T ss_pred             ccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh------CCCCCCCC
Confidence            543222 22335689999999999999999999999999999999999999987765443222211      11122222


Q ss_pred             CCchhcCccCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHh
Q 013636          383 VDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRP-----LITDVLHS  423 (439)
Q Consensus       383 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  423 (439)
                      +            ...+.+++.+||+.||++||     ++.|++++
T Consensus       244 ~------------~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h  277 (327)
T 3a62_A          244 L------------TQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH  277 (327)
T ss_dssp             S------------CHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred             C------------CHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence            2            23566799999999999999     78888865

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.3e-43  Score=337.53  Aligned_cols=253  Identities=30%  Similarity=0.509  Sum_probs=201.9

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCch--HH-----HHHHHHHHHHHhcCCCceeeeeeEEEeCCe
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHD--AE-----REFNNEVNWLTKIRHQNIISLLGYCIHAET  223 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~-----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  223 (439)
                      .++|++.+.||+|+||+||+|+.. ++..+|+|.+......  ..     +.+.+|+.++++++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            367888999999999999999884 6788999998643321  11     57899999999999999999999986544 


Q ss_pred             eEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEecCCCCCCEEEcCCCc-----EEE
Q 013636          224 RFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHP--VVHRDLKSSNILLDSSFN-----AKL  296 (439)
Q Consensus       224 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~--ivH~Dlk~~NiLl~~~~~-----~kl  296 (439)
                       ++||||+++|+|.+++..  ....+++..+..++.|++.||+|||+.   +  ++||||||+||+++.++.     +||
T Consensus        97 -~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl  170 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKV  170 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred             -eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEe
Confidence             799999999999998874  345699999999999999999999998   7  999999999999988776     999


Q ss_pred             EecccccccCCCCcceeeccccCccchhhhc--CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccc
Q 013636          297 SDFGLSVTAGTQSRNVKISGTLGYVAPEYLL--EGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLT  374 (439)
Q Consensus       297 ~DfGls~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~  374 (439)
                      +|||++.....  ......||+.|+|||.+.  ...++.++||||||+++|||++|+.||...+.............  .
T Consensus       171 ~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~--~  246 (287)
T 4f0f_A          171 ADFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE--G  246 (287)
T ss_dssp             CCCTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHS--C
T ss_pred             CCCCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhcc--C
Confidence            99999975543  233456899999999984  45678899999999999999999999987654332111111100  0


Q ss_pred             cCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhcccc
Q 013636          375 DRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPL  427 (439)
Q Consensus       375 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l  427 (439)
                      .....+..            ....+.+++..||+.||++|||+.|+++.|+++
T Consensus       247 ~~~~~~~~------------~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          247 LRPTIPED------------CPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             CCCCCCTT------------SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             CCCCCCcc------------cCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            11111111            123577899999999999999999999999764

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=2.4e-43  Score=335.12  Aligned_cols=252  Identities=23%  Similarity=0.355  Sum_probs=208.1

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      .++|++.+.||+|+||.||+|... ++..+|+|.+....  ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            478999999999999999999875 47889999986533  334467889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCc---EEEEeccccccc
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFN---AKLSDFGLSVTA  305 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~---~kl~DfGls~~~  305 (439)
                      ||+++|+|.+++..   ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.   +||+|||++...
T Consensus        85 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~  158 (284)
T 3kk8_A           85 DLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  158 (284)
T ss_dssp             CCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             ecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence            99999999988864   24589999999999999999999998   9999999999999986655   999999999776


Q ss_pred             CCCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCc
Q 013636          306 GTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDP  385 (439)
Q Consensus       306 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  385 (439)
                      ..........||+.|+|||.+.+..++.++||||||+++|+|++|+.||...+.......+.....      ..+.   +
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~------~~~~---~  229 (284)
T 3kk8_A          159 NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY------DYPS---P  229 (284)
T ss_dssp             CSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC------CCCT---T
T ss_pred             ccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccc------cCCc---h
Confidence            655444456699999999999999999999999999999999999999988765543333321111      1100   0


Q ss_pred             hhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          386 VIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       386 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      . ....    ...+.+++.+||+.||++|||+.|++++
T Consensus       230 ~-~~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          230 E-WDTV----TPEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             T-TTTS----CHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             h-hccc----CHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            0 0111    2356779999999999999999999975

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.6e-43  Score=360.02  Aligned_cols=247  Identities=26%  Similarity=0.363  Sum_probs=207.1

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC---chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      ++|.+.+.||+|+||.||+|+.. ++..+|+|.+....   ......+.+|+.+++.++||||+++++++...+..++||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            57888999999999999999986 68899999986432   123457899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~  308 (439)
                      ||+++|+|.+++..   ...+++..+..++.|++.||+|||+.   +++||||||+|||++.++++||+|||++......
T Consensus        96 E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~  169 (476)
T 2y94_A           96 EYVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  169 (476)
T ss_dssp             ECCSSEEHHHHTTS---SSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred             eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence            99999999999963   34699999999999999999999998   9999999999999999999999999999876654


Q ss_pred             CcceeeccccCccchhhhcCCCC-CCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchh
Q 013636          309 SRNVKISGTLGYVAPEYLLEGKL-TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVI  387 (439)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  387 (439)
                      ......+||+.|+|||.+.+..+ +.++||||+||++|||++|+.||...+.......+..      .....+..++   
T Consensus       170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~------~~~~~p~~~s---  240 (476)
T 2y94_A          170 EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICD------GIFYTPQYLN---  240 (476)
T ss_dssp             CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHT------TCCCCCTTCC---
T ss_pred             ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhc------CCcCCCccCC---
Confidence            44455679999999999998765 6799999999999999999999987654433222211      1111122222   


Q ss_pred             cCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          388 RDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       388 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                               ..+.+++.+||+.||++|||+.|++++
T Consensus       241 ---------~~~~~Li~~~L~~dP~~Rpt~~eil~h  267 (476)
T 2y94_A          241 ---------PSVISLLKHMLQVDPMKRATIKDIREH  267 (476)
T ss_dssp             ---------HHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             ---------HHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence                     246679999999999999999999975

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2.4e-44  Score=350.14  Aligned_cols=261  Identities=25%  Similarity=0.401  Sum_probs=210.0

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEECC------ccEEEEEEecCCCc-hHHHHHHHHHHHHHhc-CCCceeeeeeEEEe
Q 013636          149 EAATNNFQESNVIGEGGRGHVYKARFNE------KLLAAVKRIDDAGH-DAEREFNNEVNWLTKI-RHQNIISLLGYCIH  220 (439)
Q Consensus       149 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  220 (439)
                      +...++|+..+.||+|+||.||+|....      ...+|+|.+..... ...+.+.+|+.+++++ +||||+++++++..
T Consensus        42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  121 (333)
T 2i1m_A           42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH  121 (333)
T ss_dssp             BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence            3445789999999999999999998753      24789999976543 3456799999999999 89999999999999


Q ss_pred             CCeeEEEEEeccCCChhhhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc
Q 013636          221 AETRFLVYEMMQNGSLEKQLHGPT-----------HGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLD  289 (439)
Q Consensus       221 ~~~~~lV~e~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~  289 (439)
                      .+..++||||+++|+|.+++....           ....+++..+..++.|++.||+|||+.   +++||||||+|||++
T Consensus       122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~  198 (333)
T 2i1m_A          122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLT  198 (333)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEE
T ss_pred             CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEEC
Confidence            999999999999999999986421           134589999999999999999999998   999999999999999


Q ss_pred             CCCcEEEEecccccccCCCCcc---eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhh-hh
Q 013636          290 SSFNAKLSDFGLSVTAGTQSRN---VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQC-QS  364 (439)
Q Consensus       290 ~~~~~kl~DfGls~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~-~~  364 (439)
                      +++.+||+|||++.........   ....+|+.|+|||.+.+..++.++||||||+++|||++ |..||........ ..
T Consensus       199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~  278 (333)
T 2i1m_A          199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK  278 (333)
T ss_dssp             GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHH
T ss_pred             CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHH
Confidence            9999999999999765433221   22346789999999999999999999999999999998 9999987653321 11


Q ss_pred             hHhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCC
Q 013636          365 MVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVP  429 (439)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~  429 (439)
                      .....     .....+...            ...+.+++..||+.||++|||+.|+++.|+++..
T Consensus       279 ~~~~~-----~~~~~~~~~------------~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~  326 (333)
T 2i1m_A          279 LVKDG-----YQMAQPAFA------------PKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ  326 (333)
T ss_dssp             HHHHT-----CCCCCCTTC------------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHhcC-----CCCCCCCCC------------CHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence            11110     001111111            2356779999999999999999999999987654

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.1e-43  Score=348.39  Aligned_cols=248  Identities=23%  Similarity=0.280  Sum_probs=205.9

Q ss_pred             hcCCCccceecccCcEEEEEEEECC-ccEEEEEEecCCC---chHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeeEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAG---HDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFL  226 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  226 (439)
                      .++|+..+.||+|+||+||+++... +..+|+|.+....   ....+.+.+|..++..+ +||||+++++++.+.+..++
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   98 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   98 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence            4689999999999999999999875 6789999987532   23345688899999988 89999999999999999999


Q ss_pred             EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccC
Q 013636          227 VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAG  306 (439)
Q Consensus       227 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~  306 (439)
                      ||||+++|+|.+++..   ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++++||+|||++....
T Consensus        99 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~  172 (353)
T 2i0e_A           99 VMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  172 (353)
T ss_dssp             EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence            9999999999999964   23589999999999999999999998   99999999999999999999999999997643


Q ss_pred             C-CCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCc
Q 013636          307 T-QSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDP  385 (439)
Q Consensus       307 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  385 (439)
                      . .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+..      ....++..+  
T Consensus       173 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~------~~~~~p~~~--  244 (353)
T 2i0e_A          173 WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME------HNVAYPKSM--  244 (353)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------CCCCCCTTS--
T ss_pred             cCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHh------CCCCCCCCC--
Confidence            2 2233456799999999999999999999999999999999999999988766543332221      112222222  


Q ss_pred             hhcCccCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHh
Q 013636          386 VIRDTMDLKHLYQVAAVAVLCIQPEPSYRPL-----ITDVLHS  423 (439)
Q Consensus       386 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~  423 (439)
                                ...+.+++.+||+.||++||+     +.+++++
T Consensus       245 ----------s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h  277 (353)
T 2i0e_A          245 ----------SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  277 (353)
T ss_dssp             ----------CHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred             ----------CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence                      235667999999999999995     5788765

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=8.2e-44  Score=339.08  Aligned_cols=253  Identities=25%  Similarity=0.375  Sum_probs=201.5

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG-HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYE  229 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  229 (439)
                      .++|++.+.||+|+||+||+++.. ++..+|+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            367888999999999999999885 47788999886543 3345789999999999999999999999999999999999


Q ss_pred             eccCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE---cCCCcEEEEeccccccc
Q 013636          230 MMQNGSLEKQLHGP-THGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILL---DSSFNAKLSDFGLSVTA  305 (439)
Q Consensus       230 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl---~~~~~~kl~DfGls~~~  305 (439)
                      |+++|+|.+++... ..+..+++..+..++.|+++||+|||+.   +++||||||+||++   +.++.+||+|||++...
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            99999999988532 1235699999999999999999999998   99999999999999   45688999999999876


Q ss_pred             CCCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCc
Q 013636          306 GTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDP  385 (439)
Q Consensus       306 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  385 (439)
                      ..........||+.|+|||.+. +.++.++||||||+++|||++|+.||...+..+............      ....  
T Consensus       178 ~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~------~~~~--  248 (285)
T 3is5_A          178 KSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNY------AVEC--  248 (285)
T ss_dssp             ---------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC------CC----
T ss_pred             CCcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccc------cccc--
Confidence            5544445566999999999875 578999999999999999999999998877655443333211111      0000  


Q ss_pred             hhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          386 VIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       386 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                         ...    ...+.+++.+||+.||++|||+.|++++
T Consensus       249 ---~~~----~~~~~~li~~~L~~dP~~Rps~~e~l~h  279 (285)
T 3is5_A          249 ---RPL----TPQAVDLLKQMLTKDPERRPSAAQVLHH  279 (285)
T ss_dssp             ---CCC----CHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             ---CcC----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               001    2356679999999999999999999975

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.2e-44  Score=356.53  Aligned_cols=276  Identities=19%  Similarity=0.269  Sum_probs=215.5

Q ss_pred             hcCCCccceecccCcEEEEEEEECC-ccEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC--eeEEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAG-HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE--TRFLV  227 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lV  227 (439)
                      .++|++.+.||+|+||+||+|+... +..+|+|.+.... ....+.+.+|++++++++||||+++++++...+  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            3678889999999999999999865 7899999997543 233567889999999999999999999998765  67999


Q ss_pred             EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE----cCCCcEEEEeccccc
Q 013636          228 YEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILL----DSSFNAKLSDFGLSV  303 (439)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl----~~~~~~kl~DfGls~  303 (439)
                      |||+++|+|.+++........+++..+..++.|++.||+|||+.   +|+||||||+|||+    +.++.+||+|||++.
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            99999999999997644444599999999999999999999998   99999999999999    788889999999998


Q ss_pred             ccCCCCcceeeccccCccchhhhcC--------CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhh-hhhhHhhhhcccc
Q 013636          304 TAGTQSRNVKISGTLGYVAPEYLLE--------GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQ-CQSMVTWAMPQLT  374 (439)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~-~~~~~~~~~~~~~  374 (439)
                      ............||+.|+|||.+.+        ..++.++|||||||++|||++|+.||....... .............
T Consensus       165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p  244 (396)
T 4eut_A          165 ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP  244 (396)
T ss_dssp             ECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCC
T ss_pred             EccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCC
Confidence            7665554455669999999999875        467789999999999999999999997543211 1111111100000


Q ss_pred             --------cCCCCCccCCc--hhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCC
Q 013636          375 --------DRSKLPNIVDP--VIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPT  430 (439)
Q Consensus       375 --------~~~~~~~~~d~--~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~  430 (439)
                              ....-.-.+..  .............+.+++..||+.||++||++.|+++.+..++..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             cccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence                    00000000000  111233456677888999999999999999999999999877654

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.7e-43  Score=351.81  Aligned_cols=268  Identities=22%  Similarity=0.294  Sum_probs=203.1

Q ss_pred             hcCCCccceeccc--CcEEEEEEEEC-CccEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEE
Q 013636          152 TNNFQESNVIGEG--GRGHVYKARFN-EKLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFL  226 (439)
Q Consensus       152 ~~~~~~~~~LG~G--~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  226 (439)
                      .++|++.+.||+|  +||+||+|+.. ++..||+|.+....  ....+.+.+|+.++++++||||+++++++...+..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            3678889999999  99999999986 58899999987543  3344678899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccC
Q 013636          227 VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAG  306 (439)
Q Consensus       227 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~  306 (439)
                      ||||+++|+|.+++... ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||.+....
T Consensus       104 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~  179 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMI  179 (389)
T ss_dssp             EEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred             EEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence            99999999999999753 234599999999999999999999998   99999999999999999999999999885432


Q ss_pred             CCC--------cceeeccccCccchhhhcC--CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhh-hHhhhhccccc
Q 013636          307 TQS--------RNVKISGTLGYVAPEYLLE--GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQS-MVTWAMPQLTD  375 (439)
Q Consensus       307 ~~~--------~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~-~~~~~~~~~~~  375 (439)
                      ...        ......||+.|+|||.+.+  ..++.++|||||||++|||++|+.||...+...... ......+...+
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  259 (389)
T 3gni_B          180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD  259 (389)
T ss_dssp             ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred             cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence            211        1112358899999999987  678999999999999999999999998755432211 11000000000


Q ss_pred             CCC------------------CCccCCchh---------cCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          376 RSK------------------LPNIVDPVI---------RDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       376 ~~~------------------~~~~~d~~l---------~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      ...                  ..+......         ...........+.+++.+||+.||++|||+.|++++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence            000                  000000000         000011123457889999999999999999999976

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.3e-43  Score=345.32  Aligned_cols=253  Identities=23%  Similarity=0.361  Sum_probs=201.2

Q ss_pred             cCCCccceecccCcEEEEEEEECC-ccEEEEEEecCCC---chHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeeEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAG---HDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLV  227 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV  227 (439)
                      ++|+..+.||+|+||.||+++... +..+|+|.+....   ....+.+.+|..++.++ +||||+++++++.+.+..++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            578889999999999999999864 7889999987532   23445688999999988 899999999999999999999


Q ss_pred             EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCC
Q 013636          228 YEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT  307 (439)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~  307 (439)
                      |||+++|+|.+++..   ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++++||+|||+++....
T Consensus        89 ~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~  162 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  162 (345)
T ss_dssp             ECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred             EeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence            999999999999964   23589999999999999999999998   999999999999999999999999999976432


Q ss_pred             -CCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhh--hhhHhhhhcc-cccCCCCCccC
Q 013636          308 -QSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQC--QSMVTWAMPQ-LTDRSKLPNIV  383 (439)
Q Consensus       308 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~--~~~~~~~~~~-~~~~~~~~~~~  383 (439)
                       .......+||+.|+|||.+.+..++.++|||||||++|||++|+.||........  .......... ......++..+
T Consensus       163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~  242 (345)
T 3a8x_A          163 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL  242 (345)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTTS
T ss_pred             CCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCCC
Confidence             2233456799999999999999999999999999999999999999975321110  0000000000 11112222222


Q ss_pred             CchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCH------HHHHHh
Q 013636          384 DPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLI------TDVLHS  423 (439)
Q Consensus       384 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~------~evl~~  423 (439)
                                  ...+.+++.+||+.||++||++      .|++++
T Consensus       243 ------------s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h  276 (345)
T 3a8x_A          243 ------------SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  276 (345)
T ss_dssp             ------------CHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred             ------------CHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence                        2356679999999999999995      677754

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.8e-43  Score=346.61  Aligned_cols=248  Identities=29%  Similarity=0.427  Sum_probs=201.7

Q ss_pred             hcCCCccceecccCcEEEEEEEE-CCccEEEEEEecCCCc---hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARF-NEKLLAAVKRIDDAGH---DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLV  227 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  227 (439)
                      .+.|+..+.||+|+||+||+|+. .++..||+|.+.....   ...+.+.+|+.++++++||||+++++++...+..++|
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  132 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV  132 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence            35688899999999999999987 5688899999865432   2335789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCC
Q 013636          228 YEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT  307 (439)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~  307 (439)
                      |||++ |+|.+++..  ....+++..+..++.|+++||+|||+.   +++||||||+|||+++++.+||+|||++.....
T Consensus       133 ~e~~~-g~l~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  206 (348)
T 1u5q_A          133 MEYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  206 (348)
T ss_dssp             EECCS-EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             EecCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence            99997 688888753  234689999999999999999999998   999999999999999999999999999976643


Q ss_pred             CCcceeeccccCccchhhhc---CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCC
Q 013636          308 QSRNVKISGTLGYVAPEYLL---EGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVD  384 (439)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  384 (439)
                      .   ....||+.|+|||.+.   .+.++.++|||||||++|||++|+.||...+.......+..       . ..+....
T Consensus       207 ~---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~-------~-~~~~~~~  275 (348)
T 1u5q_A          207 A---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-------N-ESPALQS  275 (348)
T ss_dssp             B---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-------S-CCCCCCC
T ss_pred             C---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh-------c-CCCCCCC
Confidence            2   2346899999999985   56789999999999999999999999987665432221111       0 0011111


Q ss_pred             chhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhc
Q 013636          385 PVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL  424 (439)
Q Consensus       385 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  424 (439)
                          ...    ...+.+++..||+.||++|||+.+++++.
T Consensus       276 ----~~~----~~~l~~li~~~l~~dP~~Rps~~~ll~h~  307 (348)
T 1u5q_A          276 ----GHW----SEYFRNFVDSCLQKIPQDRPTSEVLLKHR  307 (348)
T ss_dssp             ----TTS----CHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred             ----CCC----CHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence                111    23466799999999999999999999764

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.8e-43  Score=346.69  Aligned_cols=245  Identities=20%  Similarity=0.282  Sum_probs=206.5

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC---chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      ++|+..+.||+|+||.||+++.. ++..+|+|.+....   ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            67888999999999999999986 57899999986432   123457889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~  308 (439)
                      ||+++|+|.+++...   ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++++||+|||++......
T Consensus       121 e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~  194 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC
Confidence            999999999999642   3589999999999999999999998   9999999999999999999999999999876443


Q ss_pred             CcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhc
Q 013636          309 SRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIR  388 (439)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  388 (439)
                        ....+||+.|+|||.+.+..++.++|||||||++|||++|+.||...+..+....+..      ....++..+     
T Consensus       195 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~------~~~~~p~~~-----  261 (350)
T 1rdq_E          195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS------GKVRFPSHF-----  261 (350)
T ss_dssp             --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------CCCCCCTTC-----
T ss_pred             --cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHc------CCCCCCCCC-----
Confidence              2345699999999999999999999999999999999999999988766543333221      111222222     


Q ss_pred             CccCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHh
Q 013636          389 DTMDLKHLYQVAAVAVLCIQPEPSYRPL-----ITDVLHS  423 (439)
Q Consensus       389 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~  423 (439)
                             ...+.+++.+||+.||++||+     +.|++++
T Consensus       262 -------~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h  294 (350)
T 1rdq_E          262 -------SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             -------CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             -------CHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence                   235667999999999999998     8898865

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=4.6e-44  Score=362.45  Aligned_cols=248  Identities=22%  Similarity=0.318  Sum_probs=198.0

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCC---CchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDA---GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLV  227 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  227 (439)
                      .++|++.+.||+|+||.||+++.. ++..+|+|.+...   .......+.+|+.+++.++||||+++++++...+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            467999999999999999999875 5788999998643   233345678999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCCEEEcCCCcEEEEecccccccC
Q 013636          228 YEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHE-HCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAG  306 (439)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~-~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~  306 (439)
                      |||+++|+|.+++..   ...+++..+..++.|+++||+|||+ .   +|+||||||+|||++.++++||+|||++....
T Consensus       227 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  300 (446)
T 4ejn_A          227 MEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGI  300 (446)
T ss_dssp             ECCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred             EeeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence            999999999999964   3468999999999999999999998 6   99999999999999999999999999997643


Q ss_pred             CC-CcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCc
Q 013636          307 TQ-SRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDP  385 (439)
Q Consensus       307 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  385 (439)
                      .. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+..      ....++..++ 
T Consensus       301 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~------~~~~~p~~~~-  373 (446)
T 4ejn_A          301 KDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM------EEIRFPRTLG-  373 (446)
T ss_dssp             C-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------CCCCCCTTSC-
T ss_pred             CCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHh------CCCCCCccCC-
Confidence            32 223345799999999999999999999999999999999999999988766544333321      1122222222 


Q ss_pred             hhcCccCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHh
Q 013636          386 VIRDTMDLKHLYQVAAVAVLCIQPEPSYRP-----LITDVLHS  423 (439)
Q Consensus       386 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  423 (439)
                                 ..+.+++.+||+.||++||     ++.|++++
T Consensus       374 -----------~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h  405 (446)
T 4ejn_A          374 -----------PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH  405 (446)
T ss_dssp             -----------HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             -----------HHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence                       3566799999999999999     99999964

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-43  Score=336.43  Aligned_cols=255  Identities=27%  Similarity=0.413  Sum_probs=208.6

Q ss_pred             cCCCccc-eecccCcEEEEEEEEC---CccEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEE
Q 013636          153 NNFQESN-VIGEGGRGHVYKARFN---EKLLAAVKRIDDAG-HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLV  227 (439)
Q Consensus       153 ~~~~~~~-~LG~G~fg~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  227 (439)
                      ++|.+.+ .||+|+||.||+|...   ++..+|+|.+.... ....+.+.+|+.++++++||||+++++++ ..+..++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            4555565 8999999999999864   57789999997643 34456799999999999999999999999 55678999


Q ss_pred             EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCC
Q 013636          228 YEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT  307 (439)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~  307 (439)
                      |||+++|+|.+++..  ....+++..+..++.|+++||+|||+.   +++||||||+||++++++.+||+|||++.....
T Consensus        88 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  162 (287)
T 1u59_A           88 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGA  162 (287)
T ss_dssp             EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence            999999999999963  345699999999999999999999998   999999999999999999999999999977644


Q ss_pred             CCcc----eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCcc
Q 013636          308 QSRN----VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNI  382 (439)
Q Consensus       308 ~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  382 (439)
                      ....    ....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...+..+....+...     .....+. 
T Consensus       163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~-----~~~~~~~-  236 (287)
T 1u59_A          163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-----KRMECPP-  236 (287)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT-----CCCCCCT-
T ss_pred             CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcC-----CcCCCCC-
Confidence            3322    12236789999999998899999999999999999998 99999877655433332211     0111111 


Q ss_pred             CCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCC
Q 013636          383 VDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPT  430 (439)
Q Consensus       383 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~  430 (439)
                                 .....+.+++..||+.||++||++.+++++|+.+..+
T Consensus       237 -----------~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  273 (287)
T 1u59_A          237 -----------ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  273 (287)
T ss_dssp             -----------TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----------CcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence                       1124677899999999999999999999999887654

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=2.5e-43  Score=343.43  Aligned_cols=259  Identities=25%  Similarity=0.429  Sum_probs=211.7

Q ss_pred             HhcCCCccceecccCcEEEEEEEEC--------CccEEEEEEecCCCc-hHHHHHHHHHHHHHhc-CCCceeeeeeEEEe
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARFN--------EKLLAAVKRIDDAGH-DAEREFNNEVNWLTKI-RHQNIISLLGYCIH  220 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  220 (439)
                      ..++|++.+.||+|+||.||+|+..        ++..+|+|.+..... ...+.+.+|+.+++++ +||||+++++++..
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  112 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  112 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence            4578899999999999999999873        467899999975433 3456789999999999 89999999999999


Q ss_pred             CCeeEEEEEeccCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEE
Q 013636          221 AETRFLVYEMMQNGSLEKQLHGPTH-------------GSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNIL  287 (439)
Q Consensus       221 ~~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiL  287 (439)
                      .+..++||||+++|+|.+++.....             ...+++..+..++.|+++||+|||+.   +++||||||+||+
T Consensus       113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl  189 (334)
T 2pvf_A          113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVL  189 (334)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred             CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEE
Confidence            9999999999999999999975331             23489999999999999999999998   9999999999999


Q ss_pred             EcCCCcEEEEecccccccCCCCcc---eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhh
Q 013636          288 LDSSFNAKLSDFGLSVTAGTQSRN---VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQ  363 (439)
Q Consensus       288 l~~~~~~kl~DfGls~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~  363 (439)
                      ++.++.+||+|||++.........   ....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...+..+..
T Consensus       190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~  269 (334)
T 2pvf_A          190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF  269 (334)
T ss_dssp             ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred             EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHH
Confidence            999999999999999766543221   22346788999999999899999999999999999999 99999887665443


Q ss_pred             hhHhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCC
Q 013636          364 SMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVP  429 (439)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~  429 (439)
                      ..+....     ....+.            .....+.+++..||+.||++|||+.|+++.|+.+..
T Consensus       270 ~~~~~~~-----~~~~~~------------~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~  318 (334)
T 2pvf_A          270 KLLKEGH-----RMDKPA------------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  318 (334)
T ss_dssp             HHHHHTC-----CCCCCT------------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHhcCC-----CCCCCc------------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            3332110     111111            112357779999999999999999999999988765

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.2e-44  Score=351.47  Aligned_cols=266  Identities=27%  Similarity=0.388  Sum_probs=208.4

Q ss_pred             cCCCccceecccCcEEEEEEEE-----CCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEE--eCCeeE
Q 013636          153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCI--HAETRF  225 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~  225 (439)
                      ++|++.+.||+|+||.||++++     ..+..+|+|.+........+.+.+|+.++++++||||+++++++.  +.+..+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            5788899999999999999984     457889999998776667778999999999999999999999987  445689


Q ss_pred             EEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccccccc
Q 013636          226 LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA  305 (439)
Q Consensus       226 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~  305 (439)
                      +||||+++|+|.+++...  ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++...
T Consensus       103 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  177 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLL  177 (327)
T ss_dssp             EEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred             EEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceec
Confidence            999999999999999642  23589999999999999999999998   9999999999999999999999999999876


Q ss_pred             CCCCcc----eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhh--------Hhhhhccc
Q 013636          306 GTQSRN----VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSM--------VTWAMPQL  373 (439)
Q Consensus       306 ~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~--------~~~~~~~~  373 (439)
                      ......    ....||+.|+|||.+.+..++.++||||||+++|||++|+.||...........        ........
T Consensus       178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (327)
T 3lxl_A          178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL  257 (327)
T ss_dssp             CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH
T ss_pred             ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh
Confidence            443322    223478889999999999999999999999999999999999865432211000        00000000


Q ss_pred             ccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCCCCC
Q 013636          374 TDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPTDLG  433 (439)
Q Consensus       374 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~~~~  433 (439)
                      ......          .........+.+++..||+.||++|||+.|++++|+.++....+
T Consensus       258 ~~~~~~----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~  307 (327)
T 3lxl_A          258 EEGQRL----------PAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRG  307 (327)
T ss_dssp             HTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC------
T ss_pred             hcccCC----------CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcC
Confidence            000000          00111234677899999999999999999999999988875443

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=5.1e-44  Score=346.04  Aligned_cols=264  Identities=25%  Similarity=0.398  Sum_probs=214.4

Q ss_pred             HHHHHhcCCCccceecccCcEEEEEEEEC------CccEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCceeeeeeEEE
Q 013636          147 LLEAATNNFQESNVIGEGGRGHVYKARFN------EKLLAAVKRIDDAGH-DAEREFNNEVNWLTKIRHQNIISLLGYCI  219 (439)
Q Consensus       147 ~l~~~~~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~  219 (439)
                      +++...++|++.+.||+|+||.||+|+..      .+..+|+|.+..... .....+.+|+.++++++||||+++++++.
T Consensus        19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   98 (322)
T 1p4o_A           19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS   98 (322)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence            34456688999999999999999999765      367899999975443 34457899999999999999999999999


Q ss_pred             eCCeeEEEEEeccCCChhhhhcCCC-------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC
Q 013636          220 HAETRFLVYEMMQNGSLEKQLHGPT-------HGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSF  292 (439)
Q Consensus       220 ~~~~~~lV~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~  292 (439)
                      +.+..++||||+++|+|.+++....       ....+++..+..++.|++.||+|||+.   +++||||||+||++++++
T Consensus        99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~  175 (322)
T 1p4o_A           99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDF  175 (322)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTC
T ss_pred             cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCC
Confidence            9999999999999999999986411       124579999999999999999999998   999999999999999999


Q ss_pred             cEEEEecccccccCCCCcc---eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhh
Q 013636          293 NAKLSDFGLSVTAGTQSRN---VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTW  368 (439)
Q Consensus       293 ~~kl~DfGls~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~  368 (439)
                      .+||+|||++.........   ....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...+..+....+..
T Consensus       176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~  255 (322)
T 1p4o_A          176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME  255 (322)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred             eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHc
Confidence            9999999999765432221   22346889999999999999999999999999999999 8999988765543332211


Q ss_pred             hhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCC
Q 013636          369 AMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPT  430 (439)
Q Consensus       369 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~  430 (439)
                      .     .....+.            .....+.+++.+||+.||++|||+.|++++|+++...
T Consensus       256 ~-----~~~~~~~------------~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~  300 (322)
T 1p4o_A          256 G-----GLLDKPD------------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP  300 (322)
T ss_dssp             T-----CCCCCCT------------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred             C-----CcCCCCC------------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence            0     0001111            1123567799999999999999999999999887653

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=3.3e-43  Score=345.87  Aligned_cols=273  Identities=23%  Similarity=0.298  Sum_probs=210.4

Q ss_pred             ccHHHHHHHhcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCchHHHHHHHHHHHHHhcC-----CCceeeeee
Q 013636          143 IEYELLEAATNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR-----HQNIISLLG  216 (439)
Q Consensus       143 ~~~~~l~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~~  216 (439)
                      +.+.......++|++.+.||+|+||+||+|+.. ++..+|+|.+... ....+.+..|+.+++.++     ||||+++++
T Consensus        25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~  103 (360)
T 3llt_A           25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHG  103 (360)
T ss_dssp             CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred             eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence            333344455689999999999999999999984 5788999999753 344556788999999996     999999999


Q ss_pred             EEEeCCeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC------
Q 013636          217 YCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDS------  290 (439)
Q Consensus       217 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~------  290 (439)
                      ++...+..++||||+ +++|.+++.... ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.      
T Consensus       104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~  178 (360)
T 3llt_A          104 KFMYYDHMCLIFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKS  178 (360)
T ss_dssp             EEEETTEEEEEECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEE
T ss_pred             eeeECCeeEEEEcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEcccccccc
Confidence            999999999999999 899999997532 34589999999999999999999998   9999999999999975      


Q ss_pred             -------------------CCcEEEEecccccccCCCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCC
Q 013636          291 -------------------SFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGR  351 (439)
Q Consensus       291 -------------------~~~~kl~DfGls~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~  351 (439)
                                         ++.+||+|||++.......  ....||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~  256 (360)
T 3llt_A          179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH--GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS  256 (360)
T ss_dssp             EEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC--CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSS
T ss_pred             ccchhcccccccccccccCCCCEEEEeccCceecCCCC--cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCC
Confidence                               7899999999997654322  3456899999999999999999999999999999999999


Q ss_pred             CCCCCCChhhhhhhHhhhhccccc----------------CCCCCccCCchh---------cCccC---HHHHHHHHHHH
Q 013636          352 RPVEKMSPTQCQSMVTWAMPQLTD----------------RSKLPNIVDPVI---------RDTMD---LKHLYQVAAVA  403 (439)
Q Consensus       352 ~P~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~d~~l---------~~~~~---~~~~~~l~~l~  403 (439)
                      .||...+..+....+.........                ............         .....   ......+.+++
T Consensus       257 ~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  336 (360)
T 3llt_A          257 LLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFL  336 (360)
T ss_dssp             CSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHH
T ss_pred             CCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHH
Confidence            999876654433322221111000                000000000000         00000   00114577899


Q ss_pred             HHhcCCCCCCCCCHHHHHHh
Q 013636          404 VLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       404 ~~cl~~dP~~RPt~~evl~~  423 (439)
                      .+||+.||++|||+.|++++
T Consensus       337 ~~~L~~dP~~Rpta~elL~h  356 (360)
T 3llt_A          337 YSILQIDPTLRPSPAELLKH  356 (360)
T ss_dssp             HHHCCSSGGGSCCHHHHTTS
T ss_pred             HHHhcCChhhCCCHHHHhcC
Confidence            99999999999999999875

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1e-43  Score=336.97  Aligned_cols=258  Identities=26%  Similarity=0.445  Sum_probs=211.1

Q ss_pred             HHhcCCCccceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEE
Q 013636          150 AATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYE  229 (439)
Q Consensus       150 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  229 (439)
                      ...++|++.+.||+|+||.||+|+..++..+|+|.+.... ...+.+.+|++++++++||||+++++++. .+..++|||
T Consensus        10 v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e   87 (279)
T 1qpc_A           10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITE   87 (279)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred             cCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEe
Confidence            3456888899999999999999999988899999997643 34567999999999999999999999986 456899999


Q ss_pred             eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCC
Q 013636          230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS  309 (439)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~  309 (439)
                      |+++|+|.+++... .+..+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||++.......
T Consensus        88 ~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  163 (279)
T 1qpc_A           88 YMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE  163 (279)
T ss_dssp             CCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred             cCCCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence            99999999999642 123589999999999999999999998   99999999999999999999999999997765432


Q ss_pred             cc--eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCch
Q 013636          310 RN--VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPV  386 (439)
Q Consensus       310 ~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  386 (439)
                      ..  ....+|..|+|||.+.+..++.++||||||+++|||++ |+.||...+..+....+...     .....+.     
T Consensus       164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~-----  233 (279)
T 1qpc_A          164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG-----YRMVRPD-----  233 (279)
T ss_dssp             EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-----CCCCCCT-----
T ss_pred             cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcc-----cCCCCcc-----
Confidence            21  12346788999999998899999999999999999999 99999877654433222110     0001111     


Q ss_pred             hcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCC
Q 013636          387 IRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPT  430 (439)
Q Consensus       387 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~  430 (439)
                         .    ....+.+++..||+.||++|||+.++++.|+++...
T Consensus       234 ---~----~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  270 (279)
T 1qpc_A          234 ---N----CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (279)
T ss_dssp             ---T----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---c----ccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence               1    124677899999999999999999999999887643

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=5.6e-43  Score=355.76  Aligned_cols=263  Identities=23%  Similarity=0.296  Sum_probs=199.3

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCC--CchHHHHHHHHHHHHHhcCCCceeeeeeEEEeC------C
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDA--GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHA------E  222 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~  222 (439)
                      .++|++.+.||+|+||+||+|... .+..+|+|++...  .....+.+.+|+.+++.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            478999999999999999999875 4788999999754  334456788999999999999999999999654      3


Q ss_pred             eeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccc
Q 013636          223 TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS  302 (439)
Q Consensus       223 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls  302 (439)
                      ..++||||+++ +|.+.+..     .+++..+..++.|+++||+|||+.   +|+||||||+|||++.++++||+|||++
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a  211 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA  211 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred             eEEEEEeCCCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEee
Confidence            56999999986 56666642     389999999999999999999998   9999999999999999999999999999


Q ss_pred             cccCCCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhc-----------
Q 013636          303 VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP-----------  371 (439)
Q Consensus       303 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~-----------  371 (439)
                      +............||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+..+....+.....           
T Consensus       212 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~  291 (464)
T 3ttj_A          212 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ  291 (464)
T ss_dssp             -----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred             eecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence            877655444556799999999999999999999999999999999999999988764332211111000           


Q ss_pred             -----ccccCCCCC-----ccCCchhcCcc---CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          372 -----QLTDRSKLP-----NIVDPVIRDTM---DLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       372 -----~~~~~~~~~-----~~~d~~l~~~~---~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                           .........     ..+...+....   .......+.+++.+||+.||++|||+.|++++
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                 000011111     11111110000   11224568899999999999999999999976

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=5.6e-44  Score=356.96  Aligned_cols=256  Identities=21%  Similarity=0.290  Sum_probs=207.5

Q ss_pred             HHHHHhcCCCccceecccCcEEEEEEEECC-ccEEEEEEecCCCc---hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC
Q 013636          147 LLEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGH---DAEREFNNEVNWLTKIRHQNIISLLGYCIHAE  222 (439)
Q Consensus       147 ~l~~~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  222 (439)
                      .++...++|++.+.||+|+||+||+|+... +..+|+|.+.....   .....+.+|..+++.++||||+++++++.+.+
T Consensus        63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~  142 (410)
T 3v8s_A           63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  142 (410)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence            344556899999999999999999999864 78899999864211   12234789999999999999999999999999


Q ss_pred             eeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccc
Q 013636          223 TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS  302 (439)
Q Consensus       223 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls  302 (439)
                      ..++||||+++|+|.+++..    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++++||+|||++
T Consensus       143 ~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a  215 (410)
T 3v8s_A          143 YLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTC  215 (410)
T ss_dssp             EEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEecccee
Confidence            99999999999999999964    2489999999999999999999998   9999999999999999999999999999


Q ss_pred             cccCCCCc--ceeeccccCccchhhhcCCC----CCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccC
Q 013636          303 VTAGTQSR--NVKISGTLGYVAPEYLLEGK----LTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDR  376 (439)
Q Consensus       303 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~----~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~  376 (439)
                      ........  ....+||+.|+|||++.+..    ++.++|||||||++|||++|+.||...+.......+.......   
T Consensus       216 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~---  292 (410)
T 3v8s_A          216 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL---  292 (410)
T ss_dssp             EECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC---
T ss_pred             EeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccc---
Confidence            77654332  22457999999999998765    7899999999999999999999998877654333322111001   


Q ss_pred             CCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHh
Q 013636          377 SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSY--RPLITDVLHS  423 (439)
Q Consensus       377 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~evl~~  423 (439)
                       ..+..      ..+    ...+.+++.+||+.+|.+  ||++.|+++|
T Consensus       293 -~~p~~------~~~----s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          293 -TFPDD------NDI----SKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             -CCCTT------CCC----CHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             -cCCCc------ccc----cHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence             11110      011    235667999999999998  9999999976

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=8.5e-43  Score=331.09  Aligned_cols=252  Identities=25%  Similarity=0.302  Sum_probs=204.3

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCc------hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCee
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGH------DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETR  224 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  224 (439)
                      .++|++.+.||+|+||.||+++.. ++..+|+|.+.....      ...+.+.+|+.++++++||||+++++++...+..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            357888999999999999999987 578899998864321      1356799999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC----cEEEEecc
Q 013636          225 FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSF----NAKLSDFG  300 (439)
Q Consensus       225 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~----~~kl~DfG  300 (439)
                      ++||||+++++|.+++..   ...+++..+..++.|++.||+|||+.   +++||||||+||++++++    .+||+|||
T Consensus        84 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg  157 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFG  157 (283)
T ss_dssp             EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecc
Confidence            999999999999999963   34589999999999999999999998   999999999999998877    89999999


Q ss_pred             cccccCCCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCC
Q 013636          301 LSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLP  380 (439)
Q Consensus       301 ls~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  380 (439)
                      ++.............||+.|+|||.+.+..++.++||||||+++|||++|+.||...+..+....+...      ...  
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------~~~--  229 (283)
T 3bhy_A          158 IAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV------NYD--  229 (283)
T ss_dssp             TCEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT------CCC--
T ss_pred             cceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhc------ccC--
Confidence            998765544444456899999999999999999999999999999999999999877654432222110      000  


Q ss_pred             ccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          381 NIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       381 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                        .++......    ...+.+++.+||+.||++|||+.|++++
T Consensus       230 --~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~h  266 (283)
T 3bhy_A          230 --FDEEYFSNT----SELAKDFIRRLLVKDPKRRMTIAQSLEH  266 (283)
T ss_dssp             --CCHHHHTTC----CHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred             --CcchhcccC----CHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence              111111111    2357789999999999999999999975

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=9.7e-44  Score=345.72  Aligned_cols=258  Identities=17%  Similarity=0.209  Sum_probs=207.0

Q ss_pred             hcCCCccceecccCcEEEEEEEE-CCccEEEEEEecCCCchHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeeEEEEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARF-NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYE  229 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e  229 (439)
                      .++|++.+.||+|+||+||+|+. .++..+|+|.+.....  ...+.+|+.+++++ +||||+++++++...+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            36788899999999999999997 5678999999865432  23588999999999 99999999999999999999999


Q ss_pred             eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCc-----EEEEecccccc
Q 013636          230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFN-----AKLSDFGLSVT  304 (439)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~-----~kl~DfGls~~  304 (439)
                      |+ +|+|.+++...  ...+++..+..++.|++.||+|||+.   +++||||||+|||++.++.     +||+|||++..
T Consensus        86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~  159 (330)
T 2izr_A           86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE  159 (330)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred             eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence            99 99999999742  35699999999999999999999998   9999999999999999887     99999999976


Q ss_pred             cCCCCc--------ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccC
Q 013636          305 AGTQSR--------NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDR  376 (439)
Q Consensus       305 ~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~  376 (439)
                      ......        .....||+.|+|||.+.+..++.++|||||||++|||++|+.||...+................ .
T Consensus       160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~-~  238 (330)
T 2izr_A          160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR-A  238 (330)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH-H
T ss_pred             eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhc-c
Confidence            543222        1345699999999999999999999999999999999999999987654332222211100000 0


Q ss_pred             CCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccC
Q 013636          377 SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLV  428 (439)
Q Consensus       377 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~  428 (439)
                      ..     ...+..    ... .+.+++..||+.||++||++.++++.|+.+.
T Consensus       239 ~~-----~~~~~~----~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~  280 (330)
T 2izr_A          239 TP-----IEVLCE----NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLF  280 (330)
T ss_dssp             SC-----HHHHTT----TCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             CC-----HHHHhc----cCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence            00     000000    012 7888999999999999999999999887654

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=2.3e-43  Score=335.00  Aligned_cols=255  Identities=25%  Similarity=0.398  Sum_probs=205.5

Q ss_pred             hcCCCccceecccCcEEEEEEEECC----ccEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFNE----KLLAAVKRIDDAG-HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFL  226 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  226 (439)
                      .++|++.+.||+|+||+||+|+..+    +..+|+|.+.... ....+.+.+|+.++++++||||+++++++.+ +..++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence            4678889999999999999998643    3468999987643 3455779999999999999999999999764 56789


Q ss_pred             EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccC
Q 013636          227 VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAG  306 (439)
Q Consensus       227 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~  306 (439)
                      ||||+++|+|.+++..  ....+++..+..++.|+++||+|||+.   +++||||||+||+++.++.+||+|||++....
T Consensus        90 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  164 (281)
T 3cc6_A           90 IMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIE  164 (281)
T ss_dssp             EEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred             EEecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence            9999999999999964  234589999999999999999999998   99999999999999999999999999997654


Q ss_pred             CCCcc--eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCccC
Q 013636          307 TQSRN--VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV  383 (439)
Q Consensus       307 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  383 (439)
                      .....  ....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...........+...     .....+...
T Consensus       165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~  239 (281)
T 3cc6_A          165 DEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG-----DRLPKPDLC  239 (281)
T ss_dssp             --------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHT-----CCCCCCTTC
T ss_pred             cccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcC-----CCCCCCCCC
Confidence            43221  22346789999999999999999999999999999998 99999876654433322211     111111111


Q ss_pred             CchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCC
Q 013636          384 DPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVP  429 (439)
Q Consensus       384 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~  429 (439)
                                  ...+.+++.+||+.||++|||+.|++++|+.+..
T Consensus       240 ------------~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  273 (281)
T 3cc6_A          240 ------------PPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ  273 (281)
T ss_dssp             ------------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------------CHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence                        2356779999999999999999999999987754

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=3.2e-43  Score=333.64  Aligned_cols=248  Identities=29%  Similarity=0.481  Sum_probs=203.3

Q ss_pred             hcCCCccceecccCcEEEEEEEECC-ccEEEEEEecCCCc---hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGH---DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLV  227 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  227 (439)
                      .++|++.+.||+|+||.||+|.... +..+|+|.+.....   .....+.+|+.++++++||||+++++++.+.+..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            4678889999999999999998765 56899998864321   2245688999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCC
Q 013636          228 YEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT  307 (439)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~  307 (439)
                      |||+++|+|.+++..   ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++.....
T Consensus        88 ~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~  161 (279)
T 3fdn_A           88 LEYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  161 (279)
T ss_dssp             ECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred             EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence            999999999999864   24589999999999999999999998   999999999999999999999999999865543


Q ss_pred             CCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchh
Q 013636          308 QSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVI  387 (439)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  387 (439)
                      .. .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...+..+....+...      ....+...    
T Consensus       162 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------~~~~~~~~----  230 (279)
T 3fdn_A          162 SR-RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV------EFTFPDFV----  230 (279)
T ss_dssp             -------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT------CCCCCTTS----
T ss_pred             cc-ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhC------CCCCCCcC----
Confidence            32 23456899999999999999999999999999999999999999877655433333211      11222222    


Q ss_pred             cCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhc
Q 013636          388 RDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL  424 (439)
Q Consensus       388 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  424 (439)
                              ...+.+++..||+.||++|||+.|++++-
T Consensus       231 --------~~~~~~li~~~l~~~p~~Rps~~e~l~h~  259 (279)
T 3fdn_A          231 --------TEGARDLISRLLKHNPSQRPMLREVLEHP  259 (279)
T ss_dssp             --------CHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred             --------CHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence                    23456799999999999999999999763

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=8.6e-44  Score=338.84  Aligned_cols=257  Identities=26%  Similarity=0.424  Sum_probs=214.5

Q ss_pred             HhcCCCccceecccCcEEEEEEEECC-ccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEE
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYE  229 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  229 (439)
                      ..++|++.+.||+|+||.||+|.... +..+|+|.+.... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   89 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   89 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence            45788889999999999999999875 6789999987543 456789999999999999999999999999999999999


Q ss_pred             eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCC
Q 013636          230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS  309 (439)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~  309 (439)
                      |+++|+|.+++... ....+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++.......
T Consensus        90 ~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  165 (288)
T 3kfa_A           90 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  165 (288)
T ss_dssp             CCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred             cCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence            99999999999752 235689999999999999999999998   99999999999999999999999999998765433


Q ss_pred             cc--eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCch
Q 013636          310 RN--VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPV  386 (439)
Q Consensus       310 ~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  386 (439)
                      ..  ....+|+.|+|||.+.+..++.++||||||+++|+|++ |..||...+.......+....     ....+..    
T Consensus       166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~----  236 (288)
T 3kfa_A          166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY-----RMERPEG----  236 (288)
T ss_dssp             SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-----CCCCCTT----
T ss_pred             cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccC-----CCCCCCC----
Confidence            22  22346788999999999999999999999999999999 999998876654433332110     0111111    


Q ss_pred             hcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCC
Q 013636          387 IRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVP  429 (439)
Q Consensus       387 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~  429 (439)
                              ....+.+++..||+.||++|||+.++++.|+.+..
T Consensus       237 --------~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~  271 (288)
T 3kfa_A          237 --------CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  271 (288)
T ss_dssp             --------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --------CCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence                    12357789999999999999999999999987664

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.3e-43  Score=334.23  Aligned_cols=248  Identities=26%  Similarity=0.462  Sum_probs=183.1

Q ss_pred             cCCCccceecccCcEEEEEEEE-CCccEEEEEEecCCCc---hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARF-NEKLLAAVKRIDDAGH---DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      ++|++.+.||+|+||.||+|+. .++..+|+|.+.....   ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL   90 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence            5788899999999999999987 4678899999864321   22367899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~  308 (439)
                      ||+++++|.+++..  ....+++..+..++.|+++||+|||+.   +++||||||+||+++.++.+||+|||++......
T Consensus        91 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~  165 (278)
T 3cok_A           91 EMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP  165 (278)
T ss_dssp             ECCTTEEHHHHHHT--CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred             ecCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence            99999999999974  335689999999999999999999998   9999999999999999999999999999765432


Q ss_pred             C-cceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchh
Q 013636          309 S-RNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVI  387 (439)
Q Consensus       309 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  387 (439)
                      . ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...+........      .......+.      
T Consensus       166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~------~~~~~~~~~------  233 (278)
T 3cok_A          166 HEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV------VLADYEMPS------  233 (278)
T ss_dssp             --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----C------CSSCCCCCT------
T ss_pred             CCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHH------hhcccCCcc------
Confidence            2 223456899999999999989999999999999999999999999865432211100      000111111      


Q ss_pred             cCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          388 RDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       388 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                        ..    ...+.+++.+||+.||++|||+.+++++
T Consensus       234 --~~----~~~~~~li~~~l~~dp~~Rps~~~~l~h  263 (278)
T 3cok_A          234 --FL----SIEAKDLIHQLLRRNPADRLSLSSVLDH  263 (278)
T ss_dssp             --TS----CHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             --cc----CHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence              11    2356789999999999999999999975

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2.5e-43  Score=339.93  Aligned_cols=267  Identities=25%  Similarity=0.401  Sum_probs=213.4

Q ss_pred             cHHHHHHHhcCCCccceecccCcEEEEEEEE------CCccEEEEEEecCCCc-hHHHHHHHHHHHHHhc-CCCceeeee
Q 013636          144 EYELLEAATNNFQESNVIGEGGRGHVYKARF------NEKLLAAVKRIDDAGH-DAEREFNNEVNWLTKI-RHQNIISLL  215 (439)
Q Consensus       144 ~~~~l~~~~~~~~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~  215 (439)
                      ....++...++|++.+.||+|+||+||+|+.      .++..+|+|.+..... ...+.+.+|+.+++++ +||||++++
T Consensus        18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~   97 (316)
T 2xir_A           18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   97 (316)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence            3444555678999999999999999999975      3467899999976443 3446799999999999 799999999


Q ss_pred             eEEEeCC-eeEEEEEeccCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 013636          216 GYCIHAE-TRFLVYEMMQNGSLEKQLHGPTH-------------GSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDL  281 (439)
Q Consensus       216 ~~~~~~~-~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dl  281 (439)
                      +++...+ ..++||||+++|+|.+++.....             ...+++..+..++.|+++||+|||+.   +++||||
T Consensus        98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~di  174 (316)
T 2xir_A           98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL  174 (316)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred             EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccC
Confidence            9988765 48999999999999999975332             12388999999999999999999998   9999999


Q ss_pred             CCCCEEEcCCCcEEEEecccccccCCCCcc---eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCC
Q 013636          282 KSSNILLDSSFNAKLSDFGLSVTAGTQSRN---VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKM  357 (439)
Q Consensus       282 k~~NiLl~~~~~~kl~DfGls~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~  357 (439)
                      ||+||+++.++++||+|||++.........   ....||+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~  254 (316)
T 2xir_A          175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  254 (316)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence            999999999999999999999765443322   22457889999999999999999999999999999998 99999876


Q ss_pred             Chhh-hhhhHhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCC
Q 013636          358 SPTQ-CQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPT  430 (439)
Q Consensus       358 ~~~~-~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~  430 (439)
                      .... ....+...     .....+...            ...+.+++.+||+.||++|||+.|++++|+.++..
T Consensus       255 ~~~~~~~~~~~~~-----~~~~~~~~~------------~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  311 (316)
T 2xir_A          255 KIDEEFCRRLKEG-----TRMRAPDYT------------TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  311 (316)
T ss_dssp             CCSHHHHHHHHHT-----CCCCCCTTC------------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             chhHHHHHHhccC-----ccCCCCCCC------------CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence            5322 11111110     011111111            23567799999999999999999999999887654

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=5.7e-44  Score=352.20  Aligned_cols=266  Identities=20%  Similarity=0.270  Sum_probs=202.4

Q ss_pred             HhcCCCccceecccCcEEEEEEEECC------ccEEEEEEecCCCchHH-----------HHHHHHHHHHHhcCCCceee
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARFNE------KLLAAVKRIDDAGHDAE-----------REFNNEVNWLTKIRHQNIIS  213 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~  213 (439)
                      ..++|++.+.||+|+||.||+|.+..      +..+|+|.+........           ..+..|+..++.++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            34689999999999999999998865      36789999876542211           12345666777888999999


Q ss_pred             eeeEEEeC----CeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc
Q 013636          214 LLGYCIHA----ETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLD  289 (439)
Q Consensus       214 l~~~~~~~----~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~  289 (439)
                      +++++...    ...++||||+ +|+|.+++..  ....+++..+..++.|++.||+|||+.   +|+||||||+|||++
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~  186 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLN  186 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEE
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEe
Confidence            99998765    4479999999 9999999974  335699999999999999999999998   999999999999999


Q ss_pred             --CCCcEEEEecccccccCCCCcc--------eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 013636          290 --SSFNAKLSDFGLSVTAGTQSRN--------VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSP  359 (439)
Q Consensus       290 --~~~~~kl~DfGls~~~~~~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~  359 (439)
                        .++.+||+|||+++........        ....||+.|+|||.+.+..++.++|||||||++|||++|+.||.....
T Consensus       187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~  266 (364)
T 3op5_A          187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK  266 (364)
T ss_dssp             SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred             cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence              8899999999999765432211        223499999999999999999999999999999999999999985332


Q ss_pred             hhhhhhHhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCC
Q 013636          360 TQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVP  429 (439)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~  429 (439)
                      ....  ........  ...+.++.++.+...   .....+.+++..||+.||++||++.++++.|+.++.
T Consensus       267 ~~~~--~~~~~~~~--~~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~  329 (364)
T 3op5_A          267 DPKY--VRDSKIRY--RENIASLMDKCFPAA---NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLK  329 (364)
T ss_dssp             CHHH--HHHHHHHH--HHCHHHHHHHHSCTT---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             CHHH--HHHHHHHh--hhhHHHHHHHhcccc---cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Confidence            2111  10000000  011122222222111   113467789999999999999999999999877654

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-43  Score=342.18  Aligned_cols=256  Identities=28%  Similarity=0.429  Sum_probs=203.7

Q ss_pred             hcCCCccceecccCcEEEEEEEECC-----ccEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFNE-----KLLAAVKRIDDAGH-DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRF  225 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  225 (439)
                      .++|+..+.||+|+||+||+|....     +..+|+|.+..... .....+.+|+.++++++||||+++++++...+..+
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  122 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM  122 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence            3567778999999999999998653     34689999875433 34457899999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccccccc
Q 013636          226 LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA  305 (439)
Q Consensus       226 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~  305 (439)
                      +||||+++|+|.+++..  ....+++..+..++.|+++||+|||+.   +++||||||+||++++++.+||+|||++...
T Consensus       123 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  197 (333)
T 1mqb_A          123 IITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL  197 (333)
T ss_dssp             EEEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             EEEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence            99999999999999974  235699999999999999999999998   9999999999999999999999999999765


Q ss_pred             CCCCcc----eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCC
Q 013636          306 GTQSRN----VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLP  380 (439)
Q Consensus       306 ~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  380 (439)
                      ......    ....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...+..+....+..       ....+
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~-------~~~~~  270 (333)
T 1mqb_A          198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND-------GFRLP  270 (333)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-------TCCCC
T ss_pred             ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHC-------CCcCC
Confidence            433211    12235788999999999999999999999999999999 9999987765543332221       11111


Q ss_pred             ccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCC
Q 013636          381 NIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVP  429 (439)
Q Consensus       381 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~  429 (439)
                      .  .    .    .....+.+++.+||+.||++||++.++++.|+++..
T Consensus       271 ~--~----~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~  309 (333)
T 1mqb_A          271 T--P----M----DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  309 (333)
T ss_dssp             C--C----T----TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             C--c----c----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            0  0    0    112357789999999999999999999999987654

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.7e-43  Score=343.55  Aligned_cols=259  Identities=32%  Similarity=0.482  Sum_probs=207.3

Q ss_pred             cCCCccceecccCcEEEEEEEECC-cc--EEEEEEecCCC-chHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeeEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNE-KL--LAAVKRIDDAG-HDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLV  227 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV  227 (439)
                      ++|++.+.||+|+||.||+|+... +.  .+++|.+.... ....+.+.+|+.+++++ +||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            578889999999999999998753 44  45888886532 33445789999999999 899999999999999999999


Q ss_pred             EEeccCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcE
Q 013636          228 YEMMQNGSLEKQLHGPT-------------HGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA  294 (439)
Q Consensus       228 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~  294 (439)
                      |||+++|+|.+++....             ....+++..+..++.|+++||+|||+.   +++||||||+||+++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence            99999999999997532             234699999999999999999999998   99999999999999999999


Q ss_pred             EEEecccccccCCCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhccc
Q 013636          295 KLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQL  373 (439)
Q Consensus       295 kl~DfGls~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~  373 (439)
                      ||+|||++.............+++.|+|||.+.+..++.++||||||+++|||++ |+.||...+..+....+...    
T Consensus       182 kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~----  257 (327)
T 1fvr_A          182 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG----  257 (327)
T ss_dssp             EECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT----
T ss_pred             EEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcC----
Confidence            9999999975443333333457889999999998889999999999999999998 99999887654432222110    


Q ss_pred             ccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCCC
Q 013636          374 TDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPTD  431 (439)
Q Consensus       374 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~~  431 (439)
                       .....+.        ..    ...+.+++.+||+.||++|||+.|++++|+.++...
T Consensus       258 -~~~~~~~--------~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  302 (327)
T 1fvr_A          258 -YRLEKPL--------NC----DDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  302 (327)
T ss_dssp             -CCCCCCT--------TB----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             -CCCCCCC--------CC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence             0011111        11    235778999999999999999999999998877643

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.5e-43  Score=342.59  Aligned_cols=254  Identities=25%  Similarity=0.464  Sum_probs=201.8

Q ss_pred             cCCCccceecccCcEEEEEEEECC-cc----EEEEEEecCC-CchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNE-KL----LAAVKRIDDA-GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFL  226 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  226 (439)
                      ++|++.+.||+|+||+||+|+... +.    .+++|.+... .....+.+.+|+.++++++||||+++++++... ..++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~   93 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   93 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-SEEE
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-CceE
Confidence            678889999999999999998743 22    3578877543 334567899999999999999999999999875 4889


Q ss_pred             EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccC
Q 013636          227 VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAG  306 (439)
Q Consensus       227 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~  306 (439)
                      |+||+++|+|.+++..  ....+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++....
T Consensus        94 v~~~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~  168 (327)
T 3lzb_A           94 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             EECCCSSCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred             EEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence            9999999999999974  235699999999999999999999998   99999999999999999999999999997654


Q ss_pred             CCCcc---eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCcc
Q 013636          307 TQSRN---VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNI  382 (439)
Q Consensus       307 ~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  382 (439)
                      .....   ....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...+..+....+....     ....+..
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~  243 (327)
T 3lzb_A          169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-----RLPQPPI  243 (327)
T ss_dssp             -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-----CCCCCTT
T ss_pred             CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-----CCCCCcc
Confidence            33222   22346778999999999999999999999999999999 999998877655443332110     1111111


Q ss_pred             CCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCC
Q 013636          383 VDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVP  429 (439)
Q Consensus       383 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~  429 (439)
                                  ....+.+++..||+.||++|||+.|+++.|+.+..
T Consensus       244 ------------~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  278 (327)
T 3lzb_A          244 ------------CTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             ------------BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred             ------------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence                        12357779999999999999999999999987764

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2e-43  Score=337.77  Aligned_cols=260  Identities=16%  Similarity=0.168  Sum_probs=207.8

Q ss_pred             hcCCCccceecccCcEEEEEEEE-CCccEEEEEEecCCCchHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeeEEEEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARF-NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYE  229 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e  229 (439)
                      .++|++.+.||+|+||.||+|+. .++..+|+|.+....  ....+.+|+.+++++ +|+|++++++++......++|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            46789999999999999999987 568899999886432  234578899999999 79999999999999999999999


Q ss_pred             eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCc-----EEEEecccccc
Q 013636          230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFN-----AKLSDFGLSVT  304 (439)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~-----~kl~DfGls~~  304 (439)
                      |+ +++|.+++...  +..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.     +||+|||++..
T Consensus        87 ~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~  160 (298)
T 1csn_A           87 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  160 (298)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             ec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence            99 99999999742  34699999999999999999999998   9999999999999987776     99999999976


Q ss_pred             cCCCCc--------ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccC
Q 013636          305 AGTQSR--------NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDR  376 (439)
Q Consensus       305 ~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~  376 (439)
                      ......        .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...+................ .
T Consensus       161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~  239 (298)
T 1csn_A          161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ-S  239 (298)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH-H
T ss_pred             cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc-C
Confidence            544322        2334589999999999999999999999999999999999999987543222211111100000 0


Q ss_pred             CCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCC
Q 013636          377 SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVP  429 (439)
Q Consensus       377 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~  429 (439)
                      ..     .+.+...    ....+.+++..||+.||++|||+.+|++.|+++..
T Consensus       240 ~~-----~~~~~~~----~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~  283 (298)
T 1csn_A          240 TP-----LRELCAG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE  283 (298)
T ss_dssp             SC-----HHHHTTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             cc-----HHHHHhh----CcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence            00     0001111    12467789999999999999999999999988764

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=8.1e-44  Score=368.36  Aligned_cols=259  Identities=27%  Similarity=0.418  Sum_probs=213.5

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEE
Q 013636          149 EAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       149 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      +...++|++.+.||+|+||.||+|+++++..||||.++... ...++|.+|+.+|++++||||+++++++.+ +..++||
T Consensus       263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~  340 (535)
T 2h8h_A          263 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT  340 (535)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             ecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEee
Confidence            34456788889999999999999999988889999998644 335679999999999999999999999876 6789999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~  308 (439)
                      ||+++|+|.+++... .+..+++..++.++.|+++||+|||+.   +|+||||||+|||+++++.+||+|||+++.....
T Consensus       341 e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  416 (535)
T 2h8h_A          341 EYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN  416 (535)
T ss_dssp             CCCTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred             ehhcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence            999999999999641 234589999999999999999999998   9999999999999999999999999999765432


Q ss_pred             Cc--ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCc
Q 013636          309 SR--NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDP  385 (439)
Q Consensus       309 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  385 (439)
                      ..  .....++..|+|||.+.++.++.++|||||||++|||++ |+.||......+....+...     .+...+.    
T Consensus       417 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~-----~~~~~~~----  487 (535)
T 2h8h_A          417 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-----YRMPCPP----  487 (535)
T ss_dssp             HHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTT-----CCCCCCT----
T ss_pred             ceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-----CCCCCCC----
Confidence            11  112336788999999999999999999999999999999 99999887765543333211     0011111    


Q ss_pred             hhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCC
Q 013636          386 VIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPT  430 (439)
Q Consensus       386 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~  430 (439)
                              .....+.+++.+||+.||++|||+.+|++.|+.+...
T Consensus       488 --------~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  524 (535)
T 2h8h_A          488 --------ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  524 (535)
T ss_dssp             --------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred             --------CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence                    1123567899999999999999999999999988754

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=4.7e-43  Score=335.54  Aligned_cols=259  Identities=27%  Similarity=0.441  Sum_probs=205.8

Q ss_pred             hcCCCccceecccCcEEEEEEEECC----ccEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCceeeeeeEEEe-CCeeE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFNE----KLLAAVKRIDDAGH-DAEREFNNEVNWLTKIRHQNIISLLGYCIH-AETRF  225 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~  225 (439)
                      ..+|+..+.||+|+||+||+|+..+    ...+|+|.+..... ...+.+.+|+.++++++||||+++++++.. .+..+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            3567888999999999999998643    23689999876433 344679999999999999999999998754 45789


Q ss_pred             EEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccccccc
Q 013636          226 LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA  305 (439)
Q Consensus       226 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~  305 (439)
                      +||||+++|+|.+++..  ....+++..+..++.|+++||+|||+.   +++||||||+||++++++.+||+|||++...
T Consensus       104 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~  178 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM  178 (298)
T ss_dssp             EEEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred             EEEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccc
Confidence            99999999999999974  345689999999999999999999998   9999999999999999999999999999765


Q ss_pred             CCCCc-----ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCC
Q 013636          306 GTQSR-----NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKL  379 (439)
Q Consensus       306 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  379 (439)
                      .....     .....+|+.|+|||.+.+..++.++||||||+++|||++ |.+||...+..+........     .....
T Consensus       179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~  253 (298)
T 3f66_A          179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG-----RRLLQ  253 (298)
T ss_dssp             SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTT-----CCCCC
T ss_pred             cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcC-----CCCCC
Confidence            43221     122347789999999999999999999999999999999 66677665544322222110     01111


Q ss_pred             CccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCCCC
Q 013636          380 PNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPTDL  432 (439)
Q Consensus       380 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~~~  432 (439)
                      +...            ...+.+++..||+.||++|||+.|+++.|+++...-.
T Consensus       254 ~~~~------------~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~  294 (298)
T 3f66_A          254 PEYC------------PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  294 (298)
T ss_dssp             CTTC------------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred             CccC------------CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence            1111            2357789999999999999999999999998876543

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.5e-43  Score=344.43  Aligned_cols=259  Identities=25%  Similarity=0.290  Sum_probs=202.4

Q ss_pred             HHHHhcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCC-----CchHHHHHHHHHHHHHhcCCCceeeeeeEEEeC
Q 013636          148 LEAATNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDA-----GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHA  221 (439)
Q Consensus       148 l~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  221 (439)
                      +....++|++.+.||+|+||.||+|... ++..+|+|.+...     .....+.+.+|+.++++++||||+++++++.+.
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  100 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE  100 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence            3456678999999999999999999885 4678899988642     234557899999999999999999999999999


Q ss_pred             CeeEEEEEeccCCChhhhhcCCC-------------------------------------CCCCCCHHHHHHHHHHHHHH
Q 013636          222 ETRFLVYEMMQNGSLEKQLHGPT-------------------------------------HGSNLTWHLRMKIAVDVARG  264 (439)
Q Consensus       222 ~~~~lV~e~~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~ia~g  264 (439)
                      +..++||||+++|+|.+++....                                     ....+++..+..++.|++.|
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  180 (345)
T 3hko_A          101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA  180 (345)
T ss_dssp             SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            99999999999999999985210                                     01124567788999999999


Q ss_pred             HHHHhhcCCCCeEecCCCCCCEEEcCCC--cEEEEecccccccCCCCc-----ceeeccccCccchhhhcC--CCCCCch
Q 013636          265 LEYLHEHCNHPVVHRDLKSSNILLDSSF--NAKLSDFGLSVTAGTQSR-----NVKISGTLGYVAPEYLLE--GKLTDKS  335 (439)
Q Consensus       265 l~~LH~~~~~~ivH~Dlk~~NiLl~~~~--~~kl~DfGls~~~~~~~~-----~~~~~gt~~y~aPE~~~~--~~~~~~~  335 (439)
                      |+|||+.   +++||||||+||+++.++  .+||+|||++........     .....||+.|+|||.+.+  ..++.++
T Consensus       181 l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  257 (345)
T 3hko_A          181 LHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC  257 (345)
T ss_dssp             HHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred             HHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence            9999998   999999999999998776  899999999976432111     233468999999999975  6789999


Q ss_pred             hhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCC
Q 013636          336 DVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRP  415 (439)
Q Consensus       336 DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP  415 (439)
                      ||||||+++|||++|+.||...+..+....+...      ....+   .+.. ...    ...+.+++.+||+.||++||
T Consensus       258 DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~------~~~~~---~~~~-~~~----~~~~~~li~~~l~~~p~~Rp  323 (345)
T 3hko_A          258 DAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNK------KLCFE---NPNY-NVL----SPLARDLLSNLLNRNVDERF  323 (345)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------CCCTT---SGGG-GGS----CHHHHHHHHHHSCSCTTTSC
T ss_pred             HHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhc------ccccC---Cccc-ccC----CHHHHHHHHHHcCCChhHCC
Confidence            9999999999999999999887655433222110      11110   1110 111    23567799999999999999


Q ss_pred             CHHHHHHh
Q 013636          416 LITDVLHS  423 (439)
Q Consensus       416 t~~evl~~  423 (439)
                      |+.|++++
T Consensus       324 s~~~~l~h  331 (345)
T 3hko_A          324 DAMRALQH  331 (345)
T ss_dssp             CHHHHHHS
T ss_pred             CHHHHhcC
Confidence            99999975

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-43  Score=350.39  Aligned_cols=257  Identities=27%  Similarity=0.429  Sum_probs=198.0

Q ss_pred             cCCCccceecccCcEEEEEEEECC----ccEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCceeeeeeEEEe-CCeeEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNE----KLLAAVKRIDDAG-HDAEREFNNEVNWLTKIRHQNIISLLGYCIH-AETRFL  226 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~l  226 (439)
                      ..|+..+.||+|+||+||+|+..+    ...+|+|.++... ....++|.+|+.++++++||||++++++|.. .+..++
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l  168 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  168 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence            346677899999999999998632    3468999887543 3455789999999999999999999999765 457899


Q ss_pred             EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccC
Q 013636          227 VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAG  306 (439)
Q Consensus       227 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~  306 (439)
                      ||||+++|+|.+++..  ....+++..+..++.|+++||+|||+.   +++||||||+|||+++++.+||+|||+++...
T Consensus       169 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~  243 (373)
T 3c1x_A          169 VLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY  243 (373)
T ss_dssp             EEECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccc
Confidence            9999999999999974  345689999999999999999999998   99999999999999999999999999997653


Q ss_pred             CCCc-----ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCC
Q 013636          307 TQSR-----NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLP  380 (439)
Q Consensus       307 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  380 (439)
                      ....     .....+|+.|+|||.+.+..++.++||||||+++|||++ |..||...+..+....+...     .....+
T Consensus       244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~-----~~~~~p  318 (373)
T 3c1x_A          244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG-----RRLLQP  318 (373)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTT-----CCCCCC
T ss_pred             ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcC-----CCCCCC
Confidence            3221     122346788999999999999999999999999999999 78888766544332222110     011111


Q ss_pred             ccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCCC
Q 013636          381 NIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPTD  431 (439)
Q Consensus       381 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~~  431 (439)
                      ..            ....+.+++.+||+.||++|||+.|+++.|+.+...-
T Consensus       319 ~~------------~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~  357 (373)
T 3c1x_A          319 EY------------CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  357 (373)
T ss_dssp             TT------------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             CC------------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence            11            1235777999999999999999999999998877543

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.7e-43  Score=344.94  Aligned_cols=243  Identities=23%  Similarity=0.344  Sum_probs=203.9

Q ss_pred             HhcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCc--------hHHHHHHHHHHHHHhcCCCceeeeeeEEEeC
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGH--------DAEREFNNEVNWLTKIRHQNIISLLGYCIHA  221 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  221 (439)
                      ..++|++.+.||+|+||+||+|+.. ++..+|+|.+.....        .....+.+|+.++++++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            4578999999999999999999864 578899999875431        1233577899999999999999999999999


Q ss_pred             CeeEEEEEeccCC-ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecc
Q 013636          222 ETRFLVYEMMQNG-SLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFG  300 (439)
Q Consensus       222 ~~~~lV~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfG  300 (439)
                      +..++||||+.+| +|.+++..   ...+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg  175 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFG  175 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             CEEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecc
Confidence            9999999999877 99999964   34599999999999999999999998   99999999999999999999999999


Q ss_pred             cccccCCCCcceeeccccCccchhhhcCCCC-CCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCC
Q 013636          301 LSVTAGTQSRNVKISGTLGYVAPEYLLEGKL-TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKL  379 (439)
Q Consensus       301 ls~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  379 (439)
                      ++.............||+.|+|||.+.+..+ +.++||||||+++|||++|+.||......     .       ......
T Consensus       176 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~-------~~~~~~  243 (335)
T 3dls_A          176 SAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-----V-------EAAIHP  243 (335)
T ss_dssp             TCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-----T-------TTCCCC
T ss_pred             cceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-----H-------hhccCC
Confidence            9987766555556679999999999998877 78999999999999999999999753211     0       001111


Q ss_pred             CccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          380 PNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       380 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      +..+            ...+.+++..||+.||++|||+.|++++
T Consensus       244 ~~~~------------~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          244 PYLV------------SKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             SSCC------------CHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             Cccc------------CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1111            2346779999999999999999999987

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=7.6e-43  Score=348.44  Aligned_cols=251  Identities=23%  Similarity=0.332  Sum_probs=189.9

Q ss_pred             cCCCcc-ceecccCcEEEEEEEEC-CccEEEEEEecCCCchHHHHHHHHHHHHH-hcCCCceeeeeeEEEe----CCeeE
Q 013636          153 NNFQES-NVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLT-KIRHQNIISLLGYCIH----AETRF  225 (439)
Q Consensus       153 ~~~~~~-~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~----~~~~~  225 (439)
                      ++|.+. +.||+|+||+||++... ++..+|+|.+...     ..+.+|+.++. ..+||||+++++++..    .+..+
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            455555 68999999999999886 4788999998642     34667888874 4589999999999875    55789


Q ss_pred             EEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC---CCcEEEEecccc
Q 013636          226 LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDS---SFNAKLSDFGLS  302 (439)
Q Consensus       226 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~---~~~~kl~DfGls  302 (439)
                      +||||+++|+|.+++... ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.   ++.+||+|||++
T Consensus       136 lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a  211 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA  211 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccc
Confidence            999999999999999752 234699999999999999999999998   9999999999999997   789999999999


Q ss_pred             cccCCCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhh-hHhhhhcccccCCCCCc
Q 013636          303 VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQS-MVTWAMPQLTDRSKLPN  381 (439)
Q Consensus       303 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  381 (439)
                      ............+||+.|+|||++.+..++.++|||||||++|||++|+.||...+...... ......   ......+.
T Consensus       212 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~---~~~~~~~~  288 (400)
T 1nxk_A          212 KETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR---MGQYEFPN  288 (400)
T ss_dssp             EECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH---HTCCCCCT
T ss_pred             cccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH---cCcccCCC
Confidence            87655444445678999999999999999999999999999999999999997654322110 000000   00011110


Q ss_pred             cCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          382 IVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       382 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                         +. ...+    ...+.+++..||+.||++|||+.|++++
T Consensus       289 ---~~-~~~~----s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          289 ---PE-WSEV----SEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             ---TT-TTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ---cc-cccC----CHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence               00 0111    2356789999999999999999999976

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.4e-43  Score=367.47  Aligned_cols=253  Identities=26%  Similarity=0.399  Sum_probs=203.7

Q ss_pred             CCCccc-eecccCcEEEEEEEEC---CccEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEE
Q 013636          154 NFQESN-VIGEGGRGHVYKARFN---EKLLAAVKRIDDAG-HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       154 ~~~~~~-~LG~G~fg~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      ++.+.+ .||+|+||.||+|.+.   ++..||||.++... ....++|.+|+++|++++||||++++++|.. +..++||
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~  414 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM  414 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred             ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence            333344 7999999999999874   46779999997643 3456789999999999999999999999976 6689999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~  308 (439)
                      ||+++|+|.+++..  ....+++..+..++.|+++||+|||+.   +|+||||||+|||+++++.+||+|||+++.....
T Consensus       415 E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~  489 (613)
T 2ozo_A          415 EMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD  489 (613)
T ss_dssp             ECCTTCBHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred             EeCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence            99999999999974  345699999999999999999999998   9999999999999999999999999999876433


Q ss_pred             Ccc----eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCccC
Q 013636          309 SRN----VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV  383 (439)
Q Consensus       309 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  383 (439)
                      ...    ....+|+.|+|||++.++.++.++|||||||++|||++ |+.||...+..+....+...     .....+.  
T Consensus       490 ~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~-----~~~~~p~--  562 (613)
T 2ozo_A          490 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-----KRMECPP--  562 (613)
T ss_dssp             ------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTT-----CCCCCCT--
T ss_pred             CceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-----CCCCCCC--
Confidence            221    12235689999999999999999999999999999998 99999987765544333211     0111111  


Q ss_pred             CchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCC
Q 013636          384 DPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVP  429 (439)
Q Consensus       384 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~  429 (439)
                                .....+.+++..||+.||++||++.++++.|+.+..
T Consensus       563 ----------~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~  598 (613)
T 2ozo_A          563 ----------ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  598 (613)
T ss_dssp             ----------TCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ----------cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence                      123467789999999999999999999999987643

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2.9e-43  Score=346.52  Aligned_cols=273  Identities=21%  Similarity=0.246  Sum_probs=202.3

Q ss_pred             cHHHHHHHhcCCCccceecccCcEEEEEEEECCccEEEEEEecCCCc-----------hHHHHHHHHHHHHHhcCCCcee
Q 013636          144 EYELLEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGH-----------DAEREFNNEVNWLTKIRHQNII  212 (439)
Q Consensus       144 ~~~~l~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~h~niv  212 (439)
                      ...+++...++|++.+.||+|+||.||+|...++..+|+|++.....           ...+.+.+|+.++++++||||+
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   92 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL   92 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence            34567788899999999999999999999998899999999854321           1236789999999999999999


Q ss_pred             eeeeEEEeC-----CeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEE
Q 013636          213 SLLGYCIHA-----ETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNIL  287 (439)
Q Consensus       213 ~l~~~~~~~-----~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiL  287 (439)
                      ++++++...     ...++||||++ |+|.+++..  ....+++..+..++.|++.||+|||+.   +++||||||+||+
T Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl  166 (362)
T 3pg1_A           93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNIL  166 (362)
T ss_dssp             CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEE
T ss_pred             ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEE
Confidence            999998543     35799999998 588888874  345699999999999999999999998   9999999999999


Q ss_pred             EcCCCcEEEEecccccccCCCCcceeeccccCccchhhhcC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhH
Q 013636          288 LDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLE-GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMV  366 (439)
Q Consensus       288 l~~~~~~kl~DfGls~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~  366 (439)
                      ++.++.+||+|||++.............||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...+..+....+
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i  246 (362)
T 3pg1_A          167 LADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKI  246 (362)
T ss_dssp             ECTTCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             EcCCCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            99999999999999976555444445668999999999887 67899999999999999999999999876644322221


Q ss_pred             hhhhcccc---------------cCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          367 TWAMPQLT---------------DRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       367 ~~~~~~~~---------------~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      ........               ............. ..........+.+++..||+.||++|||+.|++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  317 (362)
T 3pg1_A          247 VEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAW-TAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH  317 (362)
T ss_dssp             HHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCH-HHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHcCCCChHHhhhccchhhhHHHHhhcccCChhhH-HhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence            11000000               0000000000000 00001123457789999999999999999999975

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4e-43  Score=341.59  Aligned_cols=269  Identities=25%  Similarity=0.339  Sum_probs=203.3

Q ss_pred             HHHHHhcCCCccceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhc--CCCceeeeeeEEEeC---
Q 013636          147 LLEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKI--RHQNIISLLGYCIHA---  221 (439)
Q Consensus       147 ~l~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~---  221 (439)
                      ......++|++.+.||+|+||.||+|+.. +..+|+|.+...   ....+..|.+++...  +||||+++++++...   
T Consensus        31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~  106 (337)
T 3mdy_A           31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGS  106 (337)
T ss_dssp             HHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred             cccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence            34455678999999999999999999987 778999998643   233445555655554  899999999999887   


Q ss_pred             -CeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----CCCeEecCCCCCCEEEcCCCcEE
Q 013636          222 -ETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC-----NHPVVHRDLKSSNILLDSSFNAK  295 (439)
Q Consensus       222 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~-----~~~ivH~Dlk~~NiLl~~~~~~k  295 (439)
                       ...++||||+++|+|.+++...    .+++..+..++.|++.||+|||+.+     .++++||||||+|||++.++.+|
T Consensus       107 ~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k  182 (337)
T 3mdy_A          107 WTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC  182 (337)
T ss_dssp             GCEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred             CCceEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence             6889999999999999999642    4899999999999999999999752     33899999999999999999999


Q ss_pred             EEecccccccCCCCcc-----eeeccccCccchhhhcCCCCCCc------hhhHHHHHHHHHHHhC----------CCCC
Q 013636          296 LSDFGLSVTAGTQSRN-----VKISGTLGYVAPEYLLEGKLTDK------SDVYAFGVVLLELLMG----------RRPV  354 (439)
Q Consensus       296 l~DfGls~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~------~DvwS~Gvll~elltG----------~~P~  354 (439)
                      |+|||++.........     ....||+.|+|||.+.+...+.+      +|||||||++|||++|          +.||
T Consensus       183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~  262 (337)
T 3mdy_A          183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY  262 (337)
T ss_dssp             ECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             EEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence            9999999765433222     13468999999999988777665      9999999999999999          6666


Q ss_pred             CCCChhhhh-hhHhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCC
Q 013636          355 EKMSPTQCQ-SMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPT  430 (439)
Q Consensus       355 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~  430 (439)
                      ....+.... ........    ...........   .........+.+++.+||+.||++|||+.|++++|+.+..+
T Consensus       263 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~  332 (337)
T 3mdy_A          263 HDLVPSDPSYEDMREIVC----IKKLRPSFPNR---WSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES  332 (337)
T ss_dssp             TTTSCSSCCHHHHHHHHT----TSCCCCCCCGG---GGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             hhhcCCCCchhhhHHHHh----hhccCcccccc---chhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence            543322110 00100000    00111111110   11124567788999999999999999999999999887654

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=6.9e-43  Score=339.42  Aligned_cols=259  Identities=21%  Similarity=0.240  Sum_probs=206.2

Q ss_pred             HHHHHhcCCCcc-ceecccCcEEEEEEEEC-CccEEEEEEecCCC--chHHHHHHHHHHHHHhc-CCCceeeeeeEEEeC
Q 013636          147 LLEAATNNFQES-NVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG--HDAEREFNNEVNWLTKI-RHQNIISLLGYCIHA  221 (439)
Q Consensus       147 ~l~~~~~~~~~~-~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  221 (439)
                      ..+...+.|.+. +.||+|+||.||+|... ++..+|+|.+....  ......+.+|+.++.++ +||||+++++++...
T Consensus        22 ~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~  101 (327)
T 3lm5_A           22 SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT  101 (327)
T ss_dssp             CHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             HHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC
Confidence            344556677776 88999999999999886 47899999987532  33456789999999999 469999999999999


Q ss_pred             CeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC---CCcEEEEe
Q 013636          222 ETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDS---SFNAKLSD  298 (439)
Q Consensus       222 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~---~~~~kl~D  298 (439)
                      +..++||||+++|+|.+++.. .....+++..+..++.|++.||+|||+.   +++||||||+||+++.   ++.+||+|
T Consensus       102 ~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~D  177 (327)
T 3lm5_A          102 SEIILILEYAAGGEIFSLCLP-ELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVD  177 (327)
T ss_dssp             SEEEEEEECCTTEEGGGGGSS-CC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECC
T ss_pred             CeEEEEEEecCCCcHHHHHHH-hcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEee
Confidence            999999999999999999864 2345699999999999999999999998   9999999999999998   78999999


Q ss_pred             cccccccCCCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCC
Q 013636          299 FGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSK  378 (439)
Q Consensus       299 fGls~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~  378 (439)
                      ||++.............||+.|+|||.+.+..++.++||||||+++|||++|+.||...+..+....+.....      .
T Consensus       178 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~------~  251 (327)
T 3lm5_A          178 FGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNV------D  251 (327)
T ss_dssp             GGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC------C
T ss_pred             CccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccc------c
Confidence            9999877655444456799999999999999999999999999999999999999988765543322221110      0


Q ss_pred             CCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          379 LPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       379 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      .+..    ....    ....+.+++.+||+.||++|||+.|++++
T Consensus       252 ~~~~----~~~~----~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          252 YSEE----TFSS----VSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             CCTT----TTTT----SCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             cCch----hhcc----cCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence            0000    0011    12356779999999999999999999976

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=3.9e-43  Score=341.60  Aligned_cols=266  Identities=25%  Similarity=0.409  Sum_probs=202.7

Q ss_pred             hcCCCccceecccCcEEEEEEEECC-ccEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGH--DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      .++|+..+.||+|+||.||+++... +..+|+|.+.....  ...+.+.+|+.++++++||||+++++++...+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            3678889999999999999999865 78899998864432  33456889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~  308 (439)
                      ||+++++|.+++..   ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++......
T Consensus       104 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  177 (331)
T 4aaa_A          104 EFVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  177 (331)
T ss_dssp             ECCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             ecCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence            99999999988753   23589999999999999999999998   9999999999999999999999999999765432


Q ss_pred             Cc-ceeeccccCccchhhhcCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhh-------------hccc
Q 013636          309 SR-NVKISGTLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWA-------------MPQL  373 (439)
Q Consensus       309 ~~-~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~-------------~~~~  373 (439)
                      .. .....||+.|+|||.+.+. .++.++||||||+++|||++|+.||...+..+....+...             ....
T Consensus       178 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (331)
T 4aaa_A          178 GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV  257 (331)
T ss_dssp             ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred             ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence            22 2334589999999999875 7899999999999999999999999877654322111110             0000


Q ss_pred             ccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          374 TDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       374 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      ......+......-...........+.+++.+||+.||++|||+.|++++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            01111121111111000011123568889999999999999999999875

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.4e-43  Score=343.74  Aligned_cols=264  Identities=24%  Similarity=0.335  Sum_probs=198.5

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCchHH-HHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEe
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAE-REFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      ++|++.+.||+|+||+||+|+.. ++..+|+|.+........ ..+.+|+.++++++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            57888999999999999999986 578899999875432221 2456799999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR  310 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~  310 (439)
                      ++ |+|.+++..  .+..+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++........
T Consensus        82 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~  155 (324)
T 3mtl_A           82 LD-KDLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  155 (324)
T ss_dssp             CS-EEHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred             cc-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence            98 599998874  345689999999999999999999998   999999999999999999999999999976543222


Q ss_pred             -ceeeccccCccchhhhcC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchh-
Q 013636          311 -NVKISGTLGYVAPEYLLE-GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVI-  387 (439)
Q Consensus       311 -~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l-  387 (439)
                       .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...+..+....+........ ....+...+... 
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~~~~~~~  234 (324)
T 3mtl_A          156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPT-EETWPGILSNEEF  234 (324)
T ss_dssp             -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC-TTTSTTGGGCHHH
T ss_pred             ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC-hHhchhhhcchhh
Confidence             233458999999999886 5689999999999999999999999998776554333322211111 111111111000 


Q ss_pred             --------cC----ccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          388 --------RD----TMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       388 --------~~----~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                              ..    .........+.+++.+||+.||++|||+.|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  282 (324)
T 3mtl_A          235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH  282 (324)
T ss_dssp             HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence                    00    0000112456789999999999999999999864

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=9.5e-43  Score=332.89  Aligned_cols=248  Identities=23%  Similarity=0.411  Sum_probs=206.1

Q ss_pred             hcCCCccceecccCcEEEEEEEECC-ccEEEEEEecCC---CchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDA---GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLV  227 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  227 (439)
                      .++|+..+.||+|+||.||+++..+ +..+|+|.+...   .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            3678889999999999999999864 678899988643   233456789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCC
Q 013636          228 YEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT  307 (439)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~  307 (439)
                      |||+++++|.+++..   ...+++..+..++.|+++||+|||+.   +++||||||+||+++.++.+||+|||++.....
T Consensus        94 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  167 (294)
T 2rku_A           94 LELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  167 (294)
T ss_dssp             EECCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence            999999999998853   24689999999999999999999998   999999999999999999999999999976543


Q ss_pred             CC-cceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCch
Q 013636          308 QS-RNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPV  386 (439)
Q Consensus       308 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  386 (439)
                      .. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+....+..      ....++..++  
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~------~~~~~~~~~~--  239 (294)
T 2rku_A          168 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK------NEYSIPKHIN--  239 (294)
T ss_dssp             TTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT------TCCCCCTTSC--
T ss_pred             CccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhh------ccCCCccccC--
Confidence            22 22335689999999999999999999999999999999999999987665433222211      1112222222  


Q ss_pred             hcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          387 IRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       387 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                                ..+.+++.+||+.||++|||+.|++++
T Consensus       240 ----------~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          240 ----------PVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             ----------HHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ----------HHHHHHHHHHcccChhhCcCHHHHhhC
Confidence                      346679999999999999999999975

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=4.4e-43  Score=362.15  Aligned_cols=254  Identities=25%  Similarity=0.343  Sum_probs=208.1

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC---chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLV  227 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  227 (439)
                      .++|+..+.||+|+||.||+++.. ++..+|+|.+....   ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            467899999999999999999986 58899999986432   22345688999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCC
Q 013636          228 YEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT  307 (439)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~  307 (439)
                      |||+++|+|.+++.... ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++++||+|||++.....
T Consensus       263 mEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~  338 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE  338 (576)
T ss_dssp             ECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence            99999999999997532 34589999999999999999999998   999999999999999999999999999987665


Q ss_pred             CCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchh
Q 013636          308 QSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVI  387 (439)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  387 (439)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.....  ......+..++   
T Consensus       339 ~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~--~~~~~~p~~~s---  413 (576)
T 2acx_A          339 GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK--EVPEEYSERFS---  413 (576)
T ss_dssp             TCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHH--HCCCCCCTTSC---
T ss_pred             CccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhh--cccccCCccCC---
Confidence            5444456799999999999999999999999999999999999999987543211111111110  11112222222   


Q ss_pred             cCccCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHh
Q 013636          388 RDTMDLKHLYQVAAVAVLCIQPEPSYRP-----LITDVLHS  423 (439)
Q Consensus       388 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  423 (439)
                               ..+.+++.+||+.||++||     ++.|+++|
T Consensus       414 ---------~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          414 ---------PQARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             ---------HHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             ---------HHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence                     3566799999999999999     78999865

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=7.8e-44  Score=343.51  Aligned_cols=255  Identities=21%  Similarity=0.351  Sum_probs=196.6

Q ss_pred             hcCCCccceecccCcEEEEEEEE-CCccEEEEEEecCCC---chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCe----
Q 013636          152 TNNFQESNVIGEGGRGHVYKARF-NEKLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAET----  223 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  223 (439)
                      .++|++.+.||+|+||.||+++. .++..+|+|.+....   ......+.+|+.++++++||||+++++++...+.    
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            46889999999999999999997 567899999997542   2334578999999999999999999999876553    


Q ss_pred             eEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccccc
Q 013636          224 RFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSV  303 (439)
Q Consensus       224 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~  303 (439)
                      .++||||+++|+|.++++.   ...+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++.
T Consensus        91 ~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  164 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR  164 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred             cEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence            3999999999999999964   23589999999999999999999998   99999999999999999999999999997


Q ss_pred             ccCCCCc----ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCC
Q 013636          304 TAGTQSR----NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKL  379 (439)
Q Consensus       304 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  379 (439)
                      .......    .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...++.........      .....
T Consensus       165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~------~~~~~  238 (311)
T 3ork_A          165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR------EDPIP  238 (311)
T ss_dssp             -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH------CCCCC
T ss_pred             cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhc------CCCCC
Confidence            6543222    1234589999999999999999999999999999999999999988765443221110      00000


Q ss_pred             CccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHH-Hhccc
Q 013636          380 PNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVL-HSLIP  426 (439)
Q Consensus       380 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl-~~L~~  426 (439)
                          ........    ...+.+++.+||+.||++||+..+++ +.+..
T Consensus       239 ----~~~~~~~~----~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  278 (311)
T 3ork_A          239 ----PSARHEGL----SADLDAVVLKALAKNPENRYQTAAEMRADLVR  278 (311)
T ss_dssp             ----HHHHSTTC----CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             ----cccccCCC----CHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence                00001111    23567899999999999999766655 44433

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.6e-43  Score=335.96  Aligned_cols=252  Identities=27%  Similarity=0.450  Sum_probs=205.6

Q ss_pred             HhcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEe---------
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH---------  220 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------  220 (439)
                      ..++|+..+.||+|+||.||+|+.. ++..+|+|.+....    ..+.+|+.++++++||||+++++++..         
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            4467889999999999999999986 68899999987543    356789999999999999999998864         


Q ss_pred             -------CCeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCc
Q 013636          221 -------AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFN  293 (439)
Q Consensus       221 -------~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~  293 (439)
                             ....++||||+++|+|.+++... ....+++..+..++.|++.||+|||+.   +++||||||+||++++++.
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~  160 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQ  160 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCC
Confidence                   34579999999999999999642 235689999999999999999999998   9999999999999999999


Q ss_pred             EEEEecccccccCCCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhccc
Q 013636          294 AKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQL  373 (439)
Q Consensus       294 ~kl~DfGls~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~  373 (439)
                      +||+|||++.............||+.|+|||.+.+..++.++||||||+++|||++|..|+....     .....    .
T Consensus       161 ~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-----~~~~~----~  231 (284)
T 2a19_B          161 VKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS-----KFFTD----L  231 (284)
T ss_dssp             EEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH-----HHHHH----H
T ss_pred             EEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH-----HHHHH----h
Confidence            99999999987665444445569999999999999999999999999999999999998874211     11110    0


Q ss_pred             ccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCCCC
Q 013636          374 TDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPTDL  432 (439)
Q Consensus       374 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~~~  432 (439)
                      . ...++..++            ..+.+++.+||+.||++|||+.|++++|..+.....
T Consensus       232 ~-~~~~~~~~~------------~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~  277 (284)
T 2a19_B          232 R-DGIISDIFD------------KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE  277 (284)
T ss_dssp             H-TTCCCTTSC------------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred             h-cccccccCC------------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence            0 111222222            245679999999999999999999999987765433

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-43  Score=353.74  Aligned_cols=260  Identities=21%  Similarity=0.274  Sum_probs=207.6

Q ss_pred             HHHHHHHhcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCc---hHHHHHHHHHHHHHhcCCCceeeeeeEEEe
Q 013636          145 YELLEAATNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGH---DAEREFNNEVNWLTKIRHQNIISLLGYCIH  220 (439)
Q Consensus       145 ~~~l~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  220 (439)
                      .+..+...++|++.+.||+|+||+||+++.. ++..+|+|.++....   ...+.+.+|..++..++||||+++++++.+
T Consensus        53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  132 (412)
T 2vd5_A           53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD  132 (412)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence            3344455689999999999999999999985 588999999865321   122348899999999999999999999999


Q ss_pred             CCeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecc
Q 013636          221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFG  300 (439)
Q Consensus       221 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfG  300 (439)
                      .+..++||||+++|+|.+++..  .+..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++++||+|||
T Consensus       133 ~~~~~lVmE~~~gg~L~~~l~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFG  207 (412)
T 2vd5_A          133 ENYLYLVMEYYVGGDLLTLLSK--FGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFG  207 (412)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHH--HSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CCEEEEEEcCCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeech
Confidence            9999999999999999999974  234689999999999999999999998   99999999999999999999999999


Q ss_pred             cccccCCCCcc--eeeccccCccchhhhc-------CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhc
Q 013636          301 LSVTAGTQSRN--VKISGTLGYVAPEYLL-------EGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP  371 (439)
Q Consensus       301 ls~~~~~~~~~--~~~~gt~~y~aPE~~~-------~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~  371 (439)
                      ++.........  ...+||+.|+|||++.       ...++.++|||||||++|||++|+.||...+..+....+.....
T Consensus       208 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~  287 (412)
T 2vd5_A          208 SCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKE  287 (412)
T ss_dssp             TCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH
T ss_pred             hheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhccc
Confidence            99776543322  2357999999999997       45789999999999999999999999988776543322221110


Q ss_pred             ccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCC---CCHHHHHHh
Q 013636          372 QLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYR---PLITDVLHS  423 (439)
Q Consensus       372 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~R---Pt~~evl~~  423 (439)
                      .    ...+.     ....+    ...+.+++.+||+ +|++|   |++.|+++|
T Consensus       288 ~----~~~p~-----~~~~~----s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          288 H----LSLPL-----VDEGV----PEEARDFIQRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             H----CCCC---------CC----CHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             C----cCCCc-----cccCC----CHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence            0    11111     01111    2356679999999 99998   699999865

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.7e-43  Score=344.50  Aligned_cols=249  Identities=24%  Similarity=0.412  Sum_probs=196.3

Q ss_pred             hcCCCccceecccCcEEEEEEEECCccEEEEEEecCCC--chHHHHHHHHHHHHHhcCC--CceeeeeeEEEeCCeeEEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRH--QNIISLLGYCIHAETRFLV  227 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lV  227 (439)
                      .++|++.+.||+|+||.||++...++..+|+|.+....  ....+.+.+|+.++++++|  |||+++++++...+..++|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            46788899999999999999999889999999986433  3344678999999999986  9999999999999999999


Q ss_pred             EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCC
Q 013636          228 YEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT  307 (439)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~  307 (439)
                      || +.+|+|.+++..   ...+++..+..++.|++.||+|||+.   +|+||||||+|||++ ++.+||+|||++.....
T Consensus        88 ~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~  159 (343)
T 3dbq_A           88 ME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  159 (343)
T ss_dssp             EC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred             Ee-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence            99 568899999964   34689999999999999999999998   999999999999997 57899999999977644


Q ss_pred             CCc---ceeeccccCccchhhhcC-----------CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhccc
Q 013636          308 QSR---NVKISGTLGYVAPEYLLE-----------GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQL  373 (439)
Q Consensus       308 ~~~---~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~  373 (439)
                      ...   .....||+.|+|||.+.+           ..++.++|||||||++|||++|+.||....... ........+  
T Consensus       160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~--  236 (343)
T 3dbq_A          160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-SKLHAIIDP--  236 (343)
T ss_dssp             ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-HHHHHHHCT--
T ss_pred             ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH-HHHHHHhcC--
Confidence            322   123569999999999865           678899999999999999999999997643321 111111000  


Q ss_pred             ccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          374 TDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       374 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      ......+...            ...+.+++..||+.||++|||+.|++++
T Consensus       237 ~~~~~~~~~~------------~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          237 NHEIEFPDIP------------EKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             TSCCCCCCCS------------CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CcccCCcccC------------CHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence            0111112111            1356779999999999999999999976

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=9.1e-43  Score=339.93  Aligned_cols=269  Identities=25%  Similarity=0.352  Sum_probs=210.7

Q ss_pred             ccHHHHHHHhcCCCccceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHh--cCCCceeeeeeEEEe
Q 013636          143 IEYELLEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTK--IRHQNIISLLGYCIH  220 (439)
Q Consensus       143 ~~~~~l~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~  220 (439)
                      .+....+...++|++.+.||+|+||.||+|+.. +..+|+|.+...   ....+.+|.+++..  ++||||+++++++..
T Consensus        32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~  107 (342)
T 1b6c_B           32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNK  107 (342)
T ss_dssp             SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred             CceeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence            444445666789999999999999999999985 778999998643   34567888998887  789999999999988


Q ss_pred             CC----eeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHh--------hcCCCCeEecCCCCCCEEE
Q 013636          221 AE----TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLH--------EHCNHPVVHRDLKSSNILL  288 (439)
Q Consensus       221 ~~----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH--------~~~~~~ivH~Dlk~~NiLl  288 (439)
                      .+    ..++||||+++|+|.+++..    ..+++..+..++.|++.||+|||        +.   +++||||||+||++
T Consensus       108 ~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll  180 (342)
T 1b6c_B          108 DNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILV  180 (342)
T ss_dssp             CCSSCCCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEE
T ss_pred             cCCccceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEE
Confidence            76    78999999999999999964    24899999999999999999999        55   99999999999999


Q ss_pred             cCCCcEEEEecccccccCCCCcc-----eeeccccCccchhhhcCCC------CCCchhhHHHHHHHHHHHhC-------
Q 013636          289 DSSFNAKLSDFGLSVTAGTQSRN-----VKISGTLGYVAPEYLLEGK------LTDKSDVYAFGVVLLELLMG-------  350 (439)
Q Consensus       289 ~~~~~~kl~DfGls~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~------~~~~~DvwS~Gvll~elltG-------  350 (439)
                      +.++++||+|||++.........     ....||+.|+|||.+.+..      ++.++||||||+++|||++|       
T Consensus       181 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~  260 (342)
T 1b6c_B          181 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH  260 (342)
T ss_dssp             CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred             CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcc
Confidence            99999999999999765443321     2345899999999998753      33689999999999999999       


Q ss_pred             ---CCCCCCCChhhh--hhhHhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhcc
Q 013636          351 ---RRPVEKMSPTQC--QSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLI  425 (439)
Q Consensus       351 ---~~P~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  425 (439)
                         ..||....+...  ......    .... .....+..   ..........+.+++.+||+.||++|||+.+++++|+
T Consensus       261 ~~~~~p~~~~~~~~~~~~~~~~~----~~~~-~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~  332 (342)
T 1b6c_B          261 EDYQLPYYDLVPSDPSVEEMRKV----VCEQ-KLRPNIPN---RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS  332 (342)
T ss_dssp             CCCCCTTTTTSCSSCCHHHHHHH----HTTS-CCCCCCCG---GGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHH
T ss_pred             cccccCccccCcCcccHHHHHHH----HHHH-HhCCCCcc---cccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence               778866432211  111111    0011 11011111   1112355677889999999999999999999999999


Q ss_pred             ccCCC
Q 013636          426 PLVPT  430 (439)
Q Consensus       426 ~l~~~  430 (439)
                      ++..+
T Consensus       333 ~i~~~  337 (342)
T 1b6c_B          333 QLSQQ  337 (342)
T ss_dssp             HHHHT
T ss_pred             HHHHH
Confidence            88654

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=8e-43  Score=333.05  Aligned_cols=255  Identities=27%  Similarity=0.399  Sum_probs=206.6

Q ss_pred             hcCCCccc-eecccCcEEEEEEEEC---CccEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeE
Q 013636          152 TNNFQESN-VIGEGGRGHVYKARFN---EKLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRF  225 (439)
Q Consensus       152 ~~~~~~~~-~LG~G~fg~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  225 (439)
                      .++|++.+ .||+|+||+||+|.+.   .+..+|+|.+....  ....+++.+|+.+++.++||||+++++++ ..+..+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            35677777 9999999999999653   36789999987543  23356799999999999999999999999 567889


Q ss_pred             EEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccccccc
Q 013636          226 LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA  305 (439)
Q Consensus       226 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~  305 (439)
                      +||||+++|+|.+++..   ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++...
T Consensus        94 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  167 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL  167 (291)
T ss_dssp             EEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence            99999999999999964   24589999999999999999999998   9999999999999999999999999999776


Q ss_pred             CCCCcc----eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCC
Q 013636          306 GTQSRN----VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLP  380 (439)
Q Consensus       306 ~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  380 (439)
                      ......    ....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...+..+....+...     .....+
T Consensus       168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~  242 (291)
T 1xbb_A          168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-----ERMGCP  242 (291)
T ss_dssp             CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-----CCCCCC
T ss_pred             ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-----CCCCCC
Confidence            543322    12235788999999998889999999999999999999 99999887765543333211     011111


Q ss_pred             ccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCC
Q 013636          381 NIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPT  430 (439)
Q Consensus       381 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~  430 (439)
                      .            .....+.+++..||+.||++|||+.++++.|+.+...
T Consensus       243 ~------------~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  280 (291)
T 1xbb_A          243 A------------GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  280 (291)
T ss_dssp             T------------TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             C------------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            1            1123577899999999999999999999999887654

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=5.5e-44  Score=342.49  Aligned_cols=261  Identities=27%  Similarity=0.412  Sum_probs=202.4

Q ss_pred             cCCCccceecccCcEEEEEEEE-----CCccEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCceeeeeeEEEeC--Cee
Q 013636          153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDAG-HDAEREFNNEVNWLTKIRHQNIISLLGYCIHA--ETR  224 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  224 (439)
                      +.|+..+.||+|+||.||++++     ..+..+|+|.+.... ....+.+.+|+.++++++||||+++++++...  +..
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            4578889999999999999984     457899999987433 33446789999999999999999999999876  568


Q ss_pred             EEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccc
Q 013636          225 FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT  304 (439)
Q Consensus       225 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~  304 (439)
                      ++||||+++|+|.+++..  ....+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++..
T Consensus       101 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  175 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPK--NKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKA  175 (302)
T ss_dssp             EEEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEEeCCCCcHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccccccc
Confidence            999999999999999963  234589999999999999999999998   999999999999999999999999999977


Q ss_pred             cCCCCcc----eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhh--------hhhhHhhhhcc
Q 013636          305 AGTQSRN----VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQ--------CQSMVTWAMPQ  372 (439)
Q Consensus       305 ~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~--------~~~~~~~~~~~  372 (439)
                      .......    ....||..|+|||.+.+..++.++||||||+++|||++|+.|+.......        ...........
T Consensus       176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (302)
T 4e5w_A          176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT  255 (302)
T ss_dssp             CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred             ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence            6544322    22347888999999999999999999999999999999999864321100        00000000000


Q ss_pred             cccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccC
Q 013636          373 LTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLV  428 (439)
Q Consensus       373 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~  428 (439)
                      .......+          ........+.+++.+||+.||++|||+.++++.|+.++
T Consensus       256 ~~~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          256 LKEGKRLP----------CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHTTCCCC----------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HhccCCCC----------CCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            11111000          00111246778999999999999999999999998754

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=3.7e-43  Score=341.59  Aligned_cols=266  Identities=23%  Similarity=0.317  Sum_probs=196.9

Q ss_pred             HhcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCch--HHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEE
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHD--AEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLV  227 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  227 (439)
                      ..++|++.+.||+|+||+||+|+.. ++..+|+|.+......  ..+.+.+|+.++++++||||+++++++...+..++|
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  111 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI  111 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence            3468999999999999999999875 5788999999754322  235678999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE-----cCCCcEEEEecccc
Q 013636          228 YEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILL-----DSSFNAKLSDFGLS  302 (439)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl-----~~~~~~kl~DfGls  302 (439)
                      |||+++ +|.+++...   ..+++..+..++.|++.||+|||+.   +|+||||||+|||+     ++++.+||+|||++
T Consensus       112 ~e~~~~-~L~~~~~~~---~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a  184 (329)
T 3gbz_A          112 FEYAEN-DLKKYMDKN---PDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA  184 (329)
T ss_dssp             EECCSE-EHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred             EecCCC-CHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence            999985 999999642   3589999999999999999999998   99999999999999     45556999999999


Q ss_pred             cccCCCCc-ceeeccccCccchhhhcCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccC----
Q 013636          303 VTAGTQSR-NVKISGTLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDR----  376 (439)
Q Consensus       303 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~----  376 (439)
                      ........ .....||+.|+|||.+.+. .++.++|||||||++|||++|+.||...+..+....+..........    
T Consensus       185 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (329)
T 3gbz_A          185 RAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPG  264 (329)
T ss_dssp             HHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred             cccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhh
Confidence            76543222 2334589999999999875 48999999999999999999999998776544322221111100000    


Q ss_pred             --------CCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          377 --------SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       377 --------~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                              ...+......+...........+.+++.+||+.||++|||+.|++++
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  319 (329)
T 3gbz_A          265 VTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH  319 (329)
T ss_dssp             GGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             hhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence                    01111111111111111123467789999999999999999999975

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1e-42  Score=339.31  Aligned_cols=248  Identities=23%  Similarity=0.411  Sum_probs=206.5

Q ss_pred             hcCCCccceecccCcEEEEEEEECC-ccEEEEEEecCC---CchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDA---GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLV  227 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  227 (439)
                      .++|.+.+.||+|+||.||+++..+ +..+|+|.+...   .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            4678889999999999999999865 678899988643   234456789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCC
Q 013636          228 YEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT  307 (439)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~  307 (439)
                      |||+++++|.+++..   ...+++..+..++.|+++||+|||+.   +++||||||+||+++.++.+||+|||++.....
T Consensus       120 ~e~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  193 (335)
T 2owb_A          120 LELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  193 (335)
T ss_dssp             ECCCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence            999999999998863   24689999999999999999999998   999999999999999999999999999976543


Q ss_pred             CC-cceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCch
Q 013636          308 QS-RNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPV  386 (439)
Q Consensus       308 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  386 (439)
                      .. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+....+..      ....++..++  
T Consensus       194 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~------~~~~~~~~~~--  265 (335)
T 2owb_A          194 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK------NEYSIPKHIN--  265 (335)
T ss_dssp             TTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH------TCCCCCTTSC--
T ss_pred             CcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhc------CCCCCCccCC--
Confidence            22 22345689999999999999999999999999999999999999987665433222211      1112222222  


Q ss_pred             hcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          387 IRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       387 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                                ..+.+++.+||+.||++|||+.|++++
T Consensus       266 ----------~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          266 ----------PVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             ----------HHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ----------HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                      246679999999999999999999975

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.3e-43  Score=349.70  Aligned_cols=265  Identities=25%  Similarity=0.320  Sum_probs=194.4

Q ss_pred             HHhcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCC--CchHHHHHHHHHHHHHhcC-CCceeeeeeEEEeCC--e
Q 013636          150 AATNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDA--GHDAEREFNNEVNWLTKIR-HQNIISLLGYCIHAE--T  223 (439)
Q Consensus       150 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~  223 (439)
                      ...++|++.+.||+|+||.||+|... ++..+|+|++...  .......+.+|+.+++++. ||||+++++++...+  .
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            34578999999999999999999875 5788999998643  2344567889999999997 999999999997654  6


Q ss_pred             eEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccccc
Q 013636          224 RFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSV  303 (439)
Q Consensus       224 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~  303 (439)
                      .++||||++ |+|.+++..    ..+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        86 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~  157 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSR  157 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence            899999998 589999864    3589999999999999999999998   99999999999999999999999999997


Q ss_pred             ccCCC----------------------CcceeeccccCccchhhhcC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCChh
Q 013636          304 TAGTQ----------------------SRNVKISGTLGYVAPEYLLE-GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPT  360 (439)
Q Consensus       304 ~~~~~----------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~  360 (439)
                      .....                      .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~  237 (388)
T 3oz6_A          158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM  237 (388)
T ss_dssp             ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            64321                      11123469999999999987 67899999999999999999999999887654


Q ss_pred             hhhhhHhhhhccccc-------------------------CCCCCccCCchhcC-----ccCHHHHHHHHHHHHHhcCCC
Q 013636          361 QCQSMVTWAMPQLTD-------------------------RSKLPNIVDPVIRD-----TMDLKHLYQVAAVAVLCIQPE  410 (439)
Q Consensus       361 ~~~~~~~~~~~~~~~-------------------------~~~~~~~~d~~l~~-----~~~~~~~~~l~~l~~~cl~~d  410 (439)
                      .....+.........                         .......+. ..+.     .........+.+++.+||+.|
T Consensus       238 ~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~dll~~~L~~d  316 (388)
T 3oz6_A          238 NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFT-KWKNLLLKINPKADCNEEALDLLDKLLQFN  316 (388)
T ss_dssp             HHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHH-HHHHHHHHHCTTCCCCHHHHHHHHHHCCSS
T ss_pred             HHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCc-chhhhcccccccccCCHHHHHHHHHhhccC
Confidence            332222111100000                         000000000 0000     000011245788999999999


Q ss_pred             CCCCCCHHHHHHh
Q 013636          411 PSYRPLITDVLHS  423 (439)
Q Consensus       411 P~~RPt~~evl~~  423 (439)
                      |++|||+.|++++
T Consensus       317 P~~R~t~~e~l~H  329 (388)
T 3oz6_A          317 PNKRISANDALKH  329 (388)
T ss_dssp             GGGSCCHHHHTTS
T ss_pred             cccCCCHHHHhCC
Confidence            9999999999987

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=7.8e-43  Score=330.12  Aligned_cols=247  Identities=26%  Similarity=0.357  Sum_probs=197.3

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC---chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      ++|++.+.||+|+||.||+|+.. ++..+|+|.+....   ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (276)
T 2h6d_A           11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM   90 (276)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence            67888999999999999999986 68899999986432   223457889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~  308 (439)
                      ||+++++|.+++...   ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++......
T Consensus        91 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  164 (276)
T 2h6d_A           91 EYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  164 (276)
T ss_dssp             ECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred             eccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence            999999999999642   3589999999999999999999998   9999999999999999999999999999876554


Q ss_pred             CcceeeccccCccchhhhcCCCC-CCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchh
Q 013636          309 SRNVKISGTLGYVAPEYLLEGKL-TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVI  387 (439)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  387 (439)
                      .......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||...+.......+...      ....+..+    
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------~~~~~~~~----  234 (276)
T 2h6d_A          165 EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG------VFYIPEYL----  234 (276)
T ss_dssp             ------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------CCCCCTTS----
T ss_pred             cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC------cccCchhc----
Confidence            43344568999999999988765 58999999999999999999999876554433222211      11112111    


Q ss_pred             cCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          388 RDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       388 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                              ...+.+++.+||+.||++|||+.|++++
T Consensus       235 --------~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          235 --------NRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             --------CHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             --------CHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                    2346679999999999999999999986

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.7e-42  Score=330.87  Aligned_cols=252  Identities=25%  Similarity=0.408  Sum_probs=200.1

Q ss_pred             CCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEecc
Q 013636          154 NFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQ  232 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  232 (439)
                      +|....+||+|+||.||+|+.. ++..+|+|.+........+.+.+|+.+++.++||||+++++++...+..++||||++
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  102 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP  102 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence            4445568999999999999974 577899999987665666789999999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC-CCcEEEEecccccccCCCCc-
Q 013636          233 NGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDS-SFNAKLSDFGLSVTAGTQSR-  310 (439)
Q Consensus       233 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~-~~~~kl~DfGls~~~~~~~~-  310 (439)
                      +++|.+++........+++..+..++.|+++||+|||+.   +++||||||+||+++. ++.+||+|||++........ 
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~  179 (295)
T 2clq_A          103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC  179 (295)
T ss_dssp             EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred             CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCCc
Confidence            999999997644445678999999999999999999998   9999999999999987 89999999999976543221 


Q ss_pred             ceeeccccCccchhhhcCCC--CCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhc
Q 013636          311 NVKISGTLGYVAPEYLLEGK--LTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIR  388 (439)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~~~--~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  388 (439)
                      .....||+.|+|||.+.+..  ++.++||||||+++|||++|+.||.......... ...  ........++..+     
T Consensus       180 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~--~~~~~~~~~~~~~-----  251 (295)
T 2clq_A          180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAM-FKV--GMFKVHPEIPESM-----  251 (295)
T ss_dssp             -CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHH-HHH--HHHCCCCCCCTTS-----
T ss_pred             ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHH-Hhh--ccccccccccccC-----
Confidence            23346899999999997654  7899999999999999999999997543322111 110  0011111222211     


Q ss_pred             CccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          389 DTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       389 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                             ...+.+++.+||+.||++|||+.|++++
T Consensus       252 -------~~~~~~li~~~l~~dp~~Rps~~~ll~~  279 (295)
T 2clq_A          252 -------SAEAKAFILKCFEPDPDKRACANDLLVD  279 (295)
T ss_dssp             -------CHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred             -------CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                   2356679999999999999999999965

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-42  Score=332.57  Aligned_cols=257  Identities=27%  Similarity=0.428  Sum_probs=205.1

Q ss_pred             CCCccceecccCcEEEEEEEECC----ccEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCee-EEE
Q 013636          154 NFQESNVIGEGGRGHVYKARFNE----KLLAAVKRIDDAGH-DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETR-FLV  227 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lV  227 (439)
                      .|...+.||+|+||+||+|+..+    +..+|+|.+..... ...+.+.+|+.++++++||||+++++++...+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            45556899999999999998633    33689999876443 3456799999999999999999999999876655 999


Q ss_pred             EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCC
Q 013636          228 YEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT  307 (439)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~  307 (439)
                      +||+.+|+|.+++..  ....+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||++.....
T Consensus       102 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  176 (298)
T 3pls_A          102 LPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILD  176 (298)
T ss_dssp             ECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred             EecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence            999999999999974  345689999999999999999999998   999999999999999999999999999975533


Q ss_pred             CC-----cceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhC-CCCCCCCChhhhhhhHhhhhcccccCCCCCc
Q 013636          308 QS-----RNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMG-RRPVEKMSPTQCQSMVTWAMPQLTDRSKLPN  381 (439)
Q Consensus       308 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  381 (439)
                      ..     ......+|+.|+|||.+.+..++.++||||||+++|||++| .+||...++......+....     ....+.
T Consensus       177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~-----~~~~~~  251 (298)
T 3pls_A          177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR-----RLPQPE  251 (298)
T ss_dssp             GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTC-----CCCCCT
T ss_pred             CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCC-----CCCCCc
Confidence            22     11234578899999999999999999999999999999995 55555555444333322111     111111


Q ss_pred             cCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCCCC
Q 013636          382 IVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPTDL  432 (439)
Q Consensus       382 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~~~  432 (439)
                      ..            ...+.+++.+||+.||++|||+.++++.|+++.....
T Consensus       252 ~~------------~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~  290 (298)
T 3pls_A          252 YC------------PDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL  290 (298)
T ss_dssp             TC------------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred             cc------------hHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence            11            2357789999999999999999999999988876543

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=4.5e-43  Score=346.55  Aligned_cols=243  Identities=26%  Similarity=0.331  Sum_probs=192.9

Q ss_pred             hcCCCccceecccCcEEEEEEEECC-ccEEEEEEecCCCc---hHHHHHHHHHHH-HHhcCCCceeeeeeEEEeCCeeEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGH---DAEREFNNEVNW-LTKIRHQNIISLLGYCIHAETRFL  226 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~l  226 (439)
                      .++|++.+.||+|+||+||+++... +..+|+|.+.....   .....+.+|..+ ++.++||||+++++++.+.+..++
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            3678899999999999999999865 67899999865432   233456677776 577899999999999999999999


Q ss_pred             EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccC
Q 013636          227 VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAG  306 (439)
Q Consensus       227 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~  306 (439)
                      ||||+++|+|.+++..   ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++++||+|||+++...
T Consensus       117 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          117 VLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENI  190 (373)
T ss_dssp             EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred             EEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence            9999999999999964   24588999999999999999999998   99999999999999999999999999997633


Q ss_pred             -CCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCc
Q 013636          307 -TQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDP  385 (439)
Q Consensus       307 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  385 (439)
                       ........+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+..      ....++..+  
T Consensus       191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~------~~~~~~~~~--  262 (373)
T 2r5t_A          191 EHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN------KPLQLKPNI--  262 (373)
T ss_dssp             CCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHH------SCCCCCSSS--
T ss_pred             cCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh------cccCCCCCC--
Confidence             22333456799999999999999999999999999999999999999987765543332221      111122111  


Q ss_pred             hhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 013636          386 VIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLIT  418 (439)
Q Consensus       386 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~  418 (439)
                                ...+.+++.+||+.||++||++.
T Consensus       263 ----------~~~~~~li~~lL~~dp~~R~~~~  285 (373)
T 2r5t_A          263 ----------TNSARHLLEGLLQKDRTKRLGAK  285 (373)
T ss_dssp             ----------CHHHHHHHHHHTCSSGGGSTTTT
T ss_pred             ----------CHHHHHHHHHHcccCHHhCCCCC
Confidence                      12466799999999999999974

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=7.7e-43  Score=336.30  Aligned_cols=259  Identities=21%  Similarity=0.293  Sum_probs=201.0

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCc---hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGH---DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLV  227 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  227 (439)
                      .++|++.+.||+|+||.||+++.. ++..+|+|.+.....   ...+.+.+|+.++++++||||+++++++...+..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            478999999999999999999986 578899999875422   2346789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCC
Q 013636          228 YEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT  307 (439)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~  307 (439)
                      |||+++++|.+++..   ...+++..+..++.|+++||+|||+.   +++||||||+||+++.++.+||+|||++.....
T Consensus       113 ~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  186 (309)
T 2h34_A          113 MRLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTD  186 (309)
T ss_dssp             EECCCCEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred             EEecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence            999999999999964   24589999999999999999999998   999999999999999999999999999976543


Q ss_pred             CCc--ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCc
Q 013636          308 QSR--NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDP  385 (439)
Q Consensus       308 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  385 (439)
                      ...  .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...+.......+..       ....+....+
T Consensus       187 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-------~~~~~~~~~~  259 (309)
T 2h34_A          187 EKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQ-------AIPRPSTVRP  259 (309)
T ss_dssp             ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHS-------CCCCGGGTST
T ss_pred             cccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhcc-------CCCCccccCC
Confidence            321  1234589999999999999999999999999999999999999987654432222211       0000001111


Q ss_pred             hhcCccCHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHhccccCCCC
Q 013636          386 VIRDTMDLKHLYQVAAVAVLCIQPEPSYRP-LITDVLHSLIPLVPTD  431 (439)
Q Consensus       386 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~evl~~L~~l~~~~  431 (439)
                          ..    ...+.+++.+||+.||++|| ++.++++.|+..+...
T Consensus       260 ----~~----~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~  298 (309)
T 2h34_A          260 ----GI----PVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA  298 (309)
T ss_dssp             ----TC----CTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred             ----CC----CHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence                11    22566799999999999999 9999999998887653

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.8e-43  Score=346.86  Aligned_cols=267  Identities=20%  Similarity=0.268  Sum_probs=201.0

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEE-CCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC-----
Q 013636          149 EAATNNFQESNVIGEGGRGHVYKARF-NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE-----  222 (439)
Q Consensus       149 ~~~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  222 (439)
                      +...++|++.+.||+|+||+||+|+. .++..+|+|++.....    ...+|+.+++.++||||+++++++....     
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            45567899999999999999999987 4678999998865422    2346999999999999999999985432     


Q ss_pred             ---------------------------------eeEEEEEeccCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHH
Q 013636          223 ---------------------------------TRFLVYEMMQNGSLEKQLHGP-THGSNLTWHLRMKIAVDVARGLEYL  268 (439)
Q Consensus       223 ---------------------------------~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~~L  268 (439)
                                                       ..++||||++ |+|.+.+... ..+..+++..+..++.|+++||+||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                             3789999998 4877776531 2345699999999999999999999


Q ss_pred             hhcCCCCeEecCCCCCCEEEc-CCCcEEEEecccccccCCCCcceeeccccCccchhhhcCC-CCCCchhhHHHHHHHHH
Q 013636          269 HEHCNHPVVHRDLKSSNILLD-SSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEG-KLTDKSDVYAFGVVLLE  346 (439)
Q Consensus       269 H~~~~~~ivH~Dlk~~NiLl~-~~~~~kl~DfGls~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvll~e  346 (439)
                      |+.   +|+||||||+|||++ +++.+||+|||++.............||+.|+|||.+.+. .++.++||||+||++||
T Consensus       158 H~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e  234 (383)
T 3eb0_A          158 HSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE  234 (383)
T ss_dssp             HTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred             HHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHH
Confidence            998   999999999999998 6899999999999876555555556789999999998875 48999999999999999


Q ss_pred             HHhCCCCCCCCChhhhhhhHhhhhcc-----------cccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCC
Q 013636          347 LLMGRRPVEKMSPTQCQSMVTWAMPQ-----------LTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRP  415 (439)
Q Consensus       347 lltG~~P~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP  415 (439)
                      |++|+.||.+.+..+....+......           -......+..................+.+++.+||+.||++||
T Consensus       235 ll~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  314 (383)
T 3eb0_A          235 LILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRI  314 (383)
T ss_dssp             HHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSC
T ss_pred             HHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCC
Confidence            99999999887654422221110000           0001112222222222222222334678899999999999999


Q ss_pred             CHHHHHHh
Q 013636          416 LITDVLHS  423 (439)
Q Consensus       416 t~~evl~~  423 (439)
                      |+.|++++
T Consensus       315 t~~e~l~h  322 (383)
T 3eb0_A          315 NPYEAMAH  322 (383)
T ss_dssp             CHHHHHTS
T ss_pred             CHHHHhcC
Confidence            99999964

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=3.8e-43  Score=349.98  Aligned_cols=269  Identities=23%  Similarity=0.281  Sum_probs=201.9

Q ss_pred             hcCCCccceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCe------eE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAET------RF  225 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~~  225 (439)
                      ..+|+..+.||+|+||+||+|+...+..+|+|++.....    ...+|+.+++.++||||+++++++...+.      .+
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            357888999999999999999998777788888754322    22369999999999999999999975543      78


Q ss_pred             EEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc-CCCcEEEEecccccc
Q 013636          226 LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLD-SSFNAKLSDFGLSVT  304 (439)
Q Consensus       226 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~-~~~~~kl~DfGls~~  304 (439)
                      +||||++++.+....+.......+++..+..++.|+++||+|||+.   +|+||||||+|||++ .++.+||+|||+++.
T Consensus       115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~  191 (394)
T 4e7w_A          115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKI  191 (394)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence            9999998754444332222345699999999999999999999998   999999999999999 799999999999987


Q ss_pred             cCCCCcceeeccccCccchhhhcCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhh------------hc
Q 013636          305 AGTQSRNVKISGTLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWA------------MP  371 (439)
Q Consensus       305 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~------------~~  371 (439)
                      ...........||+.|+|||.+.+. .++.++||||+||++|||++|+.||.+.+..+....+...            .+
T Consensus       192 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~  271 (394)
T 4e7w_A          192 LIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNP  271 (394)
T ss_dssp             CCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCG
T ss_pred             ccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhCh
Confidence            6555555556789999999999765 5899999999999999999999999887654322111110            00


Q ss_pred             ccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh--ccccC
Q 013636          372 QLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS--LIPLV  428 (439)
Q Consensus       372 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~l~  428 (439)
                      .. ....++..................+.+++.+||+.||++|||+.|++++  +.++.
T Consensus       272 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  329 (394)
T 4e7w_A          272 NY-MEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR  329 (394)
T ss_dssp             GG-SSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred             hh-hhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence            00 0111111111111111111123467889999999999999999999976  44443

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=4.4e-43  Score=338.71  Aligned_cols=263  Identities=25%  Similarity=0.387  Sum_probs=205.6

Q ss_pred             hcCCCccceecccCcEEEEEEEE-CCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEe----CCeeEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARF-NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH----AETRFL  226 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~l  226 (439)
                      .++|++.+.||+|+||.||+++. .++..+|+|.+........+.+.+|+.++++++||||+++++++..    ....++
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            46899999999999999999998 5688999999876666667789999999999999999999999873    347799


Q ss_pred             EEEeccCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccccccc
Q 013636          227 VYEMMQNGSLEKQLHGP-THGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA  305 (439)
Q Consensus       227 V~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~  305 (439)
                      ||||+++|+|.+++... ..+..+++..+..++.|+++||+|||+.   +++||||||+||+++.++.+||+|||++...
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~  184 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQA  184 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence            99999999999998642 2345699999999999999999999998   9999999999999999999999999998654


Q ss_pred             CCCCcc----------eeeccccCccchhhhcCCC---CCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcc
Q 013636          306 GTQSRN----------VKISGTLGYVAPEYLLEGK---LTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQ  372 (439)
Q Consensus       306 ~~~~~~----------~~~~gt~~y~aPE~~~~~~---~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~  372 (439)
                      ......          ....||+.|+|||.+.+..   ++.++||||||+++|||++|+.||........ . ...... 
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~-~~~~~~-  261 (317)
T 2buj_A          185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-S-VALAVQ-  261 (317)
T ss_dssp             CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-C-HHHHHH-
T ss_pred             ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-h-hhHHhh-
Confidence            321110          1234799999999987654   68899999999999999999999964211110 0 000000 


Q ss_pred             cccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCCCC
Q 013636          373 LTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPTDL  432 (439)
Q Consensus       373 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~~~  432 (439)
                        .....+.  .    .    .....+.+++.+||+.||++|||+.+++++|+.+.+..-
T Consensus       262 --~~~~~~~--~----~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~  309 (317)
T 2buj_A          262 --NQLSIPQ--S----P----RHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP  309 (317)
T ss_dssp             --CC--CCC--C----T----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCC
T ss_pred             --ccCCCCc--c----c----cCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCC
Confidence              0011110  0    1    112357789999999999999999999999988876543

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=8e-43  Score=330.60  Aligned_cols=258  Identities=23%  Similarity=0.362  Sum_probs=206.5

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCceeeeeeEEEe--CCeeEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLLGYCIH--AETRFL  226 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l  226 (439)
                      .++|++.+.||+|+||.||+++.. ++..+|+|.+....  ....+.+.+|+.++++++||||+++++++..  .+..++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            367888999999999999999886 57889999986533  3445679999999999999999999998854  568899


Q ss_pred             EEEeccCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC-----eEecCCCCCCEEEcCCCcEEEEecc
Q 013636          227 VYEMMQNGSLEKQLHGP-THGSNLTWHLRMKIAVDVARGLEYLHEHCNHP-----VVHRDLKSSNILLDSSFNAKLSDFG  300 (439)
Q Consensus       227 V~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~-----ivH~Dlk~~NiLl~~~~~~kl~DfG  300 (439)
                      ||||+++|+|.+++... .....+++..+..++.|++.||+|||+.   +     ++||||||+||++++++.+||+|||
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            99999999999999642 2234599999999999999999999998   6     9999999999999999999999999


Q ss_pred             cccccCCCCcc-eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCC
Q 013636          301 LSVTAGTQSRN-VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKL  379 (439)
Q Consensus       301 ls~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  379 (439)
                      ++......... ....||+.|+|||.+.+..++.++||||||+++|||++|+.||...+..+....+...     ....+
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~-----~~~~~  236 (279)
T 2w5a_A          162 LARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG-----KFRRI  236 (279)
T ss_dssp             HHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-----CCCCC
T ss_pred             hheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhc-----ccccC
Confidence            99766443221 2345899999999999999999999999999999999999999887654433222110     01111


Q ss_pred             CccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCC
Q 013636          380 PNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVP  429 (439)
Q Consensus       380 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~  429 (439)
                      +..            ....+.+++.+||+.||++|||+.|+++++..--+
T Consensus       237 ~~~------------~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~  274 (279)
T 2w5a_A          237 PYR------------YSDELNEIITRMLNLKDYHRPSVEEILENPLILEH  274 (279)
T ss_dssp             CTT------------SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred             Ccc------------cCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence            111            12357779999999999999999999998765443

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.4e-42  Score=342.44  Aligned_cols=259  Identities=26%  Similarity=0.380  Sum_probs=210.0

Q ss_pred             HHHHHHHhcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCc--------hHHHHHHHHHHHHHhc-CCCceeee
Q 013636          145 YELLEAATNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGH--------DAEREFNNEVNWLTKI-RHQNIISL  214 (439)
Q Consensus       145 ~~~l~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~l  214 (439)
                      ........++|++.+.||+|+||.||+|+.. ++..||||.+.....        ...+.+.+|+.+++++ +||||+++
T Consensus        86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~  165 (365)
T 2y7j_A           86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL  165 (365)
T ss_dssp             HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred             chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            3444556678999999999999999999986 688999998864331        1134678999999999 79999999


Q ss_pred             eeEEEeCCeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcE
Q 013636          215 LGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA  294 (439)
Q Consensus       215 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~  294 (439)
                      ++++...+..++||||+++|+|.+++..   ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+
T Consensus       166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~i  239 (365)
T 2y7j_A          166 IDSYESSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQI  239 (365)
T ss_dssp             EEEEEBSSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCE
T ss_pred             EEEEeeCCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCE
Confidence            9999999999999999999999999963   24589999999999999999999998   99999999999999999999


Q ss_pred             EEEecccccccCCCCcceeeccccCccchhhhcC------CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhh
Q 013636          295 KLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLE------GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTW  368 (439)
Q Consensus       295 kl~DfGls~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~  368 (439)
                      ||+|||++.............||+.|+|||++.+      ..++.++|||||||++|||++|+.||...+.......+..
T Consensus       240 kl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~  319 (365)
T 2y7j_A          240 RLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIME  319 (365)
T ss_dssp             EECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             EEEecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence            9999999987665544455679999999999863      3578899999999999999999999987655433222211


Q ss_pred             hhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          369 AMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       369 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      .      ....   ..+. ....    ...+.+++.+||+.||++|||+.|++++
T Consensus       320 ~------~~~~---~~~~-~~~~----~~~~~~li~~~L~~dP~~Rps~~ell~h  360 (365)
T 2y7j_A          320 G------QYQF---SSPE-WDDR----SSTVKDLISRLLQVDPEARLTAEQALQH  360 (365)
T ss_dssp             T------CCCC---CHHH-HSSS----CHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             C------CCCC---CCcc-cccC----CHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            0      0000   0010 0111    2357789999999999999999999975

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2e-42  Score=333.14  Aligned_cols=262  Identities=23%  Similarity=0.356  Sum_probs=198.5

Q ss_pred             hcCCCccceecccCcEEEEEEEE-CCccEEEEEEecCC---CchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARF-NEKLLAAVKRIDDA---GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLV  227 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  227 (439)
                      .++|++.+.||+|+||.||+|.. .++..+|+|.+...   .......+.+|+.++++++||||+++++++...+..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            35788999999999999999987 46789999998742   234456789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccC
Q 013636          228 YEMMQNGSLEKQLHGP-THGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAG  306 (439)
Q Consensus       228 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~  306 (439)
                      |||+++|+|.+++... .....+++..+..++.|+++||+|||+.   +++||||||+||+++.++.+||+|||++....
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            9999999999998631 1245689999999999999999999998   99999999999999999999999999997654


Q ss_pred             CCCc-ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCc
Q 013636          307 TQSR-NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDP  385 (439)
Q Consensus       307 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  385 (439)
                      .... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ....... .    ....+.... 
T Consensus       188 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~-~----~~~~~~~~~-  260 (310)
T 2wqm_A          188 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLCKKI-E----QCDYPPLPS-  260 (310)
T ss_dssp             -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH-HHHHHHH-H----TTCSCCCCT-
T ss_pred             CCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH-HHHHHHh-h----cccCCCCcc-
Confidence            3322 223458999999999999999999999999999999999999997543221 1111110 0    111111110 


Q ss_pred             hhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCC
Q 013636          386 VIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPT  430 (439)
Q Consensus       386 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~  430 (439)
                         ..    ....+.+++.+||+.||++|||+.++++.|+++.+.
T Consensus       261 ---~~----~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~  298 (310)
T 2wqm_A          261 ---DH----YSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC  298 (310)
T ss_dssp             ---TT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---cc----cCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence               11    123577899999999999999999999999887654

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.5e-42  Score=329.90  Aligned_cols=246  Identities=26%  Similarity=0.432  Sum_probs=204.7

Q ss_pred             cCCCccceecccCcEEEEEEEECC-ccEEEEEEecCCC---chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      ++|++.+.||+|+||.||+|+... +..+|+|.+....   ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            678889999999999999998864 6789999986432   123457899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~  308 (439)
                      ||+++|+|.+++...   ..+++..+..++.|+++||+|||+.   +++||||||+||+++.++.+||+|||++......
T Consensus        94 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  167 (284)
T 2vgo_A           94 EFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL  167 (284)
T ss_dssp             CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred             EeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence            999999999999642   3589999999999999999999998   9999999999999999999999999999765433


Q ss_pred             CcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhc
Q 013636          309 SRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIR  388 (439)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  388 (439)
                      . .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...+..+....+..      .....+..+     
T Consensus       168 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~------~~~~~~~~~-----  235 (284)
T 2vgo_A          168 R-RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVN------VDLKFPPFL-----  235 (284)
T ss_dssp             C-BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT------TCCCCCTTS-----
T ss_pred             c-cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhc------cccCCCCcC-----
Confidence            2 2345689999999999999999999999999999999999999987665443322211      111122111     


Q ss_pred             CccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          389 DTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       389 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                             ...+.+++.+||+.||++|||+.+++++
T Consensus       236 -------~~~~~~li~~~l~~~p~~Rps~~~ll~h  263 (284)
T 2vgo_A          236 -------SDGSKDLISKLLRYHPPQRLPLKGVMEH  263 (284)
T ss_dssp             -------CHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred             -------CHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence                   2346679999999999999999999964

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.4e-42  Score=334.66  Aligned_cols=259  Identities=27%  Similarity=0.419  Sum_probs=199.5

Q ss_pred             HhcCCCccceecccCcEEEEEEEECC----ccEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCe-
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARFNE----KLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAET-  223 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-  223 (439)
                      ..++|.+.+.||+|+||.||+|+...    +..+|+|.+....  ....+.+.+|+.++++++||||+++++++...+. 
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  111 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ  111 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence            45788899999999999999997643    4579999987543  3344679999999999999999999999987653 


Q ss_pred             ----eEEEEEeccCCChhhhhcCC---CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEE
Q 013636          224 ----RFLVYEMMQNGSLEKQLHGP---THGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKL  296 (439)
Q Consensus       224 ----~~lV~e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl  296 (439)
                          .++||||+++|+|.+++...   .....+++..++.++.|+++||.|||+.   +++||||||+||++++++.+||
T Consensus       112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl  188 (313)
T 3brb_A          112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCV  188 (313)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEE
T ss_pred             CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEE
Confidence                49999999999999998431   2345699999999999999999999998   9999999999999999999999


Q ss_pred             EecccccccCCCCc---ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcc
Q 013636          297 SDFGLSVTAGTQSR---NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQ  372 (439)
Q Consensus       297 ~DfGls~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~  372 (439)
                      +|||++........   .....+++.|+|||.+.+..++.++||||||+++|||++ |..||...............   
T Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~---  265 (313)
T 3brb_A          189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG---  265 (313)
T ss_dssp             CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT---
T ss_pred             eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcC---
Confidence            99999976543321   122346889999999999999999999999999999999 99999877654433222110   


Q ss_pred             cccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCC
Q 013636          373 LTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVP  429 (439)
Q Consensus       373 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~  429 (439)
                        .....+.            .....+.+++.+||+.||++|||+.+++++|+.+..
T Consensus       266 --~~~~~~~------------~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~  308 (313)
T 3brb_A          266 --HRLKQPE------------DCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE  308 (313)
T ss_dssp             --CCCCCBT------------TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --CCCCCCc------------cccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence              0111111            112357789999999999999999999999987753

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=6.1e-43  Score=339.60  Aligned_cols=250  Identities=21%  Similarity=0.292  Sum_probs=178.8

Q ss_pred             cceecccCcEEEEEEEEC-CccEEEEEEecCCCchHHHHHHHHHHHHHhcC-CCceeeeeeEEEeCCeeEEEEEeccCCC
Q 013636          158 SNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR-HQNIISLLGYCIHAETRFLVYEMMQNGS  235 (439)
Q Consensus       158 ~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~gs  235 (439)
                      .+.||+|+||+||++... ++..+|+|.+...   ....+.+|+.+++.+. ||||+++++++.+.+..++||||+++|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            478999999999999986 4788999998643   4467789999999997 9999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC---cEEEEecccccccCCCCc-c
Q 013636          236 LEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSF---NAKLSDFGLSVTAGTQSR-N  311 (439)
Q Consensus       236 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~---~~kl~DfGls~~~~~~~~-~  311 (439)
                      |.+++..   ...+++..+..++.|++.||+|||+.   +++||||||+|||++.++   .+||+|||++........ .
T Consensus        93 L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~  166 (325)
T 3kn6_A           93 LFERIKK---KKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL  166 (325)
T ss_dssp             HHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred             HHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcc
Confidence            9999964   34699999999999999999999998   999999999999997765   899999999976544322 2


Q ss_pred             eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCcc
Q 013636          312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTM  391 (439)
Q Consensus       312 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  391 (439)
                      ....||+.|+|||.+.+..++.++||||||+++|||++|+.||...+..............+.. ... . ........ 
T Consensus       167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~-~~~-~-~~~~~~~~-  242 (325)
T 3kn6_A          167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKK-GDF-S-FEGEAWKN-  242 (325)
T ss_dssp             -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTT-TCC-C-CCSHHHHT-
T ss_pred             cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHc-CCC-C-CCcccccC-
Confidence            3456899999999999999999999999999999999999999865432111111111111111 000 0 01111111 


Q ss_pred             CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          392 DLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       392 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                         ....+.+++..||+.||++|||+.|++++
T Consensus       243 ---~s~~~~~li~~~L~~dP~~Rpt~~ell~h  271 (325)
T 3kn6_A          243 ---VSQEAKDLIQGLLTVDPNKRLKMSGLRYN  271 (325)
T ss_dssp             ---SCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred             ---CCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence               12457789999999999999999999865

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=4.8e-42  Score=329.43  Aligned_cols=249  Identities=24%  Similarity=0.424  Sum_probs=207.6

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG-HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYE  229 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  229 (439)
                      .+.|+..+.||+|+||.||+|... ++..+|+|.+.... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            356888999999999999999875 57889999986543 3445789999999999999999999999999999999999


Q ss_pred             eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCC
Q 013636          230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS  309 (439)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~  309 (439)
                      |+++++|.+++..    ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.......
T Consensus       101 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~  173 (303)
T 3a7i_A          101 YLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  173 (303)
T ss_dssp             CCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred             eCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence            9999999999963    3589999999999999999999998   99999999999999999999999999997654432


Q ss_pred             -cceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhc
Q 013636          310 -RNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIR  388 (439)
Q Consensus       310 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  388 (439)
                       ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....+......+...     ....++        
T Consensus       174 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~--------  240 (303)
T 3a7i_A          174 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN-----NPPTLE--------  240 (303)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-----CCCCCC--------
T ss_pred             cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcC-----CCCCCc--------
Confidence             223446899999999999999999999999999999999999999877654433222210     011111        


Q ss_pred             CccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhc
Q 013636          389 DTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL  424 (439)
Q Consensus       389 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  424 (439)
                      ...    ...+.+++..||+.||++|||+.|++++.
T Consensus       241 ~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~~  272 (303)
T 3a7i_A          241 GNY----SKPLKEFVEACLNKEPSFRPTAKELLKHK  272 (303)
T ss_dssp             SSC----CHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred             ccc----CHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence            111    23567799999999999999999999764

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.7e-42  Score=348.01  Aligned_cols=254  Identities=26%  Similarity=0.362  Sum_probs=193.5

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEECC-ccEEEEEEecCCC--------chHHHHHHHHHHHHHhcCCCceeeeeeEEE
Q 013636          149 EAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAG--------HDAEREFNNEVNWLTKIRHQNIISLLGYCI  219 (439)
Q Consensus       149 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  219 (439)
                      ....++|.+.+.||+|+||+||+|.... +..+|+|.+....        ......+.+|+.++++++||||+++++++.
T Consensus       131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  210 (419)
T 3i6u_A          131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD  210 (419)
T ss_dssp             HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred             hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            3456899999999999999999998754 6889999986432        111234889999999999999999999975


Q ss_pred             eCCeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC---CcEEE
Q 013636          220 HAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS---FNAKL  296 (439)
Q Consensus       220 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~---~~~kl  296 (439)
                       .+..++||||+++|+|.+++..   ...+++..+..++.|++.||+|||+.   +++||||||+|||++.+   +.+||
T Consensus       211 -~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl  283 (419)
T 3i6u_A          211 -AEDYYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKI  283 (419)
T ss_dssp             -SSEEEEEEECCTTCBGGGGTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred             -cCceEEEEEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEE
Confidence             5668999999999999999864   34699999999999999999999998   99999999999999754   45999


Q ss_pred             EecccccccCCCCcceeeccccCccchhhhcC---CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhh-hhhhHhhhhcc
Q 013636          297 SDFGLSVTAGTQSRNVKISGTLGYVAPEYLLE---GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQ-CQSMVTWAMPQ  372 (439)
Q Consensus       297 ~DfGls~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~-~~~~~~~~~~~  372 (439)
                      +|||++.............||+.|+|||.+.+   ..++.++|||||||++|||++|+.||....... ....+..    
T Consensus       284 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~----  359 (419)
T 3i6u_A          284 TDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS----  359 (419)
T ss_dssp             CCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHT----
T ss_pred             eecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhc----
Confidence            99999988765544455679999999999863   677889999999999999999999997643221 1111110    


Q ss_pred             cccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          373 LTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       373 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                          ...  ...+......    ...+.+++.+||+.||++|||+.|++++
T Consensus       360 ----~~~--~~~~~~~~~~----~~~~~~li~~~L~~dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          360 ----GKY--NFIPEVWAEV----SEKALDLVKKLLVVDPKARFTTEEALRH  400 (419)
T ss_dssp             ----TCC--CCCHHHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ----CCC--CCCchhhccc----CHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence                000  0111111111    2357789999999999999999999976

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.4e-42  Score=333.53  Aligned_cols=251  Identities=24%  Similarity=0.346  Sum_probs=204.1

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEe
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      .++|++.+.||+|+||.||+++.. ++..+|+|.+........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            467888999999999999999986 5788999999865544556789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE---cCCCcEEEEecccccccCC
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILL---DSSFNAKLSDFGLSVTAGT  307 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl---~~~~~~kl~DfGls~~~~~  307 (439)
                      +++|+|.+++..   ...+++..+..++.|++.||+|||+.   +++||||||+||++   ++++.+||+|||++.....
T Consensus        88 ~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  161 (304)
T 2jam_A           88 VSGGELFDRILE---RGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN  161 (304)
T ss_dssp             CCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred             CCCccHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence            999999999853   23589999999999999999999998   99999999999999   7889999999999976543


Q ss_pred             CCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchh
Q 013636          308 QSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVI  387 (439)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  387 (439)
                      .. .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...+.......+...      ....+.    ..
T Consensus       162 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~------~~~~~~----~~  230 (304)
T 2jam_A          162 GI-MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEG------YYEFES----PF  230 (304)
T ss_dssp             BT-THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHC------CCCCCT----TT
T ss_pred             Cc-cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC------CCCCCc----cc
Confidence            22 23345899999999999999999999999999999999999999876654433222211      001100    01


Q ss_pred             cCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          388 RDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       388 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      ....    ...+.+++..||+.||++|||+.|++++
T Consensus       231 ~~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (304)
T 2jam_A          231 WDDI----SESAKDFICHLLEKDPNERYTCEKALSH  262 (304)
T ss_dssp             TTTS----CHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             cccC----CHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            1111    2357789999999999999999999975

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.2e-42  Score=356.42  Aligned_cols=251  Identities=27%  Similarity=0.366  Sum_probs=202.5

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      .++|++.+.||+|+||+||+|+.. .+..+|+|.+....  ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            457899999999999999999986 57789999987543  233567899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC---CcEEEEeccccccc
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS---FNAKLSDFGLSVTA  305 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~---~~~kl~DfGls~~~  305 (439)
                      ||+++|+|.+++..   ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.+   +.+||+|||++...
T Consensus       116 e~~~~g~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~  189 (494)
T 3lij_A          116 ECYKGGELFDEIIH---RMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF  189 (494)
T ss_dssp             ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence            99999999998853   24589999999999999999999998   99999999999999764   55999999999877


Q ss_pred             CCCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCc
Q 013636          306 GTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDP  385 (439)
Q Consensus       306 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  385 (439)
                      ..........||+.|+|||++. +.++.++||||+||++|+|++|+.||...+..+....+.....      ..   ..+
T Consensus       190 ~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~------~~---~~~  259 (494)
T 3lij_A          190 ENQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKY------TF---DSP  259 (494)
T ss_dssp             BTTBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC------CC---CSG
T ss_pred             CCCccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC------CC---Cch
Confidence            6555545567999999999876 5799999999999999999999999998776554433322110      00   011


Q ss_pred             hhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          386 VIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       386 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      . ....    ...+.+++.+||+.||++|||+.|++++
T Consensus       260 ~-~~~~----s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          260 E-WKNV----SEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             G-GTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             h-cccC----CHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence            1 1111    2356779999999999999999999965

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=4.3e-43  Score=334.30  Aligned_cols=259  Identities=26%  Similarity=0.403  Sum_probs=198.6

Q ss_pred             cCCCccceecccCcEEEEEEEECC--c--cEEEEEEecCC---CchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNE--K--LLAAVKRIDDA---GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRF  225 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~--~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  225 (439)
                      ++|++.+.||+|+||+||+|++..  +  ..+|+|.+...   .....+.+.+|+.++++++||||+++++++...+ .+
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~   96 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK   96 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence            578889999999999999998632  2  36899988653   2344567999999999999999999999997654 89


Q ss_pred             EEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccccccc
Q 013636          226 LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA  305 (439)
Q Consensus       226 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~  305 (439)
                      +|+||+++|+|.+++...  ...+++..+..++.|+++||+|||+.   +++||||||+||+++.++.+||+|||++...
T Consensus        97 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  171 (291)
T 1u46_A           97 MVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL  171 (291)
T ss_dssp             EEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccccc
Confidence            999999999999999742  34589999999999999999999998   9999999999999999999999999999776


Q ss_pred             CCCCcc----eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCC
Q 013636          306 GTQSRN----VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLP  380 (439)
Q Consensus       306 ~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  380 (439)
                      ......    ....+|..|+|||.+.+..++.++||||||+++|||++ |+.||...+..+....+....    .....+
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~  247 (291)
T 1u46_A          172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG----ERLPRP  247 (291)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSC----CCCCCC
T ss_pred             cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccC----CCCCCC
Confidence            543322    22347788999999998889999999999999999999 999998876554332221110    000111


Q ss_pred             ccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCCCCC
Q 013636          381 NIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPTDLG  433 (439)
Q Consensus       381 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~~~~  433 (439)
                              .    .....+.+++.+||+.||++|||+.++++.|+++.+....
T Consensus       248 --------~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~  288 (291)
T 1u46_A          248 --------E----DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMR  288 (291)
T ss_dssp             --------T----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-----
T ss_pred             --------c----CcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccchh
Confidence                    1    1124577899999999999999999999999988776543

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=7.9e-43  Score=347.23  Aligned_cols=248  Identities=24%  Similarity=0.412  Sum_probs=196.2

Q ss_pred             cCCCccceecccCcEEEEEEEECCccEEEEEEecCC--CchHHHHHHHHHHHHHhcC--CCceeeeeeEEEeCCeeEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDA--GHDAEREFNNEVNWLTKIR--HQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lV~  228 (439)
                      ++|++.+.||+|+||.||++...++..+|+|.+...  .....+.+.+|+.++++++  ||||+++++++...+..++||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            468899999999999999999988999999998643  3344567999999999996  599999999999999999999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~  308 (439)
                      | +.+|+|.+++...   ..+++..+..++.|++.||+|||+.   +|+||||||+|||++ ++.+||+|||++......
T Consensus       136 E-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~  207 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  207 (390)
T ss_dssp             E-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred             e-cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence            9 5688999999642   3689999999999999999999998   999999999999995 579999999999876433


Q ss_pred             Cc---ceeeccccCccchhhhcC-----------CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccc
Q 013636          309 SR---NVKISGTLGYVAPEYLLE-----------GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLT  374 (439)
Q Consensus       309 ~~---~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~  374 (439)
                      ..   .....||+.|+|||++.+           ..++.++|||||||++|||++|+.||....... ........+  .
T Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-~~~~~~~~~--~  284 (390)
T 2zmd_A          208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-SKLHAIIDP--N  284 (390)
T ss_dssp             ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-HHHHHHHCT--T
T ss_pred             CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH-HHHHHHhCc--c
Confidence            22   123469999999999875           468899999999999999999999997653221 111110000  0


Q ss_pred             cCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          375 DRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       375 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      .....+...            ...+.+++..||+.||++|||+.|++++
T Consensus       285 ~~~~~~~~~------------~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          285 HEIEFPDIP------------EKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             SCCCCCCCS------------CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccCCCCccc------------hHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence            011111111            2356779999999999999999999976

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=8.8e-43  Score=341.17  Aligned_cols=261  Identities=22%  Similarity=0.251  Sum_probs=197.4

Q ss_pred             hcCCCccceecccCcEEEEEEEEC----CccEEEEEEecCCCchH-----------HHHHHHHHHHHHhcCCCceeeeee
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN----EKLLAAVKRIDDAGHDA-----------EREFNNEVNWLTKIRHQNIISLLG  216 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~l~~  216 (439)
                      .++|++.+.||+|+||.||+|...    .+..+|+|.........           ...+.+|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            467889999999999999999986    46788999887543221           123667889999999999999999


Q ss_pred             EEEe----CCeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC
Q 013636          217 YCIH----AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSF  292 (439)
Q Consensus       217 ~~~~----~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~  292 (439)
                      ++..    ....++||||+ +++|.+++...   ..+++..+..++.|++.||+|||+.   +++||||||+|||++.++
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~  188 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN---GTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKN  188 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGG---GBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSS
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCC
Confidence            9988    67889999999 99999999642   2699999999999999999999998   999999999999999887


Q ss_pred             --cEEEEecccccccCCCCc--------ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC--hh
Q 013636          293 --NAKLSDFGLSVTAGTQSR--------NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMS--PT  360 (439)
Q Consensus       293 --~~kl~DfGls~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~--~~  360 (439)
                        .+||+|||+++.......        .....||+.|+|||.+.+..++.++|||||||++|||++|+.||....  ..
T Consensus       189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~  268 (345)
T 2v62_A          189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV  268 (345)
T ss_dssp             TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred             CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence              999999999976533211        123468999999999999999999999999999999999999996532  21


Q ss_pred             hhhhhHhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccC
Q 013636          361 QCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLV  428 (439)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~  428 (439)
                      ..........      ..++.........   ......+.+++..||+.||++|||+.++++.|+.+.
T Consensus       269 ~~~~~~~~~~------~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  327 (345)
T 2v62_A          269 AVQTAKTNLL------DELPQSVLKWAPS---GSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG  327 (345)
T ss_dssp             HHHHHHHHHH------HTTTHHHHHHSCT---TSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred             HHHHHHHhhc------ccccHHHHhhccc---cccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence            1111111110      0111111110000   012346778999999999999999999999998765

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.8e-43  Score=343.70  Aligned_cols=254  Identities=24%  Similarity=0.335  Sum_probs=188.3

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCchHHHHHHHHHHHHHhcC-CCceeeeeeEEE--------eC
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR-HQNIISLLGYCI--------HA  221 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~--------~~  221 (439)
                      ..+|++.+.||+|+||.||+++.. ++..+|+|.+........+.+.+|+.++.++. ||||+++++++.        ..
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            457889999999999999999975 57889999987666666778999999999996 999999999994        33


Q ss_pred             CeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEecCCCCCCEEEcCCCcEEEEec
Q 013636          222 ETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHP--VVHRDLKSSNILLDSSFNAKLSDF  299 (439)
Q Consensus       222 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~--ivH~Dlk~~NiLl~~~~~~kl~Df  299 (439)
                      ...++||||+. |+|.+++........+++..+..++.|++.||+|||+.   +  ++||||||+|||+++++.+||+||
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Df  182 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDF  182 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred             ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecC
Confidence            35799999996 69999886533445699999999999999999999997   6  999999999999999999999999


Q ss_pred             ccccccCCCCcc-------------eeeccccCccchhhh---cCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhh
Q 013636          300 GLSVTAGTQSRN-------------VKISGTLGYVAPEYL---LEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQ  363 (439)
Q Consensus       300 Gls~~~~~~~~~-------------~~~~gt~~y~aPE~~---~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~  363 (439)
                      |++.........             ....||+.|+|||.+   .+..++.++||||||+++|||++|+.||........ 
T Consensus       183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-  261 (337)
T 3ll6_A          183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI-  261 (337)
T ss_dssp             TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred             ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh-
Confidence            999765443221             133589999999998   566788999999999999999999999975432211 


Q ss_pred             hhHhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCC
Q 013636          364 SMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVP  429 (439)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~  429 (439)
                        ...   ..  ........            ...+.+++..||+.||++|||+.|++++|+.+..
T Consensus       262 --~~~---~~--~~~~~~~~------------~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~  308 (337)
T 3ll6_A          262 --VNG---KY--SIPPHDTQ------------YTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA  308 (337)
T ss_dssp             ---------C--CCCTTCCS------------SGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --hcC---cc--cCCccccc------------chHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence              100   00  00000111            1235679999999999999999999999987754

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=6.8e-43  Score=343.77  Aligned_cols=266  Identities=24%  Similarity=0.377  Sum_probs=204.6

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG-HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYE  229 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  229 (439)
                      .++|++.+.||+|+||+||+++.. ++..+|+|.+.... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            467899999999999999999986 57889999987543 3445679999999999999999999999999999999999


Q ss_pred             eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCC
Q 013636          230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS  309 (439)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~  309 (439)
                      |+++|+|.+++...   ..+++..+..++.|++.||+|||+.  ++++||||||+||+++.++++||+|||++...... 
T Consensus       112 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  185 (360)
T 3eqc_A          112 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  185 (360)
T ss_dssp             CCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred             CCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEECCCCcccccc-
Confidence            99999999999642   3589999999999999999999983  27999999999999999999999999999654322 


Q ss_pred             cceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhccccc-C-------C-CCC
Q 013636          310 RNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTD-R-------S-KLP  380 (439)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~-~-------~-~~~  380 (439)
                      ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...+..+.............. .       . ...
T Consensus       186 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (360)
T 3eqc_A          186 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN  265 (360)
T ss_dssp             C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------------
T ss_pred             cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccc
Confidence            122346899999999999999999999999999999999999999877654432222100000000 0       0 000


Q ss_pred             -------------ccCCchhcC----ccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          381 -------------NIVDPVIRD----TMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       381 -------------~~~d~~l~~----~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                                   +..+.....    .........+.+++.+||+.||++|||+.|++++
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  325 (360)
T 3eqc_A          266 KFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  325 (360)
T ss_dssp             --------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             ccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence                         000000000    0000112357789999999999999999999975

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-42  Score=338.70  Aligned_cols=268  Identities=28%  Similarity=0.322  Sum_probs=200.5

Q ss_pred             HhcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCchH-----HHHHHHHHHHHHhcCCCceeeeeeEEEeCCee
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDA-----EREFNNEVNWLTKIRHQNIISLLGYCIHAETR  224 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  224 (439)
                      ..++|+..+.||+|+||.||+|+.. ++..+|+|.+.......     .+.+.+|+.++++++||||+++++++...+..
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI   87 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence            3578999999999999999999986 47889999987532211     24678999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccc
Q 013636          225 FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT  304 (439)
Q Consensus       225 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~  304 (439)
                      ++||||+++ +|.+++..  ....+++..+..++.|+++||+|||+.   +++||||||+|||++.++.+||+|||++..
T Consensus        88 ~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (346)
T 1ua2_A           88 SLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKS  161 (346)
T ss_dssp             EEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred             EEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence            999999986 89888864  335688899999999999999999998   999999999999999999999999999987


Q ss_pred             cCCCC-cceeeccccCccchhhhcCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccc-----cCC
Q 013636          305 AGTQS-RNVKISGTLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLT-----DRS  377 (439)
Q Consensus       305 ~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~-----~~~  377 (439)
                      ..... ......||+.|+|||.+.+. .++.++|||||||++|||++|..||...+..+....+........     +..
T Consensus       162 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  241 (346)
T 1ua2_A          162 FGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC  241 (346)
T ss_dssp             TTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred             ccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhc
Confidence            64332 22345689999999999764 588999999999999999999999988765443222211111000     000


Q ss_pred             CCCccCCchhcCccC-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhc
Q 013636          378 KLPNIVDPVIRDTMD-----LKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL  424 (439)
Q Consensus       378 ~~~~~~d~~l~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  424 (439)
                      ..++.....-.....     ......+.+++..||+.||++|||+.|++++-
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~  293 (346)
T 1ua2_A          242 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK  293 (346)
T ss_dssp             SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred             cCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence            111111000000000     11235678899999999999999999999864

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=3.1e-43  Score=333.50  Aligned_cols=254  Identities=29%  Similarity=0.426  Sum_probs=200.2

Q ss_pred             hcCCCccceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeC-CeeEEEEEe
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHA-ETRFLVYEM  230 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lV~e~  230 (439)
                      .++|++.+.||+|+||+||+++.. +..+|+|.++...  ..+.+.+|+.++++++||||+++++++... +..++||||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            467888999999999999999886 6788999987543  456789999999999999999999997654 478999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR  310 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~  310 (439)
                      +++|+|.+++.... ...+++..+..++.|+++||+|||+.   +++||||||+||+++.++.+||+|||++....... 
T Consensus        97 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  171 (278)
T 1byg_A           97 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-  171 (278)
T ss_dssp             CTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             CCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccccc-
Confidence            99999999996421 12378999999999999999999998   99999999999999999999999999997654332 


Q ss_pred             ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcC
Q 013636          311 NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRD  389 (439)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  389 (439)
                       ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...+..+....+...     .....+        .
T Consensus       172 -~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~-----~~~~~~--------~  237 (278)
T 1byg_A          172 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-----YKMDAP--------D  237 (278)
T ss_dssp             -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT-----CCCCCC--------T
T ss_pred             -cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-----CCCCCc--------c
Confidence             22347889999999999999999999999999999998 99999876654432222110     001111        1


Q ss_pred             ccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCCC
Q 013636          390 TMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPTD  431 (439)
Q Consensus       390 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~~  431 (439)
                          .....+.+++..||+.||++|||+.|+++.|+++...+
T Consensus       238 ----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~  275 (278)
T 1byg_A          238 ----GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE  275 (278)
T ss_dssp             ----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             ----cCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence                11235777999999999999999999999998876543

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=9.9e-43  Score=336.08  Aligned_cols=254  Identities=23%  Similarity=0.356  Sum_probs=197.4

Q ss_pred             cCCCcc-ceecccCcEEEEEEEEC-CccEEEEEEecCCCchHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeeEEEEE
Q 013636          153 NNFQES-NVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYE  229 (439)
Q Consensus       153 ~~~~~~-~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e  229 (439)
                      +.|++. +.||+|+||+||+|+.. ++..+|+|.+..........+.+|+.++.++ +||||+++++++.+.+..++|||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   91 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE   91 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence            567764 78999999999999864 5789999999766555667899999999985 79999999999999999999999


Q ss_pred             eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCc---EEEEecccccccC
Q 013636          230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFN---AKLSDFGLSVTAG  306 (439)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~---~kl~DfGls~~~~  306 (439)
                      |+++|+|.+++...   ..+++..+..++.|++.||+|||+.   +++||||||+|||++.++.   +||+|||++....
T Consensus        92 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~  165 (316)
T 2ac3_A           92 KMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK  165 (316)
T ss_dssp             CCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred             cCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence            99999999999642   4589999999999999999999998   9999999999999998776   9999999987543


Q ss_pred             CCC--------cceeeccccCccchhhhcC-----CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhh-----------
Q 013636          307 TQS--------RNVKISGTLGYVAPEYLLE-----GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQC-----------  362 (439)
Q Consensus       307 ~~~--------~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~-----------  362 (439)
                      ...        ......||+.|+|||.+..     ..++.++|||||||++|||++|+.||......+.           
T Consensus       166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  245 (316)
T 2ac3_A          166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC  245 (316)
T ss_dssp             ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred             cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence            211        1123458999999999875     5688999999999999999999999987543220           


Q ss_pred             -hhhHhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          363 -QSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       363 -~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                       ........   ......+    .......    ...+.+++.+||+.||++|||+.|++++
T Consensus       246 ~~~~~~~i~---~~~~~~~----~~~~~~~----~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          246 QNMLFESIQ---EGKYEFP----DKDWAHI----SCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             HHHHHHHHH---HCCCCCC----HHHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHHHHHh---ccCcccC----chhcccC----CHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence             00111000   0000111    0000111    2357789999999999999999999986

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=3.5e-42  Score=337.53  Aligned_cols=264  Identities=21%  Similarity=0.308  Sum_probs=202.5

Q ss_pred             cCCCccceecccCcEEEEEEEE-CCccEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCceeeeeeEEEeC--------
Q 013636          153 NNFQESNVIGEGGRGHVYKARF-NEKLLAAVKRIDDAGH--DAEREFNNEVNWLTKIRHQNIISLLGYCIHA--------  221 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------  221 (439)
                      ++|++.+.||+|+||+||+|+. .++..+|+|++.....  .....+.+|+.++++++||||+++++++...        
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            5788899999999999999998 4678999998864332  2345688999999999999999999999873        


Q ss_pred             CeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccc
Q 013636          222 ETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGL  301 (439)
Q Consensus       222 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGl  301 (439)
                      +..++||||+++ +|.+.+..  ....+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+
T Consensus        97 ~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  170 (351)
T 3mi9_A           97 GSIYLVFDFCEH-DLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGL  170 (351)
T ss_dssp             CEEEEEEECCSE-EHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             ceEEEEEeccCC-CHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchh
Confidence            468999999985 77777764  234599999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCC-----CcceeeccccCccchhhhcC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhccccc
Q 013636          302 SVTAGTQ-----SRNVKISGTLGYVAPEYLLE-GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTD  375 (439)
Q Consensus       302 s~~~~~~-----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~  375 (439)
                      +......     .......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...+.......+.........
T Consensus       171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  250 (351)
T 3mi9_A          171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  250 (351)
T ss_dssp             CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence            9765421     11233458999999999876 45899999999999999999999999987765544333322211111


Q ss_pred             CCCCCccCCchhc--------CccC-HHH------HHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          376 RSKLPNIVDPVIR--------DTMD-LKH------LYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       376 ~~~~~~~~d~~l~--------~~~~-~~~------~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      . ..+..-+....        .... ...      ...+.+++.+||+.||++|||+.|++++
T Consensus       251 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          251 E-VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             T-TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             h-hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence            0 00010000000        0000 011      2347789999999999999999999976

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=8.8e-43  Score=356.64  Aligned_cols=251  Identities=26%  Similarity=0.364  Sum_probs=207.9

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC---chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLV  227 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  227 (439)
                      .++|+..+.||+|+||.||+++.. ++..+|+|.+....   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            467888999999999999999986 67899999985432   34567799999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE---cCCCcEEEEecccccc
Q 013636          228 YEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILL---DSSFNAKLSDFGLSVT  304 (439)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl---~~~~~~kl~DfGls~~  304 (439)
                      |||+.+|+|.+++..   ...+++..+..++.|++.||+|||+.   +++||||||+|||+   +.++.+||+|||++..
T Consensus       105 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  178 (484)
T 3nyv_A          105 GEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTH  178 (484)
T ss_dssp             ECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred             EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence            999999999999864   34589999999999999999999998   99999999999999   5678999999999987


Q ss_pred             cCCCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCC
Q 013636          305 AGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVD  384 (439)
Q Consensus       305 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  384 (439)
                      ...........||+.|+|||.+.+ .++.++||||+||++|+|++|+.||...+..+....+...      ....+   .
T Consensus       179 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~------~~~~~---~  248 (484)
T 3nyv_A          179 FEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKG------KYTFE---L  248 (484)
T ss_dssp             BCCCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------CCCCC---S
T ss_pred             cccccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC------CCCCC---C
Confidence            665544445569999999999876 7999999999999999999999999987765543333211      00000   0


Q ss_pred             chhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          385 PVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       385 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      +. ....    ...+.+++.+||+.||++|||+.|++++
T Consensus       249 ~~-~~~~----s~~~~~li~~~L~~dp~~R~s~~e~l~h  282 (484)
T 3nyv_A          249 PQ-WKKV----SESAKDLIRKMLTYVPSMRISARDALDH  282 (484)
T ss_dssp             GG-GGGS----CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             cc-cccC----CHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence            10 0111    2356789999999999999999999975

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=4.2e-43  Score=339.53  Aligned_cols=258  Identities=26%  Similarity=0.362  Sum_probs=203.7

Q ss_pred             CCccceecccCcEEEEEEEEC-----CccEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCceeeeeeEEEeC--CeeEE
Q 013636          155 FQESNVIGEGGRGHVYKARFN-----EKLLAAVKRIDDAGH-DAEREFNNEVNWLTKIRHQNIISLLGYCIHA--ETRFL  226 (439)
Q Consensus       155 ~~~~~~LG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  226 (439)
                      |++.+.||+|+||+||++.+.     ++..+|+|.+..... ...+.+.+|+.++++++||||+++++++.+.  ...++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            478899999999999998753     578899999976533 4456799999999999999999999999874  57899


Q ss_pred             EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccC
Q 013636          227 VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAG  306 (439)
Q Consensus       227 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~  306 (439)
                      ||||+++|+|.+++...    .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++....
T Consensus       113 v~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  185 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  185 (318)
T ss_dssp             EECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred             EEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccccccc
Confidence            99999999999999642    389999999999999999999998   99999999999999999999999999998765


Q ss_pred             CCCcc----eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhh--------hhHhhhhcccc
Q 013636          307 TQSRN----VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQ--------SMVTWAMPQLT  374 (439)
Q Consensus       307 ~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~--------~~~~~~~~~~~  374 (439)
                      .....    ....+|..|+|||.+.+..++.++||||||+++|||++|+.||.........        ...........
T Consensus       186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (318)
T 3lxp_A          186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE  265 (318)
T ss_dssp             TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH
T ss_pred             ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh
Confidence            43321    2234788899999999999999999999999999999999998753221100        00000000000


Q ss_pred             cCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCC
Q 013636          375 DRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVP  429 (439)
Q Consensus       375 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~  429 (439)
                      .....          .........+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus       266 ~~~~~----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~  310 (318)
T 3lxp_A          266 RGERL----------PRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE  310 (318)
T ss_dssp             TTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cccCC----------CCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence            11000          0011123467789999999999999999999999987654

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.3e-44  Score=345.59  Aligned_cols=263  Identities=25%  Similarity=0.399  Sum_probs=207.7

Q ss_pred             hcCCCccceecccCcEEEEEEEE-----CCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC--ee
Q 013636          152 TNNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE--TR  224 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~  224 (439)
                      .++|++.+.||+|+||.||++++     .++..+|+|.+........+.+.+|+.++++++||||+++++++...+  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            36788899999999999999984     357899999998776667778999999999999999999999987654  67


Q ss_pred             EEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccc
Q 013636          225 FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT  304 (439)
Q Consensus       225 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~  304 (439)
                      ++||||+++|+|.+++...  ...+++..+..++.|+++||+|||+.   +++||||||+||++++++.+||+|||++..
T Consensus       120 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~  194 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKV  194 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence            9999999999999999742  34689999999999999999999998   999999999999999999999999999987


Q ss_pred             cCCCCcc----eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhh---------hhHhhhhc
Q 013636          305 AGTQSRN----VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQ---------SMVTWAMP  371 (439)
Q Consensus       305 ~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~---------~~~~~~~~  371 (439)
                      .......    ....++..|+|||.+.+..++.++||||||+++|||++|..|+.........         ........
T Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (326)
T 2w1i_A          195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE  274 (326)
T ss_dssp             CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred             ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence            6543322    1234677899999999988999999999999999999999998643111000         00000000


Q ss_pred             ccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCC
Q 013636          372 QLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVP  429 (439)
Q Consensus       372 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~  429 (439)
                      .+......+      ...    .....+.+++.+||+.||++|||+.|+++.|+++..
T Consensus       275 ~~~~~~~~~------~~~----~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~  322 (326)
T 2w1i_A          275 LLKNNGRLP------RPD----GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  322 (326)
T ss_dssp             HHHTTCCCC------CCT----TCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HhhcCCCCC------CCC----cccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            011111110      001    123467789999999999999999999999987754

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1e-42  Score=332.39  Aligned_cols=261  Identities=18%  Similarity=0.236  Sum_probs=201.2

Q ss_pred             HhcCCCccceecccCcEEEEEEEE-CCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEE-EeCCeeEEEE
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARF-NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYC-IHAETRFLVY  228 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lV~  228 (439)
                      ..++|++.+.||+|+||+||+|+. .++..+|+|.+....  ...++.+|+.+++.++|+|++..+..+ ...+..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            457899999999999999999997 567889999865432  223578899999999988877777666 5667889999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE---cCCCcEEEEeccccccc
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILL---DSSFNAKLSDFGLSVTA  305 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl---~~~~~~kl~DfGls~~~  305 (439)
                      ||+ +|+|.+++..  ....+++..+..++.|++.||+|||+.   +++||||||+|||+   ++++.+||+|||++...
T Consensus        85 e~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~  158 (296)
T 4hgt_A           85 ELL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             ECC-CCBHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             Ecc-CCCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence            999 9999999973  234599999999999999999999998   99999999999999   78999999999999765


Q ss_pred             CCCCc--------ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCC
Q 013636          306 GTQSR--------NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRS  377 (439)
Q Consensus       306 ~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~  377 (439)
                      .....        .....||+.|+|||.+.+..++.++|||||||++|||++|+.||...+.................. 
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-  237 (296)
T 4hgt_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-  237 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS-
T ss_pred             cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc-
Confidence            44322        123468999999999999999999999999999999999999998754432211111100000000 


Q ss_pred             CCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCC
Q 013636          378 KLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVP  429 (439)
Q Consensus       378 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~  429 (439)
                      .     .+.+....    ...+.+++..||+.||++|||+.++++.|+.+..
T Consensus       238 ~-----~~~~~~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~  280 (296)
T 4hgt_A          238 P-----IEVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  280 (296)
T ss_dssp             C-----HHHHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred             h-----hhhhhccC----CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence            0     00000111    2467789999999999999999999999987764

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=7.5e-42  Score=351.43  Aligned_cols=252  Identities=27%  Similarity=0.349  Sum_probs=205.2

Q ss_pred             HhcCCCccceecccCcEEEEEEEECC-ccEEEEEEecCCCc-------------hHHHHHHHHHHHHHhcCCCceeeeee
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGH-------------DAEREFNNEVNWLTKIRHQNIISLLG  216 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~~  216 (439)
                      ..++|++.+.||+|+||+||+|+... +..+|+|.+.....             ...+.+.+|+.++++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            45789999999999999999999864 67899999865321             23467899999999999999999999


Q ss_pred             EEEeCCeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC---c
Q 013636          217 YCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSF---N  293 (439)
Q Consensus       217 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~---~  293 (439)
                      ++.+.+..++||||+++|+|.+++..   ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++   .
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~  187 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLN  187 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSS
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCcc
Confidence            99999999999999999999999864   24599999999999999999999998   999999999999998776   6


Q ss_pred             EEEEecccccccCCCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhccc
Q 013636          294 AKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQL  373 (439)
Q Consensus       294 ~kl~DfGls~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~  373 (439)
                      +||+|||++.............||+.|+|||++. +.++.++||||+||++|+|++|+.||...+..+....+....   
T Consensus       188 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~---  263 (504)
T 3q5i_A          188 IKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGK---  263 (504)
T ss_dssp             EEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---
T ss_pred             EEEEECCCCEEcCCCCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC---
Confidence            9999999998776554445567999999999986 569999999999999999999999999877655443332110   


Q ss_pred             ccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          374 TDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       374 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                         ..    .+.......    ...+.+++.+||+.||++|||+.|++++
T Consensus       264 ---~~----~~~~~~~~~----s~~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          264 ---YY----FDFNDWKNI----SDEAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             ---CC----CCHHHHTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ---CC----CCccccCCC----CHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence               00    011111111    2357789999999999999999999965

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.7e-42  Score=329.60  Aligned_cols=260  Identities=18%  Similarity=0.246  Sum_probs=204.5

Q ss_pred             hcCCCccceecccCcEEEEEEEE-CCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEE-EeCCeeEEEEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARF-NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYC-IHAETRFLVYE  229 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lV~e  229 (439)
                      .++|++.+.||+|+||.||+|+. .++..+|+|.+.....  ..++.+|+.+++.++|++++..+.++ ...+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            46899999999999999999997 5688999998865432  24688999999999998877766665 56677899999


Q ss_pred             eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE---cCCCcEEEEecccccccC
Q 013636          230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILL---DSSFNAKLSDFGLSVTAG  306 (439)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl---~~~~~~kl~DfGls~~~~  306 (439)
                      |+ +++|.+++..  ....+++..+..++.|++.||+|||+.   +++||||||+|||+   ++++.+||+|||++....
T Consensus        86 ~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  159 (296)
T 3uzp_A           86 LL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             ec-CCCHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence            99 8999999973  234699999999999999999999998   99999999999999   488999999999997654


Q ss_pred             CCCc--------ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhc-ccccCC
Q 013636          307 TQSR--------NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP-QLTDRS  377 (439)
Q Consensus       307 ~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~-~~~~~~  377 (439)
                      ....        .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...+............. ..... 
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-  238 (296)
T 3uzp_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP-  238 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC-
T ss_pred             ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc-
Confidence            4322        1334689999999999999999999999999999999999999987543221111111000 00000 


Q ss_pred             CCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCC
Q 013636          378 KLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPT  430 (439)
Q Consensus       378 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~  430 (439)
                            .+.+....    ...+.+++..||+.||++|||+.++++.|+++...
T Consensus       239 ------~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  281 (296)
T 3uzp_A          239 ------IEVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  281 (296)
T ss_dssp             ------HHHHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             ------hHHHHhhC----CHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHh
Confidence                  00011111    24577899999999999999999999999877643

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.2e-43  Score=351.46  Aligned_cols=243  Identities=20%  Similarity=0.221  Sum_probs=189.7

Q ss_pred             hcCCCccceecccCcEEEEEEEE-CCccEEEEEEecC---CCchHHHHHHHHH---HHHHhcCCCceeeee-------eE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARF-NEKLLAAVKRIDD---AGHDAEREFNNEV---NWLTKIRHQNIISLL-------GY  217 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~E~---~~l~~l~h~niv~l~-------~~  217 (439)
                      .++|++.+.||+|+||+||+|+. .++..+|||.+..   ......+.+.+|+   ..+++++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            46788899999999999999997 4588999999863   2334567899999   555566899999998       66


Q ss_pred             EEeCCe-----------------eEEEEEeccCCChhhhhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 013636          218 CIHAET-----------------RFLVYEMMQNGSLEKQLHGPT----HGSNLTWHLRMKIAVDVARGLEYLHEHCNHPV  276 (439)
Q Consensus       218 ~~~~~~-----------------~~lV~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~i  276 (439)
                      +...+.                 .++||||+ +|+|.+++....    ....+++..+..++.|+++||+|||+.   +|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            655432                 78999999 689999997421    112345688899999999999999998   99


Q ss_pred             EecCCCCCCEEEcCCCcEEEEecccccccCCCCcceeeccccCccchhhhcCC-----------CCCCchhhHHHHHHHH
Q 013636          277 VHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEG-----------KLTDKSDVYAFGVVLL  345 (439)
Q Consensus       277 vH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwS~Gvll~  345 (439)
                      +||||||+|||++.++.+||+|||+++..+.  ......| +.|+|||.+.+.           .++.++|||||||++|
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~  304 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY  304 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHH
Confidence            9999999999999999999999999986443  2234457 999999999887           8999999999999999


Q ss_pred             HHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          346 ELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       346 elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      ||++|+.||...+.......+.       ..   .        ...    ...+.+++.+||+.||++|||+.|++++
T Consensus       305 elltg~~Pf~~~~~~~~~~~~~-------~~---~--------~~~----~~~~~~li~~~L~~dp~~Rpt~~e~l~h  360 (377)
T 3byv_A          305 WIWCADLPITKDAALGGSEWIF-------RS---C--------KNI----PQPVRALLEGFLRYPKEDRLLPLQAMET  360 (377)
T ss_dssp             HHHHSSCCC------CCSGGGG-------SS---C--------CCC----CHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred             HHHHCCCCCcccccccchhhhh-------hh---c--------cCC----CHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence            9999999997654332111110       00   0        111    2356779999999999999999999964

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=3.8e-42  Score=325.24  Aligned_cols=251  Identities=26%  Similarity=0.385  Sum_probs=203.3

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG-HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYE  229 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  229 (439)
                      .++|++.+.||+|+||.||+|+.. ++..+|+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            467888999999999999999986 57889999986433 3445778999999999999999999999999999999999


Q ss_pred             eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCC
Q 013636          230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS  309 (439)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~  309 (439)
                      |+++|+|.+++..   ...+++..+..++.|+++||+|||+.   +++||||||+||+++.++.+||+|||++.......
T Consensus        86 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  159 (276)
T 2yex_A           86 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (276)
T ss_dssp             CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             ecCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence            9999999999964   34689999999999999999999998   99999999999999999999999999997653222


Q ss_pred             ---cceeeccccCccchhhhcCCCC-CCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCc
Q 013636          310 ---RNVKISGTLGYVAPEYLLEGKL-TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDP  385 (439)
Q Consensus       310 ---~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  385 (439)
                         ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||...+.... ....+...    .....    +
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~----~~~~~----~  230 (276)
T 2yex_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKEK----KTYLN----P  230 (276)
T ss_dssp             EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHHHTT----CTTST----T
T ss_pred             chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhhhc----ccccC----c
Confidence               1223458999999999987765 7799999999999999999999987553221 11111110    00000    0


Q ss_pred             hhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          386 VIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       386 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                        ....    ...+.+++..||+.||++|||+.|++++
T Consensus       231 --~~~~----~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (276)
T 2yex_A          231 --WKKI----DSAPLALLHKILVENPSARITIPDIKKD  262 (276)
T ss_dssp             --GGGS----CHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             --hhhc----CHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence              0111    2356679999999999999999999975

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.9e-42  Score=364.27  Aligned_cols=246  Identities=28%  Similarity=0.411  Sum_probs=200.4

Q ss_pred             ceecccCcEEEEEEEEC---CccEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEeccC
Q 013636          159 NVIGEGGRGHVYKARFN---EKLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQN  233 (439)
Q Consensus       159 ~~LG~G~fg~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  233 (439)
                      +.||+|+||+||+|.+.   .+..+|||.++...  ....+++.+|+.++++++||||++++++|. .+..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence            47999999999999663   45789999997543  234578999999999999999999999996 4568999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCcc--
Q 013636          234 GSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN--  311 (439)
Q Consensus       234 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~~--  311 (439)
                      |+|.+++..   ...+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+||+|||+++........  
T Consensus       454 g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  527 (635)
T 4fl3_A          454 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  527 (635)
T ss_dssp             EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred             CCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence            999999963   34689999999999999999999998   9999999999999999999999999999765443221  


Q ss_pred             --eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhc
Q 013636          312 --VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIR  388 (439)
Q Consensus       312 --~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  388 (439)
                        ....+|+.|+|||++.+..++.++|||||||++|||++ |+.||...+..+....+...     .....+..      
T Consensus       528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~-----~~~~~p~~------  596 (635)
T 4fl3_A          528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-----ERMGCPAG------  596 (635)
T ss_dssp             -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-----CCCCCCTT------
T ss_pred             cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-----CCCCCCCC------
Confidence              22346788999999999999999999999999999998 99999988776544443321     01111111      


Q ss_pred             CccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccC
Q 013636          389 DTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLV  428 (439)
Q Consensus       389 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~  428 (439)
                            ....+.+++..||+.||++|||+.+|++.|+.+.
T Consensus       597 ------~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~  630 (635)
T 4fl3_A          597 ------CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  630 (635)
T ss_dssp             ------CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             ------CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence                  1245778999999999999999999999998654

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=9e-42  Score=337.40  Aligned_cols=263  Identities=23%  Similarity=0.299  Sum_probs=194.9

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCC--CchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC------
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDA--GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE------  222 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  222 (439)
                      .++|++.+.||+|+||.||+|... .+..+|+|.+...  .....+.+.+|+.+++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            368999999999999999999875 5788999998653  2334467889999999999999999999997665      


Q ss_pred             eeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccc
Q 013636          223 TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS  302 (439)
Q Consensus       223 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls  302 (439)
                      ..++||||+++ +|.+++..     .+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  174 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA  174 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred             ceEEEEEcCCC-CHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeecc
Confidence            67999999975 78888852     388999999999999999999998   9999999999999999999999999999


Q ss_pred             cccCCCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhc-----------
Q 013636          303 VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP-----------  371 (439)
Q Consensus       303 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~-----------  371 (439)
                      .............||+.|+|||.+.+..++.++|||||||++|||++|+.||.+.+..+....+.....           
T Consensus       175 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  254 (371)
T 2xrw_A          175 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ  254 (371)
T ss_dssp             ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred             cccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence            876544334445699999999999999999999999999999999999999987665332111110000           


Q ss_pred             -----ccccCCCCCc-----cCCchhcCcc---CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          372 -----QLTDRSKLPN-----IVDPVIRDTM---DLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       372 -----~~~~~~~~~~-----~~d~~l~~~~---~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                           ..........     .+........   .......+.+++.+||+.||++|||+.|++++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence                 0000000000     0000000000   11234578899999999999999999999975

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=2.2e-42  Score=331.41  Aligned_cols=253  Identities=23%  Similarity=0.415  Sum_probs=200.7

Q ss_pred             HhcCCCccceecccCcEEEEEEEECC-ccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEE
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYE  229 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  229 (439)
                      ..++|++.+.||+|+||.||+|+... +..+|+|.+........+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   96 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE   96 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence            34688999999999999999999864 78899999987666667789999999999999999999999999999999999


Q ss_pred             eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC-
Q 013636          230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ-  308 (439)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~-  308 (439)
                      |+++|+|.+++..  ....+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++...... 
T Consensus        97 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  171 (302)
T 2j7t_A           97 FCPGGAVDAIMLE--LDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL  171 (302)
T ss_dssp             CCTTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred             eCCCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence            9999999999863  234589999999999999999999998   9999999999999999999999999987542211 


Q ss_pred             CcceeeccccCccchhhhc-----CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccC
Q 013636          309 SRNVKISGTLGYVAPEYLL-----EGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV  383 (439)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  383 (439)
                      .......||+.|+|||.+.     +..++.++||||||+++|||++|+.||...+..........       . ..+...
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------~-~~~~~~  243 (302)
T 2j7t_A          172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK-------S-DPPTLL  243 (302)
T ss_dssp             HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-------S-CCCCCS
T ss_pred             cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhc-------c-CCcccC
Confidence            1112345899999999984     67789999999999999999999999987765432211111       0 001111


Q ss_pred             CchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          384 DPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       384 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      .+   ...    ...+.+++.+||+.||++|||+.+++++
T Consensus       244 ~~---~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~h  276 (302)
T 2j7t_A          244 TP---SKW----SVEFRDFLKIALDKNPETRPSAAQLLEH  276 (302)
T ss_dssp             SG---GGS----CHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred             Cc---ccc----CHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            11   111    2356789999999999999999999975

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.8e-42  Score=355.01  Aligned_cols=253  Identities=24%  Similarity=0.345  Sum_probs=204.9

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC---chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      ++|+..+.||+|+||.||+++.. ++..+|+|.+....   ......+.+|+.++++++||||+++++++...+..++||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            67888999999999999999986 58899999986432   123456889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCC
Q 013636          229 EMMQNGSLEKQLHGPT-HGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT  307 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~  307 (439)
                      ||+++|+|.+++.... ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++++||+|||++.....
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~  341 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKA  341 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence            9999999999997532 234699999999999999999999998   999999999999999999999999999987654


Q ss_pred             CCc-ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhh-hhhHhhhhcccccCCCCCccCCc
Q 013636          308 QSR-NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQC-QSMVTWAMPQLTDRSKLPNIVDP  385 (439)
Q Consensus       308 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~d~  385 (439)
                      ... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... ..+....   .......+..+  
T Consensus       342 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i---~~~~~~~p~~~--  416 (543)
T 3c4z_A          342 GQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV---LEQAVTYPDKF--  416 (543)
T ss_dssp             TCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHH---HHCCCCCCTTS--
T ss_pred             CCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHH---hhcccCCCccc--
Confidence            332 2335799999999999999999999999999999999999999987532111 1111111   11112222222  


Q ss_pred             hhcCccCHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHh
Q 013636          386 VIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLI-----TDVLHS  423 (439)
Q Consensus       386 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~-----~evl~~  423 (439)
                                ...+.+++.+||+.||++||++     .+++++
T Consensus       417 ----------s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H  449 (543)
T 3c4z_A          417 ----------SPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH  449 (543)
T ss_dssp             ----------CHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred             ----------CHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence                      2356679999999999999975     677643

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=5.2e-42  Score=328.10  Aligned_cols=253  Identities=27%  Similarity=0.360  Sum_probs=206.6

Q ss_pred             HhcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC---------chHHHHHHHHHHHHHhcC-CCceeeeeeEEE
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG---------HDAEREFNNEVNWLTKIR-HQNIISLLGYCI  219 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~  219 (439)
                      ..++|++.+.||+|+||.||+|... ++..+|+|.+....         ....+.+.+|+.+++++. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            3578999999999999999999986 57889999986542         122356889999999995 999999999999


Q ss_pred             eCCeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEec
Q 013636          220 HAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDF  299 (439)
Q Consensus       220 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~Df  299 (439)
                      ..+..++||||+++|+|.+++..   ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+||
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df  168 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF  168 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred             cCCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecc
Confidence            99999999999999999999964   24689999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCCcceeeccccCccchhhhc------CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhccc
Q 013636          300 GLSVTAGTQSRNVKISGTLGYVAPEYLL------EGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQL  373 (439)
Q Consensus       300 Gls~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~  373 (439)
                      |++.............||+.|+|||.+.      ...++.++||||||+++|||++|+.||...+.......+...    
T Consensus       169 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~----  244 (298)
T 1phk_A          169 GFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG----  244 (298)
T ss_dssp             TTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT----
T ss_pred             cchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcC----
Confidence            9998765544444556899999999985      456889999999999999999999999876654433222211    


Q ss_pred             ccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          374 TDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       374 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                        ....+   .+.. .    .....+.+++.+||+.||++|||+.|++++
T Consensus       245 --~~~~~---~~~~-~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (298)
T 1phk_A          245 --NYQFG---SPEW-D----DYSDTVKDLVSRFLVVQPQKRYTAEEALAH  284 (298)
T ss_dssp             --CCCCC---TTTG-G----GSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             --CcccC---cccc-c----ccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence              11110   0100 1    112457789999999999999999999964

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=2.2e-42  Score=328.29  Aligned_cols=246  Identities=21%  Similarity=0.323  Sum_probs=199.0

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCC--CchHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeeEEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDA--GHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLV  227 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV  227 (439)
                      .++|++.+.||+|+||+||+|... ++..+|+|.+...  ......++.+|+..+..+ +||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            467889999999999999999986 6889999998753  234556788999999999 999999999999999999999


Q ss_pred             EEeccCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC----------------
Q 013636          228 YEMMQNGSLEKQLHGPT-HGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDS----------------  290 (439)
Q Consensus       228 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~----------------  290 (439)
                      |||+++|+|.+++.... ....+++..+..++.|++.||+|||+.   +++||||||+||+++.                
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            99999999999996421 124689999999999999999999998   9999999999999984                


Q ss_pred             ---CCcEEEEecccccccCCCCcceeeccccCccchhhhcCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhH
Q 013636          291 ---SFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMV  366 (439)
Q Consensus       291 ---~~~~kl~DfGls~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~  366 (439)
                         +..+||+|||++........   ..||+.|+|||.+.+. .++.++||||||+++|||++|..|+......  ....
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~~---~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~--~~~~  241 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRISSPQV---EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW--HEIR  241 (289)
T ss_dssp             ---CCCEEECCCTTCEETTCSCC---CCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH--HHHH
T ss_pred             cCCceEEEEcccccccccCCccc---cCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH--HHHH
Confidence               44799999999987654332   3489999999999876 5668999999999999999998876543211  1111


Q ss_pred             hhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          367 TWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       367 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      .      .....++..+            ...+.+++.+||+.||++|||+.|++++
T Consensus       242 ~------~~~~~~~~~~------------~~~~~~li~~~l~~dp~~Rps~~~ll~h  280 (289)
T 1x8b_A          242 Q------GRLPRIPQVL------------SQEFTELLKVMIHPDPERRPSAMALVKH  280 (289)
T ss_dssp             T------TCCCCCSSCC------------CHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             c------CCCCCCCccc------------CHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence            1      0011111111            2356779999999999999999999976

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.4e-42  Score=336.95  Aligned_cols=259  Identities=28%  Similarity=0.422  Sum_probs=205.6

Q ss_pred             HhcCCCccceecccCcEEEEEEEEC------CccEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCe
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARFN------EKLLAAVKRIDDAG-HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAET  223 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  223 (439)
                      ..++|++.+.||+|+||.||+|+..      .+..+|+|.+.... .....++.+|+.++++++||||+++++++...+.
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP  107 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence            3478899999999999999999843      46689999997543 3455679999999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhhhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC---CCcEEE
Q 013636          224 RFLVYEMMQNGSLEKQLHGPT----HGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDS---SFNAKL  296 (439)
Q Consensus       224 ~~lV~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~---~~~~kl  296 (439)
                      .++||||+++|+|.+++....    ....+++..++.++.|++.||+|||+.   +++||||||+|||++.   +..+||
T Consensus       108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEE
Confidence            999999999999999997532    124589999999999999999999998   9999999999999984   456999


Q ss_pred             EecccccccCCCCc---ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcc
Q 013636          297 SDFGLSVTAGTQSR---NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQ  372 (439)
Q Consensus       297 ~DfGls~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~  372 (439)
                      +|||++........   .....||+.|+|||.+.+..++.++||||||+++|||++ |+.||...+.......+...   
T Consensus       185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~---  261 (327)
T 2yfx_A          185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG---  261 (327)
T ss_dssp             CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT---
T ss_pred             CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcC---
Confidence            99999865432221   122347889999999999999999999999999999998 99999877655433332211   


Q ss_pred             cccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCC
Q 013636          373 LTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVP  429 (439)
Q Consensus       373 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~  429 (439)
                        .....+..            ....+.+++..||+.||++|||+.+++++|+.+..
T Consensus       262 --~~~~~~~~------------~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  304 (327)
T 2yfx_A          262 --GRMDPPKN------------CPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  304 (327)
T ss_dssp             --CCCCCCTT------------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --CCCCCCCC------------CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence              01111111            12356779999999999999999999999976543

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.8e-42  Score=354.44  Aligned_cols=252  Identities=28%  Similarity=0.380  Sum_probs=204.7

Q ss_pred             HhcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCC--CchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEE
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDA--GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLV  227 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  227 (439)
                      ..++|++.+.||+|+||+||+++.. ++..+|+|.+...  .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            3467899999999999999999986 5788999998532  223456789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc---CCCcEEEEecccccc
Q 013636          228 YEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLD---SSFNAKLSDFGLSVT  304 (439)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~---~~~~~kl~DfGls~~  304 (439)
                      |||+++|+|.+++..   ...+++..+..++.|++.||+|||+.   +|+||||||+|||++   .++.+||+|||++..
T Consensus       100 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  173 (486)
T 3mwu_A          100 GELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (486)
T ss_dssp             ECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred             EEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence            999999999998864   24589999999999999999999998   999999999999995   556799999999987


Q ss_pred             cCCCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCC
Q 013636          305 AGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVD  384 (439)
Q Consensus       305 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  384 (439)
                      ...........||+.|+|||++.+ .++.++||||+||++|+|++|+.||...+..+....+.....    ....     
T Consensus       174 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~----~~~~-----  243 (486)
T 3mwu_A          174 FQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKY----AFDL-----  243 (486)
T ss_dssp             BCCC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC----CSCS-----
T ss_pred             CCCCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC----CCCC-----
Confidence            655544455679999999999875 599999999999999999999999988776554333321100    0000     


Q ss_pred             chhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          385 PVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       385 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      +. ....    ...+.+++..||+.||++|||+.|++++
T Consensus       244 ~~-~~~~----s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          244 PQ-WRTI----SDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             GG-GGGS----CHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             cc-cCCC----CHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            00 0111    2356789999999999999999999986

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.1e-41  Score=343.00  Aligned_cols=203  Identities=24%  Similarity=0.336  Sum_probs=175.9

Q ss_pred             HhcCCCccceecccCcEEEEEEEECC-ccEEEEEEecCCCchHHHHHHHHHHHHHhc------CCCceeeeeeEEEeCCe
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKI------RHQNIISLLGYCIHAET  223 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~  223 (439)
                      ...+|++.+.||+|+||+||+|.... +..||+|.+... ....+++.+|+.+++.+      +|+||+++++++...+.
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  173 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH  173 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence            34679999999999999999998764 788999999754 33446778888888887      57799999999999999


Q ss_pred             eEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCc--EEEEeccc
Q 013636          224 RFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFN--AKLSDFGL  301 (439)
Q Consensus       224 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~--~kl~DfGl  301 (439)
                      .++||||+. |+|.+++.... ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.  +||+|||+
T Consensus       174 ~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~  248 (429)
T 3kvw_A          174 ICMTFELLS-MNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGS  248 (429)
T ss_dssp             EEEEECCCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             EEEEEeccC-CCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeeccc
Confidence            999999996 69999887532 34589999999999999999999998   9999999999999999887  99999999


Q ss_pred             ccccCCCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhh
Q 013636          302 SVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQ  361 (439)
Q Consensus       302 s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~  361 (439)
                      +.......  ....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+
T Consensus       249 a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~  306 (429)
T 3kvw_A          249 SCYEHQRV--YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGD  306 (429)
T ss_dssp             CEETTCCC--CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             ceecCCcc--cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence            97654322  34468999999999999999999999999999999999999998876543

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=9e-42  Score=325.45  Aligned_cols=247  Identities=25%  Similarity=0.375  Sum_probs=197.3

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCC--CchHHHHHHHHHHHHHhcCCCceeeeeeEEEe----CCeeE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDA--GHDAEREFNNEVNWLTKIRHQNIISLLGYCIH----AETRF  225 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~  225 (439)
                      +.|++.+.||+|+||+||+|... ++..+|+|.+...  .....+.+.+|+.++++++||||+++++++..    ....+
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            34677789999999999999885 4678899988643  23445678999999999999999999999875    34579


Q ss_pred             EEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEecCCCCCCEEEc-CCCcEEEEecccc
Q 013636          226 LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHP--VVHRDLKSSNILLD-SSFNAKLSDFGLS  302 (439)
Q Consensus       226 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~--ivH~Dlk~~NiLl~-~~~~~kl~DfGls  302 (439)
                      +||||+++|+|.+++..   ...+++..+..++.|++.||+|||+.   +  ++||||||+||+++ +++.+||+|||++
T Consensus       106 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~  179 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA  179 (290)
T ss_dssp             EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             EEEEecCCCCHHHHHHH---ccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence            99999999999999964   24589999999999999999999998   6  99999999999998 7899999999999


Q ss_pred             cccCCCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhh-hhhHhhhhcccccCCCCCc
Q 013636          303 VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQC-QSMVTWAMPQLTDRSKLPN  381 (439)
Q Consensus       303 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  381 (439)
                      ....... .....||+.|+|||.+. +.++.++||||||+++|||++|+.||........ ...+.        ....+.
T Consensus       180 ~~~~~~~-~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~--------~~~~~~  249 (290)
T 1t4h_A          180 TLKRASF-AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT--------SGVKPA  249 (290)
T ss_dssp             GGCCTTS-BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHT--------TTCCCG
T ss_pred             ccccccc-cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHh--------ccCCcc
Confidence            7654432 23456999999999876 5689999999999999999999999986543221 11111        000011


Q ss_pred             cCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          382 IVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       382 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                          ......    ...+.+++..||+.||++|||+.|++++
T Consensus       250 ----~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~h  283 (290)
T 1t4h_A          250 ----SFDKVA----IPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             ----GGGGCC----CHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ----ccCCCC----CHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence                111111    2357789999999999999999999975

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.4e-42  Score=339.51  Aligned_cols=264  Identities=20%  Similarity=0.301  Sum_probs=205.3

Q ss_pred             hcCCCccceecccCcEEEEEEEECCccEEEEEEecCCCch-----------------HHHHHHHHHHHHHhcCCCceeee
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHD-----------------AEREFNNEVNWLTKIRHQNIISL  214 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~E~~~l~~l~h~niv~l  214 (439)
                      .++|++.+.||+|+||.||+|+. ++..+|+|.+......                 ..+.+.+|+.++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            46899999999999999999999 8889999998643211                 11689999999999999999999


Q ss_pred             eeEEEeCCeeEEEEEeccCCChhhh------hcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCCEE
Q 013636          215 LGYCIHAETRFLVYEMMQNGSLEKQ------LHGPTHGSNLTWHLRMKIAVDVARGLEYLHE-HCNHPVVHRDLKSSNIL  287 (439)
Q Consensus       215 ~~~~~~~~~~~lV~e~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~-~~~~~ivH~Dlk~~NiL  287 (439)
                      ++++.+.+..++||||+++|+|.++      +.. .....+++..+..++.|++.||+|||+ .   +++||||||+||+
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil  184 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNIL  184 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEE
Confidence            9999999999999999999999998      543 224679999999999999999999998 7   9999999999999


Q ss_pred             EcCCCcEEEEecccccccCCCCcceeeccccCccchhhhcCC-CCCC-chhhHHHHHHHHHHHhCCCCCCCCCh-hhhhh
Q 013636          288 LDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEG-KLTD-KSDVYAFGVVLLELLMGRRPVEKMSP-TQCQS  364 (439)
Q Consensus       288 l~~~~~~kl~DfGls~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwS~Gvll~elltG~~P~~~~~~-~~~~~  364 (439)
                      ++.++.+||+|||++...... ......||+.|+|||.+.+. .++. ++||||||+++|||++|+.||...+. .+...
T Consensus       185 ~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~  263 (348)
T 2pml_X          185 MDKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFN  263 (348)
T ss_dssp             ECTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHH
T ss_pred             EcCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence            999999999999999775443 22345689999999999887 6666 99999999999999999999987654 22222


Q ss_pred             hHhhhhcccccCCCCCccCCchhc---CccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          365 MVTWAMPQLTDRSKLPNIVDPVIR---DTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~d~~l~---~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      .+........  ........+...   ..........+.+++.+||+.||++|||+.|++++
T Consensus       264 ~i~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h  323 (348)
T 2pml_X          264 NIRTKNIEYP--LDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH  323 (348)
T ss_dssp             HHTSCCCCCC--CSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHhccCcCCc--cchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            2211100000  000000110000   00001123467789999999999999999999975

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2.3e-42  Score=347.19  Aligned_cols=263  Identities=24%  Similarity=0.310  Sum_probs=196.4

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeC----C--eeE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHA----E--TRF  225 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----~--~~~  225 (439)
                      .+|+..+.||+|+||.||+|+.. ++..||||++....    +.+.+|++++++++||||+++++++...    +  ..+
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            46888899999999999999986 47899999986532    2234699999999999999999988642    1  357


Q ss_pred             EEEEeccCCChhhhhcC-CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC-CcEEEEeccccc
Q 013636          226 LVYEMMQNGSLEKQLHG-PTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS-FNAKLSDFGLSV  303 (439)
Q Consensus       226 lV~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~-~~~kl~DfGls~  303 (439)
                      +||||+++ +|.+.+.. ......+++..+..++.|+++||+|||+.   +|+||||||+|||++.+ +.+||+|||+++
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            89999986 66655532 12245699999999999999999999998   99999999999999955 678999999998


Q ss_pred             ccCCCCcceeeccccCccchhhhcCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhc--------ccc
Q 013636          304 TAGTQSRNVKISGTLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP--------QLT  374 (439)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~--------~~~  374 (439)
                      ............||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+....+.....        ...
T Consensus       206 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~  285 (420)
T 1j1b_A          206 QLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN  285 (420)
T ss_dssp             ECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHC
T ss_pred             hcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence            76554444456789999999999765 789999999999999999999999988764332211111000        000


Q ss_pred             ---cCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          375 ---DRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       375 ---~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                         ....++.+....+...+.......+.+++.+||+.||++|||+.|++++
T Consensus       286 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h  337 (420)
T 1j1b_A          286 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  337 (420)
T ss_dssp             SCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence               0011111111111111111123467889999999999999999999965

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2.6e-42  Score=337.40  Aligned_cols=252  Identities=23%  Similarity=0.322  Sum_probs=198.4

Q ss_pred             HhcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCchHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeeEEEE
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      ..++|++.+.||+|+||.||++... ++..+|+|.+.....    ...+|++++.++ +||||+++++++.+.+..++||
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            3567999999999999999999886 478899999975433    234688888887 7999999999999999999999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC----CcEEEEecccccc
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS----FNAKLSDFGLSVT  304 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~----~~~kl~DfGls~~  304 (439)
                      ||+++|+|.+++..   ...+++..+..++.|++.||+|||+.   +++||||||+|||+.++    +.+||+|||++..
T Consensus        96 E~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~  169 (342)
T 2qr7_A           96 ELMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ  169 (342)
T ss_dssp             CCCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred             eCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence            99999999999964   34589999999999999999999998   99999999999998543    3599999999976


Q ss_pred             cCCCC-cceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccC
Q 013636          305 AGTQS-RNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV  383 (439)
Q Consensus       305 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  383 (439)
                      ..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||..........+......   .....+.  
T Consensus       170 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~---~~~~~~~--  244 (342)
T 2qr7_A          170 LRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGS---GKFSLSG--  244 (342)
T ss_dssp             CBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHH---CCCCCCS--
T ss_pred             CcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHcc---CCcccCc--
Confidence            54332 23345689999999999888889999999999999999999999986432211112111100   0111110  


Q ss_pred             CchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          384 DPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       384 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                        ......    ...+.+++.+||+.||++|||+.|++++
T Consensus       245 --~~~~~~----s~~~~~li~~~L~~dP~~R~t~~~il~h  278 (342)
T 2qr7_A          245 --GYWNSV----SDTAKDLVSKMLHVDPHQRLTAALVLRH  278 (342)
T ss_dssp             --TTTTTS----CHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             --cccccC----CHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence              001111    2356779999999999999999999875

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=3.4e-42  Score=338.42  Aligned_cols=271  Identities=19%  Similarity=0.225  Sum_probs=193.4

Q ss_pred             HHHHhcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCe---
Q 013636          148 LEAATNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAET---  223 (439)
Q Consensus       148 l~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---  223 (439)
                      .....++|++.+.||+|+||+||+|+.. ++..+|+|++..... ....+.+|+..++.++||||+++++++...+.   
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~   96 (360)
T 3e3p_A           18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR   96 (360)
T ss_dssp             HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred             chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence            4455689999999999999999999985 578899998865322 23356778888899999999999999976543   


Q ss_pred             ----eEEEEEeccCCChhhhhcC-CCCCCCCCHHHHHHHHHHHHHHHHHHh--hcCCCCeEecCCCCCCEEEcC-CCcEE
Q 013636          224 ----RFLVYEMMQNGSLEKQLHG-PTHGSNLTWHLRMKIAVDVARGLEYLH--EHCNHPVVHRDLKSSNILLDS-SFNAK  295 (439)
Q Consensus       224 ----~~lV~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gl~~LH--~~~~~~ivH~Dlk~~NiLl~~-~~~~k  295 (439)
                          .++||||+++ +|.+.+.. ......+++..+..++.|++.||.|||  +.   +++||||||+|||++. ++.+|
T Consensus        97 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~k  172 (360)
T 3e3p_A           97 RDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTLK  172 (360)
T ss_dssp             TCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEEE
T ss_pred             cceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcEE
Confidence                7899999987 44443321 133456899999999999999999999  76   9999999999999997 89999


Q ss_pred             EEecccccccCCCCcceeeccccCccchhhhcCCC-CCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcc--
Q 013636          296 LSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGK-LTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQ--  372 (439)
Q Consensus       296 l~DfGls~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~--  372 (439)
                      |+|||++.............||+.|+|||.+.+.. ++.++|||||||++|||++|+.||...+.......+......  
T Consensus       173 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  252 (360)
T 3e3p_A          173 LCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS  252 (360)
T ss_dssp             ECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             EeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCC
Confidence            99999998776555545566899999999987654 899999999999999999999999887654432222111000  


Q ss_pred             ------cccCCC-C-----CccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          373 ------LTDRSK-L-----PNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       373 ------~~~~~~-~-----~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                            ...... .     ...................+.+++.+||+.||++|||+.|++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          253 REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             HHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence                  000000 0     00000001111111235678899999999999999999999976

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=8.6e-43  Score=334.00  Aligned_cols=262  Identities=26%  Similarity=0.415  Sum_probs=188.6

Q ss_pred             HHhcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEE
Q 013636          150 AATNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG-HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLV  227 (439)
Q Consensus       150 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  227 (439)
                      ...++|++.+.||+|+||.||+|... ++..+|+|.+.... ....+++.+|+.++++++||||+++++++...+..++|
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   91 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV   91 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence            34578999999999999999999864 57889999886543 23446788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhcC-----CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccc
Q 013636          228 YEMMQNGSLEKQLHG-----PTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS  302 (439)
Q Consensus       228 ~e~~~~gsL~~~l~~-----~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls  302 (439)
                      |||+++|+|.+++..     ......+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++
T Consensus        92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~  168 (303)
T 2vwi_A           92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVS  168 (303)
T ss_dssp             EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred             ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccch
Confidence            999999999999863     11245689999999999999999999998   9999999999999999999999999998


Q ss_pred             cccCCCCc------ceeeccccCccchhhhcC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhccccc
Q 013636          303 VTAGTQSR------NVKISGTLGYVAPEYLLE-GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTD  375 (439)
Q Consensus       303 ~~~~~~~~------~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~  375 (439)
                      ........      .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||..............     ..
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-----~~  243 (303)
T 2vwi_A          169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ-----ND  243 (303)
T ss_dssp             HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHT-----SS
T ss_pred             heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhc-----cC
Confidence            65533211      123458999999999876 5689999999999999999999999987665432211110     00


Q ss_pred             CCCCC-ccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          376 RSKLP-NIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       376 ~~~~~-~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      ..... ...++......    ...+.+++.+||+.||++|||+.|++++
T Consensus       244 ~~~~~~~~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~h  288 (303)
T 2vwi_A          244 PPSLETGVQDKEMLKKY----GKSFRKMISLCLQKDPEKRPTAAELLRH  288 (303)
T ss_dssp             CCCTTC-----CCCCCC----CHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             CCccccccccchhhhhh----hHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            01111 01111111122    2357789999999999999999999975

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=9.6e-42  Score=328.86  Aligned_cols=252  Identities=25%  Similarity=0.396  Sum_probs=201.0

Q ss_pred             HHhcCCCccceecccCcEEEEEEEECC-ccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEE
Q 013636          150 AATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       150 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      ...++|++.+.||+|+||.||+|.... +..+|+|.+....  ..+.+.+|+.++++++||||+++++++...+..++||
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  103 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM  103 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence            445789999999999999999998864 7889999987543  3457889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~  308 (439)
                      ||+++|+|.+++..  ....+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++......
T Consensus       104 e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (314)
T 3com_A          104 EYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT  178 (314)
T ss_dssp             ECCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred             ecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence            99999999999862  234689999999999999999999998   9999999999999999999999999999765433


Q ss_pred             C-cceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchh
Q 013636          309 S-RNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVI  387 (439)
Q Consensus       309 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  387 (439)
                      . ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...+...........       . .+....+  
T Consensus       179 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-------~-~~~~~~~--  248 (314)
T 3com_A          179 MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN-------P-PPTFRKP--  248 (314)
T ss_dssp             BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-------C-CCCCSSG--
T ss_pred             ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC-------C-CcccCCc--
Confidence            2 223346899999999999999999999999999999999999999876654322221110       0 0011111  


Q ss_pred             cCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          388 RDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       388 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                       ...    ...+.+++.+||+.||++|||+.+++++
T Consensus       249 -~~~----~~~l~~li~~~l~~dp~~Rpt~~~ll~~  279 (314)
T 3com_A          249 -ELW----SDNFTDFVKQCLVKSPEQRATATQLLQH  279 (314)
T ss_dssp             -GGS----CHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             -ccC----CHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence             011    2356789999999999999999999864

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2.4e-42  Score=340.63  Aligned_cols=252  Identities=17%  Similarity=0.207  Sum_probs=202.5

Q ss_pred             HhcCCCccceecccCcEEEEEEE------ECCccEEEEEEecCCCchHHHHHHHHHHHHHhcC---CCceeeeeeEEEeC
Q 013636          151 ATNNFQESNVIGEGGRGHVYKAR------FNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR---HQNIISLLGYCIHA  221 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~  221 (439)
                      ..++|++.+.||+|+||+||+|.      ...+..+|+|.+....   ..++..|+.++.+++   |+|++++++++...
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~  139 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ  139 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence            35788899999999999999994      4567889999997643   446778888888886   99999999999999


Q ss_pred             CeeEEEEEeccCCChhhhhcCC--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC---------
Q 013636          222 ETRFLVYEMMQNGSLEKQLHGP--THGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDS---------  290 (439)
Q Consensus       222 ~~~~lV~e~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~---------  290 (439)
                      +..++||||+++|+|.++++..  .....+++..+..++.|+++||+|||+.   +|+||||||+|||++.         
T Consensus       140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~  216 (365)
T 3e7e_A          140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDED  216 (365)
T ss_dssp             SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC----
T ss_pred             CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccccc
Confidence            9999999999999999999631  1345699999999999999999999998   9999999999999998         


Q ss_pred             --CCcEEEEecccccccC---CCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhh
Q 013636          291 --SFNAKLSDFGLSVTAG---TQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSM  365 (439)
Q Consensus       291 --~~~~kl~DfGls~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~  365 (439)
                        ++.+||+|||+++...   .........||+.|+|||++.+..++.++|||||||++|||++|+.||.......    
T Consensus       217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~----  292 (365)
T 3e7e_A          217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE----  292 (365)
T ss_dssp             --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE----
T ss_pred             cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc----
Confidence              8999999999996543   2222234569999999999999999999999999999999999999996432211    


Q ss_pred             HhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHhccccCCC
Q 013636          366 VTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYR-PLITDVLHSLIPLVPT  430 (439)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~R-Pt~~evl~~L~~l~~~  430 (439)
                        +..     ...+...        .   ....+.+++..|++.+|.+| |++.++.+.|+..+..
T Consensus       293 --~~~-----~~~~~~~--------~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~  340 (365)
T 3e7e_A          293 --CKP-----EGLFRRL--------P---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ  340 (365)
T ss_dssp             --EEE-----CSCCTTC--------S---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             --eee-----chhcccc--------C---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence              000     0011111        1   13345678889999999998 6788888888776654

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=7.1e-42  Score=331.41  Aligned_cols=267  Identities=26%  Similarity=0.336  Sum_probs=202.1

Q ss_pred             HhcCCCccceecccCcEEEEEEEE--CCccEEEEEEecCCCc--hHHHHHHHHHHHHHhc---CCCceeeeeeEEE----
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARF--NEKLLAAVKRIDDAGH--DAEREFNNEVNWLTKI---RHQNIISLLGYCI----  219 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~--~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~----  219 (439)
                      ..++|++.+.||+|+||.||+|+.  .++..+|+|.+.....  .....+.+|+.+++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            457899999999999999999998  4578899998864321  1123456777777666   8999999999987    


Q ss_pred             -eCCeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEe
Q 013636          220 -HAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSD  298 (439)
Q Consensus       220 -~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~D  298 (439)
                       .....++||||++ |+|.+++.... ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~D  163 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD  163 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEec
Confidence             4567899999998 69999987532 34589999999999999999999998   999999999999999999999999


Q ss_pred             cccccccCCCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhccc-----
Q 013636          299 FGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQL-----  373 (439)
Q Consensus       299 fGls~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~-----  373 (439)
                      ||++.............||+.|+|||.+.+..++.++||||||+++|||++|+.||...+.......+.......     
T Consensus       164 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  243 (326)
T 1blx_A          164 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW  243 (326)
T ss_dssp             CCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred             CcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccC
Confidence            999987654444445568999999999999999999999999999999999999998776543222211110000     


Q ss_pred             ccCCCCCc-----cCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          374 TDRSKLPN-----IVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       374 ~~~~~~~~-----~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      ......+.     .....+. .........+.+++.+||+.||++|||+.|++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  297 (326)
T 1blx_A          244 PRDVALPRQAFHSKSAQPIE-KFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  297 (326)
T ss_dssp             CTTCSSCGGGSCCCCCCCGG-GTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ccccccchhhhcccCcchhh-hccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            00000000     0000000 0001123456789999999999999999999965

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.9e-42  Score=334.31  Aligned_cols=255  Identities=29%  Similarity=0.492  Sum_probs=199.5

Q ss_pred             HHHHhcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCchHHHHHHHHHHHHHhc-CCCceeeeeeEEEe-----
Q 013636          148 LEAATNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIH-----  220 (439)
Q Consensus       148 l~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-----  220 (439)
                      +....++|++.+.||+|+||.||+|+.. ++..+|+|.+.... ...+.+.+|+.+++++ +||||+++++++..     
T Consensus        19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   97 (326)
T 2x7f_A           19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG   97 (326)
T ss_dssp             CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred             ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence            3445688999999999999999999984 57889999986543 3446788999999999 89999999999987     


Q ss_pred             -CCeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEec
Q 013636          221 -AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDF  299 (439)
Q Consensus       221 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~Df  299 (439)
                       .+..++||||+++|+|.+++... ....+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+||
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Df  173 (326)
T 2x7f_A           98 MDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDF  173 (326)
T ss_dssp             CCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCC
T ss_pred             ccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeC
Confidence             46789999999999999999752 234689999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCC-cceeeccccCccchhhhc-----CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhccc
Q 013636          300 GLSVTAGTQS-RNVKISGTLGYVAPEYLL-----EGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQL  373 (439)
Q Consensus       300 Gls~~~~~~~-~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~  373 (439)
                      |++....... ......||+.|+|||.+.     +..++.++||||||+++|||++|+.||...++......+..     
T Consensus       174 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-----  248 (326)
T 2x7f_A          174 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR-----  248 (326)
T ss_dssp             TTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-----
T ss_pred             cCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc-----
Confidence            9997654322 223346899999999987     56789999999999999999999999987765433222211     


Q ss_pred             ccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          374 TDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       374 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                         ...+.....    ..    ...+.+++.+||+.||++|||+.+++++
T Consensus       249 ---~~~~~~~~~----~~----~~~l~~li~~~l~~dp~~Rps~~~ll~h  287 (326)
T 2x7f_A          249 ---NPAPRLKSK----KW----SKKFQSFIESCLVKNHSQRPATEQLMKH  287 (326)
T ss_dssp             ---SCCCCCSCS----CS----CHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             ---CccccCCcc----cc----CHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence               001111111    11    2356779999999999999999999975

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.3e-41  Score=330.38  Aligned_cols=259  Identities=16%  Similarity=0.235  Sum_probs=200.2

Q ss_pred             cCCCccceecccCcEEEEEEEE-CCccEEEEEEecCCCchHHHHHHHHHHHHHhcC-CCceeeeeeEEEe--CCeeEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARF-NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR-HQNIISLLGYCIH--AETRFLVY  228 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lV~  228 (439)
                      ++|++.+.||+|+||+||+|+. .++..+|+|.+...   ..+.+.+|+.++++++ ||||+++++++..  ....++||
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~  112 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  112 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence            6789999999999999999987 46789999998753   3467899999999997 9999999999987  56789999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC-cEEEEecccccccCC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSF-NAKLSDFGLSVTAGT  307 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~-~~kl~DfGls~~~~~  307 (439)
                      ||+++++|.+++.      .+++..+..++.|++.||+|||+.   +++||||||+|||++.++ .+||+|||++.....
T Consensus       113 e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~  183 (330)
T 3nsz_A          113 EHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  183 (330)
T ss_dssp             ECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             eccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence            9999999999985      288999999999999999999998   999999999999999776 899999999987655


Q ss_pred             CCcceeeccccCccchhhhcC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhh-h-hhhH---------hhhhcc-cc
Q 013636          308 QSRNVKISGTLGYVAPEYLLE-GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQ-C-QSMV---------TWAMPQ-LT  374 (439)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~-~-~~~~---------~~~~~~-~~  374 (439)
                      ........||..|+|||.+.+ ..++.++|||||||++|||++|+.||....... . ....         .+.... ..
T Consensus       184 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  263 (330)
T 3nsz_A          184 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE  263 (330)
T ss_dssp             TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred             CCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccc
Confidence            544445568999999999987 678999999999999999999999995443211 0 0000         000000 00


Q ss_pred             cC--------CCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          375 DR--------SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       375 ~~--------~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      ..        ......................+.+++.+||+.||++|||+.|++++
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h  320 (330)
T 3nsz_A          264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  320 (330)
T ss_dssp             CCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             cccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            00        00000000000010011123467889999999999999999999975

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.2e-42  Score=341.17  Aligned_cols=260  Identities=18%  Similarity=0.252  Sum_probs=204.0

Q ss_pred             hcCCCccceecccCcEEEEEEEECC---------ccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceee---------
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFNE---------KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIIS---------  213 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------  213 (439)
                      .++|++.+.||+|+||.||+|+...         +..+|+|.+...     +.+.+|+.++++++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            3689999999999999999998864         788999998754     36788999999999999988         


Q ss_pred             ------eeeEEEe-CCeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCE
Q 013636          214 ------LLGYCIH-AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNI  286 (439)
Q Consensus       214 ------l~~~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~Ni  286 (439)
                            +++++.. .+..++||||+ +|+|.+++... ....+++..+..++.|++.||+|||+.   +++||||||+||
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NI  190 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENI  190 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHE
Confidence                  6777776 67889999999 99999999742 135699999999999999999999998   999999999999


Q ss_pred             EEcCCC--cEEEEecccccccCCCCcc--------eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCC
Q 013636          287 LLDSSF--NAKLSDFGLSVTAGTQSRN--------VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEK  356 (439)
Q Consensus       287 Ll~~~~--~~kl~DfGls~~~~~~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~  356 (439)
                      |++.++  .+||+|||++.........        ....||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  270 (352)
T 2jii_A          191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN  270 (352)
T ss_dssp             EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            999998  9999999999765432211        223589999999999999999999999999999999999999986


Q ss_pred             CChh--hhhhhHhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCC
Q 013636          357 MSPT--QCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPT  430 (439)
Q Consensus       357 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~  430 (439)
                      ..+.  ..........   ..   .....+......   .....+.+++..||+.||++|||+.++++.|+++...
T Consensus       271 ~~~~~~~~~~~~~~~~---~~---~~~~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  337 (352)
T 2jii_A          271 CLPNTEDIMKQKQKFV---DK---PGPFVGPCGHWI---RPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQD  337 (352)
T ss_dssp             GTTCHHHHHHHHHHHH---HS---CCCEECTTSCEE---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             CCcCHHHHHHHHHhcc---CC---hhhhhhhccccC---CCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHh
Confidence            5422  1111111110   00   111111111000   0124577899999999999999999999999887643

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-42  Score=341.78  Aligned_cols=253  Identities=24%  Similarity=0.321  Sum_probs=200.5

Q ss_pred             hcCCCccceecccCcEEEEEEEE----CCccEEEEEEecCCC----chHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCC
Q 013636          152 TNNFQESNVIGEGGRGHVYKARF----NEKLLAAVKRIDDAG----HDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAE  222 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  222 (439)
                      .++|++.+.||+|+||.||+++.    ..+..+|+|.++...    ....+.+.+|+.+++++ +||||+++++++...+
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            36889999999999999999988    367899999986432    12334577899999999 6999999999999999


Q ss_pred             eeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccc
Q 013636          223 TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS  302 (439)
Q Consensus       223 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls  302 (439)
                      ..++||||+++|+|.+++..   ...+++..+..++.|+++||+|||+.   +|+||||||+|||++.++++||+|||++
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a  206 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS  206 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             eEEEEeecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence            99999999999999999964   23589999999999999999999998   9999999999999999999999999999


Q ss_pred             cccCCCCc--ceeeccccCccchhhhcC--CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCC
Q 013636          303 VTAGTQSR--NVKISGTLGYVAPEYLLE--GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSK  378 (439)
Q Consensus       303 ~~~~~~~~--~~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~  378 (439)
                      +.......  .....||+.|+|||.+.+  ..++.++|||||||++|||++|+.||...........+..  ........
T Consensus       207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~--~~~~~~~~  284 (355)
T 1vzo_A          207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR--RILKSEPP  284 (355)
T ss_dssp             EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH--HHHHCCCC
T ss_pred             eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHH--HHhccCCC
Confidence            76533222  233569999999999986  3578999999999999999999999975433221111110  01111112


Q ss_pred             CCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHhc
Q 013636          379 LPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRP-----LITDVLHSL  424 (439)
Q Consensus       379 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~L  424 (439)
                      .+..+            ...+.+++.+||+.||++||     ++.|++++.
T Consensus       285 ~~~~~------------~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          285 YPQEM------------SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             CCTTS------------CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             CCccc------------CHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence            22111            23466799999999999999     999999875

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-41  Score=334.66  Aligned_cols=261  Identities=21%  Similarity=0.284  Sum_probs=196.5

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC------
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE------  222 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  222 (439)
                      .++|+..+.||+|+||.||+|... ++..||+|++....  ....+.+.+|+.+++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            467899999999999999999885 57899999986532  233467899999999999999999999997653      


Q ss_pred             eeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccc
Q 013636          223 TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS  302 (439)
Q Consensus       223 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls  302 (439)
                      ..++||||+ +++|.+++..    ..+++..+..++.|+++||+|||+.   +++||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  175 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA  175 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeecc
Confidence            459999999 7899999864    3589999999999999999999998   9999999999999999999999999999


Q ss_pred             cccCCCCcceeeccccCccchhhhcC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhccccc----C-
Q 013636          303 VTAGTQSRNVKISGTLGYVAPEYLLE-GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTD----R-  376 (439)
Q Consensus       303 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~----~-  376 (439)
                      +.....  .....+|+.|+|||.+.+ ..++.++||||+||++|||++|+.||.+.+..+....+.........    . 
T Consensus       176 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~  253 (367)
T 1cm8_A          176 RQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL  253 (367)
T ss_dssp             EECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred             cccccc--cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence            876433  233468999999999987 68999999999999999999999999876653322211110000000    0 


Q ss_pred             ---------CCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          377 ---------SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       377 ---------~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                               ..++.......... .......+.+++.+||+.||++|||+.|++++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          254 QSDEAKNYMKGLPELEKKDFASI-LTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             SCHHHHHHHHHSCCCCCCCGGGT-CTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hhHHHHHHHHhCCCCCCCCHHHH-CCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence                     00000000001000 01113457789999999999999999999985

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.6e-41  Score=328.91  Aligned_cols=252  Identities=25%  Similarity=0.361  Sum_probs=198.0

Q ss_pred             HhcCCCccceecccCcEEEEEEEECC-ccEEEEEEecCCCc--------hHHHHHHHHHHHHHhcCCCceeeeeeEEEeC
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGH--------DAEREFNNEVNWLTKIRHQNIISLLGYCIHA  221 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  221 (439)
                      ..++|++.+.||+|+||.||+|+... +..+|+|.+.....        .....+.+|+.++++++||||+++++++...
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            34689999999999999999998864 68899999864321        1223588999999999999999999998765


Q ss_pred             CeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCc---EEEEe
Q 013636          222 ETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFN---AKLSD  298 (439)
Q Consensus       222 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~---~kl~D  298 (439)
                      + .++||||+++|+|.+++..   ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.   +||+|
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~D  160 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD  160 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHST---TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred             c-eEEEEecCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEcc
Confidence            4 8999999999999999864   34689999999999999999999998   9999999999999987664   99999


Q ss_pred             cccccccCCCCcceeeccccCccchhhhc---CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChh-hhhhhHhhhhcccc
Q 013636          299 FGLSVTAGTQSRNVKISGTLGYVAPEYLL---EGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPT-QCQSMVTWAMPQLT  374 (439)
Q Consensus       299 fGls~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~-~~~~~~~~~~~~~~  374 (439)
                      ||++.............||+.|+|||.+.   ...++.++||||||+++|||++|+.||...... .....+...     
T Consensus       161 fg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-----  235 (322)
T 2ycf_A          161 FGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG-----  235 (322)
T ss_dssp             CTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHT-----
T ss_pred             CccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhC-----
Confidence            99998765543333456899999999974   567899999999999999999999999765432 111111100     


Q ss_pred             cCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          375 DRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       375 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                       ...    ..+......    ...+.+++.+||+.||++|||+.+++++
T Consensus       236 -~~~----~~~~~~~~~----~~~~~~li~~~l~~dP~~Rps~~~~l~h  275 (322)
T 2ycf_A          236 -KYN----FIPEVWAEV----SEKALDLVKKLLVVDPKARFTTEEALRH  275 (322)
T ss_dssp             -CCC----CCHHHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             -ccc----cCchhhhhc----CHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence             000    111111111    2457789999999999999999999964

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2.3e-42  Score=336.43  Aligned_cols=265  Identities=26%  Similarity=0.366  Sum_probs=194.7

Q ss_pred             hcCCCccceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHH--HHhcCCCceeeeeeEEEe-----CCee
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNW--LTKIRHQNIISLLGYCIH-----AETR  224 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~-----~~~~  224 (439)
                      .++|++.+.||+|+||.||+|+. ++..+|+|.+....   ...+..|.++  +..++||||+++++.+..     ....
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            36788899999999999999987 46789999986532   3344444444  455899999999986543     2256


Q ss_pred             EEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC------CCCeEecCCCCCCEEEcCCCcEEEEe
Q 013636          225 FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC------NHPVVHRDLKSSNILLDSSFNAKLSD  298 (439)
Q Consensus       225 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~------~~~ivH~Dlk~~NiLl~~~~~~kl~D  298 (439)
                      ++||||+++|+|.+++...    ..++..+.+++.|+++||+|||+.+      .++++||||||+|||++.++.+||+|
T Consensus        88 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D  163 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD  163 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred             EEEEecCCCCcHHHHHhhc----ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence            8999999999999999643    3589999999999999999999862      23899999999999999999999999


Q ss_pred             cccccccCCCCc---------ceeeccccCccchhhhcC-------CCCCCchhhHHHHHHHHHHHhCCCCCCCCCh-hh
Q 013636          299 FGLSVTAGTQSR---------NVKISGTLGYVAPEYLLE-------GKLTDKSDVYAFGVVLLELLMGRRPVEKMSP-TQ  361 (439)
Q Consensus       299 fGls~~~~~~~~---------~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwS~Gvll~elltG~~P~~~~~~-~~  361 (439)
                      ||++........         .....||+.|+|||.+.+       ..++.++|||||||++|||++|..|+..... ..
T Consensus       164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~  243 (336)
T 3g2f_A          164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE  243 (336)
T ss_dssp             CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCC
T ss_pred             ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhH
Confidence            999976543211         123458999999999987       3556789999999999999999777643221 11


Q ss_pred             hhhhH-------------hhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccC
Q 013636          362 CQSMV-------------TWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLV  428 (439)
Q Consensus       362 ~~~~~-------------~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~  428 (439)
                      .....             ............++.....      .......+.+++.+||+.||++|||+.|+++.|++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll  317 (336)
T 3g2f_A          244 YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKE------NSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM  317 (336)
T ss_dssp             CCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCC------CSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHhhhcccCCCchHHHHHhhhcccccCCCCCccccc------ccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence            00000             0000000111111111111      1234557889999999999999999999999998876


Q ss_pred             CC
Q 013636          429 PT  430 (439)
Q Consensus       429 ~~  430 (439)
                      ..
T Consensus       318 ~~  319 (336)
T 3g2f_A          318 MI  319 (336)
T ss_dssp             HC
T ss_pred             HH
Confidence            43

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2.5e-41  Score=340.91  Aligned_cols=197  Identities=26%  Similarity=0.376  Sum_probs=166.7

Q ss_pred             hcCCCccceecccCcEEEEEEEECC-ccEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCceeeeeeEEEeC-----Ce
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLLGYCIHA-----ET  223 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  223 (439)
                      .++|++.+.||+|+||.||+|+... +..||+|++....  ....+.+.+|+.++++++||||+++++++...     +.
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            4689999999999999999998754 6789999997542  33456789999999999999999999999776     56


Q ss_pred             eEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccccc
Q 013636          224 RFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSV  303 (439)
Q Consensus       224 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~  303 (439)
                      .++||||++ |+|.+++..   ...+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus       105 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~  177 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLAR  177 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence            899999997 599999964   34699999999999999999999998   99999999999999999999999999997


Q ss_pred             ccCCCCc-----------------------ceeeccccCccchhhh-cCCCCCCchhhHHHHHHHHHHHhCCCCCC
Q 013636          304 TAGTQSR-----------------------NVKISGTLGYVAPEYL-LEGKLTDKSDVYAFGVVLLELLMGRRPVE  355 (439)
Q Consensus       304 ~~~~~~~-----------------------~~~~~gt~~y~aPE~~-~~~~~~~~~DvwS~Gvll~elltG~~P~~  355 (439)
                      .......                       .....||+.|+|||++ ....++.++||||+||++|||++|..||.
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            6543221                       1345689999999986 45679999999999999999998655553

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=5.4e-42  Score=363.26  Aligned_cols=249  Identities=23%  Similarity=0.295  Sum_probs=206.6

Q ss_pred             HhcCCCccceecccCcEEEEEEEECC-ccEEEEEEecCC---CchHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeeE
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDA---GHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRF  225 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  225 (439)
                      ..++|++.+.||+|+||.||+|+... +..+|+|.++..   .....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            34689999999999999999999864 678999998743   123345678899999988 7999999999999999999


Q ss_pred             EEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccccccc
Q 013636          226 LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA  305 (439)
Q Consensus       226 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~  305 (439)
                      +||||+++|+|.+++...   ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++++||+|||+++..
T Consensus       419 lV~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~  492 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  492 (674)
T ss_dssp             EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred             EEEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeecc
Confidence            999999999999999742   3589999999999999999999998   9999999999999999999999999999764


Q ss_pred             CC-CCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCC
Q 013636          306 GT-QSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVD  384 (439)
Q Consensus       306 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  384 (439)
                      .. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+.      .....++..++
T Consensus       493 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~------~~~~~~p~~~s  566 (674)
T 3pfq_A          493 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM------EHNVAYPKSMS  566 (674)
T ss_dssp             CCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------SSCCCCCTTSC
T ss_pred             ccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHH------hCCCCCCccCC
Confidence            32 233345679999999999999999999999999999999999999999877655433332      11222222222


Q ss_pred             chhcCccCHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHh
Q 013636          385 PVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLI-----TDVLHS  423 (439)
Q Consensus       385 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~-----~evl~~  423 (439)
                                  ..+.+++..||+.||++||++     .|++++
T Consensus       567 ------------~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h  598 (674)
T 3pfq_A          567 ------------KEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  598 (674)
T ss_dssp             ------------HHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred             ------------HHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence                        356679999999999999997     788754

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=5.9e-42  Score=326.30  Aligned_cols=254  Identities=23%  Similarity=0.344  Sum_probs=186.1

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCc-hHH-HHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGH-DAE-REFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      .++|++.+.||+|+||+||+++.. ++..+|+|.+..... ... +.+.++...++.++||||+++++++.+.+..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            468889999999999999999984 678899999975432 222 33455556688889999999999999999999999


Q ss_pred             EeccCCChhhhhcC-CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCC
Q 013636          229 EMMQNGSLEKQLHG-PTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT  307 (439)
Q Consensus       229 e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~  307 (439)
                      ||+++ +|.+++.. ...+..+++..+..++.|++.||+|||+.  .+++||||||+||+++.++++||+|||++.....
T Consensus        86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  162 (290)
T 3fme_A           86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD  162 (290)
T ss_dssp             ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred             ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence            99974 88877753 12345699999999999999999999984  2899999999999999999999999999987655


Q ss_pred             CCcceeeccccCccchhhh----cCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccC
Q 013636          308 QSRNVKISGTLGYVAPEYL----LEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV  383 (439)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  383 (439)
                      ........||+.|+|||.+    .+..++.++||||||+++|||++|+.||......... .......   ...   ...
T Consensus       163 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~---~~~---~~~  235 (290)
T 3fme_A          163 DVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ-LKQVVEE---PSP---QLP  235 (290)
T ss_dssp             -------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHH-HHHHHHS---CCC---CCC
T ss_pred             cccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHH-HHHHhcc---CCC---Ccc
Confidence            4444445699999999996    4567889999999999999999999999864322111 1111100   000   100


Q ss_pred             CchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          384 DPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       384 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      .    ..    ....+.+++.+||+.||++|||+.|++++
T Consensus       236 ~----~~----~~~~~~~li~~~l~~~p~~Rpt~~e~l~h  267 (290)
T 3fme_A          236 A----DK----FSAEFVDFTSQCLKKNSKERPTYPELMQH  267 (290)
T ss_dssp             T----TT----SCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             c----cc----CCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence            0    01    12356789999999999999999999874

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.7e-41  Score=344.70  Aligned_cols=191  Identities=27%  Similarity=0.420  Sum_probs=153.5

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCceeeeeeEEEeC-----Ce
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLLGYCIHA-----ET  223 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  223 (439)
                      .++|++.+.||+|+||+||+|+.. ++..||+|++....  ....+.+.+|+.++++++||||+++++++...     +.
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            368999999999999999999875 57889999986532  33456789999999999999999999998543     56


Q ss_pred             eEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccccc
Q 013636          224 RFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSV  303 (439)
Q Consensus       224 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~  303 (439)
                      .++||||+. |+|.+++..   ...+++..+..++.|+++||+|||+.   +|+||||||+|||++.++++||+|||+++
T Consensus       132 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~  204 (458)
T 3rp9_A          132 LYVVLEIAD-SDFKKLFRT---PVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLAR  204 (458)
T ss_dssp             EEEEECCCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEeccc-cchhhhccc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccch
Confidence            899999985 699999864   34699999999999999999999998   99999999999999999999999999997


Q ss_pred             ccCCCC----------------------------cceeeccccCccchhhh-cCCCCCCchhhHHHHHHHHHHHh
Q 013636          304 TAGTQS----------------------------RNVKISGTLGYVAPEYL-LEGKLTDKSDVYAFGVVLLELLM  349 (439)
Q Consensus       304 ~~~~~~----------------------------~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwS~Gvll~ellt  349 (439)
                      ......                            ......||+.|+|||++ ....++.++|||||||++|||++
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt  279 (458)
T 3rp9_A          205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN  279 (458)
T ss_dssp             CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred             hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence            654221                            11234589999999986 45679999999999999999999

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2.6e-41  Score=324.33  Aligned_cols=249  Identities=21%  Similarity=0.293  Sum_probs=198.4

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC----chHHHHHHHHHHHHHhcCCCceeeeeeEEE--eCCee
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG----HDAEREFNNEVNWLTKIRHQNIISLLGYCI--HAETR  224 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~  224 (439)
                      .++|++.+.||+|+||.||++... ++..+|+|.+....    ......+.+|+.++++++||||+++++++.  +.+..
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            468999999999999999999985 57789999987532    234567999999999999999999999984  44578


Q ss_pred             EEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccc
Q 013636          225 FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT  304 (439)
Q Consensus       225 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~  304 (439)
                      ++||||+++| |.+++... ....+++..+..++.|+++||+|||+.   +++||||||+||+++.++.+||+|||++..
T Consensus        84 ~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccc
Confidence            9999999986 77776542 245689999999999999999999998   999999999999999999999999999976


Q ss_pred             cCCCC---cceeeccccCccchhhhcCCCC--CCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCC
Q 013636          305 AGTQS---RNVKISGTLGYVAPEYLLEGKL--TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKL  379 (439)
Q Consensus       305 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~--~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  379 (439)
                      .....   ......||+.|+|||.+.+...  +.++||||||+++|||++|+.||...+.......+...      ....
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~------~~~~  232 (305)
T 2wtk_C          159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG------SYAI  232 (305)
T ss_dssp             CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC------CCCC
T ss_pred             cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC------CCCC
Confidence            54321   1223458999999999986543  77999999999999999999999876654433222211      1111


Q ss_pred             CccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          380 PNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       380 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      +...            ...+.+++.+||+.||++|||+.|++++
T Consensus       233 ~~~~------------~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          233 PGDC------------GPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             CSSS------------CHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             CCcc------------CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            1111            2356679999999999999999999976

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.3e-42  Score=343.44  Aligned_cols=255  Identities=13%  Similarity=0.080  Sum_probs=181.8

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCc---hHHHHHHHHHHHHHhc--CCCceeeee-------eEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGH---DAEREFNNEVNWLTKI--RHQNIISLL-------GYC  218 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~h~niv~l~-------~~~  218 (439)
                      ..+|+..+.||+|+||.||+|+.. ++..+|+|.+.....   ...+.+.+|+.+++.+  +|||+++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            345888999999999999999975 678999999986543   3345677885544444  699988754       444


Q ss_pred             EeC-----------------CeeEEEEEeccCCChhhhhcCCCCCCCCCHHHH------HHHHHHHHHHHHHHhhcCCCC
Q 013636          219 IHA-----------------ETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLR------MKIAVDVARGLEYLHEHCNHP  275 (439)
Q Consensus       219 ~~~-----------------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~ia~gl~~LH~~~~~~  275 (439)
                      ...                 ...++||||++ |+|.+++...  +..+++..+      ..++.|+++||+|||+.   +
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~  214 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--DFVYVFRGDEGILALHILTAQLIRLAANLQSK---G  214 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--ccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---C
Confidence            433                 23799999999 8999999742  223455555      78889999999999998   9


Q ss_pred             eEecCCCCCCEEEcCCCcEEEEecccccccCCCCcceeeccccCccchhhhcC--CCCCCchhhHHHHHHHHHHHhCCCC
Q 013636          276 VVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLE--GKLTDKSDVYAFGVVLLELLMGRRP  353 (439)
Q Consensus       276 ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~Gvll~elltG~~P  353 (439)
                      |+||||||+|||++.++.+||+|||++...+...  ....+|+.|+|||.+.+  ..++.++|||||||++|||++|+.|
T Consensus       215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P  292 (371)
T 3q60_A          215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG--PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP  292 (371)
T ss_dssp             EEETTCSGGGEEECTTSCEEECCGGGEEETTCEE--EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred             CccCcCCHHHEEECCCCCEEEEecceeeecCCCc--cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999999998764322  13457799999999987  6799999999999999999999999


Q ss_pred             CCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          354 VEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      |....+.......   ......... .....+. ...    ....+.+++.+||+.||++|||+.|++++
T Consensus       293 f~~~~~~~~~~~~---~~~~~~~~~-~~~~~~~-~~~----~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  353 (371)
T 3q60_A          293 FGLVTPGIKGSWK---RPSLRVPGT-DSLAFGS-CTP----LPDFVKTLIGRFLNFDRRRRLLPLEAMET  353 (371)
T ss_dssp             TTBCCTTCTTCCC---BCCTTSCCC-CSCCCTT-SSC----CCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred             CCCcCcccccchh---hhhhhhccc-cccchhh-ccC----CCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            9876543211100   000000000 0000000 011    13467789999999999999999999864

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.8e-42  Score=334.55  Aligned_cols=260  Identities=23%  Similarity=0.395  Sum_probs=201.8

Q ss_pred             HHHHhcCCCccceecccCcEEEEEEEECCccEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeE
Q 013636          148 LEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRF  225 (439)
Q Consensus       148 l~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  225 (439)
                      ++...++|++.+.||+|+||.||+|+..+.  +|+|.+....  ....+.+.+|+.++++++||||+++++++...+..+
T Consensus        28 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~--~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (319)
T 2y4i_B           28 WDIPFEQLEIGELIGKGRFGQVYHGRWHGE--VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLA  105 (319)
T ss_dssp             SSSCCSCEECCCBCCCSSSSEEEEEEESSS--EEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEE
T ss_pred             ccCCHHHeEEeeEeccCCceEEEEEEEcCe--EEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceE
Confidence            344467899999999999999999998764  7888876432  223346788999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccccccc
Q 013636          226 LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA  305 (439)
Q Consensus       226 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~  305 (439)
                      +||||+++++|.+++..  ....+++..+..++.|++.||+|||+.   +++||||||+||+++ ++.+||+|||++...
T Consensus       106 iv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~  179 (319)
T 2y4i_B          106 IITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSIS  179 (319)
T ss_dssp             EECBCCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred             EEeecccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence            99999999999999974  334689999999999999999999998   999999999999998 679999999998654


Q ss_pred             CCC------CcceeeccccCccchhhhcC---------CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhh
Q 013636          306 GTQ------SRNVKISGTLGYVAPEYLLE---------GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAM  370 (439)
Q Consensus       306 ~~~------~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~  370 (439)
                      ...      .......||+.|+|||.+..         ..++.++||||||+++|||++|+.||...+.......+... 
T Consensus       180 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-  258 (319)
T 2y4i_B          180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTG-  258 (319)
T ss_dssp             --------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTT-
T ss_pred             ccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccC-
Confidence            321      11123358999999999874         45788999999999999999999999877655433222111 


Q ss_pred             cccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCCC
Q 013636          371 PQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPTD  431 (439)
Q Consensus       371 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~~  431 (439)
                             ..+......+        ...+.+++..||+.||++|||+.++++.|+.+....
T Consensus       259 -------~~~~~~~~~~--------~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~  304 (319)
T 2y4i_B          259 -------MKPNLSQIGM--------GKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN  304 (319)
T ss_dssp             -------CCCCCCCSSC--------CTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred             -------CCCCCCcCCC--------CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence                   0111111111        124667999999999999999999999999988653

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.1e-41  Score=334.01  Aligned_cols=264  Identities=24%  Similarity=0.320  Sum_probs=200.9

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCceeeeeeEEEeC-----Cee
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGH-DAEREFNNEVNWLTKIRHQNIISLLGYCIHA-----ETR  224 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~  224 (439)
                      .++|++.+.||+|+||.||+|+.. ++..+|+|.+..... .....+.+|+.++++++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            468889999999999999999986 578899999975433 3446788999999999999999999988764     678


Q ss_pred             EEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccc
Q 013636          225 FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT  304 (439)
Q Consensus       225 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~  304 (439)
                      ++||||+. |+|.+++..    ..+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++..
T Consensus        90 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARI  161 (353)
T ss_dssp             EEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccccc
Confidence            99999997 599998864    3589999999999999999999998   999999999999999999999999999976


Q ss_pred             cCCCCc-----------ceeeccccCccchhhhcC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcc
Q 013636          305 AGTQSR-----------NVKISGTLGYVAPEYLLE-GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQ  372 (439)
Q Consensus       305 ~~~~~~-----------~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~  372 (439)
                      ......           .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...+.......+......
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  241 (353)
T 2b9h_A          162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT  241 (353)
T ss_dssp             CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence            543211           112358999999998765 77899999999999999999999999887654322222111111


Q ss_pred             cccCCCCCccCCchhc---------C-----ccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          373 LTDRSKLPNIVDPVIR---------D-----TMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       373 ~~~~~~~~~~~d~~l~---------~-----~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      ............+...         .     .........+.+++.+||+.||++|||+.|++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (353)
T 2b9h_A          242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH  306 (353)
T ss_dssp             CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            1000000000000000         0     0000123457789999999999999999999975

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=4.7e-41  Score=331.32  Aligned_cols=260  Identities=24%  Similarity=0.313  Sum_probs=201.5

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCceeeeeeEEEeC-----Cee
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGH-DAEREFNNEVNWLTKIRHQNIISLLGYCIHA-----ETR  224 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~  224 (439)
                      .++|++.+.||+|+||.||+|+.. ++..+|+|.+..... ...+.+.+|+.++++++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            467999999999999999999875 577899999975433 3346789999999999999999999999765     368


Q ss_pred             EEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccc
Q 013636          225 FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT  304 (439)
Q Consensus       225 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~  304 (439)
                      ++||||++ |+|.+++..    ..+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++..
T Consensus       106 ~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~  177 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARV  177 (364)
T ss_dssp             EEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEe
Confidence            99999997 499999864    3489999999999999999999998   999999999999999999999999999976


Q ss_pred             cCCCCc----ceeeccccCccchhhhcC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhccccc----
Q 013636          305 AGTQSR----NVKISGTLGYVAPEYLLE-GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTD----  375 (439)
Q Consensus       305 ~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~----  375 (439)
                      ......    .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...+..+....+.........    
T Consensus       178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  257 (364)
T 3qyz_A          178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN  257 (364)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHH
T ss_pred             cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            543322    123468999999998765 45899999999999999999999999877654432222111000000    


Q ss_pred             -------------CCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          376 -------------RSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       376 -------------~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                                   ...-.......+...    ....+.+++.+||+.||++|||+.|++++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~li~~~L~~dP~~R~t~~e~l~h  314 (364)
T 3qyz_A          258 CIINLKARNYLLSLPHKNKVPWNRLFPN----ADSKALDLLDKMLTFNPHKRIEVEQALAH  314 (364)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHCTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HhhhhhHHHHHHhcCCccCCCHHHhCCC----CCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                         000000000001111    12457789999999999999999999975

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=4.3e-41  Score=326.95  Aligned_cols=264  Identities=18%  Similarity=0.269  Sum_probs=206.4

Q ss_pred             hcCCCccceecccCcEEEEEEEE--CCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCc------eeeeeeEEEeCCe
Q 013636          152 TNNFQESNVIGEGGRGHVYKARF--NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQN------IISLLGYCIHAET  223 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~  223 (439)
                      .++|++.+.||+|+||+||++..  .++..+|+|.+... ....+.+.+|+.+++.++|+|      ++++++++...+.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            46889999999999999999987  35788999999754 234567889999999987654      9999999999999


Q ss_pred             eEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC-------------
Q 013636          224 RFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDS-------------  290 (439)
Q Consensus       224 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~-------------  290 (439)
                      .++||||+ +++|.+++... ....+++..+..++.|+++||+|||+.   +++||||||+|||++.             
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~  166 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKR  166 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred             EEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcccc
Confidence            99999999 88999998752 234689999999999999999999998   9999999999999987             


Q ss_pred             ------CCcEEEEecccccccCCCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhh
Q 013636          291 ------SFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQS  364 (439)
Q Consensus       291 ------~~~~kl~DfGls~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~  364 (439)
                            ++.+||+|||++.......  ....||+.|+|||.+.+..++.++||||||+++|||++|+.||...+..+...
T Consensus       167 ~~~~~~~~~~kl~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  244 (339)
T 1z57_A          167 DERTLINPDIKVVDFGSATYDDEHH--STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLA  244 (339)
T ss_dssp             EEEEESCCCEEECCCSSCEETTSCC--CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHH
T ss_pred             ccccccCCCceEeeCcccccCcccc--ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence                  6789999999997654332  33468999999999999999999999999999999999999998876554333


Q ss_pred             hHhhhhcccccC----C-----------CCCcc----------CCchh-cCccCHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 013636          365 MVTWAMPQLTDR----S-----------KLPNI----------VDPVI-RDTMDLKHLYQVAAVAVLCIQPEPSYRPLIT  418 (439)
Q Consensus       365 ~~~~~~~~~~~~----~-----------~~~~~----------~d~~l-~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~  418 (439)
                      .+..........    .           .....          ..+.. ...........+.+++.+||+.||++|||+.
T Consensus       245 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~  324 (339)
T 1z57_A          245 MMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLR  324 (339)
T ss_dssp             HHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             HHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHH
Confidence            322211110000    0           00000          00000 0011223456788999999999999999999


Q ss_pred             HHHHh
Q 013636          419 DVLHS  423 (439)
Q Consensus       419 evl~~  423 (439)
                      |++++
T Consensus       325 ell~h  329 (339)
T 1z57_A          325 EALKH  329 (339)
T ss_dssp             HHTTS
T ss_pred             HHhcC
Confidence            99976

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.2e-41  Score=334.12  Aligned_cols=258  Identities=22%  Similarity=0.308  Sum_probs=185.5

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCceeeeeeEEEeC------C
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLLGYCIHA------E  222 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~  222 (439)
                      .++|+..+.||+|+||.||+|... ++..||+|++....  ....+.+.+|+.+++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            478999999999999999999874 57889999986532  33456788999999999999999999998754      5


Q ss_pred             eeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccc
Q 013636          223 TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS  302 (439)
Q Consensus       223 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls  302 (439)
                      ..++|+||+ +++|.+++..    ..+++..+..++.|+++||+|||+.   +++||||||+|||++.++.+||+|||++
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a  179 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA  179 (367)
T ss_dssp             CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC----
T ss_pred             eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecccc
Confidence            679999999 6799988853    3599999999999999999999998   9999999999999999999999999999


Q ss_pred             cccCCCCcceeeccccCccchhhhcC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccc-------
Q 013636          303 VTAGTQSRNVKISGTLGYVAPEYLLE-GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLT-------  374 (439)
Q Consensus       303 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~-------  374 (439)
                      +.....  .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.+.+.......+........       
T Consensus       180 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~  257 (367)
T 2fst_X          180 RHTADE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI  257 (367)
T ss_dssp             -------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTC
T ss_pred             cccccc--CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence            765432  234568999999999987 6789999999999999999999999988765433222211110000       


Q ss_pred             ----------cCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          375 ----------DRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       375 ----------~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                                .....+..-.+.+..    .....+.+++.+||+.||++|||+.|++++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          258 SSESARNYIQSLTQMPKMNFANVFI----GANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             CCHHHHHHHHTSCCCCCCCHHHHTT----TCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhHHHHHHHhccCCCCCCCHHHHCC----CCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence                      000000000000001    112457789999999999999999999976

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.1e-41  Score=325.52  Aligned_cols=264  Identities=21%  Similarity=0.315  Sum_probs=195.9

Q ss_pred             hcCCCccceecccCcEEEEEEEECC-ccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEE-----------
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCI-----------  219 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-----------  219 (439)
                      .++|++.+.||+|+||.||+|.... +..+|+|.+........+++.+|+.++++++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            3678889999999999999999875 7899999998766666778999999999999999999999873           


Q ss_pred             ---eCCeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc-CCCcEE
Q 013636          220 ---HAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLD-SSFNAK  295 (439)
Q Consensus       220 ---~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~-~~~~~k  295 (439)
                         ..+..++||||++ |+|.+++..    ..+++..+..++.|+++||+|||+.   +++||||||+||+++ +++.+|
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~k  161 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLK  161 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEE
T ss_pred             cccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEE
Confidence               3467899999998 699999853    3589999999999999999999998   999999999999997 577999


Q ss_pred             EEecccccccCCCCc----ceeeccccCccchhhhcC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhh
Q 013636          296 LSDFGLSVTAGTQSR----NVKISGTLGYVAPEYLLE-GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAM  370 (439)
Q Consensus       296 l~DfGls~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~  370 (439)
                      |+|||++........    .....+|..|+|||.+.+ ..++.++||||||+++|||++|+.||...+..+....+....
T Consensus       162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~  241 (320)
T 2i6l_A          162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI  241 (320)
T ss_dssp             ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHS
T ss_pred             EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            999999976543211    122347899999998876 678999999999999999999999998876543322221111


Q ss_pred             cccccC------CCCCccCCchhcC-c-----cCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          371 PQLTDR------SKLPNIVDPVIRD-T-----MDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       371 ~~~~~~------~~~~~~~d~~l~~-~-----~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      +.....      ..++......... .     ........+.+++.+||+.||++|||+.|++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (320)
T 2i6l_A          242 PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH  306 (320)
T ss_dssp             CCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             CCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence            000000      0000000000000 0     000123467889999999999999999999975

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.8e-41  Score=323.03  Aligned_cols=254  Identities=28%  Similarity=0.382  Sum_probs=206.0

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeE
Q 013636          149 EAATNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRF  225 (439)
Q Consensus       149 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  225 (439)
                      ....++|++.+.||+|+||.||+|+.. ++..+|+|.+....  ......+.+|+.++++++||||+++++++...+..+
T Consensus        18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   97 (287)
T 2wei_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY   97 (287)
T ss_dssp             HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence            345578999999999999999999986 57889999986432  234567899999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC---CcEEEEecccc
Q 013636          226 LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS---FNAKLSDFGLS  302 (439)
Q Consensus       226 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~---~~~kl~DfGls  302 (439)
                      +|+||+++++|.+++..   ...+++..+..++.|++.||+|||+.   +++||||||+||+++.+   +.+||+|||++
T Consensus        98 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~  171 (287)
T 2wei_A           98 IVGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS  171 (287)
T ss_dssp             EEECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred             EEEEccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence            99999999999998853   23589999999999999999999998   99999999999999754   46999999999


Q ss_pred             cccCCCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCcc
Q 013636          303 VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNI  382 (439)
Q Consensus       303 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  382 (439)
                      .............||+.|+|||.+.+ .++.++||||||+++|+|++|+.||...+..+....+...      ....+  
T Consensus       172 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------~~~~~--  242 (287)
T 2wei_A          172 TCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETG------KYAFD--  242 (287)
T ss_dssp             GTBCCCSSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------CCCCC--
T ss_pred             eeecCCCccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC------CCCCC--
Confidence            87655444444558999999998865 5899999999999999999999999887655433222211      00000  


Q ss_pred             CCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          383 VDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       383 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                       .+ .....    ...+.+++.+||+.||++|||+.|++++
T Consensus       243 -~~-~~~~~----~~~~~~li~~~l~~dp~~Rps~~ell~h  277 (287)
T 2wei_A          243 -LP-QWRTI----SDDAKDLIRKMLTFHPSLRITATQCLEH  277 (287)
T ss_dssp             -SG-GGTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             -ch-hhhhc----CHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence             00 00111    2356789999999999999999999975

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1e-41  Score=360.00  Aligned_cols=259  Identities=24%  Similarity=0.379  Sum_probs=208.4

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEECC----ccEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCe
Q 013636          149 EAATNNFQESNVIGEGGRGHVYKARFNE----KLLAAVKRIDDAGH-DAEREFNNEVNWLTKIRHQNIISLLGYCIHAET  223 (439)
Q Consensus       149 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  223 (439)
                      +...++|++.+.||+|+||.||+|.+..    +..+|+|.+..... ...+.|.+|+.++++++||||+++++++. .+.
T Consensus       386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~  464 (656)
T 2j0j_A          386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP  464 (656)
T ss_dssp             BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred             ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCc
Confidence            3445788889999999999999998743    46789999875433 34467999999999999999999999985 467


Q ss_pred             eEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccccc
Q 013636          224 RFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSV  303 (439)
Q Consensus       224 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~  303 (439)
                      .++||||+++|+|.+++..  ....+++..+..++.|+++||+|||+.   +++||||||+|||++.++.+||+|||++.
T Consensus       465 ~~lv~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~  539 (656)
T 2j0j_A          465 VWIIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR  539 (656)
T ss_dssp             CEEEEECCTTCBHHHHHHH--TTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred             eEEEEEcCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCe
Confidence            8999999999999999974  234689999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCCcc--eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCC
Q 013636          304 TAGTQSRN--VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLP  380 (439)
Q Consensus       304 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  380 (439)
                      ........  ....+|+.|+|||.+.+..++.++||||||+++|||++ |..||...+..+....+...     .....+
T Consensus       540 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~-----~~~~~~  614 (656)
T 2j0j_A          540 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-----ERLPMP  614 (656)
T ss_dssp             SCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHT-----CCCCCC
T ss_pred             ecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC-----CCCCCC
Confidence            76443222  22346789999999999999999999999999999997 99999887665433322211     111111


Q ss_pred             ccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCC
Q 013636          381 NIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPT  430 (439)
Q Consensus       381 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~  430 (439)
                      ..+            ...+.+++.+||+.||++|||+.++++.|+.++.+
T Consensus       615 ~~~------------~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~  652 (656)
T 2j0j_A          615 PNC------------PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  652 (656)
T ss_dssp             TTC------------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ccc------------cHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence            111            23567799999999999999999999999887643

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.9e-41  Score=337.05  Aligned_cols=265  Identities=20%  Similarity=0.278  Sum_probs=202.0

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCchHHHHHHHHHHHHHhcC--------CCceeeeeeEEE---
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR--------HQNIISLLGYCI---  219 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~---  219 (439)
                      .++|++.+.||+|+||+||+|+.. ++..+|+|.+... ....+.+.+|+.+++.++        |+||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            478999999999999999999875 5788999999754 344567889999999985        788999999987   


Q ss_pred             -eCCeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC------
Q 013636          220 -HAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSF------  292 (439)
Q Consensus       220 -~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~------  292 (439)
                       .....++||||+ +|+|.+++.. .....+++..+..++.|++.||+|||+.+  +|+||||||+|||++.++      
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~-~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~  190 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIK-SNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRL  190 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHH
T ss_pred             CCCceEEEEEecc-CccHHHHHHh-cccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhh
Confidence             455789999999 5566666643 22356999999999999999999999852  899999999999999775      


Q ss_pred             -------------------------------------------cEEEEecccccccCCCCcceeeccccCccchhhhcCC
Q 013636          293 -------------------------------------------NAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEG  329 (439)
Q Consensus       293 -------------------------------------------~~kl~DfGls~~~~~~~~~~~~~gt~~y~aPE~~~~~  329 (439)
                                                                 .+||+|||++.......  ....||+.|+|||++.+.
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~--~~~~gt~~y~aPE~~~~~  268 (397)
T 1wak_A          191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF--TEDIQTRQYRSLEVLIGS  268 (397)
T ss_dssp             HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS--CSCCSCGGGCCHHHHHTS
T ss_pred             hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC--ccCCCCCcccCChhhcCC
Confidence                                                       79999999997765432  234589999999999999


Q ss_pred             CCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhh------hHhhhhc---------------ccccCCCCCccCCc---
Q 013636          330 KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQS------MVTWAMP---------------QLTDRSKLPNIVDP---  385 (439)
Q Consensus       330 ~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~------~~~~~~~---------------~~~~~~~~~~~~d~---  385 (439)
                      .++.++|||||||++|||++|+.||...+......      .+.....               ..........+.+.   
T Consensus       269 ~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (397)
T 1wak_A          269 GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPW  348 (397)
T ss_dssp             CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCC
T ss_pred             CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCc
Confidence            99999999999999999999999998654322110      0000000               00000111111000   


Q ss_pred             ----hh--cCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          386 ----VI--RDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       386 ----~l--~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                          .+  ...........+.+++.+||+.||++|||+.|++++
T Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  392 (397)
T 1wak_A          349 GLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH  392 (397)
T ss_dssp             CHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred             chhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence                00  012234566788999999999999999999999975

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.4e-40  Score=328.91  Aligned_cols=260  Identities=22%  Similarity=0.289  Sum_probs=198.0

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCee----
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETR----  224 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----  224 (439)
                      .++|...+.||+|+||+||+|... ++..+|+|.+....  ....+.+.+|+.+++.++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            468999999999999999999875 57899999997543  23346788999999999999999999999877655    


Q ss_pred             --EEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccc
Q 013636          225 --FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS  302 (439)
Q Consensus       225 --~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls  302 (439)
                        ++||||+. |+|.+++..     .+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++
T Consensus       121 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a  191 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLA  191 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred             eEEEEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCcc
Confidence              99999998 589888742     389999999999999999999998   9999999999999999999999999999


Q ss_pred             cccCCCCcceeeccccCccchhhhcC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccC--CC-
Q 013636          303 VTAGTQSRNVKISGTLGYVAPEYLLE-GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDR--SK-  378 (439)
Q Consensus       303 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~--~~-  378 (439)
                      ......  .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...+..+....+..........  .. 
T Consensus       192 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  269 (371)
T 4exu_A          192 RHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL  269 (371)
T ss_dssp             ----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred             cccccC--cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHh
Confidence            765432  233468999999999987 788999999999999999999999998776443222211100000000  00 


Q ss_pred             -----------CCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          379 -----------LPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       379 -----------~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                                 ++......... ........+.+++.+||+.||++|||+.|++++
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          270 NDKAAKSYIQSLPQTPRKDFTQ-LFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             SCHHHHHHHHHSCCCCCCCHHH-HSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             hhhhhhhhhhccCCCcchhHHH-hccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence                       00000000000 000113467889999999999999999999976

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=4.1e-41  Score=321.93  Aligned_cols=250  Identities=26%  Similarity=0.414  Sum_probs=191.9

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEe----------
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH----------  220 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----------  220 (439)
                      .++|++.+.||+|+||.||+|+.. ++..+|+|.+... ....+.+.+|+.++++++||||+++++++.+          
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            467889999999999999999975 6789999998643 3445678999999999999999999998865          


Q ss_pred             ---CCeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEE
Q 013636          221 ---AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLS  297 (439)
Q Consensus       221 ---~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~  297 (439)
                         .+..++||||+++|+|.+++..  ....+++..+..++.|+++||+|||+.   +++||||||+||+++.++.+||+
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~  158 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHS--ENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIG  158 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHH--SCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEEC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhc--cccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEe
Confidence               3467999999999999999974  234578899999999999999999998   99999999999999999999999


Q ss_pred             ecccccccCCC---------------CcceeeccccCccchhhhcCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCChhh
Q 013636          298 DFGLSVTAGTQ---------------SRNVKISGTLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQ  361 (439)
Q Consensus       298 DfGls~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~  361 (439)
                      |||++......               .......||+.|+|||.+.+. .++.++||||||+++|||++   ||.....  
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~--  233 (303)
T 1zy4_A          159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME--  233 (303)
T ss_dssp             CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH--
T ss_pred             eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh--
Confidence            99999765421               111234589999999999864 78999999999999999998   5542211  


Q ss_pred             hhhhHhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          362 CQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       362 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      .........   ......+..+        .......+.+++.+||+.||++|||+.+++++
T Consensus       234 ~~~~~~~~~---~~~~~~~~~~--------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          234 RVNILKKLR---SVSIEFPPDF--------DDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS  284 (303)
T ss_dssp             HHHHHHHHH---STTCCCCTTC--------CTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHhcc---ccccccCccc--------cccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence            111111110   0111111111        11223456789999999999999999999986

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=5.6e-41  Score=341.78  Aligned_cols=260  Identities=18%  Similarity=0.238  Sum_probs=204.2

Q ss_pred             hcCCCccceecccCcEEEEEEEE-CCccEEEEEEecCCCchHHHHHHHHHHHHHhcCC-CceeeeeeEEEeCCeeEEEEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARF-NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRH-QNIISLLGYCIHAETRFLVYE  229 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~e  229 (439)
                      .++|++.+.||+|+||.||+|+. .++..||||.+.....  ..++.+|+++++.++| +++..+..++...+..++|||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            46899999999999999999997 4578999998765432  2357889999999987 555566667778888999999


Q ss_pred             eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE---cCCCcEEEEecccccccC
Q 013636          230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILL---DSSFNAKLSDFGLSVTAG  306 (439)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl---~~~~~~kl~DfGls~~~~  306 (439)
                      |+ +++|.+++..  ....+++..++.++.|++.||+|||+.   +|+||||||+|||+   +.++.+||+|||++....
T Consensus        84 ~~-g~sL~~ll~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~  157 (483)
T 3sv0_A           84 LL-GPSLEDLFNF--CSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR  157 (483)
T ss_dssp             CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             CC-CCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence            99 9999999973  234699999999999999999999998   99999999999999   688999999999997654


Q ss_pred             CCCcc--------eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCC
Q 013636          307 TQSRN--------VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSK  378 (439)
Q Consensus       307 ~~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~  378 (439)
                      .....        ....||+.|+|||.+.+..++.++|||||||++|||++|+.||.....................   
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~---  234 (483)
T 3sv0_A          158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA---  234 (483)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH---
T ss_pred             CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc---
Confidence            43221        2456999999999999999999999999999999999999999876543222222111100000   


Q ss_pred             CCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCC
Q 013636          379 LPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVP  429 (439)
Q Consensus       379 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~  429 (439)
                        ... ..+...    ...++.+++..||+.||++||++.+|++.|+.+..
T Consensus       235 --~~~-~~l~~~----~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~  278 (483)
T 3sv0_A          235 --TSI-EALCRG----YPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI  278 (483)
T ss_dssp             --SCH-HHHHTT----SCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             --ccH-HHHhcC----CcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence              000 001111    12467889999999999999999999999887753

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.2e-40  Score=330.57  Aligned_cols=267  Identities=22%  Similarity=0.270  Sum_probs=204.2

Q ss_pred             HhcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCchHHHHHHHHHHHHHhcC-CC-----ceeeeeeEEEeCCe
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR-HQ-----NIISLLGYCIHAET  223 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~~  223 (439)
                      ..++|++.+.||+|+||+||+|+.. ++..||+|.+... .....++..|+.+++.++ |+     +++++++++...+.
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  130 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH  130 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence            4578999999999999999999876 5778999999753 334567788999988885 55     49999999999999


Q ss_pred             eEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc--CCCcEEEEeccc
Q 013636          224 RFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLD--SSFNAKLSDFGL  301 (439)
Q Consensus       224 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~--~~~~~kl~DfGl  301 (439)
                      .++||||++ |+|.+++.... ...+++..+..++.|++.||+|||+. ..+|+||||||+|||++  .++.+||+|||+
T Consensus       131 ~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~  207 (382)
T 2vx3_A          131 LCLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGS  207 (382)
T ss_dssp             EEEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             eEEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence            999999996 59999997532 24589999999999999999999953 23899999999999994  578899999999


Q ss_pred             ccccCCCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcc---------
Q 013636          302 SVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQ---------  372 (439)
Q Consensus       302 s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~---------  372 (439)
                      +.......  ....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+......         
T Consensus       208 a~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  285 (382)
T 2vx3_A          208 SCQLGQRI--YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQA  285 (382)
T ss_dssp             CEETTCCC--CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTC
T ss_pred             ceeccccc--ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence            98765432  3456899999999999999999999999999999999999999987654432222111000         


Q ss_pred             ---------cccC--------CCCCccCCch---h-----------------cCccCHHHHHHHHHHHHHhcCCCCCCCC
Q 013636          373 ---------LTDR--------SKLPNIVDPV---I-----------------RDTMDLKHLYQVAAVAVLCIQPEPSYRP  415 (439)
Q Consensus       373 ---------~~~~--------~~~~~~~d~~---l-----------------~~~~~~~~~~~l~~l~~~cl~~dP~~RP  415 (439)
                               +.+.        ........+.   +                 .......+...+.+++.+||+.||++||
T Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rp  365 (382)
T 2vx3_A          286 PKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRI  365 (382)
T ss_dssp             TTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSC
T ss_pred             HHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCC
Confidence                     0000        0000000000   0                 0001223445788999999999999999


Q ss_pred             CHHHHHHh
Q 013636          416 LITDVLHS  423 (439)
Q Consensus       416 t~~evl~~  423 (439)
                      |+.|++++
T Consensus       366 ta~e~L~h  373 (382)
T 2vx3_A          366 QPYYALQH  373 (382)
T ss_dssp             CHHHHTTS
T ss_pred             CHHHHhcC
Confidence            99999975

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=3.7e-41  Score=326.92  Aligned_cols=257  Identities=25%  Similarity=0.377  Sum_probs=178.5

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCc-hHHHHHHHHHH-HHHhcCCCceeeeeeEEEeCCeeEEEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGH-DAEREFNNEVN-WLTKIRHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      .++|+..+.||+|+||.||+|... ++..+|+|.+..... ....++..|+. +++.++||||+++++++...+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            468888999999999999999985 578899999875432 33445666666 677789999999999999999999999


Q ss_pred             EeccCCChhhhhcC--CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccC
Q 013636          229 EMMQNGSLEKQLHG--PTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAG  306 (439)
Q Consensus       229 e~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~  306 (439)
                      ||+++ +|.+++..  ......+++..+..++.|+++||.|||+.  .+++||||||+||+++.++.+||+|||++....
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  177 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV  177 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence            99985 88777652  11245689999999999999999999984  289999999999999999999999999997765


Q ss_pred             CCCcceeeccccCccchhhh----cCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCcc
Q 013636          307 TQSRNVKISGTLGYVAPEYL----LEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNI  382 (439)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  382 (439)
                      .........||+.|+|||.+    .+..++.++||||||+++|||++|+.||.......  ....    .... ...+..
T Consensus       178 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~----~~~~-~~~~~~  250 (327)
T 3aln_A          178 DSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF--DQLT----QVVK-GDPPQL  250 (327)
T ss_dssp             ----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------C----CCCC-SCCCCC
T ss_pred             cccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH--HHHH----HHhc-CCCCCC
Confidence            44443444689999999998    45678999999999999999999999998653211  0000    0000 001111


Q ss_pred             CCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          383 VDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       383 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      . ......    ....+.+++.+||+.||++|||+.|++++
T Consensus       251 ~-~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~h  286 (327)
T 3aln_A          251 S-NSEERE----FSPSFINFVNLCLTKDESKRPKYKELLKH  286 (327)
T ss_dssp             C-CCSSCC----CCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             C-Cccccc----CCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence            0 001111    13467789999999999999999999864

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.3e-40  Score=332.99  Aligned_cols=201  Identities=26%  Similarity=0.396  Sum_probs=155.5

Q ss_pred             cCCCc-cceecccCcEEEEEEEEC---CccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEe--CCeeEE
Q 013636          153 NNFQE-SNVIGEGGRGHVYKARFN---EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH--AETRFL  226 (439)
Q Consensus       153 ~~~~~-~~~LG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l  226 (439)
                      +.|++ .++||+|+||+||+|+..   ++..+|+|.+.....  ...+.+|+.++++++||||+++++++..  ....++
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l   97 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWL   97 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence            44555 458999999999999975   467899999976432  3467899999999999999999999965  668899


Q ss_pred             EEEeccCCChhhhhcC------CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE----cCCCcEEE
Q 013636          227 VYEMMQNGSLEKQLHG------PTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILL----DSSFNAKL  296 (439)
Q Consensus       227 V~e~~~~gsL~~~l~~------~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl----~~~~~~kl  296 (439)
                      ||||+++ +|.+++..      ......+++..+..++.|++.||+|||+.   +|+||||||+|||+    +.++.+||
T Consensus        98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl  173 (405)
T 3rgf_A           98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKI  173 (405)
T ss_dssp             EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred             EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEE
Confidence            9999975 88877742      11223599999999999999999999998   99999999999999    77899999


Q ss_pred             EecccccccCCCC----cceeeccccCccchhhhcCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 013636          297 SDFGLSVTAGTQS----RNVKISGTLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGRRPVEKMSP  359 (439)
Q Consensus       297 ~DfGls~~~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvll~elltG~~P~~~~~~  359 (439)
                      +|||++.......    ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.....
T Consensus       174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~  241 (405)
T 3rgf_A          174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE  241 (405)
T ss_dssp             CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred             EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccc
Confidence            9999997764321    12335689999999999874 589999999999999999999999976543

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=4e-41  Score=324.65  Aligned_cols=251  Identities=24%  Similarity=0.404  Sum_probs=196.2

Q ss_pred             HhcCCCccceecccCcEEEEEEEECCccEEEEEEecCC--CchHHHHHHHHHHHHHhcC--CCceeeeeeEEEeCCeeEE
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDA--GHDAEREFNNEVNWLTKIR--HQNIISLLGYCIHAETRFL  226 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~l  226 (439)
                      ..++|++.+.||+|+||.||++...++..+|+|.+...  .....+.+.+|+.++++++  ||||+++++++...+..++
T Consensus        26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l  105 (313)
T 3cek_A           26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  105 (313)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred             ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence            35678999999999999999999988999999998643  2344567899999999997  5999999999999999999


Q ss_pred             EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccC
Q 013636          227 VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAG  306 (439)
Q Consensus       227 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~  306 (439)
                      ||| +.+++|.+++..   ...+++..+..++.|+++||+|||+.   +++||||||+||++++ +.+||+|||++....
T Consensus       106 v~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~  177 (313)
T 3cek_A          106 VME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQ  177 (313)
T ss_dssp             EEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC--
T ss_pred             EEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeecccccccc
Confidence            999 668899999964   24689999999999999999999998   9999999999999965 899999999997654


Q ss_pred             CCCcc---eeeccccCccchhhhcC-----------CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcc
Q 013636          307 TQSRN---VKISGTLGYVAPEYLLE-----------GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQ  372 (439)
Q Consensus       307 ~~~~~---~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~  372 (439)
                      .....   ....||+.|+|||.+.+           ..++.++||||||+++|||++|+.||........ ........ 
T Consensus       178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~~~~~~~~-  255 (313)
T 3cek_A          178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-KLHAIIDP-  255 (313)
T ss_dssp             ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-HHHHHHCT-
T ss_pred             CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH-HHHHHHhc-
Confidence            43221   23458999999999875           4688899999999999999999999976543211 11111000 


Q ss_pred             cccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhc
Q 013636          373 LTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL  424 (439)
Q Consensus       373 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  424 (439)
                       ......+...            ...+.+++.+||+.||++|||+.|++++-
T Consensus       256 -~~~~~~~~~~------------~~~l~~li~~~l~~dp~~Rps~~ell~h~  294 (313)
T 3cek_A          256 -NHEIEFPDIP------------EKDLQDVLKCCLKRDPKQRISIPELLAHP  294 (313)
T ss_dssp             -TSCCCCCCCS------------CHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             -ccccCCcccc------------hHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence             0011111111            23567799999999999999999999753

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=3.3e-40  Score=323.75  Aligned_cols=260  Identities=22%  Similarity=0.294  Sum_probs=197.3

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCe-----
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAET-----  223 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  223 (439)
                      .++|...+.||+|+||.||+|... ++..+|+|.+....  ....+.+.+|+.+++.++||||+++++++...+.     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            367888999999999999999875 57899999987543  2334678999999999999999999999987654     


Q ss_pred             -eEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccc
Q 013636          224 -RFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS  302 (439)
Q Consensus       224 -~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls  302 (439)
                       .++||||+. |+|.+++..     .+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||++
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~  173 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLA  173 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred             eEEEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccc
Confidence             499999997 588887742     489999999999999999999998   9999999999999999999999999999


Q ss_pred             cccCCCCcceeeccccCccchhhhcC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhccc--------
Q 013636          303 VTAGTQSRNVKISGTLGYVAPEYLLE-GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQL--------  373 (439)
Q Consensus       303 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~--------  373 (439)
                      ......  .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...+..+....+.......        
T Consensus       174 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  251 (353)
T 3coi_A          174 RHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL  251 (353)
T ss_dssp             TC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTC
T ss_pred             cCCCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHH
Confidence            765432  233468999999999987 678999999999999999999999998766443222111100000        


Q ss_pred             ccC------CCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          374 TDR------SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       374 ~~~------~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      .+.      ..++....+.+.. ........+.+++.+||+.||++|||+.|++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          252 NDKAAKSYIQSLPQTPRKDFTQ-LFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             SCHHHHHHHHTSCBCSSCCTTT-TCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             hhHHHHHHHHhCcCCCCccHHH-hcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            000      0000000000000 001123467789999999999999999999975

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.9e-40  Score=324.71  Aligned_cols=264  Identities=19%  Similarity=0.262  Sum_probs=203.1

Q ss_pred             hcCCCccceecccCcEEEEEEEECC--ccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCc------eeeeeeEEEeCCe
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFNE--KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQN------IISLLGYCIHAET  223 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~  223 (439)
                      .++|++.+.||+|+||+||+|....  +..+|+|.+... ....+.+.+|+.++++++|+|      ++.+.+++...+.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            4689999999999999999998753  368999999754 344567889999999997766      8999999999999


Q ss_pred             eEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE---------------
Q 013636          224 RFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILL---------------  288 (439)
Q Consensus       224 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl---------------  288 (439)
                      .++||||+ +++|.+++... ....+++..+..++.|++.||+|||+.   +|+||||||+|||+               
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~  171 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSC  171 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred             EEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccccc
Confidence            99999999 66777777542 234689999999999999999999998   99999999999999               


Q ss_pred             ----cCCCcEEEEecccccccCCCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhh
Q 013636          289 ----DSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQS  364 (439)
Q Consensus       289 ----~~~~~~kl~DfGls~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~  364 (439)
                          +.++.+||+|||++.......  ....||+.|+|||.+.+..++.++|||||||++|||++|+.||...+..+...
T Consensus       172 ~~~~~~~~~~kl~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  249 (355)
T 2eu9_A          172 EEKSVKNTSIRVADFGSATFDHEHH--TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLV  249 (355)
T ss_dssp             CEEEESCCCEEECCCTTCEETTSCC--CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             cccccCCCcEEEeecCccccccccc--cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence                668899999999997654332  33468999999999999999999999999999999999999998776544322


Q ss_pred             hHhhhhcccccC----C-----------CCCccC----------Cch-hcCccCHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 013636          365 MVTWAMPQLTDR----S-----------KLPNIV----------DPV-IRDTMDLKHLYQVAAVAVLCIQPEPSYRPLIT  418 (439)
Q Consensus       365 ~~~~~~~~~~~~----~-----------~~~~~~----------d~~-l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~  418 (439)
                      ............    .           ......          .+. ............+.+++.+||+.||++|||+.
T Consensus       250 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~  329 (355)
T 2eu9_A          250 MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLA  329 (355)
T ss_dssp             HHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             HHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHH
Confidence            222111100000    0           000000          000 00011123355788999999999999999999


Q ss_pred             HHHHh
Q 013636          419 DVLHS  423 (439)
Q Consensus       419 evl~~  423 (439)
                      |++++
T Consensus       330 e~l~h  334 (355)
T 2eu9_A          330 EALLH  334 (355)
T ss_dssp             HHTTS
T ss_pred             HHhcC
Confidence            99965

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.4e-40  Score=335.70  Aligned_cols=251  Identities=24%  Similarity=0.309  Sum_probs=189.0

Q ss_pred             cCCCccceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeeEEEEEec
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMM  231 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~  231 (439)
                      +.|...++||+|+||+||.+...++..||||++...   ..+.+.+|+.+++++ +||||+++++++.+.+..++||||+
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~   91 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC   91 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence            345556889999999998777778899999998643   345678899999886 8999999999999999999999999


Q ss_pred             cCCChhhhhcCCCCCC----CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC-------------CcE
Q 013636          232 QNGSLEKQLHGPTHGS----NLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS-------------FNA  294 (439)
Q Consensus       232 ~~gsL~~~l~~~~~~~----~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~-------------~~~  294 (439)
                      . |+|.+++.......    ..++..+..++.|++.||+|||+.   +|+||||||+|||++.+             +.+
T Consensus        92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEE
Confidence            6 69999997533211    113334678999999999999998   99999999999999754             489


Q ss_pred             EEEecccccccCCCCcc-----eeeccccCccchhhhcC-------CCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhh
Q 013636          295 KLSDFGLSVTAGTQSRN-----VKISGTLGYVAPEYLLE-------GKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQ  361 (439)
Q Consensus       295 kl~DfGls~~~~~~~~~-----~~~~gt~~y~aPE~~~~-------~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~  361 (439)
                      ||+|||++.........     ....||+.|+|||++.+       ..++.++|||||||++|||++ |+.||.......
T Consensus       168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~  247 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE  247 (434)
T ss_dssp             EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred             EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence            99999999876543221     23469999999999976       678999999999999999999 999997654332


Q ss_pred             hhhhHhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          362 CQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       362 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                       ......       ....+..     ...........+.+++.+||+.||++|||+.|++++
T Consensus       248 -~~i~~~-------~~~~~~~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  296 (434)
T 2rio_A          248 -SNIIRG-------IFSLDEM-----KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH  296 (434)
T ss_dssp             -HHHHHT-------CCCCCCC-----TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -HHHhcC-------CCCcccc-----cccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence             112111       0111110     111123445678899999999999999999999974

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.2e-40  Score=324.98  Aligned_cols=253  Identities=23%  Similarity=0.325  Sum_probs=171.8

Q ss_pred             hcCCCcc-ceecccCcEEEEEEEEC-CccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEe----CCeeE
Q 013636          152 TNNFQES-NVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH----AETRF  225 (439)
Q Consensus       152 ~~~~~~~-~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~  225 (439)
                      .++|++. ++||+|+||+||+|+.. ++..+|+|.+.... .   ...+....++.++||||+++++++..    ....+
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~  102 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-K---ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL  102 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-H---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-H---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence            4678874 46999999999999987 57899999986532 1   12223334567799999999999876    44579


Q ss_pred             EEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC---CCcEEEEecccc
Q 013636          226 LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDS---SFNAKLSDFGLS  302 (439)
Q Consensus       226 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~---~~~~kl~DfGls  302 (439)
                      +||||+++|+|.+++... ....+++..+..++.|++.||+|||+.   +++||||||+||+++.   ++.+||+|||++
T Consensus       103 lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~  178 (336)
T 3fhr_A          103 IIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFA  178 (336)
T ss_dssp             EEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence            999999999999999753 234699999999999999999999998   9999999999999976   455999999999


Q ss_pred             cccCCCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCcc
Q 013636          303 VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNI  382 (439)
Q Consensus       303 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  382 (439)
                      ....... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.................  ......+. 
T Consensus       179 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~-  254 (336)
T 3fhr_A          179 KETTQNA-LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIR--LGQYGFPN-  254 (336)
T ss_dssp             EEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------CCCT-
T ss_pred             eeccccc-cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhh--ccccccCc-
Confidence            7654332 2344589999999999888899999999999999999999999976543322111100000  00000000 


Q ss_pred             CCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          383 VDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       383 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                        + ...    .....+.+++..||+.||++|||+.|++++
T Consensus       255 --~-~~~----~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  288 (336)
T 3fhr_A          255 --P-EWS----EVSEDAKQLIRLLLKTDPTERLTITQFMNH  288 (336)
T ss_dssp             --T-TST----TCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             --h-hhc----cCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence              0 001    112357789999999999999999999975

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=8.6e-41  Score=329.85  Aligned_cols=263  Identities=18%  Similarity=0.284  Sum_probs=198.8

Q ss_pred             cCCCccceecccCcEEEEEEEE-CCccEEEEEEecCCCchHHHHHHHHHHHHHhcC-----------CCceeeeeeEEEe
Q 013636          153 NNFQESNVIGEGGRGHVYKARF-NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR-----------HQNIISLLGYCIH  220 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~  220 (439)
                      ++|++.+.||+|+||+||+|+. .++..+|+|.+... ....+.+.+|+.++++++           ||||+++++++..
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~   97 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   97 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence            5788999999999999999987 45788999999753 334567889999999886           8999999999886


Q ss_pred             CC----eeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc------C
Q 013636          221 AE----TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLD------S  290 (439)
Q Consensus       221 ~~----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~------~  290 (439)
                      .+    ..++||||+ +++|.+++.... ...+++..+..++.|++.||+|||+.  .+++||||||+|||++      .
T Consensus        98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~--~~ivH~Dikp~NIll~~~~~~~~  173 (373)
T 1q8y_A           98 KGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPEN  173 (373)
T ss_dssp             EETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTT
T ss_pred             cCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChHHeEEeccCCCcC
Confidence            54    789999999 889999997522 34589999999999999999999984  2899999999999994      4


Q ss_pred             CCcEEEEecccccccCCCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhh-------h
Q 013636          291 SFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQC-------Q  363 (439)
Q Consensus       291 ~~~~kl~DfGls~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~-------~  363 (439)
                      ++.+||+|||++.......  ....||+.|+|||.+.+..++.++|||||||++|||++|+.||...+....       .
T Consensus       174 ~~~~kl~Dfg~a~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~  251 (373)
T 1q8y_A          174 LIQIKIADLGNACWYDEHY--TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA  251 (373)
T ss_dssp             EEEEEECCCTTCEETTBCC--CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred             cceEEEcccccccccCCCC--CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHH
Confidence            4589999999997764432  234689999999999999999999999999999999999999986542211       1


Q ss_pred             hhHhhhhcc---------------cccCCCCCccCC-------chh--cCccCHHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 013636          364 SMVTWAMPQ---------------LTDRSKLPNIVD-------PVI--RDTMDLKHLYQVAAVAVLCIQPEPSYRPLITD  419 (439)
Q Consensus       364 ~~~~~~~~~---------------~~~~~~~~~~~d-------~~l--~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e  419 (439)
                      ..... ...               .........+..       ..+  ...........+.+++..||+.||++|||+.|
T Consensus       252 ~~~~~-~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  330 (373)
T 1q8y_A          252 QIIEL-LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG  330 (373)
T ss_dssp             HHHHH-HCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred             HHHHh-cCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHH
Confidence            11100 000               000000000000       000  11233556778889999999999999999999


Q ss_pred             HHHh
Q 013636          420 VLHS  423 (439)
Q Consensus       420 vl~~  423 (439)
                      ++++
T Consensus       331 ll~h  334 (373)
T 1q8y_A          331 LVNH  334 (373)
T ss_dssp             HHTC
T ss_pred             HhhC
Confidence            9975

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=2.4e-40  Score=319.39  Aligned_cols=251  Identities=26%  Similarity=0.396  Sum_probs=179.3

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCch-HH-HHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHD-AE-REFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      .++|+..+.||+|+||.||+|+.. ++..+|+|.+...... .. +.+.++..+++.++||||+++++++...+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            367888999999999999999986 5789999998754332 22 33455556788889999999999999999999999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHE-HCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT  307 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~-~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~  307 (439)
                      ||+ ++.+..+...  ....+++..+..++.|+++||+|||+ .   +++||||||+||+++.++++||+|||++.....
T Consensus       104 e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  177 (318)
T 2dyl_A          104 ELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVD  177 (318)
T ss_dssp             CCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             ecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence            999 4455555532  23468999999999999999999998 4   899999999999999999999999999976654


Q ss_pred             CCcceeeccccCccchhhhc-----CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChh-hhhhhHhhhhcccccCCCCCc
Q 013636          308 QSRNVKISGTLGYVAPEYLL-----EGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPT-QCQSMVTWAMPQLTDRSKLPN  381 (439)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  381 (439)
                      ........||+.|+|||.+.     ...++.++||||||+++|||++|+.||...... +......   .  ......+.
T Consensus       178 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~---~--~~~~~~~~  252 (318)
T 2dyl_A          178 DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVL---Q--EEPPLLPG  252 (318)
T ss_dssp             ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH---H--SCCCCCCS
T ss_pred             CccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHh---c--cCCCCCCc
Confidence            44444456899999999994     567889999999999999999999999864322 1111111   0  00111111


Q ss_pred             cCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          382 IVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       382 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      .      ...    ...+.+++.+||+.||++|||+.+++++
T Consensus       253 ~------~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          253 H------MGF----SGDFQSFVKDCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             S------SCC----CHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             c------CCC----CHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            0      011    2356779999999999999999999864

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.9e-41  Score=322.30  Aligned_cols=246  Identities=26%  Similarity=0.372  Sum_probs=191.7

Q ss_pred             HHHHhcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCch------HHHHHHHHHHHHHhc----CCCceeeeee
Q 013636          148 LEAATNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHD------AEREFNNEVNWLTKI----RHQNIISLLG  216 (439)
Q Consensus       148 l~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~h~niv~l~~  216 (439)
                      .+...++|++.+.||+|+||.||+|+.. ++..+|+|.+......      ....+.+|+.++.++    +||||+++++
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~  105 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD  105 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence            3455688999999999999999999874 5788999999654321      223466799999998    8999999999


Q ss_pred             EEEeCCeeEEEEEe-ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc-CCCcE
Q 013636          217 YCIHAETRFLVYEM-MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLD-SSFNA  294 (439)
Q Consensus       217 ~~~~~~~~~lV~e~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~-~~~~~  294 (439)
                      ++...+..++|+|| +.+++|.+++..   ...+++..+..++.|+++||+|||+.   +++||||||+||+++ +++.+
T Consensus       106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~  179 (312)
T 2iwi_A          106 WFETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCA  179 (312)
T ss_dssp             EC-----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEE
T ss_pred             EEecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeE
Confidence            99999999999999 789999999964   23589999999999999999999998   999999999999999 89999


Q ss_pred             EEEecccccccCCCCcceeeccccCccchhhhcCCCCC-CchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhccc
Q 013636          295 KLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLT-DKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQL  373 (439)
Q Consensus       295 kl~DfGls~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~  373 (439)
                      ||+|||++....... .....||..|+|||.+.+..+. .++||||||+++|||++|+.||.....     ...      
T Consensus       180 kl~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~------  247 (312)
T 2iwi_A          180 KLIDFGSGALLHDEP-YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE-----ILE------  247 (312)
T ss_dssp             EECCCSSCEECCSSC-BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----HHH------
T ss_pred             EEEEcchhhhcccCc-ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-----Hhh------
Confidence            999999998765433 2345689999999999877664 489999999999999999999975321     111      


Q ss_pred             ccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhc
Q 013636          374 TDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL  424 (439)
Q Consensus       374 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  424 (439)
                       ....++..+            ...+.+++.+||+.||++|||+.|++++-
T Consensus       248 -~~~~~~~~~------------~~~~~~li~~~l~~~p~~Rps~~e~l~~~  285 (312)
T 2iwi_A          248 -AELHFPAHV------------SPDCCALIRRCLAPKPSSRPSLEEILLDP  285 (312)
T ss_dssp             -TCCCCCTTS------------CHHHHHHHHHHTCSSTTTSCCHHHHHHST
T ss_pred             -hccCCcccC------------CHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence             111111111            23567799999999999999999999853

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.3e-40  Score=331.57  Aligned_cols=248  Identities=25%  Similarity=0.355  Sum_probs=188.0

Q ss_pred             hcCCCccceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeeEEEEEe
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      ..+|+..+.||+|+||+||.....++..||||++......   .+.+|+.+++++ +||||+++++++.+.+..++||||
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~   99 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL   99 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence            3568888999999999977666677889999999754322   356799999999 799999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC-----CCcEEEEeccccccc
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDS-----SFNAKLSDFGLSVTA  305 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~-----~~~~kl~DfGls~~~  305 (439)
                      +. |+|.+++....  ....+..+..++.|+++||+|||+.   +|+||||||+|||++.     +..+||+|||++...
T Consensus       100 ~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~  173 (432)
T 3p23_A          100 CA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL  173 (432)
T ss_dssp             CS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred             CC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence            96 59999997533  2344455678999999999999998   9999999999999953     346889999999766


Q ss_pred             CCCC----cceeeccccCccchhhhc---CCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCC
Q 013636          306 GTQS----RNVKISGTLGYVAPEYLL---EGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRS  377 (439)
Q Consensus       306 ~~~~----~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~  377 (439)
                      ....    ......||+.|+|||++.   ...++.++|||||||++|||++ |..||.............        ..
T Consensus       174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~--------~~  245 (432)
T 3p23_A          174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLG--------AC  245 (432)
T ss_dssp             ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTT--------CC
T ss_pred             cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhc--------cC
Confidence            4332    223356999999999998   4567889999999999999999 999997654333221111        11


Q ss_pred             CCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          378 KLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       378 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      .. ....+      .......+.+++.+||+.||++|||+.|++++
T Consensus       246 ~~-~~~~~------~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h  284 (432)
T 3p23_A          246 SL-DCLHP------EKHEDVIARELIEKMIAMDPQKRPSAKHVLKH  284 (432)
T ss_dssp             CC-TTSCT------TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             Cc-cccCc------cccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence            11 00111      01223456789999999999999999999964

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=5.7e-41  Score=324.91  Aligned_cols=246  Identities=22%  Similarity=0.354  Sum_probs=199.0

Q ss_pred             HHHHHhcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCch------HHHHHHHHHHHHHhcC--CCceeeeeeE
Q 013636          147 LLEAATNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHD------AEREFNNEVNWLTKIR--HQNIISLLGY  217 (439)
Q Consensus       147 ~l~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~~~  217 (439)
                      ..+...++|++.+.||+|+||.||+|+.. ++..+|+|.+......      ....+.+|+.++++++  |+|+++++++
T Consensus        37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~  116 (320)
T 3a99_A           37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW  116 (320)
T ss_dssp             ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred             ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence            34455688999999999999999999874 5788999998653221      2245678999999996  5999999999


Q ss_pred             EEeCCeeEEEEEeccC-CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc-CCCcEE
Q 013636          218 CIHAETRFLVYEMMQN-GSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLD-SSFNAK  295 (439)
Q Consensus       218 ~~~~~~~~lV~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~-~~~~~k  295 (439)
                      +...+..++|+||+.+ ++|.+++..   ...+++..+..++.|+++||+|||+.   +++||||||+|||++ +++.+|
T Consensus       117 ~~~~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~k  190 (320)
T 3a99_A          117 FERPDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELK  190 (320)
T ss_dssp             EECSSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEE
T ss_pred             EecCCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEE
Confidence            9999999999999986 899999864   34689999999999999999999998   999999999999999 789999


Q ss_pred             EEecccccccCCCCcceeeccccCccchhhhcCCCC-CCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccc
Q 013636          296 LSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKL-TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLT  374 (439)
Q Consensus       296 l~DfGls~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~  374 (439)
                      |+|||++....... .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||.....     ...       
T Consensus       191 L~Dfg~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~~~-------  257 (320)
T 3a99_A          191 LIDFGSGALLKDTV-YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----IIR-------  257 (320)
T ss_dssp             ECCCTTCEECCSSC-BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----HHH-------
T ss_pred             EeeCcccccccccc-ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-----hhc-------
Confidence            99999997765432 234568999999999987766 6789999999999999999999975321     110       


Q ss_pred             cCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          375 DRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       375 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      .....+.        ..    ...+.+++.+||+.||++|||+.|++++
T Consensus       258 ~~~~~~~--------~~----~~~~~~li~~~l~~dp~~Rps~~~ll~h  294 (320)
T 3a99_A          258 GQVFFRQ--------RV----SSECQHLIRWCLALRPSDRPTFEEIQNH  294 (320)
T ss_dssp             CCCCCSS--------CC----CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ccccccc--------cC----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0111111        11    2356779999999999999999999975

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.6e-40  Score=346.61  Aligned_cols=264  Identities=22%  Similarity=0.273  Sum_probs=201.3

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCC-CchHHHHHHHHHHHHHhcCCCceeeeeeEEEe------CCee
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDA-GHDAEREFNNEVNWLTKIRHQNIISLLGYCIH------AETR  224 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~~  224 (439)
                      ++|++.+.||+|+||+||+|... ++..+|+|.+... .....+.+.+|+.++++++||||+++++++..      .+..
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            68999999999999999999874 5788999998754 33445679999999999999999999998765      6678


Q ss_pred             EEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCc---EEEEeccc
Q 013636          225 FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFN---AKLSDFGL  301 (439)
Q Consensus       225 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~---~kl~DfGl  301 (439)
                      ++||||+++|+|.+++........+++..+..++.|++.||+|||+.   +++||||||+||+++.++.   +||+|||+
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG~  170 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGY  170 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred             EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccccc
Confidence            99999999999999998755555799999999999999999999998   9999999999999997665   99999999


Q ss_pred             ccccCCCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhh-hhhHh-------hhhccc
Q 013636          302 SVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQC-QSMVT-------WAMPQL  373 (439)
Q Consensus       302 s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~-~~~~~-------~~~~~~  373 (439)
                      +.............||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ...+.       ......
T Consensus       171 a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l  250 (676)
T 3qa8_A          171 AKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDL  250 (676)
T ss_dssp             CCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCC
T ss_pred             ccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhh
Confidence            9877655544556799999999999999999999999999999999999999976432110 00000       000000


Q ss_pred             ccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 013636          374 TDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVL  421 (439)
Q Consensus       374 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl  421 (439)
                      ..........  .............+.+++..||+.||++|||+.|++
T Consensus       251 ~g~~~~~~~l--p~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL  296 (676)
T 3qa8_A          251 TGAVKFSSVL--PTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP  296 (676)
T ss_dssp             SSSCCCCSSS--CCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred             cccccccccc--CCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence            0000000000  001122333456788999999999999999998744

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=8.3e-39  Score=340.22  Aligned_cols=239  Identities=24%  Similarity=0.367  Sum_probs=192.0

Q ss_pred             hcCCCccceecccCcEEEEEEEEC--CccEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCe-----
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN--EKLLAAVKRIDDAG-HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAET-----  223 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  223 (439)
                      .++|++.+.||+|+||+||+|.+.  ++..||+|.+.... ......+.+|+.++++++||||+++++++...+.     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            478999999999999999999986  57889999986543 3444678999999999999999999999987665     


Q ss_pred             eEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccccc
Q 013636          224 RFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSV  303 (439)
Q Consensus       224 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~  303 (439)
                      .++||||+++++|.+++..     .+++..+..++.|+++||+|||+.   +|+||||||+|||++++ .+||+|||++.
T Consensus       159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~  229 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVS  229 (681)
T ss_dssp             EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred             eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccch
Confidence            6999999999999987753     589999999999999999999998   99999999999999986 99999999998


Q ss_pred             ccCCCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccC
Q 013636          304 TAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV  383 (439)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  383 (439)
                      .....   ....||+.|+|||.+.++. +.++|||||||++|||++|..|+......                 .++. .
T Consensus       230 ~~~~~---~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~-----------------~~~~-~  287 (681)
T 2pzi_A          230 RINSF---GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD-----------------GLPE-D  287 (681)
T ss_dssp             ETTCC---SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS-----------------SCCT-T
T ss_pred             hcccC---CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc-----------------cccc-c
Confidence            76543   2345999999999987654 88999999999999999999887642110                 0000 0


Q ss_pred             CchhcCccCHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHhcccc
Q 013636          384 DPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPL-ITDVLHSLIPL  427 (439)
Q Consensus       384 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-~~evl~~L~~l  427 (439)
                      .+      .......+.+++.+||+.||++||+ ++++.+.|..+
T Consensus       288 ~~------~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  326 (681)
T 2pzi_A          288 DP------VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV  326 (681)
T ss_dssp             CH------HHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             cc------ccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence            00      0112346778999999999999995 55566655443

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.3e-38  Score=303.64  Aligned_cols=233  Identities=15%  Similarity=0.135  Sum_probs=184.2

Q ss_pred             hcCCCccceecccCcEEEEEEEECC-ccEEEEEEecCCCc---hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGH---DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLV  227 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  227 (439)
                      .++|++.+.||+|+||.||+|+... +..+|+|.+.....   ...+.+.+|+..+++++||||+++++++...+..++|
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            3678999999999999999999865 78999999975432   3346789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCC
Q 013636          228 YEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT  307 (439)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~  307 (439)
                      |||+++++|.+++..   +  .......+++.|++.||+|||+.   +++||||||+|||+++++.+||+++|       
T Consensus       110 ~e~~~g~~L~~~l~~---~--~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~-------  174 (286)
T 3uqc_A          110 AEWIRGGSLQEVADT---S--PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA-------  174 (286)
T ss_dssp             EECCCEEEHHHHHTT---C--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred             EEecCCCCHHHHHhc---C--CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc-------
Confidence            999999999999953   1  35667889999999999999998   99999999999999999999997443       


Q ss_pred             CCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchh
Q 013636          308 QSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVI  387 (439)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  387 (439)
                                  |++|       ++.++|||||||++|||++|+.||...+.....   ..+.........    ....+
T Consensus       175 ------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~---~~~~~~~~~~~~----~~~~~  228 (286)
T 3uqc_A          175 ------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL---APAERDTAGQPI----EPADI  228 (286)
T ss_dssp             ------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS---EECCBCTTSCBC----CHHHH
T ss_pred             ------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh---HHHHHHhccCCC----Chhhc
Confidence                        3433       688999999999999999999999876543210   000000000000    00011


Q ss_pred             cCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCC
Q 013636          388 RDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPT  430 (439)
Q Consensus       388 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~  430 (439)
                      ...+    ...+.+++.+||+.||++| |+.|+++.|+++...
T Consensus       229 ~~~~----~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~  266 (286)
T 3uqc_A          229 DRDI----PFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV  266 (286)
T ss_dssp             CTTS----CHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred             ccCC----CHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence            1122    2357789999999999999 999999999876654

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=5.9e-38  Score=300.65  Aligned_cols=230  Identities=20%  Similarity=0.310  Sum_probs=176.8

Q ss_pred             cCCCcc-ceecccCcEEEEEEEEC-CccEEEEEEecCCCchHHHHHHHHHHHH-HhcCCCceeeeeeEEEe----CCeeE
Q 013636          153 NNFQES-NVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWL-TKIRHQNIISLLGYCIH----AETRF  225 (439)
Q Consensus       153 ~~~~~~-~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~~  225 (439)
                      ++|.+. +.||+|+||.||++... ++..+|+|.+...     ..+.+|+.++ +..+||||+++++++..    ....+
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   91 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   91 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence            456665 78999999999999884 5789999998642     3567788887 56699999999999887    66789


Q ss_pred             EEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC---CCcEEEEecccc
Q 013636          226 LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDS---SFNAKLSDFGLS  302 (439)
Q Consensus       226 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~---~~~~kl~DfGls  302 (439)
                      +||||+++|+|.+++... ....+++..+..++.|++.||+|||+.   +++||||||+||+++.   ++.+||+|||++
T Consensus        92 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a  167 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA  167 (299)
T ss_dssp             EEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence            999999999999999752 234699999999999999999999998   9999999999999998   789999999998


Q ss_pred             cccCCCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCcc
Q 013636          303 VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNI  382 (439)
Q Consensus       303 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  382 (439)
                      ....                     +..++.++|||||||++|||++|+.||...+........       .........
T Consensus       168 ~~~~---------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~-------~~~~~~~~~  219 (299)
T 3m2w_A          168 KETT---------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM-------KTRIRMGQY  219 (299)
T ss_dssp             EECT---------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCS-------CCSSCTTCC
T ss_pred             cccc---------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHH-------HHHHhhccc
Confidence            6532                     134677999999999999999999999765432211000       000000000


Q ss_pred             -CCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          383 -VDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       383 -~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                       ........    ....+.+++.+||+.||++|||+.|++++
T Consensus       220 ~~~~~~~~~----~~~~~~~li~~~l~~dP~~Rps~~e~l~h  257 (299)
T 3m2w_A          220 EFPNPEWSE----VSEEVKMLIRNLLKTEPTQRMTITEFMNH  257 (299)
T ss_dssp             SSCHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cCCchhccc----CCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence             00000011    13467789999999999999999999975

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.6e-38  Score=318.48  Aligned_cols=243  Identities=19%  Similarity=0.205  Sum_probs=181.0

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCch---HHHHHHHHHHHHHhcCC-Cceee---------ee--
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRH-QNIIS---------LL--  215 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h-~niv~---------l~--  215 (439)
                      ..+|...+.||+|+||+||+|++. ++..||||.+......   ..+.+.+|+.+++.++| +|...         ..  
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            345777899999999999999964 5789999998743322   24678999999999987 22111         11  


Q ss_pred             ----------eEEEe-----CCeeEEEEEeccCCChhhhhcC----CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 013636          216 ----------GYCIH-----AETRFLVYEMMQNGSLEKQLHG----PTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPV  276 (439)
Q Consensus       216 ----------~~~~~-----~~~~~lV~e~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~i  276 (439)
                                .++..     ....+++|+++ +++|.+++..    ......+++..++.++.|+++||+|||+.   +|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i  232 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL  232 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence                      11111     12356777765 6799998841    12344688899999999999999999998   99


Q ss_pred             EecCCCCCCEEEcCCCcEEEEecccccccCCCCcceeeccccCccchhhh----------cCCCCCCchhhHHHHHHHHH
Q 013636          277 VHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYL----------LEGKLTDKSDVYAFGVVLLE  346 (439)
Q Consensus       277 vH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DvwS~Gvll~e  346 (439)
                      +||||||+|||++.++.+||+|||+++..+..  .....| +.|+|||.+          .+..++.++|||||||++||
T Consensus       233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e  309 (413)
T 3dzo_A          233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW  309 (413)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred             ccCCcccceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence            99999999999999999999999999765443  234457 999999999          55568889999999999999


Q ss_pred             HHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          347 LLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       347 lltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      |++|+.||...+.......+      +....            .+    ...+.+++..||+.||++|||+.+++++
T Consensus       310 lltg~~Pf~~~~~~~~~~~~------~~~~~------------~~----~~~~~~li~~~l~~dP~~Rpt~~~~l~~  364 (413)
T 3dzo_A          310 IWCADLPNTDDAALGGSEWI------FRSCK------------NI----PQPVRALLEGFLRYPKEDRLLPLQAMET  364 (413)
T ss_dssp             HHHSSCCCCTTGGGSCSGGG------GSSCC------------CC----CHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHHCCCCCCCcchhhhHHHH------Hhhcc------------cC----CHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            99999999875543211111      11011            11    1457789999999999999998877643

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=9e-38  Score=304.36  Aligned_cols=244  Identities=17%  Similarity=0.142  Sum_probs=184.0

Q ss_pred             hcCCCccceecccCcEEEEEEEECCccEEEEEEecCCC--------chHHHHHHHHHHHHHhcC---------CCceeee
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAG--------HDAEREFNNEVNWLTKIR---------HQNIISL  214 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv~l  214 (439)
                      .++|++.+.||+|+||+||+|+. ++..+|+|.+....        ....+.+.+|+.++++++         |||++++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            35688899999999999999998 56889999987542        223367889999998886         7777777


Q ss_pred             eeEEE------------------------------eCCeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHH
Q 013636          215 LGYCI------------------------------HAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG  264 (439)
Q Consensus       215 ~~~~~------------------------------~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~g  264 (439)
                      .+.+.                              ..+..++||||+++|++.+.+.+    ..+++..+..++.|++.|
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence            76543                              26789999999999987777643    358999999999999999


Q ss_pred             HHHHh-hcCCCCeEecCCCCCCEEEcCCC--------------------cEEEEecccccccCCCCcceeeccccCccch
Q 013636          265 LEYLH-EHCNHPVVHRDLKSSNILLDSSF--------------------NAKLSDFGLSVTAGTQSRNVKISGTLGYVAP  323 (439)
Q Consensus       265 l~~LH-~~~~~~ivH~Dlk~~NiLl~~~~--------------------~~kl~DfGls~~~~~~~~~~~~~gt~~y~aP  323 (439)
                      |+||| +.   +|+||||||+|||++.++                    .+||+|||+|+.....    ...||+.|+||
T Consensus       174 L~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aP  246 (336)
T 2vuw_A          174 LAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDE  246 (336)
T ss_dssp             HHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCS
T ss_pred             HHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccCh
Confidence            99999 87   999999999999999887                    8999999999876432    34699999999


Q ss_pred             hhhcCCCCCCchhhHHHHHH-HHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHH
Q 013636          324 EYLLEGKLTDKSDVYAFGVV-LLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAV  402 (439)
Q Consensus       324 E~~~~~~~~~~~DvwS~Gvl-l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l  402 (439)
                      |++.+.. +.++||||+|++ .+++++|..||....  ................    ....+    .........+.++
T Consensus       247 E~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~--~~~~~~~~~~~~~~~~----~~~~~----~~~~~~s~~~~dl  315 (336)
T 2vuw_A          247 DLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL--WLHYLTDKMLKQMTFK----TKCNT----PAMKQIKRKIQEF  315 (336)
T ss_dssp             GGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH--HHHHHHHHHHHTCCCS----SCCCS----HHHHHHHHHHHHH
T ss_pred             hhhcCCC-ccceehhhhhCCCCcccccccCCCcchh--hhhHHHHhhhhhhccC----cccch----hhhhhcCHHHHHH
Confidence            9998766 889999998777 777888999984311  0011111111111101    00011    1112345678899


Q ss_pred             HHHhcCCCCCCCCCHHHHH-Hh
Q 013636          403 AVLCIQPEPSYRPLITDVL-HS  423 (439)
Q Consensus       403 ~~~cl~~dP~~RPt~~evl-~~  423 (439)
                      +.+||+.|     |+.|++ ++
T Consensus       316 i~~~L~~d-----sa~e~l~~H  332 (336)
T 2vuw_A          316 HRTMLNFS-----SATDLLCQH  332 (336)
T ss_dssp             HHHGGGSS-----SHHHHHHHC
T ss_pred             HHHHhccC-----CHHHHHhcC
Confidence            99999976     999998 54

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.96  E-value=5.1e-31  Score=273.62  Aligned_cols=183  Identities=20%  Similarity=0.167  Sum_probs=126.3

Q ss_pred             ecccCcEEEEEEE-ECCccEEEEEEecCCC----------chHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeeEEEE
Q 013636          161 IGEGGRGHVYKAR-FNEKLLAAVKRIDDAG----------HDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       161 LG~G~fg~Vy~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      .+.|++|.+..++ .--+..+++|.+....          ....++|.+|+++|+++ .|+||+++++++++++..||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            4566666555442 2235667888885431          12335699999999999 7999999999999999999999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~  308 (439)
                      ||++||+|.+++..   ++.++..   +|+.||+.||+|+|++   +|+||||||+|||+++++++||+|||+|+.....
T Consensus       322 Eyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~  392 (569)
T 4azs_A          322 EKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD  392 (569)
T ss_dssp             ECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred             ecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence            99999999999964   3456654   4789999999999998   9999999999999999999999999999766443


Q ss_pred             C-cceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCC
Q 013636          309 S-RNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP  353 (439)
Q Consensus       309 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P  353 (439)
                      . .....+||+.|+|||++.+ .+..++|+||+|++++++.++..|
T Consensus       393 ~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          393 CSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             -CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             CccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            2 2344679999999999865 567789999999998887665443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=2.3e-28  Score=252.35  Aligned_cols=183  Identities=15%  Similarity=0.225  Sum_probs=144.5

Q ss_pred             CccceecccCcEEEEEEEECCccEEEEEEecCCCc--------hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEE
Q 013636          156 QESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGH--------DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLV  227 (439)
Q Consensus       156 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  227 (439)
                      ...++||+|+||+||+++.. +..+++|+......        ...+.+.+|++++++++||||+++..++...+..++|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            34578999999999999555 45567776533211        1134589999999999999999877777788889999


Q ss_pred             EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCC
Q 013636          228 YEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT  307 (439)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~  307 (439)
                      |||+++|+|.+++..           +..++.|+++||+|||++   +|+||||||+|||+++  ++||+|||+++....
T Consensus       418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~  481 (540)
T 3en9_A          418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL  481 (540)
T ss_dssp             EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred             EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence            999999999999964           458999999999999998   9999999999999999  999999999987755


Q ss_pred             CCcc--------eeeccccCccchhhhcC--CCCCCchhhHHHHHHHHHHHhCCCCCC
Q 013636          308 QSRN--------VKISGTLGYVAPEYLLE--GKLTDKSDVYAFGVVLLELLMGRRPVE  355 (439)
Q Consensus       308 ~~~~--------~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~Gvll~elltG~~P~~  355 (439)
                      ....        ....||+.|+|||++..  ..|+..+|+||..+-..+-+.++.+|.
T Consensus       482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            3221        24569999999999987  567888999999998888888777663

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.91  E-value=1.7e-24  Score=205.34  Aligned_cols=149  Identities=18%  Similarity=0.126  Sum_probs=120.6

Q ss_pred             HHhcCCCccceecccCcEEEEEEEECCccEEEEEEecCCCc------------------hHHHHHHHHHHHHHhcCCCce
Q 013636          150 AATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGH------------------DAEREFNNEVNWLTKIRHQNI  211 (439)
Q Consensus       150 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~ni  211 (439)
                      .....|++.+.||+|+||.||+|...++..+|+|.+.....                  .....+.+|+.++++++  | 
T Consensus        87 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-  163 (282)
T 1zar_A           87 RSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-  163 (282)
T ss_dssp             HTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-
T ss_pred             hCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-
Confidence            34456667799999999999999997789999999864321                  13456899999999999  5 


Q ss_pred             eeeeeEEEeCCeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC
Q 013636          212 ISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS  291 (439)
Q Consensus       212 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~  291 (439)
                      +++.+++.. +..++||||+++|+|.+ +..         .....++.|+++||+|||+.   +++||||||+|||++ +
T Consensus       164 ~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~  228 (282)
T 1zar_A          164 LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-E  228 (282)
T ss_dssp             SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-T
T ss_pred             CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-C
Confidence            666665543 56699999999999998 521         12346999999999999998   999999999999999 9


Q ss_pred             CcEEEEecccccccCCCCcceeeccccCccchhhhcC
Q 013636          292 FNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLE  328 (439)
Q Consensus       292 ~~~kl~DfGls~~~~~~~~~~~~~gt~~y~aPE~~~~  328 (439)
                      +.+||+|||+++.            +..+.|||.+..
T Consensus       229 ~~vkl~DFG~a~~------------~~~~~a~e~l~r  253 (282)
T 1zar_A          229 EGIWIIDFPQSVE------------VGEEGWREILER  253 (282)
T ss_dssp             TEEEECCCTTCEE------------TTSTTHHHHHHH
T ss_pred             CcEEEEECCCCeE------------CCCCCHHHHHHH
Confidence            9999999999863            345789998753

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.81  E-value=3.4e-20  Score=173.43  Aligned_cols=136  Identities=22%  Similarity=0.170  Sum_probs=105.3

Q ss_pred             CCccceecccCcEEEEEEEE-CCccE--EEEEEecCCCch------------------------HHHHHHHHHHHHHhcC
Q 013636          155 FQESNVIGEGGRGHVYKARF-NEKLL--AAVKRIDDAGHD------------------------AEREFNNEVNWLTKIR  207 (439)
Q Consensus       155 ~~~~~~LG~G~fg~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~  207 (439)
                      |++.+.||+|+||.||+|.. .++..  +|||.++.....                        ....+.+|+..+.+++
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            56778999999999999998 67777  999986532111                        1135789999999998


Q ss_pred             CCce--eeeeeEEEeCCeeEEEEEeccC-C----ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHh-hcCCCCeEec
Q 013636          208 HQNI--ISLLGYCIHAETRFLVYEMMQN-G----SLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLH-EHCNHPVVHR  279 (439)
Q Consensus       208 h~ni--v~l~~~~~~~~~~~lV~e~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH-~~~~~~ivH~  279 (439)
                      |+++  ...+++    +..++||||+.+ |    +|.+....      .++.....++.|++.||.||| +.   +++||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~---givHr  195 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEA---ELVHA  195 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTS---CEECS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHC---CEEeC
Confidence            8764  333332    356899999953 4    66665431      224456789999999999999 87   99999


Q ss_pred             CCCCCCEEEcCCCcEEEEeccccccc
Q 013636          280 DLKSSNILLDSSFNAKLSDFGLSVTA  305 (439)
Q Consensus       280 Dlk~~NiLl~~~~~~kl~DfGls~~~  305 (439)
                      ||||+|||+++  .++|+|||+|...
T Consensus       196 Dlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          196 DLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCCHHHEEEcC--cEEEEECcccccC
Confidence            99999999998  9999999999764

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.67  E-value=2.1e-16  Score=154.30  Aligned_cols=139  Identities=12%  Similarity=0.090  Sum_probs=100.7

Q ss_pred             CCCccceecccCcEEEEEEEECCccEEEEEEecCCCc--------------hHHH--------HHHHHHHHHHhcCCCce
Q 013636          154 NFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGH--------------DAER--------EFNNEVNWLTKIRHQNI  211 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~--------~~~~E~~~l~~l~h~ni  211 (439)
                      -|++.+.||+|+||.||+|...++..+|||.++....              ....        ....|...|.++.+.++
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            3888999999999999999999999999998653110              0001        12346666777654443


Q ss_pred             eeeeeEEEeCCeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC
Q 013636          212 ISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS  291 (439)
Q Consensus       212 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~  291 (439)
                      ....-+...  ..+|||||+++++|.++...         .....++.|++.+|.|||+.   +++||||||.|||++++
T Consensus       176 ~vp~p~~~~--~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~d  241 (397)
T 4gyi_A          176 PVPEPIAQS--RHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREE  241 (397)
T ss_dssp             SCCCEEEEE--TTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEE
T ss_pred             CCCeeeecc--CceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCC
Confidence            222112112  33799999999888765421         12346789999999999998   99999999999999887


Q ss_pred             C----------cEEEEecccccccC
Q 013636          292 F----------NAKLSDFGLSVTAG  306 (439)
Q Consensus       292 ~----------~~kl~DfGls~~~~  306 (439)
                      +          .+.|+||+.+....
T Consensus       242 gd~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          242 KDAEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             ECSSCTTSEEEEEEECCCTTCEETT
T ss_pred             CCcccccccccceEEEEeCCcccCC
Confidence            6          38999999886543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.38  E-value=1.7e-12  Score=120.97  Aligned_cols=145  Identities=15%  Similarity=0.081  Sum_probs=112.5

Q ss_pred             HhcCCCccceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcC-CCceeeeeeEEEeCCeeEEEEE
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR-HQNIISLLGYCIHAETRFLVYE  229 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e  229 (439)
                      .-+.|+....++.|+.+.||++... +..+++|............+.+|+.+++.+. +.++.++++++...+..++|||
T Consensus        12 ~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e   90 (263)
T 3tm0_A           12 LIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS   90 (263)
T ss_dssp             HHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred             HhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence            3456777788888999999999865 5678899886422122345888999999984 6778889999998889999999


Q ss_pred             eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-------------------------------------
Q 013636          230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC-------------------------------------  272 (439)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~-------------------------------------  272 (439)
                      |++|.+|.+.+..        ......++.+++++++.||+..                                     
T Consensus        91 ~i~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (263)
T 3tm0_A           91 EADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT  162 (263)
T ss_dssp             CCSSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred             ecCCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence            9999999876421        1123468889999999999821                                     


Q ss_pred             -------------------CCCeEecCCCCCCEEEcCCCcEEEEecccccc
Q 013636          273 -------------------NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT  304 (439)
Q Consensus       273 -------------------~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~  304 (439)
                                         ...++|+|+++.||+++++..+.|+||+.+..
T Consensus       163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                               13599999999999998766678999997743

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.25  E-value=1.3e-11  Score=114.34  Aligned_cols=137  Identities=16%  Similarity=0.128  Sum_probs=100.4

Q ss_pred             CCCccceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCc--eeeeeeEEEeCCeeEEEEEec
Q 013636          154 NFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQN--IISLLGYCIHAETRFLVYEMM  231 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lV~e~~  231 (439)
                      ++.+..+.+.|..+.||++...++..+++|.....   ....+.+|+.+++.+.+.+  +.+++++....+..++||||+
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i   97 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV   97 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred             CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence            34433333456669999998877778899987653   2245778999999886545  445888888777889999999


Q ss_pred             cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC---------------------------------------
Q 013636          232 QNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC---------------------------------------  272 (439)
Q Consensus       232 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~---------------------------------------  272 (439)
                      +|.+|.  ...      .+   ...++.++++.++.||+..                                       
T Consensus        98 ~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (264)
T 1nd4_A           98 PGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA  166 (264)
T ss_dssp             SSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred             CCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence            998884  221      12   2357788888888888742                                       


Q ss_pred             ----------------CCCeEecCCCCCCEEEcCCCcEEEEecccccc
Q 013636          273 ----------------NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT  304 (439)
Q Consensus       273 ----------------~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~  304 (439)
                                      ...++|+|++|.||+++++..+.|+|||.+..
T Consensus       167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                            11299999999999998876678999998753

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.12  E-value=1.9e-10  Score=112.18  Aligned_cols=142  Identities=13%  Similarity=0.171  Sum_probs=106.3

Q ss_pred             cceecccCcEEEEEEEECCccEEEEEEec--CCC-chHHHHHHHHHHHHHhcC--CCceeeeeeEEEeC---CeeEEEEE
Q 013636          158 SNVIGEGGRGHVYKARFNEKLLAAVKRID--DAG-HDAEREFNNEVNWLTKIR--HQNIISLLGYCIHA---ETRFLVYE  229 (439)
Q Consensus       158 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lV~e  229 (439)
                      .+.++.|.++.||+....+ ..+++|+..  ... ......+.+|..+++.+.  +.++.++++++.+.   +..++|||
T Consensus        43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme  121 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME  121 (359)
T ss_dssp             EEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred             EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence            5678999999999998776 456777665  221 122346888999999997  45678888888766   34899999


Q ss_pred             eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-------------------------------------
Q 013636          230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC-------------------------------------  272 (439)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~-------------------------------------  272 (439)
                      |+++.++.+..     ...++...+..++.++++.|+.||+..                                     
T Consensus       122 ~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (359)
T 3dxp_A          122 FVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA  196 (359)
T ss_dssp             CCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred             ecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence            99998775421     124778888999999999999999731                                     


Q ss_pred             ------------------CCCeEecCCCCCCEEEcCCCc--EEEEeccccccc
Q 013636          273 ------------------NHPVVHRDLKSSNILLDSSFN--AKLSDFGLSVTA  305 (439)
Q Consensus       273 ------------------~~~ivH~Dlk~~NiLl~~~~~--~kl~DfGls~~~  305 (439)
                                        ...++|||+++.||+++.++.  +.|+||+.+...
T Consensus       197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                              246999999999999997753  699999998653

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.01  E-value=4e-10  Score=107.29  Aligned_cols=183  Identities=21%  Similarity=0.231  Sum_probs=121.7

Q ss_pred             cceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcC-CCc--eeeeeeEEEeCC---eeEEEEEec
Q 013636          158 SNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR-HQN--IISLLGYCIHAE---TRFLVYEMM  231 (439)
Q Consensus       158 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lV~e~~  231 (439)
                      .+.++.|....||+..    ..+++|.....  .....+.+|..+++.+. +..  +.+.+......+   ..++|||++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            4568999999999874    34677775432  34567889999998884 333  333444433332   348999999


Q ss_pred             cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC---------------------------------------
Q 013636          232 QNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC---------------------------------------  272 (439)
Q Consensus       232 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~---------------------------------------  272 (439)
                      +|.+|.+...     ..++..++..++.++++.++.||+..                                       
T Consensus        99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A           99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            9988865332     23677888888999999999998621                                       


Q ss_pred             ----------------CCCeEecCCCCCCEEEcC--CCcEEEEecccccccCCCCcceeeccccCc---cchhhhcC---
Q 013636          273 ----------------NHPVVHRDLKSSNILLDS--SFNAKLSDFGLSVTAGTQSRNVKISGTLGY---VAPEYLLE---  328 (439)
Q Consensus       273 ----------------~~~ivH~Dlk~~NiLl~~--~~~~kl~DfGls~~~~~~~~~~~~~gt~~y---~aPE~~~~---  328 (439)
                                      ...++|+|+++.||++++  +..+.++||+.+..........   ....+   ..|+....   
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~---~~~~~~~~~~~~~~~~~l~  250 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFI---SLMEDDEEYGMEFVSKILN  250 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHH---TTCCTTTSCCHHHHHHHHH
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHH---HHHhhccccCHHHHHHHHH
Confidence                            135899999999999998  5568999999886542211110   01111   22222110   


Q ss_pred             --CCC---------CCchhhHHHHHHHHHHHhCCCCC
Q 013636          329 --GKL---------TDKSDVYAFGVVLLELLMGRRPV  354 (439)
Q Consensus       329 --~~~---------~~~~DvwS~Gvll~elltG~~P~  354 (439)
                        +..         ....+.|+++.++|.+.+|..+|
T Consensus       251 ~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          251 HYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence              111         11368999999999999998776

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.51  E-value=9.4e-07  Score=82.08  Aligned_cols=135  Identities=15%  Similarity=0.109  Sum_probs=97.0

Q ss_pred             eecccCcE-EEEEEEECC-ccEEEEEEecCCCchHHHHHHHHHHHHHhcC-CCceeeeeeEEEeCCeeEEEEEeccCCCh
Q 013636          160 VIGEGGRG-HVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKIR-HQNIISLLGYCIHAETRFLVYEMMQNGSL  236 (439)
Q Consensus       160 ~LG~G~fg-~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~gsL  236 (439)
                      .+..|..| .||+..... +..+++|+-..   .....+.+|...|+.+. +-.+-++++++.+.+..++|||++++.++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            35555554 689887654 55678887643   24456888999998884 33466788899999999999999999888


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC--------------------------------------------
Q 013636          237 EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC--------------------------------------------  272 (439)
Q Consensus       237 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~--------------------------------------------  272 (439)
                      .+....       .......++.++++.|+-||+..                                            
T Consensus       108 ~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (272)
T 4gkh_A          108 FQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW  180 (272)
T ss_dssp             HHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred             cccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence            765531       11223456667777777777421                                            


Q ss_pred             -----------CCCeEecCCCCCCEEEcCCCcEEEEecccccc
Q 013636          273 -----------NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT  304 (439)
Q Consensus       273 -----------~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~  304 (439)
                                 ...++|+|+.+.||++++++.+-|+||+.+..
T Consensus       181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                       11389999999999999887778999998754

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.46  E-value=1.6e-06  Score=82.30  Aligned_cols=137  Identities=18%  Similarity=0.187  Sum_probs=95.9

Q ss_pred             cceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCC---ceeeeeeEEE-eCCeeEEEEEeccC
Q 013636          158 SNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQ---NIISLLGYCI-HAETRFLVYEMMQN  233 (439)
Q Consensus       158 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lV~e~~~~  233 (439)
                      .+.++.|....||+.    +..+++|.-..  ......+.+|..+|+.+.+.   .+.+.+.++. ..+..++||||++|
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            456888999999998    34567776432  23456789999999999753   3455666664 34567899999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc------------------------------------------
Q 013636          234 GSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH------------------------------------------  271 (439)
Q Consensus       234 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~------------------------------------------  271 (439)
                      .++.+....     .++......++.++++.|+.||+.                                          
T Consensus        98 ~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l  172 (306)
T 3tdw_A           98 QILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL  172 (306)
T ss_dssp             EECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred             eECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence            888763211     245556666666666666666643                                          


Q ss_pred             ---------------CCCCeEecCCCCCCEEEcC---CCc-EEEEeccccccc
Q 013636          272 ---------------CNHPVVHRDLKSSNILLDS---SFN-AKLSDFGLSVTA  305 (439)
Q Consensus       272 ---------------~~~~ivH~Dlk~~NiLl~~---~~~-~kl~DfGls~~~  305 (439)
                                     ....++|+|+++.||+++.   ++. +.|+||+.+...
T Consensus       173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                           1224699999999999987   455 589999987553

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.35  E-value=1e-06  Score=85.40  Aligned_cols=81  Identities=5%  Similarity=-0.029  Sum_probs=54.3

Q ss_pred             ccee-cccCcEEEEEEEEC-------CccEEEEEEecCCC---chHHHHHHHHHHHHHhcC-C--CceeeeeeEEEeC--
Q 013636          158 SNVI-GEGGRGHVYKARFN-------EKLLAAVKRIDDAG---HDAEREFNNEVNWLTKIR-H--QNIISLLGYCIHA--  221 (439)
Q Consensus       158 ~~~L-G~G~fg~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~--  221 (439)
                      .+.| +.|....+|+....       ++..+++|......   ......+.+|..+++.+. +  ..+.++++++.+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            3567 88889999998765       25567777654321   001235677888888774 2  3566677777654  


Q ss_pred             -CeeEEEEEeccCCChhh
Q 013636          222 -ETRFLVYEMMQNGSLEK  238 (439)
Q Consensus       222 -~~~~lV~e~~~~gsL~~  238 (439)
                       +..++||||+++.++.+
T Consensus       105 ~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             TSSCEEEEECCCCBCCCB
T ss_pred             cCCceEEEEecCCCChhh
Confidence             35689999999877653

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.11  E-value=2.1e-05  Score=75.25  Aligned_cols=141  Identities=20%  Similarity=0.242  Sum_probs=80.5

Q ss_pred             ceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcC-----CCceeeee-e--EEEeCCeeEEEEEe
Q 013636          159 NVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR-----HQNIISLL-G--YCIHAETRFLVYEM  230 (439)
Q Consensus       159 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~-~--~~~~~~~~~lV~e~  230 (439)
                      +.|+.|..+.||+....++. +++|.....    ..++..|..+++.+.     .|.++... |  +....+..+++|||
T Consensus        38 ~~l~gG~~n~~~~v~~~~~~-~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSGA-VCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTEE-EEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCCC-EEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            45666778999999887665 788887652    123334555555442     34444311 1  12346678999999


Q ss_pred             ccCCChh--------------hhhcC----C--CCC-----CCCCHHHHH------------------------------
Q 013636          231 MQNGSLE--------------KQLHG----P--THG-----SNLTWHLRM------------------------------  255 (439)
Q Consensus       231 ~~~gsL~--------------~~l~~----~--~~~-----~~l~~~~~~------------------------------  255 (439)
                      ++|.++.              ..+|.    .  ...     ..-.|....                              
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9986542              11221    0  000     012332210                              


Q ss_pred             -HHHHHHHHHHHHHhh----------cCCCCeEecCCCCCCEEEcCCCcEEEEecccccc
Q 013636          256 -KIAVDVARGLEYLHE----------HCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT  304 (439)
Q Consensus       256 -~i~~~ia~gl~~LH~----------~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~  304 (439)
                       .+...+.+++++|++          .....++|+|+++.||+++.++.+.++||+.+..
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence             111123445666763          1235899999999999998888999999997743

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.03  E-value=1.8e-05  Score=77.83  Aligned_cols=75  Identities=13%  Similarity=0.086  Sum_probs=48.6

Q ss_pred             cceecccCcEEEEEEEEC-CccEEEEEEecCCCc-------hHHHHHHHHHHHHHhcCC--Ccee-eeeeEEEeCCeeEE
Q 013636          158 SNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGH-------DAEREFNNEVNWLTKIRH--QNII-SLLGYCIHAETRFL  226 (439)
Q Consensus       158 ~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~niv-~l~~~~~~~~~~~l  226 (439)
                      .+.+|.|.++.||+++.. ++..+++|.......       .....+..|.++++.+..  +..+ +++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            467999999999999764 456788887643211       122346778888887742  4444 44433  4556789


Q ss_pred             EEEeccCC
Q 013636          227 VYEMMQNG  234 (439)
Q Consensus       227 V~e~~~~g  234 (439)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999764

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.98  E-value=3.6e-05  Score=72.11  Aligned_cols=79  Identities=18%  Similarity=0.239  Sum_probs=57.2

Q ss_pred             CCCccceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCC---ceeeeeeEEEeCCeeEEEEEe
Q 013636          154 NFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQ---NIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~~~~lV~e~  230 (439)
                      .....+.+|.|..+.||+.+..++..+++|+-..........|..|...|+.+.-.   .+.+.+++    +..++||||
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~   91 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEW   91 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEEC
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEe
Confidence            44446779999999999999999999999987654444445678899999888422   23344443    234789999


Q ss_pred             ccCCCh
Q 013636          231 MQNGSL  236 (439)
Q Consensus       231 ~~~gsL  236 (439)
                      ++++..
T Consensus        92 l~~~~~   97 (288)
T 3f7w_A           92 VDERPP   97 (288)
T ss_dssp             CCCCCC
T ss_pred             ecccCC
Confidence            987654

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.91  E-value=9.3e-05  Score=70.24  Aligned_cols=138  Identities=15%  Similarity=0.162  Sum_probs=91.4

Q ss_pred             cceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcC---CCceeeeeeEEEeCCeeEEEEEeccCC
Q 013636          158 SNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR---HQNIISLLGYCIHAETRFLVYEMMQNG  234 (439)
Q Consensus       158 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV~e~~~~g  234 (439)
                      .+.|+.|....+|+.... +..+++|.....   ....+..|...|+.+.   ...+.+.++++...+..++||||+++.
T Consensus        41 ~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~  116 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLINDE-VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS  116 (312)
T ss_dssp             EEEECCSSSSEEEEEESS-SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred             eEEeCCccceeeeEEEEC-CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence            467899999999999864 456777876532   3556888999888883   356778888888888899999999988


Q ss_pred             Chhh-----------hhcCCCC----C---------------CCCCHHHHH---HHHH----------------HHHHH-
Q 013636          235 SLEK-----------QLHGPTH----G---------------SNLTWHLRM---KIAV----------------DVARG-  264 (439)
Q Consensus       235 sL~~-----------~l~~~~~----~---------------~~l~~~~~~---~i~~----------------~ia~g-  264 (439)
                      .+..           .||....    +               ..-+|....   ++..                .+... 
T Consensus       117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l  196 (312)
T 3jr1_A          117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV  196 (312)
T ss_dssp             CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred             CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence            6521           2332111    0               012454322   1111                11111 


Q ss_pred             HHHHhh-cCCCCeEecCCCCCCEEEcCCCcEEEEecc
Q 013636          265 LEYLHE-HCNHPVVHRDLKSSNILLDSSFNAKLSDFG  300 (439)
Q Consensus       265 l~~LH~-~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfG  300 (439)
                      ...|.. ...+.++|+|+.+.|++++.++ +.+.|++
T Consensus       197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            223422 2245799999999999999887 8888873

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.64  E-value=0.0002  Score=70.87  Aligned_cols=77  Identities=12%  Similarity=0.044  Sum_probs=48.3

Q ss_pred             CCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCcceeec--cccCccchhhhcCC---CCCCchhhHHHHHHHHHH
Q 013636          273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS--GTLGYVAPEYLLEG---KLTDKSDVYAFGVVLLEL  347 (439)
Q Consensus       273 ~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~~~~~~--gt~~y~aPE~~~~~---~~~~~~DvwS~Gvll~el  347 (439)
                      ...++|||+++.||+++.++ ++++||+.+........-....  -...|.+|+.....   ......++.+....+|+.
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL  309 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence            34899999999999998876 9999999886543221111111  11346666655311   111235566778888887


Q ss_pred             HhC
Q 013636          348 LMG  350 (439)
Q Consensus       348 ltG  350 (439)
                      +++
T Consensus       310 y~~  312 (420)
T 2pyw_A          310 FNK  312 (420)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            764

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.43  E-value=0.0015  Score=61.77  Aligned_cols=143  Identities=13%  Similarity=0.165  Sum_probs=79.1

Q ss_pred             ceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcC-----CCceeeee-e--EEEeCCeeEEEEEe
Q 013636          159 NVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR-----HQNIISLL-G--YCIHAETRFLVYEM  230 (439)
Q Consensus       159 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~-~--~~~~~~~~~lV~e~  230 (439)
                      +.|+.|....+|+....++ .+++|.....  .....+..|..++..+.     -|.++... |  +....+..+++++|
T Consensus        28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~  104 (322)
T 2ppq_A           28 KGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF  104 (322)
T ss_dssp             EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred             eccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence            4567788899999988766 4677877652  11224556777776663     23333211 1  11234567899999


Q ss_pred             ccCCChhh--------------hhcCC----CCC--CC---CCHHHHHH------------HHHHHHHHHHHHhhc----
Q 013636          231 MQNGSLEK--------------QLHGP----THG--SN---LTWHLRMK------------IAVDVARGLEYLHEH----  271 (439)
Q Consensus       231 ~~~gsL~~--------------~l~~~----~~~--~~---l~~~~~~~------------i~~~ia~gl~~LH~~----  271 (439)
                      ++|..+..              .+|..    ...  ..   ..|.....            +...+.+.++++++.    
T Consensus       105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~  184 (322)
T 2ppq_A          105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD  184 (322)
T ss_dssp             CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred             CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence            99865421              12211    000  00   12322111            011244455566532    


Q ss_pred             CCCCeEecCCCCCCEEEcCCCcEEEEecccccc
Q 013636          272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT  304 (439)
Q Consensus       272 ~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~  304 (439)
                      ....++|+|+++.||+++++..+.++||+.+..
T Consensus       185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             SCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             CCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            134699999999999999876668999997743

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.38  E-value=0.00055  Score=64.39  Aligned_cols=139  Identities=16%  Similarity=0.085  Sum_probs=73.6

Q ss_pred             cceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCcee-eeeeEEEeCCeeEEEEEec-cCCC
Q 013636          158 SNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNII-SLLGYCIHAETRFLVYEMM-QNGS  235 (439)
Q Consensus       158 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lV~e~~-~~gs  235 (439)
                      .+.|+.|....+|+.     ..+++|....... ......+|...++.+...++. +++++  +.+..++++||+ ++.+
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~-~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTE-EYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCcc-ceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence            577999999999999     3466776654211 111234577777766433333 44433  344567899999 5544


Q ss_pred             hhh------------------hhcCCCC--CCCCCH-HHHHHHHH--------------HHHHHHH----HHhh-cCCCC
Q 013636          236 LEK------------------QLHGPTH--GSNLTW-HLRMKIAV--------------DVARGLE----YLHE-HCNHP  275 (439)
Q Consensus       236 L~~------------------~l~~~~~--~~~l~~-~~~~~i~~--------------~ia~gl~----~LH~-~~~~~  275 (439)
                      +..                  .+|....  ....+. .....+..              .+.+.+.    .+.. .....
T Consensus        95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~  174 (301)
T 3dxq_A           95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA  174 (301)
T ss_dssp             CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred             CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence            421                  1122110  000111 11111100              0111111    1111 12235


Q ss_pred             eEecCCCCCCEEEcCCCcEEEEeccccccc
Q 013636          276 VVHRDLKSSNILLDSSFNAKLSDFGLSVTA  305 (439)
Q Consensus       276 ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~  305 (439)
                      ++|+|+.+.||+ .+++.+.++||..+...
T Consensus       175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~g  203 (301)
T 3dxq_A          175 ACHCDPLCENFL-DTGERMWIVDWEYSGMN  203 (301)
T ss_dssp             EECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred             eeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence            899999999999 66678899999988543

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.14  E-value=0.0044  Score=58.66  Aligned_cols=143  Identities=13%  Similarity=0.174  Sum_probs=81.9

Q ss_pred             ceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCC--ceeeeeeE-----EEeCCeeEEEEEec
Q 013636          159 NVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQ--NIISLLGY-----CIHAETRFLVYEMM  231 (439)
Q Consensus       159 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~-----~~~~~~~~lV~e~~  231 (439)
                      ..++ |....||+....++..+++|....... ....+..|..+++.+...  .+.+++..     ....+..+++++|+
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence            4566 888899998877776788898764321 234566788877777421  23334432     22345668899999


Q ss_pred             cCCChhh--------------hhcC----CC--CCCCCCHHHH----HHH---------------HHHHHHHHHHHhhc-
Q 013636          232 QNGSLEK--------------QLHG----PT--HGSNLTWHLR----MKI---------------AVDVARGLEYLHEH-  271 (439)
Q Consensus       232 ~~gsL~~--------------~l~~----~~--~~~~l~~~~~----~~i---------------~~~ia~gl~~LH~~-  271 (439)
                      +|.++..              .+|.    ..  .....++...    ..+               ...+.+.++.+.+. 
T Consensus       110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  189 (328)
T 1zyl_A          110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW  189 (328)
T ss_dssp             CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence            8754320              0121    00  0112232211    000               01111223333221 


Q ss_pred             ---CCCCeEecCCCCCCEEEcCCCcEEEEeccccccc
Q 013636          272 ---CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA  305 (439)
Q Consensus       272 ---~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~  305 (439)
                         ....++|+|+++.||+++ + .+.++||+.+...
T Consensus       190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g  224 (328)
T 1zyl_A          190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG  224 (328)
T ss_dssp             CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred             hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence               234689999999999999 4 8999999987543

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.12  E-value=0.002  Score=61.31  Aligned_cols=33  Identities=24%  Similarity=0.312  Sum_probs=28.2

Q ss_pred             CCCeEecCCCCCCEEEcCC----CcEEEEeccccccc
Q 013636          273 NHPVVHRDLKSSNILLDSS----FNAKLSDFGLSVTA  305 (439)
Q Consensus       273 ~~~ivH~Dlk~~NiLl~~~----~~~kl~DfGls~~~  305 (439)
                      ...++|||+.+.||+++.+    +.+.++||+.+...
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            3479999999999999874    68999999988654

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.05  E-value=0.001  Score=66.05  Aligned_cols=73  Identities=15%  Similarity=0.134  Sum_probs=47.9

Q ss_pred             cceecccCcEEEEEEEECC--------ccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCce-eeeeeEEEeCCeeEEEE
Q 013636          158 SNVIGEGGRGHVYKARFNE--------KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNI-ISLLGYCIHAETRFLVY  228 (439)
Q Consensus       158 ~~~LG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~  228 (439)
                      .+.|+.|....+|+....+        +..+++|......  ....+.+|..+++.+...++ .++++.+.  +  .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEE
Confidence            4568888899999998753        4567777764321  12345578888888854344 44555543  2  3899


Q ss_pred             EeccCCCh
Q 013636          229 EMMQNGSL  236 (439)
Q Consensus       229 e~~~~gsL  236 (439)
                      ||+++.+|
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99986444

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.77  E-value=0.0074  Score=60.24  Aligned_cols=74  Identities=12%  Similarity=0.058  Sum_probs=45.9

Q ss_pred             cceecccCcEEEEEEEECC-ccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCcee-eeeeEEEeCCeeEEEEEeccCCC
Q 013636          158 SNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNII-SLLGYCIHAETRFLVYEMMQNGS  235 (439)
Q Consensus       158 ~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lV~e~~~~gs  235 (439)
                      .+.|+.|-...+|+....+ +..+++|....... ..-+..+|..+++.+...++. ++++.+  .+  .+|+||+++.+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~-~~idR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD-EIINREREKKISCILYNKNIAKKIYVFF--TN--GRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CC-SCSCHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChh-hhcCHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEeeCCcc
Confidence            3568888899999998876 45667776543211 111125788888888655554 455555  22  35999998755


Q ss_pred             h
Q 013636          236 L  236 (439)
Q Consensus       236 L  236 (439)
                      |
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.72  E-value=0.0048  Score=60.00  Aligned_cols=142  Identities=15%  Similarity=0.156  Sum_probs=81.9

Q ss_pred             cceecccCcEEEEEEEECC--------ccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCce-eeeeeEEEeCCeeEEEE
Q 013636          158 SNVIGEGGRGHVYKARFNE--------KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNI-ISLLGYCIHAETRFLVY  228 (439)
Q Consensus       158 ~~~LG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~  228 (439)
                      .+.|..|-...+|+....+        +..+++++-... ......+.+|..+++.+.-.++ .++++++.  +  .+|+
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~--g~v~  129 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFP--E--GRLE  129 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T--EEEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C--ccEE
Confidence            3567778888899998752        356777775332 2234456689998888843333 44555543  2  2999


Q ss_pred             EeccCCChhh-----------------hhcCCC--CCCCCC--HHHHHHHHHHHHH-------------------HHHHH
Q 013636          229 EMMQNGSLEK-----------------QLHGPT--HGSNLT--WHLRMKIAVDVAR-------------------GLEYL  268 (439)
Q Consensus       229 e~~~~gsL~~-----------------~l~~~~--~~~~l~--~~~~~~i~~~ia~-------------------gl~~L  268 (439)
                      ||++|.+|..                 .||...  .+....  |.++.++..++..                   .+..|
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            9999865531                 123211  112222  4555555544322                   23333


Q ss_pred             h----hc-CCCCeEecCCCCCCEEEcCC----CcEEEEecccccc
Q 013636          269 H----EH-CNHPVVHRDLKSSNILLDSS----FNAKLSDFGLSVT  304 (439)
Q Consensus       269 H----~~-~~~~ivH~Dlk~~NiLl~~~----~~~kl~DfGls~~  304 (439)
                      .    .. ....++|+|+.+.||+++++    +.+.++||..+..
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            2    21 22369999999999999876    7899999998853

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.63  E-value=0.0025  Score=61.68  Aligned_cols=74  Identities=14%  Similarity=0.086  Sum_probs=42.1

Q ss_pred             cceecccCcEEEEEEEECCc---------cEEEEEEecCCCchHHHHHHHHHHHHHhcCCCcee-eeeeEEEeCCeeEEE
Q 013636          158 SNVIGEGGRGHVYKARFNEK---------LLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNII-SLLGYCIHAETRFLV  227 (439)
Q Consensus       158 ~~~LG~G~fg~Vy~~~~~~~---------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lV  227 (439)
                      .+.++.|....+|+....++         ..+++|...... ....+...|..+++.+...+++ ++++..  .  -++|
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v  112 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI  112 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence            35678888899999987642         466677654321 1111235677777777433333 455433  2  3789


Q ss_pred             EEeccCCCh
Q 013636          228 YEMMQNGSL  236 (439)
Q Consensus       228 ~e~~~~gsL  236 (439)
                      |||+++.++
T Consensus       113 ~e~i~G~~l  121 (369)
T 3c5i_A          113 EEWLYGDPL  121 (369)
T ss_dssp             EECCCSEEC
T ss_pred             EEEecCCcC
Confidence            999987543

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.60  E-value=0.0094  Score=56.99  Aligned_cols=31  Identities=16%  Similarity=0.308  Sum_probs=27.6

Q ss_pred             CCeEecCCCCCCEEEcCCCcEEEEecccccc
Q 013636          274 HPVVHRDLKSSNILLDSSFNAKLSDFGLSVT  304 (439)
Q Consensus       274 ~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~  304 (439)
                      ..++|+|+.+.||++++++.+.++||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            4699999999999999888899999987754

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.44  E-value=0.027  Score=49.84  Aligned_cols=98  Identities=15%  Similarity=0.135  Sum_probs=64.9

Q ss_pred             ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCcceee
Q 013636          235 SLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKI  314 (439)
Q Consensus       235 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~~~~~  314 (439)
                      ||.+.|.  ..+.++++.+++.++.|.+.+|.-+-.... + ..+=+.|..|++..+|++...+ +.+.           
T Consensus        34 SL~eIL~--~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------   97 (229)
T 2yle_A           34 SLEEILR--LYNQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD-----------   97 (229)
T ss_dssp             EHHHHHH--HHTSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred             cHHHHHH--HcCCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc-----------
Confidence            7888887  456789999999999999999877632111 1 1233456899999999988764 1110           


Q ss_pred             ccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh
Q 013636          315 SGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM  349 (439)
Q Consensus       315 ~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt  349 (439)
                      .....+.|||... ...+.+.-|||+|+++|.-+-
T Consensus        98 ~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD  131 (229)
T 2yle_A           98 AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD  131 (229)
T ss_dssp             ---------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred             ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence            1123467888753 344678899999999999887

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=95.31  E-value=0.023  Score=36.29  Aligned_cols=26  Identities=27%  Similarity=0.172  Sum_probs=9.7

Q ss_pred             eehhHHHHHHHHHHHHHHHHHHHhhh
Q 013636           75 IALVVSSTLLGVLLLFLLCFWIYRWK  100 (439)
Q Consensus        75 ~~~~~~~~~~~~~l~~~~~~~~~r~~  100 (439)
                      ||..+.+.++++++++++.+++.|||
T Consensus        13 IA~gVVgGv~~~~ii~~~~~~~~RRr   38 (44)
T 2ks1_B           13 IATGMVGALLLLLVVALGIGLFMRRR   38 (44)
T ss_dssp             STHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEeehhHHHHHHHHHHHHHHHHhhhh
Confidence            34443333333333333333333333

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=94.90  E-value=0.025  Score=35.98  Aligned_cols=8  Identities=25%  Similarity=-0.022  Sum_probs=3.0

Q ss_pred             HHHHhhhc
Q 013636           94 FWIYRWKR  101 (439)
Q Consensus        94 ~~~~r~~r  101 (439)
                      +++.|||+
T Consensus        31 ~~~~RRRr   38 (44)
T 2l2t_A           31 AVYVRRKS   38 (44)
T ss_dssp             HHHHHTTC
T ss_pred             HHHhhhhh
Confidence            33333333

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.49  E-value=0.15  Score=50.17  Aligned_cols=141  Identities=13%  Similarity=0.144  Sum_probs=81.9

Q ss_pred             cceecccCcEEEEEEEECC--------ccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCce-eeeeeEEEeCCeeEEEE
Q 013636          158 SNVIGEGGRGHVYKARFNE--------KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNI-ISLLGYCIHAETRFLVY  228 (439)
Q Consensus       158 ~~~LG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~  228 (439)
                      .+.+..|-...+|+....+        +..+++++..... ...-+..+|..+++.+...++ .++++.+  .  -++|+
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~  149 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIE  149 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEE
Confidence            3567778889999998763        4567777654322 111123567777777743333 3344432  2  37899


Q ss_pred             EeccCCChhh-----------------hhcCC-------C---CCCCCCHHHHHHHHHHH-------------------H
Q 013636          229 EMMQNGSLEK-----------------QLHGP-------T---HGSNLTWHLRMKIAVDV-------------------A  262 (439)
Q Consensus       229 e~~~~gsL~~-----------------~l~~~-------~---~~~~l~~~~~~~i~~~i-------------------a  262 (439)
                      ||+++.+|..                 .||..       .   ......|.++.++..++                   .
T Consensus       150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~  229 (424)
T 3mes_A          150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL  229 (424)
T ss_dssp             ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred             EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence            9999866421                 11210       0   11112344444443322                   2


Q ss_pred             HHHHHHhh---------------------cCCCCeEecCCCCCCEEEcCCCcEEEEecccccc
Q 013636          263 RGLEYLHE---------------------HCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT  304 (439)
Q Consensus       263 ~gl~~LH~---------------------~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~  304 (439)
                      ..+.+|.+                     .....++|+|+.+.||+ ++++.+.++||..+..
T Consensus       230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            22333321                     11235899999999999 8888999999998854

>2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A

Probab=91.64  E-value=0.11  Score=31.96  Aligned_cols=25  Identities=32%  Similarity=0.383  Sum_probs=13.2

Q ss_pred             eehhHHHHHHHHHHHHHHHHHHHhh
Q 013636           75 IALVVSSTLLGVLLLFLLCFWIYRW   99 (439)
Q Consensus        75 ~~~~~~~~~~~~~l~~~~~~~~~r~   99 (439)
                      ++.++..+++++++++.+++|++||
T Consensus        13 IAGiVvG~v~gv~li~~l~~~~~rr   37 (38)
T 2k1k_A           13 IVAVIFGLLLGAALLLGILVFRSRR   37 (38)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred             eeeeehHHHHHHHHHHHHHHHHeec
Confidence            3444455555555555555555543

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=86.76  E-value=2.1  Score=37.64  Aligned_cols=115  Identities=10%  Similarity=0.060  Sum_probs=77.1

Q ss_pred             CCCceeeeeeEEEeCCeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHH-HHhhcCCCCeEecCCCCCC
Q 013636          207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE-YLHEHCNHPVVHRDLKSSN  285 (439)
Q Consensus       207 ~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~-~LH~~~~~~ivH~Dlk~~N  285 (439)
                      .||++  -...-.+.+...+.|+.-+++.=...+.      .++...+++++.+++.-.. ++++     -+|--++|+|
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~------~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~N  114 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR------KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPEN  114 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH------TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH------hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCce
Confidence            57887  3344466777777777665543334443      3778899999999888766 5554     4788899999


Q ss_pred             EEEcCCCcEEEEecccccccCCCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCC
Q 013636          286 ILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVE  355 (439)
Q Consensus       286 iLl~~~~~~kl~DfGls~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~  355 (439)
                      +++|.++.+++.-.|+-....+..           +.+|          -=.-++=+++..++.++..|+
T Consensus       115 L~f~~~~~p~i~hRGi~~~lpP~e-----------~~ee----------~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          115 LMFNRALEPFFLHVGVKESLPPDE-----------WDDE----------RLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             EEECTTCCEEESCCEETTTBSSCS-----------CCHH----------HHHHHHHHHHHHHTTCSSCHH
T ss_pred             EEEeCCCcEEEEEcCCcccCCCCC-----------CCHH----------HHHHHHHHHHHHHHcCCCCHH
Confidence            999999999998777643321111           1122          112356678888888887764

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=85.34  E-value=1.4  Score=38.75  Aligned_cols=116  Identities=7%  Similarity=0.080  Sum_probs=78.5

Q ss_pred             CCCceeeeeeEEEeCCeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCE
Q 013636          207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNI  286 (439)
Q Consensus       207 ~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~Ni  286 (439)
                      .||+.++. ..-...+...+.|+.-+++.=...+      ..++...+++++.+++.-..++++.     +|--++|+|+
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i------k~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~NL  110 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI------KSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDEL  110 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG------GGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGGE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHHH------HhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecceE
Confidence            68888876 4555566666666544432222223      2378899999999999888776643     6888999999


Q ss_pred             EEcCCCcEEEEecccccccCCCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCC
Q 013636          287 LLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVE  355 (439)
Q Consensus       287 Ll~~~~~~kl~DfGls~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~  355 (439)
                      +++.++.+++.-.|+.....+.                     ..+...=.-.+=+++..+++++..|+
T Consensus       111 ~f~~~~~p~i~~RGik~~l~P~---------------------~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          111 FFTRDGLPIAKTRGLQNVVDPL---------------------PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             EECTTSCEEESCCEETTTBSCC---------------------CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             EEcCCCCEEEEEccCccCCCCC---------------------CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            9999999999877764332211                     11112223456788889999988885

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=84.45  E-value=0.12  Score=51.52  Aligned_cols=60  Identities=5%  Similarity=0.067  Sum_probs=17.5

Q ss_pred             cceecccCcEEEEEEEECC-ccEEEE------EEecCCC--chHHHHHHHHHHHHHhcCCCceeeeeeEEEe
Q 013636          158 SNVIGEGGRGHVYKARFNE-KLLAAV------KRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLLGYCIH  220 (439)
Q Consensus       158 ~~~LG~G~fg~Vy~~~~~~-~~~vav------K~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  220 (439)
                      .+.||   ||.||+|.+.. ...||+      |......  .+....|.+|..+++.++|||+++.+++...
T Consensus       147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~  215 (463)
T 3cxl_A          147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH  215 (463)
T ss_dssp             TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred             cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence            45566   99999999875 367777      6665422  2333468889999999999999999887653

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	439
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	4e-68
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-61
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-61
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-61
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-60
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-59
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-58
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-58
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	8e-58
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	4e-57
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	4e-57
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	4e-57
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	5e-57
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	5e-56
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	6e-56
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-55
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-55
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	4e-55
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	7e-55
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	9e-55
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	9e-55
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	4e-54
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-53
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	8e-53
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-52
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-52
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-52
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	8e-52
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-51
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-48
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	8e-48
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-47
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	4e-47
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-46
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-46
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	6e-46
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	6e-46
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	4e-45
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-44
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-44
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-44
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-43
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	4e-43
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-42
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	5e-42
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	6e-41
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	7e-41
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	4e-40
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-39
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	4e-39
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-38
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	9e-38
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-37
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-36
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-36
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	5e-36
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	6e-35
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	3e-34
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	4e-32
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	7e-31
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-30
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	5e-26
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	4e-18

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (550), Expect = 4e-68
 Identities = 73/278 (26%), Positives = 122/278 (43%), Gaps = 24/278 (8%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNII 212
                   IG G  G VYK +++  +   +  +        + F NEV  L K RH NI+
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67

Query: 213 SLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
             +GY        +V +  +  SL   LH     +       + IA   A+G++YLH   
Sbjct: 68  LFMGYSTA-PQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLH--- 121

Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK---ISGTLGYVAPEYLL-- 327
              ++HRDLKS+NI L      K+ DFGL+      S + +   +SG++ ++APE +   
Sbjct: 122 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181

Query: 328 -EGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPV 386
            +   + +SDVYAFG+VL EL+ G+ P   ++       +        D SK+ +     
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA 241

Query: 387 IRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
           ++             +   C++ +   RPL   +L S+
Sbjct: 242 MKR------------LMAECLKKKRDERPLFPQILASI 267

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (509), Expect = 2e-61
 Identities = 62/220 (28%), Positives = 104/220 (47%), Gaps = 8/220 (3%)

Query: 148 LEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAERE-FNNEVNWLTK 205
           +E   ++F++ + +G G  G V+K       L+ A K I      A R     E+  L +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60

Query: 206 IRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
                I+   G         +  E M  GSL++ L        +   +  K+++ V +GL
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGL 117

Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEY 325
            YL E   H ++HRD+K SNIL++S    KL DFG+S        N  + GT  Y++PE 
Sbjct: 118 TYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-GTRSYMSPER 174

Query: 326 LLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSM 365
           L     + +SD+++ G+ L+E+ +GR P+      + + M
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 214

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (503), Expect = 3e-61
 Identities = 73/273 (26%), Positives = 121/273 (44%), Gaps = 29/273 (10%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDA---GHDAEREFNNEVNWLTKIRH 208
            +F+    +G+G  G+VY AR  + K + A+K +  A       E +   EV   + +RH
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 209 QNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYL 268
            NI+ L GY   A   +L+ E    G++ ++L      S            ++A  L Y 
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYC 122

Query: 269 HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLE 328
           H      V+HRD+K  N+LL S+   K++DFG S      SR   + GTL Y+ PE +  
Sbjct: 123 HSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEG 178

Query: 329 GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIR 388
               +K D+++ GV+  E L+G+ P E  +  +    ++            P+ V    R
Sbjct: 179 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF------TFPDFVTEGAR 232

Query: 389 DTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
           D +               ++  PS RP++ +VL
Sbjct: 233 DLIS------------RLLKHNPSQRPMLREVL 253

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (504), Expect = 3e-61
 Identities = 68/275 (24%), Positives = 120/275 (43%), Gaps = 26/275 (9%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNII 212
              +    +G G  G V+   +N     AVK +   G  +   F  E N + +++HQ ++
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLV 71

Query: 213 SLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
            L       E  +++ E M+NGSL   L  P  G  LT +  + +A  +A G+ ++ E  
Sbjct: 72  RLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN 129

Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGK 330
               +HRDL+++NIL+  + + K++DFGL+  +     +        + + APE +  G 
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 186

Query: 331 LTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRD 389
            T KSDV++FG++L E++  GR P   M+  +    +         R   P+     +  
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY-----RMVRPDNCPEELYQ 241

Query: 390 TMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
                       +  LC +  P  RP    +   L
Sbjct: 242 ------------LMRLCWKERPEDRPTFDYLRSVL 264

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 1e-60
 Identities = 65/276 (23%), Positives = 118/276 (42%), Gaps = 26/276 (9%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNII 212
            +      +G G  G V   ++  +   A+K I + G  +E EF  E   +  + H+ ++
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLV 62

Query: 213 SLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
            L G C      F++ E M NG L   L    H         +++  DV   +EYL    
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLE--- 117

Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGK 330
           +   +HRDL + N L++     K+SDFGLS  V     + +V     + +  PE L+  K
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177

Query: 331 LTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRD 389
            + KSD++AFGV++ E+  +G+ P E+ + ++    +   +     R   P++    +  
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL-----RLYRPHLASEKVYT 232

Query: 390 TMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLI 425
                       +   C   +   RP    +L +++
Sbjct: 233 ------------IMYSCWHEKADERPTFKILLSNIL 256

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 1e-59
 Identities = 67/275 (24%), Positives = 117/275 (42%), Gaps = 26/275 (9%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNII 212
           +       IG G  G V+   +  K   A+K I + G  +E +F  E   + K+ H  ++
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLV 63

Query: 213 SLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
            L G C+      LV+E M++G L    +  T          + + +DV  G+ YL E C
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121

Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGK 330
              V+HRDL + N L+  +   K+SDFG++  V     + +      + + +PE     +
Sbjct: 122 ---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR 178

Query: 331 LTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRD 389
            + KSDV++FGV++ E+   G+ P E  S ++    ++        R   P +    +  
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF-----RLYKPRLASTHVYQ 233

Query: 390 TMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
                       +   C +  P  RP  + +L  L
Sbjct: 234 ------------IMNHCWKERPEDRPAFSRLLRQL 256

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  192 bits (488), Expect = 1e-58
 Identities = 70/305 (22%), Positives = 129/305 (42%), Gaps = 43/305 (14%)

Query: 145 YELLEAATNNFQES---------NVIGEGGRGHVYKARF----NEKLLAAVKRID-DAGH 190
           +E    A   F +           VIG G  G V           ++  A+K +      
Sbjct: 9   FEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE 68

Query: 191 DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLT 250
              R+F +E + + +  H N+I L G    +    ++ E M+NGSL+  L    +    T
Sbjct: 69  KQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR--QNDGQFT 126

Query: 251 WHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS------VT 304
               + +   +A G++YL +      VHRDL + NIL++S+   K+SDFGLS       +
Sbjct: 127 VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183

Query: 305 AGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQ 363
             T +  +     + + APE +   K T  SDV+++G+V+ E++  G RP   M+     
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD-- 241

Query: 364 SMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS 423
                          + N ++   R    +     +  + + C Q + ++RP    ++++
Sbjct: 242 ---------------VINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286

Query: 424 LIPLV 428
           L  ++
Sbjct: 287 LDKMI 291

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (485), Expect = 1e-58
 Identities = 62/282 (21%), Positives = 109/282 (38%), Gaps = 27/282 (9%)

Query: 154 NFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAE--REFNNEVNWLTKIRHQN 210
           +++    IG G  G   K R      +   K +D         +   +EVN L +++H N
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64

Query: 211 IISLLGYCIHAETR--FLVYEMMQNGSLEKQLH-GPTHGSNLTWHLRMKIAVDVARGLEY 267
           I+      I       ++V E  + G L   +  G      L     +++   +   L+ 
Sbjct: 65  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124

Query: 268 LHEH--CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK-ISGTLGYVAPE 324
            H      H V+HRDLK +N+ LD   N KL DFGL+      +   K   GT  Y++PE
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPE 184

Query: 325 YLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVD 384
            +      +KSD+++ G +L EL     P    S  +    +           ++P    
Sbjct: 185 QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG-----KFRRIPYRYS 239

Query: 385 PVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVL-HSLI 425
             + + +               +  +  +RP + ++L + LI
Sbjct: 240 DELNEIIT------------RMLNLKDYHRPSVEEILENPLI 269

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (480), Expect = 8e-58
 Identities = 74/274 (27%), Positives = 118/274 (43%), Gaps = 28/274 (10%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNII 212
              +    IG+G  G V    +    +A VK I +      + F  E + +T++RH N++
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDYRGNKVA-VKCIKN--DATAQAFLAEASVMTQLRHSNLV 63

Query: 213 SLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
            LLG  +  +   ++V E M  GSL   L      S L     +K ++DV   +EYL   
Sbjct: 64  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYLEG- 121

Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKL 331
             +  VHRDL + N+L+     AK+SDFGL+  A +     K    + + APE L E K 
Sbjct: 122 --NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK--LPVKWTAPEALREKKF 177

Query: 332 TDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDT 390
           + KSDV++FG++L E+   GR P  ++        V         +   P+   P + + 
Sbjct: 178 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY-----KMDAPDGCPPAVYEV 232

Query: 391 MDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
           M              C   + + RP    +   L
Sbjct: 233 MK------------NCWHLDAAMRPSFLQLREQL 254

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 4e-57
 Identities = 85/295 (28%), Positives = 134/295 (45%), Gaps = 39/295 (13%)

Query: 153 NNFQESNVIGEGGRGHVYKARF---NEKLLAAVKRIDD-AGHDAEREFNNEVNWLTKI-R 207
           N+ +  +VIGEG  G V KAR      ++ AA+KR+ + A  D  R+F  E+  L K+  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 208 HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHG-------------PTHGSNLTWHLR 254
           H NII+LLG C H    +L  E   +G+L   L                +  S L+    
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 255 MKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKI 314
           +  A DVARG++YL +      +HRDL + NIL+  ++ AK++DFGLS       +    
Sbjct: 130 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 186

Query: 315 SGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQL 373
              + ++A E L     T  SDV+++GV+L E++  G  P   M+  +    +       
Sbjct: 187 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY--- 243

Query: 374 TDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLV 428
             R + P   D  + D            +   C + +P  RP    +L SL  ++
Sbjct: 244 --RLEKPLNCDDEVYD------------LMRQCWREKPYERPSFAQILVSLNRML 284

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  188 bits (477), Expect = 4e-57
 Identities = 70/284 (24%), Positives = 123/284 (43%), Gaps = 24/284 (8%)

Query: 144 EYELLEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNW 202
            Y+  E    +    + +G G  G VY+  + +  L  AVK + +   + E EF  E   
Sbjct: 8   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 66

Query: 203 LTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
           + +I+H N++ LLG C      +++ E M  G+L   L        ++  + + +A  ++
Sbjct: 67  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQIS 125

Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGY 320
             +EYL +      +HRDL + N L+  +   K++DFGLS  +T  T + +      + +
Sbjct: 126 SAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 182

Query: 321 VAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLP 380
            APE L   K + KSDV+AFGV+L E+                           D S++ 
Sbjct: 183 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS----------------PYPGIDLSQVY 226

Query: 381 NIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
            +++   R         +V  +   C Q  PS RP   ++  + 
Sbjct: 227 ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 4e-57
 Identities = 70/275 (25%), Positives = 113/275 (41%), Gaps = 26/275 (9%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNII 212
            + +    +G+G  G V+   +N     A+K +   G  +   F  E   + K+RH+ ++
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 75

Query: 213 SLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
            L       E  ++V E M  GSL   L G T          + +A  +A G+ Y+    
Sbjct: 76  QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVERMN 133

Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGK 330
               VHRDL+++NIL+  +   K++DFGL+  +     +        + + APE  L G+
Sbjct: 134 ---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 190

Query: 331 LTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRD 389
            T KSDV++FG++L EL   GR P   M   +    V         R   P      + D
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-----RMPCPPECPESLHD 245

Query: 390 TMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
                       +   C + EP  RP    +   L
Sbjct: 246 ------------LMCQCWRKEPEERPTFEYLQAFL 268

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  188 bits (478), Expect = 5e-57
 Identities = 71/274 (25%), Positives = 112/274 (40%), Gaps = 32/274 (11%)

Query: 155 FQESNVIGEGGRGHVYKARFNE-KLLAAVKRID---DAGHDAEREFNNEVNWLTKIRHQN 210
           F +   IG G  G VY AR      + A+K++       ++  ++   EV +L K+RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 211 IISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHE 270
            I   G  +   T +LV E     + +       H   L       +     +GL YLH 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHS 133

Query: 271 HCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLL--- 327
           H    ++HRD+K+ NILL      KL DFG +      +  V   GT  ++APE +L   
Sbjct: 134 H---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV---GTPYWMAPEVILAMD 187

Query: 328 EGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVI 387
           EG+   K DV++ G+  +EL   + P+  M+         + + Q    +          
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----ALYHIAQNESPALQSGHWSEYF 243

Query: 388 RDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
           R+ +D             C+Q  P  RP    +L
Sbjct: 244 RNFVD------------SCLQKIPQDRPTSEVLL 265

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 5e-56
 Identities = 64/278 (23%), Positives = 118/278 (42%), Gaps = 27/278 (9%)

Query: 152 TNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQN 210
            + ++    +G+G  G VYKA+  E  +LAA K ID    +   ++  E++ L    H N
Sbjct: 11  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70

Query: 211 IISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHE 270
           I+ LL    +    +++ E    G+++  +        LT      +       L YLH+
Sbjct: 71  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHD 128

Query: 271 HCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT-AGTQSRNVKISGTLGYVAPEYLL-- 327
              + ++HRDLK+ NIL     + KL+DFG+S     T  R     GT  ++APE ++  
Sbjct: 129 ---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCE 185

Query: 328 ---EGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVD 384
              +     K+DV++ G+ L+E+     P  +++P +    +  + P        P+   
Sbjct: 186 TSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEP---PTLAQPSRWS 242

Query: 385 PVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLH 422
              +D +              C++     R   + +L 
Sbjct: 243 SNFKDFLK------------KCLEKNVDARWTTSQLLQ 268

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 6e-56
 Identities = 61/289 (21%), Positives = 114/289 (39%), Gaps = 30/289 (10%)

Query: 160 VIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCI 219
            IG+G  G V++ ++  + +A VK       +       E+     +RH+NI+  +    
Sbjct: 10  SIGKGRFGEVWRGKWRGEEVA-VKIFSS-REERSWFREAEIYQTVMLRHENILGFIAADN 67

Query: 220 HAE----TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC--- 272
                    +LV +  ++GSL   L+  T    +T    +K+A+  A GL +LH      
Sbjct: 68  KDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIVGT 123

Query: 273 --NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-----GTLGYVAPEY 325
                + HRDLKS NIL+  +    ++D GL+V   + +  + I+     GT  Y+APE 
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183

Query: 326 LLE------GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQ----SMVTWAMPQLTD 375
           L +       +   ++D+YA G+V  E+             Q           ++ ++  
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243

Query: 376 RSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
                 +   +       + L  +A +   C     + R     +  +L
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 1e-55
 Identities = 64/272 (23%), Positives = 108/272 (39%), Gaps = 29/272 (10%)

Query: 159 NVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAE--REFNNEVNWLTKIRHQNIISLL 215
             IG G    VYK    E  +  A   + D        + F  E   L  ++H NI+   
Sbjct: 15  IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74

Query: 216 GYCIHAETR----FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
                         LV E+M +G+L+  L        +   +       + +GL++LH  
Sbjct: 75  DSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTR 131

Query: 272 CNHPVVHRDLKSSNILLDS-SFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGK 330
              P++HRDLK  NI +   + + K+ D GL+ T    S    + GT  ++APE   E K
Sbjct: 132 -TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA-TLKRASFAKAVIGTPEFMAPEMY-EEK 188

Query: 331 LTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDT 390
             +  DVYAFG+ +LE+     P  +    Q  + +   +      +    +  P +++ 
Sbjct: 189 YDESVDVYAFGMCMLEMATSEYPYSEC---QNAAQIYRRVTSGVKPASFDKVAIPEVKEI 245

Query: 391 MDLKHLYQVAAVAVLCIQPEPSYRPLITDVLH 422
           ++             CI+     R  I D+L+
Sbjct: 246 IE------------GCIRQNKDERYSIKDLLN 265

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (465), Expect = 2e-55
 Identities = 70/287 (24%), Positives = 119/287 (41%), Gaps = 33/287 (11%)

Query: 148 LEAATNNFQESNV-IGEGGRGHVYKARF---NEKLLAAVKRIDDAGHDAERE-FNNEVNW 202
           L    +N   +++ +G G  G V +  +    +++  A+K +      A+ E    E   
Sbjct: 3   LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQI 62

Query: 203 LTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
           + ++ +  I+ L+G C  AE   LV EM   G L K L G      +      ++   V+
Sbjct: 63  MHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVS 119

Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAG----TQSRNVKISGTL 318
            G++YL        VHRDL + N+LL +   AK+SDFGLS   G      +        L
Sbjct: 120 MGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176

Query: 319 GYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRS 377
            + APE +   K + +SDV+++GV + E L  G++P +KM   +  + +         R 
Sbjct: 177 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-----KRM 231

Query: 378 KLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
           + P    P +              +   C   +   RP    V   +
Sbjct: 232 ECPPECPPELYA------------LMSDCWIYKWEDRPDFLTVEQRM 266

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (465), Expect = 4e-55
 Identities = 73/308 (23%), Positives = 126/308 (40%), Gaps = 34/308 (11%)

Query: 138 DTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARF----NEKLLAAVKRIDDAGHDAE 193
           + V  +++ ++  ++     + VIG G  G VY         +K+  AVK ++      E
Sbjct: 12  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 71

Query: 194 -REFNNEVNWLTKIRHQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTW 251
             +F  E   +    H N++SLLG C+ +E    +V   M++G L           N T 
Sbjct: 72  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTV 129

Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSV-----TAG 306
              +   + VA+G+       +   VHRDL + N +LD  F  K++DFGL+         
Sbjct: 130 KDLIGFGLQVAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186

Query: 307 TQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMV 366
           +          + ++A E L   K T KSDV++FGV+L EL+    P     P    +  
Sbjct: 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTF 241

Query: 367 TWAMPQLTD-RSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLI 425
              +  L   R   P      + +            V + C  P+   RP  ++++  + 
Sbjct: 242 DITVYLLQGRRLLQPEYCPDPLYE------------VMLKCWHPKAEMRPSFSELVSRIS 289

Query: 426 PLVPTDLG 433
            +  T +G
Sbjct: 290 AIFSTFIG 297

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (462), Expect = 7e-55
 Identities = 64/292 (21%), Positives = 117/292 (40%), Gaps = 37/292 (12%)

Query: 152 TNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQN 210
              +     IG+G  G VY A         A+++++      +    NE+  + + ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 211 IISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHE 270
           I++ L   +  +  ++V E +  GSL   +                +  +  + LE+LH 
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECLQALEFLHS 134

Query: 271 HCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT-AGTQSRNVKISGTLGYVAPEYLLEG 329
           +    V+HRD+KS NILL    + KL+DFG        QS+   + GT  ++APE +   
Sbjct: 135 NQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK 191

Query: 330 KLTDKSDVYAFGVVLLELLMGRRPVEKMSPT-QCQSMVTWAMPQLTDRSKLPNIVDPVIR 388
               K D+++ G++ +E++ G  P    +P      + T   P+L +  KL  I    + 
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251

Query: 389 DTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLH-----------SLIPLVP 429
                            C+  +   R    ++L            SL PL+ 
Sbjct: 252 R----------------CLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIA 287

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 9e-55
 Identities = 67/290 (23%), Positives = 117/290 (40%), Gaps = 31/290 (10%)

Query: 149 EAATNNFQESNVIGEGGRGHVYKARFN-----EKLLAAVKRIDDAGHDAER-EFNNEVNW 202
           E   +      VIG G  G VYK         +++  A+K +     + +R +F  E   
Sbjct: 3   EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62

Query: 203 LTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
           + +  H NII L G     +   ++ E M+NG+L+K           +    + +   +A
Sbjct: 63  MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDK--FLREKDGEFSVLQLVGMLRGIA 120

Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS----GTL 318
            G++Y     N   VHRDL + NIL++S+   K+SDFGLS            +      +
Sbjct: 121 AGMKY---LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 177

Query: 319 GYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSK 378
            + APE +   K T  SDV++FG+V+ E++                             +
Sbjct: 178 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH----------------E 221

Query: 379 LPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLV 428
           +   ++   R    +     +  + + C Q E + RP   D++  L  L+
Sbjct: 222 VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 9e-55
 Identities = 72/278 (25%), Positives = 116/278 (41%), Gaps = 34/278 (12%)

Query: 157 ESNVIGEGGRGHVYKARFNEKLLA---AVKRIDDAGHDAE--REFNNEVNWLTKIRHQNI 211
           E   +G G  G V K  +  K +    AVK + +  +D     E   E N + ++ +  I
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 212 ISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
           + ++G C   E+  LV EM + G L K L    H   +     +++   V+ G++YL   
Sbjct: 71  VRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLE-- 124

Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSV----TAGTQSRNVKISGTLGYVAPEYLL 327
                VHRDL + N+LL +   AK+SDFGLS                   + + APE + 
Sbjct: 125 -ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183

Query: 328 EGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPV 386
             K + KSDV++FGV++ E    G++P   M  ++  +M+        +R   P      
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-----ERMGCPAGCPRE 238

Query: 387 IRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
           + D            +  LC   +   RP    V   L
Sbjct: 239 MYD------------LMNLCWTYDVENRPGFAAVELRL 264

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (459), Expect = 4e-54
 Identities = 72/304 (23%), Positives = 120/304 (39%), Gaps = 51/304 (16%)

Query: 153 NNFQESNVIGEGGRGHVYKARF------NEKLLAAVKRIDDAGHDAERE-FNNEVNWLTK 205
            N +   V+G G  G V  A           +  AVK + +    +ERE   +E+  +T+
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 206 I-RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTH------------------- 245
           +  H+NI++LLG C  +   +L++E    G L   L                        
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 246 -GSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT 304
             + LT+   +  A  VA+G+E+L        VHRDL + N+L+      K+ DFGL+  
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD 213

Query: 305 AGTQSRNVKIS---GTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPT 360
             + S  V        + ++APE L EG  T KSDV+++G++L E+  +G  P   +   
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273

Query: 361 QCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDV 420
                  + + Q   +   P      I              +   C   +   RP   ++
Sbjct: 274 A----NFYKLIQNGFKMDQPFYATEEIYI------------IMQSCWAFDSRKRPSFPNL 317

Query: 421 LHSL 424
              L
Sbjct: 318 TSFL 321

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 1e-53
 Identities = 65/283 (22%), Positives = 127/283 (44%), Gaps = 33/283 (11%)

Query: 155 FQESNVIGEGGRGHVYKARFNE-----KLLAAVKRIDDAGH-DAEREFNNEVNWLTKIRH 208
           F++  V+G G  G VYK  +       K+  A+K + +A    A +E  +E   +  + +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 209 QNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYL 268
            ++  LLG C+   T  L+ ++M  G L   +    H  N+     +   V +A+G+ YL
Sbjct: 71  PHVCRLLGICLT-STVQLITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMNYL 127

Query: 269 HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK---ISGTLGYVAPEY 325
               +  +VHRDL + N+L+ +  + K++DFGL+   G + +          + ++A E 
Sbjct: 128 ---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184

Query: 326 LLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVD 384
           +L    T +SDV+++GV + EL+  G +P + +  ++  S++        +R   P I  
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-----ERLPQPPICT 239

Query: 385 PVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPL 427
             +              + V C   +   RP   +++     +
Sbjct: 240 IDVYM------------IMVKCWMIDADSRPKFRELIIEFSKM 270

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  177 bits (449), Expect = 8e-53
 Identities = 77/313 (24%), Positives = 125/313 (39%), Gaps = 52/313 (16%)

Query: 144 EYELLEAATNNFQESNVIGEGGRGHVYKARFNEKL------LAAVKRID-DAGHDAEREF 196
           +   LE   NN +    IGEG  G V++AR    L      + AVK +  +A  D + +F
Sbjct: 4   KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63

Query: 197 NNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSN-------- 248
             E   + +  + NI+ LLG C   +   L++E M  G L + L   +  +         
Sbjct: 64  QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123

Query: 249 -------------LTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAK 295
                        L+   ++ IA  VA G+ YL E      VHRDL + N L+  +   K
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVK 180

Query: 296 LSDFGLSV---TAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRR 352
           ++DFGLS    +A     +   +  + ++ PE +   + T +SDV+A+GVVL E+     
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240

Query: 353 -PVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEP 411
            P   M+  +    V        +    P      + +            +  LC    P
Sbjct: 241 QPYYGMAHEEVIYYVRDG-----NILACPENCPLELYN------------LMRLCWSKLP 283

Query: 412 SYRPLITDVLHSL 424
           + RP    +   L
Sbjct: 284 ADRPSFCSIHRIL 296

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (446), Expect = 1e-52
 Identities = 65/275 (23%), Positives = 108/275 (39%), Gaps = 27/275 (9%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQN 210
            ++     +GEG  G V  A     +   AVK +D     D       E+     + H+N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 211 IISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHE 270
           ++   G+      ++L  E    G L  ++        +      +    +  G+ YLH 
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG 121

Query: 271 HCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS---GTLGYVAPEYLL 327
                + HRD+K  N+LLD   N K+SDFGL+      +R   ++   GTL YVAPE L 
Sbjct: 122 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178

Query: 328 EGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPV 386
             +      DV++ G+VL  +L G  P ++ S +           + +D  +    ++P 
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS---------CQEYSDWKEKKTYLNPW 229

Query: 387 IRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
            +       L          +   PS R  I D+ 
Sbjct: 230 KKIDSAPLALLH------KILVENPSARITIPDIK 258

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  177 bits (449), Expect = 3e-52
 Identities = 52/272 (19%), Positives = 104/272 (38%), Gaps = 22/272 (8%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNI 211
           +++     +G G  G V++          A K +       +     E+  ++ +RH  +
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85

Query: 212 ISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
           ++L           ++YE M  G L +++      + ++    ++    V +GL ++HE+
Sbjct: 86  VNLHDAFEDDNEMVMIYEFMSGGELFEKVA--DEHNKMSEDEAVEYMRQVCKGLCHMHEN 143

Query: 272 CNHPVVHRDLKSSNILLDSSFN--AKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEG 329
                VH DLK  NI+  +  +   KL DFGL+     +      +GT  + APE     
Sbjct: 144 N---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGK 200

Query: 330 KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRD 389
            +   +D+++ GV+   LL G  P    +  +    V      + D     + +    +D
Sbjct: 201 PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD--SAFSGISEDGKD 258

Query: 390 TMDLKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
            +               +  +P+ R  I   L
Sbjct: 259 FIR------------KLLLADPNTRMTIHQAL 278

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 3e-52
 Identities = 65/298 (21%), Positives = 107/298 (35%), Gaps = 44/298 (14%)

Query: 153 NNFQESNVIGEGGRGHVYKARF------NEKLLAAVKRIDDAGHDAERE-FNNEVNWLTK 205
           N       +G G  G V +A        +  +  AVK +  + H  ERE   +E+  L+ 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 206 I-RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGS---------------NL 249
           +  H NI++LLG C       ++ E    G L   L                       L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 250 TWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS 309
                +  +  VA+G+ +L        +HRDL + NILL      K+ DFGL+      S
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 310 RNVK---ISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMV 366
             V        + ++APE +     T +SDV+++G+ L EL                   
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP------------ 247

Query: 367 TWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
               P +   SK   ++    R         ++  +   C   +P  RP    ++  +
Sbjct: 248 ---YPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (440), Expect = 8e-52
 Identities = 71/289 (24%), Positives = 118/289 (40%), Gaps = 34/289 (11%)

Query: 144 EYELLEAATNNFQESNVIGEGGRGHVYKARF----NEKLLAAVKRIDDAGHDAERE-FNN 198
           +YE+        +    IGEG  G V++  +    N  L  A+K   +   D+ RE F  
Sbjct: 1   DYEIQR---ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ 57

Query: 199 EVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIA 258
           E   + +  H +I+ L+G        +++ E+   G L           +L     +  A
Sbjct: 58  EALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRS--FLQVRKYSLDLASLILYA 114

Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISG 316
             ++  L YL        VHRD+ + N+L+ S+   KL DFGLS  +   T  +  K   
Sbjct: 115 YQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL 171

Query: 317 TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTD 375
            + ++APE +   + T  SDV+ FGV + E+LM G +P + +        +        +
Sbjct: 172 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-----E 226

Query: 376 RSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
           R  +P    P +   M              C   +PS RP  T++   L
Sbjct: 227 RLPMPPNCPPTLYSLMT------------KCWAYDPSRRPRFTELKAQL 263

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  174 bits (443), Expect = 2e-51
 Identities = 56/280 (20%), Positives = 104/280 (37%), Gaps = 32/280 (11%)

Query: 145 YELLEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWL 203
           Y++LE           +G G  G V++        +   K I+      +    NE++ +
Sbjct: 31  YDILE----------ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIM 80

Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
            ++ H  +I+L           L+ E +  G L  ++        ++    +        
Sbjct: 81  NQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIA--AEDYKMSEAEVINYMRQACE 138

Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNA--KLSDFGLSVTAGTQSRNVKISGTLGYV 321
           GL+++HEH    +VH D+K  NI+ ++   +  K+ DFGL+            + T  + 
Sbjct: 139 GLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFA 195

Query: 322 APEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPN 381
           APE +    +   +D++A GV+   LL G  P       +    V     +        +
Sbjct: 196 APEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEF--DEDAFS 253

Query: 382 IVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
            V P  +D +               +Q EP  R  + D L
Sbjct: 254 SVSPEAKDFIK------------NLLQKEPRKRLTVHDAL 281

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 1e-48
 Identities = 66/285 (23%), Positives = 110/285 (38%), Gaps = 34/285 (11%)

Query: 153 NNFQESNVIGEGGRGHVYKARFN----EKLLAAVKRIDD---AGHDAEREFNNEVNWLTK 205
            + +    +G+G  G V +  ++    + +  AVK +     +  +A  +F  EVN +  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 206 IRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
           + H+N+I L G  +      +V E+   GSL        H  +       + AV VA G+
Sbjct: 68  LDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLD--RLRKHQGHFLLGTLSRYAVQVAEGM 124

Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSV----TAGTQSRNVKISGTLGYV 321
            YL        +HRDL + N+LL +    K+ DFGL                      + 
Sbjct: 125 GYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181

Query: 322 APEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLP 380
           APE L     +  SD + FGV L E+   G+ P   ++ +Q    +   + +  +R   P
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ----ILHKIDKEGERLPRP 237

Query: 381 NIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLI 425
                 I +            V V C   +P  RP    +   L+
Sbjct: 238 EDCPQDIYN------------VMVQCWAHKPEDRPTFVALRDFLL 270

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (414), Expect = 8e-48
 Identities = 55/275 (20%), Positives = 103/275 (37%), Gaps = 31/275 (11%)

Query: 154 NFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRHQ 209
           +F+   ++GEG    V  AR        A+K ++       +       E + ++++ H 
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68

Query: 210 NIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLH 269
             + L       E  +      +NG L K +       +           ++   LEYLH
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLH 125

Query: 270 EHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK---ISGTLGYVAPEYL 326
                 ++HRDLK  NILL+   + +++DFG +     +S+  +     GT  YV+PE L
Sbjct: 126 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182

Query: 327 LEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPV 386
            E      SD++A G ++ +L+ G  P    +       +      +      P    P 
Sbjct: 183 TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI------IKLEYDFPEKFFPK 236

Query: 387 IRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
            RD ++              +  + + R    ++ 
Sbjct: 237 ARDLVE------------KLLVLDATKRLGCEEME 259

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (412), Expect = 2e-47
 Identities = 67/290 (23%), Positives = 121/290 (41%), Gaps = 38/290 (13%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLA------AVKRIDDAGHDAER-EFNNEVNWLTK 205
                S  +G+G  G VY+      +        A+K +++A    ER EF NE + + +
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 206 IRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHG-------SNLTWHLRMKIA 258
               +++ LLG     +   ++ E+M  G L+  L             +  +    +++A
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS---VTAGTQSRNVKIS 315
            ++A G+ YL     +  VHRDL + N ++   F  K+ DFG++          +  K  
Sbjct: 140 GEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 316 GTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLT 374
             + +++PE L +G  T  SDV++FGVVL E+  +  +P + +S  Q    V        
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM------- 249

Query: 375 DRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
               L +  D       +L           +C Q  P  RP   +++ S+
Sbjct: 250 -EGGLLDKPDNCPDMLFEL---------MRMCWQYNPKMRPSFLEIISSI 289

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  164 bits (415), Expect = 4e-47
 Identities = 64/271 (23%), Positives = 110/271 (40%), Gaps = 30/271 (11%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRID------DAGHDAEREFNNEVNWLTK 205
           N+F    +IG GG G VY  R  +   + A+K +D        G          ++ ++ 
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 206 IRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
                I+ +       +    + ++M  G L   L         +       A ++  GL
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGL 120

Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEY 325
           E++H      VV+RDLK +NILLD   + ++SD GL+     + +     GT GY+APE 
Sbjct: 121 EHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS-KKKPHASVGTHGYMAPEV 176

Query: 326 LLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVD 384
           L +G   D  +D ++ G +L +LL G  P  +        +       LT   +LP+   
Sbjct: 177 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---TLTMAVELPDSFS 233

Query: 385 PVIRDTMDLKHLYQVAAVAVLCIQPEPSYRP 415
           P +R  ++              +Q + + R 
Sbjct: 234 PELRSLLE------------GLLQRDVNRRL 252

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 1e-46
 Identities = 51/280 (18%), Positives = 100/280 (35%), Gaps = 33/280 (11%)

Query: 145 YELLEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWL 203
           Y + E           +G G  G V++      K     K +   G D       E++ L
Sbjct: 7   YMIAE----------DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL-VKKEISIL 55

Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
              RH+NI+ L       E   +++E +    + ++++  T    L     +     V  
Sbjct: 56  NIARHRNILHLHESFESMEELVMIFEFISGLDIFERIN--TSAFELNEREIVSYVHQVCE 113

Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNA--KLSDFGLSVTAGTQSRNVKISGTLGYV 321
            L++LH H    + H D++  NI+  +  ++  K+ +FG +           +     Y 
Sbjct: 114 ALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYY 170

Query: 322 APEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPN 381
           APE      ++  +D+++ G ++  LL G  P    +  Q    +  A  + T   +   
Sbjct: 171 APEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNA--EYTFDEEAFK 228

Query: 382 IVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
            +     D +D              +  E   R   ++ L
Sbjct: 229 EISIEAMDFVD------------RLLVKERKSRMTASEAL 256

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  160 bits (407), Expect = 1e-46
 Identities = 59/273 (21%), Positives = 99/273 (36%), Gaps = 19/273 (6%)

Query: 152 TNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQ 209
            + +   +V+G G    V  A     + L A+K I   A    E    NE+  L KI+H 
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67

Query: 210 NIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLH 269
           NI++L          +L+ +++  G L  ++         T     ++   V   ++YLH
Sbjct: 68  NIVALDDIYESGGHLYLIMQLVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLH 124

Query: 270 EHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEG 329
           +        +        LD      +SDFGLS      S      GT GYVAPE L + 
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQK 184

Query: 330 KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRD 389
             +   D ++ GV+   LL G  P    +  +    +  A  +    S   + +    +D
Sbjct: 185 PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEF--DSPYWDDISDSAKD 242

Query: 390 TMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLH 422
            +               ++ +P  R      L 
Sbjct: 243 FIR------------HLMEKDPEKRFTCEQALQ 263

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  159 bits (403), Expect = 6e-46
 Identities = 60/267 (22%), Positives = 103/267 (38%), Gaps = 30/267 (11%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDD---AGHDAEREFNNEVNWLTKIRH 208
            +FQ    +G G  G V+  R        A+K +              N+E   L+ + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 209 QNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYL 268
             II + G    A+  F++ + ++ G L   L            +    A +V   LEYL
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYL 120

Query: 269 HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLE 328
           H      +++RDLK  NILLD + + K++DFG +           + GT  Y+APE +  
Sbjct: 121 HSKD---IIYRDLKPENILLDKNGHIKITDFGFAKY--VPDVTYTLCGTPDYIAPEVVST 175

Query: 329 GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIR 388
                  D ++FG+++ E+L G  P    +  +    +      L    + P   +  ++
Sbjct: 176 KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI------LNAELRFPPFFNEDVK 229

Query: 389 DTMDLKHLYQVAAVAVLCIQPEPSYRP 415
           D +               I  + S R 
Sbjct: 230 DLLS------------RLITRDLSQRL 244

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (401), Expect = 6e-46
 Identities = 71/303 (23%), Positives = 117/303 (38%), Gaps = 47/303 (15%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNE------KLLAAVKRID-DAGHDAEREFNNEVNWLTK 205
           +  +    +G G  G V +A              AVK +   A H   R   +E+  L  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 206 IRHQ-NIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHG-------------PTHGSNLT 250
           I H  N+++LLG C        ++ E  + G+L   L                 +   LT
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 251 WHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR 310
               +  +  VA+G+E+L        +HRDL + NILL      K+ DFGL+        
Sbjct: 133 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 311 NVK---ISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVT 367
            V+       L ++APE + +   T +SDV++FGV+L E+           P     +  
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDE 244

Query: 368 WAMPQLTD--RSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLI 425
               +L +  R + P+   P +                + C   EPS RP  ++++  L 
Sbjct: 245 EFCRRLKEGTRMRAPDYTTPEMYQ------------TMLDCWHGEPSQRPTFSELVEHLG 292

Query: 426 PLV 428
            L+
Sbjct: 293 NLL 295

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  156 bits (395), Expect = 4e-45
 Identities = 68/285 (23%), Positives = 106/285 (37%), Gaps = 37/285 (12%)

Query: 154 NFQESNVIGEGGRGHVYKARFNE-KLLAAVKRID---------DAGHDAEREFNNEVNWL 203
           N++   ++G G    V +          AVK ID         +   +       EV+ L
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 204 TKIR-HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
            K+  H NII L          FLV+++M+ G L   L        L+     KI   + 
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRALL 120

Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
             +  LH+     +VHRDLK  NILLD   N KL+DFG S       +  ++ GT  Y+A
Sbjct: 121 EVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLA 177

Query: 323 PEYLL------EGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDR 376
           PE +             + D+++ GV++  LL G  P           M+     Q    
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG-- 235

Query: 377 SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
           S   +     ++D +               +  +P  R    + L
Sbjct: 236 SPEWDDYSDTVKDLVS------------RFLVVQPQKRYTAEEAL 268

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 1e-44
 Identities = 69/299 (23%), Positives = 114/299 (38%), Gaps = 47/299 (15%)

Query: 153 NNFQESNVIGEGGRGHVYKARF--------NEKLLAAVKRID-DAGHDAEREFNNEVNWL 203
           +       +GEG  G V  A          N     AVK +  DA      +  +E+  +
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 204 TKI-RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLH-------------GPTHGSNL 249
             I +H+NII+LLG C      +++ E    G+L + L                     L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 250 TWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSV---TAG 306
           +    +  A  VARG+EYL        +HRDL + N+L+      K++DFGL+       
Sbjct: 133 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 307 TQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSM 365
              +       + ++APE L +   T +SDV++FGV+L E+  +G  P   +   +   +
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249

Query: 366 VTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
           +         R   P+     +              +   C    PS RP    ++  L
Sbjct: 250 LKEG-----HRMDKPSNCTNELYM------------MMRDCWHAVPSQRPTFKQLVEDL 291

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 3e-44
 Identities = 71/292 (24%), Positives = 104/292 (35%), Gaps = 26/292 (8%)

Query: 151 ATNNFQESNVIGEGGRGHVYKARF--NEKLLAAVKRI--DDAGHDAEREFNNEVNWLTKI 206
           A   ++    IGEG  G V+KAR   N     A+KR+               EV  L  +
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 207 ---RHQNIISLLGYCIHAETR-----FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIA 258
               H N++ L   C  + T       LV+E +           P  G  +       + 
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--VPTETIKDMM 122

Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTL 318
             + RGL++LH H    VVHRDLK  NIL+ SS   KL+DFGL+     Q     +  TL
Sbjct: 123 FQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTL 179

Query: 319 GYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQ-----CQSMVTWAMPQL 373
            Y APE LL+       D+++ G +  E+   +      S           +        
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239

Query: 374 TDRSKLPNIVDPVIRDTMDLKHLYQVAAVAV----LCIQPEPSYRPLITDVL 421
                LP             K +  +  +       C+   P+ R      L
Sbjct: 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 291

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (391), Expect = 4e-44
 Identities = 61/275 (22%), Positives = 101/275 (36%), Gaps = 30/275 (10%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRID----DAGHDAEREFNNEVNWLTKIR 207
            +F    ++G+G  G V+ A F +     A+K +         D E     +        
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 208 HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEY 267
           H  +  +       E  F V E +  G L   +                 A ++  GL++
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQF 118

Query: 268 LHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAG-TQSRNVKISGTLGYVAPEYL 326
           LH      +V+RDLK  NILLD   + K++DFG+        ++     GT  Y+APE L
Sbjct: 119 LHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEIL 175

Query: 327 LEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPV 386
           L  K     D ++FGV+L E+L+G+ P       +    +    P        P  ++  
Sbjct: 176 LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPF------YPRWLEKE 229

Query: 387 IRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
            +D +                  EP  R  +   +
Sbjct: 230 AKDLLV------------KLFVREPEKRLGVRGDI 252

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  151 bits (382), Expect = 3e-43
 Identities = 55/287 (19%), Positives = 106/287 (36%), Gaps = 33/287 (11%)

Query: 152 TNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDA---GHDAEREFNNEVNWLTKIR 207
           ++ ++   ++G GG   V+ AR        AVK +             F  E      + 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 208 HQNIISLLGYCIHAETR----FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           H  I+++              ++V E +   +L   +H       +T    +++  D  +
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 122

Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK----ISGTLG 319
            L + H++    ++HRD+K +NI++ ++   K+ DFG++        +V     + GT  
Sbjct: 123 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179

Query: 320 YVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKL 379
           Y++PE      +  +SDVY+ G VL E+L G  P    SP           P     S  
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP--IPPSAR 237

Query: 380 PNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPL-ITDVLHSLI 425
              +   +   +               +   P  R     ++   L+
Sbjct: 238 HEGLSADLDAVVL------------KALAKNPENRYQTAAEMRADLV 272

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 4e-43
 Identities = 78/282 (27%), Positives = 118/282 (41%), Gaps = 24/282 (8%)

Query: 159 NVIGEGGRGHVYKARFNE-KLLAAVKRID-----DAGHDAEREFNNEVNWLTKIRHQNII 212
           + +GEG    VYKAR      + A+K+I      +A     R    E+  L ++ H NII
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 213 SLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
            LL    H     LV++ M+       +    +   LT        +   +GLEYLH+H 
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLE---VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120

Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAG-TQSRNVKISGTLGYVAPEYLLEGKL 331
              ++HRDLK +N+LLD +   KL+DFGL+ + G           T  Y APE L   ++
Sbjct: 121 ---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARM 177

Query: 332 TD-KSDVYAFGVVLLELLMGRRPVEKMSPTQ-----CQSMVTWAMPQLTDRSKLPNIVDP 385
                D++A G +L ELL+    +   S         +++ T    Q  D   LP+ V  
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237

Query: 386 VIRDTMDLKHLYQVAAVAVL-----CIQPEPSYRPLITDVLH 422
                + L H++  A   +L          P  R   T  L 
Sbjct: 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (381), Expect = 2e-42
 Identities = 64/289 (22%), Positives = 104/289 (35%), Gaps = 27/289 (9%)

Query: 154 NFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNII 212
           ++ ++ VIG G  G VY+A+  +   L A+K++       +R  N E+  + K+ H NI+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIV 76

Query: 213 SLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
            L  +   +  +       LV + +         H       L           + R L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136

Query: 267 YLHEHCNHPVVHRDLKSSNILLDS-SFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEY 325
           Y+H      + HRD+K  N+LLD  +   KL DFG +        NV    +  Y APE 
Sbjct: 137 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 193

Query: 326 LLEG-KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQ-----------CQSMVTWAMPQL 373
           +      T   DV++ G VL ELL+G+      S                      M   
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253

Query: 374 TDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLH 422
               K P I           +   +  A+    ++  P+ R    +   
Sbjct: 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 5e-42
 Identities = 64/281 (22%), Positives = 107/281 (38%), Gaps = 31/281 (11%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAER------EFNNEVNWLTK 205
           + +     +G G    V K R     L  A K I      + R      +   EV+ L +
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 206 IRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
           I+H N+I+L     +     L+ E++  G L   L       +LT     +    +  G+
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGV 126

Query: 266 EYLHEHCNHPVVHRDLKSSNILLDS----SFNAKLSDFGLSVTAGTQSRNVKISGTLGYV 321
            YLH      + H DLK  NI+L          K+ DFGL+      +    I GT  +V
Sbjct: 127 YYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFV 183

Query: 322 APEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPN 381
           APE +    L  ++D+++ GV+   LL G  P    +  +  + V+    +  D  +  +
Sbjct: 184 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED--EYFS 241

Query: 382 IVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLH 422
               + +D +               +  +P  R  I D L 
Sbjct: 242 NTSALAKDFIR------------RLLVKDPKKRMTIQDSLQ 270

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 6e-41
 Identities = 59/296 (19%), Positives = 114/296 (38%), Gaps = 38/296 (12%)

Query: 136 KKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAER 194
           KK+ + + +Y++            V+G G  G V +      +   A+K + D       
Sbjct: 5   KKNAI-IDDYKVTS---------QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----P 49

Query: 195 EFNNEVNWLTKI-RHQNIISLLGYCIHAETR----FLVYEMMQNGSLEKQLHGPTHGSNL 249
           +   EV    +  +  +I+ ++    +         +V E +  G L  ++      +  
Sbjct: 50  KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-F 108

Query: 250 TWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFN---AKLSDFGLSVTAG 306
           T     +I   +   ++YLH      + HRD+K  N+L  S       KL+DFG +    
Sbjct: 109 TEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 165

Query: 307 TQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMV 366
           + +       T  YVAPE L   K     D+++ GV++  LL G  P            +
Sbjct: 166 SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM 225

Query: 367 TWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLH 422
              +     + + PN     + +  ++K L +        ++ EP+ R  IT+ ++
Sbjct: 226 KTRI--RMGQYEFPNPEWSEVSE--EVKMLIR------NLLKTEPTQRMTITEFMN 271

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 7e-41
 Identities = 67/290 (23%), Positives = 111/290 (38%), Gaps = 23/290 (7%)

Query: 152 TNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAERE-FNNEVNWLTKIRHQ 209
              +   + IGEG  G V  A  N  K+  A+K+I    H    +    E+  L + RH+
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 210 NIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLH 269
           NII +           +    +    +   L+      +L+          + RGL+Y+H
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126

Query: 270 EHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAG----TQSRNVKISGTLGYVAPEY 325
                 V+HRDLK SN+LL+++ + K+ DFGL+  A           +   T  Y APE 
Sbjct: 127 S---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183

Query: 326 LLEGKLTDKS-DVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVD 384
           +L  K   KS D+++ G +L E+L  R            + +   +   +       I  
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243

Query: 385 PVIRDTMDLKHLYQV-----------AAVAVL--CIQPEPSYRPLITDVL 421
                 + L H  +V            A+ +L   +   P  R  +   L
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 293

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 4e-40
 Identities = 59/268 (22%), Positives = 95/268 (35%), Gaps = 29/268 (10%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRID---DAGHDAEREFNNEVNWLTKIRH 208
           N+F    ++G+G  G V   R        A+K +        D       E   L   RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 209 QNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYL 268
             + +L       +    V E    G L   L         T         ++   LEYL
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYL 121

Query: 269 HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA-GTQSRNVKISGTLGYVAPEYLL 327
           H      VV+RD+K  N++LD   + K++DFGL        +      GT  Y+APE L 
Sbjct: 122 HSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 178

Query: 328 EGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVI 387
           +       D +  GVV+ E++ GR P       +   ++      L +  + P  + P  
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI------LMEEIRFPRTLSPEA 232

Query: 388 RDTMDLKHLYQVAAVAVLCIQPEPSYRP 415
           +  +               ++ +P  R 
Sbjct: 233 KSLLA------------GLLKKDPKQRL 248

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 3e-39
 Identities = 69/285 (24%), Positives = 111/285 (38%), Gaps = 21/285 (7%)

Query: 154 NFQESNVIGEGGRGHVYKARFNE-KLLAAVKRI--DDAGHDAEREFNNEVNWLTKIRHQN 210
           NFQ+   IGEG  G VYKAR      + A+K+I  D            E++ L ++ H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 211 IISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHE 270
           I+ LL         +LV+E +     +        G  +   L       + +GL + H 
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCHS 120

Query: 271 HCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK-ISGTLGYVAPEYLLEG 329
           H    V+HRDLK  N+L+++    KL+DFGL+   G   R       TL Y APE LL  
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177

Query: 330 K-LTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTD---------RSKL 379
           K  +   D+++ G +  E++  R      S       +   +    +             
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237

Query: 380 PNIVDPVIRDTMDLKHLYQVAAVAVL--CIQPEPSYRPLITDVLH 422
           P+      +D   +         ++L   +  +P+ R      L 
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  140 bits (353), Expect = 4e-39
 Identities = 58/284 (20%), Positives = 112/284 (39%), Gaps = 21/284 (7%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRI--DDAGHDAEREFNNEVNWLTKIRHQN 210
             +     IGEG  G VYKA+ N     A+K+I  +            E++ L +++H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 211 IISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHE 270
           I+ L       +   LV+E +     +           L         + +  G+ Y H+
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD 118

Query: 271 HCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAG-TQSRNVKISGTLGYVAPEYLL-E 328
                V+HRDLK  N+L++     K++DFGL+   G    +      TL Y AP+ L+  
Sbjct: 119 RR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175

Query: 329 GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQ-----CQSMVTWAMPQLTDRSKLPN-I 382
            K +   D+++ G +  E++ G      +S         + + T       + ++LP   
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235

Query: 383 VDPVIRDTMDLKHLYQVAAVAVL-----CIQPEPSYRPLITDVL 421
            +  + + +  +   +    + +      ++ +P+ R      L
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (347), Expect = 2e-38
 Identities = 57/280 (20%), Positives = 95/280 (33%), Gaps = 41/280 (14%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRI------DDAGHDAEREFNNEVNWLTK 205
           + +Q   ++G GG G VY        L  A+K +      D            EV  L K
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63

Query: 206 IR--HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           +      +I LL +    ++  L+ E  +           T    L   L       V  
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLE 121

Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSS-FNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
            + + H      V+HRD+K  NIL+D +    KL DFG        +      GT  Y  
Sbjct: 122 AVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTRVYSP 177

Query: 323 PEYLLEGKLTDKS-DVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPN 381
           PE++   +   +S  V++ G++L +++ G  P E                 +  +     
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI------------IRGQVFFRQ 225

Query: 382 IVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
            V    +  +              C+   PS RP   ++ 
Sbjct: 226 RVSSECQHLIR------------WCLALRPSDRPTFEEIQ 253

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  138 bits (348), Expect = 9e-38
 Identities = 52/277 (18%), Positives = 98/277 (35%), Gaps = 31/277 (11%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAERE---FNNEVNWLTKIRH 208
           + F     +G G  G V   +  E     A+K +D       ++     NE   L  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 209 QNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYL 268
             ++ L          ++V E +  G +   L         +       A  +    EYL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYL 157

Query: 269 HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLE 328
           H      +++RDLK  N+L+D     +++DFG +     + R   + GT   +APE +L 
Sbjct: 158 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTWTLCGTPEALAPEIILS 212

Query: 329 GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIR 388
                  D +A GV++ E+  G  P     P Q    +           + P+     ++
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV------RFPSHFSSDLK 266

Query: 389 DTMDLKHLYQVAAVAVLCIQPE---PSYRPLITDVLH 422
           D +            +L +       + +  + D+ +
Sbjct: 267 DLLR----------NLLQVDLTKRFGNLKNGVNDIKN 293

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (342), Expect = 3e-37
 Identities = 60/316 (18%), Positives = 128/316 (40%), Gaps = 44/316 (13%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRI--DDAGHDAEREFNNEVNWLTKIRHQ 209
           + +++   IG+G  G V+KAR  +     A+K++  ++           E+  L  ++H+
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 210 NIISLLGYCIHAETR--------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDV 261
           N+++L+  C    +         +LV++  ++       +        T     ++   +
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQML 126

Query: 262 ARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS-----VTAGTQSRNVKISG 316
             GL Y+H +    ++HRD+K++N+L+      KL+DFGL+           +R      
Sbjct: 127 LNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183

Query: 317 TLGYVAPEYLLEGKL-TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTD 375
           TL Y  PE LL  +      D++  G ++ E+      ++  +     ++++     +T 
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243

Query: 376 RSKLPNIVDPVIRDTMDLKHLYQVAAVAVL---------------CIQPEPSYRPLITDV 420
               PN+ +  + + ++L    +      L                +  +P+ R    D 
Sbjct: 244 EV-WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302

Query: 421 L-HSLI---PLVPTDL 432
           L H      P+ P+DL
Sbjct: 303 LNHDFFWSDPM-PSDL 317

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 1e-36
 Identities = 66/287 (22%), Positives = 115/287 (40%), Gaps = 23/287 (8%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRI--DDAGHDAEREFNNEVNWLTKIRHQ 209
             +++   IGEG  G V+KA+  E   + A+KR+  DD           E+  L +++H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 210 NIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLH 269
           NI+ L       +   LV+E       +   +  +   +L   +       + +GL + H
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKK---YFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118

Query: 270 EHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG-TLGYVAPEYLLE 328
                 V+HRDLK  N+L++ +   KL++FGL+   G   R       TL Y  P+ L  
Sbjct: 119 SRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175

Query: 329 GKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQ------CQSMVTWAMPQLTDRSKLPN 381
            KL     D+++ G +  EL    RP+   +          + + T    Q    +KLP+
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235

Query: 382 IVD-PVIRDTMDLKHLYQVAAVAVL-----CIQPEPSYRPLITDVLH 422
               P+   T  L ++               ++  P  R    + L 
Sbjct: 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  133 bits (335), Expect = 2e-36
 Identities = 43/277 (15%), Positives = 83/277 (29%), Gaps = 33/277 (11%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNI 211
           N ++    IG G  G +Y           A+K           + + E      ++    
Sbjct: 7   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVG 64

Query: 212 ISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
           I  + +C       ++   +   SLE   +        +    + +A  +   +EY+H  
Sbjct: 65  IPTIRWCGAEGDYNVMVMELLGPSLEDLFN--FCSRKFSLKTVLLLADQMISRIEYIHSK 122

Query: 272 CNHPVVHRDLKSSNIL---LDSSFNAKLSDFGLSVTAGTQS--------RNVKISGTLGY 320
                +HRD+K  N L           + DFGL+                N  ++GT  Y
Sbjct: 123 N---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179

Query: 321 VAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMV--TWAMPQLTDRSK 378
            +    L  + + + D+ + G VL+   +G  P + +     +            T    
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239

Query: 379 LPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRP 415
           L           ++             C       +P
Sbjct: 240 LCKGYPSEFATYLN------------FCRSLRFDDKP 264

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 5e-36
 Identities = 55/293 (18%), Positives = 98/293 (33%), Gaps = 33/293 (11%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAE--REFNNEVNWLTKIRHQ 209
             +++   +G G  G V  A         A+K++          +    E+  L  +RH+
Sbjct: 18  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77

Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           N+I LL      ET       +LV   M     +   H       L       +   + +
Sbjct: 78  NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK-----LGEDRIQFLVYQMLK 132

Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           GL Y+H        HRDLK  N+ ++     K+ DFGL+  A ++        T  Y AP
Sbjct: 133 GLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYV--VTRWYRAP 187

Query: 324 EYLLEG-KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNI 382
           E +L   + T   D+++ G ++ E++ G+   +          +                
Sbjct: 188 EVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 247

Query: 383 VDPVIRDTMDLKHLYQVAAVAVL-------------CIQPEPSYRPLITDVLH 422
            D        L  L +    ++L              +  +   R    + L 
Sbjct: 248 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  129 bits (324), Expect = 6e-35
 Identities = 44/292 (15%), Positives = 85/292 (29%), Gaps = 38/292 (13%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNI 211
            +++    IGEG  G +++          A+K           +  +E      +     
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTG 62

Query: 212 ISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
           I  + Y        ++   +   SLE  L     G   +       A  +   ++ +HE 
Sbjct: 63  IPNVYYFGQEGLHNVLVIDLLGPSLEDLLD--LCGRKFSVKTVAMAAKQMLARVQSIHEK 120

Query: 272 CNHPVVHRDLKSSNILLDSSFN-----AKLSDFGLSVTAGTQSRNVKIS--------GTL 318
               +V+RD+K  N L+    +       + DFG+            I         GT 
Sbjct: 121 S---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177

Query: 319 GYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWA--MPQLTDR 376
            Y++    L  + + + D+ A G V +  L G  P + +     +          Q T  
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237

Query: 377 SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRP---LITDVLHSLI 425
            +L           M                       P    +  +   ++
Sbjct: 238 RELCAGFPEEFYKYMH------------YARNLAFDATPDYDYLQGLFSKVL 277

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 3e-34
 Identities = 63/296 (21%), Positives = 106/296 (35%), Gaps = 43/296 (14%)

Query: 133 LAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKAR----FNEKLLAAVKRIDDA 188
           L G  + V +  +ELL+          V+G G  G V+  R     +   L A+K +  A
Sbjct: 14  LTGHAEKVGIENFELLK----------VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKA 63

Query: 189 G----HDAEREFNNEVNWLTKIRHQ-NIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGP 243
                         E   L  IR    +++L           L+ + +  G L   L   
Sbjct: 64  TIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR 123

Query: 244 THGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS- 302
              +     + +         +  L       +++RD+K  NILLDS+ +  L+DFGLS 
Sbjct: 124 ERFTEHEVQIYV------GEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK 177

Query: 303 -VTAGTQSRNVKISGTLGYVAPEYLLEGK--LTDKSDVYAFGVVLLELLMGRRPVEKMSP 359
              A    R     GT+ Y+AP+ +  G        D ++ GV++ ELL G  P      
Sbjct: 178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE 237

Query: 360 TQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRP 415
              Q+ +  +   L      P  +  + +D +               +  +P  R 
Sbjct: 238 KNSQAEI--SRRILKSEPPYPQEMSALAKDLIQ------------RLLMKDPKKRL 279

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  122 bits (307), Expect = 4e-32
 Identities = 50/295 (16%), Positives = 108/295 (36%), Gaps = 38/295 (12%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKIR-HQN 210
           +++Q    +G G    V++A          VK +       +++   E+  L  +R   N
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK---PVKKKKIKREIKILENLRGGPN 91

Query: 211 IISLLGYCIHAETR--FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYL 268
           II+L        +R   LV+E + N   ++          LT +       ++ + L+Y 
Sbjct: 92  IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYC 145

Query: 269 HEHCNHPVVHRDLKSSNILLDSSFN-AKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLL 327
           H      ++HRD+K  N+++D      +L D+GL+              +  +  PE L+
Sbjct: 146 HSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV 202

Query: 328 EGKLTD-KSDVYAFGVVLLELLMGRRP---------VEKMSPTQCQSMVTWAMPQLTDRS 377
           + ++ D   D+++ G +L  ++  + P                   +   +      +  
Sbjct: 203 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262

Query: 378 KLPNIVDPVIRDT---------MDLKHLYQVAAVAVL--CIQPEPSYRPLITDVL 421
             P   D + R +          + +HL    A+  L   ++ +   R    + +
Sbjct: 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 317

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (299), Expect = 7e-31
 Identities = 56/292 (19%), Positives = 97/292 (33%), Gaps = 29/292 (9%)

Query: 152 TNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAE--REFNNEVNWLTKIRH 208
              +Q  + +G G  G V  A   +  L  AVK++          +    E+  L  ++H
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76

Query: 209 QNIISLLGYCIHA----ETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
           +N+I LL     A    E   +       G+    +        LT      +   + RG
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQFLIYQILRG 133

Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
           L+Y+H        HRDLK SN+ ++     K+ DFGL+     +        T  Y APE
Sbjct: 134 LKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA--TRWYRAPE 188

Query: 325 YLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
            +L     +   D+++ G ++ ELL GR             ++   +             
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 248

Query: 384 DPVIRDTMDLKHLYQVAAVAVL-------------CIQPEPSYRPLITDVLH 422
           +        L  + ++    V               +  +   R      L 
Sbjct: 249 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (295), Expect = 3e-30
 Identities = 52/218 (23%), Positives = 87/218 (39%), Gaps = 18/218 (8%)

Query: 153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAE--REFNNEVNWLTKIRHQ 209
             +Q    IG G +G V  A         A+K++     +    +    E+  +  + H+
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
           NIISLL      +T       +LV E+M     +                   +   +  
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD------HERMSYLLYQMLC 130

Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
           G+++LH       +HRDLK SNI++ S    K+ DFGL+ TAGT         T  Y AP
Sbjct: 131 GIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 187

Query: 324 EYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQ 361
           E +L     +  D+++ G ++ E++  +          
Sbjct: 188 EVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 225

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  106 bits (264), Expect = 5e-26
 Identities = 42/229 (18%), Positives = 79/229 (34%), Gaps = 31/229 (13%)

Query: 145 YELLEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWL 203
           Y L+            +G G    V+ A+        A+K +       E    +E+  L
Sbjct: 15  YILVR----------KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA-AEDEIKLL 63

Query: 204 TKIRHQN-----------IISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWH 252
            ++   +           I+ LL +  H     +   M+     E  L       +    
Sbjct: 64  QRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIP 123

Query: 253 LRM--KIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS----FNAKLSDFGLSVTAG 306
           L    +I+  +  GL+Y+H  C   ++H D+K  N+L++         ++    L     
Sbjct: 124 LIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW 181

Query: 307 TQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVE 355
                     T  Y +PE LL       +D+++   ++ EL+ G    E
Sbjct: 182 YDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 230

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 79.8 bits (196), Expect = 4e-18
 Identities = 24/158 (15%), Positives = 48/158 (30%), Gaps = 20/158 (12%)

Query: 159 NVIGEGGRGHVYKARFNEKLLAAVK----------RIDDAGHDAEREFNNEVNWLTKIRH 208
            ++GEG    V+     +     VK          ++ +     +  F+       +   
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 209 QNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYL 268
           + +  L G  +        Y    N  L  +L        +      ++   +   +   
Sbjct: 66  RALQKLQGLAVPKV-----YAWEGNAVLM-ELIDAKELYRVRVENPDEVLDMILEEVAKF 119

Query: 269 HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAG 306
           +      +VH DL   N+L+       + DF  SV  G
Sbjct: 120 YHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVG 153

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	439
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.9
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.65
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.06
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.53
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.01
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.4
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.28

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-55  Score=416.38  Aligned_cols=257  Identities=30%  Similarity=0.474  Sum_probs=203.8

Q ss_pred             HhcCCCccceecccCcEEEEEEEECCccEEEEEEecCC--CchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEE
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDA--GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      ..++|++.+.||+|+||+||+|+.++  .||||.++..  .....+.|.+|+.++++++||||+++++++.+ +..++||
T Consensus         6 ~~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~   82 (276)
T d1uwha_           6 PDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT   82 (276)
T ss_dssp             CTTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             ccccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence            35688899999999999999998765  4899998643  34456789999999999999999999998754 5689999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~  308 (439)
                      ||+++|+|.++++.  ....+++..+.+++.|+|+||+|||+.   +|+||||||+|||+++++++||+|||+|+.....
T Consensus        83 Ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~  157 (276)
T d1uwha_          83 QWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW  157 (276)
T ss_dssp             ECCCEEEHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred             ecCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence            99999999999974  334699999999999999999999998   9999999999999999999999999999765432


Q ss_pred             Cc---ceeeccccCccchhhhcC---CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhh-hhHhhhhcccccCCCCCc
Q 013636          309 SR---NVKISGTLGYVAPEYLLE---GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQ-SMVTWAMPQLTDRSKLPN  381 (439)
Q Consensus       309 ~~---~~~~~gt~~y~aPE~~~~---~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  381 (439)
                      ..   .....||+.|+|||++.+   +.++.++|||||||++|||+||+.||.+.++.... ..+...    ......  
T Consensus       158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~----~~~p~~--  231 (276)
T d1uwha_         158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRG----YLSPDL--  231 (276)
T ss_dssp             --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHT----SCCCCG--
T ss_pred             CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcC----CCCCcc--
Confidence            22   234569999999999974   35889999999999999999999999876654322 222110    000010  


Q ss_pred             cCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccC
Q 013636          382 IVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLV  428 (439)
Q Consensus       382 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~  428 (439)
                         +.+...    ....+.+++.+||+.||++|||+.|++++|+.+.
T Consensus       232 ---~~~~~~----~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~  271 (276)
T d1uwha_         232 ---SKVRSN----CPKAMKRLMAECLKKKRDERPLFPQILASIELLA  271 (276)
T ss_dssp             ---GGSCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---hhcccc----chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence               011111    2246778999999999999999999999998764

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-55  Score=409.18  Aligned_cols=253  Identities=26%  Similarity=0.420  Sum_probs=204.0

Q ss_pred             cCCCccceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEecc
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQ  232 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  232 (439)
                      ++|+..+.||+|+||+||+|++.++..||||+++... ...++|.+|++++++++||||++++|+|...+..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            4678889999999999999999988899999997644 345689999999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCcc-
Q 013636          233 NGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN-  311 (439)
Q Consensus       233 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~~-  311 (439)
                      +|+|.+++..  ....+++..+.+++.|+|+||+|||+.   +|+||||||+|||+++++++||+|||+++........ 
T Consensus        84 ~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~  158 (263)
T d1sm2a_          84 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS  158 (263)
T ss_dssp             TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred             CCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence            9999999874  345689999999999999999999998   9999999999999999999999999999776443322 


Q ss_pred             -eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcC
Q 013636          312 -VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRD  389 (439)
Q Consensus       312 -~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  389 (439)
                       ....||+.|+|||.+.+..++.++|||||||++|||+| |++||...+..+....+...     .+...+...      
T Consensus       159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~-----~~~~~p~~~------  227 (263)
T d1sm2a_         159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-----FRLYKPRLA------  227 (263)
T ss_dssp             ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHT-----CCCCCCTTS------
T ss_pred             ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhc-----CCCCCcccc------
Confidence             23458999999999999999999999999999999999 56667666554443333221     111111111      


Q ss_pred             ccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccC
Q 013636          390 TMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLV  428 (439)
Q Consensus       390 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~  428 (439)
                            ..++.+++.+||+.||++|||++|++++|+++.
T Consensus       228 ------~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~  260 (263)
T d1sm2a_         228 ------STHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA  260 (263)
T ss_dssp             ------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ------CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence                  235678999999999999999999999998774

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-54  Score=399.36  Aligned_cols=252  Identities=25%  Similarity=0.428  Sum_probs=215.0

Q ss_pred             cCCCccceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEecc
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQ  232 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  232 (439)
                      ++|+..+.||+|+||+||+|+++++..||||.++.... ..++|.+|+.++++++||||++++|+|.+++..++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            57888999999999999999999888999999986543 45689999999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCcc-
Q 013636          233 NGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN-  311 (439)
Q Consensus       233 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~~-  311 (439)
                      +|+|.+++..  ....+++..+.+++.|+++||+|||+.   +|+||||||+|||+++++.+||+|||+++........ 
T Consensus        83 ~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~  157 (258)
T d1k2pa_          83 NGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS  157 (258)
T ss_dssp             TEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred             CCcHHHhhhc--cccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence            9999999864  335689999999999999999999998   9999999999999999999999999999765443322 


Q ss_pred             -eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcC
Q 013636          312 -VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRD  389 (439)
Q Consensus       312 -~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  389 (439)
                       ....||+.|+|||.+.+..++.++|||||||++|||+| |+.||...+..+....+...     .+...++..      
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~-----~~~~~p~~~------  226 (258)
T d1k2pa_         158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG-----LRLYRPHLA------  226 (258)
T ss_dssp             CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT-----CCCCCCTTC------
T ss_pred             ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhC-----CCCCCcccc------
Confidence             23458999999999999999999999999999999998 89999988876655444321     111122211      


Q ss_pred             ccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhcccc
Q 013636          390 TMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPL  427 (439)
Q Consensus       390 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l  427 (439)
                            ...+.+++.+||+.||++|||+.+++++|..+
T Consensus       227 ------~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         227 ------SEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             ------CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             ------cHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence                  23577899999999999999999999998654

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.5e-54  Score=410.22  Aligned_cols=255  Identities=26%  Similarity=0.427  Sum_probs=202.8

Q ss_pred             cCCCccceecccCcEEEEEEEECC----ccEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNE----KLLAAVKRIDDAG-HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLV  227 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  227 (439)
                      ++|++.++||+|+||+||+|++..    ...+|||.+.... ....++|.+|+.+|++++|||||+++|+|...+..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            456778899999999999998753    2368899886543 34456799999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCC
Q 013636          228 YEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT  307 (439)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~  307 (439)
                      ||||++|+|.+++..  ....++|..+++++.|+|+||+|||+.   +++||||||+||||++++++||+|||+++....
T Consensus       106 ~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLED  180 (299)
T ss_dssp             EECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEccC
Confidence            999999999999874  345699999999999999999999998   999999999999999999999999999986543


Q ss_pred             CCcc------eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCC
Q 013636          308 QSRN------VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLP  380 (439)
Q Consensus       308 ~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  380 (439)
                      ....      ....||+.|+|||.+.++.++.++|||||||++|||+| |+.||.+.+..+....+...     .+...+
T Consensus       181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~-----~~~~~~  255 (299)
T d1jpaa_         181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQD-----YRLPPP  255 (299)
T ss_dssp             ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-----CCCCCC
T ss_pred             CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-----CCCCCC
Confidence            3221      12347899999999999999999999999999999998 89999988766544333211     011111


Q ss_pred             ccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCC
Q 013636          381 NIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVP  429 (439)
Q Consensus       381 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~  429 (439)
                      .            .....+.+++.+||+.||++|||+.||++.|++++.
T Consensus       256 ~------------~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~  292 (299)
T d1jpaa_         256 M------------DCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR  292 (299)
T ss_dssp             T------------TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             c------------cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence            1            123457789999999999999999999999988764

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-54  Score=400.54  Aligned_cols=246  Identities=29%  Similarity=0.486  Sum_probs=208.8

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC---chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      ++|++.+.||+|+||+||+|+.. ++..+|+|.+....   ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            56888999999999999999985 57889999986422   233467899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~  308 (439)
                      ||+++|+|.+++..   ...+++..+..++.|+++||+|||++   +|+||||||+|||+++++++||+|||+|......
T Consensus        86 Ey~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~  159 (263)
T d2j4za1          86 EYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  159 (263)
T ss_dssp             ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred             eecCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCC
Confidence            99999999999964   34599999999999999999999998   9999999999999999999999999999776543


Q ss_pred             CcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhc
Q 013636          309 SRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIR  388 (439)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  388 (439)
                      . .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+..      ....+++.++    
T Consensus       160 ~-~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~------~~~~~p~~~s----  228 (263)
T d2j4za1         160 R-RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR------VEFTFPDFVT----  228 (263)
T ss_dssp             C-CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT------TCCCCCTTSC----
T ss_pred             c-ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHc------CCCCCCccCC----
Confidence            2 3456799999999999999999999999999999999999999988776554433321      1122222222    


Q ss_pred             CccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          389 DTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       389 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                              ..+.+++.+||+.||++|||+.|++++
T Consensus       229 --------~~~~~li~~~L~~dp~~R~t~~eil~h  255 (263)
T d2j4za1         229 --------EGARDLISRLLKHNPSQRPMLREVLEH  255 (263)
T ss_dssp             --------HHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             --------HHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence                    346679999999999999999999975

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-54  Score=406.50  Aligned_cols=255  Identities=26%  Similarity=0.442  Sum_probs=208.2

Q ss_pred             HhcCCCccceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEe
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      ..++|++.+.||+|+||+||+|+++++..||||.++... ...++|.+|+.++++++|||||+++|++.+ +..++||||
T Consensus        11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey   88 (272)
T d1qpca_          11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY   88 (272)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence            456788899999999999999999988899999997644 345679999999999999999999998754 567999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR  310 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~  310 (439)
                      +++|+|.+++... ....+++..+++++.|+++||+|||+.   +|+||||||+||||++++.+||+|||+|+.......
T Consensus        89 ~~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~  164 (272)
T d1qpca_          89 MENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY  164 (272)
T ss_dssp             CTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred             CCCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCcc
Confidence            9999999988642 234589999999999999999999998   999999999999999999999999999987654332


Q ss_pred             c--eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhC-CCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchh
Q 013636          311 N--VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMG-RRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVI  387 (439)
Q Consensus       311 ~--~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  387 (439)
                      .  ....||+.|+|||++.++.++.++|||||||++|||+|| .+|+...+..+....+...     .+...+.      
T Consensus       165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~-----~~~~~p~------  233 (272)
T d1qpca_         165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG-----YRMVRPD------  233 (272)
T ss_dssp             ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-----CCCCCCT------
T ss_pred             ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc-----CCCCCcc------
Confidence            2  234588999999999999999999999999999999995 4555555544433322211     0111111      


Q ss_pred             cCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccC
Q 013636          388 RDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLV  428 (439)
Q Consensus       388 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~  428 (439)
                        ..    ...+.+++.+||+.||++|||+.||++.|+++.
T Consensus       234 --~~----~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f  268 (272)
T d1qpca_         234 --NC----PEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF  268 (272)
T ss_dssp             --TC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --cC----hHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence              11    235678999999999999999999999998654

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-53  Score=401.98  Aligned_cols=249  Identities=21%  Similarity=0.370  Sum_probs=208.8

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEec
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMM  231 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  231 (439)
                      ++|+..+.||+|+||+||+|+.. ++..||+|.+........+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            57999999999999999999874 58899999987655556678999999999999999999999999999999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCC-c
Q 013636          232 QNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS-R  310 (439)
Q Consensus       232 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~-~  310 (439)
                      ++|+|.+++..    ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++++||+|||+|+...... .
T Consensus       100 ~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~  172 (293)
T d1yhwa1         100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  172 (293)
T ss_dssp             TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred             CCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccccc
Confidence            99999998864    2589999999999999999999998   99999999999999999999999999998764432 3


Q ss_pred             ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCc
Q 013636          311 NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDT  390 (439)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  390 (439)
                      .....||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+.......+...     ....+   ..   ...
T Consensus       173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~-----~~~~~---~~---~~~  241 (293)
T d1yhwa1         173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-----GTPEL---QN---PEK  241 (293)
T ss_dssp             BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHH-----CSCCC---SS---GGG
T ss_pred             ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhC-----CCCCC---CC---ccc
Confidence            34556999999999999999999999999999999999999999877654432222110     00011   00   011


Q ss_pred             cCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          391 MDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       391 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      +    ...+.+++.+||+.||++|||+.|+++|
T Consensus       242 ~----s~~~~~li~~~L~~dP~~R~s~~eil~H  270 (293)
T d1yhwa1         242 L----SAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (293)
T ss_dssp             S----CHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred             C----CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            1    2356679999999999999999999875

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.9e-54  Score=407.07  Aligned_cols=259  Identities=25%  Similarity=0.392  Sum_probs=213.1

Q ss_pred             HHhcCCCccceecccCcEEEEEEEECC-ccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEE
Q 013636          150 AATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       150 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      ...++|+..+.||+|+||+||+|++.+ +..||||.++... ...++|.+|+.+|++++|||||+++++|.+.+..++||
T Consensus        14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~   92 (287)
T d1opja_          14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   92 (287)
T ss_dssp             CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence            345678889999999999999999864 7789999987543 34567999999999999999999999999999999999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~  308 (439)
                      ||+++|+|.+++... ....+++..+..++.|+++||+|||+.   +|+||||||+|||+++++++||+|||+|+.....
T Consensus        93 E~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~  168 (287)
T d1opja_          93 EFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  168 (287)
T ss_dssp             ECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred             ecccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCC
Confidence            999999999999752 345799999999999999999999998   9999999999999999999999999999876544


Q ss_pred             Ccc--eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCC-CCCChhhhhhhHhhhhcccccCCCCCccCCc
Q 013636          309 SRN--VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPV-EKMSPTQCQSMVTWAMPQLTDRSKLPNIVDP  385 (439)
Q Consensus       309 ~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  385 (439)
                      ...  ....||+.|+|||++.++.++.++|||||||++|||++|..|+ ...+.......+...     .....+..   
T Consensus       169 ~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~-----~~~~~~~~---  240 (287)
T d1opja_         169 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-----YRMERPEG---  240 (287)
T ss_dssp             SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT-----CCCCCCTT---
T ss_pred             CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcC-----CCCCCCcc---
Confidence            332  2235789999999999999999999999999999999966654 444444433333211     01111111   


Q ss_pred             hhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCC
Q 013636          386 VIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPT  430 (439)
Q Consensus       386 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~  430 (439)
                           .    ...+.+++.+||+.||++|||+.|+++.|+.+..+
T Consensus       241 -----~----~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~  276 (287)
T d1opja_         241 -----C----PEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  276 (287)
T ss_dssp             -----C----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred             -----c----hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence                 1    23567899999999999999999999999887653

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-53  Score=401.16  Aligned_cols=253  Identities=27%  Similarity=0.412  Sum_probs=207.1

Q ss_pred             cCCCccce-ecccCcEEEEEEEEC---CccEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEE
Q 013636          153 NNFQESNV-IGEGGRGHVYKARFN---EKLLAAVKRIDDAG-HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLV  227 (439)
Q Consensus       153 ~~~~~~~~-LG~G~fg~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  227 (439)
                      ++|.+.+. ||+|+||+||+|.++   ++..||||.++... ....++|.+|+++|++++|||||+++|+|.. +..++|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            45666664 999999999999764   35579999997543 3445789999999999999999999999864 568999


Q ss_pred             EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCC
Q 013636          228 YEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT  307 (439)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~  307 (439)
                      |||+++|+|.+++..  ....+++..+.+++.|+|+||+|||+.   +|+||||||+|||+++++.+||+|||+++....
T Consensus        87 mE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~  161 (285)
T d1u59a_          87 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGA  161 (285)
T ss_dssp             EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcccc
Confidence            999999999999863  335699999999999999999999998   999999999999999999999999999987654


Q ss_pred             CCcc----eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCcc
Q 013636          308 QSRN----VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNI  382 (439)
Q Consensus       308 ~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  382 (439)
                      ....    ....||+.|+|||++.++.++.++|||||||++|||+| |+.||...+..+....+...     .+...+..
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~-----~~~~~p~~  236 (285)
T d1u59a_         162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-----KRMECPPE  236 (285)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT-----CCCCCCTT
T ss_pred             cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-----CCCCCCCc
Confidence            3322    22358899999999999999999999999999999998 99999987765544333211     11112211


Q ss_pred             CCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccC
Q 013636          383 VDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLV  428 (439)
Q Consensus       383 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~  428 (439)
                              +    ...+.+++.+||+.||++|||+.+|++.|+...
T Consensus       237 --------~----~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~  270 (285)
T d1u59a_         237 --------C----PPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  270 (285)
T ss_dssp             --------C----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --------C----CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence                    1    235677999999999999999999999887543

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-53  Score=403.30  Aligned_cols=251  Identities=24%  Similarity=0.403  Sum_probs=207.9

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEec
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMM  231 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  231 (439)
                      +.|++.+.||+|+||+||+|+.. ++..+|+|.++.......+.+.+|+++|++++|||||++++++.+.+..++|||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            46888899999999999999985 57889999998766666678999999999999999999999999999999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCC-c
Q 013636          232 QNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS-R  310 (439)
Q Consensus       232 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~-~  310 (439)
                      ++|+|.+++..  ....+++..+..++.|+++||+|||++   +|+||||||+|||++.++++||+|||+|....... .
T Consensus        92 ~~g~L~~~~~~--~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~  166 (288)
T d2jfla1          92 AGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR  166 (288)
T ss_dssp             TTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHH
T ss_pred             CCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCccc
Confidence            99999999763  234699999999999999999999998   99999999999999999999999999997653321 1


Q ss_pred             ceeeccccCccchhhhc-----CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCc
Q 013636          311 NVKISGTLGYVAPEYLL-----EGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDP  385 (439)
Q Consensus       311 ~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  385 (439)
                      .....||+.|+|||++.     +..++.++|||||||++|||++|+.||...++.+....+...        ..+....+
T Consensus       167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~--------~~~~~~~~  238 (288)
T d2jfla1         167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS--------EPPTLAQP  238 (288)
T ss_dssp             HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHS--------CCCCCSSG
T ss_pred             ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC--------CCCCCCcc
Confidence            23456999999999984     456889999999999999999999999887765533222211        00111111


Q ss_pred             hhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          386 VIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       386 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                         ...    ...+.+++.+||+.||++|||+.|++++
T Consensus       239 ---~~~----s~~~~~li~~~L~~dp~~R~t~~ell~h  269 (288)
T d2jfla1         239 ---SRW----SSNFKDFLKKCLEKNVDARWTTSQLLQH  269 (288)
T ss_dssp             ---GGS----CHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             ---ccC----CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               111    2356779999999999999999999975

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-53  Score=399.99  Aligned_cols=254  Identities=23%  Similarity=0.381  Sum_probs=196.9

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCceeeeeeEEEe--CCeeEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLLGYCIH--AETRFLV  227 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV  227 (439)
                      ++|++.+.||+|+||+||+|+.. ++..+|+|.+....  ....+.+.+|++++++++||||+++++++.+  .+..++|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            67899999999999999999875 57889999987543  3344678999999999999999999999865  4567999


Q ss_pred             EEeccCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCCeEecCCCCCCEEEcCCCcEEEEecccccc
Q 013636          228 YEMMQNGSLEKQLHGP-THGSNLTWHLRMKIAVDVARGLEYLHEHC--NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT  304 (439)
Q Consensus       228 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~~LH~~~--~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~  304 (439)
                      ||||++|+|.+++... .....+++..+..++.|++.||+|||+.+  .++|+||||||+|||+++++++||+|||+|+.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            9999999999998642 22456999999999999999999999862  13599999999999999999999999999987


Q ss_pred             cCCCCc-ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccC
Q 013636          305 AGTQSR-NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV  383 (439)
Q Consensus       305 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  383 (439)
                      ...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+...     ....++..+
T Consensus       164 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~-----~~~~~~~~~  238 (269)
T d2java1         164 LNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG-----KFRRIPYRY  238 (269)
T ss_dssp             C-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT-----CCCCCCTTS
T ss_pred             cccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcC-----CCCCCCccc
Confidence            654332 23467999999999999999999999999999999999999999887765543333211     011122111


Q ss_pred             CchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          384 DPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       384 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                                  ..++.+++.+||+.||++|||+.|++++
T Consensus       239 ------------s~~l~~li~~~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         239 ------------SDELNEIITRMLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             ------------CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ------------CHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence                        2356779999999999999999999875

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-53  Score=398.28  Aligned_cols=250  Identities=26%  Similarity=0.380  Sum_probs=201.2

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEe
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGH-DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      ++|++.+.||+|+||+||+|+.. ++..+|+|.+..... +..+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            57888999999999999999985 578999999865432 3345689999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCC-
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS-  309 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~-  309 (439)
                      +++|+|.+++..   ...+++..+..++.|++.||+|||++   +|+||||||+|||+++++++||+|||+|+...... 
T Consensus        85 ~~gg~L~~~l~~---~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~  158 (271)
T d1nvra_          85 CSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  158 (271)
T ss_dssp             CTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             cCCCcHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence            999999999963   34699999999999999999999998   99999999999999999999999999998654322 


Q ss_pred             --cceeeccccCccchhhhcCCCC-CCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCch
Q 013636          310 --RNVKISGTLGYVAPEYLLEGKL-TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPV  386 (439)
Q Consensus       310 --~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  386 (439)
                        .....+||+.|+|||++.+..+ +.++||||+||++|||++|+.||...+....... ...     ....... .   
T Consensus       159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~-~~~-----~~~~~~~-~---  228 (271)
T d1nvra_         159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS-DWK-----EKKTYLN-P---  228 (271)
T ss_dssp             ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHH-HHH-----TTCTTST-T---
T ss_pred             cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHH-HHh-----cCCCCCC-c---
Confidence              2234569999999999988876 5689999999999999999999976543221111 110     0100000 0   


Q ss_pred             hcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          387 IRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       387 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                       ....    ...+.+++.+||+.||++|||++|++++
T Consensus       229 -~~~~----s~~~~~li~~~L~~dP~~R~t~~eil~h  260 (271)
T d1nvra_         229 -WKKI----DSAPLALLHKILVENPSARITIPDIKKD  260 (271)
T ss_dssp             -GGGS----CHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -cccC----CHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence             0111    1345678999999999999999999875

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-52  Score=397.68  Aligned_cols=255  Identities=27%  Similarity=0.392  Sum_probs=201.1

Q ss_pred             cCCCccceecccCcEEEEEEEECCc-----cEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNEK-----LLAAVKRIDDAGH-DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFL  226 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  226 (439)
                      +.|+..++||+|+||+||+|.+++.     ..||||++..... ....+|.+|+.++++++|||||+++|++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            4577789999999999999987542     4789999875433 344579999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccC
Q 013636          227 VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAG  306 (439)
Q Consensus       227 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~  306 (439)
                      ||||+.+|++.+++..  ....+++..+.+++.|++.||+|||+.   +|+||||||+||||++++++||+|||+++...
T Consensus        87 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          87 ITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             EEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEEecccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhccc
Confidence            9999999999998863  335699999999999999999999998   99999999999999999999999999997654


Q ss_pred             CCCc----ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCC-CCCCChhhhhhhHhhhhcccccCCCCCc
Q 013636          307 TQSR----NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP-VEKMSPTQCQSMVTWAMPQLTDRSKLPN  381 (439)
Q Consensus       307 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  381 (439)
                      ....    .....||+.|+|||++.++.++.++|||||||++|||++|..| +...+..+....+...     .+...+.
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~-----~~~~~~~  236 (283)
T d1mqba_         162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG-----FRLPTPM  236 (283)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-----CCCCCCT
T ss_pred             CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhcc-----CCCCCch
Confidence            3322    1224589999999999999999999999999999999995554 5555544433322211     0111111


Q ss_pred             cCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCC
Q 013636          382 IVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVP  429 (439)
Q Consensus       382 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~  429 (439)
                                  .....+.+++.+||+.||++|||+.||++.|+++..
T Consensus       237 ------------~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~  272 (283)
T d1mqba_         237 ------------DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  272 (283)
T ss_dssp             ------------TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ------------hhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence                        112457789999999999999999999999987754

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=7.1e-52  Score=402.91  Aligned_cols=252  Identities=20%  Similarity=0.273  Sum_probs=214.5

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEec
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMM  231 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  231 (439)
                      ++|++.+.||+|+||+||+|+.. ++..+|+|.+........+.+.+|+.+|++++||||+++++++.+.+..++|||||
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  105 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  105 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            57999999999999999999985 57899999998776666778999999999999999999999999999999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc--CCCcEEEEecccccccCCCC
Q 013636          232 QNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLD--SSFNAKLSDFGLSVTAGTQS  309 (439)
Q Consensus       232 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~--~~~~~kl~DfGls~~~~~~~  309 (439)
                      ++|+|.+++..  ....+++..+..++.||+.||+|||++   +|+||||||+|||++  .++.+||+|||+|+......
T Consensus       106 ~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~  180 (350)
T d1koaa2         106 SGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ  180 (350)
T ss_dssp             CSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred             CCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence            99999999963  234699999999999999999999998   999999999999995  46789999999998877666


Q ss_pred             cceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcC
Q 013636          310 RNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRD  389 (439)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  389 (439)
                      ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+..+....+...      ....+.    ....
T Consensus       181 ~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~------~~~~~~----~~~~  250 (350)
T d1koaa2         181 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC------DWNMDD----SAFS  250 (350)
T ss_dssp             CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT------CCCSCC----GGGG
T ss_pred             ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhC------CCCCCc----cccc
Confidence            666678999999999999999999999999999999999999999887765543333211      111111    1111


Q ss_pred             ccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          390 TMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       390 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      .+    ...+.+++.+||+.||++|||+.|++++
T Consensus       251 ~~----s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         251 GI----SEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             GC----CHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             CC----CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            11    1356779999999999999999999986

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-52  Score=394.36  Aligned_cols=245  Identities=28%  Similarity=0.410  Sum_probs=200.5

Q ss_pred             ceecccCcEEEEEEEECC---ccEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEeccC
Q 013636          159 NVIGEGGRGHVYKARFNE---KLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQN  233 (439)
Q Consensus       159 ~~LG~G~fg~Vy~~~~~~---~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  233 (439)
                      +.||+|+||+||+|.+++   +..||||.++...  ....++|.+|+++|++++|||||+++|+|.. +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            469999999999998743   4679999986432  3345679999999999999999999999864 567899999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCcc--
Q 013636          234 GSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN--  311 (439)
Q Consensus       234 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~~--  311 (439)
                      |+|.++++.   ...+++..+.+++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++........  
T Consensus        92 g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~  165 (277)
T d1xbba_          92 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  165 (277)
T ss_dssp             EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred             CcHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence            999999964   34699999999999999999999998   9999999999999999999999999999865443322  


Q ss_pred             --eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhc
Q 013636          312 --VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIR  388 (439)
Q Consensus       312 --~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  388 (439)
                        ....||++|+|||.+.++.++.++|||||||++|||+| |+.||.+.+..+....+...     .+...+..      
T Consensus       166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~-----~~~~~p~~------  234 (277)
T d1xbba_         166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-----ERMGCPAG------  234 (277)
T ss_dssp             C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-----CCCCCCTT------
T ss_pred             cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcC-----CCCCCCcc------
Confidence              22458999999999999999999999999999999998 99999988766544444311     11112211      


Q ss_pred             CccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhcccc
Q 013636          389 DTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPL  427 (439)
Q Consensus       389 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l  427 (439)
                        +    ...+.+++.+||+.||++|||+.+|++.|+..
T Consensus       235 --~----~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~  267 (277)
T d1xbba_         235 --C----PREMYDLMNLCWTYDVENRPGFAAVELRLRNY  267 (277)
T ss_dssp             --C----CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             --c----CHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence              1    23567799999999999999999999888654

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-52  Score=402.70  Aligned_cols=256  Identities=26%  Similarity=0.401  Sum_probs=205.8

Q ss_pred             HHhcCCCccceecccCcEEEEEEEECC------ccEEEEEEecCCC-chHHHHHHHHHHHHHhc-CCCceeeeeeEEEeC
Q 013636          150 AATNNFQESNVIGEGGRGHVYKARFNE------KLLAAVKRIDDAG-HDAEREFNNEVNWLTKI-RHQNIISLLGYCIHA  221 (439)
Q Consensus       150 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  221 (439)
                      ...++|++.+.||+|+||+||+|+..+      ...||+|.+.... ......+.+|+.++.++ +|||||++++++.+.
T Consensus        34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~  113 (325)
T d1rjba_          34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS  113 (325)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence            345788999999999999999998743      2368999886543 33446789999999998 899999999999999


Q ss_pred             CeeEEEEEeccCCChhhhhcCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 013636          222 ETRFLVYEMMQNGSLEKQLHGPTH--------------------GSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDL  281 (439)
Q Consensus       222 ~~~~lV~e~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dl  281 (439)
                      +..++|||||++|+|.++++....                    ...+++..++.++.|+++||+|||++   +|+||||
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDl  190 (325)
T d1rjba_         114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDL  190 (325)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTC
T ss_pred             CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccC
Confidence            999999999999999999975321                    23589999999999999999999998   9999999


Q ss_pred             CCCCEEEcCCCcEEEEecccccccCCCCcc---eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCC
Q 013636          282 KSSNILLDSSFNAKLSDFGLSVTAGTQSRN---VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKM  357 (439)
Q Consensus       282 k~~NiLl~~~~~~kl~DfGls~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~  357 (439)
                      ||+|||++.++++||+|||+|+........   ....||+.|+|||++.++.++.++|||||||++|||+| |+.||.+.
T Consensus       191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~  270 (325)
T d1rjba_         191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI  270 (325)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence            999999999999999999999765443332   23457999999999999999999999999999999998 89999876


Q ss_pred             Chhhh-hhhHhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhcc
Q 013636          358 SPTQC-QSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLI  425 (439)
Q Consensus       358 ~~~~~-~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  425 (439)
                      +.... ...+...     .+...+..+            ...+.+++.+||+.||++|||++||+++|.
T Consensus       271 ~~~~~~~~~~~~~-----~~~~~p~~~------------~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         271 PVDANFYKLIQNG-----FKMDQPFYA------------TEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             CCSHHHHHHHHTT-----CCCCCCTTC------------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CHHHHHHHHHhcC-----CCCCCCCcC------------CHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            54332 2222110     011111111            235678999999999999999999999984

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-52  Score=405.09  Aligned_cols=266  Identities=24%  Similarity=0.367  Sum_probs=204.7

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG-HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYE  229 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  229 (439)
                      .++|++.+.||+|+||+||+|+.. ++..+|+|.++... .....++.+|+.+|++++|||||++++++.+.+..++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            578999999999999999999985 57899999986543 3445679999999999999999999999999999999999


Q ss_pred             eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCC
Q 013636          230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS  309 (439)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~  309 (439)
                      |+++|+|.+++.+   ...+++..+..++.|++.||+|||+.  ++|+||||||+|||+++++++||+|||+|...... 
T Consensus        85 y~~gg~L~~~l~~---~~~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-  158 (322)
T d1s9ja_          85 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  158 (322)
T ss_dssp             CCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred             cCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCCC-
Confidence            9999999999964   23589999999999999999999973  28999999999999999999999999999765432 


Q ss_pred             cceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhh-hcccccCCCCCcc------
Q 013636          310 RNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWA-MPQLTDRSKLPNI------  382 (439)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~------  382 (439)
                      ......||+.|+|||++.+..|+.++||||+||++|||++|+.||...+..+........ .............      
T Consensus       159 ~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (322)
T d1s9ja_         159 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS  238 (322)
T ss_dssp             TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------------
T ss_pred             ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccc
Confidence            223457999999999999999999999999999999999999999876543221111000 0000000000000      


Q ss_pred             -CCchhcCccC------------------HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          383 -VDPVIRDTMD------------------LKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       383 -~d~~l~~~~~------------------~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                       ..........                  .....++.+++.+||+.||++|||+.|+++|
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H  298 (322)
T d1s9ja_         239 SYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  298 (322)
T ss_dssp             -------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence             0000000000                  0012457789999999999999999999986

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.5e-52  Score=397.54  Aligned_cols=252  Identities=25%  Similarity=0.336  Sum_probs=192.9

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGH-DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYE  229 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  229 (439)
                      .+.|++.+.||+|+||+||+|+.. ++..+|+|.+..... .....+.+|+.+|++++||||+++++++.+.+..++|||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            467899999999999999999986 578899999875432 334568899999999999999999999999999999999


Q ss_pred             eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc---CCCcEEEEecccccccC
Q 013636          230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLD---SSFNAKLSDFGLSVTAG  306 (439)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~---~~~~~kl~DfGls~~~~  306 (439)
                      ||++|+|.+++..   ...+++..+..++.|++.||+|||+.   +|+||||||+|||+.   +++.+||+|||+|+...
T Consensus        88 ~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~  161 (307)
T d1a06a_          88 LVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED  161 (307)
T ss_dssp             CCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred             ccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence            9999999999964   34699999999999999999999998   999999999999994   57899999999998766


Q ss_pred             CCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCch
Q 013636          307 TQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPV  386 (439)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  386 (439)
                      .........||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+...      ....+..    
T Consensus       162 ~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~------~~~~~~~----  231 (307)
T d1a06a_         162 PGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKA------EYEFDSP----  231 (307)
T ss_dssp             -----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTT------CCCCCTT----
T ss_pred             CCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhcc------CCCCCCc----
Confidence            555445567999999999999999999999999999999999999999887655433332211      1111110    


Q ss_pred             hcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          387 IRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       387 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      ....+    ...+.+++.+||+.||++|||+.|++++
T Consensus       232 ~~~~~----s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         232 YWDDI----SDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             TTTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             cccCC----CHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence            11111    2356779999999999999999999986

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.3e-51  Score=399.63  Aligned_cols=252  Identities=20%  Similarity=0.264  Sum_probs=214.0

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEec
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMM  231 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  231 (439)
                      ++|++.+.||+|+||+||+|+.. ++..+|+|.++.......+.+.+|+.+|++++||||+++++++.+.+..++|||||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            57899999999999999999875 58899999998766666678899999999999999999999999999999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc--CCCcEEEEecccccccCCCC
Q 013636          232 QNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLD--SSFNAKLSDFGLSVTAGTQS  309 (439)
Q Consensus       232 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~--~~~~~kl~DfGls~~~~~~~  309 (439)
                      ++|+|.+++..  .+..+++..+..++.|++.||+|||+.   +|+||||||+|||++  .++.+||+|||+|.......
T Consensus       109 ~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~  183 (352)
T d1koba_         109 SGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE  183 (352)
T ss_dssp             CCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred             CCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCCC
Confidence            99999998763  345699999999999999999999998   999999999999998  67899999999998887666


Q ss_pred             cceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcC
Q 013636          310 RNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRD  389 (439)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  389 (439)
                      ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+..+....+...      ....+...    ..
T Consensus       184 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~------~~~~~~~~----~~  253 (352)
T d1koba_         184 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC------DWEFDEDA----FS  253 (352)
T ss_dssp             CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHC------CCCCCSST----TT
T ss_pred             ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------CCCCCccc----cc
Confidence            666678999999999999999999999999999999999999999887765443332211      11111111    11


Q ss_pred             ccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          390 TMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       390 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      .+    ...+.+++.+||+.||++|||+.|++++
T Consensus       254 ~~----s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         254 SV----SPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             TS----CHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             CC----CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            11    2356679999999999999999999986

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-52  Score=396.46  Aligned_cols=245  Identities=21%  Similarity=0.300  Sum_probs=203.9

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC---chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      ++|++.+.||+|+||+||+|+.. ++..+|||.+....   ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            56889999999999999999985 57899999986422   233467899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~  308 (439)
                      ||+++|+|.+++..   .+.+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+||+|||+|+.....
T Consensus        88 Ey~~gg~L~~~~~~---~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          88 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EccCCCCHHHhhhc---cCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccC
Confidence            99999999999863   34699999999999999999999998   9999999999999999999999999999876433


Q ss_pred             Cc---ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCc
Q 013636          309 SR---NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDP  385 (439)
Q Consensus       309 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  385 (439)
                      ..   .....||+.|+|||++.+..++.++||||+||++|||++|+.||...++.+....+..      ....+++.++ 
T Consensus       162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~------~~~~~p~~~s-  234 (288)
T d1uu3a_         162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK------LEYDFPEKFF-  234 (288)
T ss_dssp             --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHT------TCCCCCTTCC-
T ss_pred             CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHc------CCCCCCccCC-
Confidence            22   2345699999999999999999999999999999999999999998776554333221      1122222222 


Q ss_pred             hhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 013636          386 VIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVL  421 (439)
Q Consensus       386 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl  421 (439)
                                 ..+.+++.+||+.||++|||++|++
T Consensus       235 -----------~~~~~li~~~L~~dP~~R~t~~e~~  259 (288)
T d1uu3a_         235 -----------PKARDLVEKLLVLDATKRLGCEEME  259 (288)
T ss_dssp             -----------HHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred             -----------HHHHHHHHHHccCCHhHCcCHHHHc
Confidence                       2466799999999999999999864

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-51  Score=387.19  Aligned_cols=246  Identities=26%  Similarity=0.396  Sum_probs=195.8

Q ss_pred             CccceecccCcEEEEEEEEC-CccEEEEEEecCC--CchHHHHHHHHHHHHHhcCCCceeeeeeEEEe----CCeeEEEE
Q 013636          156 QESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDA--GHDAEREFNNEVNWLTKIRHQNIISLLGYCIH----AETRFLVY  228 (439)
Q Consensus       156 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~  228 (439)
                      +..+.||+|+||+||+|+.. ++..||+|.+...  .....+.|.+|+++|++++||||+++++++..    ....++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            44568999999999999986 4678999998654  33445679999999999999999999999875    34579999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc-CCCcEEEEecccccccCC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLD-SSFNAKLSDFGLSVTAGT  307 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~-~~~~~kl~DfGls~~~~~  307 (439)
                      ||+++|+|.+++..   ...+++..+..++.|+++||+|||++ .++|+||||||+|||++ +++.+||+|||+|+....
T Consensus        92 E~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~  167 (270)
T d1t4ha_          92 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  167 (270)
T ss_dssp             ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCcHHHHHhc---cccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence            99999999999964   34689999999999999999999997 12399999999999996 578999999999976543


Q ss_pred             CCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhh-hhhhHhhhhcccccCCCCCccCCch
Q 013636          308 QSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQ-CQSMVTWAMPQLTDRSKLPNIVDPV  386 (439)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~d~~  386 (439)
                      . ......||+.|+|||++.+ .++.++|||||||++|||++|+.||....... ....+.       . ...+    +.
T Consensus       168 ~-~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~-------~-~~~~----~~  233 (270)
T d1t4ha_         168 S-FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT-------S-GVKP----AS  233 (270)
T ss_dssp             T-SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHT-------T-TCCC----GG
T ss_pred             C-ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHH-------c-CCCC----cc
Confidence            3 3345679999999998865 69999999999999999999999997654322 111111       0 0001    11


Q ss_pred             hcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          387 IRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       387 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      .....    ..++.+++.+||+.||++|||+.|+++|
T Consensus       234 ~~~~~----~~~~~~li~~~l~~dp~~R~s~~ell~H  266 (270)
T d1t4ha_         234 FDKVA----IPEVKEIIEGCIRQNKDERYSIKDLLNH  266 (270)
T ss_dssp             GGGCC----CHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             cCccC----CHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence            11112    2246779999999999999999999975

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.3e-52  Score=395.49  Aligned_cols=246  Identities=27%  Similarity=0.395  Sum_probs=202.5

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCc---hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGH---DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      +.|+..+.||+|+||+||+|+.. ++..||||.+.....   ...+.+.+|+.+|++++|||||++++++.+.+..++||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            45888999999999999999875 578899999875432   23356899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~  308 (439)
                      |||++|+|..++..   ...+++..+..++.|++.||.|||++   +|+||||||+|||+++++++||+|||+|......
T Consensus        95 E~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~  168 (309)
T d1u5ra_          95 EYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (309)
T ss_dssp             ECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred             EecCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence            99999999876642   34699999999999999999999998   9999999999999999999999999999865432


Q ss_pred             CcceeeccccCccchhhhcC---CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCc
Q 013636          309 SRNVKISGTLGYVAPEYLLE---GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDP  385 (439)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  385 (439)
                         ....||+.|+|||++.+   +.|+.++|||||||++|||++|+.||.+.+..+....+..        ...+...+.
T Consensus       169 ---~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~--------~~~~~~~~~  237 (309)
T d1u5ra_         169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--------NESPALQSG  237 (309)
T ss_dssp             ---CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH--------SCCCCCSCT
T ss_pred             ---CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh--------CCCCCCCCC
Confidence               24569999999999864   4689999999999999999999999987765443222211        011111111


Q ss_pred             hhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          386 VIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       386 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                          ..    ...+.+++.+||+.||++|||+.|++++
T Consensus       238 ----~~----s~~~~~li~~~L~~dP~~Rpt~~ell~H  267 (309)
T d1u5ra_         238 ----HW----SEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (309)
T ss_dssp             ----TS----CHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             ----CC----CHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence                11    2356779999999999999999999874

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-52  Score=394.63  Aligned_cols=255  Identities=26%  Similarity=0.395  Sum_probs=204.4

Q ss_pred             hcCCCccceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEec
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMM  231 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  231 (439)
                      .++|++.+.||+|+||+||+|+++++..||||.++... ...+.|.+|+.++++++|||||+++++|. .+..++||||+
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~   93 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM   93 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEec
Confidence            46789999999999999999999988889999997543 34568999999999999999999999985 46689999999


Q ss_pred             cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc-
Q 013636          232 QNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR-  310 (439)
Q Consensus       232 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~-  310 (439)
                      ++|+|..++... ....++|..++.++.|++.||+|||+.   +++||||||+||||++++++||+|||+++....... 
T Consensus        94 ~~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~  169 (285)
T d1fmka3          94 SKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  169 (285)
T ss_dssp             TTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             CCCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCce
Confidence            999999998752 234599999999999999999999998   999999999999999999999999999976543322 


Q ss_pred             -ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCC-CCCChhhhhhhHhhhhcccccCCCCCccCCchhc
Q 013636          311 -NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPV-EKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIR  388 (439)
Q Consensus       311 -~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  388 (439)
                       .....||+.|+|||.+.++.++.++|||||||++|||++|..|+ ......+....+...     .+...+.       
T Consensus       170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~-----~~~~~~~-------  237 (285)
T d1fmka3         170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-----YRMPCPP-------  237 (285)
T ss_dssp             ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-----CCCCCCT-------
T ss_pred             eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhc-----CCCCCCc-------
Confidence             22345899999999999999999999999999999999965554 444444333333211     0111111       


Q ss_pred             CccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCC
Q 013636          389 DTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVP  429 (439)
Q Consensus       389 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~  429 (439)
                       ..    ..++.+++.+||+.||++|||+++|++.|++...
T Consensus       238 -~~----~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~  273 (285)
T d1fmka3         238 -EC----PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  273 (285)
T ss_dssp             -TS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             -cc----CHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence             11    2357789999999999999999999999987664

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.5e-52  Score=395.61  Aligned_cols=261  Identities=28%  Similarity=0.427  Sum_probs=214.1

Q ss_pred             HHHHhcCCCccceecccCcEEEEEEEEC------CccEEEEEEecCCCch-HHHHHHHHHHHHHhcCCCceeeeeeEEEe
Q 013636          148 LEAATNNFQESNVIGEGGRGHVYKARFN------EKLLAAVKRIDDAGHD-AEREFNNEVNWLTKIRHQNIISLLGYCIH  220 (439)
Q Consensus       148 l~~~~~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~  220 (439)
                      +|...++|++.+.||+|+||+||+|+..      ++..||||+++..... ..++|.+|+.++++++||||++++++|..
T Consensus         8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~   87 (301)
T d1lufa_           8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV   87 (301)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence            4556788999999999999999999874      3578999999764433 45679999999999999999999999999


Q ss_pred             CCeeEEEEEeccCCChhhhhcCCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEec
Q 013636          221 AETRFLVYEMMQNGSLEKQLHGPT---------------------HGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHR  279 (439)
Q Consensus       221 ~~~~~lV~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~  279 (439)
                      .+..+++|||+++|+|.++++...                     ....+++..+++++.|++.||+|||+.   +++||
T Consensus        88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHr  164 (301)
T d1lufa_          88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHR  164 (301)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEee
Confidence            999999999999999999996321                     123589999999999999999999998   99999


Q ss_pred             CCCCCCEEEcCCCcEEEEecccccccCCCCc---ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCC-CCCC
Q 013636          280 DLKSSNILLDSSFNAKLSDFGLSVTAGTQSR---NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGR-RPVE  355 (439)
Q Consensus       280 Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~-~P~~  355 (439)
                      ||||+|||++.++++||+|||+|+.......   .....||+.|+|||.+.+..++.++|||||||++|||++|. .||.
T Consensus       165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~  244 (301)
T d1lufa_         165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY  244 (301)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence            9999999999999999999999976533222   22346889999999999999999999999999999999985 6888


Q ss_pred             CCChhhhhhhHhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccC
Q 013636          356 KMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLV  428 (439)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~  428 (439)
                      ..++.+....+...     .....++        .+    ..++.+++.+||+.||++||||.||++.|+++.
T Consensus       245 ~~~~~e~~~~v~~~-----~~~~~p~--------~~----~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         245 GMAHEEVIYYVRDG-----NILACPE--------NC----PLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             TSCHHHHHHHHHTT-----CCCCCCT--------TC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCHHHHHHHHHcC-----CCCCCCc--------cc----hHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            87766554433211     0111111        11    235778999999999999999999999998875

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-51  Score=388.11  Aligned_cols=252  Identities=24%  Similarity=0.293  Sum_probs=210.3

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC------chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCee
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG------HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETR  224 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  224 (439)
                      .++|++.+.||+|+||+||+|+.. ++..+|+|.++...      ....+.+.+|+.+|++++|||||++++++.+.+..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            467999999999999999999985 57899999986422      12356799999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC----cEEEEecc
Q 013636          225 FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSF----NAKLSDFG  300 (439)
Q Consensus       225 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~----~~kl~DfG  300 (439)
                      ++|||||++|+|.+++..   ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++    .+|++|||
T Consensus        89 ~iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG  162 (293)
T d1jksa_          89 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG  162 (293)
T ss_dssp             EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEcCCCccccchhcc---ccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchh
Confidence            999999999999999964   24699999999999999999999998   999999999999998776    49999999


Q ss_pred             cccccCCCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCC
Q 013636          301 LSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLP  380 (439)
Q Consensus       301 ls~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  380 (439)
                      +|.............||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+..+....+...      .... 
T Consensus       163 ~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~------~~~~-  235 (293)
T d1jksa_         163 LAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV------NYEF-  235 (293)
T ss_dssp             TCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT------CCCC-
T ss_pred             hhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhc------CCCC-
Confidence            998776555555567999999999999999999999999999999999999999987765543332211      1111 


Q ss_pred             ccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          381 NIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       381 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                         .+......    ...+.+++.+||+.||++|||+.|++++
T Consensus       236 ---~~~~~~~~----s~~~~~li~~~L~~dP~~R~s~~eil~h  271 (293)
T d1jksa_         236 ---EDEYFSNT----SALAKDFIRRLLVKDPKKRMTIQDSLQH  271 (293)
T ss_dssp             ---CHHHHTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ---CchhcCCC----CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               11111112    2356779999999999999999999975

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-52  Score=390.61  Aligned_cols=256  Identities=25%  Similarity=0.393  Sum_probs=201.4

Q ss_pred             hcCCCccceecccCcEEEEEEEECC----ccEEEEEEecCCCch-HHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFNE----KLLAAVKRIDDAGHD-AEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFL  226 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  226 (439)
                      .++|++.+.||+|+||.||+|++..    +..+|+|.++..... ..+.|.+|+.++++++||||+++++++. .+..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence            4678899999999999999998743    356889998754433 3467999999999999999999999985 467899


Q ss_pred             EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccC
Q 013636          227 VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAG  306 (439)
Q Consensus       227 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~  306 (439)
                      ||||+++|+|.+++..  ....+++..++.++.|+++||+|||+.   +++||||||+||++++++++||+|||+|+...
T Consensus        85 v~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~  159 (273)
T d1mp8a_          85 IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  159 (273)
T ss_dssp             EEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheecc
Confidence            9999999999998763  335689999999999999999999998   99999999999999999999999999997654


Q ss_pred             CCCc--ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCccC
Q 013636          307 TQSR--NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV  383 (439)
Q Consensus       307 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  383 (439)
                      ....  .....||+.|+|||.+.++.++.++|||||||++|||++ |..||...+..+....+...     .....+.  
T Consensus       160 ~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~-----~~~~~~~--  232 (273)
T d1mp8a_         160 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-----ERLPMPP--  232 (273)
T ss_dssp             -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-----CCCCCCT--
T ss_pred             CCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-----CCCCCCC--
Confidence            3322  233458999999999999999999999999999999998 89999988766544333211     0111111  


Q ss_pred             CchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCC
Q 013636          384 DPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPT  430 (439)
Q Consensus       384 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~  430 (439)
                            ..    ...+.+++.+||+.||++|||+.||+++|+.++.+
T Consensus       233 ------~~----~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  269 (273)
T d1mp8a_         233 ------NC----PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  269 (273)
T ss_dssp             ------TC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------CC----CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence                  11    23577899999999999999999999999877643

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-52  Score=388.32  Aligned_cols=251  Identities=29%  Similarity=0.418  Sum_probs=200.3

Q ss_pred             cCCCccceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEe-CCeeEEEEEec
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH-AETRFLVYEMM  231 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV~e~~  231 (439)
                      ++|+..+.||+|+||.||+|+++ +..||||.++..  ...+.|.+|++++++++||||++++|+|.+ .+..++||||+
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~   83 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   83 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence            56778899999999999999996 567999999754  345679999999999999999999999865 45689999999


Q ss_pred             cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCcc
Q 013636          232 QNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN  311 (439)
Q Consensus       232 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~~  311 (439)
                      ++|+|.++++.. ....++|..+++++.|++.||+|||+.   +++||||||+|||++.++++|++|||+++......  
T Consensus        84 ~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~--  157 (262)
T d1byga_          84 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  157 (262)
T ss_dssp             TTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             CCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCCC--
Confidence            999999999642 123589999999999999999999998   99999999999999999999999999998754432  


Q ss_pred             eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhcCc
Q 013636          312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDT  390 (439)
Q Consensus       312 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  390 (439)
                      ....+|..|+|||++.++.++.++|||||||++|||+| |+.||...+..+....+..     ..+...+...       
T Consensus       158 ~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~-----~~~~~~~~~~-------  225 (262)
T d1byga_         158 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-----GYKMDAPDGC-------  225 (262)
T ss_dssp             ----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT-----TCCCCCCTTC-------
T ss_pred             ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc-----CCCCCCCccC-------
Confidence            23458899999999999999999999999999999998 7888887766554433321     0111122211       


Q ss_pred             cCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCC
Q 013636          391 MDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVP  429 (439)
Q Consensus       391 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~  429 (439)
                           ..++.+++.+||+.||++|||+.+++++|+++.-
T Consensus       226 -----~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         226 -----PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             -----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----CHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence                 2356779999999999999999999999987753

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-51  Score=392.31  Aligned_cols=253  Identities=26%  Similarity=0.488  Sum_probs=205.7

Q ss_pred             cCCCccceecccCcEEEEEEEECC-c----cEEEEEEecCC-CchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNE-K----LLAAVKRIDDA-GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFL  226 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~-~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  226 (439)
                      .+|+..++||+|+||+||+|++.. +    ..||+|+++.. .....++|.+|+.++++++|||||+++|+|.+ +..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCeeE
Confidence            358889999999999999998753 2    35899988643 33456789999999999999999999999986 46678


Q ss_pred             EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccC
Q 013636          227 VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAG  306 (439)
Q Consensus       227 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~  306 (439)
                      ++||+.+|+|.+++..  ....+++..+++++.|+|+||+|||++   +|+||||||+|||++.++++||+|||+|+...
T Consensus        88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             EEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceecc
Confidence            8999999999998874  345799999999999999999999998   99999999999999999999999999998765


Q ss_pred             CCCcc---eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCCcc
Q 013636          307 TQSRN---VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNI  382 (439)
Q Consensus       307 ~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  382 (439)
                      .....   ....||+.|+|||.+.++.++.++|||||||++|||+| |..||.+.+..+....+...     .+...+..
T Consensus       163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~-----~~~~~p~~  237 (317)
T d1xkka_         163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-----ERLPQPPI  237 (317)
T ss_dssp             TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHT-----CCCCCCTT
T ss_pred             cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-----CCCCCCcc
Confidence            43322   22358999999999999999999999999999999998 89999887766654444321     11111111


Q ss_pred             CCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccC
Q 013636          383 VDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLV  428 (439)
Q Consensus       383 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~  428 (439)
                      .            ...+.+++.+||+.||++|||+.|++++|..+.
T Consensus       238 ~------------~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~  271 (317)
T d1xkka_         238 C------------TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  271 (317)
T ss_dssp             B------------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             c------------CHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence            1            235677999999999999999999999987653

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-51  Score=392.94  Aligned_cols=258  Identities=32%  Similarity=0.469  Sum_probs=209.0

Q ss_pred             cCCCccceecccCcEEEEEEEECCc---cEEEEEEecCC-CchHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeeEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNEK---LLAAVKRIDDA-GHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLV  227 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV  227 (439)
                      ++|+..+.||+|+||+||+|++.+.   ..||||++... .....++|.+|+++|+++ +||||++++++|.+.+..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            5788889999999999999988543   35788887643 333456799999999999 799999999999999999999


Q ss_pred             EEeccCCChhhhhcCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcE
Q 013636          228 YEMMQNGSLEKQLHGP-------------THGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA  294 (439)
Q Consensus       228 ~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~  294 (439)
                      |||+++|+|.++++..             .....+++..+.+++.|+|+||.|||+.   +++||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence            9999999999999753             2346799999999999999999999998   99999999999999999999


Q ss_pred             EEEecccccccCCCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCC-CCCCCCChhhhhhhHhhhhccc
Q 013636          295 KLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGR-RPVEKMSPTQCQSMVTWAMPQL  373 (439)
Q Consensus       295 kl~DfGls~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~-~P~~~~~~~~~~~~~~~~~~~~  373 (439)
                      ||+|||+++............||..|+|||.+.++.++.++|||||||++|||++|. .||...+..+....+...    
T Consensus       167 kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~----  242 (309)
T d1fvra_         167 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG----  242 (309)
T ss_dssp             EECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT----
T ss_pred             EEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc----
Confidence            999999997665444444556899999999999999999999999999999999965 578877766543333210    


Q ss_pred             ccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCC
Q 013636          374 TDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPT  430 (439)
Q Consensus       374 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~  430 (439)
                       .+...+..+            ..++.+++.+||+.||++|||++||+++|+.++.+
T Consensus       243 -~~~~~~~~~------------~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~  286 (309)
T d1fvra_         243 -YRLEKPLNC------------DDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  286 (309)
T ss_dssp             -CCCCCCTTB------------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             -CCCCCCccC------------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence             111111111            23577799999999999999999999999887643

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-50  Score=389.45  Aligned_cols=247  Identities=23%  Similarity=0.325  Sum_probs=209.1

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC---chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      ++|++.+.||+|+||+||+|+.. ++..+|+|.++...   ....+.+.+|+.+|++++||||+++++++.+.+..++||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            57889999999999999999984 58899999986431   234567889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~  308 (439)
                      |||++|+|.+++..   ...+++..+..++.|++.||+|||++   +|+||||||+|||+++++.+||+|||+|+.....
T Consensus        85 ey~~gg~L~~~~~~---~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~  158 (337)
T d1o6la_          85 EYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             ECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             eccCCCchhhhhhc---ccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccC
Confidence            99999999999964   34689999999999999999999998   9999999999999999999999999999875443


Q ss_pred             -CcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchh
Q 013636          309 -SRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVI  387 (439)
Q Consensus       309 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  387 (439)
                       ......+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.+..+....+..      ....++..+.   
T Consensus       159 ~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~------~~~~~p~~~s---  229 (337)
T d1o6la_         159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM------EEIRFPRTLS---  229 (337)
T ss_dssp             TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------CCCCCCTTSC---
T ss_pred             CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhc------CCCCCCccCC---
Confidence             333456799999999999999999999999999999999999999998876554333321      1223333222   


Q ss_pred             cCccCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHh
Q 013636          388 RDTMDLKHLYQVAAVAVLCIQPEPSYRPL-----ITDVLHS  423 (439)
Q Consensus       388 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~  423 (439)
                               .++.+++.+||+.||++||+     +.|+++|
T Consensus       230 ---------~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H  261 (337)
T d1o6la_         230 ---------PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             ---------HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             ---------HHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence                     24567999999999999994     8888875

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-51  Score=382.17  Aligned_cols=252  Identities=26%  Similarity=0.407  Sum_probs=197.3

Q ss_pred             cCCCccceecccCcEEEEEEEECC----ccEEEEEEecCC---CchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNE----KLLAAVKRIDDA---GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRF  225 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  225 (439)
                      ++|++.+.||+|+||+||+|++..    ...||||.++..   .....++|.+|+.+|++++||||++++|+|.+ +..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            568889999999999999998643    347899988643   23445689999999999999999999999965 5678


Q ss_pred             EEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccccccc
Q 013636          226 LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA  305 (439)
Q Consensus       226 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~  305 (439)
                      +||||+++|++.+++..  +...+++..+++++.|+|+||+|||+.   +|+||||||+|||++.++++||+|||+++..
T Consensus        87 lv~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~  161 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL  161 (273)
T ss_dssp             EEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eeeeeecCcchhhhhhc--ccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhc
Confidence            99999999999998863  334699999999999999999999998   9999999999999999999999999999876


Q ss_pred             CCCCcc----eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhhhhHhhhhcccccCCCCC
Q 013636          306 GTQSRN----VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLP  380 (439)
Q Consensus       306 ~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  380 (439)
                      ......    ....||..|+|||.+.+..++.++|||||||++|||+| |+.||.+.+..+....+...    ......+
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~----~~~~~~~  237 (273)
T d1u46a_         162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE----GERLPRP  237 (273)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTS----CCCCCCC
T ss_pred             ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhC----CCCCCCc
Confidence            443332    22347889999999999999999999999999999998 89999987766543332211    0011111


Q ss_pred             ccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccc
Q 013636          381 NIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIP  426 (439)
Q Consensus       381 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  426 (439)
                      .        ..    ...+.+++.+||+.||++|||+.||++.|.+
T Consensus       238 ~--------~~----~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~  271 (273)
T d1u46a_         238 E--------DC----PQDIYNVMVQCWAHKPEDRPTFVALRDFLLE  271 (273)
T ss_dssp             T--------TC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             c--------cc----cHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence            1        11    1356789999999999999999999998865

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=7.4e-50  Score=376.54  Aligned_cols=252  Identities=27%  Similarity=0.346  Sum_probs=208.4

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCc---------hHHHHHHHHHHHHHhcC-CCceeeeeeEEEe
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGH---------DAEREFNNEVNWLTKIR-HQNIISLLGYCIH  220 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~  220 (439)
                      .++|++.+.||+|+||+||+|+.. ++..+|||.+.....         ...+.+.+|+.++++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            368899999999999999999874 688999999864321         12245889999999997 9999999999999


Q ss_pred             CCeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecc
Q 013636          221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFG  300 (439)
Q Consensus       221 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfG  300 (439)
                      ++..++||||+++|+|.+++..   ...+++..+..++.|+++||+|||+.   +|+||||||+|||+++++.+||+|||
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG  155 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG  155 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             CcceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccch
Confidence            9999999999999999999963   34699999999999999999999998   99999999999999999999999999


Q ss_pred             cccccCCCCcceeeccccCccchhhhcC------CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccc
Q 013636          301 LSVTAGTQSRNVKISGTLGYVAPEYLLE------GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLT  374 (439)
Q Consensus       301 ls~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~  374 (439)
                      +++............||+.|+|||.+.+      ..++.++||||+||++|||++|+.||...++......+...     
T Consensus       156 ~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~-----  230 (277)
T d1phka_         156 FSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG-----  230 (277)
T ss_dssp             TCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-----
T ss_pred             heeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhC-----
Confidence            9988766555555679999999999863      35688999999999999999999999987765543333211     


Q ss_pred             cCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          375 DRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       375 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                       ....+...    ....    ..++.+++.+||+.||++|||+.|++++
T Consensus       231 -~~~~~~~~----~~~~----s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         231 -NYQFGSPE----WDDY----SDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             -CCCCCTTT----GGGS----CHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             -CCCCCCcc----cccC----CHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence             11111100    1112    2357789999999999999999999986

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5e-50  Score=384.79  Aligned_cols=245  Identities=25%  Similarity=0.353  Sum_probs=207.6

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC---chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      ++|++.+.||+|+||+||+|+.. ++..+|+|.++...   ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            56888999999999999999985 58899999986421   233467899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~  308 (439)
                      ||+++|+|..++..   ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++++||+|||+|+.....
T Consensus        84 E~~~gg~l~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~  157 (316)
T d1fota_          84 DYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  157 (316)
T ss_dssp             CCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             eecCCccccccccc---cccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc
Confidence            99999999999863   34588899999999999999999998   9999999999999999999999999999876543


Q ss_pred             CcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhc
Q 013636          309 SRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIR  388 (439)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  388 (439)
                      .  ...+||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+....+..      .....+..++    
T Consensus       158 ~--~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~------~~~~~p~~~s----  225 (316)
T d1fota_         158 T--YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN------AELRFPPFFN----  225 (316)
T ss_dssp             B--CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH------CCCCCCTTSC----
T ss_pred             c--ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHc------CCCCCCCCCC----
Confidence            2  346799999999999999999999999999999999999999998776554433321      1222222222    


Q ss_pred             CccCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHh
Q 013636          389 DTMDLKHLYQVAAVAVLCIQPEPSYRP-----LITDVLHS  423 (439)
Q Consensus       389 ~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  423 (439)
                              ..+.+++.+||+.||++||     |++++++|
T Consensus       226 --------~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         226 --------EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             --------HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             --------HHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence                    2456799999999999996     89999875

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-51  Score=387.67  Aligned_cols=264  Identities=26%  Similarity=0.390  Sum_probs=200.4

Q ss_pred             HHHHHHhcCCCccceecccCcEEEEEEEECC------ccEEEEEEecCCC-chHHHHHHHHHHHHHhc-CCCceeeeeeE
Q 013636          146 ELLEAATNNFQESNVIGEGGRGHVYKARFNE------KLLAAVKRIDDAG-HDAEREFNNEVNWLTKI-RHQNIISLLGY  217 (439)
Q Consensus       146 ~~l~~~~~~~~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~  217 (439)
                      ..++...++|++.+.||+|+||.||+|++..      +..||||.++... ....+.+.+|...+.++ +|+||+.++++
T Consensus         6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~   85 (299)
T d1ywna1           6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA   85 (299)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence            3344455789999999999999999998642      4679999987543 34456788888888877 68999999999


Q ss_pred             EEeCC-eeEEEEEeccCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 013636          218 CIHAE-TRFLVYEMMQNGSLEKQLHGPT-------------HGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKS  283 (439)
Q Consensus       218 ~~~~~-~~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~  283 (439)
                      +...+ ..++|||||++|+|.++++...             ....+++..+..++.|+++||+|||++   +|+||||||
T Consensus        86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp  162 (299)
T d1ywna1          86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA  162 (299)
T ss_dssp             ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCG
T ss_pred             eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCc
Confidence            87654 6899999999999999996422             134589999999999999999999998   999999999


Q ss_pred             CCEEEcCCCcEEEEecccccccCCCCc---ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhC-CCCCCCCCh
Q 013636          284 SNILLDSSFNAKLSDFGLSVTAGTQSR---NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMG-RRPVEKMSP  359 (439)
Q Consensus       284 ~NiLl~~~~~~kl~DfGls~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG-~~P~~~~~~  359 (439)
                      +|||+++++++||+|||+|+.......   .....||+.|+|||.+.++.++.++|||||||++|||++| ..||...+.
T Consensus       163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~  242 (299)
T d1ywna1         163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI  242 (299)
T ss_dssp             GGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred             cceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999976543322   2335699999999999999999999999999999999996 567876543


Q ss_pred             hh-hhhhHhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCC
Q 013636          360 TQ-CQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVP  429 (439)
Q Consensus       360 ~~-~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~  429 (439)
                      .+ ....+..     ......++..            ..++.+++.+||+.||++|||+.|++++|++++.
T Consensus       243 ~~~~~~~~~~-----~~~~~~~~~~------------~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq  296 (299)
T d1ywna1         243 DEEFCRRLKE-----GTRMRAPDYT------------TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  296 (299)
T ss_dssp             SHHHHHHHHH-----TCCCCCCTTC------------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHhc-----CCCCCCCccC------------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            32 1122111     0111222211            2356779999999999999999999999988764

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-49  Score=380.86  Aligned_cols=251  Identities=27%  Similarity=0.438  Sum_probs=200.7

Q ss_pred             cceecccCcEEEEEEEECC----ccEEEEEEecCC-CchHHHHHHHHHHHHHhcCCCceeeeeeEEEeC-CeeEEEEEec
Q 013636          158 SNVIGEGGRGHVYKARFNE----KLLAAVKRIDDA-GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHA-ETRFLVYEMM  231 (439)
Q Consensus       158 ~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lV~e~~  231 (439)
                      .++||+|+||+||+|++.+    ...||||+++.. .....++|.+|+++|++++||||++++|+|... ...++|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            4789999999999998754    246899999753 344557899999999999999999999998764 5889999999


Q ss_pred             cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCcc
Q 013636          232 QNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN  311 (439)
Q Consensus       232 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~~  311 (439)
                      ++|+|.++++.  ....+++..+++++.|+++||.|||+.   +|+||||||+|||+++++.+||+|||+++........
T Consensus       112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence            99999999984  345688999999999999999999998   9999999999999999999999999999765433221


Q ss_pred             -----eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC-hhhhhhhHhhhhcccccCCCCCccCCc
Q 013636          312 -----VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMS-PTQCQSMVTWAMPQLTDRSKLPNIVDP  385 (439)
Q Consensus       312 -----~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~d~  385 (439)
                           ....||+.|+|||.+.++.++.++||||||+++|||+||..||.... ..+....+.   .  ..+...+..   
T Consensus       187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~---~--g~~~~~p~~---  258 (311)
T d1r0pa_         187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL---Q--GRRLLQPEY---  258 (311)
T ss_dssp             CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHH---T--TCCCCCCTT---
T ss_pred             cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHH---c--CCCCCCccc---
Confidence                 22458999999999999999999999999999999999877775432 222111111   0  011111111   


Q ss_pred             hhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCC
Q 013636          386 VIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPT  430 (439)
Q Consensus       386 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~  430 (439)
                           .    ...+.+++.+||+.||++|||+.||+++|+.++..
T Consensus       259 -----~----~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         259 -----C----PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             -----C----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             -----C----cHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence                 1    23567899999999999999999999999887643

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-49  Score=381.91  Aligned_cols=252  Identities=18%  Similarity=0.241  Sum_probs=211.1

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEe
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      .++|++.+.||+|+||+||+|... ++..+|+|.++... .....+.+|+++|++++||||+++++++.+.+..++||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            467899999999999999999885 57889999997654 3445688999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC--CCcEEEEecccccccCCC
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDS--SFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~--~~~~kl~DfGls~~~~~~  308 (439)
                      |++|+|.+++..  .+..+++..+..++.|++.||+|||+.   +|+||||||+|||++.  ...+||+|||++......
T Consensus        83 ~~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~  157 (321)
T d1tkia_          83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccC
Confidence            999999999963  334699999999999999999999998   9999999999999985  458999999999887665


Q ss_pred             CcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhc
Q 013636          309 SRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIR  388 (439)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  388 (439)
                      .......+|+.|+|||.+.+..++.++||||+||++|||++|+.||...+..+....+...      ....    +....
T Consensus       158 ~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~------~~~~----~~~~~  227 (321)
T d1tkia_         158 DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNA------EYTF----DEEAF  227 (321)
T ss_dssp             CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT------CCCC----CHHHH
T ss_pred             CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------CCCC----Chhhc
Confidence            5555667999999999999999999999999999999999999999987765543332211      1111    11111


Q ss_pred             CccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          389 DTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       389 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      ..++    ..+.+++..||+.||++|||+.|++++
T Consensus       228 ~~~s----~~~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         228 KEIS----IEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             TTSC----HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             cCCC----HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            1122    346789999999999999999999975

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-50  Score=383.93  Aligned_cols=265  Identities=25%  Similarity=0.387  Sum_probs=216.3

Q ss_pred             HHHHHhcCCCccceecccCcEEEEEEEEC------CccEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCceeeeeeEEE
Q 013636          147 LLEAATNNFQESNVIGEGGRGHVYKARFN------EKLLAAVKRIDDAGH-DAEREFNNEVNWLTKIRHQNIISLLGYCI  219 (439)
Q Consensus       147 ~l~~~~~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~  219 (439)
                      .++...++|+..+.||+|+||+||+|.+.      .+..||||+++.... .....|.+|+.++++++||||++++++|.
T Consensus        14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~   93 (308)
T d1p4oa_          14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS   93 (308)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence            34455678899999999999999999874      257899999975433 34456899999999999999999999999


Q ss_pred             eCCeeEEEEEeccCCChhhhhcCC-------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC
Q 013636          220 HAETRFLVYEMMQNGSLEKQLHGP-------THGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSF  292 (439)
Q Consensus       220 ~~~~~~lV~e~~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~  292 (439)
                      ..+..++||||+++|+|.++++..       .....+++..+.+++.|+|+||.|||+.   +|+||||||+|||+++++
T Consensus        94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~  170 (308)
T d1p4oa_          94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDF  170 (308)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTC
T ss_pred             cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCc
Confidence            999999999999999999998632       2224579999999999999999999998   999999999999999999


Q ss_pred             cEEEEecccccccCCCCcc---eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhC-CCCCCCCChhhhhhhHhh
Q 013636          293 NAKLSDFGLSVTAGTQSRN---VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMG-RRPVEKMSPTQCQSMVTW  368 (439)
Q Consensus       293 ~~kl~DfGls~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG-~~P~~~~~~~~~~~~~~~  368 (439)
                      ++||+|||+|+........   ....||+.|+|||.+.++.++.++||||||+++|||+|| +.||...+..+....+..
T Consensus       171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~  250 (308)
T d1p4oa_         171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME  250 (308)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred             eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence            9999999999765443222   223589999999999999999999999999999999997 578887776654433321


Q ss_pred             hhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCCC
Q 013636          369 AMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPTD  431 (439)
Q Consensus       369 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~~  431 (439)
                      .     .....+..        +    ...+.+++.+||+.||++|||+.+|+++|++.+...
T Consensus       251 ~-----~~~~~p~~--------~----~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~  296 (308)
T d1p4oa_         251 G-----GLLDKPDN--------C----PDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG  296 (308)
T ss_dssp             T-----CCCCCCTT--------C----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred             C-----CCCCCccc--------c----hHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence            0     01111111        1    235788999999999999999999999998877643

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-50  Score=381.03  Aligned_cols=259  Identities=26%  Similarity=0.403  Sum_probs=207.9

Q ss_pred             HhcCCCccceecccCcEEEEEEEECC--------ccEEEEEEecCCCc-hHHHHHHHHHHHHHhc-CCCceeeeeeEEEe
Q 013636          151 ATNNFQESNVIGEGGRGHVYKARFNE--------KLLAAVKRIDDAGH-DAEREFNNEVNWLTKI-RHQNIISLLGYCIH  220 (439)
Q Consensus       151 ~~~~~~~~~~LG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  220 (439)
                      ..++|++.+.||+|+||.||+|+...        +..||||+++.... ....++.+|...+.++ +|||||+++++|.+
T Consensus        11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~   90 (299)
T d1fgka_          11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ   90 (299)
T ss_dssp             CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence            34678889999999999999997632        35789999976544 3446788999999888 89999999999999


Q ss_pred             CCeeEEEEEeccCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEE
Q 013636          221 AETRFLVYEMMQNGSLEKQLHGPT-------------HGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNIL  287 (439)
Q Consensus       221 ~~~~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiL  287 (439)
                      ++..++||||+++|+|.+++....             ....+++..+++++.|++.||+|||+.   +++||||||+|||
T Consensus        91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiL  167 (299)
T d1fgka_          91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL  167 (299)
T ss_dssp             SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred             CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeeccccee
Confidence            999999999999999999997532             124689999999999999999999998   9999999999999


Q ss_pred             EcCCCcEEEEecccccccCCCCc---ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhhhh
Q 013636          288 LDSSFNAKLSDFGLSVTAGTQSR---NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQ  363 (439)
Q Consensus       288 l~~~~~~kl~DfGls~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~~~  363 (439)
                      ++.++.+||+|||+++.......   .....||+.|+|||.+.++.++.++|||||||++|||++ |..||...+..+..
T Consensus       168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~  247 (299)
T d1fgka_         168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF  247 (299)
T ss_dssp             ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred             ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHH
Confidence            99999999999999976544322   223458999999999999999999999999999999998 79999887766544


Q ss_pred             hhHhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCC
Q 013636          364 SMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVP  429 (439)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~  429 (439)
                      ..+...     .....+..        .    ...+.+++.+||+.||++|||+.||++.|++++.
T Consensus       248 ~~i~~~-----~~~~~p~~--------~----~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         248 KLLKEG-----HRMDKPSN--------C----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             HHHHTT-----CCCCCCSS--------C----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHcC-----CCCCCCcc--------c----hHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence            333211     11111111        1    2357789999999999999999999999988753

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.5e-49  Score=375.15  Aligned_cols=257  Identities=21%  Similarity=0.353  Sum_probs=202.6

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC---chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCe----
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAET----  223 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  223 (439)
                      .++|++.+.||+|+||+||+|+.. ++..+|+|.++...   ......|.+|+.++++++||||+++++++...+.    
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            467999999999999999999874 68899999997533   2334579999999999999999999999876543    


Q ss_pred             eEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccccc
Q 013636          224 RFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSV  303 (439)
Q Consensus       224 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~  303 (439)
                      .++||||+++|+|.+++..   ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++..+++|||.+.
T Consensus        86 ~~lvmE~~~g~~L~~~~~~---~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR  159 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred             EEEEEECCCCCEehhhhcc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhh
Confidence            7899999999999998853   34699999999999999999999998   99999999999999999999999999986


Q ss_pred             ccCCCC----cceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCC
Q 013636          304 TAGTQS----RNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKL  379 (439)
Q Consensus       304 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  379 (439)
                      ......    ......||+.|+|||++.+..++.++|||||||++|||+||+.||...++.+......      ......
T Consensus       160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~------~~~~~~  233 (277)
T d1o6ya_         160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV------REDPIP  233 (277)
T ss_dssp             ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH------HCCCCC
T ss_pred             hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHH------hcCCCC
Confidence            543322    2234569999999999999999999999999999999999999998876654322211      111111


Q ss_pred             CccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHhccccC
Q 013636          380 PNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRP-LITDVLHSLIPLV  428 (439)
Q Consensus       380 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~evl~~L~~l~  428 (439)
                      +....    ...    ...+.+++.+||+.||++|| |++++++.|.++.
T Consensus       234 ~~~~~----~~~----s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         234 PSARH----EGL----SADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             GGGTS----SSC----CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             Cchhc----cCC----CHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence            11111    111    23567799999999999999 8999999887653

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-49  Score=380.74  Aligned_cols=262  Identities=24%  Similarity=0.390  Sum_probs=212.3

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEE------CCccEEEEEEecCCCc-hHHHHHHHHHHHHHhc-CCCceeeeeeEEEe
Q 013636          149 EAATNNFQESNVIGEGGRGHVYKARF------NEKLLAAVKRIDDAGH-DAEREFNNEVNWLTKI-RHQNIISLLGYCIH  220 (439)
Q Consensus       149 ~~~~~~~~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  220 (439)
                      +...++|+..+.||+|+||.||+|++      ..+..||||+++.... ....+|.+|+.+++++ +|||||+++++|.+
T Consensus        19 ~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~   98 (311)
T d1t46a_          19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI   98 (311)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence            33457888899999999999999986      3457899999976443 3445799999999999 69999999999999


Q ss_pred             CCeeEEEEEeccCCChhhhhcCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCC
Q 013636          221 AETRFLVYEMMQNGSLEKQLHGPT---------------HGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSN  285 (439)
Q Consensus       221 ~~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~N  285 (439)
                      .+..++|||||++|+|.++++...               ....+++..+.+++.|+++||+|||++   +++||||||+|
T Consensus        99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~N  175 (311)
T d1t46a_          99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN  175 (311)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccc
Confidence            999999999999999999997532               223589999999999999999999998   99999999999


Q ss_pred             EEEcCCCcEEEEecccccccCCCCcc---eeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChhh
Q 013636          286 ILLDSSFNAKLSDFGLSVTAGTQSRN---VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQ  361 (439)
Q Consensus       286 iLl~~~~~~kl~DfGls~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~ellt-G~~P~~~~~~~~  361 (439)
                      |+++.++.+|++|||+++........   ....||+.|+|||.+.++.++.++|||||||++|||+| |.+|+...+..+
T Consensus       176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~  255 (311)
T d1t46a_         176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS  255 (311)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred             ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH
Confidence            99999999999999999876543332   22468999999999999999999999999999999999 666666554432


Q ss_pred             -hhhhHhhhhcccccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCC
Q 013636          362 -CQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPT  430 (439)
Q Consensus       362 -~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~  430 (439)
                       ....+....     +...+..            ....+.+++.+||+.||++|||+.|+++.|++++.+
T Consensus       256 ~~~~~i~~~~-----~~~~~~~------------~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~  308 (311)
T d1t46a_         256 KFYKMIKEGF-----RMLSPEH------------APAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (311)
T ss_dssp             HHHHHHHHTC-----CCCCCTT------------SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHhcCC-----CCCCccc------------ccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence             223332211     1111111            123577899999999999999999999999877654

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-49  Score=380.64  Aligned_cols=267  Identities=24%  Similarity=0.286  Sum_probs=199.3

Q ss_pred             cCCCccceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC----eeEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE----TRFLVY  228 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lV~  228 (439)
                      ..|...+.||+|+||.||+|+++ +..||||.++... .....+..|+..+.+++||||++++++|...+    ..++||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccc-hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence            45667789999999999999975 6788999986532 12222344555666789999999999998654    579999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc-----CCCCeEecCCCCCCEEEcCCCcEEEEeccccc
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH-----CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSV  303 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~-----~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~  303 (439)
                      |||++|+|.+++++.    .++|..+++++.|+|.||+|||+.     ..++|+||||||+||||+.++++||+|||++.
T Consensus        81 Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~  156 (303)
T d1vjya_          81 DYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             ECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             ecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence            999999999999753    489999999999999999999973     13589999999999999999999999999997


Q ss_pred             ccCCCCcc-----eeeccccCccchhhhcCCC------CCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhh--------
Q 013636          304 TAGTQSRN-----VKISGTLGYVAPEYLLEGK------LTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQS--------  364 (439)
Q Consensus       304 ~~~~~~~~-----~~~~gt~~y~aPE~~~~~~------~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~--------  364 (439)
                      ........     ....||++|+|||++.+..      ++.++|||||||+||||+||..|+..........        
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~  236 (303)
T d1vjya_         157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence            65443221     2346999999999987643      5678999999999999999998875433211000        


Q ss_pred             hHhhhhcccccCCCCCccCCchhcCc-cCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccCCC
Q 013636          365 MVTWAMPQLTDRSKLPNIVDPVIRDT-MDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPT  430 (439)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~~~  430 (439)
                      .......... .    +..++.+... .+.+....+.+++.+||+.||++|||+.||++.|.++..+
T Consensus       237 ~~~~~~~~~~-~----~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  298 (303)
T d1vjya_         237 SVEEMRKVVC-E----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             CHHHHHHHHT-T----SCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHh-c----cccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence            0000000000 0    1111222111 1224566788999999999999999999999999887654

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.1e-49  Score=383.56  Aligned_cols=245  Identities=20%  Similarity=0.289  Sum_probs=206.8

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC---chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVY  228 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  228 (439)
                      ++|++.+.||+|+||+||+|+.. ++..+|+|.+....   ....+.+.+|+.+|+.++||||+++++++.+.+..++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            57999999999999999999885 58899999986421   223457889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ  308 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~  308 (439)
                      ||+.+|+|.+++..   ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++++||+|||+|+.....
T Consensus       121 e~~~~g~l~~~l~~---~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             ccccccchhhhHhh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence            99999999999964   23599999999999999999999998   9999999999999999999999999999876543


Q ss_pred             CcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCchhc
Q 013636          309 SRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIR  388 (439)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  388 (439)
                      .  ....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.++......+...      ....+..+.    
T Consensus       195 ~--~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~------~~~~p~~~s----  262 (350)
T d1rdqe_         195 T--WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG------KVRFPSHFS----  262 (350)
T ss_dssp             B--CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------CCCCCTTCC----
T ss_pred             c--ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcC------CCCCCccCC----
Confidence            2  3456999999999999999999999999999999999999999887765543333211      112222222    


Q ss_pred             CccCHHHHHHHHHHHHHhcCCCCCCC-----CCHHHHHHh
Q 013636          389 DTMDLKHLYQVAAVAVLCIQPEPSYR-----PLITDVLHS  423 (439)
Q Consensus       389 ~~~~~~~~~~l~~l~~~cl~~dP~~R-----Pt~~evl~~  423 (439)
                              ..+.+++..||+.||++|     ||+.|+++|
T Consensus       263 --------~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H  294 (350)
T d1rdqe_         263 --------SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             --------HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             --------HHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence                    246679999999999999     489999864

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=6.9e-49  Score=383.93  Aligned_cols=249  Identities=25%  Similarity=0.325  Sum_probs=200.3

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCc---hHHHHHH---HHHHHHHhcCCCceeeeeeEEEeCCeeE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGH---DAEREFN---NEVNWLTKIRHQNIISLLGYCIHAETRF  225 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~---~E~~~l~~l~h~niv~l~~~~~~~~~~~  225 (439)
                      ++|++.+.||+|+||+||+|+.. ++..+|+|.+.....   .....+.   +|+.+++.++||||+++++++.+.+..+
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            57889999999999999999986 588999999864211   1122333   4467777888999999999999999999


Q ss_pred             EEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccccccc
Q 013636          226 LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA  305 (439)
Q Consensus       226 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~  305 (439)
                      +||||+++|+|.+++..   ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+|+..
T Consensus        84 ivmE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~  157 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDF  157 (364)
T ss_dssp             EEECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred             EEEEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeec
Confidence            99999999999999964   34588999999999999999999998   9999999999999999999999999999876


Q ss_pred             CCCCcceeeccccCccchhhhcC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCC
Q 013636          306 GTQSRNVKISGTLGYVAPEYLLE-GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVD  384 (439)
Q Consensus       306 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  384 (439)
                      .... .....||+.|+|||++.. ..++.++|||||||++|||++|+.||...+..........   ........+..++
T Consensus       158 ~~~~-~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~---~~~~~~~~~~~~s  233 (364)
T d1omwa3         158 SKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---TLTMAVELPDSFS  233 (364)
T ss_dssp             SSSC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHH---SSSCCCCCCSSSC
T ss_pred             CCCc-ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---cccCCCCCCCCCC
Confidence            5433 234569999999999975 4689999999999999999999999987654433222221   1111222222222


Q ss_pred             chhcCccCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHh
Q 013636          385 PVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPL-----ITDVLHS  423 (439)
Q Consensus       385 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~  423 (439)
                                  ..+.+++.+||+.||++|||     ++|+++|
T Consensus       234 ------------~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H  265 (364)
T d1omwa3         234 ------------PELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  265 (364)
T ss_dssp             ------------HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred             ------------HHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence                        24667999999999999999     6888864

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-49  Score=380.59  Aligned_cols=246  Identities=26%  Similarity=0.392  Sum_probs=203.9

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC---chHHHHHHHHHHHHH-hcCCCceeeeeeEEEeCCeeEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG---HDAEREFNNEVNWLT-KIRHQNIISLLGYCIHAETRFLV  227 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lV  227 (439)
                      ++|++.+.||+|+||+||+|+.. ++..+|||.+....   ....+.+..|..++. .++||||+++++++.+++..++|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57888999999999999999885 57889999986421   223345666777665 68999999999999999999999


Q ss_pred             EEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCC
Q 013636          228 YEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT  307 (439)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~  307 (439)
                      |||+++|+|.+++..   ...+++..+..++.|++.||+|||++   +++||||||+|||+++++++||+|||+++....
T Consensus        82 mEy~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~  155 (320)
T d1xjda_          82 MEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENML  155 (320)
T ss_dssp             EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EeecCCCcHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhccc
Confidence            999999999999964   34589999999999999999999998   999999999999999999999999999976544


Q ss_pred             CCc-ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCccCCch
Q 013636          308 QSR-NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPV  386 (439)
Q Consensus       308 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  386 (439)
                      ... .....||+.|+|||++.+..++.++||||+||++|||++|+.||.+.++.+....+..      .....+..++  
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~------~~~~~p~~~s--  227 (320)
T d1xjda_         156 GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM------DNPFYPRWLE--  227 (320)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------CCCCCCTTSC--
T ss_pred             ccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHc------CCCCCCccCC--
Confidence            332 3345799999999999999999999999999999999999999998877654443322      1222232222  


Q ss_pred             hcCccCHHHHHHHHHHHHHhcCCCCCCCCCHH-HHHH
Q 013636          387 IRDTMDLKHLYQVAAVAVLCIQPEPSYRPLIT-DVLH  422 (439)
Q Consensus       387 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~-evl~  422 (439)
                                ..+.+++.+||+.||++|||+. |+++
T Consensus       228 ----------~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         228 ----------KEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             ----------HHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             ----------HHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence                      2466799999999999999995 6764

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-48  Score=372.12  Aligned_cols=260  Identities=28%  Similarity=0.309  Sum_probs=197.8

Q ss_pred             cceecccCcEEEEEEEEC-CccEEEEEEecCCCchH-----HHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEec
Q 013636          158 SNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDA-----EREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMM  231 (439)
Q Consensus       158 ~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  231 (439)
                      .++||+|+||+||+|+.. ++..+|||+++......     .+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            578999999999999975 47899999986433221     246889999999999999999999999999999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc-
Q 013636          232 QNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR-  310 (439)
Q Consensus       232 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~-  310 (439)
                      .++++..+..   ....+++..+..++.|++.||+|||++   +++||||||+|||+++++.+||+|||+|........ 
T Consensus        83 ~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~  156 (299)
T d1ua2a_          83 ETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA  156 (299)
T ss_dssp             SEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred             cchHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCccc
Confidence            9987776663   345688999999999999999999998   999999999999999999999999999977654332 


Q ss_pred             ceeeccccCccchhhhcCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhccccc-----CCCCCccCC
Q 013636          311 NVKISGTLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTD-----RSKLPNIVD  384 (439)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~d  384 (439)
                      .....||+.|+|||++... .++.++||||+||++|||++|+.||...+..+....+.........     .........
T Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~  236 (299)
T d1ua2a_         157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT  236 (299)
T ss_dssp             CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCC
T ss_pred             ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhh
Confidence            2345699999999998754 5799999999999999999999999887665433322211110000     000000000


Q ss_pred             chhcCccCH-----HHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          385 PVIRDTMDL-----KHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       385 ~~l~~~~~~-----~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      .........     .....+.+++.+||+.||++|||++|+++|
T Consensus       237 ~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H  280 (299)
T d1ua2a_         237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  280 (299)
T ss_dssp             CCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence            000000010     112457889999999999999999999985

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-49  Score=380.53  Aligned_cols=252  Identities=22%  Similarity=0.320  Sum_probs=198.4

Q ss_pred             cCCCccc-eecccCcEEEEEEEE-CCccEEEEEEecCCCchHHHHHHHHHHHHHhc-CCCceeeeeeEEEe----CCeeE
Q 013636          153 NNFQESN-VIGEGGRGHVYKARF-NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIH----AETRF  225 (439)
Q Consensus       153 ~~~~~~~-~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~~  225 (439)
                      ++|++.+ +||+|+||+||+|+. .++..+|||.++..     ..+.+|+.++.++ +||||+++++++.+    ....+
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~   85 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   85 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence            5787764 699999999999987 45789999998643     3567899887655 89999999999875    35689


Q ss_pred             EEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC---CCcEEEEecccc
Q 013636          226 LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDS---SFNAKLSDFGLS  302 (439)
Q Consensus       226 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~---~~~~kl~DfGls  302 (439)
                      +|||||++|+|.+++... ....+++..+..++.|++.||+|||+.   +|+||||||+|||+++   ++.+||+|||+|
T Consensus        86 ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a  161 (335)
T d2ozaa1          86 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA  161 (335)
T ss_dssp             EEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccccccee
Confidence            999999999999999742 234699999999999999999999998   9999999999999985   567999999999


Q ss_pred             cccCCCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCCCcc
Q 013636          303 VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNI  382 (439)
Q Consensus       303 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  382 (439)
                      +............||+.|+|||++.+..|+.++|||||||++|||+||+.||.+.+............  .......+  
T Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i--~~~~~~~~--  237 (335)
T d2ozaa1         162 KETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI--RMGQYEFP--  237 (335)
T ss_dssp             EECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CC--CSCSSSCC--
T ss_pred             eeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHH--hcCCCCCC--
Confidence            87766555556679999999999999999999999999999999999999997654332211111000  00000111  


Q ss_pred             CCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          383 VDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       383 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                       .+ ...    .....+.+++.+||+.||++|||+.|++++
T Consensus       238 -~~-~~~----~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         238 -NP-EWS----EVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             -TT-HHH----HSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             -Cc-ccc----cCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence             00 011    123457789999999999999999999975

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-48  Score=371.75  Aligned_cols=269  Identities=24%  Similarity=0.331  Sum_probs=203.0

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGH--DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYE  229 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  229 (439)
                      ++|++.+.||+|+||+||+|+.. ++..+|+|.++....  ...+++.+|++++++++||||+++++++.+++..++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            57899999999999999999984 578999999964332  234678999999999999999999999999999999999


Q ss_pred             eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCC
Q 013636          230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS  309 (439)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~  309 (439)
                      |+.++.+ +++.. .....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++++||+|||+|+......
T Consensus        82 ~~~~~~~-~~~~~-~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~  156 (298)
T d1gz8a_          82 FLHQDLK-KFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  156 (298)
T ss_dssp             CCSEEHH-HHHHH-TTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred             ecCCchh-hhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCc
Confidence            9976544 44432 2345699999999999999999999998   99999999999999999999999999997764432


Q ss_pred             -cceeeccccCccchhhhcCCC-CCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccc--------cC---
Q 013636          310 -RNVKISGTLGYVAPEYLLEGK-LTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLT--------DR---  376 (439)
Q Consensus       310 -~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~--------~~---  376 (439)
                       ......||+.|+|||.+.... ++.++||||+||++|||++|+.||...+..+....+........        ..   
T Consensus       157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  236 (298)
T d1gz8a_         157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY  236 (298)
T ss_dssp             BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccc
Confidence             223456999999999987765 57899999999999999999999987765443222111100000        00   


Q ss_pred             -CCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh--cccc
Q 013636          377 -SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS--LIPL  427 (439)
Q Consensus       377 -~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~l  427 (439)
                       ...+........... ......+.+++.+||+.||++|||+.|++++  ++++
T Consensus       237 ~~~~~~~~~~~~~~~~-~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~  289 (298)
T d1gz8a_         237 KPSFPKWARQDFSKVV-PPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV  289 (298)
T ss_dssp             CTTSCCCCCCCHHHHS-TTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             ccccccccccchhhhc-cCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence             000011111000000 0112467789999999999999999999987  5443

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=3.9e-48  Score=367.15  Aligned_cols=265  Identities=22%  Similarity=0.286  Sum_probs=203.3

Q ss_pred             cCCCccceecccCcEEEEEEEECCccEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEEe
Q 013636          153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGH--DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM  230 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  230 (439)
                      ++|+..+.||+|+||+||+|+..++..+|||.++....  ...+.+.+|+.+|++++||||+++++++...+..++++||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            57889999999999999999999999999999965432  2246799999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCCc
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR  310 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~~  310 (439)
                      +.++.+..+..   ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+|++|||.+........
T Consensus        82 ~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~  155 (286)
T d1ob3a_          82 LDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (286)
T ss_dssp             CSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             ehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence            98877777664   345699999999999999999999998   999999999999999999999999999977544322


Q ss_pred             -ceeeccccCccchhhhcCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccc--------cCCCCC
Q 013636          311 -NVKISGTLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLT--------DRSKLP  380 (439)
Q Consensus       311 -~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~--------~~~~~~  380 (439)
                       .....+++.|+|||.+.+. .++.++||||+||++|||++|+.||...++.+....+........        ......
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T d1ob3a_         156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD  235 (286)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcc
Confidence             2334589999999998764 568999999999999999999999987765443222211111000        000000


Q ss_pred             cc---CCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          381 NI---VDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       381 ~~---~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      ..   ..+.-...........+.+++.+||+.||++|||++|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H  281 (286)
T d1ob3a_         236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (286)
T ss_dssp             TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00   00000000001112457789999999999999999999975

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-48  Score=369.39  Aligned_cols=263  Identities=25%  Similarity=0.306  Sum_probs=201.4

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-C-ccEEEEEEecCCCc--hHHHHHHHHHHHHHhc---CCCceeeeeeEEEe----
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-E-KLLAAVKRIDDAGH--DAEREFNNEVNWLTKI---RHQNIISLLGYCIH----  220 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~----  220 (439)
                      .++|++.+.||+|+||+||+|+.. . +..||||+++....  .....+.+|+.+++.+   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            468999999999999999999874 3 56789999854321  1223456777776665   89999999999863    


Q ss_pred             -CCeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEec
Q 013636          221 -AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDF  299 (439)
Q Consensus       221 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~Df  299 (439)
                       ....+++|||+++|++.....  .....+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+||+||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecch
Confidence             236799999999887765554  3345689999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccc-----
Q 013636          300 GLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLT-----  374 (439)
Q Consensus       300 Gls~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~-----  374 (439)
                      |++.............||+.|+|||++.+..++.++||||+||++|||++|+.||...++.+....+........     
T Consensus       161 g~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  240 (305)
T d1blxa_         161 GLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP  240 (305)
T ss_dssp             CSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred             hhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccc
Confidence            999876655555567799999999999999999999999999999999999999998776543333221111000     


Q ss_pred             cCCCCCcc-----C---CchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          375 DRSKLPNI-----V---DPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       375 ~~~~~~~~-----~---d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      .....+..     .   .+......    ...+.+++.+||+.||++|||+.|+++|
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~----s~~~~dli~~mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         241 RDVALPRQAFHSKSAQPIEKFVTDI----DELGKDLLLKCLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             TTCSSCGGGSCCCCCCCGGGTCCSC----CHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ccccchhhhhccccccchhhccccC----CHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            00000000     0   00011111    2356679999999999999999999986

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-48  Score=364.68  Aligned_cols=241  Identities=22%  Similarity=0.357  Sum_probs=195.8

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCc------hHHHHHHHHHHHHHhcC--CCceeeeeeEEEeCC
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGH------DAEREFNNEVNWLTKIR--HQNIISLLGYCIHAE  222 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~  222 (439)
                      .++|++.+.||+|+||+||+|+.. ++..+|||.+.....      ....++.+|+.++++++  ||||+++++++.+.+
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            367999999999999999999875 578999999864221      11234678999999996  899999999999999


Q ss_pred             eeEEEEEeccC-CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC-CCcEEEEecc
Q 013636          223 TRFLVYEMMQN-GSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDS-SFNAKLSDFG  300 (439)
Q Consensus       223 ~~~lV~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~-~~~~kl~DfG  300 (439)
                      ..++||||+.+ +++.+++..   ...+++..+..++.|+++||+|||+.   +|+||||||+|||++. ++.+||+|||
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~---~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG  156 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG  156 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             eEEEEEEeccCcchHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccc
Confidence            99999999976 578787753   34699999999999999999999998   9999999999999985 5799999999


Q ss_pred             cccccCCCCcceeeccccCccchhhhcCCCC-CCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCC
Q 013636          301 LSVTAGTQSRNVKISGTLGYVAPEYLLEGKL-TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKL  379 (439)
Q Consensus       301 ls~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  379 (439)
                      +|...... ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||...+.     ...       ....+
T Consensus       157 ~a~~~~~~-~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----i~~-------~~~~~  223 (273)
T d1xwsa_         157 SGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----IIR-------GQVFF  223 (273)
T ss_dssp             TCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----HHH-------CCCCC
T ss_pred             cceecccc-cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-----Hhh-------cccCC
Confidence            99765443 2335679999999999987765 5678999999999999999999975321     111       11111


Q ss_pred             CccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          380 PNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       380 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      +..        .+    .++.+++.+||+.||++|||++|++++
T Consensus       224 ~~~--------~s----~~~~~li~~~L~~dp~~R~s~~eil~h  255 (273)
T d1xwsa_         224 RQR--------VS----SECQHLIRWCLALRPSDRPTFEEIQNH  255 (273)
T ss_dssp             SSC--------CC----HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CCC--------CC----HHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence            111        11    356779999999999999999999986

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-47  Score=367.72  Aligned_cols=267  Identities=24%  Similarity=0.291  Sum_probs=199.4

Q ss_pred             CCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC------eeEE
Q 013636          154 NFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE------TRFL  226 (439)
Q Consensus       154 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~l  226 (439)
                      .|+..++||+|+||+||+|+.. ++..||||++.....    .+.+|+++|++++||||+++++++....      ..++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            5777899999999999999985 588999999875432    2347999999999999999999986432      4689


Q ss_pred             EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC-cEEEEeccccccc
Q 013636          227 VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSF-NAKLSDFGLSVTA  305 (439)
Q Consensus       227 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~-~~kl~DfGls~~~  305 (439)
                      ||||+++|.+..+.+.......+++..+..++.|++.||+|||++   +|+||||||+|||++.++ .+||+|||++...
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhc
Confidence            999998765444443223445799999999999999999999998   999999999999999765 8999999999877


Q ss_pred             CCCCcceeeccccCccchhhhcC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhc--------cc---
Q 013636          306 GTQSRNVKISGTLGYVAPEYLLE-GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP--------QL---  373 (439)
Q Consensus       306 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~--------~~---  373 (439)
                      ..........||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...+..+....+.....        ..   
T Consensus       174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~  253 (350)
T d1q5ka_         174 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN  253 (350)
T ss_dssp             CTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC-
T ss_pred             cCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccc
Confidence            66555556679999999998875 5789999999999999999999999987765432222111000        00   


Q ss_pred             ccCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh--cccc
Q 013636          374 TDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS--LIPL  427 (439)
Q Consensus       374 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~l  427 (439)
                      ......+..................+.+++.+||+.||++|||+.|++++  ++++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  309 (350)
T d1q5ka_         254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  309 (350)
T ss_dssp             --CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             hhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence            00111111111111111111123357789999999999999999999975  4444

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-46  Score=356.64  Aligned_cols=264  Identities=20%  Similarity=0.287  Sum_probs=199.8

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCC--CchHHHHHHHHHHHHHhcCCCceeeeeeEEEeC--------
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDA--GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHA--------  221 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------  221 (439)
                      ++|++.+.||+|+||+||+|+.. ++..||||++...  .....+++.+|+.+|++++|||++++++++...        
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            68899999999999999999985 6889999998543  223346788999999999999999999988653        


Q ss_pred             CeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccc
Q 013636          222 ETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGL  301 (439)
Q Consensus       222 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGl  301 (439)
                      +..++||||+.++++..+..   ....++...+..++.|++.||.|||+.   +|+||||||+|||+++++.+||+|||+
T Consensus        90 ~~~~iv~e~~~~~~~~~~~~---~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~  163 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGL  163 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHTC---TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             ceEEEEEeccCCCccchhhh---cccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecce
Confidence            45799999999887766553   345688999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCC-----cceeeccccCccchhhhcCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhccccc
Q 013636          302 SVTAGTQS-----RNVKISGTLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTD  375 (439)
Q Consensus       302 s~~~~~~~-----~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~  375 (439)
                      +.......     ......||+.|+|||.+.+. .++.++||||+||++|||++|+.||.+.++......+.........
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  243 (318)
T d3blha1         164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  243 (318)
T ss_dssp             CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            97654322     12234699999999998865 6899999999999999999999999887765544443332221111


Q ss_pred             CCCCCccCCch--------hcCccCH-H------HHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          376 RSKLPNIVDPV--------IRDTMDL-K------HLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       376 ~~~~~~~~d~~--------l~~~~~~-~------~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      .. ........        ....... +      ....+.+++.+||+.||++|||++|+++|
T Consensus       244 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         244 EV-WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             TT-STTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hh-ccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence            10 00000000        0000001 0      12345679999999999999999999976

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-45  Score=355.22  Aligned_cols=263  Identities=21%  Similarity=0.271  Sum_probs=197.7

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC------
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE------  222 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  222 (439)
                      .++|++.+.||+|+||+||+|... ++..+|||+++...  ....+.+.+|+.+|++++|||||++++++...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            468999999999999999999975 58899999997532  234467899999999999999999999997654      


Q ss_pred             eeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccc
Q 013636          223 TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS  302 (439)
Q Consensus       223 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls  302 (439)
                      ..++||||+ +++|..+.+.    ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+|++|||+|
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a  168 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA  168 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecc-cccHHHHHHh----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccce
Confidence            469999999 5578777753    3599999999999999999999998   9999999999999999999999999999


Q ss_pred             cccCCCCcceeeccccCccchhhhcCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccc-------
Q 013636          303 VTAGTQSRNVKISGTLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLT-------  374 (439)
Q Consensus       303 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~-------  374 (439)
                      +......  ....||+.|+|||.+.+. .++.++||||+||++|||++|+.||.+.+................       
T Consensus       169 ~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (346)
T d1cm8a_         169 RQADSEM--TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL  246 (346)
T ss_dssp             EECCSSC--CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred             eccCCcc--ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhh
Confidence            8765433  345699999999998864 568999999999999999999999987764432222111100000       


Q ss_pred             ----------cCCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh--ccccC
Q 013636          375 ----------DRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS--LIPLV  428 (439)
Q Consensus       375 ----------~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~l~  428 (439)
                                ..........+.+....+    ..+.+++.+||+.||++|||+.|+++|  ++++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s----~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         247 QSDEAKNYMKGLPELEKKDFASILTNAS----PLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             SCHHHHHHHHHSCCCCCCCGGGTCTTCC----HHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             cchhhhhhhccCCcccccchHHhccCCC----HHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence                      000000000011111112    245679999999999999999999987  65554

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-45  Score=354.21  Aligned_cols=261  Identities=23%  Similarity=0.276  Sum_probs=196.6

Q ss_pred             hcCCCccceecccCcEEEEEEEE-CCccEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC----eeE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARF-NEKLLAAVKRIDDAG-HDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE----TRF  225 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~  225 (439)
                      +++|++.+.||+|+||+||+|+. .++..+|||++.... ....+.+.+|+.+|++++|||++++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            35788999999999999999987 468899999997543 334567899999999999999999999987653    235


Q ss_pred             EEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccccccc
Q 013636          226 LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA  305 (439)
Q Consensus       226 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~  305 (439)
                      ++++|+.+|+|.+++..    ..+++..+..++.|++.||+|||++   +|+||||||+|||+++++.+||+|||++...
T Consensus        87 ~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~  159 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVA  159 (345)
T ss_dssp             EEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence            55667779999999963    2589999999999999999999998   9999999999999999999999999999765


Q ss_pred             CCCCc----ceeeccccCccchhhhcC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhccccc-----
Q 013636          306 GTQSR----NVKISGTLGYVAPEYLLE-GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTD-----  375 (439)
Q Consensus       306 ~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~-----  375 (439)
                      .....    .....||+.|+|||.+.. ..++.++||||+||++|||++|+.||...+.................     
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (345)
T d1pmea_         160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC  239 (345)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred             cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence            43222    233458999999999854 56788999999999999999999999876654322221111000000     


Q ss_pred             ------------CCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          376 ------------RSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       376 ------------~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                                  ...........+....    ..++.+++.+||+.||++|||+.|++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         240 IINLKARNYLLSLPHKNKVPWNRLFPNA----DSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHCTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhcccccCCccCCCCHHHhCCCC----CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                        0000000000011111    1356789999999999999999999986

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-45  Score=345.94  Aligned_cols=270  Identities=21%  Similarity=0.269  Sum_probs=205.0

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCC--CchHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeeEEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDA--GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYE  229 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  229 (439)
                      ++|++.+.||+|+||+||+|+.. ++..||||+++..  ......++.+|+.+++.++||||+++++++.+.+..++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            57899999999999999999975 5788999998543  23445789999999999999999999999999999999999


Q ss_pred             eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEecccccccCCCC
Q 013636          230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS  309 (439)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~~~~~~  309 (439)
                      ++.+++|..++..   ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++++||+|||.+.......
T Consensus        82 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~  155 (292)
T d1unla_          82 FCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred             ecccccccccccc---ccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCC
Confidence            9999999888753   35688999999999999999999998   99999999999999999999999999998765433


Q ss_pred             cc-eeeccccCccchhhhcCCC-CCCchhhHHHHHHHHHHHhCCCCCCCC-ChhhhhhhHhhhhccccc-----------
Q 013636          310 RN-VKISGTLGYVAPEYLLEGK-LTDKSDVYAFGVVLLELLMGRRPVEKM-SPTQCQSMVTWAMPQLTD-----------  375 (439)
Q Consensus       310 ~~-~~~~gt~~y~aPE~~~~~~-~~~~~DvwS~Gvll~elltG~~P~~~~-~~~~~~~~~~~~~~~~~~-----------  375 (439)
                      .. ....+++.|+|||.+.... ++.++||||+||++|||++|+.||... +..+....+.........           
T Consensus       156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (292)
T d1unla_         156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD  235 (292)
T ss_dssp             SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred             ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccc
Confidence            22 2344778899999988765 689999999999999999999997543 322222221111110000           


Q ss_pred             CCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh--ccccC
Q 013636          376 RSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS--LIPLV  428 (439)
Q Consensus       376 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~l~  428 (439)
                      ....+......-...........+.+++.+||+.||++|||++|++++  ++++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~  290 (292)
T d1unla_         236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred             ccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence            000000000000000011112356789999999999999999999985  44443

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.6e-44  Score=348.88  Aligned_cols=255  Identities=17%  Similarity=0.242  Sum_probs=198.1

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCchHHHHHHHHHHHHHhcC-CCceeeeeeEEEeC--CeeEEEE
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR-HQNIISLLGYCIHA--ETRFLVY  228 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lV~  228 (439)
                      ++|++.+.||+|+||+||+|+.. ++..||+|+++..   ..+++.+|+.+|++++ ||||+++++++...  ...++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            57999999999999999999984 5889999998754   3457889999999995 99999999998754  4689999


Q ss_pred             EeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC-cEEEEecccccccCC
Q 013636          229 EMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSF-NAKLSDFGLSVTAGT  307 (439)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~-~~kl~DfGls~~~~~  307 (439)
                      ||+++|+|..+..      .+++..+..++.|++.||+|||++   +|+||||||+|||++.++ .+||+|||+|.....
T Consensus       112 e~~~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         112 EHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             ECCCSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred             eecCCCcHHHHhc------CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccC
Confidence            9999999987642      489999999999999999999998   999999999999998655 699999999987766


Q ss_pred             CCcceeeccccCccchhhhcCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCChhhh-hhhHh----------hhh-cccc
Q 013636          308 QSRNVKISGTLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQC-QSMVT----------WAM-PQLT  374 (439)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~-~~~~~----------~~~-~~~~  374 (439)
                      ........+|+.|+|||.+.+. .++.++||||+||++|||++|+.||........ ...+.          +.. ....
T Consensus       183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  262 (328)
T d3bqca1         183 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE  262 (328)
T ss_dssp             TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred             CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence            5555566799999999998875 479999999999999999999999976543211 00000          000 0000


Q ss_pred             cC------------CCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          375 DR------------SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       375 ~~------------~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                      ..            ...............    ..++.+++.+||+.||++|||++|+++|
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----s~~~~dli~~mL~~dP~~R~ta~e~L~H  319 (328)
T d3bqca1         263 LDPRFNDILGRHSRKRWERFVHSENQHLV----SPEALDFLDKLLRYDHQSRLTAREAMEH  319 (328)
T ss_dssp             CCGGGGGTCCCCCCCCGGGGCCTTTGGGC----CHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             cCcccchhcccccccchhhcccccccccC----CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00            000001111111112    2356789999999999999999999974

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.4e-44  Score=344.74  Aligned_cols=257  Identities=18%  Similarity=0.213  Sum_probs=194.0

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCceeee-eeEEEeCCeeEEEEEe
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISL-LGYCIHAETRFLVYEM  230 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l-~~~~~~~~~~~lV~e~  230 (439)
                      ++|++.+.||+|+||+||+|+.. ++..||||.+.....  ..++..|+++++.++|+|++.. .++....+..++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            57999999999999999999874 578999998765432  2357889999999987775555 5555777888999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc---CCCcEEEEecccccccCC
Q 013636          231 MQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLD---SSFNAKLSDFGLSVTAGT  307 (439)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~---~~~~~kl~DfGls~~~~~  307 (439)
                      +. |+|.+.+..  ....+++..+..++.|++.||+|||++   +|+||||||+|||++   .+..+||+|||+|+....
T Consensus        85 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~  158 (299)
T d1ckia_          85 LG-PSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  158 (299)
T ss_dssp             CC-CBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred             cC-Cchhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence            95 566666542  335699999999999999999999998   999999999999986   456799999999976543


Q ss_pred             CCc--------ceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhh-hhcccccCCC
Q 013636          308 QSR--------NVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTW-AMPQLTDRSK  378 (439)
Q Consensus       308 ~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~-~~~~~~~~~~  378 (439)
                      ...        .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.............. .......   
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~---  235 (299)
T d1ckia_         159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST---  235 (299)
T ss_dssp             TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS---
T ss_pred             cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC---
Confidence            221        1234699999999999999999999999999999999999999987654332222111 1000000   


Q ss_pred             CCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccC
Q 013636          379 LPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLV  428 (439)
Q Consensus       379 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~  428 (439)
                          ..+.+...+    ..++.+++..||+.||++||++.++.+.|+.+.
T Consensus       236 ----~~~~~~~~~----p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~  277 (299)
T d1ckia_         236 ----PIEVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF  277 (299)
T ss_dssp             ----CHHHHTTTS----CHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred             ----ChhHhccCC----CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence                001111111    245778999999999999999998887776553

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-44  Score=350.96  Aligned_cols=262  Identities=23%  Similarity=0.290  Sum_probs=192.0

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCceeeeeeEEEe------CCe
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLLGYCIH------AET  223 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~  223 (439)
                      ++|++.++||+|+||+||+|++. ++..+|||++....  .....++.+|+.++++++||||+++++++..      ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            67999999999999999999986 58999999997543  3344578999999999999999999999864      367


Q ss_pred             eEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccccc
Q 013636          224 RFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSV  303 (439)
Q Consensus       224 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~  303 (439)
                      .|+||||+.++.+ +.+.     ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+|++|||++.
T Consensus        97 ~~iv~Ey~~~~l~-~~~~-----~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~  167 (355)
T d2b1pa1          97 VYLVMELMDANLC-QVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_dssp             EEEEEECCSEEHH-HHHT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             eEEEEeccchHHH-Hhhh-----cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhh
Confidence            8999999976544 4443     2489999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhh--------------
Q 013636          304 TAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWA--------------  369 (439)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~--------------  369 (439)
                      ............+|+.|+|||++.+..++.++||||+||+++||++|+.||.+.+.......+...              
T Consensus       168 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  247 (355)
T d2b1pa1         168 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP  247 (355)
T ss_dssp             -------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred             ccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence            776655555667999999999999999999999999999999999999999876543322111100              


Q ss_pred             --hcccccCCCC-----CccCCchhcCcc---CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          370 --MPQLTDRSKL-----PNIVDPVIRDTM---DLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       370 --~~~~~~~~~~-----~~~~d~~l~~~~---~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                        ..........     +...........   .......+.+++.+||+.||++|||++|+++|
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence              0000000000     111111111111   12234567889999999999999999999976

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-45  Score=352.58  Aligned_cols=251  Identities=24%  Similarity=0.333  Sum_probs=200.1

Q ss_pred             cCCCccceecccCcEEEEEEEEC----CccEEEEEEecCCC----chHHHHHHHHHHHHHhcCC-CceeeeeeEEEeCCe
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN----EKLLAAVKRIDDAG----HDAEREFNNEVNWLTKIRH-QNIISLLGYCIHAET  223 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~  223 (439)
                      ++|++.+.||+|+||+||+|+..    .+..+|+|.++...    ....+.+.+|++++++++| |||+++++++.+.+.
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            56899999999999999999762    36889999986432    2234568899999999976 899999999999999


Q ss_pred             eEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccccc
Q 013636          224 RFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSV  303 (439)
Q Consensus       224 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~  303 (439)
                      .+++|||+.+|+|.+++..   ...++......++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++.
T Consensus       104 ~~~v~e~~~~~~L~~~i~~---~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eeeeeecccccHHHHHHHh---cccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchh
Confidence            9999999999999999964   23577889999999999999999998   99999999999999999999999999997


Q ss_pred             ccCCCCc--ceeeccccCccchhhhcCC--CCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccCCCC
Q 013636          304 TAGTQSR--NVKISGTLGYVAPEYLLEG--KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKL  379 (439)
Q Consensus       304 ~~~~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  379 (439)
                      .......  .....|++.|+|||.+.+.  .++.++||||+||+||||++|+.||...+..+....+....  .......
T Consensus       178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~--~~~~~~~  255 (322)
T d1vzoa_         178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI--LKSEPPY  255 (322)
T ss_dssp             ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH--HHCCCCC
T ss_pred             hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc--ccCCCCC
Confidence            6543222  2345699999999999764  46789999999999999999999998765443322222111  1111122


Q ss_pred             CccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHh
Q 013636          380 PNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRP-----LITDVLHS  423 (439)
Q Consensus       380 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  423 (439)
                      +...            ...+.+++.+||+.||++||     |++|+++|
T Consensus       256 ~~~~------------s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H  292 (322)
T d1vzoa_         256 PQEM------------SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  292 (322)
T ss_dssp             CTTS------------CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             cccC------------CHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence            2212            23567799999999999999     58899875

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.6e-44  Score=343.17  Aligned_cols=259  Identities=16%  Similarity=0.186  Sum_probs=202.3

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCchHHHHHHHHHHHHHhcCC-CceeeeeeEEEeCCeeEEEEE
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRH-QNIISLLGYCIHAETRFLVYE  229 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~e  229 (439)
                      .++|++.+.||+|+||+||+|+.. ++..+|+|.+....  ....+.+|++.++.++| +|++.+++++..+...++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            368999999999999999999975 57889999875432  22357788999999965 899999999999999999999


Q ss_pred             eccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC-----CCcEEEEecccccc
Q 013636          230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDS-----SFNAKLSDFGLSVT  304 (439)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~-----~~~~kl~DfGls~~  304 (439)
                      |+ +|+|.+++..  .+..+++..+..++.|++.||+|||+.   +|+||||||+|||++.     ++.+||+|||+|+.
T Consensus        82 ~~-~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~  155 (293)
T d1csna_          82 LL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  155 (293)
T ss_dssp             CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             ec-CCCHHHHHHh--hccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEE
Confidence            99 6899999864  335689999999999999999999998   9999999999999974     57899999999976


Q ss_pred             cCCCC--------cceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhcccccC
Q 013636          305 AGTQS--------RNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDR  376 (439)
Q Consensus       305 ~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~  376 (439)
                      .....        ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.+................ ...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~-~~~  234 (293)
T d1csna_         156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK-KQS  234 (293)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH-HHH
T ss_pred             cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhc-cCC
Confidence            53321        122356999999999999999999999999999999999999999865543222111110000 000


Q ss_pred             CCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHhccccC
Q 013636          377 SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLV  428 (439)
Q Consensus       377 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~l~  428 (439)
                      ...     +.+...+    ..++.+++..|++.+|++||+++.+.+.|+++.
T Consensus       235 ~~~-----~~l~~~~----p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~  277 (293)
T d1csna_         235 TPL-----RELCAGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL  277 (293)
T ss_dssp             SCH-----HHHTTTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             CCh-----HHhcCCC----CHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            000     0111111    235777889999999999999988887776654

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-43  Score=344.46  Aligned_cols=259  Identities=21%  Similarity=0.280  Sum_probs=197.3

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCceeeeeeEEEeC-----Ce
Q 013636          152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG--HDAEREFNNEVNWLTKIRHQNIISLLGYCIHA-----ET  223 (439)
Q Consensus       152 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  223 (439)
                      .++|++.+.||+|+||+||+|+.. ++..||||++....  ....+++.+|+.+|++++|||++++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            467999999999999999999874 68899999997543  23445788999999999999999999998643     34


Q ss_pred             eEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEEeccccc
Q 013636          224 RFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSV  303 (439)
Q Consensus       224 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~  303 (439)
                      .+++++|+.+|+|.+++..    ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+|++|||++.
T Consensus        97 ~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~  169 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR  169 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----
T ss_pred             eEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhc
Confidence            4677788899999999953    3599999999999999999999998   99999999999999999999999999997


Q ss_pred             ccCCCCcceeeccccCccchhhhcCC-CCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhhhHhhhhccccc-------
Q 013636          304 TAGTQSRNVKISGTLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTD-------  375 (439)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~-------  375 (439)
                      .....  .....||+.|+|||...+. .++.++||||+||++|||++|+.||.+.+.......+.........       
T Consensus       170 ~~~~~--~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~  247 (348)
T d2gfsa1         170 HTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS  247 (348)
T ss_dssp             CCTGG--GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCC
T ss_pred             ccCcc--cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhcc
Confidence            65432  2345689999999987775 4688999999999999999999999877654433222211110000       


Q ss_pred             ----------CCCCCccCCchhcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHh
Q 013636          376 ----------RSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHS  423 (439)
Q Consensus       376 ----------~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  423 (439)
                                ....+..--.......    ...+.+++.+||+.||++|||++|+++|
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~----s~~~~dli~~mL~~dP~~R~ta~elL~H  301 (348)
T d2gfsa1         248 SESARNYIQSLTQMPKMNFANVFIGA----NPLAVDLLEKMLVLDSDKRITAAQALAH  301 (348)
T ss_dssp             CHHHHHHHTTSCCCCCCCHHHHSTTC----CHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             chhhhhhhhhcccCCCcchhhhcCCC----CHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence                      0000000000001111    2346789999999999999999999985

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.5e-39  Score=317.91  Aligned_cols=270  Identities=16%  Similarity=0.199  Sum_probs=193.7

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CccEEEEEEecCCCchHHHHHHHHHHHHHhcC-----------CCceeeeeeEEEe
Q 013636          153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR-----------HQNIISLLGYCIH  220 (439)
Q Consensus       153 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~  220 (439)
                      .+|++.+.||+|+||+||+|+.. ++..||||+++... ...+.+.+|+.+++.++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            35889999999999999999984 68899999997643 23456788999888875           5789999988764


Q ss_pred             C--CeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCc-----
Q 013636          221 A--ETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFN-----  293 (439)
Q Consensus       221 ~--~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~-----  293 (439)
                      .  ...+++++++..+..............+++..+..++.|++.||+|||+.  .+|+||||||+|||++.++.     
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~~~~  169 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLI  169 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTEE
T ss_pred             ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeeccCcccccc
Confidence            3  46677777776655443333324456789999999999999999999983  28999999999999986653     


Q ss_pred             -EEEEecccccccCCCCcceeeccccCccchhhhcCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChhhhhh------hH
Q 013636          294 -AKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQS------MV  366 (439)
Q Consensus       294 -~kl~DfGls~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvll~elltG~~P~~~~~~~~~~~------~~  366 (439)
                       ++++|||.+.......  ....||+.|+|||.+....++.++||||+||+++||++|+.||...+......      ..
T Consensus       170 ~~kl~dfg~s~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~  247 (362)
T d1q8ya_         170 QIKIADLGNACWYDEHY--TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI  247 (362)
T ss_dssp             EEEECCCTTCEETTBCC--CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHH
T ss_pred             eeeEeeccccccccccc--ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHH
Confidence             9999999997654332  34569999999999999999999999999999999999999997543211100      00


Q ss_pred             hhhhcc--------------cccCC----CCCccCCc----h--hcCccCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 013636          367 TWAMPQ--------------LTDRS----KLPNIVDP----V--IRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLH  422 (439)
Q Consensus       367 ~~~~~~--------------~~~~~----~~~~~~d~----~--l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  422 (439)
                      .+....              .....    .+......    .  ............+.+++.+||+.||++|||++|+++
T Consensus       248 ~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~  327 (362)
T d1q8ya_         248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN  327 (362)
T ss_dssp             HHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred             HHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            000000              00000    00000000    0  012233456678899999999999999999999998


Q ss_pred             h--cccc
Q 013636          423 S--LIPL  427 (439)
Q Consensus       423 ~--L~~l  427 (439)
                      |  +.+.
T Consensus       328 Hp~f~~~  334 (362)
T d1q8ya_         328 HPWLKDT  334 (362)
T ss_dssp             CGGGTTC
T ss_pred             CcccCCC
Confidence            6  5433

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.90  E-value=1.7e-24  Score=191.18  Aligned_cols=162  Identities=17%  Similarity=0.182  Sum_probs=119.9

Q ss_pred             CccceecccCcEEEEEEEECCccEEEEEEecCCCc------------------hHHHHHHHHHHHHHhcCCCceeeeeeE
Q 013636          156 QESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGH------------------DAEREFNNEVNWLTKIRHQNIISLLGY  217 (439)
Q Consensus       156 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~l~~~  217 (439)
                      .+.+.||+|+||+||+|+..++..+|||.++....                  .....+..|...+.++.|++++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            35689999999999999998899999998653110                  011235578889999999999988765


Q ss_pred             EEeCCeeEEEEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCcEEEE
Q 013636          218 CIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLS  297 (439)
Q Consensus       218 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NiLl~~~~~~kl~  297 (439)
                      .    ..+++|||++++.+.+          ++......++.|++++++|||+.   +++||||||+|||++++ .++|+
T Consensus        83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~li  144 (191)
T d1zara2          83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWII  144 (191)
T ss_dssp             E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEEC
T ss_pred             c----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEE
Confidence            3    3479999998865543          22334567899999999999998   99999999999999965 58999


Q ss_pred             ecccccccCCCCcceeeccccCccch------hhhcCCCCCCchhhHHHHHH
Q 013636          298 DFGLSVTAGTQSRNVKISGTLGYVAP------EYLLEGKLTDKSDVYAFGVV  343 (439)
Q Consensus       298 DfGls~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~~~DvwS~Gvl  343 (439)
                      |||+|.........       .|...      |. ..+.|+.++|+||..--
T Consensus       145 DFG~a~~~~~~~~~-------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~  188 (191)
T d1zara2         145 DFPQSVEVGEEGWR-------EILERDVRNIITY-FSRTYRTEKDINSAIDR  188 (191)
T ss_dssp             CCTTCEETTSTTHH-------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHH
T ss_pred             ECCCcccCCCCCcH-------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHH
Confidence            99999765432221       11111      11 13567889999997543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.65  E-value=6.3e-08  Score=87.41  Aligned_cols=148  Identities=16%  Similarity=0.101  Sum_probs=99.6

Q ss_pred             HHHHhcCCCccceecccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcC-CCceeeeeeEEEeCCeeEE
Q 013636          148 LEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR-HQNIISLLGYCIHAETRFL  226 (439)
Q Consensus       148 l~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l  226 (439)
                      ++..-++|+..+..+.++.+.||+...+++ .+++|+...........+.+|...+..+. +--+.++++++...+..++
T Consensus         9 l~~~~~~~~~~~~~~G~s~~~v~rv~~~~~-~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~l   87 (263)
T d1j7la_           9 LKKLIEKYRCVKDTEGMSPAKVYKLVGENE-NLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             HHHHHTTSEEEECSCCCSSSEEEEEECSSC-EEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             HHHhhhceEEEEcCCCCCCCcEEEEEeCCC-eEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEE
Confidence            334445666555544455578999875554 45677765443333345677888887774 4345667788888889999


Q ss_pred             EEEeccCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC----------------------------------
Q 013636          227 VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC----------------------------------  272 (439)
Q Consensus       227 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~----------------------------------  272 (439)
                      ||+++++.++.+.....     .   ....++.++++.++.||+..                                  
T Consensus        88 v~~~l~G~~~~~~~~~~-----~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (263)
T d1j7la_          88 LMSEADGVLCSEEYEDE-----Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE  159 (263)
T ss_dssp             EEECCSSEEHHHHTTTC-----S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred             EEEeccccccccccccc-----c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence            99999998886654211     1   12335566667777777421                                  


Q ss_pred             ----------------------CCCeEecCCCCCCEEEcCCCcEEEEecccccc
Q 013636          273 ----------------------NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT  304 (439)
Q Consensus       273 ----------------------~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~  304 (439)
                                            ...++|+|+.|.||++++++..-|.||+.+..
T Consensus       160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                  11379999999999999877778999997753

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.06  E-value=1.6e-05  Score=70.66  Aligned_cols=131  Identities=17%  Similarity=0.126  Sum_probs=87.0

Q ss_pred             eecccC-cEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcCC--CceeeeeeEEEeCCeeEEEEEeccCCCh
Q 013636          160 VIGEGG-RGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRH--QNIISLLGYCIHAETRFLVYEMMQNGSL  236 (439)
Q Consensus       160 ~LG~G~-fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lV~e~~~~gsL  236 (439)
                      .+..|. -+.||+...+++..+++|.......   ..+..|...++.+..  -.+.++++++.+.+..++||+++++-++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            344554 3689999998888888887654432   245677777777643  3356677888888889999999988665


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc---------------------------------------------
Q 013636          237 EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH---------------------------------------------  271 (439)
Q Consensus       237 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~---------------------------------------------  271 (439)
                      .+..        ...   ...+.++++.|+-||+.                                             
T Consensus        94 ~~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (255)
T d1nd4a_          94 LSSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF  162 (255)
T ss_dssp             TTSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred             cccc--------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence            3311        111   11223444444444421                                             


Q ss_pred             ----------CCCCeEecCCCCCCEEEcCCCcEEEEecccccc
Q 013636          272 ----------CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT  304 (439)
Q Consensus       272 ----------~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~~  304 (439)
                                ....++|+|+.|.||+++++..+-|+||+.+..
T Consensus       163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence                      012389999999999999877778999997744

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.53  E-value=0.00012  Score=69.61  Aligned_cols=76  Identities=16%  Similarity=0.094  Sum_probs=46.2

Q ss_pred             cceecccCcEEEEEEEECC-ccEEEEEEecCC------Cc-hHHHHHHHHHHHHHhcC-C-Cc-eeeeeeEEEeCCeeEE
Q 013636          158 SNVIGEGGRGHVYKARFNE-KLLAAVKRIDDA------GH-DAEREFNNEVNWLTKIR-H-QN-IISLLGYCIHAETRFL  226 (439)
Q Consensus       158 ~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~------~~-~~~~~~~~E~~~l~~l~-h-~n-iv~l~~~~~~~~~~~l  226 (439)
                      .+.||.|....||+....+ +..+++|.-...      +. ....+...|.+.|+.+. + |. +.+++.  .+.+..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE--EcCCCCEE
Confidence            3568999999999998765 567778854321      11 11223456777777662 2 33 444443  35567789


Q ss_pred             EEEeccCCC
Q 013636          227 VYEMMQNGS  235 (439)
Q Consensus       227 V~e~~~~gs  235 (439)
                      |||++++..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999997654

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.01  E-value=0.0019  Score=59.17  Aligned_cols=136  Identities=13%  Similarity=0.151  Sum_probs=78.3

Q ss_pred             cEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcCCCce--eeee-----eEEEeCCeeEEEEEeccCCChhh
Q 013636          166 RGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNI--ISLL-----GYCIHAETRFLVYEMMQNGSLEK  238 (439)
Q Consensus       166 fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~-----~~~~~~~~~~lV~e~~~~gsL~~  238 (439)
                      --.||+++.+++..+++|...... ...+++..|...+..|...++  +..+     ......+..+.++++++|..+..
T Consensus        35 EN~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~  113 (325)
T d1zyla1          35 ENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA  113 (325)
T ss_dssp             SSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred             cceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence            368999999999989999876543 345667888888887742221  1111     12344567788999987643311


Q ss_pred             --------------hhc----CC--CCCCCCCHHH-------------------HHHHHHHHHHHHHHHhh----cCCCC
Q 013636          239 --------------QLH----GP--THGSNLTWHL-------------------RMKIAVDVARGLEYLHE----HCNHP  275 (439)
Q Consensus       239 --------------~l~----~~--~~~~~l~~~~-------------------~~~i~~~ia~gl~~LH~----~~~~~  275 (439)
                                    .+|    ..  .....+++..                   ...+...+.+.++.+..    ....+
T Consensus       114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~  193 (325)
T d1zyla1         114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL  193 (325)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred             CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence                          011    10  1111122211                   11122222233333322    22346


Q ss_pred             eEecCCCCCCEEEcCCCcEEEEecccccc
Q 013636          276 VVHRDLKSSNILLDSSFNAKLSDFGLSVT  304 (439)
Q Consensus       276 ivH~Dlk~~NiLl~~~~~~kl~DfGls~~  304 (439)
                      ++|+|+.+.|||++++  ..++||+-+..
T Consensus       194 liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         194 RLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             eecCCCCcccEEEeCC--ceEEechhccc
Confidence            8999999999999754  45899998764

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.40  E-value=0.055  Score=48.47  Aligned_cols=157  Identities=11%  Similarity=0.044  Sum_probs=79.7

Q ss_pred             cHHHHHHHhcCCCcccee-----cccCcEEEEEEEECCccEEEEEEecCCCchHHHHHHHHHHHHHhcC-----CCceee
Q 013636          144 EYELLEAATNNFQESNVI-----GEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR-----HQNIIS  213 (439)
Q Consensus       144 ~~~~l~~~~~~~~~~~~L-----G~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~  213 (439)
                      +.++++....+|...++.     ..|---+.|+.+.+++. +++|......  ...++..|++++..+.     .|..+.
T Consensus         4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~   80 (316)
T d2ppqa1           4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP   80 (316)
T ss_dssp             CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred             CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccce
Confidence            445566666777664443     45656888999888765 6778775431  2234445666666663     222222


Q ss_pred             eee---EEEeCCeeEEEEEeccCCChhh--------------hhc----CCCC--CCCCCHH------------------
Q 013636          214 LLG---YCIHAETRFLVYEMMQNGSLEK--------------QLH----GPTH--GSNLTWH------------------  252 (439)
Q Consensus       214 l~~---~~~~~~~~~lV~e~~~~gsL~~--------------~l~----~~~~--~~~l~~~------------------  252 (439)
                      ..+   ..........++.+..+.....              .++    ....  .......                  
T Consensus        81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (316)
T d2ppqa1          81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK  160 (316)
T ss_dssp             BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred             ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence            110   1223445667777766543321              001    0000  0000000                  


Q ss_pred             HHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCCEEEcCCCcEEEEeccccc
Q 013636          253 LRMKIAVDVARGLEYLHE-HCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSV  303 (439)
Q Consensus       253 ~~~~i~~~ia~gl~~LH~-~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGls~  303 (439)
                      .....+......+.-.+. ....+++|+|+.++||+++++...-+.||+.+.
T Consensus       161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            011111112222222221 123479999999999999998878999999874

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.28  E-value=0.0051  Score=57.77  Aligned_cols=73  Identities=15%  Similarity=0.127  Sum_probs=47.2

Q ss_pred             cceecccCcEEEEEEEECCc--------cEEEEEEecCCCchHHHHHHHHHHHHHhcCCCcee-eeeeEEEeCCeeEEEE
Q 013636          158 SNVIGEGGRGHVYKARFNEK--------LLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNII-SLLGYCIHAETRFLVY  228 (439)
Q Consensus       158 ~~~LG~G~fg~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lV~  228 (439)
                      .+.|+.|-.-.+|+....++        ..+.++.... . .......+|..+++.+.-.++. ++++++.    -.+|+
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-P-ETESHLVAESVIFTLLSERHLGPKLYGIFS----GGRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-C-CCHHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-c-chhhHHHHHHHHHHHHHhCCCCCeEEEEcC----CceEE
Confidence            35788899999999987542        3344444442 2 2233456788888888544554 5566553    26899


Q ss_pred             EeccCCCh
Q 013636          229 EMMQNGSL  236 (439)
Q Consensus       229 e~~~~gsL  236 (439)
                      ||+++-++
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEeccccC
Confidence            99987544